Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" IGHV1OR15-9 "IGHV1/OR15-9, IGHV1OR159, VSIG7" ENSG00000188403 "Immunoglobulin heavy variable 1/OR15-9 (non-functional)" 15 19964666-19965101 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "breast: 4.1;intestine: 8.6;lymphoid tissue: 8.6;stomach 1: 8.3" "Not detected" "Not detected" "Cancer enhanced" "Detected in many" "lung cancer: 5.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 14: B-cells - Humoral immune response" "prognostic favorable (1.79e-4)" "unprognostic (8.93e-2)" "unprognostic (2.97e-3)" "unprognostic (9.34e-2)" "prognostic favorable (6.84e-4)" "unprognostic (1.64e-1)" "unprognostic (1.57e-1)" "unprognostic (3.79e-1)" "unprognostic (1.07e-4)" "unprognostic (3.68e-2)" "unprognostic (1.91e-1)" "unprognostic (2.66e-1)" "unprognostic (2.11e-1)" 0.0 0.0 0.0 8.6 0.0 0.0 4.1 0.0 0.0 0.0 0.0 8.6 3.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 8.3 0.0 0.0 1.1 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV3OR15-7 IGHV3/OR15-7 ENSG00000259490 "Immunoglobulin heavy variable 3/OR15-7 (pseudogene)" 15 19987656-19988117 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 2.0;stomach 1: 1.8" "Cell type enriched" "Detected in single" 104 "Plasma cells: 10.4" "Cancer enhanced" "Detected in many" "lung cancer: 3.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 56: Intestine - Transmembrane transport" "Cluster 24: Non-specific - Transcription regulation" "unprognostic (1.08e-2)" "unprognostic (8.21e-2)" "unprognostic (1.08e-2)" "unprognostic (1.07e-1)" "prognostic favorable (1.43e-5)" "unprognostic (4.56e-1)" "unprognostic (3.12e-1)" "unprognostic (2.42e-1)" "unprognostic (3.07e-4)" "unprognostic (7.46e-2)" "unprognostic (1.35e-1)" "unprognostic (3.50e-1)" "unprognostic (1.24e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD5OR15-5A "IGHD5/OR15-5A, IGHD5OR155A" ENSG00000270961 "Immunoglobulin heavy diversity 5/OR15-5A (non-functional)" 15 20003840-20003862 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD4OR15-4A "IGHD4/OR15-4A, IGHD4OR154A" ENSG00000271317 "Immunoglobulin heavy diversity 4/OR15-4A (non-functional)" 15 20004797-20004815 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD3OR15-3A "IGHD3/OR15-3A, IGHD3OR153A" ENSG00000282520 "Immunoglobulin heavy diversity 3/OR15-3A (non-functional)" 15 20005905-20005935 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 31 "brain: 3.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.3;RPMI-8226: 3.8" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 25: RPMI-8226 - Immune response" 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 2.2 0.6 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.5 0.8 0.3 0.7 2.2 0.6 3.0 0.8 1.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD2OR15-2A "IGHD2/OR15-2A, IGHD2OR152A" ENSG00000282599 "Immunoglobulin heavy diversity 2/OR15-2A (non-functional)" 15 20008402-20008432 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 31 "brain: 3.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 73: Brain - Neuropeptide signaling" 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.3 0.7 0.3 0.8 1.4 0.4 3.0 1.2 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD1OR15-1A "IGHD1/OR15-1A, IGHD1OR151A" ENSG00000271336 "Immunoglobulin heavy diversity 1/OR15-1A (non-functional)" 15 20011153-20011169 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA6L6 FLJ36131 ENSG00000277322 "Golgin A6 family like 6" A8MZA4 15 20531856-20541800 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 52 "testis: 5.2" "Cell type enriched" "Detected in some" 7 "Early spermatids: 27.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047733 Uncertain NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA047733: " "unprognostic (1.10e-1)" "unprognostic (1.67e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 27.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 POTEB2 ENSG00000230031 "POTE ankyrin domain family member B2" H3BUK9 15 20835372-20866314 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 14 "testis: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 74: Testis - Spermatogenesis" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD5OR15-5B "IGHD5/OR15-5B, IGHD5OR155B" ENSG00000270824 "Immunoglobulin heavy diversity 5/OR15-5B (non-functional)" 15 21010494-21010516 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD4OR15-4B "IGHD4/OR15-4B, IGHD4OR154B" ENSG00000270451 "Immunoglobulin heavy diversity 4/OR15-4B (non-functional)" 15 21011451-21011469 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD3OR15-3B "IGHD3/OR15-3B, IGHD3OR153B" ENSG00000282089 "Immunoglobulin heavy diversity 3/OR15-3B (non-functional)" 15 21012559-21012589 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 31 "brain: 3.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.3;RPMI-8226: 3.8" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 25: RPMI-8226 - Immune response" 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 2.2 0.6 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.5 0.8 0.3 0.7 2.2 0.6 3.0 0.8 1.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD2OR15-2B "IGHD2/OR15-2B, IGHD2OR152B" ENSG00000282268 "Immunoglobulin heavy diversity 2/OR15-2B (non-functional)" 15 21015048-21015078 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 31 "brain: 3.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 73: Brain - Neuropeptide signaling" 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 1.4 0.4 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.3 0.7 0.3 0.8 1.4 0.4 3.0 1.2 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHD1OR15-1B "IGHD1/OR15-1B, IGHD1OR151B" ENSG00000270185 "Immunoglobulin heavy diversity 1/OR15-1B (non-functional)" 15 21017800-21017816 "Immunoglobulin genes, Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 POTEB3 ENSG00000278522 "POTE ankyrin domain family member B3" A0JP26 15 21405401-21440499 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 9 "testis: 5.7" "Cell type enriched" "Detected in single" 5 "Spermatocytes: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 1.5;RPMI-8226: 1.9" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 25: RPMI-8226 - Immune response" "Cluster 66: Spermatocytes - Spermatogenesis" 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.7 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.6 0.2 0.3 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.4 0.0 0.1 0.0 0.2 0.4 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.5 0.8 0.0 0.1 0.0 0.9 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.5 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LINC02203 ENSG00000280709 "Long intergenic non-protein coding RNA 2203" 15 21552795-21653276 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 47 "testis: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 19 "U-2 OS: 5.2" HPA057442 Uncertain Approved Centrosome NA NA "Cluster 9: U-2 OS - Unknown function" Centrosome "HPA057442: AB_2683442" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4M2B ENSG00000182974 "Olfactory receptor family 4 subfamily M member 2B" 15 21637909-21638992 "Predicted membrane proteins" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058889 Uncertain NA NA "HPA058889: AB_2683845" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4N4C ENSG00000279408 "Olfactory receptor family 4 subfamily N member 4C" 15 21651844-21652968 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 9 "testis: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA057442 Uncertain Uncertain Centrosome NA NA "Cluster 78: Testis - Spermatogenesis" Centrosome "HPA057442: AB_2683442" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC135068.5 ENSG00000281179 "Novel gene identicle to IGHV1OR15-1" 15 21717808-21718245 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 78.8" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "lung cancer: 0.7" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "memory B-cell: 94.3;naive B-cell: 111.6" "Group enriched" "Detected in many" 18 "B-cells: 111.6;T-cells: 60.9" "Group enriched" "Detected in some" 4 "JURKAT: 10.3;Karpas-707: 6.9;MOLT-4: 2.5" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "unprognostic (3.64e-1)" "unprognostic (8.63e-2)" 0.6 0.4 0.0 18.2 0.1 7.0 5.8 0.1 0.1 0.8 0.0 15.6 13.8 0.8 0.0 4.0 0.6 14.4 0.6 0.0 0.1 0.4 0.7 2.8 52.0 0.2 0.1 1.0 0.4 0.1 0.1 0.1 0.1 2.3 10.2 0.0 4.9 0.4 0.0 0.1 13.7 0.4 0.2 17.6 11.1 0.1 0.1 58.7 1.0 0.0 78.8 9.4 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 6.9 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 9.2 0.0 3.3 94.3 54.9 18.1 0.1 111.6 60.9 14.5 0.5 4.8 0.1 3.3 35.9 20.5 0.0 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC135068.1 ENSG00000278263 "Novel protein, identical to IGHV4-4" 15 21742364-21742799 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 52.2;lymphoid tissue: 57.9;urinary bladder: 97.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 30 "memory B-cell: 24.0;naive B-cell: 7.7" "Lineage enriched" "Detected in single" 45 "B-cells: 24.0" "Not detected" "Not detected" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 14: B-cells - Humoral immune response" "unprognostic (1.48e-2)" "unprognostic (2.01e-1)" "unprognostic (1.93e-1)" "prognostic favorable (2.52e-4)" "unprognostic (1.05e-1)" "unprognostic (9.75e-3)" "unprognostic (1.80e-2)" "unprognostic (5.51e-6)" "unprognostic (5.57e-2)" "unprognostic (3.76e-1)" "unprognostic (1.49e-1)" "unprognostic (3.22e-1)" 1.0 0.0 0.2 27.3 0.1 4.2 5.4 0.0 0.0 3.7 0.0 52.2 22.6 0.2 0.0 3.7 0.5 0.5 2.1 0.1 0.0 0.2 1.0 5.5 5.5 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.1 0.4 22.1 0.0 30.1 2.1 0.0 1.1 6.0 0.0 0.0 9.4 22.3 0.1 0.0 7.8 0.7 0.0 57.9 97.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.2 0.0 0.0 7.7 0.3 0.0 0.0 0.0 0.0 0.0 0.5 1.9 0.2 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 POTEB "A26B1, CT104.5, POTE-15, POTE15" ENSG00000233917 "POTE ankyrin domain family member B" A0A0A6YYL3 15 21846329-21877735 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 74: Testis - Spermatogenesis" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC134980.2 ENSG00000285472 "Novel protein" 15 22015233-22095857 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 48 "testis: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA057442 Uncertain Approved Centrosome NA NA Centrosome "HPA057442: AB_2683442" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4M2 ENSG00000274102 "Olfactory receptor family 4 subfamily M member 2" Q8NGB6 15 22070241-22083221 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 6 "Sertoli cells: 6.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA058889 Uncertain NA NA "Cluster 48: Smooth muscle cells - ECM organization" "HPA058889: AB_2683845" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4N4 ENSG00000183706 "Olfactory receptor family 4 subfamily N member 4" Q8N0Y3 15 22094522-22095472 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 81 "testis: 8.0" "Group enriched" "Detected in some" 113 "Early spermatids: 29.9;Late spermatids: 15.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA057442 Uncertain Uncertain Centrosome NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 34: Spermatids - Unknown function" Centrosome "HPA057442: AB_2683442" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IGHV1OR15-1 IGHV1/OR15-1 ENSG00000270505 "Immunoglobulin heavy variable 1/OR15-1 (non-functional)" 15 22160431-22160868 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 78.8" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 3.0;B-cells: 1.1;granulocytes: 1.3;T-cells: 6.2" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "memory B-cell: 94.3;naive B-cell: 111.6" "Group enriched" "Detected in many" 18 "B-cells: 111.6;T-cells: 60.9" "Group enriched" "Detected in some" 4 "JURKAT: 10.3;Karpas-707: 6.9;MOLT-4: 2.5" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 3: T-cells - Adaptive immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 11: Alveolar cells - Smell perception" "unprognostic (2.14e-1)" "unprognostic (1.13e-1)" 0.6 0.4 0.0 18.2 0.1 7.0 5.8 0.1 0.1 0.8 0.0 15.6 13.8 0.8 0.0 4.0 0.6 14.4 0.6 0.0 0.1 0.4 0.7 2.8 52.0 0.2 0.1 1.0 0.4 0.1 0.1 0.1 0.1 2.3 10.2 0.0 4.8 0.4 0.0 0.1 13.7 0.4 0.2 18.1 11.1 0.1 0.1 58.7 1.1 0.0 78.8 9.4 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 6.9 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 9.2 0.0 3.3 94.3 54.9 18.1 0.1 111.6 60.9 14.5 0.5 4.8 0.1 3.3 35.9 20.5 0.0 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.2 0.1 0.2 0.0 0.0 3.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.2 0.0 IGHV4OR15-8 "IGHV4/OR15-8, IGHV4OR158, VSIG6" ENSG00000259261 "Immunoglobulin heavy variable 4/OR15-8 (non-functional)" 15 22184967-22185402 "Immunoglobulin genes, Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 1.9;lymphoid tissue: 1.4;urinary bladder: 2.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "stomach cancer: 0.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 14: B-cells - Humoral immune response" "unprognostic (1.68e-3)" "unprognostic (9.63e-2)" "unprognostic (1.17e-1)" 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.9 0.0 0.0 0.8 0.7 0.0 0.0 0.0 0.0 0.0 1.4 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA6L22 ENSG00000277865 "Golgin A6 family like 22" H0YM25 15 22458903-22469230 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 48 "testis: 9.2" "Cell type enriched" "Detected in some" 5 "Early spermatids: 58.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047733 Uncertain NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 29: Early spermatids - Spermatogenesis" "HPA047733: " "unprognostic (2.71e-2)" "unprognostic (1.08e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NIPA1 "MGC35570, SLC57A1, SPG6" ENSG00000170113 "NIPA magnesium transporter 1" Q7RTP0 15 22773063-22829789 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Disease variant, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.2" "Cell type enhanced" "Detected in many" "Excitatory neurons: 36.2;Inhibitory neurons: 33.8;Oligodendrocytes: 65.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 3.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023269 Uncertain NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 44: HDLM-2 - Immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "HPA023269: AB_1854485" "unprognostic (1.64e-2)" "unprognostic (7.60e-2)" "unprognostic (2.61e-2)" "unprognostic (2.13e-1)" "unprognostic (2.83e-1)" "unprognostic (1.79e-1)" "unprognostic (3.31e-2)" "unprognostic (2.13e-2)" "unprognostic (2.77e-1)" "unprognostic (2.42e-2)" "unprognostic (6.25e-2)" "unprognostic (6.32e-2)" "unprognostic (6.95e-2)" "unprognostic (8.80e-2)" "unprognostic (1.62e-1)" "unprognostic (8.42e-3)" "unprognostic (8.66e-2)" 3.1 4.2 27.7 3.7 36.9 1.2 2.8 36.8 38.1 3.7 17.9 4.6 6.5 2.2 2.1 4.3 2.5 4.8 3.5 22.8 28.7 6.2 5.7 4.7 5.3 35.4 36.9 1.5 5.7 8.7 3.6 3.5 33.8 6.7 4.3 6.2 3.6 3.4 2.5 4.9 6.6 2.6 36.1 4.2 6.4 4.3 36.0 8.2 7.3 3.5 5.5 3.2 3.5 40.2 14.9 17.4 5.4 12.4 6.9 5.6 3.8 17.6 12.7 8.5 7.1 13.3 7.4 6.9 13.5 7.3 17.4 9.7 16.0 4.6 10.1 40.2 9.8 10.8 10.8 11.4 8.3 0.1 20.8 1.7 15.2 5.5 9.2 13.6 8.2 15.2 8.4 11.3 4.8 5.6 5.9 9.7 5.9 15.9 18.2 12.1 7.7 5.4 13.0 14.9 15.2 15.4 13.2 1.6 16.7 7.0 10.3 13.8 15.4 23.9 12.2 10.1 27.2 12.7 13.6 12.4 12.3 0.0 15.6 0.4 0.1 0.2 0.6 0.0 0.6 0.9 0.7 0.6 0.5 1.1 0.4 0.3 0.3 0.3 0.0 3.9 0.8 0.3 27.7 36.9 36.8 38.1 22.8 28.7 35.4 36.9 33.8 36.1 36.0 40.2 5.9 12.8 5.9 14.4 7.4 8.8 4.0 5.9 2.2 4.1 4.4 3.0 4.3 15.7 5.2 5.5 6.2 2.6 10.5 9.9 3.9 5.7 3.3 3.6 2.4 5.9 3.0 4.0 36.2 11.6 2.1 4.5 10.2 5.7 0.0 4.1 4.6 6.0 4.1 5.0 33.8 7.1 2.0 4.4 6.9 4.2 2.1 2.9 5.4 4.7 3.8 4.7 4.1 15.6 65.2 17.7 6.8 3.0 7.2 8.6 11.8 5.8 6.2 6.6 19.7 3.0 3.6 3.4 8.5 4.2 14.9 1.5 7.1 1.6 7.5 7.3 NIPA2 SLC57A2 ENSG00000140157 "NIPA magnesium transporter 2" Q8N8Q9 15 22838644-22869362 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067160, HPA071342" Approved Approved "Golgi apparatus" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 14: B-cells - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 57: B-cells - Immune response" "Golgi apparatus" "HPA067160: AB_2685794, HPA071342: AB_2686391" "unprognostic (2.88e-3)" "unprognostic (1.82e-1)" "unprognostic (9.34e-3)" "unprognostic (1.17e-1)" "unprognostic (4.49e-1)" "unprognostic (2.34e-1)" "unprognostic (3.02e-2)" "unprognostic (1.22e-2)" "unprognostic (2.80e-1)" "unprognostic (1.38e-1)" "unprognostic (2.46e-3)" "unprognostic (2.94e-1)" "unprognostic (7.75e-3)" "unprognostic (3.53e-2)" "unprognostic (1.59e-1)" "unprognostic (3.22e-2)" "unprognostic (2.93e-2)" 24.0 26.9 15.5 35.0 15.4 30.6 20.7 14.8 16.3 21.2 19.1 40.5 39.7 21.1 18.5 25.5 17.1 24.7 18.9 15.5 17.3 31.0 27.3 23.0 36.3 15.3 17.4 15.0 24.2 25.5 18.5 28.7 17.1 26.4 38.9 15.9 26.6 17.1 27.5 15.3 35.7 24.4 16.3 27.1 28.5 16.9 16.5 28.7 26.8 27.2 42.9 34.8 15.3 16.6 103.6 103.7 51.7 61.7 55.9 58.1 57.3 117.3 99.1 78.4 90.4 76.5 64.3 101.0 70.6 71.7 88.6 82.6 99.9 58.3 77.3 109.7 61.0 89.9 66.4 61.2 72.3 127.0 81.8 54.9 61.2 64.2 65.5 51.6 87.7 79.2 137.4 117.1 99.8 39.2 40.1 56.0 60.2 109.9 99.9 88.3 87.0 74.9 71.6 120.9 69.4 71.7 95.6 84.8 98.9 48.4 74.4 114.3 91.4 104.0 65.6 73.2 237.5 90.0 153.3 107.4 76.3 129.9 88.2 72.1 44.5 38.9 41.1 55.4 46.9 76.3 36.9 45.4 54.9 67.1 34.2 34.6 32.7 48.6 55.7 82.0 52.8 49.2 15.5 15.4 14.8 16.3 15.5 17.3 15.3 17.4 17.1 16.3 16.5 16.6 26.0 16.0 23.1 10.7 62.9 45.0 41.3 26.1 20.5 9.4 25.2 16.5 3.8 22.8 25.0 12.9 12.5 39.9 45.0 53.7 21.5 39.6 10.7 21.7 24.5 28.5 24.4 29.2 14.7 43.8 65.4 23.4 26.0 27.6 10.1 26.2 22.9 22.1 48.3 21.9 15.4 30.2 38.7 30.3 41.3 3.3 13.4 35.5 23.2 14.0 31.4 27.3 35.0 9.5 13.3 57.8 31.1 21.1 60.8 56.5 31.8 23.3 20.6 13.0 13.1 17.6 28.6 32.8 35.2 28.8 57.8 84.4 37.3 38.7 38.1 89.7 CYFIP1 "KIAA0068, P140SRA-1, SHYC" ENSG00000273749 "Cytoplasmic FMR1 interacting protein 1" Q7L576 15 22867052-22981063 "Predicted intracellular proteins" "Cell shape, Differentiation, Neurogenesis" "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Microglial cells: 253.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 23.5;intermediate monocyte: 24.9;myeloid DC: 22.0;non-classical monocyte: 12.5" "Group enriched" "Detected in many" 5 "dendritic cells: 22.0;monocytes: 24.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA068106 Approved NA NA 1100000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 15: RT4 - Unknown function" "Cluster 10: Non-specific - Unknown function" "HPA068106: AB_2685955" "unprognostic (1.79e-2)" "unprognostic (1.28e-1)" "unprognostic (1.85e-1)" "unprognostic (8.20e-3)" "unprognostic (3.94e-1)" "unprognostic (2.09e-1)" "unprognostic (2.33e-1)" "prognostic unfavorable (7.39e-4)" "unprognostic (2.93e-1)" "unprognostic (8.56e-2)" "unprognostic (2.37e-3)" "unprognostic (1.02e-1)" "prognostic favorable (4.47e-5)" "unprognostic (1.20e-1)" "unprognostic (9.36e-2)" "unprognostic (1.51e-1)" "unprognostic (3.60e-3)" 41.2 26.0 16.6 19.8 16.9 4.7 36.4 15.8 20.0 33.2 16.7 37.7 31.5 33.8 23.8 46.2 24.7 24.0 21.8 15.5 17.9 25.9 26.1 40.5 19.2 20.7 19.5 28.9 41.7 37.3 13.3 39.5 23.1 29.3 28.1 4.4 39.3 24.6 21.2 39.7 29.3 24.9 23.5 26.5 33.8 15.9 21.7 10.2 27.5 14.4 16.2 29.9 36.6 28.6 67.6 74.8 35.5 72.2 42.7 49.3 49.7 47.5 35.7 32.1 31.7 70.0 32.9 0.2 34.1 50.0 32.9 64.2 31.9 58.8 29.7 36.2 45.5 41.3 40.9 51.9 37.3 14.4 29.5 39.3 43.1 25.4 29.7 33.6 48.3 37.0 20.0 23.4 37.8 58.1 1.5 25.7 25.1 87.1 61.8 18.3 45.7 16.6 81.4 114.3 43.1 44.3 40.9 67.2 46.3 35.0 53.1 30.3 49.5 58.7 47.2 24.3 69.6 3.4 7.7 0.7 56.6 32.5 33.7 0.0 23.5 0.4 0.5 24.9 2.4 2.0 2.1 1.0 22.0 0.3 0.4 0.1 0.7 4.3 12.5 3.3 1.6 8.2 16.6 16.9 15.8 20.0 15.5 17.9 20.7 19.5 23.1 23.5 21.7 28.6 56.7 35.3 37.9 18.6 5.7 20.0 27.3 33.8 23.9 2.3 28.9 29.8 7.4 17.2 37.9 18.4 2.1 38.6 4.1 78.7 11.7 33.5 4.5 33.8 35.8 50.7 17.4 9.2 41.8 35.0 40.0 32.2 42.8 50.6 8.8 99.1 35.3 31.5 108.7 5.0 46.1 34.0 28.5 104.5 29.5 5.3 36.4 73.8 28.4 253.9 43.3 17.9 0.0 19.6 16.0 43.2 43.2 32.4 6.3 33.2 41.9 21.8 39.6 2.0 26.3 29.5 40.8 9.0 17.9 40.4 26.3 31.7 4.8 38.5 33.0 34.8 TUBGCP5 "GCP5, KIAA1899" ENSG00000275835 "Tubulin gamma complex associated protein 5" Q96RT8 15 22983192-23039572 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039366, HPA040366" Supported Supported Centrosome,Cytosol NA NA "Cluster 24: B-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Centrosome, Cytosol" "HPA039366: AB_10673243, HPA040366: AB_2676942" "unprognostic (1.17e-2)" "unprognostic (2.21e-1)" "unprognostic (1.30e-1)" "unprognostic (4.27e-3)" "unprognostic (2.94e-1)" "unprognostic (2.79e-1)" "unprognostic (9.45e-2)" "unprognostic (4.97e-2)" "unprognostic (1.34e-1)" "unprognostic (1.08e-1)" "unprognostic (1.04e-1)" "unprognostic (2.27e-1)" "unprognostic (1.42e-2)" "unprognostic (1.18e-2)" "unprognostic (6.40e-2)" "unprognostic (1.13e-2)" "unprognostic (9.53e-3)" 8.4 9.1 3.5 6.5 4.2 9.0 9.7 3.8 6.6 9.7 1.8 7.3 6.3 9.7 5.7 8.0 6.7 6.0 9.1 3.3 4.7 8.2 9.3 7.0 8.4 4.8 4.1 7.4 10.6 8.4 8.0 6.9 5.1 9.6 7.3 9.8 6.7 7.7 10.7 10.0 6.3 8.7 3.3 7.2 7.8 13.4 4.3 8.9 11.2 10.2 8.7 7.6 7.6 6.5 20.3 20.8 23.9 14.4 18.3 11.9 13.8 24.3 26.6 26.2 22.7 16.1 9.3 16.0 10.3 22.3 13.8 19.8 16.0 18.8 21.8 23.6 6.6 26.9 21.2 8.8 6.4 27.7 11.6 19.4 7.2 17.5 16.2 8.6 16.1 26.4 19.8 23.6 16.9 13.1 18.8 12.1 14.2 19.8 18.8 22.9 26.1 3.2 15.3 30.6 8.3 14.0 19.7 14.2 12.7 11.8 22.2 13.4 13.9 18.4 11.7 14.0 36.6 18.3 19.8 40.0 23.8 18.3 17.3 0.2 1.4 0.6 2.6 2.1 2.7 2.2 4.0 4.4 2.3 4.2 3.5 4.7 1.5 3.9 2.1 2.5 3.7 1.7 3.5 4.2 3.8 6.6 3.3 4.7 4.8 4.1 5.1 3.3 4.3 6.5 7.4 16.0 17.7 16.0 11.0 3.3 3.2 4.2 9.1 27.6 5.2 5.0 13.2 7.2 6.3 5.5 14.6 8.3 11.6 3.0 5.9 6.5 7.8 12.5 13.4 6.4 4.2 3.8 21.4 4.6 7.2 10.4 6.1 6.2 6.3 31.4 5.7 10.2 7.9 10.1 29.7 4.7 4.1 5.2 2.9 13.4 11.1 6.2 3.6 12.2 5.1 11.6 7.2 15.6 26.2 6.6 5.0 12.8 7.9 2.3 2.9 7.1 9.0 18.9 0.0 13.6 10.6 35.0 36.7 8.6 2.7 3.4 9.6 14.1 4.6 2.0 GOLGA6L1 ENSG00000273976 "Golgin A6 family like 1" Q8N7Z2 15 23127066-23136822 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 106 "testis: 28.4" "Cell type enriched" "Detected in some" 5 "Early spermatids: 52.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA047733 Uncertain NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 29: Early spermatids - Spermatogenesis" "HPA047733: " 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 28.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.2 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA8S ENSG00000261739 "Golgin A8 family member S" H3BPF8 15 23354748-23367231 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 11 "testis: 1.0" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Early spermatids: 18.3;Horizontal cells: 6.7;Spermatocytes: 9.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (3.64e-2)" "unprognostic (7.02e-2)" "unprognostic (1.35e-1)" "unprognostic (2.11e-2)" "unprognostic (1.20e-1)" "unprognostic (1.00e-1)" "unprognostic (3.68e-1)" "unprognostic (2.80e-2)" "unprognostic (1.75e-2)" "unprognostic (9.39e-3)" "unprognostic (8.10e-2)" "unprognostic (3.01e-1)" "unprognostic (1.47e-1)" "unprognostic (1.30e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 18.3 0.6 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 6.7 0.7 0.0 0.0 0.0 0.8 2.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.1 9.3 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 GOLGA6L2 "CT105, FLJ36144" ENSG00000174450 "Golgin A6 family like 2" Q8N9W4 15 23439038-23447243 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 45 "testis: 53.7" "Cell type enriched" "Detected in some" 8 "Early spermatids: 567.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 23 "U-266/70: 5.0;U-266/84: 1.2" NA NA "Cluster 36: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (1.45e-1)" "unprognostic (4.86e-2)" "unprognostic (4.12e-1)" "unprognostic (1.92e-2)" "unprognostic (1.24e-1)" "unprognostic (5.52e-2)" "unprognostic (8.71e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 53.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 567.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 64.3 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.6 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 MKRN3 "D15S9, MGC88288, RNF63, ZFP127, ZNF127" ENSG00000179455 "Makorin ring finger protein 3" Q13064 15 23565674-23630075 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.1;retina: 8.9" "Cell type enhanced" "Detected in some" "Bipolar cells: 13.8;Cone photoreceptor cells: 25.0;Horizontal cells: 6.7;Oligodendrocyte precursor cells: 6.0;Oligodendrocytes: 9.0;Rod photoreceptor cells: 7.4" "Cancer enhanced" "Detected in some" "glioma: 1.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive CD8 T-cell: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "JURKAT: 26.3;K-562: 30.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029494 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 1: K-562 - Erythropoiesis" "Cluster 9: Photoreceptor cells - Phototransduction" "Plasma membrane, Cytosol" Nucleoplasm "HPA029494: AB_10603873" "unprognostic (3.18e-1)" "unprognostic (1.26e-1)" "unprognostic (4.26e-1)" "unprognostic (1.86e-3)" "unprognostic (1.04e-3)" "unprognostic (1.15e-2)" "unprognostic (6.27e-4)" "unprognostic (1.51e-1)" "unprognostic (8.52e-2)" "unprognostic (7.05e-2)" "unprognostic (4.97e-3)" "unprognostic (2.86e-1)" "unprognostic (1.05e-4)" "unprognostic (5.37e-2)" "unprognostic (1.52e-1)" "unprognostic (8.91e-2)" "unprognostic (9.78e-2)" 0.3 0.1 4.5 0.4 7.7 1.8 0.5 4.8 6.7 0.1 2.4 0.5 0.2 0.4 1.6 3.4 3.1 0.1 0.1 5.2 5.1 0.3 0.1 0.2 0.7 7.0 6.1 0.2 0.4 0.0 1.1 3.3 7.0 0.3 0.1 8.9 3.1 0.2 0.8 0.4 0.3 0.1 4.0 0.6 0.2 2.4 6.6 2.4 0.2 0.8 0.8 0.2 0.2 14.1 8.5 2.9 6.1 5.6 0.0 0.0 13.0 0.9 0.0 4.3 4.5 14.7 0.0 0.1 0.1 0.0 11.8 12.5 2.4 0.0 2.7 0.1 0.5 15.3 17.0 0.9 0.4 18.6 10.2 0.6 0.0 5.8 0.0 2.8 0.0 26.3 30.6 12.9 3.5 0.0 20.3 7.3 0.0 9.6 12.1 10.7 2.5 7.5 0.0 0.1 1.6 4.4 0.0 7.7 0.1 0.2 4.2 5.2 0.1 13.5 9.9 0.9 9.6 16.8 24.5 8.6 7.9 0.1 0.1 0.6 0.2 0.1 0.6 0.0 0.3 0.2 0.2 0.4 0.0 0.2 0.6 2.3 0.4 0.1 0.1 0.3 0.1 0.3 4.5 7.7 4.8 6.7 5.2 5.1 7.0 6.1 7.0 4.0 6.6 14.1 0.0 0.0 0.0 0.7 0.1 0.5 1.2 0.0 0.0 13.8 0.3 0.0 0.7 0.0 0.1 0.0 25.0 0.8 0.0 0.0 0.0 0.0 0.8 0.1 0.2 0.2 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 6.7 0.4 0.0 0.0 0.0 0.6 0.5 0.0 0.1 1.8 1.0 0.1 3.4 0.0 6.0 9.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.2 7.4 0.0 0.7 1.6 2.6 0.9 1.8 0.0 0.5 0.2 0.1 0.0 0.4 MAGEL2 "NDNL1, nM15" ENSG00000254585 "MAGE family member L2" Q9UJ55 15 23643549-23647867 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation, Transport, Ubl conjugation pathway" Repressor "Autism spectrum disorder, Mental retardation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 23.2;pituitary gland: 8.7" "Cell type enhanced" "Detected in some" "Excitatory neurons: 2.7;Granulosa cells: 5.0;Horizontal cells: 3.3;Inhibitory neurons: 5.8;Leydig cells: 2.8;Muller glia cells: 2.2;Spermatocytes: 2.7" "Cancer enriched" "Detected in some" 4 "testis cancer: 4.3" "Region enhanced" "Detected in many" "hypothalamus: 23.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.2;JURKAT: 1.2;NTERA-2: 1.9;SuSa: 2.2" "Region enhanced" "Detected in many" "hypothalamus: 17.7" "Low region specificity" "Detected in all" NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 12: NES - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (3.18e-1)" "unprognostic (2.63e-1)" "unprognostic (2.21e-1)" "unprognostic (7.47e-3)" "unprognostic (1.65e-2)" "unprognostic (3.80e-1)" "unprognostic (1.17e-1)" "unprognostic (5.38e-3)" "unprognostic (3.51e-3)" "unprognostic (8.61e-2)" "unprognostic (1.31e-2)" "unprognostic (9.55e-2)" "unprognostic (2.96e-9)" "unprognostic (1.66e-4)" "unprognostic (3.30e-2)" "unprognostic (2.06e-4)" "unprognostic (1.79e-2)" 0.4 0.2 4.6 0.1 3.2 0.0 0.3 0.1 3.9 2.4 0.0 0.2 0.0 1.5 0.2 0.0 0.5 0.2 0.1 0.9 23.2 0.1 0.0 0.0 0.0 3.8 2.6 2.1 0.8 0.0 8.7 1.3 5.4 0.2 0.0 0.7 0.1 0.4 0.0 0.1 0.1 0.6 2.3 0.3 0.1 1.5 10.6 0.0 0.7 0.1 0.0 0.1 0.9 0.9 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.2 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 3.2 0.1 3.9 0.9 23.2 3.8 2.6 5.4 2.3 10.6 0.9 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.8 0.2 0.0 0.0 2.7 0.0 0.0 0.9 0.0 0.0 0.0 5.0 1.1 0.0 0.0 3.3 5.8 0.0 0.0 0.0 0.0 0.5 2.8 0.0 0.0 1.9 0.0 2.2 0.0 2.0 0.4 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.8 0.7 2.7 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 NDN "HsT16328, PWCR" ENSG00000182636 "Necdin, MAGE family member" Q99608 15 23685400-23687305 "Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Growth regulation, Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Leydig cells: 236.4;Peritubular cells: 207.6;Theca cells: 121.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.5" "Cell line enhanced" "Detected in many" "AF22: 55.0;ASC diff: 52.9;HSkMC: 71.3;NTERA-2: 44.0;SuSa: 57.4;U-2 OS: 80.4;U-266/70: 51.7;U-266/84: 51.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074457 Approved Nucleoplasm,Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 35: Non-specific - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 48: Smooth muscle cells - ECM organization" "Nucleoplasm, Cytosol" "HPA074457: AB_2686691" "unprognostic (3.49e-1)" "unprognostic (1.65e-1)" "unprognostic (4.20e-1)" "unprognostic (2.19e-2)" "unprognostic (2.71e-1)" "unprognostic (9.04e-2)" "unprognostic (6.79e-2)" "unprognostic (3.51e-1)" "unprognostic (3.11e-2)" "unprognostic (1.57e-1)" "unprognostic (1.03e-2)" "unprognostic (4.05e-2)" "prognostic unfavorable (4.52e-4)" "unprognostic (1.89e-2)" "unprognostic (8.10e-2)" "unprognostic (1.96e-1)" "unprognostic (6.81e-2)" 46.8 49.4 43.3 11.1 40.5 1.2 35.1 26.0 39.7 70.5 30.4 35.9 11.1 63.7 24.0 16.8 47.2 23.8 34.6 36.7 89.6 13.0 4.5 19.6 10.9 36.0 41.3 69.8 11.8 8.7 56.3 32.6 46.2 27.3 10.7 20.8 12.7 39.3 14.7 11.9 20.8 33.5 36.7 19.1 20.3 18.5 69.6 6.8 17.4 22.4 6.6 31.4 40.4 32.3 0.1 0.0 55.0 0.0 52.9 20.1 0.1 35.4 0.0 0.8 9.6 0.0 0.0 0.0 0.1 10.6 8.2 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 13.3 0.0 31.8 71.3 0.0 10.2 0.0 0.0 0.0 21.7 1.2 0.0 18.0 0.0 27.6 0.1 44.0 0.0 0.0 0.0 0.0 0.1 3.8 0.0 0.1 0.4 0.0 0.4 0.0 57.4 9.4 0.0 0.0 2.6 80.4 0.0 0.1 51.7 51.7 0.0 5.5 0.0 0.4 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.2 1.5 0.0 0.0 43.3 40.5 26.0 39.7 36.7 89.6 36.0 41.3 46.2 36.7 69.6 32.3 24.1 25.6 11.0 6.8 0.3 13.0 13.8 0.3 27.9 66.0 2.3 19.8 36.8 15.7 1.4 12.9 20.9 1.9 2.9 18.5 23.5 17.9 2.5 1.4 60.8 18.7 6.7 4.2 7.8 10.7 1.4 103.1 4.1 1.1 0.0 83.9 38.9 0.2 7.3 50.5 21.8 4.3 0.0 7.6 13.3 8.6 236.4 2.8 39.2 9.4 0.7 88.7 0.0 9.5 16.4 4.5 2.6 207.6 0.0 6.9 8.1 1.1 4.1 51.0 98.6 91.4 94.0 28.5 21.8 13.4 8.2 2.5 1.4 121.8 7.1 4.1 NPAP1 C15orf2 ENSG00000185823 "Nuclear pore associated protein 1" Q9NZP6 15 24675775-24683393 "Predicted intracellular proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.8;testis: 2.9" "Cell type enriched" "Detected in some" 5 "Granulosa cells: 125.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA018828, HPA019562" Uncertain Supported "Nucleoplasm,Vesicles,Plasma membrane" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "Vesicles, Plasma membrane" "HPA018828: AB_2669941, HPA019562: AB_2670190" "unprognostic (4.40e-2)" "unprognostic (1.85e-2)" "unprognostic (6.98e-3)" "unprognostic (7.45e-2)" "unprognostic (9.90e-2)" "unprognostic (1.08e-2)" "unprognostic (5.11e-3)" 0.0 0.0 0.9 0.0 1.8 0.4 0.1 0.1 1.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.5 1.7 0.9 0.0 0.0 0.1 0.9 0.7 0.5 0.4 0.0 0.5 0.0 0.5 0.1 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.5 0.1 0.1 2.9 1.5 0.0 0.5 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.9 1.8 0.1 1.1 0.5 1.7 0.9 0.7 0.5 0.5 1.5 1.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.1 0.2 0.7 0.1 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.1 0.0 125.9 0.0 0.0 0.1 0.0 3.5 0.0 0.0 0.0 0.0 0.8 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.3 24.1 12.7 0.0 0.0 0.0 0.0 0.5 0.0 0.2 SNRPN "HCERN3, PWCR, RT-LI, SM-D, SMN, SNRNP-N, SNURF-SNRPN" ENSG00000128739 "Small nuclear ribonucleoprotein polypeptide N" P63162 15 24823637-24978723 "Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 457.8;Horizontal cells: 333.1;Proximal tubular cells: 300.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 789.5;SuSa: 505.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003482, HPA067842" Approved Approved Nucleoplasm NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 5: NTERA-2 - Transcription" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA003482: AB_1857337, HPA067842: AB_2685909" "unprognostic (9.91e-2)" "unprognostic (1.03e-3)" "unprognostic (2.79e-1)" "unprognostic (1.66e-2)" "unprognostic (3.71e-2)" "unprognostic (2.32e-2)" "unprognostic (1.08e-1)" "unprognostic (2.72e-2)" "unprognostic (9.44e-3)" "unprognostic (1.30e-1)" "unprognostic (1.04e-2)" "unprognostic (6.59e-2)" "prognostic favorable (8.93e-8)" "unprognostic (4.45e-2)" "unprognostic (1.63e-1)" "unprognostic (1.86e-1)" "unprognostic (6.74e-2)" 54.8 181.8 453.6 46.5 472.5 36.5 69.4 441.8 553.5 112.3 351.6 87.3 36.4 65.2 332.5 44.0 121.9 141.2 483.2 474.3 510.7 192.0 69.9 76.4 93.5 454.7 440.5 147.8 111.8 243.4 375.5 37.4 458.5 174.2 34.8 161.7 125.7 147.6 232.7 38.2 62.5 59.0 415.8 85.2 88.3 60.7 467.8 136.8 300.4 272.4 80.6 82.5 66.4 470.8 1.0 148.6 260.8 180.1 153.4 69.5 1.1 46.9 100.0 31.7 57.8 138.1 69.1 0.2 91.6 118.7 47.9 26.7 0.0 142.7 18.2 81.1 0.1 89.3 90.1 151.5 181.8 107.1 76.8 132.6 60.6 69.4 81.8 213.2 95.7 189.8 24.8 0.4 183.3 0.0 216.9 1.5 789.5 0.0 63.0 113.3 97.8 0.5 172.3 222.2 155.7 147.1 0.7 3.6 174.0 505.7 93.6 271.3 62.3 79.2 78.2 0.3 28.8 215.3 126.9 140.4 65.9 72.9 59.8 234.8 68.0 106.8 313.9 74.2 355.8 371.9 385.3 359.0 65.2 342.1 508.0 420.8 18.5 291.2 77.4 531.9 434.4 581.7 453.6 472.5 441.8 553.5 474.3 510.7 454.7 440.5 458.5 415.8 467.8 470.8 57.1 9.6 45.5 0.0 106.2 2.2 102.6 4.4 53.5 171.0 77.1 96.5 185.2 218.8 23.0 178.4 52.1 1.0 157.6 10.0 457.8 150.0 92.9 36.8 27.9 57.7 142.7 31.1 0.0 81.6 1.2 54.9 27.5 24.5 62.7 136.9 63.1 31.9 62.7 333.1 0.0 34.5 6.1 28.9 2.5 111.3 77.3 38.1 0.0 0.0 43.8 210.3 115.4 0.0 0.0 61.5 33.7 116.6 86.7 110.6 38.7 300.2 26.9 112.3 52.6 61.5 65.0 67.9 54.0 22.1 1.7 1.6 104.2 110.4 23.6 65.1 SNURF ENSG00000273173 "SNRPN upstream reading frame" Q9Y675 15 24954986-24977850 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 62.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 191.3;U-698: 112.1" HPA065733 Supported "Nuclear speckles" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 54: Non-specific - Microtubule organization" "Cluster 5: NTERA-2 - Transcription" "Cluster 59: Non-specific - Transcription" "Nuclear speckles" "HPA065733: AB_2685548" "unprognostic (2.08e-1)" "unprognostic (2.88e-2)" "unprognostic (6.82e-2)" "unprognostic (4.59e-3)" "unprognostic (4.03e-2)" "unprognostic (1.40e-3)" "unprognostic (4.39e-2)" "unprognostic (6.89e-3)" "unprognostic (1.56e-2)" "unprognostic (6.74e-2)" "unprognostic (8.91e-4)" "unprognostic (3.77e-1)" "unprognostic (1.77e-2)" "unprognostic (6.04e-2)" "unprognostic (1.06e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-2)" 8.1 16.1 3.7 6.9 7.5 12.5 5.3 16.3 16.0 12.1 1.2 14.6 1.9 9.6 54.8 5.3 8.5 13.2 50.7 5.6 11.8 14.6 12.9 9.8 10.2 1.5 2.8 13.7 13.5 19.8 28.5 2.7 2.4 15.2 2.5 25.3 8.4 8.3 62.9 3.7 6.4 3.8 0.5 17.2 11.5 3.3 6.5 8.1 15.5 7.4 7.0 12.8 7.3 8.6 0.1 11.9 61.9 44.1 3.1 4.1 0.1 40.7 3.3 4.2 2.8 7.0 36.4 0.5 21.0 2.7 6.0 15.3 0.0 9.1 3.2 14.1 0.0 74.3 50.2 1.8 11.0 79.2 25.4 10.0 2.3 7.7 0.5 22.1 5.2 22.4 7.3 0.2 8.3 0.0 55.5 0.5 191.3 0.0 1.9 54.7 84.7 0.9 3.3 82.0 37.1 29.1 0.0 3.8 22.3 75.2 38.7 7.1 75.8 27.2 30.2 1.0 8.9 58.8 81.6 112.1 43.9 33.6 24.5 17.7 1.5 6.3 14.9 0.7 31.0 22.3 32.9 28.4 2.7 27.8 41.2 38.1 1.7 22.4 3.1 23.6 35.7 20.1 3.7 7.5 16.3 16.0 5.6 11.8 1.5 2.8 2.4 0.5 6.5 8.6 1.0 3.2 3.7 0.0 2.9 0.5 0.6 1.4 2.2 1.6 1.4 1.1 4.1 0.0 1.1 0.0 0.0 0.0 1.1 0.7 3.9 2.1 0.4 0.7 1.2 0.9 0.0 0.8 0.0 2.4 0.0 1.4 1.5 0.7 1.3 2.0 1.1 0.7 0.3 3.3 0.0 2.7 0.0 0.8 0.4 0.3 0.6 0.6 0.0 0.0 0.7 0.4 0.0 0.0 0.0 2.2 2.8 0.4 2.7 0.6 1.1 0.7 4.1 1.5 0.0 0.9 2.0 0.3 0.8 0.7 0.3 0.0 2.8 1.9 1.2 0.3 UBE3A "ANCR, AS, E6-AP, EPVE6AP, FLJ26981, HPVE6A" ENSG00000114062 "Ubiquitin protein ligase E3A" Q05086 15 25333728-25439051 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Host-virus interaction, Ubl conjugation pathway" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009723, HPA039410, HPA040380" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Cytosol "CAB009723: AB_639982, HPA039410: AB_10671997, HPA040380: AB_2676952" "unprognostic (7.95e-2)" "unprognostic (2.61e-2)" "unprognostic (1.58e-1)" "unprognostic (2.99e-1)" "unprognostic (1.13e-1)" "unprognostic (3.55e-2)" "unprognostic (1.44e-1)" "unprognostic (3.05e-1)" "unprognostic (5.07e-2)" "unprognostic (1.69e-1)" "unprognostic (3.40e-2)" "unprognostic (4.83e-2)" "unprognostic (6.31e-2)" "unprognostic (3.08e-2)" "unprognostic (1.42e-1)" "unprognostic (1.15e-1)" "unprognostic (8.17e-2)" 29.1 29.0 28.0 27.6 30.3 32.4 32.6 42.8 41.7 33.5 14.0 33.5 22.9 32.9 29.5 32.9 29.9 24.5 40.6 31.0 28.2 32.6 42.2 24.9 33.3 22.3 23.6 37.1 27.2 38.4 15.3 28.4 24.0 31.8 28.9 32.8 23.3 28.4 109.2 26.8 29.5 30.9 19.9 26.9 26.1 45.6 28.1 41.7 41.5 92.0 34.2 32.8 20.0 29.2 55.9 33.6 77.7 46.1 45.0 56.4 38.4 84.8 54.8 59.9 55.6 76.0 27.6 103.4 61.2 68.2 57.8 51.2 106.8 62.2 75.2 54.1 32.7 85.8 49.0 43.1 65.5 107.0 60.2 60.6 56.2 58.3 71.6 60.0 47.6 87.0 89.0 71.1 95.1 32.3 84.0 29.1 50.3 62.1 46.6 88.6 117.8 45.6 51.7 91.1 80.0 59.6 72.1 72.1 102.1 51.3 57.9 56.7 59.2 102.1 84.7 52.1 64.5 77.5 103.4 139.5 60.4 56.6 55.3 14.4 12.7 17.2 17.0 11.2 19.9 17.3 18.5 20.8 16.7 22.8 20.8 18.7 2.2 29.6 22.3 15.2 15.8 9.7 28.0 30.3 42.8 41.7 31.0 28.2 22.3 23.6 24.0 19.9 28.1 29.2 56.6 96.1 80.5 112.6 74.7 71.1 83.8 40.6 84.2 82.7 59.5 42.3 175.3 42.9 58.7 38.6 56.3 52.3 74.3 43.3 19.6 51.6 139.4 53.6 75.2 58.7 68.7 64.3 187.7 49.6 49.6 64.1 52.5 63.8 62.8 84.1 44.3 58.6 46.0 80.8 196.3 55.0 12.2 60.9 41.1 61.6 56.8 64.4 53.4 87.1 53.3 54.5 54.6 126.2 124.4 59.8 41.5 64.7 95.7 102.8 51.4 50.3 59.4 59.2 78.9 119.0 80.5 146.1 88.3 78.3 90.6 74.0 63.3 65.7 52.6 98.6 ATP10A "ATP10C, ATPVA, ATPVC, KIAA0566" ENSG00000206190 "ATPase phospholipid transporting 10A (putative)" O60312 15 25677271-25865184 "Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.0" "Cell type enriched" "Detected in many" 6 "Microglial cells: 216.4" "Cancer enhanced" "Detected in all" "melanoma: 7.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 23.0;fHDF/TERT166: 22.9;HMC-1: 19.4;SK-MEL-30: 21.9;U-2197: 12.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041496, HPA042509" Uncertain NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "HPA041496: AB_2677513, HPA042509: AB_2678032" "unprognostic (3.70e-1)" "unprognostic (2.83e-2)" "unprognostic (2.30e-4)" "unprognostic (1.18e-1)" "unprognostic (9.46e-2)" "unprognostic (2.91e-2)" "unprognostic (2.67e-1)" "unprognostic (4.95e-1)" "unprognostic (1.12e-1)" "unprognostic (2.78e-1)" "unprognostic (1.26e-1)" "unprognostic (1.33e-1)" "prognostic unfavorable (6.60e-5)" "unprognostic (1.30e-1)" "unprognostic (1.38e-2)" "unprognostic (4.89e-2)" "unprognostic (9.42e-2)" 6.5 8.7 13.7 2.7 9.3 2.5 5.3 6.0 8.9 2.0 0.7 3.2 0.8 1.5 0.1 1.9 2.3 3.7 2.0 5.9 5.8 5.8 0.6 7.1 1.8 9.9 9.7 1.1 1.4 3.5 2.1 1.7 9.5 2.2 0.8 0.1 7.9 0.6 0.6 2.5 3.0 2.8 5.9 1.5 3.2 4.3 15.0 1.1 2.5 0.7 1.1 2.5 1.4 4.9 0.0 5.7 1.3 0.0 2.2 2.8 0.0 23.0 9.3 6.1 9.9 0.0 0.0 0.0 1.6 22.9 0.0 0.0 9.3 1.2 0.4 0.0 0.2 0.0 0.0 0.1 0.1 0.0 19.4 0.9 0.0 0.6 0.0 2.5 0.0 1.2 0.0 0.0 3.3 0.0 1.2 0.0 1.5 0.0 1.5 4.4 4.6 2.8 9.9 0.0 0.0 0.1 0.0 0.0 21.9 0.0 7.4 1.2 0.0 8.9 0.2 12.7 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.6 0.1 0.5 0.0 0.3 0.5 0.1 0.0 0.7 0.6 0.0 1.2 0.0 1.0 0.1 0.3 13.7 9.3 6.0 8.9 5.9 5.8 9.9 9.7 9.5 5.9 15.0 4.9 0.3 32.1 8.6 2.0 0.8 1.0 0.0 2.7 0.6 0.2 2.6 1.8 1.7 1.5 5.3 0.0 0.0 0.0 11.1 0.1 0.0 0.5 23.2 2.8 2.8 4.2 0.0 0.0 4.5 0.0 0.1 5.0 3.1 7.9 15.2 0.0 0.4 0.1 2.5 0.0 2.1 0.2 0.0 2.5 5.2 21.8 4.1 4.5 17.8 216.4 2.3 0.0 14.4 1.5 2.7 0.8 0.0 17.7 1.7 0.7 0.0 0.1 4.2 0.1 0.0 4.7 9.1 0.4 1.2 0.0 0.4 0.0 8.6 0.1 0.0 0.0 GABRB3 ENSG00000166206 "Gamma-aminobutyric acid type A receptor subunit beta3" P28472 15 26543546-26939539 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.5;retina: 31.9" "Cell type enhanced" "Detected in many" "Bipolar cells: 152.4;Excitatory neurons: 519.6;Inhibitory neurons: 258.7;Oligodendrocyte precursor cells: 139.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 68.5;HAP1: 27.9;NTERA-2: 48.3;OE19: 21.6;SCLC-21H: 44.2;U-2 OS: 18.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 58: Brain - Synaptic function" "Cluster 5: NTERA-2 - Transcription" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "unprognostic (1.72e-1)" "unprognostic (4.91e-2)" "unprognostic (3.20e-2)" "unprognostic (4.25e-2)" "unprognostic (1.66e-1)" "unprognostic (7.07e-2)" "unprognostic (1.00e-1)" "unprognostic (8.87e-2)" "unprognostic (1.02e-1)" "unprognostic (2.44e-1)" "unprognostic (1.44e-2)" "unprognostic (3.62e-1)" "unprognostic (3.56e-3)" "unprognostic (2.99e-2)" "unprognostic (1.49e-1)" "unprognostic (3.33e-2)" "unprognostic (4.05e-1)" 0.6 5.5 16.6 0.5 24.3 0.0 0.8 3.9 29.5 2.3 0.0 1.2 0.8 1.7 1.0 1.2 2.3 13.6 6.2 28.0 18.0 7.3 0.9 0.9 0.1 0.0 1.3 1.9 4.8 2.1 15.7 0.0 0.3 5.0 0.9 31.9 0.5 1.2 0.1 0.7 0.6 1.4 3.1 0.6 5.7 4.0 11.6 1.5 8.7 0.1 0.2 1.1 0.5 13.8 0.0 68.5 10.7 0.0 0.0 0.0 2.6 1.1 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.1 0.0 0.0 27.9 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.1 0.0 5.4 3.3 0.0 0.0 0.0 0.0 0.0 14.8 2.1 0.1 0.0 0.0 4.8 0.0 48.3 21.6 3.4 0.0 0.0 0.0 4.7 0.0 44.2 16.6 0.0 0.1 0.0 5.0 0.1 0.0 0.0 0.0 18.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.6 24.3 3.9 29.5 28.0 18.0 0.0 1.3 0.3 3.1 11.6 13.8 0.4 12.8 3.6 33.3 0.0 0.0 0.8 0.7 1.2 152.4 1.0 0.8 15.3 24.3 1.7 5.5 39.6 0.4 0.0 1.4 0.0 4.6 10.7 1.4 4.0 1.2 10.3 0.0 519.6 0.4 0.0 1.7 2.6 0.6 0.0 1.1 0.7 0.4 0.0 75.7 258.7 1.9 0.0 0.6 0.0 5.6 1.8 0.0 0.0 5.6 0.2 7.9 0.0 139.7 8.7 1.7 0.4 3.4 0.0 3.3 0.2 7.0 13.5 53.7 0.0 1.0 0.9 8.6 29.3 0.7 0.1 0.3 0.1 0.5 0.9 0.4 GABRA5 ENSG00000186297 "Gamma-aminobutyric acid type A receptor subunit alpha5" P31644 15 26866911-26949208 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 111.0" "Group enriched" "Detected in some" 4 "Excitatory neurons: 27.6;Inhibitory neurons: 14.1" "Cancer enhanced" "Detected in some" "glioma: 0.8" "Group enriched" "Detected in many" 4 "amygdala: 52.0;basal ganglia: 73.5;cerebral cortex: 98.6;hippocampal formation: 111.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "A549: 35.3;HAP1: 12.0;NTERA-2: 16.2;U-2 OS: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA029363, HPA077031, CAB079022" Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 5: NTERA-2 - Transcription" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane" Nucleoplasm "CAB079022: , HPA029363: , HPA077031: AB_2686825" "unprognostic (6.33e-2)" "unprognostic (8.94e-3)" "unprognostic (1.04e-1)" "unprognostic (2.50e-1)" "unprognostic (1.81e-1)" "unprognostic (3.75e-1)" "unprognostic (9.50e-3)" "unprognostic (2.57e-1)" "unprognostic (7.63e-2)" "unprognostic (8.50e-2)" "unprognostic (1.44e-2)" 0.0 0.0 52.0 0.1 73.5 0.0 0.0 0.0 98.6 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.7 0.5 111.0 7.2 0.1 0.1 0.0 0.0 0.0 3.0 0.0 0.1 0.7 0.5 0.0 0.0 0.2 0.0 1.6 0.0 0.1 0.0 0.0 0.1 0.6 0.0 0.0 1.2 0.7 12.0 9.0 0.1 0.1 0.3 0.0 0.0 19.6 0.0 35.3 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 12.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.5 0.0 0.1 0.2 1.8 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 52.0 73.5 0.0 98.6 111.0 7.2 0.0 3.0 0.0 0.0 12.0 19.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 27.6 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.1 0.0 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.8 0.0 1.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 GABRG3 ENSG00000182256 "Gamma-aminobutyric acid type A receptor subunit gamma3" Q99928 15 26971181-27541984 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "FDA approved drug targets" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 17.6;retina: 27.1;testis: 9.3" "Group enriched" "Detected in some" 4 "Excitatory neurons: 444.7;Inhibitory neurons: 615.5;Late spermatids: 351.0;Muller glia cells: 179.9" "Cancer enhanced" "Detected in single" "prostate cancer: 1.5" "Region enhanced" "Detected in many" "hypothalamus: 17.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "K-562: 4.5;PC-3: 5.5;SK-MEL-30: 3.5;U-2 OS: 2.5;U-266/70: 3.2;U-87 MG: 14.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA054010 Approved NA NA "Cluster 77: Retina - Visual perception" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA054010: AB_2682342" "unprognostic (1.23e-1)" "unprognostic (1.67e-1)" "unprognostic (1.02e-2)" "unprognostic (3.50e-2)" "unprognostic (2.61e-1)" "unprognostic (2.33e-3)" "unprognostic (1.30e-1)" "unprognostic (2.39e-2)" "unprognostic (5.15e-2)" "unprognostic (2.95e-1)" "unprognostic (4.41e-1)" "unprognostic (1.43e-5)" "unprognostic (1.52e-1)" "unprognostic (1.32e-1)" "unprognostic (2.03e-2)" "unprognostic (1.83e-1)" 0.0 0.4 3.5 0.2 3.0 0.0 0.4 0.0 4.2 0.8 0.0 0.0 0.0 0.1 1.9 0.0 0.4 0.0 0.0 0.9 17.6 0.7 0.1 0.0 0.6 0.5 0.2 0.0 0.0 0.0 3.0 0.0 0.0 6.6 0.0 27.1 0.8 0.2 0.0 0.3 0.0 0.0 0.6 1.0 0.0 9.3 10.2 1.0 1.5 0.0 0.8 0.0 0.2 2.9 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.4 0.3 0.0 5.5 0.0 0.0 1.0 0.0 0.0 0.1 1.0 0.0 0.0 3.5 0.1 0.0 0.0 0.0 0.0 2.5 0.0 0.0 3.2 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 3.0 0.0 4.2 0.9 17.6 0.5 0.2 0.0 0.6 10.2 2.9 0.1 0.0 0.0 5.5 0.0 0.0 0.1 0.0 0.0 4.6 2.5 1.4 0.9 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 86.2 3.2 0.1 0.3 0.0 0.0 444.7 0.0 0.0 0.1 0.0 0.4 0.0 0.5 0.0 0.0 0.1 0.0 615.5 0.0 0.0 0.0 0.0 351.0 0.9 0.2 0.0 7.5 0.0 179.9 0.0 16.1 7.9 0.0 0.0 0.7 0.0 3.1 0.0 0.3 0.0 4.6 0.0 0.1 0.1 1.6 7.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 OCA2 "BEY, BEY1, BEY2, D15S12, EYCL, EYCL2, EYCL3, P" ENSG00000104044 "OCA2 melanosomal transmembrane protein" Q04671 15 27754875-28099315 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Albinism, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "choroid plexus: 28.1" "Cell type enhanced" "Detected in some" "Excitatory neurons: 30.9;Inhibitory neurons: 40.8;Melanocytes: 42.7;Peritubular cells: 14.7" "Cancer enriched" "Detected in many" 17 "melanoma: 19.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SK-MEL-30: 24.6" "Low region specificity" "Detected in some" HPA036402 Approved "Plasma membrane,Cytosol" NA NA "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane" Cytosol "HPA036402: " "unprognostic (6.07e-3)" "unprognostic (1.97e-2)" "unprognostic (3.25e-1)" "unprognostic (2.82e-2)" "unprognostic (4.60e-4)" "unprognostic (7.11e-2)" "unprognostic (1.10e-1)" "unprognostic (4.12e-2)" "unprognostic (3.47e-2)" "unprognostic (4.95e-2)" "unprognostic (1.96e-2)" "unprognostic (1.60e-2)" "unprognostic (2.20e-6)" "unprognostic (2.61e-1)" "unprognostic (4.21e-1)" "unprognostic (3.28e-2)" "unprognostic (2.28e-2)" 0.3 0.0 1.8 0.1 1.8 0.0 0.3 0.1 1.8 1.2 28.1 0.1 0.0 0.2 0.3 2.2 1.1 0.0 0.3 1.4 1.8 0.3 0.1 0.6 1.8 0.5 0.9 0.3 0.0 0.0 0.8 1.5 0.6 0.6 0.0 0.0 0.8 1.0 0.2 6.4 0.2 0.0 0.0 1.1 0.1 1.9 2.4 0.4 4.2 0.0 0.7 0.2 2.4 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.2 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.1 5.6 0.0 0.0 24.6 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.8 0.1 1.8 1.4 1.8 0.5 0.9 0.6 0.0 2.4 1.0 0.0 0.0 0.0 0.7 0.0 2.0 0.1 0.1 0.6 0.0 0.0 0.4 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.4 5.6 0.2 0.1 0.0 0.0 30.9 0.0 0.1 1.4 0.0 2.8 0.0 2.3 0.0 0.0 0.1 0.0 40.8 0.1 0.0 0.0 0.9 3.0 9.3 0.1 42.7 0.0 0.0 0.0 0.0 2.5 0.8 0.0 1.2 14.7 0.0 0.0 0.0 0.1 2.0 0.0 0.0 1.0 0.8 4.2 4.9 6.1 0.9 0.1 0.1 0.4 0.1 0.2 HERC2 "D15F37S1, jdf2, p528" ENSG00000128731 "HECT and RLD domain containing E3 ubiquitin protein ligase 2" O95714 15 28111040-28322179 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 54.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017188, HPA048389, HPA074166" Approved Supported "Plasma membrane,Cytosol" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 59: Non-specific - Translation" "Cluster 36: HEL - Hemostasis" "Cluster 40: Granulosa cells - Unknown function" Cytosol "Plasma membrane" "CAB017188: , HPA048389: AB_2680382, HPA074166: " "unprognostic (1.59e-1)" "unprognostic (1.44e-1)" "unprognostic (1.92e-1)" "unprognostic (6.64e-2)" "unprognostic (6.62e-2)" "unprognostic (5.74e-2)" "unprognostic (9.17e-2)" "unprognostic (2.08e-1)" "unprognostic (1.87e-1)" "unprognostic (4.11e-2)" "unprognostic (9.40e-3)" "unprognostic (3.60e-2)" "prognostic favorable (1.41e-7)" "unprognostic (7.66e-2)" "unprognostic (2.10e-1)" "unprognostic (2.34e-2)" "unprognostic (1.71e-1)" 5.3 5.7 2.5 2.3 2.9 4.0 4.9 1.5 3.1 5.5 3.0 9.3 2.6 7.6 1.7 5.2 6.1 2.2 7.4 2.3 1.1 3.7 3.7 5.1 2.3 2.0 1.8 8.3 6.1 5.4 6.3 2.7 2.7 4.4 2.8 5.3 4.8 2.9 14.2 5.3 6.1 3.7 0.4 4.3 6.3 4.8 2.7 4.4 5.8 9.3 2.4 5.6 5.0 6.2 8.5 16.5 11.2 4.7 9.2 6.9 3.2 6.0 7.1 7.6 7.3 8.6 1.1 8.5 7.2 10.4 11.5 8.5 12.0 5.9 5.6 5.2 7.8 54.0 20.2 2.9 3.5 12.8 4.1 5.7 4.5 9.0 11.2 4.9 10.2 7.0 21.2 3.4 7.3 3.9 2.9 4.3 3.4 6.4 7.1 10.2 16.0 0.7 2.6 18.2 12.3 7.1 14.6 4.1 4.5 5.8 4.8 14.8 15.3 14.0 9.2 5.5 9.1 2.2 3.3 7.7 6.5 5.9 7.6 0.1 0.2 0.1 0.3 0.0 0.1 0.2 0.1 0.1 0.2 0.4 0.2 0.1 0.0 0.1 0.1 0.6 0.2 0.1 2.5 2.9 1.5 3.1 2.3 1.1 2.0 1.8 2.7 0.4 2.7 6.2 56.2 22.4 23.5 68.9 34.3 16.4 15.3 18.1 27.9 107.9 39.1 31.2 66.6 21.5 23.6 64.4 148.0 25.9 28.5 31.8 1.9 28.7 13.0 35.0 55.8 73.3 28.1 67.9 88.9 30.4 15.5 34.3 43.3 29.6 3.8 135.0 38.9 36.7 19.0 122.8 82.9 32.1 16.2 22.3 20.7 15.8 56.2 22.1 69.4 84.3 26.9 41.0 45.3 65.9 89.7 36.6 30.8 52.3 56.6 20.5 31.1 19.8 19.6 142.9 65.7 46.0 43.2 72.5 66.4 38.3 21.0 17.8 30.0 62.7 35.5 11.5 GOLGA8F DKFZp434P162 ENSG00000153684 "Golgin A8 family member F" Q08AF8 15 28378621-28392018 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 180 "testis: 20.1" "Cell type enhanced" "Detected in some" "Early spermatids: 1.7;Spermatocytes: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "NB-4: 2.1" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 24: NB-4 - Immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "unprognostic (4.96e-2)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA8G DKFZp434K052 ENSG00000183629 "Golgin A8 family member G" 15 28519611-28533014 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 92 "testis: 9.1" "Group enriched" "Detected in some" 14 "Early spermatids: 11.8;Spermatocytes: 19.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 36: Testis - Spermatogenesis" "Cluster 66: Spermatocytes - Spermatogenesis" "unprognostic (7.17e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA8M ENSG00000188626 "Golgin A8 family member M" H3BSY2 15 28701954-28738384 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 6.3;thyroid gland: 13.9" "Cell type enhanced" "Detected in some" "Astrocytes: 8.8;Early spermatids: 24.7;NK-cells: 7.2" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.8" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "HEL: 2.6;U-937: 6.4" NA NA "Cluster 1: Thyroid gland - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (1.40e-1)" "unprognostic (3.90e-2)" "unprognostic (2.04e-1)" "unprognostic (2.00e-2)" "unprognostic (5.25e-3)" "unprognostic (1.28e-1)" "unprognostic (2.05e-1)" "unprognostic (6.16e-3)" "unprognostic (8.16e-4)" "unprognostic (4.32e-2)" "unprognostic (2.66e-4)" "unprognostic (8.24e-3)" "unprognostic (4.06e-1)" "unprognostic (1.05e-1)" "unprognostic (1.60e-1)" 3.0 0.7 0.2 0.0 0.3 0.6 2.6 0.0 0.5 1.5 0.1 0.4 0.0 0.7 0.5 0.2 1.2 0.3 0.9 0.2 0.2 1.4 3.3 0.7 0.1 0.8 0.3 4.1 0.7 0.0 1.9 1.7 0.2 0.6 0.0 0.0 0.3 0.2 0.3 0.3 0.3 0.1 0.1 0.4 0.3 6.3 0.2 0.0 13.9 0.0 0.0 0.6 1.1 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.5 0.2 0.2 0.8 0.3 0.2 0.1 0.2 0.5 1.7 3.2 2.2 8.8 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.5 1.5 0.0 0.0 0.0 0.0 3.0 0.0 1.9 0.0 24.7 0.3 0.2 0.5 0.0 0.0 2.2 0.0 0.0 0.4 0.0 0.3 0.0 0.2 0.0 0.3 0.1 3.3 1.5 0.0 0.0 0.0 0.3 2.9 0.0 0.4 0.0 1.9 0.5 0.2 7.2 3.0 2.9 0.0 0.0 0.7 0.3 0.0 0.0 0.8 0.7 0.1 0.0 0.8 0.3 3.9 0.8 0.0 0.0 0.1 1.4 0.2 0.0 0.1 GOLGA6L7 GOLGA6L7P ENSG00000261649 "Golgin A6 family like 7" A0A1B0GV03 15 28841833-28848675 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 27.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 1.0;U-266/70: 1.3;U-266/84: 1.3" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (2.13e-1)" "unprognostic (1.98e-1)" "unprognostic (3.65e-5)" "unprognostic (3.84e-1)" "unprognostic (6.81e-2)" "unprognostic (1.66e-2)" "unprognostic (5.10e-2)" "unprognostic (5.62e-11)" "unprognostic (2.53e-1)" "unprognostic (3.14e-1)" "unprognostic (2.59e-1)" 0.0 0.2 0.7 0.0 0.5 0.1 0.0 1.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 1.4 0.6 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 27.8 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 1.5 1.0 0.3 0.1 1.4 0.6 1.6 0.1 0.6 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 APBA2 "D15S1518E, HsT16821, LIN-10, MGC:14091, MINT2, X11L" ENSG00000034053 "Amyloid beta precursor protein binding family A member 2" Q99767 15 28884483-29118315 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.7;lymphoid tissue: 10.7" "Cell type enhanced" "Detected in many" "Astrocytes: 53.2;Excitatory neurons: 142.7;Horizontal cells: 89.2;Inhibitory neurons: 106.1;NK-cells: 63.8;Oligodendrocyte precursor cells: 97.0;Oligodendrocytes: 74.1" "Cancer enhanced" "Detected in many" "glioma: 17.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 5.4;naive CD8 T-cell: 5.6" "Lineage enriched" "Detected in many" 4 "T-cells: 5.6" "Cell line enhanced" "Detected in some" "HEL: 8.4;SH-SY5Y: 20.0;U-937: 14.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037065, HPA058796, HPA070376" Uncertain Enhanced "Golgi apparatus" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 63: NK-cells & T-cells - Immune response" "Golgi apparatus" "CAB037065: AB_477178, HPA058796: , HPA070376: " "unprognostic (2.18e-1)" "unprognostic (9.20e-2)" "unprognostic (1.13e-1)" "unprognostic (6.16e-3)" "unprognostic (2.42e-1)" "unprognostic (5.96e-2)" "unprognostic (1.41e-2)" "unprognostic (1.64e-1)" "unprognostic (1.17e-1)" "unprognostic (8.19e-2)" "unprognostic (4.71e-2)" "unprognostic (9.25e-2)" "unprognostic (4.21e-5)" "unprognostic (1.98e-2)" "unprognostic (4.74e-2)" "unprognostic (7.63e-3)" "unprognostic (4.28e-1)" 1.0 1.6 4.3 0.7 4.4 0.7 0.9 8.7 8.4 2.9 0.0 1.3 0.4 1.2 0.4 1.7 1.6 0.3 0.4 8.0 2.5 0.9 0.9 3.3 0.6 3.3 2.4 1.1 5.9 0.0 7.6 0.1 2.4 2.5 0.2 1.1 0.4 0.1 0.1 1.0 4.9 0.0 2.2 10.7 1.4 5.7 3.0 1.4 2.7 0.0 0.7 1.3 1.5 4.9 0.0 1.6 0.7 3.7 0.0 0.0 0.0 0.9 1.4 0.1 0.5 0.0 0.0 0.0 3.5 0.0 2.3 0.0 0.5 0.0 0.0 0.0 3.1 8.4 0.0 0.1 3.1 0.0 0.2 0.4 2.5 0.4 0.0 0.4 4.4 1.8 5.0 0.2 0.0 0.5 0.2 2.4 1.1 0.0 3.3 0.0 0.4 0.2 0.0 0.0 5.4 20.0 0.0 0.0 0.2 0.1 0.0 1.0 4.4 0.0 4.4 0.0 0.9 0.0 0.1 0.0 0.1 14.9 1.7 0.0 0.0 0.0 0.9 0.0 0.2 0.0 1.5 3.3 0.0 0.0 5.4 5.6 0.1 1.3 0.0 0.0 0.0 2.0 4.3 4.4 8.7 8.4 8.0 2.5 3.3 2.4 2.4 2.2 3.0 4.9 0.5 0.0 0.6 53.2 1.8 0.4 0.2 0.0 0.0 21.5 1.9 2.3 1.4 0.0 0.1 0.0 0.0 0.1 36.5 0.1 1.9 1.8 18.9 2.9 6.4 1.2 0.0 2.1 142.7 5.8 0.2 2.2 0.0 2.1 0.0 1.9 3.6 0.5 1.2 89.2 106.1 0.3 0.0 1.6 0.4 10.4 1.8 0.8 3.6 33.7 1.9 1.3 63.8 97.0 74.1 3.3 0.0 3.8 12.3 0.1 0.0 0.3 0.2 4.5 0.0 0.4 2.1 1.6 14.5 0.4 0.3 0.1 30.7 10.6 0.0 0.1 FAM189A1 "KIAA0574, TMEM228" ENSG00000104059 "Family with sequence similarity 189 member A1" O60320 15 29120254-29570723 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pancreas: 5.3;thyroid gland: 3.2" "Group enriched" "Detected in some" 5 "Excitatory neurons: 202.9;Inhibitory neurons: 198.0;Oligodendrocyte precursor cells: 59.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 4.6;HDLM-2: 12.0;REH: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009410, HPA010637" Uncertain Approved Nucleoplasm NA NA "Cluster 22: Non-specific - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "HPA009410: AB_1852332, HPA010637: AB_1852333" "unprognostic (3.18e-1)" "unprognostic (3.52e-2)" "unprognostic (5.81e-2)" "unprognostic (6.52e-2)" "unprognostic (7.05e-2)" "unprognostic (4.71e-2)" "unprognostic (4.85e-3)" "unprognostic (2.21e-1)" "unprognostic (1.27e-1)" "unprognostic (3.39e-1)" "unprognostic (7.97e-2)" "unprognostic (5.00e-1)" "unprognostic (6.70e-3)" "unprognostic (2.39e-2)" "unprognostic (9.03e-2)" "unprognostic (2.50e-2)" "unprognostic (3.12e-1)" 0.6 0.4 2.2 0.0 1.8 0.0 0.1 0.0 2.4 0.3 0.3 2.6 0.1 0.2 0.0 0.0 1.0 0.0 0.8 2.5 0.4 2.1 0.1 1.1 0.0 0.2 0.3 0.2 5.3 0.4 0.4 0.0 0.2 0.4 0.5 0.1 0.6 0.0 0.0 0.1 0.9 0.0 0.0 0.2 0.4 2.0 1.2 0.0 3.2 0.0 0.1 0.9 0.2 0.8 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.2 0.0 0.0 0.0 0.1 12.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 1.5 0.0 0.4 0.0 0.0 0.3 0.0 0.0 2.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 1.8 0.0 2.4 2.5 0.4 0.2 0.3 0.2 0.0 1.2 0.8 0.5 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 4.3 0.8 0.0 0.0 0.4 3.0 0.0 202.9 0.2 0.0 0.7 0.0 0.1 0.0 0.3 0.7 0.0 0.1 0.0 198.0 2.0 0.0 0.0 0.0 1.1 0.9 0.0 0.0 29.0 0.0 0.2 0.0 59.8 8.1 0.2 2.6 1.5 0.0 1.0 2.2 0.8 0.0 0.4 0.0 0.0 0.2 0.6 1.7 0.0 0.0 0.0 0.0 1.0 3.2 0.4 NSMCE3 "HCA4, MAGEG1, MAGEL3, NDNL2, NSE3" ENSG00000185115 "NSE3 homolog, SMC5-SMC6 complex component" Q96MG7 15 29264989-29269822 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Growth regulation, Ubl conjugation pathway" "Tumor antigen" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Spermatocytes: 83.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "OE19: 2.6" "Low region specificity" "Detected in single" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 21: OE19 - Mitochondria" "Cluster 24: Non-specific - Transcription regulation" "unprognostic (1.34e-1)" "unprognostic (1.41e-1)" "unprognostic (6.38e-2)" "unprognostic (3.66e-3)" "unprognostic (3.30e-1)" "prognostic unfavorable (1.94e-4)" "unprognostic (1.97e-1)" "unprognostic (2.52e-2)" "unprognostic (2.47e-2)" "unprognostic (2.50e-2)" "unprognostic (4.76e-3)" "unprognostic (1.27e-1)" "unprognostic (1.22e-1)" "unprognostic (1.56e-1)" "unprognostic (6.84e-2)" "unprognostic (5.00e-2)" "unprognostic (2.41e-2)" 3.8 5.1 0.5 0.1 0.4 0.0 3.6 0.4 0.6 3.1 0.0 4.1 0.1 5.0 0.1 2.5 4.0 0.1 4.6 0.6 0.1 3.1 4.0 3.4 0.2 0.2 0.1 4.7 2.9 0.2 5.9 0.1 0.3 2.8 0.2 0.4 3.1 0.2 4.0 2.4 4.3 0.1 0.0 5.3 3.4 6.3 0.3 0.2 4.1 0.0 0.1 3.7 2.6 0.2 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.1 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.1 0.0 2.6 0.0 0.1 0.2 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.3 0.1 0.4 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.4 0.6 0.6 0.1 0.2 0.1 0.3 0.0 0.3 0.2 29.6 16.0 9.5 0.0 68.0 0.0 28.1 0.0 29.0 39.7 15.0 21.7 0.0 10.0 0.6 9.2 10.4 22.9 80.2 2.3 15.6 22.5 23.9 15.6 26.1 19.6 13.3 9.0 0.0 16.3 14.0 20.9 11.2 14.0 5.1 22.3 21.0 15.4 20.8 43.7 0.0 4.4 0.0 17.1 0.0 72.8 23.3 34.8 0.0 0.0 20.3 41.5 39.1 0.0 0.0 12.1 4.5 31.6 77.7 19.1 4.6 26.9 2.9 41.2 26.3 30.9 28.0 83.8 31.7 12.9 0.0 11.8 80.6 36.6 4.8 18.5 TJP1 "DKFZp686M05161, MGC133289, ZO-1" ENSG00000104067 "Tight junction protein 1" Q07157 15 29699367-29968915 "Predicted intracellular proteins, Transporters" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 893.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001636, HPA001637, CAB010822" Enhanced Enhanced "Cell Junctions" NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 44: Endometrium - Transcription" "Cell Junctions" "CAB010822: , HPA001636: AB_1080762, HPA001637: AB_1080760" "unprognostic (2.11e-2)" "unprognostic (6.83e-2)" "unprognostic (1.21e-1)" "unprognostic (2.81e-2)" "unprognostic (9.43e-2)" "unprognostic (1.21e-1)" "unprognostic (4.54e-2)" "unprognostic (6.71e-3)" "unprognostic (1.98e-1)" "unprognostic (2.86e-1)" "unprognostic (2.86e-3)" "unprognostic (3.54e-1)" "prognostic favorable (1.72e-4)" "unprognostic (2.85e-3)" "unprognostic (3.02e-1)" "unprognostic (5.04e-2)" "unprognostic (1.20e-1)" 37.4 16.5 22.1 4.4 35.3 1.1 30.8 21.4 24.4 33.2 17.9 30.5 7.1 42.3 16.5 60.4 27.8 12.6 37.1 22.0 22.2 24.3 18.6 34.0 5.7 26.6 28.6 22.3 30.0 13.4 16.8 31.6 25.2 20.4 9.5 10.0 29.6 10.9 22.0 27.8 19.8 17.4 20.6 13.5 25.8 29.7 30.3 3.7 24.8 5.0 10.2 23.8 35.3 42.6 62.4 36.8 29.1 18.4 17.0 31.7 28.9 18.6 21.1 18.0 20.2 59.2 22.9 0.3 24.8 24.6 21.3 47.4 20.1 23.8 19.0 0.5 14.9 0.3 22.3 24.7 57.9 0.1 0.8 16.5 15.8 21.4 39.2 23.0 38.2 0.1 24.3 12.5 14.2 32.2 0.2 0.7 21.9 23.4 14.6 0.1 35.0 0.2 28.1 33.4 12.9 16.8 39.2 12.8 16.8 42.9 13.3 0.6 54.7 14.3 23.9 12.5 25.6 4.4 4.6 0.4 17.8 0.3 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.1 35.3 21.4 24.4 22.0 22.2 26.6 28.6 25.2 20.6 30.3 42.6 212.1 169.9 49.2 299.7 1.6 35.8 115.2 36.4 39.3 42.4 53.7 28.6 107.2 51.5 48.6 58.8 10.4 32.3 0.8 87.7 25.4 116.0 19.1 132.2 97.0 166.0 46.0 2.7 293.8 83.7 11.3 56.6 86.6 290.7 5.7 87.7 100.3 49.1 3.8 126.2 187.3 45.4 32.6 6.1 12.1 13.7 33.8 5.2 64.0 266.1 1.6 32.8 0.0 345.3 893.8 178.3 82.0 63.9 5.9 151.4 37.8 26.0 39.2 52.4 78.9 64.1 118.7 63.0 83.9 139.2 60.1 33.7 4.1 120.8 33.1 194.6 GOLGA8J ENSG00000179938 "Golgin A8 family member J" A6NMD2 15 30083053-30093499 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 16 "testis: 4.7" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 4.2;Early spermatids: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 23: Spermatids - Flagellum & Golgi organization" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 8.4 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GOLGA8T ENSG00000261247 "Golgin A8 family member T" H3BQL2 15 30135149-30145567 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 6.9" "Cell type enriched" "Detected in single" 6 "Early spermatids: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 71: Testis - DNA repair" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (1.01e-1)" "unprognostic (1.38e-1)" "unprognostic (2.05e-1)" "unprognostic (2.41e-1)" "unprognostic (1.22e-1)" "unprognostic (1.38e-1)" "unprognostic (5.20e-2)" "unprognostic (5.37e-2)" "unprognostic (2.10e-2)" 0.4 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.1 0.3 0.0 0.4 0.0 0.2 0.4 0.0 0.7 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.0 0.7 1.1 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.2 0.2 0.2 0.0 0.0 0.2 0.2 6.9 0.0 0.0 1.2 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CHRFAM7A "CHRNA7-DR1, D-10" ENSG00000166664 "CHRNA7 (exons 5-10) and FAM7A (exons A-E) fusion" Q494W8 15 30360566-30393849 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 4.2;parathyroid gland: 5.5" "Cell type enhanced" "Detected in some" "Horizontal cells: 11.8;Inhibitory neurons: 4.1;Proximal enterocytes: 4.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "eosinophil: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HAP1: 3.6;HEK 293: 1.8;HEL: 3.8;RH-30: 2.6;SH-SY5Y: 2.0;U-937: 3.5" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 32: U-937 - Innate immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "unprognostic (3.61e-2)" "unprognostic (1.52e-1)" "unprognostic (5.59e-2)" "unprognostic (2.66e-3)" "unprognostic (2.40e-1)" "unprognostic (2.02e-1)" "unprognostic (3.55e-1)" "unprognostic (7.20e-2)" "unprognostic (3.53e-1)" "unprognostic (7.45e-2)" "unprognostic (2.41e-1)" "unprognostic (4.94e-2)" "unprognostic (1.10e-2)" "unprognostic (1.71e-4)" "unprognostic (7.33e-2)" "unprognostic (1.03e-1)" "unprognostic (1.45e-1)" 0.7 0.8 0.3 0.6 0.5 4.2 0.4 0.3 0.9 0.4 0.5 0.5 0.5 0.3 0.1 0.2 0.3 0.2 1.2 0.4 0.8 0.2 0.0 0.9 0.2 1.5 1.7 0.5 0.7 5.5 0.6 0.0 1.3 0.7 0.0 0.3 0.3 0.2 0.2 0.3 0.7 0.3 0.7 0.7 0.7 3.2 0.6 0.2 1.7 0.3 0.2 0.4 0.4 0.6 0.0 0.2 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 1.4 0.0 3.6 0.0 0.0 0.0 1.8 3.8 0.1 0.1 0.1 0.7 1.0 0.2 0.0 0.0 0.0 1.6 0.3 0.8 0.4 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.6 0.0 1.0 0.1 0.1 2.0 0.0 0.0 0.0 0.3 0.0 0.2 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.9 2.8 0.1 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.4 0.1 0.3 0.1 0.3 0.3 0.5 0.3 0.9 0.4 0.8 1.5 1.7 1.3 0.7 0.6 0.6 0.1 0.0 0.0 1.0 0.9 0.0 1.2 0.0 1.8 1.5 0.1 0.4 2.1 1.5 0.6 0.0 0.0 0.0 0.2 0.8 0.0 0.2 0.2 0.4 0.2 0.4 1.2 2.1 1.6 1.1 0.0 0.6 2.0 0.9 1.3 0.3 0.4 0.0 0.7 11.8 4.1 3.1 0.0 0.8 0.0 0.5 0.0 1.2 0.0 0.0 1.6 0.8 1.0 0.0 0.3 0.7 0.3 1.5 0.7 0.5 4.1 0.0 0.0 0.0 0.0 0.3 0.6 3.2 1.9 0.6 0.0 0.0 0.2 0.0 0.9 1.5 GOLGA8R ENSG00000186399 "Golgin A8 family member R" I6L899 15 30403740-30414162 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 69.3;NK-cells: 23.7;Sertoli cells: 13.1;Spermatocytes: 20.4" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "HEL: 23.9;THP-1: 7.6;U-937: 8.0" NA NA "Cluster 71: Testis - DNA repair" "Cluster 36: HEL - Hemostasis" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (1.13e-1)" "unprognostic (8.96e-3)" "unprognostic (1.27e-2)" "unprognostic (9.06e-2)" "unprognostic (1.87e-2)" "unprognostic (4.70e-2)" "unprognostic (2.12e-2)" "unprognostic (1.02e-1)" "unprognostic (2.58e-1)" "unprognostic (9.09e-2)" "unprognostic (9.79e-4)" "unprognostic (2.29e-1)" "unprognostic (2.12e-1)" "unprognostic (4.41e-2)" "unprognostic (1.69e-1)" "unprognostic (3.80e-2)" "unprognostic (9.68e-2)" 2.9 1.8 0.4 1.1 0.9 3.8 2.6 0.3 0.9 3.0 1.1 2.7 0.7 3.1 1.5 1.7 3.1 1.0 3.3 0.2 0.7 1.6 2.4 2.2 0.6 1.0 0.6 5.5 3.8 1.3 5.2 0.4 0.9 2.0 0.4 1.2 2.7 0.6 2.2 2.1 2.4 0.9 0.4 1.7 2.2 6.1 1.2 0.3 8.8 0.8 0.5 2.9 2.9 1.4 0.1 0.0 0.1 0.0 0.0 1.6 0.0 0.6 0.3 0.0 0.2 0.0 0.1 0.3 0.2 0.1 0.6 0.0 0.0 0.0 0.1 0.0 0.0 23.9 0.0 0.0 0.3 0.0 0.0 0.4 0.4 0.1 0.0 1.4 0.1 0.2 0.1 0.1 0.1 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.1 0.1 7.6 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.3 8.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.9 0.3 0.9 0.2 0.7 1.0 0.6 0.9 0.4 1.2 1.4 0.6 0.0 1.5 0.3 1.2 0.0 0.2 0.0 0.0 3.2 0.2 0.3 0.8 1.5 1.3 0.0 0.0 0.2 4.1 0.1 0.0 0.1 69.3 4.0 1.2 0.8 0.0 0.4 0.2 0.0 0.0 1.1 0.0 0.8 1.3 1.8 0.4 0.4 0.3 8.4 0.2 0.1 0.0 0.8 0.0 4.9 1.2 0.9 0.0 1.0 1.6 1.1 23.7 0.5 1.4 0.1 0.1 0.4 1.2 0.2 0.5 0.1 0.7 3.6 13.1 1.7 1.0 20.4 1.9 0.0 0.0 0.0 2.8 1.5 0.3 0.3 GOLGA8Q ENSG00000178115 "Golgin A8 family member Q" H3BV12 15 30552078-30562501 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "thyroid gland: 10.6" "Group enriched" "Detected in some" 4 "Early spermatids: 44.4;NK-cells: 19.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "THP-1: 4.9;U-937: 6.0" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 1: Thyroid gland - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (2.65e-2)" "unprognostic (6.48e-2)" "unprognostic (2.24e-1)" "unprognostic (5.52e-4)" "unprognostic (9.86e-3)" "unprognostic (1.26e-1)" "unprognostic (7.17e-2)" "unprognostic (3.26e-1)" "unprognostic (2.31e-1)" 0.9 0.3 0.2 0.1 0.2 1.6 0.6 0.0 0.3 1.2 0.6 0.7 0.0 1.1 2.1 0.3 0.7 0.2 0.7 0.5 0.1 0.3 0.4 0.6 0.0 0.5 0.1 1.2 1.1 1.7 1.2 0.1 0.1 0.4 0.2 0.4 0.5 0.2 0.5 0.4 0.5 0.5 0.1 0.3 0.5 4.1 0.2 0.1 10.6 0.9 0.0 0.6 0.6 0.6 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.3 0.0 1.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 4.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.3 0.5 0.1 0.5 0.1 0.1 0.1 0.2 0.6 0.2 0.0 0.5 0.0 0.8 0.0 0.3 0.1 0.0 0.7 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.0 44.4 1.5 0.3 0.3 1.2 0.0 0.0 0.2 0.0 0.8 0.0 0.1 0.0 1.0 0.4 0.5 0.5 5.0 0.0 0.1 0.0 1.0 0.5 2.3 2.1 0.6 1.8 0.0 1.6 0.3 19.6 0.0 0.0 0.0 0.1 1.5 0.3 0.1 0.2 0.1 0.1 1.0 6.6 0.8 0.6 6.2 1.9 0.0 0.1 0.0 1.1 0.8 0.2 0.2 GOLGA8H GOLGA6L11 ENSG00000261794 "Golgin A8 family member H" P0CJ92 15 30604126-30614561 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 6.4" "Cell type enhanced" "Detected in some" "Astrocytes: 6.8;Early spermatids: 20.3;Inhibitory neurons: 3.1;Microglial cells: 4.7;Spermatocytes: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 2.4;HMC-1: 2.9;RH-30: 4.1;SH-SY5Y: 2.3;TIME: 2.2;U-937: 2.3" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (4.32e-3)" "unprognostic (7.13e-2)" "unprognostic (4.86e-2)" "unprognostic (2.92e-1)" "unprognostic (2.71e-1)" "unprognostic (7.33e-2)" "unprognostic (6.91e-2)" "unprognostic (1.12e-1)" "unprognostic (2.49e-1)" "unprognostic (1.05e-1)" "unprognostic (6.44e-3)" "unprognostic (2.85e-2)" "unprognostic (1.66e-1)" "unprognostic (2.22e-2)" "unprognostic (1.10e-1)" "unprognostic (6.08e-2)" "unprognostic (1.14e-1)" 1.1 0.3 0.3 0.4 0.2 2.7 0.5 0.1 0.2 1.0 0.3 0.4 0.2 0.7 0.5 0.3 1.1 0.5 1.1 0.3 0.2 0.2 0.1 0.8 0.5 0.5 0.5 0.5 1.5 0.9 0.4 0.2 0.5 0.3 0.3 0.7 0.3 0.3 0.4 0.3 0.4 0.7 0.2 0.5 0.3 6.4 0.4 0.1 1.9 0.3 0.2 0.6 0.4 0.4 0.0 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.3 0.3 0.1 0.6 0.0 1.5 0.0 1.2 0.0 0.0 0.1 1.0 2.4 0.1 0.0 0.0 0.6 2.9 0.1 0.1 0.1 0.1 1.8 0.6 1.4 0.3 0.1 0.3 0.3 0.0 0.2 0.2 0.1 0.3 0.0 4.1 0.0 0.3 0.2 0.3 2.3 0.1 0.0 0.0 0.2 0.2 1.7 2.2 0.0 0.8 0.0 0.3 0.4 0.0 1.0 0.0 2.3 0.2 0.0 0.1 0.3 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.3 0.2 0.1 0.2 0.3 0.2 0.5 0.5 0.5 0.2 0.4 0.4 0.1 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 2.5 0.1 0.1 0.0 0.0 1.1 0.2 0.0 0.2 0.0 0.3 2.5 0.0 0.0 0.0 0.1 0.0 3.1 0.0 0.0 0.0 0.0 2.6 0.3 0.3 0.0 4.7 1.7 0.0 0.0 1.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 5.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 ARHGAP11B "B'-T, FAM7B1" ENSG00000285077 "Rho GTPase activating protein 11B" Q3KRB8 15 30624494-30649529 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 2.6;lymphoid tissue: 1.4" "Cell type enhanced" "Detected in many" "Early spermatids: 22.6;Erythroid cells: 37.4;Late spermatids: 21.7;Muller glia cells: 17.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 8.9;Karpas-707: 7.1" HPA064479 Uncertain Uncertain Vesicles NA NA "Cluster 20: HeLa - Mitochondria" "Cluster 12: Non-specific - Cell cycle regulation" Vesicles "HPA064479: AB_2685272" 0.2 0.0 0.0 0.8 0.2 2.6 0.2 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 1.4 0.2 0.2 0.0 0.0 0.1 0.2 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.6 0.2 0.2 0.1 0.2 0.2 0.3 0.1 1.4 0.1 0.0 0.8 0.1 0.1 1.2 1.0 2.8 1.3 0.0 0.4 0.8 3.2 0.9 1.6 1.8 0.6 1.8 1.5 0.1 0.2 0.9 1.4 1.6 0.6 1.3 3.0 3.9 3.1 8.9 0.2 0.0 2.8 1.8 0.1 0.0 0.4 0.2 0.5 0.9 1.9 0.8 7.1 1.7 1.0 1.0 2.8 0.8 0.7 1.2 1.9 3.2 0.8 0.7 1.3 1.5 0.8 1.9 0.7 0.4 0.7 1.5 1.4 1.0 2.6 1.7 0.5 0.8 1.4 0.5 3.1 0.4 3.5 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.3 0.0 1.5 1.0 6.1 2.0 1.0 2.8 1.8 3.2 0.6 0.3 0.7 0.0 0.6 1.8 6.2 0.0 5.1 7.0 0.0 0.4 22.6 0.4 1.3 1.1 0.0 37.4 0.4 0.6 0.0 2.3 15.3 0.7 1.3 6.9 4.2 0.8 0.0 3.3 0.2 8.3 2.0 7.9 3.1 21.7 2.1 3.3 0.0 1.0 4.8 17.3 4.1 0.0 0.7 0.4 2.5 1.2 12.6 1.0 1.6 0.6 1.2 2.3 0.0 1.3 1.5 15.5 12.9 6.9 1.4 0.0 5.8 1.2 12.1 0.9 FAN1 "KIAA1018, MTMR15" ENSG00000198690 "FANCD2 and FANCI associated nuclease 1" Q9Y2M0 15 30890559-30943108 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" "Endonuclease, Exonuclease, Hydrolase, Nuclease" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 44.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048198 Supported "Nucleoplasm,Cytokinetic bridge,Cytosol" Yes NA "Cluster 14: Monocytes - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "Cytokinetic bridge, Cytosol" "HPA048198: AB_2680311" "unprognostic (7.18e-3)" "unprognostic (5.63e-2)" "unprognostic (1.96e-1)" "unprognostic (3.30e-2)" "unprognostic (6.99e-2)" "unprognostic (2.86e-1)" "unprognostic (1.97e-1)" "unprognostic (1.19e-1)" "unprognostic (5.94e-2)" "unprognostic (3.53e-2)" "unprognostic (3.53e-2)" "unprognostic (9.67e-2)" "prognostic favorable (1.42e-6)" "unprognostic (3.73e-1)" "unprognostic (1.19e-1)" "unprognostic (8.93e-3)" "unprognostic (1.29e-1)" 6.2 8.5 9.3 0.9 9.5 0.5 6.7 9.4 9.7 10.1 9.3 10.7 0.9 9.2 6.6 6.5 9.0 1.2 8.8 8.9 9.5 9.5 9.6 5.5 0.8 9.7 9.8 11.8 12.7 5.9 11.4 3.0 10.0 11.5 2.0 2.7 9.8 1.4 18.7 10.8 7.3 2.4 9.5 6.8 8.6 8.9 9.9 4.4 10.0 7.3 0.7 9.3 9.7 10.0 5.2 9.9 3.6 1.9 12.4 9.3 0.8 4.4 2.1 4.7 5.0 4.5 1.7 0.6 7.6 3.6 7.4 9.2 4.7 9.4 5.0 4.2 1.4 1.3 5.5 1.9 4.8 1.2 1.9 2.8 7.3 3.0 7.3 7.2 3.4 5.7 4.7 6.1 4.7 0.6 8.6 3.1 2.2 11.5 2.8 7.0 12.0 2.3 6.7 2.3 4.5 4.6 9.2 5.6 3.0 8.8 4.4 3.3 3.3 9.4 3.0 5.0 3.4 7.4 8.7 1.1 4.1 1.9 1.1 0.0 0.1 0.0 1.4 0.3 2.0 1.2 1.2 0.7 0.9 1.5 1.8 1.1 0.0 1.8 4.3 1.1 1.4 0.7 9.3 9.5 9.4 9.7 8.9 9.5 9.7 9.8 10.0 9.5 9.9 10.0 9.1 16.0 8.4 21.2 5.4 4.1 5.8 4.9 9.6 17.0 11.2 9.8 17.0 0.0 10.7 9.2 20.9 6.5 3.5 7.6 9.8 4.5 11.9 10.2 12.9 8.8 7.8 6.9 23.7 2.9 2.2 8.4 8.6 9.0 8.8 15.5 6.8 13.4 3.7 26.9 25.5 11.0 8.2 5.4 2.5 7.1 10.5 3.9 5.4 15.0 3.4 14.9 7.2 13.6 44.2 3.6 6.4 6.8 7.0 6.0 4.2 8.0 13.6 23.5 6.6 9.4 7.6 20.9 16.4 7.2 2.4 4.1 5.3 9.2 10.3 3.7 MTMR10 FLJ20313 ENSG00000166912 "Myotubularin related protein 10" Q9NXD2 15 30938941-30991628 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 86.2;Oligodendrocytes: 149.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 13.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006081 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" No No "Cluster 8: Neutrophils - Inflammatory response" "Cluster 70: Brain - Nervous system development" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoplasm, Nuclear bodies" Cytosol "HPA006081: AB_2667508" "unprognostic (1.60e-1)" "unprognostic (6.09e-2)" "unprognostic (1.21e-1)" "unprognostic (1.36e-1)" "unprognostic (2.18e-1)" "unprognostic (7.36e-2)" "unprognostic (4.43e-2)" "unprognostic (7.26e-2)" "unprognostic (1.24e-1)" "unprognostic (3.31e-2)" "unprognostic (6.43e-2)" "unprognostic (2.54e-1)" "prognostic favorable (7.77e-12)" "unprognostic (9.92e-2)" "unprognostic (1.15e-1)" "unprognostic (1.79e-1)" "unprognostic (1.01e-1)" 18.6 9.5 29.3 10.7 46.9 18.7 10.3 49.4 33.3 11.2 24.8 9.9 12.8 9.4 9.4 20.9 7.5 9.6 12.7 28.0 36.3 30.6 24.2 13.6 12.0 57.6 48.5 11.5 12.4 21.3 1.9 25.9 56.5 11.0 10.3 12.1 14.9 11.4 29.4 11.2 11.6 10.0 45.3 15.1 13.0 8.5 40.8 16.7 14.2 24.0 10.6 10.1 5.4 63.3 8.1 9.0 8.2 5.2 17.7 9.6 7.2 11.9 23.9 9.4 9.4 5.9 3.5 3.9 15.5 15.5 9.1 11.5 6.5 7.0 8.9 12.5 2.1 5.5 6.2 10.4 10.3 8.9 12.2 13.2 5.4 6.1 6.7 10.8 23.7 10.9 4.9 9.2 8.9 2.3 9.3 5.6 4.7 9.7 4.3 6.7 6.7 19.5 35.6 12.7 3.0 7.8 5.4 6.3 2.4 10.4 4.2 16.4 10.9 10.6 8.0 5.6 6.8 9.4 7.8 9.0 6.7 4.7 13.4 3.7 3.2 3.1 0.7 4.0 0.8 1.9 0.8 0.6 3.1 2.8 1.2 1.2 13.5 1.4 7.4 3.7 1.2 1.7 29.3 46.9 49.4 33.3 28.0 36.3 57.6 48.5 56.5 45.3 40.8 63.3 15.8 25.6 15.2 86.2 11.3 8.9 4.3 3.3 8.0 0.0 6.7 4.6 24.1 10.0 7.0 33.1 0.0 19.3 12.9 12.7 1.9 3.4 13.6 10.1 9.6 16.8 6.0 5.2 15.4 3.8 3.1 8.6 13.3 19.7 17.1 9.4 11.4 33.9 11.8 0.0 13.6 7.7 2.0 24.9 16.2 24.9 10.5 19.0 8.8 55.3 13.8 0.0 3.1 25.6 149.3 5.6 9.2 7.5 8.0 6.7 14.4 18.6 4.7 0.0 0.0 10.6 8.9 11.1 8.9 33.6 11.1 38.4 6.8 6.7 8.2 8.7 TRPM1 "CSNB1C, LTRPC1, MLSN1" ENSG00000134160 "Transient receptor potential cation channel subfamily M member 1" Q7Z4N2 15 31001061-31161273 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital stationary night blindness, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "retina: 9.4;skin 1: 4.1" "Group enriched" "Detected in some" 7 "Bipolar cells: 627.4;Melanocytes: 158.3" "Cancer enriched" "Detected in single" 179 "melanoma: 14.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 112 "SK-MEL-30: 12.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA014779, HPA071139" Enhanced Uncertain "Golgi apparatus,Plasma membrane,Centriolar satellite" NA NA "Cluster 77: Retina - Visual perception" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 56: Bipolar cells - Visual perception" "Centriolar satellite" "Golgi apparatus, Plasma membrane" "HPA014779: AB_2669090, HPA071139: " "unprognostic (5.28e-2)" "unprognostic (1.35e-1)" "unprognostic (9.89e-2)" "unprognostic (3.07e-1)" "unprognostic (1.97e-1)" "unprognostic (1.70e-1)" "unprognostic (1.29e-3)" "unprognostic (2.83e-1)" "unprognostic (2.89e-2)" "unprognostic (1.67e-1)" "unprognostic (1.45e-2)" "unprognostic (2.58e-1)" "unprognostic (7.84e-2)" "unprognostic (6.20e-4)" "unprognostic (1.48e-1)" "unprognostic (2.63e-2)" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 9.4 0.1 0.0 0.0 4.1 0.0 0.0 0.5 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.3 0.1 0.2 0.2 0.4 0.3 0.5 0.3 0.5 0.0 0.0 0.0 0.7 0.0 4.2 0.0 0.0 0.0 627.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 50.5 0.1 0.1 1.7 0.0 0.0 0.9 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 13.5 0.8 0.0 0.0 0.0 1.0 6.3 0.0 0.0 158.3 0.0 0.0 11.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 22.2 0.0 0.1 0.1 10.1 4.4 1.8 1.0 1.0 0.0 0.0 0.0 0.1 KLF13 "BTEB3, FKLF-2, NSLP1, RFLAT-1" ENSG00000169926 "Kruppel like factor 13" Q9Y2Y9 15 31326835-31435665 "Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Horizontal cells: 275.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 85.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 24: Non-specific - Transcription regulation" "unprognostic (2.13e-2)" "unprognostic (9.41e-2)" "unprognostic (5.50e-2)" "unprognostic (1.63e-3)" "unprognostic (3.10e-1)" "unprognostic (9.32e-2)" "unprognostic (2.96e-1)" "unprognostic (5.94e-2)" "unprognostic (1.15e-2)" "unprognostic (3.17e-3)" "unprognostic (3.05e-1)" "unprognostic (2.09e-1)" "prognostic favorable (2.37e-9)" "unprognostic (2.16e-2)" "unprognostic (1.52e-1)" "unprognostic (1.62e-2)" "unprognostic (2.03e-2)" 25.0 11.7 2.8 13.0 8.2 62.0 19.3 16.8 13.7 13.3 0.0 21.5 15.1 17.5 8.6 18.5 21.0 2.7 27.7 10.0 0.0 17.4 20.5 31.8 17.7 5.7 3.4 14.2 44.3 10.9 11.6 4.8 4.6 9.9 13.5 3.9 12.8 10.7 38.6 33.7 29.2 20.8 0.0 29.6 22.6 6.7 16.9 48.8 28.3 18.8 18.1 15.2 13.0 20.8 10.7 0.9 14.8 6.0 34.3 18.2 1.3 10.5 16.7 5.7 6.9 8.8 7.4 2.1 21.5 19.8 18.6 16.1 4.1 12.6 4.3 50.9 3.5 25.6 27.6 7.0 49.3 23.3 33.1 10.7 85.8 4.6 31.9 9.4 0.2 17.3 11.2 5.2 2.9 3.3 32.2 28.1 2.9 42.5 21.0 18.4 14.6 17.3 11.2 4.6 16.7 36.5 13.4 21.6 0.0 17.7 3.3 13.6 22.3 4.3 11.6 16.7 0.1 32.3 19.2 6.6 3.7 34.6 5.1 2.2 4.7 7.0 13.1 2.3 13.8 26.5 7.7 12.6 1.2 24.2 6.7 21.0 8.6 1.5 1.9 21.0 21.3 4.3 2.8 8.2 16.8 13.7 10.0 0.0 5.7 3.4 4.6 0.0 16.9 20.8 56.6 131.4 66.0 7.5 65.4 58.5 32.9 20.2 33.0 34.7 18.9 22.1 47.9 50.1 24.8 16.5 0.0 14.7 149.3 74.0 9.8 19.2 7.7 49.5 36.2 45.1 40.6 74.5 18.6 26.5 25.0 46.0 24.5 67.1 26.6 13.3 42.5 102.5 11.6 275.9 9.1 39.1 10.2 84.8 28.5 6.5 25.4 34.4 32.0 4.7 90.7 28.7 120.5 12.1 40.6 29.8 22.4 46.6 150.0 40.5 56.7 26.0 9.5 12.3 26.3 68.6 52.5 1.5 8.2 35.1 51.3 14.6 82.1 54.2 45.8 44.1 OTUD7A "C15orf16, CEZANNE2, OTUD7" ENSG00000169918 "OTU deubiquitinase 7A" Q8TE49 15 31475398-31870789 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 20.5" "Cell type enhanced" "Detected in many" "Astrocytes: 135.2;Excitatory neurons: 303.6;Inhibitory neurons: 219.7;Oligodendrocyte precursor cells: 100.0;Oligodendrocytes: 506.1" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.7;HAP1: 1.0;SCLC-21H: 3.6;SH-SY5Y: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044554 Approved Nucleoli,Cytosol NA NA "Cluster 70: Brain - Nervous system development" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoli, Cytosol" "HPA044554: AB_10794895" "unprognostic (3.61e-2)" "unprognostic (1.35e-3)" "unprognostic (1.39e-1)" "unprognostic (1.25e-3)" "unprognostic (1.29e-1)" "unprognostic (1.03e-4)" "unprognostic (1.50e-1)" "unprognostic (1.21e-1)" "unprognostic (1.38e-1)" "unprognostic (1.67e-1)" "unprognostic (3.24e-3)" "unprognostic (1.34e-1)" "unprognostic (1.79e-11)" "unprognostic (6.78e-2)" "unprognostic (2.76e-1)" "unprognostic (8.27e-2)" "unprognostic (1.79e-1)" 1.2 0.5 6.6 0.4 9.5 0.0 1.0 7.6 8.6 1.3 0.0 1.4 0.3 1.3 0.5 0.7 1.1 0.3 1.3 6.9 5.9 0.9 0.4 0.8 0.4 8.5 6.9 0.9 1.4 1.2 1.5 0.0 8.2 0.6 0.4 1.6 0.7 0.4 1.1 2.6 0.9 0.6 5.6 0.6 0.8 4.1 8.3 0.3 1.0 0.2 0.4 0.8 0.8 20.5 0.0 0.0 0.1 1.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.4 0.8 0.0 0.2 0.1 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.3 0.5 0.0 0.0 0.1 3.6 1.8 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.6 9.5 7.6 8.6 6.9 5.9 8.5 6.9 8.2 5.6 8.3 20.5 3.5 3.2 0.0 135.2 0.1 0.4 0.7 0.0 1.8 25.7 1.1 1.3 3.2 0.0 0.6 1.8 2.1 0.0 4.3 1.3 0.0 0.5 1.4 0.4 1.2 1.3 3.6 0.0 303.6 1.0 0.1 1.8 0.5 0.4 0.0 1.0 1.4 0.8 0.2 25.2 219.7 1.7 0.0 0.0 0.3 2.0 0.9 0.3 1.8 28.1 0.2 3.9 13.4 100.0 506.1 0.3 0.7 2.6 2.6 1.9 0.4 1.7 0.0 3.1 0.0 4.1 1.5 4.6 8.3 1.8 0.4 0.1 3.1 0.9 1.5 1.0 CHRNA7 ENSG00000175344 "Cholinergic receptor nicotinic alpha 7 subunit" P36544 15 31923438-32173018 "FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 7.8;intestine: 9.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 9.0;Gastric mucus-secreting cells: 26.0;Horizontal cells: 16.8;Inhibitory neurons: 30.7;Proximal enterocytes: 14.4" "Cancer enhanced" "Detected in single" "stomach cancer: 0.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 6.3;RT4: 12.9;SH-SY5Y: 8.3;SK-BR-3: 13.3;U-2 OS: 10.8" "HPA029422, CAB033624" Enhanced NA NA "Cluster 11: Basophils - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "CAB033624: AB_784835, HPA029422: AB_10600863" "unprognostic (3.43e-2)" "unprognostic (8.44e-2)" "unprognostic (2.02e-1)" "unprognostic (4.61e-4)" "unprognostic (6.19e-2)" "unprognostic (1.31e-1)" "unprognostic (2.14e-2)" "unprognostic (5.08e-2)" "unprognostic (1.63e-1)" "unprognostic (4.31e-2)" "unprognostic (3.22e-1)" "unprognostic (1.05e-1)" "unprognostic (2.40e-2)" "unprognostic (4.36e-3)" "unprognostic (5.44e-2)" "unprognostic (7.41e-3)" "unprognostic (2.43e-1)" 0.3 7.8 1.2 0.4 1.1 0.9 1.0 1.8 1.8 0.4 2.1 1.5 4.4 0.5 0.3 0.3 0.4 0.9 0.5 1.0 4.5 0.4 0.1 0.5 0.7 4.5 3.9 1.6 2.4 6.4 1.0 0.0 7.0 1.2 2.3 2.5 0.5 0.7 0.5 0.3 9.7 0.4 1.5 1.2 6.6 2.5 3.3 0.4 2.2 0.8 0.7 1.5 0.7 1.1 0.0 1.3 2.7 6.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.3 0.0 3.1 0.0 0.0 0.0 1.7 0.6 0.0 2.2 0.0 0.4 1.0 0.0 0.0 0.2 0.0 0.1 0.4 2.5 0.0 0.2 0.3 0.2 0.0 0.2 1.5 3.7 0.0 0.0 4.2 0.3 0.5 12.9 0.5 8.3 0.2 13.3 0.0 0.7 0.0 0.5 1.2 0.0 10.8 0.3 0.0 0.0 0.0 0.3 0.0 1.3 0.0 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 1.2 1.1 1.8 1.8 1.0 4.5 4.5 3.9 7.0 1.5 3.3 1.1 0.5 0.0 0.0 1.0 0.0 0.3 3.0 0.0 7.4 1.8 1.1 1.3 1.1 2.8 0.0 0.0 0.0 0.0 0.0 3.8 0.0 1.3 0.1 0.2 0.3 1.5 3.0 0.0 9.0 2.5 0.0 0.4 26.0 0.6 1.3 4.6 0.7 0.0 0.1 16.8 30.7 8.9 0.0 0.0 0.9 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.0 1.5 1.1 1.6 2.9 0.0 0.2 0.7 14.4 0.2 0.0 0.0 0.0 0.4 0.3 0.2 5.9 3.2 0.0 0.0 0.1 0.2 2.0 1.2 GOLGA8K ENSG00000249931 "Golgin A8 family member K" D6RF30 15 32392782-32403292 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 6.6" "Cell type enriched" "Detected in some" 6 "Early spermatids: 16.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 1.0;JURKAT: 1.0;THP-1: 1.7;U-937: 2.4" NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 32: U-937 - Innate immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (2.47e-1)" "unprognostic (3.27e-1)" "unprognostic (4.01e-2)" "unprognostic (1.09e-2)" "unprognostic (6.62e-2)" "unprognostic (7.35e-2)" "unprognostic (2.86e-1)" "unprognostic (5.75e-2)" "unprognostic (1.37e-1)" "unprognostic (1.21e-1)" "unprognostic (1.97e-1)" "unprognostic (7.00e-3)" "unprognostic (4.81e-2)" "unprognostic (1.18e-2)" "unprognostic (9.81e-2)" 0.7 0.2 0.1 0.1 0.7 0.6 0.4 0.2 0.6 0.5 0.1 0.4 0.0 0.3 0.0 0.3 0.3 0.0 0.3 0.1 0.4 0.2 0.1 0.5 0.0 0.5 0.2 0.4 0.9 0.1 0.5 0.0 0.6 0.3 0.0 0.2 0.3 0.1 0.1 0.3 0.4 0.1 0.1 0.3 0.2 6.6 0.4 0.0 1.3 0.0 0.1 0.5 0.4 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.5 1.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.1 0.0 0.3 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.2 0.6 0.1 0.4 0.5 0.2 0.6 0.1 0.4 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 GOLGA8O ENSG00000206127 "Golgin A8 family member O" A6NCC3 15 32441914-32455634 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "bone marrow: 20.0;epididymis: 33.0;testis: 11.5;thyroid gland: 27.5" "Cell type enhanced" "Detected in some" "Early spermatids: 4.0;Endometrial ciliated cells: 1.3;granulocytes: 1.3;NK-cells: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "gdT-cell: 1.0;NK-cell: 2.4" "Group enriched" "Detected in many" 8 "NK-cells: 2.4;T-cells: 1.0" "Group enriched" "Detected in many" 8 "HEL: 70.0;THP-1: 38.6;U-937: 133.7" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 68: Epididymis - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" "unprognostic (2.68e-2)" "unprognostic (4.10e-1)" "unprognostic (1.20e-1)" "unprognostic (1.14e-1)" "unprognostic (1.11e-1)" "unprognostic (3.71e-1)" "unprognostic (3.13e-3)" "unprognostic (1.43e-1)" "unprognostic (8.17e-2)" "unprognostic (8.25e-2)" "unprognostic (6.04e-2)" "unprognostic (3.06e-2)" 4.6 1.2 3.2 2.8 3.8 20.0 3.7 3.4 3.9 2.1 3.9 1.5 1.8 3.4 33.0 1.3 2.8 3.1 3.3 3.4 3.4 1.7 2.9 2.7 2.4 3.8 3.8 4.2 3.4 3.5 1.9 1.4 3.7 2.3 1.9 3.6 3.0 1.6 4.4 4.0 1.5 2.2 3.5 3.6 1.9 11.5 3.6 1.3 27.5 2.0 1.4 1.5 1.2 4.5 0.3 0.5 1.0 0.0 2.6 3.8 0.1 1.7 1.0 0.4 0.8 0.0 0.2 0.4 0.5 0.3 1.0 0.1 0.7 0.1 0.4 0.1 0.6 70.0 0.0 0.0 1.1 1.5 2.6 0.9 1.0 0.5 0.3 4.4 0.8 1.3 0.2 0.0 1.0 0.8 0.0 10.2 0.3 0.0 0.3 0.2 2.1 0.0 1.6 0.3 0.0 1.0 0.4 0.1 0.0 0.5 0.6 38.6 3.8 0.8 0.3 0.1 0.6 1.7 2.5 0.6 0.4 133.7 0.8 0.0 0.0 0.0 1.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 2.4 0.0 0.2 0.0 0.1 3.2 3.8 3.4 3.9 3.4 3.4 3.8 3.8 3.7 3.5 3.6 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 1.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.6 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 GOLGA8N ENSG00000232653 "Golgin A8 family member N" F8WBI6 15 32593456-32607310 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 4 "Early spermatids: 92.7" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "gdT-cell: 1.1;NK-cell: 2.3" "Group enriched" "Detected in many" 7 "NK-cells: 2.3;T-cells: 1.1" "Group enriched" "Detected in some" 4 "HEL: 61.6;THP-1: 38.1;U-937: 33.2" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 50: Non-specific - Ribosome" "Cluster 32: U-937 - Innate immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (2.12e-1)" "unprognostic (1.11e-1)" "unprognostic (1.11e-1)" "unprognostic (1.38e-1)" "unprognostic (1.14e-1)" "unprognostic (3.55e-3)" "unprognostic (5.11e-3)" "unprognostic (1.78e-2)" "unprognostic (5.67e-2)" "unprognostic (2.01e-1)" "unprognostic (1.57e-3)" "unprognostic (1.04e-1)" "unprognostic (2.59e-3)" "unprognostic (1.93e-1)" "unprognostic (8.26e-2)" "unprognostic (3.85e-2)" "unprognostic (1.16e-1)" 10.8 6.7 1.7 1.9 2.8 6.3 9.7 1.8 2.4 12.9 2.9 10.1 1.2 10.2 4.9 6.0 12.6 0.7 11.8 1.4 2.3 8.0 12.0 8.5 1.9 2.7 2.6 19.4 31.3 3.0 22.9 0.5 2.3 8.7 0.5 2.4 8.0 2.4 6.8 7.1 8.6 1.2 1.5 9.6 8.2 16.2 3.3 0.9 34.2 1.8 1.2 10.1 10.2 2.7 0.0 0.0 0.1 0.5 2.2 3.0 0.1 1.0 0.5 0.2 0.3 0.0 0.8 0.8 0.3 0.7 0.2 0.0 0.4 0.1 0.4 0.1 0.5 61.6 0.0 0.0 0.6 1.0 0.1 0.9 1.2 0.0 0.8 3.1 0.0 0.0 0.2 0.0 0.3 1.0 0.0 10.9 0.1 0.1 0.0 0.1 1.5 0.0 0.1 0.1 0.0 0.3 0.6 0.1 0.0 0.0 0.0 38.1 1.5 1.2 0.2 0.0 0.0 3.1 3.2 0.5 0.3 33.2 0.4 0.0 0.0 0.0 1.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.0 2.3 0.0 0.2 0.0 0.1 1.7 2.8 1.8 2.4 1.4 2.3 2.7 2.6 2.3 1.5 3.3 2.7 7.4 19.2 18.6 6.2 1.6 0.0 0.4 0.0 0.0 1.8 0.9 1.4 10.9 1.5 6.2 1.8 0.0 0.2 8.3 1.3 0.0 0.4 92.7 15.9 3.7 3.6 3.5 4.2 2.9 2.0 0.0 4.9 3.6 6.5 6.3 3.3 2.2 5.3 0.6 13.5 3.3 1.1 0.0 1.3 0.0 10.1 5.6 6.2 0.0 1.9 3.2 1.8 15.5 4.5 5.4 0.6 0.8 2.2 2.5 0.3 1.4 0.8 6.6 1.9 0.0 3.4 5.6 11.5 0.9 2.0 0.0 0.1 5.4 1.4 1.3 0.2 ARHGAP11A KIAA0013 ENSG00000198826 "Rho GTPase activating protein 11A" Q6P4F7 15 32615144-32639941 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 24.2;lymphoid tissue: 26.1" "Cell type enhanced" "Detected in many" "Erythroid cells: 38.7;Extravillous trophoblasts: 23.7;Granulosa cells: 21.1;Plasma cells: 18.6;Spermatocytes: 24.7;Spermatogonia: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040830, HPA066481" Enhanced Approved Nucleoli,Cytosol No Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol Nucleoli "HPA040830: AB_10805830, HPA066481: " "unprognostic (5.00e-2)" "unprognostic (5.57e-2)" "unprognostic (6.10e-2)" "unprognostic (1.97e-1)" "unprognostic (2.93e-1)" "unprognostic (3.41e-2)" "prognostic unfavorable (2.05e-4)" "prognostic unfavorable (8.69e-4)" "unprognostic (4.87e-2)" "unprognostic (7.71e-2)" "prognostic unfavorable (2.92e-5)" "unprognostic (3.43e-2)" "unprognostic (1.07e-12)" "unprognostic (7.37e-2)" "unprognostic (5.23e-1)" "unprognostic (1.54e-2)" "unprognostic (9.64e-2)" 1.7 0.9 2.0 7.9 2.5 24.2 1.7 2.1 2.1 1.5 1.2 7.5 6.1 1.5 1.0 5.3 0.8 1.7 0.7 1.7 1.9 0.6 1.3 1.7 13.5 2.6 3.0 0.6 2.6 1.2 0.7 4.3 2.6 0.6 8.8 0.5 1.2 0.5 0.9 4.4 7.6 4.8 2.5 2.8 3.6 8.6 2.2 26.1 1.3 0.4 14.3 2.8 1.9 3.0 80.8 69.4 73.1 46.2 5.0 13.0 39.6 78.5 50.2 80.0 63.3 52.2 41.5 43.5 23.7 49.9 91.3 56.9 55.3 43.8 110.9 83.5 27.4 132.6 68.9 33.5 2.0 103.8 55.5 4.3 5.5 61.6 50.9 15.2 61.5 94.4 101.0 112.7 95.3 31.7 58.6 39.7 44.6 71.6 44.5 67.8 141.7 38.2 28.4 41.6 64.7 44.5 72.9 46.2 17.6 37.6 63.6 115.8 35.3 102.5 74.1 42.0 87.2 38.3 63.7 123.7 44.4 129.1 91.8 0.1 0.3 0.8 0.5 0.5 0.2 0.3 1.0 0.9 0.4 0.2 0.4 0.5 0.0 0.1 0.1 0.2 0.8 0.3 2.0 2.5 2.1 2.1 1.7 1.9 2.6 3.0 2.6 2.5 2.2 3.0 0.7 0.0 2.3 0.3 4.6 4.8 1.1 2.4 2.2 0.2 1.3 1.7 0.9 4.3 1.9 1.8 0.0 9.8 2.9 6.2 0.0 0.8 4.7 3.8 2.6 2.0 0.0 38.7 1.0 0.8 23.7 3.5 8.6 2.8 0.0 21.1 1.8 2.1 9.5 0.0 0.6 7.8 0.0 6.5 4.2 5.0 0.6 3.5 0.0 1.0 3.9 0.1 2.1 0.5 1.4 0.5 2.9 0.4 18.6 1.4 1.1 0.4 1.4 1.0 6.6 1.4 3.3 24.7 22.6 10.5 2.3 3.1 5.4 2.0 14.1 2.1 SCG5 "7B2, SGNE1, SgV" ENSG00000166922 "Secretogranin V" P05408 15 32641676-32697098 "Predicted secreted proteins" Transport "Chaperone, Neuropeptide" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 133.0;pituitary gland: 402.7" "Cell type enriched" "Detected in many" 4 "Enteroendocrine cells: 470.8" "Group enriched" "Detected in many" 5 "glioma: 38.2;pancreatic cancer: 82.9;thyroid cancer: 22.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 26.9;HSkMC: 33.5;NTERA-2: 15.3;SCLC-21H: 31.5;SH-SY5Y: 36.4;U-87 MG: 47.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013136, HPA074618" Enhanced "Secreted to blood" NA NA 100000 "Cluster 32: T-cells - Unknown function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "HPA013136: AB_1856657, HPA074618: AB_2732262" "unprognostic (1.71e-1)" "unprognostic (9.87e-2)" "unprognostic (7.94e-2)" "unprognostic (1.30e-2)" "unprognostic (3.59e-3)" "prognostic unfavorable (9.64e-4)" "unprognostic (2.69e-1)" "unprognostic (1.27e-3)" "unprognostic (4.69e-2)" "unprognostic (1.97e-1)" "unprognostic (5.62e-3)" "unprognostic (3.92e-1)" "prognostic unfavorable (4.51e-9)" "unprognostic (3.57e-2)" "unprognostic (8.13e-2)" "unprognostic (3.08e-3)" "unprognostic (8.88e-2)" 1.7 61.1 54.0 3.3 62.0 0.3 3.7 52.2 100.4 1.0 77.3 7.9 17.9 5.3 42.5 0.5 3.4 5.5 1.3 58.9 75.1 0.9 3.6 3.8 1.3 56.5 48.3 3.2 133.0 73.7 402.7 0.3 58.7 5.0 9.8 26.7 0.2 0.9 0.2 1.3 5.6 6.7 57.7 0.5 37.8 5.3 56.3 0.3 5.8 0.1 0.3 2.6 2.7 58.9 0.5 0.2 0.1 0.2 0.6 4.5 0.1 4.2 0.4 0.4 0.4 0.1 0.0 0.5 1.9 0.4 1.7 1.2 0.5 0.2 1.2 0.7 0.3 0.6 0.0 0.1 26.9 0.2 0.7 33.5 0.1 0.8 0.4 0.9 0.7 1.0 0.3 0.6 0.8 0.0 0.3 0.3 15.3 0.1 0.8 0.1 0.4 0.6 0.4 0.0 31.5 36.4 0.2 0.0 0.2 0.4 0.1 0.4 0.0 5.2 3.8 0.3 0.5 0.6 2.3 0.4 47.2 1.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.0 62.0 52.2 100.4 58.9 75.1 56.5 48.3 58.7 57.7 56.3 58.9 0.2 0.0 0.5 20.2 0.3 0.6 0.2 6.2 0.0 51.0 0.5 16.5 0.4 0.0 3.9 0.0 2.1 0.2 0.1 1.1 0.0 0.6 52.1 3.7 19.3 1.1 470.8 0.0 82.8 78.3 0.3 17.9 23.0 0.6 2.5 51.4 0.4 11.9 6.0 50.5 97.8 14.5 97.6 0.6 0.8 80.0 2.1 1.6 3.6 20.6 0.6 15.6 0.0 52.3 79.7 22.9 1.1 7.9 0.3 1.4 0.5 0.0 0.5 32.6 0.0 0.3 34.2 39.2 2.9 0.1 0.3 0.3 0.3 51.8 2.4 1.0 GREM1 "CKTSF1B1, CRAC1, DAND2, DRM, gremlin, HMPS" ENSG00000166923 "Gremlin 1, DAN family BMP antagonist" O60565 15 32718004-32745106 "Disease related genes, Predicted secreted proteins" Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 113.0;smooth muscle: 68.2" "Cell type enhanced" "Detected in many" "Collecting duct cells: 66.2;Granulosa cells: 121.1;Oligodendrocytes: 40.5;Skeletal myocytes: 181.4" "Cancer enhanced" "Detected in many" "stomach cancer: 24.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 294.7;BJ hTERT+: 468.5;BJ hTERT+ SV40 Large T+ RasG12V: 286.8;fHDF/TERT166: 957.0;hTEC/SVTERT24-B: 227.8" "Group enriched" "Detected in many" 5 "hippocampal formation: 3.2;olfactory bulb: 10.9" "Low region specificity" "Detected in many" HPA007526 Uncertain "Secreted to blood" NA NA 242000000 "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "HPA007526: AB_1849971" "unprognostic (4.74e-2)" "unprognostic (2.78e-1)" "unprognostic (4.63e-2)" "unprognostic (6.80e-2)" "unprognostic (3.58e-1)" "unprognostic (1.72e-1)" "unprognostic (3.19e-1)" "prognostic unfavorable (4.46e-4)" "unprognostic (5.33e-2)" "unprognostic (2.32e-1)" "unprognostic (7.20e-3)" "unprognostic (2.79e-1)" "unprognostic (2.13e-11)" "unprognostic (1.77e-2)" "unprognostic (6.60e-2)" "unprognostic (3.29e-2)" "unprognostic (1.16e-3)" 32.7 0.5 1.4 6.5 3.6 0.2 5.5 1.1 2.4 44.7 0.0 36.1 2.6 9.6 0.0 13.6 1.1 113.0 1.3 1.5 1.3 1.2 1.1 2.2 1.1 3.1 3.0 0.3 2.2 0.0 0.2 0.3 1.8 8.2 26.7 0.1 0.6 3.8 0.6 7.6 52.3 68.2 1.1 0.8 36.8 0.5 3.8 0.0 2.3 0.0 1.7 21.7 50.4 6.1 0.0 3.5 0.0 0.0 11.1 12.5 0.0 294.7 468.5 112.5 286.8 0.3 0.0 0.0 0.0 957.0 0.0 0.0 0.0 0.0 109.7 0.0 0.1 0.0 0.1 0.0 3.3 0.0 0.0 3.1 0.0 227.8 0.1 70.6 0.0 0.0 0.0 0.0 143.4 0.1 0.0 0.0 1.2 0.0 0.9 0.0 20.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.0 57.7 0.0 0.1 1.1 0.0 0.0 0.0 0.0 2.2 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 3.6 1.1 2.4 1.5 1.3 3.1 3.0 1.8 1.1 3.8 6.1 0.7 0.0 0.0 0.3 0.4 6.6 6.5 0.0 0.6 2.1 1.7 0.9 3.4 0.0 0.0 66.2 2.1 0.2 0.7 0.4 0.0 0.4 0.2 0.6 2.3 1.9 0.0 0.0 2.5 0.0 0.1 17.7 0.0 0.7 0.0 121.1 0.7 1.2 1.0 1.7 0.5 0.6 0.0 0.3 12.8 0.0 0.0 2.3 3.6 0.0 2.7 0.3 0.0 1.5 40.5 0.3 0.0 0.4 0.2 9.9 0.1 0.3 0.0 1.3 0.0 181.4 16.1 0.1 1.4 0.3 4.5 0.3 2.1 0.1 0.1 6.5 FMN1 "DKFZP686C2281, FLJ45135, FMN, LD, MGC125288, MGC125289" ENSG00000248905 "Formin 1" Q68DA7 15 32765544-33194714 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.9;retina: 30.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 117.0;Cone photoreceptor cells: 221.0;Excitatory neurons: 439.4;Inhibitory neurons: 340.0" "Cancer enriched" "Detected in many" 9 "melanoma: 14.5" "Region enriched" "Detected in some" 7 "cerebral cortex: 16.9" "Immune cell enhanced" "Detected in single" "basophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Karpas-707: 21.4;RH-30: 26.9;SK-MEL-30: 28.7;T-47d: 24.8;U-138 MG: 17.2;U-2197: 17.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005465, HPA046786" Supported Supported Nucleoplasm,Cytosol NA NA "Cluster 46: Basophils - DNA binding" "Cluster 77: Retina - Visual perception" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm Cytosol "HPA005465: AB_1859515, HPA046786: AB_10963545" "unprognostic (1.57e-1)" "unprognostic (5.92e-3)" "unprognostic (1.96e-1)" "unprognostic (2.10e-3)" "unprognostic (3.67e-2)" "unprognostic (3.00e-2)" "unprognostic (1.56e-2)" "unprognostic (2.84e-2)" "unprognostic (3.44e-1)" "unprognostic (3.31e-2)" "unprognostic (7.41e-3)" "unprognostic (3.53e-1)" "unprognostic (4.89e-2)" "unprognostic (2.89e-2)" "unprognostic (3.73e-1)" "unprognostic (4.32e-1)" "unprognostic (7.61e-2)" 1.8 0.8 0.0 2.4 0.0 1.2 3.0 0.0 16.9 5.3 0.0 5.7 1.3 1.0 0.7 2.0 3.1 2.4 0.9 0.0 0.0 2.8 0.5 3.4 0.9 2.3 0.0 0.2 1.2 1.4 3.7 3.7 0.0 1.8 4.4 30.0 4.2 1.2 0.7 4.2 1.8 2.2 0.0 1.0 7.9 10.2 1.7 3.8 2.5 0.5 0.6 1.3 3.6 0.0 3.8 4.0 0.8 0.4 0.1 0.4 4.9 5.4 4.1 1.5 4.0 0.6 5.0 0.6 1.8 6.1 3.4 3.7 0.1 3.7 3.9 0.0 0.2 3.1 0.8 0.4 0.2 0.0 0.2 1.5 0.2 7.9 0.1 3.1 0.0 0.1 0.0 21.4 8.8 3.9 0.1 0.0 1.1 7.0 0.3 0.6 26.9 4.9 1.8 1.5 0.3 0.9 0.0 3.3 28.7 0.9 24.8 0.0 4.9 17.2 2.7 17.9 1.6 0.0 0.0 0.9 7.3 0.2 10.1 1.3 0.2 0.0 0.1 0.0 0.2 0.0 0.2 0.2 0.5 0.2 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 2.3 0.0 0.0 0.0 1.7 0.0 0.4 41.7 46.9 10.1 1.6 3.7 3.2 2.0 3.4 117.0 7.7 5.1 3.1 14.3 17.3 0.0 221.0 12.0 5.4 13.3 11.7 5.7 16.5 17.4 2.4 2.7 9.0 0.4 439.4 1.8 5.9 2.6 97.9 7.0 24.0 1.8 0.0 0.4 10.9 47.1 340.0 16.8 16.2 28.0 3.9 12.8 0.9 29.6 33.8 64.6 5.8 6.9 0.0 8.0 61.9 11.4 11.4 0.7 2.2 4.5 4.0 1.6 29.4 102.4 0.0 13.0 1.0 18.4 16.0 7.3 3.4 18.3 5.0 0.1 9.9 5.7 RYR3 ENSG00000198838 "Ryanodine receptor 3" Q15413 15 33310962-33866121 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.7;choroid plexus: 33.3;skeletal muscle: 24.2;tongue: 44.2" "Cell type enriched" "Detected in many" 4 "Astrocytes: 788.8" "Cancer enriched" "Detected in single" 4 "glioma: 1.3" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 19 "basophil: 1.9" "Lineage enriched" "Detected in single" 19 "granulocytes: 1.9" "Cell line enhanced" "Detected in some" "A549: 4.4;RH-30: 6.5;RPTEC TERT1: 3.1;SuSa: 2.8" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 23.4" HPA062004 Approved Vesicles NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 70: Brain - Nervous system development" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Vesicles "HPA062004: AB_2797267" "unprognostic (5.85e-2)" "unprognostic (1.57e-1)" "unprognostic (5.30e-2)" "unprognostic (1.35e-1)" "unprognostic (1.26e-2)" "unprognostic (8.03e-4)" "unprognostic (1.10e-1)" "unprognostic (1.10e-1)" "unprognostic (7.85e-2)" "unprognostic (7.10e-2)" "unprognostic (8.25e-3)" "unprognostic (2.36e-1)" "unprognostic (2.48e-2)" "unprognostic (1.86e-2)" "unprognostic (1.15e-1)" "unprognostic (3.16e-2)" "unprognostic (1.91e-1)" 1.7 0.7 35.2 0.2 43.7 1.4 2.0 33.5 39.7 4.2 33.3 10.1 0.4 7.2 0.1 1.2 5.4 0.5 0.2 35.6 29.3 2.0 0.0 0.3 0.1 35.5 30.2 0.9 0.1 6.1 1.3 0.1 33.5 1.4 1.3 2.2 0.5 2.0 24.2 1.0 1.8 4.4 24.3 0.5 2.1 0.5 37.1 0.6 0.3 44.2 0.4 4.0 2.8 28.8 0.2 4.4 0.9 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 1.1 0.1 0.2 0.4 0.0 1.4 0.1 0.0 0.0 0.0 0.2 0.1 0.9 0.1 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 1.6 0.0 0.2 0.1 0.1 0.7 0.2 0.1 0.3 6.5 0.1 3.1 0.3 0.1 0.3 0.4 0.0 0.1 2.8 0.0 0.2 0.5 0.1 0.1 0.0 0.4 0.2 0.9 0.4 0.3 1.4 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.2 43.7 33.5 39.7 35.6 29.3 35.5 30.2 33.5 24.3 37.1 28.8 2.9 0.0 1.1 788.8 0.2 0.4 0.0 0.0 0.0 8.0 0.2 2.5 2.2 0.0 0.6 0.0 0.0 0.6 0.5 0.0 0.0 0.0 15.5 7.7 1.4 1.8 0.0 8.4 162.5 0.0 0.7 0.6 0.0 8.0 14.0 0.2 0.0 0.0 1.0 69.0 115.2 0.0 0.0 0.0 1.0 41.9 0.3 0.3 0.0 36.5 0.6 0.3 0.0 22.1 5.9 0.0 0.0 0.0 0.1 0.0 0.0 0.3 5.9 0.8 0.0 51.3 0.4 0.1 1.5 0.0 0.6 0.1 0.4 2.5 0.0 0.0 AVEN PDCD12 ENSG00000169857 "Apoptosis and caspase activation inhibitor" Q9NQS1 15 33858782-34075155 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 44.0;Oligodendrocytes: 86.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 2.3" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020863 Approved Approved "Plasma membrane,Actin filaments,Centrosome" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 30: Epithelial cell lines - Translation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Plasma membrane, Actin filaments" Centrosome "HPA020863: AB_1845219" "unprognostic (1.54e-3)" "unprognostic (1.99e-1)" "unprognostic (8.93e-2)" "unprognostic (5.77e-2)" "unprognostic (5.57e-2)" "unprognostic (2.05e-1)" "unprognostic (1.18e-1)" "unprognostic (6.32e-3)" "unprognostic (1.70e-1)" "unprognostic (1.40e-1)" "unprognostic (4.14e-3)" "unprognostic (1.79e-1)" "prognostic unfavorable (5.29e-10)" "unprognostic (7.66e-3)" "unprognostic (2.40e-1)" "unprognostic (1.63e-1)" "unprognostic (2.84e-3)" 13.7 11.4 8.5 7.2 8.6 4.4 10.8 8.9 10.1 11.4 10.5 15.2 7.4 12.5 5.2 12.3 11.3 6.4 28.5 8.2 9.2 5.5 16.9 7.2 4.8 9.2 9.0 10.5 20.8 3.0 5.8 12.4 9.4 9.4 9.4 2.5 7.9 9.1 31.1 11.2 7.5 12.5 8.8 6.5 12.3 10.7 9.0 6.9 5.6 13.6 7.9 16.2 10.8 9.1 16.4 26.3 26.0 8.6 21.4 24.1 14.7 41.1 36.2 31.9 19.9 7.2 11.3 15.2 24.8 34.8 24.2 10.4 12.2 26.9 25.7 14.6 7.7 26.1 15.9 20.5 31.5 26.6 18.2 19.8 50.9 18.4 45.8 38.6 35.2 7.6 26.6 21.1 45.6 17.3 10.5 46.1 11.9 22.2 8.5 15.7 14.6 32.2 26.4 21.0 13.4 16.8 22.6 11.6 11.4 10.7 12.6 29.4 24.5 27.7 9.5 12.0 34.6 21.2 17.7 31.1 13.3 31.0 15.2 0.0 0.2 0.0 0.5 0.6 0.6 0.4 0.5 0.2 0.2 0.1 0.2 0.3 0.0 0.5 0.2 2.3 0.9 0.1 8.5 8.6 8.9 10.1 8.2 9.2 9.2 9.0 9.4 8.8 9.0 9.1 9.0 3.2 5.3 16.6 5.6 5.7 8.7 1.8 3.4 5.6 7.5 9.0 32.7 2.8 0.8 0.0 6.2 11.0 10.5 7.4 0.0 2.9 13.8 4.4 14.3 10.2 4.8 9.5 21.8 8.6 44.0 8.5 5.6 5.6 0.0 14.7 8.6 19.1 7.4 8.4 24.1 7.7 0.0 4.1 4.4 6.5 7.5 5.0 3.6 22.5 3.5 10.9 7.2 26.7 86.6 7.0 5.2 10.5 15.6 21.5 9.4 4.6 1.5 5.3 6.6 4.9 9.7 6.2 7.4 12.9 9.7 9.4 6.5 23.1 6.0 14.7 CHRM5 ENSG00000184984 "Cholinergic receptor muscarinic 5" P08912 15 33968497-34067458 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 18.8" "Cell type enriched" "Detected in some" 9 "Oligodendrocytes: 178.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "neutrophil: 1.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "BEWO: 4.6;HMC-1: 10.4;NB-4: 1.9" "Region enhanced" "Detected in many" "hypothalamus: 13.2" "Low region specificity" "Detected in many" HPA013172 Uncertain NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 70: Brain - Nervous system development" "Cluster 3: HMC-1 - Innate immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "HPA013172: AB_1854212" "unprognostic (8.19e-2)" "unprognostic (2.13e-1)" "unprognostic (7.67e-2)" "unprognostic (4.32e-1)" "unprognostic (3.05e-3)" "unprognostic (2.77e-1)" "unprognostic (2.49e-2)" "unprognostic (2.79e-1)" "unprognostic (3.02e-1)" "unprognostic (1.27e-2)" "unprognostic (4.61e-4)" "unprognostic (7.95e-2)" "unprognostic (1.33e-6)" "unprognostic (1.42e-1)" "unprognostic (4.53e-2)" "unprognostic (1.38e-1)" "unprognostic (9.07e-2)" 0.1 0.1 2.4 0.3 5.8 0.4 0.3 4.2 4.8 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.1 0.1 0.0 1.8 8.4 0.2 0.6 0.1 0.3 9.5 8.3 0.1 0.3 0.0 0.2 1.5 9.0 0.1 0.0 1.3 0.1 0.0 0.2 0.4 0.5 0.0 3.1 0.2 0.1 1.5 18.8 0.0 0.6 0.0 0.0 0.0 0.1 13.8 0.1 0.1 0.5 0.2 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.6 0.2 0.2 0.0 0.4 10.4 0.3 0.0 0.1 0.0 0.1 0.0 0.3 0.5 1.0 0.0 0.1 0.2 1.9 0.1 0.2 0.1 0.1 0.2 0.1 0.0 0.3 0.2 0.2 0.2 0.6 0.2 0.1 0.1 1.0 0.1 0.1 0.2 0.2 0.1 0.7 0.2 0.3 0.0 0.2 0.3 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.2 0.0 0.0 2.4 5.8 4.2 4.8 1.8 8.4 9.5 8.3 9.0 3.1 18.8 13.8 0.1 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 3.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 1.5 0.2 0.0 1.9 0.0 5.9 0.2 0.1 0.0 0.0 0.0 8.7 0.0 18.9 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 12.6 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 2.8 0.1 0.2 1.0 2.5 178.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.8 0.0 0.1 0.0 0.4 0.9 0.0 0.0 0.8 0.0 0.2 0.0 0.0 EMC7 "C11orf3, C15orf24" ENSG00000134153 "ER membrane protein complex subunit 7" Q9NPA0 15 34084017-34101862 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010029 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 10: Non-specific - Unknown function" "HPA010029: AB_1078335" "unprognostic (2.16e-1)" "unprognostic (8.16e-3)" "unprognostic (5.28e-2)" "prognostic favorable (4.68e-5)" "unprognostic (7.75e-2)" "prognostic unfavorable (9.25e-5)" "unprognostic (1.35e-1)" "unprognostic (3.68e-2)" "unprognostic (1.18e-1)" "unprognostic (5.65e-3)" "unprognostic (4.67e-2)" "unprognostic (3.17e-1)" "unprognostic (1.36e-1)" "unprognostic (3.31e-1)" "unprognostic (2.58e-1)" "unprognostic (2.49e-2)" "unprognostic (2.47e-3)" 65.4 86.5 74.2 48.3 78.2 75.2 58.5 82.6 92.9 47.2 91.4 61.3 52.1 49.6 104.4 47.6 45.9 50.4 70.4 74.1 85.7 90.7 103.8 54.4 43.8 78.5 79.2 43.1 79.1 93.2 54.7 77.3 79.7 62.2 64.8 67.2 59.9 57.0 91.0 56.0 46.8 58.8 82.1 42.5 57.7 76.9 79.6 40.1 71.0 70.9 46.2 63.0 44.0 87.0 68.1 185.7 62.2 84.2 249.3 143.3 69.3 190.4 199.3 174.8 181.0 170.6 79.7 40.4 187.4 189.5 181.3 128.9 94.7 96.3 128.5 99.7 96.5 99.4 273.6 147.3 229.1 101.2 135.0 155.1 181.5 125.0 178.7 117.3 110.3 75.9 99.5 259.9 170.7 79.8 54.5 115.2 58.1 157.2 122.3 69.5 76.2 140.3 187.3 119.1 107.2 78.2 114.0 151.8 97.7 75.5 110.0 161.2 94.9 185.8 71.6 123.7 144.4 172.4 219.7 86.2 187.8 153.3 154.8 316.0 161.1 178.1 139.7 184.2 136.9 137.0 138.6 144.0 150.6 102.9 100.4 124.1 143.8 122.7 206.2 242.6 195.8 196.4 74.2 78.2 82.6 92.9 74.1 85.7 78.5 79.2 79.7 82.1 79.6 87.0 65.5 28.9 36.1 20.2 51.7 86.9 56.8 194.6 40.9 58.6 44.0 50.3 92.9 54.3 117.9 103.0 45.9 127.5 92.1 56.5 39.2 124.4 117.3 52.4 66.2 67.3 45.6 48.0 15.5 172.4 153.4 90.1 32.6 52.6 45.1 40.2 60.3 78.6 112.6 30.3 17.8 57.6 146.5 65.2 60.1 81.6 90.1 61.2 103.2 12.2 70.9 112.4 40.2 17.6 27.7 137.9 63.0 104.2 97.1 61.3 72.5 90.8 94.5 62.9 118.3 65.4 136.5 257.9 57.4 43.1 86.4 160.1 65.8 100.4 61.3 55.2 PGBD4 "FLJ32638, FLJ37497" ENSG00000182405 "PiggyBac transposable element derived 4" Q96DM1 15 34102083-34108686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Sertoli cells: 13.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 3.9" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.9" "Low cell line specificity" "Detected in many" "HPA040896, HPA059823" Uncertain Approved Nucleoplasm,Centrosome NA NA "Cluster 34: Basophils - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 52: Non-specific - Transcription" Nucleoplasm Centrosome "HPA040896: AB_10805831, HPA059823: AB_2684134" "unprognostic (9.54e-2)" "unprognostic (2.29e-1)" "unprognostic (1.45e-2)" "unprognostic (3.51e-2)" "unprognostic (7.43e-3)" "unprognostic (2.61e-2)" "unprognostic (1.10e-1)" "unprognostic (2.35e-2)" "unprognostic (6.47e-2)" "unprognostic (6.66e-2)" "unprognostic (1.32e-3)" "unprognostic (9.70e-2)" "unprognostic (6.68e-2)" "unprognostic (2.14e-2)" "unprognostic (8.54e-2)" "unprognostic (3.15e-2)" "unprognostic (7.73e-2)" 0.8 0.8 2.5 1.6 2.4 2.8 1.1 3.1 3.2 0.6 2.2 0.9 1.1 0.7 1.3 0.8 1.1 0.7 1.5 2.4 2.6 1.1 1.3 0.7 2.0 3.5 2.4 0.9 1.0 1.5 0.6 0.6 3.5 0.9 1.1 2.4 0.7 0.8 5.3 1.6 1.1 0.6 1.9 1.4 1.4 1.8 2.4 1.3 1.1 1.3 1.5 0.6 0.6 3.1 1.0 1.9 1.3 2.2 3.9 2.5 0.8 1.7 1.6 1.0 1.3 1.3 1.4 2.2 1.3 1.3 2.1 3.0 0.8 1.9 1.3 2.4 2.0 3.7 4.2 1.0 1.6 1.2 3.2 1.9 2.2 1.4 2.5 1.8 1.1 4.1 2.6 2.6 2.2 0.8 2.1 2.9 0.5 2.2 1.4 3.1 1.8 1.1 1.4 2.3 1.9 1.7 0.8 1.9 0.6 1.6 1.8 1.9 1.3 3.2 1.8 1.7 1.1 3.1 2.1 1.2 2.8 2.9 1.9 3.9 0.5 0.6 0.4 0.4 0.3 0.5 0.6 0.4 0.3 0.9 0.9 0.8 1.1 0.6 0.3 0.6 0.5 0.2 2.5 2.4 3.1 3.2 2.4 2.6 3.5 2.4 3.5 1.9 2.4 3.1 1.4 0.0 3.2 2.0 4.1 0.8 2.5 1.8 3.4 5.6 1.9 1.3 5.8 2.8 2.9 0.0 6.2 2.0 5.6 3.1 9.8 1.2 11.6 2.0 3.8 2.1 0.0 2.5 2.7 0.7 0.6 1.8 3.6 2.3 1.3 1.8 3.6 2.2 1.3 10.1 3.1 2.5 4.1 2.8 0.4 11.5 1.2 2.2 0.0 1.0 2.1 2.1 3.1 2.0 3.9 2.1 2.5 0.4 1.6 2.0 3.6 1.4 3.9 6.9 13.1 3.9 1.9 7.6 1.6 2.3 0.3 3.3 4.6 2.7 2.9 1.5 KATNBL1 "C15orf29, FLJ22557" ENSG00000134152 "Katanin regulatory subunit B1 like 1" Q9H079 15 34140674-34210096 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 128.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 128.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062573 Approved Supported "Nucleoplasm,Midbody,Cleavage furrow,Mitotic spindle" Yes No "Cluster 9: Neutrophils - Innate immune response" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "Midbody, Mitotic spindle" "Nucleoplasm, Cleavage furrow" "HPA062573: AB_2684796" "unprognostic (5.02e-1)" "unprognostic (1.67e-1)" "unprognostic (1.35e-2)" "unprognostic (2.91e-2)" "unprognostic (2.01e-2)" "unprognostic (1.38e-1)" "unprognostic (1.14e-1)" "unprognostic (1.75e-1)" "unprognostic (1.01e-1)" "unprognostic (5.16e-2)" "unprognostic (3.94e-3)" "unprognostic (8.00e-3)" "prognostic unfavorable (4.60e-5)" "unprognostic (2.71e-2)" "unprognostic (7.23e-2)" "unprognostic (2.42e-1)" "unprognostic (1.43e-1)" 22.0 12.1 16.3 22.9 16.6 16.3 20.8 25.0 20.8 22.5 22.4 19.9 15.9 20.7 19.0 39.9 16.8 15.9 13.4 15.8 14.9 17.0 17.6 18.4 17.6 15.0 13.8 14.4 14.0 14.5 12.1 32.4 16.0 16.9 21.2 31.2 14.6 13.6 13.2 31.4 15.7 25.4 12.9 18.6 17.7 18.0 18.2 15.2 12.5 13.0 20.3 17.8 27.7 25.3 37.1 31.5 49.7 33.4 39.5 39.0 37.0 49.6 30.0 38.7 38.4 17.8 19.9 17.6 31.2 32.2 54.5 47.5 24.9 28.5 45.8 36.9 12.6 31.8 34.6 21.6 27.0 33.9 33.1 23.6 40.8 26.1 51.3 39.7 70.6 45.4 34.3 36.7 53.1 17.6 21.4 27.4 35.8 47.4 25.0 32.3 30.3 16.1 35.9 49.5 28.1 24.8 30.1 21.9 14.7 49.2 27.0 38.8 40.4 51.9 26.7 46.8 39.7 21.5 32.5 37.1 46.5 35.7 38.9 62.8 18.2 29.7 18.4 17.3 23.3 23.9 19.6 18.8 20.7 25.6 21.5 19.2 128.5 13.2 11.5 28.4 17.9 12.0 16.3 16.6 25.0 20.8 15.8 14.9 15.0 13.8 16.0 12.9 18.2 25.3 59.7 38.5 25.2 83.9 41.7 41.3 65.2 60.5 34.7 57.0 42.1 43.1 12.8 24.3 51.6 25.8 52.1 58.6 42.3 30.6 33.2 59.1 75.4 40.5 53.3 47.0 23.9 39.8 104.3 54.5 86.2 38.8 39.3 50.8 44.9 68.7 37.9 20.8 39.1 67.3 96.7 35.6 52.9 27.6 48.8 59.2 31.7 36.2 32.0 64.6 49.9 53.1 27.8 86.0 114.4 105.3 37.4 33.1 41.1 116.8 21.4 41.6 49.6 44.7 59.2 52.2 45.3 47.8 44.3 45.0 54.3 179.5 39.7 31.6 39.1 132.6 EMC4 "FLJ90746, MGC24415, PIG17, TMEM85" ENSG00000128463 "ER membrane protein complex subunit 4" Q5J8M3 15 34225013-34230156 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053440 Approved NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 80: Striated muscle - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 10: Non-specific - Unknown function" "HPA053440: AB_2682151" "unprognostic (8.99e-2)" "unprognostic (1.59e-1)" "unprognostic (7.68e-2)" "unprognostic (3.29e-2)" "unprognostic (9.23e-2)" "unprognostic (1.29e-3)" "unprognostic (3.25e-1)" "unprognostic (3.61e-2)" "unprognostic (1.65e-1)" "unprognostic (1.78e-3)" "unprognostic (1.33e-1)" "unprognostic (2.20e-2)" "unprognostic (2.52e-1)" "unprognostic (5.42e-2)" "unprognostic (4.20e-2)" "unprognostic (2.96e-1)" "unprognostic (1.97e-2)" 76.1 68.1 83.8 48.8 86.5 58.7 68.4 90.3 103.7 69.3 92.0 69.1 55.1 67.0 102.9 78.3 67.8 52.3 86.4 87.6 88.8 67.9 91.3 57.3 55.4 87.2 85.2 66.2 90.7 83.0 60.3 59.2 88.4 62.3 58.2 65.4 79.0 63.7 214.4 63.9 57.1 58.8 86.9 49.1 69.8 49.4 85.7 58.1 60.6 136.7 54.2 59.2 71.4 95.2 123.1 248.2 103.9 135.1 133.2 119.6 95.0 137.7 156.9 166.0 143.4 162.0 106.1 48.5 177.7 160.0 145.6 229.4 107.0 135.3 118.7 148.3 103.7 91.9 219.4 154.8 161.0 139.8 87.8 121.4 126.3 121.4 136.0 118.1 139.8 144.6 117.0 186.6 147.1 137.9 109.9 149.9 116.9 165.0 163.5 102.0 94.7 138.3 161.0 186.9 137.1 166.4 101.7 148.3 77.6 74.8 99.3 164.7 106.5 151.3 103.8 131.8 142.7 162.8 251.5 122.0 184.5 164.1 131.1 256.5 158.6 176.9 154.5 173.9 170.0 237.2 170.6 185.8 162.6 187.7 172.2 168.8 88.5 197.8 200.2 166.6 216.1 277.6 83.8 86.5 90.3 103.7 87.6 88.8 87.2 85.2 88.4 86.9 85.7 95.2 75.3 54.5 67.7 8.8 67.9 91.5 103.7 206.5 55.8 35.8 83.7 104.1 58.7 58.6 132.4 66.2 18.8 150.6 62.5 39.5 125.2 180.3 121.8 67.6 55.1 86.1 52.0 38.7 14.1 172.3 173.6 87.8 36.7 69.1 88.0 63.2 64.2 78.6 113.7 18.5 15.4 62.8 166.8 48.5 73.2 27.4 100.6 56.5 101.4 13.1 87.9 98.4 76.2 15.1 16.9 184.0 65.4 90.7 117.9 89.6 71.8 117.5 133.3 42.8 85.5 81.4 123.2 169.7 91.9 60.2 110.0 141.7 68.8 69.7 66.4 125.4 SLC12A6 "ACCPN, KCC3" ENSG00000140199 "Solute carrier family 12 member 6" Q9UHW9 15 34229784-34338060 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" Neuropathy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 85.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 15.2;neutrophil: 23.4" "Lineage enriched" "Detected in many" 7 "granulocytes: 23.4" "Cell line enhanced" "Detected in many" "HaCaT: 44.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034563 Uncertain Approved Vesicles,Cytosol NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 34: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 57: B-cells - Immune response" "Vesicles, Cytosol" "HPA034563: AB_10603887" "unprognostic (3.53e-1)" "unprognostic (4.82e-2)" "unprognostic (4.26e-2)" "unprognostic (3.60e-1)" "unprognostic (3.55e-2)" "unprognostic (3.41e-2)" "unprognostic (1.36e-1)" "unprognostic (2.88e-1)" "unprognostic (2.07e-1)" "unprognostic (1.68e-1)" "unprognostic (6.58e-2)" "unprognostic (1.83e-1)" "prognostic favorable (3.33e-6)" "unprognostic (2.39e-1)" "unprognostic (1.61e-1)" "unprognostic (3.87e-2)" "unprognostic (1.41e-1)" 6.4 4.0 5.9 11.5 7.4 26.8 5.5 7.2 7.9 11.9 2.5 5.5 7.3 5.2 7.0 18.8 4.6 5.2 7.3 6.5 7.3 15.9 3.9 9.1 10.1 8.9 7.3 4.2 3.5 3.1 5.6 4.3 9.3 3.5 6.1 31.1 6.4 3.8 10.6 7.6 9.1 4.9 6.6 12.9 6.7 25.9 7.7 15.5 9.0 10.9 11.6 8.3 17.6 8.4 4.4 5.2 3.1 4.7 10.0 11.4 2.4 5.9 15.1 4.9 7.1 3.1 7.2 3.1 5.9 7.2 4.3 44.0 7.9 5.3 5.8 1.2 5.1 24.6 14.0 7.0 6.4 14.5 24.6 6.9 9.1 14.1 29.1 10.9 14.9 6.8 5.4 6.8 6.7 1.6 1.6 11.0 2.4 3.8 5.7 7.1 5.5 3.3 5.5 11.2 7.2 5.0 7.1 0.2 1.5 7.1 2.8 4.8 9.4 5.9 4.2 21.0 1.4 6.4 6.8 1.9 6.6 10.5 2.2 15.2 1.4 2.6 0.6 1.8 0.4 1.4 0.9 0.9 0.9 2.4 1.6 1.4 23.4 0.7 0.8 1.0 3.2 1.0 5.9 7.4 7.2 7.9 6.5 7.3 8.9 7.3 9.3 6.6 7.7 8.4 16.4 22.4 21.0 30.0 32.0 1.1 4.5 1.5 7.4 15.3 5.2 4.3 8.7 5.7 4.2 5.5 85.5 3.2 11.5 8.6 0.0 5.6 15.6 9.8 7.4 17.7 6.7 35.9 47.7 4.7 1.6 7.0 17.9 22.4 5.1 8.4 16.1 7.5 13.2 8.4 52.0 7.0 2.0 37.1 3.8 8.3 8.1 25.6 0.0 50.6 34.5 8.7 15.5 40.7 58.4 13.1 9.7 8.6 29.9 6.5 18.3 16.4 4.2 56.6 19.7 7.0 4.0 39.9 21.2 14.8 0.9 1.1 18.0 4.1 7.4 43.6 NOP10 "MGC70651, NOLA3, NOP10P" ENSG00000182117 "NOP10 ribonucleoprotein" Q9NPE3 15 34341719-34343136 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" Ribonucleoprotein "Disease variant, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 878.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059198 Supported Supported "Nuclear bodies" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 52: Non-specific - Ribosome" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 10: Non-specific - Unknown function" "Nuclear bodies" "HPA059198: AB_2683945" "unprognostic (2.65e-1)" "unprognostic (1.72e-2)" "unprognostic (1.08e-1)" "prognostic favorable (1.48e-5)" "unprognostic (3.12e-1)" "unprognostic (2.39e-3)" "unprognostic (8.11e-3)" "unprognostic (9.99e-2)" "unprognostic (2.28e-1)" "unprognostic (8.31e-3)" "unprognostic (1.77e-3)" "unprognostic (1.76e-1)" "unprognostic (1.83e-3)" "unprognostic (2.61e-1)" "unprognostic (2.59e-1)" "unprognostic (1.05e-1)" "unprognostic (6.77e-3)" 154.9 145.7 119.9 104.8 122.2 208.3 151.7 124.3 149.6 118.6 120.1 164.3 109.3 91.9 285.5 175.0 120.0 90.2 179.4 120.7 129.1 167.7 241.1 148.0 146.2 125.3 123.2 63.3 90.4 142.5 90.5 126.8 125.6 98.2 202.1 48.4 93.6 102.2 184.4 114.4 110.2 163.6 125.1 167.5 119.0 41.7 132.7 213.2 112.8 227.4 218.6 213.6 121.2 132.8 212.2 471.9 325.1 205.3 520.4 443.7 172.4 281.3 471.8 555.4 703.6 358.5 200.3 146.7 328.6 457.7 627.3 292.8 599.1 502.8 526.0 216.0 341.7 461.6 396.5 523.7 724.2 303.2 228.6 513.8 471.0 508.3 588.1 305.0 795.6 399.9 417.0 206.4 695.3 295.8 234.0 486.1 319.8 628.7 453.3 252.2 223.4 241.8 754.0 475.5 210.4 279.5 202.1 211.7 221.4 442.9 235.4 619.4 331.2 295.3 219.6 418.2 242.7 198.9 427.1 406.8 377.5 495.8 214.5 1080.4 852.4 889.6 368.7 867.8 394.9 723.0 476.7 442.7 636.3 639.5 503.6 441.2 2797.7 534.1 696.7 824.6 700.1 1065.2 119.9 122.2 124.3 149.6 120.7 129.1 125.3 123.2 125.6 125.1 132.7 132.8 202.7 109.0 153.3 7.2 175.1 239.5 179.8 470.8 130.3 30.9 158.6 195.2 299.7 143.0 273.9 149.0 12.5 210.7 158.0 286.1 446.1 365.6 15.0 230.7 148.1 257.5 195.7 169.5 6.7 351.9 402.1 154.2 122.9 234.0 164.0 81.3 240.9 359.7 878.9 13.5 7.1 283.9 315.3 504.5 321.5 16.8 103.8 309.2 190.3 12.2 322.1 70.0 250.3 5.0 10.0 600.6 362.9 100.1 209.5 251.2 304.2 668.9 298.6 33.7 105.2 91.7 336.0 19.0 101.8 224.8 302.8 214.0 154.2 128.7 241.0 451.3 NUTM1 "C15orf55, DKFZp434O192, FAM22H, NUT" ENSG00000184507 "NUT midline carcinoma family member 1" Q86Y26 15 34343315-34357737 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 42 "testis: 19.8" "Cell type enriched" "Detected in some" 6 "Early spermatids: 89.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA040421 Enhanced NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA040421: AB_10793965" "unprognostic (4.14e-2)" "unprognostic (3.61e-1)" "unprognostic (2.11e-1)" "unprognostic (7.38e-2)" "unprognostic (1.99e-1)" "unprognostic (8.37e-2)" "unprognostic (8.66e-2)" "unprognostic (2.76e-1)" "unprognostic (1.34e-1)" "unprognostic (5.55e-2)" "unprognostic (1.34e-2)" "unprognostic (5.97e-3)" "unprognostic (1.61e-1)" "unprognostic (2.77e-1)" "unprognostic (4.27e-2)" "unprognostic (4.79e-2)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 89.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LPCAT4 "AGPAT7, AYTL3, FLJ10257, LPAAT-eta, LPEAT2" ENSG00000176454 "Lysophosphatidylcholine acyltransferase 4" Q643R3 15 34358633-34367196 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 85.2;Gastric mucus-secreting cells: 131.5;Urothelial cells: 129.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HaCaT: 108.5;OE19: 113.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057321 Supported NA NA "Cluster 13: T-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA057321: " "unprognostic (2.79e-2)" "unprognostic (8.34e-2)" "unprognostic (1.08e-2)" "unprognostic (4.64e-3)" "unprognostic (1.29e-2)" "unprognostic (2.15e-2)" "prognostic unfavorable (9.99e-4)" "unprognostic (7.47e-2)" "unprognostic (1.13e-1)" "unprognostic (2.90e-1)" "unprognostic (1.23e-3)" "unprognostic (1.33e-1)" "unprognostic (9.95e-3)" "unprognostic (1.52e-2)" "unprognostic (1.37e-1)" "unprognostic (1.69e-2)" "unprognostic (3.44e-3)" 19.7 6.2 18.0 12.2 18.3 6.7 17.8 12.8 38.5 21.6 4.0 44.8 30.9 14.4 9.4 36.1 18.7 17.0 26.0 18.8 21.2 9.3 3.4 10.0 9.7 26.2 12.8 11.8 10.2 7.1 11.8 5.1 26.0 11.1 35.9 4.9 11.8 8.8 8.3 18.6 31.2 16.7 8.5 16.3 39.7 3.3 18.1 8.7 8.4 8.0 11.2 22.2 28.9 21.6 13.7 31.9 15.7 12.6 41.4 41.9 7.5 18.8 31.5 17.6 24.0 11.6 36.0 12.4 38.4 26.3 41.3 108.5 13.8 35.5 7.8 25.2 8.2 12.5 13.6 11.3 8.5 13.5 12.3 31.3 15.8 16.6 21.4 40.6 29.0 22.1 8.3 23.6 33.1 13.3 11.9 26.1 15.7 113.7 26.0 14.7 17.6 25.1 38.7 32.4 12.6 9.5 11.3 14.9 7.3 18.2 11.5 17.9 36.4 32.5 19.6 51.8 18.3 28.5 23.9 4.3 24.3 37.0 7.6 0.1 0.8 3.6 2.7 1.1 6.6 1.6 3.2 4.2 1.3 2.3 1.8 1.7 3.5 1.7 1.4 4.6 5.6 0.8 18.0 18.3 12.8 38.5 18.8 21.2 26.2 12.8 26.0 8.5 18.1 21.6 31.0 25.6 5.9 8.8 13.1 4.8 7.8 35.5 15.4 15.5 5.8 8.3 12.8 25.8 63.1 9.2 4.2 4.9 15.7 85.2 1.9 11.6 0.0 7.1 7.8 31.9 25.3 9.2 57.5 9.8 17.1 9.6 131.5 10.1 12.0 5.5 23.6 0.7 7.9 10.1 53.3 58.0 24.4 8.1 9.7 1.2 15.5 6.3 8.8 9.4 5.7 1.7 9.2 12.5 7.2 43.1 83.4 6.8 29.1 9.7 58.7 2.8 40.7 5.9 13.1 5.1 11.9 2.5 8.1 20.3 6.1 2.5 19.9 8.6 71.8 129.9 GOLGA8A "CFAP286, FAP286, GM88, GOLGIN-67" ENSG00000175265 "Golgin A8 family member A" A7E2F4 15 34379068-34437466 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 211.5;Oligodendrocyte precursor cells: 146.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEL: 48.0;HeLa: 80.1" HPA051808 Approved Approved "Golgi apparatus,Cytosol" NA Yes "Cluster 15: NK-cells - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" Cytosol "HPA051808: AB_2681620" "unprognostic (4.80e-2)" "unprognostic (1.26e-2)" "unprognostic (4.54e-1)" "unprognostic (1.32e-1)" "unprognostic (2.42e-2)" "unprognostic (2.10e-2)" "unprognostic (8.11e-3)" "prognostic favorable (7.58e-4)" "unprognostic (2.74e-2)" "unprognostic (4.37e-1)" "unprognostic (2.63e-3)" "unprognostic (2.25e-2)" "prognostic unfavorable (2.16e-6)" "unprognostic (2.23e-1)" "unprognostic (1.39e-1)" "unprognostic (2.26e-1)" "prognostic favorable (5.68e-6)" 24.5 18.6 16.1 10.4 11.7 7.9 32.4 18.5 21.4 56.3 11.0 32.7 10.5 31.6 31.8 31.2 37.6 7.3 23.6 13.1 10.0 33.2 6.8 22.4 14.0 17.8 8.8 62.5 22.9 6.3 22.8 2.2 11.9 37.8 2.2 26.4 26.8 10.2 7.6 36.8 38.2 3.2 7.0 48.1 30.3 40.0 12.8 1.2 56.8 1.0 2.1 33.0 40.2 12.2 2.4 13.4 3.7 12.5 0.1 0.0 2.8 20.3 0.1 3.4 1.5 23.3 0.0 0.1 3.6 2.4 6.9 21.7 9.5 6.8 5.3 20.1 7.6 48.0 80.1 15.0 1.3 18.4 12.6 0.0 19.5 2.3 0.5 2.3 0.3 7.0 46.0 40.0 9.2 4.3 4.7 34.6 6.9 6.4 7.2 19.6 11.2 16.2 7.7 13.8 17.1 8.2 13.6 9.2 2.2 0.1 3.6 11.4 10.5 15.7 3.5 0.0 3.6 37.5 13.4 5.5 4.7 38.9 3.5 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 16.1 11.7 18.5 21.4 13.1 10.0 17.8 8.8 11.9 7.0 12.8 12.2 37.3 211.5 71.6 82.9 16.1 26.1 10.9 13.4 7.4 95.3 36.1 41.9 35.0 5.7 127.6 1.8 100.1 2.9 21.1 6.5 0.0 4.2 37.5 17.6 83.9 18.4 16.1 2.5 114.4 2.6 5.0 17.4 13.7 52.3 13.9 39.3 14.6 1.5 2.4 84.1 91.8 11.9 14.2 6.8 20.1 8.4 31.4 8.5 23.2 38.4 1.7 14.8 6.2 146.8 62.5 4.7 6.9 21.1 19.3 8.5 6.6 0.9 52.0 117.6 0.0 26.7 22.4 33.0 23.5 7.8 21.6 3.3 32.9 39.9 11.7 9.4 GOLGA8B ENSG00000215252 "Golgin A8 family member B" A8MQT2 15 34525207-34588503 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "pancreas: 228.4" "Cell type enhanced" "Detected in all" "Alveolar cells type 1: 192.3;Excitatory neurons: 133.4;Inhibitory neurons: 126.1" "Cancer enhanced" "Detected in all" "thyroid cancer: 14.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 20.4;Hep G2: 16.2;NB-4: 24.5" HPA051808 Approved Approved "Golgi apparatus,Cytosol" NA Yes "Cluster 41: Basophils - Cellular respiration" "Cluster 25: Pancreas - Digestion" "Cluster 20: HeLa - Mitochondria" "Cluster 52: Non-specific - Transcription" "Golgi apparatus" Cytosol "HPA051808: AB_2681620" "unprognostic (2.12e-3)" "unprognostic (2.06e-1)" "unprognostic (1.85e-1)" "unprognostic (2.89e-1)" "unprognostic (2.43e-1)" "unprognostic (4.06e-2)" "unprognostic (7.90e-3)" "unprognostic (9.67e-3)" "unprognostic (9.02e-2)" "unprognostic (1.06e-1)" "unprognostic (1.60e-3)" "unprognostic (1.49e-2)" "prognostic unfavorable (9.38e-6)" "unprognostic (2.14e-1)" "unprognostic (5.31e-3)" "unprognostic (2.31e-1)" "prognostic favorable (5.79e-4)" 16.5 28.8 10.9 7.2 11.0 18.4 20.8 13.8 15.0 28.7 10.8 18.6 0.9 16.8 11.9 10.0 27.9 6.9 15.5 11.0 11.1 41.1 41.8 23.8 19.6 11.2 10.9 55.6 228.4 0.7 60.6 3.0 10.9 37.8 1.4 8.0 18.1 10.6 10.1 13.4 25.2 2.0 10.9 38.5 28.7 43.2 11.1 2.8 113.8 1.3 7.4 19.7 13.4 11.2 2.6 2.8 0.3 5.3 2.8 5.4 7.3 2.3 0.7 2.5 4.0 2.8 3.5 0.0 4.7 2.5 0.3 2.1 0.9 2.4 1.9 3.6 8.4 0.4 20.4 16.2 3.9 2.3 2.5 7.8 3.3 1.5 4.5 2.7 2.6 4.0 0.9 0.2 2.3 1.2 1.2 24.5 3.2 5.0 4.6 0.1 0.0 0.4 2.2 4.9 3.8 5.8 1.3 0.4 3.2 3.9 2.2 4.8 0.0 3.7 8.8 1.1 4.0 1.8 1.7 3.9 1.2 1.2 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 11.0 13.8 15.0 11.0 11.1 11.2 10.9 10.9 10.9 11.1 11.2 19.0 192.3 66.5 95.0 34.8 21.9 8.8 10.9 33.0 53.6 30.9 34.3 37.4 20.0 74.7 31.3 73.0 7.6 30.6 2.8 1.9 9.2 53.8 17.3 27.1 11.0 7.2 13.0 133.4 13.0 5.4 12.7 20.4 24.5 9.5 36.4 11.0 28.7 1.5 45.4 126.1 10.1 12.2 6.6 9.9 10.8 39.4 5.0 21.4 12.2 6.4 9.3 32.0 112.1 24.2 16.8 4.9 37.6 45.1 7.6 7.1 5.8 39.9 67.8 13.1 13.5 13.8 48.9 28.4 10.0 14.8 2.9 49.8 22.0 9.4 6.6 GJD2 "CX36, GJA9" ENSG00000159248 "Gap junction protein delta 2" Q9UKL4 15 34751032-34754998 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 5.9;pituitary gland: 7.5;retina: 21.3" "Cell type enhanced" "Detected in some" "Bipolar cells: 11.2;Cone photoreceptor cells: 39.6;Horizontal cells: 6.7;Rod photoreceptor cells: 13.7" "Cancer enriched" "Detected in single" 32 "pancreatic cancer: 4.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SuSa: 2.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" NA NA "Cluster 77: Retina - Visual perception" "Cluster 12: NES - Nervous system development" "Cluster 9: Photoreceptor cells - Phototransduction" "unprognostic (4.30e-2)" "unprognostic (2.87e-2)" "unprognostic (1.28e-3)" "unprognostic (1.15e-1)" 0.0 5.9 1.1 0.0 0.6 0.0 0.0 1.1 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.7 1.1 0.3 0.0 0.0 0.0 3.2 1.4 0.0 3.9 0.0 7.5 0.0 1.0 0.0 0.0 21.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 1.1 0.6 1.1 1.4 0.7 1.1 3.2 1.4 1.0 0.2 1.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.2 0.0 0.0 2.8 0.0 0.0 0.0 39.6 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACTC1 "ACTC, CMD1R" ENSG00000159251 "Actin alpha cardiac muscle 1" P68032 15 34790230-34795549 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Muscle protein" "Atrial septal defect, Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 21 "heart muscle: 11410.0" "Cell type enriched" "Detected in some" 30 "Cardiomyocytes: 9746.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 20.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 1131.8;LHCN-M2: 4544.5;RH-30: 2053.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB037330, HPA041264, HPA041271" Enhanced NA NA 2400000000 "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 54: Cardiomyocytes - Muscle contraction" "CAB037330: , HPA041264: AB_2677383, HPA041271: AB_2677386" "unprognostic (8.18e-3)" "unprognostic (3.74e-2)" "unprognostic (4.82e-3)" "unprognostic (1.19e-2)" "unprognostic (3.04e-2)" "prognostic unfavorable (3.72e-5)" "unprognostic (3.26e-1)" "unprognostic (2.05e-3)" "unprognostic (2.26e-1)" "unprognostic (7.98e-2)" "unprognostic (1.14e-2)" "unprognostic (2.10e-3)" "unprognostic (5.68e-4)" "unprognostic (8.79e-2)" "unprognostic (1.65e-1)" "unprognostic (1.48e-2)" "prognostic unfavorable (9.32e-4)" 51.1 1.8 1.9 24.7 1.7 0.0 11.9 2.1 2.6 8.6 1.3 4.0 0.8 6.9 1.1 22.8 1.6 11.8 11410.0 1.9 2.8 1.5 0.6 3.9 2.6 2.7 2.8 3.2 12.9 1.0 2.2 8.9 3.0 73.0 3.6 31.6 11.5 538.1 135.2 4.6 0.6 8.8 1.4 1.3 9.3 0.5 4.0 11.3 2.4 195.0 0.2 439.6 16.1 1.5 0.0 0.2 0.1 0.0 0.2 3.3 0.2 2.2 0.7 5.2 1.3 0.0 0.0 0.0 1.3 1131.8 0.2 0.0 0.4 0.0 1.3 0.0 0.0 0.1 23.9 0.0 0.1 1.4 0.0 457.2 0.0 0.2 0.1 0.3 0.1 0.0 0.0 0.0 4544.5 0.0 0.0 0.0 3.8 0.0 0.0 0.0 2053.3 0.0 0.0 0.0 0.1 0.1 4.0 0.0 0.0 31.2 0.0 0.0 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.2 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.7 2.1 2.6 1.9 2.8 2.7 2.8 3.0 1.4 4.0 1.5 0.0 0.0 0.0 0.3 0.0 0.5 0.3 0.0 0.0 11.9 0.1 0.0 9746.1 0.0 0.0 0.0 20.9 0.1 0.0 0.0 1.9 0.0 5.0 0.0 0.1 69.2 0.0 0.0 0.2 0.2 4.3 315.2 0.0 0.0 0.0 0.1 0.4 0.4 0.1 0.0 0.4 0.0 0.0 0.0 0.0 1.9 0.0 0.2 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.2 0.0 63.4 86.5 1.0 0.7 0.0 0.4 0.3 0.1 0.1 0.0 0.0 AQR "fSAP164, IBP160, KIAA0560" ENSG00000021776 "Aquarius intron-binding spliceosomal factor" O60306 15 34851782-34969742 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 114.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040624, HPA055647" Enhanced Nucleoplasm No No "Cluster 46: Basophils - DNA binding" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA040624: AB_2677050, HPA055647: AB_2682874" "unprognostic (1.73e-1)" "unprognostic (3.71e-2)" "unprognostic (2.97e-1)" "unprognostic (1.32e-2)" "unprognostic (1.03e-1)" "unprognostic (9.04e-2)" "unprognostic (4.25e-2)" "unprognostic (1.90e-1)" "unprognostic (5.95e-2)" "unprognostic (2.65e-1)" "unprognostic (1.14e-2)" "unprognostic (1.48e-1)" "prognostic favorable (4.83e-4)" "unprognostic (2.97e-1)" "unprognostic (2.47e-1)" "unprognostic (3.84e-1)" "unprognostic (3.13e-2)" 3.7 3.9 4.5 3.4 5.7 4.0 5.9 7.8 5.2 5.7 3.9 4.2 3.4 4.5 4.1 3.5 4.4 3.1 2.7 4.7 5.0 5.2 4.0 3.6 4.2 4.1 4.7 5.0 4.1 5.2 2.5 4.4 4.5 4.0 4.2 8.0 3.3 3.7 2.8 4.2 3.6 3.8 4.5 4.7 3.8 5.6 4.9 7.0 5.4 3.5 4.7 4.0 3.5 5.8 5.3 13.5 8.7 9.3 11.6 10.7 4.5 6.4 8.1 8.3 7.4 6.1 3.2 4.3 4.0 10.8 5.4 8.2 14.8 9.1 9.1 6.1 6.0 13.8 11.4 5.6 6.6 11.3 6.2 8.4 5.9 6.5 6.9 7.7 7.1 3.3 9.9 4.2 8.3 3.6 6.6 7.5 8.7 12.2 5.5 8.9 15.0 4.3 8.3 9.2 9.5 7.4 10.3 9.7 2.3 7.6 6.9 8.7 9.3 6.1 3.4 4.3 5.7 5.0 6.6 8.5 7.7 9.6 6.3 3.6 2.0 1.2 2.6 2.2 2.3 1.6 2.3 2.6 1.7 2.3 2.3 2.6 1.0 2.1 1.4 2.3 2.0 1.4 4.5 5.7 7.8 5.2 4.7 5.0 4.1 4.7 4.5 4.5 4.9 5.8 27.0 12.8 26.0 45.4 27.9 9.6 13.7 17.0 15.4 28.6 19.9 15.6 14.7 17.2 28.1 14.7 114.7 16.4 31.4 18.2 3.9 13.4 38.2 20.6 26.7 24.1 13.2 21.0 39.8 14.3 14.4 18.6 20.4 22.1 24.1 28.8 31.1 18.5 14.9 25.2 44.0 19.1 12.2 18.6 5.1 8.4 20.8 21.8 16.0 29.0 27.9 14.3 22.6 42.3 42.2 18.5 12.1 18.4 22.9 18.8 17.4 12.9 27.1 41.1 6.6 42.8 16.9 19.4 22.2 22.4 9.7 13.3 27.0 46.5 21.6 13.5 ZNF770 "FLJ20582, PRO1914" ENSG00000198146 "Zinc finger protein 770" Q6IQ21 15 34978341-34988287 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024518 Approved NA NA "Cluster 32: T-cells - Unknown function" "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 30: Epithelial cell lines - Translation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "HPA024518: AB_1859449" "unprognostic (1.04e-1)" "unprognostic (1.60e-2)" "unprognostic (1.75e-2)" "unprognostic (2.79e-1)" "unprognostic (2.32e-2)" "unprognostic (1.17e-1)" "unprognostic (3.11e-1)" "unprognostic (6.67e-2)" "unprognostic (1.05e-1)" "unprognostic (1.28e-1)" "unprognostic (2.67e-3)" "unprognostic (4.24e-2)" "unprognostic (2.09e-3)" "unprognostic (1.20e-1)" "unprognostic (1.41e-1)" "unprognostic (5.06e-2)" "unprognostic (2.10e-3)" 12.7 12.9 12.2 12.7 16.7 8.9 18.6 16.9 16.3 13.2 12.2 9.7 12.2 15.1 44.9 28.9 17.7 9.0 14.8 14.1 11.4 21.6 29.4 9.8 17.6 9.5 12.3 17.8 10.7 22.2 5.4 22.5 10.0 13.2 9.9 19.7 15.0 12.0 18.6 35.3 11.6 10.7 11.3 15.4 11.7 13.6 12.4 16.6 44.2 19.8 21.9 12.2 12.8 11.5 18.9 23.1 31.8 40.5 25.1 23.9 17.9 22.0 21.0 21.1 23.1 20.5 12.7 18.0 29.6 21.8 20.8 44.7 37.9 30.1 29.5 23.1 16.1 41.9 33.2 23.5 50.7 44.1 26.7 16.3 74.1 19.0 52.8 28.0 24.7 13.4 48.0 26.5 29.0 11.1 30.6 21.9 26.2 29.2 23.6 35.1 29.9 24.8 28.2 34.4 45.3 26.1 32.9 37.3 19.9 25.4 26.8 26.3 21.6 37.1 15.6 21.1 21.3 16.6 28.2 28.7 30.6 32.2 27.5 2.1 3.8 1.3 3.9 3.2 5.5 4.9 4.1 3.4 3.2 4.9 6.0 4.9 4.5 4.2 3.6 3.3 4.8 2.6 12.2 16.7 16.9 16.3 14.1 11.4 9.5 12.3 10.0 11.3 12.4 11.5 20.5 16.0 29.3 26.8 40.3 64.6 40.1 25.4 39.9 25.6 27.5 25.8 13.4 20.0 28.8 33.1 22.9 17.5 32.8 9.8 31.3 21.1 15.8 29.2 30.5 24.9 27.1 13.5 21.6 24.0 14.2 24.2 20.9 26.3 22.1 26.6 27.5 68.1 13.9 25.2 24.8 24.4 14.2 22.9 18.8 8.7 25.4 18.6 39.2 12.2 38.9 29.4 32.0 22.1 19.8 25.3 11.1 23.0 19.8 42.1 12.1 54.3 19.8 21.1 0.0 32.3 18.3 63.8 52.5 64.1 91.1 19.8 26.4 33.3 23.5 39.8 NANOGP8 ENSG00000255192 "Nanog homeobox retrogene P8" Q6NSW7 15 35083410-35085295 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 5 "brain: 3.7" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 415 "testis cancer: 20.7" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 69 "NTERA-2: 33.2;SuSa: 11.6" HPA072117 Supported Nucleoplasm,Vesicles NA NA "Cluster 6: Brain - Smell perception" "Cluster 5: NTERA-2 - Transcription" Nucleoplasm Vesicles "HPA072117: " "unprognostic (1.58e-1)" "unprognostic (9.05e-3)" "unprognostic (1.48e-1)" "unprognostic (2.37e-1)" 0.1 0.1 0.7 0.0 3.7 0.2 0.1 2.1 1.8 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.2 0.5 0.2 0.1 0.1 0.0 0.3 0.2 0.2 0.2 0.0 0.2 0.0 0.4 0.2 0.0 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.7 1.2 0.0 0.1 0.0 0.0 0.1 0.1 0.6 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 33.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.7 3.7 2.1 1.8 0.2 0.5 0.3 0.2 0.4 0.2 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DPH6 "ATPBD4, MGC14798" ENSG00000134146 "Diphthamine biosynthesis 6" Q7L8W6 15 35217345-35546193 "Enzymes, Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 91.7;Oligodendrocytes: 101.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042976, HPA055496" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 6: T47d - Mammary gland" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoli, Nucleoli rim" Nucleoplasm "HPA042976: AB_10964890, HPA055496: AB_2682835" "unprognostic (9.78e-2)" "unprognostic (1.45e-1)" "unprognostic (1.92e-1)" "unprognostic (1.14e-1)" "unprognostic (1.82e-1)" "unprognostic (1.45e-2)" "unprognostic (1.60e-1)" "unprognostic (9.94e-2)" "unprognostic (1.76e-1)" "unprognostic (1.49e-3)" "unprognostic (7.92e-3)" "unprognostic (1.13e-1)" "unprognostic (4.65e-6)" "unprognostic (9.70e-2)" "unprognostic (5.61e-2)" "unprognostic (2.18e-2)" "unprognostic (7.44e-2)" 8.6 7.5 3.7 4.9 4.7 5.4 10.8 4.6 5.0 6.8 3.6 6.7 6.1 7.9 10.7 9.6 8.1 6.0 10.2 3.6 4.7 10.4 8.1 5.3 5.3 4.6 4.4 9.7 14.3 8.7 5.9 8.1 4.8 5.8 7.0 8.9 6.7 6.1 10.8 9.7 6.6 6.4 4.3 6.3 6.8 5.9 3.9 7.0 10.8 6.9 7.4 8.0 7.1 5.7 16.9 8.9 14.7 12.5 2.6 11.7 14.3 6.2 10.8 14.7 7.6 11.9 15.5 5.2 14.8 5.7 17.9 19.0 17.2 17.9 17.5 4.1 10.7 19.6 9.9 18.9 15.3 10.6 12.1 9.9 22.2 5.9 28.5 9.0 14.4 11.0 21.8 20.6 13.6 6.6 13.0 9.8 13.0 25.4 8.1 16.0 13.7 7.2 12.9 21.0 10.7 10.4 11.6 12.8 10.7 8.5 44.6 14.4 4.4 14.2 13.8 14.4 10.0 18.2 31.3 13.4 12.3 17.7 13.9 0.0 6.7 0.3 6.0 6.7 7.7 8.9 8.1 8.4 6.7 6.3 10.3 9.3 0.3 14.7 6.2 5.8 5.8 4.5 3.7 4.7 4.6 5.0 3.6 4.7 4.6 4.4 4.8 4.3 3.9 5.7 15.9 16.0 7.5 91.7 18.7 31.0 20.0 19.8 24.5 29.2 12.0 16.6 15.8 18.6 17.2 9.2 39.6 26.7 9.3 7.5 13.7 16.3 2.2 10.7 13.7 10.0 5.4 16.8 28.0 24.1 23.5 12.0 21.4 13.3 3.8 21.1 5.7 7.4 17.5 18.5 47.0 7.4 14.2 10.3 12.9 3.3 14.0 9.8 16.0 44.0 14.3 15.0 11.3 71.9 101.5 18.7 7.1 6.8 6.9 8.9 13.4 19.9 7.6 24.2 0.0 18.9 14.0 9.8 14.0 21.2 23.2 22.6 9.9 21.9 10.5 13.4 CDIN1 "C15orf41, FLJ22851, HH114, MGC11326" ENSG00000186073 "CDAN1 interacting nuclease 1" Q9Y2V0 15 36579626-36810248 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "heart muscle: 78.6;tongue: 34.5" "Cell type enriched" "Detected in some" 9 "Cardiomyocytes: 97.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061023 Uncertain Approved Nucleoplasm NA NA "Cluster 35: T-regs - Unknown function" "Cluster 38: Heart - Muscle contraction" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoplasm "HPA061023: AB_2684417" "unprognostic (1.82e-1)" "unprognostic (1.14e-1)" "unprognostic (1.10e-2)" "unprognostic (4.92e-2)" "unprognostic (2.93e-3)" "unprognostic (2.27e-2)" "unprognostic (2.37e-2)" "unprognostic (2.02e-2)" "unprognostic (3.40e-2)" "unprognostic (3.29e-2)" "unprognostic (2.59e-3)" "unprognostic (9.14e-2)" "unprognostic (3.74e-6)" "unprognostic (1.22e-2)" "unprognostic (4.54e-2)" "unprognostic (1.62e-4)" "unprognostic (1.58e-1)" 2.8 5.1 2.9 2.4 7.9 0.7 2.9 4.3 4.1 5.9 1.6 5.6 6.7 6.8 1.8 9.4 4.1 4.0 78.6 2.5 3.5 2.8 3.7 2.5 2.4 3.9 3.4 4.3 2.2 2.4 2.3 2.1 4.3 6.0 3.2 9.6 5.0 6.6 12.0 5.6 3.3 9.5 2.9 2.2 3.3 7.1 3.4 4.2 2.5 34.5 3.6 9.5 8.3 4.9 19.0 10.0 12.4 4.7 13.5 15.6 5.1 8.9 4.5 11.1 9.1 13.9 7.4 3.0 8.8 22.1 8.1 33.8 13.0 7.7 12.7 1.5 9.1 9.9 9.0 10.3 11.8 8.4 7.1 12.0 8.3 9.5 5.2 8.5 10.7 9.6 12.9 3.1 15.4 8.6 2.6 4.9 6.8 8.6 5.1 7.9 3.5 2.0 7.4 25.8 7.1 4.4 5.7 5.5 4.8 9.0 5.5 13.1 7.6 10.8 5.9 7.3 2.5 7.2 11.2 13.7 13.7 15.0 10.2 0.0 0.5 0.3 2.5 1.3 2.2 2.1 1.9 2.4 1.4 2.2 2.3 1.9 0.0 3.3 0.4 1.1 5.1 1.1 2.9 7.9 4.3 4.1 2.5 3.5 3.9 3.4 4.3 2.9 3.4 4.9 1.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 97.6 0.0 0.0 0.0 0.0 8.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 6.6 1.4 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 10.8 0.2 0.0 0.0 0.0 MEIS2 "HsT18361, MRG1" ENSG00000134138 "Meis homeobox 2" O14770 15 36889204-37101299 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 522.3;Cone photoreceptor cells: 254.4;Excitatory neurons: 164.7;Hepatic stellate cells: 207.4;Oligodendrocyte precursor cells: 262.4;Oligodendrocytes: 219.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 27 "basophil: 2.9;eosinophil: 2.4" "Lineage enriched" "Detected in single" 29 "granulocytes: 2.9" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 114.0;SH-SY5Y: 104.0" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basal ganglia: 68.4;olfactory bulb: 177.4" "HPA003256, CAB004999" Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm Cytosol "CAB004999: AB_425545, HPA003256: AB_1079356" "unprognostic (4.33e-2)" "unprognostic (1.94e-2)" "unprognostic (6.71e-4)" "unprognostic (2.47e-3)" "unprognostic (1.65e-1)" "unprognostic (2.24e-1)" "unprognostic (5.23e-2)" "unprognostic (1.23e-1)" "unprognostic (3.66e-1)" "unprognostic (4.73e-2)" "unprognostic (7.97e-2)" "unprognostic (1.11e-1)" "prognostic unfavorable (2.64e-7)" "unprognostic (6.47e-2)" "unprognostic (8.15e-2)" "unprognostic (8.79e-5)" "unprognostic (1.15e-1)" 11.1 21.9 14.4 5.3 50.4 0.0 7.4 11.7 24.9 20.9 0.6 33.2 20.6 37.0 4.1 14.2 23.3 17.8 15.7 16.0 14.7 11.1 6.9 8.4 3.4 19.2 25.7 21.1 13.4 3.5 16.4 8.6 20.0 37.7 6.4 18.8 56.8 21.6 0.7 4.4 8.3 36.3 18.0 7.6 14.1 1.6 11.8 11.1 5.4 9.5 3.4 25.6 13.5 20.3 13.3 12.0 15.3 43.6 16.7 20.6 3.6 28.3 15.6 32.9 18.4 17.2 10.8 7.6 0.7 114.0 20.8 22.4 26.9 7.2 18.1 10.9 17.3 58.8 15.8 13.9 28.6 17.5 57.2 27.3 6.3 22.3 6.6 43.2 19.1 2.8 20.1 0.1 6.4 14.3 0.1 6.7 0.2 15.8 3.9 0.0 11.1 4.1 0.0 25.7 11.9 104.0 10.8 7.1 8.0 16.5 3.4 13.3 27.3 37.6 4.6 10.1 12.1 7.5 8.1 14.6 44.3 9.7 9.6 2.9 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 50.4 11.7 24.9 16.0 14.7 19.2 25.7 20.0 18.0 11.8 20.3 6.5 0.0 7.3 522.3 3.4 17.5 97.3 14.1 79.1 43.8 21.0 16.3 23.9 77.2 11.4 1.8 254.4 23.3 1.0 1.0 0.0 58.4 15.2 10.5 17.1 67.2 1.8 5.3 164.7 27.1 10.0 61.7 25.5 0.8 63.3 14.9 207.4 9.6 3.4 3.3 5.0 0.4 30.5 6.5 6.1 7.4 47.8 1.1 8.8 21.5 0.6 10.7 0.0 262.4 219.7 25.7 0.3 41.3 1.8 38.3 1.4 0.1 26.5 135.9 32.9 14.7 46.4 3.6 3.1 23.8 6.1 4.5 2.3 31.2 1.0 54.1 TMCO5A "MGC35118, TMCO5" ENSG00000166069 "Transmembrane and coiled-coil domains 5A" Q8N6Q1 15 37921939-37967724 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 141 "testis: 90.7" "Group enriched" "Detected in some" 104 "Early spermatids: 1153.9;Late spermatids: 3910.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA056530, HPA064017" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 31: Spermatids - Spermatogenesis" "Plasma membrane, Cytosol" "HPA056530: AB_2683167, HPA064017: " "unprognostic (2.60e-1)" "unprognostic (1.69e-4)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 90.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1153.9 0.2 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3910.6 13.4 1.1 0.0 0.0 0.0 0.0 0.0 1.0 1.4 0.0 0.0 10.9 0.0 0.0 0.0 0.0 1.1 0.0 6.6 0.0 0.0 24.2 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 SPRED1 "FLJ33903, PPP1R147" ENSG00000166068 "Sprouty related EVH1 domain containing 1" Q7Z699 15 38252836-38357249 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 173.7;Excitatory neurons: 163.4;Microglial cells: 199.5;Oligodendrocyte precursor cells: 277.9;Oligodendrocytes: 146.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 1.4" "Lineage enriched" "Detected in single" 4 "monocytes: 1.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042193, HPA061805" Approved Supported Nucleoplasm NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 12: NES - Nervous system development" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoplasm "HPA042193: AB_10794079, HPA061805: AB_2684617" "unprognostic (1.30e-1)" "unprognostic (1.28e-2)" "unprognostic (2.46e-1)" "prognostic favorable (7.08e-4)" "unprognostic (1.20e-1)" "unprognostic (2.38e-1)" "unprognostic (1.21e-3)" "unprognostic (5.71e-2)" "unprognostic (3.84e-2)" "unprognostic (2.81e-3)" "unprognostic (9.27e-3)" "unprognostic (3.33e-1)" "prognostic unfavorable (7.37e-5)" "prognostic unfavorable (8.29e-5)" "unprognostic (6.04e-2)" "unprognostic (5.77e-2)" "unprognostic (1.01e-1)" 12.7 8.2 16.0 8.8 20.3 0.7 10.9 14.7 20.6 11.5 7.1 11.4 8.2 10.9 5.7 6.1 6.9 12.8 7.3 16.5 16.3 9.1 5.6 17.4 7.1 18.9 19.6 7.9 4.5 6.8 4.0 14.0 16.2 7.2 10.9 7.5 5.6 8.6 2.6 6.1 8.4 9.5 15.6 9.0 10.3 8.2 17.9 4.4 31.1 8.0 4.9 13.2 6.8 18.3 11.0 8.2 59.0 11.3 21.4 39.0 4.8 25.1 24.7 13.1 16.2 7.6 8.7 0.1 9.0 21.7 9.5 8.6 6.2 17.3 26.2 1.5 2.0 13.0 5.2 7.3 26.3 7.1 34.6 25.5 8.5 25.5 23.4 33.6 10.7 6.5 11.7 12.1 32.2 2.9 2.6 5.2 12.0 37.6 22.0 0.0 13.3 7.3 21.2 16.9 2.9 13.0 7.2 3.5 26.7 9.3 2.8 1.7 18.2 32.0 15.7 19.7 15.4 10.1 7.1 16.7 22.5 2.8 52.1 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 16.0 20.3 14.7 20.6 16.5 16.3 18.9 19.6 16.2 15.6 17.9 18.3 26.4 99.3 26.9 173.7 2.5 28.3 24.6 9.4 45.5 12.6 17.2 20.8 7.2 28.6 12.6 1.8 6.2 1.3 1.5 15.7 1.9 9.5 40.3 12.0 29.4 28.2 6.7 4.6 163.4 4.9 0.9 33.0 17.3 14.8 41.8 5.4 26.7 4.1 57.8 5.0 100.0 21.2 6.1 48.2 24.6 9.6 21.8 38.7 28.4 199.5 7.3 25.4 0.0 277.9 146.9 15.1 7.8 30.5 1.6 12.7 6.6 12.8 11.4 5.2 6.6 44.4 44.1 8.0 5.0 18.1 9.7 1.4 2.4 21.4 15.3 14.7 FAM98B FLJ38426 ENSG00000171262 "Family with sequence similarity 98 member B" Q52LJ0 15 38454127-38487710 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008320, HPA008502" Enhanced Supported Nucleoplasm,Vesicles NA NA 20000 "Cluster 40: NK-cells - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Vesicles" "HPA008320: AB_1848419, HPA008502: AB_1848420" "unprognostic (1.05e-2)" "unprognostic (3.13e-1)" "unprognostic (1.15e-1)" "unprognostic (1.00e-2)" "unprognostic (1.54e-2)" "unprognostic (3.09e-2)" "unprognostic (9.25e-3)" "unprognostic (1.74e-1)" "unprognostic (4.69e-2)" "unprognostic (2.18e-1)" "unprognostic (3.15e-1)" "unprognostic (3.15e-2)" "unprognostic (1.51e-2)" "unprognostic (2.26e-1)" "unprognostic (4.36e-2)" "unprognostic (1.94e-1)" "unprognostic (1.13e-1)" 12.7 11.4 9.5 12.8 10.2 9.8 12.9 16.4 12.6 9.7 7.2 15.4 9.6 13.3 9.0 9.0 8.1 7.0 12.4 10.8 10.9 13.1 7.8 8.1 13.8 9.4 9.7 11.2 6.1 19.3 6.4 12.0 10.0 12.1 11.6 19.8 6.3 10.0 13.8 8.8 10.0 9.5 10.1 11.2 9.5 8.5 9.6 28.6 11.7 16.3 13.3 11.9 7.0 12.6 30.7 16.2 77.7 40.0 14.1 25.7 37.9 38.6 28.2 37.4 37.5 35.8 14.4 21.1 41.4 32.2 37.9 31.8 47.4 39.5 52.2 21.8 25.7 62.6 33.9 27.8 20.4 59.8 34.6 23.9 24.1 33.3 38.5 27.4 38.9 45.7 45.6 25.7 36.0 13.8 50.7 31.8 42.0 34.8 22.3 53.3 42.0 17.7 32.8 39.9 47.8 48.9 42.5 27.0 19.8 34.6 33.0 36.6 32.7 42.1 51.5 28.2 44.0 47.6 46.1 78.3 23.1 38.9 44.8 2.3 0.5 1.4 2.8 0.4 2.4 1.6 2.8 2.3 0.6 1.9 3.4 2.6 0.4 2.2 0.6 1.4 1.9 0.4 9.5 10.2 16.4 12.6 10.8 10.9 9.4 9.7 10.0 10.1 9.6 12.6 17.9 16.0 21.4 16.3 16.8 14.7 12.7 14.1 14.2 36.8 15.2 11.6 48.9 12.8 18.1 16.5 16.7 30.6 16.4 11.0 7.9 16.4 3.4 19.1 21.5 16.9 12.6 16.6 22.5 19.8 22.4 16.6 16.8 17.0 13.3 18.4 16.8 13.1 12.6 20.2 20.5 22.6 12.2 15.8 12.2 2.5 12.5 10.9 5.4 18.7 21.4 18.5 21.6 12.1 23.8 14.3 9.8 17.0 18.2 12.4 11.1 12.7 18.8 27.9 6.6 21.5 16.2 27.2 17.1 19.7 14.8 21.5 15.3 14.7 19.3 14.1 RASGRP1 "CalDAG-GEFII, RASGRP" ENSG00000172575 "RAS guanyl releasing protein 1" O95267 15 38488103-38565575 "Disease related genes, Predicted intracellular proteins, RAS pathway related proteins" Differentiation "Guanine-nucleotide releasing factor" "Disease variant, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.7;lymphoid tissue: 45.7;retina: 29.7" "Cell type enhanced" "Detected in many" "dendritic cells: 71.4;Excitatory neurons: 54.1;Muller glia cells: 86.9;Plasma cells: 43.0;T-cells: 84.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "T-reg: 10.3" "Lineage enriched" "Detected in many" 4 "T-cells: 10.3" "Group enriched" "Detected in many" 4 "HDLM-2: 54.5;JURKAT: 70.2;MOLT-4: 52.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039389 Supported "Plasma membrane,Cytosol" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" Cytosol "Plasma membrane" "HPA039389: AB_2732481" "unprognostic (3.44e-3)" "unprognostic (1.86e-2)" "unprognostic (1.17e-2)" "unprognostic (3.43e-3)" "unprognostic (1.82e-2)" "unprognostic (3.33e-3)" "unprognostic (9.63e-2)" "unprognostic (4.23e-2)" "unprognostic (1.91e-1)" "unprognostic (1.21e-1)" "unprognostic (4.50e-1)" "unprognostic (3.01e-2)" "unprognostic (2.54e-1)" "unprognostic (2.55e-1)" "unprognostic (1.51e-1)" "unprognostic (3.40e-1)" "unprognostic (9.30e-2)" 1.1 0.8 6.7 10.5 16.8 8.5 1.7 23.7 13.2 0.8 0.0 1.4 2.4 1.4 0.4 5.9 4.4 2.5 1.2 11.6 3.3 5.5 1.1 4.1 21.4 15.3 2.5 0.4 1.8 0.5 0.5 0.9 17.9 0.7 2.1 29.7 1.7 0.7 0.4 6.9 3.6 0.6 0.0 8.9 4.5 2.0 8.8 45.7 0.6 0.7 16.4 3.4 2.0 9.2 0.0 0.4 1.0 0.3 0.0 0.0 0.1 4.1 1.2 2.0 1.7 4.5 0.0 11.6 0.9 0.1 0.2 0.2 2.4 0.0 1.9 54.5 2.2 0.9 0.5 0.0 0.6 0.5 0.8 0.0 0.1 1.1 0.0 0.0 0.0 70.2 0.5 3.6 0.0 1.7 52.3 0.1 0.7 0.0 0.0 14.4 0.3 0.0 2.0 0.1 4.7 1.7 2.6 0.1 0.2 1.5 1.2 0.0 0.2 0.4 1.6 5.6 0.8 8.7 4.6 13.6 0.2 0.1 0.6 0.0 0.0 0.9 5.2 0.0 3.7 1.1 5.7 5.2 0.0 0.6 5.2 5.3 0.2 2.4 0.0 0.0 10.3 1.4 6.7 16.8 23.7 13.2 11.6 3.3 15.3 2.5 17.9 0.0 8.8 9.2 0.9 6.4 10.7 6.5 26.5 2.4 0.4 6.8 4.6 9.6 3.4 2.0 4.5 5.7 2.7 33.1 10.4 0.3 71.4 0.1 3.9 18.4 1.5 7.6 1.6 0.8 0.0 0.0 54.1 10.0 0.2 1.2 1.1 6.6 3.8 0.4 1.1 0.5 0.7 6.7 16.5 1.3 0.0 0.8 6.1 0.7 0.0 3.0 7.2 9.4 3.0 86.9 34.0 2.5 3.9 34.1 0.0 0.0 43.0 0.7 0.3 7.8 0.4 21.3 0.0 1.9 1.3 1.2 3.8 4.0 8.2 0.0 84.7 0.3 0.9 0.5 THBS1 "THBS, THBS-1, TSP, TSP-1, TSP1" ENSG00000137801 "Thrombospondin 1" P07996 15 39581079-39599466 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion, Unfolded protein response" Heparin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Fibroblasts: 279.5;Granulosa cells: 228.3;Macrophages: 598.0;Smooth muscle cells: 283.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "eosinophil: 15.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 2610.2;HUVEC TERT2: 2494.4;LHCN-M2: 1863.4;TIME: 3552.9" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "spinal cord: 20.6" "CAB033678, HPA059756" Approved Approved "Plasma membrane" "Secreted to extracellular matrix" NA NA 16000000000 1400000000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 19: Lung - Lung function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 41: Macrophages - Immune response" "Plasma membrane" "CAB033678: AB_793044, HPA059756: AB_2684121" "unprognostic (1.72e-2)" "unprognostic (9.55e-3)" "unprognostic (7.49e-2)" "unprognostic (3.31e-1)" "unprognostic (4.34e-2)" "unprognostic (1.03e-3)" "unprognostic (3.60e-1)" "unprognostic (1.53e-2)" "unprognostic (1.22e-1)" "unprognostic (2.07e-1)" "unprognostic (6.40e-2)" "unprognostic (9.16e-2)" "prognostic unfavorable (8.47e-5)" "prognostic unfavorable (8.50e-4)" "unprognostic (1.00e-1)" "unprognostic (9.25e-3)" "unprognostic (1.48e-3)" 364.3 72.5 1.7 394.0 3.7 114.7 95.1 2.1 11.3 66.7 27.3 166.4 24.8 161.3 3.5 49.1 142.6 275.2 98.3 2.2 2.1 70.9 129.4 309.2 32.3 10.8 4.4 76.3 69.1 7.0 26.8 99.0 10.8 89.8 85.6 0.4 137.3 12.0 16.2 35.4 83.5 243.6 0.9 79.8 150.5 2.2 14.3 12.0 34.0 4.3 7.1 396.3 36.2 2.1 171.9 62.7 49.0 17.8 199.4 233.9 0.7 1025.7 861.6 283.6 185.5 185.0 135.7 1.0 348.4 2610.2 54.4 621.0 2.2 516.1 145.0 43.4 0.5 46.6 35.0 46.9 44.4 0.3 13.2 524.9 37.2 237.2 535.1 1123.6 2494.4 1.6 1.5 1.7 1863.4 14.7 0.8 3.6 8.9 17.7 20.3 0.7 125.7 1.3 430.6 472.6 0.6 0.4 300.7 16.4 18.5 60.8 178.6 3.3 3552.9 972.6 221.0 1141.1 1146.6 2.4 1.8 2.0 33.0 0.8 1064.4 0.3 8.7 15.7 0.7 0.8 2.7 0.0 0.4 0.5 0.5 0.1 0.1 0.1 1.5 7.8 0.1 0.4 0.0 10.5 1.7 3.7 2.1 11.3 2.2 2.1 10.8 4.4 10.8 0.9 14.3 2.1 19.0 25.6 19.6 0.7 4.9 95.7 131.2 37.6 181.6 0.1 66.8 69.8 48.7 18.6 19.9 69.9 6.2 1.9 8.2 144.5 0.0 52.1 0.2 64.9 127.7 79.2 3.6 0.0 0.9 127.5 2.5 279.5 15.8 38.2 162.7 228.3 44.6 7.4 6.3 0.0 1.3 46.4 48.8 105.9 97.9 0.3 1.8 598.0 39.2 13.1 5.9 0.1 3.1 0.0 0.1 183.9 55.1 0.4 5.9 79.2 8.5 48.3 11.9 1.5 6.6 59.0 283.8 0.2 0.3 51.8 51.0 2.1 19.5 10.8 67.8 42.1 FSIP1 FLJ35989 ENSG00000150667 "Fibrous sheath interacting protein 1" Q8NA03 15 39588357-39782841 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 10.9;testis: 7.2" "Cell type enhanced" "Detected in many" "Early spermatids: 67.1;Excitatory neurons: 28.2;Inhibitory neurons: 21.5;Late spermatids: 48.3;Spermatocytes: 35.3" "Cancer enriched" "Detected in some" 8 "breast cancer: 6.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 4.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA041002 Uncertain Uncertain Nucleoplasm NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 45: Intestine - Brush border" "Cluster 12: NES - Nervous system development" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm "HPA041002: AB_10796565" "unprognostic (1.55e-2)" "unprognostic (1.49e-1)" "unprognostic (9.12e-2)" "unprognostic (2.36e-1)" "unprognostic (1.02e-2)" "unprognostic (1.43e-3)" "unprognostic (5.17e-3)" "unprognostic (5.37e-2)" "unprognostic (9.22e-2)" "unprognostic (1.60e-1)" "unprognostic (1.04e-2)" "unprognostic (2.49e-1)" "unprognostic (1.22e-2)" "unprognostic (1.14e-1)" "unprognostic (3.81e-2)" "unprognostic (2.01e-1)" "unprognostic (1.81e-1)" 0.2 0.2 1.6 0.2 1.8 0.6 0.9 0.0 1.6 0.2 1.7 7.3 0.1 0.3 0.3 0.1 1.2 0.2 0.2 1.2 1.8 0.8 0.1 0.2 0.1 1.1 1.3 0.1 0.1 0.8 1.4 0.3 0.9 0.2 10.9 0.9 0.1 0.2 0.2 0.9 0.1 0.3 0.3 0.2 0.5 7.2 2.0 1.4 0.4 0.1 0.1 0.3 0.1 0.4 0.4 1.3 3.4 0.5 0.6 1.1 0.0 4.1 0.8 0.6 1.2 1.0 0.3 0.2 0.3 1.2 1.7 0.8 0.5 0.7 1.0 1.4 0.3 2.5 0.9 0.0 0.3 0.5 2.7 0.7 2.8 1.5 0.6 0.8 0.7 1.4 0.1 0.3 1.0 0.1 0.3 0.2 0.4 0.2 0.6 0.3 0.7 0.1 1.3 1.5 0.8 2.5 0.8 0.1 0.1 0.3 1.1 0.3 0.6 1.6 0.9 0.9 0.4 0.7 1.6 0.2 3.3 0.9 0.8 0.4 0.3 0.4 0.7 0.2 0.5 0.1 0.3 0.4 0.2 0.2 0.2 0.1 0.2 0.3 0.2 0.0 0.1 0.4 1.6 1.8 0.0 1.6 1.2 1.8 1.1 1.3 0.9 0.3 2.0 0.4 0.7 0.0 0.5 8.1 1.1 0.6 0.6 3.4 0.0 1.1 14.5 7.9 0.8 2.8 2.9 1.8 12.5 0.9 1.4 17.5 1.9 1.0 67.1 10.0 2.1 1.0 0.0 0.0 28.2 0.4 0.1 1.5 0.5 0.6 15.8 0.4 0.4 0.0 0.1 0.0 21.5 3.5 0.0 0.0 0.3 48.3 1.2 0.6 0.0 7.5 0.1 1.0 3.1 3.0 3.2 0.1 6.6 0.7 0.4 0.7 0.0 3.2 12.6 6.1 0.0 1.2 1.5 35.3 8.3 0.2 0.0 5.6 3.3 0.7 2.9 0.3 GPR176 Gm1012 ENSG00000166073 "G protein-coupled receptor 176" Q14439 15 39799008-39920266 "G-protein coupled receptors, Predicted membrane proteins" "Biological rhythms" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 22.3;Excitatory neurons: 32.0;Inhibitory neurons: 56.8;Oligodendrocyte precursor cells: 40.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 276.1;fHDF/TERT166: 186.5;U-138 MG: 119.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039943, HPA039979" Approved NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA039943: AB_10697711, HPA039979: AB_2676782" "unprognostic (4.02e-2)" "unprognostic (2.65e-1)" "unprognostic (1.99e-1)" "unprognostic (1.11e-1)" "unprognostic (4.24e-1)" "unprognostic (1.04e-2)" "unprognostic (2.75e-2)" "unprognostic (1.38e-3)" "unprognostic (9.32e-2)" "unprognostic (3.23e-2)" "unprognostic (2.74e-2)" "unprognostic (2.33e-2)" "prognostic unfavorable (9.38e-7)" "prognostic unfavorable (6.84e-5)" "unprognostic (2.23e-1)" "unprognostic (1.95e-1)" "unprognostic (3.26e-2)" 13.2 6.1 10.0 4.1 10.6 0.3 6.6 11.2 10.5 6.8 1.1 3.9 2.0 5.6 2.0 1.7 4.4 7.0 4.2 10.1 10.4 3.9 1.9 7.5 6.3 9.7 8.8 1.8 1.6 1.9 5.0 2.4 12.3 7.1 2.3 6.3 2.9 3.6 1.7 3.5 3.4 4.6 6.0 4.1 2.2 7.2 8.8 2.1 5.0 1.1 5.8 6.4 5.3 5.9 52.3 2.6 3.2 0.6 36.9 64.6 0.0 108.3 276.1 64.3 99.5 3.7 8.3 0.7 8.7 186.5 37.1 1.6 7.7 8.4 100.7 1.7 11.2 7.7 7.7 0.1 41.1 0.0 0.4 50.7 1.0 56.7 47.6 65.7 24.6 2.4 1.0 1.1 91.8 2.1 0.1 0.0 3.2 0.4 9.3 2.7 32.3 0.3 1.6 0.6 12.0 47.8 27.9 0.0 4.4 0.7 9.0 0.5 31.8 119.5 33.9 7.2 40.7 1.1 3.6 0.1 24.9 0.0 47.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 10.6 11.2 10.5 10.1 10.4 9.7 8.8 12.3 6.0 8.8 5.9 3.0 0.0 0.0 8.5 0.9 1.8 0.2 0.8 0.0 1.1 0.4 0.6 0.9 1.5 0.1 0.0 0.0 0.0 0.3 0.1 0.0 9.3 22.3 0.1 3.1 1.8 0.0 0.0 32.0 3.9 0.0 3.4 0.0 0.2 0.0 0.1 0.7 0.1 0.1 1.7 56.8 0.0 0.0 0.0 1.8 13.5 1.2 0.7 1.8 3.7 0.0 14.9 0.0 40.7 1.4 12.0 0.0 1.2 3.1 3.0 0.0 1.2 0.0 1.1 13.1 3.8 15.2 2.9 3.8 0.5 1.0 0.0 0.4 0.8 0.0 0.1 EIF2AK4 "GCN2, KIAA1338" ENSG00000128829 "Eukaryotic translation initiation factor 2 alpha kinase 4" Q9P2K8 15 39934115-40035591 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Activation of host autophagy by virus, Adaptive immunity, Antiviral defense, Cell cycle, Growth arrest, Host-virus interaction, Immunity, Neurogenesis, Stress response, Translation regulation" "Activator, Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase, tRNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 66.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011811 Approved Approved Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 15: Liver - Metabolism" "Cluster 44: HDLM-2 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "HPA011811: AB_2668543" "unprognostic (3.10e-1)" "unprognostic (4.78e-3)" "unprognostic (5.97e-2)" "unprognostic (7.18e-2)" "unprognostic (1.05e-2)" "unprognostic (3.32e-2)" "unprognostic (1.18e-1)" "unprognostic (3.18e-1)" "unprognostic (1.36e-1)" "unprognostic (1.21e-1)" "unprognostic (1.38e-2)" "unprognostic (7.27e-2)" "unprognostic (2.38e-1)" "unprognostic (1.27e-2)" "unprognostic (6.47e-2)" "unprognostic (2.31e-2)" "unprognostic (5.11e-3)" 20.1 14.6 21.5 12.2 22.4 18.7 17.6 27.2 23.7 14.6 16.8 15.5 11.3 30.5 15.4 16.0 16.1 17.0 17.7 21.2 22.0 13.4 21.3 16.9 16.9 20.3 20.2 17.1 14.1 17.7 24.1 19.0 20.5 19.8 12.9 13.1 13.9 11.5 18.9 19.0 11.3 15.6 18.9 15.7 15.2 8.9 22.1 13.1 21.8 11.0 11.6 17.2 12.4 28.9 37.1 17.5 30.3 46.3 49.0 81.7 28.9 51.0 58.1 40.8 40.0 25.2 15.6 19.6 25.9 69.3 54.7 38.6 41.1 61.4 56.6 92.8 20.4 41.6 30.8 30.7 42.1 25.6 27.8 65.3 41.2 39.0 69.8 57.3 58.0 40.5 31.3 18.1 81.7 12.3 21.7 34.6 18.8 32.8 38.2 25.4 42.2 33.1 51.4 24.7 16.1 24.4 36.4 22.2 32.3 29.5 30.7 43.4 61.6 54.3 40.9 27.3 33.6 24.6 47.8 6.0 38.1 34.4 77.4 11.6 10.8 8.6 6.8 14.1 5.7 7.1 7.6 7.9 17.6 9.2 8.3 8.2 3.3 8.5 20.5 66.5 5.8 4.9 21.5 22.4 27.2 23.7 21.2 22.0 20.3 20.2 20.5 18.9 22.1 28.9 47.9 16.0 31.1 28.7 29.3 12.0 27.5 17.8 43.3 29.9 45.0 45.2 32.3 32.9 21.4 16.5 12.5 37.5 32.2 21.1 13.7 23.7 1.5 19.3 52.7 35.3 14.4 37.4 42.7 25.4 34.8 36.5 23.4 27.0 24.1 35.0 22.9 27.8 30.7 28.6 53.9 25.9 12.2 33.7 55.4 4.3 42.3 52.1 32.0 29.0 41.1 30.4 16.5 30.2 26.3 47.6 16.2 39.9 115.6 30.7 6.4 18.2 12.9 23.9 46.0 43.6 35.6 8.6 29.8 47.0 14.5 15.2 18.2 64.0 29.6 18.4 SRP14 "ALURBP, MGC14326" ENSG00000140319 "Signal recognition particle 14" P37108 15 40035690-40039181 "Plasma proteins, Predicted intracellular proteins, Transporters" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053738, HPA065118" Approved Nucleoplasm,Nucleoli NA NA 440000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli Nucleoplasm "HPA053738: , HPA065118: " "unprognostic (2.52e-1)" "unprognostic (1.65e-1)" "unprognostic (8.20e-3)" "unprognostic (1.01e-2)" "unprognostic (1.04e-1)" "unprognostic (5.39e-3)" "unprognostic (2.97e-1)" "unprognostic (2.67e-1)" "unprognostic (1.07e-1)" "unprognostic (7.99e-2)" "unprognostic (1.46e-1)" "unprognostic (1.28e-1)" "prognostic favorable (5.31e-4)" "unprognostic (2.20e-1)" "unprognostic (8.03e-3)" "unprognostic (1.41e-3)" "unprognostic (4.94e-2)" 309.1 307.5 330.1 118.1 327.1 252.7 300.4 323.8 426.0 301.7 320.4 272.5 121.5 311.2 282.1 257.7 270.7 155.8 390.1 317.9 349.3 391.5 229.5 220.8 168.0 357.0 402.7 323.5 192.4 324.3 306.8 143.8 339.7 264.4 158.9 212.8 237.8 158.9 354.7 201.2 215.7 163.4 321.1 219.7 247.6 165.6 326.2 276.9 275.6 338.5 172.9 266.7 253.9 355.1 131.8 163.7 399.5 301.4 300.0 275.5 189.4 232.4 265.0 213.4 223.3 297.8 113.7 107.9 245.0 305.1 319.5 216.6 322.8 260.9 207.0 257.5 230.3 258.3 530.2 364.0 231.4 238.2 211.8 276.0 298.3 177.8 213.3 391.0 360.6 297.7 280.2 204.2 356.3 204.5 370.2 291.4 217.6 520.1 301.3 247.6 176.8 192.6 477.5 401.7 287.2 255.0 231.2 243.2 171.2 243.7 332.8 448.6 290.9 240.4 160.3 229.4 171.1 161.8 494.7 291.0 234.7 255.4 229.7 729.8 525.0 875.7 484.5 485.8 473.9 600.9 547.9 549.0 562.5 509.0 522.0 510.2 452.7 525.9 459.5 1148.0 755.1 1262.6 330.1 327.1 323.8 426.0 317.9 349.3 357.0 402.7 339.7 321.1 326.2 355.1 1378.8 461.6 415.0 83.2 577.0 667.1 861.7 1395.7 427.4 432.9 617.7 914.5 880.3 649.1 906.9 995.0 125.1 867.3 812.5 742.7 2551.3 1366.9 353.1 1215.7 729.8 957.7 554.0 619.4 39.4 1087.2 1100.4 699.1 324.7 1513.6 564.0 669.5 654.7 819.4 1022.1 348.3 56.1 676.9 1226.8 631.1 882.8 377.3 1039.8 645.8 789.8 36.5 1174.3 1262.8 619.0 39.2 76.0 1240.7 894.4 986.9 610.9 826.3 874.5 2276.2 935.5 477.3 624.5 651.9 749.3 779.9 643.1 631.5 710.3 758.8 644.1 831.9 673.2 975.0 BMF FLJ00065 ENSG00000104081 "Bcl2 modifying factor" Q96LC9 15 40087890-40108892 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 76.0" "Cell type enhanced" "Detected in many" "Ductal cells: 14.9;Exocrine glandular cells: 15.1;Kupffer cells: 18.7;Langerhans cells: 12.8;monocytes: 14.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 43.3;HMC-1: 44.2;hTERT-RPE1: 57.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010120 Approved Approved Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 63: T-cells - Adaptive immune response" "Cluster 20: HeLa - Mitochondria" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm "HPA010120: AB_1845385" "unprognostic (2.94e-1)" "unprognostic (4.92e-3)" "unprognostic (7.63e-2)" "unprognostic (4.44e-1)" "unprognostic (1.89e-1)" "prognostic favorable (1.83e-4)" "prognostic unfavorable (6.32e-4)" "unprognostic (1.42e-2)" "unprognostic (4.26e-1)" "unprognostic (3.75e-1)" "unprognostic (5.15e-2)" "unprognostic (1.55e-1)" "unprognostic (7.06e-2)" "unprognostic (6.66e-2)" "unprognostic (1.26e-1)" "unprognostic (2.34e-2)" "unprognostic (2.35e-2)" 3.7 2.9 1.9 12.6 1.8 33.0 5.7 2.2 3.0 9.6 3.9 10.1 21.2 15.8 7.2 2.9 11.9 12.2 5.3 1.2 3.5 10.7 3.4 12.8 13.7 4.3 3.0 14.1 7.7 6.0 2.7 6.4 4.1 6.0 8.4 3.0 10.4 4.7 5.1 5.3 23.6 10.1 3.4 18.9 10.1 2.1 5.0 76.0 17.1 5.3 23.5 7.5 3.8 6.4 1.0 1.4 22.9 5.1 0.6 0.9 15.5 0.1 3.6 0.4 1.1 23.6 1.7 6.8 7.3 1.0 7.0 4.9 5.7 0.1 0.1 16.0 4.7 3.5 43.3 5.5 2.1 0.6 44.2 11.3 1.3 0.4 0.4 57.0 6.0 5.0 1.9 2.9 2.0 1.3 2.3 17.6 6.2 11.8 0.8 4.3 5.2 20.4 1.0 5.4 12.1 9.8 4.4 11.6 10.6 24.3 6.9 13.8 4.6 0.8 3.1 0.7 0.3 28.1 28.4 4.3 1.6 3.3 2.7 0.0 2.6 2.4 0.1 2.9 0.2 2.9 0.2 0.8 1.6 0.9 0.4 0.0 3.2 0.0 4.0 2.0 0.7 0.7 1.9 1.8 2.2 3.0 1.2 3.5 4.3 3.0 4.1 3.4 5.0 6.4 2.3 3.2 2.2 0.3 7.3 1.1 0.9 1.0 1.2 0.2 2.1 1.3 1.6 4.3 5.0 0.0 0.0 1.4 0.7 7.9 0.0 14.9 1.3 5.9 1.2 3.8 1.2 3.2 0.1 15.1 1.3 2.3 1.5 8.5 0.0 0.8 1.4 1.0 8.4 0.0 0.8 1.1 6.1 18.7 12.8 0.5 1.8 8.8 0.0 3.7 14.2 0.3 0.0 0.5 0.5 10.9 1.2 0.7 7.0 1.7 9.6 2.4 1.0 0.8 0.0 1.3 1.3 0.4 1.4 0.9 0.6 1.8 3.5 0.2 1.2 1.0 BUB1B "Bub1A, BUBR1, MAD3L, SSK1" ENSG00000156970 "BUB1 mitotic checkpoint serine/threonine kinase B" O60566 15 40161023-40221123 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 17.8;lymphoid tissue: 35.7;testis: 22.2" "Cell type enhanced" "Detected in many" "Erythroid cells: 23.5;Spermatocytes: 79.2;Spermatogonia: 26.8" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.1" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" HPA008419 Supported Cytosol Yes Yes "Cluster 24: B-cells - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol "HPA008419: AB_1078308" "unprognostic (4.40e-2)" "unprognostic (2.23e-1)" "unprognostic (4.65e-2)" "unprognostic (2.44e-3)" "unprognostic (9.66e-2)" "unprognostic (3.52e-2)" "prognostic unfavorable (7.43e-6)" "prognostic unfavorable (3.56e-4)" "unprognostic (3.69e-3)" "unprognostic (2.32e-1)" "prognostic unfavorable (1.79e-4)" "unprognostic (1.76e-2)" "unprognostic (0.00e+0)" "unprognostic (3.75e-2)" "unprognostic (4.66e-2)" "unprognostic (2.20e-1)" "unprognostic (3.94e-2)" 0.4 0.5 0.1 6.7 0.1 17.8 1.6 0.3 0.2 1.0 7.7 4.6 4.7 1.2 0.3 5.2 0.6 0.6 0.3 0.3 0.1 0.3 0.4 1.0 12.6 0.0 0.1 0.2 0.2 0.2 0.1 3.4 0.1 0.4 6.0 0.1 0.9 0.2 0.0 3.5 4.1 2.1 0.0 3.1 2.4 22.2 0.2 35.7 0.5 0.0 15.0 1.5 1.7 0.0 66.5 32.8 103.0 41.5 2.5 7.1 33.2 60.9 34.2 64.6 55.7 48.1 25.0 59.7 33.5 22.7 59.0 72.6 98.8 33.2 70.5 51.8 52.1 86.4 83.6 45.5 0.2 79.0 45.7 1.6 2.0 39.2 37.1 12.9 47.7 66.5 76.4 61.7 65.6 22.5 62.5 48.9 70.2 55.6 36.8 66.5 83.7 45.2 19.9 33.1 67.1 40.8 38.0 35.9 13.3 45.1 41.9 40.9 27.6 49.3 51.8 49.2 55.5 32.1 58.2 95.6 26.3 87.8 65.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.1 0.2 1.1 0.0 0.1 0.0 0.1 0.0 0.8 0.0 0.1 0.1 0.1 0.3 0.2 0.3 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.1 3.2 1.1 0.3 1.8 0.8 0.3 1.0 1.8 0.7 0.9 2.0 0.8 0.0 1.9 0.0 0.0 5.4 0.6 1.8 0.0 0.4 3.0 0.9 1.4 1.0 0.0 23.5 0.7 0.0 6.7 2.4 5.6 2.1 0.0 12.9 1.1 0.3 5.2 0.0 0.7 2.5 0.0 1.9 1.7 3.3 1.5 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 1.5 0.4 12.6 0.3 0.3 0.1 0.2 0.2 6.6 0.2 1.7 79.2 26.8 6.9 0.3 0.8 1.8 0.8 5.4 0.6 PAK6 PAK5 ENSG00000137843 "P21 (RAC1) activated kinase 6" Q9NQU5 15 40217428-40277487 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 25.6;skin 1: 28.2" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 52.7;NK-cells: 16.5;Suprabasal keratinocytes: 19.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 26.5;HaCaT: 32.2;hTCEpi: 19.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA031124 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Cell Junctions" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 47: Cytotrophoblasts - Unknown function" "Nucleoplasm, Nucleoli fibrillar center" "Cell Junctions" "HPA031124: AB_10601044" "unprognostic (1.85e-3)" "unprognostic (2.15e-1)" "unprognostic (3.33e-3)" "unprognostic (7.79e-3)" "unprognostic (7.08e-3)" "unprognostic (9.57e-2)" "unprognostic (2.71e-1)" "unprognostic (7.73e-2)" "unprognostic (1.34e-2)" "unprognostic (7.13e-3)" "unprognostic (4.04e-2)" "unprognostic (8.87e-3)" "unprognostic (1.72e-1)" "unprognostic (1.79e-1)" "unprognostic (7.37e-3)" "unprognostic (3.34e-2)" 0.2 8.2 11.6 0.4 15.9 0.9 2.1 8.5 16.6 4.5 0.0 1.3 1.5 0.9 1.0 25.6 4.3 1.1 8.3 17.6 3.0 4.7 0.3 2.5 0.9 1.4 1.1 0.6 8.0 8.0 12.1 7.6 1.9 4.4 1.1 0.8 6.1 3.8 4.5 28.2 1.5 0.3 1.8 0.9 3.9 17.7 3.0 0.5 7.5 1.3 1.9 3.5 9.4 5.4 3.9 0.0 0.2 0.0 0.0 0.0 6.0 0.0 0.2 0.7 0.7 26.5 2.9 0.1 3.6 0.0 1.3 32.2 4.5 6.9 0.3 0.2 1.0 0.0 3.0 0.2 0.0 0.1 0.3 0.0 19.4 0.3 4.5 0.2 0.0 5.5 1.8 0.3 0.0 4.5 0.0 0.5 0.5 3.9 2.9 0.2 0.2 2.9 1.5 8.4 7.3 2.0 2.6 10.9 0.3 1.7 1.7 10.3 0.0 0.3 0.6 0.0 0.3 0.1 0.3 0.1 0.7 0.6 0.2 1.2 0.1 1.2 2.3 0.1 0.8 0.6 0.1 1.9 0.3 0.1 0.1 0.4 0.5 0.9 0.1 0.1 0.0 0.6 11.6 15.9 8.5 16.6 17.6 3.0 1.4 1.1 1.9 1.8 3.0 5.4 0.0 0.0 4.2 0.7 0.3 9.8 9.6 4.8 8.6 3.5 2.8 2.9 0.0 4.3 5.4 5.5 0.0 52.7 2.1 0.3 13.7 4.4 8.6 3.3 0.4 0.3 4.9 0.0 8.9 4.3 3.0 0.7 0.5 5.1 0.0 0.7 0.0 0.0 4.1 0.0 7.3 1.1 2.0 0.6 0.9 5.8 1.8 0.3 1.8 1.0 0.0 1.3 16.5 0.5 0.3 2.5 1.0 1.9 0.1 5.2 0.2 0.2 3.9 0.2 0.0 0.3 0.4 1.9 3.3 13.9 19.0 9.0 1.0 0.8 2.0 11.3 PLCB2 FLJ38135 ENSG00000137841 "Phospholipase C beta 2" Q00722 15 40278176-40307935 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 52.4;lymphoid tissue: 40.7" "Cell type enhanced" "Detected in many" "dendritic cells: 22.6;granulocytes: 26.6;Hofbauer cells: 30.3;Kupffer cells: 46.6;Macrophages: 41.7;Microglial cells: 39.4;monocytes: 20.9;NK-cells: 26.8;T-cells: 20.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 78.6;HMC-1: 93.4;THP-1: 28.1;U-937: 53.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB009443, HPA041298, HPA068595, HPA069308" Enhanced Approved "Plasma membrane,Cytosol" NA NA 11000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Plasma membrane, Cytosol" "CAB009443: AB_632197, HPA041298: AB_2677395, HPA068595: , HPA069308: " "unprognostic (5.52e-2)" "unprognostic (4.96e-3)" "unprognostic (6.09e-3)" "unprognostic (1.88e-2)" "unprognostic (1.31e-1)" "prognostic favorable (3.00e-4)" "unprognostic (1.66e-1)" "unprognostic (3.08e-2)" "unprognostic (1.28e-1)" "unprognostic (2.34e-1)" "unprognostic (1.42e-1)" "unprognostic (2.75e-1)" "prognostic unfavorable (7.20e-5)" "unprognostic (9.89e-2)" "unprognostic (2.06e-3)" "unprognostic (5.81e-2)" "unprognostic (1.13e-1)" 5.9 4.0 3.8 29.2 3.9 52.4 2.5 3.8 5.4 3.3 3.4 5.1 6.1 2.7 1.4 3.0 4.5 9.7 3.0 4.0 5.6 1.9 6.3 16.8 28.7 8.4 7.1 1.5 1.3 1.3 2.1 7.0 7.3 2.6 8.0 0.5 5.4 4.0 1.2 1.9 10.4 7.3 6.2 40.7 5.5 1.3 7.7 20.5 2.2 1.7 22.2 7.3 1.8 9.6 0.4 0.0 0.6 0.0 0.0 0.0 10.5 0.0 0.1 0.0 0.0 0.1 19.1 1.5 17.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 78.6 0.0 0.0 0.0 16.9 93.4 0.0 0.0 0.0 0.0 0.0 0.1 10.2 0.7 4.3 0.0 0.0 4.7 9.2 0.9 0.0 0.2 13.7 2.0 0.1 0.1 0.0 0.3 0.3 0.0 0.0 0.2 5.1 0.0 28.1 10.1 0.0 9.1 0.0 0.0 0.0 0.0 3.7 0.0 53.2 0.0 1.7 2.6 5.3 1.8 2.7 1.2 0.4 0.9 0.9 2.7 0.5 0.9 1.0 4.2 1.2 2.7 1.0 1.9 1.5 3.8 3.9 3.8 5.4 4.0 5.6 8.4 7.1 7.3 6.2 7.7 9.6 0.9 6.4 16.8 0.3 9.6 0.9 0.1 0.1 0.6 0.1 1.9 2.5 3.3 1.5 3.2 1.8 0.0 0.5 22.6 0.2 0.0 0.1 2.2 0.2 0.5 1.7 0.0 8.0 1.8 0.0 0.5 1.9 0.0 0.2 26.6 0.1 1.1 0.4 30.3 0.0 0.8 1.7 0.0 46.6 15.5 0.6 0.3 41.7 3.6 39.4 20.9 0.0 26.8 0.5 0.2 0.4 0.3 0.0 5.7 0.0 0.0 0.9 4.4 0.2 0.0 0.4 0.7 0.5 2.3 0.3 0.6 0.4 20.8 0.3 2.0 0.0 ANKRD63 ENSG00000230778 "Ankyrin repeat domain 63" C9JTQ0 15 40281444-40282586 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 81 "brain: 20.9" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 20.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.9;THP-1: 1.4" "Region enhanced" "Detected in many" "basal ganglia: 56.7" HPA066743 Approved Mitochondria NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 43: Cardiomyocytes - Nuclear processes" Mitochondria "HPA066743: " "unprognostic (9.36e-2)" "unprognostic (7.45e-2)" "unprognostic (8.32e-2)" "unprognostic (4.42e-1)" 0.0 0.0 3.6 0.0 20.9 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 1.3 2.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.9 0.4 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 20.9 0.0 10.6 1.3 2.1 0.0 0.3 0.0 0.0 4.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 INAFM2 "LINC00984, OGU1" ENSG00000259330 "InaF motif containing 2" P0DMQ5 15 40323692-40326715 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 18.0;Early spermatids: 25.3;Hofbauer cells: 19.5;Spermatocytes: 32.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 2.6" "Group enriched" "Detected in many" 4 "dendritic cells: 1.1;granulocytes: 2.6;monocytes: 1.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 32: U-937 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "unprognostic (6.03e-2)" "unprognostic (2.66e-1)" "unprognostic (1.68e-2)" "unprognostic (5.59e-2)" "unprognostic (9.05e-2)" "unprognostic (8.01e-3)" "unprognostic (2.43e-2)" "prognostic favorable (7.87e-4)" "unprognostic (1.23e-1)" "unprognostic (1.20e-1)" "unprognostic (1.52e-2)" "unprognostic (2.07e-2)" "prognostic unfavorable (1.88e-7)" "prognostic unfavorable (5.01e-4)" "unprognostic (2.35e-1)" "unprognostic (1.76e-1)" "unprognostic (1.91e-1)" 11.3 8.4 16.1 9.9 17.9 12.7 7.6 15.5 17.1 8.5 15.2 49.9 6.7 12.2 5.8 8.1 21.3 11.0 28.8 16.4 18.4 7.9 6.7 11.5 5.8 19.3 16.9 10.0 11.5 12.2 10.4 17.6 16.9 10.8 13.4 12.6 9.4 22.5 13.6 6.5 12.9 17.3 18.2 10.7 28.2 10.2 17.0 5.2 26.9 15.0 6.2 14.4 7.8 22.2 18.7 1.8 16.8 10.7 14.2 6.9 38.6 23.0 11.5 18.0 14.8 6.9 3.7 1.6 19.8 12.6 10.6 41.7 26.3 27.1 25.1 5.5 8.8 50.4 6.9 3.9 18.3 27.0 34.3 18.2 9.8 6.7 18.8 26.5 18.7 12.9 27.6 39.6 25.4 2.7 7.9 21.5 12.3 14.5 14.1 3.9 20.2 44.8 13.2 21.3 35.9 14.2 8.2 9.7 8.3 28.6 9.4 33.1 24.5 24.8 18.4 12.6 16.8 10.2 2.7 4.8 18.4 43.5 24.1 0.6 1.0 2.6 0.1 1.1 0.1 0.3 0.1 0.0 0.5 0.0 0.0 0.1 0.7 0.1 1.0 1.1 0.2 0.6 16.1 17.9 15.5 17.1 16.4 18.4 19.3 16.9 16.9 18.2 17.0 22.2 6.4 0.0 3.7 3.9 2.3 0.0 1.2 0.0 0.0 7.8 6.8 5.5 18.0 4.3 0.6 3.7 4.2 3.3 3.1 4.3 0.0 2.3 25.3 2.2 3.8 6.0 2.4 1.7 3.4 2.6 0.6 2.4 3.6 2.3 1.3 1.8 12.1 2.7 19.5 8.4 4.5 1.4 0.0 14.1 0.0 4.6 1.2 13.8 0.0 6.5 8.0 6.7 4.1 4.0 1.4 2.3 1.9 4.9 0.4 3.2 1.4 0.8 1.5 4.8 0.0 2.4 9.8 32.4 4.4 1.1 0.0 1.4 1.7 4.9 1.5 2.4 CCDC9B "C15orf52, FLJ43339" ENSG00000188549 "Coiled-coil domain containing 9B" Q6ZUT6 15 40331452-40340967 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 12.8;Alveolar cells type 2: 10.0;Collecting duct cells: 20.2;Ductal cells: 30.0;Pancreatic endocrine cells: 18.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "basophil: 4.3" "Lineage enriched" "Detected in single" 10 "granulocytes: 4.3" "Cell line enhanced" "Detected in many" "HaCaT: 122.5;hTERT-RPE1: 110.8;WM-115: 138.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040484, HPA041834" Approved Approved Nucleoplasm,Cytosol NA NA 77000 "Cluster 38: Basophils - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 17: WM-115 - Nervous system development" "Cluster 1: Pancreatic cells - Digestion" "Nucleoplasm, Cytosol" "HPA040484: AB_10794742, HPA041834: AB_10795643" "unprognostic (5.57e-3)" "unprognostic (1.85e-1)" "unprognostic (2.60e-3)" "unprognostic (2.33e-2)" "unprognostic (1.48e-2)" "unprognostic (2.68e-1)" "unprognostic (1.86e-2)" "unprognostic (1.01e-1)" "unprognostic (1.50e-1)" "unprognostic (7.06e-3)" "unprognostic (1.51e-2)" "unprognostic (2.50e-1)" "unprognostic (1.04e-3)" "unprognostic (1.55e-1)" "unprognostic (3.48e-1)" "unprognostic (1.50e-2)" "unprognostic (9.68e-2)" 4.9 10.3 9.5 7.7 13.1 2.8 8.1 10.9 10.7 12.0 15.0 73.4 9.9 23.9 7.3 33.2 10.8 12.0 53.0 9.0 12.7 10.2 5.0 12.3 3.3 13.1 12.6 4.0 25.3 11.3 10.2 3.9 12.7 16.2 12.5 4.3 28.3 22.7 67.4 15.4 18.1 24.2 11.6 5.6 22.3 8.3 12.7 1.3 45.2 65.1 5.9 25.9 16.7 12.6 50.0 6.8 0.0 0.4 1.1 4.6 2.5 14.8 14.6 16.1 15.6 0.5 44.7 0.3 20.1 47.8 58.6 122.5 0.2 40.4 15.1 0.0 0.3 14.9 64.4 4.7 8.5 0.2 2.8 5.7 9.0 6.9 20.3 110.8 11.6 0.8 0.1 0.7 27.9 0.0 0.5 0.0 0.2 23.1 12.7 0.0 4.2 0.2 48.0 2.8 0.1 3.6 8.8 19.1 8.4 0.2 1.9 2.3 62.1 29.7 47.2 7.9 39.8 0.0 0.1 0.6 36.2 2.8 138.3 4.3 0.2 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.5 0.4 0.1 0.2 0.0 0.2 9.5 13.1 10.9 10.7 9.0 12.7 13.1 12.6 12.7 11.6 12.7 12.6 2.7 12.8 10.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 5.5 3.0 0.0 0.0 1.3 20.2 0.0 0.0 0.2 0.0 1.9 30.0 0.0 1.8 0.4 0.6 0.0 0.0 0.0 3.7 0.1 0.6 0.0 2.0 0.0 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 PHGR1 ENSG00000233041 "Proline, histidine and glycine rich 1" C9JFL3 15 40351033-40356434 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in many" 14 "intestine: 2541.0" "Cell type enhanced" "Detected in some" "Distal enterocytes: 19911.4;Intestinal goblet cells: 8220.0;Paneth cells: 9497.7;Proximal enterocytes: 51149.4" "Group enriched" "Detected in many" 16 "colorectal cancer: 248.3;stomach cancer: 94.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 14 "OE19: 833.5" HPA068787 Enhanced Approved Vesicles NA NA "Cluster 9: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 45: Enterocytes - Digestion" Vesicles "HPA068787: AB_2686035" "prognostic favorable (2.05e-4)" "unprognostic (1.73e-1)" "unprognostic (5.18e-2)" "unprognostic (1.18e-1)" "unprognostic (2.80e-1)" "unprognostic (1.20e-1)" "unprognostic (1.27e-2)" 3.7 0.4 0.1 88.8 0.2 0.2 11.1 0.3 0.1 0.8 0.0 2541.0 881.0 1.2 0.0 2.0 3.5 0.3 0.3 0.1 0.1 1.9 1.0 0.2 1.2 0.1 0.1 0.5 1.9 0.0 0.5 0.0 0.1 2.5 370.7 0.0 0.3 3.0 0.4 3.7 2320.2 17.3 0.1 0.4 177.1 0.3 0.1 0.0 0.4 0.0 0.0 5.6 1.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.1 18.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.0 0.1 833.5 0.3 0.1 0.0 10.8 0.0 1.5 61.5 7.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.3 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 46.0 0.0 0.2 0.3 0.0 0.0 40.2 38.0 0.0 117.2 0.0 0.0 0.0 0.0 0.1 19911.4 0.0 2.5 0.1 0.0 0.0 0.2 1938.2 0.0 0.0 0.2 0.0 0.5 884.8 0.1 213.9 0.0 0.0 0.6 0.0 0.0 0.0 8220.0 20.3 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 9497.7 0.0 2.1 1.1 51149.4 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 32.6 0.0 4881.6 1.0 DISP2 "C15orf36, DISPB, HsT16908, KIAA1742, LINC00594" ENSG00000140323 "Dispatched RND transporter family member 2" A7MBM2 15 40358219-40378621 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 17.6" "Cell type enhanced" "Detected in many" "Bipolar cells: 19.0;Distal enterocytes: 16.8;Horizontal cells: 18.5;Intestinal goblet cells: 18.2;Proximal enterocytes: 12.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 4.2;HaCaT: 6.6;SCLC-21H: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059903 Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 27: Mucus-secreting cells - Mucin production" "Nucleoplasm, Vesicles" "HPA059903: AB_2684156" "unprognostic (3.43e-4)" "unprognostic (7.65e-3)" "unprognostic (4.14e-2)" "unprognostic (2.30e-3)" "unprognostic (1.90e-1)" "unprognostic (1.25e-1)" "unprognostic (4.02e-2)" "unprognostic (3.08e-2)" "unprognostic (1.98e-1)" "unprognostic (2.13e-2)" "unprognostic (1.45e-1)" "unprognostic (6.75e-2)" "unprognostic (4.47e-8)" "unprognostic (1.96e-1)" "unprognostic (3.02e-1)" "unprognostic (2.08e-1)" "unprognostic (1.71e-1)" 0.2 0.7 5.1 0.4 4.7 0.3 0.1 17.6 5.7 0.3 0.0 1.5 1.1 0.2 0.1 0.1 0.2 0.2 0.1 3.6 3.9 0.0 0.1 0.1 0.4 5.5 1.6 0.3 0.3 0.1 1.3 0.2 5.8 0.1 1.2 1.6 0.3 0.4 0.1 0.3 1.2 0.3 0.4 0.2 1.2 0.7 4.5 0.2 1.4 0.0 0.0 0.1 0.1 1.9 1.3 0.5 0.3 2.0 0.1 0.0 0.7 0.2 0.1 0.8 1.2 1.9 0.6 0.2 1.3 0.8 4.2 6.6 0.2 1.1 0.5 0.1 0.4 0.3 0.4 0.1 0.0 0.4 1.1 1.4 0.0 0.2 0.1 0.2 0.4 0.7 0.5 0.8 1.1 0.3 0.2 0.3 0.3 1.7 0.9 0.2 0.3 0.4 0.2 1.7 13.4 1.9 0.2 0.1 0.2 0.3 0.3 0.2 0.4 0.9 0.7 0.2 0.2 0.2 0.1 0.2 0.3 0.5 1.8 0.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.5 0.2 0.0 0.2 0.0 0.0 5.1 4.7 17.6 5.7 3.6 3.9 5.5 1.6 5.8 0.4 4.5 1.9 0.9 3.2 3.6 1.0 0.5 0.0 1.9 0.0 0.0 19.0 0.8 1.3 1.7 1.5 4.4 3.7 10.4 0.2 0.2 16.8 0.0 0.4 1.3 0.3 0.6 1.4 9.6 2.7 5.1 0.4 0.3 1.6 5.1 0.5 8.8 0.4 0.4 0.4 1.0 18.5 7.0 18.2 0.0 0.6 0.0 1.8 1.2 1.1 0.0 1.0 0.3 2.3 4.1 4.0 0.3 0.3 3.2 0.0 0.3 1.2 12.1 0.2 2.2 7.6 0.0 3.1 0.8 4.1 6.1 0.0 0.0 0.3 1.1 0.8 8.6 1.1 KNSTRN "C15orf23, FLJ14502, kinastrin, SKAP, TRAF4AF1" ENSG00000128944 "Kinetochore localized astrin (SPAG5) binding protein" Q9Y448 15 40382721-40394246 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 63.6;thyroid gland: 53.1" "Cell type enhanced" "Detected in many" "Early spermatids: 328.2;Late spermatids: 600.1;Spermatocytes: 145.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" HPA042027 Enhanced Enhanced "Plasma membrane,Mitotic spindle,Centriolar satellite" Yes Yes "Cluster 51: Monocytes - Innate immune response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 34: Spermatids - Unknown function" "Mitotic spindle, Centriolar satellite" "Plasma membrane" "HPA042027: AB_10797378" "unprognostic (2.35e-3)" "unprognostic (6.83e-2)" "unprognostic (3.01e-1)" "unprognostic (5.23e-3)" "unprognostic (6.19e-2)" "unprognostic (2.28e-2)" "unprognostic (1.54e-3)" "unprognostic (2.47e-3)" "unprognostic (1.23e-1)" "unprognostic (2.55e-1)" "prognostic unfavorable (3.43e-5)" "unprognostic (6.31e-2)" "prognostic unfavorable (7.88e-9)" "unprognostic (1.70e-1)" "unprognostic (1.58e-1)" "unprognostic (2.67e-1)" "unprognostic (1.52e-2)" 8.0 6.2 6.3 8.1 7.1 14.1 14.3 7.7 8.6 5.1 4.5 7.9 9.2 6.4 12.3 9.1 5.7 4.4 7.4 7.2 6.2 7.2 12.0 5.8 14.5 6.2 6.2 5.1 5.0 8.4 5.6 10.7 6.5 6.8 10.4 9.0 10.3 7.2 12.2 6.7 6.2 10.2 5.9 7.1 10.2 63.6 6.1 25.6 53.1 12.4 16.1 5.6 5.6 7.7 103.4 47.5 92.7 61.0 20.1 30.9 48.1 69.9 54.0 141.0 123.3 102.6 44.2 39.7 34.8 47.3 112.1 115.7 100.0 64.8 126.5 70.8 48.8 117.7 107.4 65.2 18.9 63.8 58.6 16.1 36.5 71.3 70.6 34.5 80.3 97.6 86.3 66.8 120.0 52.2 55.6 51.2 58.6 87.7 71.2 56.4 69.7 45.7 49.7 42.3 89.9 62.5 58.3 63.3 15.1 55.8 66.5 45.3 41.6 67.5 68.8 69.7 98.3 56.5 98.6 70.5 41.8 84.0 56.5 13.2 17.6 17.4 7.9 24.3 6.8 9.5 5.7 7.0 18.4 11.2 5.4 5.5 9.7 9.8 47.8 12.7 9.4 7.1 6.3 7.1 7.7 8.6 7.2 6.2 6.2 6.2 6.5 5.9 6.1 7.7 2.4 9.6 1.1 2.6 4.1 2.2 2.9 7.6 3.4 8.2 4.2 3.4 7.3 1.5 5.4 0.0 8.4 25.2 2.5 1.9 3.9 8.5 328.2 5.9 4.9 3.7 2.4 34.3 5.1 9.3 40.8 5.2 5.6 4.4 1.3 16.9 3.6 8.0 21.6 5.0 4.9 5.3 14.2 9.8 2.0 600.1 9.0 8.2 3.6 4.7 8.0 8.5 6.2 2.0 4.3 12.3 0.5 7.2 12.6 4.9 2.8 5.8 7.2 8.5 0.0 3.7 6.5 145.7 19.2 7.0 1.4 21.1 5.1 8.5 6.4 3.0 IVD ACAD2 ENSG00000128928 "Isovaleryl-CoA dehydrogenase" P26440 15 40405485-40435947 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 135.0;Theca cells: 105.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041391, HPA044250" Enhanced Supported Nucleoplasm,Mitochondria NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 35: Non-specific - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 52: Non-specific - Transcription" Mitochondria Nucleoplasm "HPA041391: AB_2677449, HPA044250: AB_2678875" "unprognostic (9.30e-2)" "unprognostic (3.31e-1)" "unprognostic (1.36e-2)" "unprognostic (4.24e-2)" "unprognostic (7.53e-2)" "unprognostic (1.74e-1)" "prognostic favorable (1.95e-5)" "unprognostic (1.50e-2)" "unprognostic (2.53e-1)" "unprognostic (2.84e-2)" "unprognostic (4.08e-2)" "unprognostic (2.31e-1)" "prognostic favorable (2.91e-9)" "unprognostic (1.40e-1)" "unprognostic (3.40e-2)" "unprognostic (1.14e-1)" "unprognostic (5.46e-3)" 25.8 80.5 35.1 14.5 40.8 15.9 45.3 35.6 40.8 29.4 39.5 31.6 24.3 26.4 29.0 16.0 35.0 21.5 61.7 34.0 41.5 59.1 145.4 24.3 19.6 40.2 38.8 43.3 27.4 39.2 58.3 15.3 37.5 42.1 27.2 13.0 31.8 36.8 55.7 8.6 26.8 23.8 37.9 27.9 46.7 25.0 44.5 16.8 119.2 55.4 19.5 31.1 20.8 45.3 20.9 11.9 22.9 38.9 35.9 32.9 1.0 27.6 32.7 39.4 24.0 36.5 16.0 0.8 57.7 43.4 32.6 20.8 45.9 46.6 30.1 36.4 34.0 52.1 36.2 38.9 64.6 22.0 48.5 45.3 18.5 23.5 55.3 46.3 38.8 60.4 2.5 2.4 42.1 27.1 27.3 38.9 17.8 1.3 33.0 41.2 32.6 27.9 45.2 51.6 37.3 21.5 38.2 83.4 18.7 21.5 69.0 117.6 27.6 29.9 20.2 23.6 24.9 54.5 38.5 1.0 30.9 22.8 28.4 17.0 24.8 36.7 33.3 36.1 31.0 27.5 18.5 26.6 58.8 27.6 18.5 26.7 2.3 39.4 73.1 89.2 26.9 24.3 35.1 40.8 35.6 40.8 34.0 41.5 40.2 38.8 37.5 37.9 44.5 45.3 13.1 28.9 54.5 27.4 19.0 2.3 21.0 17.3 13.1 26.0 27.5 22.2 88.0 45.8 29.9 44.1 14.6 20.3 34.0 17.9 95.9 19.7 5.4 21.4 31.0 18.6 19.7 21.3 15.3 14.9 7.3 20.2 29.6 19.9 34.7 46.5 21.4 135.0 28.1 16.8 16.6 24.4 14.2 18.3 6.2 7.4 20.5 18.6 5.4 21.5 28.8 26.0 26.8 25.1 21.4 14.8 9.4 24.8 10.0 16.6 22.0 97.3 29.3 19.9 19.7 25.0 18.2 16.1 3.7 17.4 0.6 9.9 18.0 105.7 35.4 11.9 BAHD1 KIAA0945 ENSG00000140320 "Bromo adjacent homology domain containing 1" Q8TBE0 15 40439721-40468236 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041196 Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 71: Testis - DNA repair" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA041196: AB_10803999" "prognostic unfavorable (1.55e-4)" "unprognostic (4.08e-1)" "unprognostic (3.00e-2)" "unprognostic (1.56e-2)" "unprognostic (1.35e-2)" "unprognostic (1.04e-1)" "unprognostic (7.19e-2)" "unprognostic (1.12e-2)" "unprognostic (2.06e-2)" "unprognostic (2.00e-2)" "unprognostic (3.49e-3)" "unprognostic (4.81e-2)" "prognostic favorable (1.29e-10)" "unprognostic (4.95e-2)" "unprognostic (1.15e-1)" "unprognostic (1.70e-1)" "unprognostic (1.11e-1)" 9.6 21.9 10.8 8.0 11.5 8.1 9.2 8.6 10.5 11.0 9.9 12.3 9.1 12.5 10.2 12.0 13.6 6.3 14.3 11.9 9.8 14.2 11.6 12.5 9.8 10.3 9.5 21.4 13.8 13.0 13.3 8.7 9.4 10.3 5.8 5.2 12.6 10.2 12.6 11.0 12.0 7.2 9.1 12.6 12.7 18.6 10.9 11.6 16.5 7.6 9.1 12.3 9.1 10.1 16.9 8.5 14.7 24.5 11.7 9.1 32.0 13.3 9.5 14.4 14.0 23.1 7.9 12.5 17.6 12.0 17.6 32.6 24.2 10.1 8.0 24.2 15.2 32.9 13.2 11.5 11.1 14.4 24.0 12.0 10.2 8.8 8.7 12.8 12.5 15.8 32.8 10.4 8.6 16.0 16.2 21.8 14.6 19.7 15.6 27.3 16.6 10.4 15.9 19.7 23.0 13.9 8.2 42.8 9.7 9.1 34.4 23.1 14.8 15.6 17.4 22.4 14.1 15.5 18.4 14.2 16.3 22.1 10.7 0.6 0.3 1.4 1.3 0.6 0.6 0.5 0.9 0.7 0.3 0.7 1.2 1.0 0.3 1.4 1.2 0.6 0.3 0.4 10.8 11.5 8.6 10.5 11.9 9.8 10.3 9.5 9.4 9.1 10.9 10.1 9.7 19.2 7.0 7.8 4.9 8.3 3.7 4.1 6.8 3.9 11.4 9.4 11.7 5.7 7.7 11.0 2.1 5.5 5.6 20.7 1.9 5.4 1.0 6.1 4.9 8.4 7.8 2.5 10.3 7.4 7.3 4.7 2.0 8.4 8.9 5.6 9.7 12.0 5.7 16.8 8.1 7.4 2.0 12.0 4.6 2.7 10.2 5.4 0.0 7.5 6.7 5.2 10.3 9.0 8.9 6.7 8.9 5.7 1.6 5.3 11.6 5.0 5.0 4.7 6.6 6.1 5.5 6.3 10.9 6.9 7.7 4.1 5.8 7.6 8.0 4.9 CHST14 "D4ST-1, D4ST1, HD4ST" ENSG00000169105 "Carbohydrate sulfotransferase 14" Q8NCH0 15 40470984-40473158 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Carbohydrate metabolism" Transferase "Disease variant, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 46.5;Extravillous trophoblasts: 32.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 7.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057697, HPA071601" Enhanced Approved "Golgi apparatus" NA NA 20000 "Cluster 34: Basophils - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 47: Cytotrophoblasts - Unknown function" "Golgi apparatus" "HPA057697: AB_2683505, HPA071601: AB_2686425" "unprognostic (5.46e-2)" "unprognostic (9.23e-2)" "unprognostic (4.03e-2)" "unprognostic (2.63e-3)" "unprognostic (1.44e-1)" "unprognostic (1.86e-1)" "unprognostic (2.96e-2)" "unprognostic (6.94e-2)" "unprognostic (1.70e-1)" "unprognostic (9.95e-2)" "unprognostic (2.84e-1)" "unprognostic (3.17e-2)" "unprognostic (5.85e-3)" "unprognostic (2.01e-3)" "unprognostic (1.94e-1)" "unprognostic (6.34e-2)" "unprognostic (2.25e-2)" 14.2 9.6 6.8 7.7 7.5 3.4 13.7 7.0 6.5 22.0 7.3 11.8 4.5 21.6 8.0 8.7 16.5 11.3 13.8 6.2 7.0 10.1 8.8 13.0 8.5 8.0 7.1 21.1 8.1 11.3 14.4 27.0 7.2 14.6 4.6 1.6 11.0 15.4 5.0 9.1 9.9 12.6 7.5 13.6 9.4 7.9 7.0 8.6 15.8 7.4 7.5 16.1 16.1 7.3 26.2 17.1 26.4 71.6 40.4 31.0 43.0 25.2 47.3 43.5 40.9 21.2 12.8 4.3 37.6 42.7 76.7 43.7 23.7 14.2 20.3 31.5 15.0 13.4 16.9 19.8 22.5 5.7 33.4 38.3 11.6 15.4 11.6 47.8 39.2 15.1 13.6 15.0 32.6 20.1 9.6 29.8 17.0 7.9 20.1 26.2 33.4 7.6 29.5 13.3 19.7 30.2 22.2 24.4 8.4 31.9 35.7 23.9 31.9 73.0 27.1 23.3 25.5 30.3 22.6 12.2 32.8 19.6 53.7 7.6 1.1 2.2 2.2 1.1 0.6 0.3 1.1 1.9 2.0 1.1 0.9 0.8 0.1 3.3 0.6 0.7 0.8 0.7 6.8 7.5 7.0 6.5 6.2 7.0 8.0 7.1 7.2 7.5 7.0 7.3 10.6 12.8 1.1 2.0 5.8 3.4 5.4 4.1 9.1 0.6 5.8 9.7 3.2 7.2 4.6 3.7 0.0 46.5 3.5 0.5 0.0 7.7 1.8 3.2 14.5 10.2 2.4 10.7 0.1 4.9 32.4 19.3 0.0 5.6 4.5 14.9 15.4 3.7 9.3 1.7 0.1 1.4 2.0 5.6 3.3 1.3 17.7 5.6 5.4 2.8 3.4 9.8 6.2 2.0 0.5 5.2 0.3 11.7 1.9 3.6 0.2 1.1 3.0 0.8 6.6 11.8 9.2 7.5 1.3 5.6 2.6 13.5 4.9 3.9 1.9 1.3 CCDC32 "C15orf57, MGC20481" ENSG00000128891 "Coiled-coil domain containing 32" Q9BV29 15 40528683-40565057 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 80.5;Hofbauer cells: 72.0;Syncytiotrophoblasts: 81.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041688 Uncertain Approved "Nuclear speckles,Vesicles" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" "Nuclear speckles" Vesicles "HPA041688: AB_10796779" "unprognostic (7.10e-2)" "unprognostic (1.04e-1)" "unprognostic (9.86e-3)" "unprognostic (2.30e-2)" "unprognostic (2.65e-1)" "unprognostic (4.25e-5)" "unprognostic (4.03e-2)" "unprognostic (3.39e-2)" "unprognostic (1.15e-1)" "unprognostic (4.70e-2)" "unprognostic (2.34e-1)" "unprognostic (1.23e-2)" "unprognostic (5.77e-2)" "unprognostic (3.72e-1)" "unprognostic (1.18e-1)" "unprognostic (2.20e-1)" "unprognostic (6.47e-2)" 16.0 20.5 16.2 17.0 14.8 20.2 15.5 13.9 18.1 16.0 16.9 17.3 17.0 14.6 17.3 9.3 18.2 17.8 18.1 18.3 17.1 22.8 13.0 14.2 28.7 16.1 17.6 25.0 17.9 20.0 13.6 21.3 18.6 13.9 19.8 15.1 13.0 14.9 15.5 10.3 14.9 15.4 15.6 21.5 18.0 8.3 18.2 19.4 20.9 11.1 25.8 19.2 12.1 16.2 15.4 10.8 14.1 22.8 28.8 29.9 8.4 12.0 17.8 20.9 21.8 16.4 20.9 5.6 32.9 18.0 30.2 28.3 13.8 13.8 14.8 35.0 16.2 62.6 18.1 20.6 19.6 24.0 31.5 25.4 14.1 16.3 11.0 19.8 26.7 22.0 35.0 36.9 16.1 13.3 11.2 20.4 5.6 35.3 13.6 19.1 18.5 19.1 39.6 36.3 15.8 15.5 17.9 18.5 9.3 16.6 19.6 43.4 29.8 19.5 17.0 34.1 17.5 21.1 21.1 18.4 20.7 37.2 27.8 58.2 32.4 33.9 32.6 34.2 25.9 147.1 35.6 35.3 43.0 167.2 35.8 30.7 34.0 29.1 35.7 57.6 50.6 42.1 16.2 14.8 13.9 18.1 18.3 17.1 16.1 17.6 18.6 15.6 18.2 16.2 32.1 12.8 13.4 0.0 24.6 0.0 0.0 0.0 0.0 0.0 18.6 20.8 0.0 0.0 9.9 20.2 0.0 80.5 19.6 0.0 29.4 27.0 0.0 22.7 13.7 10.2 0.0 0.0 0.0 29.2 32.5 11.3 0.0 14.4 6.3 15.5 0.0 0.0 72.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 10.3 0.0 0.0 0.0 0.0 38.3 0.0 0.0 7.8 0.0 0.0 30.0 12.4 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 81.4 10.1 35.0 0.0 0.0 RPUSD2 "C15orf19, C18B11, FLJ31409, PUS9" ENSG00000166133 "RNA pseudouridine synthase domain containing 2" Q8IZ73 15 40569299-40574949 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042079, HPA042194" Approved Approved Nucleoplasm,Microtubules NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 59: Non-specific - Translation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Microtubules" "HPA042079: AB_10794643, HPA042194: AB_10794416" "unprognostic (3.24e-1)" "unprognostic (1.72e-1)" "unprognostic (1.32e-1)" "unprognostic (2.30e-2)" "unprognostic (2.72e-2)" "unprognostic (2.84e-2)" "unprognostic (1.31e-1)" "unprognostic (6.60e-2)" "unprognostic (8.32e-2)" "unprognostic (4.41e-2)" "unprognostic (1.26e-2)" "unprognostic (1.16e-1)" "prognostic favorable (7.63e-7)" "unprognostic (7.27e-2)" "unprognostic (8.28e-2)" "unprognostic (3.12e-2)" "unprognostic (2.75e-2)" 5.1 8.9 5.7 4.8 6.2 9.7 5.8 5.8 6.4 6.6 6.2 7.5 4.8 9.2 5.3 7.1 7.2 2.4 9.5 5.6 5.6 8.0 8.9 4.5 6.7 5.4 5.6 7.7 5.3 5.3 7.9 3.7 5.8 6.5 4.0 2.5 7.7 4.7 14.5 9.5 7.0 3.6 4.9 8.0 6.3 6.1 5.5 6.1 6.1 7.6 6.2 6.2 5.2 6.0 10.4 11.5 9.6 16.0 8.1 6.1 18.2 9.0 10.8 15.4 12.2 14.3 6.4 9.9 12.8 10.5 14.1 27.7 22.3 15.9 8.7 11.5 15.3 17.1 15.9 17.1 12.1 14.7 12.1 8.6 14.7 10.1 13.8 7.1 9.7 16.1 21.9 11.4 7.7 12.3 17.7 18.6 12.4 15.0 12.4 22.3 10.7 15.3 10.0 8.9 10.9 12.6 12.3 13.8 7.6 7.9 13.2 19.9 6.0 10.5 12.3 13.7 10.5 11.8 25.2 27.3 9.2 22.9 8.4 0.1 6.4 5.6 23.4 8.0 21.3 28.2 22.6 24.9 12.5 35.5 26.8 22.5 0.7 33.6 18.4 16.5 26.3 14.4 5.7 6.2 5.8 6.4 5.6 5.6 5.4 5.6 5.8 4.9 5.5 6.0 5.7 6.4 2.6 2.3 10.4 10.6 16.4 11.5 10.8 11.7 6.4 8.6 8.2 8.6 7.0 7.3 16.7 15.7 9.3 5.4 25.4 9.6 2.1 5.4 5.7 5.7 13.2 8.2 2.8 10.9 9.3 7.6 6.6 4.6 4.5 9.0 3.6 9.1 7.1 18.5 2.9 6.2 12.2 2.2 3.1 1.7 7.2 2.6 3.6 1.0 3.4 15.6 7.2 4.0 3.1 6.5 5.0 10.1 8.9 9.0 4.9 13.2 9.9 16.0 13.1 11.6 8.1 7.1 15.1 9.6 10.7 5.6 7.3 12.4 8.5 8.0 KNL1 "AF15Q14, CASC5, CT29, D40, hKNL-1, hSpc105, KIAA1570, MCPH4, PPP1R55, Spc7" ENSG00000137812 "Kinetochore scaffold 1" Q8NG31 15 40594020-40664342 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Cancer-related genes, Disease variant, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "bone marrow: 5.3;lymphoid tissue: 7.4;testis: 16.9" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 8.5;Extravillous trophoblasts: 11.3;Granulosa cells: 22.8;Hofbauer cells: 7.1;Proximal tubular cells: 11.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "HPA026624, HPA049647" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" Yes Yes "Cluster 21: B-cells - Adaptive immune response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nuclear bodies" "HPA026624: AB_10601696, HPA049647: AB_2680840" "unprognostic (5.35e-2)" "unprognostic (1.01e-1)" "unprognostic (5.59e-3)" "unprognostic (4.22e-2)" "unprognostic (1.59e-2)" "unprognostic (5.66e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (2.06e-2)" "unprognostic (1.43e-1)" "unprognostic (3.20e-4)" "unprognostic (2.22e-2)" "unprognostic (1.93e-12)" "unprognostic (3.07e-2)" "unprognostic (3.08e-1)" "unprognostic (8.45e-2)" "unprognostic (7.36e-2)" 0.2 0.1 0.1 1.9 0.0 5.3 0.3 0.2 0.2 0.2 0.2 1.3 1.6 0.3 0.2 1.0 0.1 0.3 0.1 0.1 0.1 0.5 0.7 0.4 3.6 0.1 0.3 0.0 0.0 0.3 0.0 1.3 0.1 0.1 1.4 0.2 0.2 0.0 0.0 0.8 1.7 0.7 0.0 0.6 0.9 16.9 0.3 7.4 0.3 0.1 3.4 0.5 0.2 0.1 19.1 9.3 18.0 13.8 0.5 2.6 8.6 20.5 8.1 16.0 13.1 11.6 7.2 11.9 6.1 9.3 12.0 21.9 17.6 9.7 16.3 21.4 5.0 35.5 15.5 3.9 0.0 26.2 17.8 0.5 0.4 10.8 6.4 2.1 13.8 20.9 22.9 19.2 18.3 6.1 23.5 6.1 9.4 11.3 9.5 21.2 25.8 5.9 2.6 15.6 15.9 7.7 17.7 10.6 2.1 5.9 11.1 9.0 13.1 18.7 16.3 21.9 11.7 7.5 27.9 22.3 7.6 18.5 18.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.3 0.5 0.0 0.1 0.1 0.1 0.1 0.0 0.6 0.0 0.1 0.0 0.2 0.2 0.1 0.1 0.1 0.3 0.1 0.0 0.3 0.1 0.3 0.0 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.1 1.1 0.0 0.0 1.8 1.8 0.0 8.5 2.6 0.0 1.9 0.2 0.0 3.5 3.5 1.9 0.0 0.0 0.0 0.6 11.3 4.2 0.0 2.9 0.0 22.8 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.1 0.0 0.0 11.5 0.7 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 3.7 1.9 1.7 0.0 0.0 RAD51 "BRCC5, FANCR, HsRad51, HsT16930, RAD51A, RECA" ENSG00000051180 "RAD51 recombinase" Q06609 15 40694774-40732340 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Disease variant, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 15.7;testis: 24.3" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 35.3;Extravillous trophoblasts: 67.2;Spermatocytes: 53.6;Spermatogonia: 24.8;Syncytiotrophoblasts: 25.3" "Cancer enhanced" "Detected in all" "testis cancer: 19.9" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB010381, HPA039310" Enhanced Supported "Nucleoli rim,Cytosol" NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoli rim" Cytosol "CAB010381: AB_2253533, HPA039310: AB_2676434" "prognostic unfavorable (7.94e-4)" "unprognostic (7.20e-3)" "unprognostic (1.22e-1)" "unprognostic (2.72e-2)" "unprognostic (8.23e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (9.33e-4)" "unprognostic (3.40e-3)" "unprognostic (2.53e-2)" "unprognostic (1.76e-1)" "unprognostic (1.41e-3)" "unprognostic (2.53e-3)" "unprognostic (0.00e+0)" "unprognostic (2.26e-2)" "unprognostic (2.34e-1)" "unprognostic (9.59e-2)" "unprognostic (1.94e-2)" 0.9 0.6 0.4 5.5 0.5 10.5 1.9 1.7 0.7 1.0 0.6 8.3 3.2 1.2 0.4 4.2 0.7 1.3 0.6 0.4 0.5 0.5 1.3 1.1 11.0 0.4 0.3 0.6 1.4 0.5 0.2 6.8 0.5 0.8 9.1 0.3 1.0 0.3 1.0 3.1 4.1 2.4 0.1 2.4 1.8 24.3 0.3 15.7 0.6 0.5 13.3 1.7 1.5 0.5 33.8 16.1 33.4 16.3 4.4 7.8 31.1 54.9 16.5 43.3 43.8 35.4 22.1 20.4 26.8 20.9 18.9 67.7 56.6 22.1 42.3 39.0 22.2 47.7 28.2 30.4 0.4 37.9 28.5 1.7 2.9 30.0 13.5 6.4 22.5 48.5 59.6 55.8 36.6 28.5 54.4 43.6 35.2 69.2 19.0 61.0 49.0 30.7 15.4 45.3 15.4 27.0 23.6 41.4 8.5 39.2 27.0 39.4 9.9 32.8 22.2 48.7 27.2 12.0 65.1 59.8 16.3 78.0 33.5 1.3 0.6 1.7 2.4 1.3 0.6 1.7 2.5 3.2 1.0 1.1 0.6 1.2 1.2 1.8 1.4 0.9 5.9 1.2 0.4 0.5 1.7 0.7 0.4 0.5 0.4 0.3 0.5 0.1 0.3 0.5 0.0 0.0 0.0 0.3 1.9 3.6 1.5 2.0 0.0 0.8 0.1 0.0 0.9 0.0 1.0 0.0 0.0 35.3 1.4 3.0 0.0 0.0 5.7 0.2 0.2 1.0 0.0 16.0 1.6 0.0 67.2 1.3 2.0 0.2 0.0 0.6 2.2 0.2 12.7 0.0 1.2 5.3 2.0 1.6 1.7 5.3 0.6 0.5 0.0 1.0 0.3 0.3 2.1 0.5 0.6 0.1 5.0 0.7 8.2 0.9 1.0 0.0 0.1 0.0 0.0 0.5 0.9 53.6 24.8 3.9 1.6 25.3 1.2 0.1 8.0 2.1 RMDN3 "FAM82A2, FAM82C, FLJ10579, PTPIP51, RMD3" ENSG00000137824 "Regulator of microtubule dynamics 3" Q96TC7 15 40735884-40755851 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 110.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009975, HPA074840" Supported Enhanced "Cytokinetic bridge,Mitochondria" Yes No 42000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 45: Intestine - Brush border" "Cluster 39: CACO-2 - Unknown function" "Cluster 4: Macrophages - Innate immune response" Mitochondria "Cytokinetic bridge" "HPA009975: AB_1078811, HPA074840: " "unprognostic (2.54e-2)" "unprognostic (3.53e-1)" "unprognostic (2.35e-2)" "unprognostic (3.97e-3)" "unprognostic (1.50e-1)" "unprognostic (2.50e-3)" "unprognostic (2.78e-2)" "unprognostic (2.54e-2)" "unprognostic (1.73e-1)" "unprognostic (1.68e-1)" "unprognostic (2.78e-2)" "unprognostic (5.94e-3)" "prognostic favorable (6.70e-8)" "unprognostic (1.71e-2)" "unprognostic (1.32e-1)" "unprognostic (5.79e-3)" "unprognostic (2.04e-3)" 30.1 22.7 37.2 16.2 40.2 24.1 26.7 38.4 48.6 18.0 31.2 18.1 43.8 15.9 5.4 22.6 18.8 16.7 16.4 36.3 36.1 18.4 37.0 36.5 15.6 40.2 38.6 17.2 27.2 36.3 10.9 19.4 36.0 17.2 9.0 6.7 33.3 15.4 20.7 21.1 51.7 11.2 37.7 13.0 21.5 13.8 42.9 15.0 19.9 14.1 8.4 20.3 17.6 41.2 19.7 17.7 21.0 35.9 19.2 17.2 36.3 50.2 19.8 34.9 25.6 63.7 21.7 16.7 65.0 27.0 26.0 66.3 26.9 37.3 3.7 44.2 33.1 53.6 51.4 31.6 62.9 36.4 41.1 30.9 34.0 25.2 23.9 16.3 24.8 32.6 57.4 44.9 15.1 40.0 27.7 23.6 16.7 52.7 34.6 42.6 25.1 38.9 28.8 32.7 49.8 18.1 39.9 53.4 19.5 8.2 41.6 39.1 37.3 37.8 27.0 51.1 42.5 34.0 42.7 26.7 26.8 38.2 42.2 4.0 13.2 5.5 28.2 17.8 25.0 16.0 20.6 26.0 14.4 13.7 15.9 17.3 2.1 65.1 22.3 54.2 20.3 26.6 37.2 40.2 38.4 48.6 36.3 36.1 40.2 38.6 36.0 37.7 42.9 41.2 20.1 32.1 28.1 18.6 11.0 15.7 16.4 26.9 15.9 20.0 21.0 13.6 8.1 15.7 27.8 18.4 4.2 44.4 22.4 17.2 1.9 27.7 2.8 20.7 17.8 18.1 4.9 42.7 23.5 22.0 28.5 17.8 13.7 22.0 19.0 8.6 17.5 36.4 110.7 18.5 18.2 12.3 26.4 14.7 10.4 3.4 16.8 21.0 19.6 8.4 11.7 21.6 43.3 16.1 21.8 21.8 16.7 14.3 18.0 17.3 77.6 14.5 29.3 17.3 6.6 22.2 16.0 40.4 40.4 21.9 11.9 62.8 18.3 16.7 21.4 23.1 GCHFR "GFRP, HsT16933" ENSG00000137880 "GTP cyclohydrolase I feedback regulator" P30047 15 40764068-40767708 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 350.1" "Cell type enhanced" "Detected in many" "Hepatocytes: 787.2;Hofbauer cells: 522.9;Proximal enterocytes: 620.8;Proximal tubular cells: 500.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 120.3;RPTEC TERT1: 146.6;SCLC-21H: 124.6" "Group enriched" "Detected in many" 5 "cerebellum: 10.3;midbrain: 11.8;pons and medulla: 9.4" HPA046258 Enhanced Supported Nucleoplasm NA NA 170000 "Cluster 48: NK-cells - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 2: Hepatocytes - Metabolism" Nucleoplasm "HPA046258: AB_10967205" "unprognostic (2.50e-1)" "unprognostic (1.49e-2)" "unprognostic (1.28e-1)" "unprognostic (1.72e-2)" "unprognostic (9.89e-3)" "unprognostic (3.51e-3)" "unprognostic (1.57e-1)" "prognostic favorable (5.62e-4)" "unprognostic (4.63e-2)" "unprognostic (1.67e-1)" "unprognostic (3.81e-1)" "unprognostic (2.31e-1)" "unprognostic (7.03e-3)" "unprognostic (9.28e-3)" "unprognostic (2.91e-2)" "unprognostic (1.84e-1)" "unprognostic (2.55e-1)" 37.4 20.1 13.6 8.9 13.3 19.5 34.5 17.4 20.1 16.1 18.5 18.7 38.8 6.5 2.2 57.2 15.8 10.0 10.9 13.1 14.5 73.5 350.1 46.4 24.7 18.2 67.3 19.2 15.3 9.8 12.2 6.6 33.7 19.4 6.9 4.2 22.3 3.2 4.5 31.1 60.7 1.7 13.5 13.0 16.4 3.3 15.9 23.0 12.8 7.4 19.5 12.2 17.6 12.2 0.3 7.7 6.2 33.3 9.5 3.4 16.7 2.2 7.8 3.7 7.4 90.7 49.7 46.0 31.1 1.9 2.4 6.1 16.4 3.1 0.8 36.2 26.2 45.5 65.3 120.3 7.7 29.9 15.2 7.8 3.8 1.6 0.6 2.9 14.4 3.7 23.2 13.2 1.1 17.2 7.9 60.4 16.0 8.2 56.5 64.7 0.5 28.8 146.6 24.2 124.6 1.9 20.1 87.7 10.4 8.1 25.3 30.0 0.0 0.6 1.2 2.2 0.3 0.9 6.0 28.9 4.9 66.3 4.0 18.0 73.3 102.4 76.8 23.6 129.0 48.2 67.1 71.1 48.7 31.2 68.3 44.7 11.7 132.6 22.4 90.4 144.4 109.0 13.6 13.3 17.4 20.1 13.1 14.5 18.2 67.3 33.7 13.5 15.9 12.2 24.3 3.2 54.0 0.3 24.9 14.5 21.6 72.2 8.6 2.5 81.4 48.0 0.1 84.4 87.0 64.4 12.5 161.9 25.9 75.7 76.3 52.5 0.6 46.2 4.9 13.7 60.6 24.4 1.6 32.7 37.0 10.1 16.3 35.7 44.4 12.2 31.4 787.2 522.9 0.0 1.7 74.4 111.9 56.1 18.5 0.5 17.7 71.9 67.6 0.0 29.0 26.1 102.0 0.0 0.4 18.7 161.8 8.6 12.8 25.6 620.8 500.2 58.3 22.4 0.0 4.7 12.4 2.9 12.5 79.7 14.9 36.5 49.2 1.7 125.3 40.8 DNAJC17 FLJ10634 ENSG00000104129 "DnaJ heat shock protein family (Hsp40) member C17" Q9NVM6 15 40765161-40807478 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chaperone, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040914, HPA041187" Approved Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm "HPA040914: AB_10794072, HPA041187: AB_10794192" "unprognostic (9.79e-2)" "unprognostic (9.63e-2)" "prognostic unfavorable (5.89e-4)" "unprognostic (1.66e-3)" "unprognostic (1.46e-1)" "unprognostic (1.32e-2)" "unprognostic (1.51e-1)" "unprognostic (1.40e-1)" "unprognostic (3.65e-1)" "unprognostic (2.84e-1)" "unprognostic (1.94e-1)" "unprognostic (5.98e-2)" "unprognostic (5.37e-2)" "unprognostic (2.72e-1)" "unprognostic (4.78e-1)" "unprognostic (2.64e-2)" "unprognostic (6.58e-2)" 13.2 11.1 6.9 9.9 6.7 6.3 13.4 9.3 9.3 12.5 4.6 13.8 8.2 14.6 9.6 12.5 14.2 10.1 8.8 6.5 6.4 12.0 14.8 11.1 13.6 6.5 6.5 17.1 9.8 16.8 8.9 13.9 6.6 9.7 11.4 5.4 9.2 11.2 8.0 12.2 10.8 12.7 5.8 12.2 10.6 4.5 6.7 16.2 11.8 11.2 16.8 10.9 10.7 7.3 10.8 9.6 23.8 23.1 10.5 26.2 10.1 19.9 19.5 32.7 26.7 7.7 15.1 16.6 21.5 23.9 15.0 22.2 24.4 32.6 28.9 30.8 15.3 28.1 19.2 7.6 29.8 14.7 24.0 26.2 20.6 25.8 46.2 18.2 30.5 28.0 20.0 8.6 25.3 13.6 21.5 19.7 8.6 25.3 14.1 15.7 19.8 8.6 33.2 19.5 15.0 9.6 14.4 13.4 10.2 16.8 17.0 29.1 30.0 18.5 16.0 21.0 17.1 9.6 31.0 36.5 11.9 37.1 15.9 30.0 21.5 28.9 24.5 28.6 17.6 19.8 21.2 23.7 24.3 19.4 22.4 21.8 7.9 13.3 17.0 19.8 39.2 14.1 6.9 6.7 9.3 9.3 6.5 6.4 6.5 6.5 6.6 5.8 6.7 7.3 26.6 12.8 16.4 9.4 16.5 5.6 19.2 40.6 8.6 15.0 24.3 14.7 5.8 22.8 33.2 25.8 12.5 25.1 15.5 17.5 19.6 18.9 3.2 13.4 15.8 16.2 7.8 9.4 13.0 17.5 15.8 14.7 12.8 16.9 22.1 13.6 19.6 14.4 22.5 13.5 15.0 16.1 20.3 10.3 10.6 2.0 15.2 13.1 7.2 12.2 13.0 8.5 36.0 11.6 16.1 16.9 24.6 16.1 9.9 12.8 30.6 27.2 20.2 10.4 0.0 14.5 22.6 5.6 4.7 16.3 5.3 17.2 16.7 16.6 16.9 20.6 C15orf62 LOC643338 ENSG00000188277 "Chromosome 15 open reading frame 62" A8K5M9 15 40769980-40772449 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 26.0;skin 1: 17.1" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 3.6;Club cells: 5.0;Glandular and luminal cells: 6.3;Ionocytes: 6.1;Prostatic glandular cells: 5.5;Squamous epithelial cells: 4.7;Urothelial cells: 11.6" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 4.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 17.7;SK-BR-3: 5.7" "Region enriched" "Detected in single" 5 "olfactory bulb: 1.2" "Low region specificity" "Detected in all" HPA044636 Approved NA NA "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 22: Epithelial cell types - Mixed function" "HPA044636: AB_10794052" "unprognostic (9.95e-3)" "unprognostic (3.73e-3)" "unprognostic (2.80e-2)" "unprognostic (1.33e-1)" "unprognostic (1.06e-1)" "unprognostic (2.22e-2)" "unprognostic (2.52e-1)" "unprognostic (2.83e-2)" "unprognostic (5.56e-2)" "unprognostic (2.24e-2)" "unprognostic (5.37e-3)" "unprognostic (7.68e-3)" "unprognostic (1.99e-2)" "unprognostic (1.42e-1)" "unprognostic (1.37e-1)" "unprognostic (1.60e-1)" "unprognostic (3.40e-1)" 1.8 1.3 0.7 1.5 1.0 1.7 2.3 4.4 1.5 3.5 0.0 2.0 1.9 1.7 0.1 26.0 2.1 1.3 1.4 0.7 0.2 2.0 4.0 1.8 2.1 0.7 0.5 2.5 2.0 0.1 2.1 0.4 0.8 2.4 0.1 2.4 8.3 0.1 2.0 17.1 2.6 0.0 0.1 2.3 1.9 0.6 0.8 0.7 2.0 0.1 5.0 1.8 6.9 1.2 0.5 0.4 1.6 2.0 0.6 0.1 0.4 0.7 0.1 0.0 0.2 1.9 2.2 1.0 1.8 0.0 1.3 4.1 0.7 0.0 0.0 1.5 1.6 1.0 4.4 0.6 0.0 0.9 1.2 0.2 0.8 0.0 0.1 1.8 0.6 0.7 0.9 1.2 0.0 0.5 1.3 1.6 0.7 2.8 0.8 1.4 0.3 0.5 17.7 1.5 3.6 0.8 0.6 5.7 0.2 0.6 2.0 1.3 0.8 2.0 0.9 1.8 0.6 1.4 1.0 0.9 0.6 3.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.0 4.4 1.5 0.7 0.2 0.7 0.5 0.8 0.1 0.8 1.2 0.2 0.0 0.0 0.3 0.3 0.0 3.6 2.1 0.6 0.3 1.7 0.6 0.7 0.0 5.0 0.0 0.0 0.1 0.2 0.1 0.0 0.5 0.0 1.6 0.9 0.3 0.0 0.0 0.1 0.2 0.0 0.2 0.0 6.3 0.0 0.1 0.0 0.8 0.2 3.3 0.1 0.1 6.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.2 0.1 0.0 0.0 5.5 0.3 0.3 1.3 0.5 0.0 0.0 0.3 0.0 0.0 4.7 1.0 0.0 0.2 0.0 0.3 11.6 ZFYVE19 "ANCHR, FLJ14840" ENSG00000166140 "Zinc finger FYVE-type containing 19" Q96K21 15 40807086-40815084 "Disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 74.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040283, HPA041946" Uncertain NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 70: Brain - Nervous system development" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" "HPA040283: AB_10673369, HPA041946: AB_2677762" "unprognostic (3.59e-2)" "unprognostic (6.62e-2)" "unprognostic (1.15e-2)" "prognostic favorable (7.36e-4)" "unprognostic (1.12e-1)" "unprognostic (1.61e-1)" "unprognostic (1.04e-1)" "unprognostic (9.84e-2)" "unprognostic (1.84e-2)" "unprognostic (1.55e-1)" "unprognostic (6.58e-2)" "unprognostic (8.61e-2)" "unprognostic (7.69e-3)" "unprognostic (1.76e-1)" "unprognostic (1.79e-1)" "unprognostic (8.40e-3)" "unprognostic (1.72e-1)" 8.8 8.9 14.2 7.9 16.5 8.6 10.2 19.6 17.2 11.1 12.5 12.0 12.3 8.9 10.7 15.4 9.1 6.6 11.5 13.5 16.9 10.4 19.3 9.1 10.0 19.8 17.4 10.5 8.3 14.1 9.5 9.0 19.1 12.4 8.1 6.6 13.7 8.1 13.5 11.6 12.5 8.8 16.9 13.7 9.6 8.1 18.0 10.9 8.9 13.5 10.5 10.8 11.4 17.5 10.0 12.3 8.8 13.3 13.9 13.9 13.4 15.0 19.4 19.9 20.7 8.9 23.5 9.2 16.5 14.7 17.5 18.0 12.7 17.4 12.1 28.6 12.4 16.6 21.5 11.2 12.5 12.0 24.1 13.5 18.3 13.0 12.6 18.0 19.6 15.2 12.9 11.9 12.7 10.7 15.2 14.8 5.5 22.4 17.6 18.8 5.1 11.4 12.1 19.7 16.0 9.7 13.7 34.6 4.8 6.7 16.4 19.8 9.6 12.4 13.8 9.2 9.9 10.3 14.3 9.8 11.8 22.9 12.4 9.0 5.8 5.2 5.3 9.4 6.2 5.2 5.5 5.2 6.5 3.7 6.0 5.5 3.1 8.9 6.2 5.5 6.1 4.7 14.2 16.5 19.6 17.2 13.5 16.9 19.8 17.4 19.1 16.9 18.0 17.5 11.4 6.4 5.6 6.2 6.6 6.4 13.3 19.7 8.0 11.1 14.8 12.2 9.3 15.7 18.0 12.9 12.5 74.7 5.7 22.6 19.6 24.4 5.3 12.4 8.0 9.7 3.5 5.2 7.6 17.6 16.8 9.6 12.2 12.5 12.7 12.7 10.4 21.8 22.4 3.3 9.4 15.5 22.4 9.9 6.8 10.9 12.8 9.7 7.2 7.5 14.3 9.8 8.2 7.1 15.7 19.3 20.7 9.4 4.2 9.1 50.3 27.4 17.9 10.7 13.1 7.3 9.6 18.6 19.4 7.9 7.7 55.1 9.3 8.9 15.5 15.1 PPP1R14D "CPI17-like, FLJ20251, GBPI-1, MGC119014, MGC119016" ENSG00000166143 "Protein phosphatase 1 regulatory inhibitor subunit 14D" Q9NXH3 15 40815451-40828709 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "intestine: 111.1" "Group enriched" "Detected in some" 4 "Distal enterocytes: 334.5;Paneth cells: 338.1;Proximal enterocytes: 412.4;Undifferentiated cells: 108.9" "Cancer enriched" "Detected in many" 4 "colorectal cancer: 45.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 1.6;RPMI-8226: 3.1;RT4: 1.9;SK-BR-3: 1.2;T-47d: 1.1;U-266/84: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA041846 Uncertain NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 9: Intestine - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA041846: AB_10794307" "unprognostic (1.29e-2)" "unprognostic (1.49e-1)" "unprognostic (1.35e-1)" "unprognostic (1.82e-1)" "unprognostic (5.91e-3)" "unprognostic (1.17e-2)" "unprognostic (4.68e-2)" "unprognostic (1.89e-1)" "unprognostic (7.74e-2)" "unprognostic (2.86e-1)" "unprognostic (5.26e-3)" "unprognostic (3.16e-2)" "prognostic unfavorable (3.07e-4)" "unprognostic (3.55e-1)" "unprognostic (1.43e-2)" "unprognostic (3.74e-3)" "unprognostic (3.11e-2)" 0.1 0.0 0.1 9.6 0.1 0.0 0.5 0.5 0.1 0.3 0.1 107.1 111.1 0.2 1.9 0.2 0.3 15.6 0.1 0.1 0.0 3.8 0.1 0.2 0.2 0.1 0.2 0.0 0.3 0.4 0.1 0.1 0.1 0.7 92.5 0.2 0.7 0.4 0.0 1.0 82.3 3.6 0.1 0.0 1.7 0.2 0.1 0.0 0.6 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.3 0.9 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 1.6 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.2 0.0 1.0 0.0 0.0 0.0 3.1 0.0 1.9 0.4 0.3 0.0 1.2 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.1 0.5 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.3 0.3 0.0 0.0 0.5 0.9 0.0 5.7 0.3 1.8 0.0 0.4 0.1 334.5 0.0 1.3 0.0 0.1 0.0 0.0 61.3 0.0 0.1 5.3 0.0 0.0 0.0 0.1 4.5 0.0 0.0 0.0 0.1 0.0 0.2 58.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 338.1 0.0 0.0 0.1 412.4 52.4 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.4 0.9 0.0 108.9 0.2 SPINT1 "HAI, MANSC2" ENSG00000166145 "Serine peptidase inhibitor, Kunitz type 1" O43278 15 40844018-40858207 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 255.5" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 1254.0;Distal enterocytes: 477.6;Proximal enterocytes: 514.5;Syncytiotrophoblasts: 1673.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 323.2;HaCaT: 377.6;hTCEpi: 264.0;RT4: 308.2;SK-BR-3: 558.8;T-47d: 267.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA006903, HPA031178" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" NA NA 7400000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" "Plasma membrane, Cytosol" Nucleoplasm "HPA006903: AB_1079038, HPA031178: AB_2732463" "prognostic unfavorable (6.97e-4)" "unprognostic (1.00e-3)" "unprognostic (3.00e-3)" "unprognostic (5.03e-2)" "unprognostic (6.06e-2)" "unprognostic (3.19e-1)" "unprognostic (5.94e-2)" "unprognostic (6.04e-2)" "unprognostic (8.24e-3)" "unprognostic (1.46e-2)" "unprognostic (1.09e-3)" "unprognostic (1.01e-1)" "prognostic favorable (1.37e-7)" "unprognostic (5.37e-2)" "unprognostic (2.22e-1)" "unprognostic (6.45e-3)" "unprognostic (2.17e-2)" 2.8 0.7 0.9 16.4 1.5 1.4 34.7 5.0 1.3 42.8 6.4 108.7 159.9 13.2 78.9 255.5 33.6 38.0 1.3 0.9 2.0 79.9 3.5 47.6 6.4 2.8 3.2 2.4 69.2 132.9 31.4 144.9 2.2 52.3 89.2 0.4 162.7 31.4 0.6 148.9 138.2 4.3 1.7 6.9 88.3 1.8 3.2 9.9 34.7 0.4 45.5 57.1 90.1 2.3 124.8 1.0 0.0 0.9 0.1 0.0 323.2 2.3 3.0 4.0 2.4 195.3 202.4 0.3 141.2 0.4 3.6 377.6 30.8 181.9 2.4 1.0 10.6 5.6 3.3 10.8 2.2 21.9 93.9 0.3 264.0 3.9 16.5 3.4 14.7 12.1 2.7 1.1 0.2 96.5 0.9 16.6 37.4 207.6 17.7 12.6 0.0 24.9 179.3 308.2 79.8 3.9 9.3 558.8 15.7 56.9 267.7 16.1 0.0 0.2 2.0 1.2 0.5 1.2 24.5 0.8 0.8 16.3 1.1 0.0 19.7 14.3 0.4 15.9 0.8 8.4 3.0 1.4 32.4 6.0 1.1 0.3 25.9 5.5 18.1 4.0 0.5 7.6 0.9 1.5 5.0 1.3 0.9 2.0 2.8 3.2 2.2 1.7 3.2 2.3 0.8 57.7 14.7 0.0 7.6 76.0 96.7 220.0 55.8 0.1 96.2 63.5 0.5 105.8 207.3 134.3 0.0 1254.0 1.4 477.6 25.4 429.4 0.8 63.3 14.2 6.9 147.3 4.8 0.5 255.1 105.1 10.4 106.5 155.6 10.2 1.9 0.4 0.5 135.4 0.0 0.5 169.4 221.8 10.0 23.8 1.1 3.7 19.8 14.2 0.0 68.6 0.0 0.0 0.0 0.0 309.8 375.2 0.0 2.1 135.7 514.5 44.2 46.6 0.3 0.0 0.1 12.6 0.6 5.9 93.2 87.9 1673.8 6.6 0.1 182.7 222.3 RHOV "ARHV, Chp, WRCH2" ENSG00000104140 "Ras homolog family member V" Q96L33 15 40872214-40874234 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 211.8;skin 1: 129.8;vagina: 92.2" "Cell type enhanced" "Detected in many" "Paneth cells: 142.3;Squamous epithelial cells: 375.0;Suprabasal keratinocytes: 283.0;Urothelial cells: 275.1" "Cancer enhanced" "Detected in many" "cervical cancer: 91.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "SK-BR-3: 328.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053343 Enhanced NA NA "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 61: Squamous epithelial cells - Keratinization" "HPA053343: AB_2682122" "unprognostic (1.42e-1)" "unprognostic (2.06e-1)" "unprognostic (8.29e-3)" "unprognostic (4.34e-2)" "unprognostic (2.20e-2)" "unprognostic (1.52e-2)" "unprognostic (2.33e-2)" "prognostic unfavorable (2.33e-4)" "unprognostic (1.71e-1)" "unprognostic (1.48e-1)" "prognostic unfavorable (4.19e-4)" "unprognostic (3.29e-3)" "unprognostic (1.05e-1)" "unprognostic (2.16e-2)" "unprognostic (1.23e-2)" "unprognostic (8.43e-3)" "unprognostic (5.63e-3)" 0.5 0.1 0.9 0.2 0.9 0.2 16.0 1.1 1.8 26.3 0.5 2.8 0.6 0.7 9.5 211.8 2.7 0.5 0.1 1.0 1.1 5.5 0.2 2.3 0.2 2.1 0.8 0.3 16.3 2.2 3.0 3.2 2.4 16.6 2.6 0.0 44.3 2.4 0.2 129.8 0.6 0.1 0.8 0.1 1.2 0.3 1.9 2.6 0.5 0.0 23.3 20.7 92.2 0.9 1.6 9.7 0.1 2.7 0.2 0.0 5.2 0.1 0.8 0.4 0.2 4.0 4.4 0.0 2.4 0.0 0.3 77.9 4.5 0.6 0.2 10.5 12.5 0.5 11.3 0.6 0.0 0.5 0.0 0.3 6.0 0.3 0.1 0.4 0.1 2.3 2.1 0.5 0.0 27.2 0.6 2.3 1.7 19.3 3.7 4.0 0.4 1.8 5.1 34.3 4.0 0.8 8.0 328.9 0.2 0.5 40.9 0.3 0.1 0.0 1.1 0.2 0.3 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.9 1.1 1.8 1.0 1.1 2.1 0.8 2.4 0.8 1.9 0.9 0.6 0.0 3.2 0.3 0.5 84.1 42.5 80.9 19.9 0.0 75.2 48.5 0.9 2.8 103.0 29.5 0.0 60.7 1.9 43.1 13.7 107.5 0.0 18.5 1.9 2.5 22.7 0.0 1.5 56.2 6.0 2.0 7.1 25.5 1.3 0.4 0.0 0.0 4.6 0.0 0.5 54.7 67.1 0.0 13.3 0.0 0.0 0.8 32.0 0.0 3.6 0.0 0.0 0.0 0.3 13.8 142.3 0.7 0.1 89.8 1.0 0.9 26.2 0.0 0.0 0.2 7.3 0.0 0.9 375.0 283.0 42.4 1.9 0.0 66.3 275.1 VPS18 "KIAA1475, PEP3" ENSG00000104142 "VPS18 core subunit of CORVET and HOPS complexes" Q9P253 15 40894450-40903975 "Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040701 Approved NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 15: RT4 - Unknown function" "Cluster 4: Macrophages - Innate immune response" "HPA040701: AB_10794145" "unprognostic (1.81e-1)" "unprognostic (4.53e-1)" "unprognostic (9.69e-3)" "unprognostic (1.55e-2)" "unprognostic (1.90e-1)" "unprognostic (1.28e-1)" "unprognostic (1.62e-3)" "unprognostic (1.60e-1)" "unprognostic (9.69e-3)" "unprognostic (2.12e-2)" "prognostic favorable (8.69e-4)" "unprognostic (1.39e-1)" "prognostic favorable (1.61e-6)" "unprognostic (1.45e-1)" "unprognostic (2.19e-1)" "unprognostic (6.73e-2)" "unprognostic (1.06e-2)" 8.6 11.8 9.2 7.3 9.9 21.3 7.4 12.0 10.3 7.5 8.0 9.7 6.8 11.3 8.7 9.2 8.3 7.7 12.9 9.2 10.8 9.8 10.7 9.0 8.8 11.5 10.3 7.5 5.9 11.2 9.6 6.2 12.9 8.7 4.1 3.8 8.3 8.3 13.0 9.5 9.0 8.2 9.1 11.9 9.6 6.2 11.3 7.5 7.9 9.5 7.2 9.8 6.1 12.1 9.9 23.1 11.1 19.1 35.5 15.1 15.2 20.3 29.4 24.5 29.9 29.5 5.9 5.3 19.0 24.3 31.1 25.7 23.4 23.0 10.3 12.2 15.8 23.5 22.2 17.0 31.3 19.8 30.2 26.2 11.9 24.6 13.6 11.5 26.0 11.8 16.5 13.1 20.9 13.0 13.4 21.8 14.7 10.1 15.7 27.1 12.6 9.9 20.0 52.3 12.8 12.8 14.6 28.4 13.7 13.5 17.7 22.0 25.8 24.8 12.9 25.0 13.4 13.0 20.9 14.4 27.2 21.5 12.5 7.3 10.9 13.1 10.1 7.4 8.3 8.3 5.2 7.8 11.1 5.8 5.4 5.8 12.0 7.8 10.6 4.8 9.8 9.0 9.2 9.9 12.0 10.3 9.2 10.8 11.5 10.3 12.9 9.1 11.3 12.1 3.3 3.2 7.2 2.0 7.5 2.4 2.3 7.7 4.0 9.0 4.2 2.3 6.7 5.7 10.4 7.3 6.2 7.1 11.0 12.0 3.9 16.7 1.1 6.8 3.7 6.9 11.9 1.3 4.0 7.7 4.6 5.0 12.2 8.2 7.0 8.1 7.5 10.8 21.4 6.7 4.1 6.4 10.2 10.9 6.6 1.8 7.2 9.5 8.8 2.8 13.2 6.8 12.3 1.5 3.1 11.5 5.9 9.8 4.0 3.2 10.3 11.4 5.4 7.1 6.6 4.1 4.5 5.8 6.2 8.0 2.0 10.8 6.9 7.5 5.8 5.8 DLL4 ENSG00000128917 "Delta like canonical Notch ligand 4" Q9NR61 15 40929340-40939073 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Angiogenesis, Differentiation, Neurogenesis, Notch signaling pathway, Sensory transduction, Vision" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 70.7;Distal enterocytes: 24.2;Endothelial cells: 48.6;Hepatic stellate cells: 30.4;Intestinal goblet cells: 36.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "BJ hTERT+: 59.4;HUVEC TERT2: 15.7;SCLC-21H: 32.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023392 Uncertain NA NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA023392: AB_1847740" "unprognostic (1.92e-2)" "prognostic unfavorable (3.97e-4)" "unprognostic (7.52e-2)" "unprognostic (4.71e-2)" "unprognostic (2.72e-1)" "unprognostic (4.16e-2)" "unprognostic (3.56e-2)" "unprognostic (1.60e-2)" "unprognostic (2.49e-1)" "unprognostic (2.73e-1)" "unprognostic (3.51e-2)" "unprognostic (6.10e-2)" "unprognostic (2.56e-3)" "unprognostic (9.92e-2)" "unprognostic (2.93e-1)" "unprognostic (1.51e-2)" "unprognostic (5.51e-3)" 25.2 2.6 6.9 2.9 6.1 0.3 21.2 6.5 7.0 8.0 4.9 7.6 4.0 8.8 1.0 3.7 7.6 3.7 23.8 5.8 6.0 10.0 3.5 22.5 5.0 7.1 6.5 4.1 2.9 2.9 5.6 19.8 7.5 7.9 3.0 0.9 4.3 2.7 10.0 5.5 6.8 4.2 6.6 4.6 4.8 1.5 8.4 5.0 15.4 10.6 1.7 8.7 7.6 6.2 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.9 59.4 0.2 0.3 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.8 0.0 0.1 0.0 1.0 0.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 15.7 0.0 0.4 1.1 0.1 0.1 0.0 0.6 0.0 0.9 0.0 1.4 0.5 1.6 0.0 0.1 32.5 0.0 0.3 0.7 0.0 0.0 0.0 3.5 0.9 0.0 0.1 0.0 0.0 1.3 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 6.1 6.5 7.0 5.8 6.0 7.1 6.5 7.5 6.6 8.4 6.2 70.7 0.0 2.7 0.0 1.7 1.3 0.2 0.2 4.0 4.9 1.6 2.8 3.2 1.5 0.9 0.0 0.0 1.5 0.2 24.2 0.0 0.2 0.2 1.9 0.7 48.6 17.4 0.0 0.9 0.2 0.6 3.1 13.3 2.6 2.5 0.0 30.4 0.1 0.2 0.0 0.6 36.3 6.1 1.6 0.8 0.3 0.0 0.8 1.8 11.2 0.0 0.2 0.0 0.5 0.5 0.2 16.7 0.0 3.5 2.3 9.2 0.0 0.2 1.4 0.0 0.9 3.8 0.8 2.0 1.0 1.6 1.9 0.4 0.4 12.0 0.6 CHAC1 MGC4504 ENSG00000128965 "ChaC glutathione specific gamma-glutamylcyclotransferase 1" Q9BUX1 15 40952962-40956512 "Enzymes, Predicted intracellular proteins" "Apoptosis, Neurogenesis, Notch signaling pathway, Unfolded protein response" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 68.6;skeletal muscle: 68.4" "Cell type enhanced" "Detected in many" "Distal tubular cells: 35.2;Exocrine glandular cells: 27.8;Gastric mucus-secreting cells: 33.6;Pancreatic endocrine cells: 19.3;Plasma cells: 21.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 109.5;HHSteC: 80.7;hTCEpi: 130.8;SK-MEL-30: 95.0;U-266/70: 81.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA042708, HPA043505" Approved Approved Mitochondria NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 80: Striated muscle - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 1: Pancreatic cells - Digestion" Mitochondria "HPA042708: AB_2678125, HPA043505: AB_2678518" "unprognostic (6.04e-3)" "unprognostic (2.81e-2)" "unprognostic (7.47e-2)" "unprognostic (2.84e-3)" "unprognostic (6.57e-3)" "unprognostic (2.00e-2)" "unprognostic (5.59e-2)" "unprognostic (2.43e-1)" "unprognostic (2.01e-1)" "unprognostic (1.72e-1)" "unprognostic (3.11e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.23e-7)" "unprognostic (1.37e-2)" "unprognostic (1.44e-1)" "unprognostic (1.67e-2)" "unprognostic (3.91e-2)" 9.1 0.6 12.3 1.4 12.0 1.8 0.9 11.1 30.7 2.1 7.1 1.9 2.0 0.7 1.5 23.3 1.7 1.8 2.4 11.4 16.6 4.0 11.5 2.0 0.9 13.0 14.5 0.7 68.6 1.4 1.9 0.8 16.9 1.3 0.8 1.1 5.1 1.0 68.4 1.6 1.4 0.8 12.6 0.9 14.8 0.7 17.6 0.5 1.5 11.7 3.0 4.3 3.7 16.6 9.1 6.0 1.5 27.2 4.3 3.2 11.1 53.5 109.5 5.8 15.5 15.1 2.2 2.8 4.1 4.8 17.2 6.0 12.0 4.4 4.1 10.4 2.5 2.5 1.6 0.0 80.7 7.3 0.1 36.1 130.8 17.1 23.2 1.8 5.4 62.3 7.7 12.5 4.8 5.5 5.3 0.1 4.9 31.0 21.3 4.8 0.1 12.8 3.0 3.5 5.3 7.9 1.6 9.5 95.0 3.3 3.6 51.1 1.8 1.3 16.1 1.5 9.4 81.1 19.0 11.0 4.8 10.3 12.7 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 12.3 12.0 11.1 30.7 11.4 16.6 13.0 14.5 16.9 12.6 17.6 16.6 6.2 0.0 2.0 0.3 3.1 2.8 3.8 11.5 3.4 2.6 2.2 2.4 4.6 4.3 6.5 0.0 2.1 0.3 2.6 8.0 35.2 6.4 0.1 1.8 0.4 2.7 3.5 3.2 1.3 27.8 0.3 0.6 33.6 2.1 0.0 0.4 1.8 0.7 0.4 0.0 1.5 8.0 6.1 0.3 1.5 0.0 0.3 0.8 5.4 0.0 1.0 0.5 0.0 0.5 0.2 19.3 2.3 0.0 21.4 6.5 0.8 0.3 3.3 0.4 0.0 0.3 3.2 1.1 1.1 1.5 4.3 3.4 1.6 0.5 4.8 14.6 INO80 "hINO80, INO80A, INOC1, KIAA1259" ENSG00000128908 "INO80 complex ATPase subunit" Q9ULG1 15 40978880-41116280 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis" "Actin-binding, DNA-binding, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041484, HPA048601" Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 15: RT4 - Unknown function" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear bodies" Cytosol "HPA041484: AB_2677506, HPA048601: " "unprognostic (5.39e-3)" "unprognostic (2.25e-1)" "unprognostic (2.73e-1)" "unprognostic (1.02e-1)" "unprognostic (1.51e-1)" "unprognostic (3.92e-2)" "unprognostic (4.24e-2)" "unprognostic (1.84e-1)" "unprognostic (1.93e-1)" "unprognostic (6.30e-2)" "unprognostic (1.18e-1)" "unprognostic (6.69e-2)" "prognostic favorable (6.30e-4)" "unprognostic (1.77e-1)" "unprognostic (1.76e-1)" "unprognostic (7.72e-2)" "unprognostic (1.47e-2)" 9.3 6.5 5.4 7.3 5.7 15.7 8.8 10.1 5.9 8.3 5.3 9.3 7.3 8.9 4.7 9.6 7.7 5.7 6.9 5.3 5.2 7.9 7.8 9.4 9.7 5.9 5.2 9.1 6.9 10.0 5.5 6.8 5.6 7.9 8.6 5.7 7.3 6.6 15.7 10.9 8.7 8.2 5.0 8.9 7.9 7.0 5.8 10.8 8.5 9.6 10.4 9.1 8.5 7.5 13.1 12.9 10.6 10.7 16.5 13.8 11.4 12.2 18.8 17.3 15.0 14.8 10.4 14.0 8.8 17.6 21.6 24.3 19.5 20.7 19.0 17.5 10.0 18.9 17.7 11.8 15.2 17.9 16.2 13.5 18.4 13.8 36.9 11.1 16.8 14.5 20.5 11.6 12.3 10.6 13.2 11.2 11.3 20.6 13.5 19.1 11.2 11.0 12.7 26.1 14.5 9.6 9.6 18.5 7.3 10.4 10.5 19.9 19.2 14.3 11.1 17.3 19.0 12.4 9.6 22.2 16.1 24.7 11.7 0.3 1.0 0.2 0.8 0.5 0.9 1.3 0.8 0.8 0.7 1.1 1.0 1.1 0.3 2.1 0.2 0.6 0.7 0.4 5.4 5.7 10.1 5.9 5.3 5.2 5.9 5.2 5.6 5.0 5.8 7.5 23.7 9.6 25.7 27.4 27.6 8.5 16.2 7.5 23.3 30.4 18.1 15.9 25.1 14.3 16.4 16.5 22.9 13.5 25.4 17.3 7.9 17.6 2.2 17.2 21.5 17.6 13.1 23.8 54.1 13.3 12.0 16.0 32.6 28.9 15.8 18.4 13.2 10.0 9.8 26.9 47.5 11.8 2.0 14.4 6.8 3.3 14.6 18.6 7.2 25.3 20.8 12.9 19.6 43.2 53.3 15.2 16.1 15.8 19.8 21.7 9.5 11.3 16.3 33.0 6.6 28.1 21.3 19.2 24.7 28.2 12.8 19.2 25.8 25.1 13.9 15.1 EXD1 "EXDL1, MGC33637" ENSG00000178997 "Exonuclease 3'-5' domain containing 1" Q8NHP7 15 41182725-41230757 "Predicted intracellular proteins" "Meiosis, RNA-mediated gene silencing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 14.9" "Cell type enhanced" "Detected in some" "Collecting duct cells: 3.7;Early spermatids: 13.4;Late spermatids: 5.7;Spermatocytes: 23.6" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "pons: 1.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 66: Spermatocytes - Spermatogenesis" "unprognostic (1.12e-1)" "unprognostic (6.33e-3)" "unprognostic (2.51e-2)" "unprognostic (2.29e-1)" "unprognostic (1.45e-1)" "unprognostic (1.21e-2)" "unprognostic (6.50e-2)" "unprognostic (4.57e-2)" "unprognostic (4.54e-2)" "unprognostic (2.15e-1)" "unprognostic (9.55e-2)" "unprognostic (1.92e-1)" "unprognostic (2.11e-6)" "unprognostic (2.15e-1)" "unprognostic (2.29e-1)" "unprognostic (2.72e-1)" "unprognostic (2.71e-2)" 0.3 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 14.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.4 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.4 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.3 0.1 0.1 0.3 0.2 1.5 0.2 0.2 0.3 0.1 0.0 1.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.3 0.3 0.5 0.0 0.6 3.7 0.0 0.0 0.1 0.0 0.0 0.0 13.4 0.2 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.5 0.0 0.0 0.0 1.6 5.7 0.0 0.2 1.8 1.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.2 0.1 23.6 2.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 CHP1 "CHP, p22, p24, Sid470p, SLC9A1BP" ENSG00000187446 "Calcineurin like EF-hand protein 1" Q99653 15 41230839-41281887 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Protein kinase inhibitor" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 434.4;Distal tubular cells: 389.4;Hepatocytes: 353.6;Proximal enterocytes: 425.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006616 Approved Approved Vesicles NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 37: Intestine - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 53: Intestinal epithelial cells - Unknown function" Vesicles "HPA006616: AB_1857461" "unprognostic (2.06e-2)" "unprognostic (3.26e-1)" "unprognostic (2.84e-1)" "prognostic favorable (9.63e-4)" "unprognostic (7.29e-2)" "unprognostic (3.74e-1)" "prognostic favorable (4.07e-6)" "unprognostic (2.20e-1)" "unprognostic (7.46e-2)" "unprognostic (3.26e-2)" "unprognostic (1.26e-3)" "unprognostic (2.79e-1)" "prognostic favorable (2.79e-6)" "unprognostic (1.06e-1)" "unprognostic (1.49e-1)" "unprognostic (4.62e-3)" "unprognostic (2.04e-1)" 66.9 55.3 22.1 28.0 24.4 58.4 32.8 26.0 26.5 34.0 24.7 113.8 85.4 21.8 34.1 74.5 20.8 48.1 53.2 30.3 32.9 76.1 185.1 52.7 18.6 32.9 31.0 19.1 42.2 54.1 21.6 26.3 35.8 34.3 81.9 20.5 49.9 27.5 81.0 45.5 70.0 27.6 26.9 20.2 112.7 10.7 33.3 20.1 49.8 86.5 41.1 44.8 41.3 28.4 72.4 72.7 28.3 109.0 120.4 113.8 41.0 56.2 69.1 44.8 48.0 66.6 140.4 12.6 59.8 77.7 47.7 89.0 56.0 83.9 51.5 44.8 20.0 50.8 58.1 103.6 93.5 66.5 73.7 116.7 98.8 51.9 53.3 68.0 82.1 37.9 81.2 79.5 52.5 43.5 27.7 72.5 29.0 118.4 35.9 35.9 46.2 34.0 92.5 144.1 17.4 44.3 96.4 178.2 48.7 49.9 101.0 66.3 108.3 47.5 50.3 76.9 36.7 45.0 131.6 59.4 84.9 42.2 44.1 255.5 227.6 274.8 49.5 204.4 51.5 40.2 46.2 50.0 152.1 33.0 29.1 41.4 173.3 56.5 207.4 95.1 60.7 116.5 22.1 24.4 26.0 26.5 30.3 32.9 32.9 31.0 35.8 26.9 33.3 28.4 28.3 44.8 117.3 20.9 26.8 72.3 62.4 48.1 20.5 11.0 101.6 39.2 80.5 243.1 50.7 103.0 10.4 33.3 38.3 434.4 389.4 96.7 52.5 68.0 48.8 39.5 55.6 58.5 24.8 150.6 62.4 38.2 112.7 114.4 37.4 18.9 78.1 353.6 68.5 11.8 21.0 136.2 34.6 170.1 134.8 122.6 29.5 77.1 129.9 19.7 113.4 32.7 36.0 9.5 23.6 173.9 206.4 29.3 24.0 80.1 425.0 231.1 33.7 10.3 26.3 46.6 41.4 13.7 19.3 50.6 108.5 66.9 32.9 65.7 161.4 130.8 AC087721.2 ENSG00000285920 "Novel protein" 15 41284007-41380996 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 6.4;Alveolar cells type 2: 5.3;Club cells: 5.6;granulocytes: 3.8;Respiratory ciliated cells: 2.9" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "HPA042904, HPA074847" Uncertain Approved "Nucleoplasm,Nucleoli,Nucleoli fibrillar center" Yes Yes "Cluster 12: Non-specific - Basic cellular processes" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 11: Alveolar cells - Smell perception" "Nucleoplasm, Nucleoli, Nucleoli fibrillar center" "HPA042904: AB_2678220, HPA074847: AB_2732269" 0.8 1.5 0.3 1.8 0.2 2.9 1.3 2.1 1.0 1.0 0.1 1.8 1.7 0.9 0.3 1.6 0.7 1.1 0.8 0.1 0.3 1.1 1.7 1.0 2.4 0.4 0.6 1.5 0.6 0.9 1.3 0.5 0.7 1.9 1.8 0.6 1.1 3.1 1.0 1.4 1.1 0.2 1.6 1.2 2.9 0.6 2.6 0.7 1.9 2.5 1.5 0.4 3.7 1.2 6.6 5.5 2.5 3.7 3.4 3.8 2.9 4.8 4.7 2.0 4.1 2.8 4.0 2.2 4.4 8.7 10.1 5.3 4.1 7.2 3.6 9.4 3.8 3.6 2.0 14.2 8.2 2.1 3.3 3.3 8.8 1.9 4.7 10.6 8.7 11.0 4.3 1.8 5.5 4.5 6.9 9.2 5.5 7.6 5.0 4.3 4.6 4.0 6.6 6.0 6.6 3.9 2.6 7.0 6.6 8.5 4.3 2.8 5.5 3.2 5.8 5.6 10.7 9.4 2.4 8.7 5.6 0.1 0.4 1.0 0.2 0.4 0.3 0.4 0.5 0.4 0.6 0.3 0.2 0.2 0.1 0.3 0.5 0.9 0.9 0.5 0.3 0.2 2.1 1.0 0.1 0.3 0.4 0.6 0.5 0.2 0.6 0.4 0.0 6.4 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 OIP5 "CT86, hMIS18beta, MIS18B" ENSG00000104147 "Opa interacting protein 5" O43482 15 41309273-41332591 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 10.3;skeletal muscle: 10.3;testis: 20.9" "Cell type enhanced" "Detected in many" "Erythroid cells: 45.9;Extravillous trophoblasts: 24.0;Spermatocytes: 110.6;Spermatogonia: 56.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA052271, HPA059602" Enhanced Supported "Nuclear speckles,Vesicles" NA Yes "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nuclear speckles" Vesicles "HPA052271: AB_2681780, HPA059602: AB_2684079" "unprognostic (5.17e-2)" "unprognostic (7.26e-2)" "unprognostic (3.07e-1)" "unprognostic (1.59e-2)" "unprognostic (6.94e-2)" "unprognostic (6.58e-2)" "prognostic unfavorable (1.79e-4)" "prognostic unfavorable (2.26e-4)" "unprognostic (2.71e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (9.34e-5)" "unprognostic (5.51e-2)" "unprognostic (0.00e+0)" "unprognostic (3.84e-2)" "unprognostic (2.02e-1)" "unprognostic (5.75e-2)" "unprognostic (2.86e-2)" 0.6 1.7 0.1 3.3 0.2 10.3 1.2 1.2 0.4 0.9 0.2 4.1 3.5 0.8 0.3 3.8 0.4 0.6 1.5 0.2 0.2 0.3 1.2 0.5 5.8 0.2 0.4 1.5 0.3 0.1 0.1 2.3 0.4 0.5 3.9 0.7 0.8 0.6 10.3 3.3 3.9 1.1 0.1 1.7 1.5 20.9 0.2 9.1 0.4 0.8 5.2 0.7 1.3 0.5 33.7 17.8 34.3 24.9 1.7 2.1 32.4 20.0 9.3 24.5 26.1 31.8 16.2 19.8 17.0 7.7 37.8 51.0 35.7 16.1 19.2 42.4 40.1 42.4 49.8 33.6 0.4 46.5 22.1 0.7 3.2 13.8 14.5 5.2 21.1 40.8 59.4 37.3 16.5 16.3 27.1 34.8 30.9 50.4 37.9 32.9 28.4 30.5 11.1 15.4 53.7 17.5 33.7 34.3 9.6 13.7 33.7 26.3 10.0 24.5 37.3 24.6 36.6 17.0 83.2 71.1 7.1 56.5 35.9 0.0 0.4 0.5 0.2 0.7 0.8 1.0 0.7 0.8 0.7 1.2 1.3 0.8 0.0 1.2 0.4 4.1 3.1 0.8 0.1 0.2 1.2 0.4 0.2 0.2 0.2 0.4 0.4 0.1 0.2 0.5 0.2 0.0 0.5 1.0 2.7 4.1 0.9 3.6 1.2 0.0 1.1 2.2 0.2 0.0 1.8 0.0 0.0 15.0 1.7 2.3 0.0 0.4 12.0 1.9 0.6 0.9 0.0 45.9 2.2 0.4 24.0 1.7 5.1 1.1 1.3 5.2 0.0 0.8 7.5 0.0 2.1 3.0 8.2 2.2 1.8 10.8 0.9 1.2 0.0 0.0 0.6 1.1 2.1 1.5 2.5 0.2 0.5 1.2 10.9 0.4 0.9 0.3 0.0 0.3 6.6 1.0 1.1 110.6 56.8 8.3 2.4 3.8 1.2 2.1 7.6 0.9 NUSAP1 "ANKT, BM037, FLJ13421, LNP, PRO0310p1, Q0310, SAPL" ENSG00000137804 "Nucleolar and spindle associated protein 1" Q9BXS6 15 41320794-41381050 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 88.6;lymphoid tissue: 101.5" "Cell type enhanced" "Detected in many" "Erythroid cells: 266.7;Extravillous trophoblasts: 121.2;Granulosa cells: 93.3;Spermatocytes: 99.6" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Group enriched" "Detected in some" 15 "basophil: 10.7;T-reg: 7.7" "Group enriched" "Detected in many" 15 "granulocytes: 10.7;T-cells: 7.7" "Low cell line specificity" "Detected in many" "HPA042904, HPA074847" Supported Approved "Nucleoplasm,Nucleoli,Nucleoli fibrillar center" Yes Yes "Cluster 34: Basophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Nucleoli, Nucleoli fibrillar center" "HPA042904: AB_2678220, HPA074847: AB_2732269" "unprognostic (1.19e-1)" "unprognostic (9.53e-3)" "unprognostic (1.65e-1)" "unprognostic (8.78e-2)" "unprognostic (3.46e-2)" "unprognostic (2.97e-2)" "unprognostic (1.16e-3)" "unprognostic (1.74e-3)" "unprognostic (1.37e-2)" "unprognostic (4.14e-1)" "prognostic unfavorable (6.27e-4)" "unprognostic (8.49e-3)" "prognostic unfavorable (6.82e-14)" "unprognostic (4.76e-3)" "unprognostic (1.23e-1)" "unprognostic (2.18e-1)" "unprognostic (1.22e-1)" 1.8 14.1 0.2 7.8 0.2 88.6 1.5 0.3 0.4 3.6 0.3 6.1 7.0 1.1 0.1 17.7 1.1 1.0 1.1 0.2 0.2 2.6 5.0 3.8 28.7 0.3 0.4 4.4 1.3 0.0 0.6 6.5 0.3 1.1 8.0 0.1 3.6 0.6 5.4 9.4 7.4 2.7 0.2 7.8 4.5 10.9 0.3 101.5 0.9 0.1 31.5 1.9 6.4 0.3 146.0 38.3 165.1 64.6 3.5 5.9 37.0 107.4 74.6 138.9 130.6 58.4 67.0 63.5 42.5 44.4 99.1 107.6 104.2 46.2 132.4 98.5 62.3 149.6 102.0 50.7 0.2 67.3 57.2 0.9 1.3 69.1 37.3 21.7 72.0 104.2 70.1 237.5 105.7 30.7 147.5 82.2 59.8 139.8 55.0 136.5 156.5 67.5 42.4 29.3 85.7 55.2 129.8 88.5 25.7 46.0 106.2 76.1 33.7 89.9 104.8 101.5 206.2 81.3 145.8 200.5 42.1 163.6 171.2 10.7 0.1 0.5 0.1 0.0 0.0 0.3 0.5 0.5 0.3 0.6 0.0 0.3 0.2 0.4 0.0 0.3 7.7 0.5 0.2 0.2 0.3 0.4 0.2 0.2 0.3 0.4 0.3 0.2 0.3 0.3 1.9 0.0 1.5 1.3 14.2 38.5 10.3 21.2 31.9 0.9 9.9 13.7 1.1 17.2 5.0 0.0 0.0 72.2 13.4 14.4 3.9 2.3 33.2 10.7 11.6 7.3 3.0 266.7 1.4 0.5 121.2 14.6 25.5 21.8 7.0 93.3 10.8 3.9 36.7 0.0 1.5 15.5 24.4 13.8 22.7 14.6 0.3 17.5 3.6 1.9 6.1 1.9 4.1 1.0 1.3 1.5 0.4 1.9 57.2 5.3 2.6 5.4 1.1 1.0 0.0 2.8 12.1 99.6 59.9 69.5 24.9 19.3 22.9 38.8 30.0 10.3 NDUFAF1 "CGI-65, CIA30" ENSG00000137806 "NADH:ubiquinone oxidoreductase complex assembly factor 1" Q9Y375 15 41387218-41409403 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Chaperone "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 85.3;Spermatocytes: 84.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039933, HPA040064" Supported Approved Mitochondria,Cytosol NA NA "Cluster 34: Basophils - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 43: THP-1 - Innate immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Mitochondria, Cytosol" "HPA039933: AB_10795265, HPA040064: AB_10795687" "unprognostic (2.02e-1)" "unprognostic (1.02e-1)" "unprognostic (1.72e-1)" "unprognostic (2.10e-3)" "unprognostic (2.38e-1)" "unprognostic (1.20e-1)" "prognostic favorable (2.88e-5)" "unprognostic (3.01e-1)" "unprognostic (2.34e-1)" "unprognostic (8.92e-2)" "unprognostic (1.34e-1)" "unprognostic (1.46e-1)" "prognostic favorable (3.34e-6)" "unprognostic (1.68e-1)" "unprognostic (3.23e-1)" "unprognostic (3.17e-2)" "unprognostic (2.05e-1)" 16.0 33.4 20.0 9.5 20.7 4.2 12.4 21.6 29.6 9.7 22.8 12.7 12.6 10.5 15.5 13.8 9.8 7.7 42.7 20.7 21.4 29.0 38.7 9.3 11.5 21.1 21.0 9.7 11.8 18.3 11.5 8.0 21.3 10.1 10.4 12.4 12.2 13.2 63.5 9.7 10.9 10.8 21.5 11.9 14.1 21.1 20.8 10.9 10.5 60.9 13.1 12.8 9.9 22.9 15.9 13.3 16.4 13.3 30.0 28.3 14.9 26.1 25.1 23.6 21.3 22.5 8.1 16.7 38.2 24.9 17.5 25.0 20.1 15.9 19.3 32.9 23.9 22.4 25.0 13.8 27.1 24.7 17.0 30.0 18.5 20.8 18.0 19.9 19.0 31.9 38.2 17.2 30.6 17.5 19.9 28.6 12.6 27.5 17.9 15.0 17.4 40.6 41.9 27.8 17.5 13.8 13.2 31.8 12.6 16.9 25.1 50.2 15.4 18.0 10.1 30.5 24.2 15.8 34.7 28.0 24.0 43.5 19.3 35.0 12.8 16.2 7.8 15.0 9.1 13.8 9.6 9.5 11.8 11.8 10.6 8.6 9.4 13.4 13.3 18.2 16.8 8.5 20.0 20.7 21.6 29.6 20.7 21.4 21.1 21.0 21.3 21.5 20.8 22.9 7.7 12.8 10.1 6.5 14.6 4.7 15.8 43.8 9.6 15.7 12.3 11.9 58.7 15.7 27.3 22.0 12.5 36.3 19.8 8.5 64.6 30.5 59.5 14.2 14.2 11.1 6.7 13.5 8.8 31.3 34.6 12.5 12.2 13.1 7.0 16.3 8.6 28.2 28.8 6.7 9.1 8.5 30.5 12.8 7.0 15.0 16.4 16.2 10.6 3.7 23.4 20.7 16.5 4.0 10.3 20.9 3.7 16.1 15.0 11.8 23.3 85.3 30.6 19.2 26.3 15.3 17.3 84.7 21.6 11.3 7.7 50.3 12.3 32.6 11.9 16.3 RTF1 KIAA0252 ENSG00000137815 "RTF1 homolog, Paf1/RNA polymerase II complex component" Q92541 15 41408408-41483563 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006714, CAB079946, CAB079947" Supported Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Cluster 37: B-cells - Transcription" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Cytosol "CAB079946: , CAB079947: , HPA006714: AB_1079855" "unprognostic (1.10e-1)" "unprognostic (5.03e-2)" "unprognostic (1.40e-1)" "unprognostic (1.86e-2)" "unprognostic (1.21e-2)" "unprognostic (1.88e-1)" "unprognostic (8.87e-2)" "unprognostic (5.36e-2)" "unprognostic (4.21e-1)" "unprognostic (2.39e-1)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.19e-1)" "unprognostic (1.69e-2)" "unprognostic (8.22e-2)" "unprognostic (3.13e-2)" "unprognostic (1.80e-1)" "unprognostic (9.50e-2)" 17.8 23.2 24.7 18.8 26.3 45.1 22.4 26.8 42.7 24.3 19.2 21.6 19.2 25.1 19.5 21.4 17.1 20.3 24.6 27.1 24.0 19.0 19.9 19.4 28.2 21.0 21.3 29.4 16.6 36.9 11.4 24.5 20.9 23.4 22.4 26.4 16.7 22.8 49.4 25.9 19.8 26.3 20.0 23.8 20.8 29.8 23.9 28.8 29.5 34.8 25.0 23.1 17.5 24.6 32.0 20.6 66.5 54.2 37.0 43.4 31.2 41.8 46.8 56.0 46.5 40.4 19.8 30.2 33.0 43.9 24.9 55.3 38.9 34.8 47.6 46.2 36.1 63.5 45.2 30.4 25.8 57.2 35.5 31.4 34.3 30.0 30.1 41.6 45.8 54.0 49.2 34.0 46.5 24.2 55.1 35.1 35.9 39.6 28.0 59.0 51.8 28.9 36.5 67.5 34.0 44.9 37.6 47.4 19.0 35.9 38.9 54.5 37.9 54.6 34.4 54.8 46.5 38.9 65.0 49.6 39.4 53.5 34.1 5.4 3.1 6.9 3.4 2.1 3.1 6.9 3.3 2.9 2.2 5.3 4.0 3.2 8.5 6.2 2.7 5.5 4.3 1.1 24.7 26.3 26.8 42.7 27.1 24.0 21.0 21.3 20.9 20.0 23.9 24.6 118.0 128.2 80.1 23.8 109.0 145.0 98.7 120.4 102.4 213.5 152.6 129.7 94.3 111.5 89.7 123.2 93.8 168.3 117.1 129.6 164.4 103.0 333.7 103.9 162.6 116.4 87.8 85.0 40.3 110.5 119.1 103.5 71.9 126.2 91.2 127.9 129.5 193.2 95.5 148.0 43.6 145.4 109.9 86.7 94.4 348.5 145.1 83.0 108.5 15.9 116.1 106.2 128.8 16.6 23.5 127.0 105.1 159.9 104.1 141.9 112.6 186.4 70.7 188.2 85.5 115.4 146.9 198.3 59.9 83.4 163.0 219.3 113.0 126.1 133.2 99.2 ITPKA "IP3-3KA, IP3KA" ENSG00000137825 "Inositol-trisphosphate 3-kinase A" P23677 15 41493393-41503551 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.5;intestine: 18.1" "Cell type enhanced" "Detected in some" "Distal enterocytes: 51.4;Early spermatids: 45.4;Gastric mucus-secreting cells: 34.1;Late spermatids: 166.4;Proximal enterocytes: 35.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 8 "MAIT T-cell: 1.4" "Lineage enriched" "Detected in single" 11 "T-cells: 1.4" "Cell line enhanced" "Detected in many" "Hep G2: 33.6;OE19: 18.2" "Low region specificity" "Detected in all" HPA040454 Enhanced Approved Approved "Vesicles,Plasma membrane" No No "Cluster 16: MAIT-cells - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 31: Spermatids - Spermatogenesis" Vesicles "Plasma membrane" "HPA040454: AB_10672897" "unprognostic (5.91e-2)" "unprognostic (2.16e-3)" "unprognostic (4.19e-1)" "unprognostic (3.57e-3)" "prognostic unfavorable (6.77e-4)" "unprognostic (2.25e-2)" "unprognostic (2.69e-2)" "unprognostic (1.01e-1)" "unprognostic (3.58e-1)" "unprognostic (1.28e-1)" "unprognostic (1.21e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (3.76e-9)" "unprognostic (2.15e-1)" "unprognostic (2.87e-1)" "unprognostic (1.12e-3)" "unprognostic (2.10e-2)" 0.2 7.3 21.4 0.7 26.7 0.4 0.2 13.8 36.5 1.3 10.9 10.7 17.6 0.3 0.1 0.3 0.5 0.2 2.6 28.7 12.4 0.2 1.7 0.5 0.1 10.9 12.0 0.3 1.9 2.0 0.4 0.3 11.6 0.8 2.7 0.3 1.4 0.3 4.4 0.4 18.1 0.3 11.3 0.2 10.9 10.4 12.1 0.0 0.2 0.0 0.0 0.6 0.9 20.4 7.1 1.9 0.3 7.9 0.0 2.5 14.3 4.3 3.4 2.8 2.9 16.3 0.3 0.0 3.5 0.4 6.3 0.8 3.4 0.3 0.2 6.6 4.3 9.9 4.7 33.6 12.6 3.4 0.5 0.2 0.2 2.7 0.8 1.6 0.2 1.3 12.9 1.9 1.0 4.7 0.3 6.5 0.9 18.2 5.6 1.7 1.4 0.6 0.3 0.4 0.7 1.5 3.2 0.0 0.3 0.0 0.9 5.0 0.3 6.9 7.1 7.7 11.8 1.0 10.8 0.0 12.6 13.2 2.3 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 21.4 26.7 13.8 36.5 28.7 12.4 10.9 12.0 11.6 11.3 12.1 20.4 0.1 0.0 0.0 3.3 0.5 0.1 0.3 0.1 0.0 0.0 0.3 0.0 1.4 0.0 0.1 0.0 0.0 0.6 0.1 51.4 0.0 0.1 45.4 0.3 2.4 0.5 0.0 0.8 23.7 0.7 0.5 0.3 34.1 0.3 0.0 1.0 0.4 0.3 0.2 0.0 0.8 12.0 0.0 0.0 0.0 166.4 2.5 0.4 0.0 1.9 0.0 7.9 0.0 1.5 2.9 0.8 16.1 1.5 0.1 0.1 35.8 0.1 0.1 0.2 6.6 0.3 0.5 14.4 4.9 0.0 0.0 0.1 0.4 0.1 18.7 0.2 LTK TYK1 ENSG00000062524 "Leukocyte receptor tyrosine kinase" P29376 15 41503637-41513887 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 13.2;lung: 15.1;salivary gland: 11.8" "Cell type enhanced" "Detected in some" "Distal enterocytes: 25.3;Gastric mucus-secreting cells: 18.8;Hepatic stellate cells: 11.4;Intestinal goblet cells: 7.9;Proximal enterocytes: 15.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "MAIT T-cell: 5.7;plasmacytoid DC: 5.0" "Group enriched" "Detected in many" 10 "dendritic cells: 5.0;T-cells: 5.7" "Cell line enhanced" "Detected in some" "HEL: 5.0;NB-4: 9.7;RH-30: 4.6;THP-1: 14.7" "Low region specificity" "Detected in many" HPA059545 Approved Vesicles NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 43: THP-1 - Innate immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Vesicles "HPA059545: AB_2684057" "unprognostic (9.47e-4)" "unprognostic (5.52e-4)" "unprognostic (1.51e-1)" "unprognostic (2.49e-1)" "unprognostic (4.12e-1)" "unprognostic (5.65e-3)" "unprognostic (1.74e-2)" "unprognostic (7.22e-2)" "unprognostic (2.89e-2)" "unprognostic (2.81e-3)" "unprognostic (9.36e-3)" "unprognostic (5.36e-2)" "unprognostic (4.68e-2)" "unprognostic (5.78e-2)" "unprognostic (1.52e-1)" "unprognostic (1.10e-1)" "unprognostic (1.90e-1)" 0.8 0.6 1.0 1.4 1.6 4.6 0.5 1.2 1.8 0.9 0.6 5.2 12.5 0.2 0.0 0.3 0.4 2.4 1.7 1.3 0.7 4.0 2.9 15.1 1.2 0.6 0.6 0.1 0.3 0.6 0.7 10.4 0.7 0.4 5.7 0.1 11.8 0.3 1.8 1.4 13.2 0.3 0.6 5.5 9.9 2.5 0.8 0.4 0.7 0.0 2.1 0.7 0.7 0.9 0.0 0.0 0.0 0.0 0.1 0.2 0.5 0.1 0.6 0.8 1.2 2.2 0.0 0.0 0.0 0.6 0.0 0.0 2.6 0.0 0.4 0.2 1.3 5.0 0.1 0.0 2.0 0.0 0.0 0.3 0.4 0.0 0.1 0.0 0.0 0.0 1.9 0.0 1.8 0.0 0.0 9.7 0.4 1.8 0.2 0.2 4.6 0.1 0.0 0.0 0.4 2.9 0.1 0.2 0.0 2.6 0.2 14.7 0.0 0.0 0.2 0.1 0.0 0.3 0.2 0.2 0.0 0.5 0.8 0.0 0.0 0.0 0.4 0.0 5.7 0.5 0.3 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.1 1.0 1.6 1.2 1.8 1.3 0.7 0.6 0.6 0.7 0.6 0.8 0.9 0.3 0.0 0.0 0.3 1.6 0.1 0.0 0.4 0.0 0.0 0.2 0.1 0.8 2.8 0.9 0.0 0.0 0.3 5.5 25.3 0.0 0.0 2.8 0.1 0.4 1.8 1.8 3.2 2.9 0.2 1.5 0.2 18.8 0.2 0.0 0.3 11.4 0.5 0.1 0.0 0.2 7.9 0.0 1.9 0.6 2.1 0.0 0.4 3.6 0.0 0.4 0.0 1.0 0.5 0.4 0.7 5.5 0.0 2.7 0.0 15.3 0.0 5.6 0.0 0.0 0.3 0.5 2.2 1.2 0.0 0.1 0.4 4.0 0.0 3.8 0.0 RPAP1 "DKFZP727M111, FLJ12732, KIAA1403, MGC858" ENSG00000103932 "RNA polymerase II associated protein 1" Q9BWH6 15 41517176-41544269 "Predicted intracellular proteins, Predicted membrane proteins" Transcription "DNA-binding, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041739 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 16: U-266 - Nucleosome" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA041739: AB_2677647" "unprognostic (8.83e-3)" "unprognostic (2.78e-3)" "unprognostic (1.63e-1)" "unprognostic (4.45e-2)" "unprognostic (1.97e-1)" "unprognostic (8.61e-2)" "unprognostic (1.78e-3)" "unprognostic (1.84e-1)" "unprognostic (3.25e-2)" "unprognostic (4.72e-2)" "unprognostic (1.23e-2)" "unprognostic (7.02e-2)" "unprognostic (3.73e-2)" "unprognostic (3.26e-1)" "unprognostic (2.46e-1)" "prognostic unfavorable (9.32e-4)" "unprognostic (4.30e-3)" 7.0 5.7 4.9 6.1 5.4 3.5 5.1 4.4 5.2 5.4 3.7 7.2 5.7 6.4 3.2 8.1 6.7 3.9 6.7 5.1 4.2 4.0 4.9 4.7 7.2 5.0 5.1 8.0 5.9 7.2 3.9 5.9 4.8 6.1 4.6 2.8 7.0 5.6 19.0 7.0 5.2 6.6 4.7 6.5 6.1 6.5 5.0 6.9 5.2 11.6 6.8 6.9 5.3 5.9 13.3 15.3 20.8 21.9 17.1 12.3 17.7 12.8 11.0 16.4 15.8 42.3 11.7 10.3 20.6 14.2 26.1 30.5 37.9 18.7 13.8 18.3 18.5 19.6 21.2 18.8 10.7 16.3 11.9 12.6 23.3 19.2 13.3 11.0 18.4 23.1 46.4 11.5 15.2 8.3 17.6 10.0 36.9 20.3 14.3 31.4 18.0 11.2 7.2 30.5 19.0 25.4 16.4 16.9 8.8 18.0 28.1 20.0 16.9 25.3 16.4 25.5 20.6 19.2 57.5 11.6 18.1 17.4 24.4 0.0 1.9 0.0 4.6 2.4 4.0 2.9 2.6 2.8 2.9 3.3 3.7 3.4 0.0 3.1 4.4 1.9 3.1 2.5 4.9 5.4 4.4 5.2 5.1 4.2 5.0 5.1 4.8 4.7 5.0 5.9 4.1 3.2 5.4 10.4 7.7 2.8 4.4 4.6 8.6 10.2 5.1 5.2 9.0 2.8 4.7 5.5 12.5 6.5 6.1 3.9 1.9 5.5 1.5 3.7 6.5 5.8 2.4 11.2 7.7 5.3 5.8 6.1 8.6 5.2 2.5 11.9 5.0 9.6 4.8 16.8 6.7 5.6 6.1 5.2 2.8 1.7 3.7 3.5 1.8 6.5 6.0 5.0 5.2 7.5 9.3 5.3 2.7 9.4 4.4 6.7 4.1 3.0 5.2 7.4 0.0 6.5 4.6 10.6 9.5 6.1 4.1 2.7 7.0 10.8 7.5 3.1 TYRO3 "Brt, Dtk, Etk-2, Rek, RSE, Sky, Tif" ENSG00000092445 "TYRO3 protein tyrosine kinase" Q06418 15 41557675-41583589 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.0;ovary: 49.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 42.4;Leydig cells: 44.4;Oligodendrocyte precursor cells: 29.1;Oligodendrocytes: 46.8;Peritubular cells: 47.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 1.5" "Lineage enriched" "Detected in single" 4 "granulocytes: 1.5" "Cell line enhanced" "Detected in many" "BEWO: 69.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071245 Approved NA NA 17000000 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 21: Non-specific - Transcription" "Cluster 28: BEWO - Transcription regulation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA071245: AB_2686371" "unprognostic (1.26e-1)" "unprognostic (6.34e-2)" "unprognostic (1.47e-1)" "unprognostic (2.68e-1)" "unprognostic (3.29e-1)" "unprognostic (6.77e-2)" "unprognostic (1.56e-3)" "unprognostic (5.41e-2)" "unprognostic (3.72e-1)" "unprognostic (3.21e-1)" "unprognostic (2.69e-1)" "unprognostic (1.37e-1)" "unprognostic (1.92e-10)" "unprognostic (7.59e-2)" "unprognostic (5.22e-1)" "unprognostic (4.04e-3)" "unprognostic (1.84e-2)" 21.5 3.5 18.2 1.4 30.3 0.8 5.2 17.7 27.1 2.1 0.0 2.3 1.6 4.6 3.5 13.1 11.5 2.5 2.2 27.7 10.7 11.3 0.8 3.3 1.3 20.9 22.6 49.7 9.8 0.9 0.9 5.7 18.6 2.6 0.9 2.6 1.9 6.1 0.9 13.8 2.4 4.4 14.4 5.5 3.2 18.8 15.7 0.4 1.1 1.8 3.7 2.1 4.1 32.0 10.3 6.7 20.7 22.7 18.9 12.8 69.2 14.6 9.3 14.2 13.1 37.7 3.4 0.4 18.3 11.9 19.9 23.7 23.3 3.6 6.5 5.8 15.5 3.2 20.2 18.1 13.3 5.2 0.4 4.1 7.3 10.9 3.6 5.8 10.6 9.8 19.1 4.3 7.9 9.8 2.4 1.0 47.7 16.0 6.7 31.9 18.6 3.8 1.2 19.7 24.6 7.0 13.7 21.6 16.3 29.8 17.8 6.0 8.4 28.0 12.2 21.0 22.5 1.7 3.5 3.1 17.2 33.8 17.2 1.1 0.2 0.2 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.3 0.2 0.2 1.5 0.3 0.1 0.3 0.1 0.1 18.2 30.3 17.7 27.1 27.7 10.7 20.9 22.6 18.6 14.4 15.7 32.0 3.4 3.2 1.1 17.6 0.9 6.8 8.5 0.4 0.6 2.7 2.2 2.2 2.9 2.8 0.7 3.7 6.2 2.9 1.1 1.3 0.0 3.9 3.6 1.1 13.0 5.4 1.8 0.0 42.4 3.6 10.2 10.5 8.6 1.9 0.0 7.6 9.7 0.4 1.2 0.0 4.6 0.9 0.0 1.9 1.3 5.1 44.4 0.9 8.8 1.0 0.1 8.3 1.0 29.1 46.8 4.6 0.1 47.0 0.3 6.4 1.2 1.2 0.5 4.0 0.0 3.9 4.3 4.0 6.5 4.2 10.9 18.9 0.7 5.8 2.3 5.7 MGA "FLJ12634, KIAA0518, MAD5, MXD5" ENSG00000174197 "MAX dimerization protein MGA" Q8IWI9 15 41621224-41773081 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.6" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 122.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042278, HPA058183" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA042278: AB_10794647, HPA058183: AB_2683632" "unprognostic (5.78e-2)" "unprognostic (7.97e-2)" "unprognostic (2.97e-1)" "unprognostic (7.20e-2)" "unprognostic (6.26e-3)" "unprognostic (5.82e-3)" "unprognostic (8.61e-3)" "unprognostic (1.70e-1)" "unprognostic (1.90e-2)" "unprognostic (3.96e-3)" "unprognostic (3.71e-1)" "unprognostic (3.80e-2)" "unprognostic (1.43e-2)" "unprognostic (1.57e-1)" "unprognostic (3.93e-1)" "unprognostic (2.50e-1)" "unprognostic (3.89e-1)" 3.9 5.2 7.0 5.4 12.1 8.7 7.2 33.6 8.5 7.3 0.0 4.5 3.7 7.4 6.0 4.5 5.8 4.2 4.5 4.9 11.6 5.2 4.6 4.3 7.6 6.4 6.9 12.0 5.0 6.0 3.9 6.9 8.8 5.7 5.1 7.0 5.1 5.5 5.1 6.2 3.9 5.7 3.8 6.8 4.6 8.7 8.6 11.6 7.5 7.8 7.6 5.4 3.9 17.3 2.4 13.5 16.6 10.9 12.8 10.1 13.3 6.7 6.8 7.8 7.7 14.5 7.8 16.2 11.8 7.8 14.2 9.3 25.9 5.9 10.7 7.7 8.5 34.3 22.1 12.8 11.3 31.9 16.4 7.7 7.2 10.9 10.7 3.2 10.3 15.5 40.7 7.2 7.1 6.7 19.4 12.3 10.3 7.0 6.9 21.7 16.9 8.5 4.1 9.8 15.7 15.3 24.0 8.2 4.3 12.1 6.6 20.1 11.0 9.5 13.3 9.8 8.0 9.8 15.7 15.3 6.0 11.9 4.8 3.6 1.4 1.6 2.5 1.0 2.5 2.8 2.1 2.9 1.4 3.0 2.1 2.4 0.6 5.8 3.3 2.4 1.1 1.0 7.0 12.1 33.6 8.5 4.9 11.6 6.4 6.9 8.8 3.8 8.6 17.3 18.5 22.4 19.8 56.5 28.1 7.9 10.9 7.2 13.6 25.5 11.1 8.9 29.5 5.7 16.2 12.9 33.3 18.1 23.6 9.7 7.9 11.8 16.7 16.8 35.4 18.6 7.8 28.6 62.4 5.3 12.0 20.5 18.8 24.9 14.5 32.9 15.0 9.3 11.8 13.5 60.1 10.0 8.2 11.9 8.8 7.0 20.8 17.1 8.8 44.0 13.2 16.0 25.7 64.8 122.6 8.1 13.5 20.7 16.4 16.2 7.6 5.2 14.9 23.6 39.5 35.6 19.2 45.4 40.4 11.7 11.2 26.0 27.5 23.5 11.3 10.7 MAPKBP1 "KIAA0596, NPHP20" ENSG00000137802 "Mitogen-activated protein kinase binding protein 1" O60336 15 41774434-41827855 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Nephronophthisis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 204.3;Excitatory neurons: 62.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030832, HPA030833" Approved Supported "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Cluster 46: Basophils - DNA binding" "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 9: Photoreceptor cells - Phototransduction" "Nucleoli, Nucleoli rim" Nucleoplasm "HPA030832: AB_10601869, HPA030833: AB_2673628" "unprognostic (2.53e-1)" "unprognostic (9.18e-2)" "unprognostic (6.56e-2)" "prognostic favorable (1.47e-4)" "unprognostic (1.16e-1)" "unprognostic (2.22e-1)" "unprognostic (9.84e-3)" "unprognostic (1.32e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (6.80e-4)" "unprognostic (1.08e-3)" "unprognostic (6.03e-3)" "unprognostic (7.94e-2)" "unprognostic (1.68e-1)" "unprognostic (8.98e-2)" "unprognostic (1.72e-1)" "unprognostic (2.28e-2)" 6.2 10.5 10.9 4.6 12.4 4.4 7.7 31.1 13.7 11.1 10.1 10.2 9.6 9.9 4.5 18.6 10.4 4.6 6.4 9.9 8.5 7.1 4.1 6.0 3.9 9.0 8.0 15.1 5.5 4.2 12.7 5.4 9.0 8.9 3.6 9.0 7.5 5.9 5.1 24.2 9.9 9.0 5.3 8.0 9.3 34.4 9.1 6.3 13.4 3.7 6.8 12.2 12.0 10.2 7.4 3.8 10.0 9.5 10.9 10.8 6.9 10.1 25.5 9.1 6.6 7.6 2.7 1.8 8.1 8.3 12.5 17.2 9.8 28.5 6.5 6.7 2.7 7.3 12.8 2.6 4.7 4.7 14.5 5.6 22.3 14.3 25.9 14.8 13.4 11.9 4.6 3.4 12.9 1.5 4.0 4.2 1.1 4.3 7.6 4.3 7.2 0.7 5.3 8.1 11.3 6.3 5.7 5.9 4.5 10.2 7.1 3.7 10.6 13.0 6.2 12.4 10.0 7.3 12.7 4.3 8.7 6.3 11.0 1.1 0.4 0.3 0.8 0.1 0.6 0.4 0.4 0.3 0.5 0.4 0.6 0.5 0.1 0.6 0.5 0.1 0.2 0.5 10.9 12.4 31.1 13.7 9.9 8.5 9.0 8.0 9.0 5.3 9.1 10.2 7.1 6.4 10.3 33.0 3.5 54.7 10.0 8.6 36.5 14.5 5.4 8.9 3.4 2.8 7.3 3.7 204.3 6.8 5.6 4.0 0.0 3.0 15.7 10.9 7.1 9.5 4.8 0.8 62.2 3.7 4.4 5.8 9.2 8.9 1.3 12.2 5.3 2.6 3.9 15.2 55.1 1.7 4.1 2.5 6.1 27.1 7.2 5.0 8.8 33.7 4.2 4.4 3.1 34.7 51.9 4.6 1.8 7.9 5.1 12.5 8.1 0.5 13.0 8.9 13.1 7.8 5.7 12.7 4.2 27.7 53.6 5.3 5.8 8.0 2.5 15.2 JMJD7 ENSG00000243789 "Jumonji domain containing 7" P0C870 15 41828092-41837581 "Enzymes, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Monooxygenase, Oxidoreductase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Alveolar cells type 2: 5.2;Basal squamous epithelial cells: 1.8;Gastric mucus-secreting cells: 2.0;Squamous epithelial cells: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 31.2;RT4: 43.5" "Low region specificity" "Detected in all" HPA005726 Approved Approved Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 15: RT4 - Unknown function" "Cluster 11: Alveolar cells - Smell perception" Cytosol "HPA005726: AB_1852017" "unprognostic (2.92e-1)" "unprognostic (7.99e-2)" "unprognostic (1.47e-2)" "unprognostic (2.30e-2)" "unprognostic (9.46e-2)" "unprognostic (1.03e-1)" "unprognostic (1.59e-1)" "unprognostic (1.78e-2)" "unprognostic (2.11e-2)" "unprognostic (1.77e-1)" "unprognostic (2.42e-1)" "unprognostic (8.74e-3)" "unprognostic (3.13e-1)" "unprognostic (7.25e-2)" "unprognostic (1.06e-1)" "unprognostic (3.30e-1)" "unprognostic (1.45e-2)" 6.7 8.4 6.3 4.2 6.2 8.2 9.0 19.9 9.5 13.6 8.0 7.3 4.8 6.5 3.1 35.4 8.6 6.5 11.2 5.8 6.3 10.1 10.3 10.8 7.3 5.8 5.2 11.6 15.9 9.0 9.8 3.0 7.0 14.5 3.0 1.9 21.9 6.8 7.7 33.3 8.0 2.9 5.1 7.9 11.5 6.7 5.9 5.6 15.6 6.6 6.6 11.4 21.0 7.0 7.9 7.5 9.3 2.6 2.5 1.7 5.8 3.1 6.6 5.1 4.1 10.5 5.9 1.0 6.4 2.0 5.3 19.6 4.3 15.6 1.6 7.7 4.6 10.5 10.4 6.5 4.1 5.1 11.0 1.1 13.6 3.4 7.2 4.7 5.8 9.9 7.0 6.2 3.7 10.8 6.6 4.9 4.0 31.2 4.8 2.9 6.3 7.6 11.5 43.5 9.9 3.5 2.6 13.5 4.3 2.7 26.2 5.4 5.4 3.7 8.3 8.0 6.1 10.2 3.7 3.2 4.9 12.4 5.7 6.1 14.8 10.8 14.1 15.8 14.8 7.2 15.7 18.6 10.6 11.1 19.7 15.6 3.9 13.0 15.8 6.7 16.7 12.6 6.3 6.2 19.9 9.5 5.8 6.3 5.8 5.2 7.0 5.1 5.9 7.0 0.1 3.2 5.2 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.1 0.0 0.8 0.0 0.2 0.0 0.2 2.0 0.1 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.1 3.4 0.1 0.0 0.6 0.0 0.0 0.0 JMJD7-PLA2G4B ENSG00000168970 "JMJD7-PLA2G4B readthrough" 15 41828095-41848155 "Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 9.6;Alveolar cells type 2: 4.8;Club cells: 2.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "gdT-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "RT4: 2.6" HPA005726 Approved Approved Cytosol NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 31: Skin - Epidermis development" "Cluster 15: RT4 - Unknown function" "Cluster 11: Alveolar cells - Smell perception" Cytosol "HPA005726: AB_1852017" "unprognostic (9.87e-3)" "unprognostic (5.65e-2)" "unprognostic (1.27e-2)" "unprognostic (6.86e-3)" "unprognostic (1.04e-1)" "unprognostic (1.84e-3)" "unprognostic (1.47e-1)" "unprognostic (7.21e-3)" "unprognostic (4.52e-2)" "unprognostic (4.92e-2)" "unprognostic (1.53e-2)" "unprognostic (1.02e-3)" "unprognostic (1.02e-3)" "unprognostic (3.98e-1)" "unprognostic (1.33e-1)" "unprognostic (2.15e-1)" "unprognostic (4.75e-3)" 1.1 0.3 0.1 0.8 0.0 1.0 0.9 0.3 0.4 1.4 0.5 0.9 0.2 1.1 0.4 1.9 1.1 0.4 0.6 0.1 0.1 0.4 0.3 0.9 0.2 0.1 0.1 1.2 0.5 0.9 0.4 0.1 0.3 0.7 0.2 0.2 1.5 0.4 0.8 2.8 0.8 0.6 0.1 0.6 0.8 0.3 0.3 0.4 0.8 0.5 0.3 1.0 1.4 0.2 0.2 0.0 0.6 2.0 0.5 1.3 0.7 0.4 1.1 0.5 0.8 0.8 0.0 0.2 0.8 0.5 0.0 1.8 0.2 1.2 0.1 0.0 0.2 0.3 0.4 0.2 1.9 0.0 0.9 0.7 0.9 0.2 0.4 0.0 0.2 0.7 0.0 0.3 0.1 0.3 0.2 0.0 0.0 0.4 0.1 0.3 0.0 0.8 0.5 2.6 0.6 0.8 1.8 0.0 0.2 0.0 0.4 2.1 0.3 0.3 0.2 2.0 0.7 0.5 0.2 0.0 1.0 0.2 0.2 0.0 0.3 0.0 1.1 0.4 0.5 0.2 0.1 0.1 0.3 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.0 0.3 0.4 0.1 0.1 0.1 0.1 0.3 0.1 0.3 0.2 0.2 9.6 4.8 0.0 0.9 0.1 0.2 0.1 2.2 0.6 0.4 0.1 0.6 1.5 2.7 0.0 0.0 0.2 0.1 1.1 0.0 0.6 0.0 0.1 0.3 0.4 2.4 0.0 0.0 0.5 0.1 0.2 1.5 0.4 1.3 0.1 0.0 0.2 0.1 0.0 0.1 0.9 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.2 0.1 1.0 0.0 0.1 1.1 0.5 0.0 2.3 0.1 1.2 0.0 0.9 0.6 0.0 0.1 0.2 0.0 0.1 2.0 1.0 0.1 1.0 0.1 1.2 0.1 PLA2G4B "cPLA2-beta, HsT16992" ENSG00000243708 "Phospholipase A2 group IVB" P0C869 15 41837775-41848147 "Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 3.1;Club cells: 1.3;Rod photoreceptor cells: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive B-cell: 1.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RT4: 7.8" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 15: RT4 - Unknown function" "Cluster 11: Alveolar cells - Smell perception" "unprognostic (6.16e-2)" "unprognostic (6.48e-3)" "unprognostic (5.06e-3)" "unprognostic (1.27e-4)" "unprognostic (1.06e-1)" "unprognostic (2.56e-3)" "unprognostic (1.53e-1)" "unprognostic (2.27e-2)" "unprognostic (3.60e-2)" "unprognostic (1.90e-2)" "unprognostic (1.23e-2)" "unprognostic (5.14e-3)" "unprognostic (3.26e-5)" "unprognostic (4.36e-1)" "unprognostic (5.91e-2)" "unprognostic (1.22e-1)" "unprognostic (2.97e-2)" 8.8 7.6 6.9 0.5 6.9 3.7 10.7 6.9 10.1 26.0 6.9 9.1 1.6 8.3 1.9 36.6 13.9 1.7 11.4 6.9 6.9 16.9 16.7 11.4 3.4 6.9 6.9 20.0 19.3 0.3 16.3 0.5 6.9 24.8 0.8 0.4 16.7 2.4 5.3 48.8 12.5 0.6 6.9 16.9 12.5 9.6 7.0 1.3 22.9 0.1 5.7 12.3 30.2 7.0 1.1 0.8 0.0 0.0 0.2 0.1 2.9 0.3 0.8 1.0 0.2 0.4 0.5 0.2 0.1 0.6 0.1 3.6 1.0 0.9 0.2 0.1 1.7 0.9 1.3 2.5 1.5 0.2 1.4 0.6 3.6 0.3 1.0 0.2 0.4 1.6 1.2 0.1 0.2 1.6 1.1 3.1 0.8 4.0 0.9 0.0 0.9 0.5 0.8 7.8 0.4 0.7 0.0 1.4 0.8 0.6 4.2 1.4 0.0 0.0 0.8 1.0 0.1 2.5 0.1 0.7 0.2 3.8 0.0 0.0 0.2 0.0 0.4 0.1 0.2 0.0 0.1 0.2 0.1 1.5 0.2 0.2 0.0 1.1 0.0 0.1 0.4 0.0 6.9 6.9 6.9 10.1 6.9 6.9 6.9 6.9 6.9 6.9 7.0 7.0 0.0 0.0 3.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 SPTBN5 "BSPECV, HUBSPECV, HUSPECV" ENSG00000137877 "Spectrin beta, non-erythrocytic 5" Q9NRC6 15 41848146-41894053 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 8.8;retina: 26.9" "Group enriched" "Detected in many" 22 "Cone photoreceptor cells: 210.6;Rod photoreceptor cells: 211.8" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 6 "cerebellum: 8.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 3.7;SCLC-21H: 5.1;TIME: 13.6;WM-115: 4.2" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "spinal cord: 3.6" HPA055283 Approved NA NA "Cluster 77: Retina - Visual perception" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 9: Photoreceptor cells - Phototransduction" "HPA055283: " "unprognostic (5.46e-2)" "unprognostic (2.49e-1)" "unprognostic (3.28e-2)" "unprognostic (2.01e-1)" "unprognostic (2.26e-2)" "unprognostic (5.84e-3)" "unprognostic (1.12e-1)" "unprognostic (6.84e-3)" "unprognostic (6.40e-3)" "unprognostic (2.25e-1)" "unprognostic (2.96e-2)" "unprognostic (6.92e-2)" "unprognostic (1.83e-2)" "unprognostic (3.98e-2)" "unprognostic (2.28e-1)" "unprognostic (1.37e-2)" "unprognostic (1.11e-2)" 1.0 0.3 0.4 0.7 1.3 0.4 1.1 8.8 1.4 0.6 0.1 0.5 0.3 0.4 0.8 1.7 0.5 0.9 2.0 0.6 0.1 1.7 1.6 1.2 0.6 0.8 0.3 0.6 1.1 0.5 1.9 0.2 1.0 1.6 0.2 26.9 2.7 0.3 0.4 1.7 0.5 0.2 0.1 0.5 1.0 0.8 0.1 0.0 2.1 0.4 0.1 2.6 0.7 0.8 0.2 0.0 0.4 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.6 0.0 0.8 0.0 1.5 0.4 0.0 0.2 0.0 0.8 0.1 0.0 1.6 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.1 0.4 0.0 0.3 0.0 0.3 1.4 5.1 0.1 0.2 0.4 0.1 0.4 0.8 0.0 13.6 0.0 1.3 0.3 1.7 1.5 2.3 0.0 0.0 0.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.3 8.8 1.4 0.6 0.1 0.8 0.3 1.0 0.1 0.1 0.8 1.9 0.0 2.4 2.9 0.2 0.8 0.9 0.4 1.2 7.9 1.8 2.0 4.0 0.0 1.5 0.0 210.6 0.1 0.8 0.7 0.0 0.5 1.1 1.1 0.3 3.7 0.0 0.0 2.3 0.2 0.3 0.6 2.0 3.8 1.3 1.0 0.4 0.5 2.0 3.3 0.5 0.5 0.0 0.0 0.6 0.9 0.0 1.0 1.8 0.0 0.8 9.6 1.0 6.0 0.5 1.0 1.4 0.0 0.9 0.2 0.2 0.6 0.8 211.8 0.0 0.2 0.3 0.5 0.5 3.9 1.3 0.0 0.5 0.2 0.6 1.0 EHD4 PAST4 ENSG00000103966 "EH domain containing 4" Q9H223 15 41895933-41972557 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 189.5;Urothelial cells: 200.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 103.8;TIME: 172.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049890, HPA049986, HPA052729, HPA066751" Approved Approved "Plasma membrane" NA NA 440000 "Cluster 7: Monocytes - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 10: Non-specific - Unknown function" "Plasma membrane" "HPA049890: AB_2680936, HPA049986: AB_2680983, HPA052729: AB_2681928, HPA066751: AB_2685713" "unprognostic (1.45e-1)" "unprognostic (1.37e-1)" "unprognostic (4.34e-3)" "unprognostic (3.36e-2)" "unprognostic (3.46e-2)" "unprognostic (4.48e-3)" "unprognostic (1.52e-1)" "unprognostic (3.36e-3)" "unprognostic (2.25e-1)" "unprognostic (3.74e-1)" "unprognostic (6.93e-2)" "unprognostic (2.35e-1)" "unprognostic (5.05e-2)" "unprognostic (3.49e-2)" "unprognostic (3.19e-2)" "unprognostic (8.27e-2)" "unprognostic (2.72e-1)" 21.6 4.6 3.1 11.8 3.2 10.9 16.4 7.5 3.5 9.4 5.3 12.1 5.5 9.6 10.5 15.0 9.8 15.2 27.8 3.3 3.8 14.3 9.6 15.0 12.8 4.8 4.0 5.6 14.3 12.8 5.8 8.3 4.8 9.5 10.2 6.1 10.4 9.7 4.4 14.3 12.4 12.9 5.2 7.4 9.9 2.8 4.0 5.3 18.4 4.7 8.8 23.8 9.0 6.6 28.7 9.8 9.3 9.6 4.6 6.5 8.1 14.9 31.4 25.9 36.1 41.4 16.1 5.9 39.2 18.8 51.6 28.4 13.9 32.6 19.0 35.7 11.7 8.7 13.5 7.1 11.3 4.0 24.4 5.5 12.6 26.3 28.8 9.9 103.8 8.7 9.2 6.6 21.1 12.2 4.2 4.5 7.1 27.8 33.5 0.1 24.5 9.4 23.4 57.0 15.4 6.5 10.9 23.2 17.0 9.0 22.9 5.6 172.8 8.1 15.7 30.5 73.1 18.1 30.9 12.4 10.3 9.4 71.6 1.1 14.0 9.0 4.0 12.4 6.1 2.1 6.2 5.0 14.9 2.6 2.6 3.8 2.3 4.4 5.2 2.5 7.9 8.0 3.1 3.2 7.5 3.5 3.3 3.8 4.8 4.0 4.8 5.2 4.0 6.6 94.9 6.4 44.2 3.9 20.0 81.6 189.5 68.1 34.1 4.9 31.4 20.1 36.6 30.0 69.0 44.1 31.3 10.1 22.2 96.0 7.9 71.3 16.1 66.1 9.7 114.9 22.6 5.7 1.2 62.6 20.4 21.3 25.5 72.4 61.6 16.2 54.7 8.7 89.0 1.7 0.7 22.5 28.5 35.6 52.7 34.7 7.5 46.3 19.6 12.2 53.5 37.5 4.1 26.7 2.7 75.1 70.9 4.9 31.5 49.9 71.4 4.6 60.8 27.8 13.1 8.0 29.0 5.4 8.2 29.3 79.8 17.4 27.8 21.2 37.3 200.1 PLA2G4E FLJ45651 ENSG00000188089 "Phospholipase A2 group IVE" Q3MJ16 15 41981582-42051190 "Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skin 1: 17.2" "Group enriched" "Detected in some" 4 "Alveolar cells type 2: 12.9;Basal keratinocytes: 18.1;Suprabasal keratinocytes: 44.9" "Cancer enhanced" "Detected in some" "head and neck cancer: 11.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041105, HPA072562" Enhanced Approved Vesicles,Cytosol NA NA "Cluster 31: Skin - Epidermis development" "Cluster 28: Keratinocytes - Keratinization" "Vesicles, Cytosol" "HPA041105: AB_2677300, HPA072562: " "unprognostic (2.98e-1)" "unprognostic (5.52e-1)" "unprognostic (2.60e-1)" "unprognostic (5.99e-2)" "unprognostic (5.12e-2)" "unprognostic (1.54e-1)" "unprognostic (1.99e-1)" "unprognostic (2.77e-1)" "unprognostic (4.22e-2)" "unprognostic (2.43e-1)" "unprognostic (1.22e-1)" "unprognostic (1.83e-7)" "unprognostic (1.81e-1)" "unprognostic (2.68e-1)" "unprognostic (7.48e-2)" "unprognostic (4.67e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.1 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 18.1 0.3 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 5.1 0.5 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.7 5.4 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 44.9 0.0 0.1 0.0 0.2 0.7 PLA2G4D cPLA2delta ENSG00000159337 "Phospholipase A2 group IVD" Q86XP0 15 42067009-42094562 "Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "prostate: 19.1;skin 1: 16.1;vagina: 22.5" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 2.1;Glandular and luminal cells: 1.1;Ionocytes: 2.0;Prostatic glandular cells: 3.0;Rod photoreceptor cells: 1.0;Suprabasal keratinocytes: 3.4" "Group enriched" "Detected in some" 4 "cervical cancer: 1.1;head and neck cancer: 2.0;melanoma: 1.8;prostate cancer: 1.3;urothelial cancer: 0.6" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 13 "RPMI-8226: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA074206 Approved "Plasma membrane,Cytosol" NA NA "Cluster 31: Skin - Epidermis development" "Cluster 25: RPMI-8226 - Immune response" "Cluster 35: Glandular cells - Unknown function" Cytosol "Plasma membrane" "HPA074206: " "unprognostic (1.16e-1)" "unprognostic (1.10e-2)" "unprognostic (2.91e-2)" "unprognostic (9.16e-3)" "unprognostic (9.33e-3)" "unprognostic (4.35e-2)" "unprognostic (5.39e-2)" "unprognostic (2.37e-1)" "unprognostic (1.84e-1)" "unprognostic (1.28e-2)" "unprognostic (2.75e-1)" "unprognostic (2.64e-7)" "unprognostic (2.54e-2)" "unprognostic (2.34e-1)" "unprognostic (3.47e-2)" "unprognostic (4.32e-2)" 0.0 0.2 0.1 0.0 0.1 0.0 0.3 0.0 0.3 5.2 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.2 19.1 0.0 0.2 0.8 0.0 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.4 22.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 15.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.3 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.0 0.1 0.1 0.0 1.0 0.0 0.0 0.1 0.0 0.4 0.0 3.4 0.0 0.0 0.0 0.1 0.4 PLA2G4F PLA2G4F/Z ENSG00000168907 "Phospholipase A2 group IVF" Q68DD2 15 42139034-42156636 "Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skin 1: 78.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 74.5;Distal enterocytes: 21.7;Gastric mucus-secreting cells: 18.3;Glandular and luminal cells: 17.1;Suprabasal keratinocytes: 13.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "OE19: 11.1;RT4: 8.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA042713, HPA056752" Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 31: Skin - Epidermis development" "Cluster 21: OE19 - Mitochondria" "Cluster 11: Alveolar cells - Smell perception" Vesicles Nucleoplasm "HPA042713: AB_10793982, HPA056752: AB_2683226" "unprognostic (1.99e-1)" "unprognostic (6.21e-3)" "unprognostic (1.59e-1)" "prognostic unfavorable (2.00e-4)" "unprognostic (1.06e-2)" "unprognostic (2.32e-3)" "unprognostic (1.48e-2)" "unprognostic (5.85e-2)" "unprognostic (2.25e-1)" "unprognostic (4.79e-2)" "unprognostic (6.65e-2)" "unprognostic (1.21e-2)" "unprognostic (9.32e-2)" "unprognostic (1.11e-1)" "unprognostic (4.55e-2)" "unprognostic (1.63e-1)" 0.0 0.0 0.1 0.4 0.3 0.3 2.4 0.1 0.1 5.7 0.0 6.4 6.7 0.0 1.6 5.7 0.1 0.1 0.3 0.1 0.0 7.8 0.2 12.2 0.1 0.0 0.0 0.0 0.1 2.9 1.7 0.1 0.0 4.3 3.8 0.2 2.6 0.4 2.9 78.1 4.2 0.1 0.0 0.1 2.4 0.1 0.0 4.4 1.9 0.5 0.3 1.2 11.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.0 11.1 0.1 0.0 0.0 0.0 0.0 8.3 0.4 0.0 0.0 0.8 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 74.5 0.0 0.0 5.5 2.7 1.3 0.6 0.0 1.2 0.3 2.9 0.0 0.5 5.5 0.0 1.7 0.0 21.7 3.9 0.4 0.0 7.3 1.0 0.1 0.0 0.0 0.0 1.3 0.7 0.1 18.3 17.1 2.5 0.0 0.0 0.0 0.1 0.0 0.0 7.7 4.1 0.0 0.3 0.0 0.0 0.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 6.3 0.0 0.3 3.1 10.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 5.6 13.8 1.2 0.6 0.0 6.7 2.0 VPS39 "KIAA0770, VAM6" ENSG00000166887 "VPS39 subunit of HOPS complex" Q96JC1 15 42158701-42208307 "Plasma proteins, Predicted intracellular proteins" "Autophagy, Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 57.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 43: Cardiomyocytes - Nuclear processes" "unprognostic (4.39e-1)" "unprognostic (2.52e-1)" "unprognostic (1.28e-2)" "prognostic favorable (3.21e-7)" "unprognostic (9.85e-2)" "unprognostic (2.14e-2)" "unprognostic (3.40e-3)" "unprognostic (2.59e-2)" "unprognostic (2.71e-1)" "unprognostic (2.81e-2)" "unprognostic (1.01e-2)" "unprognostic (6.59e-2)" "unprognostic (1.85e-3)" "unprognostic (1.53e-1)" "unprognostic (4.51e-1)" "unprognostic (3.28e-2)" "unprognostic (5.04e-2)" 24.2 24.9 16.0 18.5 17.0 23.8 19.0 13.7 19.8 23.5 12.4 22.1 18.5 23.8 24.7 20.4 25.3 20.6 28.3 17.8 17.5 22.3 13.0 24.5 23.0 15.8 16.7 21.1 26.5 43.7 19.8 22.0 16.6 24.1 19.8 21.3 22.0 26.1 36.5 29.4 21.4 27.3 15.9 22.9 20.9 20.9 19.0 31.6 26.6 34.7 26.2 20.4 17.5 15.6 15.6 21.6 30.7 35.0 55.2 52.9 19.5 27.3 49.1 32.5 34.1 18.5 13.2 13.9 27.0 50.1 34.0 36.0 24.1 27.4 29.8 43.6 13.7 33.7 34.6 17.4 38.1 30.8 25.0 46.6 38.8 30.5 31.4 38.0 34.3 38.2 25.2 37.4 36.4 13.9 23.7 17.2 19.1 34.9 18.4 17.9 28.6 22.0 23.7 36.0 27.2 39.7 22.5 21.5 14.4 31.5 34.5 39.7 37.6 28.0 11.8 33.9 20.3 31.7 45.3 20.2 34.2 27.6 23.2 38.5 14.7 18.2 14.9 16.4 15.1 15.2 13.3 16.1 15.6 11.9 13.4 12.7 16.6 20.8 15.6 6.7 13.1 18.5 16.0 17.0 13.7 19.8 17.8 17.5 15.8 16.7 16.6 15.9 19.0 15.6 14.4 22.4 43.2 27.1 15.7 3.6 3.3 5.6 10.8 11.7 14.0 13.2 57.0 15.7 11.4 9.2 14.6 10.3 12.6 17.5 1.9 7.3 11.4 16.0 16.8 14.4 9.6 16.6 31.2 8.0 7.8 13.7 24.5 15.7 9.5 15.3 9.7 11.8 12.2 11.8 32.2 11.9 10.2 16.9 4.4 21.6 12.2 14.7 3.6 30.9 16.0 13.5 8.2 29.1 34.4 10.2 11.4 13.9 28.7 5.8 14.7 6.2 13.3 11.6 0.0 8.9 10.7 5.2 4.5 12.6 7.0 13.4 13.7 10.5 10.0 4.5 TMEM87A DKFZP564G2022 ENSG00000103978 "Transmembrane protein 87A" Q8NBN3 15 42210447-42273584 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Alveolar cells type 2: 264.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018104, HPA018189" Enhanced Supported "Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 11: Alveolar cells - Smell perception" "Golgi apparatus" "HPA018104: AB_1858135, HPA018189: AB_2205198" "unprognostic (7.07e-2)" "unprognostic (1.62e-2)" "unprognostic (2.19e-1)" "unprognostic (4.05e-2)" "unprognostic (2.49e-1)" "unprognostic (6.39e-3)" "unprognostic (1.19e-2)" "unprognostic (2.44e-1)" "unprognostic (2.95e-1)" "unprognostic (8.13e-3)" "unprognostic (4.31e-3)" "unprognostic (1.38e-1)" "unprognostic (3.41e-2)" "unprognostic (7.90e-2)" "unprognostic (2.19e-1)" "unprognostic (5.49e-3)" "unprognostic (3.63e-1)" 31.8 26.3 23.7 26.1 37.7 88.2 97.7 32.0 29.5 40.2 17.7 56.5 26.6 38.6 49.3 48.2 45.3 32.4 19.7 23.5 26.3 27.1 24.5 72.8 25.4 36.7 29.4 35.4 34.9 47.9 14.2 42.7 38.7 79.8 60.9 26.1 64.7 36.6 24.9 50.2 26.9 38.0 32.5 23.1 38.6 33.0 28.8 24.8 75.9 22.2 30.9 42.0 34.3 59.1 41.0 20.5 30.5 27.0 58.5 50.3 47.7 55.1 82.0 53.5 52.0 29.8 87.5 17.4 52.9 59.9 60.5 104.0 28.3 51.2 42.8 46.8 25.0 35.6 51.5 33.5 63.4 65.6 48.3 52.3 112.1 39.5 65.3 50.6 41.9 30.1 39.4 67.4 51.7 26.3 21.3 38.8 25.7 60.8 29.3 33.5 46.6 36.8 34.5 127.4 33.7 41.2 53.1 70.1 49.9 24.0 27.4 62.4 41.3 104.4 25.5 68.1 82.6 46.8 95.0 36.5 40.1 47.9 66.8 58.3 26.9 31.2 29.0 32.3 33.3 27.6 35.6 34.0 24.4 24.4 33.6 33.5 15.2 42.4 34.7 22.4 42.2 26.0 23.7 37.7 32.0 29.5 23.5 26.3 36.7 29.4 38.7 32.5 28.8 59.1 66.2 125.0 264.0 46.0 48.9 68.6 90.2 78.8 58.1 31.2 148.7 105.9 13.9 45.8 98.0 49.7 50.1 78.1 57.5 77.7 1.9 63.7 5.6 57.0 67.0 54.6 32.2 34.5 41.7 64.2 72.7 64.0 50.0 124.7 59.5 42.9 51.0 34.4 41.6 20.2 48.2 74.1 67.1 39.2 37.0 7.9 41.0 41.3 62.2 45.0 60.1 61.8 52.5 74.4 177.5 56.1 62.4 53.8 47.6 118.5 36.6 15.5 86.4 63.0 85.5 77.0 59.0 59.4 61.4 79.1 65.5 110.4 54.8 53.3 76.9 105.6 GANC ENSG00000214013 "Glucosidase alpha, neutral C" Q8TET4 15 42273233-42356935 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Glycosidase, Hydrolase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Alveolar cells type 2: 47.9;Oligodendrocytes: 86.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016949, HPA051522" Approved Approved Cytosol NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 68: Epididymis - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol "HPA016949: AB_1849465, HPA051522: " "unprognostic (8.83e-2)" "unprognostic (1.68e-1)" "unprognostic (2.24e-1)" "unprognostic (3.04e-3)" "unprognostic (2.51e-2)" "unprognostic (9.85e-2)" "unprognostic (2.49e-2)" "prognostic favorable (9.76e-4)" "unprognostic (1.73e-1)" "unprognostic (1.43e-1)" "unprognostic (1.66e-2)" "unprognostic (1.46e-1)" "unprognostic (1.14e-1)" "unprognostic (1.05e-2)" "unprognostic (3.14e-1)" "unprognostic (1.55e-2)" "unprognostic (3.74e-2)" 8.9 7.6 8.2 10.3 13.0 14.3 8.8 9.8 10.4 9.6 10.4 10.6 8.9 11.0 17.8 12.1 8.6 9.4 8.5 7.8 9.2 9.4 13.3 20.4 10.0 12.4 11.1 13.0 8.4 11.3 7.9 8.0 13.2 8.5 12.4 9.7 14.5 8.7 12.9 10.1 9.8 9.8 10.0 11.9 8.5 12.3 10.8 10.3 12.1 10.6 10.2 8.3 9.3 19.2 9.0 4.9 10.7 11.6 12.3 17.2 7.1 19.2 19.7 19.7 16.4 6.4 6.2 4.9 10.2 18.6 14.3 18.3 12.6 19.5 13.6 12.3 6.0 11.9 12.1 12.8 10.4 11.6 10.1 11.8 11.4 8.1 13.6 11.7 13.5 12.0 12.6 13.0 15.8 1.7 7.9 12.7 6.7 4.3 5.5 14.7 12.4 17.0 14.7 8.4 8.2 11.7 10.8 9.4 7.0 5.6 3.3 27.0 13.6 21.6 5.7 17.8 12.1 13.9 20.7 9.7 10.4 20.9 12.1 16.8 11.8 10.2 4.5 13.1 6.2 19.6 7.2 8.6 15.5 23.1 8.9 5.4 6.7 5.7 10.9 12.3 7.3 6.5 8.2 13.0 9.8 10.4 7.8 9.2 12.4 11.1 13.2 10.0 10.8 19.2 6.2 19.2 47.9 35.6 14.5 10.5 17.1 7.9 12.0 5.6 5.6 6.2 8.2 4.3 8.9 1.8 10.4 5.3 4.0 9.5 5.9 5.9 18.6 7.7 11.1 5.0 4.2 5.0 18.9 3.8 5.1 8.1 9.7 11.9 10.8 8.1 5.7 12.4 6.5 3.3 28.5 5.7 10.2 11.7 5.4 4.7 7.2 10.9 14.2 36.5 14.0 9.5 7.2 31.7 86.7 5.4 15.7 6.4 7.1 9.1 7.9 7.7 9.8 8.5 13.1 9.2 7.0 20.5 15.7 18.9 5.3 2.9 6.9 6.4 8.5 20.7 CAPN3 "CANP3, LGMD2, LGMD2A, nCL-1, p94" ENSG00000092529 "Calpain 3" P20807 15 42359498-42412949 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Disease variant, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 279.2;skeletal muscle: 905.9;tongue: 377.4" "Group enriched" "Detected in many" 5 "Early spermatids: 512.5;Late spermatids: 183.6;Melanocytes: 482.0;Oligodendrocytes: 220.2" "Cancer enriched" "Detected in some" 10 "melanoma: 9.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in many" 27 "SK-MEL-30: 238.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040052 Enhanced NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 80: Striated muscle - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA040052: AB_2676821" "unprognostic (1.06e-2)" "unprognostic (1.31e-1)" "unprognostic (4.00e-2)" "unprognostic (8.71e-2)" "unprognostic (1.53e-1)" "unprognostic (1.72e-2)" "unprognostic (2.11e-4)" "unprognostic (3.12e-3)" "unprognostic (2.82e-1)" "unprognostic (2.47e-1)" "unprognostic (2.37e-3)" "unprognostic (3.26e-2)" "unprognostic (3.91e-4)" "unprognostic (5.56e-3)" "unprognostic (2.43e-1)" "unprognostic (8.93e-3)" "unprognostic (1.38e-1)" 13.5 8.8 136.1 4.0 206.6 47.6 14.1 194.2 243.3 18.8 113.0 13.3 3.1 11.2 163.7 14.5 13.7 4.5 16.1 142.9 159.9 93.6 36.9 21.5 7.0 212.0 194.9 15.7 8.7 2.4 11.3 3.0 212.1 16.0 5.3 7.5 18.6 5.2 905.9 54.9 14.0 4.7 155.2 19.1 8.9 30.8 187.8 3.4 10.7 377.4 5.1 11.7 15.5 279.2 0.5 0.3 0.6 1.1 8.8 6.1 0.6 2.6 1.9 0.5 0.8 1.2 0.5 0.2 0.9 1.6 0.4 3.7 0.4 3.5 0.3 0.9 0.8 0.8 0.8 4.1 0.6 1.0 1.5 4.7 3.7 0.8 0.7 1.5 0.1 0.7 0.2 1.8 0.7 0.1 0.2 1.2 0.4 0.2 0.9 1.1 0.4 1.9 1.9 1.3 0.4 0.1 0.2 0.5 238.0 1.0 0.0 5.4 0.9 0.3 0.4 2.6 0.7 1.5 2.1 0.2 0.4 2.4 1.8 0.5 1.0 0.1 0.7 0.2 0.8 0.3 0.1 0.3 0.5 0.5 0.1 0.9 0.9 0.6 0.1 0.5 0.4 0.6 136.1 206.6 194.2 243.3 142.9 159.9 212.0 194.9 212.1 155.2 187.8 279.2 0.5 12.8 34.5 16.0 2.9 20.1 0.8 2.2 3.4 2.2 0.4 0.3 0.4 1.5 4.4 1.8 2.1 0.7 1.4 2.0 1.9 0.1 512.5 0.5 0.6 2.2 0.0 0.0 4.0 0.0 0.6 1.6 3.6 0.7 1.3 0.4 2.2 8.7 32.7 0.0 5.2 1.8 2.0 4.4 11.6 183.6 5.3 2.9 482.0 13.1 2.5 3.7 2.1 4.5 220.2 0.0 5.4 3.4 0.6 0.9 2.4 59.5 2.6 3.9 0.0 13.8 1.6 15.9 4.7 1.6 8.5 3.3 1.8 1.2 2.3 0.8 ZNF106 "SH3BP3, ZFP106, ZNF474" ENSG00000103994 "Zinc finger protein 106" Q9H2Y7 15 42412823-42491141 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 392.5;tongue: 465.5" "Cell type enriched" "Detected in all" 9 "Cardiomyocytes: 1836.4" "Cancer enhanced" "Detected in all" "melanoma: 29.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 161.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054267 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoli "Nucleoplasm, Cytosol" "HPA054267: AB_2682431" "unprognostic (2.15e-2)" "unprognostic (3.31e-1)" "unprognostic (7.10e-2)" "unprognostic (2.61e-2)" "unprognostic (4.01e-2)" "unprognostic (1.34e-1)" "unprognostic (9.32e-2)" "unprognostic (2.49e-1)" "unprognostic (3.96e-1)" "unprognostic (1.33e-2)" "unprognostic (2.27e-1)" "unprognostic (2.07e-1)" "unprognostic (1.76e-3)" "unprognostic (8.71e-2)" "unprognostic (1.78e-1)" "unprognostic (4.36e-1)" "unprognostic (4.09e-3)" 32.4 11.2 20.8 14.3 29.8 24.4 17.9 19.0 28.1 18.0 109.2 19.7 10.0 15.9 17.3 18.5 12.7 17.2 175.6 23.3 22.6 16.5 8.7 20.9 17.5 23.6 29.1 15.9 10.3 17.8 10.3 12.9 22.5 20.9 13.9 22.0 12.9 14.7 392.5 11.7 13.3 23.0 20.8 17.1 12.8 14.3 27.4 15.6 13.2 465.5 18.6 14.6 9.1 27.7 27.2 15.1 29.0 33.5 86.8 68.5 16.1 21.7 22.2 19.6 20.5 33.9 7.8 17.8 19.0 27.7 22.8 31.8 28.3 23.4 29.5 29.0 13.1 34.7 37.9 13.6 23.2 43.1 20.2 55.4 17.8 28.0 32.6 19.5 32.3 23.2 43.0 2.7 36.9 11.9 16.2 13.3 11.0 26.1 15.1 15.2 54.3 10.8 12.1 31.5 16.5 10.2 45.0 22.8 28.7 23.4 20.0 30.0 42.2 20.8 32.5 26.1 32.3 14.8 32.2 76.5 18.4 33.6 37.6 86.8 63.8 27.1 15.6 52.3 13.5 21.8 13.0 13.3 35.6 26.8 11.3 10.6 161.0 12.5 66.8 36.0 13.0 18.0 20.8 29.8 19.0 28.1 23.3 22.6 23.6 29.1 22.5 20.8 27.4 27.7 58.0 134.6 107.7 46.0 49.6 38.5 57.9 41.9 44.3 58.5 50.9 46.0 1836.4 62.9 57.0 29.5 95.9 37.9 67.2 31.7 41.1 43.2 197.2 75.2 67.1 69.9 40.2 50.5 73.3 42.4 39.3 141.7 31.1 37.5 44.9 49.5 62.8 40.1 53.5 35.3 62.9 32.6 32.6 132.7 43.4 105.2 37.6 89.8 65.8 47.8 124.3 53.6 66.9 31.2 34.2 65.7 26.9 92.6 50.7 74.8 39.7 41.5 161.1 79.9 46.0 151.2 70.0 62.3 38.1 49.8 29.8 30.6 46.0 85.9 36.6 68.2 SNAP23 "HsT17016, SNAP23A, SNAP23B" ENSG00000092531 "Synaptosome associated protein 23" O00161 15 42491233-42545356 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 326.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 675.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001214, CAB037083, CAB037317" Approved Supported "Plasma membrane" NA NA 3900000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 16: Immune cells - Immune response" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 51: Myeloid cells - Hemostasis" "Plasma membrane" "CAB037083: AB_477494, CAB037317: AB_261925, HPA001214: AB_1080037" "unprognostic (1.77e-1)" "unprognostic (1.37e-1)" "unprognostic (1.18e-1)" "unprognostic (3.76e-3)" "unprognostic (2.42e-2)" "unprognostic (1.65e-1)" "unprognostic (9.67e-3)" "unprognostic (1.60e-1)" "unprognostic (2.60e-1)" "unprognostic (2.93e-1)" "unprognostic (7.31e-2)" "unprognostic (1.36e-1)" "unprognostic (2.04e-2)" "unprognostic (1.59e-1)" "unprognostic (8.95e-2)" "unprognostic (1.10e-1)" "unprognostic (3.93e-2)" 44.4 30.3 23.0 62.9 27.7 35.1 38.2 25.7 46.3 37.5 28.6 52.8 50.3 43.2 35.3 31.9 29.8 40.2 44.6 23.5 24.8 42.4 44.4 45.2 84.6 28.0 25.9 34.6 24.2 36.2 12.9 68.9 31.3 49.2 51.2 12.8 45.2 30.9 43.9 26.5 56.4 48.3 25.6 70.3 39.9 36.1 27.5 38.0 33.1 28.7 78.7 42.5 23.9 37.2 58.3 29.7 55.7 54.7 91.8 70.4 85.1 77.6 61.8 50.8 59.1 93.0 27.8 35.1 91.3 52.3 48.1 52.7 63.2 50.1 70.9 58.4 35.3 149.2 30.5 89.1 66.8 57.4 136.6 59.1 37.9 43.5 70.4 64.7 192.9 69.4 121.6 31.4 67.1 24.1 68.3 69.4 46.0 94.3 22.8 122.4 33.8 55.1 71.8 57.8 9.0 36.3 57.2 51.3 56.4 83.5 76.2 91.6 155.0 46.6 61.2 52.1 80.4 59.1 122.3 153.2 56.3 120.0 62.8 244.8 159.8 675.6 51.4 237.6 60.2 110.2 53.5 50.2 148.2 103.9 68.0 52.4 361.9 70.7 236.0 62.6 66.4 179.4 23.0 27.7 25.7 46.3 23.5 24.8 28.0 25.9 31.3 25.6 27.5 37.2 58.9 112.2 30.5 30.7 79.0 50.7 107.6 30.8 34.7 7.7 41.9 19.8 19.2 38.6 32.8 20.2 20.9 75.9 45.3 61.3 56.7 71.1 207.6 34.4 38.6 77.1 14.9 25.0 21.2 52.2 109.5 44.3 32.6 41.2 83.5 22.4 77.4 28.0 88.9 5.0 23.6 80.2 52.9 125.4 112.8 326.0 39.1 131.8 44.4 36.5 120.0 14.6 53.5 39.7 54.6 110.8 52.8 60.5 27.9 79.9 55.0 76.2 42.6 18.4 52.6 42.1 40.6 16.7 7.9 29.3 38.5 142.6 48.2 47.8 39.7 64.7 LRRC57 FLJ36812 ENSG00000180979 "Leucine rich repeat containing 57" Q8N9N7 15 42537820-42548802 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 60.5;Rod photoreceptor cells: 87.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA040894 Approved Approved Mitochondria,Cytosol NA NA 26000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 46: Photoreceptor cells - Phototransduction" "Mitochondria, Cytosol" "HPA040894: AB_10794996" "unprognostic (8.99e-2)" "unprognostic (1.80e-1)" "unprognostic (1.42e-2)" "unprognostic (1.68e-1)" "unprognostic (1.84e-2)" "unprognostic (4.77e-2)" "unprognostic (4.16e-2)" "unprognostic (4.78e-2)" "unprognostic (2.57e-1)" "unprognostic (1.32e-1)" "unprognostic (3.31e-2)" "unprognostic (3.73e-2)" "prognostic favorable (2.15e-4)" "unprognostic (7.45e-2)" "unprognostic (7.23e-2)" "unprognostic (2.35e-1)" "unprognostic (1.05e-2)" 7.7 7.3 4.8 5.5 4.6 22.0 7.5 4.8 8.5 7.3 3.3 9.3 6.5 7.7 5.5 9.6 8.3 5.3 6.9 6.1 3.1 8.0 6.1 8.6 6.6 3.6 3.4 8.6 7.3 14.0 6.0 7.9 4.1 6.6 10.7 14.9 8.0 5.8 6.0 9.6 8.1 7.3 3.2 6.7 7.8 5.7 3.7 9.6 7.0 6.9 7.4 6.8 8.6 5.4 14.7 11.0 19.5 13.8 16.5 12.7 9.7 20.5 11.2 14.7 15.4 23.3 11.0 6.8 13.8 16.9 16.5 22.7 13.2 16.7 14.7 12.8 12.2 27.7 23.6 10.7 14.7 17.8 15.0 14.0 22.8 13.2 17.1 10.1 23.7 17.3 21.9 14.5 13.6 6.6 9.8 7.5 4.6 26.6 8.5 15.1 19.6 10.5 9.8 24.4 9.8 11.9 24.8 16.3 11.8 12.7 16.1 19.6 24.3 16.5 11.4 17.5 15.5 11.9 36.4 29.0 8.9 16.4 21.0 36.9 9.7 32.0 7.4 14.6 9.3 5.8 7.2 7.2 10.2 7.1 5.8 7.3 12.2 16.9 19.3 5.9 8.5 6.9 4.8 4.6 4.8 8.5 6.1 3.1 3.6 3.4 4.1 3.2 3.7 5.4 16.3 9.6 10.8 6.8 10.4 5.7 13.6 6.5 6.8 13.6 9.6 8.1 11.1 15.7 7.3 9.2 60.5 11.6 18.8 16.4 13.7 10.9 18.7 13.5 13.8 17.3 12.5 15.8 17.1 9.8 19.3 12.7 9.2 13.2 14.5 10.2 19.2 7.5 14.1 20.2 8.8 13.1 6.1 14.2 4.8 20.0 9.6 13.1 7.2 7.5 21.9 21.1 20.6 11.6 8.3 15.2 15.9 16.1 8.4 12.4 15.2 8.4 14.8 87.4 6.6 16.9 10.1 7.8 6.4 11.4 5.5 15.9 11.3 18.4 12.2 12.8 HAUS2 "C15orf25, CEP27, FLJ10460, HsT17025" ENSG00000137814 "HAUS augmin like complex subunit 2" Q9NVX0 15 42548828-42569994 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 36.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039965 Approved Approved Nucleoplasm,Centrosome,Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 16: U-266 - Nucleosome" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Cytosol" Centrosome "HPA039965: AB_10673025" "unprognostic (5.17e-2)" "unprognostic (1.59e-1)" "unprognostic (2.36e-1)" "unprognostic (6.69e-2)" "unprognostic (5.57e-2)" "unprognostic (3.55e-3)" "unprognostic (1.47e-3)" "unprognostic (1.62e-2)" "unprognostic (2.24e-1)" "unprognostic (2.17e-1)" "unprognostic (1.17e-3)" "unprognostic (1.33e-1)" "unprognostic (6.81e-3)" "unprognostic (4.54e-2)" "unprognostic (2.58e-1)" "unprognostic (3.22e-1)" "unprognostic (2.62e-3)" 7.9 5.7 5.5 5.8 5.8 36.5 7.5 5.8 9.5 4.7 4.2 5.8 4.8 6.0 5.5 6.4 4.7 4.6 5.8 6.2 5.8 5.3 5.4 7.0 8.1 6.1 5.6 5.4 6.6 4.5 4.2 6.4 6.2 4.2 5.9 5.4 5.0 3.8 7.2 6.2 5.4 6.7 5.8 5.4 4.9 5.0 5.8 8.9 5.1 5.8 7.9 7.0 4.7 7.6 23.6 12.0 21.5 13.7 10.9 12.3 20.3 22.9 13.9 21.8 17.1 24.5 11.8 13.8 11.1 13.4 18.6 34.6 23.7 15.2 21.5 19.4 13.3 20.0 19.7 19.0 15.6 34.2 14.5 10.6 11.1 16.2 17.7 9.2 22.0 19.2 36.2 17.5 21.3 14.1 21.4 28.5 16.8 31.9 15.3 27.9 26.4 15.0 12.6 16.4 17.8 14.8 23.2 20.6 13.2 15.6 18.7 22.4 17.1 28.7 21.4 39.0 43.8 18.7 61.1 40.0 18.5 38.0 21.6 4.0 4.3 3.9 4.4 5.3 4.5 6.0 4.4 3.7 3.9 5.1 3.3 4.5 1.9 2.9 7.5 4.5 5.2 2.8 5.5 5.8 5.8 9.5 6.2 5.8 6.1 5.6 6.2 5.8 5.8 7.6 17.5 12.8 14.4 5.5 19.4 13.6 20.9 10.9 18.2 7.8 8.6 8.0 4.2 14.3 11.6 3.7 16.7 14.5 17.7 7.1 3.9 14.2 35.2 10.9 12.3 14.6 17.3 31.1 11.6 16.5 27.6 12.9 12.2 10.4 24.6 9.0 7.9 9.7 21.7 16.8 9.3 10.6 8.2 18.5 23.6 7.3 11.1 19.0 1.8 9.4 19.6 9.7 10.3 11.6 10.4 18.8 11.2 11.3 20.1 20.2 8.7 13.3 15.8 16.3 19.7 16.5 12.4 34.0 9.6 23.2 15.3 13.4 21.1 14.0 10.8 17.1 STARD9 "KIAA1300, KIF16A" ENSG00000159433 "StAR related lipid transfer domain containing 9" Q9P2P6 15 42575606-42720998 "Metabolic proteins, Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 52.1;Early spermatids: 52.8;Excitatory neurons: 39.3;Oligodendrocytes: 80.9;Rod photoreceptor cells: 57.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" HPA014562 Uncertain NA NA "Cluster 21: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 9: Photoreceptor cells - Phototransduction" "HPA014562: AB_10603033" "unprognostic (2.69e-2)" "unprognostic (2.93e-1)" "unprognostic (1.14e-1)" "unprognostic (1.34e-1)" "unprognostic (6.74e-2)" "unprognostic (5.54e-5)" "unprognostic (7.45e-2)" "unprognostic (1.59e-1)" "unprognostic (1.01e-1)" "unprognostic (1.94e-2)" "unprognostic (1.91e-2)" "unprognostic (8.60e-3)" "unprognostic (1.45e-3)" "unprognostic (1.53e-2)" "unprognostic (3.92e-2)" "unprognostic (3.13e-1)" "unprognostic (1.83e-3)" 6.2 0.5 1.5 1.2 5.2 0.6 4.3 3.1 3.3 5.9 2.4 9.1 1.3 5.3 3.0 2.2 3.3 2.4 3.3 1.3 1.6 0.8 0.4 4.5 1.2 4.7 2.5 6.0 0.4 0.4 0.8 3.9 2.8 2.6 2.8 12.9 1.5 3.2 2.5 2.6 3.2 4.8 1.0 2.0 3.2 8.5 4.4 3.5 1.7 3.5 1.1 4.4 5.0 9.9 0.9 0.5 5.9 2.3 3.1 4.5 0.3 1.0 1.3 1.8 2.7 0.0 0.0 0.7 0.1 1.1 1.2 0.1 2.0 0.9 2.4 3.5 1.7 0.3 4.3 1.3 1.3 0.9 1.1 2.6 0.4 1.5 1.0 1.5 1.8 2.5 1.6 3.8 1.5 0.0 0.7 0.7 0.9 0.0 1.1 5.1 3.2 1.1 0.7 0.0 1.2 2.9 1.3 0.0 0.4 0.7 0.1 0.4 3.6 2.5 1.9 0.9 2.4 3.8 2.2 1.3 1.0 2.2 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 5.2 3.1 3.3 1.3 1.6 4.7 2.5 2.8 1.0 4.4 9.9 26.1 12.8 2.8 7.2 2.9 3.6 1.2 0.8 1.2 8.1 0.6 1.0 6.8 0.0 0.7 1.8 52.1 0.2 4.2 0.3 0.0 0.3 52.8 3.5 12.2 19.8 8.4 3.2 39.3 0.0 0.3 15.2 2.6 0.6 2.5 3.6 9.7 0.5 2.8 11.8 33.5 2.8 0.0 2.4 7.7 15.4 24.5 2.3 8.8 24.4 2.4 2.9 11.3 20.1 80.9 0.2 0.0 22.2 2.7 0.9 0.1 0.3 9.1 57.7 19.7 11.8 13.7 3.9 8.0 0.3 3.1 0.3 6.3 7.8 0.4 0.7 CDAN1 "CDA-I, CDAI" ENSG00000140326 "Codanin 1" Q8IWY9 15 42723544-42737128 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Congenital dyserythropoietic anemia, Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Sertoli cells: 19.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 1.0" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039404, HPA040787" Supported Enhanced "Plasma membrane,Cytosol" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Cytosol "Plasma membrane" "HPA039404: AB_10673530, HPA040787: AB_2677137" "unprognostic (1.11e-1)" "unprognostic (1.24e-1)" "unprognostic (5.79e-3)" "unprognostic (1.24e-1)" "unprognostic (2.10e-1)" "unprognostic (7.71e-2)" "prognostic unfavorable (1.07e-4)" "unprognostic (7.17e-2)" "unprognostic (9.82e-2)" "unprognostic (1.24e-1)" "unprognostic (2.95e-2)" "unprognostic (1.26e-1)" "unprognostic (4.35e-3)" "unprognostic (2.05e-1)" "unprognostic (1.16e-1)" "unprognostic (9.20e-3)" "unprognostic (2.04e-1)" 4.0 5.0 2.1 3.6 2.2 8.1 4.3 4.3 3.1 7.7 3.2 4.5 2.8 5.9 4.4 4.1 6.1 2.5 2.9 2.1 0.9 3.2 4.0 3.5 4.2 3.0 1.5 11.3 4.8 3.5 5.1 3.2 2.7 6.9 2.5 2.6 5.4 3.5 4.2 4.9 4.2 2.8 0.7 4.6 4.5 6.3 1.4 5.2 5.1 2.8 3.4 5.8 5.6 2.6 8.1 5.4 7.2 10.4 6.3 5.4 8.6 10.4 4.3 9.9 7.2 13.6 4.2 3.9 11.2 5.8 9.7 15.5 7.7 4.7 2.9 9.9 7.2 14.5 10.3 5.3 4.7 10.8 13.2 7.4 5.2 6.3 4.5 6.1 7.6 13.0 18.9 5.7 8.2 4.5 8.4 14.2 3.6 7.7 8.5 11.9 9.0 3.4 3.1 7.9 5.9 6.8 8.2 11.3 1.7 4.6 8.6 15.9 5.6 10.4 9.2 8.6 12.1 11.2 12.7 8.7 5.4 15.8 8.6 1.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 2.1 2.2 4.3 3.1 2.1 0.9 3.0 1.5 2.7 0.7 1.4 2.6 2.0 0.0 3.7 4.6 2.4 1.9 2.0 1.5 1.8 3.3 3.2 1.8 2.2 2.8 1.5 7.3 4.2 3.0 2.6 1.9 0.0 1.5 0.4 2.0 2.8 2.3 4.8 1.7 7.6 1.8 1.6 2.9 3.6 2.0 1.3 9.0 3.9 3.6 2.1 1.7 6.3 1.6 4.1 2.5 0.9 1.2 4.4 1.6 0.0 4.7 1.5 4.5 2.1 5.5 3.8 1.6 0.5 4.9 2.5 2.3 2.2 1.3 1.9 4.7 19.7 3.4 2.4 5.4 2.1 2.8 1.3 2.2 2.5 4.6 2.6 1.7 TTBK2 "KIAA0847, SCA11" ENSG00000128881 "Tau tubulin kinase 2" Q6IQ55 15 42738730-42920809 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Kinase, Serine/threonine-protein kinase, Transferase" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 33.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 153.8;Inhibitory neurons: 185.1;Late spermatids: 146.2;Oligodendrocytes: 125.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018113, HPA049866" Approved Uncertain "Intermediate filaments" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Intermediate filaments" "HPA018113: AB_1858421, HPA049866: AB_2680923" "unprognostic (2.15e-1)" "unprognostic (1.67e-1)" "unprognostic (1.08e-1)" "unprognostic (6.30e-2)" "unprognostic (7.73e-2)" "unprognostic (4.26e-1)" "unprognostic (6.64e-2)" "unprognostic (5.11e-2)" "unprognostic (1.32e-1)" "unprognostic (2.43e-2)" "unprognostic (2.78e-2)" "unprognostic (8.62e-2)" "unprognostic (3.46e-2)" "unprognostic (7.29e-2)" "unprognostic (3.63e-2)" "unprognostic (2.18e-1)" "unprognostic (1.38e-1)" 5.3 4.2 7.7 3.0 9.9 5.2 4.4 11.3 20.0 6.0 2.1 6.7 1.6 5.3 3.9 2.6 5.5 3.7 7.2 6.9 13.9 3.4 3.1 4.8 3.4 17.4 9.1 6.4 2.5 4.6 5.6 4.0 18.9 4.7 3.0 17.7 3.2 3.8 10.4 3.1 3.9 5.0 6.3 4.3 3.4 33.4 16.9 5.2 3.8 6.3 3.1 5.3 4.7 13.8 5.7 3.8 8.4 4.2 6.5 6.6 1.8 4.6 7.4 4.5 6.9 4.3 1.3 3.3 6.1 4.7 9.2 3.9 8.1 6.7 6.8 13.0 3.6 4.8 6.9 1.6 5.0 6.7 7.8 4.7 6.5 3.9 21.1 9.9 5.2 5.1 7.0 4.9 4.5 0.9 4.1 4.3 2.3 1.7 3.8 7.2 9.1 1.7 5.8 4.0 6.6 6.5 12.6 0.9 2.5 5.8 2.6 8.7 5.8 5.1 4.7 5.7 6.0 7.1 11.3 5.5 3.9 5.8 3.0 0.1 0.5 0.2 0.2 0.3 0.5 0.3 0.2 0.2 0.1 0.3 0.3 0.2 0.2 0.4 0.2 0.2 0.1 0.1 7.7 9.9 11.3 20.0 6.9 13.9 17.4 9.1 18.9 6.3 16.9 13.8 16.2 6.4 11.8 75.7 11.5 10.7 12.1 11.8 26.2 36.3 9.6 7.6 17.6 12.8 10.0 9.2 37.5 4.1 9.1 3.9 0.0 5.7 80.5 24.9 11.7 17.0 14.3 17.4 153.8 4.3 3.2 15.5 4.6 4.6 19.0 16.2 17.5 9.8 7.4 45.4 185.1 5.1 2.0 16.0 25.9 146.2 16.8 16.4 12.4 69.3 16.9 16.5 6.2 97.5 125.6 7.5 2.6 20.3 6.6 12.4 5.5 5.5 40.5 39.4 13.1 24.6 16.3 34.5 10.1 12.5 9.2 3.1 13.4 11.3 5.3 7.4 UBR1 ENSG00000159459 "Ubiquitin protein ligase E3 component n-recognin 1" Q8IWV7 15 42942897-43106113 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 48.6" "Cell type enhanced" "Detected in many" "Excitatory neurons: 108.9;Inhibitory neurons: 108.8;Oligodendrocyte precursor cells: 102.1;Oligodendrocytes: 127.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038838, HPA038839" Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Vesicles "Nucleoplasm, Cytosol" "HPA038838: AB_10673120, HPA038839: " "unprognostic (1.07e-2)" "unprognostic (5.02e-2)" "unprognostic (9.77e-2)" "unprognostic (1.55e-2)" "unprognostic (1.89e-2)" "unprognostic (1.29e-1)" "unprognostic (2.67e-1)" "unprognostic (1.49e-1)" "unprognostic (4.79e-1)" "unprognostic (2.97e-2)" "unprognostic (1.93e-2)" "unprognostic (1.79e-1)" "unprognostic (1.27e-3)" "unprognostic (5.78e-2)" "unprognostic (1.52e-1)" "unprognostic (2.00e-1)" "unprognostic (1.89e-1)" 9.1 7.9 12.5 8.8 29.4 24.9 9.3 11.7 17.4 9.9 4.8 8.6 7.8 10.7 7.4 5.8 8.0 8.6 13.7 11.6 31.5 9.2 7.1 8.6 10.9 24.2 18.3 7.7 9.5 14.3 6.6 10.5 21.6 10.0 8.0 14.3 6.3 10.5 12.0 5.6 7.8 9.6 8.5 9.5 7.2 10.1 21.2 13.3 12.6 14.0 8.7 9.1 5.8 48.6 7.4 10.2 11.6 9.6 17.1 14.7 10.7 17.6 19.4 15.9 19.2 13.3 5.5 8.6 10.1 18.4 18.9 12.4 17.1 15.5 18.1 18.0 8.4 33.1 20.4 6.3 12.3 23.0 14.4 15.3 8.4 18.8 14.8 14.6 17.0 16.7 19.6 12.3 18.7 4.5 12.7 6.8 6.5 18.9 10.6 16.4 15.7 6.4 14.9 16.6 12.0 10.3 22.7 12.0 7.7 13.1 10.9 12.2 24.3 17.9 11.1 16.7 18.0 14.6 26.4 23.6 12.2 14.6 16.6 3.7 1.5 2.5 2.4 1.8 2.9 1.9 2.6 2.9 1.4 2.3 2.6 3.2 2.9 3.2 1.7 2.2 1.9 0.9 12.5 29.4 11.7 17.4 11.6 31.5 24.2 18.3 21.6 8.5 21.2 48.6 46.4 48.1 30.7 73.1 28.9 10.6 11.6 9.3 17.1 27.5 15.4 10.8 28.0 12.8 19.1 9.2 27.1 14.7 35.8 12.8 0.0 10.8 16.8 13.4 27.4 24.5 14.4 23.8 108.9 14.4 7.7 25.6 20.9 18.2 28.5 22.8 17.2 9.9 8.1 32.0 108.8 10.9 14.2 16.4 10.6 16.9 16.1 17.1 8.8 73.1 15.6 13.5 23.7 102.1 127.6 10.3 8.2 20.7 33.2 7.7 12.3 9.2 15.7 38.8 13.1 34.7 36.5 27.0 17.8 8.6 7.2 36.9 31.4 16.5 10.6 9.8 TMEM62 FLJ23375 ENSG00000137842 "Transmembrane protein 62" Q0P6H9 15 43123279-43185144 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 61.0;U-266/84: 67.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044461, HPA062359" Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Cytoplasmic bodies" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 16: U-266 - Nucleosome" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Nucleoli fibrillar center, Nuclear bodies, Cytoplasmic bodies" "HPA044461: AB_2678950, HPA062359: AB_2684747" "unprognostic (7.43e-2)" "unprognostic (4.96e-2)" "unprognostic (4.56e-2)" "prognostic favorable (9.72e-7)" "unprognostic (2.53e-1)" "unprognostic (1.98e-1)" "unprognostic (2.39e-2)" "unprognostic (1.41e-2)" "unprognostic (4.83e-2)" "unprognostic (3.30e-1)" "unprognostic (3.90e-2)" "unprognostic (1.77e-1)" "unprognostic (8.61e-2)" "unprognostic (1.20e-1)" "unprognostic (6.48e-2)" "unprognostic (1.20e-1)" "unprognostic (6.67e-2)" 7.1 4.6 4.8 6.0 5.0 9.0 22.9 8.2 6.7 8.1 3.6 13.1 13.1 5.4 12.3 6.2 7.5 7.9 5.1 5.3 4.8 7.6 10.3 8.8 7.2 4.5 4.5 3.2 8.1 13.7 4.6 10.3 5.0 6.1 14.4 8.9 13.6 7.1 9.4 5.2 11.7 6.5 5.0 6.1 10.2 2.0 5.4 4.0 8.5 6.6 8.0 7.6 5.4 5.6 14.9 7.9 3.5 6.8 4.3 5.5 36.4 13.9 17.6 24.1 33.3 12.5 28.5 15.0 7.9 13.2 21.7 27.6 14.8 10.9 8.7 17.7 6.8 12.2 15.4 9.5 9.4 12.7 10.5 3.9 13.0 10.6 7.4 6.8 13.6 3.7 10.9 12.7 2.8 3.5 0.0 3.0 1.2 61.0 3.2 7.5 3.7 7.9 12.9 18.6 22.2 9.6 10.9 27.2 6.7 3.9 14.6 12.9 8.0 11.9 4.9 8.5 22.7 10.6 67.1 10.7 11.0 14.0 10.4 0.5 0.7 1.1 0.8 0.3 1.0 0.7 1.1 1.0 0.7 0.8 0.7 0.9 0.2 1.6 0.4 1.7 2.0 0.4 4.8 5.0 8.2 6.7 5.3 4.8 4.5 4.5 5.0 5.0 5.4 5.6 7.7 16.0 4.6 12.1 18.8 2.3 4.1 2.8 5.7 5.6 12.3 6.3 2.6 8.6 5.0 12.9 10.4 21.9 7.0 12.5 5.9 12.9 1.6 9.6 3.7 5.6 4.2 9.1 36.3 14.8 25.2 4.8 11.2 13.9 5.1 7.0 6.1 7.3 7.5 1.7 33.4 11.4 6.1 6.5 4.8 3.7 2.5 7.1 5.4 18.7 6.4 7.8 6.2 29.1 34.5 12.2 8.1 1.2 16.5 2.7 12.8 3.4 6.1 9.9 6.6 4.1 5.2 2.2 1.0 8.6 2.8 34.1 7.4 3.8 11.0 4.8 CCNDBP1 "DIP1, GCIP, HHM" ENSG00000166946 "Cyclin D1 binding protein 1" O95273 15 43185118-43197177 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "bone marrow: 20.0" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 362.7;Erythroid cells: 361.2;Syncytiotrophoblasts: 1055.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 8 "HEL: 13.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020664, HPA041065" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 36: HEL - Hemostasis" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Nucleoplasm "Nuclear bodies" "CAB020664: , HPA041065: AB_2677282" "unprognostic (4.48e-1)" "unprognostic (3.98e-2)" "unprognostic (5.00e-2)" "unprognostic (2.37e-2)" "unprognostic (1.18e-1)" "unprognostic (1.27e-2)" "unprognostic (2.95e-1)" "unprognostic (7.75e-2)" "unprognostic (2.13e-1)" "unprognostic (4.94e-3)" "unprognostic (1.36e-1)" "unprognostic (1.86e-1)" "prognostic favorable (2.06e-4)" "unprognostic (1.40e-2)" "unprognostic (1.87e-1)" "unprognostic (7.95e-2)" "unprognostic (1.68e-2)" 3.2 1.4 2.3 1.3 2.1 20.0 2.1 3.8 2.6 1.4 1.9 1.7 1.5 1.4 2.1 1.2 2.0 1.0 1.3 2.0 2.4 1.5 1.7 2.7 2.2 2.4 2.3 0.7 1.3 1.1 1.2 1.4 2.5 1.3 1.9 1.8 1.5 1.1 1.7 2.8 2.6 1.2 1.8 2.6 2.1 0.9 2.6 1.5 1.7 1.2 1.9 1.7 1.1 2.4 0.2 0.2 0.4 0.2 1.3 0.8 0.4 0.3 1.6 0.3 0.3 0.4 0.3 0.5 0.4 1.1 0.1 0.5 1.1 0.5 0.2 0.7 1.1 13.5 0.6 0.5 0.9 0.7 0.7 1.5 1.2 0.1 0.2 1.3 1.0 0.2 0.8 0.4 0.4 0.0 0.4 1.4 0.9 0.5 0.3 0.4 0.5 1.2 1.7 0.6 0.6 0.9 0.5 0.4 0.3 0.5 0.0 1.1 1.2 0.2 0.1 1.0 0.2 1.4 0.6 0.1 1.3 1.4 0.4 21.8 1.9 5.6 5.1 3.7 5.4 4.7 5.5 5.2 1.8 5.3 5.6 5.9 6.2 4.8 9.5 3.0 8.4 1.8 2.3 2.1 3.8 2.6 2.0 2.4 2.4 2.3 2.5 1.8 2.6 2.4 59.8 48.1 54.9 11.1 81.8 34.7 55.7 83.3 25.0 28.9 38.0 40.9 52.6 40.0 78.6 29.5 20.9 362.7 92.0 63.6 90.1 64.0 24.2 61.6 33.8 45.2 46.2 361.2 20.7 59.3 82.1 55.9 45.3 37.0 57.0 40.2 53.6 31.0 85.4 45.4 17.8 47.7 154.6 83.5 36.2 12.6 47.2 57.1 64.0 11.2 137.8 55.9 74.2 9.5 23.4 68.6 55.8 29.3 54.2 42.1 85.8 47.5 128.0 66.0 46.0 35.2 49.4 124.3 61.6 27.8 40.3 1055.9 85.9 37.8 42.2 88.5 EPB42 "MGC116735, MGC116737, PA" ENSG00000166947 "Erythrocyte membrane protein band 4.2" P16452 15 43197227-43221018 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell shape, Erythrocyte maturation" "Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 30 "bone marrow: 98.9" "Cell type enriched" "Detected in many" 33 "Erythroid cells: 480.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 91 "HEL: 85.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040261 Supported Uncertain Nucleoplasm,Cytosol NA NA 1400000 "Cluster 67: Neutrophils - Humoral immune response" "Cluster 36: HEL - Hemostasis" "Cluster 6: Erythroid cells - Oxygen transport" "Nucleoplasm, Cytosol" "HPA040261: AB_10673441" "unprognostic (8.45e-2)" "unprognostic (4.66e-1)" "unprognostic (4.15e-1)" "unprognostic (1.13e-1)" "unprognostic (2.28e-1)" "unprognostic (1.99e-1)" "unprognostic (1.54e-1)" "unprognostic (1.59e-3)" "unprognostic (2.95e-1)" "unprognostic (6.05e-2)" "unprognostic (5.27e-3)" "unprognostic (1.31e-1)" "unprognostic (1.48e-5)" "unprognostic (1.70e-2)" "unprognostic (1.20e-1)" "unprognostic (5.88e-2)" "unprognostic (3.47e-3)" 3.1 0.0 0.0 0.0 0.0 98.9 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.4 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 2.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 85.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 1.9 1.5 0.5 0.0 4.0 0.0 0.0 0.6 1.5 0.5 0.0 6.2 4.5 0.0 1.5 0.0 0.0 14.4 0.0 0.0 1.2 0.0 480.0 0.1 0.0 2.3 0.8 0.0 0.0 4.5 0.0 2.5 1.1 1.1 6.7 0.1 0.9 4.1 2.2 2.8 10.5 2.8 1.1 1.8 0.0 3.6 2.5 14.4 0.0 0.0 0.0 1.7 0.7 0.4 1.5 2.4 0.0 0.6 8.4 6.6 1.0 1.0 13.5 4.6 0.0 2.8 6.7 3.8 0.0 0.8 2.0 TGM5 "TGMX, TGX" ENSG00000104055 "Transglutaminase 5" O43548 15 43232590-43266928 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Acyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 12.0;skin 1: 39.3" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 2.6;Club cells: 4.3;Early spermatids: 3.2;Late spermatids: 4.0;Suprabasal keratinocytes: 6.7;Urothelial cells: 12.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 2.2" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HEL: 16.6" "Region enriched" "Detected in single" 12 "cerebellum: 2.6" "Low region specificity" "Detected in many" NA NA "Cluster 31: Skin - Epidermis development" "Cluster 36: HEL - Hemostasis" "Cluster 22: Epithelial cell types - Mixed function" "unprognostic (3.17e-2)" "unprognostic (1.03e-2)" "unprognostic (5.92e-2)" "unprognostic (2.65e-1)" "unprognostic (2.24e-2)" "unprognostic (1.94e-2)" "unprognostic (1.78e-1)" "unprognostic (7.68e-2)" "unprognostic (2.25e-2)" "unprognostic (1.77e-1)" "unprognostic (1.44e-15)" "unprognostic (1.94e-1)" "unprognostic (3.14e-1)" "unprognostic (7.22e-3)" "unprognostic (5.71e-2)" 0.8 0.0 0.0 0.0 0.0 0.2 1.7 0.2 0.0 3.9 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.2 1.0 0.0 0.0 4.3 1.2 0.3 39.3 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 2.3 0.5 7.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 16.6 0.0 0.3 0.0 0.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.4 0.2 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 2.6 1.5 0.0 0.0 1.0 0.5 0.2 0.0 4.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 3.2 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 4.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.2 0.8 6.7 1.9 0.0 0.0 0.0 12.1 TGM7 TGMZ ENSG00000159495 "Transglutaminase 7" Q96PF1 15 43276271-43302255 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "lymphoid tissue: 1.6" "Group enriched" "Detected in some" 11 "Early spermatids: 62.0;Late spermatids: 16.7" "Cancer enriched" "Detected in single" 13 "endometrial cancer: 2.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 35 "EFO-21: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 16: Immune cells - Immune response" "Cluster 38: EFO-21 - Unknown function" "Cluster 29: Early spermatids - Spermatogenesis" "unprognostic (2.45e-2)" "unprognostic (2.04e-1)" "unprognostic (2.82e-2)" "unprognostic (1.71e-2)" "unprognostic (1.07e-1)" "unprognostic (2.01e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.4 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 16.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 3.5 LCMT2 "KIAA0547, MGC9534, PPM2, TYW4" ENSG00000168806 "Leucine carboxyl methyltransferase 2" O60294 15 43323649-43330582 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 23.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039401 Approved Approved Cytosol NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Cytosol "HPA039401: AB_10805478" "unprognostic (4.32e-2)" "unprognostic (1.44e-1)" "unprognostic (1.55e-1)" "unprognostic (4.11e-2)" "unprognostic (1.99e-1)" "unprognostic (2.27e-1)" "unprognostic (9.08e-2)" "unprognostic (5.14e-2)" "unprognostic (3.52e-2)" "unprognostic (2.20e-1)" "unprognostic (3.33e-3)" "unprognostic (9.57e-2)" "prognostic favorable (5.69e-9)" "unprognostic (2.28e-1)" "unprognostic (3.21e-2)" "unprognostic (1.62e-2)" "unprognostic (1.57e-1)" 5.1 4.7 5.3 4.8 5.2 1.9 6.3 6.8 10.2 6.3 6.4 4.8 3.4 6.0 7.6 5.0 6.3 3.1 5.5 5.0 6.2 7.3 6.0 4.0 6.5 5.1 5.2 5.7 3.8 8.0 4.2 3.6 5.5 6.2 4.6 7.3 3.9 6.4 4.0 3.8 4.3 5.3 5.2 4.4 4.1 3.9 5.2 7.8 5.7 4.7 9.2 5.2 3.2 5.3 8.8 6.7 15.7 13.7 16.3 5.1 7.7 10.7 12.3 13.2 14.6 10.2 4.0 7.5 20.8 12.0 14.2 20.0 0.0 13.8 10.1 11.6 7.3 13.3 18.3 5.9 9.9 0.0 9.8 7.8 13.0 9.8 9.0 8.9 4.3 16.9 17.1 9.6 16.1 13.4 15.4 6.3 6.8 19.0 5.8 17.8 13.7 7.2 23.4 9.8 21.1 17.6 13.8 11.6 6.0 12.1 14.1 20.2 3.7 15.6 7.1 18.1 17.4 6.5 16.6 3.0 9.7 10.9 16.5 1.7 2.6 3.8 2.3 2.4 3.3 3.2 3.9 2.9 4.4 3.5 6.0 4.1 0.8 2.0 2.2 2.6 3.3 3.2 5.3 5.2 6.8 10.2 5.0 6.2 5.1 5.2 5.5 5.2 5.2 5.3 1.5 0.0 3.1 1.3 3.5 3.1 3.7 1.9 1.8 7.6 2.9 2.8 3.6 5.7 5.7 3.7 8.4 4.3 2.7 2.8 3.9 6.5 2.1 3.6 3.9 3.1 5.4 4.8 1.1 4.0 2.3 3.7 2.0 4.1 1.3 2.2 5.0 4.1 2.7 3.3 1.6 2.2 4.1 1.3 0.8 1.5 5.0 2.7 0.0 1.9 2.4 7.3 4.1 0.5 1.7 3.4 2.1 1.5 2.5 3.3 1.8 4.7 6.2 6.6 6.6 5.1 3.7 23.4 10.5 2.7 2.8 2.5 2.6 2.4 3.3 2.8 ADAL ENSG00000168803 "Adenosine deaminase like" Q6DHV7 15 43330672-43354569 "Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 81.3;Rod photoreceptor cells: 84.8;Spermatocytes: 99.5;Spermatogonia: 82.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039879, HPA048175, HPA058795" Approved Approved "Nucleoplasm,Nuclear speckles,Vesicles" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 16: U-266 - Nucleosome" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm "Nuclear speckles, Vesicles" "HPA039879: , HPA048175: AB_2680298, HPA058795: " "unprognostic (1.65e-2)" "unprognostic (1.53e-3)" "unprognostic (9.80e-2)" "unprognostic (3.15e-3)" "unprognostic (2.46e-3)" "unprognostic (1.86e-1)" "unprognostic (2.00e-1)" "unprognostic (5.83e-2)" "unprognostic (5.90e-2)" "unprognostic (2.68e-1)" "unprognostic (6.85e-3)" "unprognostic (1.69e-1)" "prognostic favorable (7.64e-9)" "unprognostic (2.37e-3)" "unprognostic (8.77e-2)" "unprognostic (5.31e-2)" "unprognostic (2.44e-2)" 6.2 6.6 6.7 4.2 7.1 4.4 5.9 7.6 9.6 3.6 10.2 5.7 5.8 4.3 8.4 4.1 3.3 3.8 20.9 6.3 7.4 11.9 8.2 3.5 4.8 6.7 7.2 3.6 3.6 10.4 6.1 2.7 7.0 6.2 4.8 21.2 4.2 6.4 20.4 2.6 4.6 4.7 6.9 3.8 4.0 11.1 7.1 5.4 10.9 23.4 4.8 4.6 3.0 7.4 6.8 3.4 13.3 15.1 5.5 7.1 6.3 8.1 8.2 12.6 19.3 14.2 3.5 8.0 13.0 8.9 16.7 7.5 0.0 5.7 10.8 8.5 8.0 19.0 23.1 12.0 6.9 0.0 14.8 9.1 10.3 8.5 8.7 8.1 2.7 19.4 21.1 16.2 13.2 4.6 12.3 9.7 5.5 7.8 4.6 15.9 19.9 12.7 11.0 4.1 16.3 11.6 13.1 11.7 12.4 7.2 12.5 12.5 3.7 21.9 10.6 16.6 16.5 16.6 29.9 3.4 12.2 21.2 18.1 5.9 1.4 3.8 2.4 2.0 1.8 2.0 2.2 1.9 2.0 1.6 2.3 2.9 1.1 2.3 1.9 2.9 4.5 1.3 6.7 7.1 7.6 9.6 6.3 7.4 6.7 7.2 7.0 6.9 7.1 7.4 5.9 9.6 10.3 32.7 10.0 7.0 7.4 9.3 7.4 40.7 9.2 9.9 51.2 10.0 6.9 18.4 81.3 7.1 13.3 7.0 58.7 8.9 17.6 10.6 10.3 8.2 7.7 19.1 24.4 8.5 7.0 10.4 5.1 6.8 7.6 15.7 11.0 30.8 8.9 42.1 26.7 7.2 10.2 8.8 7.0 12.7 9.6 8.9 8.8 10.3 5.4 35.5 24.7 19.1 18.3 5.7 1.3 8.6 6.9 7.1 13.0 29.0 10.9 84.8 6.6 11.6 7.3 99.5 82.5 8.8 4.4 2.6 7.0 12.6 11.6 4.4 ZSCAN29 "FLJ35867, Zfp690, ZNF690" ENSG00000140265 "Zinc finger and SCAN domain containing 29" Q8IWY8 15 43358172-43371025 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 81.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 3.1" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007241, HPA011109" Enhanced Approved "Nucleoplasm,Plasma membrane,Actin filaments" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 16: U-266 - Nucleosome" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm "Plasma membrane, Actin filaments" "HPA007241: AB_10600420, HPA011109: AB_10611525" "unprognostic (3.90e-2)" "unprognostic (2.70e-1)" "unprognostic (1.15e-1)" "unprognostic (4.06e-2)" "unprognostic (2.21e-2)" "unprognostic (2.02e-2)" "unprognostic (1.57e-1)" "unprognostic (5.25e-1)" "unprognostic (2.12e-2)" "unprognostic (4.77e-3)" "unprognostic (1.64e-1)" "unprognostic (1.44e-3)" "unprognostic (9.61e-2)" "unprognostic (1.30e-1)" "unprognostic (1.31e-1)" "unprognostic (8.33e-2)" "unprognostic (3.43e-2)" 6.3 5.6 7.9 8.6 10.1 5.6 6.8 8.1 7.4 7.2 8.1 7.6 8.8 8.9 5.2 7.2 6.4 6.0 5.5 6.6 7.4 5.7 6.9 6.9 10.7 9.3 9.7 7.4 11.4 7.7 5.5 8.1 8.9 6.8 7.6 13.6 8.5 6.5 9.7 5.8 9.9 6.4 7.7 9.0 8.8 17.3 8.5 10.7 7.2 8.5 10.4 6.6 6.0 10.3 11.7 12.5 28.9 17.9 10.0 10.5 15.6 9.0 13.9 15.6 16.2 19.7 8.1 11.4 14.7 11.1 12.6 33.7 21.5 11.0 13.9 29.6 11.8 25.1 20.5 15.5 11.1 17.3 21.2 9.3 19.0 10.6 14.9 11.0 8.0 17.3 23.7 13.5 12.7 7.4 16.7 14.2 14.5 17.1 9.6 25.7 16.1 14.0 9.1 13.9 20.6 22.2 13.9 22.5 10.4 14.5 15.8 26.6 9.1 18.3 14.4 14.0 16.4 25.8 38.4 21.6 10.7 16.9 14.1 0.4 0.3 3.1 0.4 0.4 0.3 0.8 0.4 0.3 0.4 0.5 0.2 0.6 0.7 1.0 0.3 0.3 0.8 0.3 7.9 10.1 8.1 7.4 6.6 7.4 9.3 9.7 8.9 7.7 8.5 10.3 3.5 6.4 7.9 6.8 5.8 3.6 2.6 3.7 4.6 10.8 4.8 4.8 7.8 4.3 7.8 7.3 27.1 5.1 7.1 11.0 0.0 5.4 81.7 5.0 8.2 4.9 6.1 1.3 6.4 7.1 4.4 5.8 9.7 7.8 0.0 6.5 3.9 7.2 5.8 13.5 5.2 8.1 4.1 10.6 3.7 20.7 6.8 4.8 5.4 9.4 6.7 5.5 10.3 10.1 10.2 8.7 5.0 6.0 3.3 3.9 7.7 2.6 5.2 18.0 0.0 4.9 3.8 12.0 6.7 4.4 3.1 3.8 4.2 2.8 7.0 2.4 TUBGCP4 "76P, FLJ14797" ENSG00000137822 "Tubulin gamma complex associated protein 4" Q9UGJ1 15 43369221-43409771 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Horizontal cells: 55.5;Rod photoreceptor cells: 57.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 13.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043212 Approved Supported Centrosome NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 54: Non-specific - Microtubule organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 62: Horizontal cells - Visual perception" Centrosome "HPA043212: AB_10796690" "unprognostic (1.34e-2)" "unprognostic (3.57e-2)" "unprognostic (4.27e-2)" "unprognostic (1.01e-1)" "unprognostic (2.90e-2)" "unprognostic (3.37e-1)" "unprognostic (1.18e-1)" "unprognostic (3.86e-2)" "unprognostic (1.91e-1)" "unprognostic (2.05e-1)" "unprognostic (2.09e-2)" "unprognostic (2.91e-2)" "unprognostic (5.65e-1)" "unprognostic (1.73e-1)" "unprognostic (7.49e-2)" "unprognostic (1.72e-1)" "unprognostic (2.28e-1)" 3.9 4.3 5.1 3.7 6.9 4.8 5.1 8.4 8.4 5.3 6.4 5.0 4.8 4.5 3.5 5.8 4.5 2.9 4.9 5.6 5.6 4.7 5.9 3.9 4.6 5.6 5.7 5.2 6.1 8.3 5.2 3.7 5.9 5.1 5.2 11.1 5.1 3.7 9.7 4.6 5.2 4.9 5.4 4.4 4.9 4.1 5.7 6.1 4.5 9.8 5.5 4.6 5.1 6.4 18.2 5.6 13.3 13.7 12.9 13.9 10.3 10.2 7.3 13.9 14.0 18.0 11.1 11.3 15.2 8.8 19.5 29.4 28.3 18.2 16.3 19.0 26.9 29.5 30.2 15.9 10.7 20.4 17.6 7.6 17.9 14.4 20.0 11.0 11.5 18.5 28.4 9.6 10.4 6.3 16.4 15.7 6.3 29.6 22.1 22.0 17.5 15.9 9.2 17.1 35.5 12.1 12.4 23.8 4.1 8.4 14.1 15.8 9.5 13.2 13.5 18.3 22.7 9.9 12.5 19.6 12.1 29.0 15.1 0.1 2.5 13.8 3.7 2.9 2.7 3.6 2.8 2.6 5.3 3.2 2.0 2.9 0.3 5.3 1.6 2.8 3.2 2.4 5.1 6.9 8.4 8.4 5.6 5.6 5.6 5.7 5.9 5.4 5.7 6.4 6.5 19.2 14.5 12.1 14.9 11.0 16.3 4.5 5.2 30.9 8.8 7.4 1.7 18.6 10.8 16.5 22.9 16.1 6.5 8.5 7.9 12.2 28.7 9.4 15.3 8.8 14.4 15.4 17.3 9.9 14.7 10.4 5.6 10.4 11.4 15.9 10.0 11.4 6.9 55.5 13.8 10.6 8.2 7.6 5.6 43.6 15.2 6.1 3.6 4.7 7.7 13.1 22.6 17.1 9.2 11.0 9.4 12.4 5.8 20.1 12.7 6.1 9.5 57.1 6.6 19.1 10.2 25.0 14.5 9.2 8.9 11.5 9.8 11.2 17.7 16.9 TP53BP1 "53BP1, p202, TDRD30" ENSG00000067369 "Tumor protein p53 binding protein 1" Q12888 15 43403061-43510728 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004083, HPA008788, HPA022133, CAB079980" Supported Supported "Nucleoplasm,Nuclear bodies,Mitotic chromosome,Vesicles" Yes No "Cluster 46: Basophils - DNA binding" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" "Nuclear bodies" "Nucleoplasm, Mitotic chromosome, Vesicles" "CAB004083: AB_10694558, CAB079980: , HPA008788: AB_1078070, HPA022133: AB_1844382" "unprognostic (2.12e-1)" "unprognostic (7.96e-2)" "unprognostic (1.11e-1)" "unprognostic (1.85e-2)" "unprognostic (4.42e-3)" "unprognostic (2.32e-1)" "unprognostic (2.03e-2)" "unprognostic (3.96e-1)" "unprognostic (2.17e-1)" "unprognostic (2.81e-2)" "unprognostic (3.34e-2)" "unprognostic (4.07e-1)" "unprognostic (8.06e-2)" "unprognostic (9.11e-2)" "unprognostic (1.52e-1)" "unprognostic (6.99e-2)" "unprognostic (3.38e-2)" 6.9 11.5 17.4 10.1 16.6 11.5 10.7 19.9 14.5 17.7 21.5 9.7 6.4 16.0 15.9 6.1 14.7 10.7 8.8 15.4 26.3 9.1 4.1 8.3 8.6 13.5 16.7 16.8 7.4 22.3 24.1 12.2 15.7 12.1 10.2 22.0 10.1 12.8 7.2 9.2 6.4 16.3 9.6 8.7 7.6 21.6 23.0 15.3 17.9 11.0 12.6 11.2 8.7 12.1 13.5 22.3 63.8 40.1 25.8 31.9 15.8 22.8 33.8 31.0 39.1 19.4 15.8 14.5 19.2 39.0 66.9 32.4 46.3 27.5 36.8 38.9 15.8 27.1 40.1 11.7 16.8 30.2 37.4 24.9 19.0 41.8 31.2 51.7 37.4 24.2 26.9 12.3 36.5 9.6 23.7 14.1 41.1 24.2 13.9 25.1 23.9 9.3 22.9 31.8 57.3 26.8 33.8 14.3 8.5 48.6 29.9 16.9 27.5 33.7 22.3 27.0 20.5 9.8 22.4 33.0 27.6 14.6 17.5 1.4 0.5 1.0 1.6 0.7 1.3 1.9 1.6 1.6 1.2 1.8 1.8 1.6 0.6 0.9 0.5 1.3 1.4 0.7 17.4 16.6 19.9 14.5 15.4 26.3 13.5 16.7 15.7 9.6 23.0 12.1 11.5 22.4 22.3 53.2 17.8 6.4 10.2 10.0 13.6 32.4 17.4 13.2 14.9 5.7 20.8 29.5 47.9 13.4 11.1 7.4 9.8 14.5 38.8 47.0 44.8 16.8 41.9 8.4 66.2 7.1 11.2 23.9 14.8 26.8 26.6 47.0 15.0 3.3 10.8 47.1 81.9 15.7 12.2 3.8 6.9 17.8 23.6 9.3 1.8 17.8 4.0 11.9 7.2 62.8 50.4 7.5 5.8 17.7 17.1 11.0 2.6 8.8 60.7 51.7 13.1 35.2 20.5 33.1 36.2 14.7 5.3 18.5 17.0 29.9 13.4 8.9 MAP1A MAP1L ENSG00000166963 "Microtubule associated protein 1A" P78559 15 43510958-43531620 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 14 "brain: 325.5" "Cell type enhanced" "Detected in many" "dendritic cells: 90.9;Horizontal cells: 299.5;Peritubular cells: 76.3" "Cancer enhanced" "Detected in many" "glioma: 18.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 61 "plasmacytoid DC: 10.5" "Lineage enriched" "Detected in single" 61 "dendritic cells: 10.5" "Cell line enhanced" "Detected in many" "ASC diff: 60.7;BJ hTERT+: 61.8;fHDF/TERT166: 94.0;hTEC/SVTERT24-B: 58.1;U-87 MG: 121.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039063, HPA039064, HPA066488" Enhanced Approved Cytosol No No 55000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 62: Horizontal cells - Visual perception" Cytosol "HPA039063: AB_2676327, HPA039064: AB_10673302, HPA066488: AB_2685676" "unprognostic (1.60e-1)" "unprognostic (1.31e-1)" "unprognostic (3.29e-2)" "unprognostic (1.86e-3)" "unprognostic (4.45e-2)" "unprognostic (3.58e-2)" "unprognostic (5.66e-2)" "unprognostic (1.12e-1)" "unprognostic (2.65e-2)" "unprognostic (1.13e-3)" "unprognostic (8.36e-3)" "unprognostic (3.45e-3)" "prognostic unfavorable (6.59e-5)" "unprognostic (5.83e-2)" "unprognostic (2.53e-1)" "prognostic unfavorable (1.09e-5)" "prognostic unfavorable (1.66e-5)" 7.2 6.0 65.3 3.8 78.6 0.9 4.4 39.5 325.5 8.0 0.0 16.5 1.2 8.2 2.4 3.0 7.2 4.2 15.5 92.8 37.5 1.2 0.2 2.2 1.0 201.4 41.4 5.0 1.0 2.0 11.7 2.7 186.0 4.8 3.5 21.7 2.5 7.5 4.5 3.2 4.0 13.1 22.5 0.9 4.3 3.8 85.8 24.0 4.1 5.1 0.9 11.9 4.5 156.7 0.3 2.5 11.1 6.4 60.7 41.5 0.1 36.3 61.8 10.5 10.1 4.4 0.1 0.2 15.3 94.0 3.3 0.5 15.0 0.1 6.1 5.5 1.4 14.2 3.5 0.3 5.8 0.4 5.8 31.3 0.1 58.1 0.3 15.8 8.0 41.3 24.0 0.3 42.8 0.5 26.6 0.8 8.1 0.0 1.0 7.2 32.1 0.1 0.2 0.1 34.8 10.6 1.2 0.1 0.3 14.6 2.3 0.6 1.5 33.7 11.3 11.3 0.5 0.0 1.6 5.0 121.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.1 0.1 65.3 78.6 39.5 325.5 92.8 37.5 201.4 41.4 186.0 22.5 85.8 156.7 6.7 3.2 1.1 11.8 2.2 5.5 1.4 1.4 2.8 43.4 1.7 3.6 55.1 0.0 7.9 3.7 25.0 0.3 90.9 1.0 0.0 0.4 13.1 33.2 19.5 5.7 11.4 3.0 34.4 0.0 0.6 46.9 2.6 1.0 7.0 16.7 4.2 0.0 2.4 299.5 45.1 1.7 10.2 0.3 7.4 5.6 51.0 9.4 8.8 12.2 0.7 16.7 0.0 9.5 51.4 0.7 0.0 76.3 1.1 0.5 0.0 0.5 63.6 27.2 32.9 45.7 48.2 10.6 25.6 1.1 4.1 1.1 5.6 3.1 1.4 0.5 PPIP5K1 "HISPPD2A, IPS1, KIAA0377, VIP1" ENSG00000168781 "Diphosphoinositol pentakisphosphate kinase 1" Q6PFW1 15 43533462-43590253 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 41.7;Excitatory neurons: 46.6;Inhibitory neurons: 37.6;Rod photoreceptor cells: 44.2" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebellum: 45.4" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039380 Approved Supported "Plasma membrane,Cytosol" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 21: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 9: Photoreceptor cells - Phototransduction" "Plasma membrane, Cytosol" "HPA039380: AB_10673528" "unprognostic (8.72e-2)" "unprognostic (6.49e-2)" "unprognostic (1.90e-2)" "unprognostic (1.12e-1)" "unprognostic (2.38e-1)" "unprognostic (2.78e-1)" "unprognostic (8.18e-2)" "unprognostic (5.78e-2)" "unprognostic (2.59e-3)" "prognostic unfavorable (8.57e-4)" "unprognostic (6.67e-2)" "unprognostic (2.85e-3)" "prognostic favorable (7.14e-8)" "unprognostic (2.67e-2)" "unprognostic (3.35e-2)" "unprognostic (5.92e-3)" "unprognostic (7.95e-3)" 6.6 14.8 5.7 7.3 9.8 5.9 10.3 45.4 21.0 8.3 1.1 17.6 24.7 7.4 15.1 11.6 9.4 8.3 7.5 8.0 1.8 8.5 5.6 5.8 7.8 6.0 0.6 9.2 9.4 33.7 21.6 4.5 8.8 10.0 17.6 53.7 13.8 8.3 20.0 20.0 24.3 7.7 0.0 8.6 15.5 15.5 2.8 5.4 14.3 21.2 10.0 9.0 9.9 9.2 14.5 9.3 8.1 15.0 4.8 3.0 13.8 7.1 9.0 10.0 14.6 11.0 13.5 13.5 10.5 9.8 14.9 38.6 15.8 30.6 10.1 13.3 12.5 20.3 29.9 5.9 11.0 23.4 20.2 5.4 26.6 12.2 18.6 13.5 10.7 31.0 15.0 19.4 7.4 11.3 7.8 13.2 3.9 27.0 10.0 16.7 8.2 6.8 10.7 25.9 24.1 7.6 18.3 17.2 6.7 11.4 31.7 19.4 4.7 8.7 10.2 11.1 17.4 4.3 5.7 16.4 16.3 26.5 8.5 2.4 0.5 0.0 1.0 1.1 1.3 2.0 1.2 1.3 1.2 1.2 0.9 0.9 0.3 1.5 0.8 0.9 0.3 1.3 5.7 9.8 45.4 21.0 8.0 1.8 6.0 0.6 8.8 0.0 2.8 9.2 2.3 0.0 2.2 11.4 5.2 4.0 1.5 3.2 7.4 16.5 3.2 3.3 5.4 2.8 3.4 7.3 41.7 3.3 2.9 9.2 0.0 2.1 2.7 2.1 1.4 2.9 2.4 5.5 46.6 1.5 0.9 1.8 20.9 2.8 0.0 9.5 3.3 1.8 1.9 10.1 37.6 5.9 0.0 2.8 1.8 2.4 1.8 2.1 0.0 15.0 1.8 3.9 0.0 11.6 11.0 1.9 5.2 7.2 3.1 1.2 12.2 1.5 2.3 44.2 6.6 2.3 3.2 8.1 3.3 7.3 3.3 2.2 3.1 3.5 8.2 3.2 CKMT1B "CKMT, CKMT1, UMTCK" ENSG00000237289 "Creatine kinase, mitochondrial 1B" P12532 15 43593054-43604901 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.5;esophagus: 74.3;intestine: 80.7" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 122.4;Distal enterocytes: 146.4;Intestinal goblet cells: 78.3;Paneth cells: 69.9;Proximal enterocytes: 124.6;Syncytiotrophoblasts: 137.9;Undifferentiated cells: 123.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 139.8;hTCEpi: 69.2;OE19: 156.0;SK-BR-3: 183.1;T-47d: 100.7" HPA043491 Uncertain "Intracellular and membrane" NA NA 2000000 "Cluster 45: Intestine - Brush border" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA043491: AB_2678510" "unprognostic (3.47e-2)" "unprognostic (9.73e-3)" "unprognostic (3.10e-1)" "prognostic unfavorable (2.55e-5)" "unprognostic (1.29e-1)" "unprognostic (1.96e-1)" "unprognostic (5.19e-2)" "unprognostic (2.84e-1)" "unprognostic (3.64e-1)" "unprognostic (5.75e-2)" "unprognostic (2.39e-1)" "unprognostic (1.15e-2)" "unprognostic (2.26e-8)" "unprognostic (1.71e-2)" "unprognostic (1.69e-1)" "unprognostic (4.43e-2)" "unprognostic (4.36e-2)" 1.9 1.9 24.6 6.3 25.1 0.0 6.0 38.0 58.5 8.0 14.3 80.7 63.4 0.3 0.4 74.3 1.9 8.9 0.7 26.5 31.5 5.3 0.1 0.7 0.1 32.4 25.2 0.1 3.1 11.9 9.5 12.8 34.6 3.1 66.0 23.4 28.5 0.8 0.1 26.7 49.4 4.0 13.8 0.0 29.6 0.2 28.6 0.1 6.2 0.0 13.3 8.4 22.0 22.2 0.3 0.9 0.8 0.0 0.2 0.0 35.3 0.0 0.0 0.1 0.1 7.8 23.8 0.0 1.0 0.0 7.2 139.8 28.4 55.8 0.1 0.8 16.0 0.0 3.0 3.8 0.0 0.1 8.6 0.0 69.2 0.0 6.9 0.0 0.0 5.9 9.1 0.0 0.0 38.2 0.1 0.2 12.0 156.0 14.9 0.0 0.0 0.8 3.0 3.7 55.4 19.5 0.9 183.1 10.9 2.3 100.7 0.0 0.0 0.1 1.8 0.2 2.3 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.6 25.1 38.0 58.5 26.5 31.5 32.4 25.2 34.6 13.8 28.6 22.2 0.1 0.0 0.5 2.6 0.1 25.1 10.4 40.5 3.4 7.5 3.8 4.1 0.4 5.7 12.7 5.5 18.8 122.4 0.4 146.4 21.5 4.0 0.0 0.9 0.0 0.5 21.0 0.0 37.6 28.0 26.1 0.5 33.1 0.5 0.0 1.1 0.0 0.0 9.4 6.7 36.5 78.3 10.2 0.0 0.7 0.0 0.0 0.1 3.6 2.8 0.0 2.2 0.0 5.0 2.4 18.6 69.9 0.0 0.1 2.0 124.6 0.9 6.0 12.2 0.0 0.0 0.7 0.0 0.0 17.5 24.7 137.9 0.6 0.0 123.7 19.9 STRC DFNB16 ENSG00000242866 Stereocilin Q7RTU9 15 43599563-43618800 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Hearing "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "brain: 9.0;pituitary gland: 4.4;retina: 3.6;testis: 5.0" "Cell type enhanced" "Detected in some" "Astrocytes: 10.1;Excitatory neurons: 55.7;Inhibitory neurons: 35.4;Oligodendrocyte precursor cells: 13.0;Oligodendrocytes: 15.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA048083 Enhanced NA NA "Cluster 6: Brain - Smell perception" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA048083: AB_2732545" "unprognostic (8.60e-3)" "unprognostic (5.77e-3)" "unprognostic (6.14e-2)" "unprognostic (1.60e-2)" "unprognostic (1.47e-1)" "unprognostic (1.15e-3)" "unprognostic (1.65e-1)" "unprognostic (1.36e-1)" "unprognostic (1.20e-1)" "unprognostic (1.79e-1)" "unprognostic (1.84e-2)" "unprognostic (5.92e-3)" "unprognostic (1.99e-4)" "unprognostic (1.58e-1)" "unprognostic (6.56e-2)" "unprognostic (1.78e-1)" "unprognostic (1.59e-4)" 0.1 0.6 3.5 0.0 3.8 0.0 0.3 9.0 8.0 0.3 0.3 0.3 0.1 0.1 1.0 0.2 0.4 0.0 0.1 3.8 2.4 0.5 0.6 0.1 0.0 3.8 2.2 0.6 0.2 0.0 4.4 0.0 3.7 1.0 0.0 3.6 0.7 0.0 0.4 0.7 0.4 0.0 1.5 0.3 0.3 5.0 3.2 0.6 1.0 0.0 0.0 0.1 0.3 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 3.8 9.0 8.0 3.8 2.4 3.8 2.2 3.7 1.5 3.2 4.8 0.2 0.0 0.0 10.1 0.0 0.6 0.1 0.2 0.0 2.6 0.6 0.9 0.3 0.0 0.2 0.0 6.2 0.3 0.0 0.1 0.0 0.1 0.5 0.3 0.1 0.2 0.0 0.0 55.7 0.2 0.1 0.1 0.0 0.3 0.0 2.0 0.4 0.3 0.1 3.3 35.4 0.2 0.0 0.3 0.2 0.5 0.0 0.1 1.8 6.5 0.0 2.3 0.0 13.0 15.4 0.2 1.3 0.4 0.1 0.2 0.7 0.1 0.3 8.7 0.0 0.2 0.1 4.5 0.9 0.0 0.4 0.7 0.2 0.0 0.1 0.0 CATSPER2 ENSG00000166762 "Cation channel sperm associated 2" Q96P56 15 43628503-43668118 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport" "Calcium channel, Developmental protein, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.6;retina: 22.8;testis: 15.5" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 254.4;Early spermatids: 73.6;Rod photoreceptor cells: 221.8;Spermatocytes: 117.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 14.6" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HeLa: 11.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "Cluster 37: B-cells - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 9: Photoreceptor cells - Phototransduction" "unprognostic (6.88e-3)" "unprognostic (6.79e-2)" "unprognostic (2.08e-2)" "unprognostic (2.65e-2)" "unprognostic (4.05e-1)" "unprognostic (1.05e-2)" "unprognostic (7.11e-3)" "unprognostic (1.48e-2)" "unprognostic (6.35e-2)" "unprognostic (1.15e-2)" "unprognostic (1.09e-2)" "unprognostic (3.37e-2)" "unprognostic (3.74e-3)" "unprognostic (1.15e-1)" "unprognostic (6.04e-2)" "unprognostic (8.87e-2)" "unprognostic (8.23e-5)" 1.2 1.4 2.0 0.8 2.2 4.2 1.8 14.6 4.0 1.3 0.1 2.3 3.3 1.4 5.4 2.4 1.4 0.7 0.9 2.2 0.7 1.4 1.5 1.2 2.0 1.4 0.6 1.6 1.2 4.0 3.2 0.8 1.7 1.6 2.3 22.8 1.6 2.2 1.2 5.4 3.8 0.6 0.1 1.5 1.8 15.5 0.9 0.9 1.9 1.5 1.5 1.7 1.3 3.1 2.0 2.8 1.2 4.4 0.0 0.0 2.0 0.7 1.7 1.2 2.9 0.7 1.1 2.4 1.0 0.5 1.4 4.4 1.1 3.9 1.2 2.0 5.4 7.0 11.2 1.0 1.8 1.6 2.2 0.2 3.0 1.7 4.3 3.2 1.5 4.3 2.8 2.4 0.4 0.5 1.3 2.8 0.4 2.7 1.2 1.9 1.4 1.1 2.4 3.2 2.6 0.9 1.1 1.6 0.1 1.6 3.2 1.5 0.4 3.0 1.3 0.0 1.8 0.4 0.3 5.1 2.1 4.9 1.1 0.1 0.3 0.1 0.3 0.1 0.4 1.1 0.2 0.4 0.2 0.3 0.3 0.7 0.5 0.5 0.3 0.4 0.1 0.0 2.0 2.2 14.6 4.0 2.2 0.7 1.4 0.6 1.7 0.1 0.9 3.1 4.8 0.0 4.5 0.0 4.9 7.0 8.2 8.3 1.8 56.7 6.9 6.9 4.2 5.7 8.0 7.3 254.4 6.0 6.0 3.9 3.9 3.2 73.6 5.2 2.5 6.0 21.5 2.7 0.0 2.7 2.1 3.2 6.1 4.2 9.5 29.7 8.6 3.9 4.3 38.7 0.0 4.6 4.1 5.0 6.5 37.4 6.2 4.5 1.8 0.0 4.5 13.4 7.2 0.0 0.0 2.0 3.3 7.2 1.1 6.7 11.1 4.1 10.8 221.8 0.0 9.3 5.1 117.4 17.1 2.7 8.0 3.0 4.6 5.8 8.5 8.4 CKMT1A CKMT1 ENSG00000223572 "Creatine kinase, mitochondrial 1A" P12532 15 43692886-43699222 "Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 83.9;intestine: 75.0" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 73.0;Distal enterocytes: 110.5;Intestinal goblet cells: 53.4;Paneth cells: 57.4;Proximal enterocytes: 94.5;Syncytiotrophoblasts: 94.0;Undifferentiated cells: 92.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 127.5;hTCEpi: 56.8;OE19: 144.3;SK-BR-3: 107.8;T-47d: 100.3" HPA043491 Uncertain "Intracellular and membrane" NA NA 2000000 "Cluster 37: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA043491: AB_2678510" "unprognostic (2.04e-2)" "unprognostic (2.53e-2)" "unprognostic (1.17e-1)" "unprognostic (4.02e-3)" "unprognostic (3.80e-1)" "unprognostic (7.44e-2)" "unprognostic (2.21e-1)" "unprognostic (3.10e-1)" "unprognostic (1.75e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-1)" "unprognostic (2.51e-2)" "unprognostic (3.78e-9)" "unprognostic (3.52e-2)" "unprognostic (1.03e-1)" "unprognostic (7.37e-2)" "unprognostic (1.73e-3)" 1.8 3.8 20.8 7.1 22.1 0.0 7.7 29.3 46.4 10.1 12.6 75.0 70.6 0.5 0.4 83.9 2.1 9.4 0.8 21.9 27.3 6.0 0.2 0.9 0.1 24.9 15.8 0.1 3.5 12.3 8.5 9.5 26.9 4.4 69.4 31.8 31.4 1.1 0.1 38.0 63.1 3.4 10.7 0.1 23.3 0.3 23.0 0.2 2.8 0.0 14.7 8.3 26.1 25.7 0.3 2.9 0.7 0.1 1.3 0.0 31.9 0.0 0.0 0.0 0.0 6.8 22.1 0.1 1.4 0.0 2.4 127.5 22.4 39.0 0.0 0.0 17.1 0.0 2.1 0.7 0.0 0.0 6.1 0.2 56.8 0.0 10.3 0.0 0.0 5.0 5.7 0.1 0.0 34.8 0.0 0.2 10.1 144.3 8.2 0.1 0.0 6.7 6.7 4.7 47.1 20.0 0.0 107.8 8.6 2.9 100.3 0.8 0.0 0.0 2.3 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.8 22.1 29.3 46.4 21.9 27.3 24.9 15.8 26.9 10.7 23.0 25.7 0.1 0.0 0.0 2.3 0.3 17.7 10.5 30.3 1.8 6.7 4.2 5.2 0.5 10.0 14.9 1.8 20.9 73.0 0.1 110.5 27.4 4.2 0.0 0.7 0.0 0.3 18.0 0.0 10.6 20.2 23.5 0.4 26.0 0.8 8.9 1.5 0.0 0.0 4.5 6.7 9.0 53.4 12.2 0.0 0.7 0.2 0.0 0.0 5.4 1.0 0.0 4.8 0.0 1.5 1.6 12.9 57.4 0.0 0.0 2.7 94.5 1.0 4.1 11.6 0.0 0.0 0.9 0.0 0.1 16.1 18.5 94.0 0.4 0.0 92.7 20.1 PDIA3 "ERp57, ERp60, ERp61, GRP57, GRP58, HsT17083, P58, PI-PLC" ENSG00000167004 "Protein disulfide isomerase family A member 3" P30101 15 43746410-43773278 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 1048.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002645, HPA003230, CAB011199, CAB015181, CAB075744" Enhanced Enhanced "Endoplasmic reticulum" "Intracellular and membrane" NA NA 200000000 "Cluster 44: Non-specific - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "CAB011199: AB_609902, CAB015181: AB_2160857, CAB075744: AB_2665750, HPA002645: AB_1079031, HPA003230: AB_1079030" "unprognostic (9.20e-2)" "unprognostic (1.21e-3)" "unprognostic (1.34e-1)" "prognostic favorable (2.05e-4)" "unprognostic (2.40e-2)" "prognostic unfavorable (8.95e-5)" "unprognostic (1.67e-1)" "unprognostic (8.60e-2)" "unprognostic (2.65e-1)" "unprognostic (2.24e-1)" "unprognostic (1.84e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (2.11e-8)" "unprognostic (1.82e-1)" "unprognostic (1.73e-1)" "unprognostic (1.19e-1)" "unprognostic (6.63e-2)" 17.0 16.6 7.5 16.5 8.0 27.1 15.6 9.2 7.6 24.7 13.9 20.6 23.6 16.4 44.7 18.9 15.4 13.5 17.3 7.7 9.8 15.3 34.5 16.8 18.7 9.3 8.2 16.5 36.0 22.6 16.2 23.8 9.1 25.2 22.5 8.4 21.6 19.1 7.6 17.3 21.4 17.0 9.0 12.5 20.4 10.8 9.3 9.6 56.0 4.1 12.3 15.6 15.2 9.8 29.4 11.9 24.6 55.1 48.9 51.9 70.8 58.6 62.1 46.0 56.7 33.6 32.1 33.8 37.4 72.9 30.8 47.8 31.8 61.5 39.7 24.3 44.7 47.2 17.6 30.9 80.1 26.0 33.8 33.6 49.8 35.0 58.5 54.0 81.3 11.1 27.7 17.4 45.5 11.1 9.1 30.4 24.4 48.5 44.0 17.9 36.7 26.2 39.3 26.0 22.9 25.4 48.7 49.0 19.4 25.0 33.1 28.1 50.9 37.7 18.9 29.7 29.1 7.1 8.6 33.9 48.1 41.2 28.8 11.6 8.8 13.3 12.1 9.2 12.8 5.4 6.8 9.5 8.3 6.1 6.0 7.1 2.4 12.7 9.9 17.6 5.8 15.8 7.5 8.0 9.2 7.6 7.7 9.8 9.3 8.2 9.1 9.0 9.3 9.8 224.9 192.3 183.9 31.6 177.8 192.2 313.7 665.2 114.4 56.5 137.9 95.5 58.3 124.4 427.7 167.3 41.7 655.2 319.6 228.7 70.5 401.2 24.3 178.8 300.3 223.7 186.1 95.3 29.2 390.4 807.8 350.7 261.0 328.5 261.6 255.1 233.1 342.2 426.0 70.7 38.3 523.1 231.9 157.3 292.2 26.7 253.5 246.5 243.7 36.5 258.0 128.3 279.1 29.7 38.8 279.9 196.8 276.8 341.1 286.5 234.3 129.1 245.6 61.9 124.9 138.4 389.7 186.4 147.6 138.9 148.5 1048.8 237.8 390.8 335.4 291.7 ELL3 FLJ22637 ENSG00000128886 "Elongation factor for RNA polymerase II 3" Q9HB65 15 43772605-43777315 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 57.7;skin 1: 25.0" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 5.2;Gastric mucus-secreting cells: 4.6;Proximal enterocytes: 6.5;Squamous epithelial cells: 21.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "memory B-cell: 10.5;naive B-cell: 15.9" "Lineage enriched" "Detected in many" 7 "B-cells: 15.9" "Cell line enhanced" "Detected in many" "Daudi: 73.8;OE19: 28.5;T-47d: 39.0;U-698: 149.9" "Region enriched" "Detected in single" 11 "olfactory bulb: 1.9" "Not detected" "Not detected" "HPA028938, HPA073494" Approved Supported "Nucleoplasm,Nucleoli,Mitotic chromosome" Yes NA "Cluster 37: B-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 61: Squamous epithelial cells - Keratinization" "Nucleoplasm, Nucleoli" "Mitotic chromosome" "HPA028938: AB_10795352, HPA073494: " "unprognostic (2.59e-2)" "unprognostic (4.41e-1)" "unprognostic (1.76e-1)" "unprognostic (1.28e-1)" "unprognostic (3.59e-1)" "unprognostic (2.30e-2)" "unprognostic (1.17e-1)" "unprognostic (2.42e-3)" "unprognostic (1.52e-2)" "unprognostic (3.89e-1)" "unprognostic (2.19e-1)" "unprognostic (3.53e-1)" "unprognostic (1.87e-1)" "unprognostic (3.67e-2)" "unprognostic (8.95e-2)" "unprognostic (1.08e-1)" "unprognostic (1.24e-2)" 0.5 0.9 1.0 9.7 1.0 0.2 5.2 1.0 1.1 1.6 4.7 8.0 14.1 0.6 1.1 4.5 3.9 0.7 0.5 1.0 1.1 1.4 0.7 1.5 49.7 1.0 1.1 1.7 0.4 1.6 0.5 3.7 1.1 2.0 12.3 0.1 2.2 1.0 0.4 25.0 12.9 1.0 1.0 1.0 1.8 16.2 1.4 1.5 0.7 1.9 57.7 0.7 0.8 1.1 2.1 0.2 0.6 1.1 4.9 1.2 0.4 0.2 1.3 2.8 3.1 0.0 1.3 73.8 0.1 1.2 0.1 13.7 1.3 0.7 1.4 1.6 7.3 0.4 2.6 4.6 1.0 0.1 0.0 1.4 12.3 0.7 0.2 0.2 1.1 0.4 0.2 0.0 0.7 4.0 1.5 1.4 0.1 28.5 2.4 0.8 0.0 0.0 1.8 0.0 9.5 0.0 1.7 21.5 0.0 0.3 39.0 0.2 0.0 0.3 0.0 0.0 0.1 0.0 0.0 149.9 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.1 0.2 10.5 0.6 0.1 0.0 15.9 1.1 0.2 0.0 0.1 0.0 2.2 0.6 0.6 1.0 1.0 1.0 1.1 1.0 1.1 1.0 1.1 1.1 1.0 1.4 1.1 0.1 0.0 0.0 0.0 2.2 0.4 0.1 0.2 5.2 0.0 0.7 0.5 0.0 0.0 0.2 0.0 0.0 0.1 0.3 1.2 0.0 0.1 1.8 0.4 0.1 0.2 0.0 0.4 0.1 0.7 0.0 0.5 4.6 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 2.5 0.0 0.0 0.5 2.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.1 6.5 0.1 3.1 0.0 0.0 0.2 0.4 0.2 0.2 21.0 1.0 0.3 0.1 0.1 2.3 0.2 SERF2 "4F5REL, FAM2C, H4F5rel, HsT17089" ENSG00000140264 "Small EDRK-rich factor 2" P84101 15 43777087-43804427 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056613 Uncertain Nucleoplasm,Nucleoli NA Yes "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Nucleoli "HPA056613: " "unprognostic (3.29e-1)" "unprognostic (7.29e-2)" "unprognostic (1.13e-3)" "prognostic favorable (5.33e-4)" "unprognostic (1.40e-1)" "unprognostic (3.91e-2)" "unprognostic (6.06e-2)" "unprognostic (1.61e-1)" "unprognostic (1.13e-1)" "unprognostic (2.50e-1)" "unprognostic (3.04e-1)" "unprognostic (1.36e-1)" "unprognostic (3.37e-2)" "unprognostic (2.84e-1)" "unprognostic (3.35e-2)" "unprognostic (2.76e-2)" "unprognostic (9.42e-2)" 760.6 1067.4 704.4 446.7 726.4 944.9 619.4 750.2 906.3 650.8 1027.1 728.4 443.4 509.9 776.2 887.9 456.8 469.4 1187.9 698.1 712.2 1002.2 1328.7 700.8 686.4 737.1 725.3 474.3 795.1 490.9 569.3 484.2 734.7 794.5 631.9 72.8 823.7 312.8 636.9 631.1 593.2 507.4 739.4 745.3 784.3 400.2 759.4 450.7 706.6 723.6 628.9 595.0 634.1 758.8 497.5 770.8 573.8 792.9 1963.2 1431.3 438.9 844.8 1042.5 540.4 682.7 991.5 470.0 250.4 694.7 1429.2 698.7 641.1 454.6 623.8 271.1 699.6 526.2 610.9 1074.9 1936.8 934.7 581.8 1235.8 1349.9 810.5 425.8 452.1 836.1 783.5 680.7 630.2 1593.5 1067.4 1441.8 758.6 1337.2 501.5 1849.7 885.1 743.9 382.6 1147.2 1462.5 1695.7 450.6 481.1 458.9 1871.5 463.9 488.4 1574.7 2363.9 682.9 920.0 469.0 1409.4 669.3 593.3 886.2 1837.8 989.2 1032.8 980.4 4033.8 5391.9 5884.9 2716.6 5055.2 2481.3 3853.8 2938.5 2784.5 4649.4 3901.8 2713.3 2731.7 3154.6 2568.8 4495.9 6486.5 3793.5 12856.7 704.4 726.4 750.2 906.3 698.1 712.2 737.1 725.3 734.7 739.4 759.4 758.8 1269.2 506.4 789.0 0.0 1149.8 1151.3 1379.1 3393.0 861.6 53.9 2373.1 2483.2 2229.8 1338.2 2099.5 1736.1 54.2 2660.9 1475.6 2388.2 3897.3 1707.6 576.8 1243.6 1343.1 1283.3 1167.5 1310.8 0.5 2255.2 3410.2 1489.3 1403.7 1261.0 785.9 775.2 1532.4 2884.5 3545.2 47.1 0.5 2862.6 2278.6 2262.1 2298.5 319.2 1225.3 2102.8 1817.8 0.0 2626.4 544.5 1881.6 1.5 0.3 1804.7 2363.9 992.2 1546.7 2188.9 3013.2 5083.6 1950.6 148.4 604.8 680.1 1737.3 750.2 381.1 1725.5 1556.5 3275.8 1216.9 1446.6 2042.5 2819.5 SERINC4 FLJ40363 ENSG00000184716 "Serine incorporator 4" A6NH21 15 43794162-43800221 "Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "retina: 15.4" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 43.8;Early spermatids: 32.8;Late spermatids: 39.6;Rod photoreceptor cells: 54.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "Cluster 77: Retina - Visual perception" "Cluster 46: Photoreceptor cells - Phototransduction" 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.3 0.2 0.1 0.2 0.2 0.2 0.1 0.3 0.2 0.4 0.0 0.0 1.3 0.0 0.1 0.3 0.3 0.0 6.4 0.5 0.5 0.0 0.0 0.1 0.0 43.8 0.2 0.5 0.4 0.0 0.1 32.8 0.2 0.2 0.5 0.0 0.0 0.4 0.4 0.2 0.2 1.1 0.4 0.0 0.0 0.7 0.0 0.2 5.0 0.4 0.4 0.0 0.3 0.3 39.6 0.3 0.3 0.0 0.0 0.7 5.2 0.0 0.0 1.1 0.1 0.0 0.0 1.6 0.3 0.2 0.1 0.1 54.9 0.0 0.3 0.2 8.3 4.3 0.5 0.0 0.4 0.2 0.0 0.1 0.4 HYPK "C15orf63, FLJ20431, HSPC136" ENSG00000242028 "Huntingtin interacting protein K" Q9NX55 15 43796142-43804427 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 54.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055252 Uncertain Supported Nucleoplasm,Microtubules NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm Microtubules "HPA055252: AB_2682759" "unprognostic (2.89e-2)" "unprognostic (5.82e-2)" "unprognostic (2.14e-2)" "unprognostic (7.58e-3)" "unprognostic (1.15e-1)" "unprognostic (1.08e-3)" "unprognostic (3.55e-1)" "unprognostic (1.48e-1)" "unprognostic (4.41e-2)" "unprognostic (1.04e-1)" "unprognostic (5.36e-3)" "unprognostic (2.39e-3)" "unprognostic (6.52e-7)" "unprognostic (2.05e-1)" "unprognostic (8.89e-2)" "unprognostic (2.61e-1)" "unprognostic (2.78e-4)" 8.9 9.8 13.8 5.9 13.8 4.9 6.5 16.6 22.0 5.0 13.8 5.0 3.7 4.3 5.1 4.2 6.0 2.9 8.5 13.8 15.0 6.5 14.2 7.6 6.5 14.7 15.2 6.2 9.4 6.2 5.6 3.6 14.7 6.8 3.8 8.6 5.5 4.3 19.2 6.1 5.1 4.9 13.4 5.5 5.8 7.9 14.2 6.1 5.2 14.7 7.7 8.3 4.3 15.4 13.5 36.8 17.3 19.5 11.6 11.5 6.5 21.8 13.1 18.9 12.6 23.7 7.4 19.8 25.9 16.7 17.8 23.1 30.3 24.9 14.3 17.3 37.3 26.4 64.6 34.0 17.8 30.4 16.3 10.1 24.2 21.3 18.1 9.3 14.7 20.9 40.5 16.9 17.2 33.5 19.2 33.9 19.5 48.6 40.9 15.4 12.6 22.4 17.7 26.5 33.9 24.7 20.7 31.1 13.3 10.6 23.7 19.5 13.3 22.6 11.8 24.2 55.8 20.5 40.6 46.2 15.1 33.1 26.8 16.8 25.7 22.1 25.0 37.7 26.4 30.0 26.8 26.7 23.5 31.4 29.9 27.9 9.4 26.7 47.7 39.8 27.5 23.5 13.8 13.8 16.6 22.0 13.8 15.0 14.7 15.2 14.7 13.4 14.2 15.4 11.3 6.4 14.5 0.0 11.1 30.0 15.0 8.1 13.6 11.2 14.4 11.9 0.7 8.6 12.1 7.3 54.2 6.6 8.2 6.4 9.8 6.5 2.4 7.2 9.6 10.7 10.7 9.5 0.0 8.4 4.4 12.5 26.0 7.7 8.8 4.5 6.4 6.5 3.9 13.5 0.0 11.6 8.2 4.4 26.2 1.1 5.0 9.1 23.2 0.0 4.7 4.9 6.2 0.0 0.0 6.8 4.7 2.2 11.3 14.8 7.2 10.4 15.4 28.5 0.0 23.2 11.8 3.9 4.7 19.4 37.4 4.9 10.4 9.1 9.4 11.1 MFAP1 AMP ENSG00000140259 "Microfibril associated protein 1" P55081 15 43804492-43824690 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 147.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015583, HPA042370" Uncertain Supported Nucleoplasm,Centrosome NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Centrosome "HPA015583: , HPA042370: AB_10796904" "unprognostic (1.05e-1)" "unprognostic (5.94e-2)" "unprognostic (2.56e-2)" "unprognostic (1.23e-2)" "unprognostic (2.06e-1)" "unprognostic (5.28e-2)" "prognostic unfavorable (2.50e-4)" "unprognostic (4.08e-1)" "unprognostic (1.48e-1)" "unprognostic (1.66e-2)" "unprognostic (3.12e-1)" "unprognostic (7.02e-2)" "prognostic favorable (1.04e-9)" "unprognostic (1.66e-2)" "unprognostic (9.68e-2)" "unprognostic (3.82e-3)" "unprognostic (1.54e-2)" 15.9 24.0 17.5 17.6 18.0 12.9 21.4 21.3 23.2 16.6 19.7 17.1 14.5 18.8 23.4 22.2 18.4 14.9 22.1 17.7 19.3 23.7 18.1 15.2 26.6 18.3 19.3 24.8 15.3 33.2 14.5 23.2 18.7 22.8 18.1 25.0 17.0 17.7 26.3 20.5 15.0 19.1 17.7 17.1 16.8 19.3 18.5 24.4 24.7 23.2 32.4 20.6 17.5 19.1 40.1 41.0 69.4 46.0 57.9 36.3 42.7 63.1 43.8 50.3 58.2 64.1 25.6 42.8 58.7 39.4 50.9 70.8 62.5 51.7 58.9 72.9 37.6 103.7 71.6 48.5 45.4 62.3 53.2 34.1 55.3 48.0 43.3 48.0 49.8 48.3 95.8 35.7 60.9 30.0 51.1 47.0 49.2 74.2 35.4 73.9 69.6 27.6 52.0 59.0 43.8 43.0 55.6 47.0 27.0 55.2 70.7 39.5 47.4 50.6 35.8 56.3 51.7 43.5 112.2 91.8 42.5 58.4 37.9 42.5 25.5 56.9 35.3 34.8 34.7 35.0 35.1 33.6 32.6 28.3 35.7 35.0 22.6 50.5 29.1 26.8 44.1 26.3 17.5 18.0 21.3 23.2 17.7 19.3 18.3 19.3 18.7 17.7 18.5 19.1 30.4 35.3 30.2 5.2 32.8 30.3 59.6 50.1 35.9 41.8 22.4 28.8 31.0 25.8 43.2 51.5 6.2 94.6 33.2 27.4 56.7 44.2 6.2 43.1 39.9 35.6 11.3 32.0 9.0 29.4 55.0 29.8 21.4 39.4 46.3 37.6 20.7 18.8 35.4 32.0 8.6 24.4 38.7 20.7 20.5 6.3 28.0 25.5 26.6 5.6 30.6 51.5 33.0 2.0 8.2 26.8 27.1 35.7 20.6 39.3 22.1 42.9 60.0 35.2 19.7 35.9 41.7 49.7 84.8 28.1 27.7 147.4 33.6 39.4 21.3 50.6 WDR76 FLJ12973 ENSG00000092470 "WD repeat domain 76" Q9H967 15 43826980-43868412 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 19.1;lymphoid tissue: 21.3" "Cell type enhanced" "Detected in many" "Erythroid cells: 35.3;Spermatocytes: 23.5;Spermatogonia: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039804, HPA040626" Uncertain Approved "Nucleoli fibrillar center,Nuclear bodies" NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nuclear bodies" "Nucleoli fibrillar center" "HPA039804: AB_10795297, HPA040626: AB_10795527" "unprognostic (2.26e-1)" "unprognostic (7.56e-3)" "unprognostic (7.05e-2)" "unprognostic (1.88e-1)" "unprognostic (5.85e-2)" "unprognostic (3.12e-2)" "prognostic unfavorable (6.98e-4)" "prognostic unfavorable (8.02e-5)" "unprognostic (4.24e-3)" "unprognostic (6.25e-2)" "prognostic unfavorable (5.02e-4)" "unprognostic (1.91e-2)" "prognostic unfavorable (1.35e-8)" "unprognostic (7.71e-2)" "unprognostic (9.42e-2)" "unprognostic (4.02e-2)" "unprognostic (3.28e-2)" 2.6 1.2 1.0 8.4 1.1 19.1 3.5 4.8 1.7 3.0 0.8 4.8 3.2 3.3 0.9 4.5 1.7 1.9 1.1 0.7 1.1 1.5 2.2 2.4 19.8 1.3 1.1 2.2 3.1 2.7 1.1 3.9 1.3 1.9 6.0 6.3 2.4 2.0 0.8 4.1 3.3 3.9 1.0 3.6 2.9 5.3 1.3 19.5 2.5 1.3 21.3 2.8 2.8 1.2 35.1 17.5 40.7 31.3 4.5 10.7 11.1 57.3 33.9 61.5 76.8 22.1 17.8 51.4 24.8 26.9 31.0 49.4 42.4 20.5 53.1 80.4 25.2 63.3 52.1 7.3 2.5 65.0 27.0 3.4 3.3 33.8 7.7 8.9 19.9 54.7 48.6 86.9 42.6 12.2 63.4 15.4 14.6 11.0 18.1 66.9 70.1 32.4 11.4 35.5 31.3 30.9 36.1 22.5 7.0 12.6 35.0 31.0 9.1 56.3 26.5 63.5 58.9 42.7 114.6 129.1 40.4 56.7 31.5 0.0 0.6 0.3 3.8 0.5 4.1 1.8 4.6 3.4 1.0 2.2 3.8 2.9 0.0 4.8 0.2 1.2 6.6 2.0 1.0 1.1 4.8 1.7 0.7 1.1 1.3 1.1 1.3 1.0 1.3 1.2 4.1 3.2 1.3 2.6 8.2 7.4 3.2 2.4 4.6 3.7 3.7 2.8 1.2 1.5 2.3 1.8 10.4 12.8 6.2 3.5 1.9 2.9 1.7 1.8 3.9 4.8 0.0 35.3 2.5 4.2 13.0 3.9 4.6 3.3 5.7 12.2 2.9 0.9 8.9 1.7 3.3 3.7 0.0 3.5 5.3 0.9 1.8 3.9 3.6 2.8 3.3 8.0 10.3 0.5 1.9 1.1 3.1 2.2 16.1 1.5 1.4 0.9 0.4 16.2 6.6 5.8 5.7 23.5 35.9 7.4 5.8 3.6 11.6 1.5 9.0 1.8 FRMD5 MGC14161 ENSG00000171877 "FERM domain containing 5" Q7Z6J6 15 43870761-44195271 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 38.7;heart muscle: 46.6;retina: 20.0" "Cell type enhanced" "Detected in some" "Excitatory neurons: 375.2;Inhibitory neurons: 646.2;Oligodendrocyte precursor cells: 298.6;Oligodendrocytes: 2000.1" "Cancer enhanced" "Detected in many" "glioma: 6.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 26.4;U-251 MG: 21.8;WM-115: 61.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 17: WM-115 - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "unprognostic (9.54e-2)" "unprognostic (2.16e-2)" "unprognostic (2.39e-1)" "unprognostic (1.19e-2)" "unprognostic (1.33e-1)" "unprognostic (7.26e-7)" "unprognostic (3.55e-2)" "unprognostic (3.08e-1)" "unprognostic (1.62e-1)" "unprognostic (5.00e-3)" "prognostic unfavorable (5.89e-4)" "unprognostic (7.01e-2)" "unprognostic (2.92e-4)" "unprognostic (1.21e-1)" "unprognostic (7.31e-2)" "unprognostic (1.18e-1)" "unprognostic (3.31e-1)" 0.2 8.3 14.8 0.5 24.2 0.8 0.4 18.0 20.5 0.3 4.5 1.4 0.2 0.1 0.4 0.3 1.0 0.4 46.6 15.1 18.9 0.3 0.0 0.1 0.3 22.1 21.2 0.3 0.2 0.8 2.0 0.0 20.6 0.5 0.8 20.0 1.1 0.3 0.0 0.3 0.5 0.2 15.6 0.3 1.3 3.4 19.5 0.0 0.3 0.0 0.0 0.4 0.4 38.7 6.6 3.5 2.3 1.3 2.6 0.2 0.4 1.4 2.1 3.9 7.4 11.2 6.6 0.5 1.3 0.9 10.6 7.3 3.3 7.0 3.3 0.4 3.7 1.0 3.1 4.4 0.3 0.1 0.4 0.0 0.7 10.6 20.8 7.6 26.4 5.7 0.2 0.7 4.1 0.6 1.0 0.1 1.9 21.3 3.8 0.1 4.7 0.0 3.6 2.3 14.3 4.8 0.8 0.1 15.0 1.8 0.2 0.2 1.0 7.1 13.4 1.8 21.8 0.5 2.0 0.8 10.4 0.4 61.2 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 14.8 24.2 18.0 20.5 15.1 18.9 22.1 21.2 20.6 15.6 19.5 38.7 0.0 0.0 0.0 134.8 0.0 0.4 0.0 0.8 0.6 11.4 0.1 0.3 14.8 0.0 0.1 0.0 2.1 0.0 0.0 0.3 0.0 2.8 14.7 0.3 0.1 0.2 1.2 0.0 375.2 6.0 0.0 1.1 7.1 0.1 0.0 3.9 0.0 0.0 0.1 0.0 646.2 0.8 0.0 0.0 0.3 5.2 0.3 0.0 0.0 14.0 0.0 17.5 0.0 298.6 2000.1 8.6 0.3 0.0 0.3 0.4 0.0 1.0 0.1 4.4 0.0 0.1 0.7 6.6 3.9 0.2 0.0 0.0 0.1 0.0 1.3 0.1 GOLM2 "CASC4, DKFZp459F1927, H63" ENSG00000166734 "Golgi membrane protein 2" Q6P4E1 15 44288719-44415758 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 19.9;Cardiomyocytes: 24.0;Cytotrophoblasts: 16.3;dendritic cells: 16.1;Extravillous trophoblasts: 19.4;Fibroblasts: 18.2;Hofbauer cells: 27.3;Syncytiotrophoblasts: 12.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043015, HPA049488" Enhanced Enhanced "Golgi apparatus" NA NA 1200000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 35: Non-specific - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 24: Non-specific - Transcription regulation" "Golgi apparatus" "HPA043015: AB_2678271, HPA049488: AB_2680790" "unprognostic (2.64e-2)" "unprognostic (2.63e-1)" "unprognostic (3.38e-1)" "unprognostic (1.81e-2)" "unprognostic (8.08e-2)" "unprognostic (1.35e-1)" "unprognostic (1.20e-2)" "unprognostic (2.20e-1)" "unprognostic (2.40e-1)" "unprognostic (1.68e-2)" "unprognostic (4.99e-2)" "unprognostic (2.60e-2)" "prognostic favorable (1.45e-5)" "unprognostic (2.15e-1)" "unprognostic (3.56e-2)" "unprognostic (9.65e-2)" "unprognostic (1.12e-1)" 39.5 84.5 48.5 32.4 47.0 16.5 43.2 43.1 59.2 57.9 62.4 45.7 28.8 50.4 53.5 23.7 53.8 50.5 33.1 42.8 52.6 54.0 60.9 40.9 30.8 49.6 51.5 55.3 37.4 82.0 38.7 34.4 46.9 67.5 43.8 33.7 47.8 56.1 22.3 13.2 29.8 44.4 46.7 35.4 49.4 34.6 52.9 28.9 84.6 26.3 29.5 39.2 24.3 52.7 45.0 38.7 51.9 92.6 141.4 121.8 32.0 78.6 125.2 44.9 57.1 19.3 80.0 13.5 106.4 119.3 47.8 53.8 34.4 25.5 48.2 64.6 19.5 21.4 41.8 35.9 65.1 42.5 68.1 72.1 28.3 49.8 38.4 126.8 53.4 34.2 33.0 103.4 56.2 23.2 36.7 33.2 14.8 60.8 27.5 30.5 29.3 43.3 58.8 54.4 23.3 53.2 60.7 57.0 26.6 28.1 64.1 49.2 76.4 78.1 39.8 112.5 69.5 79.0 145.1 27.9 92.6 58.5 51.7 20.9 14.7 20.8 15.2 9.8 16.3 11.9 12.4 15.2 12.0 10.7 9.5 9.9 37.8 10.5 18.2 10.6 13.2 13.6 48.5 47.0 43.1 59.2 42.8 52.6 49.6 51.5 46.9 46.7 52.9 52.7 19.9 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.0 0.0 0.0 0.0 0.0 16.3 16.1 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 19.4 18.2 0.0 0.0 0.0 0.0 0.0 0.0 27.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 12.7 2.9 0.0 0.0 0.0 CTDSPL2 "FLJ10523, HSPC129" ENSG00000137770 "CTD small phosphatase like 2" Q05D32 15 44427622-44529038 "Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 165.5;Late spermatids: 166.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040763, HPA062198" Approved Approved Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 34: Spermatids - Unknown function" Nucleoplasm "HPA040763: AB_10960989, HPA062198: AB_2684708" "unprognostic (6.64e-2)" "unprognostic (4.30e-2)" "unprognostic (1.43e-1)" "unprognostic (2.06e-1)" "unprognostic (7.39e-3)" "unprognostic (5.20e-2)" "unprognostic (7.40e-2)" "unprognostic (1.23e-1)" "unprognostic (5.37e-2)" "unprognostic (2.54e-2)" "unprognostic (3.68e-3)" "unprognostic (5.35e-2)" "unprognostic (8.36e-3)" "unprognostic (7.49e-2)" "unprognostic (1.37e-1)" "unprognostic (1.53e-1)" "unprognostic (1.16e-1)" 9.1 7.4 2.9 12.9 3.6 20.5 14.1 12.8 5.3 14.0 3.4 10.8 10.0 17.5 7.0 12.5 11.1 11.9 9.5 3.4 4.4 10.7 10.3 10.4 19.4 3.4 2.7 19.1 11.5 11.1 4.0 15.8 3.1 10.2 11.3 15.1 9.1 10.2 5.4 8.1 12.7 13.9 3.0 13.3 9.8 21.0 2.9 25.3 15.0 9.4 19.0 12.2 6.2 6.0 28.6 14.2 57.7 29.4 9.1 19.9 31.9 29.1 25.4 37.3 46.8 29.3 26.4 30.1 27.7 20.3 20.6 39.2 33.4 19.6 42.6 30.9 16.1 37.4 34.8 17.6 12.3 65.7 33.5 15.7 14.0 25.6 33.4 15.8 28.4 37.9 44.2 34.0 26.7 12.1 78.2 23.1 31.2 30.4 20.3 86.7 80.5 28.0 19.4 38.9 26.7 38.5 36.0 28.5 16.2 21.2 38.7 57.7 24.9 46.0 49.5 44.3 49.4 19.3 79.2 93.9 22.2 50.4 36.0 7.4 10.8 9.2 10.3 11.3 9.4 10.6 9.8 9.3 13.8 10.5 10.4 11.8 7.7 15.7 8.9 8.8 14.9 9.4 2.9 3.6 12.8 5.3 3.4 4.4 3.4 2.7 3.1 3.0 2.9 6.0 34.4 19.2 35.7 26.4 25.4 24.6 14.7 14.5 27.9 23.7 24.5 21.0 23.1 11.5 31.3 12.9 10.4 18.9 40.9 16.9 17.6 12.5 165.5 18.3 35.4 27.2 9.0 16.2 41.8 14.6 18.4 30.2 11.7 29.6 36.0 26.7 20.3 13.6 14.0 30.3 41.2 13.9 20.3 22.2 20.9 166.9 20.2 22.1 16.0 49.6 23.8 19.2 39.1 50.3 65.7 17.7 10.4 13.2 24.0 18.0 17.2 14.5 19.5 31.1 26.3 30.4 34.2 23.7 31.4 19.6 21.9 14.6 31.4 21.9 15.3 16.8 EIF3J "eIF3-alpha, eIF3-p35, EIF3S1" ENSG00000104131 "Eukaryotic translation initiation factor 3 subunit J" O75822 15 44537125-44563029 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 209.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050977 Approved Approved Cytosol NA NA 280000 "Cluster 6: Non-specific - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 16: U-266 - Nucleosome" "Cluster 39: Non-specific - Basic cellular processes" Cytosol "HPA050977: AB_2681297" "unprognostic (4.47e-2)" "unprognostic (1.28e-1)" "unprognostic (7.68e-2)" "unprognostic (3.76e-2)" "unprognostic (1.72e-3)" "unprognostic (1.47e-3)" "unprognostic (2.33e-2)" "unprognostic (1.41e-2)" "unprognostic (3.01e-3)" "unprognostic (8.31e-2)" "unprognostic (1.17e-3)" "unprognostic (4.52e-2)" "unprognostic (3.43e-3)" "unprognostic (1.39e-2)" "unprognostic (1.97e-1)" "unprognostic (4.76e-1)" "prognostic unfavorable (4.96e-5)" 48.2 34.2 40.0 40.8 42.3 38.7 39.9 41.5 51.7 26.8 34.7 36.2 36.2 26.8 30.8 48.8 22.0 26.1 40.1 39.8 45.0 46.4 58.7 25.8 38.9 44.6 47.9 22.3 65.5 34.9 22.9 44.8 46.1 32.3 37.1 21.2 56.3 29.8 209.6 37.1 31.4 35.5 41.0 30.5 35.3 31.6 44.4 34.0 35.9 104.0 49.8 49.6 31.6 47.0 103.5 55.7 88.4 55.5 60.7 60.0 113.1 161.0 46.9 108.5 72.9 165.6 59.6 96.0 184.6 67.1 102.5 192.3 137.7 99.5 129.5 114.5 79.8 222.5 129.4 108.6 115.1 239.2 98.4 54.6 130.7 72.8 141.6 65.1 117.2 111.1 294.9 119.8 97.8 73.1 124.0 160.8 55.4 190.5 92.9 141.2 145.4 146.1 122.4 118.0 118.4 74.9 150.6 137.1 89.7 69.3 118.0 196.6 140.3 117.6 140.7 127.9 216.4 145.5 302.4 244.8 80.9 249.0 114.0 64.3 40.3 40.7 35.6 41.6 40.8 59.2 45.9 43.7 46.8 53.4 44.1 47.5 18.3 60.4 40.7 76.7 52.9 13.1 40.0 42.3 41.5 51.7 39.8 45.0 44.6 47.9 46.1 41.0 44.4 47.0 92.8 60.9 54.6 16.3 93.1 175.1 112.6 86.5 49.5 56.2 174.6 114.2 95.2 108.7 79.7 145.3 20.9 148.7 122.8 148.0 193.7 145.2 149.7 118.6 141.0 92.2 117.3 139.5 22.0 149.6 170.8 69.2 50.0 175.5 127.4 73.1 99.2 404.3 110.7 43.7 24.1 172.9 61.1 98.7 106.6 103.4 91.0 78.5 60.5 18.7 108.5 50.1 109.2 16.6 27.4 152.3 118.6 71.1 91.9 119.0 94.9 266.4 43.1 66.8 46.0 74.1 94.3 205.4 153.4 70.6 172.0 247.1 88.5 54.7 180.6 102.8 SPG11 "ALS5, FLJ21439, KIAA1840" ENSG00000104133 "SPG11 vesicle trafficking associated, spatacsin" Q96JI7 15 44562696-44663678 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 121.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040412, HPA040947" Approved Supported "Nucleoli,Plasma membrane,Cytosol" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" "Plasma membrane, Cytosol" Nucleoli "HPA040412: AB_10795418, HPA040947: AB_10796232" "unprognostic (1.10e-1)" "unprognostic (1.74e-1)" "unprognostic (2.39e-1)" "unprognostic (1.98e-3)" "unprognostic (1.99e-1)" "unprognostic (9.31e-2)" "unprognostic (2.91e-1)" "unprognostic (2.32e-1)" "unprognostic (6.71e-2)" "unprognostic (2.26e-3)" "unprognostic (2.58e-2)" "unprognostic (9.19e-2)" "prognostic favorable (6.28e-5)" "unprognostic (8.73e-2)" "unprognostic (2.48e-1)" "unprognostic (3.72e-1)" "unprognostic (6.06e-2)" 21.1 27.1 18.4 18.2 25.7 27.4 21.6 24.4 21.3 21.5 23.9 25.6 17.1 17.9 25.3 25.6 20.2 16.1 25.5 17.5 22.2 25.0 29.8 24.8 28.4 23.8 22.1 21.4 28.6 26.7 21.3 14.9 23.9 25.3 19.9 30.5 24.7 15.0 22.9 30.4 30.1 12.7 19.1 43.0 26.0 25.5 24.6 23.7 30.9 14.3 18.6 23.8 22.6 33.4 13.2 8.8 21.9 21.6 33.7 33.0 15.8 13.4 17.4 13.0 16.6 10.8 12.5 9.7 16.5 18.2 22.5 29.0 15.1 20.8 12.5 29.3 9.0 22.1 21.1 16.4 23.7 22.2 19.2 25.3 23.3 10.7 30.5 20.4 18.6 16.6 28.8 24.2 18.6 11.5 10.1 19.7 11.5 40.3 11.6 12.9 18.5 10.6 28.0 33.6 14.2 16.8 14.6 23.3 13.1 18.0 22.0 30.2 19.9 17.1 8.5 21.4 16.5 23.8 22.6 19.2 17.6 28.8 17.9 5.7 7.7 11.8 6.5 9.2 6.9 10.0 5.4 4.9 6.2 11.3 4.3 5.3 11.6 6.2 12.4 6.3 6.1 3.7 18.4 25.7 24.4 21.3 17.5 22.2 23.8 22.1 23.9 19.1 24.6 33.4 21.0 44.8 22.2 56.2 40.4 9.3 15.6 18.8 14.2 25.1 19.0 12.6 20.1 18.6 31.3 27.6 47.9 16.5 30.1 29.3 5.9 21.3 28.2 31.7 23.2 17.6 20.0 22.3 62.9 16.9 10.1 19.3 37.2 33.6 27.3 31.9 21.8 23.5 20.1 16.8 68.1 31.2 26.4 43.3 23.5 33.2 17.7 40.4 14.2 74.9 88.1 14.0 50.4 68.3 121.4 17.7 24.0 13.9 21.4 19.3 30.8 14.9 53.6 21.7 6.6 24.8 16.3 51.7 31.6 20.1 11.1 9.3 29.5 24.4 27.3 22.2 PATL2 Pat1a ENSG00000229474 "PAT1 homolog 2" C9JE40 15 44665732-44711316 "Disease related genes, Human disease related genes, Predicted intracellular proteins" RNA-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 7.7;lymphoid tissue: 17.2" "Cell type enhanced" "Detected in many" "B-cells: 29.2;dendritic cells: 19.1;NK-cells: 51.5;Plasma cells: 15.7;T-cells: 29.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "gdT-cell: 21.6;memory CD4 T-cell: 6.0;memory CD8 T-cell: 17.7;naive CD8 T-cell: 12.8" "Lineage enriched" "Detected in many" 6 "T-cells: 21.6" "Cell line enriched" "Detected in some" 28 "U-266/70: 124.9" "Not detected" "Not detected" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 16: Immune cells - Immune response" "Cluster 29: U-266 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "unprognostic (1.28e-2)" "unprognostic (8.59e-3)" "unprognostic (3.30e-3)" "unprognostic (5.55e-2)" "unprognostic (7.28e-2)" "unprognostic (1.11e-2)" "unprognostic (3.00e-3)" "unprognostic (7.82e-2)" "unprognostic (3.69e-1)" "unprognostic (1.75e-2)" "unprognostic (1.44e-2)" "unprognostic (9.48e-2)" "unprognostic (1.35e-3)" "unprognostic (2.27e-1)" "unprognostic (1.51e-1)" "unprognostic (1.20e-1)" "unprognostic (9.69e-4)" 0.9 1.1 0.8 7.7 1.1 7.7 1.3 0.6 0.8 0.3 1.5 2.1 2.4 1.1 1.7 0.6 1.4 2.3 0.7 0.7 0.8 0.5 1.7 3.9 17.2 1.8 1.1 0.9 0.6 0.4 0.2 1.0 1.1 0.8 2.5 0.1 2.5 0.6 0.3 2.7 3.2 0.8 0.9 13.9 3.2 0.5 1.2 3.6 0.7 0.0 10.8 2.1 0.2 1.4 0.2 0.0 0.0 0.1 0.0 1.1 2.8 0.1 0.4 0.9 0.9 0.6 1.2 0.9 0.1 0.3 1.8 1.3 0.1 0.2 0.5 2.1 0.0 1.2 0.0 0.1 0.5 0.5 0.7 1.2 0.1 0.5 0.3 0.2 0.0 1.4 0.2 4.5 0.3 0.3 0.1 1.4 0.4 0.1 0.1 1.8 0.0 0.5 0.1 0.4 0.1 0.0 0.0 1.3 0.1 0.2 0.1 0.9 0.6 0.3 0.0 0.8 0.0 124.9 4.3 0.4 1.2 3.1 0.4 1.5 0.3 2.6 21.6 0.7 3.2 3.3 6.0 17.7 0.7 3.5 3.6 12.8 1.6 2.7 0.5 0.6 0.9 3.7 0.8 1.1 0.6 0.8 0.7 0.8 1.8 1.1 1.1 0.9 1.2 1.4 1.4 3.2 1.7 1.6 29.2 0.9 0.6 0.5 0.6 0.0 0.6 0.6 11.7 0.0 0.4 0.0 0.0 0.2 19.1 2.0 0.0 0.4 0.3 2.4 1.0 1.8 0.0 3.0 0.3 0.6 0.5 1.9 8.2 0.8 0.0 1.2 1.4 1.0 2.0 0.0 0.4 1.4 0.0 4.8 2.3 0.0 0.3 5.6 0.0 3.7 5.2 0.0 51.5 0.5 1.3 0.4 0.3 0.0 15.7 0.6 2.2 0.4 8.5 0.0 0.0 1.0 2.6 0.1 0.4 1.4 0.9 0.3 29.8 1.8 0.9 1.3 B2M ENSG00000166710 Beta-2-microglobulin P61769 15 44711487-44718851 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters" Immunity "Amyloidosis, Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "monocytes: 31919.3;NK-cells: 24726.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002572, HPA006361" Enhanced Enhanced "Golgi apparatus,Plasma membrane,Cytosol" "Secreted to blood" NA NA 1790000000 2100000000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 64: Macrophages - Immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 3: Monocytes - Immune response regulation" "Golgi apparatus, Plasma membrane" Cytosol "CAB002572: AB_563434, HPA006361: AB_1078278" "unprognostic (9.45e-2)" "unprognostic (5.63e-2)" "unprognostic (3.02e-1)" "unprognostic (8.14e-2)" "unprognostic (1.18e-1)" "unprognostic (4.82e-2)" "unprognostic (1.81e-2)" "unprognostic (1.25e-1)" "unprognostic (2.69e-2)" "unprognostic (1.12e-1)" "unprognostic (2.44e-3)" "unprognostic (2.02e-2)" "unprognostic (4.77e-2)" "unprognostic (2.39e-1)" "unprognostic (5.25e-2)" "unprognostic (1.97e-2)" "unprognostic (2.17e-2)" 3160.2 3214.7 697.6 5686.5 705.1 7839.2 2606.9 711.8 1145.0 2539.9 789.6 5139.0 5180.7 2192.2 1735.6 2283.9 1648.3 4948.8 2327.2 651.0 769.9 2462.6 6206.2 6159.2 9311.8 889.5 763.2 1945.7 1310.9 1940.5 318.4 3502.0 815.3 2345.0 5593.5 139.3 5657.1 1784.5 931.7 3015.6 5693.3 2545.3 838.3 7896.1 4878.2 615.6 771.9 4217.4 2340.8 2026.5 5333.4 5753.1 549.4 909.5 1735.4 378.9 226.0 633.6 4348.7 4719.4 1662.5 2045.5 4961.9 3609.7 6561.4 425.3 5417.9 554.8 2567.9 1948.8 2410.2 2537.0 497.2 878.7 1226.2 4762.2 435.9 2956.9 2263.6 600.3 3609.3 2074.5 3328.6 2735.9 609.8 1075.7 1044.4 2442.6 1884.1 965.4 611.9 3649.1 2195.5 476.9 1518.4 3213.8 206.5 629.8 1014.3 2240.2 1926.6 4789.2 2425.5 3486.4 254.1 179.1 1288.4 1571.2 1338.5 394.3 655.3 6180.6 2548.7 4531.4 676.5 5389.2 2193.3 4771.7 7118.6 1683.1 5384.6 3783.6 2567.3 48105.4 18117.1 33178.9 20639.1 17775.0 20836.8 15768.0 23783.0 22245.1 9978.8 11988.4 17122.9 22791.8 50453.6 18779.6 19034.9 12052.6 29659.1 56957.2 697.6 705.1 711.8 1145.0 651.0 769.9 889.5 763.2 815.3 838.3 771.9 909.5 12048.3 3387.8 3505.1 28.7 8472.8 7843.7 3197.1 8420.8 1628.8 33.3 2399.5 2015.2 1068.8 3593.1 5347.4 2100.3 27.1 1354.6 14028.8 8753.6 1038.9 13898.6 43.1 2073.7 2414.0 8385.6 2266.0 2087.2 7.3 9034.5 4397.5 3691.1 1981.7 2282.2 3029.5 1270.6 6835.7 3832.6 11985.7 5.0 22.0 5982.6 8701.4 12536.8 14507.0 158.8 3018.0 10687.9 6744.8 368.2 31919.3 322.0 24726.3 95.0 129.2 10115.7 7085.6 1688.8 11026.6 5300.4 18327.7 3122.5 8367.9 52.5 4016.7 2055.2 4107.1 64.2 72.1 1541.4 8619.8 804.8 14266.2 3229.8 3063.4 8248.6 TRIM69 "RNF36, Trif, TRIMLESS" ENSG00000185880 "Tripartite motif containing 69" Q86WT6 15 44728988-44767829 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 35.0" "Cell type enhanced" "Detected in all" "Early spermatids: 213.2;Late spermatids: 93.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "T-reg: 4.2" "Lineage enriched" "Detected in single" 7 "T-cells: 4.2" "Cell line enhanced" "Detected in some" "Karpas-707: 2.4;U-266/70: 8.2;U-266/84: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA028894 Enhanced NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 78: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA028894: AB_10603136" "unprognostic (4.82e-3)" "unprognostic (1.23e-2)" "unprognostic (4.10e-1)" "unprognostic (2.01e-1)" "unprognostic (1.75e-2)" "unprognostic (4.20e-1)" "unprognostic (9.27e-2)" "unprognostic (4.95e-2)" "unprognostic (6.49e-2)" "unprognostic (3.53e-3)" "unprognostic (1.38e-1)" "unprognostic (3.72e-2)" "prognostic favorable (2.26e-5)" "unprognostic (4.79e-2)" "unprognostic (1.82e-1)" "unprognostic (1.91e-2)" "unprognostic (1.49e-2)" 0.8 0.8 5.2 0.4 5.2 0.2 0.8 4.7 7.1 0.9 4.5 1.2 0.4 0.6 0.4 0.7 0.8 0.5 2.8 5.0 5.1 1.6 1.5 1.3 0.9 5.2 5.0 0.8 0.4 0.3 1.5 0.2 5.1 0.8 0.5 0.6 0.8 0.2 5.9 1.0 1.3 0.6 5.0 2.4 0.7 35.0 5.0 0.5 0.6 6.0 1.2 0.7 0.8 5.4 0.1 0.1 0.2 0.6 0.2 0.7 0.0 0.1 0.3 0.8 1.3 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.4 1.7 0.0 0.2 0.1 0.0 0.7 0.0 0.1 0.9 0.6 0.1 0.1 1.1 0.2 0.7 0.0 2.4 0.2 0.0 0.0 0.1 0.1 0.4 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.4 0.2 8.2 2.3 1.4 0.2 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.6 0.6 0.8 0.9 0.0 0.0 0.2 0.6 0.1 0.0 0.2 0.0 4.2 0.1 5.2 5.2 4.7 7.1 5.0 5.1 5.2 5.0 5.1 5.0 5.0 5.4 41.8 6.4 5.1 9.4 22.1 21.3 21.3 8.0 12.0 10.8 9.3 9.1 60.2 8.6 11.0 9.2 4.2 6.1 20.4 16.5 41.1 42.1 213.2 9.0 12.2 22.2 4.2 5.7 16.0 16.0 4.2 17.8 13.7 10.6 14.0 10.5 11.4 5.1 36.3 23.5 9.8 7.5 8.2 25.4 39.7 93.9 9.3 22.6 12.4 1.0 52.7 21.2 20.6 9.5 1.7 14.8 13.4 11.7 21.9 11.4 18.6 27.0 8.8 4.2 6.6 27.0 19.7 78.8 1.7 25.0 41.2 1.5 25.6 5.1 7.0 52.5 TERB2 "C15orf43, MGC33951" ENSG00000167014 "Telomere repeat binding bouquet formation protein 2" Q8NHR7 15 44956687-44979229 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 22.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA041780 Uncertain Nucleoplasm,Nucleoli No NA "Cluster 83: Testis - Spermatogenesis" Nucleoli Nucleoplasm "HPA041780: AB_10796460" "unprognostic (1.42e-3)" "unprognostic (4.19e-2)" "unprognostic (1.29e-1)" "unprognostic (3.62e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SORD ENSG00000140263 "Sorbitol dehydrogenase" Q00796 15 45023147-45077185 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease variant, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix: 163.8;liver: 247.0" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 138.7;Hepatocytes: 649.4;Prostatic glandular cells: 218.8;Proximal tubular cells: 270.2" "Group enriched" "Detected in all" 4 "liver cancer: 30.3;prostate cancer: 72.5;thyroid cancer: 30.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 10 "basophil: 86.3;eosinophil: 55.9" "Lineage enriched" "Detected in all" 12 "granulocytes: 86.3" "Cell line enhanced" "Detected in many" "SK-BR-3: 57.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040260, HPA040621" Enhanced Approved Cytosol NA NA 2800000 "Cluster 52: Eosinophils - Transcription" "Cluster 85: Liver - Metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol "HPA040260: AB_10794872, HPA040621: AB_10795384" "unprognostic (8.18e-2)" "unprognostic (7.58e-2)" "unprognostic (8.19e-2)" "unprognostic (1.51e-1)" "unprognostic (5.69e-3)" "unprognostic (3.90e-2)" "prognostic favorable (6.14e-5)" "unprognostic (3.33e-3)" "unprognostic (1.67e-1)" "unprognostic (4.95e-2)" "unprognostic (7.04e-3)" "unprognostic (1.40e-1)" "unprognostic (4.26e-2)" "unprognostic (1.23e-2)" "unprognostic (8.53e-2)" "unprognostic (2.31e-2)" "unprognostic (1.56e-1)" 2.0 15.7 4.9 3.1 3.8 2.8 53.8 7.4 8.4 163.8 1.9 5.3 7.5 4.3 6.9 10.2 6.7 8.2 5.6 5.0 4.5 50.3 247.0 3.2 2.6 4.3 3.7 2.4 5.7 4.4 3.1 2.5 4.0 87.9 7.8 4.8 5.3 27.0 2.2 16.6 7.2 3.5 4.2 2.3 9.2 12.2 3.9 3.7 89.4 2.8 3.4 9.1 6.9 6.3 12.3 12.2 4.7 20.8 4.4 5.3 5.9 1.8 3.5 12.2 7.0 12.2 5.8 2.7 8.0 5.4 4.1 17.6 19.9 19.1 9.2 29.9 12.3 13.5 12.1 50.3 0.2 18.0 25.5 6.7 18.0 6.6 9.5 5.4 12.5 15.1 11.7 10.6 14.9 8.1 18.4 38.3 39.0 29.4 13.8 0.9 16.6 6.4 16.8 12.1 25.1 12.2 2.1 57.3 5.9 5.2 16.4 22.5 4.7 3.5 38.0 1.6 5.8 8.7 4.5 4.4 14.2 18.6 10.6 86.3 1.7 55.9 1.6 1.5 1.7 5.4 1.3 1.6 1.7 6.9 1.6 1.4 3.8 1.1 2.1 2.4 2.5 2.0 4.9 3.8 7.4 8.4 5.0 4.5 4.3 3.7 4.0 4.2 3.9 6.3 3.9 0.0 3.1 5.5 11.9 7.8 26.5 14.8 17.6 10.8 24.7 17.5 3.2 25.8 28.1 33.1 0.0 1.3 2.3 15.0 29.4 68.2 31.7 40.2 17.4 4.9 84.8 37.5 4.8 138.7 5.1 7.5 31.1 43.7 8.8 11.5 15.7 649.4 16.0 3.3 5.4 32.5 22.4 24.2 6.4 24.1 3.7 12.2 16.0 1.0 13.3 9.0 2.1 7.1 8.9 89.0 18.1 6.0 7.9 218.8 8.0 270.2 42.5 4.7 0.0 8.9 8.9 7.4 2.8 35.1 20.3 1.0 6.5 15.3 39.4 131.2 DUOX2 "LNOX2, P138-TOX, P138(TOX), THOX2" ENSG00000140279 "Dual oxidase 2" Q9NRD8 15 45092650-45114172 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Hydrogen peroxide, Thyroid hormones biosynthesis" "Oxidoreductase, Peroxidase" "Congenital hypothyroidism, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 290.2;thyroid gland: 75.7;urinary bladder: 92.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 159.3;Ductal cells: 225.2;Exocrine glandular cells: 125.5;Gastric mucus-secreting cells: 85.1;Pancreatic endocrine cells: 411.7;Urothelial cells: 110.4" "Cancer enhanced" "Detected in many" "thyroid cancer: 60.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "HaCaT: 6.3" "Region enhanced" "Detected in single" "basal ganglia: 1.2" "Not detected" "Not detected" NA NA "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 16: Pancreatic endocrine cells - Mixed function" "unprognostic (3.19e-1)" "unprognostic (7.51e-2)" "unprognostic (3.77e-2)" "unprognostic (5.99e-2)" "unprognostic (1.09e-1)" "unprognostic (1.40e-2)" "unprognostic (7.93e-2)" "unprognostic (3.32e-1)" "unprognostic (1.42e-1)" "unprognostic (4.49e-2)" "unprognostic (9.59e-3)" "unprognostic (7.11e-2)" "unprognostic (5.32e-5)" "unprognostic (1.71e-1)" "unprognostic (1.62e-2)" "unprognostic (4.12e-2)" "unprognostic (1.63e-2)" 0.5 1.4 0.0 21.5 0.1 0.0 0.6 0.1 0.3 2.8 0.0 11.6 1.5 0.2 3.1 21.5 0.5 290.2 0.8 0.1 0.1 0.7 0.8 2.5 0.1 0.2 0.6 0.5 1.2 0.2 0.1 0.0 0.1 11.8 5.5 0.0 4.6 1.9 0.0 4.9 8.3 2.7 0.1 0.0 42.3 1.4 0.1 0.0 75.7 0.0 4.2 92.8 21.7 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 6.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.1 0.2 0.6 0.1 0.1 0.1 0.3 0.1 48.1 36.9 0.0 3.0 1.9 5.2 11.7 1.8 0.4 0.6 0.6 1.9 54.3 31.5 0.0 0.0 0.1 0.0 159.3 0.0 225.2 0.6 1.0 0.5 5.6 1.2 0.0 0.1 125.5 0.0 5.1 85.1 3.5 32.8 0.1 0.4 0.1 0.1 0.0 0.1 10.1 4.1 0.0 0.4 0.3 0.3 3.9 0.0 0.0 5.2 0.2 0.0 0.0 0.1 411.7 45.5 0.0 0.8 4.5 2.9 0.0 43.4 0.3 0.0 0.2 2.7 0.9 1.0 3.6 1.8 0.0 4.6 0.1 34.7 110.4 DUOXA2 ENSG00000140274 "Dual oxidase maturation factor 2" Q1HG44 15 45114326-45118421 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Protein transport, Transport" "Congenital hypothyroidism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 63.9;urinary bladder: 41.9" "Cell type enhanced" "Detected in some" "Ductal cells: 856.3;Exocrine glandular cells: 178.0;Pancreatic endocrine cells: 696.7;Urothelial cells: 552.0" "Cancer enhanced" "Detected in many" "pancreatic cancer: 27.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-2 OS: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA063548 Enhanced NA NA "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 9: U-2 OS - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "HPA063548: AB_2685037" "unprognostic (1.87e-1)" "unprognostic (9.88e-2)" "unprognostic (7.37e-2)" "unprognostic (6.45e-2)" "unprognostic (1.72e-1)" "unprognostic (2.00e-3)" "unprognostic (6.73e-2)" "unprognostic (2.03e-1)" "unprognostic (2.10e-1)" "unprognostic (3.15e-2)" "unprognostic (1.26e-2)" "unprognostic (1.17e-1)" "unprognostic (3.67e-4)" "unprognostic (9.75e-2)" "unprognostic (3.11e-1)" "unprognostic (1.37e-1)" "unprognostic (5.54e-2)" 0.1 0.3 0.0 5.9 0.0 0.0 0.1 0.0 0.0 0.6 0.0 2.1 0.4 0.0 0.0 5.6 0.0 63.9 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.9 0.1 0.0 1.5 0.0 0.0 0.0 2.1 0.2 0.0 0.0 15.9 0.0 0.0 0.0 11.4 0.0 0.6 41.9 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 1.1 0.0 2.2 0.0 28.1 46.4 0.0 0.0 0.0 0.0 0.9 12.8 32.7 0.0 0.0 0.0 0.0 85.2 0.0 856.3 0.0 0.3 0.1 1.0 0.0 0.0 0.0 178.0 0.0 0.5 57.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 4.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 10.9 0.0 0.0 0.0 0.1 696.7 61.8 0.0 0.0 14.2 0.9 0.1 106.7 0.0 0.0 0.0 7.1 0.3 0.2 0.0 0.0 0.0 0.6 0.2 23.8 552.0 DUOXA1 "FLJ32334, mol, NIP, NUMBIP" ENSG00000140254 "Dual oxidase maturation factor 1" Q1HG43 15 45117367-45129938 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 189.0;skin 1: 91.6;thyroid gland: 111.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 60.9;Alveolar cells type 2: 118.0;Club cells: 35.5;Glandular and luminal cells: 47.7;Respiratory ciliated cells: 36.9;Squamous epithelial cells: 53.6;Urothelial cells: 44.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 30.4" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HaCaT: 103.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA041578 Approved NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 11: Alveolar cells - Smell perception" "HPA041578: AB_10795691" "unprognostic (1.28e-1)" "unprognostic (1.32e-3)" "unprognostic (1.88e-1)" "unprognostic (2.66e-2)" "unprognostic (2.71e-1)" "unprognostic (6.87e-3)" "unprognostic (1.03e-1)" "unprognostic (4.45e-2)" "unprognostic (6.69e-2)" "unprognostic (3.68e-2)" "unprognostic (5.82e-2)" "unprognostic (1.86e-1)" "unprognostic (2.17e-5)" "unprognostic (8.11e-2)" "unprognostic (1.12e-2)" "unprognostic (4.69e-2)" "unprognostic (5.36e-2)" 1.1 5.0 0.2 1.3 0.5 0.1 4.0 0.7 1.1 32.1 0.0 0.9 0.8 4.6 49.3 189.0 5.7 4.3 2.1 0.5 0.3 0.8 0.3 64.3 0.1 0.6 0.1 1.1 0.4 5.0 0.7 0.8 0.8 21.6 0.5 0.1 27.5 12.0 0.5 91.6 0.8 0.2 0.1 0.1 43.6 0.2 0.7 0.7 111.1 0.0 17.9 23.3 77.4 2.9 10.6 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 103.9 0.0 0.2 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 14.5 0.0 0.3 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.7 1.1 0.5 0.3 0.6 0.1 0.8 0.1 0.7 2.9 0.0 60.9 118.0 1.0 0.0 9.4 18.8 26.9 18.2 0.6 1.4 1.7 0.5 0.0 35.5 0.0 2.1 2.4 0.0 3.3 0.0 2.0 0.1 28.7 4.0 0.8 3.0 0.0 0.7 3.1 0.1 1.6 8.6 47.7 1.3 0.3 0.0 0.0 0.3 0.0 0.4 0.1 4.1 0.0 1.2 0.0 0.3 0.8 0.0 0.0 0.6 0.1 0.0 0.5 1.8 1.9 3.3 0.0 0.0 13.4 0.0 0.0 36.9 0.1 0.0 0.7 1.1 0.0 0.9 53.6 21.9 3.0 0.6 0.1 0.4 44.2 DUOX1 "LNOX1, NOXEF1, THOX1" ENSG00000137857 "Dual oxidase 1" Q9NRD9 15 45129933-45165576 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrogen peroxide, Thyroid hormones biosynthesis" "Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 108.5;skin 1: 81.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 83.3;Alveolar cells type 2: 168.6;Endometrial ciliated cells: 67.1;Glandular and luminal cells: 88.5;Respiratory ciliated cells: 64.9" "Cancer enhanced" "Detected in many" "thyroid cancer: 32.4" "Group enriched" "Detected in many" 6 "cerebellum: 12.4;white matter: 3.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 64.4;hTCEpi: 30.5;RT4: 36.3" "Not detected" "Not detected" "Region enriched" "Detected in some" 5 "cerebellum: 9.6" HPA023544 Approved NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 44: Endometrium - Transcription" "HPA023544: AB_1847878" "unprognostic (2.85e-2)" "prognostic favorable (4.31e-6)" "unprognostic (2.49e-2)" "unprognostic (8.84e-3)" "unprognostic (1.44e-2)" "unprognostic (3.27e-2)" "unprognostic (1.23e-1)" "unprognostic (2.57e-2)" "unprognostic (5.87e-2)" "unprognostic (6.02e-3)" "unprognostic (5.13e-2)" "unprognostic (1.19e-1)" "unprognostic (8.91e-3)" "unprognostic (2.23e-1)" "unprognostic (3.06e-2)" "unprognostic (1.14e-2)" "unprognostic (3.03e-1)" 1.5 14.1 0.7 1.0 1.0 0.2 4.5 12.4 1.2 44.5 0.0 1.0 0.6 3.0 50.0 108.5 14.0 3.3 3.3 1.0 0.3 0.7 0.4 70.1 0.3 0.3 0.3 1.8 0.5 5.2 1.3 1.5 0.6 13.8 0.3 0.6 18.7 13.0 0.4 81.7 0.7 0.4 0.1 0.3 64.3 1.6 0.4 1.1 70.4 0.0 14.7 11.1 42.0 3.2 8.3 0.1 0.5 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 64.4 0.0 6.1 0.0 0.8 0.4 0.0 0.9 0.1 0.0 0.0 0.3 0.0 30.5 0.0 1.9 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 1.2 0.1 0.0 0.0 36.3 0.8 1.5 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.2 0.0 0.0 0.1 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 1.0 12.4 1.2 1.0 0.3 0.3 0.3 0.6 0.1 0.4 3.2 0.9 83.3 168.6 4.2 4.5 11.1 14.3 22.8 11.4 21.3 4.7 2.8 2.4 8.6 32.5 3.7 8.4 5.3 7.6 2.5 0.0 3.8 0.7 67.1 9.4 3.8 21.7 2.7 5.1 5.4 0.6 5.1 17.9 88.5 8.2 7.9 7.9 1.5 1.2 6.7 3.9 4.0 16.2 3.1 43.5 0.3 3.4 3.3 16.0 1.0 3.2 3.5 33.0 9.5 10.6 4.7 4.0 3.8 0.1 9.5 6.8 0.5 64.9 4.4 0.0 8.5 4.7 11.5 7.5 36.4 18.0 3.7 4.5 0.4 5.6 30.0 SHF ENSG00000138606 "Src homology 2 domain containing F" Q7M4L6 15 45167214-45201175 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 143.8" "Cell type enhanced" "Detected in many" "Bipolar cells: 50.6;Granulosa cells: 58.8" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 143.8" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 121.0;SH-SY5Y: 54.1" "Region enriched" "Detected in all" 5 "cerebellum: 240.6" "Region enriched" "Detected in all" 4 "cerebellum: 106.2" HPA057381 Approved Nucleoplasm NA NA "Cluster 24: B-cells - Unknown function" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA057381: AB_2683423" "unprognostic (4.05e-2)" "unprognostic (2.02e-3)" "unprognostic (7.59e-2)" "unprognostic (1.54e-1)" "unprognostic (1.88e-2)" "unprognostic (2.18e-1)" "unprognostic (2.38e-1)" "unprognostic (7.61e-2)" "unprognostic (2.18e-1)" "unprognostic (3.50e-2)" "unprognostic (6.88e-2)" "unprognostic (5.12e-2)" "unprognostic (6.89e-2)" "unprognostic (2.83e-2)" "unprognostic (1.17e-1)" "unprognostic (5.09e-3)" "unprognostic (1.83e-2)" 6.1 22.7 21.9 4.3 20.5 1.0 6.3 143.8 27.8 14.4 0.2 13.4 13.1 11.9 4.7 5.0 10.5 6.6 9.0 21.5 19.5 4.4 38.6 5.6 2.7 12.8 16.9 23.7 3.1 4.4 8.3 1.9 15.9 10.1 5.3 7.1 6.7 5.9 3.8 12.7 8.4 7.5 9.4 4.3 6.7 8.4 21.4 2.4 7.5 4.7 1.9 10.2 11.7 13.4 0.1 1.4 24.0 0.7 1.8 0.9 11.2 3.0 2.1 6.7 9.5 3.6 11.6 1.3 9.5 4.2 6.6 2.1 9.2 0.7 3.2 2.2 4.2 0.8 2.2 24.8 1.0 0.1 8.0 2.2 0.6 0.9 0.2 5.0 5.2 12.0 5.0 0.5 9.5 4.1 5.5 0.9 9.6 4.5 0.6 15.0 19.1 0.5 2.3 0.5 121.0 54.1 0.7 0.8 0.4 7.4 1.2 2.4 0.3 0.8 10.0 0.7 0.4 1.1 0.9 1.1 0.3 0.6 3.8 0.1 0.6 0.5 1.3 0.6 1.4 0.8 0.5 0.8 0.6 1.5 0.7 0.5 0.8 2.0 0.6 0.9 0.1 0.5 21.9 20.5 143.8 27.8 21.5 19.5 12.8 16.9 15.9 9.4 21.4 13.4 4.1 0.0 0.6 3.3 4.2 3.6 5.8 1.7 0.0 50.6 3.6 5.5 2.8 0.0 1.3 0.0 0.0 1.1 2.6 2.1 0.0 0.8 7.9 1.1 3.5 5.7 13.1 0.0 5.9 1.3 0.5 5.8 1.5 2.2 2.5 58.8 5.3 11.7 0.6 10.1 6.9 10.9 2.0 1.0 15.0 15.3 4.4 2.9 8.8 5.6 0.1 5.9 2.1 9.0 1.8 0.7 5.6 4.1 0.7 3.5 18.0 1.1 0.8 5.0 6.6 6.7 9.6 5.4 2.9 1.4 2.6 0.7 2.8 1.8 4.6 9.7 SLC28A2 "CNT2, HCNT2, HsT17153, SPNT1" ENSG00000137860 "Solute carrier family 28 member 2" O43868 15 45252234-45277846 "Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "intestine: 92.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 19.6;Paneth cells: 35.7;Proximal enterocytes: 43.4;Undifferentiated cells: 48.9" "Cancer enhanced" "Detected in many" "stomach cancer: 3.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046068, HPA055623" Enhanced Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Cluster 56: Intestine - Transmembrane transport" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA046068: AB_2679523, HPA055623: AB_2682866" "unprognostic (2.75e-1)" "unprognostic (2.34e-2)" "unprognostic (1.62e-3)" "unprognostic (5.46e-2)" "unprognostic (1.13e-1)" "unprognostic (6.85e-2)" "unprognostic (6.31e-2)" "unprognostic (1.59e-2)" "unprognostic (1.61e-1)" "unprognostic (6.40e-4)" "unprognostic (3.34e-3)" "unprognostic (2.63e-1)" "unprognostic (1.28e-2)" "unprognostic (2.74e-1)" "unprognostic (2.24e-1)" "unprognostic (1.44e-2)" "unprognostic (8.95e-2)" 0.1 0.3 0.4 0.7 0.4 0.1 0.0 0.3 0.4 2.6 0.0 9.5 68.0 0.5 0.4 0.1 0.1 9.8 0.3 0.3 0.1 3.5 0.8 0.1 0.3 0.4 0.0 0.3 0.3 0.0 0.0 0.6 0.4 0.1 34.6 0.7 0.2 0.0 0.3 0.3 92.3 0.0 0.1 0.2 22.8 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.2 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.3 0.4 0.3 0.1 0.4 0.0 0.4 0.1 0.2 0.6 0.5 0.0 8.1 1.6 0.9 0.1 0.4 0.4 0.0 2.9 0.3 0.0 0.7 8.6 4.5 0.0 2.1 12.3 0.3 19.6 0.0 0.1 0.7 1.0 0.4 1.0 13.9 2.7 1.8 0.0 2.7 1.0 4.6 1.2 8.8 0.7 0.7 0.3 0.9 1.7 1.5 14.5 0.0 0.3 0.4 0.4 0.0 1.3 0.0 0.0 0.2 1.0 2.1 2.0 2.0 0.0 35.7 0.7 0.4 0.2 43.4 1.2 4.6 6.6 0.0 0.3 0.2 2.4 2.1 0.0 0.3 4.7 1.3 0.2 48.9 0.2 GATM AGAT ENSG00000171766 "Glycine amidinotransferase" P50440 15 45361124-45402327 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 12 "kidney: 2099.3;liver: 2804.2;pancreas: 2935.3" "Group enriched" "Detected in many" 8 "Hepatocytes: 1495.2;Proximal tubular cells: 3703.0" "Cancer enhanced" "Detected in all" "liver cancer: 135.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "memory B-cell: 11.0;myeloid DC: 6.6;naive B-cell: 5.4;plasmacytoid DC: 6.8" "Group enriched" "Detected in many" 5 "B-cells: 11.0;dendritic cells: 6.8" "Group enriched" "Detected in many" 4 "RH-30: 210.1;RT4: 55.8;U-266/70: 126.3;U-266/84: 165.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026077 Enhanced Supported Mitochondria NA NA 600000 "Cluster 43: B-cells - Humoral immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Mitochondria "HPA026077: AB_1849528" "unprognostic (1.91e-1)" "unprognostic (1.33e-2)" "unprognostic (2.77e-2)" "unprognostic (6.57e-2)" "unprognostic (9.43e-2)" "unprognostic (1.67e-2)" "unprognostic (6.99e-3)" "unprognostic (1.04e-1)" "unprognostic (4.51e-2)" "unprognostic (3.36e-2)" "unprognostic (1.33e-1)" "unprognostic (5.67e-2)" "prognostic favorable (1.38e-4)" "unprognostic (1.09e-1)" "unprognostic (4.07e-2)" "unprognostic (3.60e-2)" "unprognostic (1.80e-1)" 14.4 21.4 133.9 12.4 138.4 1.8 25.4 152.5 216.5 9.9 94.3 19.6 175.5 8.4 10.5 25.1 11.6 47.7 57.2 131.1 140.9 2099.3 2804.2 7.3 18.4 148.0 135.4 165.2 2935.3 2.7 8.3 74.7 153.4 12.4 11.5 7.5 57.5 15.1 142.5 137.6 110.2 14.5 149.2 33.6 99.2 78.2 140.4 12.6 63.0 46.9 29.7 18.0 15.5 181.2 12.9 6.5 4.4 0.6 0.1 0.2 0.8 0.1 0.1 0.0 0.2 1.4 21.4 34.4 1.0 0.0 5.7 2.2 17.0 0.6 0.4 1.9 0.3 2.8 0.4 0.3 0.8 20.7 2.6 0.8 0.7 0.0 0.4 0.0 0.3 7.8 0.4 0.7 0.2 0.6 2.2 0.6 11.2 31.3 0.0 0.5 210.1 1.5 3.5 55.8 23.5 4.1 6.9 0.4 1.2 2.1 2.9 23.7 0.0 0.0 0.5 0.2 6.3 126.3 165.5 0.8 1.6 0.3 1.0 0.0 1.1 0.3 0.2 1.6 0.0 11.0 0.0 0.2 6.6 5.4 0.0 1.4 0.0 0.1 0.6 6.8 0.0 1.0 133.9 138.4 152.5 216.5 131.1 140.9 148.0 135.4 153.4 149.2 140.4 181.2 2.4 3.2 1.1 67.3 42.3 54.3 14.9 5.2 5.7 8.1 16.9 9.5 35.5 228.8 5.4 71.7 0.0 1.0 0.8 3.1 295.4 58.2 8.8 1.3 0.4 7.3 0.0 29.3 6.8 290.0 1.2 19.8 69.8 2.7 3.8 219.5 23.9 1495.2 89.6 8.4 3.3 3.1 2.0 80.3 80.3 18.3 4.4 50.6 23.2 20.6 3.1 19.1 2.1 57.3 196.3 97.3 3.9 3.4 7.2 6.4 98.4 3703.0 1.9 3.8 6.6 38.4 16.8 22.0 9.7 16.0 133.7 1.8 17.6 4.1 3.4 20.4 SPATA5L1 "FLJ12286, MGC5347" ENSG00000171763 "Spermatogenesis associated 5 like 1" Q9BVQ7 15 45402336-45421415 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043679 Uncertain Approved Nucleoplasm,Nucleoli NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 59: Non-specific - Translation" "Cluster 24: NB-4 - Immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm Nucleoli "HPA043679: AB_10964179" "unprognostic (6.22e-2)" "unprognostic (3.34e-2)" "unprognostic (7.03e-2)" "unprognostic (1.57e-2)" "unprognostic (9.67e-2)" "unprognostic (6.85e-2)" "unprognostic (2.46e-2)" "unprognostic (3.13e-2)" "unprognostic (3.69e-2)" "unprognostic (3.69e-1)" "unprognostic (4.97e-2)" "prognostic unfavorable (7.88e-4)" "unprognostic (5.40e-2)" "unprognostic (2.98e-2)" "unprognostic (2.55e-2)" "unprognostic (2.72e-2)" "unprognostic (4.80e-2)" 4.5 4.9 4.7 4.6 5.1 6.3 4.5 5.5 6.2 5.5 4.4 5.2 5.9 4.4 3.9 10.0 5.0 2.7 5.7 4.9 5.0 6.0 7.5 3.3 4.6 4.9 4.8 6.1 5.8 4.3 3.1 5.2 5.0 4.2 4.8 4.6 4.4 3.9 8.9 7.4 5.5 4.4 5.0 4.5 4.5 3.4 5.2 4.9 5.3 5.4 5.0 5.4 6.0 5.6 10.0 6.3 9.9 7.3 8.0 7.8 12.0 8.7 7.9 9.3 9.0 17.3 6.3 7.3 9.5 5.8 16.9 22.5 14.8 10.9 10.3 10.0 8.4 9.5 11.2 13.6 9.0 12.8 4.0 6.2 12.2 7.7 10.1 10.6 7.4 9.4 15.6 11.4 10.5 6.7 8.9 24.5 7.1 24.8 9.7 9.8 13.9 6.8 11.7 9.8 13.5 6.9 7.2 15.5 8.4 11.7 13.7 23.1 4.7 4.5 6.9 27.8 18.8 9.7 20.8 11.3 11.6 20.8 8.3 0.0 0.9 1.2 1.1 0.7 0.4 0.6 0.7 1.5 0.9 0.7 0.6 0.9 1.1 1.1 1.9 1.0 0.8 0.2 4.7 5.1 5.5 6.2 4.9 5.0 4.9 4.8 5.0 5.0 5.2 5.6 4.7 0.0 1.1 7.2 8.9 5.0 8.9 4.6 5.2 7.9 3.7 2.4 6.9 7.2 5.2 3.7 16.7 12.2 7.3 5.4 3.9 6.2 20.6 6.2 5.4 6.3 3.6 2.5 11.0 7.3 11.9 5.2 9.2 8.4 4.5 8.6 1.1 5.7 8.0 6.7 10.1 6.3 0.0 3.7 7.6 7.1 7.8 7.7 3.6 6.5 7.7 5.0 2.1 16.6 14.6 5.5 3.1 3.8 8.5 6.2 9.2 5.7 2.4 6.5 0.0 4.1 4.1 6.2 5.6 10.4 6.8 6.7 5.8 6.1 7.3 8.2 C15orf48 "COXFA4L3, MIR147BHG, NMES1" ENSG00000166920 "Chromosome 15 open reading frame 48" Q9C002 15 45430579-45448761 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 924.2" "Cell type enhanced" "Detected in many" "Distal enterocytes: 2962.4;Exocrine glandular cells: 2020.8;Langerhans cells: 2043.7;Pancreatic endocrine cells: 3493.6;Paneth cells: 2254.4;Proximal enterocytes: 2942.0;Undifferentiated cells: 1875.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "classical monocyte: 1.3;intermediate monocyte: 1.6;myeloid DC: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 70.9;CAPAN-2: 128.8;GAMG: 126.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA012943 Enhanced NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 37: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 16: Pancreatic endocrine cells - Mixed function" "HPA012943: AB_2668774" "unprognostic (5.29e-3)" "unprognostic (1.76e-1)" "unprognostic (2.08e-1)" "unprognostic (7.83e-2)" "unprognostic (1.17e-1)" "unprognostic (9.74e-3)" "unprognostic (1.48e-3)" "unprognostic (1.28e-3)" "unprognostic (1.59e-1)" "unprognostic (1.15e-1)" "unprognostic (4.93e-3)" "unprognostic (5.95e-2)" "unprognostic (8.86e-2)" "unprognostic (2.37e-1)" "unprognostic (6.51e-2)" "unprognostic (1.39e-1)" "unprognostic (3.66e-1)" 2.2 0.3 0.5 98.5 0.5 88.0 30.7 0.4 3.2 38.9 0.7 863.4 61.9 5.3 0.2 172.4 6.8 45.9 0.8 0.5 0.5 5.8 6.0 11.5 5.7 0.6 0.4 0.7 13.0 0.1 0.5 46.4 1.3 13.9 924.2 3.6 23.0 11.5 0.4 69.9 341.3 31.3 0.4 2.3 107.6 128.1 1.0 7.0 5.2 0.2 84.8 38.9 46.6 0.6 70.9 18.1 0.2 0.3 0.9 0.0 2.7 3.5 25.1 4.6 12.7 2.9 128.8 0.2 3.1 0.4 126.2 1.8 2.3 0.9 10.7 7.0 1.9 0.0 0.2 0.5 11.2 0.1 29.1 1.3 1.2 22.9 0.0 0.0 0.0 0.5 0.1 0.5 0.6 3.5 0.1 1.8 0.1 31.4 0.3 0.0 0.4 0.4 2.7 5.7 0.1 0.6 4.1 8.0 0.3 14.0 1.4 1.6 0.6 0.4 1.6 1.0 0.9 2.1 1.2 0.4 1.9 0.7 0.5 0.0 1.3 0.1 0.0 1.6 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.8 0.0 0.2 0.1 0.0 0.8 0.5 0.5 0.4 3.2 0.5 0.5 0.6 0.4 1.3 0.4 1.0 0.6 5.5 16.0 15.0 0.3 20.4 66.4 20.2 846.0 1.2 0.5 143.2 111.9 1.0 188.8 1117.6 5.5 0.0 286.2 7.4 2962.4 3.9 811.3 188.3 29.2 11.0 11.6 645.1 0.0 0.2 2020.8 450.3 16.4 250.2 67.7 33.0 0.2 1.4 3.7 398.4 114.4 0.1 1408.8 270.6 25.9 2043.7 235.4 7.2 388.4 58.7 0.0 489.4 0.7 1.0 0.5 0.4 3493.6 2254.4 7.5 4.1 200.5 2942.0 18.7 700.9 1.2 0.0 1.2 75.2 567.9 124.4 10.6 61.2 165.5 13.9 0.1 1875.4 633.4 SLC30A4 ZNT4 ENSG00000104154 "Solute carrier family 30 member 4" O14863 15 45479606-45522755 "Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "prostate: 39.9" "Cell type enhanced" "Detected in many" "Early spermatids: 76.3;Late spermatids: 78.5;Prostatic glandular cells: 39.2;Spermatocytes: 52.1" "Cancer enriched" "Detected in all" 20 "prostate cancer: 34.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 37: Intestine - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 45: Enterocytes - Digestion" "unprognostic (1.64e-2)" "unprognostic (1.40e-1)" "unprognostic (3.71e-1)" "unprognostic (9.49e-2)" "unprognostic (1.98e-1)" "unprognostic (3.29e-2)" "unprognostic (6.15e-2)" "unprognostic (9.74e-2)" "unprognostic (7.38e-3)" "unprognostic (1.51e-1)" "prognostic favorable (6.02e-4)" "unprognostic (2.66e-2)" "unprognostic (4.72e-3)" "unprognostic (1.29e-2)" "unprognostic (9.83e-2)" "unprognostic (8.28e-3)" "unprognostic (2.01e-3)" 2.8 1.8 2.6 1.9 9.3 0.8 1.9 3.1 4.5 2.8 1.5 3.2 7.0 2.9 2.7 4.2 2.0 2.0 1.9 2.7 2.4 4.2 2.5 1.8 2.7 2.2 2.6 2.5 1.8 4.1 1.5 3.4 2.4 39.9 3.1 3.7 1.3 2.2 1.7 2.5 8.5 3.4 2.1 3.0 2.0 6.3 3.8 1.0 4.7 1.9 3.4 1.8 2.5 7.3 1.8 2.1 0.6 4.7 8.3 5.8 0.4 4.5 4.1 2.7 3.8 0.3 1.5 6.9 1.5 4.7 1.1 1.2 2.0 2.1 2.5 1.7 1.8 0.1 2.0 0.1 5.3 0.1 3.5 4.9 3.4 3.6 0.9 4.2 3.2 3.2 1.0 3.8 5.1 0.8 2.4 0.3 0.1 0.4 0.4 3.6 4.0 1.1 2.2 0.4 1.5 2.3 3.0 3.4 0.8 0.6 2.9 0.2 6.1 4.0 2.3 4.9 1.5 7.0 5.5 1.7 1.7 0.2 3.1 1.3 0.1 0.1 2.2 0.1 2.1 2.0 1.5 1.3 0.2 3.5 1.5 2.1 0.5 1.3 0.1 0.2 0.2 0.7 2.6 9.3 3.1 4.5 2.7 2.4 2.2 2.6 2.4 2.1 3.8 7.3 6.7 3.2 3.9 5.5 6.6 6.8 2.2 1.1 6.8 3.2 2.8 2.2 3.1 0.0 0.1 1.8 16.7 1.0 3.9 15.2 0.0 1.3 76.3 5.0 8.4 6.9 1.2 0.4 14.0 1.1 0.9 7.5 4.6 12.7 1.3 1.9 11.0 3.3 3.1 13.5 9.4 7.1 0.0 1.6 30.8 78.5 6.2 4.4 7.2 9.4 5.3 4.3 10.3 6.0 28.8 0.7 22.0 8.2 6.0 39.2 32.4 12.5 0.7 2.2 6.6 6.2 5.2 52.1 19.9 7.4 6.5 0.3 5.4 3.6 5.1 1.7 BLOC1S6 "HPS9, PA, PLDN" ENSG00000104164 "Biogenesis of lysosomal organelles complex 1 subunit 6" Q9UL45 15 45587214-45615945 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Albinism, Disease variant, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Alveolar cells type 1: 230.8;Alveolar cells type 2: 292.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039928 Approved NA NA "Cluster 34: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 11: Alveolar cells - Smell perception" "HPA039928: AB_10673538" "unprognostic (6.90e-2)" "unprognostic (3.38e-1)" "unprognostic (7.73e-2)" "unprognostic (2.32e-2)" "unprognostic (9.92e-3)" "unprognostic (1.51e-1)" "unprognostic (8.52e-3)" "unprognostic (1.32e-1)" "unprognostic (1.03e-1)" "unprognostic (4.34e-2)" "unprognostic (4.72e-2)" "unprognostic (1.14e-1)" "unprognostic (6.44e-2)" "unprognostic (8.96e-2)" "unprognostic (2.78e-1)" "unprognostic (5.13e-2)" "unprognostic (2.50e-2)" 30.0 31.2 15.3 31.1 17.1 58.2 25.5 15.6 19.1 25.8 13.9 21.2 20.2 30.7 18.4 21.0 18.1 26.5 25.1 17.0 22.7 24.2 26.8 20.4 41.9 14.8 18.6 37.8 20.4 16.8 19.0 26.3 17.7 36.4 21.5 24.6 20.7 20.4 23.6 18.2 21.3 24.3 13.8 27.9 20.1 17.0 19.2 25.2 44.4 23.2 35.4 28.5 15.6 16.8 31.5 15.9 38.9 46.2 70.1 57.0 22.2 59.0 58.4 28.5 30.4 37.6 15.9 78.1 36.2 47.5 42.6 27.6 41.7 43.2 36.6 52.8 22.0 79.8 34.9 26.2 44.1 82.2 112.9 44.6 36.7 30.7 55.9 43.8 42.4 54.7 62.4 78.7 50.7 11.8 40.0 38.6 22.5 31.4 22.4 55.8 60.3 43.9 36.6 47.9 29.3 49.4 32.7 21.2 33.9 36.8 33.8 83.2 49.0 68.6 35.6 68.6 55.7 81.2 134.8 102.4 69.5 57.1 62.5 19.3 12.5 10.5 7.5 12.6 10.5 12.9 7.3 7.7 16.8 12.8 9.0 10.2 6.0 7.0 11.1 8.1 6.7 8.9 15.3 17.1 15.6 19.1 17.0 22.7 14.8 18.6 17.7 13.8 19.2 16.8 42.0 230.8 292.6 13.7 59.6 34.5 38.7 21.5 39.3 59.8 33.5 30.4 38.4 21.5 126.0 18.4 37.5 26.0 58.9 15.9 37.2 29.9 37.2 36.2 81.8 54.8 62.1 57.4 31.8 33.0 25.6 75.9 22.4 58.7 197.7 38.0 35.0 36.6 37.6 50.5 27.3 30.4 12.2 67.9 123.0 28.4 28.0 97.6 26.6 17.8 80.4 54.0 40.2 22.6 31.0 40.1 25.9 37.2 67.7 71.8 21.2 60.4 141.5 46.7 19.7 52.1 39.2 51.8 37.8 36.9 32.8 22.0 56.1 34.5 24.7 34.4 AC090527.2 ENSG00000260170 "Novel protein" 15 45587351-45676314 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in many" "neutrophil: 6.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HBEC3-KT: 1.3;THP-1: 1.1" HPA041589 Approved NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 43: THP-1 - Innate immune response" "Cluster 11: Alveolar cells - Smell perception" "HPA041589: AB_2677565" "unprognostic (5.93e-2)" "unprognostic (1.18e-1)" "unprognostic (2.03e-2)" "unprognostic (1.54e-1)" 0.1 0.0 0.1 0.0 0.2 0.4 0.1 0.0 0.2 0.0 0.2 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 1.3 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 1.1 0.0 0.7 0.0 0.7 0.1 0.0 0.1 0.0 0.0 0.3 0.2 2.2 1.7 0.9 0.8 0.8 1.0 0.7 0.7 0.3 0.0 1.3 1.6 0.4 6.2 0.0 0.9 0.5 1.2 0.4 0.1 0.2 0.0 0.2 0.2 0.1 0.1 0.2 0.2 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SQOR "CGI-44, SQR, SQRDL" ENSG00000137767 "Sulfide quinone oxidoreductase" Q9Y6N5 15 45631148-45691281 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 210.0" "Cell type enhanced" "Detected in many" "Ductal cells: 118.1;Exocrine glandular cells: 176.2;Hofbauer cells: 134.3;monocytes: 154.5;Pancreatic endocrine cells: 156.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 304.0" "HPA017079, HPA041589" Enhanced Supported Mitochondria NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 37: Intestine - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA017079: AB_1857467, HPA041589: AB_2677565" "unprognostic (6.15e-2)" "unprognostic (3.28e-2)" "unprognostic (2.15e-1)" "prognostic favorable (2.57e-4)" "unprognostic (2.75e-2)" "unprognostic (5.51e-2)" "unprognostic (6.68e-3)" "prognostic unfavorable (8.80e-4)" "unprognostic (1.81e-1)" "unprognostic (3.77e-1)" "unprognostic (6.65e-3)" "unprognostic (2.37e-1)" "unprognostic (3.14e-3)" "unprognostic (2.29e-1)" "unprognostic (4.92e-2)" "unprognostic (7.44e-2)" "unprognostic (4.38e-1)" 46.4 22.6 14.5 59.5 14.6 55.6 41.2 14.6 19.7 36.3 17.2 210.0 57.7 18.8 19.3 112.9 26.6 31.4 22.0 13.6 14.7 36.6 82.6 61.5 38.2 16.7 15.1 8.8 39.8 24.1 12.5 17.6 15.6 41.2 178.8 4.9 56.3 27.8 132.8 41.7 55.9 43.2 15.9 47.3 54.4 5.1 15.8 23.7 32.5 43.7 57.7 48.8 50.3 17.2 38.3 68.0 0.1 3.9 125.5 151.4 0.4 40.8 132.3 23.6 35.7 2.7 59.0 33.7 38.7 29.9 72.6 33.3 2.0 304.0 13.9 121.7 1.1 3.0 14.5 48.2 38.8 20.2 5.1 45.2 88.2 54.9 119.8 59.4 66.1 32.0 0.4 40.6 24.6 31.3 12.2 44.9 0.0 147.7 41.8 1.4 6.7 47.1 184.9 55.2 1.2 1.2 10.1 25.8 13.1 0.8 56.9 61.7 76.8 9.7 2.2 131.6 9.0 53.5 61.0 2.0 96.9 104.6 10.9 112.5 212.1 84.6 76.6 161.0 104.6 54.3 97.9 83.6 135.2 48.6 51.8 55.2 302.5 53.4 152.4 40.5 149.0 169.6 14.5 14.6 14.6 19.7 13.6 14.7 16.7 15.1 15.6 15.9 15.8 17.2 24.4 32.1 64.1 0.0 5.8 0.0 0.0 0.0 0.0 0.0 31.4 14.7 0.0 0.0 14.9 14.7 0.0 0.7 19.8 0.0 11.7 118.1 0.0 15.9 7.0 13.9 0.0 0.0 0.0 176.2 0.9 11.3 0.0 37.6 11.4 1.3 0.0 0.0 134.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.3 0.0 0.0 154.5 0.0 0.0 0.0 0.0 156.2 0.0 0.0 3.3 0.0 0.0 45.8 24.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.8 13.5 1.6 0.0 0.0 SEMA6D "FLJ11598, KIAA1479" ENSG00000137872 "Semaphorin 6D" Q8NFY4 15 47184101-47774228 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 38.5;placenta: 43.1" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 114.7;Excitatory neurons: 120.7;Horizontal cells: 79.1;Inhibitory neurons: 319.5;Oligodendrocytes: 140.1" "Cancer enriched" "Detected in many" 4 "glioma: 8.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 14.9;SCLC-21H: 13.3;SH-SY5Y: 12.1;SuSa: 14.2;U-266/70: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043109 Approved "Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA 1100000 "Cluster 45: Intestine - Brush border" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane" "Golgi apparatus" "HPA043109: AB_10793941" "unprognostic (2.00e-1)" "unprognostic (4.62e-2)" "unprognostic (3.10e-2)" "unprognostic (3.83e-3)" "unprognostic (1.38e-1)" "unprognostic (3.85e-2)" "unprognostic (1.98e-1)" "unprognostic (2.17e-3)" "unprognostic (1.24e-1)" "unprognostic (5.36e-2)" "unprognostic (7.96e-4)" "unprognostic (1.42e-1)" "prognostic favorable (5.96e-5)" "unprognostic (3.74e-2)" "unprognostic (8.56e-2)" "unprognostic (3.30e-3)" "unprognostic (2.39e-4)" 5.5 1.5 11.3 3.9 27.9 0.4 5.0 11.1 21.3 5.8 0.0 10.6 21.8 1.6 2.5 1.7 4.9 4.0 9.4 9.8 16.3 15.1 3.1 8.9 2.1 17.2 31.1 26.7 16.1 10.6 5.5 43.1 23.1 4.5 12.7 15.8 4.5 8.4 20.9 3.0 38.5 3.3 12.0 2.5 3.0 2.6 20.5 2.7 5.8 6.0 0.6 3.1 10.0 28.8 0.0 0.0 2.5 0.0 1.5 1.2 0.2 0.6 14.9 0.4 0.0 0.3 0.1 2.2 0.0 4.0 0.0 7.6 3.4 1.1 0.1 1.1 1.7 0.0 5.0 0.0 4.0 0.0 0.2 1.1 8.3 0.0 0.5 0.0 1.0 5.7 0.1 3.4 0.4 0.8 2.8 0.7 4.6 0.0 0.0 1.6 0.1 2.4 1.1 1.1 13.3 12.1 0.1 1.0 4.3 14.2 0.5 0.0 0.0 6.9 0.3 0.2 0.0 10.0 0.0 2.3 1.8 0.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 11.3 27.9 11.1 21.3 9.8 16.3 17.2 31.1 23.1 12.0 20.5 28.8 13.9 51.3 1.5 72.8 0.2 2.0 4.0 1.4 1.2 6.2 0.5 10.7 10.0 4.3 2.1 11.0 114.7 19.7 0.1 40.6 5.9 1.0 0.2 0.5 2.3 10.1 17.4 0.0 120.7 0.2 1.8 10.8 0.0 0.3 3.8 71.0 5.0 0.9 2.6 79.1 319.5 5.4 0.0 0.0 1.9 1.2 23.3 1.0 8.8 15.9 0.0 9.3 0.0 43.2 140.1 0.3 8.5 13.5 0.0 1.2 53.5 0.2 0.1 2.3 0.0 9.3 13.9 0.8 6.3 0.3 1.1 4.7 0.2 3.4 15.1 1.6 SLC24A5 "JSX, OCA6" ENSG00000188467 "Solute carrier family 24 member 5" Q71RS6 15 48120990-48142672 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport" Albinism "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 8.2" "Group enriched" "Detected in some" 7 "Early spermatids: 20.7;Melanocytes: 76.5" "Cancer enriched" "Detected in single" 162 "melanoma: 8.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 800 "SK-MEL-30: 251.8" "Group enriched" "Detected in some" 5 "hippocampal formation: 3.0;pons and medulla: 4.1;thalamus: 1.5" "Low region specificity" "Detected in all" NA NA "Cluster 61: Skin - Cornification" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 29: Early spermatids - Spermatogenesis" "unprognostic (3.47e-2)" "unprognostic (1.80e-1)" "unprognostic (1.35e-1)" "unprognostic (1.92e-3)" 0.0 0.0 0.3 0.0 0.3 0.0 0.2 0.3 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.1 0.9 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.1 1.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 251.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.2 0.1 0.5 0.1 0.9 0.2 0.0 0.9 0.2 0.3 0.0 0.5 0.7 0.2 2.4 0.0 0.0 0.0 6.4 0.0 0.1 0.3 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 20.7 1.5 0.1 0.1 0.0 0.4 2.9 0.0 0.0 0.5 0.0 0.9 0.0 0.1 0.0 0.0 0.1 5.0 2.7 0.0 0.0 0.0 0.7 6.6 0.0 0.0 76.5 1.0 0.0 0.9 0.0 1.5 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 4.6 0.0 0.1 0.1 0.1 0.1 0.0 1.0 0.0 0.1 0.0 0.0 0.0 MYEF2 "FLJ11213, HsT18564, KIAA1341, MEF-2" ENSG00000104177 "Myelin expression factor 2" 15 48134632-48178353 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 87.8;Oligodendrocyte precursor cells: 88.4;Spermatocytes: 106.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 101.9;SCLC-21H: 90.8;SK-MEL-30: 91.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004883 Supported Supported Nucleoplasm NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 62: Horizontal cells - Visual perception" Nucleoplasm "HPA004883: AB_1079436" "unprognostic (4.30e-2)" "unprognostic (8.59e-2)" "unprognostic (5.01e-2)" "unprognostic (2.17e-1)" "unprognostic (2.02e-2)" "unprognostic (7.18e-3)" "unprognostic (2.76e-3)" "unprognostic (6.81e-2)" "unprognostic (2.35e-1)" "unprognostic (4.09e-2)" "unprognostic (1.55e-5)" "unprognostic (1.32e-2)" "unprognostic (3.76e-3)" "unprognostic (7.94e-2)" "unprognostic (2.51e-2)" "unprognostic (7.26e-2)" "unprognostic (4.05e-1)" 4.7 15.0 17.2 4.9 18.1 1.6 7.7 26.0 23.5 2.3 13.5 11.4 3.6 5.7 10.0 2.5 12.1 6.9 8.8 17.4 21.1 17.8 0.5 5.8 7.0 17.6 17.1 1.7 14.2 13.9 22.8 1.4 16.9 8.9 4.9 33.1 6.4 10.5 1.4 4.4 4.9 7.5 17.2 6.2 9.2 28.2 17.4 10.4 5.5 2.2 7.6 3.7 1.3 20.8 0.3 30.1 101.9 63.9 1.0 0.1 0.0 31.4 8.3 15.7 6.9 12.1 12.8 22.1 40.2 7.1 10.9 0.2 43.1 1.9 20.9 60.3 16.5 13.5 0.0 5.1 5.1 15.6 10.5 0.5 1.2 0.2 2.1 47.5 28.5 30.5 2.2 30.5 12.8 17.6 24.0 0.2 44.1 7.5 5.3 0.0 8.0 0.7 51.2 5.8 90.8 69.7 0.0 9.2 91.9 47.6 49.3 19.7 18.6 5.0 24.3 18.9 73.6 13.5 54.4 0.1 9.3 0.1 20.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.1 0.1 0.2 0.0 0.2 0.1 0.0 0.4 0.0 0.2 0.2 0.0 17.2 18.1 26.0 23.5 17.4 21.1 17.6 17.1 16.9 17.2 17.4 20.8 15.9 12.8 16.8 56.8 13.9 0.8 2.3 1.2 1.2 80.4 26.2 17.0 9.4 7.2 11.6 49.7 79.2 0.6 7.9 3.3 31.3 20.5 70.7 40.1 3.0 10.9 52.1 8.8 80.8 11.3 0.2 5.5 4.1 18.3 4.5 47.6 6.8 0.1 0.4 82.4 87.8 8.2 2.0 1.0 6.8 41.0 2.1 3.9 10.6 22.5 3.8 33.5 3.1 88.4 43.9 11.0 6.8 1.2 5.8 7.3 0.5 26.7 47.7 61.0 0.0 7.1 13.2 106.1 25.3 0.5 1.0 0.0 7.8 2.8 6.9 1.6 CTXN2 ENSG00000233932 "Cortexin 2" P0C2S0 15 48178122-48203758 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.9;choroid plexus: 1.6;pituitary gland: 1.1;retina: 1.2" "Group enriched" "Detected in some" 4 "Early spermatids: 43.4;Late spermatids: 34.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA053168 Uncertain NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA053168: AB_2682066" "unprognostic (1.90e-1)" "unprognostic (3.85e-3)" "unprognostic (7.43e-2)" "unprognostic (2.18e-4)" "unprognostic (6.81e-3)" "unprognostic (1.72e-1)" "unprognostic (2.80e-1)" "unprognostic (4.61e-2)" 0.0 0.1 2.6 0.0 2.4 0.0 0.0 2.3 3.9 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.3 3.1 0.0 0.0 0.0 0.0 2.8 2.7 0.0 0.1 0.0 1.1 0.0 3.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.0 0.0 0.8 3.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.6 2.4 2.3 3.9 2.3 3.1 2.8 2.7 3.1 2.2 3.1 2.2 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.0 1.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 43.4 0.4 0.0 0.0 4.9 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 34.0 0.9 0.0 0.0 1.9 0.0 2.0 0.0 5.5 0.8 0.1 2.7 0.0 0.0 0.0 0.1 0.6 0.2 1.1 0.0 0.0 0.0 8.2 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 SLC12A1 NKCC2 ENSG00000074803 "Solute carrier family 12 member 1" Q13621 15 48178438-48304078 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Symport, Transport" "Bartter syndrome, Disease variant, FDA approved drug targets, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 878 "kidney: 705.6" "Cell type enriched" "Detected in some" 5 "Distal tubular cells: 209.4" "Cancer enriched" "Detected in single" 4 "renal cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 26 "RPTEC TERT1: 25.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA014967, HPA018107" Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 39: Non-specific - Basic cellular processes" Vesicles Nucleoplasm "HPA014967: AB_1854503, HPA018107: AB_1854504" "unprognostic (3.52e-2)" "unprognostic (1.30e-2)" "unprognostic (9.65e-2)" "unprognostic (1.74e-2)" "unprognostic (7.77e-2)" "unprognostic (1.04e-1)" "unprognostic (8.72e-2)" "unprognostic (2.06e-1)" "unprognostic (9.85e-3)" "unprognostic (2.81e-4)" "unprognostic (9.75e-2)" "unprognostic (2.61e-1)" "unprognostic (5.47e-2)" "unprognostic (2.03e-1)" "unprognostic (5.20e-4)" "unprognostic (8.52e-2)" 0.1 0.0 0.3 0.1 0.2 0.2 0.1 0.5 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 705.6 0.4 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.1 0.0 0.4 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.5 0.4 0.2 0.6 0.5 0.6 0.4 0.2 0.3 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.0 0.0 38.6 0.0 0.0 0.0 0.0 209.4 0.0 13.5 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.7 0.0 0.0 0.0 0.0 13.2 0.3 0.1 0.0 1.0 0.0 0.0 0.0 1.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DUT dUTPase ENSG00000128951 "Deoxyuridine triphosphatase" P33316 15 48331011-48343373 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 508.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054422, HPA060360" Enhanced Supported Nucleoplasm No Yes 31000 "Cluster 26: Non-specific - Mitochondria" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 32: U-937 - Innate immune response" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA054422: AB_2682483, HPA060360: AB_2684262" "unprognostic (1.82e-1)" "unprognostic (3.49e-2)" "unprognostic (7.89e-2)" "unprognostic (5.27e-2)" "unprognostic (2.20e-1)" "unprognostic (7.17e-2)" "unprognostic (1.65e-1)" "unprognostic (1.16e-2)" "unprognostic (4.42e-3)" "unprognostic (1.87e-2)" "unprognostic (4.25e-1)" "unprognostic (3.54e-2)" "unprognostic (3.68e-2)" "unprognostic (4.23e-2)" "unprognostic (1.47e-1)" "unprognostic (2.09e-2)" "unprognostic (1.71e-2)" 73.0 65.3 54.7 61.7 58.9 162.9 76.4 57.1 77.2 90.7 60.0 69.5 29.3 76.9 49.7 72.1 77.6 33.6 68.9 53.9 59.6 67.6 53.6 58.1 97.8 58.2 55.5 86.1 53.2 48.3 80.0 45.1 58.3 77.8 47.1 49.1 66.5 48.3 57.9 71.6 66.5 40.4 57.7 82.1 61.5 57.3 57.5 111.4 89.2 53.0 87.8 69.1 78.0 63.5 196.1 60.2 143.9 137.1 98.4 104.0 85.3 202.1 128.1 182.8 224.6 69.8 131.0 539.3 106.0 112.0 149.4 262.1 152.4 138.4 177.6 383.4 157.2 442.2 151.8 96.1 54.8 469.0 202.0 64.4 92.1 123.9 65.0 117.8 123.3 316.6 244.0 297.6 136.5 79.3 422.4 548.7 90.7 197.4 114.5 338.6 313.9 570.0 120.8 130.4 207.2 210.1 150.0 119.6 184.4 145.5 169.6 368.6 103.0 190.1 183.1 228.3 269.7 238.1 534.3 532.5 143.6 789.4 213.4 32.5 50.3 46.8 52.9 53.1 68.7 94.8 94.7 84.6 74.0 90.0 97.4 64.3 30.9 60.5 68.4 85.3 94.3 71.4 54.7 58.9 57.1 77.2 53.9 59.6 58.2 55.5 58.3 57.7 57.5 63.5 153.6 54.5 38.9 39.8 126.8 179.6 212.0 222.4 131.5 48.3 158.0 205.5 120.1 95.8 118.5 104.8 14.6 221.8 103.9 62.8 203.5 94.3 36.8 67.2 123.5 123.0 96.1 418.8 36.5 46.5 286.8 147.9 76.5 86.0 84.4 118.3 101.4 77.6 174.5 82.4 32.1 98.4 105.8 87.7 112.6 31.5 184.8 92.0 154.7 23.4 89.5 106.3 95.8 23.6 45.1 45.4 58.8 177.6 192.3 133.2 27.2 256.4 59.6 40.9 157.8 167.1 154.0 508.7 270.0 206.4 168.5 97.1 124.4 82.3 195.4 181.2 FBN1 "FBN, MASS, MFS1, OCTD, SGS, WMS" ENSG00000166147 "Fibrillin 1" P35555 15 48408313-48645721 "Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Heparin-binding, Hormone" "Aortic aneurysm, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 60.9;placenta: 76.7" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 132.4;Fibroblasts: 388.5;Leydig cells: 236.1;Oligodendrocytes: 218.7;Peritubular cells: 227.2;Skeletal myocytes: 139.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 215.1;ASC TERT1: 460.7;fHDF/TERT166: 420.8;HSkMC: 251.3;hTERT-RPE1: 211.1;U-138 MG: 206.9;U-2197: 305.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002670, HPA017759, HPA021057, CAB058696, CAB068188" Enhanced Approved Cytosol "Secreted to blood" NA NA 520000000 "Cluster 82: Adipose tissue - ECM organization" "Cluster 18: U-2197 - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Cytosol "CAB002670: , CAB058696: AB_2665596, CAB068188: AB_2665597, HPA017759: AB_1848584, HPA021057: AB_1848586" "unprognostic (3.97e-2)" "unprognostic (1.55e-2)" "unprognostic (2.40e-2)" "unprognostic (9.50e-2)" "unprognostic (1.51e-1)" "unprognostic (9.49e-2)" "unprognostic (2.00e-2)" "unprognostic (4.79e-2)" "unprognostic (7.82e-2)" "unprognostic (1.50e-2)" "unprognostic (2.78e-2)" "unprognostic (1.14e-1)" "prognostic unfavorable (7.44e-5)" "prognostic unfavorable (6.57e-4)" "unprognostic (1.25e-2)" "unprognostic (8.69e-3)" "prognostic unfavorable (5.11e-4)" 60.9 4.4 1.4 14.5 5.4 3.4 13.7 2.8 2.8 36.0 9.5 8.3 3.8 15.2 6.3 12.6 12.2 27.3 23.5 0.8 2.0 2.7 2.9 10.0 3.7 5.2 6.0 28.4 3.3 3.0 2.5 76.7 3.7 8.0 11.7 1.3 4.6 13.2 4.5 5.7 6.6 35.7 2.3 6.4 6.0 7.1 4.7 2.9 18.6 21.2 3.5 18.8 9.9 5.0 0.1 5.2 19.8 22.4 215.1 460.7 0.2 175.8 62.9 51.1 32.4 0.1 0.3 0.1 7.9 420.8 0.4 0.7 3.9 0.6 45.9 20.7 1.2 2.0 88.5 0.2 120.7 0.8 0.3 251.3 0.1 135.9 15.6 211.1 55.5 1.6 0.0 0.4 55.6 0.0 1.5 0.2 4.0 0.2 7.1 0.1 17.0 0.2 5.9 0.5 0.2 12.9 0.0 2.2 0.1 15.3 0.2 1.4 106.8 206.9 6.2 305.8 37.6 1.2 1.0 0.0 138.9 0.3 13.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 1.4 5.4 2.8 2.8 0.8 2.0 5.2 6.0 3.7 2.3 4.7 5.0 50.0 0.0 1.3 34.9 0.4 25.6 0.8 1.5 0.6 6.1 1.3 3.4 14.2 0.0 5.8 12.9 0.0 132.4 0.4 0.0 0.0 0.2 8.7 4.2 105.2 36.1 0.0 5.5 82.3 0.6 40.8 388.5 3.1 2.0 1.3 22.5 34.6 0.6 15.3 0.0 123.5 0.0 0.0 0.8 39.0 22.8 236.1 5.7 42.7 30.0 2.3 0.8 0.0 76.9 218.7 1.7 0.0 227.2 1.7 0.7 0.1 0.6 3.3 0.2 26.3 139.5 55.8 3.3 3.4 0.8 20.6 65.8 4.3 51.3 0.0 0.2 CEP152 "KIAA0912, MCPH9, SCKL5" ENSG00000103995 "Centrosomal protein 152" O94986 15 48712928-48811146 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Disease variant, Dwarfism, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 16.3" "Cell type enhanced" "Detected in many" "Early spermatids: 192.5;Late spermatids: 49.5;Syncytiotrophoblasts: 46.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA039408 Approved Supported Nucleoplasm,Centrosome NA Yes "Cluster 42: Non-specific - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 29: Early spermatids - Spermatogenesis" Centrosome Nucleoplasm "HPA039408: AB_10795288" "unprognostic (3.64e-1)" "unprognostic (1.91e-1)" "unprognostic (2.61e-1)" "unprognostic (4.08e-2)" "unprognostic (2.09e-1)" "unprognostic (3.87e-4)" "unprognostic (4.78e-2)" "unprognostic (8.02e-3)" "unprognostic (1.04e-2)" "unprognostic (5.82e-2)" "unprognostic (4.70e-3)" "unprognostic (3.47e-2)" "unprognostic (6.24e-3)" "unprognostic (5.29e-2)" "unprognostic (3.55e-1)" "unprognostic (4.60e-2)" "unprognostic (1.25e-1)" 2.2 1.3 1.2 3.5 1.4 16.3 1.9 2.0 1.9 1.9 2.6 2.3 2.9 1.4 0.9 2.6 1.9 1.8 2.1 1.0 0.9 2.2 1.0 2.2 4.3 1.2 1.2 2.5 2.9 1.3 0.9 4.7 1.4 1.7 3.1 1.9 2.4 0.9 1.0 3.0 2.9 1.9 0.7 2.4 2.3 9.8 1.8 5.6 2.9 0.6 3.7 1.4 2.3 1.8 8.0 6.1 12.2 15.0 2.1 3.9 7.9 13.9 5.6 10.0 12.3 13.2 6.8 18.6 5.9 4.0 14.1 18.6 13.6 5.0 14.5 16.5 8.3 30.1 34.6 7.2 1.4 25.6 13.4 1.4 3.9 11.1 6.6 3.9 7.5 19.2 18.4 21.6 8.6 4.5 18.6 23.8 7.7 9.5 6.1 22.7 16.4 22.9 3.6 7.5 14.6 9.8 10.7 8.9 4.2 13.3 6.7 12.3 6.2 24.4 12.9 18.9 15.6 9.2 10.8 21.4 7.8 36.2 17.6 2.1 1.0 1.9 0.8 1.4 0.7 0.9 0.9 0.9 0.8 1.7 1.0 1.0 1.8 1.2 1.5 1.5 1.0 0.5 1.2 1.4 2.0 1.9 1.0 0.9 1.2 1.2 1.4 0.7 1.8 1.8 3.9 6.4 2.8 22.2 9.3 3.8 4.1 2.8 4.0 1.5 2.9 3.6 3.9 4.3 1.8 3.7 2.1 31.5 6.8 7.8 0.0 4.7 192.5 6.4 5.3 6.7 3.6 29.9 14.7 6.7 8.5 9.0 7.1 5.0 8.2 20.9 6.1 3.3 7.6 0.0 8.4 8.2 4.1 7.2 6.4 49.5 23.9 8.6 1.8 16.9 6.9 2.9 10.3 6.0 7.0 7.9 3.5 27.1 15.9 3.2 9.1 1.7 8.4 3.6 6.6 6.5 5.4 24.4 10.3 7.0 3.4 46.9 9.9 3.4 10.1 4.1 SHC4 "RaLP, SHCD" ENSG00000185634 "SHC adaptor protein 4" Q6S5L8 15 48823741-48963919 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.6;testis: 10.5" "Cell type enhanced" "Detected in some" "Astrocytes: 16.6;Oligodendrocyte precursor cells: 30.7;Oligodendrocytes: 81.8" "Cancer enhanced" "Detected in some" "melanoma: 9.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AN3-CA: 10.0;SK-MEL-30: 19.1;WM-115: 16.5" "Low region specificity" "Detected in all" HPA074146 Approved Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 70: Brain - Nervous system development" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Cytosol "HPA074146: AB_2686667" "unprognostic (4.34e-3)" "unprognostic (1.01e-3)" "unprognostic (6.70e-2)" "unprognostic (1.06e-1)" "unprognostic (1.81e-1)" "unprognostic (1.05e-3)" "unprognostic (1.23e-2)" "unprognostic (3.47e-2)" "unprognostic (2.59e-1)" "unprognostic (2.21e-2)" "unprognostic (3.80e-2)" "unprognostic (3.71e-1)" "unprognostic (1.04e-5)" "unprognostic (9.84e-3)" "unprognostic (3.26e-2)" "unprognostic (3.49e-2)" "unprognostic (1.36e-2)" 0.5 0.9 12.7 1.0 21.0 0.1 1.6 15.8 18.9 1.0 6.7 2.8 0.3 0.4 0.9 0.5 1.0 1.4 3.3 14.0 14.3 0.3 0.1 0.3 0.3 18.3 16.9 0.5 0.2 0.1 1.0 0.4 19.0 0.7 0.5 0.9 2.1 1.3 0.9 0.6 0.8 0.7 13.6 0.2 0.7 10.5 17.8 0.3 0.3 1.2 0.1 0.4 0.9 36.6 0.0 0.4 1.0 10.0 0.4 1.3 0.0 1.5 2.9 0.6 1.2 0.0 0.3 0.1 2.6 0.6 0.1 0.0 0.2 0.4 0.8 2.2 0.1 0.6 0.0 0.0 1.1 0.0 0.2 1.9 0.0 1.3 0.1 1.3 0.1 1.0 0.0 0.2 1.4 1.9 0.4 0.2 0.1 0.0 3.7 0.2 2.7 0.3 2.1 0.4 0.5 0.8 0.2 0.1 19.1 0.9 0.0 0.1 0.0 0.9 0.5 0.6 1.0 0.9 0.1 0.1 0.8 0.5 16.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 21.0 15.8 18.9 14.0 14.3 18.3 16.9 19.0 13.6 17.8 36.6 0.2 0.0 0.0 16.6 0.0 0.3 0.0 2.3 0.0 0.6 1.6 6.7 2.5 0.0 2.8 0.0 0.0 0.7 0.0 0.0 0.0 6.4 2.5 0.4 0.4 0.2 0.0 0.0 9.3 0.0 0.2 1.8 0.0 0.3 0.0 0.0 0.7 0.0 0.1 1.7 6.1 0.0 0.0 0.0 0.4 4.5 1.2 0.1 7.2 1.0 0.0 2.7 0.0 30.7 81.8 0.2 0.0 3.4 0.0 0.0 0.0 0.1 2.6 1.0 0.0 0.5 0.3 6.0 6.3 0.1 0.3 0.8 0.3 0.5 0.0 0.0 EID1 "C15orf3, CRI1, EID-1" ENSG00000255302 "EP300 interacting inhibitor of differentiation 1" Q9Y6B2 15 48878134-48880173 "Predicted intracellular proteins" "Cell cycle, Differentiation, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA051122, HPA051123" Approved Supported Nucleoplasm NA Yes "Cluster 12: Non-specific - Basic cellular processes" "Cluster 38: Heart - Muscle contraction" "Cluster 44: HDLM-2 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA051122: AB_2681350, HPA051123: AB_2681351" "unprognostic (1.38e-1)" "unprognostic (6.69e-2)" "unprognostic (1.64e-1)" "unprognostic (3.18e-2)" "unprognostic (7.81e-2)" "prognostic unfavorable (9.99e-4)" "unprognostic (1.10e-1)" "unprognostic (2.79e-2)" "unprognostic (1.39e-1)" "unprognostic (1.41e-1)" "unprognostic (6.75e-3)" "unprognostic (2.46e-1)" "unprognostic (3.62e-3)" "prognostic unfavorable (2.91e-4)" "unprognostic (2.04e-2)" "unprognostic (2.13e-1)" "unprognostic (2.09e-1)" 128.6 206.3 96.9 95.4 103.7 61.0 112.0 98.7 153.6 149.8 107.2 143.9 81.6 161.0 132.1 96.6 134.9 120.9 280.1 103.9 111.3 147.9 125.1 99.5 112.0 102.6 101.7 186.7 102.0 144.8 130.1 93.3 100.5 156.1 71.3 158.4 98.3 147.3 278.8 57.6 79.0 141.8 102.1 115.3 84.2 67.9 104.5 117.2 138.5 227.6 83.9 113.1 81.4 123.2 131.5 109.1 260.9 231.6 239.9 316.9 16.4 337.6 304.5 220.3 294.3 95.0 58.0 174.9 305.3 207.0 155.5 115.4 130.2 130.8 247.9 484.1 127.1 300.6 235.8 4.1 186.0 183.0 132.2 278.1 115.1 146.1 91.9 221.4 262.8 151.2 182.3 162.6 258.5 188.7 134.6 174.1 0.5 98.9 97.4 185.1 302.6 290.6 287.4 142.3 233.8 234.6 210.2 80.2 401.2 212.7 145.0 240.6 262.9 322.4 177.7 305.6 299.3 208.4 616.7 125.1 264.6 410.0 230.0 345.0 311.5 275.5 221.3 285.3 209.2 168.3 249.4 231.8 358.1 183.2 179.6 165.3 40.4 230.0 297.5 354.9 332.4 440.1 96.9 103.7 98.7 153.6 103.9 111.3 102.6 101.7 100.5 102.1 104.5 123.2 327.4 387.8 207.7 31.3 127.5 175.5 139.9 459.5 138.9 345.3 188.5 286.4 480.8 183.0 329.9 261.1 120.9 351.6 168.0 46.0 606.5 386.5 17.5 116.0 324.4 356.8 233.7 219.2 38.0 268.0 151.2 443.4 88.2 116.7 188.0 173.8 339.8 166.2 211.3 238.9 43.5 114.0 301.1 208.1 262.0 49.2 702.4 189.7 487.4 30.9 302.2 844.1 213.1 28.6 80.9 191.0 102.1 651.4 134.3 81.4 91.9 446.5 240.2 329.9 322.1 350.7 379.1 98.6 75.0 125.9 145.6 109.6 180.7 463.2 101.5 96.9 SECISBP2L KIAA0256 ENSG00000138593 "SECIS binding protein 2 like" Q93073 15 48988476-49046447 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 119.4" "Cell type enhanced" "Detected in all" "Alveolar cells type 2: 248.6;Oligodendrocytes: 429.8;Syncytiotrophoblasts: 711.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039875 Approved Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 44: HDLM-2 - Immune response" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Nucleoplasm "HPA039875: AB_10673365" "unprognostic (7.86e-3)" "unprognostic (2.53e-2)" "unprognostic (1.33e-1)" "unprognostic (3.19e-3)" "unprognostic (9.29e-2)" "unprognostic (5.35e-2)" "unprognostic (1.58e-1)" "unprognostic (1.09e-1)" "unprognostic (1.12e-1)" "unprognostic (9.58e-3)" "unprognostic (2.16e-1)" "unprognostic (3.08e-2)" "prognostic favorable (5.65e-8)" "unprognostic (1.87e-2)" "unprognostic (1.27e-1)" "unprognostic (2.01e-2)" "unprognostic (2.28e-1)" 18.8 16.1 36.4 11.9 72.7 22.6 18.6 61.1 57.1 18.6 5.8 13.5 9.6 18.4 21.9 17.0 18.4 14.6 15.4 39.5 43.2 25.0 18.7 37.2 13.7 69.2 58.2 19.5 15.0 76.3 9.2 29.9 61.8 20.8 11.6 32.4 45.0 17.5 12.1 11.0 11.4 14.9 58.8 15.1 19.1 13.9 54.7 14.9 23.9 18.3 13.4 12.9 11.8 119.4 9.5 10.4 20.7 18.0 28.6 21.9 12.9 31.3 25.8 25.1 31.6 11.2 8.2 6.6 15.1 24.0 26.5 8.0 26.2 8.2 30.0 40.7 7.0 18.4 14.1 8.4 15.5 10.0 20.0 17.5 9.7 22.1 12.3 27.0 25.3 16.2 11.4 16.0 29.9 4.2 11.8 9.6 7.5 5.9 9.0 11.1 23.2 25.4 32.8 19.5 3.7 14.7 21.5 36.5 29.5 34.7 11.2 11.4 31.7 23.3 11.3 23.6 15.1 13.5 25.0 11.5 17.9 14.8 30.8 10.8 5.3 16.3 8.9 5.1 8.2 12.8 7.9 6.2 3.8 14.4 10.7 8.6 9.9 8.7 6.9 8.8 6.3 4.5 36.4 72.7 61.1 57.1 39.5 43.2 69.2 58.2 61.8 58.8 54.7 119.4 41.6 115.4 248.6 60.7 47.8 14.8 15.1 24.3 18.2 34.7 26.0 21.7 43.1 18.6 55.2 33.1 27.1 105.2 33.3 27.3 15.6 28.1 15.0 94.8 49.2 39.4 9.6 15.8 105.9 18.6 37.8 37.8 34.1 153.2 33.5 32.3 29.6 25.2 26.5 57.2 74.0 14.9 28.5 20.8 18.3 11.1 33.5 29.8 46.2 53.4 30.9 39.7 37.0 82.4 429.8 37.8 15.7 36.5 48.8 31.3 20.9 37.9 86.4 27.2 6.6 47.0 35.2 22.2 31.1 18.8 13.5 711.3 35.6 21.1 11.7 41.5 COPS2 "ALIEN, CSN2, TRIP15" ENSG00000166200 "COP9 signalosome subunit 2" P61201 15 49106068-49155661 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016867, HPA018271, HPA061071" Approved Supported "Vesicles,Cytokinetic bridge" Yes No 190000 "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 18: U-2197 - ECM organization" "Cluster 10: Non-specific - Unknown function" Vesicles "Cytokinetic bridge" "HPA016867: AB_1858336, HPA018271: AB_1858335, HPA061071: AB_2684424" "unprognostic (3.47e-1)" "unprognostic (2.28e-2)" "unprognostic (1.66e-1)" "unprognostic (7.20e-2)" "unprognostic (1.86e-1)" "unprognostic (7.84e-3)" "unprognostic (1.04e-1)" "unprognostic (6.77e-2)" "unprognostic (2.49e-2)" "unprognostic (6.09e-2)" "unprognostic (3.86e-3)" "unprognostic (1.42e-1)" "unprognostic (4.35e-3)" "unprognostic (1.02e-1)" "unprognostic (1.97e-1)" "unprognostic (5.62e-2)" "unprognostic (1.10e-3)" 61.7 43.4 24.8 34.4 28.5 124.5 67.0 35.0 36.8 61.9 25.3 43.2 43.3 58.4 44.0 63.2 43.2 53.7 61.5 26.1 30.4 60.8 57.6 35.0 45.5 30.9 27.7 76.7 54.0 65.7 26.4 45.0 32.8 45.2 41.6 32.2 40.0 47.0 92.6 35.5 37.2 56.5 35.2 32.0 36.4 51.0 27.5 49.6 61.8 112.1 48.8 59.0 35.3 41.7 92.0 53.1 111.6 94.4 134.2 189.9 76.7 157.3 149.8 135.4 123.5 113.0 49.1 151.1 105.2 152.2 108.7 131.9 160.3 130.9 148.0 103.3 64.5 141.0 105.4 91.7 102.6 134.7 70.7 161.2 104.3 110.4 193.3 149.3 144.0 82.5 184.4 78.8 149.3 49.5 72.3 67.3 72.6 128.4 68.9 78.2 105.2 227.7 143.5 136.5 108.4 78.6 90.7 96.4 127.8 129.4 95.6 133.3 93.4 132.1 71.0 249.6 167.9 71.0 196.3 191.0 123.4 215.1 109.4 11.7 17.9 12.2 13.1 23.5 24.4 14.6 19.7 19.2 21.0 13.9 24.8 16.2 7.4 16.6 22.9 13.3 28.4 16.0 24.8 28.5 35.0 36.8 26.1 30.4 30.9 27.7 32.8 35.2 27.5 41.7 72.8 76.9 56.1 14.4 50.0 87.1 57.1 90.8 80.8 23.2 47.6 59.3 104.3 27.1 69.8 23.9 10.4 56.1 48.2 18.5 54.8 40.3 28.2 56.7 91.6 53.6 20.8 50.1 35.2 29.9 71.0 79.6 36.2 94.0 52.6 39.3 46.1 32.5 43.9 33.7 36.1 25.1 32.6 47.5 44.9 21.6 55.3 46.1 35.6 19.7 49.3 24.8 27.8 21.6 48.7 35.9 21.6 53.4 63.5 53.0 41.0 84.8 47.4 19.7 19.7 74.6 109.0 93.1 43.3 63.2 98.9 131.9 54.0 58.6 34.6 64.4 GALK2 GK2 ENSG00000156958 "Galactokinase 2" Q01415 15 49155656-49367869 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 92.2;Inhibitory neurons: 90.1;Oligodendrocytes: 109.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043564, HPA048267" Uncertain Approved Nucleoplasm,Cytosol NA NA 24000 "Cluster 44: Non-specific - Transcription" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 16: U-266 - Nucleosome" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoplasm, Cytosol" "HPA043564: AB_2678557, HPA048267: AB_2680335" "unprognostic (2.27e-2)" "unprognostic (1.45e-1)" "unprognostic (2.38e-1)" "prognostic favorable (7.31e-4)" "unprognostic (3.04e-1)" "unprognostic (9.78e-2)" "unprognostic (2.66e-1)" "unprognostic (1.95e-1)" "unprognostic (2.30e-1)" "unprognostic (8.67e-3)" "unprognostic (2.25e-2)" "unprognostic (2.43e-1)" "prognostic favorable (1.88e-5)" "unprognostic (2.33e-1)" "unprognostic (9.79e-2)" "unprognostic (2.13e-2)" "unprognostic (1.93e-1)" 10.3 16.8 8.5 8.5 9.3 6.6 11.2 10.1 9.3 12.5 14.8 15.2 20.2 8.5 8.7 8.1 12.2 8.9 12.8 8.7 8.5 30.4 21.1 10.5 8.3 8.6 9.0 9.3 12.2 17.5 9.6 9.9 9.0 9.7 16.2 7.7 9.9 10.9 10.5 9.0 16.6 10.7 8.5 8.9 13.2 7.0 8.3 12.6 14.8 16.9 10.0 9.3 8.5 11.4 14.7 17.1 7.5 10.1 19.1 29.7 21.9 14.7 20.2 14.7 17.2 21.6 15.0 4.8 11.6 15.9 18.0 20.5 30.2 21.6 20.6 26.2 9.1 26.8 15.7 18.4 20.9 19.2 8.2 15.4 38.4 15.7 37.4 16.8 30.2 11.0 27.4 25.5 16.1 15.9 13.9 15.3 3.3 44.0 15.9 16.7 9.5 71.0 27.3 13.8 9.1 6.0 16.6 33.3 29.6 15.0 16.9 18.3 16.6 14.1 9.6 58.4 14.3 20.9 76.2 8.9 22.2 70.1 19.8 45.4 15.3 28.4 18.1 16.7 18.9 14.0 18.0 17.3 15.2 11.1 14.2 14.3 7.6 19.6 17.2 13.3 35.3 13.1 8.5 9.3 10.1 9.3 8.7 8.5 8.6 9.0 9.0 8.5 8.3 11.4 13.6 3.2 14.9 48.6 12.7 5.6 13.6 16.8 9.1 13.3 12.1 10.3 3.1 27.1 14.5 5.5 37.5 14.8 10.6 14.5 29.4 20.0 12.0 19.2 15.7 12.0 9.0 12.0 92.2 13.1 29.0 12.7 18.3 12.0 2.5 9.8 22.9 25.7 20.4 15.2 90.1 25.1 20.3 16.8 5.7 4.8 11.5 12.6 14.2 63.7 16.5 11.6 20.6 41.7 109.5 10.7 16.2 11.3 27.9 8.3 30.5 56.5 34.1 25.8 0.0 13.4 11.6 22.3 5.9 9.0 6.3 25.7 13.9 13.8 19.0 9.7 FAM227B "C15orf33, FLJ32800" ENSG00000166262 "Family with sequence similarity 227 member B" Q96M60 15 49326962-49620929 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 39.5;Early spermatids: 41.0;Oligodendrocytes: 55.1;Spermatocytes: 48.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA049774, HPA061695" Uncertain Approved "Nuclear speckles" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 21: Non-specific - Transcription" "Cluster 29: U-266 - Adaptive immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Nuclear speckles" "HPA049774: AB_2680873, HPA061695: AB_2684588" "unprognostic (1.19e-2)" "unprognostic (2.57e-1)" "unprognostic (1.89e-2)" "unprognostic (4.74e-3)" "unprognostic (1.17e-1)" "unprognostic (1.80e-1)" "unprognostic (5.28e-4)" "unprognostic (3.32e-2)" "unprognostic (9.21e-2)" "unprognostic (6.57e-3)" "unprognostic (6.32e-3)" "unprognostic (6.41e-2)" "unprognostic (7.48e-5)" "unprognostic (2.70e-1)" "unprognostic (9.01e-2)" "unprognostic (7.47e-2)" "unprognostic (1.76e-1)" 1.1 5.1 4.2 1.9 5.1 1.5 6.6 4.2 5.2 4.7 4.6 4.3 2.8 6.3 7.3 3.5 7.7 3.4 7.3 3.9 4.8 7.7 7.5 2.7 4.8 4.8 5.0 9.9 6.4 5.6 6.4 1.3 5.2 5.7 2.8 7.9 5.3 5.1 7.9 3.9 2.3 3.9 4.9 2.8 3.6 10.4 4.5 6.8 7.4 8.9 4.4 3.5 2.2 6.3 0.8 0.7 5.1 2.8 1.5 3.0 0.6 2.1 2.8 3.2 5.1 0.7 2.4 1.5 4.9 3.5 3.7 0.8 1.8 3.1 3.7 3.7 1.5 3.2 1.3 1.7 4.2 1.5 1.3 3.1 4.0 1.8 2.0 6.2 3.0 7.7 5.4 2.4 7.1 3.5 3.2 1.3 2.0 1.2 1.3 2.7 4.5 8.1 4.8 1.0 3.8 5.3 1.9 2.5 6.2 3.7 3.1 1.1 2.2 2.2 1.7 3.0 1.3 12.2 9.8 4.8 2.4 3.9 2.4 5.8 0.2 1.7 3.4 0.5 4.5 2.8 3.5 4.6 0.3 3.5 5.8 5.6 0.3 2.7 0.6 3.4 3.4 2.0 4.2 5.1 4.2 5.2 3.9 4.8 4.8 5.0 5.2 4.9 4.5 6.3 1.1 9.6 4.8 39.5 5.8 2.8 5.4 5.4 3.4 4.3 6.2 7.6 10.8 1.5 9.4 3.7 0.0 1.7 3.3 1.3 25.4 3.9 41.0 19.1 3.1 2.8 8.4 2.1 12.8 3.2 1.5 3.7 3.6 3.2 3.8 1.8 1.8 4.1 0.6 5.0 12.1 1.8 6.1 0.6 2.0 21.1 4.1 2.0 3.6 5.6 0.6 11.7 4.1 16.1 55.1 2.5 1.6 3.0 6.1 2.6 1.9 12.5 21.3 8.0 0.0 4.7 2.0 48.7 13.2 2.5 4.3 0.4 5.7 6.3 2.2 2.6 FGF7 KGF ENSG00000140285 "Fibroblast growth factor 7" P21781 15 49423237-49488775 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor, Heparin-binding, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "urinary bladder: 63.3" "Cell type enhanced" "Detected in many" "Distal tubular cells: 119.3;Fibroblasts: 216.6;Leydig cells: 83.3;Proximal tubular cells: 53.4;Smooth muscle cells: 71.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 112.1;ASC TERT1: 66.1;BJ: 45.6;fHDF/TERT166: 50.3;HSkMC: 84.8;RH-30: 119.7;U-138 MG: 56.5" "Region enriched" "Detected in some" 6 "cerebellum: 8.7" HPA043605 Uncertain Approved Nucleoplasm,Nucleoli "Secreted in other tissues" NA NA "Cluster 46: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Nucleoplasm, Nucleoli" "HPA043605: AB_10960215" "unprognostic (4.65e-1)" "unprognostic (7.62e-2)" "unprognostic (2.50e-1)" "unprognostic (6.98e-2)" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (3.62e-2)" "unprognostic (5.74e-3)" "unprognostic (2.56e-2)" "unprognostic (7.30e-2)" "unprognostic (5.79e-2)" "unprognostic (1.91e-3)" "unprognostic (1.22e-3)" "unprognostic (7.59e-2)" "unprognostic (1.98e-3)" "unprognostic (1.63e-3)" 43.8 4.5 3.4 31.5 3.9 0.1 8.5 4.2 5.2 29.4 2.1 11.1 3.7 29.2 4.3 9.5 15.4 46.0 10.5 3.3 4.8 4.5 1.4 12.9 8.3 4.6 4.6 13.4 2.2 3.6 2.2 23.5 5.1 16.2 9.6 8.4 5.1 12.0 2.2 2.6 3.6 26.9 4.1 1.8 5.5 2.3 4.5 3.0 7.4 23.8 4.8 63.3 10.3 4.5 0.2 0.0 0.2 0.3 112.1 66.1 0.1 45.6 25.7 0.0 0.1 0.0 0.3 0.2 0.2 50.3 0.4 0.9 0.0 0.3 0.0 0.1 0.2 0.0 0.5 0.0 10.6 0.3 0.1 84.8 0.8 9.4 0.0 0.3 0.0 0.0 0.1 0.3 5.4 0.1 0.0 0.1 0.2 0.1 0.3 0.1 119.7 0.1 0.1 0.1 1.8 0.6 0.4 0.0 0.4 0.2 0.2 0.2 0.2 56.5 0.5 1.1 0.2 0.5 0.4 0.0 13.3 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 3.9 4.2 5.2 3.3 4.8 4.6 4.6 5.1 4.1 4.5 4.5 16.1 12.8 19.3 2.0 2.2 14.4 16.8 1.3 1.2 7.9 11.1 9.5 46.8 7.2 0.5 9.2 2.1 6.2 3.2 0.2 119.3 2.0 3.3 8.8 46.2 5.2 0.0 2.7 1.9 0.6 3.3 216.6 2.0 29.2 1.3 0.6 1.8 2.7 2.0 3.3 3.3 0.0 2.0 1.6 15.9 4.0 83.3 1.9 7.2 1.0 0.2 9.8 2.1 1.5 2.9 0.6 0.0 4.9 0.7 9.4 0.0 53.4 0.3 6.1 6.6 43.6 71.6 0.6 0.7 1.8 12.6 2.9 2.9 2.9 0.1 8.4 DTWD1 "MDS009, MGC111207" ENSG00000104047 "DTW domain containing 1" Q8N5C7 15 49621037-49656232 "Enzymes, Predicted intracellular proteins" "tRNA processing" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042214 Uncertain Approved "Nucleoplasm,Nucleoli rim,Mitotic chromosome,Vesicles" Yes No "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 36: Stromal cells - Cell proliferation" "Nucleoli rim" "Nucleoplasm, Mitotic chromosome, Vesicles" "HPA042214: AB_2677903" "unprognostic (2.60e-2)" "unprognostic (1.73e-1)" "unprognostic (3.00e-1)" "unprognostic (3.70e-4)" "unprognostic (8.12e-2)" "unprognostic (2.37e-1)" "unprognostic (1.82e-1)" "unprognostic (9.87e-2)" "unprognostic (4.44e-3)" "unprognostic (4.25e-2)" "unprognostic (5.42e-2)" "unprognostic (1.48e-1)" "unprognostic (2.32e-3)" "unprognostic (1.02e-1)" "unprognostic (7.85e-2)" "unprognostic (2.80e-2)" "unprognostic (2.35e-1)" 19.6 11.8 7.7 13.0 10.1 5.4 18.2 8.2 9.1 27.4 6.5 21.1 7.4 22.6 16.8 13.3 21.1 23.0 11.0 9.0 8.9 11.0 11.5 10.9 12.9 5.7 6.9 22.7 33.3 11.5 9.2 12.8 6.0 15.7 11.9 8.8 21.5 14.7 10.3 12.2 9.1 20.5 6.4 9.0 14.9 9.5 9.9 11.7 17.6 21.1 10.0 20.4 15.9 9.8 10.0 11.9 21.2 11.5 41.3 84.1 16.6 29.3 28.6 36.8 27.5 4.2 8.3 16.7 20.3 38.7 16.8 17.8 15.6 15.8 37.7 10.8 11.2 13.8 23.5 14.5 29.1 18.0 11.1 38.8 20.4 24.3 29.7 32.9 15.5 19.3 26.3 17.3 41.7 23.3 12.3 15.1 12.4 22.6 15.7 17.4 44.7 64.9 12.3 7.1 18.6 14.4 34.7 11.5 27.3 22.1 12.1 25.4 10.7 43.6 17.3 25.6 32.3 13.2 22.2 10.0 37.5 53.9 28.3 8.7 9.7 5.2 6.8 11.7 9.8 9.7 10.3 11.6 12.8 10.1 12.0 11.5 2.6 13.9 15.3 25.3 8.9 6.0 7.7 10.1 8.2 9.1 9.0 8.9 5.7 6.9 6.0 6.4 9.9 9.8 39.9 19.2 15.0 36.6 16.6 19.2 15.4 31.9 18.2 41.8 23.0 34.0 18.8 12.8 22.1 35.0 31.3 23.4 27.1 4.7 31.3 20.1 21.0 27.8 88.1 23.6 15.5 20.8 57.2 21.0 27.7 49.9 20.4 14.1 7.0 29.3 25.4 14.9 19.5 18.5 55.2 19.2 40.7 16.4 14.9 11.2 37.9 16.7 16.0 18.7 10.4 20.3 18.6 33.7 66.1 20.8 10.3 28.2 27.0 21.5 9.5 22.0 37.9 40.0 6.6 35.5 46.7 51.2 44.3 19.6 19.0 9.7 16.2 35.4 17.1 12.7 ATP8B4 "ATPIM, KIAA1939" ENSG00000104043 "ATPase phospholipid transporting 8B4 (putative)" Q8TF62 15 49858238-50182817 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "bone marrow: 78.1" "Cell type enriched" "Detected in many" 6 "Microglial cells: 248.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 15.2;NK-cell: 11.0" "Group enriched" "Detected in many" 5 "granulocytes: 15.2;NK-cells: 11.0" "Cell line enhanced" "Detected in some" "HMC-1: 40.2;NB-4: 19.2;THP-1: 26.7;U-937: 103.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA040254 Approved Uncertain Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 4: Macrophages - Innate immune response" "Nucleoplasm, Vesicles" Cytosol "HPA040254: AB_10673028" "unprognostic (6.45e-3)" "unprognostic (3.83e-2)" "unprognostic (5.39e-2)" "unprognostic (2.96e-3)" "unprognostic (3.25e-1)" "unprognostic (6.51e-3)" "unprognostic (1.03e-1)" "unprognostic (4.87e-3)" "unprognostic (1.64e-2)" "unprognostic (5.11e-2)" "unprognostic (1.20e-1)" "unprognostic (3.74e-2)" "unprognostic (5.99e-2)" "unprognostic (5.12e-2)" "unprognostic (1.20e-2)" "unprognostic (1.53e-1)" "unprognostic (2.08e-1)" 1.4 1.1 2.3 2.5 2.4 78.1 0.7 3.5 6.5 1.5 3.0 1.1 0.7 6.4 4.2 0.5 3.1 2.2 0.4 4.5 2.9 1.2 1.6 1.1 1.0 2.5 2.6 0.4 0.5 0.2 0.3 3.5 2.8 0.6 1.7 0.1 0.5 0.8 0.1 0.3 1.3 3.1 3.1 2.6 0.6 0.4 2.4 0.5 0.1 0.1 1.0 1.4 0.4 4.9 0.1 0.6 0.0 0.0 0.0 0.7 0.2 0.1 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.5 0.5 0.2 0.0 0.2 12.2 0.0 7.3 1.7 0.1 0.0 13.6 40.2 0.7 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 19.2 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.1 1.5 0.1 1.2 0.0 0.0 0.1 0.0 26.7 0.0 0.0 0.3 1.0 0.0 0.1 0.0 0.0 1.3 103.7 0.0 15.2 2.0 3.8 0.4 1.2 0.1 0.0 0.0 0.1 2.7 0.0 0.0 0.0 0.8 11.0 0.4 0.0 0.0 0.9 2.3 2.4 3.5 6.5 4.5 2.9 2.5 2.6 2.8 3.1 2.4 4.9 1.7 0.0 1.9 1.6 0.8 1.5 0.1 0.2 0.6 0.6 0.2 0.6 1.3 0.0 0.1 0.0 0.0 5.4 12.5 0.3 0.0 0.0 27.6 0.3 1.7 1.0 0.0 12.2 20.3 0.0 1.8 8.1 3.1 0.2 19.7 0.0 1.1 3.7 16.4 0.0 17.5 0.3 2.0 37.0 17.7 25.3 1.8 27.0 1.8 248.3 6.3 0.5 15.5 1.0 2.1 0.0 0.1 0.7 4.8 2.3 0.7 1.2 0.7 0.2 0.0 1.0 7.0 0.5 0.6 0.6 0.3 2.9 13.4 1.1 0.2 0.3 SLC27A2 "ACSVL1, FACVL1, FATP2, hFACVL1, HsT17226, VLACS, VLCS" ENSG00000140284 "Solute carrier family 27 member 2" O14975 15 50182196-50236385 "Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 157.7;liver: 288.0" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 265.5;Hepatocytes: 205.7;Proximal enterocytes: 81.0;Proximal tubular cells: 198.9;Respiratory ciliated cells: 70.2" "Cancer enhanced" "Detected in many" "liver cancer: 49.2" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 30 "basophil: 63.5" "Lineage enriched" "Detected in many" 30 "granulocytes: 63.5" "Cell line enhanced" "Detected in many" "A549: 50.0;HaCaT: 89.3;HL-60: 66.3;OE19: 101.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA026089 Enhanced NA NA "Cluster 10: Basophils - Unknown function" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 21: OE19 - Mitochondria" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA026089: AB_1857060" "unprognostic (3.03e-2)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (2.10e-2)" "unprognostic (3.06e-1)" "unprognostic (1.10e-1)" "unprognostic (4.06e-3)" "unprognostic (3.33e-1)" "unprognostic (1.89e-1)" "unprognostic (6.38e-3)" "unprognostic (4.83e-2)" "unprognostic (1.82e-1)" "prognostic favorable (7.48e-6)" "unprognostic (5.01e-3)" "unprognostic (4.08e-1)" "unprognostic (1.22e-2)" "prognostic favorable (6.40e-4)" 4.8 16.0 1.7 2.9 2.0 6.5 13.3 1.7 3.2 1.6 9.2 18.2 11.1 0.3 65.9 2.6 10.9 2.3 0.0 2.7 2.4 157.7 288.0 1.7 1.5 0.8 1.1 0.1 7.2 4.1 12.4 17.3 0.8 5.4 16.2 3.4 0.9 1.0 0.0 1.2 21.3 0.8 0.8 0.4 1.8 0.9 2.5 0.5 4.6 0.0 1.7 3.6 1.2 0.7 0.0 50.0 0.0 0.0 0.0 0.0 0.1 0.9 0.4 0.9 1.3 26.2 6.9 0.0 0.6 1.2 0.6 89.3 22.8 0.7 2.3 36.0 27.9 37.5 43.0 23.6 0.5 66.3 25.8 0.0 2.1 0.2 0.1 0.0 0.0 16.9 11.6 0.0 0.0 8.3 1.8 44.5 1.7 101.8 1.8 0.0 0.0 1.8 4.7 45.7 40.4 2.6 8.7 1.1 0.0 1.1 4.7 22.8 0.0 0.0 2.1 0.0 0.0 0.2 0.0 0.0 0.0 21.2 0.0 63.5 0.0 0.9 0.8 0.0 0.7 0.3 0.7 0.8 0.0 0.2 0.1 0.2 0.3 2.0 0.0 0.0 0.9 0.5 1.7 2.0 1.7 3.2 2.7 2.4 0.8 1.1 0.8 0.8 2.5 0.7 0.3 0.0 1.1 0.7 2.2 1.0 1.3 8.7 1.2 1.1 1.1 0.3 0.3 0.0 13.6 9.2 0.0 265.5 1.6 17.2 11.7 0.6 0.7 9.8 0.1 0.8 4.2 8.0 4.9 2.0 7.6 0.9 1.5 0.7 6.3 0.1 3.9 205.7 16.4 1.7 6.6 18.9 10.2 3.2 0.3 0.9 0.3 1.2 0.0 1.0 0.0 0.6 1.0 0.0 0.4 1.4 26.6 0.0 0.8 3.3 81.0 198.9 70.2 1.9 0.0 0.0 1.0 4.4 4.2 5.1 0.3 54.9 4.6 0.2 25.9 4.9 HDC ENSG00000140287 "Histidine decarboxylase" P19113 15 50241947-50265965 "Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Catecholamine biosynthesis" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 102.9;epididymis: 46.1" "Cell type enriched" "Detected in some" 12 "granulocytes: 596.0" "Cancer enhanced" "Detected in some" "breast cancer: 2.9;testis cancer: 2.7" "Region enriched" "Detected in many" 6 "hypothalamus: 102.9" "Immune cell enriched" "Detected in single" 2140 "basophil: 686.2" "Lineage enriched" "Detected in single" 2140 "granulocytes: 686.2" "Group enriched" "Detected in some" 4 "HEL: 460.8;HMC-1: 1051.3" "Region enriched" "Detected in many" 5 "hypothalamus: 43.9" "Group enriched" "Detected in some" 10 "hypothalamus: 16.5;midbrain: 4.2" HPA038891 Enhanced Approved "Nuclear bodies" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" "Nuclear bodies" "HPA038891: AB_10673231" "unprognostic (4.97e-2)" "unprognostic (7.42e-2)" "unprognostic (1.43e-4)" "unprognostic (1.08e-1)" "unprognostic (6.16e-2)" "unprognostic (3.93e-7)" "unprognostic (4.18e-5)" "unprognostic (8.79e-3)" "unprognostic (1.48e-1)" "unprognostic (8.46e-2)" "unprognostic (4.60e-2)" "unprognostic (1.05e-1)" "unprognostic (2.53e-1)" "unprognostic (7.20e-2)" "unprognostic (9.78e-2)" "unprognostic (2.15e-1)" "unprognostic (1.50e-1)" 2.3 0.4 0.0 3.5 5.6 4.7 1.4 0.0 0.2 2.3 0.7 3.8 4.1 2.5 46.1 4.8 0.8 11.2 0.7 0.2 102.9 0.4 0.5 6.9 0.9 0.0 13.7 0.1 1.2 0.5 0.4 0.4 0.0 1.7 3.6 0.8 1.3 0.9 0.3 2.3 4.6 2.5 0.0 0.5 12.9 1.3 17.8 0.9 0.1 0.8 1.0 3.8 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 460.8 0.2 0.0 0.0 1.2 1051.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.5 181.8 0.3 0.0 0.0 0.2 0.4 0.4 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.5 0.2 0.4 686.2 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 1.6 0.0 5.6 0.0 0.2 0.2 102.9 0.0 13.7 0.0 0.0 17.8 0.1 0.0 12.8 47.5 0.3 0.0 0.8 0.0 0.0 0.0 2.6 0.0 0.0 0.5 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 10.9 0.3 0.0 0.0 2.3 9.2 0.0 596.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 1.8 0.4 0.0 1.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 3.8 0.0 0.0 0.0 4.5 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.0 3.5 0.0 0.1 0.1 GABPB1 "E4TF1-47, GABPB, GABPB2" ENSG00000104064 "GA binding protein transcription factor subunit beta 1" Q06547 15 50275389-50355408 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019653, HPA067444" Supported Supported "Nucleoplasm,Cytoplasmic bodies" NA Yes "Cluster 10: Basophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm "Cytoplasmic bodies" "HPA019653: AB_1849370, HPA067444: AB_2685842" "unprognostic (7.79e-3)" "unprognostic (2.42e-2)" "unprognostic (3.84e-1)" "unprognostic (1.92e-1)" "unprognostic (9.33e-2)" "unprognostic (3.99e-2)" "unprognostic (3.25e-2)" "unprognostic (5.65e-2)" "unprognostic (1.86e-2)" "unprognostic (8.94e-3)" "unprognostic (1.23e-1)" "unprognostic (4.54e-3)" "prognostic unfavorable (2.53e-4)" "unprognostic (3.18e-2)" "unprognostic (2.37e-1)" "unprognostic (1.13e-1)" "unprognostic (3.93e-3)" 14.1 7.5 5.5 13.6 6.1 34.7 11.5 11.1 7.1 8.5 5.8 9.0 7.6 10.4 9.5 8.0 8.6 9.2 7.1 5.7 5.7 7.4 13.9 9.3 18.8 6.2 5.2 8.2 7.4 9.8 4.7 14.3 6.3 9.6 10.7 8.1 8.5 6.9 7.4 8.2 7.9 10.0 5.3 11.9 8.8 16.1 5.8 24.8 9.6 8.1 20.1 16.8 6.9 9.2 25.4 28.6 41.0 32.0 10.6 14.8 54.7 32.5 25.5 37.6 32.9 48.9 20.3 33.0 19.3 26.9 29.7 40.8 37.2 27.9 47.5 46.1 22.2 39.2 29.3 33.7 25.3 37.9 29.1 19.7 26.8 35.3 45.6 21.0 66.9 35.6 36.6 40.4 25.4 58.1 56.5 34.1 28.2 27.8 19.2 68.6 29.8 31.7 22.9 31.7 38.9 32.0 29.0 27.0 33.4 38.9 23.5 37.1 32.1 34.2 28.3 60.4 58.9 28.6 42.0 57.8 21.1 34.5 35.2 44.5 16.2 32.7 19.8 20.1 26.5 31.6 19.4 21.4 22.4 26.4 17.7 20.5 16.1 27.3 15.7 17.7 27.9 20.2 5.5 6.1 11.1 7.1 5.7 5.7 6.2 5.2 6.3 5.3 5.8 9.2 18.2 9.6 11.2 10.7 80.0 47.2 126.7 15.1 23.9 43.1 10.1 9.4 17.7 24.3 7.2 7.3 35.5 43.2 47.3 11.4 3.9 12.2 79.5 8.3 11.9 38.0 50.4 38.7 13.9 7.6 50.5 33.2 23.9 10.9 47.0 8.6 41.7 30.6 37.0 37.0 12.3 24.9 12.2 73.4 22.3 33.3 57.8 42.2 19.6 15.9 54.0 32.4 120.5 22.1 19.1 14.6 21.6 38.4 58.7 89.3 21.4 8.4 8.7 45.8 26.3 64.0 32.5 28.9 34.0 32.7 35.8 55.4 77.2 6.7 27.8 116.6 USP8 "HumORF8, KIAA0055, SPG59, UBPY" ENSG00000138592 "Ubiquitin specific peptidase 8" P40818 15 50424380-50514421 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Cancer-related genes, Cushing syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050215 Approved Supported "Golgi apparatus,Cytosol" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 18: U-2197 - ECM organization" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus" Cytosol "HPA050215: AB_2681054" "unprognostic (5.81e-2)" "unprognostic (1.34e-1)" "unprognostic (1.46e-1)" "unprognostic (9.58e-2)" "unprognostic (2.35e-2)" "unprognostic (2.91e-1)" "unprognostic (1.42e-1)" "unprognostic (3.96e-1)" "unprognostic (1.68e-2)" "unprognostic (5.08e-2)" "unprognostic (2.94e-1)" "unprognostic (3.99e-2)" "prognostic favorable (1.29e-5)" "unprognostic (4.89e-2)" "unprognostic (1.13e-1)" "unprognostic (3.79e-1)" "unprognostic (1.58e-1)" 20.3 18.8 11.5 21.1 11.0 27.6 19.6 14.4 13.3 20.5 18.1 21.5 26.7 19.1 10.4 20.7 18.5 16.4 15.1 9.1 14.6 27.0 28.1 19.5 19.0 14.1 13.1 19.9 17.4 45.1 10.6 20.3 12.5 17.0 20.8 22.2 19.8 17.2 17.6 14.2 24.4 18.4 11.5 18.7 22.5 32.0 13.6 20.9 25.4 22.7 24.3 20.0 12.6 13.2 30.6 35.8 23.7 41.1 32.3 44.3 31.0 45.7 43.9 35.7 40.4 19.5 17.7 28.8 35.0 43.5 46.6 57.8 28.8 28.3 39.9 27.2 19.3 52.9 31.9 27.3 35.9 34.3 34.4 32.4 36.2 26.0 55.8 37.0 36.3 23.3 28.4 36.8 32.9 45.9 26.6 12.0 28.5 32.6 17.1 24.1 39.1 45.8 29.5 61.3 29.1 23.8 42.5 55.9 57.4 48.9 35.8 36.9 45.0 41.1 24.1 122.7 52.7 28.5 69.8 32.4 30.6 65.6 40.1 114.6 27.7 50.1 21.4 26.1 22.1 37.3 22.9 23.3 22.7 34.3 24.0 21.2 47.9 22.1 35.0 20.5 20.0 16.0 11.5 11.0 14.4 13.3 9.1 14.6 14.1 13.1 12.5 11.5 13.6 13.2 63.5 96.1 130.8 36.2 101.8 28.9 40.7 47.3 35.9 54.5 41.7 40.0 69.8 51.5 72.7 47.8 68.8 59.0 92.7 79.5 25.4 53.7 153.7 91.5 79.7 53.8 53.3 36.8 41.0 51.3 45.4 55.8 58.1 65.6 86.7 48.5 51.0 56.6 45.4 33.7 44.3 68.7 36.7 73.2 38.2 28.4 53.7 77.6 40.9 46.9 85.3 45.5 72.1 34.7 46.1 57.3 58.2 61.7 87.1 51.0 88.9 49.9 114.9 74.2 46.0 108.2 56.2 140.5 54.8 39.6 41.5 105.2 72.6 77.1 64.8 55.3 USP50 ENSG00000170236 "Ubiquitin specific peptidase 50" Q70EL3 15 50494018-50546708 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 1.6" "Group enriched" "Detected in some" 8 "Early spermatids: 107.8;Late spermatids: 58.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA039470 Uncertain NA NA "Cluster 71: Testis - DNA repair" "Cluster 23: Spermatids - Flagellum & Golgi organization" "HPA039470: AB_10672964" "unprognostic (7.05e-3)" "unprognostic (2.38e-1)" "unprognostic (2.01e-2)" "unprognostic (4.04e-3)" "unprognostic (3.37e-1)" "unprognostic (2.53e-2)" "unprognostic (3.95e-2)" "unprognostic (1.73e-2)" "unprognostic (1.51e-1)" "unprognostic (1.42e-1)" "unprognostic (1.85e-1)" "unprognostic (3.81e-2)" "unprognostic (4.65e-2)" "unprognostic (2.47e-1)" "unprognostic (7.49e-4)" "unprognostic (3.03e-1)" 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.0 1.6 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 107.8 0.1 0.2 0.1 0.0 0.0 2.6 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.4 0.2 0.1 0.0 3.2 0.0 0.0 0.0 0.0 58.0 0.3 0.2 0.0 2.8 0.0 0.0 0.0 3.0 9.5 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.1 3.8 0.4 0.0 0.0 0.1 0.1 0.1 0.0 0.1 TRPM7 "CHAK1, LTRPC7, TRP-PLIK" ENSG00000092439 "Transient receptor potential cation channel subfamily M member 7" Q96QT4 15 50552473-50686797 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Necrosis, Transport" "Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase" "Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 108.9" "Cell type enhanced" "Detected in all" "Excitatory neurons: 122.2;Oligodendrocytes: 109.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 122.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035522, HPA052173" Enhanced Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 18: U-2197 - ECM organization" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane" "Vesicles, Cytosol" "HPA035522: , HPA052173: AB_2681749" "unprognostic (3.14e-2)" "unprognostic (1.86e-1)" "unprognostic (1.58e-1)" "unprognostic (1.42e-2)" "unprognostic (1.89e-1)" "unprognostic (1.60e-2)" "unprognostic (1.85e-2)" "unprognostic (2.59e-2)" "unprognostic (5.46e-3)" "unprognostic (2.64e-1)" "unprognostic (2.91e-1)" "unprognostic (1.59e-2)" "unprognostic (3.20e-2)" "unprognostic (2.08e-1)" "unprognostic (7.59e-2)" "unprognostic (9.45e-2)" "unprognostic (1.97e-1)" 11.5 9.6 4.3 13.3 6.5 21.4 13.6 15.4 6.7 10.3 29.3 13.8 14.4 12.7 14.6 8.6 9.4 11.1 15.5 4.8 3.5 22.9 25.3 11.6 16.6 4.9 3.9 16.4 12.2 108.9 5.3 13.3 5.9 10.9 14.4 10.5 10.9 10.6 7.8 16.6 13.1 11.4 3.2 12.2 13.6 9.9 6.4 15.5 17.3 9.1 14.4 11.4 8.1 10.4 21.4 21.0 17.2 19.1 48.5 36.2 20.9 26.4 36.7 16.5 21.6 29.1 11.6 46.4 12.7 30.8 42.5 35.1 23.3 19.5 23.4 26.0 13.7 37.1 31.5 15.4 44.0 38.8 27.6 33.9 22.4 18.8 35.0 24.0 13.5 28.8 42.6 34.5 30.4 33.7 25.1 18.8 13.0 29.4 12.8 27.2 23.7 22.7 23.0 49.9 14.2 18.1 18.2 28.7 35.8 30.1 18.0 41.6 20.7 26.1 12.4 122.4 30.8 23.3 54.9 44.0 28.4 77.5 24.8 1.8 1.3 1.6 2.5 1.3 2.9 2.2 1.8 1.7 1.5 2.3 1.6 1.9 1.7 2.4 1.4 1.9 2.0 0.8 4.3 6.5 15.4 6.7 4.8 3.5 4.9 3.9 5.9 3.2 6.4 10.4 23.9 19.2 31.3 73.1 36.4 31.6 17.2 11.0 44.9 21.9 18.8 11.9 25.9 21.5 8.2 12.9 12.5 23.0 38.4 17.0 3.9 11.7 33.3 21.6 27.1 19.7 18.5 29.6 122.2 12.7 9.4 26.1 37.8 23.1 17.7 26.0 14.6 43.9 14.6 21.9 92.7 19.5 6.1 22.4 19.8 26.0 26.4 26.5 19.6 66.5 24.2 8.5 29.9 80.9 109.1 15.5 13.9 20.3 33.2 24.9 23.4 11.0 19.3 22.6 13.1 30.0 22.0 23.1 23.6 25.7 24.2 16.3 34.5 22.2 20.4 11.1 AC084756.2 ENSG00000288645 "Novel protein" 15 50648802-50686717 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "brain: 5.1;choroid plexus: 10.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 4 "U-266/84: 16.0" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 16: U-266 - Nucleosome" 0.0 0.0 2.1 0.0 2.7 0.0 0.0 1.8 2.7 0.0 10.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.6 0.0 0.0 0.0 0.0 2.4 2.0 0.0 1.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.7 16.0 3.6 0.0 0.0 0.0 0.1 1.5 2.9 3.9 0.7 3.3 3.8 2.1 1.6 1.7 4.8 2.4 2.9 1.9 1.7 1.1 2.4 1.1 0.7 2.1 2.7 1.8 2.7 1.9 1.6 2.4 2.0 2.1 2.0 2.3 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPPL2A "IMP3, PSL2" ENSG00000138600 "Signal peptide peptidase like 2A" Q8TCT8 15 50702266-50765709 "Enzymes, Plasma proteins, Predicted membrane proteins, Transporters" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036062, HPA067304" Enhanced Supported Vesicles NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 8: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Vesicles "HPA036062: AB_10611670, HPA067304: AB_2685820" "unprognostic (1.66e-1)" "unprognostic (1.03e-1)" "unprognostic (2.70e-1)" "unprognostic (5.82e-3)" "unprognostic (3.71e-1)" "unprognostic (1.70e-1)" "unprognostic (2.15e-1)" "unprognostic (1.88e-1)" "unprognostic (2.22e-2)" "unprognostic (6.36e-2)" "unprognostic (2.04e-2)" "unprognostic (4.00e-2)" "unprognostic (3.11e-2)" "unprognostic (2.26e-2)" "unprognostic (1.44e-2)" "unprognostic (6.96e-2)" "unprognostic (3.66e-1)" 41.1 34.7 8.3 57.6 10.9 54.5 32.0 11.1 8.5 36.6 48.6 93.4 79.6 27.9 21.5 26.5 26.8 39.4 37.1 6.8 12.3 57.9 107.0 43.4 40.2 15.3 12.8 13.6 63.7 158.5 13.0 54.1 12.5 29.5 82.8 12.5 44.5 32.6 109.3 25.2 67.6 41.0 11.2 37.3 41.7 18.5 12.1 39.5 35.2 81.8 41.7 51.7 20.9 14.5 57.3 96.9 37.0 49.2 142.3 84.3 58.2 89.1 149.1 80.5 114.1 113.1 64.3 35.1 65.0 176.3 120.7 83.5 45.2 54.3 89.5 72.2 27.5 67.0 61.5 58.9 117.4 42.0 104.5 73.9 98.3 66.8 106.7 59.4 80.2 37.7 51.3 134.2 107.6 131.5 20.1 16.2 15.8 90.8 22.0 24.2 57.3 77.6 109.7 130.4 29.7 33.4 54.0 102.7 63.4 74.0 73.2 81.6 98.9 128.7 51.7 83.7 106.7 54.0 100.2 38.8 58.1 69.4 90.3 48.7 52.3 48.9 27.9 48.6 17.4 18.3 22.3 25.5 37.4 19.2 12.4 20.5 37.7 23.5 56.6 33.1 30.4 50.2 8.3 10.9 11.1 8.5 6.8 12.3 15.3 12.8 12.5 11.2 12.1 14.5 66.2 48.1 35.9 20.5 51.9 43.1 79.1 76.3 37.5 14.8 36.4 21.3 77.5 52.9 44.3 68.0 20.9 136.5 72.7 215.5 23.5 87.1 18.8 107.2 56.6 59.6 38.4 30.3 32.0 167.1 88.3 74.3 52.0 57.3 45.7 20.5 46.8 124.1 85.9 8.4 31.4 86.5 36.7 68.7 55.7 7.0 44.7 83.0 32.0 23.4 134.5 27.5 64.9 25.6 26.2 131.9 127.3 36.5 49.9 92.2 143.0 46.8 41.8 17.2 26.3 88.0 51.6 31.7 15.3 39.3 38.8 204.5 60.6 30.8 76.0 94.1 AP4E1 "AP-4-EPSILON, SPG51" ENSG00000081014 "Adaptor related protein complex 4 subunit epsilon 1" Q9UPM8 15 50908672-51005895 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 36.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 2.7" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041749, HPA041891" Approved NA NA "Cluster 34: Basophils - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 32: U-937 - Innate immune response" "Cluster 59: Non-specific - Transcription" "HPA041749: AB_10794490, HPA041891: AB_10796462" "unprognostic (1.72e-2)" "unprognostic (3.44e-1)" "unprognostic (9.21e-2)" "unprognostic (2.22e-3)" "unprognostic (1.27e-1)" "unprognostic (9.46e-2)" "unprognostic (6.83e-3)" "unprognostic (1.06e-2)" "unprognostic (2.37e-2)" "unprognostic (1.01e-1)" "unprognostic (1.77e-1)" "unprognostic (6.84e-2)" "unprognostic (3.59e-2)" "unprognostic (1.09e-1)" "unprognostic (1.18e-1)" "unprognostic (3.40e-1)" "unprognostic (2.03e-2)" 3.7 3.0 2.5 4.4 2.9 3.1 3.0 3.3 2.7 3.7 3.2 3.6 3.0 4.3 2.1 4.7 3.2 2.6 3.9 2.4 2.6 2.8 2.9 3.1 5.5 2.9 2.8 2.9 2.2 5.1 2.4 4.7 2.9 2.7 3.4 3.8 3.3 2.6 8.2 5.4 3.2 4.5 2.6 4.6 2.9 3.9 3.0 6.5 3.8 6.3 4.7 4.0 4.1 3.5 11.5 8.7 6.0 7.1 7.9 12.0 11.7 11.1 8.9 10.7 11.1 10.7 1.8 11.2 4.3 12.5 10.8 13.7 9.0 9.6 12.4 12.3 4.6 9.8 14.5 4.3 11.1 12.1 8.2 12.2 11.6 13.4 21.0 6.6 7.2 8.8 9.1 6.3 14.7 15.4 7.1 6.9 3.9 5.2 4.4 9.7 8.5 6.9 7.9 10.4 4.1 6.7 11.8 8.4 8.7 10.7 7.6 11.7 10.0 15.7 5.8 9.5 15.9 9.6 11.7 14.1 12.3 26.1 7.3 2.7 0.6 0.3 0.8 0.9 0.5 0.5 0.6 0.7 0.6 0.3 0.4 0.9 0.1 0.5 0.5 0.4 0.3 0.4 2.5 2.9 3.3 2.7 2.4 2.6 2.9 2.8 2.9 2.6 3.0 3.5 6.6 6.4 6.1 17.6 8.7 5.7 1.5 3.8 4.0 9.8 4.9 3.7 10.4 2.8 8.4 5.5 18.8 7.3 7.7 7.9 0.0 4.9 2.0 5.9 10.0 7.8 3.0 6.9 26.7 4.8 5.7 4.7 7.1 6.2 10.2 7.2 6.8 8.1 7.2 8.4 27.0 5.3 2.0 17.0 4.1 1.4 5.9 10.2 1.8 25.3 6.5 3.9 8.2 19.1 36.0 10.6 2.4 4.1 9.6 2.2 6.2 3.6 4.8 11.2 6.6 7.1 6.6 10.2 7.7 6.6 7.0 7.3 9.6 4.8 5.5 2.4 TNFAIP8L3 FLJ41287 ENSG00000183578 "TNF alpha induced protein 8 like 3" Q5GJ75 15 51056598-51105276 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 86.9;smooth muscle: 84.8" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 10.3;Inhibitory neurons: 14.4;Langerhans cells: 10.8;Smooth muscle cells: 9.3;Spermatocytes: 23.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 35.0;ASC TERT1: 87.8;HUVEC TERT2: 78.7;LHCN-M2: 74.5;TIME: 105.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA077484 Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 11: Basophils - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol Nucleoplasm "HPA077484: AB_2732347" "unprognostic (1.38e-1)" "unprognostic (6.22e-2)" "unprognostic (1.12e-3)" "unprognostic (6.63e-2)" "unprognostic (2.54e-1)" "unprognostic (1.35e-2)" "unprognostic (3.08e-2)" "unprognostic (2.15e-2)" "unprognostic (4.21e-2)" "unprognostic (4.70e-3)" "unprognostic (6.54e-2)" "unprognostic (9.35e-2)" "unprognostic (7.12e-2)" "unprognostic (1.04e-2)" "unprognostic (1.96e-1)" "unprognostic (1.37e-3)" "prognostic unfavorable (3.51e-4)" 9.4 3.8 9.2 7.1 8.3 0.8 5.7 3.5 8.2 13.7 4.3 8.6 1.6 86.9 6.0 20.4 45.6 6.2 6.3 15.3 6.6 2.7 2.4 15.5 3.9 5.5 8.5 15.9 2.4 0.8 3.0 2.0 4.8 6.8 8.6 0.3 3.9 5.4 4.7 23.1 7.9 84.8 4.3 19.9 5.8 4.4 6.6 0.9 5.4 3.5 3.2 18.6 15.1 5.6 0.1 0.4 0.1 0.2 35.0 87.8 0.4 0.3 0.1 1.0 1.6 0.1 1.0 0.1 1.5 5.0 11.2 0.1 1.2 0.8 0.4 0.1 0.7 0.0 2.4 5.9 9.1 0.3 1.9 32.5 7.1 6.7 26.8 5.8 78.7 0.1 0.1 0.1 74.5 0.9 0.0 0.6 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.8 0.1 0.1 0.1 0.1 0.9 0.5 0.6 105.5 8.0 0.5 26.5 2.3 0.4 0.0 0.1 16.7 0.1 0.1 0.9 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.6 0.3 0.2 0.2 0.0 0.0 9.2 8.3 3.5 8.2 15.3 6.6 5.5 8.5 4.8 4.3 6.6 5.6 1.2 0.0 0.5 4.6 0.0 3.3 1.1 0.4 0.0 0.1 0.2 0.1 1.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.1 0.3 2.3 1.7 3.9 10.3 0.0 4.5 0.4 0.0 5.8 0.0 0.1 0.0 7.1 1.8 0.3 2.9 0.0 14.4 3.3 2.0 2.9 10.8 0.7 9.0 3.5 1.8 1.0 0.6 0.1 0.0 1.0 2.6 0.1 1.5 5.3 0.1 0.4 0.0 0.1 1.3 0.2 6.6 1.6 9.3 23.7 0.8 0.3 8.4 0.0 0.1 0.1 1.5 0.5 CYP19A1 "ARO, ARO1, aromatase, CPV1, CYAR, CYP19, P-450AROM" ENSG00000137869 "Cytochrome P450 family 19 subfamily A member 1" P11511 15 51208057-51338601 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Cancer-related genes, Disease variant, FDA approved drug targets, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 14 "placenta: 124.4" "Cell type enriched" "Detected in some" 10 "Syncytiotrophoblasts: 2007.5" "Cancer enhanced" "Detected in single" "glioma: 0.6" "Group enriched" "Detected in many" 4 "amygdala: 4.8;hypothalamus: 4.1;medulla oblongata: 1.4;midbrain: 2.0;thalamus: 3.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 92.8;HDLM-2: 17.5;HSkMC: 31.4;SuSa: 16.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB000355, HPA051194" Enhanced Uncertain Mitochondria NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 28: Placenta - Pregnancy" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Mitochondria "CAB000355: , HPA051194: AB_2681381" "unprognostic (9.41e-2)" "unprognostic (7.44e-2)" "unprognostic (9.52e-5)" "unprognostic (6.81e-2)" "unprognostic (2.72e-1)" "unprognostic (4.25e-4)" "unprognostic (5.18e-5)" "unprognostic (1.54e-3)" "unprognostic (2.38e-2)" "unprognostic (2.52e-1)" "unprognostic (1.97e-1)" "unprognostic (5.37e-2)" "unprognostic (1.54e-5)" "unprognostic (2.52e-3)" "unprognostic (2.11e-1)" "unprognostic (1.40e-2)" "unprognostic (1.11e-1)" 8.3 9.0 4.8 0.4 0.6 0.2 2.1 0.1 0.5 0.6 0.0 0.2 0.7 0.3 0.0 0.1 0.3 0.5 1.2 0.3 4.1 0.1 0.1 0.7 0.0 1.4 2.0 3.2 1.3 0.2 0.0 124.4 0.7 0.6 0.1 0.6 0.9 2.7 0.6 1.8 0.2 1.3 0.2 0.6 0.2 6.5 3.7 0.2 2.4 0.3 0.0 3.5 0.5 0.7 0.1 0.0 0.0 0.0 1.7 92.8 6.0 0.1 0.3 0.0 0.1 0.2 0.0 0.0 0.3 0.5 0.4 0.0 0.0 0.0 0.0 17.5 0.0 0.6 0.2 8.1 0.6 0.0 0.1 31.4 0.0 0.3 4.0 0.3 0.0 0.0 0.0 0.8 0.4 0.7 0.0 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 2.4 0.2 16.3 0.0 0.5 0.1 0.3 0.1 0.2 0.0 3.0 1.6 0.0 0.8 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.8 0.6 0.1 0.5 0.3 4.1 1.4 2.0 0.7 0.2 3.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 52.8 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.7 0.0 0.0 0.1 0.0 7.9 1.5 0.0 0.0 0.0 191.3 0.0 0.0 14.0 0.0 0.3 0.0 0.0 0.9 0.0 5.1 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.2 0.9 12.3 0.3 0.0 0.0 2007.5 0.0 22.2 0.0 0.0 GLDN "CLOM, COLM, colmedin, CRG-L2, UNC-122" ENSG00000186417 Gliomedin Q6ZMI3 15 51341655-51408005 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 84.8" "Cell type enriched" "Detected in many" 5 "Oligodendrocytes: 510.8" "Cancer enhanced" "Detected in many" "glioma: 4.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 2.7;MCF7: 1.3;SuSa: 1.8;U-266/70: 3.3;U-266/84: 2.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA050873, HPA059441" Uncertain Supported "Vesicles,Plasma membrane" "Secreted to extracellular matrix" NA NA 410000 "Cluster 70: Brain - Nervous system development" "Cluster 29: U-266 - Adaptive immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Vesicles, Plasma membrane" "HPA050873: , HPA059441: AB_2684018" "unprognostic (5.04e-2)" "unprognostic (2.57e-2)" "unprognostic (5.15e-5)" "unprognostic (3.21e-3)" "unprognostic (2.82e-2)" "unprognostic (2.33e-1)" "unprognostic (2.07e-4)" "unprognostic (2.02e-1)" "unprognostic (1.22e-1)" "unprognostic (3.30e-2)" "unprognostic (3.15e-1)" "unprognostic (2.14e-2)" "unprognostic (9.89e-2)" "unprognostic (1.60e-2)" "unprognostic (2.20e-1)" "unprognostic (3.80e-3)" "unprognostic (1.37e-1)" 18.5 2.3 18.1 1.6 51.1 0.7 9.7 35.0 28.6 1.8 0.0 3.5 0.2 0.5 0.5 0.5 1.2 3.4 5.0 15.5 31.2 0.4 0.1 8.7 0.2 47.6 48.9 0.5 0.5 0.4 0.6 3.9 56.4 2.4 6.4 1.3 1.4 0.7 1.0 5.0 0.6 0.6 26.0 2.9 2.1 0.2 41.7 0.1 0.8 0.9 0.2 1.5 1.5 84.8 0.1 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 2.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.1 0.0 0.1 0.5 0.8 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 1.0 0.0 1.8 0.0 0.5 0.0 0.0 0.0 0.1 0.0 3.3 2.9 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 18.1 51.1 35.0 28.6 15.5 31.2 47.6 48.9 56.4 26.0 41.7 84.8 40.1 0.0 2.6 2.0 0.0 6.2 0.0 0.3 0.0 9.2 0.2 0.3 8.4 0.0 0.1 0.0 0.0 5.2 0.0 47.0 0.0 0.0 0.0 0.0 0.1 3.7 1.2 0.0 7.4 0.0 0.6 7.9 4.6 0.2 0.0 4.5 0.0 0.2 4.9 0.0 17.2 1.7 0.0 14.9 9.5 0.0 0.3 16.1 3.6 42.2 0.0 0.3 0.0 2.0 510.8 0.1 28.6 0.0 0.0 0.1 0.0 0.1 0.9 0.8 0.0 4.7 9.8 0.1 0.1 0.0 4.0 100.4 0.6 0.4 5.1 1.6 DMXL2 "DFNA71, KIAA0856, RC3" ENSG00000104093 "Dmx like 2" Q8TDJ6 15 51447711-51622833 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Deafness, Diabetes mellitus, Disease variant, Epilepsy, Hypogonadotropic hypogonadism, Neuropathy, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 138.9;Inhibitory neurons: 122.9;Kupffer cells: 96.1;Macrophages: 106.3;monocytes: 84.9;Oligodendrocyte precursor cells: 96.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "classical monocyte: 2.8;intermediate monocyte: 2.2;neutrophil: 2.2;non-classical monocyte: 2.7" "Group enriched" "Detected in many" 4 "granulocytes: 2.2;monocytes: 2.8" "Cell line enhanced" "Detected in many" "U-937: 44.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039375 Approved NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 32: U-937 - Innate immune response" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "HPA039375: AB_10673610" "unprognostic (5.66e-2)" "unprognostic (9.67e-2)" "unprognostic (1.40e-2)" "unprognostic (2.21e-1)" "unprognostic (1.74e-1)" "unprognostic (1.60e-1)" "unprognostic (1.05e-2)" "unprognostic (8.38e-2)" "unprognostic (3.39e-1)" "unprognostic (2.32e-1)" "unprognostic (3.67e-3)" "unprognostic (1.24e-1)" "prognostic unfavorable (7.50e-4)" "unprognostic (1.09e-1)" "unprognostic (1.67e-1)" "unprognostic (8.60e-3)" "unprognostic (2.70e-2)" 5.3 4.7 4.1 11.1 4.7 17.1 3.4 4.0 7.3 4.6 8.1 6.5 9.2 4.4 13.9 1.9 5.2 4.5 3.1 8.9 2.8 5.7 4.5 6.8 4.7 2.5 1.1 4.1 5.4 8.0 8.4 7.2 3.0 2.7 7.5 16.3 5.4 2.5 1.1 1.7 7.1 5.3 0.0 6.5 5.3 9.0 4.2 4.7 4.2 1.7 2.6 6.0 2.8 2.4 9.1 11.7 12.6 7.3 5.3 9.1 3.1 6.9 7.5 6.5 8.5 1.7 4.4 0.0 3.3 4.1 12.5 4.8 8.1 4.8 8.7 10.6 3.9 3.6 10.6 2.1 4.9 20.6 5.8 4.2 3.9 8.4 3.7 6.8 4.5 10.9 8.3 0.8 6.7 10.0 8.9 19.2 9.2 4.3 3.8 7.9 10.3 13.5 3.4 18.1 18.0 7.8 7.3 4.1 8.5 11.0 6.9 21.9 5.7 7.8 5.3 11.0 8.2 16.0 25.2 0.0 9.2 44.0 7.4 0.0 2.8 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 2.2 0.0 2.7 0.3 0.0 0.4 4.1 4.7 4.0 7.3 8.9 2.8 2.5 1.1 3.0 0.0 4.2 2.4 5.2 3.2 15.7 68.6 2.1 3.1 2.5 4.1 4.6 41.4 4.9 2.0 8.4 1.5 6.7 7.3 64.6 5.7 13.1 22.7 1.9 3.0 2.5 11.6 18.9 5.4 28.1 0.8 138.9 3.8 4.9 8.7 28.5 5.5 10.8 10.6 5.7 6.0 36.5 58.9 122.9 13.3 2.0 96.1 16.4 3.5 6.5 106.3 3.6 50.6 84.9 8.6 1.0 96.5 50.7 5.2 17.4 9.1 2.1 2.5 24.9 8.1 18.7 31.9 6.6 8.1 8.7 37.2 30.3 2.8 1.7 3.8 3.6 9.1 15.9 2.7 SCG3 "FLJ90833, SgIII" ENSG00000104112 "Secretogranin III" Q8WXD2 15 51681492-51721026 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 133.5;choroid plexus: 40.1;pituitary gland: 39.4;retina: 56.8" "Group enriched" "Detected in many" 4 "Astrocytes: 79.3;Bipolar cells: 120.4;Cone photoreceptor cells: 102.2;Enteroendocrine cells: 148.4;Excitatory neurons: 46.2;Horizontal cells: 148.0;Inhibitory neurons: 64.0;Ionocytes: 38.7;Oligodendrocyte precursor cells: 63.3;Rod photoreceptor cells: 93.3" "Group enriched" "Detected in many" 7 "glioma: 41.0;pancreatic cancer: 15.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "NTERA-2: 50.5;SCLC-21H: 121.2;SH-SY5Y: 57.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006880, CAB033274, HPA053715" Enhanced Supported Supported Vesicles "Secreted in brain" NA NA 3100000 "Cluster 58: Brain - Synaptic function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 62: Horizontal cells - Visual perception" Vesicles "CAB033274: AB_2302033, HPA006880: AB_1079898, HPA053715: AB_2682239" "unprognostic (1.38e-2)" "unprognostic (2.42e-1)" "unprognostic (1.40e-1)" "unprognostic (5.24e-5)" "unprognostic (1.59e-2)" "unprognostic (3.63e-2)" "unprognostic (1.74e-1)" "unprognostic (9.93e-2)" "unprognostic (1.40e-1)" "unprognostic (2.46e-1)" "unprognostic (1.71e-2)" "unprognostic (8.17e-2)" "unprognostic (1.03e-1)" "unprognostic (2.78e-1)" "unprognostic (2.78e-1)" "unprognostic (8.88e-2)" "unprognostic (1.27e-1)" 0.5 16.7 71.0 1.1 87.0 0.6 0.5 85.8 133.5 0.1 40.1 1.8 2.3 0.2 0.3 0.3 0.3 0.2 0.2 88.2 112.7 0.2 0.2 0.6 0.4 68.7 75.8 0.1 15.6 0.2 39.4 0.1 68.9 0.3 2.0 56.8 0.2 0.0 0.1 0.6 2.0 0.5 71.9 0.2 9.9 2.6 79.8 0.5 1.0 0.0 0.2 0.2 0.2 71.6 0.2 0.1 4.8 0.3 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.2 0.2 0.3 0.5 0.0 0.6 0.4 0.1 0.0 0.1 0.1 0.5 0.1 0.3 0.1 0.0 0.3 3.0 0.1 0.1 0.1 0.0 0.2 0.0 0.2 0.2 0.8 0.0 0.3 0.1 0.1 50.5 0.1 0.2 0.3 0.1 0.4 0.0 0.5 121.2 57.5 0.2 0.4 0.2 15.5 0.1 3.8 0.1 0.3 0.7 0.2 0.2 0.4 0.2 0.4 0.7 0.3 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 71.0 87.0 85.8 133.5 88.2 112.7 68.7 75.8 68.9 71.9 79.8 71.6 0.2 0.0 0.0 79.3 0.0 0.3 0.0 0.3 0.0 120.4 0.0 0.1 0.2 0.0 0.1 0.0 102.2 0.0 0.0 0.2 1.9 0.4 20.0 0.0 0.0 4.3 148.4 0.0 46.2 1.0 0.1 4.1 0.0 0.0 0.0 0.0 1.8 0.0 0.4 148.0 64.0 3.4 38.7 0.0 0.3 11.3 0.0 0.1 1.8 7.5 6.7 19.2 0.0 63.3 8.9 5.3 0.0 0.4 0.0 0.4 0.1 0.0 0.8 93.3 0.0 0.4 0.2 13.8 5.8 0.0 0.0 0.0 0.0 0.2 0.3 0.3 LYSMD2 MGC35274 ENSG00000140280 "LysM domain containing 2" Q8IV50 15 51723011-51751585 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 164.4;monocytes: 97.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 77.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040460 Approved Approved "Nuclear bodies,Mitochondria" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 57: B-cells - Immune response" Mitochondria "Nuclear bodies" "HPA040460: AB_10794874" "unprognostic (7.71e-3)" "unprognostic (2.69e-1)" "unprognostic (3.38e-1)" "unprognostic (1.86e-1)" "unprognostic (1.11e-2)" "unprognostic (1.99e-2)" "unprognostic (1.01e-1)" "unprognostic (1.60e-1)" "unprognostic (1.85e-1)" "unprognostic (3.98e-1)" "unprognostic (4.17e-3)" "unprognostic (6.86e-2)" "unprognostic (1.58e-2)" "unprognostic (5.03e-1)" "unprognostic (4.69e-2)" "unprognostic (2.01e-1)" "unprognostic (1.10e-1)" 11.6 19.7 33.0 22.2 34.0 15.1 8.7 30.9 42.0 10.4 22.3 12.7 15.8 10.7 11.1 8.7 10.9 11.4 7.1 33.8 39.6 11.5 21.1 14.4 29.0 34.1 33.2 8.5 12.9 10.7 22.8 9.5 39.3 9.4 9.7 7.6 7.3 13.8 18.3 5.6 13.6 11.7 32.4 21.3 12.0 11.0 35.0 17.9 8.1 13.1 25.7 12.8 8.8 29.4 14.6 10.6 1.7 13.2 4.4 8.4 0.1 16.8 9.2 20.0 25.8 1.3 13.0 56.9 2.4 9.0 23.1 21.0 11.0 11.1 14.0 55.1 5.4 15.9 8.9 0.2 9.3 38.2 6.9 8.4 22.0 8.2 8.6 9.0 12.1 20.5 0.7 0.0 6.5 21.0 14.8 47.6 4.6 0.6 14.5 23.1 0.2 20.6 19.9 11.5 45.3 11.5 16.2 0.4 29.8 2.5 11.7 28.5 7.8 19.8 11.1 20.9 23.7 0.0 0.0 0.2 10.1 77.4 15.1 0.3 39.5 76.6 29.8 48.8 42.3 47.0 29.1 36.3 33.4 49.7 35.6 29.4 112.5 34.9 62.0 54.4 19.4 40.4 33.0 34.0 30.9 42.0 33.8 39.6 34.1 33.2 39.3 32.4 35.0 29.4 45.7 3.2 4.8 18.3 70.8 19.4 31.2 8.0 20.5 16.7 17.5 23.4 3.3 22.8 6.4 14.7 0.0 1.2 89.1 4.1 25.4 16.7 164.4 2.6 2.8 32.3 79.8 17.2 25.4 18.3 0.8 15.6 15.3 0.9 12.7 4.3 27.8 14.6 38.0 32.0 28.7 16.2 8.2 46.4 24.7 71.2 16.1 49.0 7.2 23.4 97.4 7.0 45.3 15.1 7.3 10.8 17.1 15.8 5.1 38.5 32.6 29.0 9.9 4.1 26.3 14.1 24.0 5.0 8.3 31.7 16.2 0.8 51.3 12.4 21.2 24.6 TMOD2 NTMOD ENSG00000128872 "Tropomodulin 2" Q9NZR1 15 51751597-51816363 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 63.0" "Cell type enhanced" "Detected in many" "Astrocytes: 101.9;Excitatory neurons: 147.3;Horizontal cells: 87.5;Inhibitory neurons: 125.9;Oligodendrocyte precursor cells: 98.0;Oligodendrocytes: 94.1" "Cancer enhanced" "Detected in many" "glioma: 7.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 13.1" "Group enriched" "Detected in all" 4 "granulocytes: 13.1;monocytes: 10.6" "Cell line enhanced" "Detected in many" "SCLC-21H: 37.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041365 Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoli fibrillar center" Nucleoplasm "HPA041365: AB_10794665" "unprognostic (1.09e-1)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (1.34e-3)" "unprognostic (9.11e-2)" "unprognostic (3.74e-2)" "unprognostic (1.18e-1)" "unprognostic (1.81e-1)" "unprognostic (3.32e-1)" "unprognostic (5.33e-4)" "prognostic favorable (4.53e-4)" "unprognostic (2.82e-1)" "unprognostic (1.39e-3)" "unprognostic (2.36e-2)" "unprognostic (6.86e-2)" "unprognostic (2.62e-1)" "unprognostic (2.89e-1)" 6.1 5.2 30.0 5.6 43.1 0.7 4.2 9.8 63.0 8.8 0.0 12.2 2.2 5.2 3.3 3.9 6.9 4.4 6.3 48.3 17.9 2.5 1.3 3.7 4.4 16.8 12.7 5.4 2.3 4.3 6.0 2.0 21.3 4.3 4.1 15.7 3.1 8.3 2.0 3.7 5.8 5.8 9.5 3.8 3.7 2.2 18.1 4.8 4.0 3.7 4.0 4.7 7.6 27.3 1.2 0.7 2.4 5.7 11.3 12.1 0.4 6.5 2.2 4.8 5.2 0.1 0.6 5.3 0.2 5.1 5.0 3.4 10.2 5.8 1.5 0.1 5.0 0.0 1.0 0.1 1.9 2.1 0.4 7.1 7.7 0.7 1.4 6.4 1.0 13.6 0.0 0.1 6.0 0.9 4.4 0.7 1.6 0.0 1.2 3.4 1.4 0.1 0.8 1.7 37.0 9.1 6.0 0.0 1.7 3.0 1.4 0.3 2.4 12.9 1.0 8.3 4.7 0.0 0.0 0.0 4.1 14.2 6.0 0.2 5.9 8.6 2.3 2.4 0.9 2.7 1.3 1.0 1.6 1.6 1.6 0.7 13.1 1.3 10.6 1.3 0.5 1.2 30.0 43.1 9.8 63.0 48.3 17.9 16.8 12.7 21.3 9.5 18.1 27.3 13.8 0.0 4.1 101.9 7.4 4.8 3.6 1.2 3.4 26.3 3.0 3.0 7.9 0.0 1.7 11.0 22.9 0.1 1.8 0.1 7.9 3.3 30.8 0.9 4.3 13.5 23.4 0.8 147.3 1.8 0.1 12.2 1.1 0.5 0.0 3.0 12.8 0.4 4.9 87.5 125.9 0.7 2.0 7.9 4.4 19.6 11.1 9.1 1.8 53.4 29.8 12.6 3.1 98.0 94.1 2.2 0.2 5.7 2.6 1.9 1.8 1.2 2.8 19.7 6.6 13.1 5.8 6.6 4.9 6.3 7.5 0.3 6.5 1.3 0.5 1.8 TMOD3 UTMOD ENSG00000138594 "Tropomodulin 3" Q9NYL9 15 51829628-51947295 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Alveolar cells type 1: 397.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001849 Approved Approved "Actin filaments,Cytosol" NA NA 1200000 "Cluster 42: Non-specific - Transcription" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" Cytosol "Actin filaments" "HPA001849: AB_1080313" "unprognostic (6.31e-2)" "prognostic unfavorable (3.25e-4)" "unprognostic (2.39e-1)" "unprognostic (7.31e-3)" "unprognostic (1.29e-1)" "unprognostic (1.71e-1)" "unprognostic (7.53e-2)" "prognostic unfavorable (6.25e-4)" "unprognostic (3.19e-2)" "unprognostic (1.66e-1)" "prognostic unfavorable (3.38e-5)" "unprognostic (7.06e-2)" "unprognostic (7.97e-2)" "unprognostic (1.18e-1)" "unprognostic (2.15e-1)" "unprognostic (1.97e-1)" "unprognostic (5.58e-3)" 12.2 7.4 4.8 13.6 4.9 9.7 9.4 4.2 5.3 11.4 6.7 15.4 15.5 9.9 10.3 43.4 13.2 11.8 6.9 4.2 3.7 13.5 13.7 21.7 12.8 5.0 5.2 6.9 8.0 7.3 3.4 21.9 4.9 7.5 15.4 3.6 12.8 9.8 3.4 15.0 16.0 9.6 4.9 13.7 16.9 3.4 5.8 12.6 9.6 6.4 19.5 16.4 18.7 5.0 59.4 56.0 22.3 5.8 21.6 35.9 25.8 26.1 35.5 26.7 23.8 21.8 42.4 13.9 21.7 28.0 18.9 82.3 20.7 58.5 33.9 23.8 9.1 20.6 62.6 17.9 24.0 26.6 22.1 24.2 55.7 21.5 66.2 32.9 47.7 20.0 22.3 20.6 32.6 43.9 17.8 17.7 12.4 36.3 10.3 21.0 26.7 37.8 43.5 41.5 5.4 14.6 43.5 28.9 15.6 29.7 19.7 21.0 53.8 33.9 22.6 27.8 31.3 12.5 39.5 15.6 21.7 48.0 20.4 47.6 27.9 41.4 22.7 34.7 20.2 20.4 19.8 20.3 20.6 23.8 16.7 15.7 45.5 18.8 39.3 29.0 26.0 16.7 4.8 4.9 4.2 5.3 4.2 3.7 5.0 5.2 4.9 4.9 5.8 5.0 147.9 397.4 68.2 23.8 43.5 106.9 91.4 66.3 70.6 8.3 38.8 27.3 45.8 30.0 112.7 42.3 14.6 56.1 63.3 117.4 41.1 85.8 38.9 67.5 87.6 131.6 18.6 50.9 29.4 71.6 66.3 84.1 71.9 91.3 143.0 28.8 101.4 52.9 53.9 15.2 25.5 52.0 36.7 51.7 74.1 99.3 45.1 88.4 32.0 33.7 67.5 19.2 60.8 17.1 17.1 152.6 79.0 44.4 44.1 160.3 65.5 56.5 82.2 12.6 13.1 35.2 58.0 14.5 13.9 137.0 132.1 51.3 74.3 57.4 59.9 215.9 LEO1 ENSG00000166477 "LEO1 homolog, Paf1/RNA polymerase II complex component" Q8WVC0 15 51938025-51971778 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 7 "granulocytes: 272.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040741, HPA040941" Enhanced Enhanced "Nucleoplasm,Nucleoli fibrillar center,Centrosome" No No "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" "Nucleoplasm, Nucleoli fibrillar center" Centrosome "HPA040741: AB_10794859, HPA040941: AB_10805832" "unprognostic (2.76e-2)" "unprognostic (2.14e-2)" "unprognostic (2.44e-1)" "unprognostic (1.81e-3)" "unprognostic (2.85e-2)" "unprognostic (1.03e-1)" "unprognostic (1.09e-2)" "unprognostic (1.04e-2)" "unprognostic (1.83e-2)" "unprognostic (2.10e-1)" "unprognostic (1.20e-1)" "unprognostic (1.02e-2)" "unprognostic (1.30e-1)" "unprognostic (1.04e-1)" "unprognostic (8.48e-2)" "unprognostic (2.10e-2)" "unprognostic (1.08e-1)" 10.2 11.4 8.1 13.8 8.8 9.0 15.5 14.7 12.9 11.6 6.4 17.0 13.3 10.4 10.0 19.8 8.7 13.2 8.1 8.0 10.0 13.7 22.2 9.7 18.0 8.0 8.1 8.5 8.1 18.8 9.1 12.1 7.7 12.3 19.2 12.0 18.5 8.6 13.9 20.8 14.5 11.7 6.9 10.5 13.2 9.3 8.3 22.1 11.1 11.7 17.9 19.3 14.0 10.0 28.0 63.9 40.3 32.6 40.7 35.0 28.8 44.4 36.6 37.3 33.9 44.3 17.9 56.2 25.3 45.8 41.3 53.2 54.2 39.6 35.8 37.5 24.5 88.5 50.6 78.5 32.0 80.7 118.2 37.9 30.5 29.2 37.6 35.2 37.0 46.5 54.6 30.1 44.9 118.7 43.0 61.1 17.4 82.6 27.0 47.6 69.7 58.9 32.8 77.0 28.5 43.4 33.9 51.5 36.5 43.8 42.8 72.6 44.4 36.8 25.5 34.3 53.7 23.4 78.2 50.7 32.2 113.1 40.0 11.5 14.5 15.7 27.4 23.3 25.7 18.7 27.2 22.3 23.8 16.4 27.9 25.2 3.3 30.9 26.0 17.8 31.7 16.3 8.1 8.8 14.7 12.9 8.0 10.0 8.0 8.1 7.7 6.9 8.3 10.0 16.2 35.3 24.6 10.1 15.2 26.1 16.8 33.4 18.2 38.2 11.8 10.2 21.2 17.2 37.0 7.3 10.4 24.9 24.8 24.6 15.6 26.3 2.4 19.5 38.8 18.0 7.7 12.4 16.5 24.2 26.7 19.9 15.8 29.8 272.8 16.2 10.0 18.0 19.5 26.9 16.9 17.9 26.4 14.8 6.0 2.7 8.1 13.0 3.6 5.6 12.8 23.1 22.6 13.0 13.3 18.2 14.7 13.5 11.0 9.0 20.5 23.3 31.4 23.2 6.6 18.5 29.3 21.5 11.0 19.5 24.7 17.6 25.0 23.8 17.0 21.2 MAPK6 "ERK3, HsT17250, p97MAPK, PRKM6" ENSG00000069956 "Mitogen-activated protein kinase 6" Q16659 15 51952106-52067375 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 218.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005184, HPA030262, HPA047825" Approved Supported Supported Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 44: Endometrium - Transcription" Cytosol "CAB005184: AB_2140298, HPA030262: AB_10601868, HPA047825: " "unprognostic (6.61e-2)" "unprognostic (1.75e-2)" "unprognostic (5.05e-2)" "unprognostic (3.40e-3)" "unprognostic (2.72e-1)" "unprognostic (5.52e-2)" "unprognostic (6.13e-2)" "unprognostic (2.32e-3)" "unprognostic (3.99e-2)" "unprognostic (8.54e-2)" "unprognostic (3.68e-2)" "unprognostic (3.90e-2)" "unprognostic (3.27e-3)" "unprognostic (2.03e-1)" "unprognostic (1.72e-1)" "unprognostic (3.07e-2)" "unprognostic (2.31e-2)" 10.9 7.0 8.6 12.1 11.1 32.4 13.9 14.5 13.3 15.3 7.6 20.3 17.5 16.4 10.9 28.0 8.2 17.5 7.7 10.5 10.5 15.2 35.3 8.8 10.8 10.5 10.8 6.2 8.3 11.0 8.0 12.6 10.6 10.1 18.7 17.9 15.3 8.7 27.7 23.1 24.5 13.7 9.7 8.3 16.9 29.3 10.6 14.5 13.9 32.9 13.6 27.3 21.3 12.0 27.1 36.0 69.1 26.7 21.1 34.3 50.5 38.0 38.0 34.2 40.1 43.3 15.9 38.9 26.0 48.9 50.0 37.5 53.8 72.4 46.5 24.0 16.8 58.0 20.3 68.9 50.4 43.9 118.6 36.8 130.0 41.5 106.8 36.4 32.7 26.1 76.5 64.3 44.2 61.3 30.8 34.4 24.7 33.6 17.2 26.8 44.5 62.3 32.8 112.3 33.8 31.9 30.7 24.6 56.5 94.9 22.6 64.3 32.9 40.7 43.9 26.8 51.4 33.2 104.4 47.5 50.4 62.9 51.2 1.7 2.5 0.7 1.9 2.3 2.3 2.5 2.8 2.2 2.3 1.3 2.6 1.9 0.3 3.6 1.5 1.0 4.3 1.9 8.6 11.1 14.5 13.3 10.5 10.5 10.5 10.8 10.6 9.7 10.6 12.0 31.3 28.9 31.5 24.5 24.2 111.9 123.8 50.6 24.5 55.6 39.3 19.3 21.9 25.8 43.1 16.5 16.7 16.9 15.9 110.2 17.6 35.2 147.5 61.3 75.7 28.8 31.0 17.1 29.1 50.1 39.5 39.2 35.7 126.4 137.9 19.3 17.9 59.6 28.0 33.7 31.0 42.9 42.7 41.8 66.6 218.1 22.7 50.5 30.2 17.8 15.7 32.3 11.3 28.6 63.7 69.1 46.5 23.7 35.3 89.0 110.6 60.3 42.9 23.8 19.7 24.7 33.9 72.7 81.0 49.6 110.7 33.1 23.0 13.9 28.6 174.0 BCL2L10 "BCL-B, Boo, Diva" ENSG00000137875 "BCL2 like 10" Q9HD36 15 52109263-52112775 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 9.6;skin 1: 6.9" "Cell type enhanced" "Detected in many" "Distal tubular cells: 13.7;Proximal enterocytes: 11.4;Proximal tubular cells: 9.8;Squamous epithelial cells: 7.9;Suprabasal keratinocytes: 8.7" "Cancer enhanced" "Detected in many" "liver cancer: 6.4" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "basophil: 1.4" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 8 "NB-4: 34.1" "Not detected" "Not detected" HPA042222 Approved NA NA "Cluster 10: Basophils - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 44: Endometrium - Transcription" "HPA042222: AB_10794271" "unprognostic (5.33e-4)" "unprognostic (1.26e-1)" "unprognostic (1.58e-1)" "unprognostic (3.22e-4)" "unprognostic (1.19e-2)" "unprognostic (1.20e-1)" "unprognostic (5.07e-2)" "unprognostic (4.80e-3)" "unprognostic (8.86e-2)" "unprognostic (3.47e-2)" "unprognostic (9.52e-2)" "unprognostic (3.83e-1)" "unprognostic (2.18e-9)" "unprognostic (9.59e-2)" "unprognostic (1.86e-1)" "unprognostic (1.92e-1)" "unprognostic (3.20e-2)" 0.2 2.6 1.2 0.3 1.6 0.1 1.0 0.8 1.1 2.3 0.5 1.0 1.9 0.8 0.0 3.5 0.6 0.9 0.0 0.9 1.7 3.1 9.6 0.0 0.2 0.6 0.6 0.4 0.6 0.2 1.2 0.0 0.8 0.5 0.8 0.4 0.8 0.1 0.1 6.9 2.1 0.2 0.5 0.6 0.9 0.2 1.8 0.1 0.3 0.0 0.2 1.2 3.6 0.7 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.7 0.4 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 34.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.1 4.2 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.2 1.6 0.8 1.1 0.9 1.7 0.6 0.6 0.8 0.5 1.8 0.7 0.1 0.0 0.0 0.0 0.6 6.1 5.3 2.5 4.6 1.0 1.7 2.5 0.3 4.3 0.7 0.0 0.0 0.1 0.2 2.8 13.7 2.2 0.0 1.4 1.4 0.3 0.0 0.8 0.4 1.5 0.2 0.3 0.0 5.2 0.0 0.1 0.0 4.5 0.1 0.0 0.2 2.1 6.1 0.0 0.7 0.1 0.3 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.4 0.7 0.4 1.1 2.0 11.4 9.8 0.4 0.2 0.0 0.2 0.3 0.0 0.1 7.9 8.7 0.1 0.2 0.1 3.1 5.4 GNB5 GB5 ENSG00000069966 "G protein subunit beta 5" O14775 15 52115100-52191392 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" Transducer "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 120.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 267.5;Cone photoreceptor cells: 279.4;Muller glia cells: 206.9;Rod photoreceptor cells: 296.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032353, HPA041942, HPA044198" Uncertain Approved "Nuclear speckles,Centrosome,Rods & Rings" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 77: Retina - Visual perception" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 9: Photoreceptor cells - Phototransduction" "Nuclear speckles" "Centrosome, Rods & Rings" "CAB032353: AB_2263274, HPA041942: AB_10794309, HPA044198: AB_2678853" "unprognostic (2.38e-2)" "unprognostic (3.58e-1)" "unprognostic (1.97e-3)" "prognostic favorable (1.47e-6)" "unprognostic (6.15e-2)" "unprognostic (1.37e-2)" "unprognostic (2.57e-2)" "unprognostic (2.63e-2)" "unprognostic (1.54e-1)" "unprognostic (2.44e-1)" "unprognostic (1.67e-3)" "unprognostic (2.10e-1)" "prognostic favorable (3.32e-11)" "unprognostic (1.40e-3)" "unprognostic (8.12e-3)" "unprognostic (3.55e-3)" "unprognostic (1.52e-1)" 11.2 14.5 20.7 11.8 22.5 5.4 12.7 26.7 28.3 27.1 8.7 18.8 5.9 28.3 17.2 11.8 26.8 20.8 22.8 21.9 25.6 36.3 18.8 8.9 21.9 22.5 13.6 49.4 18.9 40.6 25.9 5.7 23.4 16.6 5.5 120.0 11.2 25.5 2.5 8.7 13.1 17.4 9.4 13.5 11.1 15.7 23.6 14.9 21.7 4.7 19.9 20.8 18.1 15.1 18.9 47.6 12.9 23.1 21.5 26.9 12.5 36.1 34.8 31.4 34.0 13.3 13.9 32.6 11.0 29.7 52.9 27.0 23.1 34.3 23.6 25.5 17.5 21.8 60.7 15.6 25.7 11.0 75.8 25.0 28.3 25.2 9.3 33.3 19.9 28.2 1.7 29.9 34.8 33.6 17.6 31.4 12.1 6.3 20.9 23.4 44.9 40.0 22.4 56.7 20.8 18.0 34.6 3.2 28.7 15.8 11.1 33.9 49.5 28.1 30.7 32.2 36.8 18.9 39.0 35.7 58.9 26.6 46.2 10.1 3.8 0.4 21.4 3.8 17.6 41.5 27.2 25.5 10.1 43.8 25.2 21.9 2.2 23.6 3.2 20.6 42.5 18.7 20.7 22.5 26.7 28.3 21.9 25.6 22.5 13.6 23.4 9.4 23.6 15.1 15.9 22.4 23.8 17.0 79.5 19.2 22.8 15.5 21.1 267.5 20.7 27.9 18.3 34.3 21.8 18.4 279.4 4.8 27.1 2.7 19.6 28.9 1.8 28.3 28.7 17.7 19.7 6.1 72.8 18.5 24.8 23.5 8.6 59.9 29.8 20.1 13.6 10.0 3.8 111.0 67.7 1.7 14.2 6.2 15.2 4.6 39.7 20.5 19.6 8.4 4.0 206.9 15.5 22.1 7.8 19.1 5.1 116.9 18.7 10.9 0.8 36.3 24.6 296.5 46.0 16.6 23.9 2.1 6.2 10.8 16.3 2.9 31.9 20.1 2.8 17.8 MYO5C MGC74969 ENSG00000128833 "Myosin VC" Q9NQX4 15 52192322-52295804 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 68.5;Alveolar cells type 1: 131.4;Alveolar cells type 2: 84.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 25.4;MCF7: 46.3;OE19: 41.2;RT4: 26.4;SK-BR-3: 34.0;T-47d: 40.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB020790, HPA032115, HPA032116" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 11: Alveolar cells - Smell perception" Cytosol Nucleoplasm "CAB020790: , HPA032115: AB_2674158, HPA032116: AB_2674159" "unprognostic (1.85e-1)" "unprognostic (1.29e-1)" "unprognostic (3.49e-2)" "prognostic favorable (5.18e-5)" "unprognostic (2.94e-1)" "unprognostic (4.01e-2)" "unprognostic (2.07e-1)" "unprognostic (1.53e-1)" "unprognostic (4.53e-3)" "unprognostic (1.02e-1)" "unprognostic (4.04e-3)" "unprognostic (4.82e-2)" "prognostic favorable (2.47e-5)" "prognostic favorable (5.82e-4)" "unprognostic (9.15e-2)" "unprognostic (2.34e-1)" "unprognostic (2.32e-1)" 11.1 1.5 3.0 2.8 3.3 0.8 13.2 7.9 3.1 14.1 17.0 14.0 5.3 4.2 12.8 7.0 11.5 6.9 1.6 2.6 2.9 5.6 3.4 13.8 1.9 5.1 2.8 1.6 27.3 13.7 7.3 2.5 6.3 10.3 17.7 1.6 21.1 4.4 2.1 4.8 5.1 4.0 7.3 3.5 19.4 4.7 3.3 1.9 17.9 2.6 2.4 4.4 4.4 5.9 21.4 25.4 3.5 0.0 0.0 0.1 3.0 0.0 0.3 0.1 0.0 3.9 8.8 1.2 5.3 0.1 0.2 3.4 5.3 7.4 0.0 1.1 8.4 0.1 17.3 15.7 0.0 0.0 0.2 0.0 7.2 0.0 6.8 3.6 5.6 0.9 0.0 0.3 0.1 46.3 1.3 0.2 1.4 41.2 12.0 17.6 2.1 10.6 19.5 26.4 3.5 3.9 1.6 34.0 0.0 5.4 40.9 0.0 0.0 0.0 0.2 0.0 3.3 0.7 0.7 2.1 0.1 0.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.7 0.0 3.0 3.3 7.9 3.1 2.6 2.9 5.1 2.8 6.3 7.3 3.3 5.9 68.5 131.4 84.5 3.9 1.5 0.6 20.5 10.2 2.2 0.4 22.4 10.9 4.9 18.6 47.1 22.0 0.0 2.3 0.3 26.5 3.9 21.1 2.8 34.1 4.8 26.1 5.4 2.1 29.3 29.6 1.5 3.7 41.3 50.4 3.8 5.1 2.5 5.1 0.9 0.0 3.9 47.1 22.4 0.8 3.1 3.2 1.8 1.4 7.2 14.0 0.1 5.6 1.0 8.0 2.8 39.0 21.5 0.4 2.7 28.1 2.1 1.3 49.8 0.5 0.0 1.3 1.5 9.0 5.9 14.1 1.4 0.7 1.6 2.0 25.8 38.7 MYO5A "GS1, MYH12, MYO5, MYR12" ENSG00000197535 "Myosin VA" Q9Y4I1 15 52307283-52529050 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.1;parathyroid gland: 47.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 353.0;Inhibitory neurons: 241.0;Oligodendrocyte precursor cells: 330.8;Oligodendrocytes: 404.2" "Cancer enhanced" "Detected in all" "melanoma: 25.2" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 201.0;RPMI-8226: 140.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001356 Enhanced Approved "Focal adhesion sites,Centriolar satellite" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 2: Karpas-707 - Immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Focal adhesion sites, Centriolar satellite" "HPA001356: AB_1079441" "unprognostic (1.54e-1)" "unprognostic (1.78e-1)" "unprognostic (6.95e-2)" "unprognostic (2.29e-2)" "unprognostic (1.97e-2)" "unprognostic (3.91e-2)" "unprognostic (2.30e-2)" "unprognostic (6.65e-2)" "unprognostic (7.89e-2)" "unprognostic (4.74e-2)" "unprognostic (9.36e-3)" "unprognostic (1.71e-1)" "unprognostic (5.63e-3)" "unprognostic (3.79e-3)" "unprognostic (1.24e-1)" "unprognostic (7.16e-2)" "prognostic unfavorable (4.22e-4)" 10.3 8.3 17.0 12.1 20.8 21.8 6.5 3.0 39.1 6.8 0.0 6.1 3.8 5.0 3.7 5.3 4.0 8.5 5.8 19.0 3.6 5.3 2.9 8.8 15.0 9.6 4.2 5.7 5.2 47.4 8.9 6.3 9.8 5.1 5.9 26.1 5.2 3.5 5.4 11.8 5.0 9.4 0.0 9.5 4.7 5.9 6.6 11.0 8.4 5.0 13.1 9.7 5.3 20.8 19.5 33.7 17.6 21.3 16.2 19.3 19.0 34.7 31.1 18.1 14.0 3.2 7.8 18.7 8.9 41.8 26.5 15.7 40.7 35.6 22.3 105.5 9.6 16.7 8.8 4.2 8.3 9.0 16.3 13.0 21.9 26.6 52.4 17.6 106.8 12.0 0.7 201.0 34.8 34.4 8.2 1.2 8.1 0.5 26.6 14.5 27.8 140.8 15.1 14.0 12.7 7.8 32.3 26.2 59.4 13.1 14.0 9.1 52.0 36.4 15.7 17.1 34.1 20.9 49.9 22.0 39.4 25.1 53.5 0.4 2.4 3.1 1.4 1.7 2.1 1.1 1.3 0.9 2.7 0.7 0.2 0.4 3.0 0.3 1.4 1.5 2.2 1.1 17.0 20.8 3.0 39.1 19.0 3.6 9.6 4.2 9.8 0.0 6.6 20.8 11.2 12.8 11.4 68.2 19.8 20.8 9.3 10.5 7.4 75.1 6.7 5.5 12.1 2.8 19.8 14.7 39.6 0.6 18.4 0.3 0.0 5.4 18.0 9.3 8.0 12.7 1.2 2.5 353.0 6.3 0.4 7.5 3.1 6.7 22.8 5.0 2.5 1.3 24.4 26.9 241.0 0.2 2.0 27.1 28.0 10.8 3.7 50.2 97.8 52.5 36.7 6.0 15.5 330.8 404.2 6.1 2.5 1.9 32.4 10.2 0.0 2.8 11.1 28.7 6.6 16.7 10.8 14.0 9.4 3.9 11.6 1.1 23.7 2.1 0.3 7.3 ARPP19 "ARPP-16, ARPP-19, ARPP16, ENSAL" ENSG00000128989 "CAMP regulated phosphoprotein 19" P56211 15 52547045-52569883 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 268.9" "Cell type enriched" "Detected in all" 4 "Late spermatids: 3587.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056851 Approved NA NA 270000 "Cluster 52: Eosinophils - Transcription" "Cluster 47: Non-specific - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 31: Spermatids - Spermatogenesis" "HPA056851: AB_2683255" "unprognostic (2.83e-1)" "unprognostic (2.80e-1)" "unprognostic (3.44e-1)" "unprognostic (8.09e-2)" "unprognostic (1.58e-1)" "unprognostic (6.14e-2)" "unprognostic (3.63e-2)" "unprognostic (2.33e-2)" "unprognostic (7.21e-2)" "unprognostic (5.67e-2)" "unprognostic (6.80e-2)" "unprognostic (2.15e-1)" "prognostic favorable (1.72e-4)" "unprognostic (1.40e-2)" "unprognostic (4.82e-2)" "unprognostic (3.05e-1)" "unprognostic (3.27e-1)" 61.2 51.7 109.3 38.6 268.9 103.3 46.2 99.6 166.2 38.1 56.0 39.6 28.9 47.9 36.3 52.1 33.4 39.2 81.4 154.5 113.0 56.4 42.2 45.1 48.4 116.4 100.4 46.2 46.3 109.2 38.7 57.0 106.1 39.5 35.8 57.4 31.7 40.9 240.3 32.1 30.6 58.0 117.5 43.7 38.6 84.6 107.0 52.9 57.4 170.6 51.7 55.4 30.1 140.2 115.1 126.3 178.2 81.3 69.8 77.6 91.7 103.8 88.7 75.9 76.9 111.7 56.6 120.2 110.3 75.0 110.3 100.4 126.1 116.7 98.2 412.3 59.9 138.0 126.0 99.9 59.4 131.8 99.3 74.0 116.1 78.5 128.2 90.0 119.8 115.3 86.2 224.4 113.9 129.0 126.4 51.6 110.1 81.0 63.8 134.1 102.6 243.3 108.2 146.7 179.4 145.2 76.6 99.2 102.6 194.4 99.2 89.0 109.4 120.3 86.1 87.0 151.1 104.4 289.8 154.8 84.9 116.8 116.7 53.5 38.5 88.1 47.7 44.5 47.4 69.9 50.0 57.4 32.5 50.8 47.9 53.1 63.8 65.6 55.6 41.5 80.2 53.9 109.3 268.9 99.6 166.2 154.5 113.0 116.4 100.4 106.1 117.5 107.0 140.2 90.8 64.1 59.4 33.6 93.9 215.7 190.7 142.2 55.8 54.3 107.3 72.5 156.5 61.5 96.1 62.5 20.9 75.7 100.3 46.2 135.0 88.9 743.5 66.3 60.4 83.0 84.6 63.3 133.2 67.9 94.2 73.7 43.3 104.4 62.1 58.5 80.7 93.1 72.3 85.8 33.9 45.6 81.4 81.7 211.9 3587.2 70.8 73.4 165.4 32.8 144.5 105.5 65.9 24.6 54.3 117.0 38.1 108.3 94.8 174.0 37.0 129.4 62.7 59.4 72.3 78.7 131.1 154.9 196.1 82.0 222.8 87.7 95.0 40.3 43.4 262.9 FAM214A "FLJ10980, KIAA1370" ENSG00000047346 "Family with sequence similarity 214 member A" Q32MH5 15 52581317-52709817 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-698: 63.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039369, HPA040180" Approved Approved Nucleoplasm NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA039369: AB_10795250, HPA040180: AB_10794736" "unprognostic (1.75e-1)" "unprognostic (6.40e-2)" "unprognostic (4.54e-1)" "prognostic favorable (7.27e-6)" "unprognostic (1.08e-2)" "unprognostic (5.96e-3)" "unprognostic (1.32e-3)" "prognostic favorable (8.68e-4)" "unprognostic (6.84e-2)" "unprognostic (2.62e-1)" "unprognostic (2.91e-2)" "unprognostic (2.20e-1)" "unprognostic (2.26e-2)" "unprognostic (1.63e-1)" "unprognostic (3.22e-1)" "unprognostic (3.79e-2)" "unprognostic (6.94e-3)" 37.2 20.3 6.4 15.1 12.0 21.3 28.2 24.5 9.0 12.6 41.1 15.4 14.2 17.5 10.2 27.6 16.5 12.6 15.9 6.6 6.5 12.1 38.8 14.4 24.5 7.3 8.9 12.5 21.8 43.4 11.5 8.5 10.3 15.3 16.9 17.5 16.9 15.9 50.1 11.7 14.2 13.4 5.8 16.0 18.4 21.2 9.8 18.1 25.3 27.0 30.6 12.7 12.3 13.6 5.1 6.8 6.9 12.0 20.7 12.4 8.1 12.5 21.8 6.6 8.6 3.9 5.4 35.3 14.7 11.9 3.1 10.2 5.0 11.6 5.8 28.4 7.1 8.9 15.9 3.3 7.3 4.3 4.6 29.6 18.2 6.5 7.2 12.4 22.0 10.9 5.2 36.1 9.4 20.1 6.8 10.9 1.3 8.7 8.1 16.3 7.2 27.1 10.8 23.7 7.8 13.6 12.6 23.5 9.5 21.1 36.6 9.3 16.4 6.6 2.0 7.4 2.7 55.2 35.8 63.6 11.4 5.7 2.2 0.7 0.6 5.3 3.6 0.2 3.9 6.3 2.7 2.4 0.7 5.4 3.0 2.8 3.8 4.9 0.3 8.4 4.7 1.1 6.4 12.0 24.5 9.0 6.6 6.5 7.3 8.9 10.3 5.8 9.8 13.6 43.5 44.8 27.1 60.7 53.5 16.3 13.2 23.7 28.5 19.3 50.8 30.2 27.7 24.3 35.6 3.7 62.6 2.6 49.2 25.4 3.9 11.4 2.8 78.1 34.7 28.0 29.2 20.4 80.0 14.9 3.0 25.3 30.5 123.9 3.8 19.3 24.7 39.0 7.3 26.9 90.1 27.0 28.5 18.0 9.9 3.7 28.3 15.8 26.6 57.1 7.4 24.7 16.5 73.4 123.7 15.2 13.2 32.0 100.5 20.1 12.3 7.6 46.2 28.6 13.1 36.6 20.9 36.5 9.4 28.7 14.3 20.2 34.6 26.9 11.5 42.0 ONECUT1 "HNF-6, HNF6, HNF6A" ENSG00000169856 "One cut homeobox 1" Q9UBC0 15 52755053-52791078 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "gallbladder: 6.0;liver: 12.9;pancreas: 13.6;retina: 4.6" "Cell type enriched" "Detected in some" 16 "Horizontal cells: 647.8" "Group enriched" "Detected in some" 7 "liver cancer: 2.9;pancreatic cancer: 0.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.8;Hep G2: 1.4;MCF7: 1.3;NTERA-2: 1.8;SuSa: 1.9;WM-115: 1.2" "Region enhanced" "Detected in single" "hypothalamus: 1.0" "Low region specificity" "Detected in many" HPA003457 Enhanced NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 12: NES - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" "HPA003457: AB_1079525" "unprognostic (5.12e-2)" "unprognostic (2.45e-2)" "unprognostic (2.64e-2)" "unprognostic (4.82e-2)" "unprognostic (9.19e-2)" "unprognostic (7.05e-2)" "unprognostic (5.73e-2)" "unprognostic (2.59e-3)" "unprognostic (1.03e-1)" "unprognostic (1.70e-7)" "unprognostic (9.76e-3)" "unprognostic (2.11e-1)" "unprognostic (1.17e-1)" 0.0 0.0 0.7 0.0 0.7 0.5 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.4 2.0 0.0 12.9 0.0 0.0 1.8 2.1 0.0 13.6 0.0 0.0 0.0 1.7 0.0 0.0 4.6 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 1.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 1.8 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 1.3 0.0 0.0 1.8 0.1 0.1 0.3 0.0 0.0 0.0 0.8 0.4 0.0 0.1 0.0 0.2 1.9 0.3 0.0 0.0 0.6 0.8 0.0 0.1 0.1 0.0 0.0 0.2 0.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.4 0.3 0.4 2.0 1.8 2.1 1.7 0.6 0.4 0.6 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 1.3 40.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 21.1 1.4 0.1 0.0 0.3 0.0 0.0 0.4 13.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 647.8 0.2 0.0 0.0 0.3 0.0 3.1 0.0 0.0 0.0 0.0 0.0 1.8 0.0 15.6 0.2 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.2 3.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 WDR72 FLJ38736 ENSG00000166415 "WD repeat domain 72" Q3MJ13 15 53513741-53762878 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Biomineralization "Amelogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 105.7;liver: 33.1;thyroid gland: 57.9" "Cell type enhanced" "Detected in some" "Cholangiocytes: 12.8;Collecting duct cells: 22.0;Glandular and luminal cells: 13.2;Hepatocytes: 44.3;Proximal tubular cells: 93.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 9.9;OE19: 18.3;RPMI-8226: 17.5;RPTEC TERT1: 10.1;SuSa: 15.2;U-266/70: 7.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA048212, HPA057410, HPA059819" Uncertain Approved Vesicles NA NA "Cluster 7: Kidney - Transmembrane transport" "Cluster 21: OE19 - Mitochondria" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Vesicles "HPA048212: AB_2680315, HPA057410: AB_2683430, HPA059819: AB_2684133" "unprognostic (6.39e-4)" "unprognostic (1.41e-1)" "unprognostic (3.19e-2)" "unprognostic (1.79e-2)" "unprognostic (2.63e-2)" "unprognostic (3.37e-2)" "unprognostic (5.54e-2)" "unprognostic (2.20e-1)" "unprognostic (1.13e-1)" "unprognostic (1.26e-1)" "unprognostic (2.78e-2)" "unprognostic (1.09e-2)" "prognostic favorable (3.33e-16)" "unprognostic (2.83e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.80e-4)" "unprognostic (7.67e-2)" 0.1 0.0 0.1 0.2 0.1 0.0 0.8 0.0 0.1 7.2 0.0 0.6 2.6 1.4 0.5 0.4 2.6 3.9 0.1 0.0 0.1 105.7 33.1 0.8 0.1 0.1 0.4 0.2 3.5 1.8 0.3 0.1 0.1 0.1 0.8 0.7 18.4 0.6 0.0 2.0 0.9 0.0 0.0 0.1 1.1 0.5 0.1 0.0 57.9 0.0 0.0 1.7 0.0 0.3 0.0 9.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.6 3.2 0.1 6.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 3.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.9 18.3 0.1 0.0 0.1 17.5 10.1 3.5 1.9 0.0 0.0 0.1 0.0 15.2 2.4 0.0 0.1 0.3 0.5 0.0 0.1 7.5 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.4 0.1 0.0 0.1 0.3 0.1 6.4 3.6 0.0 0.5 0.1 1.1 0.0 0.6 0.5 0.0 0.1 0.6 12.8 0.0 22.0 0.0 0.6 0.0 0.2 9.8 3.2 1.2 4.9 1.0 0.1 0.0 0.0 0.4 0.5 2.1 0.2 0.0 13.2 0.0 0.0 0.0 44.3 0.1 3.3 0.5 0.0 0.0 0.6 0.0 0.3 0.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.1 93.2 0.1 0.1 0.0 0.0 0.1 1.0 1.6 0.9 0.4 0.1 0.7 0.0 0.3 6.4 UNC13C "DKFZp547H074, Munc13-3" ENSG00000137766 "Unc-13 homolog C" Q8NB66 15 53978201-54633414 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 103.6" "Cell type enhanced" "Detected in some" "Bipolar cells: 73.1;Early spermatids: 184.4;Excitatory neurons: 130.3;Inhibitory neurons: 301.3;Late spermatids: 65.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "Karpas-707: 73.7;U-266/70: 97.7" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebellum: 198.6" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "unprognostic (4.85e-2)" "unprognostic (2.22e-1)" "unprognostic (1.24e-1)" "unprognostic (2.56e-1)" "unprognostic (6.65e-2)" "unprognostic (2.92e-2)" "unprognostic (1.13e-1)" "unprognostic (2.13e-1)" "unprognostic (1.45e-1)" "unprognostic (6.90e-3)" "unprognostic (1.58e-2)" "unprognostic (9.69e-2)" "unprognostic (2.42e-2)" "unprognostic (1.26e-1)" 0.1 0.2 10.5 0.1 11.2 0.1 0.1 103.6 25.6 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.4 0.2 19.0 26.4 0.9 0.0 0.1 0.3 29.5 38.4 0.8 0.0 0.0 1.1 0.0 34.9 0.0 0.1 19.1 0.1 0.0 3.5 0.1 0.1 0.0 6.2 0.1 0.1 8.7 16.9 0.0 0.6 0.0 0.3 0.0 0.0 11.7 0.8 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 73.7 0.1 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 97.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.5 11.2 103.6 25.6 19.0 26.4 29.5 38.4 34.9 6.2 16.9 11.7 0.1 0.0 0.0 8.5 0.1 0.4 0.4 0.0 0.0 73.1 0.1 0.3 0.8 1.5 0.0 3.7 6.2 1.0 1.3 0.0 0.0 0.0 184.4 0.0 0.0 0.4 0.0 0.0 130.3 0.0 0.1 0.4 0.0 0.1 0.0 0.5 0.7 0.0 0.1 0.0 301.3 0.0 0.0 0.0 0.6 65.9 2.1 0.3 0.0 3.7 0.0 3.2 0.0 4.5 3.2 0.0 0.0 0.4 0.0 0.3 0.0 0.4 0.0 33.8 0.0 2.2 0.7 1.2 1.2 0.0 0.1 0.3 0.1 0.5 0.0 0.5 RSL24D1 "C15orf15, HRP-L30-iso, L30, RPL24, RPL24L" ENSG00000137876 "Ribosomal L24 domain containing 1" Q9UHA3 15 55180806-55197049 "Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062724, HPA063392" Enhanced Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA062724: AB_2684850, HPA063392: AB_2685002" "unprognostic (3.40e-2)" "unprognostic (3.00e-1)" "unprognostic (3.83e-1)" "unprognostic (7.28e-2)" "unprognostic (3.80e-2)" "unprognostic (1.07e-3)" "unprognostic (6.71e-3)" "unprognostic (1.15e-1)" "unprognostic (6.56e-3)" "unprognostic (1.34e-1)" "unprognostic (6.19e-3)" "unprognostic (7.22e-2)" "unprognostic (1.13e-1)" "unprognostic (4.44e-1)" "unprognostic (4.54e-2)" "unprognostic (4.95e-1)" "unprognostic (2.41e-1)" 67.0 62.0 47.9 60.2 50.4 238.6 121.8 59.7 71.1 69.6 43.9 57.9 48.2 89.8 68.7 55.2 59.8 55.2 66.1 50.0 51.9 64.2 73.0 48.3 88.0 49.1 49.1 138.6 77.0 52.5 34.2 45.8 50.1 55.1 53.0 54.1 65.2 49.0 91.2 51.6 48.7 61.8 51.3 52.0 60.3 51.0 49.0 82.2 74.3 74.5 76.6 75.0 46.1 59.9 122.0 115.2 130.2 168.5 95.7 172.4 104.6 126.1 127.5 95.6 117.0 112.2 70.8 361.8 110.5 86.5 100.9 141.4 165.3 137.2 125.9 183.6 104.1 191.3 89.1 148.7 219.6 365.0 121.7 154.1 282.4 98.9 286.0 162.6 120.5 275.2 352.0 256.2 114.3 122.5 202.5 324.3 159.8 246.9 105.9 156.7 162.8 565.2 148.3 108.8 181.0 218.7 57.6 159.2 430.1 100.6 152.3 524.9 90.4 82.1 98.5 99.3 181.6 249.5 420.2 382.3 129.3 353.9 142.4 61.3 99.2 51.1 76.9 101.5 124.8 123.6 115.9 98.2 116.9 98.1 173.9 134.8 24.9 103.3 108.9 90.0 142.4 229.9 47.9 50.4 59.7 71.1 50.0 51.9 49.1 49.1 50.1 51.3 49.0 59.9 146.9 99.3 79.8 6.8 259.2 580.6 425.7 437.4 275.4 85.4 258.9 299.5 69.0 140.2 177.6 84.6 22.9 150.2 219.9 51.2 285.7 182.2 100.6 127.2 177.7 154.9 140.2 189.9 14.8 271.1 247.6 191.9 99.4 126.3 152.8 103.6 114.5 64.0 143.1 15.2 15.2 128.0 197.4 212.2 414.4 40.8 203.5 164.2 284.6 11.2 247.2 91.0 170.0 8.5 13.9 218.9 118.2 149.3 174.8 347.4 114.6 355.1 105.0 62.8 157.8 274.6 215.6 116.9 151.8 173.3 522.2 174.4 251.7 118.3 144.3 332.5 RAB27A "GS2, HsT18676, RAB27, RAM" ENSG00000069974 "RAB27A, member RAS oncogene family" P51159 15 55202966-55319113 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" Exocytosis Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "stomach 1: 119.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 147.1;Intestinal goblet cells: 252.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 261.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HL-60: 208.7;K-562: 238.0;Karpas-707: 179.4;SK-MEL-30: 188.3;U-937: 185.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001333, CAB034046" Enhanced NA NA "Cluster 46: Basophils - DNA binding" "Cluster 37: Intestine - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 27: Mucus-secreting cells - Mucin production" "CAB034046: AB_2176724, HPA001333: AB_1079730" "prognostic favorable (2.56e-4)" "unprognostic (9.75e-2)" "unprognostic (2.01e-2)" "unprognostic (1.81e-1)" "unprognostic (1.08e-1)" "unprognostic (1.79e-1)" "unprognostic (1.73e-1)" "unprognostic (2.32e-1)" "unprognostic (2.62e-1)" "unprognostic (2.77e-1)" "unprognostic (6.24e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (1.67e-4)" "unprognostic (4.23e-2)" "unprognostic (4.34e-1)" "unprognostic (7.95e-3)" "unprognostic (4.32e-1)" 17.5 27.8 3.5 40.2 3.9 100.2 13.9 4.4 4.4 12.9 5.6 53.0 30.0 12.8 5.0 20.6 12.3 17.6 7.7 3.4 6.7 19.2 43.6 42.4 46.0 5.8 5.0 8.0 29.2 11.4 31.4 17.6 5.9 61.2 66.1 4.2 18.3 11.8 3.2 12.8 40.9 25.8 5.0 30.8 119.9 10.0 5.9 19.3 30.5 7.0 46.2 37.5 13.9 5.7 23.0 10.0 9.7 11.3 8.3 38.8 9.5 29.4 32.5 19.2 26.4 7.0 15.6 0.9 22.3 16.0 38.9 16.0 15.7 27.0 18.3 84.9 9.7 5.4 37.6 18.1 56.0 208.7 26.5 34.3 44.2 29.0 71.6 80.7 46.9 26.4 238.0 179.4 20.7 27.7 1.5 57.6 3.6 38.9 14.7 32.4 27.3 50.3 28.7 17.7 14.9 7.1 31.4 15.2 188.3 24.3 13.3 162.2 25.3 52.5 20.3 33.1 33.6 72.0 88.2 6.0 70.2 185.1 19.0 261.3 72.4 99.8 59.2 30.1 58.2 8.0 28.6 61.9 39.0 13.4 13.9 37.4 114.9 34.1 24.0 2.1 36.2 48.9 3.5 3.9 4.4 4.4 3.4 6.7 5.8 5.0 5.9 5.0 5.9 5.7 27.5 76.9 147.1 12.7 18.6 14.1 25.7 19.2 6.2 3.0 16.3 18.3 7.4 15.7 50.1 11.0 2.1 6.3 81.0 18.5 13.7 24.6 2.8 10.1 15.6 32.1 74.3 12.8 12.5 87.6 18.7 16.9 93.3 16.7 31.7 8.8 41.7 41.7 15.6 0.0 12.2 252.0 12.2 33.3 15.2 2.2 7.5 31.1 71.2 10.3 71.9 2.4 104.0 10.1 7.1 62.9 15.9 13.9 38.6 32.3 14.6 6.7 31.3 4.4 19.7 9.4 15.8 9.3 4.6 7.1 15.5 7.5 81.4 4.6 18.4 23.4 PIGBOS1 ENSG00000225973 "PIGB opposite strand 1" A0A0B4J2F0 15 55317184-55319161 "Predicted intracellular proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 18: Non-specific - Mitochondria" "Cluster 1: K-562 - Erythropoiesis" "Cluster 39: Non-specific - Basic cellular processes" "prognostic favorable (4.19e-4)" "unprognostic (1.61e-1)" "unprognostic (1.25e-1)" "unprognostic (5.58e-3)" "unprognostic (1.21e-1)" "unprognostic (3.41e-1)" "unprognostic (1.84e-1)" "unprognostic (1.33e-2)" "unprognostic (3.08e-2)" "unprognostic (2.31e-1)" "unprognostic (3.27e-2)" "unprognostic (2.58e-3)" "unprognostic (4.62e-3)" "unprognostic (7.75e-2)" "unprognostic (2.74e-1)" "unprognostic (1.30e-1)" "unprognostic (4.96e-1)" 14.5 13.0 6.1 11.6 6.6 17.4 14.9 6.4 7.4 12.5 7.5 12.7 10.2 13.6 9.1 9.1 13.5 8.2 11.9 6.2 7.1 15.3 15.0 11.4 13.9 7.7 6.8 12.5 12.4 8.2 13.4 11.7 7.7 11.4 8.1 6.6 12.8 6.4 13.8 8.9 13.5 7.7 6.5 16.4 15.4 11.3 6.9 10.1 16.3 6.8 8.8 12.9 10.8 8.9 15.7 15.3 12.7 9.2 16.3 18.0 16.2 14.8 15.2 12.3 8.3 8.4 9.7 19.8 18.3 10.6 19.6 13.8 4.6 8.3 7.8 25.2 7.4 33.6 14.6 15.8 14.1 23.4 26.6 16.3 14.8 8.1 9.2 16.6 14.1 17.7 39.5 17.6 11.1 12.9 12.0 44.9 7.7 16.3 7.7 16.6 12.3 36.8 10.1 10.2 9.5 15.9 9.5 15.6 48.6 15.9 15.8 52.1 14.1 19.1 22.4 11.0 23.9 17.8 48.9 16.2 17.8 49.3 19.7 49.7 41.9 58.0 24.7 33.2 23.5 31.0 29.8 27.1 33.6 30.6 40.3 29.4 44.3 33.3 46.3 42.7 41.0 26.4 6.1 6.6 6.4 7.4 6.2 7.1 7.7 6.8 7.7 6.5 6.9 8.9 20.0 28.9 21.6 0.0 24.8 0.0 12.3 0.0 14.8 14.1 15.9 22.2 8.9 14.3 9.9 18.4 6.2 33.4 34.0 15.6 39.2 24.6 19.4 21.0 23.7 22.5 30.1 23.8 0.0 39.5 35.3 21.7 13.3 15.4 7.0 21.7 25.0 34.5 38.7 18.5 0.0 18.5 0.0 27.4 0.0 5.1 29.8 21.9 0.0 0.0 45.1 21.4 50.4 0.0 0.0 31.2 22.5 19.5 19.6 21.3 34.6 48.1 19.0 19.2 32.9 16.6 16.3 23.4 15.8 14.2 0.0 23.8 19.7 22.3 15.3 12.1 PIGB ENSG00000069943 "Phosphatidylinositol glycan anchor biosynthesis class B" Q92521 15 55318960-55355648 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039929 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 32: U-937 - Innate immune response" "Cluster 57: B-cells - Immune response" "Plasma membrane, Cytosol" "HPA039929: AB_10673539" "unprognostic (1.91e-2)" "unprognostic (7.45e-2)" "unprognostic (3.00e-1)" "unprognostic (2.03e-2)" "unprognostic (2.96e-2)" "unprognostic (4.65e-2)" "unprognostic (2.04e-1)" "unprognostic (3.37e-3)" "unprognostic (7.52e-2)" "unprognostic (3.52e-2)" "unprognostic (2.56e-2)" "unprognostic (4.27e-2)" "unprognostic (2.13e-1)" "unprognostic (1.30e-1)" "unprognostic (2.86e-1)" "unprognostic (5.93e-2)" "unprognostic (4.24e-2)" 6.4 4.8 2.3 5.8 2.6 9.1 9.0 2.8 2.6 5.5 3.1 7.0 7.5 6.4 11.0 5.7 7.8 6.3 2.8 2.5 3.3 10.3 9.4 6.3 8.2 2.8 2.7 4.7 5.7 10.6 3.9 4.8 2.6 7.7 7.8 7.9 4.3 6.8 1.5 6.1 5.8 5.6 2.7 6.1 7.6 6.5 2.7 6.3 13.3 1.8 8.6 7.5 3.7 3.1 10.5 12.2 5.8 4.1 6.6 13.2 7.8 9.0 19.9 10.4 17.8 5.1 10.3 10.9 10.4 12.9 15.6 18.3 3.3 9.5 8.6 10.4 6.4 10.9 13.6 6.7 11.9 30.8 8.7 12.5 11.4 7.9 10.7 13.8 13.6 9.2 12.2 6.9 15.0 9.1 3.4 12.8 3.1 7.9 4.8 4.9 5.6 24.1 18.4 12.4 2.5 6.2 8.1 12.2 17.3 5.4 11.7 22.2 9.5 13.6 4.3 3.7 18.6 8.1 15.9 8.6 12.4 34.5 10.2 13.6 7.7 3.3 6.2 9.7 7.0 6.0 6.1 6.9 7.0 3.9 4.8 5.5 14.5 5.3 11.4 5.4 6.5 5.5 2.3 2.6 2.8 2.6 2.5 3.3 2.8 2.7 2.6 2.7 2.7 3.1 3.5 9.6 9.5 17.6 27.5 4.6 9.5 14.9 4.6 3.3 5.6 4.2 3.4 1.5 14.9 0.0 12.5 12.4 11.2 4.8 1.9 7.4 26.8 4.3 3.2 4.7 6.6 8.2 18.3 10.9 12.0 6.0 6.1 6.4 8.2 4.6 6.8 4.4 8.6 1.7 17.7 4.1 4.1 7.5 6.7 5.1 1.5 8.8 3.6 12.2 8.4 2.7 11.3 17.1 14.6 6.9 4.0 1.5 3.8 3.4 6.4 9.7 7.9 9.4 6.6 4.8 4.2 5.9 3.8 5.7 4.0 6.6 12.5 4.2 4.0 7.4 CCPG1 "CPR8, KIAA1254" ENSG00000260916 "Cell cycle progression 1" Q9ULG6 15 55340032-55408510 "Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 279.2;neutrophil: 296.6" "Group enriched" "Detected in all" 7 "granulocytes: 296.6;monocytes: 84.2" "Cell line enhanced" "Detected in many" "HHSteC: 223.9;Karpas-707: 337.4;U-266/84: 259.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009432, HPA026861" Approved Approved "Endoplasmic reticulum,Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "Endoplasmic reticulum" "HPA009432: AB_2668242, HPA026861: AB_1846192" "unprognostic (3.14e-2)" "unprognostic (2.94e-2)" "unprognostic (3.03e-1)" "unprognostic (2.51e-2)" "unprognostic (1.13e-1)" "unprognostic (1.28e-1)" "unprognostic (1.40e-2)" "unprognostic (8.34e-2)" "unprognostic (1.59e-1)" "unprognostic (1.94e-1)" "unprognostic (3.17e-2)" "unprognostic (2.61e-2)" "prognostic unfavorable (5.07e-4)" "prognostic unfavorable (5.02e-5)" "unprognostic (1.15e-1)" "unprognostic (1.71e-2)" "unprognostic (1.72e-2)" 38.9 37.8 24.0 23.7 27.7 63.8 34.1 23.1 28.4 61.1 36.8 33.3 24.3 26.7 36.1 20.1 22.0 53.8 56.2 24.7 26.9 51.5 66.9 39.3 22.2 18.4 17.3 22.9 84.8 73.3 32.3 27.4 17.7 41.0 33.2 48.2 77.1 42.3 53.0 13.5 25.6 33.5 17.2 28.7 47.5 29.6 27.3 12.2 84.4 35.3 24.2 29.9 9.7 22.9 13.9 47.7 10.9 24.4 173.6 59.3 15.5 30.0 56.4 17.2 26.1 14.4 23.5 20.8 99.5 97.5 33.6 18.7 9.5 25.1 14.4 55.5 14.2 28.1 58.4 12.8 223.9 39.6 84.2 49.5 59.8 35.6 34.4 143.3 65.2 0.8 47.7 337.4 55.1 17.9 0.2 19.3 6.5 54.4 11.8 6.2 17.4 84.8 36.1 10.1 14.0 21.5 35.3 19.5 151.4 35.0 31.0 85.1 65.7 50.8 11.1 38.9 20.4 65.2 259.6 13.0 95.6 77.2 41.0 220.8 59.4 279.2 26.8 50.7 22.5 18.1 16.6 20.7 27.6 13.4 13.9 20.0 296.6 25.7 84.2 4.7 23.0 32.9 24.0 27.7 23.1 28.4 24.7 26.9 18.4 17.3 17.7 17.2 27.3 22.9 92.3 115.4 118.1 0.0 44.6 15.4 30.3 99.2 13.6 68.7 40.2 40.1 14.4 50.1 136.5 88.3 93.8 29.3 42.9 43.7 5.9 60.9 136.2 49.6 41.0 60.1 16.7 25.2 0.0 145.3 23.2 78.6 33.1 62.3 39.1 30.0 76.1 96.1 51.0 85.8 0.0 28.8 114.0 55.9 25.2 216.1 56.5 71.7 48.0 0.0 89.8 72.6 38.1 0.0 0.0 67.6 45.1 116.6 180.8 42.6 29.5 36.7 123.8 128.0 52.6 80.2 48.1 43.3 41.1 11.8 16.6 24.6 41.8 70.0 16.2 21.8 C15orf65 FLJ27352 ENSG00000261652 "Chromosome 15 open reading frame 65" H3BRN8 15 55408495-55418798 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Early spermatids: 168.5;Endometrial ciliated cells: 79.4;Respiratory ciliated cells: 47.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 4.7" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.7" "Cell line enhanced" "Detected in many" "hTCEpi: 13.2;SK-MEL-30: 13.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067189 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 34: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm Cytosol "HPA067189: AB_2685800" "unprognostic (2.77e-2)" "unprognostic (7.42e-2)" "unprognostic (7.50e-2)" "prognostic favorable (3.18e-7)" "unprognostic (1.59e-1)" "unprognostic (9.56e-3)" "unprognostic (1.16e-3)" "unprognostic (6.69e-2)" "unprognostic (2.54e-1)" "unprognostic (1.51e-1)" "unprognostic (2.25e-1)" "unprognostic (8.89e-2)" "unprognostic (1.84e-3)" "unprognostic (2.09e-1)" "unprognostic (1.81e-1)" "unprognostic (1.42e-1)" "unprognostic (1.80e-1)" 1.3 2.1 2.8 0.5 3.0 0.6 3.2 2.6 3.4 4.3 5.3 4.0 1.8 1.9 6.0 0.8 7.9 3.1 5.6 2.8 3.1 7.2 1.3 2.3 1.1 3.6 3.5 1.2 8.5 4.6 8.9 0.5 3.4 3.3 3.6 7.5 9.0 2.7 6.9 1.4 1.6 2.1 3.1 1.2 6.3 9.0 3.0 1.5 4.0 2.8 1.1 1.6 1.1 2.9 0.9 1.3 2.7 1.7 4.0 5.8 0.4 1.5 2.2 1.2 2.5 0.0 1.5 1.2 4.0 5.1 3.2 1.2 0.0 2.5 0.4 2.5 1.8 1.2 9.3 0.4 7.6 2.8 1.5 1.9 13.2 3.8 1.0 6.9 2.4 0.0 2.3 4.0 5.8 2.1 0.1 7.6 0.7 4.8 3.0 0.5 0.0 10.5 7.0 0.0 7.7 4.3 1.9 3.2 13.0 1.1 6.4 2.7 1.8 2.1 0.9 2.0 0.7 1.8 4.8 1.0 5.9 6.7 1.1 4.7 0.4 1.7 0.2 0.7 0.0 0.9 0.0 0.3 0.3 0.8 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.2 2.8 3.0 2.6 3.4 2.8 3.1 3.6 3.5 3.4 3.1 3.0 2.9 3.3 3.2 1.1 4.6 3.3 1.3 3.7 13.1 2.2 1.7 8.6 10.8 7.8 5.7 8.0 5.5 0.0 1.1 0.5 6.7 17.6 8.8 168.5 79.4 4.1 3.9 3.6 0.4 4.0 11.0 1.5 3.6 5.1 7.2 4.5 1.9 4.6 1.7 2.9 3.3 2.7 18.8 14.2 1.9 1.9 17.0 4.4 1.0 3.6 1.0 0.8 5.1 0.0 1.0 0.9 6.6 16.8 5.7 2.6 4.8 1.9 22.5 47.5 8.2 6.6 3.2 3.4 23.9 3.6 0.8 1.7 0.0 1.0 4.2 4.8 2.1 DNAAF4 "CILD25, DYX1C1, EKN1, FLJ37882" ENSG00000256061 "Dynein axonemal assembly factor 4" Q8WXU2 15 55410525-55508234 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Neurogenesis "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 27.5" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 171.5;Proximal tubular cells: 34.4;Respiratory ciliated cells: 102.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 17.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051048 Uncertain Supported "Plasma membrane,Cytosol" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 49: Ciliated cells - Cilium organization" "Plasma membrane, Cytosol" "HPA051048: AB_2681325" "unprognostic (5.97e-4)" "unprognostic (3.60e-2)" "unprognostic (1.69e-1)" "unprognostic (7.45e-4)" "unprognostic (1.74e-1)" "unprognostic (5.30e-3)" "unprognostic (4.05e-2)" "unprognostic (3.08e-2)" "unprognostic (8.24e-2)" "unprognostic (2.91e-1)" "unprognostic (9.47e-2)" "unprognostic (1.75e-1)" "unprognostic (5.29e-2)" "unprognostic (3.85e-2)" "unprognostic (3.06e-2)" "unprognostic (1.34e-1)" "unprognostic (1.84e-1)" 1.0 2.0 4.7 1.1 4.7 1.2 3.3 3.6 6.8 2.8 8.4 0.9 0.6 3.7 10.6 1.2 11.1 2.2 1.0 4.8 5.8 5.0 0.5 4.3 1.1 5.1 5.0 2.6 2.1 8.5 3.5 0.7 3.8 2.0 0.9 27.5 1.5 2.0 0.8 1.7 0.8 2.0 3.6 1.3 1.0 11.3 6.7 0.7 8.6 0.5 0.9 1.4 0.7 3.7 7.0 4.8 4.9 10.4 2.0 3.5 1.5 1.0 2.6 3.2 3.6 1.0 2.9 0.6 4.4 2.1 5.2 2.1 1.9 2.7 3.7 2.4 2.5 2.6 3.2 1.7 1.8 5.4 4.2 2.2 5.7 7.6 2.9 5.1 7.2 2.2 0.8 0.3 4.8 2.9 1.3 4.7 2.9 11.0 3.7 1.1 2.3 0.9 17.6 2.3 4.9 10.7 4.3 1.3 6.5 4.2 6.2 1.4 2.5 5.0 2.5 4.4 5.2 2.1 5.4 1.7 8.3 1.3 1.5 0.1 0.7 0.5 0.3 0.5 0.3 1.4 0.5 0.5 0.6 1.3 0.7 0.5 1.4 0.4 0.5 1.9 0.7 0.3 4.7 4.7 3.6 6.8 4.8 5.8 5.1 5.0 3.8 3.6 6.7 3.7 4.1 12.8 15.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 7.9 9.8 0.0 0.0 15.5 12.9 0.0 2.0 0.4 0.0 5.9 13.6 0.0 171.5 9.0 2.8 0.0 0.0 0.0 5.1 1.5 3.4 0.0 13.3 2.5 9.7 0.0 0.0 19.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.4 0.0 0.0 34.4 102.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.5 0.7 7.2 0.0 0.0 PYGO1 ENSG00000171016 "Pygopus family PHD finger 1" Q9Y3Y4 15 55538884-55588947 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 23.5;Endometrial stromal cells: 18.2;Inhibitory neurons: 30.4;Oligodendrocyte precursor cells: 59.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-698: 33.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042248 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 80: Striated muscle - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoplasm Cytosol "HPA042248: AB_10794272" "unprognostic (5.55e-2)" "unprognostic (9.82e-2)" "unprognostic (2.61e-2)" "unprognostic (4.54e-2)" "unprognostic (7.20e-2)" "unprognostic (1.61e-1)" "unprognostic (1.31e-1)" "unprognostic (8.23e-2)" "unprognostic (1.41e-1)" "unprognostic (1.06e-1)" "unprognostic (2.68e-1)" "unprognostic (2.29e-1)" "unprognostic (6.72e-6)" "unprognostic (3.36e-4)" "unprognostic (4.84e-2)" "unprognostic (2.30e-2)" "unprognostic (1.80e-2)" 1.8 2.3 2.6 0.9 3.0 0.2 1.7 7.3 2.3 3.7 2.9 3.2 0.4 5.6 2.0 1.8 2.5 2.3 1.3 2.6 4.6 0.9 0.1 1.9 0.5 3.3 4.5 6.1 1.4 13.2 3.0 2.0 3.1 4.5 1.0 4.5 0.9 4.8 11.7 0.7 0.9 4.7 3.3 0.3 1.4 3.2 4.9 0.4 6.8 9.1 0.4 2.2 1.7 2.4 3.7 6.3 12.2 6.2 4.4 10.0 4.6 7.8 8.9 6.2 7.1 4.5 0.0 0.0 2.4 5.3 8.9 0.0 12.4 0.1 8.3 0.0 3.9 1.8 1.8 0.4 5.9 6.6 0.0 5.5 6.2 5.5 0.9 6.9 3.2 1.0 0.1 0.0 10.3 0.1 0.3 0.0 3.3 0.9 3.4 0.0 14.8 0.0 2.1 2.7 6.5 7.3 7.6 0.0 5.6 1.7 2.3 2.1 0.0 15.8 6.9 0.3 9.5 0.2 0.2 33.6 4.9 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 3.0 7.3 2.3 2.6 4.6 3.3 4.5 3.1 3.3 4.9 2.4 0.6 9.6 6.3 23.5 0.0 1.7 5.9 0.1 4.6 5.6 2.4 3.6 6.1 0.0 1.9 9.2 0.0 1.5 0.1 0.0 0.0 0.5 2.9 1.6 18.2 1.1 0.0 0.0 1.8 0.0 0.2 9.3 0.0 1.9 0.0 7.1 1.1 0.0 0.5 0.0 30.4 0.0 0.0 0.6 1.4 2.6 9.9 0.3 7.2 4.7 0.0 7.0 0.0 59.8 1.9 0.5 0.0 12.0 0.0 5.7 0.0 0.2 1.8 4.5 0.0 12.7 6.1 11.6 2.8 1.4 0.9 0.3 0.6 2.0 0.0 0.7 PRTG "FLJ25756, IGDCC5" ENSG00000166450 Protogenin Q2VWP7 15 55611544-55743152 "Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 10.4;thyroid gland: 10.7" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 191.8;Oligodendrocyte precursor cells: 51.8;Rod photoreceptor cells: 62.3" "Cancer enhanced" "Detected in some" "testis cancer: 1.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "AF22: 148.6;SuSa: 172.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA032138 Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 77: Retina - Visual perception" "Cluster 12: NES - Nervous system development" "Cluster 9: Photoreceptor cells - Phototransduction" Cytosol "Vesicles, Plasma membrane" "HPA032138: AB_10669675" "unprognostic (2.80e-1)" "unprognostic (2.42e-2)" "unprognostic (1.32e-1)" "unprognostic (4.64e-2)" "unprognostic (2.07e-2)" "unprognostic (4.96e-4)" "unprognostic (1.82e-4)" "unprognostic (1.31e-1)" "unprognostic (3.19e-1)" "unprognostic (4.76e-3)" "unprognostic (1.37e-1)" "unprognostic (5.32e-2)" "unprognostic (5.67e-2)" "unprognostic (2.42e-6)" "unprognostic (8.81e-2)" "unprognostic (3.17e-2)" "unprognostic (2.70e-1)" 0.5 1.0 1.7 0.4 2.2 0.1 1.1 2.2 1.1 1.2 1.4 0.5 0.1 3.6 0.5 0.1 1.1 0.3 0.6 1.3 2.8 1.5 0.1 1.7 0.1 3.2 2.4 1.9 0.1 1.9 0.9 2.7 3.7 0.4 0.2 10.4 0.2 0.5 0.6 0.1 0.3 1.3 2.9 0.1 0.5 3.6 2.9 0.0 10.7 0.4 0.1 0.4 0.5 5.0 1.2 3.4 148.6 3.2 0.0 0.1 13.2 1.2 4.5 3.9 5.4 25.8 0.8 0.0 5.4 0.2 5.8 0.0 0.6 0.3 5.2 0.0 6.4 1.0 1.1 9.8 1.1 1.0 0.0 0.5 0.2 1.7 2.7 3.0 2.8 0.3 2.7 0.0 2.3 2.2 0.0 0.0 5.9 0.0 3.0 0.0 22.3 0.0 3.1 0.4 1.8 7.6 1.2 1.9 8.3 172.9 0.7 0.5 0.2 2.1 1.6 0.0 4.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.7 2.2 2.2 1.1 1.3 2.8 3.2 2.4 3.7 2.9 2.9 5.0 3.2 9.6 20.2 17.6 0.0 0.3 0.0 0.0 0.0 12.4 5.0 4.4 6.0 0.0 2.5 16.5 191.8 19.9 0.1 0.1 0.0 0.0 21.8 2.8 25.5 9.7 0.0 0.0 0.7 0.2 4.1 4.0 3.6 3.1 0.0 2.9 3.6 0.0 1.7 0.0 11.1 0.0 0.0 0.0 0.0 25.3 5.3 0.2 0.0 28.1 0.0 4.4 0.0 51.8 13.6 0.4 0.0 2.6 0.1 0.1 0.0 1.4 0.0 62.3 0.0 5.8 2.4 8.9 12.1 0.0 0.0 6.0 0.1 9.5 0.5 0.1 NEDD4 "KIAA0093, MGC176705, NEDD4-1, RPF1" ENSG00000069869 "NEDD4 E3 ubiquitin protein ligase" P46934 15 55826922-55993660 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Neurogenesis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 67.6;tongue: 58.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 93.0;Alveolar cells type 2: 116.7;granulocytes: 73.2;Oligodendrocyte precursor cells: 69.9;Respiratory ciliated cells: 75.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001991, HPA039883, CAB072833" Approved Approved Cytosol NA NA 6500 "Cluster 39: Non-specific - mRNA processing" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 11: Alveolar cells - Smell perception" Cytosol "CAB001991: , CAB072833: , HPA039883: AB_10795683" "unprognostic (1.18e-1)" "unprognostic (2.10e-2)" "unprognostic (5.66e-3)" "unprognostic (1.15e-1)" "unprognostic (6.97e-2)" "unprognostic (2.23e-1)" "unprognostic (3.18e-3)" "prognostic unfavorable (5.14e-4)" "unprognostic (1.36e-2)" "unprognostic (1.62e-1)" "unprognostic (4.96e-2)" "unprognostic (1.43e-2)" "prognostic unfavorable (3.74e-6)" "unprognostic (6.38e-3)" "unprognostic (2.98e-1)" "unprognostic (2.22e-1)" "unprognostic (2.35e-2)" 6.2 3.6 1.7 4.0 2.0 6.2 6.9 1.9 2.0 5.4 1.9 5.7 4.1 7.1 2.9 4.3 3.5 5.6 4.5 1.5 2.7 6.7 27.4 5.3 3.1 2.5 1.9 4.0 1.8 5.4 2.1 15.6 2.6 5.5 4.4 4.5 3.1 7.6 67.6 9.2 8.1 8.0 2.0 4.9 3.4 1.8 2.2 5.6 7.1 58.1 3.0 5.6 4.4 2.6 21.5 32.8 9.0 8.8 11.5 18.5 14.1 40.0 62.9 29.1 28.5 14.5 6.3 4.8 10.4 15.4 70.2 34.6 9.7 26.3 48.2 11.1 5.6 26.1 7.2 7.9 59.0 10.6 2.3 30.8 64.7 35.2 58.9 14.2 24.3 14.9 11.5 0.0 86.4 10.7 15.2 0.1 2.2 10.9 5.1 10.5 67.5 3.1 11.9 42.3 0.7 5.1 17.4 12.5 15.7 15.8 15.2 8.8 84.5 63.9 20.6 13.5 66.0 3.4 8.1 12.3 42.0 24.6 15.7 0.0 0.1 0.0 0.1 0.4 0.3 0.0 0.2 0.1 0.0 0.0 0.2 0.2 0.2 0.1 0.2 0.2 0.1 0.1 1.7 2.0 1.9 2.0 1.5 2.7 2.5 1.9 2.6 2.0 2.2 2.6 35.9 93.0 116.7 28.4 1.6 12.1 3.4 5.5 8.6 0.7 4.6 8.0 5.7 7.2 44.8 0.0 22.9 23.2 2.0 5.2 1.9 3.3 1.7 1.7 13.3 31.1 0.0 17.5 4.2 5.8 7.5 18.5 5.1 1.6 73.2 4.2 17.5 20.5 4.7 0.0 11.9 4.0 2.0 2.2 2.3 1.6 5.6 8.8 1.8 30.0 1.1 8.6 6.2 69.9 28.7 2.9 0.8 7.2 1.9 4.5 25.8 13.4 75.5 6.7 0.0 11.5 17.7 5.3 7.2 7.1 10.4 13.8 9.4 4.8 5.6 1.9 RFX7 "FLJ12994, RFXDC2" ENSG00000181827 "Regulatory factor X7" Q2KHR2 15 56087280-56245082 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Astrocytes: 108.4;Excitatory neurons: 149.4;Inhibitory neurons: 164.0;Microglial cells: 91.8;Oligodendrocyte precursor cells: 187.0;Oligodendrocytes: 169.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035462, HPA057957" Approved Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoplasm, Nuclear membrane" "HPA035462: AB_10602152, HPA057957: " "unprognostic (2.36e-1)" "unprognostic (2.09e-2)" "unprognostic (1.53e-1)" "unprognostic (1.32e-1)" "unprognostic (4.72e-2)" "unprognostic (2.73e-2)" "unprognostic (9.58e-2)" "unprognostic (1.50e-1)" "unprognostic (4.10e-2)" "unprognostic (2.78e-2)" "unprognostic (2.60e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (1.12e-5)" "unprognostic (2.24e-1)" "unprognostic (5.09e-1)" "unprognostic (1.50e-1)" "unprognostic (1.84e-1)" 3.4 5.9 3.9 5.6 3.5 8.5 5.2 11.6 4.0 5.2 1.3 4.0 5.3 5.6 5.3 4.7 5.7 4.0 3.2 3.0 4.4 3.5 4.0 4.8 8.9 3.5 3.3 6.3 3.2 5.7 2.7 5.4 3.7 4.6 5.0 11.0 3.8 5.3 8.8 9.9 4.5 5.7 3.0 7.4 4.8 8.7 3.5 15.2 5.1 9.8 9.3 5.7 2.9 4.2 7.7 15.6 31.3 22.0 11.0 13.9 7.6 6.6 9.1 8.3 13.1 8.4 6.3 24.0 9.7 9.9 7.7 20.9 18.7 14.7 11.1 13.3 6.6 31.5 19.0 17.6 11.6 24.1 4.6 12.0 21.7 9.0 19.5 12.2 14.7 24.1 14.2 12.7 11.9 9.8 21.3 6.9 13.4 5.9 4.5 23.1 20.0 19.8 9.2 24.0 16.4 18.8 8.2 8.3 9.4 21.5 7.1 15.3 11.9 21.8 11.3 5.1 13.2 10.2 11.4 27.6 7.8 22.2 9.7 2.0 0.2 0.5 0.5 0.3 0.6 0.5 0.6 0.7 0.4 0.4 0.4 0.6 0.0 0.5 0.2 0.5 1.1 0.3 3.9 3.5 11.6 4.0 3.0 4.4 3.5 3.3 3.7 3.0 3.5 4.2 8.6 6.4 13.4 108.4 9.7 13.4 4.4 9.5 20.5 16.2 9.9 7.5 6.5 2.8 6.2 7.3 10.4 4.2 7.3 5.3 3.9 3.4 19.9 7.2 10.3 9.4 4.8 17.1 149.4 4.7 1.4 6.8 4.6 6.4 12.6 14.2 7.9 8.9 5.6 16.8 164.0 5.7 10.2 9.5 8.8 15.9 6.5 8.8 5.4 91.8 8.4 5.1 2.1 187.0 169.7 3.7 6.0 10.5 7.9 6.6 4.3 4.2 8.5 9.1 0.0 13.2 7.0 6.6 6.8 16.8 17.6 1.6 9.0 10.6 6.8 5.6 TEX9 ENSG00000151575 "Testis expressed 9" Q8N6V9 15 56244009-56445997 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 89.1;Endometrial ciliated cells: 86.2;Respiratory ciliated cells: 125.6;Spermatocytes: 74.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "basophil: 4.3;memory B-cell: 14.4;naive B-cell: 11.4" "Group enriched" "Detected in many" 12 "B-cells: 14.4;granulocytes: 4.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039415 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "Plasma membrane" "HPA039415: AB_10672775" "unprognostic (3.27e-1)" "unprognostic (2.77e-2)" "unprognostic (2.25e-1)" "unprognostic (4.71e-3)" "unprognostic (2.34e-1)" "unprognostic (5.13e-2)" "unprognostic (1.54e-2)" "unprognostic (1.22e-1)" "unprognostic (3.75e-2)" "unprognostic (8.85e-2)" "unprognostic (6.91e-3)" "unprognostic (2.00e-2)" "unprognostic (1.24e-2)" "unprognostic (8.00e-2)" "unprognostic (1.15e-1)" "unprognostic (1.06e-1)" "unprognostic (1.24e-1)" 1.8 6.1 4.1 4.6 3.9 3.4 10.1 7.4 3.9 8.8 17.0 3.6 11.6 5.2 8.4 4.4 28.0 5.2 1.1 3.2 4.2 10.8 1.5 4.4 6.0 9.4 8.6 5.4 5.4 14.2 9.9 1.6 4.5 4.5 4.8 18.0 10.5 3.4 1.2 5.6 8.0 2.2 5.3 3.2 12.2 16.4 6.6 3.7 17.4 1.5 10.6 2.7 1.6 5.7 7.8 7.1 15.3 13.7 3.7 10.8 2.0 1.7 6.3 4.8 5.7 1.7 6.9 15.5 7.0 1.2 8.2 6.6 6.6 7.4 5.5 1.7 7.8 9.1 6.7 5.2 1.1 3.3 1.3 5.9 13.3 5.4 4.1 6.9 0.2 11.1 5.2 1.4 2.6 4.5 6.5 1.2 7.2 13.2 3.0 2.6 7.1 5.5 15.9 4.4 24.3 9.8 8.7 4.9 5.5 11.2 14.6 3.0 0.7 20.3 5.8 6.5 6.4 2.1 16.5 11.7 8.0 1.7 3.9 4.3 0.1 0.1 0.4 0.6 0.1 14.4 0.4 0.3 0.2 11.4 0.2 0.8 0.3 0.4 0.4 0.4 0.6 0.7 4.1 3.9 7.4 3.9 3.2 4.2 9.4 8.6 4.5 5.3 6.6 5.7 1.5 6.4 7.5 38.8 21.0 4.2 7.3 13.2 20.5 6.4 11.3 11.7 0.8 5.7 23.5 11.0 12.5 1.8 0.3 2.3 21.5 15.6 89.1 86.2 5.1 3.2 7.7 5.9 14.3 7.0 0.5 5.0 17.3 4.8 1.3 5.1 1.8 0.4 1.3 1.7 20.4 3.7 16.2 0.0 2.1 40.9 4.7 2.7 3.6 4.7 1.2 6.8 1.0 14.6 15.1 4.5 5.4 3.8 15.8 3.7 12.3 21.7 125.6 37.5 0.0 4.6 6.0 74.6 36.6 6.9 2.3 0.3 1.0 6.2 6.7 4.9 MNS1 "FLJ11222, SPATA40" ENSG00000138587 "Meiosis specific nuclear structural 1" Q8NEH6 15 56421544-56465137 "Human disease related genes, Predicted intracellular proteins" Meiosis "Disease variant, Heterotaxy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 21.2;testis: 48.2" "Group enriched" "Detected in many" 5 "Early spermatids: 504.6;Endometrial ciliated cells: 256.5;Respiratory ciliated cells: 232.5;Spermatocytes: 249.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039975, HPA040382" Uncertain Approved "Nucleoplasm,Nuclear speckles" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Nuclear speckles" "HPA039975: AB_10793858, HPA040382: AB_10794740" "unprognostic (7.78e-2)" "unprognostic (2.54e-2)" "unprognostic (1.19e-1)" "unprognostic (5.07e-2)" "unprognostic (2.25e-1)" "unprognostic (6.62e-2)" "unprognostic (1.15e-1)" "unprognostic (3.45e-2)" "unprognostic (1.13e-2)" "unprognostic (2.05e-2)" "unprognostic (6.63e-2)" "unprognostic (1.06e-1)" "unprognostic (1.12e-3)" "unprognostic (8.20e-3)" "unprognostic (1.15e-1)" "unprognostic (2.72e-2)" "unprognostic (7.71e-2)" 1.9 1.4 2.6 1.6 2.4 4.6 3.1 10.1 2.9 3.5 12.3 1.9 2.3 3.6 1.3 2.7 21.2 3.3 2.5 2.2 2.4 10.5 1.9 3.4 1.3 7.2 6.8 4.0 2.4 0.6 3.5 1.6 5.1 2.3 2.0 4.7 2.0 1.7 1.0 1.4 2.1 1.3 6.1 1.4 2.2 48.2 2.7 5.6 2.9 1.1 1.2 1.3 2.5 3.9 32.1 7.4 3.8 11.3 3.1 6.7 0.7 7.6 4.4 8.8 18.6 10.5 15.0 17.8 9.4 3.2 12.8 12.3 4.7 4.4 17.9 0.0 1.9 22.9 8.8 1.8 1.1 7.9 2.4 2.7 0.2 17.9 2.6 3.7 1.6 6.8 5.2 0.0 7.6 4.2 0.3 9.8 1.2 16.4 4.3 15.0 22.6 0.2 8.7 6.1 29.5 8.9 12.7 3.8 13.6 0.9 9.1 12.1 0.7 12.0 13.6 11.6 18.8 3.6 11.9 0.3 13.4 18.3 14.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.4 10.1 2.9 2.2 2.4 7.2 6.8 5.1 6.1 2.7 3.9 0.7 0.0 4.7 1.0 0.8 3.3 8.8 9.3 1.8 10.5 4.7 8.3 6.0 4.3 28.3 35.0 25.0 1.8 0.2 3.7 11.7 10.9 504.6 256.5 7.8 2.0 1.2 3.0 4.9 1.9 3.9 14.0 5.1 7.2 0.0 11.0 6.8 0.4 7.0 15.2 3.7 4.5 10.2 1.0 5.5 60.8 12.8 2.0 0.0 0.0 0.8 12.4 0.0 1.5 2.8 1.2 0.1 8.6 0.5 3.0 0.3 12.3 232.5 32.6 0.0 21.6 6.5 249.6 25.0 7.1 1.4 0.5 1.0 6.4 6.0 3.5 ZNF280D "FLJ20086, SUHW4, ZNF634" ENSG00000137871 "Zinc finger protein 280D" Q6N043 15 56630176-56734086 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 176.6;Oligodendrocyte precursor cells: 200.1;Oligodendrocytes: 293.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA030233 Approved Approved "Nucleoplasm,Golgi apparatus,Centrosome,Cytosol" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 68: Oligodendrocytes - Mixed function" "Nucleoplasm, Cytosol" "Golgi apparatus, Centrosome" "HPA030233: AB_10602590" "unprognostic (1.57e-1)" "unprognostic (2.17e-1)" "unprognostic (3.55e-2)" "unprognostic (1.47e-2)" "unprognostic (1.64e-2)" "unprognostic (1.70e-2)" "unprognostic (3.08e-1)" "unprognostic (3.77e-2)" "unprognostic (6.15e-2)" "unprognostic (3.63e-1)" "unprognostic (7.33e-2)" "unprognostic (1.33e-1)" "unprognostic (1.11e-2)" "unprognostic (1.98e-1)" "unprognostic (9.75e-2)" "unprognostic (2.19e-1)" "unprognostic (7.72e-2)" 11.3 11.4 3.4 8.7 3.9 23.1 15.4 9.0 4.6 18.0 4.8 10.2 7.5 20.1 8.1 8.4 12.4 9.6 9.2 3.6 3.8 10.3 13.2 10.1 10.0 3.1 3.0 23.7 13.7 11.1 4.5 11.5 3.6 10.6 11.5 12.4 10.5 9.9 12.6 6.6 9.5 15.1 4.0 10.3 10.3 7.8 3.5 35.9 11.5 11.6 9.9 10.9 8.5 9.8 13.4 7.4 13.6 20.9 13.3 18.7 9.9 20.2 14.3 8.2 9.3 5.4 13.6 22.7 8.4 14.5 7.9 10.0 6.7 5.3 9.9 11.6 4.1 2.4 12.5 8.2 13.3 20.4 6.6 12.8 7.6 5.6 8.0 20.6 18.3 23.0 11.9 25.7 13.0 9.6 14.4 2.3 0.0 15.6 5.8 4.3 22.2 16.1 10.1 15.4 11.2 20.0 16.9 10.5 6.7 0.7 11.4 19.9 16.2 12.1 18.2 11.3 16.1 13.2 21.6 0.0 13.7 31.0 13.2 7.8 2.6 3.5 2.1 2.2 2.0 3.4 1.9 1.7 3.6 3.2 2.0 2.4 0.4 1.8 2.0 3.6 1.9 1.0 3.4 3.9 9.0 4.6 3.6 3.8 3.1 3.0 3.6 4.0 3.5 9.8 32.4 9.6 18.9 176.6 31.1 11.1 18.3 12.9 42.7 79.8 20.5 20.7 37.9 22.8 14.6 3.7 83.4 23.0 25.5 12.2 7.9 12.0 18.3 14.3 33.0 36.5 32.3 27.5 107.2 14.0 21.5 37.5 26.0 14.2 17.7 37.8 34.2 31.1 36.6 69.0 151.3 25.7 16.2 35.6 18.1 49.5 33.2 22.9 16.0 91.8 27.0 24.9 28.8 200.1 293.3 10.5 10.4 21.1 41.4 21.1 26.8 14.2 12.8 84.5 6.6 47.4 30.8 49.4 33.8 26.8 13.9 13.3 21.4 27.7 22.2 16.3 AC090517.4 ENSG00000285253 "Zinc finger protein 280D" 15 56652488-56918571 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 1.5;Alveolar cells type 1: 3.2;Alveolar cells type 2: 1.5;Distal tubular cells: 3.9;Endometrial stromal cells: 2.2" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 6.9" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" 1.6 1.2 1.5 1.2 2.9 1.0 1.5 1.6 2.0 1.9 0.0 1.2 1.1 2.1 1.0 1.1 1.6 1.4 1.7 1.3 2.5 1.6 1.2 1.3 1.1 2.1 2.2 2.4 3.7 1.5 1.5 2.2 1.4 1.3 1.8 4.3 1.4 2.0 0.9 1.3 1.9 1.4 1.4 1.4 2.5 2.2 2.6 2.3 2.3 0.8 1.1 4.6 1.5 4.0 1.3 1.1 2.6 1.7 1.1 1.1 1.4 1.3 0.9 0.9 1.8 0.3 2.1 1.5 1.2 1.3 0.5 1.3 1.0 2.4 0.0 2.2 1.6 0.1 1.0 0.4 2.3 1.7 0.7 1.2 1.3 1.0 2.5 0.4 3.3 6.1 1.7 0.4 1.2 0.3 1.1 1.2 0.5 3.3 0.3 0.5 1.8 0.3 1.9 3.3 2.0 1.2 2.0 2.5 2.7 3.5 1.8 0.4 3.1 1.7 0.4 2.7 6.9 0.2 1.8 2.9 2.5 0.0 1.5 0.7 1.2 1.6 1.8 0.8 1.2 1.1 1.2 0.9 0.5 1.1 0.1 1.2 0.7 0.3 0.7 0.8 1.5 2.9 1.6 2.0 1.3 2.5 2.1 2.2 2.2 1.4 2.2 4.6 1.5 3.2 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 3.9 0.6 0.0 0.8 2.2 0.4 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 TCF12 "bHLHb20, HEB, HsT17266, HTF4, p64" ENSG00000140262 "Transcription factor 12" Q99081 15 56918623-57299281 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Craniosynostosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 319.8;Microglial cells: 440.3;Oligodendrocyte precursor cells: 618.3;Oligodendrocytes: 1512.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004432, HPA065827" Approved Supported "Nucleoplasm,Nuclear speckles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoplasm, Nuclear speckles" "CAB004432: AB_671267, HPA065827: AB_2685564" "unprognostic (1.19e-1)" "unprognostic (1.11e-1)" "unprognostic (8.26e-2)" "unprognostic (1.65e-1)" "unprognostic (2.07e-3)" "unprognostic (1.11e-1)" "unprognostic (6.63e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (8.89e-4)" "unprognostic (7.83e-2)" "unprognostic (7.26e-3)" "unprognostic (5.57e-3)" "prognostic unfavorable (5.24e-5)" "unprognostic (2.03e-1)" "unprognostic (2.93e-1)" "unprognostic (3.15e-2)" "unprognostic (1.41e-1)" 26.1 21.5 29.2 23.4 45.5 21.2 29.5 37.1 34.0 75.6 17.2 26.7 28.4 47.9 24.3 26.6 46.3 37.1 21.8 30.5 32.6 28.4 25.0 28.9 26.0 43.1 39.3 43.3 19.7 44.0 11.5 33.4 38.3 32.0 30.3 29.4 23.3 28.3 20.5 21.3 28.4 44.1 34.5 25.0 25.5 27.4 35.5 133.0 29.0 26.6 28.1 31.2 22.4 55.7 25.4 50.8 204.5 70.6 90.0 79.0 36.1 52.2 89.6 45.1 58.9 34.0 20.3 35.5 42.3 78.3 33.4 30.4 84.3 37.3 56.7 47.5 29.8 71.7 52.7 40.4 62.4 46.1 36.1 69.4 66.2 42.9 112.2 60.1 81.0 163.0 81.7 46.8 61.8 9.5 109.4 25.0 57.5 26.4 20.9 143.2 234.9 33.9 61.5 53.1 43.6 121.2 58.7 21.0 52.0 65.3 33.6 93.9 63.2 75.5 57.5 32.2 78.2 24.6 49.7 59.4 40.8 86.3 90.9 27.4 13.8 11.3 17.4 17.9 14.3 13.4 14.0 16.5 20.0 14.7 16.2 14.8 1.5 16.8 26.3 8.4 23.0 14.1 29.2 45.5 37.1 34.0 30.5 32.6 43.1 39.3 38.3 34.5 35.5 55.7 35.5 54.5 19.6 212.9 37.7 26.6 20.6 14.2 44.9 13.8 24.0 20.4 19.3 14.3 21.2 16.5 35.5 10.4 20.6 17.0 13.7 16.0 23.7 25.9 148.0 38.2 9.0 34.9 117.7 11.8 15.5 42.3 52.0 33.3 23.4 26.9 25.7 18.2 27.5 13.5 319.8 16.8 10.2 38.1 30.0 19.9 25.7 33.0 14.2 440.3 17.4 29.0 18.6 618.3 1512.7 15.9 18.4 34.6 29.1 23.4 20.0 15.3 15.9 23.3 46.0 39.9 36.5 22.2 15.0 33.6 33.8 13.0 28.4 16.5 20.1 18.2 CGNL1 "FLJ14957, JACOP, KIAA1749, PCING" ENSG00000128849 "Cingulin like 1" Q0VF96 15 57375967-57550717 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 68.3" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 87.2;Astrocytes: 79.7;Hepatic stellate cells: 58.5;Hepatocytes: 65.5;Microglial cells: 156.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 52.7;SuSa: 37.6;TIME: 32.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013500, HPA056911, HPA069214" Enhanced Supported "Nuclear bodies,Cell Junctions" No No "Cluster 15: Liver - Metabolism" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 11: Alveolar cells - Smell perception" "Cell Junctions" "Nuclear bodies" "CAB013500: , HPA056911: AB_2683274, HPA069214: AB_2686102" "unprognostic (1.04e-2)" "unprognostic (2.42e-1)" "unprognostic (1.52e-2)" "prognostic favorable (3.55e-4)" "unprognostic (3.22e-1)" "unprognostic (1.51e-3)" "prognostic favorable (5.58e-4)" "unprognostic (4.32e-2)" "unprognostic (2.34e-1)" "unprognostic (4.86e-2)" "unprognostic (4.05e-2)" "unprognostic (1.91e-2)" "prognostic favorable (1.37e-6)" "unprognostic (2.26e-2)" "unprognostic (3.39e-1)" "unprognostic (1.88e-3)" "unprognostic (1.18e-2)" 5.0 11.5 23.6 1.5 23.0 0.0 19.8 19.8 18.5 32.0 47.2 3.2 1.2 17.8 4.4 11.0 8.9 2.8 20.1 18.6 24.2 68.3 36.0 21.0 1.1 28.9 28.2 5.8 18.6 9.6 4.1 28.8 27.7 28.7 2.3 12.3 32.3 16.2 0.7 11.5 2.5 10.8 20.0 0.4 15.5 6.6 29.9 4.6 19.8 1.9 3.2 8.9 20.2 15.7 0.0 1.3 13.1 0.0 0.0 0.0 0.2 0.2 2.9 1.1 2.4 8.4 0.1 0.0 11.4 1.7 1.9 0.0 6.2 0.1 1.8 0.1 1.0 0.1 0.1 5.7 0.2 0.1 0.0 0.4 0.4 1.3 0.0 4.4 52.7 0.5 0.0 0.0 2.1 2.4 0.0 0.2 6.5 3.7 0.6 0.1 6.6 0.3 4.4 0.0 0.3 0.7 0.0 5.1 0.0 37.6 0.5 0.6 32.5 0.0 3.3 0.1 1.9 0.0 0.0 0.0 0.2 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 23.0 19.8 18.5 18.6 24.2 28.9 28.2 27.7 20.0 29.9 15.7 3.9 51.3 87.2 79.7 0.2 4.6 13.4 5.1 4.6 0.4 27.4 27.1 21.0 10.0 11.7 22.0 0.0 1.0 1.6 0.9 41.1 9.9 3.0 11.0 9.4 21.8 13.1 2.7 0.7 13.2 1.0 17.1 11.2 11.8 1.3 3.5 58.5 65.5 0.3 0.0 1.9 3.7 18.3 1.6 4.9 18.1 19.9 0.9 7.2 156.4 0.6 43.7 0.0 11.1 1.5 4.3 1.2 27.8 0.0 18.6 0.2 39.4 2.2 1.4 0.0 6.6 2.3 0.6 0.6 0.8 2.4 1.4 1.2 0.6 2.2 7.0 MYZAP "GCOM1, Gup, Gup1, MYOZAP" ENSG00000263155 "Myocardial zonula adherens protein" P0CAP1 15 57591904-57685364 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "heart muscle: 588.9" "Cell type enriched" "Detected in many" 7 "Cardiomyocytes: 481.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive B-cell: 3.4;naive CD4 T-cell: 2.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 137.3;hTERT-HME1: 24.0;HUVEC TERT2: 28.3;OE19: 47.5;RT4: 25.1;TIME: 33.1" HPA039827 Approved NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 36: HEL - Hemostasis" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA039827: AB_10673364" "unprognostic (1.30e-2)" "unprognostic (1.25e-1)" "unprognostic (2.44e-1)" "unprognostic (1.66e-1)" "unprognostic (9.26e-3)" "unprognostic (1.49e-1)" "unprognostic (6.10e-3)" "unprognostic (5.19e-2)" "unprognostic (8.92e-2)" "unprognostic (2.30e-2)" "unprognostic (1.26e-1)" "unprognostic (9.67e-2)" "unprognostic (1.44e-1)" "unprognostic (1.12e-1)" "unprognostic (1.07e-1)" "unprognostic (3.86e-2)" "unprognostic (1.77e-2)" 65.3 54.7 2.0 2.6 2.4 4.0 22.3 6.3 1.8 17.3 1.3 18.1 16.8 29.4 1.8 41.4 4.7 4.8 588.9 1.8 2.5 5.7 2.4 31.8 6.0 6.7 2.8 5.1 35.1 0.6 1.7 56.6 7.7 19.8 11.8 1.3 18.3 38.2 11.6 9.6 15.4 17.2 1.6 12.4 23.4 2.5 3.5 1.4 3.7 15.5 8.6 84.1 26.9 1.7 6.0 1.7 0.0 10.5 2.3 0.1 3.2 0.9 8.6 1.4 1.7 7.3 4.1 0.1 0.7 0.0 8.9 2.6 0.0 4.4 1.7 0.0 0.2 137.3 1.7 0.1 0.4 0.0 0.1 0.0 3.1 0.3 24.0 0.1 28.3 0.2 1.9 0.0 0.7 2.3 0.0 0.1 0.1 47.5 2.4 0.0 11.4 0.3 0.0 25.1 0.0 4.1 0.6 5.9 0.0 1.2 7.9 0.1 33.1 0.1 2.6 0.4 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.4 0.4 0.0 0.0 3.4 2.0 0.0 0.5 0.0 0.8 0.0 0.2 2.4 2.0 2.4 6.3 1.8 1.8 2.5 6.7 2.8 7.7 1.6 3.5 1.7 22.9 9.6 0.6 0.0 0.3 0.0 10.2 0.0 0.0 0.3 3.0 1.0 481.4 5.7 0.6 25.8 0.0 4.4 0.0 26.9 7.9 32.5 0.1 1.1 3.0 15.1 1.8 1.3 0.0 18.9 2.4 9.8 7.1 3.5 0.0 65.1 4.6 0.2 1.4 0.0 0.0 7.9 0.0 7.9 0.0 0.7 4.7 8.7 0.0 0.0 3.4 0.6 0.0 0.0 0.0 21.5 24.9 17.0 0.0 11.0 18.1 0.3 0.7 0.2 0.0 0.2 8.1 0.0 1.6 0.0 0.0 1.2 0.2 13.2 6.6 22.4 GCOM1 "FLJ30973, GRINL1A, MYZAP-POLR2M" ENSG00000137878 "GRINL1A complex locus 1" 15 57591908-57714745 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 20.1" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Cardiomyocytes: 3.9;Gastric mucus-secreting cells: 4.1;Granulosa cells: 5.7;Paneth cells: 4.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "naive B-cell: 1.4;naive CD4 T-cell: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 49.0;RT4: 19.1;TIME: 20.4" "HPA039827, HPA068141" Approved Approved Nucleoplasm NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 46: Fibroblasts - ECM organization" "Cluster 36: HEL - Hemostasis" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm "HPA039827: AB_10673364, HPA068141: AB_2685962" "unprognostic (1.10e-1)" "unprognostic (3.62e-4)" "unprognostic (1.10e-1)" "unprognostic (5.43e-3)" "unprognostic (1.31e-3)" "unprognostic (1.55e-1)" "unprognostic (1.29e-1)" "unprognostic (7.69e-4)" "unprognostic (1.22e-1)" "unprognostic (3.22e-3)" "unprognostic (3.13e-2)" "unprognostic (1.27e-1)" "unprognostic (2.61e-1)" "unprognostic (4.03e-2)" "unprognostic (7.44e-2)" "unprognostic (1.67e-1)" "unprognostic (5.78e-2)" 5.2 9.1 0.4 2.0 0.7 3.0 2.4 3.9 0.3 1.8 0.0 3.8 5.9 3.1 0.1 14.8 0.8 2.1 20.1 0.2 1.7 1.5 0.6 7.0 2.0 3.3 0.7 2.3 9.1 0.4 0.0 10.3 3.5 2.9 3.6 0.9 3.7 2.4 6.4 5.7 7.2 2.5 0.0 3.4 7.0 2.1 1.2 0.5 0.7 1.1 4.7 9.9 0.6 0.2 6.3 1.3 0.1 5.8 0.3 0.0 1.4 0.8 5.1 1.6 1.7 4.0 5.6 0.0 0.7 0.0 5.0 3.4 0.0 4.2 1.6 0.0 0.2 49.0 1.4 0.2 0.0 0.1 0.1 0.2 2.2 0.4 11.7 0.2 6.3 0.1 2.4 0.1 0.3 1.1 0.0 0.0 0.1 12.0 0.6 0.0 10.7 0.0 0.0 19.1 0.0 1.9 1.2 2.7 0.0 0.7 5.3 0.2 20.4 0.4 3.1 0.4 0.3 0.2 0.0 0.0 3.1 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.0 0.5 0.2 0.0 0.2 1.4 1.4 0.0 0.1 0.0 0.7 0.0 0.1 2.1 0.4 0.7 3.9 0.3 0.2 1.7 3.3 0.7 3.5 0.0 1.2 0.2 2.7 3.2 0.5 0.3 0.4 0.0 0.3 0.0 1.8 0.0 0.5 0.3 3.9 0.0 0.6 0.0 0.0 0.1 0.0 1.7 0.0 1.8 0.2 0.4 1.0 1.8 0.0 0.0 0.2 1.1 0.1 0.2 4.1 1.4 0.0 5.7 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 1.1 0.4 0.0 0.3 1.8 0.0 0.7 0.0 0.0 0.5 0.0 1.6 4.8 1.5 0.0 0.4 1.4 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.1 0.6 0.1 0.1 0.0 1.1 0.5 0.9 POLR2M "GCOM1, Gdown, Gdown1, GRINL1A" ENSG00000255529 "RNA polymerase II subunit M" "P0CAP2, Q6EEV4" 15 57706695-57782762 "Predicted intracellular proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068141 Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 80: Striated muscle - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 35: Glandular cells - Unknown function" Nucleoplasm "HPA068141: AB_2685962" "unprognostic (3.07e-1)" "unprognostic (1.08e-1)" "unprognostic (2.63e-1)" "unprognostic (3.73e-1)" "unprognostic (1.11e-2)" "unprognostic (1.38e-1)" "unprognostic (9.80e-2)" "unprognostic (7.30e-2)" "unprognostic (4.30e-2)" "unprognostic (9.25e-2)" "unprognostic (2.81e-1)" "unprognostic (3.56e-2)" "unprognostic (6.61e-2)" "unprognostic (1.39e-1)" "unprognostic (3.25e-2)" "unprognostic (2.43e-1)" "unprognostic (1.07e-1)" 19.4 20.0 24.6 10.6 34.0 17.0 18.4 28.6 27.0 21.8 13.6 15.5 12.3 34.7 19.6 15.3 19.5 16.1 29.2 22.1 30.0 20.1 15.4 14.3 19.2 30.7 37.6 31.3 16.2 25.5 9.1 18.1 28.0 26.1 15.0 12.7 16.1 24.1 36.0 15.3 13.1 27.0 31.1 21.3 15.0 10.4 31.6 21.4 24.1 38.9 17.3 15.2 13.3 39.0 18.4 21.8 20.9 52.2 38.6 38.4 15.8 29.4 49.0 33.3 30.4 19.5 14.8 27.7 25.9 22.3 25.2 33.1 26.2 24.3 44.5 24.3 27.9 37.9 21.5 15.6 42.1 33.4 31.0 36.3 38.3 19.0 54.2 37.5 26.1 29.5 34.6 20.7 28.5 8.8 38.2 22.7 31.9 27.7 19.0 37.8 49.1 22.0 25.2 19.5 14.6 26.6 21.2 25.1 35.9 29.2 28.4 49.0 24.7 47.0 47.2 68.4 30.7 26.5 27.1 36.1 28.4 52.4 32.2 26.6 14.7 12.1 17.4 13.3 16.2 16.1 15.1 16.4 13.9 17.1 19.6 14.6 1.5 24.4 11.6 12.4 19.0 15.6 24.6 34.0 28.6 27.0 22.1 30.0 30.7 37.6 28.0 31.1 31.6 39.0 19.5 22.4 11.5 0.0 25.7 16.8 20.2 12.4 26.7 14.9 16.9 12.6 27.7 10.0 14.5 25.8 4.2 12.8 25.3 11.8 25.4 13.3 48.5 13.9 22.7 23.2 23.4 24.0 0.0 15.3 19.1 24.3 16.8 32.4 12.6 11.0 25.0 15.4 18.2 11.8 0.0 16.6 18.3 27.4 15.8 14.6 22.1 17.9 24.9 0.0 18.9 24.9 29.9 0.0 0.0 19.5 15.8 28.2 13.3 30.3 13.6 17.2 13.3 9.8 19.7 17.2 20.8 21.2 24.2 22.7 14.3 12.0 22.9 16.9 20.0 23.7 ALDH1A2 RALDH2 ENSG00000128918 "Aldehyde dehydrogenase 1 family member A2" O94788 15 57953424-58497866 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 82.2;fallopian tube: 74.5" "Group enriched" "Detected in many" 4 "Early spermatids: 115.7;Endometrial stromal cells: 142.2;Late spermatids: 48.7;Microglial cells: 42.2;Spermatocytes: 78.9" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "cerebral cortex: 13.1;hippocampal formation: 8.4" "Immune cell enriched" "Detected in some" 15 "neutrophil: 32.6" "Lineage enriched" "Detected in single" 62 "granulocytes: 32.6" "Group enriched" "Detected in some" 5 "AN3-CA: 402.4;HEK 293: 128.8;JURKAT: 387.2;K-562: 316.2;MOLT-4: 408.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA010022 Approved NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 36: Stromal cells - Cell proliferation" "HPA010022: AB_1844723" "unprognostic (1.11e-2)" "unprognostic (2.52e-2)" "unprognostic (2.00e-1)" "unprognostic (3.09e-1)" "unprognostic (1.44e-2)" "unprognostic (1.16e-2)" "unprognostic (1.04e-4)" "unprognostic (1.08e-1)" "unprognostic (9.03e-3)" "unprognostic (6.92e-3)" "unprognostic (5.48e-2)" "unprognostic (6.19e-2)" "unprognostic (2.57e-3)" "unprognostic (3.18e-2)" "unprognostic (4.95e-2)" "unprognostic (1.99e-2)" "unprognostic (1.80e-3)" 21.3 3.9 1.9 2.9 1.4 4.0 5.9 2.1 13.1 52.3 3.4 1.7 0.7 82.2 7.8 2.4 74.5 24.0 28.4 8.4 0.9 19.5 2.6 7.8 0.6 1.7 1.6 24.0 3.2 29.8 14.6 5.2 1.9 21.0 0.7 6.0 2.0 53.3 10.7 1.7 1.3 31.9 1.8 4.3 0.7 57.6 2.5 2.8 1.4 3.0 0.4 4.0 12.9 1.1 1.2 0.0 0.0 402.4 0.0 0.0 0.1 0.0 5.7 0.6 1.3 0.0 0.3 0.4 3.9 0.0 0.1 1.0 11.8 0.0 0.7 0.0 128.8 0.0 2.7 0.7 0.3 0.0 3.0 2.3 0.0 0.0 0.0 0.0 21.4 387.2 316.2 0.0 0.0 0.0 408.5 0.1 0.7 11.2 19.6 0.0 0.8 0.0 70.7 2.0 0.8 0.1 0.4 0.4 1.9 0.4 0.2 0.1 0.9 0.3 1.0 3.8 0.0 0.3 0.0 0.0 0.2 0.2 0.1 2.1 0.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.6 0.0 0.3 0.0 0.0 0.0 1.9 1.4 2.1 13.1 8.4 0.9 1.7 1.6 1.9 1.8 2.5 1.1 13.1 6.4 13.9 0.0 0.0 0.6 1.9 0.2 0.0 1.1 1.1 0.9 2.4 20.0 3.4 7.3 0.0 0.3 0.1 5.2 13.7 11.6 115.7 6.8 142.2 7.6 0.0 0.0 5.8 0.4 0.3 17.6 0.0 3.6 1.3 0.3 10.8 17.4 2.2 0.0 9.6 0.1 0.0 1.6 0.8 48.7 5.3 3.0 1.8 42.2 0.7 10.1 0.0 0.0 1.2 0.7 0.3 5.3 0.0 1.3 0.3 0.3 1.4 0.3 0.0 8.3 3.3 78.9 14.7 0.2 0.4 0.5 1.0 0.1 0.7 1.3 AQP9 "HsT17287, SSC1" ENSG00000103569 "Aquaporin 9" O43315 15 58138169-58185911 "Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "liver: 702.7" "Group enriched" "Detected in some" 4 "Hepatocytes: 313.9;Macrophages: 82.1" "Cancer enriched" "Detected in many" 30 "liver cancer: 132.4" "Region enhanced" "Detected in many" "cerebral cortex: 14.4" "Immune cell enriched" "Detected in many" 20 "neutrophil: 1161.4" "Lineage enriched" "Detected in many" 20 "granulocytes: 1161.4" "Cell line enriched" "Detected in some" 29 "U-87 MG: 29.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA074762, CAB075684" Enhanced NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 41: Macrophages - Immune response" "CAB075684: , HPA074762: AB_2732267" "unprognostic (1.91e-1)" "unprognostic (1.92e-1)" "unprognostic (7.30e-2)" "unprognostic (2.67e-1)" "unprognostic (1.24e-2)" "unprognostic (4.15e-2)" "unprognostic (1.36e-3)" "unprognostic (2.28e-2)" "unprognostic (3.82e-2)" "unprognostic (2.03e-1)" "unprognostic (4.80e-3)" "unprognostic (6.98e-2)" "prognostic unfavorable (5.72e-11)" "unprognostic (8.78e-2)" "unprognostic (1.13e-2)" "unprognostic (1.25e-1)" "unprognostic (8.39e-2)" 18.2 0.8 0.8 72.9 0.9 67.5 2.4 0.9 14.4 1.3 0.8 0.9 0.2 1.2 43.4 1.2 7.1 5.3 1.7 3.2 0.5 0.9 702.7 22.2 0.6 0.7 1.0 0.5 1.6 5.6 0.3 6.2 4.0 0.9 0.3 0.4 1.1 0.7 0.5 22.0 0.9 6.4 0.6 42.7 1.5 0.3 6.9 1.8 0.6 7.5 0.8 32.6 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 29.7 0.1 0.0 0.2 58.4 1.2 0.1 17.5 0.1 0.5 0.1 0.0 1.8 0.1 0.1 0.0 1161.4 0.3 23.0 0.6 0.3 18.9 0.8 0.9 0.9 14.4 3.2 0.5 0.7 1.0 4.0 0.6 6.9 0.8 0.7 0.0 12.2 0.3 2.3 0.4 0.2 0.0 0.0 0.0 0.1 0.0 1.1 5.7 3.1 0.0 0.0 0.3 0.5 0.0 0.0 0.1 2.1 0.3 0.1 0.7 0.0 13.9 2.4 0.2 0.9 1.9 0.0 1.8 7.6 0.0 7.9 313.9 40.8 0.0 0.8 0.0 0.0 28.5 6.2 1.9 0.3 82.1 0.0 0.0 18.9 0.0 1.0 0.5 0.2 0.5 0.0 0.0 0.7 0.2 0.0 0.3 1.5 0.0 0.0 0.5 0.2 0.1 0.0 0.0 0.6 0.8 1.5 0.0 0.0 0.1 LIPC "HL, HTGL" ENSG00000166035 "Lipase C, hepatic type" P11150 15 58410569-58569844 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" "Heparin-binding, Hydrolase" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 28 "liver: 171.0" "Cell type enriched" "Detected in some" 9 "Hepatocytes: 161.7" "Group enriched" "Detected in some" 14 "liver cancer: 20.4;renal cancer: 10.4" "Low region specificity" "Detected in some" "Low immune cell specificity" "Detected in some" "Group enriched" "Detected in many" 7 "granulocytes: 1.6;NK-cells: 1.5;T-cells: 1.8" "Cell line enhanced" "Detected in some" "CACO-2: 8.5;EFO-21: 6.1;Hep G2: 24.4;HMC-1: 6.8;MOLT-4: 5.5;U-2197: 18.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Secreted to blood" NA NA 5500000 "Cluster 10: Basophils - Unknown function" "Cluster 62: Liver - Hemostasis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" "unprognostic (1.76e-2)" "unprognostic (9.15e-3)" "unprognostic (7.89e-2)" "unprognostic (7.15e-4)" "unprognostic (1.40e-1)" "unprognostic (1.33e-2)" "unprognostic (9.93e-3)" "unprognostic (6.25e-2)" "unprognostic (3.79e-2)" "unprognostic (1.10e-2)" "unprognostic (3.06e-1)" "unprognostic (2.31e-1)" "unprognostic (2.82e-2)" "unprognostic (1.41e-1)" "unprognostic (2.87e-2)" "unprognostic (1.80e-2)" "unprognostic (2.27e-2)" 0.4 0.1 0.5 0.3 0.5 0.2 1.5 0.8 0.9 0.4 0.0 0.6 1.8 0.2 0.9 0.6 1.0 0.8 0.5 0.6 0.3 6.0 171.0 0.3 0.7 0.8 0.7 0.8 2.5 0.0 1.5 0.4 1.0 0.1 0.8 0.1 0.2 0.9 0.0 0.6 0.8 0.1 0.6 0.8 0.5 0.1 0.4 2.1 1.2 0.3 0.2 1.6 0.3 1.2 0.0 0.0 0.0 0.0 0.3 1.0 0.1 0.1 0.8 0.0 0.0 8.5 0.0 0.0 6.1 0.2 0.3 0.0 0.0 0.0 0.0 0.4 0.0 3.0 0.0 24.4 0.5 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.2 0.1 5.5 0.8 0.0 0.1 0.0 1.1 0.3 0.0 2.6 0.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 18.4 0.0 0.1 0.0 0.1 0.2 0.5 0.0 1.6 0.1 0.0 1.3 0.1 1.8 0.0 0.3 0.9 0.1 0.0 0.4 1.3 0.2 1.5 0.2 0.0 0.9 1.1 0.5 0.5 0.8 0.9 0.6 0.3 0.8 0.7 1.0 0.6 0.4 1.2 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.0 0.0 0.0 2.2 0.8 11.5 0.7 3.7 0.0 0.0 0.9 1.2 5.9 7.8 0.0 0.4 0.5 1.2 0.0 2.7 6.1 3.7 0.1 2.9 0.5 2.7 0.0 0.2 4.2 161.7 0.1 0.0 4.3 0.0 0.0 3.8 0.8 0.1 0.3 0.3 1.8 16.9 0.6 0.0 3.1 0.0 12.9 0.2 0.0 0.0 0.0 0.2 0.3 15.7 0.0 0.0 0.0 1.6 0.3 0.0 0.0 0.3 0.6 0.0 1.1 1.2 0.0 0.1 ADAM10 "CD156C, HsT18717, kuz, MADM" ENSG00000137845 "ADAM metallopeptidase domain 10" O14672 15 58588809-58749791 "Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Notch signaling pathway" "Hydrolase, Metalloprotease, Protease" "Alzheimer disease, Amyloidosis, Cancer-related genes, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 377.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 296.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001709, HPA050670" Approved Supported "Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 690000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 3: T-cells - Adaptive immune response" "Cluster 18: U-2197 - ECM organization" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Vesicles, Plasma membrane" "CAB001709: , HPA050670: " "unprognostic (1.43e-1)" "unprognostic (1.38e-1)" "unprognostic (2.77e-1)" "unprognostic (5.04e-2)" "unprognostic (3.09e-1)" "unprognostic (2.70e-3)" "unprognostic (7.48e-2)" "prognostic unfavorable (8.46e-5)" "unprognostic (3.99e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (6.69e-2)" "unprognostic (2.57e-2)" "unprognostic (2.57e-3)" "unprognostic (9.14e-2)" "unprognostic (2.09e-2)" "unprognostic (1.60e-2)" 14.9 8.7 11.4 19.0 18.6 18.7 15.2 20.2 15.0 16.0 9.7 22.2 15.9 16.3 7.7 15.4 13.9 18.9 12.1 12.2 12.7 18.0 16.1 21.0 22.2 18.2 17.6 14.1 8.8 7.9 8.2 29.0 17.5 25.2 17.2 10.8 9.3 12.2 6.1 16.9 17.5 13.3 13.7 29.0 20.3 8.5 15.5 42.7 28.6 7.1 16.4 28.0 10.4 25.2 48.4 88.5 27.6 31.2 34.8 49.8 70.0 39.0 116.0 28.6 39.1 39.9 62.6 22.7 118.0 35.2 49.2 95.9 16.8 43.5 37.0 30.1 19.3 38.7 35.1 42.1 40.8 25.0 103.8 44.4 30.0 19.9 29.2 41.1 55.6 45.0 24.5 57.9 50.4 15.4 89.5 32.0 40.2 15.4 14.6 36.4 91.6 57.1 66.6 121.4 29.9 20.3 44.0 52.8 73.1 60.0 30.4 55.0 41.4 37.1 41.2 296.6 39.6 30.7 70.7 23.5 54.1 50.8 67.3 30.9 36.2 19.2 12.8 41.1 19.2 8.3 12.7 11.6 23.6 9.6 12.7 10.8 51.5 17.7 48.6 10.2 18.2 25.8 11.4 18.6 20.2 15.0 12.2 12.7 18.2 17.6 17.5 13.7 15.5 25.2 60.1 83.3 50.8 83.2 37.9 26.6 30.7 33.3 33.0 22.7 61.6 30.9 40.0 30.0 46.7 80.9 27.1 35.6 69.4 79.0 1.9 56.0 21.2 39.5 56.4 72.5 36.1 20.8 106.1 31.8 57.8 36.1 53.0 74.0 30.3 31.5 71.4 36.2 63.8 45.4 96.2 43.6 36.7 90.1 28.9 19.4 18.0 77.9 46.2 147.1 69.0 30.6 44.3 75.9 377.6 48.9 48.1 17.0 51.0 89.1 45.1 23.7 41.2 33.4 13.1 34.4 42.8 20.3 17.8 39.5 22.3 26.5 51.3 34.1 39.5 83.9 MINDY2 "FAM63B, KIAA1164" ENSG00000128923 "MINDY lysine 48 deubiquitinase 2" Q8NBR6 15 58771192-58861900 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 147.4;Collecting duct cells: 82.8;Endometrial ciliated cells: 66.4;Extravillous trophoblasts: 108.7;Glandular and luminal cells: 73.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "U-2197: 72.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051103, HPA063669" Approved Enhanced Nucleoplasm No No "Cluster 18: Basophils - Vesicular transport" "Cluster 57: Non-specific - Angiogenesis" "Cluster 18: U-2197 - ECM organization" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA051103: AB_2681345, HPA063669: AB_2685082" "unprognostic (4.71e-2)" "unprognostic (8.92e-3)" "unprognostic (4.63e-2)" "unprognostic (4.13e-2)" "unprognostic (1.32e-1)" "unprognostic (1.06e-1)" "unprognostic (2.14e-1)" "unprognostic (8.60e-2)" "unprognostic (7.23e-2)" "unprognostic (7.09e-2)" "unprognostic (2.36e-3)" "unprognostic (4.74e-2)" "prognostic favorable (3.00e-8)" "unprognostic (2.53e-1)" "unprognostic (3.59e-1)" "unprognostic (6.76e-2)" "unprognostic (4.77e-2)" 9.4 5.4 9.3 5.7 9.6 3.8 6.6 15.0 10.4 7.0 8.9 5.4 3.5 7.1 4.6 7.1 6.8 6.3 10.8 8.0 11.6 10.1 3.5 7.7 4.1 10.5 11.0 6.8 3.3 7.3 4.9 9.0 10.0 8.9 3.9 16.3 4.9 6.1 3.4 7.1 3.6 8.5 9.2 6.1 4.8 3.9 11.2 5.9 9.6 8.9 3.7 8.0 5.2 10.3 10.9 5.3 7.3 4.4 10.7 19.7 11.5 9.8 20.8 3.0 4.3 8.4 5.4 5.6 10.5 11.8 5.3 10.3 13.4 7.9 4.6 5.6 4.9 7.8 5.7 7.6 6.6 5.9 6.9 8.7 12.9 3.5 8.0 11.3 7.4 5.9 13.7 6.1 7.1 1.4 7.4 4.4 15.7 1.4 2.7 3.3 21.0 6.0 8.9 12.1 6.7 4.9 7.1 10.0 17.9 15.3 3.0 12.5 8.7 4.2 3.7 72.5 4.3 5.4 8.3 5.4 9.4 9.5 10.2 3.0 0.7 1.3 1.1 0.6 2.1 0.9 1.0 1.3 0.2 1.6 0.8 1.2 1.4 0.8 1.4 1.1 0.9 0.5 9.3 9.6 15.0 10.4 8.0 11.6 10.5 11.0 10.0 9.2 11.2 10.3 65.2 147.4 39.1 0.0 5.1 0.0 0.0 0.0 0.0 0.0 43.8 44.8 0.0 0.0 18.0 82.8 0.0 65.2 27.5 0.0 46.9 44.4 0.0 66.4 46.8 19.8 0.0 0.0 0.0 21.2 108.7 21.7 0.0 73.2 11.4 11.6 0.0 0.0 33.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 32.4 0.0 0.0 7.5 0.0 0.0 14.2 28.4 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.0 53.2 11.3 17.6 0.0 0.0 RNF111 "ARK, Arkadia, DKFZP761D081, FLJ38008" ENSG00000157450 "Ring finger protein 111" Q6ZNA4 15 58865175-59097419 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 81.6;Inhibitory neurons: 80.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038576, HPA038577" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 59: Non-specific - Transcription" Nucleoplasm Cytosol "HPA038576: AB_10964492, HPA038577: AB_10960052" "unprognostic (7.30e-2)" "unprognostic (2.60e-2)" "unprognostic (2.39e-1)" "unprognostic (3.37e-1)" "unprognostic (7.94e-2)" "unprognostic (2.09e-1)" "unprognostic (2.19e-1)" "unprognostic (3.21e-1)" "unprognostic (5.10e-2)" "unprognostic (6.12e-3)" "unprognostic (3.10e-2)" "unprognostic (1.42e-1)" "unprognostic (2.05e-3)" "unprognostic (2.05e-1)" "unprognostic (6.61e-2)" "unprognostic (1.20e-1)" "unprognostic (9.74e-2)" 8.2 7.5 2.0 11.8 3.1 17.3 7.8 8.7 5.3 8.6 1.4 7.2 8.4 9.0 6.7 11.4 8.7 9.3 7.3 3.5 4.7 8.8 10.5 8.4 10.8 1.4 1.7 11.4 9.2 11.9 4.3 11.4 2.1 8.7 7.2 12.5 8.1 8.3 9.5 8.2 8.0 8.3 1.2 11.0 9.0 9.4 3.2 11.5 11.6 11.8 13.3 10.3 7.2 4.3 13.8 31.3 19.6 16.8 16.6 18.5 16.7 17.6 20.6 17.2 22.0 13.9 8.9 16.8 19.4 24.8 14.7 26.3 5.3 13.1 21.3 17.6 11.1 20.9 12.6 10.7 18.0 12.3 22.6 14.7 14.0 18.6 20.4 15.6 19.5 15.4 19.7 16.4 21.5 6.7 16.3 7.9 16.1 4.3 12.0 16.2 27.9 13.8 13.1 24.2 16.0 23.3 15.8 15.5 14.7 22.7 12.2 14.9 22.6 27.4 22.8 14.5 17.1 11.8 17.3 19.9 16.7 19.5 21.1 11.4 15.0 15.7 7.0 11.0 7.1 11.8 7.2 6.5 8.3 10.9 7.9 6.3 41.0 5.6 13.0 7.9 10.0 3.4 2.0 3.1 8.7 5.3 3.5 4.7 1.4 1.7 2.1 1.2 3.2 4.3 11.7 3.2 14.4 34.6 31.9 20.1 12.3 7.3 26.7 12.2 13.0 10.2 19.7 7.2 10.6 12.9 8.4 9.0 12.8 10.0 3.9 12.6 27.6 14.4 15.1 15.3 16.2 11.6 81.6 6.9 10.5 15.0 17.3 15.8 15.8 12.3 17.9 11.2 13.4 10.1 80.4 10.0 12.2 19.8 15.7 7.5 7.8 21.2 12.4 56.2 22.7 8.4 16.5 65.4 66.2 12.9 11.4 14.7 19.5 14.5 11.6 9.9 14.9 13.6 26.3 15.1 13.6 13.8 8.9 27.3 19.9 32.0 21.4 11.8 9.2 21.2 SLTM "FLJ13213, Met" ENSG00000137776 "SAFB like transcription modulator" Q9NWH9 15 58879050-58933679 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040256, HPA040381" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Nuclear bodies" "HPA040256: AB_10674990, HPA040381: AB_2676953" "unprognostic (2.36e-1)" "unprognostic (6.56e-2)" "unprognostic (2.23e-1)" "unprognostic (1.81e-1)" "unprognostic (2.52e-3)" "unprognostic (9.65e-2)" "unprognostic (1.00e-1)" "unprognostic (2.48e-1)" "unprognostic (2.82e-3)" "unprognostic (3.44e-1)" "unprognostic (2.09e-1)" "unprognostic (6.10e-3)" "unprognostic (8.03e-2)" "unprognostic (7.09e-2)" "unprognostic (3.69e-1)" "unprognostic (5.71e-2)" "unprognostic (3.24e-3)" 31.2 21.5 27.3 31.5 30.6 57.7 29.5 35.6 34.6 29.9 26.3 30.0 30.0 27.6 20.8 38.5 27.8 23.8 28.4 25.6 28.6 33.6 34.9 28.2 42.7 28.3 29.1 29.6 24.9 36.1 28.4 21.0 28.6 29.2 32.1 44.9 30.6 24.2 46.1 35.1 33.4 25.8 27.5 38.1 38.9 27.8 28.7 57.3 34.1 43.6 44.1 33.8 31.3 31.3 77.8 84.1 72.0 36.6 48.1 36.2 60.6 55.1 64.3 49.9 48.2 58.4 45.7 144.6 50.5 50.8 54.4 67.9 72.3 62.9 68.7 93.7 46.4 105.4 91.8 44.7 42.0 83.8 78.1 34.1 61.0 52.8 44.1 30.4 46.9 66.0 95.5 81.7 58.2 56.1 84.1 64.6 80.9 46.3 40.5 63.6 65.4 70.1 60.2 99.8 58.9 50.8 57.0 55.1 57.8 79.3 44.0 90.1 48.6 60.2 88.5 66.3 74.6 57.3 123.1 105.5 47.6 101.7 61.5 67.9 30.3 44.4 45.2 29.5 46.1 53.5 36.0 39.3 31.2 47.3 39.2 35.6 42.8 47.0 37.7 53.6 36.5 22.7 27.3 30.6 35.6 34.6 25.6 28.6 28.3 29.1 28.6 27.5 28.7 31.3 92.5 153.8 161.2 61.4 125.8 96.9 100.2 85.6 107.0 116.3 77.3 66.0 107.8 64.3 122.8 106.7 98.0 73.5 155.9 88.4 78.2 98.4 100.8 110.5 99.0 94.7 73.4 115.7 67.7 115.7 160.1 94.3 99.4 119.1 118.9 75.3 63.9 104.1 63.9 119.5 67.3 94.4 59.0 88.6 73.0 120.8 86.3 108.8 78.2 72.1 121.0 84.9 126.7 74.4 141.8 131.1 76.5 88.4 140.0 92.4 57.4 90.6 103.9 145.3 72.3 106.6 95.6 215.1 85.2 100.0 104.6 112.5 134.9 78.0 94.0 125.6 CCNB2 HsT17299 ENSG00000157456 "Cyclin B2" O95067 15 59105126-59125045 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell cycle, Cell division, Mitosis" Cyclin "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 74.6;lymphoid tissue: 73.1;testis: 69.4" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 67.9;Early spermatids: 228.5;Erythroid cells: 123.6;Extravillous trophoblasts: 128.3;Spermatocytes: 288.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 5 "T-reg: 22.7" "Lineage enriched" "Detected in many" 6 "T-cells: 22.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA008873, CAB009575" Enhanced Enhanced "Golgi apparatus,Cytosol" Yes Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol "Golgi apparatus" "CAB009575: AB_2072392, HPA008873: AB_1078604" "unprognostic (2.69e-2)" "unprognostic (2.25e-1)" "unprognostic (4.43e-2)" "unprognostic (1.96e-2)" "unprognostic (1.77e-1)" "unprognostic (4.65e-2)" "prognostic unfavorable (2.83e-4)" "prognostic unfavorable (4.63e-4)" "prognostic unfavorable (3.21e-5)" "unprognostic (1.09e-1)" "prognostic unfavorable (1.74e-5)" "unprognostic (4.48e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.96e-1)" "unprognostic (1.41e-1)" "unprognostic (3.98e-2)" "unprognostic (4.44e-1)" 1.0 1.1 0.4 12.2 1.1 74.6 2.9 0.7 0.7 2.9 1.1 14.3 14.1 2.6 0.3 16.1 1.1 1.9 0.7 0.6 0.7 1.1 1.4 2.2 33.0 1.3 1.0 0.8 0.7 0.2 0.3 11.4 1.0 1.6 16.8 0.3 2.8 0.4 0.7 9.4 12.0 6.4 0.7 7.1 5.6 69.4 1.1 73.1 1.0 0.4 43.7 3.6 5.6 2.2 132.5 112.1 188.6 47.1 8.5 16.6 97.5 104.8 69.9 165.2 135.6 187.8 81.1 122.1 75.4 71.8 97.2 160.1 181.4 92.6 157.8 124.1 92.4 153.1 127.3 108.1 2.5 118.1 98.6 6.3 12.6 71.4 91.9 32.7 114.1 147.0 163.1 194.5 128.2 96.5 137.9 177.2 138.6 58.5 65.2 157.5 260.0 124.4 53.3 91.9 115.2 75.9 148.9 80.2 97.3 147.9 139.4 120.4 58.5 81.6 134.4 90.5 210.5 84.2 133.2 213.8 53.6 267.1 117.9 0.0 0.1 0.7 0.1 0.0 0.3 2.1 4.6 5.0 3.0 1.7 0.0 0.1 0.8 3.6 0.1 0.1 22.7 2.1 0.4 1.1 0.7 0.7 0.6 0.7 1.3 1.0 1.0 0.7 1.1 2.2 0.3 0.0 0.6 0.0 6.8 4.8 2.8 11.5 1.8 0.2 2.5 3.3 0.5 0.0 3.2 0.0 0.0 67.9 1.6 4.1 0.0 0.7 228.5 5.3 3.1 3.9 3.0 123.6 0.7 0.2 128.3 7.2 7.1 5.9 0.0 29.9 6.1 1.1 29.9 0.0 0.8 10.1 20.3 10.6 3.3 53.5 4.4 7.9 0.0 0.0 2.4 0.2 1.0 0.0 1.4 0.4 1.9 1.9 18.7 2.3 2.1 0.0 1.8 0.3 0.0 1.0 5.7 288.7 32.1 20.3 6.1 16.3 4.4 4.1 23.4 5.0 MYO1E "HuncM-IC, MGC104638, MYO1C" ENSG00000157483 "Myosin IE" Q12965 15 59132434-59372871 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 319.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 23.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 224.1;HaCaT: 208.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003003, HPA023886" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 13000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 20: HeLa - Mitochondria" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoplasm, Plasma membrane" Cytosol "HPA003003: , HPA023886: AB_1854253" "unprognostic (7.90e-2)" "unprognostic (1.35e-1)" "unprognostic (1.52e-1)" "prognostic favorable (4.19e-4)" "unprognostic (1.49e-1)" "unprognostic (3.59e-1)" "unprognostic (1.16e-2)" "prognostic unfavorable (1.57e-6)" "unprognostic (1.89e-1)" "unprognostic (5.38e-3)" "prognostic unfavorable (7.99e-4)" "unprognostic (2.41e-1)" "unprognostic (7.92e-2)" "unprognostic (7.31e-2)" "unprognostic (9.71e-2)" "unprognostic (1.15e-1)" "unprognostic (5.62e-2)" 30.6 7.1 19.4 32.9 34.9 1.8 19.5 32.2 30.7 27.7 43.6 54.3 25.3 31.0 29.6 37.6 17.4 38.7 13.3 19.6 24.9 47.7 52.2 19.9 36.9 38.6 35.0 10.3 12.0 22.4 9.3 34.7 39.4 22.9 34.4 9.9 18.7 21.6 11.9 45.6 44.2 22.2 28.4 17.1 32.5 8.3 33.1 7.6 15.2 10.9 41.2 38.1 28.1 57.1 133.3 224.1 12.1 8.2 92.4 74.8 62.2 52.9 25.7 28.8 33.6 55.7 50.5 52.7 37.0 41.3 117.5 208.6 18.9 81.5 38.2 24.1 10.5 0.5 178.4 50.3 85.5 0.3 7.2 103.4 48.8 37.0 107.4 90.7 47.8 0.9 0.3 0.8 49.2 12.4 0.6 1.2 29.3 21.5 49.8 0.2 53.8 32.4 156.9 61.8 6.5 21.9 117.1 24.2 45.8 36.5 16.3 5.8 58.4 57.5 16.6 177.1 52.0 0.3 3.3 1.3 105.4 0.6 53.2 0.0 4.5 0.0 0.2 4.6 0.0 9.2 0.0 0.0 15.4 8.6 0.0 0.0 0.6 3.6 1.6 23.7 0.5 2.5 19.4 34.9 32.2 30.7 19.6 24.9 38.6 35.0 39.4 28.4 33.1 57.1 31.0 6.4 7.7 27.1 19.6 24.9 40.0 24.7 24.5 0.2 9.3 10.2 3.9 17.2 15.4 25.8 0.0 4.3 19.9 73.6 3.9 39.8 4.2 49.4 30.2 30.4 19.7 2.5 9.3 18.1 23.8 14.9 86.6 47.3 4.5 6.7 5.0 13.0 33.5 0.0 8.7 31.2 8.2 5.0 50.1 8.5 9.3 17.6 19.6 56.2 9.0 11.3 3.1 6.6 319.1 64.0 60.0 12.0 9.2 28.3 37.4 3.1 40.9 0.9 13.1 33.7 25.0 1.3 5.1 30.1 24.0 12.9 4.7 6.7 29.3 56.9 LDHAL6B "LDH6B, LDHAL6, LDHL" ENSG00000171989 "Lactate dehydrogenase A like 6B" Q9BYZ2 15 59206843-59208588 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "testis: 40.6" "Cell type enriched" "Detected in some" 13 "Spermatocytes: 101.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HeLa: 1.1" "Region enriched" "Detected in single" 6 "olfactory bulb: 1.3" HPA053962 Enhanced NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 20: HeLa - Mitochondria" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA053962: AB_2682324" "unprognostic (1.59e-1)" "unprognostic (9.41e-2)" "unprognostic (2.37e-1)" "unprognostic (4.46e-2)" "unprognostic (6.59e-2)" "unprognostic (2.23e-1)" "unprognostic (1.34e-1)" "unprognostic (1.58e-1)" "unprognostic (2.29e-1)" "unprognostic (1.66e-1)" "unprognostic (5.13e-3)" "unprognostic (1.64e-1)" "unprognostic (3.12e-7)" "unprognostic (3.47e-2)" "unprognostic (1.49e-2)" "unprognostic (8.53e-2)" "unprognostic (7.80e-2)" 0.3 0.0 0.2 0.2 0.9 0.0 0.2 0.5 0.9 0.2 2.3 0.2 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.3 0.7 0.2 0.3 0.1 0.1 1.1 0.6 0.0 0.1 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.1 0.0 0.1 0.3 0.3 0.0 0.5 0.0 0.1 40.6 1.0 0.0 0.1 0.0 0.0 0.1 0.2 1.9 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.5 0.9 0.3 0.7 1.1 0.6 1.2 0.5 1.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 101.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM81A MGC26690 ENSG00000157470 "Family with sequence similarity 81 member A" Q8TBF8 15 59372693-59523555 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.0" "Group enriched" "Detected in many" 5 "Collecting duct cells: 31.3;Excitatory neurons: 83.0;Inhibitory neurons: 67.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "myeloid DC: 5.1;plasmacytoid DC: 11.7" "Lineage enriched" "Detected in many" 5 "dendritic cells: 11.7" "Cell line enriched" "Detected in many" 4 "Daudi: 66.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001847, HPA065797" Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 10: Brain - Neuronal signaling" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm Cytosol "HPA001847: AB_2666462, HPA065797: AB_2685560" "unprognostic (3.43e-3)" "unprognostic (4.47e-3)" "unprognostic (1.93e-1)" "unprognostic (1.32e-3)" "unprognostic (2.15e-1)" "unprognostic (1.30e-2)" "unprognostic (1.53e-2)" "unprognostic (1.43e-1)" "unprognostic (2.39e-1)" "unprognostic (8.90e-2)" "unprognostic (4.68e-2)" "unprognostic (2.13e-1)" "unprognostic (9.95e-3)" "unprognostic (1.08e-2)" "unprognostic (6.53e-2)" "unprognostic (3.76e-1)" "unprognostic (7.80e-2)" 0.4 0.1 7.0 2.4 10.5 0.2 1.4 0.0 17.0 6.7 0.5 4.3 2.4 2.4 4.4 0.4 6.1 1.6 1.5 11.0 3.2 6.8 0.4 0.7 4.9 0.0 0.1 0.6 1.9 1.1 2.6 0.8 0.1 2.3 5.2 1.3 2.6 1.5 0.5 0.9 1.4 1.2 0.0 1.4 2.4 1.8 6.0 0.4 2.1 2.8 5.5 0.4 0.4 8.3 10.5 15.0 1.1 0.2 0.4 0.2 6.0 0.6 0.0 1.0 2.8 1.8 1.7 66.5 0.3 0.2 14.1 7.8 8.3 2.5 1.9 0.7 4.3 0.0 10.6 0.8 0.0 5.7 1.3 0.0 1.5 0.4 0.8 0.8 0.1 2.7 0.1 0.0 1.0 3.5 0.1 0.1 0.9 2.7 5.4 1.5 14.8 1.7 3.3 3.8 3.0 0.8 6.0 0.3 9.9 0.6 2.5 3.4 0.3 2.4 7.4 2.9 11.4 0.1 0.0 0.8 2.5 2.2 6.7 0.0 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 5.1 2.3 0.0 0.0 0.3 0.1 0.0 11.7 0.0 0.3 7.0 10.5 0.0 17.0 11.0 3.2 0.0 0.1 0.1 0.0 6.0 8.3 0.2 0.0 1.3 11.4 2.5 0.5 1.4 0.2 0.6 0.0 2.4 2.4 6.9 0.0 1.0 31.3 0.0 0.1 0.0 1.7 5.9 0.5 0.5 11.2 0.9 0.7 1.2 1.3 83.0 0.2 1.6 0.6 1.1 1.5 1.3 0.2 0.4 0.2 1.3 10.1 67.0 1.9 2.0 0.6 1.5 1.4 0.3 0.7 8.8 4.7 0.7 1.1 0.0 2.5 8.1 0.4 1.9 0.0 1.2 1.4 0.8 0.3 8.4 0.2 0.0 1.1 3.1 0.2 1.6 1.5 0.4 0.0 0.4 0.2 4.0 1.0 GCNT3 "C2/4GnT, C2GnT-M, C2GnT2" ENSG00000140297 "Glucosaminyl (N-acetyl) transferase 3, mucin type" O95395 15 59594875-59640239 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 75.5;intestine: 142.9;salivary gland: 55.8" "Cell type enhanced" "Detected in many" "Collecting duct cells: 104.8;Distal enterocytes: 360.1;Ductal cells: 92.6;Glandular and luminal cells: 75.6;Paneth cells: 163.2;Proximal enterocytes: 85.5" "Group enriched" "Detected in many" 4 "colorectal cancer: 16.4;pancreatic cancer: 29.8;stomach cancer: 20.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 147.4;EFO-21: 24.6;Hep G2: 30.3;OE19: 75.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA011154 Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 9: Intestine - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" Vesicles "HPA011154: AB_1078961" "unprognostic (5.09e-2)" "unprognostic (2.39e-1)" "unprognostic (5.92e-2)" "prognostic favorable (1.78e-4)" "unprognostic (3.99e-3)" "unprognostic (2.02e-2)" "prognostic unfavorable (6.49e-5)" "unprognostic (1.69e-1)" "unprognostic (1.31e-1)" "unprognostic (2.34e-1)" "unprognostic (1.64e-2)" "unprognostic (1.63e-1)" "unprognostic (4.02e-3)" "unprognostic (1.48e-1)" "unprognostic (1.06e-2)" "unprognostic (4.65e-2)" "unprognostic (2.43e-1)" 0.2 0.7 0.2 11.9 0.2 0.5 0.4 0.6 0.4 19.2 0.2 142.9 97.5 2.0 0.0 15.8 4.2 75.5 0.1 0.2 0.1 17.9 0.4 0.7 0.9 0.1 0.4 0.1 2.1 0.9 0.1 0.1 0.2 1.2 123.2 0.1 55.8 0.3 0.2 0.3 123.3 4.6 0.0 0.1 25.8 4.3 0.2 1.3 2.1 0.0 10.6 9.1 29.9 0.4 0.1 147.4 0.0 0.2 0.0 1.0 0.2 0.1 7.7 0.0 0.0 6.3 6.0 0.6 24.6 0.0 9.5 0.5 0.0 0.0 0.0 0.5 0.1 0.0 0.5 30.3 0.0 0.2 0.2 0.3 3.5 0.7 0.0 0.1 0.0 0.2 0.0 0.4 1.4 0.6 0.1 0.2 0.2 75.9 0.3 0.4 0.0 0.6 10.2 1.2 0.2 0.2 0.0 0.2 0.4 0.1 0.1 0.0 0.1 0.2 0.4 7.3 0.1 0.2 0.5 0.8 8.9 0.3 0.1 0.9 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.7 0.2 0.1 0.3 0.1 0.0 0.2 0.2 0.6 0.4 0.2 0.1 0.1 0.4 0.2 0.0 0.2 0.4 0.0 0.0 2.2 0.0 1.0 0.0 18.3 8.9 0.0 0.0 0.5 0.0 0.7 11.5 40.5 104.8 0.0 0.0 0.1 360.1 0.0 92.6 9.8 23.3 8.6 0.3 7.8 0.0 0.0 14.9 0.0 0.2 27.5 75.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 26.9 8.2 0.6 0.0 19.2 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 58.4 163.2 0.0 0.1 8.0 85.5 4.4 9.8 0.0 6.6 0.6 1.5 3.0 0.3 1.4 0.0 0.0 0.8 0.0 48.5 52.4 GTF2A2 "HsT18745, TFIIA" ENSG00000140307 "General transcription factor IIA subunit 2" P52657 15 59638062-59657541 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 1134.9;Late spermatids: 732.8;Spermatocytes: 1264.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056239 Supported Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 16: U-266 - Nucleosome" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "HPA056239: AB_2683074" "unprognostic (2.18e-2)" "unprognostic (3.21e-1)" "unprognostic (9.37e-2)" "unprognostic (1.09e-2)" "unprognostic (1.16e-1)" "unprognostic (1.53e-2)" "unprognostic (3.06e-2)" "unprognostic (1.31e-2)" "unprognostic (7.35e-2)" "unprognostic (6.29e-2)" "unprognostic (3.47e-1)" "unprognostic (7.13e-2)" "unprognostic (1.58e-1)" "unprognostic (2.79e-1)" "unprognostic (2.74e-2)" "unprognostic (1.47e-1)" "unprognostic (8.90e-2)" 54.4 56.9 37.6 54.5 39.5 72.0 49.6 42.7 44.0 52.5 38.8 62.8 40.3 48.7 54.6 60.9 46.2 43.6 64.0 38.1 42.7 69.8 49.8 39.7 52.6 41.5 40.1 52.0 43.1 65.4 58.3 43.3 41.0 46.0 51.1 41.9 58.2 34.3 75.1 39.5 42.0 45.4 42.2 43.3 46.3 211.9 38.6 60.0 41.1 55.1 51.8 61.4 65.5 44.1 149.1 206.4 136.8 130.9 83.8 70.5 157.7 164.0 79.8 134.6 133.3 224.4 58.9 136.5 149.5 107.9 197.6 124.3 138.7 100.6 95.4 242.2 112.9 157.4 146.5 143.4 107.5 171.5 134.1 66.0 95.1 112.3 94.9 95.3 87.6 105.6 226.7 136.1 113.6 103.8 112.9 130.8 181.7 49.6 120.0 104.4 142.9 166.5 133.7 172.2 148.0 157.1 152.1 171.5 160.1 180.5 120.7 179.2 121.5 126.4 224.7 142.5 297.7 134.1 426.3 303.8 143.2 284.0 157.2 174.0 129.8 170.3 88.1 140.7 92.4 126.9 103.1 98.9 174.2 100.2 87.4 96.7 70.0 117.5 135.1 201.0 132.7 134.9 37.6 39.5 42.7 44.0 38.1 42.7 41.5 40.1 41.0 42.2 38.6 44.1 109.4 41.7 58.5 17.0 89.8 98.7 184.6 213.0 83.1 51.1 107.3 155.8 120.4 62.9 132.2 64.4 47.9 217.8 99.9 122.4 211.3 148.8 1134.9 129.9 85.8 96.6 82.1 121.4 22.4 148.8 199.7 103.7 51.5 92.4 82.2 87.9 74.6 78.4 148.3 50.5 27.5 100.8 195.3 100.1 107.7 732.8 125.9 101.9 80.0 16.9 158.9 173.8 107.1 24.1 35.4 181.6 104.6 137.3 109.6 210.7 83.5 149.2 129.7 62.2 65.7 102.9 133.7 1264.3 166.3 89.8 106.8 151.9 87.3 120.8 120.5 236.2 BNIP2 "BNIP-2, Nip2" ENSG00000140299 "BCL2 interacting protein 2" Q12982 15 59659146-59689534 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 131.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026843 Approved Supported Nucleoli,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 30: Epithelial cell lines - Translation" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Cytosol Nucleoli "HPA026843: AB_1845403" "unprognostic (3.41e-2)" "unprognostic (2.26e-1)" "unprognostic (4.51e-2)" "prognostic favorable (8.42e-4)" "unprognostic (6.70e-2)" "unprognostic (4.81e-2)" "unprognostic (2.47e-1)" "unprognostic (1.19e-1)" "unprognostic (6.44e-2)" "unprognostic (1.26e-1)" "unprognostic (4.72e-2)" "unprognostic (6.73e-2)" "prognostic unfavorable (2.19e-5)" "unprognostic (4.68e-3)" "unprognostic (1.81e-1)" "unprognostic (2.10e-2)" "unprognostic (1.01e-1)" 49.6 22.4 14.2 41.0 15.8 131.6 30.7 14.7 13.5 28.7 10.6 20.8 16.4 36.9 19.2 30.5 20.5 27.8 47.7 11.9 16.8 19.3 46.5 41.4 48.6 17.2 15.9 31.2 13.9 17.5 10.3 42.7 17.2 26.6 23.2 27.3 20.5 29.4 32.6 20.9 20.3 41.4 16.7 46.5 18.0 22.8 16.2 43.4 18.9 48.8 48.1 41.2 21.2 18.1 39.4 35.9 45.9 37.8 70.8 57.9 40.2 60.3 85.0 54.3 61.9 29.0 18.2 67.9 39.5 87.9 74.4 72.7 48.9 70.1 73.4 49.3 31.1 83.0 52.6 30.8 77.6 107.3 91.7 68.6 71.9 49.4 85.0 51.2 91.1 78.9 48.3 70.8 88.5 22.6 50.5 44.6 41.2 7.7 25.8 55.3 57.5 87.7 56.9 87.3 36.9 50.2 39.5 52.7 104.4 66.4 43.7 112.9 72.2 58.3 71.0 38.0 60.2 52.6 112.7 90.0 46.5 98.1 60.5 50.6 46.6 72.2 29.6 46.9 35.1 31.9 31.1 31.8 43.1 28.9 31.8 32.1 81.5 34.8 40.1 34.5 36.3 43.8 14.2 15.8 14.7 13.5 11.9 16.8 17.2 15.9 17.2 16.7 16.2 18.1 116.7 73.7 44.0 20.2 87.9 86.7 98.8 56.0 70.6 32.5 35.3 29.6 81.9 28.6 43.0 14.7 47.9 64.0 82.6 31.3 37.2 31.5 9.0 41.8 44.5 105.6 15.5 57.7 15.4 26.8 76.8 68.0 46.9 65.8 96.4 31.0 87.8 49.6 91.7 50.5 17.5 24.3 32.6 115.6 106.7 6.1 43.5 125.6 51.6 25.3 120.8 55.3 64.9 20.6 28.2 36.9 22.1 57.2 63.1 75.1 20.0 16.6 45.4 50.2 78.9 56.2 68.1 28.8 32.2 64.4 92.5 193.9 73.5 42.3 19.4 136.8 FOXB1 "FKH5, HFKH-5" ENSG00000171956 "Forkhead box B1" Q99853 15 60004234-60061730 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 34 "brain: 21.6" "Cell type enriched" "Detected in some" 4 "Early spermatids: 32.5" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.2" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 5 "T-reg: 1.1" "Lineage enriched" "Detected in single" 12 "T-cells: 1.1" "Cell line enhanced" "Detected in some" "AF22: 6.6;HDLM-2: 14.7;HEK 293: 10.7;JURKAT: 5.6" "Region enhanced" "Detected in many" "hypothalamus: 6.6" "Low region specificity" "Detected in many" HPA073369 Approved Nucleoplasm,Mitochondria NA NA "Cluster 35: T-regs - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoplasm, Mitochondria" "HPA073369: AB_2686597" "unprognostic (1.69e-1)" "unprognostic (3.33e-2)" "unprognostic (1.14e-1)" "unprognostic (7.40e-3)" "unprognostic (1.33e-3)" "unprognostic (1.17e-2)" "unprognostic (1.47e-2)" "unprognostic (5.32e-4)" "unprognostic (1.06e-1)" "unprognostic (9.21e-2)" "unprognostic (3.21e-1)" "unprognostic (8.12e-9)" "unprognostic (8.74e-2)" "unprognostic (1.74e-1)" "unprognostic (9.38e-2)" 0.0 0.0 2.0 0.0 3.0 0.0 0.0 5.4 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 21.6 0.0 0.0 0.0 0.2 9.7 8.5 0.0 0.0 0.0 0.0 0.2 5.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 8.2 0.0 0.2 0.6 9.5 0.0 0.0 0.0 0.0 0.0 0.0 4.1 2.5 0.0 6.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.7 10.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 1.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 2.0 3.0 5.4 0.8 0.2 21.6 9.7 8.5 5.8 8.2 9.5 4.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.7 0.1 0.1 0.0 0.0 32.5 7.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 3.6 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 6.8 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 4.8 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ANXA2 "ANX2, ANX2L4, CAL1H, LIP2, LPC2D" ENSG00000182718 "Annexin A2" P07355 15 60347134-60402883 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Host-virus interaction" RNA-binding "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 2185.3" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 5755.6;Pancreatic endocrine cells: 5217.8;Prostatic glandular cells: 4575.5;Urothelial cells: 4326.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 4429.7;classical monocyte: 2762.3;intermediate monocyte: 2401.9;myeloid DC: 4018.8;non-classical monocyte: 2686.5;T-reg: 1681.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "spinal cord: 174.7" "CAB004311, HPA046964, HPA061798" Enhanced Approved "Plasma membrane,Cytosol" "Secreted to blood" NA NA 19000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Plasma membrane" Cytosol "CAB004311: AB_626677, HPA046964: AB_2732537, HPA061798: AB_2732671" "unprognostic (1.61e-1)" "unprognostic (1.31e-3)" "unprognostic (1.84e-1)" "prognostic favorable (6.88e-5)" "unprognostic (4.06e-3)" "unprognostic (5.42e-3)" "prognostic unfavorable (2.54e-5)" "prognostic unfavorable (7.51e-4)" "unprognostic (2.94e-1)" "unprognostic (4.10e-3)" "prognostic unfavorable (8.47e-6)" "unprognostic (5.16e-2)" "prognostic unfavorable (2.11e-6)" "unprognostic (7.74e-2)" "unprognostic (2.55e-1)" "unprognostic (7.41e-2)" "prognostic unfavorable (6.59e-5)" 975.6 370.5 49.0 461.9 50.5 151.7 708.5 49.6 96.9 806.3 95.6 631.2 502.0 296.2 267.2 2185.3 388.4 453.9 393.0 47.6 79.4 358.3 185.5 878.3 200.7 90.0 83.6 187.0 324.3 344.0 163.9 650.4 84.9 399.3 606.1 30.2 933.4 386.4 304.8 1140.8 487.5 425.4 73.3 301.6 379.0 116.1 120.9 188.7 351.2 205.8 541.1 842.2 1256.7 80.1 4183.3 4421.4 223.6 105.5 2962.4 4744.2 971.0 4703.6 2968.4 2868.4 2534.9 2083.5 1903.6 10.0 3907.2 5983.6 2185.1 4304.9 992.9 8695.5 3113.5 846.8 103.9 78.2 1918.7 882.7 1782.0 4.5 59.9 2324.4 2278.6 2013.2 4335.0 3477.2 5455.0 58.4 320.9 447.9 6271.8 468.4 18.5 239.1 508.2 3444.1 3283.5 48.9 1198.8 226.6 5172.4 2410.7 295.1 171.9 1774.5 424.8 1942.8 2305.1 922.7 173.6 6336.8 2534.1 3406.8 8668.0 4807.4 172.6 616.3 83.8 2449.2 47.9 5206.0 4429.7 2762.3 355.0 603.8 2401.9 668.5 657.9 686.4 701.7 4018.8 412.1 77.0 313.9 73.6 287.1 2686.5 609.4 1681.4 3754.4 49.0 50.5 49.6 96.9 47.6 79.4 90.0 83.6 84.9 73.3 120.9 80.1 673.9 2141.0 414.8 0.3 101.3 2512.2 3396.9 5755.6 246.4 2.5 395.9 337.4 28.2 773.5 3086.6 560.9 0.0 1874.5 135.9 933.6 13.7 3941.4 93.0 855.9 457.1 772.0 103.4 38.7 0.2 2411.4 2714.4 1076.7 328.7 1376.3 105.7 97.5 474.0 64.2 1537.2 0.0 1.3 689.0 1668.2 429.6 1992.1 126.6 771.1 715.1 1417.6 15.9 1284.0 19.4 138.0 1.5 0.1 5217.8 920.9 638.7 144.5 4575.5 845.8 51.8 2446.8 8.1 184.1 437.7 831.1 13.0 29.3 789.7 2325.1 1150.1 224.1 8.6 749.9 4326.1 ICE2 "BRCC1, FLJ11896, NARG2" ENSG00000128915 "Interactor of little elongation complex ELL subunit 2" Q659A1 15 60419609-60479160 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 34.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040058 Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear bodies" "HPA040058: AB_10795686" "unprognostic (3.80e-1)" "unprognostic (1.72e-1)" "unprognostic (1.61e-1)" "unprognostic (5.59e-3)" "unprognostic (8.78e-3)" "unprognostic (2.71e-1)" "unprognostic (8.29e-2)" "unprognostic (2.22e-1)" "unprognostic (8.39e-3)" "unprognostic (1.68e-1)" "unprognostic (3.45e-1)" "unprognostic (3.56e-2)" "unprognostic (1.18e-2)" "unprognostic (1.06e-1)" "unprognostic (2.92e-2)" "unprognostic (1.95e-1)" "unprognostic (5.74e-2)" 5.5 5.5 3.0 6.2 4.0 5.5 8.4 4.5 3.2 5.0 5.8 4.8 4.4 8.0 5.5 6.6 6.4 6.5 5.3 2.6 3.2 6.5 7.0 4.9 9.1 3.9 3.3 9.9 6.3 34.6 4.2 7.9 4.2 6.6 7.1 4.8 6.0 5.4 4.4 5.0 5.4 6.4 3.4 7.7 5.3 6.8 3.2 12.7 9.3 5.1 9.8 6.1 3.6 6.7 14.7 25.5 21.1 20.3 15.6 16.9 11.0 8.5 13.1 13.3 14.4 20.0 10.6 25.5 18.3 9.2 25.2 27.2 28.3 11.4 18.3 30.9 12.6 25.8 17.4 11.8 8.4 28.8 17.6 8.5 13.6 11.0 19.7 17.7 22.2 24.9 39.9 23.3 16.7 6.3 22.9 7.6 26.3 26.8 17.1 27.1 16.7 22.4 10.7 18.0 23.8 22.8 12.0 12.2 15.1 24.8 19.7 14.6 10.5 18.4 16.0 15.8 26.5 11.0 31.6 37.7 12.1 32.4 17.4 4.0 4.5 5.3 5.7 6.3 9.7 7.6 7.0 7.6 5.9 10.5 9.3 9.1 0.7 4.2 5.8 4.9 8.1 6.0 3.0 4.0 4.5 3.2 2.6 3.2 3.9 3.3 4.2 3.4 3.2 6.7 32.5 19.2 19.6 34.6 30.6 0.0 20.4 0.0 16.5 31.3 24.4 27.7 20.2 15.7 17.3 20.2 39.6 22.7 32.4 8.8 21.5 12.2 15.5 25.6 27.5 25.1 19.2 28.0 39.9 10.4 14.9 21.1 25.0 21.8 29.8 70.6 29.6 20.6 14.0 30.3 42.6 16.1 0.0 16.8 0.0 17.4 25.4 21.1 0.0 49.6 25.3 19.6 25.7 49.3 83.6 14.6 13.7 17.7 15.9 23.0 11.6 18.1 19.7 33.3 0.0 31.4 17.5 22.1 34.8 21.3 0.0 14.6 31.3 39.3 19.4 19.2 RORA "NR1F1, ROR1, ROR2, ROR3, RZRA" ENSG00000069667 "RAR related orphan receptor A" P35398 15 60488284-61229302 "Disease related genes, Human disease related genes, Metabolic proteins, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Receptor" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 82.8" "Cell type enhanced" "Detected in many" "Astrocytes: 2125.3;Excitatory neurons: 627.1;Inhibitory neurons: 1056.8;Microglial cells: 757.0;Oligodendrocyte precursor cells: 1524.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Lineage enriched" "Detected in many" 4 "T-cells: 26.7" "Cell line enhanced" "Detected in many" "Karpas-707: 73.2;U-266/70: 41.7;U-266/84: 62.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009861, HPA074448" Approved Supported Nucleoli NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 64: Astrocytes - Nervous system maintenance" Nucleoli "CAB009861: AB_2180141, HPA074448: " "unprognostic (1.57e-1)" "unprognostic (4.76e-2)" "unprognostic (2.22e-1)" "unprognostic (2.92e-2)" "unprognostic (1.79e-2)" "unprognostic (1.00e-1)" "unprognostic (2.91e-3)" "unprognostic (4.08e-3)" "unprognostic (2.02e-2)" "unprognostic (1.13e-1)" "unprognostic (9.93e-2)" "unprognostic (1.34e-1)" "prognostic favorable (5.42e-6)" "unprognostic (6.94e-2)" "unprognostic (1.35e-1)" "unprognostic (2.55e-1)" "unprognostic (4.62e-2)" 8.2 38.0 19.9 6.2 11.7 17.5 13.6 51.1 13.1 10.5 10.2 6.9 2.6 6.0 4.7 17.3 6.8 9.1 7.2 3.7 12.6 12.6 28.7 11.2 6.2 7.8 36.0 9.9 14.0 10.1 7.6 2.9 5.9 5.7 3.5 37.8 8.5 5.5 41.4 82.8 6.3 5.4 4.5 9.3 6.2 13.9 49.6 4.3 12.8 20.3 7.5 5.2 9.2 4.2 0.1 0.8 2.7 0.0 3.4 1.7 0.9 1.3 1.5 1.2 1.4 1.8 0.5 0.0 0.6 3.4 3.6 0.5 6.1 2.6 2.2 2.9 5.2 0.0 0.4 2.9 1.3 0.0 0.3 7.8 0.6 3.3 0.0 1.1 11.6 11.2 0.2 73.2 5.1 0.2 0.6 0.0 2.1 1.9 1.1 0.1 2.4 1.1 2.4 0.5 1.9 4.4 0.3 0.6 0.1 7.3 0.0 0.0 0.3 10.1 4.5 4.2 0.1 41.7 62.1 0.2 17.0 0.0 1.2 0.2 0.1 0.0 23.2 0.0 26.7 1.4 17.4 16.0 0.0 0.1 5.4 11.5 0.5 6.5 0.1 0.7 16.3 4.7 19.9 11.7 51.1 13.1 3.7 12.6 7.8 36.0 5.9 4.5 49.6 4.2 32.5 41.7 31.7 2125.3 23.4 185.2 30.1 17.0 55.2 167.5 24.7 16.1 26.3 30.0 23.4 58.8 454.5 0.7 185.3 1.4 13.7 21.4 148.8 26.9 52.9 40.8 18.5 42.5 627.1 12.3 1.9 69.4 11.7 36.1 2.5 7.9 34.2 97.2 0.8 126.2 1056.8 3.3 10.2 9.1 35.8 97.1 46.6 8.3 60.5 757.0 4.7 50.4 250.3 1524.0 114.9 8.2 0.5 87.3 88.7 24.0 0.7 44.6 16.0 160.0 39.5 57.9 32.2 1.9 3.8 73.2 423.4 4.7 237.6 11.5 2.1 61.9 VPS13C "FLJ10381, FLJ20136, KIAA1421" ENSG00000129003 "Vacuolar protein sorting 13 homolog C" Q709C8 15 61852389-62060473 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 272.2;Oligodendrocytes: 291.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043507 Uncertain Approved Microtubules NA NA "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 32: U-937 - Innate immune response" "Cluster 52: Non-specific - Transcription" Microtubules "HPA043507: AB_10960840" "unprognostic (1.09e-2)" "unprognostic (5.42e-2)" "unprognostic (1.07e-1)" "unprognostic (1.94e-2)" "unprognostic (5.90e-2)" "unprognostic (2.31e-2)" "unprognostic (3.92e-1)" "unprognostic (3.18e-2)" "unprognostic (2.15e-1)" "unprognostic (1.48e-1)" "unprognostic (3.61e-1)" "unprognostic (1.79e-1)" "unprognostic (1.17e-2)" "unprognostic (3.92e-2)" "unprognostic (1.03e-1)" "unprognostic (2.01e-1)" "unprognostic (5.58e-3)" 9.3 8.3 6.0 13.3 13.8 10.5 9.6 10.2 8.4 11.7 3.1 8.9 6.8 12.0 7.6 4.1 9.4 9.1 6.7 4.4 6.9 8.9 7.2 10.9 17.7 12.9 8.3 16.9 8.6 12.3 5.5 7.9 15.2 7.9 9.1 18.8 8.0 6.1 7.1 5.7 7.7 9.4 8.3 17.8 12.8 6.1 9.9 14.6 11.5 12.8 15.1 9.1 3.5 24.6 8.2 13.9 5.2 5.5 22.8 20.1 6.1 6.4 25.4 6.2 7.5 5.8 5.3 27.9 7.4 12.5 11.6 9.3 18.8 7.2 5.5 20.1 3.4 28.3 7.9 5.4 11.3 13.7 17.6 14.3 4.8 6.7 13.9 14.0 19.2 28.1 8.9 19.5 9.9 3.5 8.1 5.4 3.4 8.7 3.7 19.0 16.1 7.5 10.5 32.5 7.7 9.4 11.5 6.6 7.0 9.1 7.2 19.9 28.9 14.0 7.8 8.5 8.2 9.8 9.4 16.3 11.1 28.8 6.8 3.7 4.2 2.5 3.3 3.1 2.8 4.9 2.7 2.7 3.0 5.3 3.0 2.5 1.1 2.2 5.4 5.9 2.3 1.2 6.0 13.8 10.2 8.4 4.4 6.9 12.9 8.3 15.2 8.3 9.9 24.6 92.5 67.3 61.6 161.6 108.5 18.6 32.3 33.1 26.7 84.9 41.8 24.5 75.2 25.8 83.2 57.0 146.0 14.8 141.1 16.7 9.8 36.7 6.4 92.9 79.6 57.3 53.0 30.7 182.8 29.6 8.3 56.2 83.1 118.9 89.7 51.8 43.2 22.7 31.3 124.5 272.2 29.9 44.7 71.0 58.1 7.3 50.4 107.2 35.6 148.9 118.5 29.6 84.5 217.1 291.3 26.7 21.0 51.6 83.9 25.2 21.6 12.3 113.1 84.5 32.9 86.5 66.9 20.8 20.4 5.9 23.3 8.2 98.8 88.2 23.9 28.3 C2CD4A "FAM148A, NLF1" ENSG00000198535 "C2 calcium dependent domain containing 4A" Q8NCU7 15 62066977-62070917 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 5.1;pituitary gland: 13.5" "Cell type enriched" "Detected in many" 5 "Glandular and luminal cells: 107.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "OE19: 34.4;RPTEC TERT1: 29.9" HPA078864 Supported Nucleoplasm,Nucleoli NA NA "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 21: OE19 - Mitochondria" "Cluster 44: Endometrium - Transcription" Nucleoplasm Nucleoli "HPA078864: " "unprognostic (3.85e-2)" "unprognostic (6.68e-2)" "unprognostic (5.00e-3)" "unprognostic (1.73e-1)" "unprognostic (1.32e-1)" "unprognostic (5.38e-3)" "unprognostic (5.49e-3)" "unprognostic (3.85e-1)" "unprognostic (1.67e-1)" "unprognostic (9.21e-2)" "unprognostic (3.89e-2)" "unprognostic (2.99e-1)" "prognostic unfavorable (4.15e-4)" "unprognostic (4.72e-2)" "unprognostic (2.07e-2)" "unprognostic (6.26e-2)" "unprognostic (3.35e-1)" 0.2 0.4 0.2 0.6 0.2 0.2 0.2 0.2 2.2 0.7 0.3 0.5 1.0 1.3 0.0 0.1 0.0 0.4 0.1 0.2 2.5 5.1 2.4 0.5 0.2 1.0 0.8 0.1 4.0 0.0 13.5 0.1 0.7 0.6 0.6 0.2 1.2 0.1 0.3 0.5 0.5 0.0 0.1 0.1 2.0 0.1 0.3 2.1 0.1 0.0 0.5 3.6 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 1.6 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.4 0.1 0.2 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.2 0.0 0.1 0.0 0.1 0.1 34.4 0.2 0.1 0.0 0.2 29.9 0.7 1.3 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.1 0.2 0.0 0.2 0.2 0.2 2.2 0.2 2.5 1.0 0.8 0.7 0.1 0.3 0.1 0.6 0.0 0.0 0.3 0.3 0.5 1.8 3.8 0.0 0.9 4.3 6.2 1.4 0.0 2.7 0.0 0.0 0.0 0.0 1.2 1.9 2.8 0.0 11.7 14.6 3.9 20.8 0.0 0.0 6.6 0.0 1.2 3.6 107.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 5.2 14.2 0.0 0.8 0.0 0.0 0.8 0.0 0.0 1.0 0.3 0.0 0.0 0.0 3.7 0.0 0.0 0.8 2.2 0.3 0.0 1.1 0.2 0.0 1.0 1.4 0.0 0.0 0.0 1.1 0.0 1.1 0.1 1.0 1.1 C2CD4B "FAM148B, NLF2" ENSG00000205502 "C2 calcium dependent domain containing 4B" A6NLJ0 15 62163535-62165285 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "pancreas: 99.3" "Cell type enhanced" "Detected in many" "Adipocytes: 169.8;Endothelial cells: 116.2;Enteroendocrine cells: 214.4;Glandular and luminal cells: 128.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HUVEC TERT2: 1.9" HPA046880 Uncertain NA NA "Cluster 25: Pancreas - Digestion" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 44: Endometrium - Transcription" "HPA046880: AB_10959458" "unprognostic (6.60e-2)" "prognostic favorable (4.22e-4)" "unprognostic (2.24e-2)" "unprognostic (1.25e-1)" "unprognostic (4.15e-1)" "unprognostic (4.06e-3)" "unprognostic (2.29e-1)" "unprognostic (5.02e-2)" "unprognostic (3.36e-2)" "unprognostic (2.33e-1)" "unprognostic (5.30e-2)" "unprognostic (1.83e-1)" "unprognostic (6.16e-3)" "unprognostic (7.89e-2)" "unprognostic (5.24e-1)" "unprognostic (8.64e-3)" "unprognostic (1.48e-1)" 23.1 1.2 1.5 0.6 1.0 3.0 19.6 0.8 1.2 7.2 0.5 2.5 2.2 4.1 0.0 1.6 2.8 1.6 6.3 0.9 0.9 5.5 1.9 13.0 0.4 1.5 1.3 1.0 99.3 0.3 6.5 0.4 1.5 2.3 0.4 0.0 1.6 0.2 2.8 4.7 2.4 0.7 1.7 0.5 24.4 1.0 2.1 2.7 2.7 1.3 0.0 5.0 2.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.0 0.8 1.2 0.9 0.9 1.5 1.3 1.5 1.7 2.1 0.9 169.8 3.2 5.5 0.0 0.1 6.8 3.0 0.1 0.6 0.8 14.5 4.3 1.3 5.7 0.9 1.8 0.0 0.0 0.9 6.1 0.0 2.1 0.0 40.4 15.2 116.2 214.4 0.0 0.0 24.0 0.0 3.2 17.9 128.9 2.5 0.0 11.4 0.4 0.4 0.0 0.1 22.5 6.1 1.0 12.1 0.0 0.0 1.3 3.6 1.9 1.6 0.1 0.0 0.0 0.0 9.8 1.3 0.0 0.1 2.4 1.3 0.0 0.1 0.6 0.0 6.8 4.1 0.1 0.4 0.8 7.0 0.0 1.7 0.5 4.3 3.5 TLN2 "ILWEQ, KIAA0320" ENSG00000171914 "Talin 2" Q9Y4G6 15 62390526-62844631 "Plasma proteins, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 38.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 153.7;Inhibitory neurons: 127.2;Microglial cells: 139.6;Oligodendrocyte precursor cells: 108.6;Oligodendrocytes: 93.6;Skeletal myocytes: 135.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 59.3;hTERT-HME1: 48.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017194, HPA051828, HPA054787" Enhanced Supported "Focal adhesion sites,Cytosol" NA NA 46000000 "Cluster 39: Non-specific - Mitochondria" "Cluster 18: U-2197 - ECM organization" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Focal adhesion sites, Cytosol" "CAB017194: , HPA051828: AB_2732570, HPA054787: AB_2732587" "prognostic favorable (6.53e-4)" "unprognostic (2.61e-1)" "unprognostic (9.47e-2)" "unprognostic (8.95e-2)" "unprognostic (3.74e-1)" "unprognostic (1.43e-1)" "unprognostic (8.24e-2)" "unprognostic (9.94e-2)" "unprognostic (1.68e-1)" "unprognostic (6.02e-2)" "unprognostic (2.81e-2)" "unprognostic (1.91e-1)" "prognostic favorable (1.81e-6)" "prognostic favorable (7.74e-4)" "unprognostic (1.34e-1)" "unprognostic (5.79e-2)" "unprognostic (2.30e-1)" 19.0 4.1 14.2 2.2 15.6 3.8 10.4 3.2 16.9 8.0 20.2 9.3 4.7 3.7 2.1 2.1 4.3 1.9 12.1 18.3 8.2 38.4 4.8 2.4 0.5 7.6 8.2 4.6 4.7 2.4 5.5 1.2 6.2 2.3 7.3 7.7 7.8 2.1 26.1 3.6 5.1 2.9 11.2 1.3 5.5 5.4 7.0 3.1 13.0 12.2 0.5 4.1 4.2 13.8 1.8 5.6 8.0 9.4 59.3 5.6 9.0 13.7 10.8 12.4 12.2 15.1 1.9 4.8 6.2 24.0 20.5 2.4 10.3 2.2 10.8 15.2 1.0 0.6 22.8 10.1 2.0 1.6 0.4 10.3 5.6 16.6 48.9 7.1 0.5 5.7 0.6 0.2 21.0 7.5 0.7 0.6 14.2 26.3 4.1 5.8 20.3 5.8 6.5 11.6 1.9 9.3 10.6 1.1 3.5 17.1 2.9 3.6 3.9 22.2 30.0 36.3 35.6 0.3 0.9 3.1 10.1 3.4 27.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 15.6 3.2 16.9 18.3 8.2 7.6 8.2 6.2 11.2 7.0 13.8 11.5 0.0 3.2 50.6 1.1 2.4 1.8 0.7 1.2 18.6 16.5 10.2 41.1 5.7 0.9 27.6 37.5 1.2 0.7 39.0 11.7 3.5 4.3 10.9 14.3 9.0 2.4 37.7 153.7 3.9 29.7 21.5 40.8 17.4 0.0 9.3 3.3 12.6 4.9 48.8 127.2 20.0 6.1 6.2 3.1 5.2 11.8 5.5 0.0 139.6 0.8 11.1 1.0 108.6 93.6 3.7 21.0 15.8 0.7 1.5 14.6 35.1 0.1 48.3 0.0 135.6 12.3 6.7 24.5 3.1 1.6 1.4 1.3 25.8 37.7 1.7 TPM1 "C15orf13, CMH3" ENSG00000140416 "Tropomyosin 1" P09493 15 63042632-63071915 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Actin-binding, Muscle protein" "Cancer-related genes, Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 10621.0;skeletal muscle: 12678.0;tongue: 5183.6" "Cell type enriched" "Detected in all" 4 "Cardiomyocytes: 13012.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 48.7" "Group enriched" "Detected in all" 4 "dendritic cells: 14.1;granulocytes: 48.7;monocytes: 19.2" "Cell line enhanced" "Detected in all" "hTERT-RPE1: 3141.3;SuSa: 3810.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000261, HPA009066, CAB017698, HPA047089, HPA053624" Supported Approved "Actin filaments,Cytosol" NA NA 120000000 "Cluster 38: Basophils - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 12: NES - Nervous system development" "Cluster 54: Cardiomyocytes - Muscle contraction" "Actin filaments" Cytosol "CAB017698: AB_2272017, HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: AB_2679928, HPA053624: AB_2682210" "unprognostic (1.07e-1)" "unprognostic (4.20e-2)" "unprognostic (1.00e-2)" "unprognostic (6.20e-2)" "unprognostic (1.28e-1)" "unprognostic (1.45e-2)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (1.35e-2)" "unprognostic (3.27e-1)" "unprognostic (1.27e-2)" "unprognostic (1.20e-1)" "unprognostic (1.66e-3)" "unprognostic (3.38e-2)" "unprognostic (1.78e-1)" "unprognostic (5.53e-2)" "prognostic unfavorable (7.30e-4)" 372.0 103.6 49.8 232.9 53.2 21.6 348.8 52.4 53.9 577.4 59.3 2947.3 289.6 1566.9 250.5 639.0 823.8 288.0 10621.0 53.3 42.2 215.5 94.8 247.1 48.1 42.5 44.3 320.3 383.4 37.5 70.6 206.4 43.7 809.6 523.1 83.9 258.2 1545.5 12678.0 150.7 680.8 1754.9 44.8 134.3 976.5 52.3 50.0 21.1 156.8 5183.6 29.4 1511.0 425.8 42.2 554.5 357.3 418.1 20.9 143.1 89.9 1335.5 1509.1 552.8 905.9 669.2 253.9 107.6 1.7 677.7 1517.1 602.7 295.9 361.8 243.4 597.0 14.5 50.9 81.2 376.3 124.5 403.3 3.8 17.9 125.7 138.0 742.1 198.2 3141.3 243.2 14.7 8.7 20.4 695.3 286.4 25.6 7.1 496.0 129.0 61.1 9.0 146.5 15.8 1308.7 298.8 101.1 71.7 180.9 284.4 65.1 3810.3 204.8 15.3 1095.8 1178.8 572.0 181.6 1094.8 5.9 4.3 7.8 335.9 22.4 842.1 48.7 9.9 4.8 4.0 19.2 3.1 5.5 3.6 4.3 14.1 5.6 4.0 3.6 10.7 1.9 14.3 2.4 6.3 15.6 49.8 53.2 52.4 53.9 53.3 42.2 42.5 44.3 43.7 44.8 50.0 42.2 542.3 57.7 86.3 19.9 12.1 71.9 202.0 344.1 18.2 49.0 450.1 953.1 13012.4 346.0 147.0 318.2 383.7 212.1 20.6 561.3 187.9 2502.6 6.5 147.2 614.4 294.3 267.7 137.0 44.2 1671.1 3094.8 557.1 279.3 211.2 52.0 85.3 175.6 138.1 201.5 52.2 53.2 964.7 183.1 42.5 72.1 27.3 205.0 114.3 81.8 111.5 47.5 47.4 28.8 36.2 6.0 2372.3 623.4 1130.3 8.8 244.3 724.7 361.1 104.2 447.5 1038.7 484.0 1685.9 27.4 82.2 29.4 50.4 103.0 29.0 130.7 385.3 198.2 LACTB "FLJ14902, MRPL56" ENSG00000103642 "Lactamase beta" P83111 15 63121833-63142061 "Enzymes, Predicted intracellular proteins" "Lipid metabolism" "Hydrolase, Protease" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "monocytes: 152.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036361, HPA036362" Supported Supported Mitochondria "Intracellular and membrane" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 3: Monocytes - Immune response regulation" Mitochondria "HPA036361: AB_10672244, HPA036362: AB_10670798" "unprognostic (6.07e-2)" "unprognostic (2.02e-1)" "unprognostic (2.22e-2)" "unprognostic (2.87e-1)" "unprognostic (1.20e-2)" "unprognostic (3.10e-2)" "unprognostic (8.08e-2)" "unprognostic (6.25e-2)" "unprognostic (8.98e-2)" "unprognostic (3.08e-1)" "unprognostic (6.22e-3)" "unprognostic (5.16e-3)" "unprognostic (6.28e-2)" "unprognostic (3.24e-1)" "unprognostic (8.64e-2)" "unprognostic (7.90e-2)" "unprognostic (3.88e-3)" 17.3 25.4 7.1 21.2 7.4 57.0 12.5 7.2 8.0 8.4 10.8 18.5 19.6 7.6 8.4 14.9 7.0 14.3 22.2 7.2 7.3 23.6 42.4 19.0 19.8 7.3 7.5 8.1 10.6 9.9 6.7 11.8 7.4 9.2 15.9 4.7 9.9 6.8 49.2 12.0 16.9 9.0 7.2 18.3 12.8 22.1 8.3 9.1 9.3 36.3 13.2 19.7 9.2 8.4 60.3 37.0 10.4 7.3 51.9 27.4 8.7 25.7 39.4 43.3 79.9 9.3 37.5 8.0 31.0 37.5 46.9 16.6 35.6 16.7 54.2 55.1 8.9 15.6 12.2 23.7 48.0 14.2 26.1 37.3 35.1 44.5 36.4 64.9 45.2 46.4 14.9 22.1 74.7 22.6 10.9 17.3 15.6 36.7 11.7 8.0 26.6 18.5 23.6 92.5 9.3 4.4 18.6 20.7 59.0 36.0 15.9 23.4 81.5 57.8 44.8 26.2 32.9 23.3 21.8 2.2 44.3 39.2 27.3 4.4 8.4 4.4 1.1 8.3 1.8 3.1 0.9 0.9 9.8 2.6 0.8 1.4 5.3 2.1 7.3 0.8 3.0 2.2 7.1 7.4 7.2 8.0 7.2 7.3 7.3 7.5 7.4 7.2 8.3 8.4 24.6 25.6 22.6 4.9 25.7 58.2 27.2 12.0 19.9 6.5 21.7 16.1 42.5 22.8 10.9 12.9 12.5 15.8 19.3 26.0 25.4 56.0 62.9 13.2 16.4 31.1 7.3 10.8 12.5 43.1 40.5 26.4 17.3 19.3 66.5 12.1 8.9 57.0 88.6 8.4 14.5 27.1 16.2 71.3 72.5 30.6 14.3 97.0 26.6 15.9 152.9 6.9 7.2 10.1 8.1 75.0 19.0 16.1 21.3 35.6 25.2 79.2 9.2 11.3 6.6 37.9 31.5 122.9 25.6 26.3 60.0 18.1 21.8 23.9 20.4 39.6 RPS27L ENSG00000185088 "Ribosomal protein S27 like" Q71UM5 15 63125872-63158021 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 2535.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA066851 Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 29: Non-specific - Vesicular transport" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 10: Non-specific - Unknown function" "Endoplasmic reticulum, Cytosol" Nucleoli "HPA066851: AB_2685737" "unprognostic (4.62e-2)" "unprognostic (5.81e-2)" "unprognostic (1.38e-1)" "prognostic favorable (9.08e-6)" "unprognostic (1.75e-1)" "unprognostic (7.24e-2)" "unprognostic (1.42e-3)" "unprognostic (2.98e-1)" "unprognostic (6.38e-2)" "unprognostic (1.80e-1)" "unprognostic (2.19e-3)" "unprognostic (2.51e-1)" "unprognostic (1.97e-2)" "unprognostic (5.31e-2)" "unprognostic (1.36e-1)" "unprognostic (1.97e-3)" "unprognostic (5.10e-3)" 142.2 242.4 78.6 71.3 80.6 73.2 127.1 81.5 113.1 124.7 102.5 190.8 157.4 108.4 157.9 70.8 117.9 94.8 181.0 78.1 84.2 194.5 266.0 109.4 83.5 82.9 81.7 95.9 247.4 94.0 88.6 69.3 84.5 156.2 178.0 31.8 164.7 106.7 190.1 75.9 161.4 80.7 86.0 103.2 174.7 38.1 81.4 86.3 106.5 97.7 68.2 149.2 94.1 90.0 140.4 383.0 340.4 92.9 486.4 571.3 341.3 432.1 306.0 93.8 225.3 71.1 190.0 130.8 150.9 415.9 166.0 52.9 116.5 212.9 155.7 97.8 157.5 108.3 329.1 512.7 558.7 86.8 287.0 452.1 279.0 211.2 158.4 701.2 535.2 81.2 101.6 127.7 785.1 194.1 112.4 134.9 101.0 178.0 112.6 86.9 163.1 149.5 266.7 278.8 49.2 74.7 157.6 65.8 326.2 677.8 145.4 199.1 571.1 490.6 463.8 106.7 195.3 142.3 132.3 117.5 518.5 235.6 453.8 263.8 132.5 164.6 99.4 145.2 125.2 132.0 149.9 118.1 122.0 105.2 116.9 119.4 44.3 110.9 198.2 121.3 305.2 166.0 78.6 80.6 81.5 113.1 78.1 84.2 82.9 81.7 84.5 86.0 81.4 90.0 210.9 96.1 198.6 9.4 255.9 255.4 262.6 424.8 230.5 33.4 361.3 429.1 349.0 511.9 424.6 410.1 47.9 300.1 144.9 694.7 903.9 802.7 60.9 202.3 185.3 245.8 285.4 184.5 12.6 782.4 1269.2 269.2 327.8 155.5 302.6 250.8 302.0 994.8 542.1 13.5 15.6 742.3 520.8 372.1 358.1 34.4 314.7 270.3 466.0 17.8 1049.6 184.8 221.4 16.1 18.5 1019.3 745.5 297.5 495.5 324.6 1513.1 2535.3 330.9 75.2 263.0 180.5 742.6 144.7 82.1 183.6 247.6 235.2 224.7 214.3 732.5 215.2 RAB8B ENSG00000166128 "RAB8B, member RAS oncogene family" Q92930 15 63189560-63267776 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 81.1" "Cell type enhanced" "Detected in all" "Early spermatids: 220.6;Langerhans cells: 195.6;Late spermatids: 399.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 125.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 4700000 "Cluster 38: Basophils - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 17: WM-115 - Nervous system development" "Cluster 24: Non-specific - Transcription regulation" "unprognostic (7.67e-2)" "unprognostic (3.33e-2)" "unprognostic (2.75e-1)" "unprognostic (1.32e-1)" "unprognostic (5.20e-2)" "unprognostic (4.01e-2)" "unprognostic (1.46e-2)" "unprognostic (5.94e-2)" "unprognostic (3.19e-1)" "unprognostic (2.75e-2)" "unprognostic (1.71e-2)" "unprognostic (4.17e-1)" "prognostic unfavorable (2.44e-4)" "unprognostic (1.97e-2)" "unprognostic (3.14e-2)" "unprognostic (4.19e-2)" "unprognostic (7.47e-2)" 26.7 14.7 10.6 30.0 12.3 81.1 13.3 11.0 13.1 19.3 14.3 12.5 18.8 17.7 8.4 13.5 10.8 24.4 12.6 12.7 12.2 12.6 15.3 22.4 43.2 10.1 12.3 32.0 7.4 7.7 5.7 30.3 11.5 14.6 11.5 12.0 7.1 10.0 5.4 7.4 17.5 18.7 13.4 34.4 13.2 15.9 13.0 37.8 21.6 10.1 38.9 27.9 9.3 15.3 13.9 12.0 43.4 18.6 82.1 67.0 12.9 13.3 30.3 24.1 46.5 12.7 11.6 38.2 11.8 29.6 26.3 7.0 37.5 18.0 40.8 54.9 7.4 45.4 9.9 8.4 76.1 17.9 28.0 40.8 9.5 45.2 26.7 31.0 60.4 37.1 19.1 36.2 44.3 9.4 27.5 10.3 27.6 12.8 11.2 24.7 57.3 5.6 19.5 66.7 3.8 9.4 20.1 2.8 39.0 27.5 9.4 19.0 68.6 44.8 27.1 24.2 18.2 23.1 24.0 34.6 28.7 50.4 125.5 62.1 26.3 22.4 26.5 23.3 23.6 18.8 20.9 25.9 18.1 17.3 15.8 20.2 56.4 25.0 22.7 2.4 35.7 30.0 10.6 12.3 11.0 13.1 12.7 12.2 10.1 12.3 11.5 13.4 13.0 15.3 32.9 19.2 13.7 18.9 71.8 31.1 7.8 18.8 12.5 2.2 14.8 10.3 5.4 11.5 12.4 7.3 12.5 13.8 140.6 2.4 11.7 37.4 220.6 4.3 28.2 29.5 10.7 19.1 23.7 13.5 102.8 58.9 14.3 8.1 39.3 11.2 33.5 6.6 56.1 20.2 45.4 4.1 14.2 76.9 195.6 399.8 31.7 79.3 35.6 40.3 142.7 13.9 97.9 64.3 62.9 33.3 1.1 38.0 37.6 11.7 11.4 32.8 10.3 14.8 19.7 15.8 29.3 71.3 17.2 7.7 22.4 37.4 105.0 16.3 3.4 22.5 APH1B "APH-1B, DKFZp564D0372, PSFL" ENSG00000138613 "Aph-1 homolog B, gamma-secretase subunit" Q8WW43 15 63276018-63309126 "Predicted membrane proteins, Transporters" "Notch signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "testis: 122.8" "Group enriched" "Detected in many" 15 "Early spermatids: 1363.2;Late spermatids: 359.9;Spermatocytes: 838.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "non-classical monocyte: 107.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 78: Testis - Spermatogenesis" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 66: Spermatocytes - Spermatogenesis" "unprognostic (9.92e-2)" "unprognostic (1.03e-2)" "unprognostic (1.49e-1)" "unprognostic (1.75e-1)" "unprognostic (3.55e-2)" "unprognostic (3.57e-1)" "unprognostic (7.86e-2)" "unprognostic (1.78e-1)" "unprognostic (3.86e-1)" "unprognostic (4.56e-2)" "prognostic favorable (1.05e-4)" "unprognostic (8.44e-2)" "prognostic favorable (2.25e-4)" "unprognostic (4.29e-3)" "unprognostic (2.54e-1)" "unprognostic (1.01e-1)" "unprognostic (1.62e-1)" 10.1 12.1 9.4 9.7 10.9 8.1 10.6 9.8 10.8 8.4 10.9 6.0 3.8 6.9 11.6 3.8 16.2 7.5 5.7 8.2 10.0 7.7 3.4 8.8 10.1 10.6 11.8 14.6 4.5 7.4 6.9 8.1 10.7 11.7 4.4 12.2 8.2 8.0 4.0 5.4 7.7 6.4 11.6 13.6 5.1 122.8 10.3 9.7 19.5 5.6 7.8 7.7 6.7 12.7 1.3 8.8 9.3 7.5 20.7 36.2 3.3 11.2 22.6 8.3 13.9 8.1 12.3 11.1 5.2 12.4 15.4 1.2 15.8 4.4 15.5 7.6 2.5 19.6 1.9 0.3 17.1 4.3 30.9 22.8 7.0 12.3 8.3 14.1 17.6 13.9 6.7 8.0 26.1 3.9 5.9 13.2 8.8 2.8 4.6 5.7 5.1 0.2 4.3 8.9 8.1 4.4 4.5 3.7 0.1 9.8 13.6 25.1 11.8 24.5 9.4 4.0 1.6 19.6 35.3 15.2 17.8 25.1 14.6 32.0 31.8 41.4 10.7 63.1 9.0 24.1 10.8 9.7 15.3 18.0 11.8 12.0 44.1 6.2 107.5 5.5 11.7 18.6 9.4 10.9 9.8 10.8 8.2 10.0 10.6 11.8 10.7 11.6 10.3 12.7 8.4 9.6 18.8 16.3 21.7 5.2 12.4 15.5 5.7 6.8 16.2 13.7 6.1 11.5 15.9 22.0 2.1 6.3 10.4 1.0 1.9 36.9 1363.2 25.6 12.7 12.0 20.4 5.0 18.1 6.2 38.7 18.1 4.6 4.5 22.8 12.5 17.9 1.7 55.7 1.7 22.9 4.1 22.4 52.0 17.7 359.9 24.5 41.8 10.6 16.9 29.6 21.4 6.2 27.2 28.9 11.1 0.8 16.6 16.3 8.9 0.7 6.8 38.6 14.8 13.1 12.6 15.5 838.0 20.0 2.3 3.4 6.0 14.5 16.4 2.8 9.0 CA12 HsT18816 ENSG00000074410 "Carbonic anhydrase 12" O43570 15 63321378-63381846 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins" Lyase "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 290.2;skin 1: 142.1" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 174.6;Distal enterocytes: 422.6;Paneth cells: 160.8;Squamous epithelial cells: 185.3;Suprabasal keratinocytes: 252.2;Undifferentiated cells: 138.8" "Cancer enhanced" "Detected in all" "renal cancer: 109.3" "Region enhanced" "Detected in many" "basal ganglia: 42.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 213.0;ASC TERT1: 213.0;RT4: 226.2;SK-BR-3: 177.9;T-47d: 286.8;U-138 MG: 300.5;U-87 MG: 361.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008773, CAB025181, CAB062549, CAB068179, HPA073203" Enhanced NA NA 52000 "Cluster 7: Kidney - Transmembrane transport" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 53: Intestinal epithelial cells - Unknown function" "CAB025181: , CAB062549: AB_2665617, CAB068179: AB_2665616, HPA008773: AB_1078394, HPA073203: AB_2686580" "unprognostic (2.01e-1)" "unprognostic (8.38e-3)" "unprognostic (3.47e-1)" "unprognostic (3.25e-3)" "unprognostic (2.73e-2)" "unprognostic (2.47e-2)" "unprognostic (7.48e-2)" "unprognostic (3.43e-3)" "unprognostic (2.29e-1)" "unprognostic (4.67e-2)" "prognostic unfavorable (3.80e-6)" "unprognostic (2.59e-1)" "unprognostic (1.51e-1)" "unprognostic (2.38e-1)" "unprognostic (6.56e-2)" "unprognostic (7.26e-2)" "unprognostic (1.21e-1)" 8.3 0.2 6.1 18.7 42.9 0.1 42.8 5.2 7.2 50.7 129.0 104.1 0.4 28.4 4.1 75.4 25.0 7.7 3.2 6.8 6.6 290.2 0.7 3.0 0.3 0.9 9.6 0.6 70.2 0.3 10.7 2.3 3.2 5.5 94.2 1.9 26.3 8.7 0.6 142.1 8.2 56.2 0.9 0.8 7.9 0.6 16.1 0.1 4.6 0.1 8.7 27.4 49.0 1.5 0.0 213.0 3.5 0.5 27.3 213.0 11.2 15.7 13.7 2.5 4.1 1.6 0.5 0.0 51.4 12.6 81.7 1.1 0.0 10.4 6.2 0.3 7.7 0.0 13.9 0.4 0.6 0.0 0.3 81.3 11.4 63.6 20.4 0.1 2.7 0.1 0.0 0.3 2.8 125.2 0.3 0.2 3.4 0.0 33.4 0.1 0.0 0.1 0.2 226.2 1.8 0.2 0.9 177.9 0.0 2.1 286.8 0.1 0.4 300.5 16.0 10.1 0.2 0.0 0.0 0.1 361.6 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 42.9 5.2 7.2 6.8 6.6 0.9 9.6 3.2 0.9 16.1 1.5 0.7 0.0 6.9 11.4 1.1 174.6 20.0 87.7 93.4 0.1 93.5 50.4 1.3 1.5 30.3 40.5 0.0 0.4 1.6 422.6 54.8 17.2 12.1 28.4 6.2 2.1 8.4 0.0 1.3 58.4 2.0 14.6 8.2 75.0 1.3 0.3 0.0 0.2 0.6 0.0 0.8 111.4 20.3 0.3 11.9 3.9 0.0 4.0 23.2 0.0 0.0 2.7 0.0 1.0 0.1 10.2 160.8 0.0 0.0 19.8 15.6 73.9 6.9 0.2 0.0 0.2 4.1 0.0 0.0 185.3 252.2 1.8 2.8 0.1 138.8 17.4 USP3 ENSG00000140455 "Ubiquitin specific peptidase 3" Q9Y6I4 15 63504511-63594640 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, Ubl conjugation pathway" "Chromatin regulator, Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 36.4" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053275, HPA060513, HPA077975" Supported "Nucleoplasm,Midbody ring" "Intracellular and membrane" Yes No "Cluster 1: Neutrophils - Mixed function" "Cluster 50: Non-specific - Ribosome" "Cluster 15: RT4 - Unknown function" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Nucleoplasm "Midbody ring" "HPA053275: AB_2682096, HPA060513: AB_2684299, HPA077975: AB_2732365" "unprognostic (4.63e-3)" "unprognostic (2.71e-1)" "unprognostic (7.88e-2)" "unprognostic (3.33e-2)" "unprognostic (2.16e-2)" "unprognostic (6.03e-2)" "unprognostic (6.26e-2)" "unprognostic (4.52e-2)" "unprognostic (1.62e-2)" "unprognostic (2.36e-1)" "unprognostic (3.54e-2)" "unprognostic (4.87e-2)" "unprognostic (1.17e-1)" "unprognostic (8.61e-2)" "unprognostic (2.78e-1)" "unprognostic (6.21e-2)" "prognostic favorable (1.38e-4)" 12.7 8.2 5.8 5.4 7.0 21.4 11.2 36.4 5.9 11.7 15.4 13.4 6.5 12.9 4.7 10.9 10.9 5.4 6.0 5.3 6.3 10.1 8.2 13.2 6.5 6.9 6.9 16.2 18.9 3.1 6.2 2.7 7.6 10.4 5.6 6.3 12.4 6.0 10.0 14.6 13.9 4.5 5.3 17.6 15.7 5.3 8.6 7.4 9.1 3.6 6.4 12.4 11.9 7.5 10.4 21.0 12.1 8.1 5.5 7.6 8.2 6.7 9.6 7.1 5.8 6.6 13.1 8.7 15.3 9.3 3.6 12.0 11.6 11.1 5.6 12.2 5.8 10.4 8.6 9.8 6.8 6.4 11.4 11.3 7.8 7.7 10.6 8.9 12.4 17.3 9.5 9.0 3.3 5.2 11.0 8.8 16.2 13.7 5.3 22.2 8.4 11.3 4.5 23.8 9.6 9.5 3.3 13.0 6.7 7.8 5.5 9.5 13.4 7.2 16.9 3.3 10.3 9.3 24.4 18.2 7.4 13.8 7.5 120.0 84.7 12.7 24.8 66.0 28.4 34.1 34.3 26.0 59.8 34.8 34.0 25.2 169.1 19.8 65.4 13.1 28.1 45.2 5.8 7.0 36.4 5.9 5.3 6.3 6.9 6.9 7.6 5.3 8.6 7.5 23.6 38.5 69.2 76.7 63.4 52.6 34.3 24.8 23.3 31.4 27.9 20.3 9.2 25.8 41.4 16.5 12.5 19.8 48.4 37.6 41.1 41.0 21.6 37.8 32.8 26.0 43.8 15.8 11.2 37.2 57.3 28.3 39.8 74.6 27.1 64.5 11.4 24.0 24.8 13.5 40.0 35.4 30.5 78.4 109.6 77.4 15.8 74.5 42.7 75.9 101.8 25.9 41.2 80.4 40.6 39.8 35.6 18.4 69.7 40.6 33.2 28.3 33.3 17.9 13.1 25.3 34.5 14.8 40.3 33.9 59.0 34.1 64.6 40.1 40.6 37.6 FBXL22 "Fbl22, FLJ39626" ENSG00000197361 "F-box and leucine rich repeat protein 22" Q6P050 15 63597353-63602428 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 60.4;intestine: 60.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "MCF7: 4.9;SCLC-21H: 5.3;U-937: 3.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA047624, HPA054627" Uncertain Uncertain Nucleoli,Cytosol NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 48: Smooth muscle cells - ECM organization" "Nucleoli, Cytosol" "HPA047624: AB_2680107, HPA054627: AB_2682548" "unprognostic (2.17e-1)" "unprognostic (3.19e-2)" "unprognostic (2.99e-3)" "unprognostic (5.28e-2)" "unprognostic (3.03e-2)" "unprognostic (1.29e-2)" "unprognostic (1.15e-1)" "unprognostic (6.51e-2)" "unprognostic (2.53e-1)" "unprognostic (1.65e-1)" "unprognostic (2.82e-2)" "unprognostic (1.34e-1)" "unprognostic (1.07e-3)" "unprognostic (1.90e-2)" "unprognostic (1.99e-1)" "unprognostic (1.01e-2)" "unprognostic (1.02e-2)" 3.6 0.9 1.9 2.8 1.7 0.3 1.8 2.7 2.0 15.7 0.2 60.1 2.9 60.4 3.6 7.0 21.2 8.8 17.2 1.6 1.3 1.0 0.5 1.1 0.9 0.8 1.1 4.5 0.7 0.6 0.7 0.9 0.9 16.9 4.8 0.6 3.2 29.4 4.9 1.4 7.3 28.9 0.5 0.6 11.1 3.0 1.8 0.4 1.5 1.8 0.2 26.3 10.1 1.0 0.7 1.2 0.2 0.8 0.5 0.5 0.1 0.2 0.0 0.3 0.0 0.8 0.9 0.3 0.7 0.2 0.4 0.8 0.6 0.4 0.0 0.8 0.6 0.3 1.1 2.2 0.1 0.4 0.1 0.2 0.2 0.1 0.5 0.1 0.2 2.2 0.0 1.1 0.0 4.9 0.7 0.7 1.7 0.8 0.4 0.7 0.0 2.4 0.3 0.3 5.3 0.2 0.6 1.0 0.3 0.0 1.9 0.6 0.8 0.3 1.0 0.5 0.2 0.7 1.5 0.8 0.5 3.7 0.8 0.2 0.0 0.0 0.5 0.0 0.5 0.6 0.6 0.6 0.0 0.4 1.0 0.4 0.1 0.7 0.0 1.6 0.0 0.2 1.9 1.7 2.7 2.0 1.6 1.3 0.8 1.1 0.9 0.5 1.8 1.0 1.4 0.0 0.0 1.0 3.4 0.1 1.8 0.4 0.6 10.1 4.7 8.6 7.7 2.8 0.7 7.3 4.2 0.7 2.7 2.3 9.8 1.2 0.9 3.2 5.8 1.3 4.9 2.5 1.5 1.1 1.2 3.4 7.7 5.8 0.0 0.9 3.9 4.0 0.7 0.0 1.8 6.1 0.0 1.6 0.4 0.5 0.3 1.7 0.0 0.0 0.7 10.6 2.1 1.5 0.5 0.8 3.0 11.3 9.1 1.7 1.9 4.0 0.1 3.8 0.0 6.2 8.1 3.8 3.2 4.4 0.9 0.5 4.4 2.7 4.0 0.8 HERC1 "p532, p619" ENSG00000103657 "HECT and RLD domain containing E3 ubiquitin protein ligase family member 1" Q15751 15 63608618-63833948 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Transport, Ubl conjugation pathway" "Guanine-nucleotide releasing factor, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 458.8;Inhibitory neurons: 338.0;Oligodendrocytes: 201.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049749 Uncertain NA NA "Cluster 17: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA049749: AB_2680866" "unprognostic (9.72e-2)" "unprognostic (7.51e-2)" "unprognostic (3.43e-1)" "unprognostic (3.80e-1)" "unprognostic (2.35e-1)" "prognostic favorable (4.87e-5)" "unprognostic (1.53e-1)" "unprognostic (2.15e-2)" "unprognostic (3.02e-2)" "unprognostic (2.89e-3)" "prognostic favorable (3.66e-4)" "unprognostic (1.24e-1)" "prognostic favorable (1.36e-6)" "unprognostic (2.87e-1)" "unprognostic (3.36e-2)" "unprognostic (9.04e-3)" "unprognostic (3.94e-1)" 10.5 7.4 8.6 10.3 10.1 27.4 12.7 14.1 20.3 13.0 5.2 11.8 5.3 10.8 6.5 8.1 7.6 9.6 15.2 9.3 0.0 9.1 9.1 10.6 13.7 1.7 0.3 18.5 8.4 22.7 8.8 10.3 1.8 8.6 9.2 18.3 8.8 10.3 30.4 12.1 9.9 12.4 0.0 15.2 10.2 11.5 0.0 25.6 14.0 29.3 12.8 9.2 7.9 22.7 13.5 17.1 19.1 6.6 33.3 21.1 6.4 10.3 13.4 10.7 12.3 10.9 5.3 19.8 9.3 19.8 9.7 14.5 31.2 9.0 14.6 15.4 9.6 42.5 26.4 7.8 5.3 31.6 25.1 15.3 8.5 15.1 14.5 9.3 22.7 13.3 44.0 8.6 9.4 21.7 11.3 6.5 9.3 10.4 8.7 12.2 20.6 11.6 4.4 32.9 17.0 8.4 18.2 12.5 10.5 23.0 6.1 12.7 23.6 13.6 12.6 11.9 13.6 9.4 17.4 13.3 7.8 23.3 4.9 24.4 3.8 8.7 4.9 3.4 3.7 5.9 5.5 4.6 3.4 9.5 5.5 5.4 13.5 2.9 6.7 7.5 7.8 1.8 8.6 10.1 14.1 20.3 9.3 0.0 1.7 0.3 1.8 0.0 0.0 22.7 66.0 6.4 39.5 113.0 44.2 14.9 10.6 16.1 17.1 65.3 19.7 17.1 64.8 17.2 19.9 22.0 66.7 8.8 66.1 11.4 1.9 11.0 28.7 13.5 24.0 44.5 10.2 47.5 458.8 14.1 15.1 28.5 34.7 17.8 50.6 36.5 47.2 21.0 16.2 85.8 338.0 13.1 10.2 43.2 27.4 14.3 27.7 39.2 19.6 137.7 36.0 29.9 35.0 160.4 201.5 11.7 14.7 39.9 44.9 12.7 12.5 15.7 16.6 55.0 6.6 34.4 36.0 43.5 31.3 17.1 15.3 8.9 61.1 31.9 14.4 12.1 DAPK2 "DRP-1, MGC119312" ENSG00000035664 "Death associated protein kinase 2" Q9UIK4 15 63907036-64072033 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 50.2;thyroid gland: 41.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 86.6;Late spermatids: 112.5;Oligodendrocytes: 99.9;Proximal enterocytes: 64.0" "Cancer enriched" "Detected in many" 15 "thyroid cancer: 30.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 14 "basophil: 94.3;eosinophil: 213.0;neutrophil: 65.9" "Lineage enriched" "Detected in many" 25 "granulocytes: 213.0" "Cell line enhanced" "Detected in many" "ASC diff: 10.6;HaCaT: 9.2;HMC-1: 18.3;MCF7: 9.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA071581 Supported "Golgi apparatus,Vesicles" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 3: HMC-1 - Innate immune response" "Cluster 31: Spermatids - Spermatogenesis" "Golgi apparatus, Vesicles" "HPA071581: AB_2686421" "unprognostic (3.20e-2)" "unprognostic (4.07e-2)" "unprognostic (4.23e-2)" "unprognostic (1.95e-3)" "unprognostic (2.88e-2)" "unprognostic (1.30e-2)" "unprognostic (2.32e-1)" "prognostic favorable (5.63e-4)" "unprognostic (1.04e-1)" "unprognostic (3.18e-1)" "unprognostic (9.21e-2)" "unprognostic (8.51e-2)" "unprognostic (4.77e-7)" "unprognostic (5.98e-2)" "unprognostic (1.45e-1)" "unprognostic (3.20e-3)" "unprognostic (9.07e-2)" 12.5 2.2 5.9 2.7 7.6 15.9 8.8 5.9 8.1 6.7 4.3 9.8 20.6 1.6 0.2 3.3 1.7 1.5 28.0 5.5 6.7 4.5 2.0 20.0 3.1 6.2 6.8 0.9 2.7 0.9 1.6 0.4 6.6 5.1 6.6 0.4 7.5 3.6 50.2 8.1 21.3 1.7 6.0 7.8 9.9 3.1 6.6 1.5 41.9 19.6 2.6 2.4 9.5 9.5 3.1 2.3 6.1 1.5 10.6 0.5 0.0 2.1 6.7 1.1 1.2 1.0 1.6 0.2 0.7 6.7 3.7 9.2 3.8 0.1 0.6 0.2 0.2 1.3 4.5 0.1 0.1 0.1 18.3 1.1 7.9 0.4 0.2 7.0 0.7 0.1 0.4 0.1 0.7 9.7 0.0 0.4 0.7 3.1 2.2 2.9 0.0 0.3 0.0 3.2 0.4 0.3 0.4 1.2 0.0 1.5 5.2 0.4 0.4 0.9 1.0 1.4 1.8 0.6 0.2 0.0 0.0 3.0 0.3 94.3 0.2 213.0 2.1 0.1 0.9 1.3 0.6 2.2 0.2 0.4 0.0 1.4 65.9 2.7 0.1 8.6 0.1 1.3 5.9 7.6 5.9 8.1 5.5 6.7 6.2 6.8 6.6 6.0 6.6 9.5 24.9 86.6 22.3 5.2 4.8 11.6 7.0 8.7 0.6 0.1 9.4 7.4 46.2 1.5 14.6 0.0 0.0 0.1 22.6 45.2 1.9 9.1 25.3 3.0 1.6 6.4 8.4 0.8 15.9 35.6 0.2 8.7 16.3 7.8 15.2 1.3 5.7 1.3 0.4 5.0 2.1 17.0 6.1 1.3 0.8 112.5 3.1 3.2 0.0 15.0 0.3 2.1 2.1 11.1 99.9 9.4 30.6 5.7 0.4 12.0 64.0 0.3 2.8 0.3 13.1 7.6 4.5 2.6 4.9 0.5 4.1 0.1 14.9 1.9 19.6 14.0 CIAO2A "CIA2A, FAM96A, FLJ22875" ENSG00000166797 "Cytosolic iron-sulfur assembly component 2A" Q9H5X1 15 64072565-64093857 "Predicted intracellular proteins" "Chromosome partition" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 262.4" "Group enriched" "Detected in some" 9 "Cardiomyocytes: 74.8;Cytotrophoblasts: 116.5;Extravillous trophoblasts: 100.6;Hofbauer cells: 218.2;Syncytiotrophoblasts: 88.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040459, HPA063729" Approved Enhanced Nucleoplasm,Cytosol "Intracellular and membrane" No No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 8: Non-specific - Mitochondria" "Cluster 32: U-937 - Innate immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Cytosol" "HPA040459: AB_10796456, HPA063729: AB_2685105" "unprognostic (1.15e-1)" "unprognostic (8.49e-2)" "unprognostic (6.59e-2)" "unprognostic (3.58e-1)" "unprognostic (1.30e-1)" "unprognostic (8.07e-2)" "unprognostic (4.06e-3)" "unprognostic (5.02e-2)" "unprognostic (7.16e-2)" "unprognostic (5.87e-2)" "unprognostic (1.04e-1)" "unprognostic (6.48e-3)" "unprognostic (8.06e-3)" "unprognostic (1.81e-1)" "unprognostic (2.58e-1)" "unprognostic (2.11e-2)" "unprognostic (1.50e-2)" 27.8 68.6 23.1 53.6 26.0 70.7 48.5 25.7 26.7 31.5 39.1 82.8 107.9 22.6 41.1 30.1 32.1 43.0 78.0 22.0 24.6 81.3 262.4 43.4 105.3 26.1 24.0 20.6 59.8 75.5 24.6 65.5 26.6 39.1 68.4 24.7 44.0 26.8 125.5 19.4 86.8 23.8 26.4 52.8 68.8 20.7 26.9 60.3 80.2 97.4 66.9 46.3 20.3 32.0 114.6 168.6 104.3 71.7 91.7 110.7 61.2 92.7 105.4 120.2 133.5 157.7 172.9 186.9 157.4 56.2 155.7 118.3 197.9 90.2 95.4 171.3 124.2 156.2 137.7 161.2 70.7 240.5 123.1 90.8 87.2 76.7 67.6 84.5 130.1 118.5 222.3 148.8 89.5 197.8 100.1 202.8 144.6 148.9 96.3 154.5 139.8 410.4 154.3 127.0 112.2 87.5 76.8 150.9 180.6 113.9 120.6 243.6 83.0 98.2 129.4 104.7 193.6 144.4 353.8 186.4 109.5 429.3 96.9 122.4 255.8 117.0 67.3 254.1 83.0 346.0 94.8 88.1 231.6 345.5 75.5 74.4 132.0 86.9 228.3 386.5 146.1 269.0 23.1 26.0 25.7 26.7 22.0 24.6 26.1 24.0 26.6 26.4 26.9 32.0 10.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.8 0.0 0.0 0.0 0.0 116.5 10.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 100.6 13.2 0.0 0.0 0.0 0.0 0.0 0.0 218.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 88.8 2.0 0.0 0.0 0.0 SNX1 "HsT17379, MGC8664, SNX1A, Vps5" ENSG00000028528 "Sorting nexin 1" Q13596 15 64094123-64146090 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 177.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA047373, HPA052761" Approved Enhanced Endosomes,Lysosomes NA NA 6100000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 16: U-266 - Nucleosome" "Cluster 10: Non-specific - Unknown function" "Endosomes, Lysosomes" "HPA047373: AB_2680018, HPA052761: AB_2681939" "unprognostic (3.99e-2)" "unprognostic (8.65e-3)" "unprognostic (1.96e-1)" "unprognostic (1.50e-2)" "unprognostic (7.13e-2)" "unprognostic (2.73e-1)" "unprognostic (7.15e-2)" "unprognostic (6.49e-3)" "unprognostic (1.53e-1)" "unprognostic (8.28e-2)" "unprognostic (2.47e-2)" "unprognostic (3.26e-1)" "prognostic favorable (9.88e-6)" "unprognostic (2.27e-1)" "unprognostic (3.98e-1)" "unprognostic (2.59e-2)" "unprognostic (1.95e-1)" 63.4 69.0 47.1 59.0 64.1 34.8 46.2 60.9 49.8 52.8 44.5 60.2 49.8 47.6 67.7 60.6 37.5 42.9 50.4 46.2 51.4 56.8 69.3 54.7 67.1 67.5 63.6 39.0 44.3 72.1 32.0 57.8 66.4 51.9 47.6 27.0 55.4 64.4 69.1 48.5 52.4 53.0 62.5 61.0 54.8 34.2 57.2 79.5 102.9 36.8 66.8 62.1 51.2 76.8 75.4 93.5 69.1 60.8 116.4 81.3 23.0 93.5 91.5 81.4 94.5 64.6 115.6 74.4 100.5 86.7 79.7 113.8 102.6 95.2 63.5 136.1 56.0 101.2 110.4 98.2 63.6 94.7 108.0 102.9 62.6 65.2 50.2 59.7 86.1 77.0 74.0 29.2 85.1 107.8 111.4 80.2 54.5 103.2 52.1 100.0 65.3 118.1 127.1 170.5 56.3 56.4 91.4 61.1 86.3 59.5 87.0 86.6 103.0 80.1 120.2 50.8 52.5 93.4 220.5 120.1 72.9 123.5 85.8 144.1 149.1 162.1 83.4 143.1 70.9 101.1 70.4 82.2 127.3 101.9 67.0 66.6 113.7 98.1 144.2 86.1 95.8 156.0 47.1 64.1 60.9 49.8 46.2 51.4 67.5 63.6 66.4 62.5 57.2 76.8 34.4 115.4 74.2 35.6 32.9 26.5 38.1 39.3 29.0 18.9 29.7 29.2 50.6 34.3 52.8 18.4 22.9 51.5 51.6 32.1 33.2 40.9 3.7 36.4 36.7 34.2 26.5 26.5 44.2 37.2 35.1 36.2 27.5 44.9 39.2 44.9 35.3 34.2 72.2 15.2 39.3 28.3 28.5 46.8 27.4 4.0 32.3 42.7 32.0 44.0 56.3 19.7 35.0 121.7 177.7 34.6 30.3 37.6 34.0 32.7 39.2 53.6 31.9 16.5 46.0 36.0 64.0 33.3 23.4 33.8 27.1 47.7 35.0 39.3 28.8 33.9 SNX22 FLJ13952 ENSG00000157734 "Sorting nexin 22" Q96L94 15 64151715-64157481 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.8;thyroid gland: 38.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 28.9;B-cells: 33.4;Erythroid cells: 136.8;Oligodendrocyte precursor cells: 95.5" "Cancer enriched" "Detected in many" 7 "thyroid cancer: 47.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 3.3;naive B-cell: 6.1" "Lineage enriched" "Detected in many" 6 "B-cells: 6.1" "Cell line enriched" "Detected in some" 5 "Daudi: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038470 Approved Nucleoplasm,Vesicles NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 6: Erythroid cells - Oxygen transport" Vesicles Nucleoplasm "HPA038470: AB_10673174" "prognostic favorable (2.89e-5)" "unprognostic (8.93e-3)" "unprognostic (2.89e-1)" "unprognostic (3.55e-2)" "unprognostic (3.24e-1)" "unprognostic (5.38e-3)" "unprognostic (2.29e-1)" "unprognostic (3.05e-2)" "unprognostic (1.94e-1)" "unprognostic (5.29e-2)" "unprognostic (2.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.27e-4)" "unprognostic (3.92e-1)" "unprognostic (2.52e-1)" "prognostic favorable (2.19e-4)" "unprognostic (1.74e-2)" 0.4 0.4 11.2 3.7 12.5 6.5 0.5 12.0 11.6 0.6 4.7 0.4 0.5 0.2 1.9 0.3 0.2 0.3 11.9 11.2 11.1 1.0 2.9 5.7 7.2 16.8 13.1 0.1 1.7 0.0 3.2 0.2 14.4 4.2 0.2 0.0 1.4 4.5 0.1 0.2 3.4 0.2 14.4 5.4 2.3 0.4 12.9 2.5 38.7 0.0 8.6 0.5 0.3 15.4 0.0 0.4 0.4 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.1 0.3 0.4 17.5 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.1 1.7 0.3 0.0 1.8 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.5 2.6 0.0 0.7 0.2 0.0 1.3 0.2 0.2 3.7 0.1 0.7 0.8 0.1 3.8 0.7 0.0 0.5 0.0 0.2 1.5 0.0 0.0 0.1 1.0 0.0 0.1 3.1 1.3 3.5 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 3.3 0.0 0.0 1.0 6.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 1.4 11.2 12.5 12.0 11.6 11.2 11.1 16.8 13.1 14.4 14.4 12.9 15.4 0.7 28.9 8.8 0.0 33.4 1.5 2.3 1.3 1.2 0.9 3.2 3.2 21.0 0.0 1.4 0.0 4.2 3.3 2.0 1.5 0.0 0.6 1.6 0.5 1.6 1.0 0.0 136.8 0.1 3.8 8.6 4.1 2.6 1.3 2.5 1.9 1.4 4.3 4.6 0.0 0.3 1.2 0.0 1.9 7.4 1.7 0.6 2.5 3.6 3.7 1.9 0.5 1.0 95.5 17.7 1.3 0.6 0.4 9.5 6.2 0.6 1.6 0.5 2.0 0.0 3.1 1.9 1.4 2.1 1.3 2.8 4.0 3.0 0.3 0.8 1.6 PPIB "B, CYP-S1, CYPB, OI9, PPIase, SCYLP" ENSG00000166794 "Peptidylprolyl isomerase B" P23284 15 64155740-64163134 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Isomerase, Rotamase" "Disease variant, Dwarfism, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 1473.7;Plasma cells: 2242.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011487, HPA012720" Enhanced Supported "Nucleoplasm,Endoplasmic reticulum" "Secreted to blood" No No 33000000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 25: RPMI-8226 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" Nucleoplasm "CAB011487: AB_443295, HPA012720: AB_1847399" "unprognostic (3.00e-3)" "unprognostic (5.65e-3)" "unprognostic (2.81e-1)" "prognostic favorable (1.56e-5)" "unprognostic (1.65e-1)" "unprognostic (1.07e-3)" "unprognostic (3.69e-2)" "unprognostic (1.27e-2)" "unprognostic (7.19e-2)" "unprognostic (8.80e-3)" "unprognostic (2.87e-1)" "unprognostic (2.79e-2)" "prognostic unfavorable (2.02e-11)" "unprognostic (7.05e-2)" "unprognostic (3.77e-2)" "unprognostic (1.82e-1)" "unprognostic (3.90e-2)" 375.5 377.5 230.7 449.5 240.3 571.9 361.9 247.9 259.2 611.5 257.2 401.0 365.0 383.9 899.0 298.8 401.5 379.2 262.0 229.7 256.9 312.3 737.4 351.1 344.5 258.1 241.4 386.2 644.2 345.4 416.8 515.2 255.1 375.7 411.3 72.3 513.1 488.6 62.2 205.5 334.3 482.4 247.0 360.5 375.0 110.0 254.9 315.6 672.8 91.1 346.4 510.9 295.6 262.6 675.6 847.9 736.7 1666.7 2577.0 1492.3 641.9 1570.3 2108.3 1248.7 1472.3 1242.6 1223.1 653.6 1227.4 2513.0 1235.3 1067.7 1384.6 1080.4 641.1 406.2 491.0 914.5 915.3 1643.7 2682.9 915.0 778.1 1374.2 1149.4 725.9 1751.3 1516.7 1539.2 301.1 645.9 2174.7 966.0 1102.6 280.6 1404.9 625.1 1879.0 529.5 520.6 784.1 3347.9 1312.7 1062.6 410.5 647.7 726.0 1224.5 1194.2 1086.0 727.6 2767.0 927.6 1213.7 975.8 679.2 1079.4 1152.5 1269.5 693.4 1129.0 1478.0 1238.2 716.7 712.5 491.7 929.6 547.3 931.8 827.8 645.0 762.4 930.9 541.4 411.3 558.0 347.5 668.1 369.3 2643.5 569.3 1512.3 230.7 240.3 247.9 259.2 229.7 256.9 258.1 241.4 255.1 247.0 254.9 262.6 389.3 125.0 209.0 16.6 375.3 160.2 426.2 614.6 234.5 34.5 264.3 303.8 0.8 270.2 328.7 272.2 31.3 625.9 560.0 271.0 90.1 665.1 19.0 295.8 910.1 285.0 297.0 172.6 10.2 566.4 1473.7 627.8 441.4 494.2 181.2 540.4 322.7 473.2 630.1 45.4 15.8 603.9 205.4 216.9 333.4 29.5 456.3 316.6 281.1 19.7 299.1 149.1 368.7 35.2 37.0 435.1 338.9 393.1 2242.6 569.3 338.6 287.4 168.2 43.7 230.1 204.3 445.6 38.4 76.6 337.0 144.8 1118.9 352.3 674.0 477.2 422.3 CSNK1G1 CK1gamma1 ENSG00000169118 "Casein kinase 1 gamma 1" Q9HCP0 15 64165525-64356173 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 35.0" "Cell type enhanced" "Detected in all" "Early spermatids: 130.6;Late spermatids: 261.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018209 Supported Cytosol NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" Cytosol "HPA018209: AB_1847278" "unprognostic (9.10e-2)" "unprognostic (8.09e-2)" "unprognostic (1.20e-1)" "unprognostic (2.65e-2)" "unprognostic (1.20e-1)" "unprognostic (1.64e-1)" "unprognostic (7.90e-3)" "unprognostic (3.07e-1)" "unprognostic (1.61e-2)" "unprognostic (2.02e-1)" "unprognostic (8.63e-2)" "unprognostic (3.75e-2)" "unprognostic (7.51e-2)" "unprognostic (8.16e-3)" "unprognostic (1.31e-1)" "unprognostic (2.59e-2)" "unprognostic (2.41e-1)" 4.0 3.4 6.1 6.1 6.9 9.0 6.0 6.4 7.7 5.4 6.3 5.0 3.9 4.5 6.7 7.9 7.3 4.0 2.9 10.4 7.1 5.3 2.9 5.3 5.9 2.8 4.3 5.2 4.1 6.3 4.7 4.9 2.6 3.7 5.4 14.5 3.6 4.4 4.1 6.6 3.8 5.3 3.6 5.9 4.3 35.0 6.8 9.3 7.9 3.3 6.8 5.5 4.6 4.9 6.8 14.2 10.0 13.2 8.3 11.4 8.9 8.3 8.5 13.8 12.5 11.5 13.2 10.8 4.3 13.3 14.2 15.4 26.7 16.5 16.1 20.6 6.8 10.1 11.2 8.0 9.8 18.9 11.4 10.3 21.7 14.0 20.0 11.9 15.4 10.6 12.3 10.4 12.8 9.4 9.7 5.8 9.4 8.9 7.4 16.1 12.5 8.6 11.2 26.8 16.2 9.9 11.1 6.5 9.5 16.4 11.4 7.4 16.8 12.6 14.9 9.8 10.5 12.3 26.0 8.8 11.6 13.5 7.9 0.4 1.9 3.1 2.8 2.8 4.0 1.8 2.5 2.1 1.4 1.8 2.4 2.3 4.5 2.8 2.3 2.1 2.2 1.3 6.1 6.9 6.4 7.7 10.4 7.1 2.8 4.3 2.6 3.6 6.8 4.9 10.9 28.9 11.3 35.6 12.9 11.6 10.5 13.7 19.9 47.1 11.6 7.9 7.3 11.5 12.7 5.5 68.8 6.9 12.6 12.2 1.9 9.6 130.6 37.4 17.9 12.2 22.8 7.8 69.4 7.0 9.0 10.3 15.3 24.6 3.8 15.8 10.4 4.4 10.4 10.1 49.8 10.5 6.1 9.7 10.0 261.1 6.2 14.1 7.2 40.3 13.5 7.9 5.2 40.2 41.3 12.0 7.5 10.1 14.3 11.1 8.2 9.7 23.3 29.3 6.6 14.4 11.8 31.9 19.8 26.7 15.6 4.1 13.2 7.9 10.4 13.2 PCLAF "KIAA0101, NS5ATP9, OEATC-1, p15(PAF), PAF15" ENSG00000166803 "PCNA clamp associated factor" Q15004 15 64364304-64387687 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 128.6;lymphoid tissue: 73.8" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 82.2;Extravillous trophoblasts: 160.2;Granulosa cells: 48.8;Hofbauer cells: 110.2;Syncytiotrophoblasts: 42.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in many" 4 "T-reg: 23.6" "Lineage enriched" "Detected in many" 4 "T-cells: 23.6" "Low cell line specificity" "Detected in all" HPA047929 Supported Centrosome NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 24: NB-4 - Immune response" "Cluster 12: Non-specific - Cell cycle regulation" Centrosome "HPA047929: AB_2680215" "unprognostic (5.34e-2)" "unprognostic (1.36e-3)" "unprognostic (9.39e-2)" "unprognostic (1.28e-1)" "unprognostic (4.16e-1)" "unprognostic (2.22e-1)" "prognostic unfavorable (3.26e-5)" "unprognostic (4.38e-3)" "unprognostic (1.91e-3)" "unprognostic (7.26e-2)" "unprognostic (2.56e-3)" "unprognostic (9.65e-2)" "prognostic unfavorable (9.77e-15)" "unprognostic (5.59e-2)" "unprognostic (2.05e-1)" "unprognostic (8.65e-2)" "unprognostic (3.22e-1)" 2.1 1.4 0.9 22.9 1.0 128.6 3.9 1.4 1.1 1.7 0.8 19.0 14.7 4.5 1.2 15.2 1.3 2.5 0.4 0.9 0.6 1.2 3.6 2.5 49.5 1.0 0.8 0.4 1.9 0.8 0.5 8.7 0.9 2.0 22.6 0.3 2.3 0.3 0.4 6.7 15.8 5.0 0.5 7.4 8.1 1.1 1.0 73.8 2.2 0.1 47.1 7.9 4.9 1.9 212.6 165.8 154.4 140.8 15.9 60.9 134.4 146.2 84.8 185.4 276.4 198.4 202.1 343.7 46.4 57.4 64.8 153.6 340.7 83.1 235.3 192.5 124.8 352.5 202.5 209.8 1.5 285.3 153.8 20.0 7.9 156.4 31.9 52.3 168.9 175.9 201.3 104.4 248.1 187.8 268.0 605.5 73.9 179.9 73.4 416.6 353.8 247.1 115.9 200.2 19.1 86.7 112.8 105.2 69.3 78.9 153.8 365.3 36.3 158.4 308.6 177.8 386.7 65.5 223.4 229.0 67.7 512.9 108.5 2.4 0.3 0.9 1.4 0.2 0.2 2.0 4.4 4.2 2.8 0.6 0.5 1.0 2.7 5.7 0.4 0.3 23.6 2.3 0.9 1.0 1.4 1.1 0.9 0.6 1.0 0.8 0.9 0.5 1.0 1.9 0.5 9.6 11.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 27.5 25.5 0.0 0.0 5.0 1.8 0.0 82.2 8.3 0.0 1.9 6.5 0.0 18.6 10.4 8.5 0.0 0.0 0.0 3.0 160.2 25.4 0.0 13.8 3.8 48.8 0.0 0.0 110.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 1.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 4.3 0.0 0.0 3.0 3.6 0.0 0.0 0.0 20.6 0.0 0.0 0.0 0.0 42.1 5.8 7.6 0.0 0.0 TRIP4 "ASC-1, HsT17391, ZC2HC5" ENSG00000103671 "Thyroid hormone receptor interactor 4" Q15650 15 64387748-64455303 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Cancer-related genes, Congenital muscular dystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016605, HPA050666" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoplasm, Nuclear bodies" "HPA016605: AB_1858339, HPA050666: AB_2681211" "unprognostic (1.56e-1)" "unprognostic (1.14e-1)" "unprognostic (2.62e-1)" "unprognostic (4.50e-2)" "unprognostic (5.79e-2)" "unprognostic (1.08e-1)" "unprognostic (7.16e-2)" "unprognostic (3.01e-2)" "unprognostic (4.98e-2)" "unprognostic (2.83e-1)" "unprognostic (1.25e-1)" "unprognostic (2.37e-2)" "prognostic favorable (6.34e-6)" "unprognostic (2.41e-1)" "unprognostic (2.96e-1)" "unprognostic (2.61e-2)" "unprognostic (1.25e-1)" 14.9 12.4 13.6 13.3 14.7 15.3 17.1 14.1 20.6 13.0 14.9 17.1 17.1 13.2 11.6 19.4 14.1 11.0 15.5 13.7 14.0 27.5 14.3 15.0 16.4 14.4 14.2 13.1 16.6 20.0 13.0 16.9 14.8 12.7 19.2 16.8 13.3 12.1 8.9 18.0 17.9 16.5 14.2 16.6 15.6 12.0 14.5 19.8 25.6 9.2 18.7 17.7 14.7 15.6 18.6 27.1 23.3 16.7 18.9 24.6 21.8 19.3 24.7 32.7 31.5 22.8 40.5 13.3 6.3 29.4 26.6 25.7 38.3 22.0 30.9 27.0 10.9 19.4 19.2 24.1 33.5 21.2 35.1 30.9 28.2 25.9 27.0 18.7 28.9 19.2 22.7 16.2 30.4 21.2 13.5 21.3 13.7 32.7 14.4 20.4 17.7 22.2 31.6 35.1 12.6 19.8 17.3 20.7 35.3 43.5 26.2 31.3 25.7 23.2 15.8 15.6 27.7 13.5 25.9 13.5 19.2 21.4 29.6 70.1 22.2 54.3 20.8 29.1 17.7 16.0 19.7 21.2 20.5 16.3 16.6 17.3 30.9 21.2 42.4 16.2 23.3 16.9 13.6 14.7 14.1 20.6 13.7 14.0 14.4 14.2 14.8 14.2 14.5 15.6 12.7 22.4 13.2 15.3 10.0 8.4 9.6 23.3 2.2 11.1 7.6 7.1 10.3 7.2 18.1 12.9 12.5 22.2 20.1 15.3 13.7 25.2 20.4 21.7 10.7 13.2 11.4 9.9 32.5 27.1 26.8 10.2 10.2 16.2 19.6 12.3 10.0 4.4 21.7 15.2 25.8 8.2 24.4 12.9 7.6 3.7 11.8 15.3 14.2 22.5 27.5 10.0 27.8 18.1 30.9 33.6 10.5 12.8 6.5 6.0 13.5 44.6 26.7 17.3 6.6 9.0 15.0 19.3 21.4 5.4 6.3 24.2 14.4 12.1 8.1 7.8 ZNF609 KIAA0295 ENSG00000180357 "Zinc finger protein 609" O15014 15 64460742-64686068 "Predicted intracellular proteins" "Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 123.4;Cone photoreceptor cells: 141.8;Excitatory neurons: 142.1;Microglial cells: 139.6;Oligodendrocytes: 208.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040742, HPA040832" Approved Enhanced Nucleoplasm,Cytosol NA NA "Cluster 11: Basophils - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm Cytosol "HPA040742: AB_10963581, HPA040832: AB_10960400" "unprognostic (2.09e-1)" "unprognostic (1.17e-1)" "unprognostic (1.71e-1)" "unprognostic (1.44e-1)" "unprognostic (1.25e-1)" "unprognostic (2.48e-1)" "unprognostic (1.36e-1)" "unprognostic (1.47e-1)" "unprognostic (2.61e-1)" "unprognostic (3.11e-2)" "unprognostic (5.02e-2)" "unprognostic (7.21e-2)" "unprognostic (9.51e-2)" "unprognostic (2.17e-1)" "unprognostic (1.22e-1)" "unprognostic (1.37e-2)" "unprognostic (2.28e-1)" 9.5 8.3 11.3 8.3 10.1 5.5 8.5 13.0 9.6 11.3 8.8 12.0 8.7 12.0 4.5 7.8 11.9 7.2 8.1 11.2 12.6 6.7 7.1 10.9 8.7 10.6 10.4 20.5 7.2 14.1 8.4 11.9 7.4 10.3 7.8 20.5 9.7 9.5 7.2 9.6 8.7 11.1 8.3 9.8 8.2 22.0 10.1 18.0 9.0 9.9 8.3 11.3 10.8 12.1 11.1 27.6 29.1 11.2 11.0 13.8 9.9 14.2 18.8 17.5 17.5 17.1 17.2 19.0 11.7 16.9 23.9 23.2 43.1 19.6 18.2 22.2 9.2 34.7 16.0 8.4 20.2 20.2 22.3 14.1 17.6 18.3 35.8 25.3 32.8 15.9 55.6 12.0 14.5 10.1 15.7 8.5 22.1 14.8 7.7 14.3 26.5 10.0 12.7 19.7 23.6 18.0 19.5 21.9 13.1 27.7 10.9 14.0 33.0 16.2 25.8 8.4 17.9 13.3 16.1 16.6 10.1 21.6 13.4 1.3 0.4 0.6 0.5 0.1 0.3 0.2 0.3 0.4 0.1 0.2 0.8 0.8 0.5 1.1 0.2 0.5 0.2 0.2 11.3 10.1 13.0 9.6 11.2 12.6 10.6 10.4 7.4 8.3 10.1 12.1 14.6 12.8 25.4 123.4 8.8 18.0 16.2 10.5 8.0 35.8 12.6 11.8 20.1 24.3 20.3 18.4 141.8 19.1 13.9 12.2 3.9 13.8 22.6 42.2 21.9 18.4 18.6 11.1 142.1 14.6 14.7 13.6 13.7 16.1 10.1 19.4 18.9 14.6 10.0 45.4 116.5 11.9 4.1 30.5 18.3 12.7 18.0 16.4 14.2 139.6 19.1 17.3 19.6 108.6 208.0 13.2 13.5 13.9 10.5 22.9 9.9 3.9 33.8 54.9 19.7 14.4 16.9 48.3 17.0 9.3 17.3 31.2 17.0 20.8 11.2 20.1 OAZ2 ENSG00000180304 "Ornithine decarboxylase antizyme 2" O95190 15 64687573-64703281 "Predicted intracellular proteins" "Polyamine biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 324.9;Sertoli cells: 374.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 418.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047694 Uncertain Approved "Golgi apparatus" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 54: Non-specific - Microtubule organization" "Cluster 5: NTERA-2 - Transcription" "Cluster 48: Smooth muscle cells - ECM organization" "Golgi apparatus" "HPA047694: AB_2680121" "unprognostic (2.67e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (9.05e-4)" "unprognostic (2.09e-2)" "unprognostic (4.44e-2)" "unprognostic (2.32e-3)" "unprognostic (3.46e-2)" "unprognostic (7.94e-2)" "unprognostic (3.11e-2)" "unprognostic (5.24e-2)" "unprognostic (1.76e-3)" "unprognostic (1.78e-1)" "unprognostic (2.24e-2)" "unprognostic (7.50e-2)" "unprognostic (2.99e-1)" "unprognostic (2.54e-1)" "unprognostic (1.45e-1)" 65.1 68.5 110.1 49.5 111.8 32.9 55.1 112.2 112.5 61.1 108.0 72.4 28.4 64.7 57.2 44.4 59.8 46.9 79.3 110.1 114.5 68.4 89.3 55.8 50.7 112.6 114.6 56.5 35.9 96.8 75.0 75.1 112.4 53.3 35.8 123.4 45.3 49.1 207.9 45.9 40.9 72.3 114.3 89.8 47.7 80.8 114.4 41.7 65.8 152.5 45.4 56.3 48.3 116.4 71.2 63.5 130.6 43.5 91.8 79.4 24.6 80.5 120.6 113.4 98.5 43.5 62.2 61.6 72.7 113.4 84.5 37.5 126.7 71.6 99.2 82.4 48.3 40.3 48.3 32.5 52.2 35.7 125.7 104.4 49.6 57.0 40.1 147.4 109.2 42.9 30.1 29.6 123.4 45.3 24.5 43.8 223.1 39.1 50.7 57.5 74.5 54.0 102.0 55.7 68.4 125.1 30.4 45.0 80.3 161.6 75.6 52.7 66.0 76.4 102.2 38.0 87.0 65.1 104.6 58.2 87.4 75.2 69.8 22.1 145.3 268.4 29.3 247.8 24.2 30.2 24.6 24.0 91.1 29.1 27.9 25.3 418.0 39.5 209.6 49.4 30.7 115.5 110.1 111.8 112.2 112.5 110.1 114.5 112.6 114.6 112.4 114.3 114.4 116.4 67.5 25.6 43.5 15.3 36.1 121.7 99.5 67.7 47.8 93.8 57.9 40.4 61.9 44.3 41.0 42.3 104.3 114.1 33.4 19.2 168.3 109.5 324.9 35.2 30.0 109.3 81.9 33.3 14.6 66.0 70.9 61.3 14.3 20.5 103.3 36.9 134.6 83.6 133.9 74.0 13.6 26.0 91.6 115.4 238.1 80.9 114.3 86.6 103.2 20.6 114.2 268.2 49.4 12.1 26.9 81.8 25.7 68.1 19.1 88.9 29.2 94.2 51.1 180.8 374.7 68.1 160.9 166.2 83.9 28.0 121.2 68.5 31.7 44.3 27.4 72.4 RBPMS2 ENSG00000166831 "RNA binding protein, mRNA processing factor 2" Q6ZRY4 15 64739891-64775589 "Predicted intracellular proteins" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 300.8;intestine: 147.2" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 215.3" "Cancer enriched" "Detected in all" 4 "testis cancer: 37.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 39.0;AN3-CA: 55.4;HEL: 86.2;NTERA-2: 76.4;SuSa: 86.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 46: Fibroblasts - ECM organization" "Cluster 12: NES - Nervous system development" "Cluster 54: Cardiomyocytes - Muscle contraction" "unprognostic (1.68e-1)" "unprognostic (2.29e-1)" "unprognostic (1.07e-2)" "unprognostic (6.79e-2)" "unprognostic (1.08e-1)" "unprognostic (1.51e-1)" "unprognostic (1.61e-1)" "unprognostic (4.51e-2)" "unprognostic (6.41e-2)" "unprognostic (5.86e-2)" "unprognostic (2.21e-2)" "unprognostic (4.47e-2)" "prognostic favorable (1.48e-4)" "unprognostic (2.05e-2)" "unprognostic (1.12e-1)" "unprognostic (1.23e-1)" "unprognostic (4.68e-3)" 20.0 4.9 5.2 6.7 6.1 1.6 12.5 2.7 4.7 18.4 14.7 147.2 6.0 53.1 7.5 20.3 30.8 9.9 300.8 3.7 4.3 17.8 13.9 7.6 1.0 3.3 5.0 10.6 2.7 16.5 4.1 7.7 3.0 27.5 8.1 2.0 2.5 45.8 5.6 4.9 30.2 37.6 2.9 4.4 51.9 6.4 12.6 2.5 13.8 4.9 0.6 94.0 14.4 3.2 0.0 6.3 39.0 55.4 0.0 0.0 5.9 1.2 0.2 7.0 1.6 4.9 0.5 0.0 5.2 1.1 6.5 0.0 28.8 0.0 2.6 0.0 9.0 86.2 9.5 9.9 3.7 0.0 0.7 0.1 0.0 4.4 0.0 1.5 0.7 1.9 0.5 0.0 0.5 2.9 0.0 0.3 76.4 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.1 13.5 8.5 0.1 1.6 86.5 7.9 0.3 0.0 0.0 28.4 3.7 3.7 0.4 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 5.2 6.1 2.7 4.7 3.7 4.3 3.3 5.0 3.0 2.9 12.6 3.2 3.1 0.0 0.0 0.0 1.1 0.8 0.3 0.0 0.6 0.3 0.5 0.5 215.3 0.0 0.0 3.7 0.0 0.6 2.0 0.0 9.8 0.4 4.7 0.4 3.4 6.4 0.0 7.4 0.3 1.6 1.1 11.1 5.1 0.7 0.0 0.9 2.9 8.5 0.3 0.0 0.2 0.0 0.0 1.3 1.3 1.0 3.7 10.4 1.8 1.0 0.2 3.3 9.2 0.0 0.0 1.2 0.0 6.4 0.0 1.5 0.0 31.0 0.0 1.7 46.0 1.7 51.0 0.8 14.1 0.3 1.1 3.1 0.7 1.0 0.0 0.2 PIF1 "C15orf20, FLJ22692" ENSG00000140451 "PIF1 5'-to-3' DNA helicase" Q9H611 15 64815632-64825668 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 4.8" "Cell type enhanced" "Detected in many" "Early spermatids: 21.3;Erythroid cells: 17.7;Granulosa cells: 15.1;NK-cells: 15.5;Theca cells: 18.3" "Cancer enhanced" "Detected in many" "testis cancer: 10.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" CAB018701 Supported Supported Nucleoplasm NA Yes "Cluster 35: T-regs - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 20: HeLa - Mitochondria" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "CAB018701: AB_2164654" "unprognostic (1.99e-1)" "unprognostic (6.11e-2)" "unprognostic (1.34e-1)" "unprognostic (3.12e-2)" "unprognostic (1.62e-1)" "unprognostic (8.33e-3)" "unprognostic (8.66e-4)" "unprognostic (1.47e-1)" "prognostic unfavorable (5.22e-4)" "unprognostic (6.68e-2)" "unprognostic (2.38e-2)" "unprognostic (3.27e-2)" "unprognostic (0.00e+0)" "unprognostic (2.96e-3)" "unprognostic (1.78e-1)" "unprognostic (9.61e-2)" "unprognostic (5.95e-2)" 0.7 1.0 0.8 2.6 0.8 3.8 0.4 0.7 1.3 0.9 0.7 2.4 1.9 0.8 0.1 3.1 0.7 0.8 0.9 0.7 1.2 0.6 0.6 1.0 4.6 1.4 1.0 0.4 0.2 0.2 0.5 0.9 1.1 1.7 1.0 0.1 0.6 0.7 0.3 1.0 2.6 1.2 0.9 4.8 1.8 2.5 1.2 3.6 0.5 0.1 3.3 1.5 1.4 0.8 7.7 8.7 21.1 8.6 3.7 4.3 7.8 7.4 3.9 7.3 5.6 14.0 12.6 9.3 3.0 3.6 6.8 20.9 21.8 6.2 2.7 14.8 8.0 10.8 28.5 10.2 1.9 4.3 8.4 2.5 0.0 3.2 2.6 1.8 7.5 13.6 7.2 18.0 7.0 6.7 4.7 17.9 17.2 9.7 6.0 9.7 7.0 13.0 4.1 4.3 8.7 5.6 5.7 6.3 3.3 9.2 7.0 4.7 5.2 4.4 22.6 7.0 14.0 14.3 14.3 9.0 4.2 18.8 6.4 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.1 0.8 0.8 0.7 1.3 0.7 1.2 1.4 1.0 1.1 0.9 1.2 0.8 1.2 0.0 1.1 3.6 6.5 1.9 0.8 0.6 0.0 0.5 0.6 0.6 1.9 0.0 0.1 0.0 0.0 5.1 7.5 3.2 0.0 0.0 21.3 0.4 4.4 2.3 0.0 17.7 2.6 0.0 6.5 5.6 3.6 0.7 0.0 15.1 5.3 0.5 5.8 0.0 1.0 2.4 0.0 5.1 2.0 2.3 1.5 4.5 0.0 1.9 0.1 0.8 15.5 3.5 0.1 0.2 0.1 2.2 9.7 1.1 0.2 0.1 0.1 1.2 6.6 4.2 3.5 0.8 2.0 1.6 1.0 1.1 7.5 18.3 6.2 1.3 PLEKHO2 "DKFZp761K2312, PLEKHQ1, PP1628, pp9099" ENSG00000241839 "Pleckstrin homology domain containing O2" Q8TD55 15 64841883-64868002 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 103.2" "Cell type enhanced" "Detected in many" "Hofbauer cells: 63.2;Kupffer cells: 52.3;Macrophages: 46.5;Muller glia cells: 56.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 27.1;granulocytes: 77.3;monocytes: 73.0" "Cell line enhanced" "Detected in many" "ASC diff: 68.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040055 Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 200000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 2: Immune cells - Immune response" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 4: Macrophages - Innate immune response" "Plasma membrane, Cytosol" Nucleoplasm "HPA040055: AB_10793954" "unprognostic (4.32e-2)" "unprognostic (7.32e-3)" "unprognostic (8.60e-2)" "unprognostic (9.10e-2)" "unprognostic (1.11e-1)" "unprognostic (2.90e-2)" "unprognostic (3.05e-2)" "unprognostic (2.80e-1)" "unprognostic (7.70e-2)" "unprognostic (2.05e-2)" "unprognostic (8.67e-2)" "unprognostic (1.02e-1)" "unprognostic (3.08e-3)" "unprognostic (1.12e-1)" "unprognostic (4.20e-2)" "unprognostic (1.78e-1)" "unprognostic (5.85e-3)" 37.9 31.8 23.1 30.5 26.9 52.0 22.7 25.0 25.0 17.0 16.7 23.6 10.0 19.8 5.7 13.9 22.4 26.0 16.5 21.7 24.4 14.2 11.8 42.2 34.3 31.8 26.2 14.9 8.2 7.4 10.3 25.4 26.6 17.4 7.8 14.4 9.9 13.9 5.8 10.6 17.8 22.9 27.6 103.2 16.3 8.3 28.0 16.0 29.9 8.2 21.1 25.8 16.7 25.5 6.5 4.2 7.9 7.8 68.0 38.8 18.4 18.5 27.4 19.2 19.6 5.1 4.0 17.1 9.5 37.7 19.5 2.2 9.0 7.4 11.2 26.6 2.7 17.2 1.9 6.0 52.2 19.4 24.7 28.3 6.5 24.0 7.8 16.6 27.0 3.5 5.2 59.5 25.9 1.9 4.1 20.9 15.0 3.2 3.7 14.9 19.0 12.2 3.1 4.4 0.6 6.7 7.7 2.6 25.4 12.9 2.7 26.1 35.3 14.8 13.4 14.1 7.8 22.0 37.1 5.8 16.0 24.8 8.8 22.2 43.2 25.6 13.2 52.3 11.9 9.8 7.4 12.2 27.1 6.8 3.1 6.5 77.3 7.0 73.0 3.1 10.7 36.0 23.1 26.9 25.0 25.0 21.7 24.4 31.8 26.2 26.6 27.6 28.0 25.5 24.9 0.0 5.6 17.3 9.1 5.6 2.3 2.3 0.6 0.6 6.4 8.3 3.6 2.8 2.4 9.2 0.0 4.2 15.9 0.5 3.9 2.4 5.0 1.4 5.9 26.1 0.0 2.1 0.2 1.5 5.9 8.6 0.5 2.3 18.4 2.5 34.2 2.1 63.2 0.0 0.2 0.3 4.1 52.3 24.3 2.9 18.3 46.5 14.2 8.4 18.9 56.8 16.5 2.5 2.7 2.0 0.0 25.6 2.7 3.5 0.0 2.2 2.1 3.8 13.1 10.2 5.9 0.9 2.3 1.9 4.4 6.0 10.5 4.6 0.4 3.4 AC069368.1 ENSG00000249240 "Novel protein" 15 64841883-64930920 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 4.8;lymphoid tissue: 6.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-266/84: 30.4" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 16: U-266 - Nucleosome" "unprognostic (2.49e-1)" "unprognostic (1.95e-2)" "unprognostic (3.20e-2)" "unprognostic (1.22e-2)" "unprognostic (3.28e-1)" "unprognostic (3.68e-2)" "unprognostic (4.45e-2)" "unprognostic (7.51e-2)" "unprognostic (1.21e-1)" "unprognostic (1.01e-1)" "unprognostic (3.37e-1)" "unprognostic (4.25e-1)" "unprognostic (2.83e-1)" "unprognostic (1.97e-1)" 1.3 2.8 1.0 4.3 1.3 0.0 0.1 1.0 4.8 0.2 1.4 1.6 2.8 1.2 0.0 0.5 0.2 0.6 0.2 0.9 2.6 0.7 0.8 0.8 1.3 1.5 0.5 0.4 0.1 0.1 0.0 0.8 2.1 0.4 0.6 0.9 0.5 0.0 0.6 0.1 0.8 0.9 1.1 6.2 2.1 0.4 1.8 0.3 0.5 0.0 0.1 0.7 0.1 2.1 2.9 0.0 0.6 0.9 0.7 3.3 1.0 11.4 5.0 0.6 1.8 0.9 0.0 10.0 4.2 2.8 0.5 0.2 0.0 0.0 1.7 11.4 0.0 9.0 2.9 0.0 1.4 12.1 5.5 1.1 0.5 0.7 0.0 1.3 0.0 0.9 2.5 11.0 0.0 0.2 1.5 0.1 1.5 0.0 0.0 1.8 9.3 3.4 0.0 2.2 0.0 2.7 2.7 0.0 1.5 0.1 0.4 1.2 11.9 3.3 2.8 3.4 2.7 5.6 30.4 3.0 4.3 6.1 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.0 1.3 1.0 4.8 0.9 2.6 1.5 0.5 2.1 1.1 1.8 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANKDD1A FLJ25870 ENSG00000166839 "Ankyrin repeat and death domain containing 1A" Q495B1 15 64911902-64958691 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 209.6;Leydig cells: 61.8;Peritubular cells: 78.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 24.1;RT4: 17.7;U-266/84: 25.4" "Low region specificity" "Detected in some" "Region enhanced" "Detected in all" "cerebellum: 13.8" HPA040757 Approved Approved Nucleoplasm "Secreted - unknown location" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 64: Macrophages - Immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 64: Astrocytes - Nervous system maintenance" Nucleoplasm "HPA040757: AB_10960566" "unprognostic (3.72e-4)" "unprognostic (1.86e-1)" "unprognostic (6.07e-3)" "unprognostic (3.25e-2)" "unprognostic (4.78e-1)" "unprognostic (2.49e-1)" "unprognostic (1.14e-1)" "unprognostic (1.22e-3)" "unprognostic (5.11e-3)" "unprognostic (5.57e-2)" "unprognostic (4.37e-2)" "unprognostic (1.60e-1)" "unprognostic (3.15e-7)" "unprognostic (1.06e-1)" "unprognostic (1.98e-1)" "unprognostic (8.04e-3)" "unprognostic (1.64e-2)" 3.6 9.0 5.1 2.6 4.5 2.7 1.5 2.0 5.4 2.3 0.1 1.3 1.2 2.2 1.9 3.6 4.0 2.9 2.2 3.8 2.5 0.8 0.4 2.6 4.8 4.7 2.7 3.8 4.4 4.4 1.2 1.6 2.2 2.3 0.4 2.8 2.4 2.1 1.2 3.3 1.8 1.6 2.1 10.7 1.7 3.6 3.5 0.8 2.6 0.1 1.3 3.0 2.0 2.5 1.2 3.7 1.6 1.6 2.7 2.1 6.9 1.6 4.4 1.7 2.5 2.1 1.7 1.6 1.9 3.8 1.4 1.3 3.7 0.3 1.4 0.7 1.1 1.5 4.6 1.5 2.0 1.2 2.5 1.6 0.5 1.1 0.6 0.9 1.2 1.7 0.3 24.1 0.5 3.5 0.6 2.6 2.2 0.6 1.7 0.8 1.0 12.1 0.2 17.7 3.2 4.5 1.0 1.2 1.8 1.5 1.2 1.5 1.8 3.2 3.3 2.8 1.6 6.4 25.4 1.2 3.6 3.0 1.0 0.5 0.4 0.0 1.0 0.9 0.3 0.4 0.5 1.4 0.7 0.3 0.3 0.4 0.7 3.1 0.9 0.0 2.1 0.4 5.1 4.5 2.0 5.4 3.8 2.5 4.7 2.7 2.2 2.1 3.5 2.5 8.0 0.0 1.3 209.6 1.5 5.6 4.2 1.1 4.0 11.2 0.7 1.0 1.4 1.5 1.3 0.0 12.5 3.1 3.8 0.1 0.0 0.9 1.1 1.7 9.6 12.7 1.2 0.0 37.7 2.3 5.6 6.5 0.0 3.6 5.7 1.1 5.3 0.0 5.4 3.3 24.6 0.0 2.0 6.0 25.4 4.1 61.8 7.1 10.6 19.7 1.1 28.9 5.2 30.2 10.7 2.8 0.1 78.6 6.2 2.7 0.0 0.3 0.2 8.2 13.1 11.8 7.1 2.6 1.3 0.8 3.7 2.2 3.0 3.3 0.1 5.2 SPG21 "ABHD21, ACP33, BM-019, GL010, MAST" ENSG00000090487 "SPG21 abhydrolase domain containing, maspardin" Q9NZD8 15 64963022-64990310 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 181.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040407, HPA040436" Approved Supported Vesicles,Cytosol NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 19: Monocytes & Neutrophils - Innate immune response" "Vesicles, Cytosol" "HPA040407: AB_2676965, HPA040436: AB_10796454" "unprognostic (7.47e-2)" "unprognostic (2.94e-2)" "unprognostic (5.81e-2)" "unprognostic (2.98e-1)" "unprognostic (1.64e-1)" "unprognostic (5.40e-3)" "unprognostic (7.25e-2)" "unprognostic (1.43e-1)" "unprognostic (4.19e-2)" "unprognostic (8.07e-2)" "unprognostic (4.24e-3)" "unprognostic (1.15e-1)" "unprognostic (3.96e-1)" "unprognostic (1.55e-1)" "unprognostic (3.49e-1)" "unprognostic (2.57e-1)" "unprognostic (3.19e-1)" 56.6 61.7 48.4 50.8 54.1 69.4 68.8 51.5 52.9 60.4 66.0 61.6 52.1 60.2 150.1 46.1 73.4 54.7 54.4 47.8 50.3 85.3 113.1 61.9 56.9 52.1 50.2 55.3 54.7 72.1 47.1 66.3 52.7 49.8 59.3 38.6 45.7 59.0 74.3 58.5 46.6 64.5 51.1 52.6 60.1 35.0 52.6 57.7 83.1 42.4 58.8 61.2 47.8 59.4 87.0 127.0 62.8 119.5 158.7 155.7 78.0 52.8 179.7 103.2 119.8 57.4 131.1 99.1 80.6 124.8 153.1 113.3 182.1 124.5 97.8 41.0 58.5 85.7 81.7 104.0 200.7 82.2 72.7 107.0 139.3 82.1 154.2 100.7 125.6 112.2 72.7 78.3 127.8 124.1 75.8 71.5 69.6 193.9 66.3 78.2 67.3 174.6 107.1 103.6 76.7 68.6 62.7 131.4 124.9 123.3 89.9 140.9 61.5 87.1 90.6 125.4 80.6 55.6 101.8 58.2 112.8 215.1 75.1 9.9 138.2 15.5 14.1 84.2 13.1 39.0 13.8 14.7 76.9 37.6 19.9 10.9 181.4 15.7 69.8 25.1 17.5 52.3 48.4 54.1 51.5 52.9 47.8 50.3 52.1 50.2 52.7 51.1 52.6 59.4 29.4 9.6 56.3 11.1 67.7 74.9 81.8 70.6 66.6 16.2 62.7 39.4 32.1 61.5 51.5 71.7 37.5 202.9 33.6 42.7 137.0 97.1 6.0 32.9 36.9 56.9 64.8 54.3 13.1 74.1 92.2 67.5 46.9 34.3 28.5 37.5 38.2 121.6 153.9 20.2 13.7 58.2 61.1 158.7 145.4 13.2 86.6 128.5 80.0 16.9 123.2 24.8 64.9 5.5 19.6 62.3 93.5 89.9 66.2 145.2 121.1 202.3 57.9 18.9 39.5 93.4 39.5 35.4 51.3 75.4 82.8 186.5 46.5 35.5 69.5 123.5 MTFMT FMT1 ENSG00000103707 "Mitochondrial methionyl-tRNA formyltransferase" Q96DP5 15 65001512-65029639 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" Transferase "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040710 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 35: Non-specific - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm Cytosol "HPA040710: AB_10794879" "unprognostic (1.20e-1)" "unprognostic (2.72e-2)" "unprognostic (9.28e-3)" "unprognostic (4.35e-2)" "unprognostic (1.28e-1)" "unprognostic (1.42e-2)" "unprognostic (6.63e-2)" "unprognostic (2.02e-1)" "unprognostic (6.95e-2)" "unprognostic (2.18e-2)" "unprognostic (2.41e-2)" "unprognostic (1.78e-1)" "prognostic favorable (3.31e-8)" "unprognostic (2.75e-2)" "unprognostic (4.06e-2)" "unprognostic (3.26e-1)" "unprognostic (1.85e-2)" 1.6 2.2 2.6 0.7 2.9 1.9 1.6 3.8 3.1 2.4 4.0 2.5 1.5 2.5 1.5 2.2 2.6 0.9 4.3 2.5 3.4 2.4 3.5 1.5 1.3 2.5 2.2 2.7 1.4 1.7 2.2 0.8 2.5 2.8 1.5 1.6 1.8 1.3 3.0 1.7 2.2 1.7 1.9 2.3 2.0 1.5 2.9 1.0 1.7 1.5 1.2 2.5 2.1 2.6 1.4 1.9 1.8 3.2 2.5 1.7 1.7 1.3 2.2 1.6 1.5 1.2 1.5 4.7 1.7 2.3 2.7 4.0 3.3 2.2 1.5 1.9 2.8 1.9 1.9 1.3 2.9 2.7 0.6 2.3 2.8 0.9 1.9 2.2 1.5 4.2 2.3 2.2 2.4 1.9 2.3 3.1 2.4 4.0 3.6 2.0 2.5 2.2 2.7 1.6 1.8 1.8 3.1 2.7 2.5 2.2 1.6 2.0 2.8 1.9 1.9 2.4 2.6 1.9 3.1 1.8 1.7 4.6 1.9 3.7 3.3 2.6 4.8 3.1 4.8 4.8 4.7 5.0 6.0 4.7 5.1 5.4 16.5 4.5 2.2 10.1 5.4 2.3 2.6 2.9 3.8 3.1 2.5 3.4 2.5 2.2 2.5 1.9 2.9 2.6 8.5 3.2 9.7 17.0 11.8 3.3 15.2 19.1 14.8 0.0 7.0 7.7 15.8 10.0 10.5 3.7 0.0 11.4 18.1 10.5 25.4 11.8 1.7 7.8 11.6 8.2 7.8 9.4 49.8 10.0 11.7 11.8 8.6 7.0 8.8 8.0 12.8 12.2 16.5 0.0 44.2 8.9 2.0 12.2 12.2 1.7 15.5 9.7 8.8 27.2 7.1 0.0 11.3 19.1 12.9 10.3 15.9 15.4 10.3 16.7 17.5 25.1 5.1 0.0 0.0 12.5 14.5 13.3 20.7 10.7 4.5 8.9 10.1 11.4 15.7 14.5 SLC51B OSTbeta ENSG00000186198 "Solute carrier family 51 subunit beta" Q86UW2 15 65045387-65053397 "Metabolic proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 41.8;intestine: 107.1" "Cell type enhanced" "Detected in some" "Distal enterocytes: 354.6;Paneth cells: 145.1;Proximal enterocytes: 721.4" "Cancer enhanced" "Detected in many" "liver cancer: 9.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "CACO-2: 18.5;EFO-21: 11.9;Hep G2: 15.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA008398, HPA008533" Enhanced Approved Vesicles,Mitochondria No NA "Cluster 9: Intestine - Unknown function" "Cluster 39: CACO-2 - Unknown function" "Cluster 45: Enterocytes - Digestion" Mitochondria Vesicles "HPA008398: , HPA008533: AB_1854824" "unprognostic (6.18e-2)" "unprognostic (6.75e-3)" "unprognostic (1.66e-1)" "unprognostic (1.31e-2)" "unprognostic (5.88e-2)" "unprognostic (9.49e-2)" "unprognostic (9.77e-3)" "unprognostic (1.81e-2)" "unprognostic (3.35e-2)" "unprognostic (2.76e-1)" "unprognostic (2.24e-1)" "unprognostic (4.34e-2)" "prognostic favorable (8.46e-5)" "unprognostic (5.87e-2)" "unprognostic (2.64e-2)" "unprognostic (1.05e-2)" "unprognostic (1.17e-2)" 0.7 1.1 5.8 3.5 5.5 0.8 0.3 4.0 3.9 41.8 0.0 41.9 86.9 3.0 0.3 2.4 3.6 2.8 2.3 3.8 6.5 19.5 2.2 6.1 0.6 7.3 10.9 1.1 0.3 0.0 0.4 0.6 7.7 2.7 29.4 0.7 1.0 0.6 1.0 0.8 107.1 1.7 6.5 0.8 0.8 9.6 11.8 0.0 0.7 0.0 0.0 1.5 0.9 4.2 0.0 1.5 0.2 0.8 0.0 0.1 0.4 0.0 0.0 0.2 0.0 18.5 0.0 0.1 11.9 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.1 15.7 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.2 0.0 0.4 0.1 0.4 0.4 0.1 0.4 0.0 0.0 0.9 0.4 0.0 0.6 0.5 0.0 0.0 0.0 2.2 0.5 0.0 0.0 0.3 0.0 0.1 0.2 0.2 0.4 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 5.5 4.0 3.9 3.8 6.5 7.3 10.9 7.7 6.5 11.8 4.2 0.0 0.0 1.1 0.3 1.3 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.0 1.5 0.7 0.0 0.0 0.1 0.0 354.6 13.7 0.0 60.8 10.4 0.2 1.2 1.8 2.7 0.0 0.0 0.0 0.5 0.0 1.9 4.5 0.0 0.4 1.8 0.1 0.0 0.0 23.0 0.0 0.3 0.0 14.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 145.1 0.0 0.0 0.0 721.4 73.3 15.6 0.0 6.6 1.0 0.4 27.9 0.5 0.0 0.0 0.1 0.6 0.1 45.8 0.0 RASL12 RIS ENSG00000103710 "RAS like family 12" Q9NYN1 15 65053337-65076690 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Astrocytes: 22.5;Peritubular cells: 57.9;Sertoli cells: 98.6;Smooth muscle cells: 55.7" "Cancer enhanced" "Detected in all" "glioma: 21.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.0;CACO-2: 14.5;EFO-21: 22.7;NTERA-2: 9.9;SuSa: 17.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 38: EFO-21 - Unknown function" "Cluster 48: Smooth muscle cells - ECM organization" "unprognostic (6.13e-3)" "unprognostic (1.06e-1)" "unprognostic (2.47e-2)" "unprognostic (6.95e-2)" "unprognostic (1.39e-1)" "unprognostic (1.21e-2)" "unprognostic (4.10e-2)" "unprognostic (1.40e-1)" "unprognostic (1.29e-3)" "unprognostic (1.60e-1)" "unprognostic (4.45e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (7.20e-5)" "unprognostic (1.76e-2)" "unprognostic (4.72e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (2.17e-4)" 27.9 3.9 32.9 5.1 36.8 0.0 15.7 30.8 24.4 49.8 8.5 35.6 3.6 61.6 27.9 19.2 54.7 13.2 53.4 26.0 38.4 6.9 1.1 38.4 3.3 39.4 57.4 16.5 2.4 1.8 7.0 17.0 38.0 52.5 6.7 3.3 8.0 76.4 37.1 12.1 9.4 33.0 38.8 9.6 7.7 15.6 66.1 0.9 8.4 20.6 1.7 40.2 33.5 32.6 0.1 0.1 0.2 0.0 0.6 5.0 0.2 0.0 0.5 0.0 0.0 14.5 0.1 0.0 22.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 9.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 17.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.9 36.8 30.8 24.4 26.0 38.4 39.4 57.4 38.0 38.8 66.1 32.6 7.4 0.0 0.0 22.5 0.0 1.5 3.9 0.0 0.0 0.3 2.0 5.6 16.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 4.7 0.3 12.6 3.6 0.0 0.0 0.1 0.0 0.1 15.2 0.5 0.5 0.0 12.3 1.4 0.1 0.3 0.0 0.1 0.0 2.0 0.0 1.3 3.9 13.1 0.2 0.0 2.8 0.0 17.9 0.0 0.0 0.0 0.1 0.0 57.9 0.0 0.4 0.5 0.0 0.0 0.8 98.6 0.9 55.7 0.7 1.1 0.4 0.1 0.3 0.2 0.4 0.2 0.1 KBTBD13 "hCG_1645727, NEM6" ENSG00000234438 "Kelch repeat and BTB domain containing 13" C9JR72 15 65076746-65079948 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease variant, Nemaline myopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 30.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA062737 Uncertain NA NA "Cluster 33: Striated muscle - Muscle contraction" "Cluster 48: Smooth muscle cells - ECM organization" "HPA062737: AB_2684856" "unprognostic (1.18e-1)" "unprognostic (7.88e-2)" "unprognostic (6.07e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.0 0.2 0.5 0.1 0.3 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 30.7 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 6.8 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UBAP1L ENSG00000246922 "Ubiquitin associated protein 1 like" F5GYI3 15 65092760-65115200 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "brain: 14.5;retina: 26.4" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 241.8;Rod photoreceptor cells: 167.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SK-MEL-30: 2.5;U-266/70: 1.2" "Low region specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 15.8" HPA065334 Uncertain "Nuclear bodies" NA NA "Cluster 77: Retina - Visual perception" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 9: Photoreceptor cells - Phototransduction" "Nuclear bodies" "HPA065334: AB_2685472" "unprognostic (6.89e-3)" "unprognostic (2.62e-1)" "unprognostic (2.66e-3)" "unprognostic (2.73e-2)" "unprognostic (1.64e-1)" "unprognostic (2.98e-3)" "unprognostic (6.59e-2)" "unprognostic (7.02e-2)" "unprognostic (2.78e-1)" "unprognostic (2.56e-1)" "unprognostic (5.62e-5)" "unprognostic (6.40e-3)" "unprognostic (3.11e-6)" "unprognostic (5.03e-2)" "unprognostic (1.39e-1)" "unprognostic (3.70e-1)" "unprognostic (6.11e-3)" 1.2 1.1 8.2 0.3 9.1 0.4 1.3 14.5 13.5 2.9 4.4 1.6 0.2 2.0 0.3 1.1 2.6 0.2 1.0 7.0 10.1 1.2 2.1 1.0 0.4 11.8 7.8 3.4 1.0 0.1 2.1 0.2 10.5 2.0 0.1 26.4 0.8 0.5 2.2 1.2 1.3 0.4 6.1 1.6 0.8 1.7 9.6 0.5 2.1 0.3 0.2 1.6 1.7 11.0 0.0 0.0 0.2 0.7 0.2 0.0 0.6 0.4 0.0 0.2 0.2 0.4 0.1 0.3 0.5 0.0 0.1 0.5 0.4 0.0 0.0 0.6 0.3 0.0 0.4 0.1 0.2 0.3 0.3 0.2 0.3 0.1 0.1 0.5 0.0 0.2 0.2 0.2 0.0 0.1 0.1 0.4 0.2 0.0 0.2 0.5 0.1 0.4 0.0 0.1 0.3 0.2 0.2 0.0 2.5 0.3 0.1 0.3 0.0 0.2 0.1 0.2 0.2 1.2 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.2 9.1 14.5 13.5 7.0 10.1 11.8 7.8 10.5 6.1 9.6 11.0 2.1 0.0 1.1 6.2 1.0 0.6 1.7 1.2 2.2 35.3 2.5 1.9 5.0 0.0 1.5 3.7 241.8 0.8 2.4 0.3 1.9 0.5 0.6 1.7 1.9 2.3 1.2 0.4 18.4 0.9 0.3 1.4 1.1 1.7 0.0 3.3 1.8 2.0 0.3 3.3 18.3 1.2 2.0 0.6 0.8 1.3 3.4 1.0 1.8 3.7 0.0 21.8 0.0 5.5 19.9 1.0 1.1 3.4 1.4 1.3 3.1 9.9 0.3 167.3 6.6 1.8 2.2 2.0 3.4 0.8 0.9 0.7 1.9 1.5 0.8 0.6 PDCD7 "ES18, HES18" ENSG00000090470 "Programmed cell death 7" Q8N8D1 15 65117379-65133808 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 176.1;Cone photoreceptor cells: 221.0;Rod photoreceptor cells: 176.3;Spermatocytes: 164.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049388 Approved Approved "Nucleoli,Plasma membrane" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 9: Photoreceptor cells - Phototransduction" "Plasma membrane" Nucleoli "HPA049388: AB_2680741" "unprognostic (7.71e-3)" "unprognostic (3.25e-1)" "unprognostic (4.09e-1)" "unprognostic (1.52e-1)" "unprognostic (1.54e-1)" "unprognostic (1.22e-1)" "unprognostic (6.68e-3)" "unprognostic (2.36e-2)" "unprognostic (3.18e-3)" "unprognostic (8.18e-2)" "unprognostic (3.28e-2)" "unprognostic (5.36e-2)" "prognostic unfavorable (1.00e-4)" "unprognostic (5.29e-2)" "unprognostic (3.42e-2)" "unprognostic (1.44e-1)" "unprognostic (1.62e-2)" 12.0 12.4 13.8 11.9 14.3 10.0 11.9 18.0 18.2 16.2 12.2 15.8 9.9 16.5 12.7 17.8 13.6 8.4 11.4 14.2 13.3 10.3 12.5 10.2 14.5 14.2 13.5 16.8 11.2 11.6 10.9 11.9 14.6 13.0 9.3 10.8 10.0 11.9 13.1 11.1 11.3 13.3 12.0 13.4 11.0 18.9 14.2 15.7 12.5 8.7 15.1 14.8 14.0 16.7 18.2 14.9 24.8 25.7 24.4 34.2 15.0 20.4 22.6 24.7 18.8 18.2 19.7 34.9 21.7 16.5 18.5 33.5 63.9 14.7 17.7 21.3 17.0 33.9 12.8 15.9 22.5 46.6 21.8 20.0 22.0 13.6 25.4 23.7 19.8 25.6 44.0 27.6 21.7 13.9 48.7 33.2 30.1 21.1 13.3 42.7 31.8 39.0 15.2 28.5 20.4 24.3 22.8 19.1 31.3 27.0 15.4 37.7 20.0 25.2 24.6 14.8 31.9 49.1 60.4 24.9 22.7 50.5 13.2 2.1 1.4 0.9 2.0 1.2 1.7 2.3 1.9 1.8 1.3 2.4 2.0 1.9 0.3 3.3 1.2 1.8 1.5 0.7 13.8 14.3 18.0 18.2 14.2 13.3 14.2 13.5 14.6 12.0 14.2 16.7 33.6 0.0 14.3 10.1 46.3 38.0 67.8 6.0 89.4 176.1 33.1 40.9 17.7 21.5 11.1 29.5 221.0 55.3 55.8 17.2 29.4 9.0 5.9 26.8 51.8 36.5 14.4 27.5 31.0 8.2 32.6 38.4 20.4 28.2 19.7 49.0 31.1 19.4 23.6 75.7 32.9 26.9 6.1 23.2 22.8 8.9 58.1 24.7 12.4 9.4 14.5 47.2 45.3 15.1 28.9 7.3 11.6 48.2 37.9 56.8 14.2 22.7 8.5 176.3 46.0 45.5 38.8 164.6 107.3 48.8 39.9 71.4 49.5 60.3 26.1 51.5 CLPX ENSG00000166855 "Caseinolytic mitochondrial matrix peptidase chaperone subunit X" O76031 15 65148219-65185342 "Disease related genes, Predicted intracellular proteins" Chaperone "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 242.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040262, HPA048199" Approved Supported Nucleoplasm,Mitochondria,Cytosol "Intracellular and membrane" NA NA 65000 "Cluster 49: Eosinophils - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 25: Spermatids - Spermatogenesis" Mitochondria "Nucleoplasm, Cytosol" "HPA040262: AB_10793961, HPA048199: AB_2680312" "unprognostic (2.78e-1)" "unprognostic (6.58e-2)" "unprognostic (1.21e-1)" "unprognostic (2.69e-2)" "unprognostic (2.00e-2)" "unprognostic (3.06e-1)" "unprognostic (1.18e-3)" "unprognostic (2.64e-1)" "unprognostic (3.99e-2)" "unprognostic (1.29e-1)" "unprognostic (2.53e-2)" "unprognostic (6.99e-2)" "prognostic favorable (1.93e-9)" "unprognostic (1.76e-1)" "unprognostic (2.64e-1)" "unprognostic (5.95e-2)" "unprognostic (3.50e-2)" 7.9 10.8 9.2 6.1 9.7 8.0 9.3 9.5 11.0 7.6 7.4 9.2 8.8 7.8 8.6 13.3 7.9 6.3 14.1 7.8 8.3 12.2 32.9 6.5 9.1 9.8 8.9 9.4 9.4 11.9 4.6 9.8 8.5 8.0 8.0 10.1 7.6 6.0 26.8 14.7 7.4 7.1 8.8 8.4 9.2 9.1 9.4 10.6 9.8 24.0 9.9 7.9 8.9 10.1 8.1 13.7 11.7 14.8 12.2 15.5 12.5 9.2 10.2 9.8 10.3 13.7 11.1 25.0 7.5 12.3 7.3 16.9 43.2 12.1 10.5 9.9 7.9 18.9 12.8 17.4 17.3 24.4 10.5 18.6 16.2 9.0 17.1 11.3 12.6 13.3 17.6 8.6 11.7 10.3 11.6 21.4 13.1 16.0 6.1 22.4 13.9 26.1 18.6 18.5 10.1 8.1 12.4 19.3 13.8 15.3 8.9 20.3 11.2 9.8 8.7 8.0 8.7 9.2 15.0 13.0 9.6 30.4 7.8 2.2 4.1 6.5 4.3 3.5 3.9 4.4 3.7 3.2 3.9 3.9 5.0 4.0 6.4 4.7 3.3 5.9 3.5 2.7 9.2 9.7 9.5 11.0 7.8 8.3 9.8 8.9 8.5 8.8 9.4 10.1 16.4 35.3 35.5 15.3 23.6 19.2 18.8 20.9 18.8 32.3 17.0 15.6 69.9 27.1 29.5 33.1 14.6 41.0 28.5 16.7 21.5 36.8 104.5 24.4 28.7 21.0 10.3 56.8 15.6 31.6 29.2 25.5 33.6 27.5 16.4 37.8 21.0 90.1 22.6 32.0 15.2 20.3 28.5 28.3 16.6 242.3 28.9 20.3 17.8 16.9 34.1 25.9 20.6 12.5 23.9 29.0 18.2 29.7 30.8 24.9 23.1 33.8 27.7 27.2 26.3 23.1 30.1 45.0 30.6 29.1 30.1 89.2 24.4 59.0 24.3 25.5 CILP HsT18872 ENSG00000138615 "Cartilage intermediate layer protein" O75339 15 65194760-65211473 "Disease related genes, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 42.9;Fibroblasts: 138.1;Leydig cells: 231.5;Peritubular cells: 57.6;Theca cells: 83.5" "Cancer enhanced" "Detected in many" "breast cancer: 30.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 4.2;ASC TERT1: 2.5;EFO-21: 1.1;HSkMC: 6.5" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA003195 Uncertain "Secreted to extracellular matrix" NA NA 13000000 "Cluster 46: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "HPA003195: AB_1078524" "unprognostic (2.21e-2)" "unprognostic (3.43e-2)" "unprognostic (4.22e-2)" "unprognostic (7.18e-2)" "unprognostic (2.94e-1)" "unprognostic (2.28e-1)" "unprognostic (2.60e-1)" "unprognostic (1.14e-1)" "unprognostic (1.88e-2)" "unprognostic (3.00e-2)" "unprognostic (1.84e-1)" "unprognostic (1.27e-1)" "unprognostic (2.31e-13)" "unprognostic (5.10e-2)" "unprognostic (2.50e-1)" "prognostic unfavorable (2.24e-5)" "unprognostic (4.68e-3)" 49.8 0.8 0.2 9.5 0.2 0.1 21.9 0.3 0.3 44.9 0.1 20.3 2.3 13.8 3.6 11.0 15.8 36.8 27.4 0.2 0.2 1.0 1.6 2.9 1.6 0.2 0.2 7.5 3.0 0.3 0.7 2.5 0.2 3.1 6.9 0.5 9.4 4.8 15.5 14.0 22.6 51.0 0.2 0.6 8.3 12.1 0.2 1.8 2.4 32.9 0.8 26.9 28.1 0.2 0.0 0.0 0.0 0.0 4.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 8.1 0.0 0.0 0.0 0.0 5.2 0.1 0.2 0.0 0.9 0.4 0.5 2.1 0.0 0.4 1.8 0.0 0.0 0.2 0.1 0.0 0.1 1.7 1.2 42.9 1.5 0.0 0.0 0.3 0.0 0.0 138.1 4.1 1.7 0.0 0.1 2.2 0.1 0.1 0.0 0.6 0.1 2.0 0.0 11.9 7.1 231.5 1.7 1.8 1.9 0.0 0.2 0.0 1.0 0.3 0.0 0.0 57.6 0.3 0.1 0.0 0.0 0.0 0.1 0.0 14.7 6.6 0.6 0.3 0.1 6.1 0.0 1.6 83.5 0.2 0.0 PARP16 "ARTD15, C15orf30, FLJ20509, FLJ25281, pART15" ENSG00000138617 "Poly(ADP-ribose) polymerase family member 16" Q8N5Y8 15 65234460-65300618 "Metabolic proteins, Predicted membrane proteins" "Unfolded protein response" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 33.0;Spermatogonia: 28.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017081 Approved NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 46: Photoreceptor cells - Phototransduction" "HPA017081: AB_10963218" "unprognostic (1.17e-2)" "unprognostic (6.51e-3)" "unprognostic (2.82e-2)" "unprognostic (6.37e-2)" "unprognostic (7.38e-2)" "unprognostic (2.88e-2)" "unprognostic (3.05e-2)" "unprognostic (6.82e-2)" "unprognostic (2.18e-1)" "unprognostic (2.70e-1)" "unprognostic (1.00e-1)" "unprognostic (1.78e-1)" "unprognostic (3.41e-3)" "unprognostic (1.11e-1)" "unprognostic (2.71e-1)" "unprognostic (1.01e-1)" "unprognostic (9.61e-2)" 6.6 9.8 5.0 4.7 4.8 6.0 8.8 7.0 5.6 12.6 4.4 10.2 6.2 8.7 5.1 7.5 9.7 4.3 4.9 4.9 4.9 6.2 13.2 5.1 7.0 4.8 4.8 11.9 7.5 8.2 5.5 6.0 4.9 8.4 6.4 5.1 7.2 6.2 3.8 8.1 7.1 6.8 4.7 6.5 7.9 4.8 4.9 10.0 6.4 3.9 8.2 10.0 9.1 5.1 6.0 6.3 6.5 10.4 5.3 4.9 2.8 2.8 7.1 7.0 7.3 4.5 5.4 18.9 7.3 3.5 15.3 9.4 30.3 3.7 5.0 7.3 11.3 3.1 6.5 6.3 9.1 8.7 5.6 6.1 6.0 2.0 7.2 10.6 6.4 17.9 7.6 7.1 5.9 6.8 19.0 8.8 2.8 29.7 8.2 33.5 11.8 14.3 5.0 5.3 10.8 7.2 8.3 7.5 6.8 5.1 8.7 7.5 2.7 8.5 6.5 4.7 3.9 13.3 16.5 24.2 7.0 12.5 4.2 19.9 3.9 12.2 12.6 6.0 14.0 8.5 11.9 12.8 5.2 11.1 14.7 10.9 15.0 12.5 6.5 4.4 10.8 6.9 5.0 4.8 7.0 5.6 4.9 4.9 4.8 4.8 4.9 4.7 4.9 5.1 3.7 3.2 3.1 10.1 9.6 5.2 6.0 3.9 9.6 12.1 5.0 4.7 4.1 7.2 3.4 3.7 0.0 12.5 9.1 3.4 0.0 5.8 0.8 1.5 4.7 4.5 1.8 3.0 14.0 9.1 5.7 7.0 11.7 2.7 0.0 6.5 2.9 6.0 3.8 3.3 18.3 4.9 4.1 2.5 1.7 1.9 9.9 4.3 3.6 11.2 4.3 7.3 9.2 10.6 13.4 5.3 2.5 7.9 9.8 3.2 7.1 4.0 2.6 33.0 6.6 4.3 4.5 1.6 28.6 4.6 4.3 5.5 9.0 6.3 5.4 3.0 IGDCC3 "HsT18880, PUNC" ENSG00000174498 "Immunoglobulin superfamily DCC subclass member 3" Q8IVU1 15 65327127-65378002 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.3;parathyroid gland: 5.1;placenta: 6.0" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 33.3;Cytotrophoblasts: 104.8;Early spermatids: 37.6;Late spermatids: 98.6;Syncytiotrophoblasts: 41.3" "Group enriched" "Detected in many" 5 "glioma: 2.2;testis cancer: 5.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 105.8;CACO-2: 27.4;Hep G2: 87.8;SuSa: 41.9" "Low region specificity" "Detected in many" HPA015713 Uncertain Nucleoplasm,Vesicles NA NA "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 12: NES - Nervous system development" "Cluster 47: Cytotrophoblasts - Unknown function" "Nucleoplasm, Vesicles" "HPA015713: " "unprognostic (7.11e-2)" "unprognostic (1.99e-1)" "unprognostic (4.24e-2)" "unprognostic (7.25e-3)" "unprognostic (6.67e-2)" "unprognostic (7.35e-3)" "unprognostic (3.93e-2)" "unprognostic (1.53e-1)" "unprognostic (1.82e-2)" "unprognostic (4.56e-1)" "unprognostic (1.61e-1)" "unprognostic (1.78e-1)" "unprognostic (5.77e-5)" "unprognostic (4.15e-1)" "unprognostic (1.26e-1)" "unprognostic (1.28e-1)" "unprognostic (1.33e-2)" 0.0 0.2 2.3 0.0 2.0 0.0 0.8 4.3 3.2 1.0 0.0 0.4 0.0 0.7 0.1 0.0 0.6 0.1 0.1 2.6 1.9 0.2 0.0 0.0 0.0 2.4 2.7 0.8 0.0 5.1 1.9 6.0 2.4 0.1 0.0 1.0 0.0 0.1 0.1 0.1 0.1 0.2 1.6 0.0 0.2 2.8 3.0 1.4 0.9 0.0 0.0 0.1 0.4 1.9 0.0 0.0 105.8 4.7 0.0 0.0 1.3 0.0 0.0 0.0 0.0 27.4 0.2 0.0 0.3 0.0 0.0 0.0 7.2 0.0 0.0 0.0 1.0 0.0 0.2 87.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 16.1 0.0 0.0 0.1 0.0 0.0 0.0 0.5 2.2 1.5 0.1 0.1 0.0 41.9 3.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 2.0 4.3 3.2 2.6 1.9 2.4 2.7 2.4 1.6 3.0 1.9 0.1 0.0 0.0 15.3 0.0 0.0 0.2 0.0 0.0 4.1 2.2 1.0 0.6 0.0 0.0 1.8 33.3 104.8 0.0 0.4 0.0 0.0 37.6 0.4 4.8 1.0 0.0 0.0 2.8 0.0 4.3 3.0 0.0 0.6 0.0 0.1 0.0 0.0 7.2 0.0 7.0 0.0 0.0 0.0 0.0 98.6 0.6 0.1 0.0 1.0 0.0 3.7 0.0 16.1 8.9 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 3.1 0.0 0.7 0.4 1.3 11.0 0.0 0.0 41.3 0.1 0.1 0.2 0.0 IGDCC4 "LOC57722, NOPE" ENSG00000103742 "Immunoglobulin superfamily DCC subclass member 4" Q8TDY8 15 65381484-65422947 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.3;skeletal muscle: 10.6;tongue: 14.0" "Cell type enhanced" "Detected in many" "Astrocytes: 18.6;Cone photoreceptor cells: 31.3;Fibroblasts: 14.7;Leydig cells: 34.8;Microglial cells: 14.0;Oligodendrocyte precursor cells: 17.6;Skeletal myocytes: 29.8" "Cancer enhanced" "Detected in many" "glioma: 6.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 4.4;AF22: 9.4;CAPAN-2: 8.1;EFO-21: 4.5;HSkMC: 5.2;NTERA-2: 7.2;SuSa: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008510, HPA008576" Approved Approved Approved Nucleoplasm,Cytosol NA NA 64000000 "Cluster 80: Striated muscle - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 33: Fibroblasts - ECM organization" "Nucleoplasm, Cytosol" "HPA008510: , HPA008576: AB_1079496" "unprognostic (1.16e-1)" "unprognostic (9.38e-2)" "unprognostic (1.92e-2)" "unprognostic (1.20e-2)" "unprognostic (1.58e-1)" "unprognostic (1.77e-2)" "unprognostic (2.75e-3)" "unprognostic (9.94e-2)" "unprognostic (4.18e-2)" "unprognostic (3.65e-2)" "unprognostic (3.29e-2)" "unprognostic (6.36e-2)" "unprognostic (1.83e-8)" "unprognostic (3.30e-2)" "unprognostic (4.54e-2)" "unprognostic (2.33e-1)" "unprognostic (5.32e-3)" 0.9 2.5 5.6 2.4 6.9 0.0 0.5 5.8 2.5 3.4 0.0 0.8 0.5 1.4 4.2 1.6 1.7 4.2 0.9 2.9 7.2 0.1 0.0 0.2 0.6 11.2 9.4 8.5 0.1 0.3 0.9 5.6 6.8 0.4 0.6 0.8 0.5 0.4 10.6 0.8 0.8 1.0 6.9 0.2 1.1 0.6 11.3 0.7 1.9 14.0 0.6 2.1 2.0 4.5 0.0 4.4 9.4 0.0 0.0 1.0 0.0 0.4 0.0 0.0 0.3 0.5 8.1 0.0 4.5 0.3 0.0 0.0 2.3 0.0 0.1 0.0 0.5 0.0 0.0 0.2 0.3 0.0 0.0 5.2 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 1.7 0.0 0.0 0.8 7.2 0.0 0.0 0.0 2.3 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.4 5.4 0.0 0.0 0.0 3.7 2.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 6.9 5.8 2.5 2.9 7.2 11.2 9.4 6.8 6.9 11.3 4.5 0.2 0.0 0.0 18.6 0.0 2.3 0.0 0.0 0.0 7.7 0.2 0.5 2.2 0.0 0.0 3.7 31.3 0.4 0.1 0.0 0.0 0.4 0.4 0.0 2.1 0.3 0.0 0.0 0.9 0.0 0.6 14.7 1.1 0.0 0.0 8.8 0.0 0.0 0.7 0.0 6.3 0.0 0.0 0.0 2.5 1.4 34.8 0.3 5.4 14.0 0.0 1.0 1.0 17.6 1.0 0.3 0.0 4.1 0.1 0.1 0.0 0.7 0.0 12.2 6.6 29.8 1.0 0.8 2.6 0.1 1.1 0.8 0.3 7.0 0.0 0.0 DPP8 "DP8, DPRP1, FLJ14920, FLJ20283, MGC26191, MSTP141" ENSG00000074603 "Dipeptidyl peptidase 8" Q6V1X1 15 65442463-65517704 "Enzymes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Aminopeptidase, Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008706 Approved Supported Cytosol NA NA "Cluster 38: Basophils - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 16: U-266 - Nucleosome" "Cluster 66: Spermatocytes - Spermatogenesis" Cytosol "HPA008706: AB_1078665" "unprognostic (3.65e-1)" "unprognostic (2.38e-2)" "unprognostic (2.15e-1)" "unprognostic (1.13e-1)" "unprognostic (1.24e-1)" "unprognostic (8.60e-2)" "unprognostic (2.98e-1)" "unprognostic (2.46e-1)" "unprognostic (2.52e-2)" "unprognostic (1.81e-1)" "unprognostic (4.09e-2)" "unprognostic (3.60e-2)" "unprognostic (1.99e-2)" "unprognostic (1.01e-1)" "unprognostic (7.58e-2)" "unprognostic (8.56e-2)" "unprognostic (2.59e-1)" 12.7 10.2 7.0 12.1 8.5 14.9 11.8 9.3 11.3 11.8 5.5 11.4 14.4 11.7 9.7 10.0 8.3 9.7 14.9 8.3 9.2 12.7 7.9 11.1 12.9 7.3 8.3 10.8 7.4 15.2 5.7 11.2 7.2 10.8 12.9 15.4 9.5 11.5 27.5 9.8 13.5 13.1 8.5 14.8 11.0 26.1 9.7 13.8 14.1 30.6 11.3 11.2 8.3 9.7 14.1 24.4 15.7 15.8 17.4 25.2 12.8 22.5 28.4 21.1 20.3 10.6 12.6 25.1 16.3 30.3 14.5 25.9 30.6 17.6 26.0 20.9 17.2 24.2 18.1 10.4 17.9 34.3 23.8 18.6 18.3 17.0 16.0 18.5 23.2 19.2 16.4 24.1 26.5 12.5 17.1 12.0 9.9 15.7 11.1 22.6 27.9 24.7 19.8 32.7 10.5 17.0 14.3 15.8 25.3 15.6 14.4 22.5 28.6 28.2 19.2 12.7 25.5 26.9 42.2 25.8 21.3 32.8 20.4 30.5 11.7 15.1 12.1 11.7 12.6 11.8 10.0 11.2 10.9 12.2 9.5 10.6 20.9 8.2 15.8 8.6 11.3 7.2 7.0 8.5 9.3 11.3 8.3 9.2 7.3 8.3 7.2 8.5 9.7 9.7 39.1 35.3 27.9 65.6 30.0 13.4 15.0 20.4 15.9 24.1 21.1 14.2 43.4 21.5 25.4 14.7 37.5 20.4 35.3 25.8 23.5 22.7 57.4 17.3 19.3 39.5 25.9 17.9 50.1 30.0 15.2 22.3 31.1 17.5 27.8 24.7 46.1 18.2 21.5 28.6 58.6 27.0 16.2 36.0 15.1 59.7 29.2 31.9 23.2 38.4 47.6 32.3 45.3 36.2 57.1 38.4 25.8 29.3 24.7 19.3 24.2 27.5 25.9 28.1 19.7 29.9 22.1 69.3 24.4 21.9 20.2 17.6 28.5 46.5 26.7 23.6 HACD3 "B-ind1, HSPC121, PTPLAD1" ENSG00000074696 "3-hydroxyacyl-CoA dehydratase 3" Q9P035 15 65530418-65578349 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014837, HPA060347" Enhanced Enhanced "Endoplasmic reticulum" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 21: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Endoplasmic reticulum" "HPA014837: AB_1855914, HPA060347: AB_2684260" "unprognostic (1.51e-2)" "unprognostic (2.89e-1)" "unprognostic (2.29e-1)" "unprognostic (2.18e-1)" "unprognostic (3.52e-1)" "unprognostic (1.92e-2)" "unprognostic (1.67e-1)" "unprognostic (2.28e-1)" "unprognostic (3.36e-2)" "unprognostic (1.09e-1)" "unprognostic (1.73e-1)" "unprognostic (2.57e-1)" "prognostic favorable (3.09e-5)" "unprognostic (3.44e-2)" "unprognostic (5.33e-2)" "unprognostic (1.10e-2)" "unprognostic (2.04e-2)" 23.1 84.1 56.1 18.5 57.1 17.3 74.4 64.6 67.5 40.2 73.2 30.0 28.9 29.9 43.0 19.2 32.4 34.1 11.8 54.3 87.8 79.6 119.1 30.3 18.8 68.3 79.6 47.8 29.8 61.5 44.2 37.2 87.2 41.6 34.3 54.0 28.6 34.3 6.9 27.7 29.2 28.1 70.0 21.2 68.7 34.6 88.3 29.0 70.8 7.8 20.3 43.0 17.8 75.8 88.9 194.4 211.3 106.2 130.3 78.0 99.8 95.9 82.4 106.6 119.6 149.9 129.1 110.8 81.8 104.7 132.6 237.9 344.4 80.1 94.8 61.9 191.8 88.1 88.7 165.3 65.9 110.6 64.9 80.3 58.7 73.3 52.5 102.7 105.5 65.1 117.5 40.8 174.3 105.6 82.5 86.0 180.6 235.3 65.4 91.8 178.9 125.0 152.1 151.2 126.8 111.9 103.6 114.9 110.5 197.5 117.1 57.9 84.2 134.4 117.6 66.9 134.9 79.1 251.2 154.5 89.7 105.8 82.6 8.5 7.5 2.5 31.7 11.2 36.1 23.7 28.6 30.2 13.2 22.2 33.0 32.9 1.0 23.2 12.7 17.4 24.6 22.7 56.1 57.1 64.6 67.5 54.3 87.8 68.3 79.6 87.2 70.0 88.3 75.8 63.6 64.1 64.8 84.5 18.7 0.0 60.5 0.0 76.2 121.3 94.8 64.5 9.9 62.9 27.9 176.6 100.1 189.1 23.8 6.1 25.4 71.3 107.2 62.8 76.2 51.8 43.7 67.3 57.5 46.3 124.4 62.7 73.4 39.8 16.4 127.0 42.1 165.2 51.2 139.7 97.1 26.3 0.0 23.1 0.0 32.5 87.3 22.2 0.0 29.0 5.2 89.8 16.5 57.8 66.7 32.1 18.2 88.4 28.9 71.5 28.3 56.2 36.5 83.7 78.9 40.9 41.9 156.9 110.3 54.3 0.0 113.1 22.3 136.2 45.1 78.7 INTS14 "C15orf44, DKFZP564O1664, VWA9" ENSG00000138614 "Integrator complex subunit 14" Q96SY0 15 65578753-65611289 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 40.5;Extravillous trophoblasts: 30.5;Syncytiotrophoblasts: 49.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040255, HPA040651" Approved Approved "Nucleoplasm,Nuclear membrane,Nuclear bodies,Mitochondria" No No "Cluster 44: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Nuclear bodies, Mitochondria" "Nuclear membrane" "HPA040255: AB_10805710, HPA040651: AB_10796559" "unprognostic (2.92e-1)" "unprognostic (3.01e-1)" "unprognostic (2.78e-1)" "unprognostic (2.41e-1)" "unprognostic (4.06e-1)" "unprognostic (2.35e-2)" "unprognostic (1.36e-1)" "unprognostic (1.63e-1)" "unprognostic (5.80e-2)" "unprognostic (5.60e-2)" "unprognostic (2.57e-2)" "unprognostic (2.67e-2)" "unprognostic (1.03e-3)" "unprognostic (1.92e-2)" "unprognostic (1.23e-1)" "unprognostic (5.75e-2)" "unprognostic (1.30e-1)" 12.5 15.8 13.2 14.2 15.8 18.0 22.3 14.7 16.6 20.9 18.2 21.8 14.1 18.1 27.4 16.1 24.2 19.6 13.4 13.5 14.8 21.3 21.1 15.6 22.7 14.5 14.9 18.4 17.7 22.9 16.3 19.2 14.6 19.1 23.6 13.1 16.2 19.8 9.9 18.0 17.2 18.8 14.8 18.9 18.1 18.9 15.8 25.4 23.2 13.6 24.3 23.6 13.6 17.7 26.4 46.7 46.1 36.8 25.2 31.4 29.5 28.4 36.5 46.4 42.5 42.2 61.2 42.9 38.9 35.6 38.5 52.0 99.4 47.6 40.5 37.8 60.2 37.5 32.2 46.4 50.0 38.7 46.2 30.6 46.9 35.1 53.7 34.1 50.8 64.8 52.2 24.3 33.4 41.7 44.3 41.2 33.8 66.2 25.6 37.5 38.8 49.0 36.7 48.6 33.1 26.3 34.2 34.5 49.5 39.2 32.3 44.0 25.2 31.8 33.2 28.8 45.6 23.9 48.4 58.1 32.1 70.0 38.1 25.7 11.0 6.2 19.8 12.7 22.3 19.3 20.3 22.6 19.8 14.8 21.1 19.2 1.2 23.8 9.5 17.9 30.8 16.6 13.2 15.8 14.7 16.6 13.5 14.8 14.5 14.9 14.6 14.8 15.8 17.7 12.2 22.4 10.9 0.0 3.8 0.0 0.0 0.0 0.0 0.0 13.0 11.0 0.0 0.0 5.6 12.9 0.0 40.5 7.7 0.0 21.5 18.2 0.0 12.8 11.8 6.8 0.0 0.0 0.0 15.4 30.5 6.7 0.0 12.6 7.6 22.5 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 9.3 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.5 0.0 0.0 15.1 10.9 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 49.8 4.8 24.0 0.0 0.0 SLC24A1 "CSNB1D, HsT17412, KIAA0702, NCKX, NCKX1, RODX" ENSG00000074621 "Solute carrier family 24 member 1" O60721 15 65611366-65660995 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sensory transduction, Symport, Transport, Vision" "Congenital stationary night blindness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 34 "retina: 193.5" "Cell type enriched" "Detected in many" 11 "Rod photoreceptor cells: 338.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA039370 Enhanced Approved Microtubules NA NA "Cluster 6: Non-specific - Transcription" "Cluster 79: Retina - Phototransduction" "Cluster 21: OE19 - Mitochondria" "Cluster 46: Photoreceptor cells - Phototransduction" Microtubules "HPA039370: AB_10960279" "unprognostic (9.47e-2)" "unprognostic (9.97e-2)" "unprognostic (1.66e-1)" "unprognostic (3.66e-3)" "unprognostic (6.39e-3)" "unprognostic (4.64e-1)" "unprognostic (8.82e-2)" "unprognostic (1.86e-1)" "unprognostic (4.69e-2)" "unprognostic (3.94e-1)" "unprognostic (2.01e-1)" "unprognostic (9.91e-2)" "prognostic favorable (2.33e-6)" "unprognostic (8.45e-2)" "unprognostic (9.22e-2)" "unprognostic (3.04e-2)" "unprognostic (1.96e-2)" 4.0 3.0 2.4 1.9 2.2 1.8 4.9 5.7 2.7 4.8 2.5 2.6 2.2 3.8 4.7 2.4 5.1 3.8 1.6 2.1 2.1 5.1 2.9 3.1 3.3 2.3 2.3 5.4 2.9 3.8 2.7 3.6 2.3 3.2 2.4 193.5 2.6 3.1 1.0 5.1 3.0 2.9 2.3 3.9 2.5 4.1 2.1 2.4 5.1 1.3 1.8 3.0 3.2 2.5 1.5 3.0 3.2 2.9 4.7 7.9 4.0 3.7 4.2 3.7 2.4 1.4 6.5 2.1 12.4 3.7 1.3 4.1 3.9 4.2 2.1 2.2 2.8 4.6 2.5 6.8 6.8 3.1 6.0 6.7 5.9 2.1 12.3 5.1 6.4 4.8 5.0 7.0 6.0 6.4 2.0 2.8 4.1 13.5 1.2 2.0 1.0 1.4 5.6 6.0 1.5 2.1 1.0 2.8 8.0 4.4 6.0 4.2 9.3 3.7 3.7 1.4 2.6 2.8 5.5 2.4 3.9 6.4 3.1 2.6 0.4 0.7 0.4 0.4 0.5 0.4 0.4 0.4 0.3 1.0 0.3 0.4 0.6 0.8 0.2 0.8 0.1 0.1 2.4 2.2 5.7 2.7 2.1 2.1 2.3 2.3 2.3 2.3 2.1 2.5 4.0 6.4 5.1 5.2 3.4 1.5 1.4 1.2 1.8 29.8 3.5 2.8 2.3 0.0 3.8 0.0 27.1 4.2 1.6 2.9 0.0 1.5 1.6 6.3 5.4 15.6 1.8 1.7 2.2 1.3 2.7 2.6 4.1 7.9 2.5 4.7 3.6 1.4 1.9 20.2 2.0 2.5 2.0 3.1 1.6 2.5 3.1 2.7 1.8 4.7 1.2 26.1 2.1 3.0 1.4 2.6 0.5 2.2 3.3 1.4 2.6 0.7 4.1 338.3 0.0 3.4 2.5 20.3 10.1 2.9 1.0 2.5 2.5 8.3 2.6 0.9 DENND4A "IRLB, MYCPBP" ENSG00000174485 "DENN domain containing 4A" Q7Z401 15 65658046-65792293 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 59.3" "Cell type enhanced" "Detected in many" "Excitatory neurons: 195.4;Oligodendrocyte precursor cells: 176.5;Oligodendrocytes: 180.2;Rod photoreceptor cells: 155.9" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 29.9" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065343 Uncertain Approved "Nucleoplasm,Nucleoli rim,Mitotic chromosome" Yes No "Cluster 21: B-cells - Adaptive immune response" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 46: Photoreceptor cells - Phototransduction" "Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA065343: AB_2685476" "unprognostic (1.10e-1)" "unprognostic (8.43e-2)" "unprognostic (4.96e-2)" "unprognostic (1.60e-1)" "unprognostic (1.31e-1)" "unprognostic (3.29e-1)" "unprognostic (8.02e-2)" "unprognostic (2.30e-2)" "unprognostic (8.88e-2)" "unprognostic (2.28e-1)" "unprognostic (1.82e-1)" "unprognostic (1.38e-1)" "unprognostic (1.66e-1)" "unprognostic (7.83e-2)" "unprognostic (3.45e-1)" "unprognostic (2.24e-1)" "unprognostic (3.48e-1)" 6.2 9.8 4.0 11.4 6.5 33.8 6.8 29.9 7.5 7.4 11.2 6.6 5.8 8.8 5.1 6.6 7.2 11.2 5.1 5.6 5.1 7.9 16.8 9.5 19.7 3.5 4.7 12.8 15.5 10.1 8.4 8.5 4.7 6.0 6.8 59.3 6.1 5.6 9.2 6.5 6.3 7.4 4.2 12.4 8.9 7.9 3.3 12.7 9.3 7.8 18.2 10.2 4.5 7.6 9.9 9.6 4.9 5.1 14.3 15.9 5.9 10.1 13.9 6.8 9.9 5.5 7.8 52.0 6.8 15.1 8.4 18.1 9.7 9.2 12.0 56.7 11.2 49.4 11.7 10.4 8.3 16.8 16.7 10.6 10.3 9.5 20.0 12.0 18.5 11.4 15.2 31.5 7.9 5.2 8.1 9.1 1.5 30.5 6.9 3.9 17.2 45.1 8.0 19.0 7.7 7.0 9.8 6.9 8.9 5.8 6.7 43.1 19.6 9.3 10.3 16.7 14.2 16.8 20.1 19.3 13.1 36.2 7.8 3.2 2.6 5.2 3.6 1.0 5.5 5.4 3.1 4.6 2.3 6.1 3.2 3.1 1.4 3.5 0.9 0.9 3.3 1.5 4.0 6.5 29.9 7.5 5.6 5.1 3.5 4.7 4.7 4.2 3.3 7.6 22.7 16.0 23.1 126.7 81.5 27.9 29.8 7.9 36.5 73.8 23.9 12.2 12.3 20.0 15.2 9.2 60.5 5.6 47.8 5.8 0.0 10.1 2.4 29.3 22.2 23.7 17.4 83.1 195.4 13.0 6.8 22.4 25.0 46.1 48.8 10.5 21.0 25.9 20.4 111.0 140.3 9.7 0.0 19.0 47.5 3.0 13.1 42.2 24.9 145.2 24.5 26.9 20.6 176.5 180.2 12.0 10.1 12.4 55.1 20.2 6.4 9.8 18.1 155.9 6.6 37.9 15.7 11.3 10.9 18.7 17.0 12.6 56.5 13.2 10.0 17.3 RAB11A YL8 ENSG00000103769 "RAB11A, member RAS oncogene family" P62491 15 65726054-65891989 "Predicted intracellular proteins" "Cell cycle, Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 969.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013097, HPA051697, HPA060686" Approved Enhanced "Vesicles,Centriolar satellite" No No "Cluster 45: Eosinophils - Innate immune response" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 21: OE19 - Mitochondria" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Vesicles, Centriolar satellite" "CAB013097: AB_2533987, HPA051697: AB_2732569, HPA060686: AB_2684342" "unprognostic (4.15e-2)" "unprognostic (5.86e-2)" "unprognostic (1.22e-1)" "unprognostic (8.74e-3)" "unprognostic (6.85e-2)" "unprognostic (6.07e-2)" "unprognostic (3.17e-2)" "unprognostic (7.12e-2)" "unprognostic (8.60e-2)" "unprognostic (4.83e-2)" "prognostic unfavorable (4.37e-4)" "unprognostic (4.29e-2)" "prognostic favorable (1.46e-5)" "unprognostic (9.93e-2)" "unprognostic (1.83e-2)" "unprognostic (5.23e-3)" "unprognostic (1.21e-1)" 140.0 231.6 79.7 123.9 86.4 126.0 150.1 83.4 105.0 159.3 78.5 223.8 139.8 117.4 130.9 480.0 146.1 185.1 156.3 86.1 97.4 162.9 124.1 148.1 141.2 87.0 83.0 104.9 107.6 192.5 106.8 214.4 101.3 150.3 224.2 99.0 195.1 126.2 119.6 288.5 158.9 149.2 87.2 183.9 216.2 201.8 86.0 143.6 155.3 109.6 246.0 269.8 232.2 86.7 285.2 330.3 330.1 240.8 294.7 275.0 431.1 297.0 300.4 264.4 313.0 305.8 497.4 370.7 295.8 342.6 262.3 429.0 525.0 393.2 248.2 243.7 314.9 445.3 219.9 274.1 224.7 211.5 254.0 282.8 438.1 260.2 214.7 281.7 595.2 197.8 364.5 214.3 378.1 283.7 209.9 167.3 275.9 1057.4 185.9 176.3 250.5 346.3 716.1 734.7 237.4 251.9 214.0 335.6 286.5 387.8 445.0 243.0 453.7 208.4 296.4 203.1 267.8 112.2 289.5 288.8 193.7 353.5 228.8 183.5 154.8 235.2 56.7 133.9 58.8 78.8 85.3 68.6 137.1 64.1 78.9 63.6 232.8 71.3 154.6 87.6 109.5 340.2 79.7 86.4 83.4 105.0 86.1 97.4 87.0 83.0 101.3 87.2 86.0 86.7 155.7 57.7 57.8 15.3 90.2 192.2 180.2 375.2 134.3 42.3 107.5 69.6 89.5 105.8 245.4 187.6 33.3 326.4 76.0 313.4 346.3 360.6 413.1 119.3 72.7 260.7 206.2 91.1 31.3 337.0 340.4 96.9 149.9 194.5 74.9 75.9 235.2 88.4 239.2 57.2 27.7 227.4 244.1 114.8 214.2 80.9 97.3 148.1 186.7 42.2 217.8 137.9 65.9 25.6 21.9 391.1 277.0 86.5 72.1 187.6 205.8 271.5 240.0 36.1 46.0 45.2 161.5 407.5 95.3 225.5 284.4 969.3 96.6 97.6 209.2 360.8 MEGF11 "DKFZp434L121, KIAA1781" ENSG00000157890 "Multiple EGF like domains 11" A6BM72 15 65895079-66253747 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 23.0;fallopian tube: 7.8;kidney: 8.4;retina: 14.2" "Group enriched" "Detected in many" 9 "Early spermatids: 175.8;Horizontal cells: 126.2;Late spermatids: 177.8;Oligodendrocyte precursor cells: 460.4" "Group enriched" "Detected in some" 5 "endometrial cancer: 0.7;glioma: 2.3;renal cancer: 0.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.3;HEK 293: 2.7;RPTEC TERT1: 9.2;SCLC-21H: 7.2;U-698: 2.0" "Region enriched" "Detected in all" 4 "cerebellum: 35.0" "Region enriched" "Detected in all" 7 "cerebellum: 25.8" NA NA "Cluster 77: Retina - Visual perception" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 68: Oligodendrocytes - Mixed function" "unprognostic (2.97e-2)" "unprognostic (1.23e-1)" "unprognostic (7.95e-2)" "unprognostic (1.84e-2)" "unprognostic (9.02e-3)" "unprognostic (6.45e-3)" "unprognostic (1.51e-1)" "unprognostic (4.08e-2)" "unprognostic (2.92e-1)" "unprognostic (1.23e-1)" "unprognostic (6.79e-3)" "unprognostic (6.81e-3)" "unprognostic (5.71e-5)" "unprognostic (7.94e-2)" "unprognostic (9.78e-3)" "unprognostic (2.03e-1)" "unprognostic (4.89e-2)" 0.0 0.1 8.3 0.2 5.3 0.3 0.1 23.0 7.0 0.1 0.4 0.1 0.0 0.1 0.8 0.1 7.8 0.0 0.1 10.5 7.5 8.4 0.0 0.5 0.1 6.6 8.8 0.3 0.2 0.0 3.0 0.0 7.0 0.1 0.0 14.2 0.1 0.1 0.1 1.3 0.1 0.0 4.5 0.2 0.3 3.9 8.0 0.1 0.0 0.0 0.0 0.0 0.1 7.4 0.0 0.1 0.3 3.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.5 0.0 0.2 0.0 0.2 0.0 0.1 0.1 2.7 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.8 0.1 0.0 1.2 0.0 0.0 9.2 0.2 7.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 8.3 5.3 23.0 7.0 10.5 7.5 6.6 8.8 7.0 4.5 8.0 7.4 0.2 0.0 3.7 5.2 0.4 2.2 0.7 1.0 0.6 5.3 0.8 0.0 1.4 0.0 0.3 3.7 8.4 0.3 0.4 0.0 0.0 0.1 175.8 0.3 0.3 1.5 0.0 0.4 9.5 0.2 0.1 0.7 2.6 0.8 0.0 0.2 2.9 0.0 0.1 126.2 18.4 0.0 0.0 0.3 3.5 177.8 2.5 0.4 0.0 1.0 0.0 4.4 0.0 460.4 1.7 0.1 0.1 1.5 1.3 0.6 0.0 2.2 0.8 25.7 0.0 1.0 0.5 2.9 1.9 0.6 3.8 0.5 0.9 0.1 0.0 0.5 DIS3L "DIS3L1, FLJ38088, KIAA1955, MGC4562" ENSG00000166938 "DIS3 like exosome 3'-5' exoribonuclease" Q8TF46 15 66293217-66333898 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041805 Approved Supported "Plasma membrane,Centrosome,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Plasma membrane, Cytosol" Centrosome "HPA041805: AB_10796783" "unprognostic (2.57e-1)" "unprognostic (5.37e-2)" "unprognostic (1.12e-1)" "unprognostic (3.99e-2)" "unprognostic (3.16e-1)" "unprognostic (1.40e-1)" "unprognostic (1.68e-1)" "unprognostic (2.94e-2)" "unprognostic (2.27e-2)" "unprognostic (1.28e-2)" "unprognostic (1.59e-3)" "unprognostic (1.86e-1)" "unprognostic (3.42e-3)" "unprognostic (2.66e-1)" "unprognostic (6.18e-2)" "unprognostic (9.58e-2)" "unprognostic (3.40e-1)" 11.0 11.8 7.9 6.2 9.8 7.6 9.3 8.9 8.6 10.3 7.7 11.1 5.1 11.1 9.5 7.5 9.6 5.5 12.7 8.0 9.1 8.3 11.0 5.9 7.6 8.7 9.4 11.1 12.8 15.8 10.0 5.4 9.6 8.7 6.0 11.4 8.9 9.0 23.2 7.4 7.7 8.8 8.8 8.7 9.0 9.8 8.9 7.8 11.0 28.3 7.2 9.6 8.1 12.2 14.0 32.6 10.6 14.1 12.2 16.4 12.4 9.5 11.1 14.3 13.2 17.6 10.1 51.6 10.3 13.4 14.9 23.3 25.7 9.2 9.2 12.0 24.1 26.7 25.1 20.1 9.5 27.7 10.1 6.9 9.7 4.5 14.8 9.7 13.1 17.7 18.6 12.6 14.4 12.3 13.8 17.3 15.4 12.7 20.0 18.3 42.1 30.0 5.7 18.9 17.1 15.7 22.3 7.6 11.4 10.0 10.6 21.8 14.4 18.7 16.8 7.4 18.7 10.1 36.9 24.0 6.4 35.9 7.8 8.5 5.1 4.3 7.6 6.1 10.2 6.5 7.7 10.0 8.5 7.8 8.8 7.3 0.6 11.7 13.2 6.7 8.0 6.7 7.9 9.8 8.9 8.6 8.0 9.1 8.7 9.4 9.6 8.8 8.9 12.2 7.1 6.4 16.2 22.5 14.6 4.2 5.5 4.0 17.1 15.6 9.4 7.6 30.3 15.7 7.1 3.7 4.2 17.0 9.6 5.0 5.9 6.5 7.1 8.3 14.6 10.2 3.0 24.2 11.4 3.5 4.5 12.4 10.7 7.3 16.5 25.1 7.1 19.2 9.6 10.1 17.2 10.6 8.2 12.3 7.8 9.9 19.9 10.1 1.8 13.1 14.4 17.7 12.3 22.6 23.1 3.3 5.1 20.3 18.4 4.8 5.4 9.8 8.1 23.2 19.7 9.5 10.1 28.5 17.2 12.1 5.4 3.7 16.0 16.5 14.0 3.8 TIPIN FLJ20516 ENSG00000075131 "TIMELESS interacting protein" Q9BVW5 15 66336191-66386746 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 98.0;Langerhans cells: 93.7;Spermatocytes: 120.6;Suprabasal keratinocytes: 108.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039704, HPA058799" Enhanced NA Yes "Cluster 24: B-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA039704: AB_10795258, HPA058799: AB_2683824" "unprognostic (3.47e-1)" "prognostic favorable (4.15e-4)" "unprognostic (3.49e-3)" "unprognostic (6.34e-2)" "unprognostic (1.87e-1)" "unprognostic (5.14e-2)" "prognostic unfavorable (2.47e-4)" "unprognostic (3.75e-1)" "unprognostic (1.32e-3)" "unprognostic (1.42e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (9.35e-4)" "unprognostic (2.18e-3)" "unprognostic (9.47e-2)" "unprognostic (1.09e-1)" "unprognostic (4.91e-1)" "unprognostic (2.89e-3)" 4.2 4.4 3.3 7.1 3.3 12.6 5.9 5.4 4.6 3.9 2.0 4.8 2.8 4.7 1.8 4.9 5.5 2.6 3.1 3.2 3.1 4.0 4.9 3.5 9.5 3.2 3.9 6.4 4.7 5.2 3.2 3.8 3.1 3.5 5.3 8.1 3.3 3.2 4.0 3.9 3.0 4.4 2.9 3.7 3.8 20.5 3.2 7.8 4.4 4.8 10.8 3.6 3.3 3.7 28.6 33.9 36.9 17.7 6.4 13.6 30.2 39.1 16.0 54.8 48.0 49.9 32.1 58.5 27.8 14.9 31.9 44.8 94.2 34.1 51.7 39.0 52.4 51.7 33.0 28.0 12.9 54.4 17.1 17.5 11.1 51.2 41.2 7.8 23.0 47.6 43.6 27.4 47.8 32.7 50.3 35.2 37.7 66.7 26.7 50.1 54.9 58.0 19.0 32.5 35.0 21.9 27.5 17.4 25.3 26.8 26.6 32.9 15.3 38.9 42.6 33.7 73.4 16.4 91.2 92.7 26.0 98.8 40.3 0.4 2.1 1.4 2.7 4.3 3.2 2.3 2.0 2.4 3.8 4.3 3.0 3.4 0.4 4.5 2.7 2.9 1.9 1.9 3.3 3.3 5.4 4.6 3.2 3.1 3.2 3.9 3.1 2.9 3.2 3.7 7.8 6.4 7.0 14.0 15.7 98.0 72.4 24.3 5.7 11.8 7.1 9.0 2.7 28.6 11.5 9.2 10.4 35.9 7.8 5.4 86.1 11.8 63.3 8.3 8.6 18.4 4.8 15.6 7.8 8.6 41.2 16.5 5.1 4.8 8.2 11.8 14.6 13.7 21.4 8.4 11.1 7.1 14.2 27.4 93.7 31.4 19.0 13.2 56.9 1.0 12.3 9.2 15.5 10.1 9.6 7.3 7.0 18.0 8.7 41.2 3.8 63.5 6.8 14.7 32.9 51.9 29.0 120.6 62.5 6.6 108.8 19.4 21.0 9.3 10.1 34.1 MAP2K1 "MAPKK1, MEK1, PRKMK1" ENSG00000169032 "Mitogen-activated protein kinase kinase 1" Q02750 15 66386837-66491544 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Cardiomyopathy, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 172.5;Langerhans cells: 265.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003834, HPA026430" Approved Enhanced "Plasma membrane,Cytosol" NA NA 120000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 39: Non-specific - Mitochondria" "Cluster 18: U-2197 - ECM organization" "Cluster 41: Macrophages - Immune response" "Plasma membrane, Cytosol" "CAB003834: AB_562310, HPA026430: AB_1853742" "unprognostic (4.05e-2)" "unprognostic (1.23e-2)" "unprognostic (2.07e-1)" "unprognostic (4.92e-2)" "prognostic unfavorable (1.95e-4)" "unprognostic (1.81e-3)" "unprognostic (5.78e-2)" "unprognostic (9.91e-3)" "unprognostic (1.11e-1)" "unprognostic (1.77e-1)" "unprognostic (1.45e-1)" "unprognostic (7.62e-3)" "unprognostic (1.20e-1)" "unprognostic (2.71e-1)" "unprognostic (1.96e-1)" "unprognostic (1.15e-1)" "unprognostic (9.40e-3)" 57.9 31.0 47.6 38.3 79.7 63.7 32.5 30.2 61.3 31.1 22.5 26.5 19.4 26.3 29.6 51.8 23.7 27.0 40.7 69.4 44.3 31.2 105.3 34.7 49.5 31.6 32.6 25.7 22.4 38.5 26.8 29.6 40.1 26.2 23.6 34.1 29.3 21.8 85.5 23.7 27.0 31.9 35.7 32.6 24.1 15.2 42.8 33.8 22.8 51.3 55.4 31.2 33.7 49.9 105.8 55.3 94.4 39.0 55.3 41.3 53.8 83.6 61.6 76.6 68.1 79.0 82.1 96.8 93.2 59.9 58.2 93.3 88.8 106.4 89.8 79.1 56.8 30.9 50.4 40.7 45.1 41.0 45.3 32.3 64.0 55.9 81.6 81.5 60.7 48.0 54.3 116.7 113.4 40.3 33.5 51.9 47.9 93.9 42.9 39.2 58.1 84.7 74.8 48.5 58.3 31.7 60.8 45.5 63.0 74.9 41.0 33.7 90.8 99.5 63.8 71.1 112.4 74.0 143.1 60.6 105.1 69.9 48.4 3.0 7.5 5.4 6.4 7.7 5.8 2.8 5.6 6.1 7.7 4.6 6.9 4.2 3.5 8.3 7.7 15.1 4.6 2.8 47.6 79.7 30.2 61.3 69.4 44.3 31.6 32.6 40.1 35.7 42.8 49.9 24.5 28.9 24.8 24.2 40.0 82.8 45.9 32.3 21.1 10.0 22.2 10.2 21.5 40.0 24.9 25.8 14.6 48.1 45.0 25.1 46.9 69.4 12.1 16.3 13.9 34.6 21.7 19.0 69.7 23.1 48.8 30.3 17.9 35.4 8.9 19.8 18.9 172.5 51.4 10.1 46.4 15.4 20.3 90.7 265.3 23.6 22.4 115.1 53.4 48.7 87.9 34.9 35.0 28.1 31.7 103.9 23.5 21.8 49.1 87.7 22.2 35.9 17.7 7.8 6.6 16.3 52.4 35.6 42.7 30.3 67.3 51.7 54.0 5.9 19.1 65.4 SNAPC5 SNAP19 ENSG00000174446 "Small nuclear RNA activating complex polypeptide 5" O75971 15 66490135-66497780 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 118.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024379 Uncertain Supported Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 1: K-562 - Erythropoiesis" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA024379: AB_2671552" "unprognostic (4.43e-2)" "unprognostic (1.53e-3)" "unprognostic (4.39e-3)" "unprognostic (4.56e-2)" "unprognostic (3.49e-2)" "unprognostic (2.31e-1)" "unprognostic (1.06e-1)" "unprognostic (8.07e-2)" "unprognostic (1.12e-2)" "unprognostic (3.39e-2)" "unprognostic (3.13e-1)" "unprognostic (6.28e-2)" "unprognostic (1.64e-2)" "unprognostic (1.25e-1)" "unprognostic (2.21e-1)" "unprognostic (9.40e-2)" "unprognostic (5.69e-2)" 22.4 26.0 31.5 17.3 32.0 15.0 21.8 33.3 40.5 20.4 34.9 32.9 15.7 25.1 41.1 15.8 22.9 13.9 42.3 32.4 34.2 33.0 35.1 19.4 23.8 31.8 33.2 20.9 22.3 32.9 27.4 18.2 33.0 24.4 18.7 28.6 18.5 22.1 60.1 15.1 19.7 20.2 31.3 22.8 23.2 32.6 33.3 21.3 26.9 27.5 22.3 27.3 17.8 33.6 17.3 54.2 23.4 50.4 27.8 26.5 26.3 19.4 27.1 24.5 17.2 31.1 40.3 21.2 44.6 22.6 22.4 35.5 62.6 27.0 27.3 37.7 34.6 28.5 56.2 47.0 33.0 72.8 30.2 22.4 33.2 20.2 49.9 16.5 17.0 38.6 92.8 43.3 18.2 37.7 35.0 28.5 24.3 72.2 23.0 33.8 23.0 79.5 30.2 24.9 30.1 24.3 22.1 44.0 86.5 49.4 40.5 48.7 17.8 23.0 43.2 25.1 33.3 30.2 56.5 36.3 23.7 93.2 47.9 32.5 26.7 34.7 33.6 43.3 42.3 43.8 40.4 45.2 22.6 32.7 53.5 45.3 13.0 49.2 47.0 39.1 50.7 32.3 31.5 32.0 33.3 40.5 32.4 34.2 31.8 33.2 33.0 31.3 33.3 33.6 24.2 22.4 19.2 13.1 20.1 9.4 16.2 33.0 8.6 13.7 19.1 24.5 53.1 18.6 27.9 27.6 10.4 33.4 23.9 13.9 84.1 27.1 118.4 28.4 18.1 23.3 13.9 17.9 8.6 47.6 26.6 22.5 11.7 14.0 19.6 25.1 12.5 48.2 47.2 18.5 10.2 18.1 38.7 18.2 11.8 98.3 26.8 20.3 26.6 8.4 33.2 22.2 43.3 8.5 13.6 27.9 11.1 27.8 19.2 28.7 17.1 79.7 46.4 19.7 0.0 21.3 25.5 92.3 40.7 15.7 9.7 22.3 26.0 30.0 18.6 19.2 RPL4 L4 ENSG00000174444 "Ribosomal protein L4" P36578 15 66498015-66524532 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034600 Uncertain Approved "Nucleoli,Nuclear bodies,Endoplasmic reticulum,Cytosol" Yes No 1300000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Endoplasmic reticulum, Cytosol" "Nucleoli, Nuclear bodies" "HPA034600: AB_10601483" "unprognostic (1.51e-2)" "unprognostic (3.77e-1)" "unprognostic (6.02e-2)" "unprognostic (3.68e-2)" "unprognostic (6.23e-3)" "unprognostic (1.03e-1)" "unprognostic (1.90e-2)" "unprognostic (3.20e-2)" "unprognostic (3.73e-1)" "unprognostic (2.85e-1)" "unprognostic (1.56e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (5.20e-5)" "unprognostic (1.27e-1)" "unprognostic (5.60e-2)" "unprognostic (4.63e-2)" "unprognostic (2.27e-1)" 831.6 565.7 367.7 738.6 404.0 1928.0 2030.6 377.1 545.7 1385.7 370.7 970.8 451.2 1276.0 1088.2 1289.4 1454.2 776.9 914.1 385.6 388.6 751.5 914.9 666.3 1630.2 376.4 380.9 3022.1 1740.5 954.0 504.0 746.1 386.6 709.1 1143.5 350.6 1234.8 1092.1 1314.7 1327.1 507.9 1353.5 383.2 776.9 643.8 296.4 373.4 1883.4 1289.5 1921.7 2451.3 1322.4 782.5 406.8 1192.9 2343.4 973.0 1646.3 4272.4 7697.6 1710.1 1416.1 2899.7 2143.0 1648.1 2611.3 2025.2 4676.6 1572.3 3396.6 1011.9 2105.0 7026.5 5476.3 2352.2 1301.4 4208.3 2872.9 1955.7 2201.2 6007.7 3042.0 1376.1 7627.4 6980.3 2334.4 9237.8 2620.8 3489.1 2180.2 2682.6 1785.2 3252.1 1956.0 2044.2 1348.1 2136.9 2634.2 1661.9 2256.2 2213.4 4588.3 2958.1 2321.4 1718.4 1794.6 872.3 2447.5 3515.4 2022.2 1812.5 4303.4 2059.2 1111.1 1662.1 1048.4 2297.9 1736.5 2937.8 3118.9 1368.2 4015.4 1281.7 46.4 455.3 62.2 359.4 370.9 668.1 711.1 698.6 506.5 586.8 644.5 888.5 721.6 26.9 478.1 361.3 372.8 589.8 1758.0 367.7 404.0 377.1 545.7 385.6 388.6 376.4 380.9 386.6 383.2 373.4 406.8 393.9 451.9 1004.9 28.1 1553.4 2423.4 2769.6 2082.8 1295.3 122.6 1594.0 1140.4 403.3 760.7 1165.2 342.1 81.3 2059.9 1055.8 364.9 1651.3 1162.8 672.5 337.9 821.0 840.2 761.1 1195.8 26.2 2141.0 3735.7 879.7 467.9 430.0 945.5 899.2 711.0 715.5 1211.2 40.4 23.9 1089.8 636.8 1281.3 2031.3 1392.4 1334.0 991.6 1088.5 27.2 1920.9 417.7 1196.8 15.1 30.0 1239.9 737.1 996.0 1019.5 2031.3 370.6 1572.3 603.9 169.9 460.2 1196.4 934.7 376.4 454.9 1632.1 2583.2 2398.3 1289.5 1184.6 1371.2 2628.6 ZWILCH "FLJ10036, KNTC1AP" ENSG00000174442 "Zwilch kinetochore protein" Q9H900 15 66504959-66550130 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 53.9" "Cell type enhanced" "Detected in many" "Early spermatids: 97.3;Late spermatids: 74.5;Spermatocytes: 167.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "unprognostic (1.10e-1)" "unprognostic (9.99e-2)" "unprognostic (9.44e-2)" "unprognostic (1.02e-1)" "unprognostic (3.79e-1)" "unprognostic (4.83e-3)" "unprognostic (3.32e-2)" "unprognostic (1.31e-2)" "unprognostic (2.17e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (2.90e-5)" "prognostic unfavorable (7.34e-4)" "prognostic unfavorable (2.58e-4)" "unprognostic (2.81e-2)" "unprognostic (4.37e-2)" "unprognostic (1.18e-1)" "unprognostic (1.42e-1)" 3.8 2.2 2.9 8.4 2.7 10.3 6.7 2.3 2.8 4.9 4.1 8.7 5.5 6.2 6.3 6.7 4.0 5.9 2.6 3.0 2.7 4.7 5.4 5.2 11.6 3.3 2.1 6.0 3.2 2.6 2.4 7.3 2.9 4.6 9.9 3.8 3.4 3.7 3.3 7.9 5.5 6.2 3.0 5.5 5.5 53.9 3.1 14.1 3.9 3.1 14.1 5.5 4.1 3.8 38.1 48.5 58.0 51.5 13.6 24.0 31.3 58.8 35.6 69.4 76.5 39.4 32.2 81.6 26.3 38.6 57.7 92.6 156.4 42.2 83.9 41.7 31.9 59.5 63.9 31.3 4.9 41.4 32.0 9.9 10.7 71.2 51.8 21.4 44.8 34.3 57.4 43.2 54.7 38.2 36.7 25.2 111.7 75.2 31.0 41.9 72.1 59.6 24.9 42.6 34.5 37.5 32.1 41.4 50.6 66.1 32.9 27.6 30.0 63.2 68.7 37.6 87.2 21.6 92.6 85.0 42.9 94.5 53.5 4.0 2.1 3.6 4.3 4.2 3.7 4.3 4.3 4.1 2.1 4.1 2.8 4.0 2.5 5.0 5.4 2.2 4.5 2.2 2.9 2.7 2.3 2.8 3.0 2.7 3.3 2.1 2.9 3.0 3.1 3.8 6.1 3.2 4.6 1.3 7.5 11.1 6.4 8.4 4.0 5.1 5.8 4.2 1.5 5.7 8.7 1.8 0.0 14.1 7.0 5.3 3.9 8.2 97.3 5.9 6.6 6.5 4.8 31.5 5.2 6.5 25.1 6.7 10.7 7.8 15.2 9.6 3.9 4.7 12.5 0.0 4.3 10.3 12.2 4.1 8.4 74.5 7.5 7.4 5.4 2.8 7.4 1.5 7.2 2.5 2.7 8.1 2.1 5.3 15.0 4.6 2.0 2.8 5.2 3.7 26.3 3.1 6.4 167.9 43.1 11.2 8.5 12.9 8.3 4.8 10.1 6.9 LCTL "FLJ33279, KLG, KLPH" ENSG00000188501 "Lactase like" Q6UWM7 15 66547179-66565979 "Cancer-related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.0" "Cell type enhanced" "Detected in some" "Astrocytes: 2.9;Early spermatids: 5.8;Late spermatids: 9.0" "Group enriched" "Detected in some" 5 "glioma: 1.5;melanoma: 0.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 5.6;hTERT-RPE1: 6.7;NTERA-2: 5.2;SuSa: 6.0;U-2 OS: 14.3;U-251 MG: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA071640 Approved "Endoplasmic reticulum,Plasma membrane" NA NA "Cluster 70: Brain - Nervous system development" "Cluster 9: U-2 OS - Unknown function" "Cluster 25: Spermatids - Spermatogenesis" "Plasma membrane" "Endoplasmic reticulum" "HPA071640: AB_2686428" "unprognostic (4.60e-2)" "unprognostic (5.46e-2)" "unprognostic (8.70e-2)" "unprognostic (1.56e-2)" "unprognostic (3.22e-3)" "unprognostic (3.53e-2)" "unprognostic (6.67e-2)" "unprognostic (1.06e-2)" "unprognostic (2.59e-2)" "unprognostic (1.04e-1)" "unprognostic (3.47e-1)" "unprognostic (4.51e-3)" "unprognostic (4.44e-16)" "unprognostic (6.06e-2)" "unprognostic (3.39e-1)" "unprognostic (5.48e-2)" "unprognostic (1.39e-1)" 0.1 0.1 1.4 0.2 1.5 0.4 0.1 1.2 1.5 0.1 1.0 0.2 0.2 0.1 0.1 0.1 0.0 0.2 0.0 1.3 1.3 0.1 0.1 0.0 0.2 2.1 1.4 0.1 0.1 0.0 0.1 0.0 1.8 0.1 0.0 0.3 0.1 0.0 0.7 0.5 0.1 0.0 1.5 0.1 0.1 0.3 1.6 0.0 0.1 0.0 0.0 0.0 0.1 3.0 0.3 0.2 2.8 0.2 0.1 0.1 0.7 0.7 0.0 0.0 0.3 0.3 0.4 0.4 5.6 0.2 0.5 0.6 0.0 0.0 0.1 0.2 0.1 0.7 0.9 1.4 0.0 0.2 0.3 0.3 0.0 0.3 0.0 6.7 0.0 0.2 0.3 0.3 0.1 0.1 0.2 0.4 5.2 0.4 0.1 0.2 3.1 0.3 0.0 0.3 0.3 0.2 0.1 0.3 1.6 6.0 0.4 0.5 0.2 1.4 14.3 0.5 6.4 0.1 0.2 0.2 1.9 0.6 2.7 0.5 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.2 0.1 0.1 0.1 0.0 1.4 1.5 1.2 1.5 1.3 1.3 2.1 1.4 1.8 1.5 1.6 3.0 0.0 0.0 0.0 2.9 0.7 0.4 0.6 0.0 0.0 0.6 0.1 0.1 0.3 1.5 0.1 0.0 0.0 0.1 0.6 0.2 0.0 0.1 5.8 0.2 0.3 0.2 0.0 0.0 0.2 0.0 0.3 0.2 0.0 0.3 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.6 0.3 9.0 0.6 0.1 0.0 0.0 0.0 1.4 2.1 0.5 1.0 0.1 0.0 0.0 0.0 0.8 0.2 0.0 0.0 1.4 0.0 0.6 0.4 1.6 2.1 0.0 0.3 0.3 0.9 0.3 0.1 0.4 SMAD6 "HsT17432, MADH6, MADH7" ENSG00000137834 "SMAD family member 6" O43541 15 66702236-66782849 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Craniosynostosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 30.1;lung: 27.9" "Cell type enhanced" "Detected in many" "Endothelial cells: 25.1;Hepatic stellate cells: 91.4;Microglial cells: 57.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 29.8;HaCaT: 18.2;HeLa: 28.6;U-2197: 17.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA061917 Supported "Nucleoplasm,Nuclear bodies,Golgi apparatus" NA NA "Cluster 46: Fibroblasts - ECM organization" "Cluster 20: HeLa - Mitochondria" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm "Nuclear bodies, Golgi apparatus" "HPA061917: AB_2684637" "unprognostic (1.20e-1)" "unprognostic (7.43e-3)" "unprognostic (5.62e-2)" "unprognostic (1.26e-1)" "unprognostic (3.02e-1)" "unprognostic (3.50e-3)" "unprognostic (9.59e-2)" "unprognostic (4.50e-1)" "unprognostic (3.47e-2)" "unprognostic (1.50e-1)" "unprognostic (1.10e-3)" "unprognostic (1.68e-1)" "unprognostic (1.67e-2)" "unprognostic (1.55e-3)" "unprognostic (4.30e-2)" "unprognostic (1.33e-1)" "prognostic favorable (5.45e-5)" 9.5 2.6 5.2 1.6 4.9 0.1 7.6 4.9 4.3 6.8 8.6 3.7 1.9 6.2 0.6 2.1 5.4 1.4 30.1 3.4 4.1 8.9 6.7 27.9 0.5 7.6 5.4 5.9 2.7 1.1 3.4 7.4 5.8 7.0 1.1 0.9 2.1 3.5 1.6 2.4 3.9 0.9 4.4 2.6 5.5 1.8 6.8 0.4 15.5 1.5 0.2 8.0 5.7 4.6 1.3 10.2 1.6 3.5 6.0 1.6 9.4 7.2 0.1 1.1 0.1 2.0 4.6 0.7 29.8 6.1 0.9 18.2 2.2 0.0 0.2 2.3 8.4 16.1 28.6 1.7 0.7 0.1 1.2 2.0 0.0 0.1 0.0 3.4 1.3 5.1 1.4 1.0 0.5 2.0 0.1 4.4 3.0 10.5 3.8 0.0 1.8 2.2 3.4 8.1 3.6 1.6 3.9 4.3 0.8 5.9 1.4 2.9 6.2 4.3 5.5 17.6 1.4 0.5 1.8 0.3 3.1 5.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 4.9 4.9 4.3 3.4 4.1 7.6 5.4 5.8 4.4 6.8 4.6 19.8 12.8 6.0 5.2 0.9 0.8 1.2 2.1 0.6 0.6 0.9 1.1 4.9 4.3 3.0 1.8 2.1 0.8 0.1 4.3 3.9 4.7 3.4 8.3 5.5 25.1 0.0 0.0 0.3 5.8 0.9 4.9 5.1 6.5 4.5 5.9 91.4 4.0 1.7 0.0 0.3 2.1 0.0 10.0 0.3 1.4 2.8 1.2 0.0 57.1 0.7 10.2 0.0 0.5 0.4 8.4 1.5 8.2 0.0 1.3 2.1 1.9 0.1 0.6 0.0 0.9 1.5 0.2 3.2 0.4 0.1 0.8 0.4 0.1 5.5 0.4 SMAD3 "HsT17436, JV15-2, MADH3" ENSG00000166949 "SMAD family member 3" P84022 15 67063763-67195173 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Host-virus interaction, Transcription, Transcription regulation" DNA-binding "Aortic aneurysm, Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 162.5;Prostatic glandular cells: 149.3;Urothelial cells: 276.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008094, HPA046386, HPA067203, CAB069409" Approved Supported Nucleoplasm,Cytosol NA Yes "Cluster 52: Eosinophils - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm Cytosol "CAB008094: AB_2302271, CAB069409: AB_1622941, HPA046386: AB_2679647, HPA067203: AB_2685803" "unprognostic (1.04e-1)" "unprognostic (1.83e-1)" "unprognostic (1.06e-1)" "unprognostic (1.99e-2)" "unprognostic (1.61e-1)" "unprognostic (1.98e-2)" "unprognostic (8.40e-3)" "unprognostic (1.80e-2)" "unprognostic (7.62e-2)" "unprognostic (6.82e-2)" "prognostic unfavorable (2.48e-4)" "unprognostic (2.93e-1)" "unprognostic (2.14e-2)" "unprognostic (3.10e-1)" "unprognostic (1.79e-1)" "unprognostic (1.15e-1)" "unprognostic (5.97e-2)" 30.0 6.3 17.9 15.8 22.4 18.8 22.2 6.8 16.1 32.2 31.5 15.4 17.7 20.3 13.6 51.9 23.3 21.2 28.1 16.1 9.3 35.7 19.8 21.4 16.8 17.0 9.0 30.7 18.2 10.5 14.5 16.8 9.3 24.4 12.9 6.2 17.2 13.8 55.0 29.1 21.6 21.1 10.9 15.4 22.2 3.9 12.9 19.6 30.2 39.0 25.7 43.6 31.5 8.5 49.3 157.0 30.6 13.9 50.8 115.9 22.5 27.6 114.0 37.8 30.7 33.7 125.3 16.5 36.6 79.4 169.8 111.3 31.2 116.9 38.1 13.1 11.9 1.8 43.4 26.2 38.2 6.6 2.7 106.5 26.7 33.2 27.7 83.2 128.2 5.2 40.3 40.8 47.1 24.2 1.5 26.0 17.7 26.1 50.5 1.6 9.1 5.9 25.2 149.4 0.8 10.3 36.6 19.5 32.5 59.2 5.3 30.2 109.4 50.4 47.1 36.5 31.7 16.5 5.0 21.0 45.8 7.0 45.9 0.0 1.0 2.3 3.2 0.9 3.3 1.2 3.6 3.4 1.0 2.8 1.6 1.4 0.0 0.3 0.9 1.5 1.9 1.1 17.9 22.4 6.8 16.1 16.1 9.3 17.0 9.0 9.3 10.9 12.9 8.5 18.2 48.1 19.9 28.4 33.9 89.0 90.2 70.6 53.5 10.8 13.3 10.5 12.2 17.2 49.6 36.8 6.2 1.1 19.7 48.2 3.9 61.9 1.0 23.6 30.2 26.6 3.5 9.1 63.2 50.7 4.2 42.6 28.5 75.2 24.1 162.5 11.4 12.6 10.7 0.0 6.9 13.0 24.4 6.2 40.8 5.7 26.8 18.8 21.4 67.5 9.7 8.5 20.6 140.2 1.3 99.7 49.2 20.7 10.6 149.3 34.2 14.0 52.2 0.6 26.3 28.9 27.5 0.6 2.3 70.3 48.9 1.6 21.6 18.8 16.6 276.2 AAGAB "FLJ11506, p34" ENSG00000103591 "Alpha and gamma adaptin binding protein" Q6PD74 15 67200667-67255195 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039371, HPA040174" Supported Supported "Nuclear speckles,Cytosol" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nuclear speckles, Cytosol" "HPA039371: AB_10805476, HPA040174: AB_10805605" "unprognostic (1.48e-2)" "unprognostic (1.50e-1)" "unprognostic (8.25e-2)" "unprognostic (3.27e-2)" "unprognostic (1.06e-1)" "unprognostic (3.10e-2)" "unprognostic (2.84e-2)" "unprognostic (4.52e-2)" "unprognostic (9.10e-2)" "unprognostic (5.28e-2)" "unprognostic (1.24e-1)" "unprognostic (2.10e-1)" "prognostic favorable (1.36e-4)" "unprognostic (9.88e-2)" "unprognostic (3.05e-1)" "prognostic unfavorable (9.48e-4)" "unprognostic (1.53e-1)" 15.1 19.1 10.5 19.2 13.3 19.8 22.5 7.2 14.5 17.9 12.7 27.8 15.8 14.8 25.9 20.5 16.5 18.5 15.8 12.9 15.7 27.4 18.1 15.6 19.9 9.8 11.5 8.0 17.0 35.2 19.0 15.8 11.5 18.8 33.8 22.1 15.4 20.5 32.8 12.9 19.5 21.2 9.5 15.4 23.9 21.9 15.7 29.9 33.0 23.0 25.9 27.5 13.2 12.2 49.7 89.9 63.2 64.8 60.0 49.3 31.1 51.4 74.7 60.6 68.7 66.8 52.9 48.1 51.1 52.9 74.4 98.2 129.9 59.4 62.9 65.0 62.0 46.2 63.2 26.8 66.0 78.8 51.2 48.6 80.6 45.8 94.3 41.0 47.8 59.7 96.5 63.7 60.2 61.3 47.6 32.7 53.1 61.7 31.5 53.1 81.1 57.7 55.9 116.1 89.7 57.3 60.7 44.0 75.7 54.7 71.5 59.2 51.7 54.2 64.5 50.0 73.0 33.7 119.3 69.2 52.7 71.8 55.4 56.4 27.0 28.2 31.3 35.4 36.2 22.0 28.2 29.7 33.2 17.3 23.7 25.0 14.6 42.7 38.1 25.4 37.3 30.2 10.5 13.3 7.2 14.5 12.9 15.7 9.8 11.5 11.5 9.5 15.7 12.2 10.8 3.2 7.7 26.1 19.0 12.0 18.8 19.4 15.9 13.4 17.8 10.3 12.9 4.3 19.0 27.6 27.1 16.3 8.8 33.4 17.6 28.6 14.6 14.5 11.6 12.0 15.7 10.9 45.4 31.2 14.8 14.1 22.4 18.0 10.8 8.2 8.2 12.7 17.0 18.5 33.1 17.3 14.2 15.5 8.4 8.6 7.8 11.6 7.2 30.0 21.3 14.4 16.5 26.2 31.9 25.3 20.9 11.3 15.5 22.9 15.3 19.1 20.5 19.4 13.1 10.5 10.2 43.0 33.8 17.6 13.8 16.6 17.8 25.3 15.7 24.5 IQCH FLJ12476 ENSG00000103599 "IQ motif containing H" Q86VS3 15 67254786-67502260 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 11.5" "Cell type enhanced" "Detected in many" "Astrocytes: 27.4;Early spermatids: 59.4;Excitatory neurons: 26.5;Late spermatids: 37.3;Respiratory ciliated cells: 30.3;Spermatocytes: 48.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040845 Uncertain Approved Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "HPA040845: AB_10672898" "unprognostic (2.69e-1)" "unprognostic (2.94e-3)" "unprognostic (3.11e-2)" "unprognostic (5.89e-5)" "unprognostic (2.48e-1)" "unprognostic (9.83e-2)" "unprognostic (2.57e-1)" "unprognostic (1.18e-1)" "unprognostic (2.64e-1)" "unprognostic (3.25e-1)" "unprognostic (5.37e-2)" "unprognostic (1.70e-1)" "unprognostic (1.51e-3)" "unprognostic (2.81e-1)" "unprognostic (3.81e-2)" "unprognostic (6.16e-3)" "unprognostic (6.42e-2)" 0.3 1.1 0.7 0.3 0.8 0.1 1.6 0.7 1.4 0.9 4.2 0.5 0.2 0.8 2.6 0.5 6.8 0.6 0.9 0.7 1.8 2.2 1.0 0.9 0.4 2.5 2.2 0.3 0.7 3.7 2.0 0.4 1.6 0.6 0.7 5.0 0.6 0.8 0.5 0.6 0.1 0.3 2.0 0.4 1.1 11.5 1.9 1.0 4.1 0.0 0.2 0.7 0.3 1.4 1.7 1.6 0.8 1.3 1.1 2.6 0.6 0.9 0.7 1.3 0.9 0.1 1.9 1.2 0.8 1.5 1.5 2.8 2.6 1.0 2.3 0.2 1.2 0.3 1.6 0.2 1.7 0.5 0.3 1.7 1.1 2.9 2.8 1.3 0.5 3.1 2.6 1.1 1.0 1.8 0.4 0.4 0.9 1.0 1.1 0.3 1.2 1.3 1.6 0.7 2.6 0.7 1.2 1.6 4.8 1.6 4.3 0.3 1.2 1.5 0.7 2.4 1.0 2.5 3.2 0.3 3.1 1.3 1.4 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.7 0.8 0.7 1.4 0.7 1.8 2.5 2.2 1.6 2.0 1.9 1.4 0.7 3.2 1.1 27.4 0.3 1.3 1.0 1.6 1.8 1.5 2.7 2.2 1.1 0.0 2.8 1.8 8.4 0.2 0.3 0.4 0.0 1.0 59.4 15.9 1.1 0.9 0.0 0.4 26.5 0.8 0.5 0.7 8.2 2.0 0.0 0.7 0.0 0.0 0.3 1.7 18.2 0.5 4.1 0.0 0.7 37.3 0.9 0.3 0.0 8.4 1.0 1.1 0.0 9.0 9.5 0.7 0.0 0.7 0.5 0.3 0.2 2.2 30.3 5.4 0.0 1.5 0.6 48.8 18.2 1.2 0.4 0.3 0.4 4.2 0.4 1.0 C15orf61 LOC145853 ENSG00000189227 "Chromosome 15 open reading frame 61" A6NNL5 15 67521131-67530146 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 23.7" "Cell type enhanced" "Detected in all" "Early spermatids: 222.6;Spermatocytes: 258.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062820 Approved Nucleoli,Vesicles,Cytosol "Secreted - unknown location" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoli, Vesicles" Cytosol "HPA062820: AB_2684874" "unprognostic (1.35e-1)" "unprognostic (9.42e-3)" "unprognostic (2.11e-1)" "unprognostic (5.41e-2)" "unprognostic (2.40e-1)" "unprognostic (2.49e-1)" "unprognostic (1.49e-1)" "unprognostic (3.87e-3)" "unprognostic (8.95e-2)" "unprognostic (4.01e-2)" "unprognostic (1.04e-2)" "unprognostic (8.45e-2)" "prognostic favorable (5.31e-5)" "unprognostic (2.42e-2)" "unprognostic (9.78e-2)" "unprognostic (1.42e-1)" "unprognostic (8.32e-2)" 4.7 3.8 2.3 1.5 6.2 5.3 3.6 7.1 4.2 3.1 0.0 2.3 2.8 2.3 1.9 2.0 2.9 1.5 5.7 3.8 1.6 3.0 2.5 2.3 1.3 1.0 2.4 2.7 4.2 4.4 5.1 2.0 1.0 2.5 2.2 10.8 2.6 2.1 23.7 4.1 1.8 1.4 0.7 1.7 2.4 7.7 2.1 1.4 2.8 8.3 1.0 2.2 2.4 2.3 4.2 4.4 1.1 4.9 5.0 7.2 3.1 1.8 3.2 3.3 2.6 3.4 2.9 3.5 3.8 2.0 3.9 4.9 4.4 1.2 2.7 2.1 10.4 3.7 3.3 4.6 3.2 4.6 3.0 7.5 3.4 1.1 4.0 2.4 1.6 10.6 4.3 7.6 1.0 2.4 3.8 7.6 1.8 3.3 5.6 5.1 2.5 13.0 2.3 2.9 6.4 4.8 3.2 3.0 6.1 2.1 2.7 7.1 1.6 4.4 6.8 5.5 4.7 7.1 11.2 8.5 1.9 9.0 2.2 7.9 4.3 7.8 4.5 3.7 5.2 5.3 5.9 4.5 4.8 3.6 6.2 5.0 0.5 3.8 3.2 4.9 4.0 3.5 2.3 6.2 7.1 4.2 3.8 1.6 1.0 2.4 1.0 0.7 2.1 2.3 28.0 22.4 13.5 4.9 23.1 67.2 32.6 32.3 120.7 75.5 55.7 82.3 74.5 18.6 14.3 16.5 37.5 42.6 23.8 38.6 80.3 25.1 222.6 17.5 24.2 26.8 27.1 11.8 14.8 29.8 31.9 56.8 15.8 17.1 34.8 15.2 22.9 44.7 30.5 13.5 15.7 47.5 48.8 24.8 25.6 42.6 41.0 19.9 37.4 3.7 15.6 97.1 23.7 5.0 8.5 27.6 48.4 25.6 37.4 63.3 49.0 77.1 8.4 93.9 32.9 38.2 38.7 258.9 52.1 62.7 60.9 20.5 34.4 28.9 39.2 20.0 MAP2K5 "HsT17454, MAPKK5, MEK5, PRKMK5" ENSG00000137764 "Mitogen-activated protein kinase kinase 5" Q13163 15 67542703-67807117 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 8 "Astrocytes: 119.5;Early spermatids: 138.1;Excitatory neurons: 201.4;Inhibitory neurons: 169.3;Late spermatids: 212.4;Microglial cells: 87.1;Oligodendrocyte precursor cells: 146.3;Oligodendrocytes: 146.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022094, HPA027347, HPA027755" Supported Approved Nucleoli,Microtubules NA NA "Cluster 15: NK-cells - Transcription" "Cluster 8: Non-specific - Mitochondria" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoli, Microtubules" "CAB022094: , HPA027347: AB_10599290, HPA027755: AB_10600883" "unprognostic (4.54e-2)" "unprognostic (1.87e-2)" "unprognostic (4.16e-2)" "unprognostic (9.06e-2)" "unprognostic (1.77e-3)" "unprognostic (1.06e-1)" "unprognostic (1.96e-1)" "unprognostic (3.73e-1)" "unprognostic (2.41e-2)" "unprognostic (2.83e-1)" "unprognostic (1.47e-2)" "unprognostic (5.41e-2)" "prognostic favorable (8.03e-5)" "unprognostic (1.68e-1)" "unprognostic (2.74e-1)" "unprognostic (3.99e-2)" "unprognostic (2.73e-2)" 14.3 14.8 9.2 6.3 9.8 10.3 12.4 11.2 14.1 13.2 4.6 15.7 9.2 11.5 6.1 8.7 12.1 8.8 15.0 11.6 9.9 9.9 10.0 9.7 8.5 9.6 6.5 17.2 13.2 18.8 10.2 11.1 9.4 9.4 8.8 11.2 10.5 10.6 23.2 14.5 10.1 8.9 5.6 9.0 11.6 13.8 7.3 17.2 10.6 17.8 7.6 11.8 11.1 12.3 9.0 23.4 13.8 16.3 20.0 34.9 10.9 8.8 17.8 16.3 17.7 9.4 15.8 14.8 18.2 14.8 17.7 13.3 23.8 14.3 13.4 21.6 23.7 20.2 17.0 10.3 25.1 12.3 12.1 23.9 18.3 11.8 26.6 35.7 21.7 33.6 18.0 24.1 13.6 11.6 20.1 14.7 19.4 10.4 11.3 19.7 16.0 24.9 9.8 16.3 8.6 13.4 9.9 14.5 36.5 23.6 18.2 23.7 18.2 16.7 10.9 11.7 12.1 33.7 43.4 17.5 22.4 27.6 12.3 10.9 5.8 5.6 5.6 4.4 8.3 4.8 5.3 6.7 8.1 4.3 7.3 7.0 1.4 9.4 5.4 3.0 6.2 4.4 9.2 9.8 11.2 14.1 11.6 9.9 9.6 6.5 9.4 5.6 7.3 12.3 7.9 6.4 5.8 119.5 10.0 6.9 8.1 3.7 8.6 12.6 8.6 6.1 8.1 5.7 3.2 5.5 10.4 13.4 10.2 13.2 7.9 9.3 138.1 4.4 5.0 7.6 9.5 9.4 201.4 8.5 10.7 9.7 7.7 3.9 2.5 12.3 12.5 8.7 10.0 5.0 169.3 9.2 4.1 10.1 6.1 212.4 12.5 7.9 10.6 87.1 7.2 17.9 11.3 146.3 146.5 7.5 12.5 11.7 5.6 5.3 12.2 9.7 4.0 8.2 0.0 7.9 6.3 11.9 13.0 9.9 8.2 9.9 10.4 11.6 10.4 4.6 SKOR1 "CORL1, FUSSEL15, LBXCOR1" ENSG00000188779 "SKI family transcriptional corepressor 1" P84550 15 67819704-67834582 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 5.5" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 5.6;Early spermatids: 20.5;Late spermatids: 36.2;Spermatocytes: 8.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 1.0;U-266/70: 2.4;U-266/84: 2.0;U-698: 2.1" "Group enriched" "Detected in some" 11 "cerebellum: 3.7;pons and medulla: 1.2" "Region enriched" "Detected in single" 5 "cerebellum: 5.0" HPA071150 Enhanced NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" "HPA071150: " "unprognostic (8.98e-2)" "unprognostic (4.15e-2)" "unprognostic (5.44e-7)" "unprognostic (1.76e-1)" "unprognostic (2.90e-2)" "unprognostic (2.45e-3)" "unprognostic (8.40e-5)" "unprognostic (5.51e-3)" "unprognostic (1.00e-1)" "unprognostic (8.13e-2)" "unprognostic (9.31e-2)" "unprognostic (1.93e-1)" "unprognostic (4.28e-5)" "unprognostic (1.96e-1)" "unprognostic (1.18e-1)" "unprognostic (1.59e-1)" "unprognostic (1.35e-1)" 0.5 0.4 0.4 0.0 0.3 0.3 0.5 5.5 1.2 0.7 0.0 0.7 0.2 0.7 0.1 0.2 0.6 0.1 0.3 0.4 0.8 0.3 0.2 0.4 0.0 2.5 0.5 0.9 0.4 0.0 1.1 0.1 1.6 0.5 0.0 0.5 0.3 0.1 0.4 0.8 0.5 0.1 2.1 0.4 0.4 1.1 0.3 0.2 0.4 0.0 0.0 0.5 0.5 0.9 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.4 0.1 0.0 0.0 1.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.7 0.0 0.3 0.0 0.1 0.2 0.4 0.0 0.0 0.1 0.3 0.1 0.5 0.0 0.0 0.1 0.8 0.0 0.0 0.2 0.1 0.1 0.5 0.1 0.0 0.2 0.1 0.1 2.4 2.0 2.1 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 5.5 1.2 0.4 0.8 2.5 0.5 1.6 2.1 0.3 0.9 0.2 0.0 0.0 1.6 0.0 0.1 0.0 0.0 0.6 0.7 0.2 0.1 5.6 0.0 0.0 0.0 0.0 0.1 0.1 0.1 1.9 0.0 20.5 0.0 0.1 0.4 0.0 0.0 1.1 0.0 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.3 36.2 0.9 0.2 0.0 0.0 0.0 0.2 0.0 1.0 0.6 0.0 0.0 0.7 0.1 0.0 0.0 3.0 0.0 0.1 0.0 0.5 0.3 8.0 0.3 0.1 0.4 0.0 0.0 0.2 0.1 0.1 PIAS1 "DDXBP1, GBP, GU/RH-II, ZMIZ3" ENSG00000033800 "Protein inhibitor of activated STAT 1" O75925 15 68054309-68198603 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Microglial cells: 248.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005743, CAB012304" Supported Approved Microtubules NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Microtubules "CAB012304: AB_777265, HPA005743: " "unprognostic (1.36e-1)" "unprognostic (1.11e-1)" "unprognostic (2.40e-1)" "unprognostic (6.29e-2)" "unprognostic (1.61e-1)" "unprognostic (2.75e-1)" "unprognostic (4.21e-2)" "unprognostic (1.68e-1)" "unprognostic (4.35e-2)" "unprognostic (1.10e-1)" "unprognostic (3.47e-1)" "unprognostic (1.90e-2)" "unprognostic (1.10e-3)" "unprognostic (6.93e-2)" "unprognostic (6.35e-2)" "unprognostic (1.31e-1)" "unprognostic (9.28e-2)" 10.2 10.2 5.6 14.1 7.0 23.2 11.7 11.9 9.4 15.3 5.7 12.0 12.0 14.7 13.9 15.1 14.0 12.7 11.5 7.6 8.3 10.8 9.7 14.9 18.2 4.8 4.9 22.7 11.3 12.5 6.5 12.9 4.9 15.5 11.1 21.3 10.4 17.7 12.4 12.6 12.3 13.6 4.7 15.3 12.7 20.6 6.9 24.9 18.8 16.3 17.6 14.1 10.8 7.0 13.1 17.6 27.9 13.6 16.4 16.8 8.4 19.6 19.8 21.1 23.6 14.7 19.2 24.6 13.1 16.5 13.5 35.5 41.5 10.7 22.7 14.2 15.5 29.6 17.3 16.3 10.7 29.0 23.0 15.2 30.5 13.7 12.4 16.2 15.1 14.1 20.7 18.3 16.3 10.7 24.1 15.0 15.8 14.4 9.9 21.2 26.8 24.1 13.8 16.4 23.3 9.8 13.1 12.1 13.4 25.4 10.7 26.9 13.5 18.3 19.3 10.6 14.6 13.6 19.2 26.2 11.4 30.2 13.7 33.8 31.4 41.9 18.7 23.9 19.3 20.8 18.7 19.8 30.7 19.5 22.3 19.6 70.8 19.2 25.7 16.7 21.5 27.3 5.6 7.0 11.9 9.4 7.6 8.3 4.8 4.9 4.9 4.7 6.9 7.0 38.7 109.0 58.4 106.7 91.5 38.0 58.2 29.4 132.1 72.2 30.3 25.1 28.3 45.8 35.9 12.9 106.3 35.5 61.3 35.2 21.5 32.5 67.1 23.5 48.2 42.0 27.6 41.0 165.7 22.6 20.4 37.5 43.8 27.2 56.3 30.6 40.0 34.9 45.8 48.8 136.6 30.2 14.2 102.4 38.8 33.4 123.6 62.6 21.4 248.3 104.9 57.8 56.7 120.1 126.2 25.5 25.0 113.6 59.3 48.3 38.1 20.0 25.0 64.8 32.9 47.7 31.6 66.7 45.4 51.1 33.0 36.0 67.6 22.6 22.4 64.5 AC107871.1 ENSG00000260007 "Novel protein" 15 68184032-68229718 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Alveolar cells type 2: 2.6;Club cells: 1.8;Endometrial stromal cells: 1.5;Exocrine glandular cells: 1.4;granulocytes: 1.3;Respiratory ciliated cells: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 1.6;HAP1: 1.6;HEK 293: 2.9" NA NA "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 11: Alveolar cells - Smell perception" "unprognostic (1.22e-1)" "unprognostic (3.42e-1)" "unprognostic (1.80e-2)" "unprognostic (9.23e-3)" "unprognostic (2.82e-1)" "unprognostic (4.30e-2)" "unprognostic (2.34e-1)" "unprognostic (1.95e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.4 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 1.6 0.9 0.8 0.0 0.4 0.0 0.0 0.1 0.0 0.0 1.6 0.4 0.7 0.0 2.9 0.2 0.2 0.0 0.3 0.0 0.1 0.2 0.1 0.5 0.9 0.0 0.2 0.4 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.2 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.2 2.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.8 1.5 0.3 0.0 0.0 0.0 1.4 0.0 0.7 0.0 1.2 1.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 5.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 CALML4 "MGC4809, NY-BR-20" ENSG00000129007 "Calmodulin like 4" Q96GE6 15 68190705-68206079 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 91.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 49.2;Gastric mucus-secreting cells: 31.6;Paneth cells: 39.3;Proximal enterocytes: 36.2;Respiratory ciliated cells: 107.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "intermediate monocyte: 184.3;non-classical monocyte: 216.9" "Lineage enriched" "Detected in many" 7 "monocytes: 216.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051109 Enhanced Approved "Nucleoplasm,Golgi apparatus,Cytosol" Yes No "Cluster 51: Monocytes - Innate immune response" "Cluster 9: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 49: Ciliated cells - Cilium organization" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA051109: AB_2681346" "unprognostic (1.69e-2)" "unprognostic (1.78e-1)" "unprognostic (4.97e-2)" "unprognostic (8.50e-2)" "unprognostic (1.63e-1)" "unprognostic (3.71e-2)" "unprognostic (4.05e-2)" "unprognostic (6.53e-2)" "unprognostic (6.77e-2)" "unprognostic (2.10e-1)" "unprognostic (4.19e-3)" "unprognostic (6.24e-2)" "unprognostic (3.85e-2)" "unprognostic (7.92e-3)" "unprognostic (2.46e-1)" "unprognostic (7.49e-2)" "unprognostic (1.32e-1)" 5.2 5.1 2.9 14.5 2.9 4.5 3.1 3.9 3.8 9.2 12.6 70.1 91.9 3.3 1.4 2.1 19.3 18.7 1.2 3.1 2.7 29.1 15.0 5.1 3.9 2.8 2.7 1.7 7.0 0.9 3.5 5.4 2.9 6.2 64.7 4.3 2.2 4.4 3.4 4.8 76.0 7.3 2.4 5.9 15.6 3.3 3.0 4.5 1.6 0.7 4.0 3.5 2.3 3.3 3.4 11.6 7.9 4.8 1.6 1.7 5.7 2.2 2.3 4.8 3.0 22.1 29.8 3.7 3.0 1.9 3.7 15.1 18.2 2.8 2.0 3.3 16.9 6.7 21.6 7.9 3.5 5.8 14.7 1.6 4.4 1.8 3.4 3.0 5.9 10.8 6.2 3.9 0.7 10.2 14.5 12.6 8.5 24.1 3.4 30.1 8.1 8.2 1.3 6.0 4.4 4.3 3.5 3.2 9.9 3.1 2.8 12.6 3.5 5.0 4.5 9.2 8.7 14.4 9.4 10.0 3.3 14.9 2.2 0.1 43.7 0.2 0.1 184.3 0.6 0.6 0.6 0.2 29.1 0.1 0.5 0.3 21.3 0.0 216.9 1.4 0.4 18.3 2.9 2.9 3.9 3.8 3.1 2.7 2.8 2.7 2.9 2.4 3.0 3.3 1.3 0.0 1.5 3.3 0.7 1.5 0.8 2.8 1.8 11.1 0.4 0.1 0.3 12.8 15.8 3.7 0.0 0.5 0.3 49.2 0.0 2.5 6.5 9.4 0.6 6.4 7.7 1.3 3.8 4.3 0.5 3.2 31.6 0.4 0.0 0.4 5.0 8.1 3.9 8.4 4.0 17.1 0.0 11.7 1.5 0.5 3.7 8.1 0.0 4.7 3.9 2.0 2.1 3.0 3.4 3.0 39.3 6.8 2.4 1.1 36.2 25.4 107.8 3.1 0.0 1.1 0.7 0.0 0.4 1.3 2.0 0.1 1.2 0.1 21.1 1.1 CLN6 "FLJ20561, HsT18960, nclf" ENSG00000128973 "CLN6 transmembrane ER protein" Q9NWW5 15 68206992-68257211 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 181.8;Hofbauer cells: 88.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066046, HPA066759" Approved Approved "Nucleoli,Endoplasmic reticulum,Vesicles" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 20: HeLa - Mitochondria" "Cluster 56: Bipolar cells - Visual perception" "Endoplasmic reticulum" "Nucleoli, Vesicles" "HPA066046: AB_2685604, HPA066759: " "unprognostic (1.01e-1)" "unprognostic (1.54e-3)" "unprognostic (7.01e-2)" "unprognostic (3.58e-2)" "unprognostic (2.71e-2)" "unprognostic (3.08e-1)" "unprognostic (2.24e-2)" "unprognostic (5.07e-2)" "unprognostic (2.40e-2)" "unprognostic (2.11e-1)" "unprognostic (1.69e-1)" "unprognostic (1.85e-1)" "prognostic favorable (4.87e-4)" "unprognostic (1.22e-2)" "unprognostic (2.22e-1)" "unprognostic (2.49e-1)" "unprognostic (6.78e-2)" 11.6 17.6 12.7 14.8 13.0 29.9 11.5 13.3 14.9 11.0 13.2 17.5 14.6 9.8 6.8 16.9 9.8 9.6 9.3 12.1 12.6 20.0 22.7 13.2 16.2 13.3 13.1 6.8 19.1 10.4 10.1 11.6 13.8 12.4 14.9 11.8 14.8 9.2 17.0 14.7 14.6 10.4 12.8 20.7 13.3 10.9 13.0 11.6 12.9 7.3 16.7 10.7 9.6 14.5 38.2 93.1 23.9 33.9 14.5 11.8 57.1 35.3 17.0 42.8 34.9 72.1 60.5 57.6 17.2 21.4 31.7 69.5 69.8 34.5 17.0 38.5 82.3 84.3 66.1 54.3 29.7 95.6 58.1 20.8 11.4 34.7 23.7 9.0 29.1 33.1 56.9 116.0 33.6 103.8 44.0 69.4 57.1 67.3 38.3 42.1 71.8 80.6 36.2 97.0 48.2 20.0 39.5 61.7 34.3 18.0 33.1 95.5 19.3 48.1 55.7 35.8 127.2 81.3 97.3 47.4 30.0 115.4 47.6 0.0 8.8 0.6 3.0 13.0 4.0 2.9 2.2 4.3 5.2 2.3 2.8 1.3 10.5 2.0 16.1 4.4 2.3 3.5 12.7 13.0 13.3 14.9 12.1 12.6 13.3 13.1 13.8 12.8 13.0 14.5 1.4 9.6 6.9 7.2 13.4 20.1 22.0 13.9 14.8 181.8 2.0 1.9 27.4 10.0 9.6 5.5 16.7 42.8 7.1 22.7 0.0 3.3 0.4 1.0 4.8 9.7 15.1 32.8 8.9 1.8 58.4 9.1 8.2 1.4 8.9 5.6 11.0 21.9 88.4 21.9 8.1 20.5 16.2 24.2 14.0 1.4 9.0 11.3 19.6 8.4 12.9 16.9 11.3 5.0 10.2 3.6 26.0 8.2 33.4 23.7 15.6 2.1 3.3 32.7 6.6 7.5 5.6 1.0 19.5 21.1 14.1 21.8 9.5 5.3 35.6 16.3 FEM1B ENSG00000169018 "Fem-1 homolog B" Q9UK73 15 68277745-68295862 "Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 835.0;Late spermatids: 289.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041920, HPA042192" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 23: Testis - Cell cycle regulation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm Cytosol "HPA041920: AB_10796788, HPA042192: AB_10796574" "unprognostic (1.50e-1)" "unprognostic (1.27e-1)" "unprognostic (1.12e-1)" "unprognostic (1.16e-1)" "unprognostic (2.87e-2)" "unprognostic (6.29e-2)" "unprognostic (1.83e-1)" "unprognostic (3.27e-1)" "unprognostic (9.91e-2)" "unprognostic (1.52e-1)" "unprognostic (2.72e-1)" "unprognostic (6.84e-2)" "unprognostic (1.89e-2)" "unprognostic (3.49e-3)" "unprognostic (1.35e-1)" "unprognostic (2.89e-2)" "unprognostic (4.67e-2)" 17.3 13.6 15.1 16.2 16.8 60.1 23.7 21.3 18.7 18.0 6.9 17.5 15.4 26.8 14.6 24.6 15.3 14.9 19.8 17.3 14.7 13.7 20.1 16.4 15.8 12.9 12.5 20.0 11.6 18.0 9.0 18.9 16.2 18.6 16.4 22.6 12.7 20.8 49.3 23.3 16.6 30.2 13.8 17.2 12.9 71.7 14.3 18.9 17.1 27.4 18.6 22.0 16.1 23.1 17.3 31.2 31.7 29.9 27.8 25.6 21.1 24.1 25.1 24.5 22.3 21.1 22.7 39.8 17.1 33.2 17.6 61.6 66.5 30.7 20.3 19.1 26.3 43.7 36.8 13.4 24.1 35.8 26.1 23.8 64.9 29.6 71.3 34.9 19.5 19.9 37.3 47.2 20.9 20.1 26.0 18.2 32.2 13.9 10.0 37.1 35.5 51.6 15.5 62.1 42.2 26.6 25.0 25.6 67.4 39.8 23.1 33.0 25.6 42.2 37.1 14.8 22.3 30.7 71.2 42.4 24.1 38.3 25.6 0.0 3.1 2.0 3.0 4.2 2.8 2.0 2.9 3.2 2.4 2.3 3.5 2.7 2.3 3.7 3.6 1.7 1.6 2.0 15.1 16.8 21.3 18.7 17.3 14.7 12.9 12.5 16.2 13.8 14.3 23.1 25.2 22.4 35.4 12.7 16.9 98.7 56.3 32.1 48.3 31.5 29.2 25.7 51.6 21.5 23.7 18.4 12.5 17.1 20.8 25.8 0.0 23.4 835.0 21.7 34.3 24.4 19.9 21.4 33.4 12.0 12.7 26.5 15.3 25.6 14.5 26.9 16.1 30.9 31.8 38.7 29.4 23.2 12.2 27.3 33.4 289.6 24.5 24.9 40.9 30.0 22.4 17.6 10.3 17.6 33.5 20.8 17.9 27.8 14.9 37.0 22.2 13.3 29.4 13.1 26.3 26.7 31.3 25.2 8.9 49.5 111.2 16.8 17.2 23.6 20.3 59.3 ITGA11 HsT18964 ENSG00000137809 "Integrin subunit alpha 11" Q9UKX5 15 68296532-68432163 "Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 26.3;endometrium 1: 53.1;smooth muscle: 25.0" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 13.8;Excitatory neurons: 13.4;Fibroblasts: 30.1;Microglial cells: 18.7;Peritubular cells: 13.5;Sertoli cells: 19.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "fHDF/TERT166: 119.5;hTERT-RPE1: 174.5;U-138 MG: 80.6;WM-115: 45.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basal ganglia: 7.3;spinal cord: 2.1" HPA051813 Uncertain NA NA 260000 "Cluster 89: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "HPA051813: AB_2681622" "unprognostic (4.85e-2)" "unprognostic (3.51e-1)" "unprognostic (6.20e-2)" "unprognostic (1.89e-1)" "unprognostic (1.87e-2)" "unprognostic (3.07e-1)" "unprognostic (1.29e-1)" "unprognostic (1.03e-2)" "unprognostic (9.29e-3)" "unprognostic (6.63e-2)" "unprognostic (5.68e-3)" "unprognostic (3.36e-1)" "prognostic unfavorable (3.22e-7)" "unprognostic (8.38e-3)" "unprognostic (2.28e-4)" "unprognostic (3.57e-2)" "unprognostic (1.33e-2)" 6.5 3.4 0.2 1.1 1.5 0.2 3.2 0.7 1.1 26.3 0.4 2.1 0.8 53.1 13.5 1.5 12.0 2.4 12.7 0.2 0.3 6.5 0.7 1.7 0.5 0.2 0.2 4.6 0.8 0.4 1.8 1.5 0.1 5.2 1.3 0.4 1.2 7.4 2.1 2.7 1.6 25.0 0.1 3.2 1.6 0.9 0.1 0.2 2.0 2.4 0.1 3.9 8.2 0.5 0.0 0.2 0.4 0.9 3.7 0.1 0.1 7.9 15.1 1.6 0.5 0.1 0.2 0.1 0.6 119.5 2.1 0.2 0.0 0.0 0.4 0.0 0.2 0.5 6.8 0.0 10.8 0.2 7.0 1.5 0.0 3.1 0.3 174.5 0.0 0.1 0.2 0.3 20.9 0.1 0.1 0.4 0.7 0.0 0.1 0.2 0.1 0.2 0.0 0.2 0.2 0.1 5.5 0.1 0.1 18.5 0.1 0.5 5.0 80.6 0.7 2.1 0.1 0.2 0.0 0.1 13.5 0.2 45.4 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 1.5 0.7 1.1 0.2 0.3 0.2 0.2 0.1 0.1 0.1 0.5 2.9 0.0 0.0 0.3 0.3 0.8 0.5 0.0 0.6 3.9 1.0 7.0 13.8 0.0 0.0 1.8 0.0 0.0 0.3 0.1 1.9 0.3 0.3 0.2 0.8 1.1 0.0 0.0 13.4 0.0 0.1 30.1 1.5 0.3 0.0 0.2 2.2 0.5 0.3 0.0 0.7 0.0 0.0 0.6 1.2 0.5 6.8 0.6 0.0 18.7 0.0 0.3 0.0 0.0 0.5 0.2 0.0 13.5 0.2 0.3 0.1 0.3 0.0 1.6 19.7 2.7 5.4 0.0 0.2 0.2 0.4 0.1 0.6 0.2 0.0 0.3 CORO2B "ClipinC, KIAA0925" ENSG00000103647 "Coronin 2B" Q9UQ03 15 68578993-68727806 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 83.4;retina: 45.2" "Cell type enhanced" "Detected in many" "Astrocytes: 57.1;Bipolar cells: 43.2;Cone photoreceptor cells: 37.5;Excitatory neurons: 96.6;Inhibitory neurons: 50.0;Oligodendrocytes: 146.4" "Group enriched" "Detected in many" 8 "glioma: 34.7;melanoma: 21.5" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive B-cell: 1.2" "Lineage enriched" "Detected in single" 13 "B-cells: 1.2" "Cell line enhanced" "Detected in many" "ASC diff: 26.8;ASC TERT1: 57.5;HSkMC: 41.6;hTEC/SVTERT24-B: 34.6;U-87 MG: 59.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017960 Enhanced Supported Approved "Plasma membrane,Focal adhesion sites" NA NA "Cluster 37: B-cells - Transcription" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Plasma membrane, Focal adhesion sites" "HPA017960: AB_1847167" "unprognostic (1.35e-1)" "unprognostic (2.63e-2)" "unprognostic (2.81e-3)" "unprognostic (4.71e-3)" "unprognostic (3.28e-1)" "unprognostic (8.11e-5)" "unprognostic (4.77e-2)" "unprognostic (1.24e-1)" "unprognostic (3.68e-2)" "unprognostic (1.81e-1)" "unprognostic (1.33e-3)" "unprognostic (4.12e-2)" "unprognostic (1.26e-1)" "unprognostic (1.10e-2)" "unprognostic (5.83e-2)" "unprognostic (3.59e-2)" "unprognostic (1.87e-2)" 10.9 3.5 44.1 2.0 60.9 0.7 7.2 62.1 66.5 7.2 28.2 5.9 1.2 7.5 2.2 1.4 27.5 4.7 16.4 48.1 43.5 9.2 1.3 5.1 1.8 62.4 62.7 14.9 2.2 0.5 3.5 3.2 58.0 4.3 1.5 45.2 2.7 4.9 2.6 4.1 2.8 6.3 51.9 3.9 3.1 1.0 66.5 1.3 6.1 4.5 0.8 4.1 3.7 83.4 0.6 0.8 26.2 2.2 26.8 57.5 0.0 13.7 15.0 2.3 3.2 0.3 3.0 3.5 1.6 2.3 3.7 0.2 1.0 0.3 9.5 0.0 1.2 0.0 0.0 1.2 9.8 0.0 0.4 41.6 0.3 34.6 2.0 20.4 1.0 0.0 0.0 0.1 24.4 0.1 0.0 0.1 6.5 0.0 0.1 2.2 0.1 1.2 3.7 0.0 15.3 0.3 0.2 0.0 7.8 4.8 0.0 3.1 0.2 7.8 8.9 1.7 18.3 0.0 0.0 3.5 59.2 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.1 60.9 62.1 66.5 48.1 43.5 62.4 62.7 58.0 51.9 66.5 83.4 2.8 0.0 0.0 57.1 1.1 1.0 0.4 0.0 0.0 43.2 0.1 1.0 1.5 0.0 0.0 7.3 37.5 0.0 0.0 0.0 0.0 3.8 0.4 2.1 11.6 3.0 3.6 0.0 96.6 0.6 0.0 8.0 0.0 0.3 0.0 0.9 6.4 0.0 0.2 0.0 50.0 0.3 0.0 0.3 0.7 0.7 7.8 0.3 7.2 11.2 0.1 12.5 0.0 17.1 146.4 0.6 0.0 0.4 0.0 0.1 0.0 0.1 8.1 21.4 6.6 1.4 2.1 0.2 0.5 0.1 0.9 0.0 0.1 7.5 0.0 0.1 ANP32A "C15orf1, I1PP2A, LANP, MAPM, mapmodulin, PHAPI, PP32" ENSG00000140350 "Acidic nuclear phosphoprotein 32 family member A" P39687 15 68778535-68820897 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005231, HPA063133, HPA067561" Supported Enhanced Nucleoplasm,Centrosome,Cytosol NA NA 770000 "Cluster 52: Eosinophils - Transcription" "Cluster 3: T-cells - Adaptive immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 47: Cytotrophoblasts - Unknown function" "Nucleoplasm, Centrosome" Cytosol "CAB005231: AB_2289588, HPA063133: AB_2684947, HPA067561: AB_2685861" "unprognostic (1.41e-2)" "unprognostic (1.91e-1)" "unprognostic (2.46e-1)" "unprognostic (3.03e-1)" "unprognostic (6.96e-2)" "unprognostic (2.29e-2)" "unprognostic (1.04e-2)" "unprognostic (4.44e-2)" "unprognostic (4.00e-2)" "unprognostic (3.74e-2)" "unprognostic (1.20e-1)" "unprognostic (7.83e-2)" "unprognostic (4.16e-2)" "unprognostic (3.24e-2)" "unprognostic (2.38e-2)" "unprognostic (1.42e-1)" "unprognostic (1.17e-1)" 50.8 34.7 50.2 87.3 60.5 137.0 71.6 62.3 59.1 54.0 33.3 81.0 70.8 59.1 50.7 65.8 75.1 59.8 127.9 48.8 57.3 75.1 76.4 71.0 156.2 60.0 56.5 57.8 53.7 61.4 27.5 101.5 65.4 75.4 89.0 106.0 54.0 66.8 62.4 36.1 76.9 57.0 62.7 85.5 78.9 20.8 54.3 203.0 73.6 64.5 141.2 76.4 43.6 71.0 196.4 234.7 303.2 263.2 104.2 90.9 200.5 101.0 134.3 193.5 161.8 195.3 358.0 629.8 184.5 114.5 114.2 279.9 709.5 206.6 230.8 286.6 241.2 478.6 192.7 247.8 64.5 380.8 247.4 72.9 143.1 106.3 210.2 126.6 285.9 300.0 354.5 239.1 168.2 136.1 386.1 311.6 270.1 192.5 118.2 531.7 280.7 375.3 170.5 304.5 399.8 247.8 153.7 170.8 282.7 301.1 227.2 491.4 129.0 199.0 313.5 139.3 275.2 143.8 433.9 733.8 132.2 632.1 186.7 12.9 26.4 44.9 16.8 30.6 14.2 18.7 13.8 17.8 30.0 17.9 16.5 14.9 27.2 28.8 27.5 26.8 17.2 16.0 50.2 60.5 62.3 59.1 48.8 57.3 60.0 56.5 65.4 62.7 54.3 71.0 100.2 109.0 118.0 20.2 98.1 64.7 67.7 147.0 91.0 92.2 57.3 70.6 80.0 60.1 105.4 69.9 35.5 258.2 119.7 57.1 107.6 112.5 6.7 61.2 67.7 91.8 78.5 144.2 16.8 96.1 172.4 57.5 69.3 70.1 92.4 63.6 78.1 81.8 194.1 65.6 17.4 92.1 114.0 150.1 112.6 6.3 34.8 111.6 78.2 37.5 158.9 103.7 84.5 15.6 55.4 79.8 57.0 29.7 92.6 59.7 99.3 148.0 113.7 87.2 26.3 49.9 75.1 8.8 18.2 86.4 34.9 232.5 99.5 82.5 94.7 52.0 SPESP1 SP-ESP ENSG00000258484 "Sperm equatorial segment protein 1" Q6UW49 15 68818221-68946811 "Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "testis: 73.2" "Group enriched" "Detected in many" 4 "Early spermatids: 400.4;Spermatocytes: 455.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+ SV40 Large T+: 17.8;BJ hTERT+ SV40 Large T+ RasG12V: 18.6;HBF TERT88: 21.7;HMC-1: 13.4;OE19: 15.9;RPTEC TERT1: 26.8;SCLC-21H: 19.9;WM-115: 31.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA045936, HPA051040" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Secreted in male reproductive system" NA NA 52000 "Cluster 46: Basophils - DNA binding" "Cluster 83: Testis - Spermatogenesis" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Vesicles" Cytosol "HPA045936: AB_2679504, HPA051040: AB_2681322" "unprognostic (1.14e-1)" "unprognostic (1.43e-1)" "unprognostic (1.73e-3)" "unprognostic (9.82e-2)" "unprognostic (1.59e-1)" "unprognostic (1.42e-2)" "unprognostic (1.06e-1)" "unprognostic (5.96e-2)" "unprognostic (2.79e-1)" "unprognostic (2.40e-1)" "unprognostic (8.99e-2)" "unprognostic (1.10e-2)" "unprognostic (1.16e-2)" "unprognostic (2.68e-2)" "unprognostic (1.15e-1)" "unprognostic (1.75e-1)" "unprognostic (9.67e-2)" 2.3 3.4 1.1 0.8 1.1 0.4 2.2 1.2 1.6 1.2 1.0 1.6 1.2 1.5 6.3 2.6 1.8 3.5 3.1 1.1 1.2 2.0 1.2 1.1 0.8 1.3 1.2 3.4 1.9 4.7 1.2 12.9 1.3 3.5 1.1 2.8 1.8 2.9 1.6 1.0 0.9 1.2 1.3 1.3 1.5 73.2 1.1 0.9 1.9 1.9 0.7 2.4 0.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 17.8 18.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 21.7 5.0 0.0 0.0 0.0 0.0 6.3 0.0 13.4 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 2.9 0.0 0.0 3.3 15.9 0.0 0.0 1.4 0.0 26.8 0.2 19.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 31.6 1.1 1.3 0.4 0.2 1.1 0.5 0.5 0.4 0.3 0.8 0.3 0.3 0.5 0.5 0.2 0.8 0.4 0.4 0.5 1.1 1.1 1.2 1.6 1.1 1.2 1.3 1.2 1.3 1.3 1.1 1.6 5.1 0.0 0.0 0.0 0.2 1.9 3.0 23.7 1.8 1.0 2.7 4.1 4.1 1.5 4.0 7.3 4.2 92.3 0.3 0.2 1.9 2.1 400.4 3.9 3.4 3.6 1.8 0.8 0.0 2.7 7.2 5.5 0.0 2.0 0.0 1.7 2.2 1.8 7.8 0.0 0.0 0.9 6.1 2.1 3.3 90.3 21.1 1.2 5.4 0.0 1.0 5.3 0.0 0.0 0.0 0.9 0.0 8.6 0.0 3.3 0.0 3.9 6.3 5.6 46.0 3.4 4.2 455.0 88.7 1.1 2.3 62.1 0.5 11.1 0.2 1.5 NOX5 "NOX5A, NOX5B" ENSG00000255346 "NADPH oxidase 5" Q96PH1 15 68930525-69062762 "Predicted membrane proteins, Transporters" "Angiogenesis, Electron transport, Ion transport, Transport" "Ion channel, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lymphoid tissue: 8.8;testis: 2.2" "Cell type enhanced" "Detected in some" "Early spermatids: 17.6;Excitatory neurons: 6.4;Inhibitory neurons: 5.4;Late spermatids: 11.2;Theca cells: 31.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 64: Macrophages - Immune response" "Cluster 52: Non-specific - Transcription" "unprognostic (2.33e-1)" "unprognostic (1.63e-2)" "unprognostic (6.11e-2)" "unprognostic (1.80e-1)" "unprognostic (1.95e-1)" "unprognostic (4.91e-3)" "unprognostic (6.80e-2)" "unprognostic (5.50e-3)" "unprognostic (3.48e-2)" "unprognostic (2.08e-1)" "unprognostic (1.41e-1)" "unprognostic (8.21e-2)" "unprognostic (4.58e-3)" "unprognostic (2.71e-3)" "unprognostic (4.81e-2)" "unprognostic (1.59e-1)" "unprognostic (1.54e-1)" 0.1 0.2 0.2 0.0 0.1 0.0 0.2 0.0 0.1 1.0 0.0 0.0 0.0 0.4 0.9 0.2 0.3 0.1 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.3 0.2 0.1 0.7 0.0 0.5 0.0 0.2 0.0 0.1 0.2 0.8 0.0 8.8 0.2 2.2 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.3 0.5 0.2 0.2 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.1 0.2 0.0 1.7 0.4 0.3 1.2 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 17.6 0.4 0.3 0.6 0.0 0.0 6.4 0.0 0.1 0.7 0.0 0.1 0.0 0.6 0.0 0.0 0.5 0.0 5.4 0.0 0.0 0.0 0.0 11.2 0.6 0.1 0.0 1.9 0.0 0.4 0.0 1.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.8 0.0 0.3 0.1 5.0 2.3 0.0 0.0 1.8 0.0 31.0 0.0 0.1 GLCE "HSEPI, KIAA0836" ENSG00000138604 "Glucuronic acid epimerase" O94923 15 69160584-69272217 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.8" "Cell type enhanced" "Detected in many" "Excitatory neurons: 79.0;Microglial cells: 76.8;Oligodendrocytes: 154.9" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 35.8" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 8 "dendritic cells: 1.9;monocytes: 2.3;T-cells: 2.0" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 119.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040481, HPA048216" Uncertain Approved Mitochondria "Intracellular and membrane" NA NA 240000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Mitochondria "HPA040481: AB_2677004, HPA048216: AB_2680317" "unprognostic (1.30e-1)" "unprognostic (2.39e-1)" "unprognostic (1.20e-3)" "unprognostic (7.77e-2)" "unprognostic (1.58e-1)" "unprognostic (5.55e-3)" "unprognostic (1.00e-1)" "unprognostic (2.84e-1)" "unprognostic (1.48e-1)" "unprognostic (2.56e-1)" "unprognostic (7.47e-2)" "unprognostic (1.41e-1)" "unprognostic (2.40e-2)" "unprognostic (1.53e-1)" "unprognostic (6.00e-2)" "unprognostic (5.23e-1)" "unprognostic (4.07e-2)" 9.1 12.2 6.7 5.6 7.8 0.9 8.9 35.8 6.2 8.2 8.4 12.8 14.2 6.4 6.9 10.0 5.5 7.5 6.3 6.0 6.7 13.3 16.8 8.4 3.5 5.7 8.5 12.7 4.7 8.7 6.4 13.4 7.2 5.8 14.2 13.2 10.9 5.8 4.1 10.4 11.5 7.0 7.5 4.4 9.1 3.9 8.8 4.9 4.1 4.9 5.1 6.6 4.6 8.0 9.6 8.5 5.6 9.7 18.6 17.6 2.0 17.6 23.2 13.3 25.2 7.1 23.6 5.8 8.5 14.4 16.8 14.0 12.1 11.4 27.1 2.2 13.4 9.7 15.0 7.2 17.9 4.2 19.0 12.1 7.8 16.6 18.6 9.7 119.4 4.3 3.9 6.0 25.4 5.9 2.6 7.4 2.7 9.7 5.9 5.8 22.6 7.3 12.3 10.1 17.9 3.7 18.0 11.0 38.1 3.8 7.9 5.8 41.8 12.7 15.7 14.3 15.8 2.5 3.7 1.3 12.9 7.0 18.8 0.0 2.1 0.0 0.3 1.6 0.5 0.2 0.8 0.4 1.8 0.2 0.5 0.7 0.0 0.2 2.3 1.9 2.0 0.9 6.7 7.8 35.8 6.2 6.0 6.7 5.7 8.5 7.2 7.5 8.8 8.0 16.9 0.0 15.4 4.9 6.2 4.8 10.1 8.3 26.2 10.3 18.8 19.4 8.1 7.2 8.8 11.0 10.4 22.7 12.1 21.3 5.9 13.0 3.9 4.0 5.4 22.6 20.4 9.4 79.0 13.8 12.7 14.0 28.1 4.9 2.5 11.8 16.4 27.2 16.4 8.4 41.5 27.1 10.2 13.3 4.4 5.1 6.2 10.7 8.8 76.8 13.7 13.1 4.1 35.7 154.9 16.9 28.2 17.7 7.1 5.3 32.4 18.3 18.2 16.6 13.1 6.6 9.4 29.8 25.9 27.9 6.5 33.0 5.9 17.1 26.4 13.3 PAQR5 "FLJ20190, MPRG" ENSG00000137819 "Progestin and adipoQ receptor family member 5" Q9NXK6 15 69298912-69407780 "Predicted membrane proteins" "Differentiation, Oogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 52.9" "Cell type enhanced" "Detected in many" "Cholangiocytes: 32.9;Distal tubular cells: 46.9;Early spermatids: 38.2;granulocytes: 67.2;Late spermatids: 123.0;Proximal tubular cells: 42.3" "Cancer enhanced" "Detected in many" "renal cancer: 8.6" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 6 "basophil: 1.1" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.1" "Cell line enhanced" "Detected in many" "A549: 38.1;CAPAN-2: 46.4;fHDF/TERT166: 33.1;HMC-1: 79.8;U-87 MG: 33.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076729 Approved Vesicles NA NA "Cluster 38: Basophils - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 3: HMC-1 - Innate immune response" "Cluster 31: Spermatids - Spermatogenesis" Vesicles "HPA076729: AB_2686813" "unprognostic (4.47e-2)" "unprognostic (3.11e-2)" "unprognostic (1.46e-1)" "unprognostic (4.05e-4)" "unprognostic (1.53e-1)" "unprognostic (8.28e-2)" "unprognostic (3.58e-3)" "unprognostic (6.12e-3)" "unprognostic (1.47e-1)" "unprognostic (1.67e-1)" "prognostic unfavorable (2.15e-5)" "unprognostic (2.00e-1)" "prognostic favorable (1.47e-14)" "unprognostic (5.64e-2)" "unprognostic (1.73e-1)" "unprognostic (4.16e-4)" "unprognostic (4.94e-2)" 0.6 16.0 3.5 2.6 2.8 1.2 1.2 2.7 3.0 1.7 12.0 19.0 2.3 1.0 0.2 12.4 0.9 2.0 0.8 3.1 2.8 52.9 1.1 9.1 0.3 3.4 3.1 0.6 5.1 11.3 0.8 1.6 4.0 0.6 16.2 1.9 1.8 3.7 0.2 4.9 8.0 0.9 2.8 0.4 7.7 2.4 4.4 0.2 0.8 0.2 2.1 3.6 2.9 2.9 11.7 38.1 0.8 0.8 1.6 4.2 0.3 3.7 22.2 4.3 9.1 2.2 46.4 0.1 5.9 33.1 3.7 0.7 10.9 0.6 7.4 0.1 1.7 6.9 5.6 0.8 2.9 0.2 79.8 2.2 1.7 19.4 20.7 5.5 0.0 0.2 0.1 0.7 18.4 1.6 0.2 0.2 2.6 6.1 3.2 0.1 0.6 2.2 16.6 0.9 3.3 0.7 6.0 2.3 3.1 2.1 1.0 2.8 0.6 13.1 4.2 1.1 0.4 0.2 0.3 0.1 33.1 0.1 3.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 3.5 2.8 2.7 3.0 3.1 2.8 3.4 3.1 4.0 2.8 4.4 2.9 0.1 12.8 21.0 1.0 0.5 0.9 1.3 0.4 1.2 0.7 1.3 0.8 0.7 32.9 0.9 20.2 0.0 0.0 0.0 31.1 46.9 19.0 38.2 0.7 0.1 1.9 0.0 0.0 0.5 0.4 0.0 2.8 2.0 1.5 67.2 2.2 0.0 0.0 3.7 0.0 0.7 4.8 0.0 0.3 0.7 123.0 0.9 1.8 0.0 20.6 0.0 5.9 0.0 1.0 0.5 2.6 6.9 1.2 0.0 1.4 26.8 42.3 0.8 0.1 6.6 0.1 0.6 0.5 0.5 15.1 1.8 0.1 0.4 19.6 13.7 0.8 KIF23 "KNSL5, MKLP-1, MKLP1" ENSG00000137807 "Kinesin family member 23" Q02241 15 69414246-69448427 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 21.6;lymphoid tissue: 15.9" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 24.2;Erythroid cells: 42.3;Extravillous trophoblasts: 32.4;Granulosa cells: 22.4;Spermatocytes: 70.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "eosinophil: 4.6" "Group enriched" "Detected in many" 13 "granulocytes: 4.6;monocytes: 1.2;T-cells: 1.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB010414, HPA045208, HPA068831" Uncertain Enhanced "Nucleoplasm,Midbody ring,Mitotic spindle" Yes Yes "Cluster 49: Eosinophils - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Midbody ring, Mitotic spindle" "CAB010414: AB_631959, HPA045208: AB_2679254, HPA068831: AB_2686045" "unprognostic (1.29e-1)" "unprognostic (2.40e-1)" "unprognostic (5.57e-2)" "prognostic unfavorable (8.62e-4)" "unprognostic (1.86e-1)" "unprognostic (7.99e-3)" "prognostic unfavorable (3.18e-5)" "unprognostic (1.43e-3)" "unprognostic (4.25e-3)" "unprognostic (2.60e-1)" "prognostic unfavorable (3.69e-5)" "unprognostic (5.85e-3)" "unprognostic (0.00e+0)" "unprognostic (1.15e-2)" "unprognostic (2.59e-1)" "unprognostic (1.17e-1)" "unprognostic (9.17e-2)" 1.0 1.5 0.3 5.7 0.2 21.6 1.4 0.2 0.3 1.5 1.4 4.1 3.9 2.0 0.1 5.3 0.9 1.3 0.6 0.3 0.2 4.6 0.5 1.5 7.9 0.2 0.3 0.7 0.5 0.4 0.1 6.4 0.3 0.9 5.0 0.2 1.1 1.2 0.1 3.7 3.8 4.2 0.2 2.2 2.0 10.6 0.3 15.9 0.3 0.2 9.8 1.8 2.1 0.2 100.7 81.5 64.2 59.0 3.7 7.3 36.3 105.3 57.0 154.8 120.6 50.2 72.4 56.8 31.4 53.1 78.6 110.5 121.6 39.5 158.7 52.9 60.2 55.3 78.8 30.7 2.1 55.6 48.3 3.3 4.2 71.8 60.5 19.4 52.0 46.9 36.0 70.2 95.4 44.1 31.2 28.2 71.6 35.5 33.2 37.0 133.8 31.2 39.3 49.7 32.5 25.3 120.4 51.9 44.9 74.5 50.6 25.3 34.5 90.0 120.8 62.0 157.6 26.3 74.3 48.4 31.5 72.2 78.0 0.0 1.2 4.6 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.6 0.0 1.2 0.3 0.3 0.2 0.2 0.3 0.3 0.2 0.2 0.3 0.3 0.2 0.3 0.2 0.4 0.0 0.5 0.0 2.3 1.9 3.7 4.2 0.0 0.2 1.8 2.8 0.8 5.7 4.7 7.3 2.1 24.2 1.4 3.3 3.9 1.8 13.3 13.1 3.6 2.2 1.8 42.3 1.8 0.0 32.4 5.8 3.6 8.7 2.5 22.4 3.9 0.3 8.1 0.0 1.0 3.1 0.0 2.8 3.4 4.8 0.9 3.2 0.0 1.0 8.1 0.2 0.0 0.0 0.2 0.4 0.4 1.9 6.8 1.6 0.8 0.9 3.6 0.1 6.6 0.4 8.2 70.8 20.9 11.3 1.0 2.5 4.2 3.6 8.6 3.3 RPLP1 LP1 ENSG00000137818 "Ribosomal protein lateral stalk subunit P1" P05386 15 69452814-69456205 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Suprabasal keratinocytes: 28402.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003368 Supported "Endoplasmic reticulum,Cytosol" NA NA 2000000 "Cluster 30: Non-specific - Translation" "Cluster 59: Non-specific - Translation" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 32: Non-specific - Translation" "Endoplasmic reticulum, Cytosol" "HPA003368: AB_1079845" "unprognostic (5.04e-3)" "unprognostic (2.26e-2)" "unprognostic (2.02e-2)" "unprognostic (4.29e-2)" "unprognostic (6.32e-2)" "unprognostic (1.35e-1)" "unprognostic (4.36e-2)" "unprognostic (2.92e-1)" "unprognostic (1.30e-1)" "unprognostic (2.36e-1)" "unprognostic (2.79e-1)" "unprognostic (9.55e-2)" "prognostic unfavorable (2.30e-9)" "unprognostic (7.75e-2)" "unprognostic (1.57e-1)" "unprognostic (2.59e-1)" "unprognostic (5.83e-2)" 1779.5 1664.6 852.0 893.4 872.7 2781.2 1895.2 821.7 1109.7 2465.3 920.5 2035.4 1200.3 1805.3 349.4 2773.4 1670.9 579.0 2121.7 813.6 844.4 1703.1 1566.2 1439.7 1583.3 871.6 857.5 3354.5 2003.6 264.6 924.6 565.5 866.0 1991.6 449.1 157.6 1705.8 417.0 4746.4 4498.6 1693.4 529.7 892.5 1992.0 2147.0 492.5 873.6 643.5 1140.9 761.4 1017.9 2099.9 2372.6 891.4 1890.5 1882.4 827.9 1919.4 1172.4 1394.2 1770.4 1615.7 960.9 892.0 711.8 1918.7 1861.9 2622.2 2346.4 869.5 811.2 2521.6 1296.6 1287.5 193.1 2639.9 3956.6 2208.5 2153.1 1914.5 2045.2 1976.4 1931.2 1782.1 2199.9 653.6 1219.6 1438.9 1092.7 2265.9 2127.7 2160.7 642.2 1757.0 2163.4 5781.3 3098.7 1172.2 1802.9 2192.5 2696.6 3893.7 876.0 2002.9 1319.3 2558.5 1620.5 1978.2 6979.8 742.8 1633.9 4449.5 1915.7 1273.2 2851.6 1535.0 2672.3 4382.2 7690.0 2245.6 1524.1 4968.6 1076.9 2903.3 5350.5 1819.3 3182.4 3677.4 5811.2 9096.0 6532.4 4349.4 6100.6 7551.7 6871.8 6057.1 733.9 5147.0 2138.6 6392.6 5921.8 13416.9 852.0 872.7 821.7 1109.7 813.6 844.4 871.6 857.5 866.0 892.5 873.6 891.4 3508.0 1891.0 3795.4 16.0 11229.3 24186.3 18565.6 9896.5 18630.1 626.6 14197.1 19613.8 1854.3 3877.6 5293.4 2265.9 350.3 9217.3 6668.2 2484.5 5141.7 5608.7 475.1 2702.4 5765.4 5131.7 2926.5 6423.8 19.7 7158.4 12076.7 5235.1 3541.4 4232.4 2605.7 4287.7 5261.2 6536.1 8166.9 373.5 22.5 7238.9 2396.6 8309.7 12226.0 1764.3 8447.2 6779.7 9051.8 28.1 11829.2 4015.4 6451.2 15.6 42.8 7495.3 5127.5 4732.9 10308.0 16198.4 5565.3 8039.9 2204.8 1167.3 2530.9 5356.8 5872.6 690.3 1864.1 18779.3 28402.5 9502.3 9179.6 6940.6 8549.1 17342.5 TLE3 "ESG, ESG3, GRG3, HsT18976, KIAA1547" ENSG00000140332 "TLE family member 3, transcriptional corepressor" Q04726 15 70047790-70098176 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 65.1" "Cell type enhanced" "Detected in many" "Suprabasal keratinocytes: 132.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "neutrophil: 49.1" "Lineage enriched" "Detected in all" 5 "granulocytes: 49.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054116 Approved Supported Nucleoplasm NA Yes "Cluster 9: Neutrophils - Innate immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 20: HeLa - Mitochondria" "Cluster 28: Keratinocytes - Keratinization" Nucleoplasm "HPA054116: AB_2682386" "unprognostic (5.57e-2)" "prognostic favorable (2.09e-5)" "unprognostic (5.18e-2)" "unprognostic (5.13e-2)" "unprognostic (1.15e-1)" "unprognostic (4.05e-2)" "unprognostic (1.35e-2)" "unprognostic (5.53e-2)" "unprognostic (6.74e-2)" "unprognostic (3.11e-2)" "unprognostic (1.72e-1)" "unprognostic (6.07e-2)" "unprognostic (4.90e-2)" "unprognostic (2.43e-1)" "unprognostic (6.71e-2)" "unprognostic (6.29e-2)" "unprognostic (2.74e-1)" 16.1 6.4 9.2 18.3 11.5 65.1 15.2 10.7 10.9 17.4 2.9 20.6 17.3 10.8 3.0 31.1 10.1 5.8 9.9 12.3 15.3 16.4 13.3 20.3 17.7 15.1 13.9 14.0 14.9 5.8 10.3 12.6 11.8 23.2 6.4 4.9 19.1 10.1 8.3 29.4 21.8 6.9 13.4 23.1 15.7 22.1 15.1 13.5 13.5 2.9 18.9 9.8 19.4 12.2 7.8 24.2 13.3 23.6 12.1 9.9 80.3 1.5 4.1 3.1 2.5 34.0 22.8 22.0 32.8 2.1 4.8 14.3 32.3 11.5 1.6 30.9 45.9 36.9 50.8 6.6 11.5 11.4 51.1 20.5 6.3 9.1 8.2 19.7 15.5 47.9 26.1 96.0 4.5 20.9 41.2 28.3 14.2 7.4 24.9 36.8 13.6 24.7 7.1 41.7 19.5 28.7 66.2 29.7 28.7 14.5 33.6 24.9 11.7 9.5 18.7 29.6 16.4 84.6 57.2 35.3 13.3 37.3 25.1 2.6 4.5 2.5 1.9 4.8 1.8 9.9 2.6 2.5 2.9 4.9 2.5 3.3 49.1 2.8 5.2 8.7 1.6 1.7 9.2 11.5 10.7 10.9 12.3 15.3 15.1 13.9 11.8 13.4 15.1 12.2 27.5 12.8 27.7 16.0 49.2 115.1 47.8 19.5 59.2 19.9 45.5 28.4 8.1 4.3 18.9 62.5 31.3 25.3 38.2 55.2 7.9 11.6 45.5 17.2 5.0 27.6 28.8 15.2 6.1 5.6 64.4 25.0 17.9 32.1 53.2 25.5 23.9 21.5 37.3 0.0 5.0 30.3 10.2 41.5 78.2 76.9 14.0 51.5 35.6 13.1 35.8 32.6 1.0 9.5 0.4 11.0 31.7 18.4 47.2 39.9 41.0 13.2 8.1 4.4 0.0 39.8 24.7 5.8 28.0 67.7 132.8 82.4 37.6 0.7 43.9 31.5 UACA "FLJ10128, KIAA1561" ENSG00000137831 "Uveal autoantigen with coiled-coil domains and ankyrin repeats" Q9BZF9 15 70654554-70763558 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 142.0" "Cell type enhanced" "Detected in many" "Adipocytes: 293.0;Cardiomyocytes: 175.1;Endothelial cells: 177.4;Microglial cells: 184.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 1.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 244.5;BJ hTERT+: 148.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041412, HPA043503, HPA056006" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm Cytosol "HPA041412: AB_10966708, HPA043503: AB_2678517, HPA056006: " "unprognostic (1.58e-1)" "unprognostic (1.05e-1)" "unprognostic (2.56e-2)" "unprognostic (1.54e-1)" "unprognostic (2.79e-1)" "unprognostic (1.16e-1)" "unprognostic (1.19e-1)" "unprognostic (1.43e-2)" "unprognostic (1.12e-1)" "unprognostic (2.80e-1)" "prognostic unfavorable (7.01e-5)" "unprognostic (4.95e-2)" "prognostic unfavorable (1.62e-4)" "unprognostic (1.14e-3)" "unprognostic (1.45e-1)" "unprognostic (2.42e-2)" "prognostic unfavorable (1.03e-4)" 37.7 17.9 10.5 7.8 13.1 1.0 33.0 11.0 12.9 25.1 24.2 14.6 22.2 22.1 21.5 28.9 21.6 32.2 28.0 9.4 11.8 30.8 17.3 30.7 8.0 13.3 12.8 31.2 12.7 12.5 11.5 28.6 13.0 21.6 15.4 11.9 25.3 18.4 142.0 19.4 22.3 16.0 12.1 30.0 15.9 16.1 14.2 4.6 35.6 106.0 6.7 13.2 25.4 14.7 42.7 34.8 15.2 20.2 29.9 127.9 0.1 244.5 148.4 62.7 53.8 58.5 61.5 29.2 65.6 61.4 18.4 48.1 34.4 19.4 78.3 0.1 15.3 16.4 27.9 12.3 38.8 0.4 6.0 60.8 10.7 37.1 28.1 103.3 67.7 6.9 4.1 0.1 78.7 14.0 0.1 2.6 12.7 19.3 18.0 0.0 109.6 0.2 30.3 14.4 4.0 7.6 46.5 7.1 48.9 30.3 13.4 4.9 130.5 3.6 24.8 20.6 39.1 2.3 8.8 0.2 31.4 4.4 27.4 0.1 0.9 0.0 0.0 1.7 0.0 0.5 0.0 0.0 0.8 1.2 0.1 0.0 0.0 0.0 1.2 0.0 0.0 0.3 10.5 13.1 11.0 12.9 9.4 11.8 13.3 12.8 13.0 12.1 14.2 14.7 293.0 6.4 6.4 31.6 5.4 11.3 14.6 13.7 10.2 6.3 22.2 33.3 175.1 18.6 19.2 49.7 4.2 1.0 2.1 66.5 3.9 49.0 21.0 75.3 46.3 177.4 9.1 3.0 0.9 48.7 1.9 81.6 33.6 53.0 15.2 34.9 47.5 18.8 9.6 25.2 0.7 33.1 6.1 24.3 8.6 15.2 125.2 15.8 30.2 184.6 9.5 49.4 2.1 6.0 62.0 78.8 35.7 141.1 0.8 21.8 45.3 5.0 61.9 4.2 52.6 53.5 96.2 46.4 35.2 16.4 13.1 1.0 2.9 62.7 24.2 10.9 LARP6 "acheron, FLJ11196" ENSG00000166173 "La ribonucleoprotein 6, translational regulator" Q9BRS8 15 70829130-70854157 "Predicted intracellular proteins" "Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 429.0;Late spermatids: 259.8;Spermatocytes: 166.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-2197: 232.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020338, HPA049029" Approved Approved "Microtubules,Cytokinetic bridge" Yes No "Cluster 57: Non-specific - Angiogenesis" "Cluster 18: U-2197 - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Microtubules "Cytokinetic bridge" "HPA020338: AB_1844500, HPA049029: AB_2680604" "unprognostic (1.35e-3)" "unprognostic (1.95e-1)" "unprognostic (7.43e-2)" "unprognostic (2.63e-3)" "unprognostic (2.96e-2)" "unprognostic (4.70e-2)" "unprognostic (2.44e-2)" "unprognostic (2.80e-3)" "unprognostic (4.27e-2)" "unprognostic (2.87e-2)" "unprognostic (1.07e-1)" "unprognostic (1.28e-2)" "prognostic unfavorable (9.90e-5)" "unprognostic (4.51e-3)" "unprognostic (8.90e-2)" "unprognostic (2.13e-1)" "unprognostic (3.43e-1)" 51.4 9.8 42.8 6.5 69.8 0.1 44.0 56.9 65.5 27.5 22.8 18.5 2.1 22.8 28.4 7.9 29.0 10.9 43.4 44.5 52.0 27.9 10.6 17.9 2.3 57.8 56.6 30.4 10.9 19.6 23.6 7.7 56.4 26.1 4.0 11.8 19.5 14.1 17.6 14.0 10.3 12.1 46.8 2.6 26.9 9.6 55.9 5.1 40.8 26.1 1.5 21.1 31.0 90.4 42.3 44.2 14.1 28.3 70.2 77.9 0.1 127.7 99.0 67.4 71.2 12.9 12.0 0.0 50.9 69.9 65.4 22.7 32.0 11.2 66.4 0.4 78.3 0.2 37.6 12.0 127.1 0.2 0.2 49.0 45.6 67.9 107.5 70.6 22.2 15.4 0.1 0.6 30.4 7.3 0.3 0.3 14.9 0.0 113.9 0.2 50.6 0.3 22.0 35.9 8.4 18.5 42.5 0.5 93.1 21.7 2.3 2.4 29.6 27.4 109.6 232.0 107.5 0.2 0.3 0.4 116.9 0.0 14.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 42.8 69.8 56.9 65.5 44.5 52.0 57.8 56.6 56.4 46.8 55.9 90.4 32.3 0.0 1.1 2.9 0.1 18.1 47.7 20.4 9.6 41.4 15.4 18.3 22.2 24.3 11.8 12.9 2.1 0.5 1.0 0.3 54.8 59.4 429.0 24.6 31.8 24.5 12.0 0.0 10.8 25.1 0.8 87.5 4.1 8.4 0.0 7.5 11.4 15.3 1.2 25.2 11.8 1.5 10.2 0.6 13.3 259.8 73.3 3.2 19.6 7.5 0.1 28.5 0.0 5.5 105.9 62.9 0.0 45.9 0.5 61.9 0.0 100.9 16.8 4.8 19.7 28.3 34.8 166.8 11.0 1.4 8.9 0.4 1.9 5.3 0.6 37.7 LRRC49 FLJ20156 ENSG00000137821 "Leucine rich repeat containing 49" Q8IUZ0 15 70853239-71053658 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 56.3" "Cell type enhanced" "Detected in many" "Bipolar cells: 85.0;Cardiomyocytes: 145.1;Early spermatids: 92.8;Excitatory neurons: 79.1;Inhibitory neurons: 88.4;Late spermatids: 105.3;Spermatocytes: 91.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HHSteC: 24.2;SH-SY5Y: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015596 Uncertain NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA015596: AB_2669230" "unprognostic (9.74e-2)" "unprognostic (7.94e-2)" "unprognostic (3.25e-3)" "unprognostic (1.15e-2)" "unprognostic (6.10e-2)" "unprognostic (3.07e-2)" "unprognostic (1.07e-2)" "unprognostic (1.72e-1)" "unprognostic (3.36e-2)" "unprognostic (9.43e-2)" "unprognostic (7.66e-4)" "unprognostic (3.02e-1)" "unprognostic (5.29e-2)" "unprognostic (7.60e-2)" "unprognostic (3.06e-2)" "unprognostic (2.35e-1)" "unprognostic (3.09e-2)" 2.4 2.8 7.9 0.8 10.4 0.3 2.7 13.7 11.2 6.6 7.3 3.9 0.4 8.7 29.6 1.9 9.0 3.7 56.3 6.7 10.7 4.6 0.5 2.7 0.7 12.2 10.5 11.1 1.4 9.1 11.6 1.0 13.2 5.3 1.7 26.8 1.8 4.8 1.1 1.7 1.7 5.0 5.1 0.8 2.7 11.9 18.8 1.0 4.8 1.7 0.8 4.5 3.8 6.1 2.1 3.9 8.5 14.9 3.8 6.4 0.1 3.6 6.3 2.4 5.8 1.3 1.6 0.0 2.6 1.5 6.0 3.5 8.4 4.3 2.0 0.0 4.5 1.0 4.1 0.1 24.2 0.1 0.5 2.9 1.5 7.2 12.3 12.5 6.5 0.0 0.1 0.0 3.6 0.7 0.0 0.7 5.0 0.3 2.8 0.0 5.7 0.0 8.0 4.5 17.2 18.0 4.3 2.0 4.0 3.1 4.6 1.4 5.9 2.9 9.0 5.4 6.2 1.1 4.3 0.0 6.8 0.2 2.2 0.1 0.0 0.0 0.1 0.3 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.9 10.4 13.7 11.2 6.7 10.7 12.2 10.5 13.2 5.1 18.8 6.1 4.3 3.2 3.7 63.3 0.7 2.3 22.9 11.5 5.7 85.0 2.2 3.0 145.1 1.5 13.0 7.3 62.6 0.1 0.1 1.5 5.9 7.0 92.8 30.8 8.0 7.2 18.5 0.0 79.1 0.9 0.1 11.6 2.6 4.3 0.0 8.0 2.5 0.0 0.1 30.3 88.4 1.9 0.0 0.3 0.7 105.3 5.6 0.7 0.0 19.7 0.0 10.9 0.0 63.8 34.1 1.7 1.6 9.8 0.2 11.7 0.3 3.5 54.8 37.3 0.0 7.4 8.0 91.9 11.4 0.7 1.6 0.3 0.8 2.5 1.2 8.0 THAP10 ENSG00000129028 "THAP domain containing 10" Q9P2Z0 15 70881342-70892433 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 17.5;Early spermatids: 12.6;Spermatocytes: 19.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 7 "non-classical monocyte: 4.2" "Lineage enriched" "Detected in single" 7 "monocytes: 4.2" "Cell line enhanced" "Detected in many" "U-2197: 40.4" "HPA041416, HPA073220" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 18: U-2197 - ECM organization" "Cluster 56: Bipolar cells - Visual perception" Nucleoplasm "Golgi apparatus, Cytosol" "HPA041416: AB_10795592, HPA073220: " "unprognostic (1.00e-1)" "unprognostic (3.51e-1)" "unprognostic (5.42e-2)" "unprognostic (2.43e-2)" "unprognostic (1.34e-1)" "unprognostic (6.15e-2)" "unprognostic (6.25e-2)" "unprognostic (2.16e-2)" "unprognostic (2.99e-2)" "unprognostic (6.47e-2)" "unprognostic (1.55e-3)" "unprognostic (3.71e-2)" "prognostic favorable (3.05e-5)" "unprognostic (1.25e-2)" "unprognostic (2.12e-2)" "unprognostic (7.46e-2)" "unprognostic (9.44e-3)" 1.7 2.2 4.6 1.3 5.2 0.1 1.9 6.1 7.3 2.4 2.4 2.2 2.3 2.1 1.8 1.9 3.2 1.5 4.7 3.9 5.2 3.0 2.1 1.8 1.0 5.1 5.4 3.7 1.9 5.1 1.7 1.8 5.2 3.0 1.9 10.8 1.8 3.1 2.3 1.3 1.2 2.0 5.0 0.9 2.9 3.4 6.3 0.9 3.6 2.3 0.9 2.6 1.4 5.9 7.3 12.6 7.7 9.8 4.1 5.0 0.1 13.5 6.1 11.4 13.5 2.0 9.5 0.0 8.2 3.8 14.3 11.3 16.2 3.7 10.2 0.0 8.3 2.6 6.2 0.9 2.0 0.7 5.2 1.6 5.1 6.5 6.2 7.9 5.8 0.0 0.9 0.0 8.3 5.7 0.0 2.9 11.2 5.2 5.3 0.0 9.9 0.3 5.1 5.9 8.6 8.9 9.3 3.9 6.5 7.5 4.6 6.3 4.3 7.9 5.6 40.4 9.6 3.4 4.3 0.0 5.0 0.9 11.6 0.0 0.3 0.0 0.0 0.5 0.0 0.3 0.2 0.0 0.6 0.1 0.0 0.1 0.0 0.4 4.2 0.0 0.2 0.1 4.6 5.2 6.1 7.3 3.9 5.2 5.1 5.4 5.2 5.0 6.3 5.9 3.5 0.0 0.5 0.0 0.5 1.8 4.1 2.4 1.2 17.5 2.0 2.0 6.1 1.5 2.0 11.0 0.0 0.2 0.0 2.5 9.8 3.0 12.6 5.5 1.9 2.7 3.0 0.4 3.0 1.1 0.3 2.4 1.1 1.1 0.0 2.1 1.4 1.8 1.3 1.7 4.0 1.5 8.2 0.6 1.0 7.8 2.5 0.7 0.0 0.0 0.1 5.2 0.0 1.0 4.7 0.8 5.3 4.9 1.2 2.2 0.6 6.8 5.4 4.6 0.0 1.5 2.9 19.3 2.7 2.6 1.4 0.1 0.2 1.8 2.9 4.2 THSD4 "ADAMTSL6, FLJ13710, FVSY9334, PRO34005" ENSG00000187720 "Thrombospondin type 1 domain containing 4" Q6ZMP0 15 71096952-71783383 "Predicted membrane proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 103.7" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 106.4;Basal squamous epithelial cells: 449.0;Microglial cells: 247.3;Squamous epithelial cells: 141.5" "Cancer enhanced" "Detected in many" "ovarian cancer: 18.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 45.3;BJ hTERT+: 53.0;T-47d: 43.3;TIME: 66.6;U-2197: 44.4" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 4 "spinal cord: 39.0" "Secreted - unknown location" NA NA "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 61: Squamous epithelial cells - Keratinization" "unprognostic (1.59e-1)" "unprognostic (4.38e-2)" "unprognostic (3.14e-2)" "unprognostic (1.04e-1)" "unprognostic (1.52e-1)" "unprognostic (2.82e-2)" "unprognostic (2.63e-2)" "unprognostic (1.14e-1)" "unprognostic (7.80e-2)" "unprognostic (2.51e-2)" "unprognostic (1.13e-1)" "unprognostic (9.67e-2)" "unprognostic (1.43e-1)" "unprognostic (3.64e-1)" "unprognostic (1.30e-1)" "unprognostic (1.33e-2)" "unprognostic (3.01e-3)" 4.8 8.4 9.8 1.6 7.8 0.0 14.7 6.1 8.6 103.7 9.5 7.0 7.9 22.2 7.8 60.3 37.0 10.9 41.6 8.5 7.2 14.2 7.0 10.3 0.9 7.8 9.1 3.1 6.4 0.7 9.7 3.6 7.6 34.0 6.9 1.2 11.4 15.0 3.0 8.5 8.7 10.3 7.0 1.9 12.0 3.1 15.9 1.6 8.8 2.5 2.5 13.3 38.5 5.9 6.0 45.3 0.8 13.0 6.7 40.2 0.2 22.0 53.0 11.2 5.8 0.3 8.7 0.0 17.7 7.8 38.5 17.0 1.8 9.1 6.8 2.0 2.0 0.0 4.4 0.0 4.3 0.0 0.0 3.0 6.7 6.7 26.6 30.5 20.7 0.0 0.0 0.5 9.2 9.1 0.0 0.1 3.9 0.1 7.8 0.0 0.7 0.8 29.5 6.0 0.7 5.5 8.8 10.9 0.0 5.0 43.3 0.1 66.6 0.2 1.0 44.4 11.8 0.0 0.3 0.0 10.4 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 7.8 6.1 8.6 8.5 7.2 7.8 9.1 7.6 7.0 15.9 5.9 1.1 19.2 9.0 6.5 0.0 13.9 106.4 11.3 449.0 3.0 48.7 43.9 60.1 58.6 7.5 5.5 6.2 0.4 0.8 16.2 1.9 18.3 7.5 19.3 13.2 9.8 3.0 0.0 17.1 1.8 0.4 12.5 2.6 31.8 0.0 0.3 6.1 12.3 0.2 0.0 19.1 6.1 0.0 0.0 2.1 16.9 17.4 1.6 8.8 247.3 0.0 0.3 0.0 8.5 6.7 13.6 11.0 74.4 1.2 94.6 29.3 0.5 11.0 0.9 0.0 16.8 6.6 0.9 1.7 141.5 10.9 0.8 3.1 42.2 13.2 29.7 NR2E3 "PNR, rd7, RP37" ENSG00000278570 "Nuclear receptor subfamily 2 group E member 3" Q9Y5X4 15 71792638-71818259 "Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Transcription regulation, Vision" "DNA-binding, Receptor, Repressor" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 131 "retina: 131.4" "Cell type enriched" "Detected in some" 30 "Rod photoreceptor cells: 1357.8" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 79: Retina - Phototransduction" "Cluster 46: Photoreceptor cells - Phototransduction" "unprognostic (9.90e-2)" "unprognostic (2.50e-1)" "unprognostic (8.25e-3)" "unprognostic (2.63e-3)" "unprognostic (2.04e-1)" "unprognostic (1.01e-1)" "unprognostic (9.85e-3)" "unprognostic (3.60e-2)" "unprognostic (2.59e-1)" "unprognostic (2.89e-1)" "unprognostic (3.51e-1)" "unprognostic (3.65e-1)" "unprognostic (4.75e-2)" "unprognostic (2.11e-2)" "unprognostic (2.75e-1)" "unprognostic (2.55e-1)" "unprognostic (1.82e-1)" 0.1 0.2 0.1 0.0 0.1 0.1 0.3 0.1 0.3 0.6 0.0 0.2 0.0 0.2 0.3 0.4 0.4 0.1 0.1 0.1 0.0 0.6 0.3 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 1.0 0.1 131.4 0.4 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.5 0.7 0.0 0.0 0.6 0.0 0.0 0.2 0.3 0.0 0.0 0.5 0.0 0.8 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.3 0.0 0.7 0.6 0.2 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.1 0.4 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.8 0.0 0.4 0.1 0.0 0.3 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 2.0 0.0 1.2 33.1 2.1 0.5 0.7 0.0 0.0 0.0 41.7 0.0 0.1 0.7 0.0 0.3 1.1 1.4 1.5 3.9 0.0 0.0 0.3 0.2 0.3 0.3 0.0 1.8 0.0 0.2 0.0 0.4 0.1 30.3 0.2 0.0 0.0 0.3 0.0 0.3 0.6 0.1 0.0 0.0 0.0 45.0 0.0 0.5 0.0 0.6 0.3 1.9 0.0 4.3 0.2 0.0 0.0 1357.8 0.0 3.3 0.3 0.6 0.4 0.8 0.0 0.0 0.0 4.3 0.5 1.1 MYO9A "FLJ11061, FLJ13244, MGC71859" ENSG00000066933 "Myosin IXA" B2RTY4 15 71822291-72118577 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, GTPase activation, Motor protein, Myosin" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 61.7" "Cell type enhanced" "Detected in all" "Excitatory neurons: 225.5;Inhibitory neurons: 192.9;Rod photoreceptor cells: 462.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 43.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039812, HPA040071" Approved Approved "Plasma membrane" NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 46: Photoreceptor cells - Phototransduction" "Plasma membrane" "HPA039812: AB_10961421, HPA040071: AB_10961117" "unprognostic (7.53e-2)" "unprognostic (2.40e-1)" "unprognostic (1.96e-1)" "unprognostic (2.42e-3)" "unprognostic (1.63e-1)" "unprognostic (8.69e-3)" "unprognostic (3.77e-2)" "unprognostic (3.56e-2)" "unprognostic (1.26e-1)" "unprognostic (5.50e-2)" "unprognostic (1.32e-1)" "unprognostic (1.34e-1)" "prognostic favorable (2.14e-4)" "unprognostic (3.44e-1)" "unprognostic (4.41e-1)" "unprognostic (1.25e-1)" "unprognostic (4.23e-2)" 6.5 3.9 11.3 4.8 14.9 4.8 10.7 14.3 13.3 8.7 2.5 7.1 2.1 9.9 7.4 7.7 7.2 5.2 6.7 12.8 9.2 13.7 3.7 8.8 6.4 8.7 8.0 12.1 3.3 7.4 4.7 7.6 9.2 8.0 6.3 61.7 4.5 7.5 8.1 8.7 4.6 10.2 6.7 7.3 5.2 28.7 9.5 6.7 13.2 14.9 6.4 6.5 6.1 13.5 9.7 14.6 9.6 6.8 14.2 16.5 5.7 9.1 9.8 9.0 9.1 7.1 6.6 43.3 5.4 17.9 11.8 9.0 19.2 10.3 11.9 9.5 11.1 11.1 8.9 3.2 9.0 11.2 8.5 9.5 10.2 10.6 15.2 7.6 11.5 7.7 7.2 10.3 12.2 6.0 6.4 4.5 5.2 3.5 5.9 4.6 18.2 4.3 10.9 14.3 5.4 5.9 12.0 10.0 9.5 11.6 8.0 5.3 15.5 18.0 8.7 29.7 10.4 6.5 17.3 11.3 10.8 9.2 8.1 1.7 1.5 3.7 3.6 1.4 4.9 3.1 3.5 3.0 1.6 4.0 3.6 3.4 0.2 2.8 2.6 6.3 3.1 0.9 11.3 14.9 14.3 13.3 12.8 9.2 8.7 8.0 9.2 6.7 9.5 13.5 37.0 115.4 77.4 145.6 18.4 20.9 22.2 12.4 20.5 56.3 26.2 25.0 35.5 5.7 24.1 29.5 54.2 11.9 30.2 21.1 17.6 6.1 131.8 27.9 47.3 29.6 12.6 19.6 225.5 8.0 11.3 35.6 15.8 41.2 10.1 53.1 22.1 5.7 9.0 53.8 192.9 9.7 8.2 54.8 10.0 161.9 38.8 17.7 23.2 113.4 13.0 24.0 14.4 177.0 180.2 10.9 15.5 42.9 12.2 25.0 10.4 14.1 28.3 462.1 19.7 54.9 32.6 115.2 41.8 18.4 23.9 12.0 18.5 17.0 12.8 15.7 SENP8 "DEN1, HsT17512, NEDP1, PRSC2" ENSG00000166192 "SUMO peptidase family member, NEDD8 specific" Q96LD8 15 72114258-72143692 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 15.6" "Group enriched" "Detected in many" 11 "Early spermatids: 86.5;Late spermatids: 222.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036273 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Vesicles" "HPA036273: AB_10669985" "unprognostic (1.83e-2)" "unprognostic (1.78e-1)" "unprognostic (9.85e-4)" "unprognostic (5.43e-2)" "unprognostic (1.49e-1)" "unprognostic (6.09e-3)" "unprognostic (3.06e-2)" "unprognostic (4.35e-2)" "unprognostic (1.06e-1)" "unprognostic (2.04e-1)" "unprognostic (3.11e-2)" "unprognostic (1.19e-1)" "unprognostic (8.46e-12)" "unprognostic (1.24e-1)" "unprognostic (1.12e-1)" "unprognostic (1.85e-2)" "unprognostic (1.54e-2)" 1.1 1.7 2.7 1.1 2.4 2.8 2.0 1.1 3.1 1.7 0.0 1.9 1.8 1.7 3.3 2.3 2.5 1.9 4.0 2.2 2.1 4.4 2.5 1.5 1.5 1.4 1.7 2.4 1.5 2.4 2.1 1.7 1.9 2.1 1.9 4.6 1.6 1.7 6.3 1.6 1.5 1.6 0.4 1.5 2.0 15.6 1.7 1.5 5.0 5.7 1.2 1.7 1.0 2.6 1.5 2.7 4.7 3.8 5.6 6.9 2.7 4.1 2.5 2.2 2.0 2.1 3.4 1.5 5.7 2.4 4.0 3.4 7.4 5.9 3.3 1.6 4.0 2.5 3.7 1.9 3.9 2.8 1.3 3.3 5.8 1.4 6.2 2.9 2.1 4.4 3.7 2.7 5.4 3.8 2.9 3.7 4.0 3.4 2.5 1.9 4.2 3.3 6.0 2.6 5.8 2.0 4.4 3.3 4.2 5.6 5.1 2.1 2.2 4.5 1.7 7.8 2.0 2.2 2.9 1.8 2.1 4.0 3.3 1.1 0.9 0.7 0.8 2.2 1.1 1.9 1.3 1.2 2.9 0.6 1.5 1.8 0.3 3.5 3.2 0.8 1.1 1.0 2.7 2.4 1.1 3.1 2.2 2.1 1.4 1.7 1.9 0.4 1.7 2.6 1.2 6.4 5.3 3.9 0.4 0.3 1.4 2.5 1.2 4.5 2.4 2.4 5.4 1.5 4.5 1.8 4.2 6.7 0.3 1.5 13.7 3.3 86.5 2.5 2.7 1.8 1.2 3.2 4.6 1.7 3.4 2.6 4.1 2.6 0.0 3.4 1.8 1.5 2.1 1.7 6.1 1.5 2.0 2.6 0.6 222.9 1.8 1.7 0.0 2.8 3.8 10.6 0.0 6.0 4.0 1.4 3.2 1.2 0.2 1.7 2.3 8.1 6.0 4.0 0.0 2.3 1.3 10.7 12.6 1.4 0.4 7.8 1.0 3.0 2.2 1.0 GRAMD2A GRAMD2 ENSG00000175318 "GRAM domain containing 2A" Q8IUY3 15 72159806-72197787 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 35.9;placenta: 48.7" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 70.5;Cytotrophoblasts: 106.2;Extravillous trophoblasts: 29.5;Syncytiotrophoblasts: 147.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "BEWO: 165.5;SK-BR-3: 75.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA029435 Uncertain Approved "Nucleoli,Nuclear speckles,Cytosol" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 47: Cytotrophoblasts - Unknown function" "Nucleoli, Nuclear speckles" Cytosol "HPA029435: AB_10601811" "unprognostic (5.70e-2)" "unprognostic (7.55e-2)" "unprognostic (3.33e-1)" "unprognostic (1.24e-1)" "unprognostic (9.51e-3)" "unprognostic (2.95e-1)" "unprognostic (9.96e-2)" "unprognostic (3.90e-3)" "unprognostic (2.80e-1)" "unprognostic (1.96e-1)" "unprognostic (2.62e-1)" "unprognostic (5.77e-2)" "unprognostic (4.45e-1)" "unprognostic (2.35e-1)" "unprognostic (6.33e-2)" "prognostic unfavorable (7.01e-4)" "unprognostic (7.29e-2)" 0.0 0.0 2.1 0.5 1.7 0.0 10.2 2.0 1.3 1.9 2.1 1.2 1.0 0.4 35.9 1.1 5.8 0.3 0.1 2.2 3.9 3.2 0.0 15.0 0.4 6.5 13.1 0.1 0.5 0.1 0.7 48.7 10.1 1.3 0.8 0.9 2.1 5.2 0.0 2.5 3.3 0.2 2.6 0.2 0.8 0.4 3.0 0.2 8.9 0.0 0.4 0.3 0.7 2.0 2.1 0.0 0.1 0.0 0.0 0.0 165.5 0.0 0.0 0.0 0.0 0.2 0.4 0.2 0.6 0.0 0.0 1.2 0.0 10.0 0.2 0.0 0.2 0.3 0.1 0.0 1.2 0.0 0.0 0.1 2.1 0.0 7.5 0.0 0.2 0.0 0.1 0.0 0.0 1.0 0.1 0.0 0.5 0.6 0.0 0.1 0.0 0.1 0.2 0.1 1.7 0.1 0.3 75.8 0.1 5.5 3.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.7 2.0 1.3 2.2 3.9 6.5 13.1 10.1 2.6 3.0 2.0 0.1 70.5 15.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 5.3 0.0 0.0 7.4 3.7 0.0 106.2 0.1 0.0 0.0 0.1 0.0 14.0 0.2 0.2 0.0 0.0 0.0 0.0 29.5 0.8 0.0 0.7 1.3 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.5 10.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 147.1 0.3 0.1 0.0 0.0 PKM "OIP3, PK3, PKM2, THBP1" ENSG00000067225 "Pyruvate kinase M1/2" P14618 15 72199029-72231822 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Glycolysis, Translation regulation" "Allosteric enzyme, Kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 4207.6;tongue: 2900.8" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 2065.2;Late spermatids: 1763.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019421, HPA029501" Uncertain Enhanced Cytosol No No 310000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 80: Striated muscle - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 16: Pancreatic endocrine cells - Mixed function" Cytosol "CAB019421: AB_2252325, HPA029501: AB_10602118" "unprognostic (8.73e-3)" "unprognostic (4.63e-3)" "unprognostic (1.68e-2)" "unprognostic (3.09e-1)" "unprognostic (6.51e-2)" "prognostic unfavorable (1.30e-4)" "prognostic unfavorable (2.74e-6)" "prognostic unfavorable (2.85e-4)" "unprognostic (9.51e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (5.17e-5)" "unprognostic (3.16e-1)" "unprognostic (3.22e-1)" "unprognostic (7.85e-2)" "unprognostic (3.17e-2)" "unprognostic (1.44e-1)" "unprognostic (1.25e-2)" 190.5 600.9 539.0 341.4 552.3 439.0 190.5 586.8 629.9 406.8 755.0 225.0 170.8 202.8 205.7 658.3 240.0 212.0 779.6 549.1 561.6 549.5 32.2 236.9 284.1 640.0 559.1 169.4 112.6 269.6 224.1 168.6 636.2 252.6 206.2 1266.7 389.8 291.6 4207.6 350.5 218.0 298.9 522.3 239.2 228.6 235.1 677.1 203.5 174.6 2900.8 429.2 578.5 374.9 530.6 1584.6 3937.1 788.9 938.8 914.3 1009.4 638.7 1684.6 3878.2 2619.1 2623.6 1094.4 1931.2 1184.5 1627.3 3157.6 1937.8 2253.9 2480.9 3383.2 2051.7 2134.0 1126.5 727.7 1809.1 929.7 637.1 955.2 1525.1 926.4 1559.2 2025.1 810.9 3403.0 1558.6 587.3 182.8 933.3 4267.0 965.1 359.4 419.6 966.2 2438.6 1433.3 1046.5 2560.0 2301.7 3557.2 1973.8 804.4 871.5 2226.3 1344.7 1755.4 1291.4 932.0 675.7 1247.3 3003.7 1622.0 2928.7 3110.3 1170.0 1762.1 1037.2 3720.5 1534.4 3002.3 131.9 836.3 138.6 192.6 466.7 187.9 205.2 254.1 190.4 685.6 142.9 215.8 162.5 100.7 108.4 380.1 140.5 334.0 1261.7 539.0 552.3 586.8 629.9 549.1 561.6 640.0 559.1 636.2 522.3 677.1 530.6 95.9 118.6 88.1 107.7 169.6 565.5 708.9 2065.2 307.9 480.7 157.8 174.7 313.2 87.2 759.4 829.4 369.1 566.1 100.2 358.9 802.2 1395.6 315.0 169.2 77.3 207.7 282.2 44.8 90.2 597.0 1416.7 220.1 138.1 188.0 206.7 144.0 73.2 4.3 750.0 1065.0 97.6 166.8 925.7 297.7 532.9 1763.1 157.2 558.8 355.8 38.4 1255.0 784.1 78.2 53.3 33.4 1213.2 264.5 268.1 209.9 431.4 389.1 208.7 396.9 708.6 124.9 160.9 398.2 43.4 98.6 341.6 389.0 575.7 192.7 157.4 380.7 860.7 PARP6 "ARTD17, pART17" ENSG00000137817 "Poly(ADP-ribose) polymerase family member 6" Q2NL67 15 72241181-72272999 "Metabolic proteins, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 178.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026991 Approved Approved "Plasma membrane" Yes No "Cluster 45: Eosinophils - Innate immune response" "Cluster 58: Brain - Synaptic function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 25: Spermatids - Spermatogenesis" "Plasma membrane" "HPA026991: AB_1854989" "unprognostic (3.88e-2)" "prognostic favorable (3.17e-5)" "prognostic unfavorable (3.37e-4)" "unprognostic (3.36e-1)" "unprognostic (7.13e-2)" "unprognostic (3.05e-1)" "unprognostic (2.37e-2)" "unprognostic (1.33e-1)" "unprognostic (2.00e-1)" "unprognostic (2.64e-1)" "unprognostic (8.55e-2)" "unprognostic (6.92e-2)" "prognostic unfavorable (8.02e-8)" "unprognostic (6.81e-2)" "unprognostic (1.14e-1)" "unprognostic (1.45e-1)" "unprognostic (4.42e-2)" 20.0 20.9 63.2 14.6 64.8 30.5 20.0 62.2 84.6 22.2 61.2 28.7 15.3 24.5 24.0 17.7 22.6 21.3 19.6 64.5 57.7 23.8 15.5 19.7 19.4 55.7 55.9 29.2 32.5 12.6 49.7 18.3 55.3 25.1 14.8 52.9 23.2 17.3 34.8 23.0 21.7 20.2 51.0 20.6 24.2 34.5 57.1 21.0 30.2 21.2 17.4 22.7 19.1 64.9 15.9 27.6 29.0 37.8 30.5 25.2 23.7 13.8 19.9 21.8 31.1 18.5 28.2 22.3 8.4 20.3 31.4 20.9 32.4 18.1 12.4 26.5 30.6 31.7 55.0 0.2 25.4 16.7 30.1 32.6 43.5 20.1 55.2 33.7 14.6 35.6 16.6 24.3 17.5 28.4 14.4 28.7 14.2 13.2 0.0 26.7 20.8 17.2 19.9 30.4 81.4 43.1 22.6 17.8 37.0 38.2 22.8 18.8 14.0 26.7 24.7 35.7 20.7 27.9 27.7 23.2 19.1 31.4 19.1 1.1 3.6 8.2 2.3 3.1 1.6 2.4 1.7 2.5 2.6 2.3 2.6 2.0 3.6 3.0 3.5 2.2 2.9 2.1 63.2 64.8 62.2 84.6 64.5 57.7 55.7 55.9 55.3 51.0 57.1 64.9 11.5 22.4 21.2 54.9 15.3 14.4 9.6 6.9 31.3 16.4 13.0 13.7 20.9 2.8 12.9 9.2 20.9 7.3 12.0 8.0 7.9 9.7 61.4 8.0 10.3 11.1 17.4 4.6 19.7 12.7 5.3 13.9 21.4 10.0 15.8 17.3 6.4 6.1 8.9 18.5 20.5 6.5 6.1 14.8 11.1 178.1 12.5 14.0 16.0 20.6 9.3 8.8 6.2 27.2 54.6 9.2 9.0 9.8 12.3 9.0 17.7 12.3 5.8 15.5 6.6 13.7 12.5 44.3 12.6 19.3 15.8 6.4 13.3 8.6 7.5 9.3 CELF6 BRUNOL6 ENSG00000140488 "CUGBP Elav-like family member 6" Q96J87 15 72284727-72320157 "Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 6 "Astrocytes: 17.3;Excitatory neurons: 18.9;Inhibitory neurons: 21.9;Microglial cells: 9.4;Oligodendrocyte precursor cells: 5.5;Oligodendrocytes: 13.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-266/70: 3.6;U-937: 1.9" "HPA046985, HPA053526" Uncertain NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 29: U-266 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "HPA046985: AB_2679891, HPA053526: AB_2682178" "unprognostic (6.83e-3)" "unprognostic (7.06e-3)" "unprognostic (9.55e-2)" "unprognostic (2.77e-1)" "unprognostic (7.49e-2)" "unprognostic (1.65e-1)" "unprognostic (1.01e-2)" "unprognostic (1.15e-1)" "unprognostic (2.09e-4)" "unprognostic (1.16e-1)" "unprognostic (1.14e-2)" "unprognostic (2.16e-1)" 5.2 5.7 17.9 1.0 16.8 2.7 4.8 7.5 17.3 9.6 3.6 8.5 1.1 6.5 7.4 1.6 10.8 1.9 4.0 12.9 28.5 19.6 3.8 5.3 1.8 13.0 23.7 14.3 3.7 0.7 23.8 1.7 23.1 7.2 1.6 22.1 2.8 4.1 1.5 2.4 5.4 2.0 8.2 6.1 3.4 12.3 21.8 1.9 14.6 0.4 1.3 5.4 4.8 10.3 0.0 0.0 0.1 0.0 0.6 0.3 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.2 0.0 0.1 0.3 0.3 0.0 0.0 0.6 0.4 0.1 1.1 0.5 1.4 0.0 0.0 0.3 0.0 0.5 0.0 1.4 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.5 0.1 0.0 0.1 0.7 0.6 1.0 0.0 0.1 1.4 0.1 0.0 0.2 0.0 0.0 0.2 1.1 0.0 3.6 1.1 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 16.8 7.5 17.3 12.9 28.5 13.0 23.7 23.1 8.2 21.8 10.3 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 18.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.4 0.0 0.0 0.0 5.5 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HEXA ENSG00000213614 "Hexosaminidase subunit alpha" P06865 15 72340924-72376420 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease variant, Gangliosidosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hofbauer cells: 234.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018082, HPA054583" Supported Supported Vesicles,Cytosol "Intracellular and membrane" NA NA 20000000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 4: Macrophages - Innate immune response" Vesicles Cytosol "HPA018082: , HPA054583: AB_2682531" "unprognostic (1.51e-2)" "unprognostic (1.73e-2)" "unprognostic (3.41e-1)" "prognostic favorable (5.63e-8)" "unprognostic (6.58e-2)" "unprognostic (1.32e-2)" "unprognostic (1.34e-2)" "unprognostic (2.82e-2)" "unprognostic (3.75e-1)" "unprognostic (1.09e-1)" "unprognostic (1.59e-2)" "unprognostic (9.98e-2)" "unprognostic (3.98e-1)" "unprognostic (7.05e-3)" "unprognostic (3.02e-2)" "unprognostic (4.73e-2)" "unprognostic (8.69e-2)" 49.8 56.1 18.3 37.6 21.1 110.0 58.5 20.4 21.6 73.8 28.5 55.1 49.8 42.6 164.6 24.8 47.8 76.7 54.3 19.9 20.1 90.1 79.4 84.2 54.2 23.0 21.3 39.3 30.6 54.0 26.3 102.0 24.6 45.3 67.0 32.1 45.0 53.3 22.1 21.8 41.2 59.5 21.7 54.7 45.1 35.6 27.0 38.1 76.5 33.2 42.4 71.6 19.7 29.9 39.8 66.4 27.8 53.8 223.6 253.1 39.7 54.8 274.1 115.3 182.8 34.6 282.7 32.9 50.9 110.0 59.9 77.1 74.5 34.6 72.5 26.5 30.0 41.4 60.4 60.9 172.9 99.9 113.1 216.7 101.3 50.4 89.3 210.3 107.4 48.4 65.1 197.6 156.0 33.9 21.7 50.0 16.0 128.9 0.3 22.3 60.6 75.3 129.1 61.6 23.8 26.4 136.5 126.6 307.3 56.1 23.4 123.9 54.1 171.9 70.7 160.1 59.3 104.7 151.8 33.4 62.1 130.4 85.3 24.2 84.6 60.1 43.8 35.7 38.7 41.1 28.8 38.9 98.0 38.0 22.5 33.2 8.1 51.3 13.3 37.3 28.2 63.0 18.3 21.1 20.4 21.6 19.9 20.1 23.0 21.3 24.6 21.7 27.0 29.9 68.9 64.1 62.4 19.9 46.3 22.2 33.3 94.3 19.4 42.4 28.6 30.4 26.9 30.0 68.0 66.2 106.3 150.2 54.2 36.6 60.7 88.3 20.6 27.2 30.2 50.8 47.2 19.1 22.7 38.0 68.0 78.7 42.8 40.6 29.9 49.9 43.5 42.9 234.3 26.9 24.7 46.3 81.4 92.8 75.0 13.7 74.3 118.1 94.3 24.4 60.3 38.4 82.4 20.6 26.7 39.1 74.6 44.8 37.7 33.0 68.5 66.7 37.5 56.9 46.0 24.5 31.7 24.3 32.3 13.5 15.6 157.6 36.7 45.2 50.6 27.5 TMEM202 FLJ27523 ENSG00000187806 "Transmembrane protein 202" A6NGA9 15 72398302-72408367 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 116 "testis: 12.3" "Group enriched" "Detected in some" 34 "Early spermatids: 67.6;Late spermatids: 58.5;Spermatocytes: 61.2" "Cancer enriched" "Detected in single" 11 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 66: Spermatocytes - Spermatogenesis" "unprognostic (1.31e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 61.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARIH1 "ARI, HARI, HHARI, UBCH7BP" ENSG00000166233 "Ariadne RBR E3 ubiquitin protein ligase 1" Q9Y4X5 15 72474330-72602987 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 47.8;testis: 42.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003295 Approved Supported Nucleoplasm NA NA "Cluster 46: Basophils - DNA binding" "Cluster 23: Testis - Cell cycle regulation" "Cluster 18: U-2197 - ECM organization" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA003295: AB_1845017" "unprognostic (3.31e-2)" "unprognostic (1.92e-1)" "unprognostic (2.25e-1)" "unprognostic (3.18e-2)" "unprognostic (8.21e-2)" "unprognostic (5.45e-2)" "unprognostic (1.73e-1)" "unprognostic (9.43e-2)" "unprognostic (7.92e-2)" "unprognostic (1.37e-1)" "unprognostic (4.96e-2)" "unprognostic (9.19e-2)" "unprognostic (1.78e-1)" "unprognostic (2.93e-1)" "unprognostic (3.19e-1)" "unprognostic (1.04e-1)" "unprognostic (5.70e-2)" 8.5 7.9 2.5 10.1 3.9 16.5 6.0 7.0 5.8 6.4 7.1 8.2 9.5 7.5 3.2 6.8 5.4 4.4 11.4 4.4 4.0 5.2 6.2 7.3 4.9 3.4 2.7 9.0 6.6 3.9 5.9 6.5 3.6 5.8 3.3 10.4 4.3 4.8 47.8 7.6 7.4 6.3 3.0 6.0 6.3 42.5 3.8 3.9 5.0 8.5 4.1 7.6 6.5 4.3 17.6 18.0 17.5 10.2 8.9 6.2 20.6 19.3 7.0 8.6 5.9 18.3 14.6 17.2 28.4 8.3 30.3 24.8 18.1 10.1 4.8 30.6 12.4 13.0 22.5 12.4 6.3 19.6 14.4 7.4 3.4 9.5 12.2 8.2 6.4 12.4 13.8 19.7 8.5 11.5 18.9 7.5 18.9 6.3 6.5 21.4 21.3 9.8 4.8 29.0 16.3 18.4 25.1 11.2 31.4 23.0 9.0 22.0 16.7 14.1 19.6 54.8 27.4 20.7 45.2 20.6 9.2 17.5 15.2 1.6 0.2 0.7 0.5 0.4 0.4 0.2 0.3 0.3 0.2 0.6 0.4 0.4 1.0 0.6 0.2 0.3 0.8 0.1 2.5 3.9 7.0 5.8 4.4 4.0 3.4 2.7 3.6 3.0 3.8 4.3 79.5 19.2 37.7 88.5 64.0 66.3 52.7 13.3 76.2 63.3 74.9 53.3 46.9 30.0 25.7 18.4 91.8 18.4 83.3 32.9 3.9 18.4 110.3 108.7 84.8 50.7 46.5 24.8 141.6 18.9 21.8 43.3 63.7 148.4 43.2 43.7 40.0 28.5 19.0 62.2 152.0 31.2 8.2 30.5 42.1 55.4 28.6 67.5 16.0 104.0 24.2 25.7 27.8 129.7 135.1 24.7 19.1 27.4 60.9 55.8 20.8 13.9 33.0 58.8 19.7 96.8 59.9 45.3 32.1 68.8 59.8 40.8 68.3 36.8 27.0 63.7 GOLGA6B ENSG00000215186 "Golgin A6 family member B" A6NDN3 15 72654738-72666394 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Group enriched" "Detected in some" 19 "liver: 3.5;testis: 7.2" "Group enriched" "Detected in some" 4 "Astrocytes: 3.9;Early spermatids: 8.6;Excitatory neurons: 2.7;Inhibitory neurons: 2.7;Oligodendrocytes: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044978, HPA050087, HPA072134" Supported Approved Nucleoplasm,Vesicles,Centrosome NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 23: Spermatids - Flagellum & Golgi organization" Vesicles "Nucleoplasm, Centrosome" "HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: " "unprognostic (5.47e-3)" "unprognostic (1.88e-2)" "unprognostic (2.07e-1)" "unprognostic (2.01e-1)" "unprognostic (2.03e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HIGD2B HIGD2BP ENSG00000175202 "HIG1 hypoxia inducible domain family member 2B" Q4VC39 15 72675798-72686182 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "testis: 3.6" "Group enriched" "Detected in some" 10 "Early spermatids: 18.3;Late spermatids: 8.6;Spermatocytes: 20.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019016, HPA042715" Uncertain Supported Mitochondria,Cytosol NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 66: Spermatocytes - Spermatogenesis" Mitochondria Cytosol "HPA019016: AB_1850711, HPA042715: AB_2678127" "unprognostic (1.22e-1)" "unprognostic (1.09e-1)" "unprognostic (2.24e-3)" "unprognostic (5.09e-2)" "unprognostic (3.34e-1)" "unprognostic (2.42e-1)" "unprognostic (6.88e-2)" "unprognostic (1.39e-1)" "unprognostic (6.98e-2)" "unprognostic (3.90e-1)" "unprognostic (8.80e-2)" "unprognostic (6.11e-4)" "unprognostic (6.95e-2)" "unprognostic (2.97e-1)" "unprognostic (1.11e-2)" "unprognostic (3.18e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.2 0.1 0.0 0.0 0.1 0.4 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 18.3 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.0 8.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.4 0.0 0.3 0.0 0.2 0.4 0.0 0.0 0.1 0.0 20.1 1.5 0.0 0.1 0.1 0.1 0.0 0.1 0.2 BBS4 ENSG00000140463 "Bardet-Biedl syndrome 4" Q96RK4 15 72686179-72738475 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision" "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 120.9;Rod photoreceptor cells: 89.9;Spermatocytes: 79.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 62.3" "Low region specificity" "Detected in all" HPA039418 Approved Approved Cytosol NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 18: U-2197 - ECM organization" "Cluster 9: Photoreceptor cells - Phototransduction" Cytosol "HPA039418: AB_10672962" "unprognostic (3.47e-1)" "unprognostic (2.83e-1)" "unprognostic (1.35e-1)" "prognostic favorable (2.57e-4)" "unprognostic (3.54e-1)" "unprognostic (2.91e-1)" "unprognostic (8.76e-2)" "unprognostic (5.47e-2)" "unprognostic (5.70e-2)" "unprognostic (2.56e-1)" "unprognostic (3.22e-3)" "unprognostic (1.26e-1)" "unprognostic (5.15e-2)" "unprognostic (4.87e-2)" "unprognostic (1.56e-1)" "unprognostic (1.11e-1)" "unprognostic (3.05e-1)" 9.5 14.8 11.0 6.8 11.2 7.7 10.9 10.1 13.1 13.3 18.1 12.0 5.1 12.5 15.4 5.8 17.5 9.3 11.1 10.9 11.9 15.6 12.7 10.4 8.0 10.9 12.4 14.0 11.1 17.4 20.7 7.9 12.6 20.7 7.6 45.4 7.9 9.4 18.7 9.2 7.9 9.3 10.9 7.6 11.0 20.4 11.5 11.5 16.1 10.2 7.0 11.1 9.1 11.0 6.1 15.7 34.0 14.4 16.5 19.7 9.0 11.9 24.4 11.3 14.8 8.1 20.2 9.6 24.7 10.2 8.6 9.4 9.1 9.9 10.3 10.0 11.0 11.4 13.3 9.2 13.5 10.2 8.6 18.8 13.2 16.3 12.8 17.1 8.9 18.3 25.4 8.2 18.1 10.7 9.6 9.6 48.8 12.3 6.8 6.4 17.1 12.3 19.2 15.2 16.4 19.2 20.8 15.0 31.2 13.1 20.4 11.3 12.5 13.2 10.0 62.3 6.7 17.1 17.8 21.0 14.9 15.3 18.1 5.5 1.9 3.3 5.1 2.9 4.9 4.8 4.3 5.5 1.6 6.0 4.3 5.9 1.6 11.0 2.5 3.1 5.7 2.8 11.0 11.2 10.1 13.1 10.9 11.9 10.9 12.4 12.6 10.9 11.5 11.0 6.0 19.2 19.2 35.3 8.3 3.1 6.0 9.4 10.8 39.0 8.4 10.5 19.8 4.3 18.2 12.9 120.9 10.0 10.6 3.5 5.9 14.4 19.9 28.8 11.1 8.1 4.2 5.2 18.6 11.3 5.8 12.4 7.7 8.4 13.9 8.7 7.1 7.4 7.8 21.9 22.8 8.0 6.1 5.8 2.4 12.2 15.8 5.9 5.4 19.7 4.4 39.4 9.2 31.7 30.7 8.9 4.9 20.3 9.0 8.0 5.1 9.4 48.8 89.9 0.0 11.0 11.5 79.0 63.6 4.6 2.8 5.3 9.3 24.3 5.1 2.8 ADPGK "ADP-GK, DKFZp434B195" ENSG00000159322 "ADP dependent glucokinase" Q9BRR6 15 72751369-72785846 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Glycolysis "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "monocytes: 140.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045194, HPA058525" Approved Approved Centrosome "Intracellular and membrane" NA NA 66000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 18: U-2197 - ECM organization" "Cluster 3: Monocytes - Immune response regulation" Centrosome "HPA045194: AB_10964638, HPA058525: AB_2683742" "unprognostic (5.96e-3)" "unprognostic (1.19e-1)" "unprognostic (2.22e-1)" "unprognostic (1.82e-1)" "unprognostic (1.29e-1)" "unprognostic (1.98e-1)" "unprognostic (1.45e-1)" "unprognostic (8.50e-2)" "unprognostic (2.27e-1)" "unprognostic (1.09e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (2.22e-4)" "prognostic unfavorable (4.52e-7)" "unprognostic (1.92e-1)" "unprognostic (6.05e-2)" "unprognostic (1.60e-1)" "unprognostic (2.07e-2)" 10.1 7.5 2.7 15.3 2.8 23.7 8.7 3.3 3.8 7.3 9.7 10.3 8.0 5.4 12.1 7.5 9.5 7.0 5.3 2.9 4.9 11.7 10.8 17.0 13.5 4.4 4.4 5.9 7.8 6.6 3.8 16.5 5.0 12.1 11.8 4.3 9.6 5.3 4.7 7.1 8.6 7.8 3.8 13.6 9.8 7.2 3.9 15.3 9.2 5.3 16.4 13.7 5.9 4.9 18.5 37.8 19.8 23.5 43.8 33.2 26.6 52.7 51.0 54.0 74.4 21.5 47.6 34.7 38.3 33.1 53.6 49.0 56.6 27.7 40.2 34.5 38.8 26.0 9.9 20.3 28.2 60.3 37.3 36.2 15.7 28.6 26.4 26.4 31.8 26.7 27.7 57.6 33.1 11.6 18.8 27.0 29.6 36.7 17.6 21.9 32.3 48.5 27.9 21.3 14.3 14.7 48.2 19.7 26.3 30.8 18.9 71.9 26.4 27.0 22.4 103.2 48.5 57.8 119.3 34.6 47.2 58.4 45.7 56.8 69.2 51.6 22.4 48.4 27.9 30.4 20.6 22.8 72.5 26.7 17.7 20.2 27.2 32.0 41.5 55.4 17.9 59.6 2.7 2.8 3.3 3.8 2.9 4.9 4.4 4.4 5.0 3.8 3.9 4.9 19.3 19.2 34.3 22.5 61.7 15.3 20.9 22.7 17.1 15.6 20.1 14.7 3.9 8.6 23.8 20.2 14.6 38.2 75.6 15.1 7.9 25.8 14.9 18.2 22.6 20.2 7.8 10.5 13.0 17.4 62.0 27.4 23.4 17.5 48.9 31.6 21.4 23.9 80.4 15.2 17.5 17.0 24.4 101.3 51.6 6.4 21.8 68.5 26.6 31.9 140.6 11.7 42.2 13.0 22.1 22.3 16.9 15.4 34.9 34.4 15.6 10.7 24.8 24.4 19.7 19.2 16.4 24.4 31.3 11.8 18.2 41.7 36.0 22.9 20.9 31.2 NEO1 "HsT17534, IGDCC2, NGN, NTN1R2" ENSG00000067141 "Neogenin 1" Q92859 15 73051710-73305205 "Cancer-related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 231.8;Excitatory neurons: 124.5;Oligodendrocyte precursor cells: 120.1;Oligodendrocytes: 439.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009320, HPA027804, HPA027805, HPA027806" Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA 390000000 "Cluster 16: MAIT-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 12: NES - Nervous system development" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoplasm, Plasma membrane" "Golgi apparatus" "CAB009320: AB_2150998, HPA027804: AB_10600771, HPA027805: AB_10601755, HPA027806: AB_10601006" "unprognostic (1.90e-1)" "unprognostic (2.38e-2)" "unprognostic (7.60e-3)" "unprognostic (3.76e-2)" "unprognostic (5.44e-1)" "unprognostic (3.83e-2)" "unprognostic (8.30e-2)" "unprognostic (2.31e-1)" "unprognostic (3.22e-1)" "unprognostic (3.30e-2)" "unprognostic (5.51e-2)" "unprognostic (8.05e-2)" "prognostic favorable (4.39e-4)" "unprognostic (1.51e-1)" "unprognostic (1.41e-1)" "unprognostic (1.33e-2)" "unprognostic (3.75e-1)" 9.6 7.4 28.9 8.9 43.8 1.5 16.7 38.1 31.4 18.2 10.7 46.0 27.3 19.6 9.9 11.5 21.9 19.6 7.8 29.4 29.2 23.4 8.7 15.9 3.9 34.6 38.0 24.8 17.2 41.8 6.7 1.7 35.6 33.0 55.1 19.5 18.3 36.0 30.9 37.5 26.5 23.3 28.7 5.3 22.9 13.5 36.6 7.2 18.2 24.8 6.2 10.5 9.6 60.0 8.9 42.9 50.1 33.2 29.6 8.6 12.5 3.3 4.1 8.2 1.7 6.4 42.8 2.5 4.9 9.4 30.8 1.9 35.3 19.5 3.5 15.8 26.0 29.0 0.5 6.0 8.6 0.8 0.9 21.3 35.4 1.6 16.2 9.5 0.0 22.3 0.2 53.9 2.0 26.8 10.5 0.7 47.9 6.7 3.6 23.9 26.8 5.8 15.8 23.7 22.7 32.1 40.2 17.6 20.7 39.9 18.6 5.3 0.1 38.0 19.9 12.5 9.3 22.8 45.2 6.2 8.2 8.3 10.9 0.0 0.0 0.1 0.4 0.0 0.7 0.0 0.2 0.3 0.0 0.0 0.1 0.1 0.3 0.2 0.0 0.0 0.0 0.1 28.9 43.8 38.1 31.4 29.4 29.2 34.6 38.0 35.6 28.7 36.6 60.0 3.1 9.6 10.4 231.8 2.3 14.1 8.2 20.7 13.6 15.7 14.2 18.2 6.9 21.5 11.4 22.0 14.6 0.5 4.8 55.6 1.9 11.6 3.3 14.4 13.4 3.4 60.1 3.0 124.5 6.4 0.8 14.6 20.9 24.6 0.0 11.8 5.7 8.9 0.9 10.1 72.8 51.2 10.2 1.2 2.7 7.1 31.7 1.2 10.6 62.8 0.1 12.5 2.1 120.1 439.4 9.9 40.0 62.8 2.6 11.5 39.6 15.5 12.7 21.9 6.6 22.2 10.2 11.8 20.3 14.7 25.4 0.3 6.0 3.1 60.5 7.2 HCN4 ENSG00000138622 "Hyperpolarization activated cyclic nucleotide gated potassium channel 4" Q9Y3Q4 15 73319859-73368958 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Sodium transport, Transport" "Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel" "Brugada syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "brain: 8.5;heart muscle: 8.4;testis: 7.2" "Group enriched" "Detected in some" 5 "Early spermatids: 29.4;Late spermatids: 49.5" "Cancer enriched" "Detected in some" 4 "testis cancer: 3.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.3;CACO-2: 1.7;HDLM-2: 1.1;NTERA-2: 4.9;SuSa: 1.2;U-2 OS: 2.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA073174 Approved NA NA "Cluster 43: Testis - Unknown function" "Cluster 5: NTERA-2 - Transcription" "Cluster 31: Spermatids - Spermatogenesis" "HPA073174: " "unprognostic (2.21e-1)" "unprognostic (1.39e-1)" "unprognostic (2.18e-2)" "unprognostic (3.14e-2)" "unprognostic (5.30e-3)" "unprognostic (1.92e-2)" "unprognostic (2.19e-1)" "unprognostic (3.50e-2)" "unprognostic (2.37e-1)" "unprognostic (6.56e-2)" "unprognostic (1.13e-3)" "unprognostic (1.13e-1)" "unprognostic (6.05e-5)" "unprognostic (5.56e-2)" "unprognostic (4.60e-2)" "unprognostic (1.51e-2)" "unprognostic (7.95e-2)" 0.0 0.4 3.6 0.0 0.7 0.0 0.0 2.2 1.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 8.4 1.0 2.8 0.0 0.0 0.0 0.0 5.0 4.2 0.0 0.1 0.0 0.5 0.0 4.6 0.1 0.0 0.4 0.0 0.3 0.0 0.0 0.1 0.0 2.5 0.0 0.1 7.2 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.7 0.0 0.3 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.7 2.2 1.8 1.0 2.8 5.0 4.2 4.6 2.5 8.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 29.4 0.6 0.0 0.2 1.8 0.0 1.5 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 49.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.7 1.2 0.0 0.0 0.3 1.6 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 REC114 "C15orf60, CT147, FLJ27520, FLJ36860, FLJ44083, LOC283677" ENSG00000183324 "REC114 meiotic recombination protein" Q7Z4M0 15 73443164-73560013 "Predicted intracellular proteins" "DNA recombination, Meiosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "testis: 39.2" "Group enriched" "Detected in some" 5 "Early spermatids: 184.0;Spermatocytes: 143.4" "Cancer enriched" "Detected in single" 11 "testis cancer: 1.3" "Region enhanced" "Detected in single" "cerebellum: 1.0" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/84: 1.0" "Region enhanced" "Detected in many" "olfactory bulb: 6.1" "Low region specificity" "Detected in many" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 16: U-266 - Nucleosome" "Cluster 66: Spermatocytes - Spermatogenesis" "unprognostic (1.64e-1)" "unprognostic (1.14e-1)" "unprognostic (1.12e-1)" "unprognostic (2.01e-1)" "unprognostic (4.58e-2)" "unprognostic (2.97e-1)" "unprognostic (8.06e-2)" "unprognostic (2.63e-2)" "unprognostic (2.48e-2)" "unprognostic (1.53e-7)" "unprognostic (1.33e-1)" "unprognostic (7.62e-2)" "unprognostic (1.98e-2)" "unprognostic (1.74e-1)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.0 0.4 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 1.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 184.0 0.1 0.0 0.2 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 25.1 3.1 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 143.4 29.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPTN "GP55, GP65, np55, np65, SDFR1, SDR1" ENSG00000156642 Neuroplastin Q9Y639 15 73560014-73634134 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 216.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051497, HPA072453" Approved Approved "Plasma membrane" NA No 15000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane" "HPA051497: AB_2681507, HPA072453: AB_2686523" "unprognostic (9.30e-3)" "unprognostic (1.70e-1)" "unprognostic (5.01e-2)" "unprognostic (4.14e-1)" "unprognostic (3.11e-2)" "unprognostic (7.42e-3)" "unprognostic (9.74e-2)" "unprognostic (9.67e-2)" "unprognostic (3.63e-2)" "unprognostic (1.68e-1)" "unprognostic (3.57e-2)" "unprognostic (1.93e-1)" "unprognostic (1.60e-3)" "unprognostic (5.55e-2)" "unprognostic (7.41e-2)" "unprognostic (1.70e-1)" "unprognostic (1.17e-1)" 84.6 95.7 81.4 75.9 104.4 32.7 82.6 52.1 176.7 112.4 72.4 133.0 134.9 180.7 150.9 133.9 135.0 97.2 196.4 122.6 65.6 126.5 74.0 110.5 48.7 42.9 42.2 79.1 96.6 167.2 47.1 123.1 39.8 170.8 142.0 135.5 101.0 204.4 51.2 68.1 124.9 298.4 28.5 71.8 96.4 69.2 60.4 42.6 112.4 70.1 69.4 140.6 84.9 87.9 101.9 179.1 100.9 74.5 201.6 180.7 141.1 229.1 373.5 258.3 228.4 122.4 317.7 58.7 133.0 331.2 319.2 411.1 164.4 191.3 147.6 105.6 109.3 46.7 83.3 110.2 143.1 72.6 124.9 149.1 165.2 167.4 100.7 254.8 139.5 52.0 26.7 65.2 187.2 81.2 32.4 45.3 93.5 127.3 63.3 52.1 115.8 49.9 353.7 148.3 61.6 19.2 222.4 122.4 151.3 249.6 110.9 97.7 159.0 199.7 133.8 116.0 135.8 56.5 113.8 51.4 185.8 111.0 140.0 5.9 13.5 13.8 6.4 18.5 5.2 3.8 3.6 5.9 5.3 2.9 3.6 4.2 28.0 3.9 14.8 5.5 4.3 13.6 81.4 104.4 52.1 176.7 122.6 65.6 42.9 42.2 39.8 28.5 60.4 87.9 67.1 76.9 66.0 72.1 18.3 65.0 27.0 43.3 51.2 93.0 50.5 45.7 106.9 48.6 60.6 82.8 50.1 7.0 28.8 133.8 1.9 18.1 3.7 73.4 46.7 44.6 103.0 7.4 216.6 24.0 9.2 64.5 41.3 92.1 28.4 33.9 50.0 43.1 25.0 38.7 162.7 90.9 42.7 77.4 46.6 9.9 15.2 61.8 42.7 86.2 43.4 41.2 12.3 63.8 67.4 41.4 66.7 38.4 20.2 26.9 52.3 20.7 92.1 49.7 19.7 35.5 74.0 11.7 10.8 61.9 54.6 6.8 23.9 35.3 52.6 30.7 CD276 "B7-H3, B7H3, B7RP-2" ENSG00000103855 "CD276 molecule" Q5ZPR3 15 73683966-73714514 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 215.6;Hofbauer cells: 82.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 175.0;U-2197: 231.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009285, HPA017139, CAB017826" Enhanced Approved Vesicles NA NA 16000000 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 82: Adipose tissue - ECM organization" "Cluster 18: U-2197 - ECM organization" "Cluster 38: Extravillous trophoblasts - Unknown function" Vesicles "CAB017826: , HPA009285: AB_1078258, HPA017139: AB_1845246" "unprognostic (1.05e-1)" "unprognostic (4.74e-3)" "unprognostic (4.57e-3)" "unprognostic (9.62e-2)" "unprognostic (1.26e-2)" "unprognostic (5.50e-3)" "prognostic unfavorable (9.81e-4)" "unprognostic (2.57e-3)" "unprognostic (1.89e-1)" "unprognostic (3.75e-2)" "unprognostic (1.54e-2)" "unprognostic (3.29e-2)" "prognostic unfavorable (6.31e-5)" "unprognostic (1.17e-1)" "unprognostic (9.22e-2)" "unprognostic (1.21e-1)" "unprognostic (1.34e-3)" 24.1 19.1 6.6 12.9 4.3 0.7 15.3 0.4 6.5 22.2 15.6 11.4 11.0 20.2 4.3 5.8 10.0 18.2 14.8 4.2 5.7 5.4 11.8 11.6 3.6 5.9 6.7 13.4 15.3 4.3 6.1 26.2 4.1 16.7 4.2 4.6 15.0 9.6 5.0 16.2 8.4 10.8 2.4 9.0 10.9 6.0 7.5 1.6 8.5 2.2 1.6 14.6 13.0 6.7 43.7 44.6 32.5 82.8 57.7 35.0 102.8 47.5 42.0 33.4 30.4 85.3 90.1 0.6 77.7 39.5 64.1 175.0 31.7 39.9 4.4 30.6 76.3 2.8 47.6 47.1 20.9 0.7 51.8 32.7 17.9 28.3 15.4 19.7 38.7 0.0 15.0 0.8 6.2 66.0 0.3 2.3 84.9 8.6 35.9 0.5 47.9 7.0 27.9 53.8 24.9 59.5 40.1 21.2 88.0 23.0 38.1 26.4 49.8 68.6 60.0 231.6 52.5 0.9 0.8 0.8 114.8 3.4 49.4 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.1 0.0 0.1 0.0 0.0 6.6 4.3 0.4 6.5 4.2 5.7 5.9 6.7 4.1 2.4 7.5 6.7 4.4 19.2 8.1 6.5 1.2 15.0 11.5 12.5 8.0 20.2 14.1 11.8 9.1 2.8 17.0 11.0 31.3 11.6 0.2 6.7 1.9 48.6 0.9 14.4 26.7 22.0 9.0 0.0 18.4 19.0 215.6 43.7 14.3 31.6 14.7 41.4 4.6 14.6 82.5 10.1 12.9 13.1 4.1 8.8 30.8 2.2 9.9 14.7 24.9 7.5 4.2 8.4 0.0 5.5 1.7 24.7 15.1 17.3 1.7 12.1 3.1 2.7 5.8 27.5 13.1 7.0 32.1 1.8 4.9 3.4 10.2 12.3 1.4 8.4 10.6 8.4 INSYN1 "C15orf59, LOC388135, MGC131524" ENSG00000205363 "Inhibitory synaptic factor 1" Q2T9L4 15 73735458-73753351 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.6;heart muscle: 48.5" "Cell type enriched" "Detected in single" 24 "Cardiomyocytes: 14.7" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 8.7;fHDF/TERT166: 5.8;HEK 293: 3.9;NTERA-2: 3.4;SK-BR-3: 4.7;U-2 OS: 4.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041563 Approved Approved Nucleoplasm,Cytosol No NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 54: Cardiomyocytes - Muscle contraction" "Nucleoplasm, Cytosol" "HPA041563: AB_10794670" "unprognostic (2.28e-2)" "unprognostic (2.47e-2)" "unprognostic (4.85e-2)" "unprognostic (2.36e-1)" "unprognostic (1.71e-1)" "unprognostic (9.36e-2)" "unprognostic (3.37e-2)" "unprognostic (1.02e-2)" "unprognostic (1.60e-1)" "unprognostic (8.36e-2)" "unprognostic (2.67e-4)" "unprognostic (2.67e-2)" "prognostic favorable (5.38e-9)" "unprognostic (4.98e-2)" "unprognostic (5.19e-2)" "unprognostic (2.46e-4)" "unprognostic (1.20e-3)" 3.5 2.6 32.6 0.9 30.1 0.1 1.9 27.2 42.8 7.9 1.6 6.6 0.8 4.2 3.4 12.0 7.8 1.9 48.5 38.9 28.8 15.5 0.4 2.7 0.2 26.9 56.6 13.5 1.4 2.9 5.2 0.5 27.7 10.6 0.6 3.9 3.3 11.0 4.6 13.3 2.4 3.2 22.8 0.7 3.7 4.5 46.3 0.2 2.1 2.6 0.9 6.4 16.9 34.7 0.0 0.0 1.8 1.2 8.7 0.1 0.0 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.5 5.8 1.0 2.1 1.9 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.7 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.5 0.4 4.7 0.4 1.3 2.0 0.1 0.0 1.3 4.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 32.6 30.1 27.2 42.8 38.9 28.8 26.9 56.6 27.7 22.8 46.3 34.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D21 "MGC34741, MgcRabGAP" ENSG00000167139 "TBC1 domain family member 21" Q8IYX1 15 73873564-73889214 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 238 "testis: 49.7" "Group enriched" "Detected in some" 112 "Early spermatids: 401.0;Late spermatids: 1080.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA043319 Enhanced NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 31: Spermatids - Spermatogenesis" "HPA043319: AB_10966214" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 401.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1080.9 5.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 5.7 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LOXL1 "LOL, LOXL" ENSG00000129038 "Lysyl oxidase like 1" Q08397 15 73925989-73952137 "Disease related genes, Plasma proteins, Predicted secreted proteins" Oxidoreductase Glaucoma "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 92.3;Extravillous trophoblasts: 145.8;Fibroblasts: 76.0;Smooth muscle cells: 32.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "T-reg: 3.4" "Lineage enriched" "Detected in single" 34 "T-cells: 3.4" "Cell line enhanced" "Detected in many" "BJ: 66.5;BJ hTERT+: 75.2;hTERT-RPE1: 73.7;U-87 MG: 61.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042111, HPA063583" Approved Approved "Endoplasmic reticulum" "Secreted to extracellular matrix" No No 280000 "Cluster 35: T-regs - Unknown function" "Cluster 46: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "Endoplasmic reticulum" "HPA042111: AB_10794412, HPA063583: AB_2685050" "unprognostic (6.39e-2)" "unprognostic (1.23e-1)" "unprognostic (3.05e-2)" "unprognostic (3.61e-2)" "prognostic unfavorable (9.52e-5)" "unprognostic (7.95e-2)" "unprognostic (2.49e-1)" "unprognostic (2.44e-1)" "unprognostic (3.10e-1)" "unprognostic (1.57e-1)" "unprognostic (1.63e-1)" "unprognostic (9.83e-2)" "unprognostic (1.14e-3)" "unprognostic (4.51e-2)" "unprognostic (5.81e-2)" "unprognostic (1.41e-2)" "unprognostic (9.76e-2)" 12.4 3.1 1.4 5.4 0.8 0.8 6.8 0.2 1.4 12.7 12.3 10.2 1.9 16.0 1.4 4.7 8.3 5.0 27.9 1.7 1.9 8.7 1.5 10.1 4.4 1.4 1.7 8.0 3.3 2.2 9.2 8.0 1.1 15.3 1.4 0.0 7.6 11.9 3.8 6.4 5.6 4.9 0.8 3.2 7.8 2.4 1.9 0.9 5.2 1.9 2.3 16.6 14.8 0.6 3.3 0.0 0.9 0.0 45.6 54.8 2.2 66.5 75.2 27.6 48.7 1.3 1.7 0.0 12.1 49.1 6.9 19.9 0.3 0.2 6.5 0.0 4.3 0.2 2.0 0.3 6.2 0.0 0.1 45.0 0.0 20.8 0.2 73.7 1.0 1.2 0.0 0.3 33.3 2.4 0.4 1.3 6.3 4.4 45.1 0.0 38.7 0.6 2.5 12.0 5.5 0.0 2.0 0.4 0.0 6.5 0.4 0.0 4.9 53.8 47.0 42.8 25.8 0.2 0.0 0.0 61.9 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.9 0.0 1.3 0.7 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 3.4 0.2 1.4 0.8 0.2 1.4 1.7 1.9 1.4 1.7 1.1 0.8 1.9 0.6 4.1 0.0 0.6 3.3 0.1 5.9 7.6 6.0 4.0 0.9 2.3 4.8 92.3 2.8 0.9 9.2 0.0 2.2 0.6 0.1 3.9 5.2 1.7 9.2 8.0 4.1 3.5 0.0 0.5 1.3 145.8 76.0 8.6 9.3 1.3 5.5 12.1 0.1 6.6 0.0 0.4 0.6 2.0 0.0 6.2 1.3 9.9 0.9 10.6 0.0 0.1 6.4 0.0 1.5 0.3 12.2 0.1 21.1 0.1 4.8 0.4 2.5 1.2 0.4 0.0 6.0 32.7 8.9 4.9 2.4 3.4 5.1 3.4 0.3 1.1 5.0 STOML1 "FLJ36370, hUNC-24, SLP-1, STORP" ENSG00000067221 "Stomatin like 1" Q9UBI4 15 73978926-73994622 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042353 Approved Approved Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 65: Brain - Ion transport" "Cluster 18: U-2197 - ECM organization" "Cluster 1: Pancreatic cells - Digestion" Cytosol "HPA042353: AB_10797387" "unprognostic (5.75e-2)" "unprognostic (1.70e-1)" "unprognostic (7.76e-2)" "unprognostic (4.54e-3)" "unprognostic (1.39e-2)" "unprognostic (1.81e-2)" "unprognostic (1.54e-1)" "unprognostic (2.45e-1)" "unprognostic (1.78e-1)" "unprognostic (2.64e-1)" "unprognostic (1.13e-1)" "unprognostic (2.30e-3)" "unprognostic (2.26e-3)" "unprognostic (2.14e-1)" "unprognostic (1.37e-1)" "unprognostic (1.55e-1)" "unprognostic (2.67e-2)" 11.4 17.3 33.0 6.5 33.7 4.5 10.4 22.0 38.5 9.8 17.1 11.0 5.9 9.1 5.6 9.4 7.3 6.3 23.6 36.8 32.4 8.6 13.2 10.2 5.6 34.6 30.5 8.5 10.1 7.8 16.6 7.5 36.8 9.9 3.6 3.1 8.3 8.8 18.6 9.4 7.9 7.7 26.5 7.9 9.5 13.1 32.6 8.1 13.6 8.9 3.8 11.8 9.2 28.4 5.8 10.8 6.4 8.8 12.7 8.0 5.4 18.3 7.1 9.8 8.3 3.2 31.4 5.8 28.3 14.9 7.3 18.9 6.1 12.9 3.1 19.4 6.6 6.1 10.0 3.6 12.5 4.0 4.6 14.3 9.9 15.4 14.5 8.1 9.3 13.1 14.6 10.9 14.3 8.8 7.6 2.9 3.1 8.9 8.6 4.5 6.5 8.9 20.7 6.3 12.1 7.9 8.4 10.9 11.9 4.0 9.1 4.4 14.3 22.4 7.2 25.8 24.9 10.6 5.8 3.0 20.6 12.1 11.6 1.0 4.1 2.5 5.3 7.7 4.4 4.5 4.3 7.0 6.5 5.6 8.7 9.2 2.1 8.0 18.2 11.5 8.1 5.5 33.0 33.7 22.0 38.5 36.8 32.4 34.6 30.5 36.8 26.5 32.6 28.4 15.2 0.0 4.1 7.2 5.3 3.2 3.7 7.2 1.8 13.1 7.0 4.8 10.8 2.8 5.8 7.3 6.2 13.0 3.5 8.9 1.9 25.1 1.0 2.8 6.2 7.7 10.2 4.2 6.9 19.0 8.6 11.4 12.8 5.4 4.5 8.5 5.0 5.1 10.8 16.8 8.1 7.3 4.1 3.3 2.2 2.6 9.0 3.3 3.6 2.8 2.5 11.9 2.1 7.5 4.1 20.8 4.9 11.7 3.4 6.8 12.6 4.8 2.7 14.0 6.6 7.5 9.7 20.8 7.8 4.7 2.0 5.6 4.1 13.7 5.6 3.3 PML "MYL, RNF71, TRIM19" ENSG00000140464 "PML nuclear body scaffold" P29590 15 73994673-74047827 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Apoptosis, Biological rhythms, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation" "Activator, DNA-binding, Transferase" "Cancer-related genes, Proto-oncogene, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 127.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008312, CAB010194, CAB016304" Supported Enhanced "Nuclear bodies" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 82: Adipose tissue - ECM organization" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nuclear bodies" "CAB010194: AB_2166848, CAB016304: AB_628162, HPA008312: AB_1079643" "prognostic favorable (3.24e-4)" "unprognostic (4.83e-2)" "unprognostic (5.76e-2)" "unprognostic (1.58e-3)" "unprognostic (7.53e-3)" "unprognostic (1.58e-1)" "unprognostic (2.35e-2)" "unprognostic (5.30e-3)" "unprognostic (4.54e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (3.29e-4)" "unprognostic (2.67e-2)" "prognostic unfavorable (6.27e-8)" "unprognostic (1.58e-2)" "unprognostic (4.17e-2)" "unprognostic (1.02e-1)" "unprognostic (8.99e-2)" 84.4 29.4 14.4 25.6 13.8 38.1 77.0 11.8 16.4 53.7 11.6 46.7 18.4 47.1 7.5 38.3 44.6 21.6 39.3 13.8 13.1 35.4 25.4 75.2 25.6 18.2 13.8 37.5 20.3 8.3 26.8 23.7 14.8 41.5 8.5 3.9 44.2 17.2 22.5 47.4 39.0 19.5 14.6 48.6 35.3 11.3 15.2 17.0 48.1 7.9 15.2 42.7 44.5 13.1 37.2 13.8 11.8 11.4 30.2 43.2 40.6 18.5 31.6 55.9 63.3 14.6 64.2 16.4 63.7 31.6 53.3 66.6 16.3 37.1 7.6 58.0 25.1 35.8 21.3 16.3 36.9 33.9 31.1 83.7 24.8 37.5 19.2 39.3 38.3 26.1 30.6 28.3 32.7 17.3 28.3 52.6 12.8 7.7 25.0 21.6 13.4 30.8 60.3 59.5 10.1 11.1 29.7 16.3 44.8 10.3 12.8 28.7 66.1 56.6 15.5 28.5 38.1 29.4 20.0 8.0 38.9 42.2 18.2 7.4 14.7 23.4 13.0 20.2 9.8 12.4 10.4 14.1 14.5 10.2 8.2 8.5 12.0 14.5 22.6 9.2 14.3 10.1 14.4 13.8 11.8 16.4 13.8 13.1 18.2 13.8 14.8 14.6 15.2 13.1 127.8 16.0 12.2 8.8 24.9 22.9 14.3 30.4 37.5 8.1 13.5 12.8 10.0 5.7 16.7 5.5 2.1 9.4 18.8 13.1 7.9 25.8 3.4 16.0 16.7 48.0 14.3 29.3 4.7 19.1 15.0 20.7 58.1 26.0 12.0 11.5 32.2 11.3 30.8 8.4 4.8 14.3 14.2 20.1 18.5 4.0 27.7 19.6 7.2 7.5 24.6 8.5 20.6 4.5 6.0 62.8 15.5 24.0 21.6 26.2 22.8 10.4 18.3 5.4 39.5 7.7 20.4 1.1 4.0 27.1 19.6 4.9 20.4 16.8 12.1 26.0 GOLGA6A "GLP, GOLGA6" ENSG00000159289 "Golgin A6 family member A" Q9NYA3 15 74069857-74082550 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 18 "liver: 4.1;testis: 15.1" "Cell type enriched" "Detected in some" 8 "Early spermatids: 47.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "U-266/70: 1.3" "HPA044978, HPA050087, HPA072134" Supported Approved Nucleoplasm,Vesicles,Centrosome NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" Vesicles "Nucleoplasm, Centrosome" "HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: " "unprognostic (1.68e-1)" "unprognostic (2.09e-2)" "unprognostic (9.50e-2)" "unprognostic (9.67e-2)" "unprognostic (6.70e-2)" 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 4.1 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 15.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.2 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ISLR2 KIAA1465 ENSG00000167178 "Immunoglobulin superfamily containing leucine rich repeat 2" Q6UXK2 15 74100311-74138540 "Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 32.1;testis: 13.6" "Group enriched" "Detected in some" 5 "Early spermatids: 52.1;Late spermatids: 64.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 32.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "SCLC-21H: 57.9;SH-SY5Y: 86.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA012930, HPA067333" Uncertain NA NA 110000 "Cluster 78: Testis - Spermatogenesis" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 29: Early spermatids - Spermatogenesis" "HPA012930: AB_2668772, HPA067333: AB_2685824" "unprognostic (1.31e-2)" "unprognostic (3.27e-3)" "unprognostic (1.44e-2)" "unprognostic (8.65e-3)" "unprognostic (1.53e-3)" "unprognostic (7.73e-2)" "unprognostic (6.64e-2)" "unprognostic (1.46e-2)" "unprognostic (9.19e-3)" "unprognostic (1.72e-1)" "unprognostic (2.94e-2)" "unprognostic (2.46e-1)" "unprognostic (2.44e-4)" "unprognostic (1.31e-2)" "unprognostic (1.75e-1)" "unprognostic (1.05e-1)" "unprognostic (2.64e-2)" 1.7 1.3 9.9 0.6 32.1 0.1 1.6 0.0 16.0 2.7 0.0 1.0 0.6 2.7 0.2 0.7 1.2 1.0 4.6 11.0 3.9 0.3 0.1 0.7 2.1 0.0 0.0 0.2 0.8 0.6 0.6 0.2 0.0 0.4 0.4 1.2 0.7 0.5 2.2 0.6 1.2 1.1 0.0 0.9 0.6 13.6 6.6 0.2 0.4 3.1 0.2 0.4 0.3 8.5 0.0 0.3 5.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 57.9 86.2 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.2 0.1 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 9.9 32.1 0.0 16.0 11.0 3.9 0.0 0.0 0.0 0.0 6.6 8.5 9.8 0.0 0.6 0.7 0.0 0.1 0.0 0.1 0.6 1.9 0.2 0.3 6.8 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 52.1 0.3 3.8 3.3 0.0 0.0 5.4 0.0 0.0 0.9 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.0 64.1 0.3 0.2 0.0 6.5 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.7 0.0 0.1 0.0 0.1 0.0 1.4 0.0 0.3 0.4 1.9 0.6 0.1 0.0 0.0 0.1 0.1 0.0 0.0 ISLR HsT17563 ENSG00000129009 "Immunoglobulin superfamily containing leucine rich repeat" O14498 15 74173710-74176872 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 216.2" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 193.5;Fibroblasts: 154.5;Leydig cells: 214.9;Peritubular cells: 159.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 62.7;ASC TERT1: 33.5;fHDF/TERT166: 148.1;HSkMC: 25.5;RPMI-8226: 47.0" "Region enriched" "Detected in all" 5 "olfactory bulb: 118.0" "Region enriched" "Detected in all" 5 "spinal cord: 124.7" "HPA040326, HPA050811" Approved Approved "Golgi apparatus,Plasma membrane" "Secreted - unknown location" NA NA 130000000 "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane" "Golgi apparatus" "HPA040326: AB_2676928, HPA050811: AB_2681243" "unprognostic (2.58e-1)" "unprognostic (1.36e-2)" "unprognostic (3.54e-2)" "unprognostic (3.06e-2)" "unprognostic (1.30e-1)" "unprognostic (1.76e-2)" "unprognostic (1.51e-1)" "unprognostic (1.21e-1)" "unprognostic (6.76e-3)" "unprognostic (1.16e-2)" "unprognostic (6.81e-2)" "unprognostic (8.93e-3)" "prognostic unfavorable (4.89e-8)" "unprognostic (1.64e-2)" "unprognostic (3.42e-2)" "unprognostic (2.28e-1)" "unprognostic (9.86e-3)" 89.3 17.5 4.4 5.5 11.8 0.0 66.9 1.7 10.4 216.2 5.4 75.1 5.7 181.4 18.9 17.1 78.7 38.6 63.3 4.6 5.2 20.9 8.2 37.7 9.9 2.8 3.2 170.9 10.1 2.1 44.6 10.2 2.8 51.4 5.2 0.3 33.6 22.9 18.5 46.7 31.3 26.3 2.3 33.0 32.5 14.9 4.5 3.3 63.4 19.7 5.3 63.5 111.9 5.0 0.0 1.5 0.1 0.0 62.7 33.5 0.2 10.2 0.1 0.0 0.0 0.0 4.0 0.0 0.6 148.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 25.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.0 0.0 47.0 0.0 0.0 0.5 5.8 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.3 0.4 7.6 0.1 0.1 1.1 0.0 0.3 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 11.8 1.7 10.4 4.6 5.2 2.8 3.2 2.8 2.3 4.5 5.0 10.3 0.0 1.3 0.7 0.1 11.7 0.1 0.2 0.0 0.1 4.8 3.9 3.9 1.5 0.7 0.0 0.0 1.3 0.8 0.0 0.0 0.2 2.4 7.2 193.5 14.0 0.0 0.0 1.9 0.2 1.4 154.5 2.0 4.2 0.0 0.0 7.5 0.0 3.8 0.0 0.2 0.0 0.0 0.0 16.2 6.1 214.9 2.6 12.4 34.7 0.0 0.2 0.0 0.5 0.7 0.8 0.0 159.9 0.0 0.1 0.0 0.1 1.5 0.5 26.3 7.0 49.8 0.7 0.7 1.3 8.8 1.0 2.6 7.0 0.0 0.2 STRA6 FLJ12541 ENSG00000137868 "Signaling receptor and transporter of retinol STRA6" Q9BX79 15 74179466-74212267 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport Receptor "Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 24.5" "Cell type enhanced" "Detected in many" "Club cells: 17.6;Endometrial stromal cells: 43.1;Extravillous trophoblasts: 12.1;Fibroblasts: 16.1;Proximal tubular cells: 10.3;Syncytiotrophoblasts: 26.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 33.7;CAPAN-2: 94.5;SH-SY5Y: 59.2;WM-115: 142.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040839 Approved NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 17: WM-115 - Nervous system development" "Cluster 33: Fibroblasts - ECM organization" "HPA040839: AB_10794881" "unprognostic (1.20e-2)" "unprognostic (4.99e-2)" "unprognostic (3.71e-2)" "unprognostic (3.55e-3)" "unprognostic (1.37e-1)" "unprognostic (2.09e-2)" "unprognostic (4.38e-3)" "unprognostic (1.67e-2)" "unprognostic (9.16e-2)" "unprognostic (1.21e-1)" "unprognostic (5.35e-2)" "unprognostic (3.89e-1)" "unprognostic (7.91e-13)" "unprognostic (2.90e-2)" "unprognostic (2.03e-1)" "unprognostic (1.51e-2)" "unprognostic (1.91e-1)" 0.1 1.0 0.1 0.3 0.0 0.0 0.9 0.0 0.4 24.5 0.4 0.1 0.0 4.3 0.5 1.1 3.6 0.3 0.1 0.1 0.1 4.3 0.0 0.2 0.8 0.1 0.0 0.6 0.1 0.0 5.5 7.6 0.0 5.2 0.0 0.0 0.7 1.4 0.0 0.3 0.2 0.2 0.1 0.1 0.0 3.1 0.3 0.2 0.1 0.1 0.5 1.3 2.4 0.0 0.5 33.7 1.9 0.1 0.0 0.0 6.0 1.0 0.2 0.0 0.0 11.7 94.5 0.0 22.1 0.1 0.7 3.4 1.8 0.0 0.0 0.0 0.2 3.0 1.3 2.5 0.5 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.4 6.1 0.6 2.9 0.1 0.0 0.4 0.0 0.0 0.0 2.9 17.4 59.2 0.0 3.6 0.0 3.6 0.2 0.1 0.0 0.2 7.3 0.6 1.6 0.1 0.2 0.0 0.6 0.0 142.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.1 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.4 1.0 9.7 0.0 0.0 0.2 0.3 1.0 0.0 17.6 0.0 0.0 4.2 0.0 0.0 1.9 0.3 1.7 2.1 43.1 1.3 0.0 0.0 0.1 0.0 12.1 16.1 0.0 1.8 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 2.0 0.0 0.8 0.8 6.8 0.4 1.8 1.9 0.1 0.0 0.0 0.0 0.0 4.7 0.0 4.1 0.0 0.4 0.0 10.3 6.6 0.0 0.0 1.3 4.7 0.5 0.5 0.0 0.0 26.4 0.3 0.1 0.0 1.3 CCDC33 "CT61, FLJ32855" ENSG00000140481 "Coiled-coil domain containing 33" Q8N5R6 15 74202705-74336472 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "fallopian tube: 23.6;testis: 20.2" "Group enriched" "Detected in some" 9 "Early spermatids: 54.2;Endometrial ciliated cells: 70.1;Late spermatids: 54.6;Respiratory ciliated cells: 56.7" "Group enriched" "Detected in some" 5 "endometrial cancer: 1.4;ovarian cancer: 0.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "CAPAN-2: 4.4;SCLC-21H: 2.4;SH-SY5Y: 2.9" "Low region specificity" "Detected in some" "Region enhanced" "Detected in many" "midbrain: 7.4" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" "unprognostic (1.11e-2)" "unprognostic (5.53e-2)" "unprognostic (3.57e-1)" "unprognostic (5.13e-3)" "unprognostic (6.37e-3)" "unprognostic (2.16e-1)" "unprognostic (3.16e-3)" "unprognostic (3.68e-2)" "unprognostic (9.87e-2)" "unprognostic (2.05e-2)" "unprognostic (4.46e-1)" "unprognostic (4.18e-2)" "unprognostic (6.12e-2)" "unprognostic (9.37e-2)" 0.0 0.2 0.6 0.0 0.4 0.0 0.0 0.2 0.0 2.0 0.5 0.0 0.0 0.3 0.1 0.0 23.6 0.0 0.1 0.5 0.6 0.0 0.0 2.6 0.0 2.1 3.4 0.1 0.0 0.0 0.4 0.1 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.1 20.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.4 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.4 2.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.2 0.0 0.5 0.6 2.1 3.4 1.6 2.3 0.4 0.6 0.2 0.0 1.5 0.3 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.1 0.3 0.0 5.8 0.0 0.0 0.1 0.0 0.0 0.0 0.3 54.2 70.1 1.5 0.2 0.0 0.0 0.6 0.0 0.0 0.5 2.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 6.1 0.0 0.0 54.6 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.6 0.0 0.4 0.0 0.0 0.0 0.4 56.7 0.0 0.0 0.0 1.1 0.6 0.2 0.0 0.0 1.8 0.1 0.2 0.0 0.1 CYP11A1 "CYP11A, P450SCC" ENSG00000140459 "Cytochrome P450 family 11 subfamily A member 1" P05108 15 74337759-74367646 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Steroidogenesis, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 26 "adrenal gland: 1009.9" "Cell type enhanced" "Detected in some" "Extravillous trophoblasts: 345.1;Peritubular cells: 173.8;Syncytiotrophoblasts: 1452.0;Theca cells: 637.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 48 "basophil: 10.2" "Lineage enriched" "Detected in single" 48 "granulocytes: 10.2" "Group enriched" "Detected in some" 5 "BEWO: 55.2;HEL: 46.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basal ganglia: 1.8;hippocampal formation: 1.1;hypothalamus: 1.3;midbrain: 4.5;pons: 1.1" HPA016436 Enhanced NA NA "Cluster 46: Basophils - DNA binding" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 28: BEWO - Transcription regulation" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "HPA016436: AB_1847423" "unprognostic (8.89e-2)" "unprognostic (6.96e-2)" "unprognostic (4.95e-3)" "unprognostic (9.31e-2)" "unprognostic (9.42e-4)" "unprognostic (1.90e-1)" "unprognostic (1.55e-3)" "unprognostic (8.06e-2)" "unprognostic (3.04e-1)" "unprognostic (2.95e-1)" "unprognostic (1.77e-2)" "unprognostic (5.45e-2)" "unprognostic (9.66e-4)" "unprognostic (2.40e-2)" "unprognostic (2.74e-1)" "unprognostic (3.04e-2)" "unprognostic (7.95e-2)" 2.0 1009.9 2.0 0.6 2.1 0.1 1.9 2.3 2.0 2.0 3.5 0.8 0.3 1.6 0.8 6.3 2.4 0.4 1.4 2.0 2.1 0.6 3.6 0.6 0.1 2.8 2.5 38.9 0.3 0.0 2.8 25.2 2.8 1.2 0.2 0.7 1.2 0.5 2.5 0.6 0.8 0.9 2.6 4.9 0.9 23.0 1.9 0.3 0.3 1.0 2.1 0.5 1.0 1.9 0.0 0.0 0.0 0.2 0.0 0.4 55.2 0.1 0.0 0.4 0.1 0.0 0.0 0.0 1.3 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.2 46.8 1.2 0.5 0.2 0.0 0.2 1.9 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 11.1 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 2.1 2.3 2.0 2.0 2.1 2.8 2.5 2.8 2.6 1.9 1.9 0.1 0.0 0.0 6.2 0.0 0.3 0.0 0.0 34.1 0.1 0.6 0.9 1.2 2.8 0.0 0.0 0.0 144.6 0.0 0.0 1.9 0.0 1.6 0.2 4.9 0.8 0.0 0.0 0.2 0.0 345.1 10.0 0.0 0.2 0.0 41.3 0.0 3.6 22.0 0.0 0.2 0.0 0.0 0.0 0.0 6.7 48.7 0.4 0.0 1.0 0.6 6.2 0.0 0.0 0.2 0.5 0.0 173.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 1.2 4.6 2.8 8.7 0.0 1452.0 0.0 637.4 0.0 0.0 SEMA7A "CD108, H-Sema-L, SEMAL" ENSG00000138623 "Semaphorin 7A (John Milton Hagen blood group)" O75326 15 74409289-74433958 "Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins" "Differentiation, Inflammatory response, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 60.1;retina: 34.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 68.8;Extravillous trophoblasts: 58.8;Granulosa cells: 65.1;Pancreatic endocrine cells: 91.0;Rod photoreceptor cells: 58.3;Syncytiotrophoblasts: 166.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 1.8;eosinophil: 3.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.1" "Cell line enhanced" "Detected in many" "HMC-1: 275.8;hTEC/SVTERT24-B: 108.7;U-251 MG: 166.3;U-87 MG: 92.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008210, HPA042273" Uncertain Uncertain Vesicles NA NA 38000000 "Cluster 52: Eosinophils - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Vesicles "HPA008210: , HPA042273: AB_10806234" "unprognostic (2.00e-1)" "unprognostic (2.72e-1)" "unprognostic (2.02e-2)" "unprognostic (5.81e-2)" "unprognostic (6.49e-2)" "unprognostic (8.61e-2)" "unprognostic (2.54e-2)" "unprognostic (4.18e-3)" "unprognostic (1.33e-1)" "unprognostic (1.39e-1)" "unprognostic (5.18e-3)" "unprognostic (1.44e-1)" "prognostic unfavorable (2.45e-11)" "unprognostic (1.32e-1)" "unprognostic (2.01e-2)" "unprognostic (6.25e-2)" "unprognostic (2.57e-2)" 2.0 2.5 4.6 7.0 11.0 9.9 1.9 19.1 14.4 2.2 0.9 2.4 1.5 2.9 0.9 4.8 1.4 1.8 2.3 5.1 8.2 2.8 1.6 8.1 13.2 19.9 11.6 7.8 0.9 1.9 2.7 16.3 22.9 1.8 0.9 34.6 2.2 1.2 2.0 8.5 10.8 1.1 10.6 60.1 3.5 29.5 17.2 9.4 1.3 0.3 12.9 8.2 2.5 20.2 16.7 0.2 4.8 1.4 6.0 20.1 39.7 75.2 30.1 15.5 23.8 6.5 26.6 0.1 4.3 34.2 12.6 4.9 1.5 4.8 16.0 1.3 0.9 30.0 0.1 8.3 1.3 0.9 275.8 14.3 0.2 108.7 6.0 39.0 0.2 2.0 17.5 10.1 51.2 1.4 4.3 9.9 5.2 0.4 11.3 0.6 3.3 4.4 6.5 7.1 0.3 0.5 0.5 13.4 6.1 4.1 1.0 6.0 3.0 28.8 19.2 14.1 166.3 1.8 1.3 0.3 92.4 3.4 1.5 1.8 0.0 3.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 4.6 11.0 19.1 14.4 5.1 8.2 19.9 11.6 22.9 10.6 17.2 20.2 1.8 3.2 0.0 1.0 22.6 0.4 1.6 3.1 0.6 13.7 1.2 1.3 1.4 0.0 4.0 1.8 68.8 25.6 5.2 0.6 0.0 19.8 0.5 4.6 1.5 5.3 0.0 21.7 12.4 13.9 58.8 1.8 1.5 10.6 8.2 65.1 0.7 0.7 7.2 1.7 5.9 0.0 0.0 0.3 12.0 2.5 3.7 4.8 8.8 0.0 28.6 6.8 1.0 4.0 16.3 91.0 0.1 1.9 6.4 3.3 0.1 0.1 2.0 58.3 0.0 0.2 9.0 0.9 0.8 0.2 1.4 166.4 5.7 22.0 0.0 24.4 UBL7 "BMSC-UbP, MGC14421" ENSG00000138629 "Ubiquitin like 7" Q96S82 15 74445977-74461182 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 175.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040423, HPA041897" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 5: NTERA-2 - Transcription" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Cytosol "HPA040423: AB_10673442, HPA041897: AB_2677732" "unprognostic (4.21e-2)" "prognostic favorable (6.37e-5)" "unprognostic (2.93e-3)" "unprognostic (5.56e-2)" "unprognostic (1.83e-1)" "unprognostic (1.60e-1)" "unprognostic (3.43e-2)" "unprognostic (1.29e-1)" "unprognostic (1.80e-1)" "unprognostic (6.71e-2)" "unprognostic (5.80e-2)" "unprognostic (2.62e-1)" "unprognostic (4.47e-3)" "unprognostic (8.94e-3)" "unprognostic (7.05e-2)" "unprognostic (2.75e-1)" "unprognostic (3.43e-2)" 33.8 38.4 27.0 13.5 28.9 15.9 32.9 26.7 35.0 34.0 23.9 48.1 15.0 36.8 15.4 37.8 30.3 10.6 67.9 29.4 26.9 38.1 32.0 29.7 21.4 28.2 27.3 31.1 44.7 25.0 30.3 15.6 29.2 36.4 16.5 13.1 34.2 16.3 114.6 54.3 36.9 18.4 25.5 48.2 43.5 55.8 25.9 27.3 37.0 37.8 29.6 38.7 33.1 29.0 18.7 20.3 31.6 42.3 32.4 42.1 21.8 29.8 36.0 37.6 46.6 24.7 26.4 27.2 31.1 35.9 48.6 29.4 88.4 40.4 36.5 36.0 55.6 35.8 32.2 45.3 31.7 22.4 29.1 32.9 35.5 32.1 43.0 32.3 32.0 60.8 30.9 39.3 39.3 26.2 28.1 35.3 75.7 31.2 24.6 29.4 25.0 60.5 32.6 21.2 31.1 61.8 28.8 26.8 40.1 44.1 28.6 36.7 18.8 34.6 20.4 17.4 37.5 39.8 82.1 30.5 22.7 40.3 30.6 32.9 51.6 59.7 35.1 58.5 33.7 50.5 35.3 37.1 70.6 55.3 33.9 40.6 65.3 55.5 55.5 151.5 65.6 52.1 27.0 28.9 26.7 35.0 29.4 26.9 28.2 27.3 29.2 25.5 25.9 29.0 17.3 32.1 18.2 3.9 35.4 15.8 24.1 35.6 26.7 5.8 24.9 23.9 29.9 18.6 20.0 14.7 8.4 71.1 36.8 25.5 58.7 37.3 75.3 12.7 13.0 20.7 23.4 45.8 5.7 34.7 66.9 20.7 22.4 13.5 19.0 21.5 22.5 16.3 41.9 5.0 3.8 26.9 20.3 38.3 31.4 175.8 24.5 31.4 21.4 5.6 82.6 18.2 23.7 4.0 4.5 29.5 27.6 21.1 51.6 19.5 48.9 44.6 16.1 9.0 19.7 13.5 50.5 59.2 31.1 29.8 25.1 68.4 23.0 19.6 28.0 25.2 ARID3B "BDP, DRIL2" ENSG00000179361 "AT-rich interaction domain 3B" Q8IVW6 15 74541206-74598131 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 24.6" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 43.8;Early spermatids: 45.4;Glandular and luminal cells: 45.6;Late spermatids: 65.8;Rod photoreceptor cells: 50.8;Syncytiotrophoblasts: 64.0" "Cancer enhanced" "Detected in all" "testis cancer: 10.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 87.8;SuSa: 95.4;U-266/70: 53.0" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 28.8" HPA050320 Enhanced Supported Nucleoplasm NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA050320: AB_2681085" "unprognostic (2.97e-1)" "unprognostic (5.91e-2)" "unprognostic (6.41e-2)" "unprognostic (8.15e-2)" "unprognostic (8.42e-2)" "unprognostic (1.13e-1)" "unprognostic (3.33e-3)" "unprognostic (3.95e-1)" "unprognostic (1.41e-1)" "unprognostic (2.60e-1)" "unprognostic (1.27e-2)" "unprognostic (1.64e-2)" "unprognostic (1.42e-2)" "unprognostic (4.71e-2)" "unprognostic (3.52e-2)" "unprognostic (9.45e-3)" "unprognostic (2.20e-1)" 2.8 2.4 3.1 6.1 2.4 24.6 2.6 5.2 3.4 3.3 6.6 4.9 4.4 2.3 1.9 6.2 2.5 2.4 2.3 3.3 4.4 3.6 4.0 7.3 7.2 2.9 3.4 1.5 5.7 1.7 6.2 15.7 2.9 4.6 4.0 18.7 3.8 1.7 3.4 3.2 7.0 1.6 2.3 9.5 7.1 22.1 3.7 6.0 3.8 2.2 6.3 3.2 3.9 2.8 7.6 3.1 40.7 8.9 1.5 0.8 43.8 1.8 2.0 2.5 2.7 49.9 3.6 0.7 2.0 1.9 14.3 9.0 49.8 6.8 2.2 47.7 11.6 29.5 6.0 13.7 1.0 4.7 18.5 1.0 3.0 4.2 4.3 2.0 4.3 11.7 26.1 16.8 0.7 1.8 12.9 15.7 87.8 3.2 2.7 5.7 1.6 12.1 2.4 7.9 10.4 18.4 2.2 4.5 8.8 95.4 5.8 8.5 2.7 3.4 4.3 2.7 5.6 53.0 36.1 5.3 1.8 7.3 1.3 2.6 1.9 7.0 5.0 1.5 3.0 3.1 2.9 3.8 1.4 1.4 2.2 2.9 13.0 4.0 2.0 1.9 4.4 3.4 3.1 2.4 5.2 3.4 3.3 4.4 2.9 3.4 2.9 2.3 3.7 2.8 3.5 3.2 5.6 10.7 11.8 5.2 5.2 3.5 3.4 23.9 4.4 2.3 1.2 4.3 1.9 0.0 43.8 36.0 10.2 10.2 0.0 2.5 45.4 20.5 4.4 4.8 5.4 9.7 7.3 3.5 20.6 2.3 8.6 45.6 2.5 4.2 4.2 2.5 8.3 11.8 7.8 6.0 0.0 8.7 9.1 65.8 2.8 9.5 3.6 5.6 6.4 5.9 18.6 5.5 7.8 7.6 8.4 3.0 19.2 7.8 7.0 1.7 3.8 50.8 0.0 1.5 1.8 17.2 19.4 10.4 3.3 64.0 12.8 5.5 4.0 8.0 CLK3 ENSG00000179335 "CDC like kinase 3" P49761 15 74598500-74645414 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046817 Approved Supported "Nucleoplasm,Intermediate filaments" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 30: Epithelial cell lines - Translation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "Intermediate filaments" "HPA046817: AB_10964124" "unprognostic (4.10e-2)" "unprognostic (8.43e-2)" "prognostic unfavorable (2.05e-6)" "unprognostic (1.91e-3)" "unprognostic (7.91e-2)" "unprognostic (5.76e-2)" "unprognostic (1.46e-1)" "unprognostic (1.30e-2)" "unprognostic (1.95e-1)" "unprognostic (2.54e-1)" "unprognostic (8.14e-3)" "prognostic unfavorable (5.92e-4)" "unprognostic (1.35e-2)" "unprognostic (2.24e-1)" "unprognostic (9.73e-2)" "unprognostic (2.48e-1)" "unprognostic (2.25e-2)" 35.9 28.7 30.3 26.5 31.8 112.4 34.6 36.4 35.9 36.7 32.8 36.6 28.9 32.3 25.9 38.6 31.3 32.7 28.3 30.2 31.2 30.0 29.4 34.0 37.7 32.8 31.6 38.4 33.9 35.3 32.3 31.6 32.5 31.9 21.8 33.1 36.1 29.7 50.7 41.7 33.7 26.2 29.5 41.7 35.1 44.4 32.2 55.8 32.3 52.1 30.3 37.8 33.8 35.4 56.7 35.1 45.5 25.6 57.2 43.4 35.8 37.7 59.2 52.7 64.3 47.9 36.4 51.2 27.2 33.9 73.5 39.0 85.4 36.3 34.3 73.2 46.9 63.0 52.0 33.6 90.7 17.2 46.6 54.8 71.0 69.4 57.4 64.0 58.6 51.0 31.3 36.2 31.1 39.9 50.9 57.3 29.1 55.7 24.6 40.7 21.8 33.7 41.1 40.3 25.5 29.9 30.2 33.0 34.3 34.7 31.4 33.8 27.3 31.0 23.7 19.7 50.2 59.0 51.8 42.2 27.2 82.4 40.1 74.2 65.5 90.0 68.9 74.1 68.2 71.0 73.6 71.9 61.3 78.8 74.4 70.9 115.9 90.7 97.7 69.5 87.7 85.9 30.3 31.8 36.4 35.9 30.2 31.2 32.8 31.6 32.5 29.5 32.2 35.4 29.8 6.4 38.4 14.0 34.1 44.9 44.9 41.6 26.2 35.5 22.8 15.9 18.6 28.6 35.1 12.9 56.3 27.7 41.8 46.7 31.3 34.2 83.6 25.8 19.9 28.6 29.3 31.5 6.6 24.2 46.2 24.5 37.8 41.5 21.5 27.4 21.4 13.4 27.5 28.6 7.9 34.7 42.7 23.3 34.4 19.8 27.7 28.4 28.4 6.5 29.5 18.0 29.9 7.1 9.6 30.8 52.0 20.3 26.6 38.9 35.5 18.6 23.4 42.6 13.1 20.4 35.8 45.4 21.4 21.0 41.9 58.6 40.1 20.4 28.1 63.5 EDC3 "FLJ21128, hYjeF_N2-15q23, LSM16, YJDC, YJEFN2" ENSG00000179151 "Enhancer of mRNA decapping 3" Q96F86 15 74630558-74696292 "Disease related genes, Human disease related genes, Predicted intracellular proteins" RNA-binding "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Early spermatids: 117.2;Late spermatids: 192.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040650, HPA044206, HPA066137" Uncertain Supported "Cytoplasmic bodies" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" "Cytoplasmic bodies" "HPA040650: AB_2677061, HPA044206: AB_2678857, HPA066137: AB_2685625" "unprognostic (4.22e-1)" "unprognostic (1.85e-1)" "unprognostic (9.13e-2)" "unprognostic (1.04e-1)" "unprognostic (2.55e-1)" "unprognostic (1.25e-1)" "prognostic unfavorable (7.80e-5)" "unprognostic (3.06e-1)" "unprognostic (2.58e-2)" "unprognostic (4.45e-2)" "unprognostic (1.33e-1)" "unprognostic (3.92e-1)" "unprognostic (1.19e-1)" "unprognostic (8.85e-2)" "unprognostic (2.80e-1)" "unprognostic (3.81e-1)" "unprognostic (4.81e-2)" 12.8 8.7 14.3 11.7 15.6 7.9 13.8 18.1 16.6 13.0 15.6 12.4 10.4 15.2 11.0 15.5 16.4 10.2 10.5 14.0 15.3 12.9 11.2 10.5 15.1 15.2 15.0 18.6 10.5 13.4 11.9 12.4 14.9 14.3 13.8 11.8 10.3 10.8 14.8 15.3 12.3 17.0 12.7 12.9 11.5 34.8 15.0 18.5 13.1 11.5 18.1 13.0 10.7 18.6 24.9 20.8 39.0 34.9 24.6 22.5 35.7 26.1 30.5 42.4 40.6 58.9 30.2 39.6 24.1 35.8 39.2 50.6 99.0 40.4 29.5 33.7 54.3 41.0 46.9 30.8 29.4 47.8 24.4 23.0 36.9 36.8 39.0 26.8 38.9 45.7 59.3 30.4 30.5 39.8 32.8 26.7 39.2 34.0 22.9 40.8 42.7 40.0 19.4 42.7 42.5 38.8 38.8 33.5 41.8 51.8 34.6 34.6 24.3 36.7 20.3 22.2 38.4 31.9 65.2 44.3 29.1 46.6 29.5 6.1 5.8 4.6 9.6 5.9 10.3 8.3 6.8 7.9 6.8 6.3 6.9 7.5 1.9 13.7 5.0 6.7 8.5 7.1 14.3 15.6 18.1 16.6 14.0 15.3 15.2 15.0 14.9 12.7 15.0 18.6 10.8 6.4 7.8 21.9 7.2 4.7 5.0 7.6 9.6 9.7 6.8 6.2 6.3 8.6 6.7 7.3 0.0 9.7 8.4 7.0 3.9 11.4 117.2 10.2 7.5 9.6 15.6 7.8 19.5 8.1 12.1 7.9 9.7 9.4 4.5 10.2 8.2 8.2 7.6 5.0 18.0 6.8 8.2 7.1 2.4 192.2 9.0 4.6 8.8 17.8 11.5 5.2 11.3 18.6 19.0 9.5 11.1 6.4 14.0 7.6 6.6 5.8 11.3 6.3 13.1 4.6 6.8 12.8 16.3 7.7 2.8 9.3 7.4 7.6 6.0 8.1 CYP1A1 "CP11, CYP1, P1-450, P450-C, P450DX" ENSG00000140465 "Cytochrome P450 family 1 subfamily A member 1" P04798 15 74719542-74725536 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" "Lyase, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 66.1;urinary bladder: 63.6" "Cell type enhanced" "Detected in some" "Adipocytes: 21.9;Endothelial cells: 13.7;Glandular and luminal cells: 5.9;Hepatocytes: 9.9;Urothelial cells: 16.4" "Group enriched" "Detected in some" 24 "liver cancer: 18.6;urothelial cancer: 54.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 36.9;hTCEpi: 19.5;HUVEC TERT2: 19.1;SK-BR-3: 14.7;SuSa: 35.6" "Not detected" "Not detected" "Not detected" "Not detected" CAB018654 Uncertain NA NA "Cluster 85: Liver - Metabolism" "Cluster 39: CACO-2 - Unknown function" "Cluster 22: Epithelial cell types - Mixed function" "CAB018654: AB_2088699" "unprognostic (1.71e-2)" "unprognostic (7.86e-2)" "unprognostic (2.57e-2)" "unprognostic (2.89e-1)" "unprognostic (5.45e-3)" "unprognostic (6.34e-2)" "unprognostic (3.08e-1)" "unprognostic (6.24e-3)" "unprognostic (1.11e-1)" "unprognostic (1.01e-1)" "unprognostic (1.41e-1)" "unprognostic (1.03e-1)" "unprognostic (4.21e-2)" "unprognostic (6.70e-2)" "unprognostic (2.20e-1)" "unprognostic (4.77e-1)" "unprognostic (1.28e-1)" 18.5 0.6 0.2 0.0 0.2 0.0 14.7 0.1 0.3 3.6 0.0 2.0 0.6 2.4 0.6 1.9 1.2 0.7 10.7 0.2 0.4 1.4 66.1 12.2 0.0 0.3 0.4 0.5 0.6 0.0 0.5 0.3 0.3 0.7 0.1 0.3 1.8 0.6 4.1 13.9 19.8 0.0 0.1 0.1 1.8 0.3 0.2 0.2 2.0 0.2 0.1 63.6 2.2 0.1 0.3 2.1 0.2 0.0 0.5 0.1 11.7 0.0 0.1 0.7 0.3 36.9 1.6 0.3 9.6 0.0 8.8 11.4 0.7 7.3 0.3 0.0 1.0 0.5 2.6 5.5 0.2 0.3 11.5 0.0 19.5 0.3 1.4 0.4 19.1 0.3 2.3 0.3 0.1 0.7 0.1 0.4 0.2 12.1 2.9 1.2 0.0 0.4 0.0 2.4 0.6 0.3 1.7 14.7 3.8 35.6 0.4 0.2 1.0 1.6 0.5 5.2 0.0 0.7 0.2 0.5 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.3 0.2 0.4 0.3 0.4 0.3 0.1 0.2 0.1 21.9 0.0 0.0 0.0 0.1 0.5 2.4 0.0 0.0 0.0 0.4 0.5 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 3.4 1.1 13.7 0.0 0.0 0.1 0.2 0.0 0.2 0.0 5.9 0.0 0.0 0.0 9.9 0.0 0.0 0.4 0.0 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.4 0.0 0.1 0.0 0.0 16.4 CYP1A2 "CP12, P3-450" ENSG00000140505 "Cytochrome P450 family 1 subfamily A member 2" P05177 15 74748845-74756607 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Lyase, Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 313 "liver: 513.4" "Cell type enriched" "Detected in some" 57 "Hepatocytes: 85.7" "Group enriched" "Detected in some" 22 "liver cancer: 25.3;urothelial cancer: 6.5" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in some" "neutrophil: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "SK-BR-3: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" CAB016531 Enhanced NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 2: Hepatocytes - Metabolism" "CAB016531: AB_629359" "unprognostic (1.54e-4)" "unprognostic (1.29e-1)" "unprognostic (1.98e-1)" "unprognostic (1.74e-1)" "unprognostic (1.59e-2)" "unprognostic (1.76e-1)" "unprognostic (1.17e-2)" "unprognostic (5.48e-2)" "unprognostic (2.33e-2)" "unprognostic (7.41e-2)" "unprognostic (2.53e-1)" 0.2 0.3 0.5 0.2 0.5 1.0 0.1 1.6 0.8 0.0 0.2 0.0 0.2 0.2 0.4 0.1 0.2 0.2 0.1 0.5 0.5 0.2 513.4 0.4 0.3 0.6 0.5 0.1 0.0 0.0 0.0 0.7 0.6 0.1 0.1 0.4 0.2 0.3 0.3 0.6 0.2 0.0 0.1 0.3 0.2 0.3 0.6 0.1 1.4 0.0 0.1 0.1 0.0 1.3 0.4 0.3 0.8 0.5 0.1 0.0 0.6 0.2 0.0 0.0 0.1 0.3 0.4 0.8 0.1 0.0 0.6 0.4 0.0 0.0 0.0 0.1 0.4 0.9 0.6 0.1 0.0 0.7 0.3 0.1 0.1 0.0 0.0 0.3 0.1 1.3 0.7 1.3 0.0 0.2 0.9 0.3 0.4 0.3 0.2 0.9 0.8 0.3 0.1 0.7 0.7 0.3 0.6 2.3 0.1 0.6 0.5 0.2 0.2 0.3 0.4 0.3 0.3 0.3 0.2 0.5 0.3 0.9 0.3 1.5 0.3 0.5 0.2 0.2 0.1 0.3 0.2 0.1 0.1 0.5 0.2 0.2 2.1 0.4 0.2 0.4 0.1 0.1 0.5 0.5 1.6 0.8 0.5 0.5 0.6 0.5 0.6 0.1 0.6 1.3 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 85.7 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 CSK ENSG00000103653 "C-terminal Src kinase" P41240 15 74782057-74803198 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 169.3" "Cell type enhanced" "Detected in all" "B-cells: 130.9;dendritic cells: 99.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011203, HPA026488, HPA028425" Approved Approved Enhanced Vesicles,Cytosol No No 150000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 16: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 57: B-cells - Immune response" "Vesicles, Cytosol" "CAB011203: AB_259070, HPA026488: AB_1847273, HPA028425: AB_10600899" "unprognostic (1.05e-1)" "prognostic favorable (5.14e-5)" "unprognostic (2.59e-3)" "prognostic favorable (8.22e-4)" "unprognostic (4.15e-2)" "unprognostic (4.11e-2)" "unprognostic (1.87e-1)" "unprognostic (2.96e-1)" "unprognostic (2.20e-1)" "unprognostic (1.31e-1)" "unprognostic (4.12e-2)" "unprognostic (4.61e-2)" "prognostic unfavorable (1.74e-4)" "prognostic favorable (1.07e-4)" "unprognostic (1.44e-1)" "unprognostic (1.01e-1)" "unprognostic (6.29e-2)" 21.4 19.9 23.4 89.1 26.2 50.6 19.4 26.5 26.7 26.8 18.2 33.6 36.7 22.4 8.0 98.5 20.0 22.9 29.3 22.5 23.9 21.3 48.8 32.0 169.3 31.0 29.8 19.0 17.2 15.8 21.1 17.6 31.6 24.8 19.5 6.9 31.6 14.1 14.8 36.7 59.9 18.7 29.1 127.9 30.0 19.2 28.2 68.5 19.5 15.8 106.3 33.0 32.8 28.4 62.2 85.6 41.2 68.1 38.5 29.2 35.3 40.7 38.8 75.7 53.6 78.9 56.0 275.7 52.6 37.0 70.2 62.9 87.2 82.1 21.2 134.7 107.8 233.8 29.5 80.2 53.3 123.6 285.1 41.7 39.6 54.0 48.1 37.9 58.1 127.5 68.7 93.1 45.7 104.6 89.7 72.7 51.2 55.7 60.6 98.0 35.4 201.9 34.9 135.6 68.1 47.2 52.8 109.5 72.3 26.2 75.5 179.5 50.7 91.1 47.8 72.5 71.7 49.6 108.7 283.8 47.1 232.5 63.1 88.7 68.0 176.1 74.3 146.8 63.4 95.6 63.6 73.9 76.6 113.6 48.3 57.0 130.8 58.6 169.8 44.3 106.2 79.5 23.4 26.2 26.5 26.7 22.5 23.9 31.0 29.8 31.6 29.1 28.2 28.4 21.3 3.2 9.2 8.5 130.9 9.3 8.2 7.6 13.1 16.6 16.7 17.1 11.5 12.8 9.3 9.2 6.2 7.5 99.1 40.6 1.9 9.3 15.8 10.0 15.1 15.3 9.5 29.2 5.3 14.0 13.7 11.3 27.0 15.3 26.6 19.0 12.5 34.3 50.7 28.6 10.0 23.2 6.1 91.2 44.9 3.3 9.0 85.1 8.8 23.4 86.9 6.4 90.6 3.5 4.7 21.2 18.4 8.2 56.7 13.9 27.5 8.0 9.3 5.1 6.6 6.9 18.1 5.7 12.5 49.4 9.1 5.6 90.3 21.5 27.5 14.9 LMAN1L "ERGIC-53L, ERGL" ENSG00000140506 "Lectin, mannose binding 1 like" Q9HAT1 15 74812716-74825757 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "heart muscle: 31.7;lymphoid tissue: 25.7;prostate: 60.9;salivary gland: 20.7" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 2.1;Late spermatids: 2.6;Prostatic glandular cells: 10.9;Spermatocytes: 7.3;Spermatogonia: 2.4" "Cancer enriched" "Detected in single" 45 "prostate cancer: 2.2" "Region enhanced" "Detected in many" "cerebellum: 13.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Daudi: 1.1" "Not detected" "Not detected" "Region enhanced" "Detected in single" "spinal cord: 1.4" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 35: Glandular cells - Unknown function" "unprognostic (4.51e-1)" "unprognostic (2.44e-1)" "unprognostic (4.26e-2)" "unprognostic (3.09e-1)" 0.0 1.8 0.0 0.2 0.8 0.0 0.0 13.3 0.5 0.1 0.0 0.1 0.1 0.0 0.3 0.6 0.0 0.0 31.7 0.2 0.1 0.0 0.0 0.0 0.3 2.3 0.7 0.0 0.0 0.0 0.2 0.0 2.1 60.9 0.1 4.2 20.7 0.0 0.1 0.1 0.3 0.0 2.1 25.7 4.6 1.2 0.3 0.1 0.0 0.0 0.1 0.1 0.1 3.5 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.1 0.7 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 13.3 0.5 0.2 0.1 2.3 0.7 2.1 2.1 0.3 3.5 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 1.2 0.1 0.1 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.1 0.0 1.3 0.0 0.0 0.4 7.3 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 CPLX3 CPX-III ENSG00000213578 "Complexin 3" Q8WVH0 15 74826627-74831802 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Sensory transduction, Transport, Vision" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "heart muscle: 44.2;lymphoid tissue: 110.3;prostate: 122.4;retina: 98.6" "Cell type enriched" "Detected in some" 6 "Bipolar cells: 496.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 2.4;Karpas-707: 2.0;SK-BR-3: 1.1;U-266/84: 1.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" CAB079003 Supported NA NA "Cluster 77: Retina - Visual perception" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 56: Bipolar cells - Visual perception" "CAB079003: " 0.1 7.2 10.6 0.2 9.6 0.1 0.2 18.9 10.2 0.2 4.0 0.4 0.1 0.0 0.1 0.8 0.1 0.0 44.2 18.2 6.7 0.0 0.1 0.1 0.2 8.4 12.7 0.1 0.1 0.1 5.3 0.0 8.3 122.4 0.1 98.6 17.9 0.0 0.0 0.4 0.3 0.0 6.1 110.3 14.9 6.4 21.4 0.1 0.0 0.0 0.2 0.1 0.3 7.9 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 1.1 0.5 0.1 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.5 1.4 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 9.6 18.9 10.2 18.2 6.7 8.4 12.7 8.3 6.1 21.4 7.9 0.0 0.0 0.0 2.6 0.1 0.0 0.1 0.0 0.0 496.1 0.1 0.0 0.0 0.0 0.0 0.0 77.2 0.0 0.1 0.5 0.0 0.0 3.9 0.1 0.0 0.5 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 15.2 6.9 0.0 0.0 0.0 0.0 4.9 0.0 0.1 0.0 0.0 0.0 19.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 9.9 0.0 0.0 0.0 56.0 0.0 0.0 0.0 8.9 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 ULK3 "DKFZP434C131, FLJ90566" ENSG00000140474 "Unc-51 like kinase 3" Q6PHR2 15 74836118-74843346 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Autophagy "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 89.7;Horizontal cells: 89.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040474 Approved NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 62: Horizontal cells - Visual perception" "HPA040474: AB_2677003" "unprognostic (3.67e-2)" "unprognostic (8.90e-3)" "unprognostic (2.65e-3)" "unprognostic (1.59e-2)" "unprognostic (1.70e-1)" "unprognostic (2.07e-3)" "unprognostic (1.19e-1)" "unprognostic (1.58e-2)" "unprognostic (1.47e-2)" "unprognostic (4.18e-2)" "prognostic favorable (7.47e-4)" "unprognostic (1.97e-2)" "unprognostic (2.70e-2)" "unprognostic (1.30e-2)" "unprognostic (1.63e-1)" "unprognostic (1.16e-1)" "unprognostic (4.97e-3)" 7.1 15.2 29.5 6.4 31.5 2.2 6.1 28.1 32.2 13.6 23.0 12.1 5.0 4.4 3.5 35.7 5.5 4.5 15.9 29.4 27.3 17.6 13.8 8.3 5.8 34.0 26.6 5.7 12.0 16.2 12.5 3.5 35.8 9.9 9.4 15.4 11.5 3.1 21.0 24.7 15.7 4.4 26.1 13.1 10.6 7.1 27.8 6.3 7.6 19.0 7.8 9.4 15.4 30.4 6.7 17.7 7.4 14.4 9.3 6.7 6.0 5.1 7.3 10.1 11.1 7.0 15.4 13.0 8.8 6.2 10.8 4.7 23.1 7.6 4.4 26.1 26.1 30.3 25.0 7.4 14.8 10.3 22.5 9.4 14.0 8.2 7.1 3.5 15.8 16.8 10.3 11.9 7.0 9.4 7.3 6.6 10.0 10.6 8.7 18.6 10.3 23.0 6.0 7.4 16.7 22.3 8.6 9.8 25.6 9.1 11.0 26.8 9.4 16.0 8.9 12.7 10.3 20.7 19.7 9.3 7.4 29.5 12.4 5.2 3.5 1.4 10.9 7.3 8.7 3.3 6.4 9.0 3.7 2.8 7.1 4.8 0.8 5.8 6.1 4.0 9.2 5.1 29.5 31.5 28.1 32.2 29.4 27.3 34.0 26.6 35.8 26.1 27.8 30.4 16.5 9.6 15.3 37.2 11.4 10.1 7.5 6.0 10.2 89.7 18.1 13.6 17.1 14.3 6.7 12.9 16.7 9.2 23.3 46.4 19.6 11.0 1.0 8.9 8.8 10.7 11.4 14.1 64.7 11.7 2.5 9.2 23.4 11.9 21.0 6.2 13.2 13.3 16.1 89.2 56.5 17.5 4.1 7.9 8.2 2.2 13.1 11.2 5.4 18.7 13.2 18.4 29.9 16.6 15.3 12.3 17.9 11.7 8.6 10.4 68.5 16.5 8.0 54.5 0.0 12.9 8.8 9.5 17.3 19.7 21.7 5.7 19.7 12.3 27.9 8.9 SCAMP2 ENSG00000140497 "Secretory carrier membrane protein 2" O15127 15 74843730-74873365 "Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014699, HPA019194" Approved Supported "Golgi apparatus,Vesicles" NA NA 71000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 10: Non-specific - Unknown function" "Golgi apparatus, Vesicles" "HPA014699: AB_1856605, HPA019194: AB_1856604" "unprognostic (1.74e-1)" "unprognostic (1.27e-2)" "unprognostic (2.05e-1)" "unprognostic (5.23e-3)" "unprognostic (2.89e-1)" "unprognostic (1.38e-1)" "unprognostic (1.53e-2)" "unprognostic (7.23e-2)" "unprognostic (9.73e-3)" "unprognostic (7.26e-2)" "unprognostic (8.44e-2)" "unprognostic (1.97e-1)" "prognostic favorable (1.12e-6)" "unprognostic (3.40e-1)" "unprognostic (1.79e-2)" "unprognostic (1.19e-2)" "unprognostic (3.10e-2)" 43.1 46.7 27.8 40.3 32.8 51.5 40.7 31.9 31.2 40.5 38.8 76.0 75.7 36.9 36.9 103.4 47.4 35.4 32.4 26.1 29.8 44.9 42.0 49.6 47.9 40.7 30.9 26.5 54.5 85.6 29.4 48.9 36.7 35.5 72.7 4.7 92.7 32.4 34.2 68.3 80.1 33.6 33.6 66.8 64.9 36.2 33.3 33.0 38.3 18.9 53.4 38.1 49.4 35.4 44.7 57.3 24.2 37.6 72.0 37.2 72.0 45.0 56.6 46.9 50.1 83.0 102.6 36.5 57.8 68.1 67.7 157.8 72.3 55.9 19.4 145.8 71.1 92.8 31.2 57.6 54.3 48.0 170.9 48.0 97.6 44.4 32.0 37.0 46.0 42.0 31.3 67.5 33.3 68.1 24.6 55.3 24.1 111.0 36.6 42.6 22.3 126.4 54.0 63.1 24.9 25.0 36.7 64.3 42.4 35.4 88.5 76.3 43.4 40.2 23.9 43.8 53.0 46.1 73.2 37.6 37.8 112.2 30.2 118.3 111.3 90.0 94.1 106.9 76.1 80.8 85.3 95.9 81.8 70.9 69.4 75.8 74.4 83.8 119.3 128.7 105.3 120.8 27.8 32.8 31.9 31.2 26.1 29.8 40.7 30.9 36.7 33.6 33.3 35.4 36.0 73.7 31.7 17.9 49.5 17.5 41.7 40.5 19.4 6.8 28.0 24.8 14.4 24.3 53.1 40.5 2.1 156.9 63.4 116.8 15.6 67.4 132.3 30.8 22.0 36.2 37.3 29.0 7.7 92.8 61.9 37.2 54.0 40.6 79.2 31.3 26.4 27.7 164.7 6.7 6.1 77.5 42.7 78.3 44.5 56.2 32.0 77.0 32.0 21.5 56.9 41.4 63.8 12.1 17.9 96.1 75.5 23.0 73.1 54.0 105.7 48.1 52.6 8.4 26.3 25.6 35.8 47.1 35.3 39.6 22.3 136.4 55.1 40.0 64.2 58.5 MPI ENSG00000178802 "Mannose phosphate isomerase" P34949 15 74890005-74902219 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Isomerase "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 70.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007200 Approved Approved "Plasma membrane,Cytosol" NA NA 350000 "Cluster 20: T-cells - T-cell receptor" "Cluster 39: Non-specific - Mitochondria" "Cluster 25: RPMI-8226 - Immune response" "Cluster 45: Enterocytes - Digestion" Cytosol "Plasma membrane" "HPA007200: AB_1854079" "unprognostic (1.38e-1)" "unprognostic (7.18e-2)" "unprognostic (1.63e-1)" "unprognostic (1.65e-3)" "unprognostic (7.34e-2)" "prognostic unfavorable (2.39e-4)" "unprognostic (1.79e-1)" "unprognostic (2.76e-1)" "unprognostic (3.20e-1)" "unprognostic (2.93e-2)" "unprognostic (1.47e-1)" "unprognostic (1.27e-1)" "unprognostic (3.34e-2)" "unprognostic (2.11e-1)" "unprognostic (1.15e-1)" "unprognostic (2.09e-1)" "unprognostic (6.58e-2)" 18.9 50.5 45.4 16.7 47.3 11.7 20.1 52.2 49.2 23.9 41.1 31.8 45.6 23.6 35.3 27.7 27.8 16.0 44.8 46.6 47.9 31.2 39.1 14.9 20.9 55.5 50.1 30.6 31.8 31.1 22.9 16.2 56.2 27.5 31.4 33.6 23.7 22.9 52.2 16.5 33.0 22.5 45.7 23.0 20.9 26.2 50.0 23.2 23.2 70.9 24.2 24.2 19.5 47.1 27.2 36.9 29.8 34.0 66.7 32.2 26.0 22.8 37.2 38.4 53.4 36.7 35.0 38.3 48.6 33.6 30.6 65.9 60.0 66.7 36.2 29.4 74.9 68.8 35.3 39.9 47.5 32.0 19.4 43.1 16.9 36.2 64.4 58.1 52.9 45.2 23.4 30.7 50.1 23.2 34.6 14.2 16.4 40.9 31.0 35.0 28.0 94.9 45.5 30.4 55.7 24.4 26.7 47.5 28.7 43.5 65.3 21.9 24.1 22.9 19.4 17.3 22.6 75.0 48.4 25.1 47.9 45.8 17.1 2.3 16.2 5.7 28.2 17.0 37.0 27.4 38.3 32.6 23.0 31.9 56.0 40.8 2.7 43.1 15.5 19.1 53.1 29.0 45.4 47.3 52.2 49.2 46.6 47.9 55.5 50.1 56.2 45.7 50.0 47.1 5.6 6.4 15.0 7.8 10.8 1.9 7.6 16.4 5.2 23.4 9.2 10.7 54.1 7.2 10.9 14.7 4.2 31.8 9.1 28.3 15.6 19.6 18.9 5.6 9.2 9.6 10.8 4.2 4.9 8.8 11.4 10.9 6.1 8.5 15.2 13.3 6.1 18.8 23.9 35.3 6.1 19.0 8.2 7.2 2.2 31.3 11.1 6.6 3.6 3.7 9.7 20.7 12.3 2.0 6.9 12.2 33.2 8.6 11.8 7.2 70.1 31.4 7.8 16.7 6.6 8.2 10.1 34.5 9.0 9.1 2.7 16.3 11.1 21.0 16.4 6.2 FAM219B "C15orf17, FLJ00005" ENSG00000178761 "Family with sequence similarity 219 member B" Q5XKK7 15 74899992-74906883 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048929, HPA058064" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 46: Photoreceptor cells - Phototransduction" Nucleoplasm "Golgi apparatus" "HPA048929: AB_2680561, HPA058064: AB_2683592" "unprognostic (1.12e-1)" "unprognostic (6.10e-2)" "prognostic unfavorable (1.75e-4)" "unprognostic (8.08e-2)" "unprognostic (1.05e-2)" "unprognostic (5.65e-2)" "unprognostic (2.41e-2)" "unprognostic (5.66e-3)" "unprognostic (1.32e-1)" "unprognostic (1.92e-1)" "unprognostic (3.17e-2)" "unprognostic (3.11e-2)" "prognostic favorable (1.29e-4)" "unprognostic (1.13e-1)" "unprognostic (1.46e-1)" "unprognostic (1.30e-1)" "unprognostic (4.91e-3)" 21.9 19.8 31.5 9.9 30.8 6.4 13.7 31.9 35.5 15.4 32.5 17.1 12.0 16.8 22.5 23.6 22.3 10.6 30.3 31.6 36.3 16.1 6.6 16.9 15.2 32.7 33.6 19.5 13.0 32.4 28.1 13.3 35.0 24.0 14.6 44.7 18.2 17.0 18.7 22.0 13.9 17.8 31.6 24.3 15.3 6.3 34.4 8.5 18.2 25.1 17.4 20.1 16.0 31.3 6.6 9.6 25.9 11.4 42.9 31.6 11.6 18.7 9.8 16.7 10.5 9.1 18.0 12.9 10.4 13.0 16.8 16.8 35.9 10.3 9.1 32.5 20.4 12.3 22.9 7.7 20.3 11.9 16.2 19.2 47.3 7.3 13.7 36.0 18.7 9.6 9.6 15.4 17.1 5.5 7.1 10.4 14.3 19.4 14.4 19.0 9.0 9.7 25.7 21.1 21.7 14.1 20.9 11.6 33.7 27.1 23.3 14.0 21.7 13.5 7.3 11.4 15.2 11.6 12.1 5.5 17.1 24.2 13.8 3.8 1.0 6.9 1.4 0.9 2.4 2.2 2.1 1.2 1.0 2.0 0.9 1.5 1.2 1.8 1.3 0.1 0.2 1.3 31.5 30.8 31.9 35.5 31.6 36.3 32.7 33.6 35.0 31.6 34.4 31.3 13.3 19.2 20.6 22.5 18.4 6.4 21.2 17.9 13.6 41.6 16.2 13.5 5.1 10.0 18.9 27.6 58.4 17.1 22.3 23.3 13.7 14.4 1.0 22.9 14.8 16.0 20.9 7.6 23.9 10.5 11.4 17.4 9.7 13.9 24.7 15.0 17.2 5.8 17.9 23.5 20.8 16.0 28.5 13.3 8.5 4.7 23.3 13.0 14.2 13.1 19.8 26.7 30.9 11.1 9.4 17.5 16.2 28.6 15.7 19.9 23.3 11.9 30.6 69.2 26.3 15.8 15.2 9.1 17.5 18.2 7.7 8.3 16.0 15.0 14.0 22.6 COX5A ENSG00000178741 "Cytochrome c oxidase subunit 5A" P20674 15 74919791-74938083 "Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 1749.5;skeletal muscle: 1609.7;tongue: 1735.8" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 1645.3;Distal tubular cells: 1475.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027526 Supported NA NA 530000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "HPA027526: AB_10602802" "unprognostic (7.32e-2)" "prognostic favorable (2.15e-4)" "unprognostic (4.06e-2)" "unprognostic (9.85e-2)" "unprognostic (1.22e-1)" "unprognostic (1.03e-1)" "unprognostic (2.78e-1)" "unprognostic (3.79e-2)" "unprognostic (9.63e-2)" "unprognostic (2.77e-1)" "unprognostic (1.77e-1)" "unprognostic (8.62e-2)" "prognostic favorable (6.06e-7)" "unprognostic (9.78e-2)" "unprognostic (2.22e-1)" "unprognostic (1.30e-1)" "unprognostic (3.81e-3)" 175.6 176.7 187.1 105.1 189.5 148.5 150.8 231.1 258.1 109.8 201.3 454.2 326.9 98.2 110.7 293.0 89.3 67.8 1749.5 193.1 229.3 373.5 349.6 133.0 125.6 216.1 207.5 71.1 259.3 385.3 141.1 88.0 208.8 118.4 398.2 194.1 211.2 99.2 1609.7 169.0 269.6 95.0 194.8 150.8 306.8 217.8 220.4 150.7 141.5 1735.8 197.9 141.2 146.3 193.8 300.4 309.1 376.8 331.1 227.2 260.2 443.1 262.7 222.3 317.7 294.8 346.0 352.1 700.0 322.0 219.5 387.8 567.7 898.3 368.4 263.7 401.0 906.2 566.6 299.7 436.0 283.9 642.7 335.0 266.6 389.9 198.3 445.1 217.4 377.7 450.0 522.2 429.9 321.2 222.4 558.8 494.6 408.7 575.8 540.1 499.0 369.7 778.4 469.8 472.4 570.5 250.1 396.6 569.2 871.3 407.6 286.3 507.6 274.3 241.4 238.7 303.9 421.1 508.4 1000.3 759.0 258.2 836.1 224.5 332.4 361.5 210.2 198.1 465.6 238.6 296.4 242.4 235.7 452.9 227.3 171.6 198.0 87.4 354.9 432.7 365.2 372.6 426.4 187.1 189.5 231.1 258.1 193.1 229.3 216.1 207.5 208.8 194.8 220.4 193.8 120.7 99.3 119.6 20.5 166.6 158.2 235.3 623.6 151.4 113.4 202.6 313.4 1645.3 221.6 324.0 171.0 39.6 502.8 162.7 987.6 1475.2 407.5 1046.3 199.4 124.3 163.8 461.4 227.3 18.9 436.7 528.2 156.3 247.2 192.8 104.0 143.3 117.8 471.8 571.5 92.5 25.1 890.5 496.4 286.0 209.1 819.6 100.3 238.6 250.8 17.8 413.7 159.9 162.7 15.6 20.2 412.1 817.3 85.7 350.7 319.3 1276.3 921.7 242.7 176.8 92.1 139.6 590.9 523.0 253.6 371.3 159.0 511.0 144.2 216.5 1045.6 393.3 RPP25 FLJ20374 ENSG00000178718 "Ribonuclease P and MRP subunit p25" Q9BUL9 15 74954418-74956772 "Enzymes, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Bipolar cells: 95.1;Hofbauer cells: 77.0;Rod photoreceptor cells: 72.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 25.8" "Group enriched" "Detected in many" 5 "dendritic cells: 25.8;monocytes: 10.1" "Cell line enhanced" "Detected in many" "HHSteC: 46.0;SCLC-21H: 42.9;SK-MEL-30: 67.4" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "olfactory bulb: 23.0" HPA046900 Approved Supported "Nucleoplasm,Centriolar satellite" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 56: Bipolar cells - Visual perception" Nucleoplasm "Centriolar satellite" "HPA046900: AB_10962049" "unprognostic (9.36e-2)" "unprognostic (7.17e-3)" "unprognostic (5.54e-2)" "unprognostic (2.27e-1)" "prognostic unfavorable (2.24e-5)" "unprognostic (7.18e-2)" "unprognostic (5.73e-3)" "unprognostic (5.50e-3)" "unprognostic (7.78e-2)" "unprognostic (1.44e-1)" "unprognostic (3.58e-2)" "unprognostic (1.70e-1)" "unprognostic (4.71e-3)" "unprognostic (5.50e-3)" "unprognostic (5.58e-2)" "unprognostic (1.10e-1)" "unprognostic (2.53e-1)" 6.0 13.2 7.4 2.7 8.9 0.4 4.5 14.6 8.5 7.1 6.5 7.9 7.2 3.7 1.8 6.9 4.4 4.5 5.5 4.9 10.8 5.1 3.1 5.8 3.9 16.5 12.7 15.4 7.6 23.0 5.2 7.2 16.4 4.2 4.8 12.8 4.6 1.7 1.4 4.9 5.7 2.5 10.8 10.8 7.1 3.0 12.8 2.4 8.9 1.5 3.4 7.7 5.4 12.7 23.6 17.5 4.4 0.1 1.5 0.9 7.4 4.3 5.2 1.3 1.2 24.1 21.0 0.0 19.4 4.4 1.2 6.9 13.7 0.8 0.3 8.9 0.7 0.1 19.9 0.5 46.0 0.0 13.3 5.9 0.6 8.5 0.0 0.9 20.4 5.5 16.1 0.0 4.6 9.1 3.8 6.3 20.8 40.9 7.0 0.1 0.0 15.8 4.2 0.4 42.9 32.1 32.6 28.8 67.4 2.2 5.7 18.7 4.6 0.0 1.4 3.8 0.2 0.4 0.1 0.1 2.3 36.6 25.1 0.0 5.2 0.0 2.3 10.1 1.3 3.4 1.5 1.8 5.1 3.7 3.8 3.0 0.4 0.5 7.7 25.8 0.7 2.5 7.4 8.9 14.6 8.5 4.9 10.8 16.5 12.7 16.4 10.8 12.8 12.7 5.3 3.2 1.1 0.3 4.9 11.0 7.5 9.1 11.4 95.1 11.8 9.9 1.6 14.3 6.4 9.2 4.2 2.3 17.0 24.4 13.7 13.7 0.3 1.6 4.7 8.9 10.2 0.8 0.7 19.3 4.3 23.9 14.8 3.6 0.0 3.4 31.8 1.6 77.0 21.9 10.0 12.5 14.2 14.8 8.6 2.6 39.4 9.3 14.2 1.0 16.1 13.4 4.1 0.0 6.3 13.8 20.5 30.1 8.2 19.1 27.5 16.6 1.3 72.3 13.1 4.3 10.4 1.4 6.5 18.2 11.5 2.3 2.1 26.6 20.7 10.5 SCAMP5 MGC24969 ENSG00000198794 "Secretory carrier membrane protein 5" Q8TAC9 15 74957219-75021495 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 179.9;parathyroid gland: 103.1;retina: 283.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 113.3;Cone photoreceptor cells: 125.1;Enteroendocrine cells: 62.5;Excitatory neurons: 75.1;Horizontal cells: 70.7;Inhibitory neurons: 99.3;Rod photoreceptor cells: 168.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 33 "plasmacytoid DC: 27.7" "Lineage enriched" "Detected in single" 33 "dendritic cells: 27.7" "Cell line enhanced" "Detected in many" "SCLC-21H: 88.1;SH-SY5Y: 49.3;THP-1: 34.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046645 Enhanced NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 46: Photoreceptor cells - Phototransduction" "HPA046645: AB_2679734" "unprognostic (1.37e-1)" "unprognostic (3.30e-1)" "unprognostic (1.80e-1)" "unprognostic (1.20e-2)" "unprognostic (2.74e-1)" "unprognostic (4.46e-2)" "unprognostic (2.56e-1)" "unprognostic (4.13e-1)" "unprognostic (2.34e-1)" "unprognostic (8.37e-2)" "prognostic favorable (5.67e-5)" "unprognostic (9.82e-2)" "prognostic favorable (1.34e-6)" "unprognostic (7.27e-2)" "unprognostic (3.01e-1)" "unprognostic (1.69e-1)" "unprognostic (3.31e-2)" 3.0 20.6 106.7 4.3 125.2 2.6 3.1 75.1 179.9 2.8 12.5 5.8 41.6 5.7 3.6 1.5 5.0 5.6 5.5 128.7 74.8 16.7 4.2 2.8 7.9 113.9 67.4 6.0 53.4 103.1 67.7 6.7 112.5 4.6 4.9 283.7 7.2 2.7 0.6 2.1 30.4 3.2 35.8 8.5 15.6 10.7 80.6 4.4 6.5 0.8 10.0 5.9 1.8 124.4 1.5 17.8 3.8 12.6 0.3 0.2 0.5 0.4 0.6 4.0 1.4 4.9 8.9 28.0 8.5 1.1 3.3 1.2 15.6 1.1 1.4 4.4 2.0 3.5 2.1 25.8 2.7 0.4 11.5 1.3 2.1 1.0 0.3 2.8 1.7 10.1 0.2 22.1 1.0 15.1 1.1 10.2 13.4 2.1 7.1 0.4 3.2 6.7 1.0 8.6 88.1 49.3 19.8 13.6 27.6 2.7 7.7 34.0 1.1 1.2 8.2 1.6 1.3 1.8 2.4 2.6 3.0 21.2 4.3 0.6 0.2 0.1 0.1 0.1 0.1 0.2 0.1 0.2 0.0 0.2 0.2 0.1 0.8 0.4 0.1 27.7 0.0 0.4 106.7 125.2 75.1 179.9 128.7 74.8 113.9 67.4 112.5 35.8 80.6 124.4 2.2 0.0 1.1 14.7 2.5 0.3 0.5 0.4 2.8 113.3 3.2 2.7 3.0 7.2 0.4 5.5 125.1 0.1 35.5 2.9 1.9 4.4 0.5 0.4 0.7 3.6 62.5 0.0 75.1 43.3 0.3 1.9 12.8 0.3 0.0 4.1 6.8 0.6 13.8 70.7 99.3 5.0 0.0 6.9 0.2 0.7 2.1 2.0 1.8 6.5 0.4 29.9 0.0 32.2 26.2 6.8 5.3 6.4 8.9 0.8 34.0 13.0 2.7 168.0 0.0 0.9 2.8 1.8 4.7 1.7 0.1 0.1 0.6 2.0 2.7 0.3 PPCDC "FLJ14585, MDS018" ENSG00000138621 "Phosphopantothenoylcysteine decarboxylase" Q96CD2 15 75023586-75117462 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Coenzyme A biosynthesis" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 5 "dendritic cells: 71.4;granulocytes: 153.5;monocytes: 71.6" "Cell line enhanced" "Detected in all" "Karpas-707: 133.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045667 Approved Approved Cytosol NA NA 25000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" Cytosol "HPA045667: AB_2679412" "unprognostic (8.66e-2)" "unprognostic (1.07e-3)" "unprognostic (6.03e-2)" "unprognostic (2.57e-2)" "unprognostic (2.95e-2)" "unprognostic (6.53e-2)" "unprognostic (1.76e-2)" "unprognostic (8.40e-2)" "unprognostic (1.72e-1)" "unprognostic (1.53e-1)" "unprognostic (1.48e-1)" "unprognostic (1.48e-1)" "unprognostic (1.60e-2)" "unprognostic (7.67e-2)" "unprognostic (1.73e-1)" "unprognostic (3.43e-1)" "unprognostic (2.13e-3)" 11.1 19.1 7.4 10.8 8.8 19.7 10.9 8.3 8.4 9.7 8.7 11.5 9.7 8.3 9.8 19.0 10.8 8.4 8.5 6.9 8.0 17.2 13.1 10.8 16.4 9.2 8.8 9.0 16.5 21.3 9.3 9.2 8.5 13.0 9.4 7.6 13.9 7.6 11.9 9.0 9.9 5.4 8.0 18.8 11.3 9.7 8.6 12.1 11.2 5.9 12.3 11.2 10.0 10.3 15.6 28.8 11.8 9.2 7.0 6.4 10.1 15.5 7.0 20.3 15.9 16.9 41.2 17.7 26.8 7.8 12.5 15.9 19.2 25.6 10.4 62.6 23.4 31.1 18.8 18.3 19.9 18.3 38.7 8.6 16.7 21.0 32.3 8.2 16.6 25.8 21.3 133.2 14.8 30.0 10.9 28.1 18.9 32.9 13.4 18.2 23.0 38.3 15.3 22.2 28.3 8.3 22.9 31.3 34.6 13.4 38.7 23.4 9.4 20.6 14.4 10.5 27.6 40.5 29.3 30.1 12.7 45.9 23.7 47.2 23.1 153.5 11.6 65.6 19.4 15.7 10.6 13.0 17.6 8.6 11.7 14.5 139.7 18.5 71.6 71.4 12.7 15.8 7.4 8.8 8.3 8.4 6.9 8.0 9.2 8.8 8.5 8.0 8.6 10.3 10.2 16.0 5.2 2.9 10.5 3.8 6.1 8.5 8.6 2.8 9.6 8.8 4.2 4.3 9.7 9.2 0.0 17.5 16.0 19.7 25.4 17.3 1.0 8.2 4.3 10.7 4.2 11.6 1.4 15.3 13.6 7.4 14.8 8.3 12.0 9.9 10.4 5.3 20.0 8.4 1.7 10.9 12.2 15.7 6.7 2.5 4.4 15.5 14.2 2.8 20.0 4.7 8.2 2.5 4.6 18.0 38.1 5.3 33.9 6.5 10.5 19.0 12.2 10.7 6.6 6.3 8.7 6.9 15.7 10.8 4.0 10.9 9.7 11.3 11.7 13.6 C15orf39 "DKFZP434H132, FLJ46337" ENSG00000167173 "Chromosome 15 open reading frame 39" Q6ZRI6 15 75195643-75212169 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 61.9;testis: 73.7" "Cell type enhanced" "Detected in many" "Early spermatids: 50.9;Late spermatids: 68.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in all" 5 "dendritic cells: 8.0;granulocytes: 23.5;monocytes: 16.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039961, HPA041907" Enhanced Enhanced Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 44: Endometrium - Transcription" Cytosol "HPA039961: AB_10673024, HPA041907: AB_2677736" "unprognostic (3.53e-2)" "unprognostic (1.66e-1)" "unprognostic (4.57e-2)" "unprognostic (1.51e-2)" "unprognostic (1.47e-1)" "unprognostic (2.00e-1)" "unprognostic (2.20e-2)" "unprognostic (3.46e-2)" "prognostic favorable (7.94e-4)" "unprognostic (3.38e-2)" "unprognostic (2.74e-1)" "unprognostic (8.47e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.07e-1)" "prognostic unfavorable (6.02e-4)" "unprognostic (2.95e-1)" "unprognostic (1.14e-1)" 14.9 15.5 4.4 12.7 4.6 61.9 13.7 2.4 8.3 13.7 4.6 10.8 11.5 14.4 1.9 20.4 16.1 7.9 14.4 3.3 5.7 8.6 4.3 15.3 10.9 6.3 5.4 18.2 14.5 15.7 8.9 15.2 4.6 8.8 5.3 1.8 14.4 6.8 4.1 15.3 10.2 7.2 5.0 25.5 9.6 73.7 7.7 8.7 11.1 3.8 6.7 15.0 14.4 4.2 20.5 41.2 8.8 10.3 11.7 7.6 26.4 5.8 11.7 6.7 7.2 51.2 27.8 45.9 19.1 8.6 24.0 27.0 37.6 17.5 1.9 45.0 42.7 91.0 19.6 35.4 13.3 26.4 90.1 10.0 13.7 14.2 6.6 8.3 17.2 17.1 39.7 66.4 2.2 12.3 25.5 32.2 27.4 13.6 16.3 23.0 6.6 49.3 4.1 15.9 25.4 8.1 13.4 30.6 21.2 8.8 10.5 33.2 14.7 11.6 17.3 20.6 17.0 47.8 32.9 26.3 11.4 50.3 11.5 8.5 6.4 18.6 1.7 11.7 1.3 1.1 1.0 1.2 3.9 0.7 0.7 1.1 23.5 3.4 16.2 8.0 1.4 4.1 4.4 4.6 2.4 8.3 3.3 5.7 6.3 5.4 4.6 5.0 7.7 4.2 13.0 25.6 5.5 0.7 7.8 14.9 7.0 5.5 19.9 0.3 8.1 5.8 2.3 7.2 9.6 3.7 0.0 12.6 17.7 13.5 0.0 15.8 50.9 17.2 10.0 10.4 7.7 5.9 0.4 14.6 16.8 7.8 8.6 30.0 17.7 14.3 10.8 2.8 12.4 0.0 1.0 6.1 6.1 23.6 10.5 68.8 11.8 24.0 7.2 1.9 31.6 0.7 12.3 1.0 0.1 18.1 26.1 10.9 19.9 5.2 3.4 1.6 8.1 2.2 13.1 6.5 10.0 37.2 5.6 15.5 14.2 20.9 7.3 3.7 8.6 17.8 GOLGA6C ENSG00000167195 "Golgin A6 family member C" A6NDK9 15 75258599-75270199 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 27 "testis: 9.9" "Cell type enriched" "Detected in some" 6 "Early spermatids: 9.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044978, HPA050087, HPA072134" Supported Approved Nucleoplasm,Vesicles,Centrosome NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 23: Spermatids - Flagellum & Golgi organization" Vesicles "Nucleoplasm, Centrosome" "HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: " "unprognostic (6.53e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 GOLGA6D ENSG00000140478 "Golgin A6 family member D" P0CG33 15 75282835-75295807 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 12.1" "Cell type enriched" "Detected in some" 4 "Early spermatids: 12.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA044978, HPA050087, HPA072134" Supported Approved Nucleoplasm,Vesicles,Centrosome NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 23: Spermatids - Flagellum & Golgi organization" Vesicles "Nucleoplasm, Centrosome" "HPA044978: AB_2679165, HPA050087: AB_2681010, HPA072134: " "unprognostic (7.95e-3)" 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.1 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.8 0.1 0.0 0.0 0.1 0.0 0.0 12.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 COMMD4 FLJ20452 ENSG00000140365 "COMM domain containing 4" Q9H0A8 15 75336020-75343224 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039935, HPA066957" Uncertain Supported "Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 43: Testis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Cytosol "Vesicles, Plasma membrane" "HPA039935: , HPA066957: AB_2685754" "unprognostic (7.77e-2)" "unprognostic (3.07e-3)" "unprognostic (1.03e-1)" "unprognostic (6.57e-3)" "unprognostic (1.32e-1)" "unprognostic (1.89e-1)" "unprognostic (1.49e-1)" "unprognostic (2.60e-1)" "unprognostic (9.11e-2)" "unprognostic (1.78e-3)" "unprognostic (2.01e-1)" "unprognostic (2.65e-1)" "unprognostic (1.39e-3)" "unprognostic (2.51e-1)" "unprognostic (2.27e-1)" "unprognostic (1.96e-1)" "unprognostic (5.07e-2)" 36.2 72.3 38.8 33.5 39.4 52.9 36.8 40.5 50.4 31.1 43.7 41.6 48.3 30.3 30.2 39.9 34.6 37.3 38.9 36.9 39.7 54.6 51.0 34.6 44.7 39.5 38.1 24.4 33.8 48.9 33.9 31.2 38.6 34.2 33.8 13.4 43.4 34.0 30.3 35.0 42.2 24.7 40.8 41.3 42.5 81.2 42.4 53.3 38.8 15.3 36.7 33.6 31.8 42.0 138.2 222.5 97.5 124.8 42.3 64.9 98.5 98.8 106.2 191.2 196.6 133.8 184.0 88.8 100.2 79.5 168.8 144.8 175.2 116.5 82.7 70.1 242.4 104.8 169.8 151.0 76.4 79.4 111.0 74.3 63.6 116.2 21.9 48.4 96.5 103.6 108.2 128.1 147.1 179.7 71.0 117.4 140.9 75.2 127.9 127.5 137.4 127.8 98.6 127.8 79.2 114.8 131.2 105.1 169.8 63.8 164.7 160.9 78.6 135.3 119.2 125.8 184.8 93.4 218.7 101.4 138.9 181.9 125.4 27.0 44.1 40.7 84.7 61.8 52.8 47.5 51.7 63.2 50.0 46.4 31.9 47.4 9.5 76.8 55.6 70.6 87.6 39.4 38.8 39.4 40.5 50.4 36.9 39.7 39.5 38.1 38.6 40.8 42.4 42.0 43.7 28.9 52.4 15.0 26.2 27.0 44.8 58.5 28.5 40.7 44.3 50.3 18.7 38.6 46.2 35.0 31.3 80.9 34.8 59.6 58.7 72.6 12.2 37.1 44.9 42.7 30.5 60.8 9.0 78.7 107.0 43.4 33.1 45.7 41.8 91.1 37.5 41.9 127.5 16.8 8.8 72.8 44.7 35.8 27.0 17.6 49.0 41.3 37.4 11.2 28.5 78.1 53.5 7.1 17.6 72.4 61.7 34.3 43.0 26.6 71.2 98.1 39.8 49.4 46.0 36.1 59.3 152.9 63.5 34.3 30.7 50.8 32.2 53.4 58.7 48.7 NEIL1 "FLJ22402, FPG1, hFPG1, NEI1" ENSG00000140398 "Nei like DNA glycosylase 1" Q96FI4 15 75346955-75357115 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Granulosa cells: 105.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "gdT-cell: 5.2;memory B-cell: 4.8;naive B-cell: 6.4;NK-cell: 15.8" "Group enriched" "Detected in many" 11 "B-cells: 6.4;NK-cells: 15.8;T-cells: 5.2" "Cell line enhanced" "Detected in many" "Daudi: 11.5;HeLa: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054084 Approved Supported Nucleoplasm NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA054084: AB_2682372" "unprognostic (9.84e-3)" "unprognostic (1.19e-1)" "unprognostic (1.15e-2)" "unprognostic (4.62e-3)" "unprognostic (3.21e-2)" "unprognostic (1.81e-2)" "unprognostic (2.24e-2)" "unprognostic (1.17e-3)" "unprognostic (1.67e-1)" "unprognostic (1.33e-1)" "prognostic favorable (2.09e-4)" "unprognostic (3.50e-3)" "unprognostic (8.60e-2)" "unprognostic (9.24e-2)" "unprognostic (2.05e-1)" "unprognostic (3.03e-1)" "unprognostic (2.27e-3)" 8.0 14.6 2.0 3.1 3.1 4.3 11.6 6.2 5.0 14.7 2.0 9.3 5.8 10.0 1.7 7.3 12.9 3.9 5.8 2.2 1.7 8.8 12.8 8.3 6.1 1.4 0.4 13.3 10.9 3.3 11.0 2.5 0.7 12.4 1.1 2.6 16.6 4.1 9.0 8.9 8.3 1.9 0.0 8.8 10.5 3.7 1.1 2.7 10.7 0.6 3.0 8.2 10.9 2.2 2.2 3.6 2.3 1.4 0.7 0.8 4.5 1.3 0.0 0.5 0.1 0.6 4.0 11.5 2.1 0.2 1.1 6.1 1.4 0.4 0.0 5.7 9.1 2.0 11.8 1.7 0.9 2.1 2.6 0.3 1.7 0.6 0.0 5.6 1.4 1.1 1.4 3.3 0.3 2.9 0.4 6.3 2.1 0.4 0.8 2.1 1.5 0.5 2.1 2.4 1.4 2.8 2.2 1.0 3.2 1.2 4.2 3.5 6.3 1.3 2.3 1.8 1.2 5.2 5.5 9.7 1.1 9.4 1.2 0.0 0.6 0.0 5.2 0.3 1.3 4.8 0.9 1.2 0.2 6.4 1.4 1.4 0.8 15.8 0.2 0.3 0.3 1.4 2.0 3.1 6.2 5.0 2.2 1.7 1.4 0.4 0.7 0.0 1.1 2.2 15.9 22.4 19.2 19.9 33.7 6.4 15.4 10.1 23.3 20.0 22.1 15.9 2.9 10.0 21.9 14.7 10.4 10.8 19.1 13.6 1.9 9.0 20.4 31.8 7.3 16.9 21.6 8.0 33.5 8.3 3.6 7.7 22.4 15.4 11.4 105.6 24.3 11.5 3.4 10.1 29.9 20.0 10.2 5.7 7.0 2.6 19.0 3.3 8.8 8.4 1.7 14.6 55.6 5.5 4.5 7.3 16.0 13.5 9.1 9.2 21.4 8.9 41.9 6.5 6.6 6.6 6.4 1.6 1.5 11.0 5.8 4.8 10.0 2.0 14.5 8.7 MAN2C1 "MANA, MANA1" ENSG00000140400 "Mannosidase alpha class 2C member 1" Q9NTJ4 15 75355207-75368612 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040627, HPA067407" Uncertain Enhanced Nucleoplasm NA NA 110000 "Cluster 7: Monocytes - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 15: RT4 - Unknown function" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA040627: AB_10795490, HPA067407: AB_2685834" "unprognostic (4.68e-2)" "unprognostic (1.95e-1)" "unprognostic (3.84e-3)" "unprognostic (3.48e-2)" "unprognostic (3.85e-1)" "unprognostic (3.00e-2)" "unprognostic (1.26e-2)" "unprognostic (6.26e-2)" "unprognostic (2.47e-1)" "unprognostic (5.02e-2)" "unprognostic (1.06e-2)" "unprognostic (3.40e-2)" "unprognostic (4.87e-3)" "unprognostic (9.56e-2)" "unprognostic (1.33e-1)" "unprognostic (2.91e-1)" "unprognostic (1.39e-3)" 49.3 66.1 20.2 23.9 21.1 37.6 49.3 17.7 28.8 52.1 18.6 41.8 25.5 49.3 12.1 29.9 50.5 16.4 55.6 20.0 17.8 52.8 50.0 50.3 20.3 22.8 18.1 58.5 49.1 26.3 56.6 21.1 20.9 49.4 14.9 14.8 37.3 19.5 58.5 36.8 41.6 18.6 17.5 54.7 46.0 34.8 19.8 17.1 64.8 24.5 12.7 45.7 41.5 22.0 11.0 25.5 21.3 15.7 23.8 20.4 27.1 25.3 23.5 12.9 10.9 20.3 38.3 5.7 14.6 18.6 11.8 33.0 11.7 17.1 8.4 30.8 26.1 34.0 58.5 18.1 35.3 23.1 5.7 25.3 17.0 12.3 15.3 27.3 30.9 16.9 20.5 27.4 10.7 22.1 11.9 25.2 9.0 13.2 11.8 16.0 11.0 34.6 16.8 49.8 13.2 22.7 16.4 23.9 11.5 15.6 26.1 26.1 61.5 27.1 18.7 19.0 25.5 27.9 7.1 9.3 17.6 25.9 27.6 4.0 19.8 3.5 9.2 23.0 9.1 3.2 6.9 6.8 22.6 2.6 9.5 6.9 2.2 6.0 18.9 9.2 10.2 14.3 20.2 21.1 17.7 28.8 20.0 17.8 22.8 18.1 20.9 17.5 19.8 22.0 34.1 22.4 51.7 29.0 12.5 13.5 15.2 13.0 11.4 30.7 18.2 16.3 2.8 5.7 19.2 9.2 54.2 17.2 17.2 22.4 3.9 11.4 10.4 10.1 18.3 23.2 34.2 7.6 28.9 8.7 10.9 20.4 39.3 12.7 31.7 46.8 32.5 22.4 20.4 28.6 23.8 19.5 12.2 29.8 20.2 14.0 23.3 26.3 16.0 15.0 31.4 17.3 19.6 18.1 19.5 11.2 20.0 12.4 12.9 16.0 27.9 15.9 19.3 52.4 26.3 25.6 16.3 21.1 10.4 14.9 8.5 21.2 16.2 17.0 24.0 15.3 SIN3A "DKFZP434K2235, KIAA0700" ENSG00000169375 "SIN3 transcription regulator family member A" Q96ST3 15 75369379-75455842 "Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" Repressor "Cancer-related genes, Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004506, HPA047213, HPA062123" Enhanced Enhanced Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 44: Endometrium - Transcription" Nucleoplasm "CAB004506: AB_2187766, HPA047213: AB_2679984, HPA062123: AB_2684689" "unprognostic (1.94e-1)" "unprognostic (1.38e-1)" "unprognostic (1.48e-1)" "unprognostic (1.27e-1)" "unprognostic (1.99e-1)" "unprognostic (2.90e-1)" "unprognostic (4.74e-2)" "unprognostic (1.91e-1)" "unprognostic (2.26e-1)" "unprognostic (2.15e-1)" "unprognostic (8.52e-2)" "unprognostic (1.37e-1)" "unprognostic (1.17e-3)" "unprognostic (7.33e-2)" "unprognostic (2.19e-1)" "unprognostic (1.33e-1)" "unprognostic (3.52e-1)" 19.2 12.4 10.0 19.8 10.9 42.5 18.0 21.0 11.7 21.0 12.5 19.6 13.8 25.6 16.6 19.1 24.3 17.4 14.8 9.6 13.3 15.1 16.0 18.0 25.9 11.7 12.0 30.0 15.3 22.5 12.1 20.1 10.3 19.7 16.1 24.1 16.6 20.7 16.6 21.5 16.3 19.6 8.3 22.1 16.5 29.6 14.0 43.2 27.2 18.7 26.3 20.2 16.7 10.8 31.2 63.6 55.5 36.7 27.0 28.4 32.1 22.9 35.3 33.0 35.2 35.2 41.2 67.8 23.3 34.0 45.0 54.5 81.2 34.4 35.9 55.0 42.1 64.0 46.2 27.9 20.5 61.4 52.5 34.7 26.1 38.5 39.8 34.0 30.0 47.5 51.5 73.2 27.0 36.2 60.7 39.1 54.2 41.3 26.3 60.5 73.3 41.8 23.6 56.4 43.7 43.7 56.6 25.0 31.0 53.0 38.1 47.9 26.4 40.6 54.5 27.2 34.3 49.8 85.0 70.8 24.2 61.2 23.2 2.9 4.2 5.9 6.3 3.8 9.6 7.0 8.1 8.1 5.2 7.7 8.2 7.2 7.3 8.1 7.4 3.5 7.7 5.7 10.0 10.9 21.0 11.7 9.6 13.3 11.7 12.0 10.3 8.3 14.0 10.8 26.0 35.3 32.4 13.7 35.8 39.4 23.6 21.2 60.9 19.7 36.5 25.4 13.4 17.2 30.5 27.6 31.3 23.5 29.0 17.8 5.9 15.1 10.1 35.7 30.8 32.1 17.3 24.4 19.2 12.8 11.1 24.4 15.3 42.1 29.9 30.1 26.0 17.4 13.2 20.2 18.3 19.0 10.2 21.3 31.7 5.8 23.0 19.5 10.6 27.2 18.8 16.8 24.7 16.6 24.1 14.1 14.0 20.3 33.1 29.8 13.7 9.2 33.4 33.8 13.1 34.7 24.7 42.1 42.7 37.5 53.1 21.9 34.6 21.2 19.2 19.4 PTPN9 MEG2 ENSG00000169410 "Protein tyrosine phosphatase non-receptor type 9" P43378 15 75463251-75579315 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 63.0;Excitatory neurons: 66.1;Inhibitory neurons: 63.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041922 Approved Approved Vesicles NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 43: THP-1 - Innate immune response" "Cluster 50: Fibroblasts - ECM organization" Vesicles "HPA041922: AB_10795269" "unprognostic (9.58e-2)" "unprognostic (1.87e-1)" "unprognostic (1.28e-1)" "unprognostic (2.42e-1)" "unprognostic (1.54e-2)" "unprognostic (6.80e-2)" "unprognostic (7.38e-2)" "unprognostic (5.95e-2)" "unprognostic (3.93e-1)" "unprognostic (3.14e-1)" "unprognostic (9.25e-3)" "unprognostic (6.35e-2)" "prognostic favorable (2.49e-6)" "unprognostic (2.26e-1)" "unprognostic (1.05e-1)" "unprognostic (2.71e-1)" "unprognostic (2.39e-1)" 15.9 12.0 14.8 13.0 16.3 10.8 15.1 11.9 18.8 16.6 11.7 18.0 17.9 16.5 13.3 9.9 16.2 12.1 11.0 16.9 18.4 18.2 14.7 15.8 14.5 18.6 14.4 14.0 10.2 17.9 9.7 19.9 15.1 16.6 19.7 8.9 13.0 21.2 6.4 11.0 20.0 18.0 13.6 13.4 13.5 7.2 17.0 16.1 32.8 13.1 15.0 18.1 13.8 14.5 20.3 24.1 36.7 24.6 26.8 29.3 12.0 29.8 46.2 36.9 33.4 14.5 30.0 32.6 23.3 51.1 29.5 30.0 79.9 34.3 37.0 40.5 19.8 18.4 16.2 15.7 40.2 28.2 27.1 38.4 35.2 29.6 45.9 37.7 31.4 21.3 12.4 11.5 42.1 13.5 20.0 26.3 33.6 18.2 12.1 38.9 18.2 9.1 46.6 32.5 14.4 29.9 42.4 23.3 46.3 34.9 12.1 47.8 36.5 35.2 11.3 23.3 32.2 16.9 18.9 30.0 20.5 41.9 35.3 3.2 2.2 2.3 3.4 3.0 2.8 1.7 2.4 3.0 3.0 1.3 1.0 1.8 0.3 3.9 2.9 2.0 1.6 1.7 14.8 16.3 11.9 18.8 16.9 18.4 18.6 14.4 15.1 13.6 17.0 14.5 12.7 6.4 13.4 63.0 9.2 3.3 8.2 6.6 5.7 12.1 8.0 7.1 3.7 10.0 8.1 11.0 8.4 20.0 7.3 25.0 15.6 10.8 3.0 7.9 19.4 10.0 7.2 13.7 66.1 9.9 4.2 20.6 10.7 11.4 15.2 23.6 17.5 12.6 18.8 3.3 63.2 11.5 6.1 18.9 18.1 4.7 12.5 16.5 7.2 46.9 24.2 5.6 19.6 48.7 19.6 18.2 12.6 27.4 9.7 12.1 24.9 14.0 8.1 17.1 13.1 11.7 20.8 10.6 9.4 6.6 3.3 10.1 13.4 11.6 13.2 13.1 SNUPN "RNUT1, SNURPORTIN-1, Snurportin1" ENSG00000169371 "Snurportin 1" O95149 15 75598083-75626469 "Predicted intracellular proteins" Transport RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 137.1;Spermatocytes: 93.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005004 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 80: Striated muscle - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "CAB005004: AB_425829" "unprognostic (2.37e-2)" "unprognostic (1.54e-1)" "unprognostic (2.36e-2)" "unprognostic (8.73e-2)" "unprognostic (2.25e-1)" "unprognostic (1.18e-1)" "unprognostic (4.76e-2)" "unprognostic (6.74e-2)" "unprognostic (1.35e-1)" "unprognostic (2.14e-1)" "unprognostic (1.99e-3)" "unprognostic (9.07e-2)" "unprognostic (9.97e-2)" "unprognostic (1.66e-1)" "unprognostic (1.46e-1)" "unprognostic (3.12e-1)" "unprognostic (2.14e-2)" 18.2 16.0 21.0 15.5 21.6 13.8 23.5 20.5 26.3 20.4 21.9 18.1 14.9 18.9 20.3 14.3 23.7 13.5 16.4 22.1 20.9 20.1 22.1 14.9 20.1 19.5 20.1 26.3 12.7 21.0 12.1 15.2 20.1 16.5 17.4 13.2 19.8 17.6 34.7 16.7 15.4 24.5 18.7 17.2 15.8 34.3 20.5 22.1 20.9 30.5 21.1 18.0 15.5 21.2 26.1 34.1 30.4 21.6 42.1 46.8 23.2 26.1 38.5 44.2 47.8 25.4 62.6 47.4 35.7 34.0 36.6 29.9 60.3 38.3 34.5 27.3 56.1 56.4 29.3 16.4 40.6 39.4 37.3 44.6 37.3 32.8 41.0 40.1 42.4 36.8 36.8 30.9 45.4 9.0 38.5 38.7 40.6 42.7 19.5 48.7 23.7 46.7 39.7 13.6 28.5 19.9 11.4 38.7 68.9 37.5 33.0 73.8 27.9 35.3 32.8 19.4 23.3 21.9 43.7 69.8 38.7 59.6 47.0 10.3 39.5 12.2 47.4 37.7 57.3 34.7 48.9 45.8 47.7 41.1 63.2 53.0 6.7 36.9 40.1 47.0 42.1 41.0 21.0 21.6 20.5 26.3 22.1 20.9 19.5 20.1 20.1 18.7 20.5 21.2 19.1 12.8 14.5 7.8 13.1 13.3 10.4 30.5 18.2 19.0 18.7 21.5 11.7 14.3 16.8 9.2 12.5 28.7 19.2 10.3 54.8 23.1 137.1 14.9 23.6 14.4 16.2 14.1 9.0 19.3 38.5 25.2 10.7 12.8 12.7 20.4 17.2 18.5 24.7 13.5 8.2 12.4 14.2 17.7 17.3 60.3 31.4 19.1 19.6 7.5 24.2 18.3 25.7 3.0 7.6 14.7 10.5 29.3 9.9 11.5 17.6 34.1 15.1 20.4 19.7 16.6 14.5 93.2 14.6 15.0 10.9 11.9 16.2 27.3 18.1 5.7 IMP3 "BRMS2, C15orf12, FLJ10968, MRPS4" ENSG00000177971 "IMP U3 small nucleolar ribonucleoprotein 3" Q9NV31 15 75639085-75648706 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis, rRNA processing" "Ribonucleoprotein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060955, HPA061177" Enhanced Nucleoplasm,Nucleoli No No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 18: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 28: Keratinocytes - Keratinization" "Nucleoplasm, Nucleoli" "HPA060955: AB_2684397, HPA061177: AB_2684445" "unprognostic (6.01e-2)" "unprognostic (5.40e-3)" "unprognostic (7.04e-2)" "unprognostic (7.64e-3)" "unprognostic (1.61e-1)" "unprognostic (1.22e-1)" "unprognostic (8.44e-2)" "unprognostic (4.51e-2)" "unprognostic (2.69e-3)" "unprognostic (1.18e-1)" "unprognostic (1.59e-1)" "unprognostic (1.14e-1)" "unprognostic (1.25e-1)" "unprognostic (8.26e-2)" "unprognostic (1.19e-1)" "unprognostic (1.23e-1)" "unprognostic (3.22e-2)" 45.8 61.8 37.1 26.4 38.7 29.3 43.9 39.3 49.1 36.9 46.6 43.4 36.6 30.1 30.4 79.8 32.7 14.2 53.1 38.3 41.6 49.6 90.4 33.9 34.9 38.7 36.7 33.3 50.6 23.2 40.1 21.1 39.5 39.7 24.4 17.8 44.8 22.2 71.5 71.6 51.6 14.0 40.0 63.0 50.9 16.8 38.7 34.7 36.1 33.1 38.4 35.1 47.4 41.2 75.1 82.9 39.5 68.8 68.6 39.0 58.5 61.6 48.8 49.3 56.6 64.1 64.3 88.7 65.5 32.2 54.5 121.7 131.1 100.0 43.4 67.2 157.3 93.6 64.9 112.8 50.6 95.9 62.5 36.1 81.0 39.8 48.8 36.6 32.8 71.3 122.8 70.4 45.4 89.9 76.3 232.9 106.4 75.7 86.4 82.1 48.4 98.3 68.1 100.2 67.1 69.4 52.2 89.8 119.4 56.8 78.5 87.9 37.6 64.0 51.9 46.4 84.6 95.4 188.5 100.3 70.7 153.2 43.0 80.6 109.0 85.2 137.4 87.3 148.8 143.2 131.5 133.8 117.4 127.3 150.7 144.3 13.7 126.4 87.4 119.3 140.9 192.2 37.1 38.7 39.3 49.1 38.3 41.6 38.7 36.7 39.5 40.0 38.7 41.2 85.9 38.5 41.6 6.5 81.4 228.5 93.1 177.0 149.7 22.4 72.1 79.4 12.1 77.2 89.7 40.5 14.6 106.8 79.0 47.5 144.8 105.2 1.6 71.7 54.9 74.0 43.9 56.8 6.8 105.9 106.5 63.0 78.0 70.9 48.7 50.8 76.4 114.1 94.2 21.9 7.1 71.2 93.6 54.3 106.6 6.6 60.9 51.0 97.8 8.4 118.0 58.2 152.4 6.0 10.2 113.7 56.0 44.0 66.5 107.0 113.8 209.5 65.2 23.7 26.3 46.1 50.7 13.9 38.2 144.4 237.4 54.9 83.3 77.2 98.8 86.9 SNX33 "MGC32065, SH3PX3, SH3PXD3C, SNX30" ENSG00000173548 "Sorting nexin 33" Q8WV41 15 75647912-75662301 "Predicted intracellular proteins" "Cell cycle, Cell division, Endocytosis, Mitosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040988 Approved NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 50: Fibroblasts - ECM organization" "HPA040988: AB_10794983" "unprognostic (1.83e-2)" "unprognostic (2.75e-2)" "unprognostic (1.09e-2)" "unprognostic (1.94e-3)" "unprognostic (1.73e-1)" "unprognostic (3.18e-1)" "unprognostic (2.51e-2)" "unprognostic (9.93e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (5.24e-4)" "unprognostic (5.00e-3)" "unprognostic (3.00e-2)" "unprognostic (5.23e-3)" "unprognostic (5.99e-2)" "unprognostic (1.15e-2)" "unprognostic (1.14e-1)" "unprognostic (8.54e-2)" 26.2 17.2 11.1 7.1 11.1 0.5 21.3 9.5 9.8 29.3 11.8 19.7 12.1 23.6 8.4 42.5 21.9 14.3 19.6 10.2 9.9 12.5 29.0 19.3 8.2 14.2 10.8 25.6 27.2 11.1 7.0 11.9 10.3 23.5 10.0 1.6 20.6 16.6 5.9 29.6 15.5 14.6 10.1 11.8 18.8 3.5 13.0 7.6 16.7 9.2 10.6 20.2 30.2 9.1 14.9 13.1 12.6 13.5 48.7 31.5 13.9 14.3 29.8 15.6 14.2 8.3 15.3 0.4 10.3 31.7 22.3 35.1 15.7 37.4 8.3 16.4 5.3 4.6 15.5 15.2 32.3 0.4 4.7 32.6 44.5 15.2 21.2 37.4 10.0 1.4 11.0 2.0 18.4 2.9 0.1 9.4 12.1 9.3 7.3 2.3 9.9 0.7 15.9 22.1 1.1 8.6 21.1 22.7 17.4 23.4 13.6 10.5 14.6 22.1 10.4 16.6 7.7 0.3 0.4 0.1 22.3 5.4 6.0 0.0 0.5 0.0 0.2 0.1 0.2 0.0 0.3 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 11.1 11.1 9.5 9.8 10.2 9.9 14.2 10.8 10.3 10.1 13.0 9.1 8.3 6.4 5.6 2.9 0.2 12.1 3.4 9.3 6.2 0.0 6.8 5.7 3.8 2.8 8.2 7.3 2.1 3.1 1.2 13.5 0.0 7.5 0.3 4.8 7.5 5.7 9.1 0.4 0.5 6.5 4.1 13.3 14.3 4.8 1.3 6.8 10.0 12.6 5.1 0.0 0.1 8.1 8.2 2.8 7.8 0.6 13.1 2.9 3.6 2.8 3.0 3.8 0.0 2.5 0.2 15.9 7.6 15.1 1.1 7.5 12.4 3.7 9.5 0.2 19.7 8.5 9.5 0.1 0.6 5.5 11.2 1.4 1.8 2.5 7.3 11.3 CSPG4 "CSPG4A, HMW-MAA, MCSP, MCSPG, MEL-CSPG, MSK16, NG2" ENSG00000173546 "Chondroitin sulfate proteoglycan 4" Q6UVK1 15 75674322-75712848 "Predicted membrane proteins" "Angiogenesis, Differentiation, Tissue remodeling" "Developmental protein, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 55.4" "Group enriched" "Detected in some" 5 "Oligodendrocyte precursor cells: 57.3;Sertoli cells: 118.3;Smooth muscle cells: 47.1" "Cancer enhanced" "Detected in all" "melanoma: 74.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 64.7;SK-MEL-30: 146.1;U-138 MG: 92.1;WM-115: 138.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001933, HPA002951, CAB016189, HPA042785, HPA050008" Approved Enhanced "Nucleoplasm,Plasma membrane" NA NA 48000000 "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 48: Smooth muscle cells - ECM organization" "Plasma membrane" Nucleoplasm "CAB016189: AB_784821, HPA001933: , HPA002951: AB_1854449, HPA042785: AB_10964270, HPA050008: AB_2680991" "unprognostic (5.21e-2)" "unprognostic (2.17e-3)" "unprognostic (3.55e-2)" "unprognostic (1.01e-2)" "unprognostic (3.56e-2)" "unprognostic (3.58e-1)" "unprognostic (1.09e-2)" "unprognostic (2.11e-2)" "unprognostic (1.07e-1)" "unprognostic (5.00e-2)" "unprognostic (1.63e-1)" "unprognostic (3.14e-1)" "prognostic unfavorable (7.60e-6)" "unprognostic (1.23e-2)" "unprognostic (2.04e-2)" "unprognostic (3.21e-2)" "prognostic unfavorable (4.93e-5)" 29.6 1.8 9.0 7.3 7.1 0.0 18.5 6.6 9.3 16.0 1.8 55.4 2.8 34.5 1.4 8.3 15.0 5.6 14.6 7.5 8.2 4.9 0.9 19.4 0.4 11.7 7.8 8.9 2.1 1.2 2.2 15.5 9.7 14.4 2.2 0.1 4.7 11.2 39.6 7.8 15.3 22.7 6.7 5.6 19.1 1.3 7.7 0.6 5.6 10.0 0.3 30.3 12.6 9.8 11.9 0.1 1.0 7.1 1.6 9.8 0.1 64.7 28.6 44.4 28.8 0.1 45.0 0.0 1.5 45.4 6.2 0.6 0.1 0.3 13.6 0.6 0.2 0.0 19.2 0.0 10.0 0.0 0.1 4.8 0.1 13.5 1.5 16.5 0.0 0.0 0.1 0.1 7.6 0.1 0.0 0.2 1.2 0.0 0.3 0.1 4.0 0.1 0.0 0.0 0.1 0.2 1.7 0.1 146.1 1.2 0.9 1.2 0.1 92.1 17.9 3.6 0.8 0.0 0.2 0.0 20.3 0.5 138.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 9.0 7.1 6.6 9.3 7.5 8.2 11.7 7.8 9.7 6.7 7.7 9.8 4.9 0.0 0.0 1.0 0.0 2.8 0.7 4.7 0.0 1.4 0.1 0.8 11.4 0.0 0.8 1.8 0.0 0.2 0.5 0.1 0.0 0.0 0.6 0.7 0.7 2.7 0.0 0.0 0.4 0.0 0.6 5.9 1.5 0.4 0.0 1.8 1.1 0.2 1.1 0.0 0.2 0.0 0.0 0.0 3.2 0.0 0.3 0.3 12.4 3.7 0.0 0.0 0.0 57.3 0.1 0.0 0.0 0.4 0.0 4.3 0.0 0.1 1.0 0.2 118.3 3.1 47.1 0.0 1.3 0.1 1.8 0.3 0.3 0.1 0.0 0.4 ODF3L1 MGC48986 ENSG00000182950 "Outer dense fiber of sperm tails 3 like 1" Q8IXM7 15 75724041-75727688 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "testis: 22.6" "Cell type enriched" "Detected in some" 9 "Early spermatids: 111.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 1.0;HeLa: 1.2;U-87 MG: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 20: HeLa - Mitochondria" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (6.24e-2)" "unprognostic (1.97e-2)" "unprognostic (4.58e-2)" "unprognostic (8.42e-2)" "unprognostic (2.08e-2)" "unprognostic (1.41e-1)" "unprognostic (2.77e-1)" "unprognostic (1.56e-1)" "unprognostic (1.99e-1)" "unprognostic (2.74e-1)" "unprognostic (7.55e-4)" "unprognostic (9.65e-2)" "unprognostic (9.96e-3)" "unprognostic (6.40e-2)" "unprognostic (4.14e-2)" "unprognostic (8.94e-3)" "unprognostic (1.45e-2)" 1.4 0.1 0.3 0.3 0.2 0.3 1.1 1.3 0.4 0.6 0.4 1.4 0.5 1.2 0.1 1.2 1.0 2.6 1.1 0.4 0.1 0.2 1.1 1.6 0.1 0.1 0.5 0.2 0.4 0.1 1.1 0.2 0.1 0.4 0.4 0.0 0.1 0.1 0.1 1.7 0.8 0.9 0.0 0.3 1.7 22.6 0.2 0.6 1.4 0.0 0.1 0.9 0.2 0.1 0.0 1.0 0.3 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.2 0.9 0.0 0.0 0.1 0.0 0.9 0.0 0.6 0.0 0.7 0.4 0.0 1.2 0.2 0.2 0.0 0.0 0.6 0.0 0.2 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.4 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 1.3 0.4 0.4 0.1 0.1 0.5 0.1 0.0 0.2 0.1 0.1 0.0 1.1 0.0 0.4 6.1 9.7 0.9 0.0 0.0 0.6 0.3 0.0 0.0 2.5 0.0 0.0 1.6 0.1 0.7 0.0 0.3 111.2 2.7 0.5 0.3 0.0 0.0 0.1 0.0 0.9 2.1 1.5 1.8 0.0 0.2 1.1 0.3 0.4 0.0 0.0 1.2 0.0 0.0 2.7 11.9 0.0 1.3 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.7 0.8 0.9 1.6 0.7 0.3 0.0 6.6 2.7 1.0 8.0 0.4 0.0 6.5 1.9 0.4 0.1 0.5 4.1 UBE2Q2 DKFZp762C143 ENSG00000140367 "Ubiquitin conjugating enzyme E2 Q2" Q8WVN8 15 75843307-75901078 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 160.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 9: Photoreceptor cells - Phototransduction" "unprognostic (1.28e-1)" "unprognostic (1.66e-2)" "unprognostic (2.45e-2)" "unprognostic (4.28e-2)" "unprognostic (8.82e-2)" "unprognostic (1.13e-1)" "unprognostic (1.07e-3)" "unprognostic (1.32e-1)" "unprognostic (6.38e-2)" "prognostic favorable (5.73e-4)" "unprognostic (1.67e-1)" "unprognostic (1.87e-1)" "unprognostic (1.47e-3)" "unprognostic (1.01e-3)" "unprognostic (1.92e-1)" "unprognostic (1.69e-2)" "unprognostic (5.92e-2)" 24.3 26.7 18.3 16.7 19.3 40.2 24.4 20.0 28.9 25.5 15.0 37.2 9.3 24.9 18.8 22.5 17.4 22.3 29.5 18.3 21.9 22.5 7.2 19.2 18.6 21.8 22.7 22.8 19.4 17.4 16.1 29.0 22.4 30.4 19.8 39.0 25.4 20.9 23.0 16.5 15.7 30.5 22.9 21.7 19.5 21.1 19.9 21.0 31.8 16.9 17.7 27.1 17.0 24.4 23.0 35.5 30.0 22.6 42.8 56.7 47.2 50.4 57.2 32.8 37.1 18.7 30.7 22.7 36.2 73.5 27.8 18.1 58.5 33.5 39.9 24.1 23.7 28.5 20.1 24.5 48.1 28.9 15.7 40.7 37.4 23.1 33.4 46.3 46.2 40.5 11.3 33.2 70.1 18.0 24.7 27.6 22.4 3.5 25.3 29.5 47.2 9.4 51.8 36.8 27.4 21.6 42.4 39.6 55.6 42.3 25.6 40.3 60.7 40.2 36.1 27.3 17.8 36.3 68.1 17.6 15.9 44.9 25.2 31.3 6.3 21.3 9.0 7.3 11.2 8.1 11.8 9.7 5.7 7.8 9.4 7.9 0.9 14.6 10.0 2.1 8.4 6.4 18.3 19.3 20.0 28.9 18.3 21.9 21.8 22.7 22.4 22.9 19.9 24.4 54.3 3.2 6.5 17.6 29.0 50.3 27.7 12.9 33.6 30.3 39.3 26.0 32.1 18.6 17.4 23.9 135.5 55.0 42.6 9.4 23.5 23.8 95.7 18.3 47.4 40.7 18.6 19.1 15.2 16.9 126.2 38.2 12.2 28.9 20.3 27.8 36.4 4.7 23.0 6.7 22.6 30.0 26.4 25.9 51.8 36.7 24.2 34.0 37.4 17.8 30.6 20.2 68.0 30.7 29.5 22.5 10.7 29.0 43.3 58.4 1.3 39.6 9.3 160.8 26.3 28.9 42.9 64.8 64.4 34.4 46.5 110.0 36.1 28.3 17.7 38.7 FBXO22 "FBX22, FISTC1" ENSG00000167196 "F-box protein 22" Q8NEZ5 15 75903876-75942511 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 183.5;Rod photoreceptor cells: 182.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 28: BEWO - Transcription regulation" "Cluster 9: Photoreceptor cells - Phototransduction" "unprognostic (1.48e-1)" "unprognostic (3.76e-1)" "unprognostic (1.00e-1)" "unprognostic (4.19e-2)" "unprognostic (3.40e-1)" "unprognostic (1.50e-2)" "unprognostic (4.12e-2)" "unprognostic (1.15e-1)" "unprognostic (1.14e-1)" "unprognostic (1.73e-2)" "unprognostic (4.03e-3)" "unprognostic (9.27e-2)" "unprognostic (3.06e-2)" "unprognostic (1.29e-1)" "unprognostic (8.51e-2)" "unprognostic (9.88e-2)" "unprognostic (3.24e-2)" 6.5 10.8 5.6 6.7 5.1 5.7 5.9 8.7 8.4 6.7 7.7 8.8 9.0 6.2 4.0 10.2 6.0 5.3 7.8 5.2 6.9 8.5 16.9 6.4 7.0 5.6 5.6 7.2 10.3 7.6 8.8 7.0 5.9 7.6 5.9 21.9 8.0 4.1 12.0 8.3 8.4 5.9 5.2 5.5 7.5 11.2 6.7 5.8 7.0 6.9 6.0 8.2 7.3 7.2 30.7 53.6 23.2 33.8 19.6 18.8 83.5 26.5 18.5 19.1 20.9 41.5 35.5 24.8 34.6 15.5 44.9 45.7 45.2 49.4 17.8 21.1 24.6 20.2 45.6 74.0 31.1 31.3 35.8 22.2 36.5 20.8 26.7 16.2 30.5 30.5 37.0 17.3 21.3 35.8 8.9 22.0 24.8 27.8 13.6 33.3 20.8 24.6 11.0 39.9 22.1 21.6 36.3 26.2 62.6 47.9 41.1 28.4 31.7 78.9 50.9 26.2 39.6 21.7 42.2 32.1 31.2 39.4 49.7 23.2 19.3 14.9 13.8 19.8 14.5 13.8 14.2 14.3 24.0 23.0 16.2 13.9 4.5 15.3 18.8 16.5 20.2 13.5 5.6 5.1 8.7 8.4 5.2 6.9 5.6 5.6 5.9 5.2 6.7 7.2 17.0 16.0 17.3 9.4 18.3 28.4 22.6 57.5 15.9 53.3 20.5 22.1 25.1 14.3 30.2 16.5 183.5 52.4 24.6 12.6 46.9 24.6 86.3 23.0 25.2 16.7 18.6 22.7 29.5 30.9 66.4 17.8 17.3 20.7 12.0 37.5 13.9 27.9 22.6 63.9 32.8 12.5 34.6 8.1 9.4 20.8 18.0 11.9 10.6 15.0 25.5 26.7 20.6 22.6 20.6 25.8 15.7 20.3 20.3 28.8 21.6 46.4 29.5 182.5 13.1 20.5 22.2 56.8 47.2 17.4 28.4 43.2 16.0 28.4 17.6 23.9 NRG4 HRG4 ENSG00000169752 "Neuregulin 4" Q8WWG1 15 75935969-76059795 "Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.8;retina: 4.3" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 14.6;Early spermatids: 16.1;Exocrine glandular cells: 23.3;Gastric mucus-secreting cells: 31.1;Rod photoreceptor cells: 22.9" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 5 "cerebellum: 3.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 6.8;HL-60: 2.1;U-937: 2.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA010957 Uncertain "Secreted to digestive system" NA NA "Cluster 77: Retina - Visual perception" "Cluster 20: HeLa - Mitochondria" "Cluster 9: Photoreceptor cells - Phototransduction" "HPA010957: AB_1079504" "unprognostic (1.25e-1)" "unprognostic (1.54e-2)" "unprognostic (3.94e-2)" "unprognostic (1.67e-2)" "unprognostic (5.66e-2)" "unprognostic (4.10e-2)" "unprognostic (1.12e-2)" "unprognostic (1.17e-2)" "unprognostic (2.81e-2)" "unprognostic (2.82e-5)" "unprognostic (1.91e-2)" "unprognostic (1.56e-2)" "unprognostic (6.90e-5)" "unprognostic (8.28e-2)" "unprognostic (7.45e-2)" "unprognostic (1.08e-2)" "unprognostic (2.06e-1)" 0.0 0.1 0.3 0.1 0.2 1.0 0.2 3.8 0.7 0.1 0.1 0.2 0.2 0.1 0.0 0.0 0.8 0.0 0.0 0.4 0.4 0.1 0.4 0.2 0.2 0.5 0.5 0.1 0.9 0.0 0.0 0.4 0.4 0.2 0.1 4.3 0.5 0.1 0.8 0.7 0.1 0.0 0.5 0.1 0.9 0.7 0.6 0.1 0.1 0.2 0.1 0.0 0.0 0.3 0.1 0.0 0.4 0.2 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.1 1.6 0.6 0.3 0.0 0.0 0.9 0.6 0.1 0.0 0.1 0.4 0.1 6.8 0.0 0.0 2.1 0.2 0.1 0.1 0.2 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.7 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.1 0.2 0.2 0.0 0.0 0.1 0.4 1.6 0.0 0.0 0.1 0.1 0.1 0.0 0.1 1.5 0.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 3.8 0.7 0.4 0.4 0.5 0.5 0.4 0.5 0.6 0.3 0.7 0.0 0.0 3.9 0.9 7.5 1.2 3.9 0.6 3.7 0.5 0.0 0.2 0.0 3.9 1.8 14.6 2.2 0.5 1.1 1.9 0.3 16.1 6.1 1.2 0.7 1.2 0.0 13.3 23.3 2.5 2.6 31.1 1.4 2.5 0.9 0.7 3.4 0.3 6.7 9.7 0.1 2.0 0.0 0.8 8.9 0.6 0.3 1.8 0.0 0.2 1.9 1.0 3.5 0.8 9.6 3.2 0.0 0.3 2.3 0.1 0.1 10.7 22.9 0.0 0.5 1.1 7.6 1.3 3.4 1.3 0.8 0.4 0.6 0.5 4.5 TMEM266 "C15orf27, FLJ38190" ENSG00000169758 "Transmembrane protein 266" Q2M3C6 15 76059958-76229121 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 8.4;skeletal muscle: 5.8;tongue: 2.2" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 10.4;Cytotrophoblasts: 16.0;Early spermatids: 7.0;Late spermatids: 19.7;Rod photoreceptor cells: 9.1;Sertoli cells: 6.6;Spermatogonia: 6.3" "Cancer enhanced" "Detected in some" "testis cancer: 2.3" "Region enriched" "Detected in many" 5 "cerebellum: 8.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "NTERA-2: 1.3" "Region enriched" "Detected in all" 6 "cerebellum: 58.7" "Region enriched" "Detected in many" 5 "cerebellum: 26.8" "HPA041921, HPA049425" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Cluster 54: Non-specific - Microtubule organization" "Cluster 5: NTERA-2 - Transcription" "Cluster 47: Cytotrophoblasts - Unknown function" "Plasma membrane, Cytosol" "HPA041921: AB_10796789, HPA049425: AB_2732552" "unprognostic (8.63e-3)" "unprognostic (6.11e-3)" "unprognostic (3.44e-3)" "unprognostic (9.17e-5)" "unprognostic (4.67e-1)" "unprognostic (2.61e-2)" "unprognostic (9.34e-3)" "unprognostic (5.61e-2)" "unprognostic (8.48e-3)" "unprognostic (2.89e-2)" "unprognostic (1.18e-2)" "unprognostic (3.95e-2)" "unprognostic (1.68e-3)" "unprognostic (1.25e-1)" "unprognostic (1.31e-1)" "unprognostic (1.13e-2)" "unprognostic (7.86e-2)" 0.0 0.9 0.9 0.0 1.0 0.0 0.1 8.4 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.9 0.5 0.0 0.5 0.1 0.6 0.8 0.0 1.1 0.0 1.2 0.9 0.7 0.1 0.0 1.1 0.0 0.0 5.8 0.5 0.0 0.0 0.5 0.1 0.0 0.6 1.4 0.3 0.0 2.2 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.6 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.0 8.4 1.7 1.2 0.9 0.6 0.8 0.7 0.5 1.4 0.8 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 4.3 0.5 0.5 0.0 0.0 0.0 1.8 10.4 16.0 0.0 0.0 1.9 0.0 7.0 0.2 0.1 0.4 0.0 0.0 0.0 0.2 2.2 0.9 1.5 0.1 0.0 0.2 0.4 0.4 4.5 1.7 0.0 0.0 0.0 0.3 0.0 19.7 0.0 0.4 0.0 0.0 0.0 0.5 1.0 0.0 0.0 0.1 0.0 0.7 0.0 1.0 0.0 0.7 1.5 9.1 6.6 1.3 0.2 0.5 6.3 0.0 0.0 5.9 0.2 0.5 0.0 0.7 ETFA "EMA, GA2, MADD" ENSG00000140374 "Electron transfer flavoprotein subunit alpha" P13804 15 76215353-76311472 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport" "Disease variant, Glutaricaciduria" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 389.7;tongue: 493.5" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 402.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018990, HPA018993, HPA018996, HPA024089" Enhanced Enhanced Mitochondria NA NA 680000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 8: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Mitochondria "HPA018990: AB_1848277, HPA018993: AB_1848275, HPA018996: AB_1848276, HPA024089: AB_1848278" "unprognostic (3.44e-3)" "unprognostic (1.50e-1)" "unprognostic (2.29e-1)" "unprognostic (2.26e-1)" "unprognostic (3.71e-3)" "unprognostic (5.99e-2)" "unprognostic (6.81e-3)" "unprognostic (3.02e-1)" "unprognostic (5.01e-2)" "unprognostic (6.01e-2)" "unprognostic (3.38e-3)" "unprognostic (1.99e-1)" "prognostic favorable (5.04e-8)" "unprognostic (2.87e-1)" "unprognostic (4.90e-2)" "unprognostic (9.22e-2)" "unprognostic (2.90e-2)" 93.0 112.3 33.8 55.0 36.0 63.0 70.4 36.0 54.6 38.7 40.3 131.4 135.6 27.0 30.6 85.1 30.1 44.7 243.0 34.2 37.6 180.0 389.7 39.0 60.9 35.6 35.7 25.6 81.6 71.0 13.9 70.9 36.0 42.2 123.5 34.3 49.3 38.2 300.8 40.1 116.3 65.7 35.5 38.8 67.7 28.4 38.2 54.5 38.7 493.5 65.9 74.0 33.1 36.9 122.4 196.7 128.2 134.8 141.7 149.1 201.0 144.4 166.2 183.0 162.8 175.3 221.3 203.5 141.3 144.3 138.5 304.6 502.7 200.2 211.9 245.8 98.0 222.2 131.4 205.2 114.7 214.5 158.7 112.7 185.9 93.1 153.5 100.0 187.8 64.7 214.1 205.2 190.3 191.2 44.9 178.2 99.9 225.3 58.4 192.8 158.6 272.8 202.1 386.9 133.3 67.2 218.2 492.2 205.0 294.4 254.1 223.4 111.4 178.2 119.5 157.0 177.4 99.0 221.0 255.9 127.8 281.1 128.5 50.0 120.3 82.7 65.4 110.3 61.7 77.3 60.6 67.6 159.4 67.3 48.8 60.1 30.2 122.9 96.1 63.4 95.8 141.9 33.8 36.0 36.0 54.6 34.2 37.6 35.6 35.7 36.0 35.5 38.2 36.9 65.7 57.7 41.6 45.1 54.3 53.4 110.8 151.5 44.9 13.1 47.2 46.4 352.9 65.8 84.5 36.8 22.9 277.4 61.1 250.9 209.4 106.5 11.7 29.5 45.1 51.8 65.4 117.8 26.0 84.1 180.8 66.8 90.2 37.0 38.6 53.1 48.9 348.8 132.3 53.8 31.5 141.6 89.5 79.0 84.5 7.9 59.4 103.0 56.9 28.1 129.0 26.7 85.5 37.2 46.9 92.1 176.2 58.3 87.8 92.4 231.1 402.9 50.2 20.4 46.0 44.0 113.7 66.4 40.5 79.5 57.1 300.2 55.5 123.4 187.3 162.0 ISL2 FLJ10160 ENSG00000159556 "ISL LIM homeobox 2" Q96A47 15 76336773-76342475 "Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 2.6;prostate: 2.3;vagina: 3.5" "Cell type enriched" "Detected in some" 7 "Cone photoreceptor cells: 27.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "neutrophil: 9.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 15.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 10 "spinal cord: 1.8" HPA075192 Approved "Rods & Rings" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 37: Intestine - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 9: Photoreceptor cells - Phototransduction" "Rods & Rings" "HPA075192: AB_2686738" "unprognostic (7.30e-2)" "unprognostic (7.96e-2)" "unprognostic (9.01e-3)" "unprognostic (4.44e-3)" "unprognostic (1.44e-1)" "unprognostic (7.77e-2)" "unprognostic (1.25e-2)" "unprognostic (1.45e-1)" "unprognostic (1.67e-1)" "unprognostic (2.84e-1)" "unprognostic (9.03e-2)" "unprognostic (3.93e-2)" "unprognostic (3.55e-15)" "unprognostic (1.78e-1)" "unprognostic (4.19e-1)" "unprognostic (4.07e-1)" "unprognostic (2.26e-1)" 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.8 0.0 1.9 0.8 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.8 0.2 0.0 0.0 0.0 2.6 0.0 0.2 2.3 0.0 1.4 1.8 0.0 0.0 0.6 1.2 0.0 0.0 0.5 1.6 0.8 0.1 0.0 0.0 0.0 0.1 0.0 3.5 0.8 1.5 1.8 0.0 1.7 0.1 0.1 1.5 4.5 2.1 1.2 1.5 3.4 0.7 3.3 2.1 0.0 1.1 1.9 6.4 0.1 0.2 3.2 15.4 1.6 4.0 4.1 1.4 3.6 4.3 0.0 0.8 0.0 0.0 0.0 0.0 4.8 5.1 2.6 0.3 0.1 4.4 8.4 0.0 0.6 2.8 2.7 2.0 4.4 0.0 0.6 4.9 5.0 3.0 0.0 0.0 0.9 0.3 8.2 0.0 1.5 3.2 0.6 4.3 3.8 4.1 2.0 1.1 2.5 0.0 0.0 0.8 0.0 0.1 0.9 0.0 0.8 0.0 0.5 0.1 1.7 0.1 0.0 9.5 0.0 3.5 0.0 0.0 0.5 0.0 0.1 0.1 0.1 0.1 0.1 0.8 0.2 0.2 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.6 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 27.1 0.1 0.2 0.2 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.2 0.7 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.0 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.6 0.0 0.0 0.0 3.5 0.6 0.0 0.0 0.0 2.1 0.0 0.2 0.5 1.5 1.0 0.0 0.0 0.3 0.2 0.0 0.0 3.0 SCAPER "Zfp291, ZNF291" ENSG00000140386 "S-phase cyclin A associated protein in the ER" Q9BY12 15 76347904-76905444 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Mental retardation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 55.4" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 252.3;Oligodendrocytes: 251.5;Rod photoreceptor cells: 710.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046253, HPA048077" Approved Supported "Nucleoplasm,Nuclear speckles,Cytosol" NA No "Cluster 11: Basophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 16: U-266 - Nucleosome" "Cluster 46: Photoreceptor cells - Phototransduction" "Nucleoplasm, Nuclear speckles" Cytosol "HPA046253: AB_2679600, HPA048077: " "unprognostic (3.67e-1)" "unprognostic (8.60e-2)" "unprognostic (6.08e-2)" "unprognostic (8.37e-2)" "unprognostic (1.48e-1)" "unprognostic (1.63e-1)" "unprognostic (1.37e-1)" "unprognostic (2.76e-2)" "unprognostic (4.94e-2)" "unprognostic (3.74e-2)" "unprognostic (5.40e-2)" "unprognostic (1.02e-1)" "prognostic favorable (2.69e-9)" "unprognostic (2.14e-1)" "unprognostic (3.79e-1)" "unprognostic (1.86e-1)" "unprognostic (2.89e-3)" 5.5 7.9 9.7 4.0 12.2 7.4 6.9 18.2 10.4 6.2 6.5 6.0 6.5 7.4 7.7 8.9 6.4 5.3 13.8 9.0 12.8 9.0 7.5 6.3 4.7 11.5 10.5 12.1 8.3 14.5 8.2 6.5 11.3 7.0 4.4 55.4 7.9 6.2 13.6 6.9 6.3 6.3 9.2 5.9 6.1 21.0 10.7 8.6 12.2 12.0 6.0 5.0 6.5 16.3 6.3 5.8 7.8 4.5 3.9 7.0 6.5 8.3 5.9 3.8 5.4 6.1 5.0 6.3 7.2 2.8 10.0 6.7 18.5 3.5 5.7 14.7 9.1 3.3 6.8 3.0 4.9 9.0 7.6 5.9 6.0 4.5 7.3 8.2 5.2 12.6 4.8 17.5 6.6 2.6 8.8 2.7 2.3 5.5 3.3 7.9 12.4 2.2 3.5 6.3 18.4 8.9 11.2 3.9 9.0 9.4 5.8 7.3 6.3 8.7 8.1 4.1 7.4 10.5 23.7 8.9 5.1 11.1 5.9 40.8 6.3 17.4 11.4 3.5 13.1 16.3 11.5 10.3 3.6 17.0 18.8 12.1 10.7 17.1 4.2 9.3 9.7 4.2 9.7 12.2 18.2 10.4 9.0 12.8 11.5 10.5 11.3 9.2 10.7 16.3 28.5 99.3 61.5 190.7 33.2 20.6 28.9 10.6 18.8 91.5 13.9 15.5 191.3 12.8 27.4 12.9 252.3 33.8 26.6 17.1 1.9 14.6 59.1 10.6 13.8 23.5 16.2 1.7 151.5 6.0 11.8 22.1 17.3 18.4 22.1 41.9 21.8 9.3 14.3 77.4 201.8 9.0 6.1 13.6 11.3 24.9 20.5 14.4 10.6 135.9 12.8 51.3 34.0 203.1 251.5 6.5 11.4 19.2 28.6 15.9 72.6 7.8 12.3 710.6 19.7 39.1 23.5 143.9 68.9 15.1 18.8 52.0 30.5 26.7 13.4 19.7 RCN2 "E6BP, ERC-55, ERC55, TCBP49" ENSG00000117906 "Reticulocalbin 2" Q14257 15 76931738-76954393 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 321.5" "Cell type enhanced" "Detected in all" "Spermatocytes: 528.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030694, HPA030695" Enhanced Supported Enhanced "Endoplasmic reticulum" "Intracellular and membrane" NA NA 92000 "Cluster 26: Non-specific - Mitochondria" "Cluster 68: Epididymis - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Endoplasmic reticulum" "HPA030694: AB_2673573, HPA030695: AB_2673574" "unprognostic (1.69e-2)" "unprognostic (1.79e-1)" "unprognostic (1.92e-2)" "unprognostic (3.45e-2)" "unprognostic (2.42e-1)" "unprognostic (8.71e-2)" "prognostic unfavorable (7.36e-5)" "unprognostic (1.74e-1)" "unprognostic (2.20e-2)" "unprognostic (4.61e-3)" "unprognostic (1.39e-1)" "unprognostic (1.98e-1)" "unprognostic (1.70e-2)" "unprognostic (2.11e-2)" "unprognostic (2.99e-1)" "unprognostic (1.15e-1)" "unprognostic (3.67e-2)" 31.3 30.8 42.5 24.9 43.9 24.6 35.8 35.8 57.8 34.1 41.4 33.1 22.2 44.0 321.5 28.5 54.3 32.6 38.8 44.0 55.0 49.3 19.8 28.8 30.0 38.0 45.1 34.2 21.5 80.6 30.8 49.2 46.9 41.2 36.5 43.9 22.7 41.1 56.9 22.6 23.3 39.6 40.0 25.4 26.9 93.4 51.4 40.3 48.0 60.4 32.4 39.0 25.2 40.8 93.9 65.3 284.1 134.9 120.1 135.6 177.3 109.1 147.5 138.7 115.1 81.2 78.2 58.3 154.3 119.3 149.5 139.9 217.4 94.0 176.0 45.3 170.8 28.9 91.4 135.0 143.0 105.4 42.9 123.6 126.8 68.2 87.5 146.1 148.9 98.3 74.2 56.3 146.6 60.3 104.9 71.9 216.6 98.0 72.1 109.4 187.0 37.3 91.6 123.8 161.8 161.1 178.8 98.6 220.5 251.1 96.0 115.0 80.5 162.8 131.2 104.8 228.0 80.4 266.6 69.6 92.8 87.6 151.1 7.5 7.6 16.2 21.7 7.4 24.9 23.4 23.0 28.1 16.1 22.9 25.5 25.1 3.9 23.5 12.3 19.1 18.1 20.0 42.5 43.9 35.8 57.8 44.0 55.0 38.0 45.1 46.9 40.0 51.4 40.8 87.3 25.6 36.8 56.8 111.2 82.1 125.0 85.5 96.2 87.1 75.9 74.8 94.9 62.9 52.5 99.3 37.5 183.1 76.3 23.3 49.0 116.0 44.8 87.0 101.6 64.8 73.5 91.5 48.4 45.1 296.8 106.0 54.6 85.6 28.6 120.9 60.0 32.8 57.3 127.9 72.0 55.0 101.7 30.5 38.3 81.7 61.8 30.0 92.5 19.7 34.1 99.7 89.6 149.8 63.3 56.9 43.2 93.6 85.6 127.5 25.8 56.2 48.7 58.9 59.2 78.9 126.3 528.6 140.8 109.3 70.8 163.6 76.7 131.8 84.4 117.0 PSTPIP1 "CD2BP1, CD2BP1L, CD2BP1S, H-PIP, PAPAS, PSTPIP" ENSG00000140368 "Proline-serine-threonine phosphatase interacting protein 1" O43586 15 76993359-77037475 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell adhesion, Endocytosis, Immunity, Inflammatory response, Innate immunity" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 56.6;lymphoid tissue: 33.9" "Cell type enhanced" "Detected in many" "dendritic cells: 60.0;Enteroendocrine cells: 60.0;Hofbauer cells: 42.5;Kupffer cells: 41.8;Macrophages: 41.8;monocytes: 51.1;NK-cells: 91.6;T-cells: 68.4;Theca cells: 78.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 55.1;HL-60: 14.4;NB-4: 20.9;THP-1: 14.7;U-937: 59.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA010116, HPA010600, HPA072744" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 32: U-937 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Plasma membrane, Cytosol" "HPA010116: , HPA010600: AB_1855870, HPA072744: " "unprognostic (4.42e-3)" "unprognostic (1.31e-3)" "unprognostic (3.56e-2)" "prognostic favorable (4.74e-5)" "unprognostic (3.79e-2)" "unprognostic (1.12e-3)" "unprognostic (2.16e-2)" "unprognostic (1.23e-2)" "unprognostic (1.16e-1)" "unprognostic (9.85e-2)" "unprognostic (2.96e-2)" "unprognostic (3.18e-1)" "prognostic unfavorable (7.36e-9)" "unprognostic (1.39e-1)" "unprognostic (1.84e-1)" "unprognostic (1.91e-1)" "unprognostic (5.42e-2)" 6.0 2.6 2.8 11.7 2.7 56.6 2.3 2.7 3.1 2.0 3.4 3.3 2.5 1.6 0.1 2.0 3.1 2.9 2.4 2.7 2.8 3.4 3.4 10.4 13.5 3.1 3.1 1.0 1.3 0.2 1.6 1.8 3.0 2.9 0.8 0.1 2.4 1.0 1.5 1.8 9.4 1.4 3.1 33.9 2.9 0.7 3.6 4.2 2.9 1.0 5.5 4.3 2.7 3.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.0 55.1 0.0 0.0 0.0 3.3 0.0 14.4 0.1 0.2 0.1 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 2.4 20.9 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.1 4.0 0.6 0.0 0.1 0.0 0.0 0.0 14.7 0.0 0.0 0.1 0.1 0.0 0.0 1.3 2.4 0.1 59.8 0.0 4.8 71.5 71.4 39.9 33.5 30.8 13.3 27.2 32.7 59.0 18.5 14.3 22.3 85.3 41.6 38.3 5.2 27.0 42.2 2.8 2.7 2.7 3.1 2.7 2.8 3.1 3.1 3.0 3.1 3.6 3.1 1.1 0.0 5.1 1.0 19.2 9.3 1.2 0.4 0.0 1.1 0.9 1.1 1.9 0.0 2.5 0.0 0.0 0.3 60.0 3.1 0.0 0.0 9.6 0.3 0.3 0.8 60.0 4.8 0.4 0.2 0.7 1.9 0.0 0.3 2.5 0.1 2.2 0.9 42.5 0.0 0.1 6.1 2.0 41.8 36.5 18.6 0.9 41.8 7.2 0.0 51.1 0.2 91.6 5.5 1.0 0.1 2.5 2.6 8.5 0.3 0.3 0.4 0.0 0.4 0.0 0.8 3.1 0.2 1.2 0.2 4.8 0.5 68.4 78.1 0.3 1.2 TSPAN3 "TM4-A, TM4SF8, TSPAN-3" ENSG00000140391 "Tetraspanin 3" O60637 15 77041404-77083984 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 705.9;Muller glia cells: 508.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "memory B-cell: 481.0;naive B-cell: 488.1;plasmacytoid DC: 313.2" "Group enriched" "Detected in all" 5 "B-cells: 488.1;dendritic cells: 313.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015996 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 37: B-cells - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Golgi apparatus" "HPA015996: AB_1858406" "unprognostic (5.94e-2)" "unprognostic (3.05e-1)" "unprognostic (7.32e-2)" "unprognostic (2.15e-2)" "unprognostic (4.16e-2)" "unprognostic (1.38e-1)" "unprognostic (1.92e-2)" "unprognostic (1.31e-1)" "unprognostic (1.09e-1)" "unprognostic (5.41e-3)" "unprognostic (3.51e-3)" "unprognostic (2.90e-2)" "unprognostic (2.11e-2)" "unprognostic (1.51e-1)" "unprognostic (1.75e-1)" "unprognostic (3.79e-3)" "unprognostic (1.35e-1)" 333.8 143.9 257.2 87.3 248.9 33.3 143.3 253.4 292.4 138.2 288.7 364.2 342.1 130.9 432.8 78.4 249.8 186.2 108.8 247.8 296.3 211.3 87.4 202.1 88.0 250.0 267.7 148.1 140.2 283.4 189.7 111.6 260.2 96.2 386.3 418.6 152.2 187.3 429.1 78.3 349.2 128.3 266.7 84.8 221.2 84.8 282.5 71.6 200.3 374.4 106.9 170.1 67.4 281.3 130.6 347.6 282.8 179.3 484.7 295.8 93.3 203.7 220.2 245.1 265.7 213.5 264.7 126.9 294.8 211.6 234.0 289.0 271.2 139.5 182.9 143.4 410.4 91.0 252.5 204.4 234.5 118.4 64.3 280.9 165.5 135.8 120.1 372.6 304.8 83.1 98.0 109.2 243.3 49.5 105.7 112.1 200.5 414.7 152.4 130.8 351.0 135.3 408.0 73.0 255.0 282.1 139.8 116.9 393.7 269.3 125.0 220.8 292.1 225.7 88.4 138.0 290.7 237.4 346.6 67.1 200.1 173.5 131.9 8.8 51.3 10.4 32.6 69.6 34.1 481.0 16.5 23.9 99.2 488.1 42.6 39.3 4.8 60.3 77.1 313.2 4.6 95.2 257.2 248.9 253.4 292.4 247.8 296.3 250.0 267.7 260.2 266.7 282.5 281.3 76.1 112.2 213.4 69.5 83.8 34.7 77.5 114.6 36.5 247.7 43.6 32.3 98.2 108.7 169.0 68.0 183.5 89.9 41.3 705.9 25.4 250.2 28.5 86.1 63.4 57.6 91.3 19.4 47.8 354.0 35.6 90.8 85.1 41.7 23.4 88.6 53.6 29.5 65.4 127.9 54.3 290.4 97.6 58.0 27.5 57.9 64.3 38.2 72.9 29.0 35.1 508.9 36.0 116.6 32.7 245.1 410.7 51.6 81.2 220.1 364.3 65.5 201.7 185.1 26.3 44.8 189.0 108.0 64.6 34.2 34.2 75.9 19.4 149.5 205.2 381.4 PEAK1 "KIAA2002, sgk269" ENSG00000173517 "Pseudopodium enriched atypical kinase 1" Q9H792 15 77100656-77420144 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 147.4;Excitatory neurons: 162.1;Oligodendrocyte precursor cells: 513.2;Oligodendrocytes: 338.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "NK-cell: 1.8" "Lineage enriched" "Detected in single" 4 "NK-cells: 1.8" "Cell line enhanced" "Detected in all" "TIME: 52.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026313, HPA026517" Approved NA NA "Cluster 15: NK-cells - Transcription" "Cluster 2: Immune cells - Immune response" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 68: Oligodendrocytes - Mixed function" "HPA026313: AB_1856801, HPA026517: AB_1856802" "unprognostic (1.15e-1)" "unprognostic (2.89e-1)" "unprognostic (1.05e-1)" "unprognostic (4.20e-1)" "unprognostic (6.26e-2)" "unprognostic (8.82e-2)" "unprognostic (6.63e-3)" "unprognostic (1.90e-1)" "unprognostic (2.42e-2)" "unprognostic (6.00e-3)" "unprognostic (1.06e-1)" "unprognostic (9.75e-2)" "unprognostic (2.25e-3)" "unprognostic (5.73e-2)" "unprognostic (2.09e-2)" "unprognostic (3.33e-1)" "unprognostic (5.65e-3)" 13.8 4.4 8.9 5.8 13.3 9.1 9.5 5.5 8.8 11.3 1.0 7.8 5.9 7.4 6.4 5.2 5.7 10.0 16.2 8.2 8.4 5.0 3.8 18.0 6.8 6.4 7.8 7.5 4.8 5.4 2.9 16.7 5.8 6.0 8.1 13.7 5.5 7.3 6.7 6.7 7.3 9.9 4.9 29.4 4.9 9.9 11.8 4.7 6.3 8.5 4.7 9.0 7.5 11.7 5.4 7.8 18.1 4.3 33.4 35.7 6.3 28.6 19.7 14.9 14.9 6.3 4.7 4.1 5.0 41.4 5.7 2.6 14.6 4.5 16.9 4.2 7.6 7.7 12.2 3.8 12.2 4.6 3.9 27.6 4.3 28.8 4.8 16.3 42.3 6.6 10.0 4.0 16.1 2.2 2.6 4.9 8.4 3.7 2.1 5.3 10.8 3.0 4.4 9.6 4.0 4.9 11.2 2.3 18.6 19.7 1.7 3.2 52.1 31.5 15.2 13.2 12.2 6.3 9.5 5.9 5.5 10.5 17.3 0.1 0.2 0.4 0.2 0.0 0.4 0.3 0.0 0.0 0.1 0.2 0.1 0.1 0.1 1.8 0.1 0.2 0.0 0.2 8.9 13.3 5.5 8.8 8.2 8.4 6.4 7.8 5.8 4.9 11.8 11.7 48.3 147.4 46.8 101.9 12.6 21.9 7.5 5.6 2.2 18.4 6.1 5.8 46.9 10.0 29.2 1.8 12.5 3.1 12.3 23.9 0.0 6.9 15.1 22.9 19.5 41.2 3.0 10.8 162.1 5.4 2.0 35.6 15.8 10.1 17.7 6.3 31.8 6.0 18.9 20.2 84.4 11.9 2.0 21.3 34.7 13.6 19.9 20.2 12.4 124.6 8.5 28.1 10.3 513.2 338.1 9.8 10.7 16.1 7.0 8.3 15.7 3.7 41.6 20.1 13.1 23.0 37.7 13.6 13.7 5.8 18.0 6.3 8.2 22.6 12.3 7.2 HMG20A "FLJ10739, HMGX1, HMGXB1" ENSG00000140382 "High mobility group 20A" Q9NP66 15 77420412-77485607 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 79.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008126 Supported Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 16: Immune cells - Immune response" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "HPA008126: AB_1079072" "unprognostic (2.04e-1)" "unprognostic (6.87e-2)" "unprognostic (2.88e-1)" "unprognostic (1.11e-1)" "unprognostic (2.56e-1)" "unprognostic (1.70e-1)" "unprognostic (1.38e-1)" "unprognostic (1.04e-1)" "unprognostic (1.64e-1)" "unprognostic (1.14e-1)" "unprognostic (4.61e-2)" "unprognostic (1.75e-1)" "unprognostic (9.74e-3)" "unprognostic (3.40e-1)" "unprognostic (1.58e-1)" "unprognostic (1.50e-1)" "unprognostic (2.65e-1)" 12.2 18.2 14.5 15.9 14.2 10.2 14.2 15.1 17.6 15.2 7.8 15.4 12.4 20.3 13.6 13.4 13.2 15.5 25.1 14.4 14.8 14.0 24.9 15.7 25.2 11.5 12.9 22.2 13.0 18.1 9.7 21.8 11.3 11.6 17.0 26.0 13.5 13.9 27.2 13.4 14.2 15.7 12.0 35.8 13.6 21.3 15.0 31.6 15.0 26.4 22.1 14.4 10.8 16.6 17.8 29.8 53.8 38.4 22.4 28.4 21.6 23.2 34.6 27.2 29.5 18.6 26.7 30.2 26.4 27.0 21.0 23.8 76.6 29.3 27.6 27.1 38.4 62.3 26.6 24.5 33.4 46.1 35.7 31.9 20.9 24.2 26.8 36.3 54.9 38.9 47.8 24.6 25.1 14.1 36.8 32.1 39.0 15.8 14.2 48.0 52.1 34.2 31.1 30.7 21.1 45.3 37.5 22.6 70.6 51.2 22.3 48.3 33.8 32.3 28.4 15.2 28.4 33.2 75.7 59.9 24.1 66.3 38.4 9.2 20.8 16.9 29.1 21.2 34.4 31.3 22.9 27.3 27.8 27.3 30.8 27.3 3.4 49.2 26.1 21.1 23.7 24.9 14.5 14.2 15.1 17.6 14.4 14.8 11.5 12.9 11.3 12.0 15.0 16.6 14.6 12.8 11.5 39.2 18.1 8.8 5.3 10.0 13.6 20.6 13.0 12.3 47.2 14.3 10.7 11.0 25.0 13.7 12.9 12.2 5.9 9.9 25.9 10.4 21.1 16.8 18.0 15.4 60.1 8.0 9.5 17.2 13.7 10.0 12.7 16.5 22.9 32.4 16.6 38.7 56.9 15.6 6.1 28.6 11.9 79.5 12.8 13.0 14.2 29.0 22.1 14.3 19.6 64.3 71.1 9.0 10.8 13.9 13.3 6.0 8.4 10.6 4.9 20.6 19.7 13.4 13.2 28.2 17.0 11.3 7.4 13.8 16.4 25.5 13.8 5.5 LINGO1 "FLJ14594, LERN1, LRRN6A" ENSG00000169783 "Leucine rich repeat and Ig domain containing 1" Q96FE5 15 77613027-77820900 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.1" "Group enriched" "Detected in many" 4 "Astrocytes: 271.0;Excitatory neurons: 271.6;Horizontal cells: 132.9;Inhibitory neurons: 220.5;Microglial cells: 167.7;Oligodendrocyte precursor cells: 240.8;Oligodendrocytes: 324.2" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 10 "amygdala: 37.4;basal ganglia: 43.9;cerebral cortex: 56.1;hippocampal formation: 49.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 23.9;AN3-CA: 20.1;HAP1: 30.2;HEK 293: 21.0;MCF7: 13.5;NTERA-2: 56.9;SuSa: 21.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074653 Enhanced Supported "Plasma membrane" NA NA 25000 "Cluster 10: Brain - Neuronal signaling" "Cluster 5: NTERA-2 - Transcription" "Cluster 64: Astrocytes - Nervous system maintenance" "Plasma membrane" "HPA074653: AB_2686706" "unprognostic (1.06e-1)" "unprognostic (7.07e-2)" "unprognostic (2.16e-2)" "unprognostic (1.48e-2)" "unprognostic (3.09e-1)" "unprognostic (2.20e-1)" "unprognostic (2.84e-2)" "unprognostic (3.77e-2)" "unprognostic (3.40e-1)" "unprognostic (1.10e-1)" "unprognostic (7.36e-2)" "unprognostic (2.74e-2)" "prognostic unfavorable (3.23e-7)" "unprognostic (2.07e-1)" "unprognostic (7.06e-2)" "unprognostic (2.85e-1)" "unprognostic (2.59e-2)" 3.9 1.1 37.4 1.2 43.9 0.0 3.5 0.0 56.1 4.6 0.0 2.2 1.5 4.5 2.2 0.9 2.7 2.1 11.8 49.1 0.0 4.2 0.8 1.0 0.7 0.0 0.0 2.3 2.5 4.1 1.9 6.7 0.0 1.6 0.8 16.2 3.2 2.0 0.8 2.8 1.7 4.6 0.0 3.3 1.4 5.3 0.2 0.3 2.2 1.4 0.3 2.3 2.9 4.6 0.0 2.1 23.9 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 1.4 0.0 0.4 0.1 30.2 0.0 0.0 0.0 21.0 0.0 0.0 0.4 0.3 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.0 13.5 0.0 0.0 56.9 1.3 0.0 0.0 0.0 0.5 0.0 0.0 4.2 1.2 0.1 2.4 4.9 21.6 0.3 0.4 2.1 0.0 5.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.4 43.9 0.0 56.1 49.1 0.0 0.0 0.0 0.0 0.0 0.2 4.6 2.1 0.0 0.0 271.0 0.0 0.3 0.1 0.0 0.0 21.8 0.7 0.3 7.3 1.5 0.0 0.0 2.1 0.1 0.0 1.8 0.0 0.3 8.6 0.8 3.7 2.3 0.0 0.0 271.6 0.2 0.2 1.8 0.0 0.2 0.0 14.9 4.2 0.0 0.3 132.9 220.5 0.3 0.0 0.0 0.0 16.5 0.3 0.1 3.6 167.7 0.0 51.1 0.0 240.8 324.2 0.2 7.7 0.4 0.0 0.0 0.0 0.0 0.0 19.5 26.3 0.0 21.9 0.2 3.1 0.0 0.1 0.3 0.1 0.5 0.2 0.0 TBC1D2B KIAA1055 ENSG00000167202 "TBC1 domain family member 2B" Q9UPU7 15 77984036-78077724 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 90.7;Theca cells: 79.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041833, HPA048174, HPA052663" Approved Enhanced Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 52: Non-specific - Transcription" Cytosol "HPA041833: AB_2732494, HPA048174: AB_2680297, HPA052663: AB_2681906" "unprognostic (3.13e-1)" "unprognostic (2.16e-1)" "unprognostic (8.25e-2)" "unprognostic (1.28e-2)" "unprognostic (3.94e-2)" "unprognostic (1.43e-1)" "unprognostic (5.07e-3)" "unprognostic (2.41e-1)" "unprognostic (1.08e-1)" "unprognostic (8.22e-3)" "unprognostic (2.21e-1)" "unprognostic (1.25e-1)" "unprognostic (1.23e-3)" "unprognostic (6.68e-2)" "unprognostic (3.07e-2)" "unprognostic (3.37e-1)" "unprognostic (3.19e-2)" 23.1 15.4 4.8 20.4 5.1 22.5 17.3 4.6 5.0 25.1 9.3 15.8 12.9 23.3 11.7 11.4 20.8 28.2 10.2 4.1 6.6 7.7 16.3 33.9 23.1 9.7 5.5 46.1 18.3 17.1 5.9 25.0 6.0 11.5 17.4 4.5 8.7 14.3 5.1 13.4 16.0 21.2 6.3 25.5 12.9 12.6 6.7 23.8 12.1 10.8 19.3 19.1 14.9 6.6 12.0 9.4 11.1 10.5 76.2 60.4 19.3 27.1 40.7 24.9 27.3 12.0 4.8 18.5 10.6 23.0 13.8 17.1 24.4 29.9 18.9 35.2 18.8 11.8 9.1 8.2 36.1 30.1 17.3 59.2 20.4 16.5 11.0 36.8 28.6 23.5 6.2 12.5 32.5 13.2 11.2 19.7 8.8 9.3 9.0 16.8 50.9 4.1 12.7 45.1 5.9 16.0 25.3 17.0 31.9 10.2 5.6 31.1 35.5 27.1 17.8 8.6 14.5 20.9 23.8 9.7 9.3 39.8 14.6 0.0 0.8 0.3 1.4 0.6 0.8 0.0 0.9 1.6 0.5 0.1 0.7 0.6 1.4 1.4 0.2 1.2 0.5 0.6 4.8 5.1 4.6 5.0 4.1 6.6 9.7 5.5 6.0 6.3 6.7 6.6 13.9 3.2 17.3 26.4 6.4 9.3 7.3 13.9 1.8 10.7 5.3 4.3 3.3 14.3 9.7 5.5 6.2 20.6 24.0 12.8 0.0 8.8 10.0 7.1 33.7 16.1 7.3 4.4 23.3 10.0 6.9 28.0 17.3 6.3 9.5 6.3 21.4 90.7 19.0 15.2 20.3 19.7 10.2 31.9 29.3 10.3 42.6 21.5 14.2 45.9 23.7 6.2 6.2 12.5 10.4 15.3 13.4 42.2 9.5 6.3 15.3 4.3 10.9 8.9 26.3 19.4 18.2 6.0 7.1 4.5 9.9 28.5 26.0 79.0 15.7 8.1 SH2D7 LOC646892 ENSG00000183476 "SH2 domain containing 7" A6NKC9 15 78077808-78104909 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "intestine: 2.1;testis: 3.1" "Group enriched" "Detected in some" 4 "Early spermatids: 21.1;Late spermatids: 35.1" "Cancer enhanced" "Detected in single" "pancreatic cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SH-SY5Y: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA051320, HPA058382, HPA076728" Enhanced Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 45: Intestine - Brush border" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 31: Spermatids - Spermatogenesis" Nucleoli "Nucleoplasm, Cytosol" "HPA051320: AB_2681439, HPA058382: , HPA076728: " "unprognostic (1.22e-2)" "unprognostic (4.31e-2)" "unprognostic (2.24e-1)" "unprognostic (1.24e-2)" "unprognostic (2.53e-1)" "unprognostic (1.42e-1)" "unprognostic (2.99e-2)" "unprognostic (7.26e-2)" "unprognostic (1.38e-1)" "unprognostic (8.63e-3)" "unprognostic (4.73e-2)" "unprognostic (2.92e-1)" "unprognostic (2.32e-3)" "unprognostic (5.15e-3)" "unprognostic (1.01e-1)" "unprognostic (1.26e-1)" "unprognostic (1.04e-1)" 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 1.6 2.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.3 0.1 0.0 0.0 0.1 1.7 0.1 0.2 0.0 0.1 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.8 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.4 0.0 0.0 0.1 0.7 1.3 0.1 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 21.1 0.0 0.0 0.0 5.3 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 35.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.4 0.2 0.0 0.0 3.0 0.0 0.0 0.4 0.0 CIB2 "DFNB48, KIP2, USH1J" ENSG00000136425 "Calcium and integrin binding family member 2" O75838 15 78104606-78131535 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 47.7;lymphoid tissue: 47.8" "Group enriched" "Detected in many" 4 "Early spermatids: 73.1;Late spermatids: 269.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 48 "plasmacytoid DC: 18.7" "Lineage enriched" "Detected in single" 48 "dendritic cells: 18.7" "Cell line enhanced" "Detected in many" "AN3-CA: 44.0;GAMG: 39.0;HAP1: 38.6;SCLC-21H: 38.8;SH-SY5Y: 40.1;SuSa: 49.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036697 Approved NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 25: Spermatids - Spermatogenesis" "HPA036697: AB_10672475" "unprognostic (5.77e-2)" "unprognostic (1.83e-2)" "unprognostic (2.81e-2)" "prognostic unfavorable (7.05e-4)" "unprognostic (1.46e-1)" "unprognostic (2.57e-1)" "unprognostic (1.11e-2)" "unprognostic (6.73e-3)" "unprognostic (1.66e-1)" "unprognostic (9.94e-3)" "unprognostic (3.18e-1)" "unprognostic (7.49e-2)" "prognostic favorable (6.16e-4)" "unprognostic (9.78e-2)" "unprognostic (1.01e-1)" "unprognostic (1.68e-1)" "unprognostic (7.64e-3)" 7.0 12.1 16.7 3.1 16.9 1.6 4.8 15.9 22.9 13.1 13.8 9.6 18.7 9.1 3.1 4.0 5.7 2.8 47.7 18.1 17.4 9.1 1.2 3.0 3.5 20.1 18.3 7.3 5.9 13.4 10.4 3.7 20.1 10.4 7.1 5.0 8.1 8.7 11.4 6.8 24.6 6.6 17.5 3.0 3.9 23.3 16.9 47.8 4.0 1.9 6.5 8.6 7.8 16.2 3.5 8.6 24.2 44.0 1.1 1.4 18.1 2.4 0.9 2.0 4.2 0.0 9.6 0.4 4.8 11.3 39.0 1.9 38.6 7.7 0.6 21.7 26.8 2.6 1.6 1.4 4.3 0.0 3.4 2.1 3.2 3.5 2.0 5.0 4.2 13.0 9.1 0.2 3.7 0.7 1.1 0.4 31.1 1.2 0.3 16.9 0.1 1.0 2.8 0.7 38.8 40.1 5.9 3.1 3.5 49.2 0.6 2.6 0.3 0.1 20.3 2.2 0.3 0.4 0.4 6.7 1.0 0.1 5.4 0.0 0.0 0.0 0.3 0.1 0.2 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 18.7 0.0 0.2 16.7 16.9 15.9 22.9 18.1 17.4 20.1 18.3 20.1 17.5 16.9 16.2 11.0 0.0 0.0 1.6 3.6 5.5 26.6 2.3 1.8 2.9 3.4 12.6 11.4 1.5 0.5 1.8 6.2 19.4 17.3 14.9 9.8 3.0 73.1 1.6 8.1 3.0 3.0 3.0 1.6 1.1 15.5 9.5 2.0 1.5 0.0 10.7 2.5 0.4 2.8 5.0 3.9 25.1 2.0 0.6 1.4 269.9 3.4 2.3 7.2 1.0 0.1 18.1 1.0 2.5 0.4 1.5 16.2 2.6 1.7 12.3 35.9 10.6 0.2 2.2 6.6 11.5 4.9 10.0 17.5 0.4 3.1 9.3 2.5 18.0 11.1 11.5 IDH3A ENSG00000166411 "Isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha" P50213 15 78131498-78171945 "Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 99.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 144.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041465, HPA062971" Supported Enhanced Mitochondria No No 110000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Mitochondria "HPA041465: AB_10794377, HPA062971: AB_2684913" "unprognostic (2.33e-1)" "unprognostic (1.21e-1)" "unprognostic (5.76e-3)" "unprognostic (2.26e-1)" "unprognostic (1.02e-1)" "unprognostic (4.01e-1)" "unprognostic (2.29e-1)" "unprognostic (6.47e-2)" "unprognostic (1.69e-2)" "unprognostic (2.30e-1)" "unprognostic (3.05e-1)" "unprognostic (1.42e-1)" "prognostic favorable (6.49e-8)" "unprognostic (1.40e-1)" "unprognostic (3.08e-2)" "unprognostic (4.49e-2)" "unprognostic (3.39e-2)" 22.6 25.1 11.5 19.9 12.6 9.7 9.6 17.0 14.7 12.4 21.4 26.2 36.6 13.7 7.8 17.0 11.0 9.0 62.5 14.8 13.2 16.8 14.2 11.9 17.1 13.0 13.1 10.8 13.0 54.7 6.9 12.1 15.2 13.9 26.7 26.2 16.2 16.1 79.4 15.8 36.0 17.1 10.1 15.3 11.9 16.9 14.3 35.0 11.2 99.7 24.8 17.7 11.1 14.8 43.8 58.5 10.4 36.5 25.5 26.1 22.6 50.8 24.5 40.6 30.5 41.6 25.8 91.6 36.8 29.9 59.9 64.2 98.2 39.3 37.0 40.7 32.2 35.7 62.4 19.2 21.8 69.8 48.8 19.9 23.6 39.4 41.2 19.3 25.7 32.0 46.4 35.9 26.0 41.4 51.4 17.4 12.9 25.2 21.8 29.3 44.4 28.1 33.4 58.3 41.4 15.8 58.2 82.1 47.1 19.1 32.7 37.4 26.4 47.6 43.9 63.1 83.1 41.5 99.9 48.8 33.2 64.9 37.7 16.9 27.9 8.3 15.1 52.9 16.4 27.7 14.7 13.5 43.5 32.6 15.2 16.4 15.5 17.3 54.8 144.4 17.7 23.2 11.5 12.6 17.0 14.7 14.8 13.2 13.0 13.1 15.2 10.1 14.3 14.8 18.0 9.6 16.5 22.9 30.6 56.0 58.7 51.4 33.0 35.1 10.9 12.6 17.5 14.3 22.6 25.8 37.5 38.3 63.0 69.0 82.2 26.1 52.2 19.9 13.4 17.5 19.2 9.4 45.9 17.9 40.4 21.2 11.7 9.2 27.3 14.5 10.8 22.4 26.5 26.9 53.3 37.6 69.2 24.9 28.6 23.4 20.8 26.4 26.6 12.2 16.0 29.3 12.3 19.6 17.9 21.5 37.9 23.7 33.2 40.6 49.6 48.1 38.2 34.6 13.1 23.8 25.5 45.7 26.2 28.4 41.2 68.4 17.7 37.2 56.0 42.0 ACSBG1 "BG1, BGM, FLJ30320, hBG1, hsBG, KIAA0631, MGC14352" ENSG00000103740 "Acyl-CoA synthetase bubblegum family member 1" Q96GR2 15 78167468-78245688 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 56.6;skin 1: 14.3" "Cell type enriched" "Detected in some" 5 "Astrocytes: 158.0" "Cancer enriched" "Detected in some" 4 "glioma: 3.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "NTERA-2: 3.1;SK-MEL-30: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041642, CAB045955, HPA058869" Approved Approved Vesicles NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 70: Brain - Nervous system development" "Cluster 5: NTERA-2 - Transcription" "Cluster 64: Astrocytes - Nervous system maintenance" Vesicles "CAB045955: AB_11124196, HPA041642: AB_2677593, HPA058869: AB_2683840" "unprognostic (1.28e-1)" "unprognostic (1.63e-2)" "unprognostic (1.29e-2)" "unprognostic (2.28e-1)" "unprognostic (2.29e-2)" "unprognostic (4.18e-2)" "unprognostic (1.32e-2)" "unprognostic (1.58e-2)" "unprognostic (1.86e-1)" "unprognostic (5.64e-2)" "unprognostic (2.02e-1)" "unprognostic (4.13e-1)" "unprognostic (1.05e-1)" "unprognostic (1.40e-1)" "unprognostic (2.96e-1)" "unprognostic (4.19e-2)" "unprognostic (1.42e-2)" 0.1 5.5 23.0 0.4 42.6 2.4 1.6 30.5 24.0 0.5 0.0 1.1 0.4 0.2 0.7 0.3 2.8 0.2 0.8 19.6 35.9 0.5 0.4 0.5 0.4 46.0 39.9 0.3 0.2 0.0 0.5 0.1 47.7 0.8 0.1 0.6 0.3 0.2 0.2 14.3 0.5 0.2 45.8 0.3 0.3 3.7 36.6 3.4 0.2 0.0 0.1 0.3 0.5 56.6 0.3 0.0 0.6 0.9 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.2 0.2 0.3 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.1 0.5 0.3 0.6 0.3 0.0 0.2 0.6 0.2 0.0 0.1 0.1 0.2 0.0 0.4 0.2 0.4 0.0 0.1 0.2 0.5 3.1 0.2 0.1 0.1 0.4 0.2 0.0 0.4 0.2 0.3 0.1 0.4 1.5 0.3 0.1 0.2 0.4 0.2 0.2 0.1 0.1 0.3 0.1 0.3 0.1 0.2 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 1.0 0.0 0.3 23.0 42.6 30.5 24.0 19.6 35.9 46.0 39.9 47.7 45.8 36.6 56.6 0.1 0.0 2.0 158.0 0.6 1.1 0.6 0.3 0.6 1.9 0.2 0.1 3.0 0.0 2.7 0.0 4.2 0.2 0.5 0.3 0.0 0.0 1.8 4.4 0.3 0.2 0.0 4.6 0.7 0.0 0.2 0.7 0.5 0.3 0.0 0.1 0.0 0.0 0.1 0.0 1.0 0.2 0.0 0.0 0.0 1.7 0.3 4.0 1.8 2.8 0.1 0.2 1.0 7.5 26.9 0.2 0.0 0.0 0.9 0.3 0.1 0.2 19.1 3.3 0.0 0.3 1.0 2.0 10.0 0.4 0.6 0.4 0.5 1.6 0.1 0.7 DNAJA4 PRO1472 ENSG00000140403 "DnaJ heat shock protein family (Hsp40) member A4" Q8WW22 15 78264086-78282196 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 138.4;tongue: 144.6" "Group enriched" "Detected in many" 5 "Early spermatids: 673.9;Late spermatids: 1608.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 33.6;CAPAN-2: 43.3;HeLa: 47.3;MCF7: 33.6;RT4: 85.2;SCLC-21H: 53.3;SiHa: 42.7;THP-1: 39.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004646, HPA041790" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 15: RT4 - Unknown function" "Cluster 34: Spermatids - Unknown function" "Plasma membrane, Cytosol" "CAB004646: AB_426011, HPA041790: AB_2677674" "unprognostic (8.41e-2)" "unprognostic (2.48e-1)" "unprognostic (3.00e-2)" "unprognostic (8.20e-3)" "unprognostic (1.14e-3)" "unprognostic (1.99e-1)" "unprognostic (2.28e-2)" "unprognostic (2.46e-1)" "unprognostic (5.86e-2)" "unprognostic (7.78e-2)" "unprognostic (2.31e-2)" "unprognostic (1.28e-1)" "prognostic favorable (1.08e-7)" "unprognostic (1.89e-1)" "unprognostic (2.84e-1)" "unprognostic (9.01e-2)" "unprognostic (2.93e-2)" 16.5 20.0 60.6 14.0 67.7 63.7 12.6 62.6 138.4 14.1 45.6 18.0 13.8 8.3 20.2 15.8 38.9 11.2 123.3 68.6 93.1 26.7 3.3 19.7 11.3 65.7 73.3 12.1 6.6 7.4 30.9 9.5 89.8 26.7 18.5 33.0 15.6 15.6 123.2 28.6 16.3 19.6 59.8 13.5 24.2 78.3 73.5 9.4 9.6 144.6 12.4 29.6 13.6 71.3 33.6 0.2 0.0 0.0 0.0 0.0 0.1 4.1 0.0 1.1 0.5 0.0 43.3 0.0 0.3 3.2 0.0 31.3 0.0 0.0 0.1 0.1 0.0 19.9 47.3 0.0 9.4 0.0 20.6 3.6 4.1 2.6 0.0 0.0 6.6 0.0 0.0 0.0 0.4 33.6 0.0 0.0 0.0 14.4 0.3 0.0 0.0 0.0 0.1 85.2 53.3 0.0 42.7 8.6 3.6 2.3 32.4 39.8 0.5 0.0 8.7 4.0 0.4 0.6 2.4 0.0 0.1 4.2 0.0 0.0 0.3 1.1 0.6 0.3 1.0 0.7 0.9 0.9 0.4 0.1 1.7 1.4 0.0 0.1 0.4 0.2 0.5 0.6 60.6 67.7 62.6 138.4 68.6 93.1 65.7 73.3 89.8 59.8 73.5 71.3 41.9 6.4 4.8 12.7 10.0 28.8 209.9 14.0 2.2 19.6 44.6 29.2 43.6 2.8 33.5 7.3 81.3 1.9 6.7 55.5 1.9 1.3 673.9 124.0 11.4 18.9 100.3 92.8 16.6 2.4 3.8 18.3 21.4 41.8 36.9 7.5 6.8 0.2 16.5 6.7 24.0 34.9 10.2 9.5 81.7 1608.0 10.2 51.7 51.6 6.5 3.5 10.3 6.2 15.1 19.0 5.1 55.3 11.3 3.7 115.8 15.8 7.2 138.9 22.6 6.6 17.4 20.2 33.8 27.7 16.9 46.7 6.8 37.1 6.9 42.1 190.1 WDR61 REC14 ENSG00000140395 "WD repeat domain 61" Q9GZS3 15 78277835-78299703 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039932, HPA040065" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 28000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Cytosol" "HPA039932: AB_10796336, HPA040065: AB_10793926" "unprognostic (1.08e-1)" "unprognostic (1.85e-2)" "unprognostic (8.91e-2)" "unprognostic (1.07e-1)" "unprognostic (2.09e-1)" "unprognostic (3.36e-1)" "unprognostic (2.44e-1)" "unprognostic (1.60e-1)" "unprognostic (3.05e-1)" "unprognostic (2.74e-3)" "unprognostic (4.21e-1)" "unprognostic (5.72e-2)" "prognostic favorable (2.03e-10)" "unprognostic (1.04e-1)" "unprognostic (3.13e-1)" "unprognostic (3.18e-1)" "unprognostic (1.09e-2)" 38.8 52.7 34.5 29.6 36.5 61.5 59.9 50.4 63.0 40.8 31.1 39.5 36.2 34.9 115.7 40.1 46.6 28.6 41.0 40.8 40.4 60.8 50.9 34.6 37.4 41.5 41.2 34.6 41.3 55.6 49.9 35.5 40.0 46.0 43.5 49.4 39.5 37.4 45.4 52.1 30.4 41.4 38.2 29.9 33.5 49.0 37.0 48.5 56.8 38.2 46.0 41.4 32.4 61.5 39.3 92.4 74.3 77.4 74.1 61.6 56.1 60.9 68.6 76.6 73.6 87.9 67.9 80.7 72.6 69.8 119.2 78.2 165.8 71.5 58.3 53.9 123.8 66.2 79.9 84.6 62.6 99.2 63.3 52.8 50.5 30.8 24.0 52.7 82.7 80.0 113.1 78.8 92.5 116.6 82.3 81.6 54.3 98.5 76.2 74.7 59.7 89.1 81.3 112.3 103.7 56.2 88.0 90.9 323.7 76.9 56.0 124.2 58.2 53.7 66.0 38.2 103.6 69.3 113.7 113.0 80.5 153.3 112.6 39.0 91.2 33.6 59.6 100.0 65.0 66.4 59.7 62.1 134.2 53.5 62.2 68.6 7.7 72.4 86.0 71.6 72.7 89.1 34.5 36.5 50.4 63.0 40.8 40.4 41.5 41.2 40.0 38.2 37.0 61.5 38.7 35.3 44.7 20.5 26.7 49.1 61.5 105.0 31.9 57.2 44.8 47.2 25.8 28.6 57.5 38.6 47.9 106.1 29.2 23.2 125.2 62.5 32.2 41.5 38.6 42.2 23.4 37.6 34.6 55.6 78.1 51.0 20.4 29.1 47.5 49.1 40.0 47.0 66.1 43.7 36.8 38.0 93.6 37.0 47.2 12.4 50.1 37.0 58.7 12.2 61.1 81.9 42.2 17.1 33.1 41.0 28.5 50.8 36.4 51.6 35.4 132.7 70.1 50.7 6.6 37.8 90.2 122.4 60.2 38.3 58.7 92.4 31.7 59.4 52.4 57.7 CRABP1 "CRABP, CRABP-I, CRABPI, RBP5" ENSG00000166426 "Cellular retinoic acid binding protein 1" P29762 15 78340353-78348225 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "retina: 544.1;thyroid gland: 173.2" "Cell type enriched" "Detected in some" 24 "Muller glia cells: 4845.4" "Cancer enhanced" "Detected in many" "ovarian cancer: 117.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "AF22: 1022.7;NTERA-2: 307.4" "Group enriched" "Detected in many" 5 "amygdala: 6.4;basal ganglia: 23.4;hypothalamus: 13.3;olfactory bulb: 12.8;pons and medulla: 7.4" "Low region specificity" "Detected in all" HPA017203 Enhanced Supported NA NA "Cluster 77: Retina - Visual perception" "Cluster 12: NES - Nervous system development" "Cluster 5: Muller glia cells - Visual perception" "HPA017203: AB_1846512" "unprognostic (1.23e-1)" "unprognostic (3.76e-3)" "unprognostic (1.46e-1)" "prognostic unfavorable (4.72e-4)" "unprognostic (2.01e-1)" "unprognostic (4.35e-2)" "unprognostic (1.05e-1)" "unprognostic (1.35e-1)" "unprognostic (2.45e-2)" "unprognostic (9.79e-2)" "unprognostic (1.21e-1)" "unprognostic (2.79e-2)" "unprognostic (9.37e-2)" "unprognostic (2.17e-1)" "unprognostic (1.07e-1)" "unprognostic (2.69e-1)" 0.9 1.7 14.2 2.5 24.8 0.2 56.1 25.6 26.4 1.3 28.5 6.9 0.8 2.3 2.0 0.6 0.3 1.6 0.4 9.6 39.6 15.5 0.0 0.7 0.2 61.7 62.6 0.4 0.7 0.0 27.6 15.0 58.4 2.6 1.7 544.1 1.1 47.4 0.2 26.7 5.0 1.8 23.8 75.2 7.1 0.5 86.2 1.7 173.2 0.2 1.2 0.6 2.5 13.7 0.0 0.2 1022.7 0.1 0.0 0.0 0.3 0.1 0.3 0.0 0.0 65.3 0.9 0.0 6.3 0.0 0.3 0.0 9.3 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 57.9 0.4 307.4 1.0 0.8 0.0 0.0 0.0 0.0 1.5 85.5 58.0 0.0 0.2 0.1 24.8 1.4 35.9 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.2 24.8 25.6 26.4 9.6 39.6 61.7 62.6 58.4 23.8 86.2 13.7 1.0 0.0 0.0 0.3 0.8 9.7 0.1 0.0 0.0 31.1 112.6 199.0 0.0 0.0 0.0 0.0 33.3 1.1 2.9 1.1 70.5 0.0 0.0 0.1 0.1 4.8 0.0 0.0 0.2 0.0 0.8 11.3 0.0 0.1 0.0 4.2 0.0 0.0 1.5 10.1 1.5 0.4 0.0 0.0 5.3 0.0 0.0 0.5 192.1 0.0 0.0 4845.4 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.4 0.5 0.0 91.2 0.0 0.0 1.0 0.1 2.2 0.0 2.6 1.4 0.9 0.0 1.6 0.1 IREB2 IRP2 ENSG00000136381 "Iron responsive element binding protein 2" P48200 15 78437431-78501453 "Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" RNA-binding "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032885, HPA040371, HPA068982" Uncertain Approved "Cell Junctions,Cytosol" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Cell Junctions" Cytosol "CAB032885: AB_2126703, HPA040371: AB_2676945, HPA068982: AB_2686064" "unprognostic (1.00e-2)" "unprognostic (1.30e-1)" "unprognostic (6.54e-2)" "unprognostic (3.44e-2)" "unprognostic (3.39e-2)" "unprognostic (2.29e-1)" "unprognostic (2.33e-1)" "unprognostic (1.06e-1)" "unprognostic (7.30e-2)" "unprognostic (1.01e-1)" "unprognostic (1.38e-1)" "unprognostic (6.51e-2)" "unprognostic (3.85e-3)" "unprognostic (4.09e-1)" "unprognostic (1.36e-1)" "unprognostic (1.47e-2)" "unprognostic (9.40e-2)" 17.1 25.2 7.5 18.2 7.7 27.7 18.8 16.3 9.3 15.2 8.4 17.4 17.9 17.9 11.8 15.2 14.6 14.9 12.5 7.4 10.5 18.3 23.1 14.9 22.8 7.0 7.2 22.0 11.4 17.8 8.2 21.8 7.1 16.5 20.3 19.4 10.6 15.4 18.8 14.4 18.4 16.1 7.0 24.8 16.4 15.1 9.5 29.7 28.7 23.5 20.9 13.4 11.7 8.8 19.9 34.9 52.8 33.2 45.5 29.7 35.5 33.3 26.0 29.7 26.9 34.6 33.8 73.1 22.1 28.0 20.3 37.8 124.7 33.2 26.1 23.4 43.0 63.6 35.0 24.4 23.8 69.4 65.7 31.5 22.4 22.9 27.7 30.2 35.4 42.6 67.9 25.4 25.5 29.7 42.8 35.2 69.1 24.1 12.4 49.6 53.0 20.8 32.4 54.2 31.7 47.3 45.1 31.4 35.7 59.2 29.5 59.7 28.9 30.3 20.8 16.8 29.2 31.5 74.8 41.7 21.8 63.1 22.2 3.8 2.5 2.0 2.4 3.3 3.1 2.7 2.6 2.4 3.5 2.6 2.5 3.5 2.8 3.0 2.6 4.0 2.3 1.4 7.5 7.7 16.3 9.3 7.4 10.5 7.0 7.2 7.1 7.0 9.5 8.8 24.3 22.4 40.7 33.0 37.5 14.1 16.6 19.3 14.8 55.6 23.1 18.4 24.9 25.8 26.1 23.9 66.7 35.0 56.2 45.3 0.0 19.9 18.1 19.3 38.2 26.6 31.9 42.3 52.3 19.6 23.7 27.7 32.1 21.2 17.7 66.2 38.9 41.8 26.1 79.1 55.6 31.0 18.3 61.3 18.4 10.8 32.9 37.7 14.2 28.1 52.9 22.4 54.6 50.3 49.0 26.3 49.8 30.5 28.5 33.7 49.1 19.6 25.7 51.1 6.6 29.5 23.2 33.9 29.6 24.5 18.6 30.6 33.9 56.3 36.0 29.6 HYKK "AGPHD1, LOC123688" ENSG00000188266 "Hydroxylysine kinase" A2RU49 15 78507564-78537372 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 29.4;Late spermatids: 33.7;Proximal enterocytes: 37.0;Proximal tubular cells: 39.4;Skeletal myocytes: 28.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 3.0" "Lineage enriched" "Detected in single" 6 "T-cells: 3.0" "Cell line enhanced" "Detected in many" "HEK 293: 22.2;U-266/84: 24.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040706 Approved Approved Vesicles,Aggresome NA NA "Cluster 32: T-cells - Unknown function" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Vesicles Aggresome "HPA040706: AB_10795528" "unprognostic (9.26e-2)" "unprognostic (1.98e-4)" "unprognostic (7.84e-2)" "unprognostic (3.16e-2)" "unprognostic (3.64e-1)" "unprognostic (2.72e-2)" "unprognostic (1.14e-1)" "unprognostic (8.00e-3)" "unprognostic (2.73e-1)" "unprognostic (5.16e-2)" "unprognostic (6.24e-3)" "unprognostic (6.37e-2)" "unprognostic (3.44e-3)" "unprognostic (2.19e-1)" "unprognostic (1.04e-1)" "unprognostic (3.11e-3)" "unprognostic (3.90e-2)" 4.5 4.8 2.8 1.0 3.1 1.3 4.5 2.2 3.2 5.6 1.6 4.6 7.3 3.8 5.9 2.8 4.3 2.4 5.3 2.7 2.2 12.3 5.7 2.1 2.0 2.0 2.0 6.1 6.8 4.8 3.5 0.7 1.8 4.1 3.4 2.6 3.5 4.1 6.2 2.8 7.2 3.6 1.6 1.3 5.1 5.3 2.3 1.9 4.5 5.4 1.7 3.9 3.8 2.9 4.3 6.3 1.0 11.3 2.3 5.3 2.7 1.5 2.7 3.7 4.2 2.2 4.9 3.1 1.4 2.5 6.3 5.2 10.0 3.3 3.5 1.5 22.2 1.7 3.8 5.6 6.0 0.5 1.9 4.8 6.4 1.4 2.7 1.8 2.7 13.8 4.0 8.4 2.2 5.0 4.2 1.0 0.7 9.8 8.3 2.4 12.4 2.7 7.1 5.1 1.3 1.6 2.9 8.6 10.9 1.9 9.5 0.4 1.9 2.4 1.8 4.3 4.4 12.9 24.2 0.2 3.2 0.2 3.4 0.4 0.1 0.2 0.1 0.0 0.1 0.1 1.1 0.1 0.0 0.1 3.0 0.6 0.3 0.1 0.0 0.3 0.5 0.4 2.8 3.1 2.2 3.2 2.7 2.2 2.0 2.0 1.8 1.6 2.3 2.9 4.1 12.8 4.1 4.6 1.4 3.6 7.7 4.5 6.2 2.0 4.5 9.8 6.7 0.0 2.9 7.3 2.1 7.3 1.5 2.8 29.4 2.5 14.0 2.7 3.3 4.1 4.2 1.3 2.8 7.9 4.4 5.4 5.1 1.5 0.0 2.4 6.8 7.1 0.8 0.0 2.7 3.9 2.0 1.0 0.9 33.7 5.3 1.0 7.2 2.8 0.3 7.5 0.0 0.5 1.1 2.9 3.6 3.8 1.7 3.7 37.0 39.4 3.5 1.9 0.0 28.1 4.0 5.4 8.0 4.9 1.6 3.4 1.6 3.9 5.7 4.7 PSMA4 "HC9, HsT17706" ENSG00000041357 "Proteasome 20S subunit alpha 4" P25789 15 78540405-78552417 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004973, HPA055466, HPA060613" Supported Supported Nucleoplasm,Vesicles,Cytosol No No 13000000 "Cluster 7: Monocytes - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 32: U-937 - Innate immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nucleoplasm, Cytosol" Vesicles "CAB004973: AB_425627, HPA055466: AB_2682824, HPA060613: AB_2684332" "unprognostic (1.80e-1)" "unprognostic (7.08e-3)" "unprognostic (1.31e-1)" "unprognostic (1.62e-1)" "unprognostic (4.71e-2)" "unprognostic (5.35e-2)" "unprognostic (6.26e-3)" "unprognostic (1.09e-1)" "unprognostic (3.28e-2)" "unprognostic (2.08e-3)" "unprognostic (2.75e-3)" "unprognostic (1.26e-1)" "prognostic unfavorable (6.74e-10)" "unprognostic (1.68e-1)" "unprognostic (1.56e-1)" "unprognostic (3.78e-3)" "unprognostic (6.32e-3)" 92.9 105.0 62.5 106.3 64.4 107.6 87.5 66.2 98.8 78.9 65.6 105.1 108.9 89.6 74.5 118.2 71.6 66.0 108.4 64.7 69.1 98.1 152.1 87.9 136.9 67.6 65.5 64.6 67.3 73.4 54.4 85.8 67.5 97.2 109.6 50.3 70.3 64.2 180.6 78.3 101.3 99.3 69.3 115.3 88.5 109.9 65.6 156.5 70.6 121.6 128.7 118.8 81.2 69.9 274.2 386.9 327.7 290.8 202.1 189.5 256.3 250.2 199.9 301.4 320.6 404.9 386.9 590.8 359.7 232.5 337.4 363.9 669.1 271.8 289.1 244.2 465.7 497.6 271.6 330.1 326.9 512.6 294.5 154.6 166.8 255.0 250.9 185.4 330.7 319.1 544.2 225.0 249.6 392.3 347.5 477.4 309.7 315.3 224.5 297.7 432.9 198.9 309.5 469.4 287.6 209.9 401.3 289.5 327.5 402.2 267.8 414.7 265.8 223.7 298.6 249.3 434.2 204.0 517.9 556.2 209.9 756.7 252.6 126.0 251.9 172.9 136.2 403.9 140.3 156.0 142.0 144.7 327.4 119.9 111.7 137.0 112.8 209.4 394.8 185.4 216.8 405.6 62.5 64.4 66.2 98.8 64.7 69.1 67.6 65.5 67.5 69.3 65.6 69.9 119.0 128.2 118.5 17.3 124.1 231.6 269.6 765.7 84.2 57.8 88.5 95.8 163.7 105.8 327.0 121.4 10.4 478.9 128.4 145.3 311.0 296.2 689.4 158.0 183.6 162.5 146.2 153.2 18.0 292.7 450.6 159.9 78.0 126.0 174.2 152.9 114.9 178.9 320.4 72.3 19.6 216.2 506.6 143.2 201.7 399.0 151.0 176.9 133.4 23.4 308.6 63.5 149.3 11.1 21.5 256.0 165.7 147.4 108.0 249.3 195.8 367.2 280.0 39.8 151.2 95.4 241.1 417.1 181.0 106.4 212.8 447.1 128.6 166.7 234.7 258.4 CHRNA5 ENSG00000169684 "Cholinergic receptor nicotinic alpha 5 subunit" P30532 15 78565520-78595269 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 13.0;Extravillous trophoblasts: 11.5;Intestinal goblet cells: 9.8;Spermatocytes: 12.4;Spermatogonia: 28.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA054381 Approved Approved "Plasma membrane,Focal adhesion sites" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Focal adhesion sites" "Plasma membrane" "HPA054381: AB_2682468" "unprognostic (2.66e-1)" "unprognostic (1.76e-1)" "unprognostic (2.32e-2)" "unprognostic (3.20e-3)" "unprognostic (6.66e-2)" "unprognostic (1.29e-3)" "unprognostic (7.03e-5)" "prognostic unfavorable (3.64e-5)" "unprognostic (1.34e-2)" "unprognostic (1.31e-2)" "unprognostic (4.52e-2)" "unprognostic (8.97e-2)" "unprognostic (6.50e-11)" "unprognostic (4.37e-1)" "unprognostic (5.39e-1)" "unprognostic (5.44e-2)" "unprognostic (2.22e-1)" 0.8 2.0 1.9 1.9 1.8 0.5 1.5 2.7 3.0 1.0 2.0 4.0 4.8 1.3 1.1 1.6 0.5 4.4 1.3 1.7 1.8 0.3 0.3 0.5 0.7 1.7 2.2 0.7 1.9 0.3 0.2 1.1 2.4 1.9 4.2 2.5 0.7 0.4 3.9 0.6 2.4 2.1 1.6 0.3 2.8 3.1 2.4 0.7 0.3 0.5 1.1 1.8 1.1 2.7 16.5 41.8 22.4 12.5 2.7 1.9 9.1 12.0 5.8 13.0 23.4 16.1 76.7 9.8 28.6 2.6 34.7 14.3 43.5 17.6 13.2 20.1 51.9 18.3 29.5 16.2 1.4 12.4 24.7 0.7 3.1 3.5 4.7 4.8 24.5 13.6 18.2 12.5 8.3 36.1 15.9 4.3 18.2 32.4 11.5 20.1 25.8 9.9 15.7 39.2 37.7 55.0 28.6 27.5 14.1 12.7 61.2 3.2 5.3 17.6 21.0 13.0 38.0 14.3 63.4 11.3 10.6 19.8 16.5 1.0 0.4 0.7 0.1 0.4 0.1 0.0 0.1 0.1 0.2 0.1 0.3 0.3 0.7 0.3 0.4 0.2 0.0 0.1 1.9 1.8 2.7 3.0 1.7 1.8 1.7 2.2 2.4 1.6 2.4 2.7 0.9 0.0 0.0 0.3 1.4 3.2 13.0 0.5 8.6 7.6 1.2 2.9 1.2 2.8 0.2 0.0 0.0 2.6 0.4 1.2 0.0 0.3 1.2 0.5 0.6 2.0 3.5 0.8 1.0 2.0 11.5 1.0 0.5 0.6 0.0 1.5 0.0 0.3 1.0 5.0 1.1 9.8 0.0 0.0 2.3 2.6 0.3 0.8 1.8 0.0 0.2 0.4 1.0 0.5 0.9 0.7 0.1 0.4 0.9 6.7 0.1 0.4 0.1 0.7 0.0 1.3 1.6 12.4 28.8 2.9 1.6 1.0 2.0 0.2 2.1 3.2 CHRNA3 ENSG00000080644 "Cholinergic receptor nicotinic alpha 3 subunit" P32297 15 78593052-78621295 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "adrenal gland: 39.3;lymphoid tissue: 65.8;retina: 53.5" "Cell type enriched" "Detected in some" 19 "Cone photoreceptor cells: 164.7" "Cancer enhanced" "Detected in some" "testis cancer: 1.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 356.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029430 Enhanced Supported "Nuclear speckles,Plasma membrane" NA NA "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 9: Photoreceptor cells - Phototransduction" "Plasma membrane" "Nuclear speckles" "HPA029430: AB_10603785" "unprognostic (2.28e-1)" "unprognostic (3.45e-1)" "unprognostic (2.58e-2)" "unprognostic (2.36e-1)" "unprognostic (1.32e-1)" "unprognostic (1.12e-1)" "unprognostic (9.16e-3)" "unprognostic (1.97e-1)" "unprognostic (4.28e-2)" "unprognostic (7.20e-2)" "unprognostic (3.12e-1)" "unprognostic (1.01e-1)" "unprognostic (1.86e-4)" "unprognostic (2.65e-3)" "unprognostic (2.76e-1)" "unprognostic (1.53e-1)" "unprognostic (4.48e-1)" 0.3 39.3 4.4 5.1 2.0 0.0 0.1 6.3 1.0 1.0 0.3 8.1 1.5 0.5 0.0 0.1 0.0 0.3 0.4 0.7 2.3 0.0 0.0 0.2 0.3 3.1 6.4 0.1 0.2 0.0 1.1 0.1 10.0 0.2 4.0 53.5 0.1 0.0 0.1 0.7 3.0 3.7 0.3 0.1 2.8 1.0 9.2 65.8 0.2 0.0 0.8 0.2 0.7 1.0 0.1 0.3 0.7 0.6 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.2 0.1 0.2 0.0 1.5 0.0 8.8 0.0 0.0 0.3 1.4 0.5 0.4 0.1 0.0 0.1 4.0 0.0 0.3 0.0 0.0 0.0 0.0 22.6 0.2 0.0 0.0 0.3 7.1 0.0 1.6 0.1 0.2 0.4 0.3 0.1 0.0 0.4 67.7 356.1 0.3 0.1 0.1 0.5 0.4 0.0 0.0 0.1 1.7 0.1 0.4 0.2 0.7 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 2.0 6.3 1.0 0.7 2.3 3.1 6.4 10.0 0.3 9.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.8 0.0 0.0 0.0 164.7 0.0 0.0 0.2 1.9 0.0 3.7 0.1 1.2 0.4 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.7 0.4 3.6 0.0 0.0 0.0 3.5 0.0 0.2 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.1 0.1 0.3 2.1 0.0 0.0 0.0 0.0 2.6 0.1 0.1 CHRNB4 ENSG00000117971 "Cholinergic receptor nicotinic beta 4 subunit" P30926 15 78624111-78727754 "FDA approved drug targets, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 3.0;retina: 2.7;testis: 5.8" "Group enriched" "Detected in some" 11 "Early spermatids: 44.1;Late spermatids: 54.9" "Cancer enhanced" "Detected in some" "testis cancer: 2.0" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 16 "SCLC-21H: 30.9;SH-SY5Y: 40.7" "Group enriched" "Detected in some" 5 "olfactory bulb: 5.3;pons and medulla: 1.4;thalamus: 4.2" HPA059484 Approved "Endoplasmic reticulum,Cell Junctions" NA NA "Cluster 77: Retina - Visual perception" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 34: Spermatids - Unknown function" "Endoplasmic reticulum" "Cell Junctions" "HPA059484: " "unprognostic (4.74e-2)" "unprognostic (4.54e-1)" "unprognostic (1.26e-2)" "unprognostic (8.77e-5)" "unprognostic (8.15e-2)" "unprognostic (6.43e-3)" "unprognostic (1.10e-1)" "unprognostic (2.30e-2)" "unprognostic (1.09e-1)" "unprognostic (3.19e-1)" "unprognostic (1.40e-1)" "unprognostic (1.49e-1)" "unprognostic (1.45e-4)" "unprognostic (7.00e-3)" "unprognostic (2.58e-1)" "unprognostic (8.50e-2)" "unprognostic (7.76e-2)" 0.0 2.4 0.2 0.6 0.1 0.3 0.0 0.1 0.2 0.2 0.2 1.1 0.0 0.3 0.3 0.6 0.0 0.0 0.0 0.2 0.5 0.2 0.0 0.0 0.5 0.7 1.8 0.1 0.0 0.2 0.4 0.0 1.4 0.0 0.4 2.7 0.1 0.0 0.3 0.1 0.3 0.4 0.0 0.4 0.3 5.8 0.2 3.0 0.1 0.0 0.4 0.0 0.2 0.3 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.7 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.6 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 30.9 40.7 0.2 0.5 0.1 0.3 0.1 0.1 0.0 0.2 0.5 0.0 0.0 2.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.2 0.5 0.7 1.8 1.4 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 44.1 0.3 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 54.9 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.5 0.1 0.2 0.0 0.4 0.0 0.0 0.3 0.4 0.1 0.1 0.0 0.0 0.0 1.6 2.0 0.0 0.0 0.0 0.0 4.5 0.0 0.1 ADAMTS7 "ADAM-TS7, DKFZp434H204" ENSG00000136378 "ADAM metallopeptidase with thrombospondin type 1 motif 7" Q9UKP4 15 78759206-78811464 "Plasma proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "heart muscle: 30.6" "Cell type enriched" "Detected in some" 4 "Theca cells: 44.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 9 "HMC-1: 259.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA045284, HPA048453" Uncertain Supported Vesicles "Secreted to extracellular matrix" NA NA "Cluster 46: Fibroblasts - ECM organization" "Cluster 3: HMC-1 - Innate immune response" "Cluster 52: Non-specific - Transcription" Vesicles "HPA045284: AB_2679285, HPA048453: AB_2680399" "unprognostic (5.94e-3)" "unprognostic (9.94e-3)" "unprognostic (2.76e-2)" "unprognostic (7.09e-2)" "unprognostic (3.38e-1)" "unprognostic (1.93e-1)" "unprognostic (5.88e-4)" "unprognostic (3.34e-3)" "unprognostic (2.89e-2)" "unprognostic (3.31e-2)" "unprognostic (1.83e-2)" "unprognostic (3.79e-1)" "unprognostic (1.34e-2)" "prognostic unfavorable (9.53e-4)" "unprognostic (1.59e-1)" "unprognostic (2.66e-2)" "unprognostic (8.86e-2)" 6.6 5.3 0.5 1.8 0.4 0.1 3.8 0.3 0.5 6.0 0.6 4.2 1.1 7.2 0.1 0.9 2.2 2.3 30.6 0.4 0.5 2.2 1.1 6.3 0.9 0.5 0.5 6.1 0.5 0.4 0.8 2.1 0.4 1.8 0.2 0.5 1.3 0.4 1.1 1.8 2.6 1.4 0.2 5.2 2.2 4.1 0.7 0.1 2.1 0.5 0.2 3.0 2.5 0.6 0.0 1.1 16.5 7.5 6.9 8.2 20.9 3.7 1.3 1.0 0.6 0.0 0.1 0.0 4.8 0.4 1.0 0.4 0.4 2.0 0.0 0.3 0.6 2.1 0.5 0.1 6.9 0.0 259.9 3.3 2.0 1.9 1.0 5.3 24.0 0.0 0.3 0.7 5.6 0.0 0.1 4.9 4.7 0.0 1.4 17.3 7.7 0.3 0.5 0.9 0.3 23.9 4.8 0.0 0.6 4.0 3.2 0.4 29.8 9.4 1.0 3.3 0.0 0.1 0.0 0.0 1.6 0.1 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.3 0.5 0.4 0.5 0.5 0.5 0.4 0.2 0.7 0.6 7.5 0.0 0.0 3.6 0.3 0.4 0.2 0.7 0.0 0.3 0.1 0.5 9.8 0.0 0.3 0.0 0.0 0.3 0.2 0.1 0.0 0.1 4.9 0.8 7.5 10.5 0.0 0.0 0.1 0.0 0.3 10.1 0.5 0.9 3.8 7.2 2.9 0.3 0.7 0.0 0.2 0.0 2.0 0.0 0.8 2.7 1.5 0.1 1.8 1.0 0.1 1.3 0.0 9.5 1.4 0.3 0.0 1.9 0.0 0.3 0.0 0.1 0.3 0.1 0.0 3.7 5.0 2.6 2.0 0.2 0.1 0.3 0.5 44.9 0.1 0.3 MORF4L1 "Eaf3, HsT17725, MEAF3, MORFRG15, MRG15" ENSG00000185787 "Mortality factor 4 like 1" Q9UBU8 15 78810487-78898139 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Growth regulation, Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042360, HPA062010" Approved Supported "Nuclear speckles" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 23: Testis - Cell cycle regulation" "Cluster 12: NES - Nervous system development" "Cluster 66: Spermatocytes - Spermatogenesis" "Nuclear speckles" "HPA042360: AB_10794275, HPA062010: AB_2684655" "unprognostic (5.36e-2)" "unprognostic (4.30e-1)" "unprognostic (3.68e-1)" "unprognostic (9.69e-2)" "unprognostic (1.27e-1)" "unprognostic (1.83e-3)" "unprognostic (3.61e-3)" "unprognostic (8.61e-3)" "unprognostic (3.15e-1)" "unprognostic (3.58e-2)" "unprognostic (6.96e-2)" "unprognostic (3.69e-1)" "unprognostic (5.77e-2)" "unprognostic (1.17e-1)" "unprognostic (2.12e-1)" "unprognostic (3.92e-2)" "unprognostic (2.60e-3)" 272.8 306.3 183.9 237.6 193.6 427.6 241.5 197.6 285.5 283.8 188.9 270.1 169.4 305.1 213.0 201.1 257.9 256.5 396.6 187.9 240.5 332.2 258.9 243.4 251.8 232.8 221.6 318.2 165.5 263.6 175.1 300.9 223.4 228.7 225.7 265.5 195.9 282.7 559.3 140.5 187.4 331.5 205.4 217.4 186.9 588.7 220.1 297.6 270.2 425.2 279.6 266.2 184.3 227.9 362.0 480.3 863.5 355.4 603.2 620.4 453.2 644.3 636.0 570.7 554.0 436.9 532.7 446.7 517.2 649.1 376.0 442.1 1054.3 432.8 534.3 446.0 420.3 493.5 483.5 406.5 617.9 410.4 424.3 436.7 482.5 323.1 447.6 550.1 689.1 309.7 526.3 398.2 659.2 335.3 392.9 301.6 930.7 472.9 208.5 431.8 673.0 431.0 459.2 488.1 443.6 457.7 578.1 367.2 825.7 871.1 441.7 533.9 543.1 667.2 471.6 359.0 549.6 256.4 770.6 499.2 412.3 647.4 501.4 118.5 195.0 197.5 123.0 188.4 149.4 172.7 176.9 141.6 225.5 163.7 241.9 174.2 154.9 145.1 155.8 214.4 214.2 318.6 183.9 193.6 197.6 285.5 187.9 240.5 232.8 221.6 223.4 205.4 220.1 227.9 374.2 301.3 249.0 38.2 300.0 418.1 624.1 724.2 256.6 104.5 236.1 198.9 372.2 286.0 512.3 290.6 62.6 611.9 309.4 173.4 686.7 545.5 740.6 377.8 352.6 391.1 275.2 298.0 69.6 312.8 815.0 468.2 153.4 282.5 465.8 179.5 372.3 328.6 379.1 200.2 68.5 263.6 451.6 310.9 601.3 504.6 389.5 325.7 501.6 52.5 450.8 322.0 306.9 40.2 80.0 407.4 185.5 464.9 232.0 489.8 178.6 805.1 582.5 97.5 315.5 368.3 500.6 1322.3 467.9 185.3 370.4 663.0 338.2 279.9 199.0 597.1 CTSH "ACC-4, ACC-5, ACC4, ACC5, CPSB" ENSG00000103811 "Cathepsin H" P09668 15 78921058-78949574 "Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 349.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 1569.9;Proximal tubular cells: 523.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 208.5;intermediate monocyte: 137.7;memory B-cell: 83.3;myeloid DC: 183.6;naive B-cell: 56.0;non-classical monocyte: 94.8" "Group enriched" "Detected in all" 5 "B-cells: 83.3;dendritic cells: 183.6;monocytes: 208.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 306.4;HaCaT: 228.2;HDLM-2: 183.0;OE19: 197.4;RT4: 362.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000458, HPA003524" Enhanced Supported "Vesicles,Cytosol,Cytoplasmic bodies" "Intracellular and membrane" NA NA 8700000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 11: Alveolar cells - Smell perception" "Vesicles, Cytosol, Cytoplasmic bodies" "CAB000458: , HPA003524: AB_1846075" "unprognostic (6.47e-2)" "unprognostic (4.65e-3)" "unprognostic (1.05e-1)" "prognostic favorable (6.90e-4)" "unprognostic (4.37e-2)" "unprognostic (1.93e-1)" "unprognostic (7.18e-2)" "unprognostic (3.30e-3)" "unprognostic (2.22e-1)" "unprognostic (5.96e-2)" "unprognostic (4.10e-2)" "unprognostic (3.89e-2)" "unprognostic (6.63e-3)" "unprognostic (3.83e-1)" "unprognostic (4.42e-2)" "unprognostic (2.70e-3)" "unprognostic (1.79e-3)" 34.3 36.4 29.4 100.6 30.2 36.9 48.8 29.9 47.1 112.8 31.4 32.5 77.8 46.7 26.8 37.9 57.6 104.6 51.3 29.6 32.9 238.2 89.5 349.6 191.8 30.8 31.4 30.0 75.5 77.6 10.1 25.7 31.5 59.7 27.3 4.7 63.0 70.7 16.3 48.4 56.7 43.1 30.7 51.8 93.9 10.1 32.7 51.8 27.7 37.7 131.3 202.2 30.6 32.4 122.0 10.0 1.2 30.5 5.4 0.5 20.3 8.6 3.0 13.9 7.0 17.6 306.4 34.6 12.6 0.0 13.5 228.2 5.2 52.6 10.1 183.0 0.4 3.0 1.3 38.4 12.1 0.4 7.1 5.6 10.7 0.2 0.0 59.4 1.0 5.9 76.0 0.0 17.9 2.8 32.6 87.8 8.9 197.4 4.9 0.3 0.4 5.9 49.9 362.1 2.6 5.2 41.5 27.8 75.4 10.1 12.5 48.0 16.4 0.2 6.2 0.0 5.3 0.8 92.4 19.5 0.1 89.2 12.3 0.0 208.5 2.0 7.6 137.7 29.7 83.3 20.5 7.4 183.6 56.0 1.8 3.8 8.7 3.2 94.8 22.9 18.3 147.5 29.4 30.2 29.9 47.1 29.6 32.9 30.8 31.4 31.5 30.7 32.7 32.4 169.8 237.2 1569.9 59.1 127.4 24.2 280.7 363.9 30.1 1.3 45.5 41.7 26.2 358.9 258.7 367.8 4.2 19.8 8.1 9.1 84.1 225.0 25.3 67.0 86.0 124.5 9.1 3.0 2.2 142.0 39.6 53.8 106.0 42.8 32.8 2.7 14.3 115.5 256.7 0.0 2.9 18.6 101.7 177.8 259.6 22.6 73.0 350.4 80.0 15.9 360.9 22.6 5.2 1.5 1.1 84.6 16.0 6.0 155.8 112.0 153.0 523.2 261.6 6.6 19.7 4.5 22.3 12.3 56.4 41.6 18.6 23.4 29.4 17.8 40.1 340.4 RASGRF1 "CDC25, CDC25L, GNRP, GRF1, GRF55, H-GRF55, PP13187" ENSG00000058335 "Ras protein specific guanine nucleotide releasing factor 1" Q13972 15 78959906-79090780 "Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 26.5;lung: 7.5;retina: 7.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 80.6;Excitatory neurons: 80.9;Inhibitory neurons: 91.2;Oligodendrocytes: 121.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 8.5;BEWO: 7.7;Karpas-707: 10.4;RPMI-8226: 13.0;U-2 OS: 15.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010413, HPA041965" Approved Supported "Golgi apparatus" NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 2: Karpas-707 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "CAB010413: AB_2238127, HPA041965: AB_10793939" "unprognostic (2.57e-3)" "unprognostic (3.08e-2)" "unprognostic (3.14e-2)" "prognostic favorable (6.14e-6)" "unprognostic (1.90e-1)" "unprognostic (1.15e-3)" "unprognostic (5.37e-2)" "unprognostic (6.16e-2)" "unprognostic (7.58e-2)" "unprognostic (3.25e-2)" "unprognostic (1.00e-1)" "unprognostic (2.03e-1)" "unprognostic (4.02e-6)" "unprognostic (2.35e-1)" "unprognostic (8.02e-2)" "unprognostic (3.81e-2)" "unprognostic (8.81e-2)" 0.1 0.1 4.2 1.0 4.1 0.0 0.1 24.4 24.4 0.6 0.0 0.2 0.2 0.4 0.1 0.1 0.4 0.1 0.0 12.2 6.4 0.7 0.0 7.5 1.3 13.9 10.2 0.8 2.3 0.6 1.1 0.2 16.4 0.5 0.2 7.4 0.1 0.2 0.0 0.0 1.4 0.1 8.7 0.6 0.2 0.3 14.9 0.5 0.0 0.0 1.4 0.3 0.1 26.5 8.5 0.1 0.1 0.0 0.0 0.0 7.7 0.0 0.4 0.5 1.2 0.0 1.5 0.4 0.2 0.0 0.6 0.7 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.4 0.1 0.0 0.1 0.1 0.3 0.0 0.0 0.0 10.4 1.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.9 13.0 0.1 0.3 0.8 0.0 0.0 0.1 1.6 0.7 0.0 1.7 0.0 0.0 15.1 0.0 0.3 0.0 3.8 2.9 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 4.1 24.4 24.4 12.2 6.4 13.9 10.2 16.4 8.7 14.9 26.5 0.2 3.2 80.6 8.5 4.5 0.6 0.6 0.2 0.0 13.7 0.2 0.1 1.0 0.0 1.9 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.2 0.6 0.4 0.5 0.0 0.0 80.9 0.0 2.7 0.3 0.0 1.8 0.0 0.0 0.0 0.0 2.0 25.2 91.2 0.0 0.0 0.3 16.1 0.0 0.0 1.8 3.6 5.6 0.6 1.1 0.0 1.5 121.5 0.3 0.0 0.4 2.1 0.2 0.0 6.8 2.0 2.5 0.0 0.0 0.1 0.0 0.5 0.0 0.3 0.8 0.1 1.6 0.0 0.4 ANKRD34C ENSG00000235711 "Ankyrin repeat domain 34C" P0C6C1 15 79293285-79298235 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 7 "brain: 5.5" "Group enriched" "Detected in some" 4 "Excitatory neurons: 3.0;Inhibitory neurons: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 17 "SCLC-21H: 8.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA045329 Approved Mitochondria NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Mitochondria "HPA045329: AB_2679291" "unprognostic (3.20e-1)" "unprognostic (1.08e-1)" "unprognostic (1.52e-2)" "unprognostic (1.81e-1)" "unprognostic (3.42e-3)" "unprognostic (5.31e-2)" "unprognostic (2.48e-1)" 0.1 0.1 1.4 0.0 0.5 0.0 0.0 2.0 1.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 3.0 0.0 0.0 0.1 0.0 2.2 2.8 0.0 0.2 0.0 0.7 0.0 3.4 0.0 0.0 0.5 0.0 0.0 0.1 0.7 0.0 0.0 0.2 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.5 2.0 1.9 0.4 3.0 2.2 2.8 3.4 0.2 5.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMED3 "C15orf22, p24B, p24g4, p24gamma4" ENSG00000166557 "Transmembrane p24 trafficking protein 3" Q9Y3Q3 15 79311112-79427432 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 409.4" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 294.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049314, HPA076949" Enhanced Supported "Golgi apparatus" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 21: OE19 - Mitochondria" "Cluster 55: Plasma cells - Humoral immune response" "Golgi apparatus" "HPA049314: AB_2680708, HPA076949: AB_2686820" "prognostic unfavorable (7.71e-4)" "unprognostic (1.60e-1)" "unprognostic (3.54e-3)" "unprognostic (8.86e-3)" "unprognostic (1.41e-1)" "unprognostic (2.03e-3)" "unprognostic (2.42e-2)" "unprognostic (2.49e-1)" "unprognostic (4.85e-1)" "unprognostic (9.06e-2)" "unprognostic (8.09e-2)" "unprognostic (9.90e-2)" "prognostic unfavorable (3.73e-4)" "unprognostic (2.16e-1)" "unprognostic (2.88e-1)" "unprognostic (2.50e-1)" "unprognostic (1.52e-1)" 25.9 26.2 19.6 23.1 19.2 37.0 66.4 21.5 20.5 56.6 30.6 49.9 25.4 38.3 138.7 132.3 38.7 37.8 41.9 20.8 31.9 34.7 12.4 30.9 26.0 22.4 22.0 30.9 246.7 54.9 89.6 42.4 26.5 60.0 55.4 11.3 409.4 54.6 4.6 106.8 26.6 37.3 21.6 32.4 73.1 35.0 22.6 23.1 76.3 7.2 37.8 48.7 75.1 25.1 68.1 169.0 31.9 63.6 220.3 167.5 69.0 153.0 206.7 103.3 126.9 141.4 123.3 31.5 117.3 236.0 135.9 124.5 95.7 98.5 53.0 62.7 145.6 104.5 143.0 110.3 131.5 112.2 200.4 126.5 144.4 59.6 86.9 123.5 120.8 105.9 47.1 0.6 101.4 144.3 32.1 106.0 45.7 251.6 92.2 39.1 47.4 158.9 94.2 51.4 99.4 48.8 80.6 162.1 159.3 103.5 141.5 81.7 98.5 85.2 75.7 2.2 111.4 61.7 78.8 44.1 109.8 180.7 103.1 74.9 69.8 95.1 58.1 85.3 62.7 75.5 57.2 63.9 106.7 63.6 71.4 69.1 6.0 61.4 95.7 109.1 73.1 92.2 19.6 19.2 21.5 20.5 20.8 31.9 22.4 22.0 26.5 21.6 22.6 25.1 9.9 28.9 43.6 6.8 41.2 95.8 109.4 125.6 64.9 14.9 153.8 132.8 16.9 55.8 108.5 57.0 8.4 167.8 40.7 67.7 23.5 143.4 48.9 31.6 39.6 31.7 83.9 33.7 10.0 250.5 294.5 68.1 54.6 70.4 47.0 44.0 65.7 6.4 100.5 13.5 10.2 219.3 87.5 52.7 54.4 118.6 49.7 49.2 85.4 9.4 60.0 38.0 44.3 17.1 12.9 173.3 79.9 27.4 71.1 165.2 43.9 28.9 37.7 17.0 19.7 25.6 57.0 51.1 60.3 104.7 121.8 172.4 30.4 64.6 126.4 200.1 MINAR1 "KIAA1024, UBTOR" ENSG00000169330 "Membrane integral NOTCH2 associated receptor 1" Q9UPX6 15 79432336-79472304 "Predicted membrane proteins" Angiogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 10.3;brain: 4.7;retina: 6.8" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "melanoma: 1.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "U-138 MG: 8.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA011545 Uncertain Approved "Golgi apparatus" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 77: Retina - Visual perception" "Cluster 10: BJ & FHDF - ECM organization" "Golgi apparatus" "HPA011545: AB_1852361" "unprognostic (5.45e-5)" "unprognostic (3.26e-1)" "unprognostic (4.56e-3)" "unprognostic (2.12e-2)" "unprognostic (1.74e-1)" "unprognostic (6.82e-2)" "unprognostic (4.49e-2)" "unprognostic (5.66e-2)" "unprognostic (2.90e-1)" "unprognostic (3.16e-1)" "unprognostic (1.96e-1)" "unprognostic (4.45e-2)" "unprognostic (6.66e-13)" "unprognostic (7.08e-2)" "unprognostic (2.73e-2)" "unprognostic (3.19e-3)" "unprognostic (1.19e-1)" 0.1 10.3 1.0 0.1 0.8 0.4 0.3 4.7 0.7 0.3 0.2 0.2 0.0 0.2 0.3 0.2 0.1 0.3 0.1 0.6 1.6 0.1 0.0 0.1 0.4 3.2 3.5 0.1 2.1 0.0 0.7 0.2 3.4 0.7 0.2 6.8 2.8 0.1 0.1 0.2 0.2 0.1 1.5 0.3 0.3 0.2 1.8 0.2 0.2 0.0 0.2 0.1 0.2 1.1 0.3 0.2 0.4 0.5 1.1 0.9 0.4 0.5 0.8 0.4 0.4 0.0 0.3 0.7 0.1 0.8 0.5 0.2 0.9 0.1 0.3 0.8 1.0 1.9 0.5 0.0 0.6 2.7 0.9 0.4 0.2 0.7 0.1 0.8 0.4 0.8 0.1 0.0 0.1 0.0 0.3 1.0 0.4 0.4 0.4 0.4 0.1 0.4 0.1 0.0 1.8 1.0 0.2 1.6 1.0 0.7 0.2 1.3 0.3 8.7 0.3 0.0 1.9 1.1 1.4 0.3 0.9 1.5 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.8 4.7 0.7 0.6 1.6 3.2 3.5 3.4 1.5 1.8 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MTHFS HsT19268 ENSG00000136371 "Methenyltetrahydrofolate synthetase" P49914 15 79833585-79897379 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Ligase "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 253.4" "Cell type enhanced" "Detected in many" "Hepatocytes: 205.5;monocytes: 150.8;Proximal tubular cells: 201.6;Syncytiotrophoblasts: 253.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 134.1" "Group enriched" "Detected in all" 5 "granulocytes: 134.1;monocytes: 49.1" "Low cell line specificity" "Detected in many" "HPA008067, HPA054177" Approved Supported Cytosol NA NA 13000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 62: Liver - Hemostasis" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Cytosol "HPA008067: AB_1078882, HPA054177: AB_2682405" "unprognostic (4.57e-2)" "unprognostic (9.76e-2)" "unprognostic (6.11e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (8.52e-4)" "unprognostic (9.13e-3)" "prognostic favorable (1.29e-6)" "unprognostic (1.34e-2)" "unprognostic (1.03e-1)" "unprognostic (6.18e-3)" "unprognostic (2.91e-2)" "unprognostic (2.76e-1)" "prognostic favorable (2.04e-4)" "unprognostic (1.36e-1)" "unprognostic (2.85e-1)" "unprognostic (7.60e-2)" "unprognostic (2.90e-1)" 21.9 19.8 8.0 4.6 8.2 5.0 19.0 9.6 12.7 9.9 6.9 12.0 13.7 9.0 10.3 10.1 9.4 7.0 19.0 8.0 9.2 53.1 253.4 17.8 6.4 8.7 9.3 8.6 32.8 26.3 21.5 8.3 9.1 19.5 6.4 5.9 13.6 5.5 20.2 6.2 14.5 6.2 8.8 14.9 19.5 12.1 8.7 10.6 15.9 11.1 10.8 12.4 9.9 9.1 12.6 35.8 5.0 2.6 15.8 12.0 11.9 8.8 13.0 16.4 10.5 34.5 22.4 15.1 25.1 15.5 15.0 19.5 31.9 10.7 15.4 14.7 28.4 14.8 22.9 39.8 25.3 7.8 0.8 17.5 27.8 8.1 23.0 19.6 7.4 16.0 28.8 12.0 17.4 36.0 10.2 36.1 15.6 51.4 17.0 10.8 17.2 25.8 35.1 34.3 8.9 4.8 25.1 14.2 43.8 20.0 17.3 13.0 3.3 5.7 11.1 3.6 7.1 6.8 20.2 17.8 3.3 25.9 6.2 17.5 25.7 73.5 9.4 35.3 12.4 13.5 13.7 12.9 12.3 11.1 16.5 12.6 134.1 17.8 49.1 13.3 15.7 19.1 8.0 8.2 9.6 12.7 8.0 9.2 8.7 9.3 9.1 8.8 8.7 9.1 11.3 19.2 44.0 0.0 20.7 10.7 9.9 63.0 35.9 0.0 25.5 32.5 0.7 58.6 34.3 22.0 0.0 68.1 10.1 10.0 64.6 55.8 2.2 11.9 7.8 10.5 17.6 36.6 0.0 75.7 37.1 13.5 39.8 11.0 8.8 7.2 21.8 205.5 45.7 0.0 0.0 18.7 24.4 22.1 34.8 3.8 13.7 29.3 21.4 0.0 150.8 0.0 35.0 0.0 0.0 75.3 35.9 15.8 13.3 13.3 101.7 201.6 29.9 0.0 13.1 8.4 10.5 6.7 8.5 21.1 8.1 253.8 22.2 9.2 24.9 7.7 ST20-MTHFS ENSG00000259332 "ST20-MTHFS readthrough" 15 79845150-79923754 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 96.6" "Cell type enhanced" "Detected in some" "Basal squamous epithelial cells: 1.8;Collecting duct cells: 1.8;Erythroid cells: 4.2;Gastric mucus-secreting cells: 5.1;Squamous epithelial cells: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 492.2" "Group enriched" "Detected in all" 4 "granulocytes: 492.2;monocytes: 133.6" "Low cell line specificity" "Detected in all" HPA008067 Uncertain NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 59: Non-specific - Transcription" "HPA008067: AB_1078882" "unprognostic (9.84e-2)" "unprognostic (1.74e-2)" "unprognostic (2.06e-2)" "unprognostic (4.41e-2)" "unprognostic (1.46e-2)" "unprognostic (1.94e-1)" "unprognostic (3.75e-3)" "unprognostic (6.63e-3)" "unprognostic (1.02e-1)" "unprognostic (8.19e-4)" "unprognostic (2.38e-1)" "unprognostic (5.26e-2)" "unprognostic (1.26e-1)" "unprognostic (6.53e-2)" "unprognostic (1.28e-1)" "unprognostic (2.04e-1)" 9.9 10.2 7.3 15.2 7.5 10.1 7.8 8.2 12.0 8.5 8.9 9.5 10.9 6.7 10.0 3.8 7.3 7.7 6.5 8.1 8.4 38.6 96.6 11.0 11.8 8.2 8.8 6.0 15.0 24.0 2.4 9.7 8.4 15.5 8.7 12.2 12.8 8.5 10.5 3.8 14.6 7.5 7.4 7.7 12.0 7.6 9.1 10.3 11.1 10.1 12.8 7.2 1.5 9.1 16.2 33.1 6.6 6.5 24.0 14.2 19.1 13.9 22.1 27.4 24.6 15.7 35.9 20.1 29.6 13.1 25.6 29.7 44.2 13.6 17.3 24.8 14.6 20.5 20.4 24.3 25.2 10.5 3.7 21.1 32.2 8.1 27.0 19.5 7.9 26.7 37.6 19.7 13.0 20.9 13.7 26.2 16.3 56.3 13.5 20.4 12.4 22.0 32.5 14.8 16.2 9.8 33.3 22.6 40.8 24.3 26.6 21.0 11.4 11.7 19.9 1.2 10.9 10.8 37.0 21.9 6.4 45.4 9.7 76.4 82.3 223.6 38.9 87.1 48.2 53.1 51.3 42.9 50.8 53.7 58.9 51.0 492.2 77.5 133.6 35.5 60.6 75.7 7.3 7.5 8.2 12.0 8.1 8.4 8.2 8.8 8.4 7.4 9.1 9.1 0.0 0.0 0.5 0.0 1.6 0.1 0.0 0.5 1.8 0.0 0.0 0.0 0.0 0.0 1.4 1.8 0.0 0.4 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.1 0.0 4.2 0.1 0.0 0.2 0.8 5.1 0.2 0.0 0.1 0.0 1.5 0.3 0.0 0.2 0.2 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.3 0.0 1.3 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 4.4 0.3 1.4 1.6 0.0 0.3 0.0 ST20 HCCS-1 ENSG00000180953 "Suppressor of tumorigenicity 20" Q9HBF5 15 79898840-79923702 "Metabolic proteins, Predicted intracellular proteins" "Tumor suppressor" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Hepatocytes: 51.3;monocytes: 84.8;Proximal tubular cells: 52.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 7 "eosinophil: 88.6;neutrophil: 313.4" "Lineage enriched" "Detected in all" 11 "granulocytes: 313.4" "Cell line enhanced" "Detected in many" "SK-MEL-30: 54.6" NA NA "Cluster 50: Neutrophils - Cellular senescence" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 3: Monocytes - Immune response regulation" "unprognostic (2.48e-1)" "unprognostic (1.28e-1)" "unprognostic (1.02e-2)" "unprognostic (6.35e-2)" "unprognostic (2.04e-2)" "unprognostic (3.20e-1)" "unprognostic (1.39e-1)" "unprognostic (3.86e-1)" "unprognostic (1.35e-3)" "unprognostic (4.21e-2)" "unprognostic (3.03e-3)" "unprognostic (2.02e-1)" "prognostic unfavorable (7.69e-8)" "unprognostic (6.49e-2)" "unprognostic (2.61e-2)" "unprognostic (9.88e-2)" "unprognostic (4.19e-2)" 8.1 5.4 9.3 7.0 9.0 4.8 7.5 11.3 12.4 8.2 8.0 7.5 2.0 5.2 8.3 6.3 7.9 2.8 9.4 8.9 10.0 11.6 23.8 10.4 7.6 8.6 8.7 7.0 6.5 4.9 11.2 3.2 9.6 11.0 2.7 8.9 6.0 3.4 4.1 6.8 10.0 2.7 8.2 24.1 5.6 11.0 9.7 6.2 10.5 4.9 5.6 7.8 5.8 9.0 8.6 17.6 7.7 9.3 12.9 10.9 16.2 8.7 5.8 4.5 5.8 3.8 13.7 10.4 5.5 6.5 14.8 14.0 16.2 5.0 3.3 14.8 13.6 12.1 13.5 5.4 11.6 4.6 6.8 12.1 6.4 3.2 9.2 12.4 5.0 19.6 10.1 6.1 7.1 26.4 6.2 31.6 17.8 26.8 11.6 9.1 2.5 5.5 11.4 7.2 11.0 11.9 16.2 10.8 54.6 19.8 9.0 29.4 6.0 11.4 2.9 0.0 7.3 6.6 37.4 16.5 8.8 25.3 5.9 2.2 17.5 88.6 8.0 10.9 6.8 17.1 9.1 8.9 14.1 17.0 8.5 7.8 313.4 18.8 27.8 8.0 8.8 11.0 9.3 9.0 11.3 12.4 8.9 10.0 8.6 8.7 9.6 8.2 9.7 9.0 2.7 6.4 17.9 0.0 6.1 4.8 6.8 17.5 1.2 8.6 16.5 22.1 13.5 7.2 11.8 14.7 8.4 12.2 5.6 12.1 23.5 17.0 17.1 6.9 6.5 5.2 19.3 4.0 0.0 11.9 9.9 5.9 4.1 10.0 7.0 10.2 6.1 51.3 40.0 1.7 0.0 11.7 16.2 8.8 8.1 6.4 7.2 17.7 5.4 0.0 84.8 14.8 2.1 0.0 0.0 15.9 23.2 4.9 1.6 10.9 23.9 52.3 9.8 5.9 6.6 4.4 6.2 23.4 23.5 3.2 4.3 43.1 6.0 6.5 10.7 6.6 BCL2A1 "ACC-1, ACC-2, ACC1, ACC2, BCL2L5, BFL1, GRS, HBPA1" ENSG00000140379 "BCL2 related protein A1" Q16548 15 79960892-79971196 "Cancer-related genes, Predicted intracellular proteins" Apoptosis "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "bone marrow: 617.3" "Group enriched" "Detected in many" 5 "B-cells: 177.4;granulocytes: 220.7;Hofbauer cells: 214.9;Langerhans cells: 508.2;Macrophages: 604.2;monocytes: 386.0" "Cancer enhanced" "Detected in all" "melanoma: 39.4" "Group enriched" "Detected in all" 4 "cerebral cortex: 39.7;pons: 12.5" "Group enriched" "Detected in all" 5 "eosinophil: 284.0;intermediate monocyte: 195.8;neutrophil: 534.0;non-classical monocyte: 378.9" "Group enriched" "Detected in all" 7 "granulocytes: 534.0;monocytes: 378.9" "Cell line enriched" "Detected in many" 5 "SK-MEL-30: 525.0" "Low region specificity" "Detected in single" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 41: Macrophages - Immune response" "unprognostic (3.19e-3)" "unprognostic (2.61e-1)" "unprognostic (3.99e-2)" "unprognostic (3.54e-3)" "unprognostic (9.65e-3)" "unprognostic (1.47e-1)" "unprognostic (1.35e-1)" "unprognostic (1.03e-1)" "unprognostic (1.78e-1)" "unprognostic (1.78e-2)" "unprognostic (4.01e-2)" "unprognostic (2.09e-1)" "prognostic unfavorable (2.77e-5)" "unprognostic (4.61e-2)" "unprognostic (8.96e-2)" "unprognostic (2.78e-1)" "unprognostic (1.87e-1)" 28.6 1.7 2.5 105.1 2.7 617.3 4.3 2.8 39.7 4.3 4.3 5.9 4.6 2.8 1.5 2.4 8.4 17.4 4.6 2.4 2.7 3.4 14.7 59.0 72.0 4.9 3.9 0.9 4.7 0.9 1.3 20.4 12.5 2.3 5.9 0.6 4.4 0.9 0.9 1.7 8.0 13.5 3.4 57.9 5.6 0.4 6.3 17.2 2.4 10.8 56.7 52.1 1.7 5.8 0.4 1.4 0.0 0.1 0.6 0.9 0.0 0.0 6.9 0.0 0.6 0.0 0.1 3.0 0.2 0.0 0.2 0.0 0.0 14.3 4.1 1.5 0.0 0.6 0.0 1.4 2.2 3.7 111.4 2.0 0.1 8.2 0.0 0.2 0.7 0.6 0.0 0.4 0.2 0.0 0.1 19.3 0.1 0.0 3.5 0.2 0.1 0.2 0.6 0.1 0.0 0.1 0.0 0.0 525.0 0.0 0.0 5.0 0.0 51.8 4.9 0.2 1.1 0.5 0.3 4.3 2.3 40.3 27.4 24.2 42.3 284.0 24.5 195.8 13.9 64.4 31.3 32.4 25.2 44.2 38.1 35.1 534.0 21.5 378.9 5.0 8.0 49.1 2.5 2.7 2.8 39.7 2.4 2.7 4.9 3.9 12.5 3.4 6.3 5.8 7.6 22.4 57.3 0.0 177.4 11.0 0.8 50.9 0.6 0.1 2.9 3.7 4.3 0.0 38.0 1.8 0.0 1.9 33.9 0.3 1.9 2.2 1.3 12.0 4.2 6.2 0.0 1.3 0.1 1.6 2.3 8.4 2.0 41.1 220.7 0.2 1.4 1.6 214.9 0.0 0.1 0.1 2.0 60.5 508.2 1.5 0.0 604.2 33.8 0.0 386.0 0.3 13.4 0.0 0.0 6.5 0.1 0.0 14.6 1.4 0.1 0.8 13.8 0.2 0.0 1.3 4.8 0.3 0.2 0.5 10.2 4.5 53.3 0.1 0.2 1.8 ZFAND6 "AWP1, ZA20D3, ZFAND5B" ENSG00000086666 "Zinc finger AN1-type containing 6" Q6FIF0 15 80059568-80138393 "Predicted intracellular proteins" "Apoptosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 496.7;Late spermatids: 598.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034845, HPA052746, HPA077824" Uncertain Approved Nucleoplasm NA NA "Cluster 38: Basophils - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm "HPA034845: AB_10671234, HPA052746: , HPA077824: " "unprognostic (2.04e-1)" "unprognostic (2.25e-2)" "unprognostic (3.26e-1)" "unprognostic (2.31e-1)" "unprognostic (1.29e-1)" "unprognostic (3.70e-2)" "unprognostic (4.26e-2)" "unprognostic (1.03e-1)" "unprognostic (4.91e-2)" "unprognostic (1.22e-1)" "unprognostic (1.74e-2)" "unprognostic (6.48e-3)" "unprognostic (4.90e-3)" "unprognostic (1.22e-1)" "unprognostic (1.45e-1)" "unprognostic (1.55e-1)" "prognostic favorable (8.20e-4)" 63.2 70.2 41.3 48.4 43.1 79.9 65.4 54.5 48.8 47.8 48.7 61.5 54.8 58.2 66.2 54.9 54.9 49.8 90.5 42.1 50.1 76.3 123.5 55.7 73.2 50.6 46.4 40.8 42.1 60.6 41.2 50.6 47.7 56.3 61.1 74.2 52.9 50.6 128.5 44.0 53.9 59.8 53.7 60.9 59.6 135.9 44.0 50.9 100.9 109.8 75.5 55.2 43.1 57.2 78.9 161.0 116.9 67.3 118.0 93.4 110.3 91.7 127.2 78.7 107.0 56.6 133.6 87.5 115.7 94.3 76.6 63.1 125.9 92.3 83.8 52.8 107.2 207.1 72.7 78.5 138.2 74.7 131.9 83.3 117.8 87.3 117.7 108.3 120.0 74.4 84.5 66.8 87.3 83.3 59.5 74.0 73.6 70.3 53.4 48.1 102.6 200.8 196.3 129.4 23.9 68.8 79.2 91.0 238.4 144.5 89.1 106.7 111.5 82.1 66.5 53.2 89.8 88.9 189.1 102.6 85.0 127.1 58.6 505.1 90.0 290.1 93.6 118.9 82.5 226.4 84.7 91.2 103.1 174.4 88.2 98.4 216.3 85.0 167.1 89.5 91.2 135.7 41.3 43.1 54.5 48.8 42.1 50.1 50.6 46.4 47.7 53.7 44.0 57.2 60.5 54.5 86.8 76.0 122.5 149.5 141.3 236.1 46.7 40.3 96.2 60.1 92.7 85.8 147.8 75.4 41.7 125.3 101.1 95.9 199.6 103.7 496.7 102.0 57.0 75.0 82.6 97.2 18.1 98.3 130.8 75.0 69.8 135.3 105.1 57.0 72.8 154.6 144.2 32.0 27.7 88.6 203.4 96.1 173.5 598.2 53.1 109.8 124.5 78.7 167.2 101.3 91.6 61.9 73.9 126.5 107.6 62.8 92.7 174.1 64.8 278.8 168.3 89.9 92.1 70.0 98.6 230.6 173.3 62.8 169.3 392.8 87.0 67.6 67.3 183.4 FAH ENSG00000103876 "Fumarylacetoacetate hydrolase" P16930 15 80152490-80186946 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Phenylalanine catabolism, Tyrosine catabolism" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 301.5" "Cell type enhanced" "Detected in many" "Hepatocytes: 266.8;Proximal tubular cells: 305.5" "Cancer enhanced" "Detected in all" "liver cancer: 23.7" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 34.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 316.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041370, HPA044093" Enhanced Approved Nucleoplasm,Cytosol NA NA 220000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 32: U-937 - Innate immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol Nucleoplasm "HPA041370: AB_2677438, HPA044093: AB_2678806" "unprognostic (3.15e-1)" "unprognostic (5.65e-2)" "unprognostic (1.64e-1)" "unprognostic (6.16e-2)" "unprognostic (2.33e-3)" "prognostic unfavorable (8.51e-4)" "unprognostic (1.19e-2)" "unprognostic (5.83e-2)" "unprognostic (2.51e-2)" "unprognostic (5.21e-2)" "unprognostic (1.80e-1)" "unprognostic (1.23e-1)" "unprognostic (2.17e-2)" "unprognostic (4.21e-2)" "unprognostic (2.99e-1)" "unprognostic (2.93e-1)" "unprognostic (8.98e-2)" 99.2 65.4 16.0 7.0 17.1 20.0 59.0 16.6 21.1 19.2 15.1 13.8 14.6 19.3 50.4 15.2 23.0 9.7 20.3 16.3 18.8 65.0 301.5 20.0 5.7 17.9 19.6 26.4 9.9 18.4 16.8 7.8 16.9 16.6 11.9 1.6 14.8 13.6 31.0 10.9 16.8 13.5 17.2 19.1 14.2 20.8 17.4 6.7 14.5 27.7 5.8 16.4 15.8 17.5 20.1 34.4 13.5 17.0 60.2 62.2 32.9 24.3 56.8 26.2 22.3 22.0 35.9 0.4 39.0 52.6 36.8 29.1 46.8 59.6 25.1 12.5 28.5 166.6 18.0 112.1 316.6 79.6 88.8 107.5 37.1 22.9 39.7 84.2 37.4 38.3 71.1 35.7 50.3 31.0 22.3 42.0 9.9 15.5 37.6 12.2 19.3 123.4 77.0 25.2 0.7 8.3 27.4 76.7 77.9 21.6 58.3 55.0 126.1 46.8 30.0 25.5 42.7 32.7 69.5 13.8 99.6 187.5 26.9 34.5 18.8 3.3 9.6 8.1 2.3 0.1 2.4 6.0 25.3 0.1 3.1 2.7 1.3 5.7 8.4 1.9 2.5 9.7 16.0 17.1 16.6 21.1 16.3 18.8 17.9 19.6 16.9 17.2 17.4 17.5 3.0 3.2 13.8 9.8 4.1 6.8 17.5 30.8 15.4 0.4 19.1 13.7 15.5 21.5 12.5 33.1 0.0 37.9 4.9 9.3 52.8 9.3 7.5 3.0 16.2 3.2 4.2 24.4 0.4 3.5 14.1 16.6 3.6 4.0 41.9 6.3 8.9 266.8 72.5 0.0 2.5 13.0 24.4 21.4 6.6 13.5 9.9 30.5 19.6 1.0 5.7 7.3 3.1 2.5 0.6 4.5 12.8 7.9 5.2 9.7 54.1 305.5 5.3 0.4 0.0 9.2 11.2 1.5 2.1 18.2 5.7 22.0 7.7 8.7 22.4 16.4 CTXND1 LINC01314 ENSG00000259417 "Cortexin domain containing 1" A0A1B0GTU2 15 80195481-80252213 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 30.9;liver: 9.4" "Group enriched" "Detected in some" 5 "Alveolar cells type 2: 6.3;Proximal tubular cells: 14.0" "Group enriched" "Detected in many" 7 "glioma: 3.4;liver cancer: 2.7;melanoma: 9.1;thyroid cancer: 5.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SK-MEL-30: 1.6;WM-115: 4.7" "Region enriched" "Detected in all" 4 "hippocampal formation: 35.0" NA NA "Cluster 65: Brain - Ion transport" "Cluster 17: WM-115 - Nervous system development" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "unprognostic (4.15e-5)" "unprognostic (8.42e-2)" "unprognostic (6.08e-2)" "unprognostic (1.86e-3)" "unprognostic (5.59e-2)" "unprognostic (3.48e-1)" "unprognostic (1.90e-2)" "unprognostic (2.61e-1)" "unprognostic (2.41e-1)" "unprognostic (7.04e-2)" "unprognostic (3.90e-4)" "unprognostic (2.43e-1)" "unprognostic (1.72e-2)" "unprognostic (1.92e-3)" "unprognostic (1.06e-1)" "unprognostic (5.14e-3)" "unprognostic (1.34e-1)" 0.3 3.7 11.4 0.2 9.4 0.0 0.2 4.9 14.0 0.3 3.0 0.9 0.4 0.1 5.4 0.1 0.3 0.1 2.7 30.9 9.8 2.2 9.4 1.5 0.2 7.2 11.1 0.4 0.5 0.0 1.4 0.0 8.4 0.3 0.2 1.4 0.1 0.1 0.5 0.8 0.5 0.0 6.4 1.4 2.6 0.4 14.4 0.0 0.4 0.1 0.2 0.5 0.3 6.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 9.4 4.9 14.0 30.9 9.8 7.2 11.1 8.4 6.4 14.4 6.0 0.0 0.0 6.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.1 0.0 1.9 1.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 ARNT2 "bHLHe1, KIAA0307" ENSG00000172379 "Aryl hydrocarbon receptor nuclear translocator 2" Q9HBZ2 15 80404350-80597933 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 128.0" "Group enriched" "Detected in many" 4 "Astrocytes: 209.6;Excitatory neurons: 204.7;Inhibitory neurons: 301.5;Microglial cells: 98.4;Oligodendrocyte precursor cells: 232.7;Oligodendrocytes: 136.9" "Cancer enhanced" "Detected in all" "glioma: 27.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 28.4;BJ hTERT+ SV40 Large T+ RasG12V: 28.2;hTERT-RPE1: 29.7;LHCN-M2: 26.0;SK-MEL-30: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001056, CAB005081" Enhanced Supported Nucleoplasm NA NA "Cluster 65: Brain - Ion transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "CAB005081: AB_2243005, HPA001056: AB_1845042" "unprognostic (2.04e-3)" "unprognostic (8.32e-2)" "unprognostic (2.10e-1)" "unprognostic (1.95e-1)" "unprognostic (1.11e-1)" "unprognostic (5.65e-2)" "unprognostic (2.61e-2)" "unprognostic (1.48e-1)" "unprognostic (2.74e-2)" "unprognostic (3.00e-1)" "prognostic favorable (1.46e-6)" "unprognostic (2.20e-1)" "prognostic favorable (7.51e-4)" "unprognostic (2.53e-1)" "unprognostic (2.31e-1)" "unprognostic (3.39e-1)" "unprognostic (3.62e-2)" 2.2 2.1 94.4 2.1 100.6 0.4 1.4 47.8 111.7 5.6 29.8 5.8 1.7 5.9 8.2 2.0 5.3 2.5 4.1 128.0 64.2 21.7 0.4 5.0 2.3 61.8 70.5 10.7 3.4 6.4 11.5 1.1 53.6 5.5 2.1 8.1 1.2 5.0 9.7 2.1 2.7 3.9 60.2 3.5 4.1 9.9 84.0 2.2 7.0 6.0 3.0 4.3 2.0 66.7 0.4 16.1 28.4 0.0 0.1 3.6 0.1 12.2 17.3 13.9 28.2 0.0 0.0 0.0 3.0 14.7 7.2 0.4 10.5 0.6 17.7 0.0 2.9 0.5 0.0 1.0 0.9 0.0 7.2 13.2 0.5 6.1 0.3 29.7 0.0 0.0 0.0 0.1 26.0 14.0 0.0 0.0 5.7 0.0 0.2 0.0 0.3 0.0 6.0 20.5 14.9 20.6 1.5 0.2 30.8 1.8 0.6 0.0 0.0 22.2 4.4 0.6 14.7 0.0 0.0 0.0 8.4 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 94.4 100.6 47.8 111.7 128.0 64.2 61.8 70.5 53.6 60.2 84.0 66.7 0.1 0.0 2.3 209.6 0.0 1.3 1.2 1.5 4.0 17.0 3.2 3.4 7.6 2.8 4.7 3.7 8.4 0.2 0.1 0.2 13.7 6.0 36.7 8.5 2.7 1.8 22.9 0.0 204.7 0.2 3.6 2.7 3.1 4.4 2.5 5.7 0.4 0.0 0.2 1.7 301.5 2.6 8.2 0.0 1.6 39.8 0.6 0.4 7.2 98.4 0.1 5.9 2.1 232.7 136.9 2.4 2.3 3.0 0.0 2.2 0.3 1.0 1.6 9.3 6.6 2.6 2.5 2.1 3.0 0.5 0.3 2.7 0.6 1.9 1.3 1.4 ABHD17C FAM108C1 ENSG00000136379 "Abhydrolase domain containing 17C, depalmitoylase" Q6PCB6 15 80679684-80755621 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 65.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 201.4;Intestinal goblet cells: 103.7;Urothelial cells: 86.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 127.1;RT4: 102.6;SK-MEL-30: 119.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048890 Uncertain NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 37: Intestine - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA048890: AB_2680546" "unprognostic (3.60e-1)" "unprognostic (5.07e-2)" "unprognostic (1.58e-1)" "unprognostic (2.19e-2)" "unprognostic (7.51e-2)" "unprognostic (1.20e-1)" "unprognostic (1.59e-2)" "unprognostic (2.32e-1)" "unprognostic (1.40e-1)" "unprognostic (2.59e-2)" "unprognostic (5.08e-3)" "unprognostic (2.87e-1)" "unprognostic (1.23e-3)" "unprognostic (5.75e-2)" "unprognostic (2.91e-1)" "unprognostic (1.35e-1)" "unprognostic (1.89e-3)" 2.5 4.7 17.6 10.3 17.7 5.9 11.7 14.3 18.4 19.3 13.6 65.3 23.3 6.1 2.1 46.5 10.9 6.3 4.2 19.2 16.3 15.6 5.6 19.5 7.2 16.4 16.2 2.0 7.9 7.0 6.0 4.7 14.5 18.1 56.2 16.8 23.6 3.4 1.8 18.7 30.6 5.5 17.0 8.1 36.0 5.2 18.2 5.6 8.0 2.8 23.0 28.7 21.3 16.2 26.4 24.7 15.7 19.8 5.7 11.6 26.8 24.9 93.0 20.7 20.0 20.6 57.7 8.7 9.9 26.4 14.7 52.7 44.1 23.0 18.5 62.0 25.0 0.1 17.7 22.1 9.9 8.0 12.3 24.9 27.1 15.0 7.4 17.9 22.6 9.1 0.2 10.8 12.1 73.3 0.7 0.8 23.3 127.1 9.2 17.4 13.4 24.5 17.0 102.6 13.9 5.7 19.8 33.7 119.9 6.8 16.8 13.5 7.7 12.8 10.5 14.1 22.4 0.8 0.3 8.6 8.3 71.6 14.3 0.0 0.0 0.0 0.7 0.0 0.5 0.3 0.5 0.7 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 17.6 17.7 14.3 18.4 19.2 16.3 16.4 16.2 14.5 17.0 18.2 16.2 2.0 12.8 12.5 32.3 1.4 7.1 13.2 14.3 9.6 4.8 15.7 9.4 5.3 17.2 11.1 7.3 8.4 2.2 2.8 201.4 45.0 6.5 0.3 13.4 7.8 6.9 14.5 0.8 18.4 8.9 5.8 3.1 39.8 35.4 0.0 3.0 6.4 6.0 1.1 10.1 20.1 103.7 10.2 1.3 1.5 0.7 1.2 5.9 8.8 6.5 1.4 4.8 0.0 12.1 3.1 28.1 58.6 0.0 2.4 34.5 46.3 5.6 10.5 22.4 0.0 1.0 2.0 0.7 6.0 19.3 22.7 1.0 2.6 19.6 53.2 86.1 CEMIP "HYBID, IR2155535, KIAA1199, TMEM2L" ENSG00000103888 "Cell migration inducing hyaluronidase 1" Q8WUJ3 15 80779343-80951776 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 25.3;endometrium 1: 31.9" "Group enriched" "Detected in some" 5 "Excitatory neurons: 62.5;Inhibitory neurons: 40.0;Microglial cells: 101.2" "Cancer enhanced" "Detected in all" "colorectal cancer: 21.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 204.1;BJ hTERT+: 321.8;fHDF/TERT166: 258.7;HSkMC: 169.3;hTERT-RPE1: 187.6;U-138 MG: 90.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted in other tissues" NA NA 1700000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "unprognostic (1.14e-3)" "unprognostic (6.80e-2)" "unprognostic (5.95e-2)" "unprognostic (3.15e-3)" "unprognostic (3.49e-3)" "unprognostic (6.80e-2)" "unprognostic (5.47e-2)" "unprognostic (1.22e-1)" "unprognostic (7.49e-2)" "unprognostic (1.53e-1)" "unprognostic (7.24e-2)" "unprognostic (1.36e-1)" "unprognostic (5.27e-10)" "unprognostic (1.82e-2)" "unprognostic (1.93e-1)" "unprognostic (1.34e-1)" "prognostic unfavorable (2.65e-4)" 5.7 1.7 1.6 11.2 8.8 1.5 0.8 5.5 11.1 13.3 25.3 1.3 0.8 31.9 6.9 6.4 6.2 2.1 1.9 2.4 3.5 0.9 0.8 15.0 9.5 3.0 1.7 4.7 1.0 1.5 8.0 2.6 2.4 2.0 1.8 4.1 1.9 1.6 0.4 5.9 1.6 0.6 5.1 1.8 0.9 2.9 4.4 0.3 3.9 0.0 4.7 14.0 2.6 3.1 0.7 7.7 1.5 1.1 0.5 2.8 0.9 204.1 321.8 5.4 4.1 2.4 1.0 1.0 0.6 258.7 0.9 4.9 0.0 0.7 1.1 0.6 1.9 0.7 1.3 17.1 1.9 0.5 1.0 169.3 0.2 39.6 0.2 187.6 0.0 1.0 1.0 0.8 4.8 4.7 0.7 0.5 1.0 68.9 9.2 1.2 0.3 0.9 0.0 3.5 12.7 0.4 3.5 0.5 17.7 2.7 1.0 0.4 1.0 90.6 0.9 6.8 3.5 0.8 0.7 1.2 9.6 1.8 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 1.6 8.8 5.5 11.1 2.4 3.5 3.0 1.7 2.4 5.1 4.4 3.1 0.1 0.0 1.5 2.9 0.1 0.0 0.3 0.0 11.4 2.9 0.0 0.1 1.2 0.0 4.3 0.0 6.2 0.2 0.0 1.1 0.0 0.1 1.0 0.7 4.3 1.6 4.8 0.0 62.5 0.4 0.2 4.3 0.0 7.0 1.3 0.1 0.4 0.0 0.4 3.3 40.0 0.5 0.0 0.0 0.0 0.6 0.3 0.9 0.0 101.2 0.0 0.4 0.0 6.6 8.2 0.7 0.1 0.0 0.1 2.7 0.0 0.1 0.0 3.0 0.0 0.4 0.8 0.2 0.7 1.0 0.0 0.3 0.1 0.1 0.8 0.9 MESD "BOCA, KIAA0081, MESDC2" ENSG00000117899 "Mesoderm development LRP chaperone" Q14696 15 80946289-80989828 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" Chaperone "Disease variant, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 341.4;Extravillous trophoblasts: 279.3;Syncytiotrophoblasts: 436.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039414, HPA041721" Approved Supported "Nuclear bodies,Endoplasmic reticulum,Cytosol" "Intracellular and membrane" NA NA 1600000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 29: Non-specific - Vesicular transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 7: Non-specific - Mitochondria" "Endoplasmic reticulum" "Nuclear bodies, Cytosol" "HPA039414: AB_10674981, HPA041721: AB_2756310" "unprognostic (9.21e-2)" "unprognostic (4.50e-2)" "unprognostic (8.02e-2)" "prognostic favorable (2.31e-4)" "unprognostic (4.93e-3)" "unprognostic (2.32e-3)" "unprognostic (3.47e-2)" "unprognostic (3.09e-3)" "unprognostic (4.04e-1)" "prognostic favorable (1.12e-4)" "unprognostic (7.93e-2)" "unprognostic (3.05e-2)" "unprognostic (3.42e-2)" "unprognostic (1.68e-1)" "unprognostic (4.32e-2)" "unprognostic (3.83e-1)" "unprognostic (1.88e-1)" 14.4 17.4 11.9 13.7 13.6 5.4 13.9 13.7 13.0 17.8 14.6 14.6 12.8 11.3 42.7 14.6 12.4 11.5 12.8 11.7 14.2 14.4 20.6 14.1 14.0 13.4 13.1 17.4 19.2 14.0 17.8 26.9 13.8 18.2 14.5 10.4 18.4 14.3 7.7 10.9 12.7 11.1 13.4 13.8 15.3 9.8 13.8 14.2 33.7 10.6 13.2 15.4 14.4 15.0 26.8 40.2 34.6 22.3 57.1 32.4 54.0 40.0 47.4 42.7 51.6 36.0 72.9 22.4 45.4 32.3 45.1 43.8 54.1 41.1 40.3 50.2 35.5 28.3 33.0 61.9 43.7 33.8 30.0 33.9 46.6 36.1 42.4 35.7 41.1 27.0 34.7 55.5 36.7 34.0 20.9 28.3 41.9 39.3 16.4 31.7 21.3 59.7 35.6 36.3 29.9 17.6 43.9 29.3 70.0 62.4 34.0 26.8 32.4 40.9 39.1 22.1 52.2 35.0 48.0 30.2 38.5 59.7 43.8 39.4 26.1 19.1 35.6 24.9 41.8 34.5 37.2 35.4 27.2 35.4 34.6 34.7 8.1 44.8 22.5 45.2 42.5 31.1 11.9 13.6 13.7 13.0 11.7 14.2 13.4 13.1 13.8 13.4 13.8 15.0 59.7 80.1 59.6 0.0 20.6 0.0 0.0 0.0 0.0 0.0 51.0 44.2 0.0 0.0 27.9 58.8 0.0 341.4 41.6 0.0 13.7 100.9 0.0 41.4 79.4 36.9 0.0 0.0 0.0 111.9 279.3 48.4 0.0 69.8 36.6 56.4 0.0 0.0 122.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.0 0.0 0.0 86.3 0.0 0.0 0.0 0.0 82.5 0.0 0.0 18.8 0.0 0.0 48.8 43.0 0.0 0.0 0.0 36.8 0.0 0.0 0.0 0.0 436.0 25.8 63.6 0.0 0.0 TLNRD1 "MESDC1, MGC99595" ENSG00000140406 "Talin rod domain containing 1" Q9H1K6 15 81000923-81005788 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 36.8;Exocrine glandular cells: 31.5;Extravillous trophoblasts: 31.5;Glandular and luminal cells: 27.7;Hofbauer cells: 35.2;Pancreatic endocrine cells: 44.1;Proximal tubular cells: 30.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "HDLM-2: 47.0;SK-MEL-30: 48.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071716 Approved "Nucleoplasm,Cytoplasmic bodies" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 64: Macrophages - Immune response" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Cytoplasmic bodies" "HPA071716: AB_2732183" "unprognostic (1.32e-2)" "unprognostic (5.30e-2)" "unprognostic (9.29e-2)" "unprognostic (5.37e-3)" "unprognostic (9.10e-3)" "unprognostic (1.24e-2)" "unprognostic (1.61e-2)" "prognostic unfavorable (1.47e-5)" "unprognostic (1.68e-2)" "unprognostic (6.82e-2)" "unprognostic (1.81e-1)" "unprognostic (3.24e-1)" "prognostic unfavorable (1.87e-7)" "unprognostic (1.91e-1)" "unprognostic (1.44e-1)" "unprognostic (8.32e-2)" "unprognostic (3.82e-3)" 13.5 9.6 4.8 5.4 8.7 7.5 7.8 12.5 6.4 6.2 6.3 7.1 3.7 7.3 2.0 8.2 7.1 3.7 10.0 5.2 3.9 7.4 6.2 14.5 4.3 6.8 4.8 4.6 10.1 1.6 5.9 4.6 5.3 5.3 2.9 1.2 6.3 1.8 1.9 3.4 6.9 2.4 5.0 11.8 8.0 1.6 6.3 3.5 5.3 2.1 2.9 7.7 5.5 4.9 11.2 3.6 9.4 6.8 4.1 2.4 15.5 10.0 2.8 6.2 4.5 6.3 10.0 12.1 13.7 2.5 3.7 14.2 5.8 3.2 3.5 47.0 17.0 23.8 2.2 6.9 3.1 8.4 16.6 2.5 4.2 3.8 3.7 2.2 9.4 10.3 13.7 29.3 4.2 5.6 13.3 9.7 14.9 7.2 5.0 16.9 9.5 27.7 4.0 11.2 14.7 12.5 5.6 6.1 48.0 8.0 5.4 7.3 11.2 7.1 22.3 9.9 15.1 20.2 21.4 12.9 4.8 12.0 7.5 0.5 0.3 0.4 0.6 0.5 0.5 0.8 0.7 0.7 0.2 0.5 0.3 0.5 0.5 1.2 0.4 0.5 0.3 0.3 4.8 8.7 12.5 6.4 5.2 3.9 6.8 4.8 5.3 5.0 6.3 4.9 36.8 0.0 9.4 0.0 8.2 0.0 0.0 0.0 0.0 0.0 23.3 12.7 0.0 0.0 4.3 12.9 0.0 8.4 19.3 0.0 1.9 15.1 0.0 13.4 21.4 17.6 0.0 0.0 0.0 31.5 31.5 10.4 0.0 27.7 2.5 15.9 0.0 0.0 35.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 3.1 0.0 0.0 0.0 0.0 44.1 0.0 0.0 4.1 0.0 0.0 30.9 2.2 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 9.0 6.5 11.1 0.0 0.0 AC068870.4 ENSG00000288625 "Novel protein" 15 81002142-81002279 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 13 "brain: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "TIME: 8.9" NA NA "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 8.9 0.0 0.7 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.1 0.6 0.2 0.3 0.8 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CFAP161 "C15orf26, FLJ38615" ENSG00000156206 "Cilia and flagella associated protein 161" Q6P656 15 81007033-81149179 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 34.8;fallopian tube: 15.8" "Cell type enhanced" "Detected in some" "Early spermatids: 18.1;Endometrial ciliated cells: 26.5;Late spermatids: 5.4;Respiratory ciliated cells: 23.3;Spermatocytes: 15.6" "Cancer enriched" "Detected in some" 4 "endometrial cancer: 2.4" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "HEL: 84.4;K-562: 29.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA076975 Supported NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 36: HEL - Hemostasis" "Cluster 49: Ciliated cells - Cilium organization" "HPA076975: " "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (6.07e-2)" "prognostic favorable (3.05e-4)" "unprognostic (1.57e-3)" "unprognostic (2.81e-1)" "unprognostic (1.22e-1)" "unprognostic (1.38e-1)" "unprognostic (2.18e-1)" "unprognostic (1.73e-1)" "unprognostic (3.33e-2)" "unprognostic (3.13e-1)" "unprognostic (1.29e-3)" "unprognostic (8.93e-2)" "unprognostic (1.47e-1)" "unprognostic (9.24e-2)" "unprognostic (6.22e-2)" 0.4 0.1 0.8 0.1 1.2 0.6 0.2 4.3 1.1 0.6 34.8 0.1 0.0 0.6 0.6 0.1 15.8 0.2 0.6 1.2 0.6 0.3 0.2 2.7 0.1 2.5 3.5 0.1 0.2 0.3 1.7 1.3 2.0 0.1 0.0 1.3 0.2 0.2 0.2 0.5 0.1 0.2 3.0 0.5 0.2 6.4 1.2 0.0 0.6 0.8 0.2 0.2 0.1 1.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.2 0.2 0.3 0.0 0.0 0.2 0.2 0.0 0.2 0.2 0.3 0.0 84.4 0.2 0.2 0.0 0.0 11.0 0.0 0.0 0.3 1.0 0.0 1.7 0.0 29.2 0.9 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.8 0.0 1.2 0.2 0.2 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 1.4 0.1 0.0 0.2 0.2 0.0 0.1 0.2 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 3.4 0.8 1.2 4.3 1.1 1.2 0.6 2.5 3.5 2.0 3.0 1.2 1.0 0.2 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.1 26.5 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 2.8 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 23.3 0.6 0.0 0.0 0.0 15.6 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.2 IL16 "FLJ16806, FLJ42735, HsT19289, IL-16, LCF, prIL-16" ENSG00000172349 "Interleukin 16" Q14005 15 81159575-81314058 "Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Chemotaxis, Host-virus interaction, Transcription, Transcription regulation" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 135.3" "Cell type enhanced" "Detected in many" "B-cells: 135.3;dendritic cells: 78.1;Kupffer cells: 59.2;Langerhans cells: 94.4;NK-cells: 121.5;Plasma cells: 55.6;T-cells: 76.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 57.3" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 27.7;HEL: 29.4;HMC-1: 50.6;RPMI-8226: 51.0;U-266/70: 60.3;U-698: 25.8;U-937: 35.1" "Group enriched" "Detected in all" 11 "cerebellum: 54.5;hippocampal formation: 27.0" "Region enriched" "Detected in many" 12 "cerebellum: 48.8" "CAB005247, HPA018467, HPA048861" Enhanced Supported "Nuclear speckles,Plasma membrane,Cytosol" "Secreted to blood" NA NA 208000 7300 "Cluster 5: Granulocytes - Unknown function" "Cluster 3: T-cells - Adaptive immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Nuclear speckles" "Plasma membrane, Cytosol" "CAB005247: AB_2124730, HPA018467: AB_1851642, HPA048861: " "unprognostic (8.23e-3)" "unprognostic (2.70e-3)" "unprognostic (1.97e-2)" "unprognostic (9.61e-4)" "unprognostic (2.01e-1)" "unprognostic (5.26e-4)" "unprognostic (2.63e-2)" "unprognostic (6.72e-3)" "unprognostic (2.25e-1)" "unprognostic (3.91e-1)" "unprognostic (1.47e-1)" "unprognostic (6.21e-2)" "unprognostic (3.16e-3)" "unprognostic (1.21e-1)" "unprognostic (3.23e-2)" "unprognostic (5.26e-2)" "unprognostic (1.29e-1)" 18.9 6.3 3.5 63.3 3.0 62.1 15.5 57.3 4.1 9.6 13.8 14.4 11.3 9.9 7.7 7.4 17.8 16.2 5.9 2.9 5.7 3.2 9.7 23.7 132.6 5.9 5.7 6.1 2.6 2.3 2.1 9.0 10.5 5.8 16.8 0.5 11.2 4.5 3.3 12.0 39.9 9.8 5.8 86.2 15.6 4.2 5.2 130.4 6.9 8.5 135.3 18.9 10.4 7.6 0.0 0.0 0.0 0.1 17.5 7.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 27.7 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.4 0.0 29.4 0.0 0.0 0.9 21.0 50.6 0.9 0.0 0.1 0.6 0.0 0.4 3.5 3.2 10.7 0.1 0.0 1.7 22.2 0.0 0.1 0.0 0.1 0.1 51.0 0.0 0.2 0.1 0.1 0.1 0.0 9.9 0.0 0.0 4.6 0.2 0.3 0.2 1.0 0.0 60.3 5.5 25.8 1.8 35.1 1.5 252.8 116.2 321.3 164.5 142.7 185.9 166.0 170.6 180.6 150.9 157.2 224.9 185.6 282.5 213.2 149.1 113.7 197.0 338.0 3.5 3.0 57.3 4.1 2.9 5.7 5.9 5.7 10.5 5.8 5.2 7.6 9.4 3.2 6.6 0.0 135.3 8.2 0.2 0.8 1.2 0.2 0.8 1.4 2.7 8.6 1.9 1.8 0.0 0.3 78.1 0.3 0.0 0.1 1.4 3.1 6.6 7.5 0.0 20.2 3.4 0.2 0.3 15.9 1.1 0.7 27.1 0.0 26.7 9.2 19.0 0.0 4.9 0.3 0.0 59.2 94.4 1.4 10.8 33.1 28.4 18.7 30.2 0.3 121.5 0.0 0.3 0.0 1.2 18.0 55.6 0.1 0.1 0.4 7.7 0.7 6.6 1.1 3.2 2.1 7.5 1.2 3.7 0.4 76.3 0.2 0.7 0.2 STARD5 MGC10327 ENSG00000172345 "StAR related lipid transfer domain containing 5" Q9NSY2 15 81309053-81324183 "Metabolic proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 28.0;Plasma cells: 31.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 5.8;RPMI-8226: 6.2;U-266/70: 7.1;U-937: 6.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA040662 Approved Approved Vesicles,Cytosol NA NA "Cluster 44: Non-specific - Transcription" "Cluster 31: Skin - Epidermis development" "Cluster 3: HMC-1 - Innate immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Vesicles Cytosol "HPA040662: AB_10959593" "unprognostic (5.35e-4)" "unprognostic (1.55e-1)" "unprognostic (2.58e-2)" "unprognostic (2.76e-1)" "unprognostic (1.21e-1)" "unprognostic (1.78e-1)" "unprognostic (2.22e-4)" "unprognostic (1.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.10e-2)" "unprognostic (2.08e-2)" "unprognostic (8.08e-2)" "unprognostic (6.81e-2)" "unprognostic (2.08e-2)" "unprognostic (1.46e-2)" "unprognostic (4.84e-3)" "unprognostic (7.55e-3)" 1.0 0.6 0.6 6.0 0.8 4.3 0.7 3.4 1.3 7.2 1.9 2.8 2.2 4.6 5.0 3.4 1.8 1.3 0.8 0.6 0.7 0.7 5.1 1.1 7.7 0.9 1.0 1.2 0.6 0.6 0.4 1.6 1.2 3.6 3.7 0.4 1.6 2.1 0.6 7.9 4.2 1.8 0.9 6.2 2.1 0.7 0.7 0.5 0.8 0.3 1.5 2.5 5.5 1.4 0.3 0.0 0.0 0.9 2.3 2.3 0.1 0.3 0.3 0.8 1.2 0.1 0.1 4.8 0.0 1.5 0.2 4.0 1.1 1.0 0.6 0.1 0.4 1.8 0.3 0.4 0.5 2.8 5.8 2.0 2.0 0.3 0.6 1.5 0.1 1.9 0.6 1.3 0.5 0.1 0.5 4.0 0.3 0.2 0.0 0.1 0.7 6.2 0.3 1.4 0.3 0.1 0.1 0.5 0.6 0.3 0.6 0.6 0.2 1.3 0.6 1.3 0.1 7.1 1.5 1.8 0.9 6.8 0.4 5.0 1.8 2.3 3.0 2.4 2.5 1.0 2.7 3.2 2.6 0.7 3.9 3.9 1.3 2.6 2.3 1.4 3.6 3.7 0.6 0.8 3.4 1.3 0.6 0.7 0.9 1.0 1.2 0.9 0.7 1.4 3.8 0.0 1.1 0.0 11.4 13.3 12.0 28.0 10.8 1.8 2.7 4.2 0.3 0.0 4.9 0.0 6.2 2.5 4.2 22.1 3.9 1.3 15.2 2.5 14.4 2.5 11.4 2.5 2.2 1.4 4.0 8.5 15.8 2.3 10.2 1.0 3.6 25.4 5.2 1.7 2.0 24.3 2.0 7.9 10.9 1.5 5.0 8.0 1.8 1.9 0.7 1.2 2.1 0.0 0.4 1.8 14.4 9.8 31.5 3.3 23.9 0.7 4.0 0.9 0.0 3.8 2.8 0.9 0.7 19.6 16.3 4.9 4.2 6.3 19.9 9.6 TMC3 ENSG00000188869 "Transmembrane channel like 3" Q7Z5M5 15 81331088-81374213 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 30 "parathyroid gland: 83.6" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 1.7;Distal tubular cells: 1.9;Excitatory neurons: 1.0;Spermatocytes: 1.1" "Cancer enhanced" "Detected in single" "breast cancer: 0.5" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA040265, HPA040510" Enhanced Supported Cytosol NA NA "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 25: RPMI-8226 - Immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" Cytosol "HPA040265: AB_10795379, HPA040510: AB_10796123" "unprognostic (1.17e-2)" "unprognostic (3.43e-1)" "unprognostic (3.14e-1)" "unprognostic (8.33e-2)" "unprognostic (1.22e-2)" "unprognostic (1.63e-2)" "unprognostic (4.85e-3)" "unprognostic (2.20e-2)" "unprognostic (3.12e-2)" "unprognostic (1.77e-1)" "unprognostic (6.20e-5)" "unprognostic (2.32e-1)" "unprognostic (1.97e-7)" "unprognostic (1.60e-1)" "unprognostic (5.31e-2)" "unprognostic (1.26e-1)" "unprognostic (5.96e-2)" 0.1 0.2 0.7 0.4 0.7 0.8 0.4 2.4 0.9 0.3 0.3 0.4 0.6 0.4 1.6 0.1 0.9 0.6 0.2 0.6 0.2 0.2 0.3 0.1 0.4 0.7 1.0 0.4 0.2 83.6 0.1 0.2 2.7 0.4 0.1 0.7 0.6 0.5 0.2 0.4 0.4 0.1 0.5 0.3 0.2 0.7 0.5 0.1 0.8 0.1 0.1 0.1 0.8 0.7 0.3 0.3 0.1 0.9 0.1 0.0 0.6 0.2 0.1 0.0 0.1 0.2 0.6 0.8 0.0 0.0 0.8 0.2 0.1 0.0 0.0 0.5 0.5 0.6 0.3 0.3 0.1 0.5 0.3 0.1 0.0 0.1 0.1 0.4 0.0 0.9 0.2 1.0 0.0 0.3 0.3 0.4 0.5 0.3 0.3 0.2 0.3 1.5 0.0 0.2 0.3 0.6 0.2 0.3 0.6 0.2 0.7 0.3 0.1 0.5 0.6 0.4 0.2 1.5 0.6 0.5 0.3 0.8 0.3 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.3 0.3 0.2 0.0 0.0 0.0 0.1 0.2 0.1 0.7 0.7 2.4 0.9 0.6 0.2 0.7 1.0 2.7 0.5 0.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.1 0.6 0.1 0.6 0.0 0.0 1.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MEX3B "DKFZp434J0617, RKHD3, RNF195" ENSG00000183496 "Mex-3 RNA binding family member B" Q6ZN04 15 82041778-82046119 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "cervix: 14.0;testis: 46.8" "Group enriched" "Detected in many" 8 "Early spermatids: 204.7;Granulosa cells: 99.5;Late spermatids: 201.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 65.9;HEL: 49.2;SH-SY5Y: 26.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041093 Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 23: Testis - Cell cycle regulation" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Cytosol" "HPA041093: AB_10793868" "unprognostic (2.42e-1)" "unprognostic (1.76e-1)" "unprognostic (2.74e-2)" "unprognostic (6.84e-2)" "unprognostic (1.43e-1)" "unprognostic (1.64e-1)" "unprognostic (5.22e-2)" "unprognostic (7.56e-2)" "unprognostic (4.98e-2)" "unprognostic (1.18e-1)" "unprognostic (2.31e-1)" "unprognostic (9.31e-3)" "unprognostic (5.93e-8)" "unprognostic (1.24e-2)" "unprognostic (9.05e-2)" "unprognostic (4.09e-2)" "unprognostic (1.51e-2)" 2.2 0.4 1.7 1.5 1.6 2.0 1.5 2.8 2.8 14.0 0.0 3.4 0.6 6.2 0.5 0.9 1.3 2.5 2.7 1.8 0.7 0.7 0.9 1.5 2.7 0.7 0.9 5.6 0.6 0.2 0.8 2.3 0.7 2.5 0.7 0.8 2.6 3.2 1.6 1.1 1.1 1.4 0.3 1.1 1.0 46.8 1.9 6.4 0.8 2.0 1.0 1.4 4.1 1.0 0.2 2.5 17.2 65.9 1.4 2.0 4.9 2.1 1.0 3.6 3.2 0.5 0.4 3.2 1.2 3.9 1.1 0.5 8.2 0.3 2.5 0.7 5.3 49.2 2.8 2.2 2.8 0.6 15.1 1.0 1.3 2.0 4.0 8.4 7.6 6.1 2.4 0.0 6.2 1.6 8.3 4.2 22.4 0.1 0.6 11.4 10.4 1.7 0.1 0.0 13.7 26.2 3.5 0.6 2.4 4.8 0.2 0.8 6.9 9.0 10.3 5.0 3.1 6.1 3.4 3.7 2.9 5.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.6 2.8 2.8 1.8 0.7 0.7 0.9 0.7 0.3 1.9 1.0 3.6 0.0 0.6 0.0 1.3 2.8 0.4 1.4 5.2 3.1 6.0 8.0 4.5 1.5 0.4 0.0 2.1 11.3 1.6 0.7 0.0 0.8 204.7 1.8 13.5 5.3 1.2 7.2 2.1 0.2 8.7 8.3 0.5 1.3 1.3 99.5 2.5 0.2 1.5 0.0 3.4 1.0 0.0 1.0 9.8 201.1 6.5 5.0 7.2 1.0 0.5 5.2 0.0 4.0 1.3 0.5 0.2 4.5 0.8 0.8 0.0 0.0 0.3 2.9 6.6 1.9 16.8 2.7 18.8 5.8 2.0 2.5 2.0 1.0 1.4 0.2 EFL1 "EFTUD1, FAM42A, FLJ13119, HsT19294, RIA1" ENSG00000140598 "Elongation factor like GTPase 1" Q7Z2Z2 15 82130233-82262734 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Protein biosynthesis, Ribosome biogenesis" "Elongation factor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 9.2;Glandular and luminal cells: 9.5;Granulosa cells: 16.0;Pancreatic endocrine cells: 9.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039654, HPA047110, HPA052345" Uncertain Approved Cytosol NA NA "Cluster 34: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 18: U-2197 - ECM organization" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA039654: AB_2676610, HPA047110: AB_2797233, HPA052345: AB_2681794" "unprognostic (2.53e-1)" "unprognostic (2.04e-1)" "unprognostic (9.92e-3)" "unprognostic (8.99e-2)" "unprognostic (1.84e-1)" "unprognostic (1.60e-1)" "unprognostic (2.64e-3)" "unprognostic (3.35e-1)" "unprognostic (1.14e-1)" "unprognostic (4.75e-3)" "unprognostic (3.56e-2)" "unprognostic (3.14e-1)" "prognostic favorable (1.50e-6)" "unprognostic (8.58e-2)" "unprognostic (2.96e-1)" "unprognostic (2.60e-1)" "unprognostic (7.05e-2)" 6.2 7.4 5.0 8.2 5.3 8.8 9.9 4.9 5.4 7.3 6.7 13.3 11.6 7.1 7.5 8.3 7.7 7.0 7.3 4.6 5.4 8.6 9.3 6.9 9.6 5.0 5.1 4.9 6.2 14.7 4.6 6.9 5.7 7.2 16.5 7.2 6.7 6.8 11.6 9.0 12.8 8.8 4.8 7.0 8.3 11.2 5.3 16.6 7.8 12.4 10.8 8.1 7.2 6.0 9.8 24.5 18.0 14.9 11.7 16.1 11.6 28.0 33.1 19.9 26.1 12.2 16.7 24.0 11.4 21.4 25.2 24.9 47.5 18.5 31.8 21.8 23.1 26.8 20.2 9.3 18.3 17.0 18.3 7.9 28.9 20.5 46.0 23.7 27.0 30.8 20.5 10.8 23.6 14.1 22.5 13.9 16.0 17.5 12.6 23.8 26.4 13.3 14.1 29.7 15.8 16.8 17.7 20.5 21.6 30.7 15.6 15.1 22.9 28.1 18.5 71.6 28.6 13.4 54.9 20.1 25.1 32.2 10.5 23.1 5.7 14.6 8.6 8.2 6.9 9.4 8.0 7.5 7.0 9.9 6.9 6.0 1.0 6.5 9.9 3.3 7.9 4.8 5.0 5.3 4.9 5.4 4.6 5.4 5.0 5.1 5.7 4.8 5.3 6.0 4.1 3.2 5.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 5.7 3.9 0.0 0.0 4.3 0.0 0.0 7.1 5.5 0.0 3.9 6.8 0.0 9.2 5.1 1.4 0.0 0.0 0.0 6.0 4.0 2.5 0.0 9.5 5.1 16.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 2.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.4 0.0 0.0 5.5 7.3 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 6.8 2.9 4.9 0.0 0.0 SAXO2 "DKFZp666G057, FAM154B" ENSG00000188659 "Stabilizer of axonemal microtubules 2" Q658L1 15 82262810-82284930 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 59.9;testis: 21.6" "Group enriched" "Detected in many" 4 "Early spermatids: 90.9;Endometrial ciliated cells: 71.5;Late spermatids: 175.4;Respiratory ciliated cells: 201.9;Spermatocytes: 57.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 10.5;K-562: 10.0;SCLC-21H: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040487, HPA040833" Enhanced Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 1: K-562 - Erythropoiesis" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "Golgi apparatus" "HPA040487: AB_10796457, HPA040833: AB_10796561" "unprognostic (3.03e-2)" "unprognostic (3.59e-1)" "unprognostic (1.91e-2)" "unprognostic (1.19e-2)" "unprognostic (1.98e-1)" "unprognostic (2.28e-1)" "unprognostic (4.13e-1)" "unprognostic (4.69e-2)" "unprognostic (6.26e-2)" "unprognostic (3.11e-2)" "unprognostic (1.04e-3)" "unprognostic (1.97e-1)" "unprognostic (2.91e-1)" "unprognostic (2.90e-2)" "unprognostic (4.71e-2)" "unprognostic (6.20e-2)" "unprognostic (3.87e-2)" 0.9 1.1 2.1 0.3 2.2 0.6 3.2 2.3 2.7 2.3 8.3 1.3 0.7 2.2 17.9 0.6 59.9 1.0 1.3 2.5 2.3 2.7 0.9 8.0 1.2 3.2 5.0 1.7 1.6 4.7 4.9 0.4 2.4 2.6 2.0 6.9 2.8 1.2 1.3 2.1 1.6 0.6 3.1 1.2 2.5 21.6 2.5 2.6 3.5 0.8 1.6 1.3 1.0 3.7 1.4 1.9 1.1 4.1 0.9 1.8 0.5 0.5 0.3 0.8 1.5 0.2 2.3 1.4 1.0 0.0 2.2 10.5 1.8 1.6 1.8 1.0 6.8 0.5 3.4 0.0 0.1 0.3 0.4 1.2 2.2 1.4 1.2 2.3 1.7 2.9 10.0 0.7 1.0 1.0 0.5 0.0 2.7 0.5 0.8 1.4 0.5 0.9 0.8 0.9 7.8 1.2 1.1 0.0 1.5 0.6 4.0 0.4 0.2 2.0 1.1 4.2 0.8 2.1 2.6 0.9 1.9 0.5 1.3 0.0 0.0 3.0 0.5 0.0 0.8 1.3 0.2 1.5 0.1 3.3 0.9 0.4 0.0 2.0 0.1 0.8 0.0 0.3 2.1 2.2 2.3 2.7 2.5 2.3 3.2 5.0 2.4 3.1 2.5 3.7 1.8 0.0 2.7 9.1 1.5 0.0 2.0 0.0 2.8 2.7 4.5 4.1 2.7 1.5 24.1 3.7 4.2 0.5 0.9 0.1 1.9 0.7 90.9 71.5 1.5 0.9 2.4 0.8 21.1 0.5 0.4 1.5 10.2 2.0 1.3 3.7 0.4 0.3 0.1 0.0 16.4 1.9 0.0 0.6 0.0 175.4 2.5 0.5 0.0 3.7 0.0 3.7 0.0 9.0 8.0 0.3 0.1 2.2 1.9 1.5 0.3 4.6 201.9 5.0 6.6 1.0 1.0 57.7 12.7 0.9 0.0 0.3 0.7 3.0 0.5 1.6 GOLGA6L10 GOLGA6L18 ENSG00000278662 "Golgin A6 family like 10" A6NI86 15 82339993-82349475 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 16.6" "Cell type enriched" "Detected in many" 5 "Early spermatids: 175.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 3.3;K-562: 1.1;SuSa: 1.2" NA NA "Cluster 71: Testis - DNA repair" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (8.06e-2)" "unprognostic (2.56e-1)" "unprognostic (2.51e-1)" "unprognostic (8.31e-2)" "unprognostic (2.97e-1)" "unprognostic (1.43e-1)" "unprognostic (7.37e-2)" "unprognostic (6.12e-2)" "unprognostic (7.01e-2)" "unprognostic (4.10e-1)" "unprognostic (2.36e-4)" "unprognostic (8.30e-2)" "unprognostic (6.06e-6)" "unprognostic (4.13e-2)" "unprognostic (3.08e-1)" "unprognostic (2.16e-1)" "unprognostic (5.34e-2)" 1.3 1.9 0.3 0.1 0.4 0.3 1.5 0.3 0.4 4.1 1.3 2.2 0.1 2.1 0.1 6.2 3.3 0.2 1.5 0.3 0.3 1.5 1.3 1.6 0.1 0.2 0.2 3.6 3.0 0.2 2.1 0.1 0.2 2.2 0.1 0.6 4.6 0.1 1.8 2.5 1.6 0.2 0.2 1.3 2.8 16.6 0.3 0.1 2.0 0.2 0.1 2.6 5.5 0.3 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.4 0.2 0.1 0.3 0.6 0.1 0.0 0.0 0.0 3.3 0.0 0.7 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.5 1.1 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.1 0.3 0.7 0.1 0.2 0.0 1.0 1.2 0.2 0.1 0.0 0.4 0.1 0.1 0.0 1.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.3 0.4 0.3 0.3 0.2 0.2 0.2 0.2 0.3 0.3 1.4 6.4 5.5 2.3 0.9 0.0 4.4 0.0 1.2 6.1 2.2 2.0 2.2 2.8 3.1 5.5 4.2 2.6 2.3 1.0 0.0 2.8 175.7 11.2 3.0 1.1 4.9 0.0 1.9 2.9 0.6 2.6 5.1 6.0 1.3 6.7 2.5 2.0 0.8 3.3 1.5 2.4 0.0 0.3 0.0 26.5 3.7 0.8 0.0 1.0 0.1 4.5 1.0 2.0 0.4 4.8 3.3 1.5 0.7 2.9 2.5 0.5 2.2 7.5 0.0 1.6 1.2 34.0 12.4 3.1 0.0 0.3 0.7 4.6 3.5 3.3 GOLGA6L9 GOLGA6L20 ENSG00000197978 "Golgin A6 family like 9" A6NEM1 15 82430018-82439153 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 1.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 30.0;Astrocytes: 30.3;Early spermatids: 72.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 4.0;HDLM-2: 3.6;U-266/84: 3.3" NA NA "Cluster 24: Salivary gland - Salivary secretion" "Cluster 44: HDLM-2 - Immune response" "Cluster 29: Early spermatids - Spermatogenesis" "unprognostic (2.13e-1)" "unprognostic (1.51e-2)" "unprognostic (3.80e-1)" "unprognostic (7.40e-2)" "unprognostic (1.53e-1)" "unprognostic (9.09e-3)" "unprognostic (5.73e-2)" "unprognostic (2.48e-3)" "unprognostic (2.92e-2)" "unprognostic (4.76e-3)" "unprognostic (1.22e-2)" "unprognostic (6.63e-3)" "unprognostic (5.09e-5)" "unprognostic (4.78e-2)" "unprognostic (1.65e-1)" "unprognostic (7.06e-2)" "unprognostic (5.29e-3)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.9 0.0 0.0 0.0 0.4 0.6 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.5 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 1.4 0.8 4.0 0.0 0.0 2.1 0.6 0.0 0.2 0.0 0.0 1.3 1.6 0.0 0.2 0.0 0.6 0.5 0.2 0.1 3.6 0.0 0.0 1.7 0.9 0.4 0.1 1.3 0.0 1.5 0.0 0.5 0.7 0.5 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 1.4 0.0 0.0 2.5 0.0 2.6 0.0 0.9 2.2 0.7 0.6 0.0 0.0 0.0 2.0 1.5 1.6 1.9 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.4 1.7 9.6 30.0 30.3 2.1 0.1 1.5 0.0 8.6 5.9 2.9 2.2 5.6 4.3 19.8 3.7 8.4 1.5 2.4 6.4 0.0 4.4 72.6 18.0 3.5 2.5 16.2 5.9 27.5 3.7 0.7 3.6 18.3 8.1 1.3 6.9 4.2 2.0 0.7 6.7 17.9 7.6 0.0 0.6 0.4 10.2 1.2 1.1 0.0 12.2 1.1 4.0 0.0 19.1 2.6 6.3 3.3 1.2 1.9 3.1 2.9 0.5 7.4 9.1 0.0 3.0 2.2 13.7 6.1 22.1 0.0 0.8 1.9 4.7 8.7 2.7 RPS17 "MGC72007, RPS17L, RPS17L1, RPS17L2, S17" ENSG00000182774 "Ribosomal protein S17" P08708 15 82536750-82540459 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal prostatic cells: 5841.9;Extravillous trophoblasts: 6575.5;Prostatic glandular cells: 6309.4;Urothelial cells: 5768.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055060 Approved Approved "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 340000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Endoplasmic reticulum, Cytosol" Nucleoli "HPA055060: AB_2682686" "unprognostic (3.37e-3)" "unprognostic (1.49e-1)" "unprognostic (2.06e-2)" "unprognostic (6.90e-2)" "unprognostic (2.04e-1)" "unprognostic (1.63e-2)" "unprognostic (2.29e-1)" "unprognostic (2.32e-1)" "unprognostic (1.46e-1)" "unprognostic (1.28e-1)" "unprognostic (4.49e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (2.83e-1)" "unprognostic (5.40e-2)" "unprognostic (2.09e-1)" "unprognostic (2.31e-1)" 1722.3 1537.3 1226.9 1519.3 1244.9 3816.2 3065.8 1206.6 1768.4 1818.7 1277.0 1724.0 1318.8 1489.3 1967.3 2266.9 1763.0 881.9 1192.2 1197.9 1253.8 1298.7 1646.6 1132.3 2832.4 1261.6 1218.6 3571.4 3388.7 859.1 987.5 1099.1 1264.1 1418.3 1477.9 477.2 2051.9 967.4 1588.9 2566.0 1319.4 1188.3 1265.4 1560.6 1555.5 375.1 1245.4 2012.1 1216.9 1063.5 2563.2 1567.2 1790.5 1281.2 3535.7 4567.8 3027.7 2844.3 3850.6 6013.0 3418.3 3504.2 3142.7 2924.3 2235.3 5420.6 3683.5 5561.4 3680.3 3142.1 2276.7 4963.3 6162.5 4765.3 2251.9 4262.2 8647.1 3224.4 5009.5 4698.1 5817.4 4197.2 2100.2 5478.2 7877.0 1959.5 6027.1 4520.5 3281.1 3993.8 3909.8 4288.1 3200.3 6205.4 3467.9 7403.5 4567.2 4224.9 2885.2 3333.8 3746.8 4676.4 3425.9 6945.5 2678.6 3325.2 2101.9 4289.8 9110.0 3205.5 3707.5 10012.4 2932.1 2388.1 3534.7 2353.9 6119.2 3312.3 7992.5 5635.5 2580.9 8286.2 2335.3 519.6 1072.5 302.9 1155.2 949.1 1830.0 2371.9 1954.3 1477.4 1685.5 2173.6 2280.0 1986.3 148.5 1335.8 859.0 1700.9 1707.8 3337.5 1226.9 1244.9 1206.6 1768.4 1197.9 1253.8 1261.6 1218.6 1264.1 1265.4 1245.4 1281.2 118.0 814.1 1488.0 8.1 1824.1 43.2 5841.9 11.0 675.6 83.2 1696.6 859.5 428.3 2093.2 1039.5 176.6 50.1 3419.1 1523.2 487.4 545.9 1846.4 75.5 269.9 496.3 1390.0 963.5 1971.9 5.5 3041.8 6575.5 973.4 375.1 305.1 937.3 67.5 2470.1 3241.0 2716.5 42.1 6.3 2545.9 2.0 3330.0 46.3 229.6 4400.2 1201.6 30.2 7.5 3519.0 296.5 3137.0 6.0 10.1 2490.2 2021.5 1873.5 547.9 6309.4 1840.9 1036.8 504.2 121.4 1183.3 2746.2 689.9 611.9 701.6 1140.4 63.9 3414.9 1379.0 53.7 3448.3 5768.6 AC245033.1 ENSG00000260836 "Novel protein" 15 82536788-82573194 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 32.1;Alveolar cells type 2: 45.1;Club cells: 8.6;granulocytes: 12.6;Respiratory ciliated cells: 10.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "U-2197: 12.6" HPA055060 Uncertain Approved "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Cluster 18: U-2197 - ECM organization" "Cluster 11: Alveolar cells - Smell perception" "Endoplasmic reticulum" "Nucleoli, Cytosol" "HPA055060: AB_2682686" "unprognostic (2.91e-2)" 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.4 0.4 12.6 0.2 0.0 0.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.6 0.2 0.1 0.3 0.4 0.5 0.2 0.3 0.3 0.0 32.1 45.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 CPEB1 "CPEB, FLJ13203" ENSG00000214575 "Cytoplasmic polyadenylation element binding protein 1" Q9BZB8 15 82543201-82648861 "Predicted intracellular proteins" "mRNA processing, Translation regulation" "Activator, Repressor, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.6;testis: 32.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 70.0;Inhibitory neurons: 44.3;Oligodendrocytes: 196.5;Spermatocytes: 34.1;Spermatogonia: 62.3" "Cancer enriched" "Detected in some" 6 "testis cancer: 14.0" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SK-MEL-30: 37.9;U-2197: 106.0;U-87 MG: 39.1" HPA040396 Supported Nucleoplasm,Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 18: U-2197 - ECM organization" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoplasm, Cytosol" "HPA040396: AB_2676960" "unprognostic (3.97e-2)" "unprognostic (1.01e-1)" "unprognostic (1.44e-2)" "unprognostic (1.77e-3)" "unprognostic (1.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.98e-1)" "unprognostic (7.74e-2)" "unprognostic (3.90e-2)" "unprognostic (2.07e-2)" "unprognostic (1.35e-2)" "unprognostic (7.51e-3)" "unprognostic (1.97e-3)" "unprognostic (9.50e-3)" "unprognostic (8.17e-2)" "unprognostic (2.05e-2)" "unprognostic (5.37e-4)" 2.8 5.0 10.4 1.3 18.6 0.2 2.5 20.3 18.6 9.3 4.5 6.8 1.2 4.2 7.9 3.6 8.3 4.0 2.9 12.7 17.0 1.2 0.2 1.6 0.5 21.3 21.7 14.3 1.3 0.8 21.8 0.3 24.0 2.3 2.4 4.5 1.5 3.7 2.4 1.9 2.5 3.4 15.0 0.6 2.5 32.4 20.4 0.4 2.3 10.5 0.5 7.7 6.1 33.6 0.1 3.6 0.3 0.4 2.6 0.2 0.1 2.8 0.3 1.8 1.4 0.2 0.1 0.0 6.3 1.1 19.5 0.1 5.1 0.0 0.4 0.0 4.2 0.1 0.1 0.1 1.8 0.1 2.3 1.4 0.0 3.5 0.0 0.2 0.0 7.6 8.9 0.2 1.3 0.2 0.6 0.1 8.2 0.1 1.0 0.0 0.2 0.1 0.0 0.1 10.5 2.4 9.2 0.5 37.9 11.2 0.1 1.1 0.1 18.9 7.5 106.0 6.0 5.3 14.3 1.4 39.1 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.5 0.0 0.1 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.1 10.4 18.6 20.3 18.6 12.7 17.0 21.3 21.7 24.0 15.0 20.4 33.6 0.3 0.0 0.0 19.6 0.1 0.8 0.3 0.0 0.0 11.5 0.6 0.3 1.9 0.0 0.0 0.0 10.4 0.0 0.1 0.1 0.0 0.1 12.6 0.5 1.4 0.2 0.0 0.0 70.0 0.0 0.0 5.9 0.5 0.1 1.3 0.3 0.4 0.0 0.3 11.8 44.3 0.0 0.0 0.0 0.8 20.0 4.1 0.4 5.4 10.3 0.1 5.2 0.0 10.1 196.5 0.1 0.0 2.2 0.2 0.5 0.0 0.4 2.2 4.3 6.6 1.9 1.8 34.1 62.3 0.0 0.6 0.1 0.4 0.0 0.0 0.1 AP3B2 NAPTB ENSG00000103723 "Adaptor related protein complex 3 subunit beta 2" Q13367 15 82659281-82710112 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.7;pituitary gland: 18.8;retina: 33.0" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 27.1;Excitatory neurons: 61.7;Inhibitory neurons: 56.9;Oligodendrocyte precursor cells: 44.7;Oligodendrocytes: 22.8;Rod photoreceptor cells: 58.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 9.5;NTERA-2: 9.5;RT4: 17.3;SCLC-21H: 29.0;SH-SY5Y: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039467, HPA039818" Enhanced Supported Approved "Nucleoplasm,Golgi apparatus,Cytosol" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 58: Brain - Synaptic function" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 46: Photoreceptor cells - Phototransduction" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039467: AB_10795143, HPA039818: AB_10795299" "unprognostic (3.17e-1)" "unprognostic (9.40e-2)" "unprognostic (5.33e-2)" "unprognostic (1.48e-6)" "unprognostic (8.44e-2)" "unprognostic (7.62e-2)" "unprognostic (5.82e-2)" "unprognostic (2.32e-1)" "unprognostic (3.85e-1)" "unprognostic (1.63e-1)" "unprognostic (3.57e-3)" "unprognostic (1.12e-1)" "unprognostic (8.66e-2)" "unprognostic (4.95e-2)" "unprognostic (3.21e-2)" "unprognostic (7.52e-2)" "unprognostic (1.43e-2)" 0.7 4.5 15.3 0.9 18.6 1.1 1.4 15.5 20.7 0.9 0.0 1.1 0.7 1.1 2.3 0.7 0.9 0.4 0.2 19.6 5.5 0.6 0.2 0.3 0.5 15.6 5.4 1.2 2.1 12.7 18.8 0.6 13.2 1.4 0.6 33.0 0.9 1.4 0.3 0.9 0.9 1.3 1.1 0.7 1.1 6.2 4.7 1.0 2.1 0.4 1.3 0.8 0.6 11.3 0.2 0.4 9.5 3.2 1.6 0.2 5.7 0.5 0.0 0.8 0.2 0.4 0.4 0.8 4.9 0.2 1.8 0.9 1.0 0.0 0.2 3.2 0.7 0.3 0.4 0.2 0.3 0.4 1.8 1.0 1.1 0.1 0.7 0.1 0.0 2.8 1.0 0.7 0.1 2.5 0.3 0.5 9.5 0.1 0.1 0.3 0.0 0.2 0.0 17.3 29.0 17.5 3.2 1.4 2.4 1.0 0.2 1.9 0.2 0.3 0.9 0.4 1.3 1.6 8.8 0.7 2.2 0.5 1.7 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.1 0.3 0.2 0.9 0.1 0.1 0.4 0.0 0.1 15.3 18.6 15.5 20.7 19.6 5.5 15.6 5.4 13.2 1.1 4.7 11.3 0.1 0.0 1.1 20.9 0.1 0.4 2.1 0.6 1.2 18.4 1.5 2.3 0.8 0.0 0.1 0.0 27.1 0.1 0.2 0.1 0.0 0.2 8.0 0.2 0.6 0.1 13.9 0.0 61.7 0.4 0.1 1.1 0.0 0.3 0.0 0.1 0.0 0.0 0.1 13.5 56.9 0.5 6.1 0.0 0.6 5.4 0.9 0.1 0.0 4.7 0.0 4.1 0.0 44.7 22.8 0.0 0.1 0.4 1.2 0.7 0.0 0.4 0.0 58.6 0.0 1.3 0.7 9.8 3.1 0.7 0.1 0.0 0.1 0.2 0.0 0.6 FSD2 "RP11-127F21, SPRYD1" ENSG00000186628 "Fibronectin type III and SPRY domain containing 2" A1L4K1 15 82755362-82806070 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 35 "heart muscle: 52.3;skeletal muscle: 154.3;tongue: 44.3" "Cell type enriched" "Detected in some" 6 "Cardiomyocytes: 81.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 3.6;U-266/70: 4.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046263 Approved Cytosol NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 29: U-266 - Adaptive immune response" "Cluster 54: Cardiomyocytes - Muscle contraction" Cytosol "HPA046263: AB_2679604" "unprognostic (2.80e-1)" "unprognostic (3.54e-1)" "unprognostic (6.63e-2)" "unprognostic (6.30e-2)" "unprognostic (7.71e-2)" "unprognostic (1.83e-1)" "unprognostic (5.97e-2)" "unprognostic (7.66e-2)" "unprognostic (1.07e-1)" "unprognostic (9.37e-2)" "unprognostic (3.05e-2)" "unprognostic (2.21e-1)" "unprognostic (1.07e-2)" "unprognostic (1.27e-1)" "unprognostic (8.03e-2)" "unprognostic (1.68e-2)" "unprognostic (1.59e-2)" 0.2 0.7 0.2 0.9 0.2 0.8 0.1 0.7 0.4 0.0 0.0 0.1 0.9 0.4 0.6 1.9 0.3 0.3 52.3 0.3 0.5 0.3 0.1 0.2 1.1 0.1 0.1 0.6 0.6 0.7 0.1 0.3 0.2 1.2 0.0 2.4 0.8 0.0 154.3 1.5 0.8 0.1 0.0 0.6 0.6 0.7 0.3 0.0 0.9 44.3 0.1 0.1 0.0 0.6 0.7 0.7 1.1 1.3 0.0 0.0 0.6 0.7 0.0 0.0 0.0 0.6 1.2 2.3 0.5 0.0 0.6 2.8 0.0 0.0 0.2 0.4 3.1 1.3 3.6 1.0 0.0 0.7 0.5 0.0 0.0 0.0 0.1 0.7 0.0 1.0 1.2 2.0 0.0 0.7 0.4 1.4 1.0 0.5 0.6 0.8 0.8 0.6 0.1 1.3 1.1 0.9 0.5 0.5 0.9 0.5 0.9 1.0 0.5 1.6 0.8 0.6 1.0 4.7 2.1 0.8 1.0 2.8 0.4 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.2 0.7 0.4 0.3 0.5 0.1 0.1 0.2 0.0 0.3 0.6 0.4 0.0 2.2 1.3 0.2 0.4 1.0 0.2 0.0 2.1 0.5 0.3 81.6 1.5 0.8 0.0 6.2 0.1 0.3 0.1 0.0 0.0 4.8 1.7 0.3 1.2 1.2 0.0 3.9 0.4 0.1 3.0 0.0 1.6 1.3 0.6 0.0 0.0 0.3 11.8 3.6 0.0 2.0 0.3 2.1 6.1 0.3 0.2 0.0 1.0 0.1 0.7 0.0 4.0 3.3 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.5 4.5 0.0 4.5 0.6 0.6 0.3 0.0 0.6 0.3 0.4 0.2 0.1 0.3 WHAMM "KIAA1971, WHAMM1, WHDC1" ENSG00000156232 "WASP homolog associated with actin, golgi membranes and microtubules" Q8TF30 15 82809628-82836108 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 29.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039690, HPA040231" Approved Supported Cytosol NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 15: RT4 - Unknown function" "Cluster 22: Epithelial cell types - Mixed function" Cytosol "HPA039690: AB_10795405, HPA040231: AB_10795361" "unprognostic (7.98e-2)" "prognostic favorable (7.09e-4)" "unprognostic (1.21e-1)" "unprognostic (8.56e-2)" "unprognostic (6.68e-2)" "unprognostic (8.21e-3)" "unprognostic (1.82e-1)" "unprognostic (1.37e-2)" "unprognostic (1.32e-1)" "unprognostic (2.09e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (2.31e-4)" "unprognostic (1.31e-1)" "unprognostic (1.65e-2)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (2.20e-2)" 7.7 4.8 4.3 3.9 4.4 29.7 7.2 6.1 4.7 6.6 8.8 6.8 4.6 5.5 2.8 7.2 6.1 2.9 5.8 4.3 3.9 7.0 8.8 7.8 5.5 4.5 4.3 7.2 7.5 6.1 5.4 4.6 4.3 7.7 4.0 4.0 6.6 3.5 17.7 9.0 7.3 3.3 3.8 8.5 6.2 3.7 4.3 5.1 6.6 7.8 4.7 7.5 6.4 5.8 4.0 4.1 2.5 3.6 7.9 5.5 4.2 5.5 5.5 6.0 5.9 2.6 7.2 8.7 6.7 5.2 5.6 8.8 7.7 4.5 3.9 2.9 4.4 5.0 4.5 3.9 8.0 3.6 5.7 5.4 6.0 2.8 5.9 6.0 4.3 4.1 4.6 11.3 6.0 3.1 3.0 5.2 1.0 5.0 2.4 4.4 5.3 2.5 10.4 16.1 2.3 1.9 8.5 5.5 5.8 5.1 3.7 7.7 6.8 7.9 2.7 5.3 6.3 12.0 7.3 4.2 5.6 4.9 5.0 2.6 0.5 0.5 1.2 0.4 1.0 1.0 1.1 0.8 0.3 1.1 1.0 1.0 1.3 2.3 0.4 0.9 1.0 0.4 4.3 4.4 6.1 4.7 4.3 3.9 4.5 4.3 4.3 3.8 4.3 5.8 36.6 16.0 17.3 18.9 37.1 26.5 42.8 6.6 34.1 16.2 16.7 17.7 15.6 17.2 7.6 20.2 14.6 14.5 47.3 18.1 5.9 8.9 6.9 19.6 13.9 23.2 6.7 31.5 10.1 10.3 16.6 18.7 23.9 29.4 10.8 12.6 19.2 13.8 19.9 23.5 15.9 19.4 6.1 15.8 41.4 5.5 17.4 25.4 19.6 15.0 19.3 17.9 61.8 14.1 23.4 13.0 15.5 23.7 24.1 49.0 16.8 11.2 7.1 18.0 32.9 24.5 19.5 29.8 31.1 29.2 25.1 25.4 36.1 15.5 13.8 75.1 HOMER2 "CPD, Cupidin, DFNA68, HOMER-2, HOMER-2A, HOMER-2B, Vesl-2" ENSG00000103942 "Homer scaffold protein 2" Q9NSB8 15 82836946-82986153 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Hearing "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 226.2" "Cell type enhanced" "Detected in many" "Cholangiocytes: 215.9;Endometrial ciliated cells: 184.4;Glandular and luminal cells: 151.9" "Cancer enhanced" "Detected in many" "prostate cancer: 15.2" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "myeloid DC: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HAP1: 52.7;Karpas-707: 92.6;SCLC-21H: 50.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040134, CAB079014" Uncertain Supported Supported Cytosol NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 25: Pancreas - Digestion" "Cluster 2: Karpas-707 - Immune response" "Cluster 44: Endometrium - Transcription" Cytosol "CAB079014: , HPA040134: AB_10795272" "unprognostic (7.34e-2)" "unprognostic (3.58e-2)" "unprognostic (5.75e-4)" "unprognostic (3.31e-3)" "unprognostic (4.85e-2)" "unprognostic (1.24e-1)" "unprognostic (1.04e-2)" "unprognostic (7.13e-3)" "unprognostic (2.69e-1)" "unprognostic (1.40e-1)" "unprognostic (1.02e-1)" "unprognostic (2.75e-1)" "unprognostic (8.16e-4)" "unprognostic (2.30e-1)" "unprognostic (3.21e-2)" "unprognostic (1.26e-1)" "unprognostic (4.45e-3)" 1.5 6.3 6.5 1.1 7.6 4.6 26.9 8.2 12.8 23.1 69.8 3.2 8.5 8.4 33.7 21.2 25.9 12.8 21.9 16.2 7.8 7.2 46.4 5.3 1.3 5.7 4.6 2.6 226.2 5.1 7.7 0.6 5.7 57.7 1.0 6.4 71.2 4.6 108.7 45.0 1.3 1.4 4.1 4.8 55.4 6.1 6.0 3.0 28.9 55.9 3.6 1.3 11.7 8.0 16.6 6.9 7.2 18.9 0.2 0.1 1.1 1.1 0.0 1.7 0.6 1.2 11.5 0.1 8.8 8.4 8.3 9.1 52.7 24.9 1.2 45.1 33.5 10.6 0.4 8.3 0.7 0.4 32.6 1.8 37.4 0.6 2.1 1.9 0.0 20.6 0.4 92.6 7.0 48.4 3.2 1.1 11.4 1.4 5.1 2.2 11.5 5.5 25.3 20.1 50.8 13.1 18.6 14.1 17.6 5.2 17.1 3.5 0.2 17.2 31.7 1.3 15.3 11.8 5.9 1.8 29.0 0.4 6.4 0.1 0.1 0.4 0.0 0.1 0.0 0.2 0.1 0.0 1.1 0.3 0.1 0.0 0.4 0.0 0.0 0.5 0.2 0.3 6.5 7.6 8.2 12.8 16.2 7.8 5.7 4.6 5.7 4.1 6.0 8.0 1.9 16.0 10.1 24.8 3.8 4.6 56.1 7.2 10.2 15.0 39.7 20.4 23.0 215.9 14.6 11.0 18.8 1.1 4.4 0.3 7.9 29.6 1.9 184.4 15.4 12.4 3.0 8.2 24.8 76.5 0.4 3.6 14.3 151.9 0.0 11.9 1.4 59.6 13.3 20.2 35.1 0.4 0.0 3.2 73.9 4.0 1.8 9.2 37.4 7.5 7.9 18.5 1.0 6.6 11.8 25.9 0.1 0.7 4.1 81.5 0.7 12.1 4.0 5.1 0.0 7.8 4.8 5.5 16.6 19.4 6.0 0.7 3.1 4.1 0.4 30.5 RAMAC "C15orf18, FAM103A1, HsT19360, MGC2560, RAM, RAMMET" ENSG00000169612 "RNA guanine-7 methyltransferase activating subunit" Q9BTL3 15 82986210-82991057 "Predicted intracellular proteins" "mRNA capping, mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Cytotrophoblasts: 108.2;Extravillous trophoblasts: 82.2;Hofbauer cells: 69.4;Syncytiotrophoblasts: 92.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA041923, HPA041948" Supported Supported Nucleoplasm No No "Cluster 31: Non-specific - Inflammatory response" "Cluster 34: Non-specific - Transcription" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "HPA041923: AB_10796467, HPA041948: AB_10797270" "unprognostic (1.51e-1)" "unprognostic (1.16e-2)" "unprognostic (5.30e-2)" "unprognostic (1.03e-2)" "unprognostic (2.21e-1)" "unprognostic (1.15e-1)" "unprognostic (1.96e-1)" "unprognostic (2.58e-1)" "unprognostic (2.32e-2)" "unprognostic (3.63e-3)" "unprognostic (2.09e-2)" "unprognostic (4.72e-2)" "unprognostic (7.46e-3)" "unprognostic (9.57e-2)" "unprognostic (2.72e-2)" "unprognostic (9.47e-2)" "unprognostic (2.45e-1)" 12.9 14.8 10.9 16.4 11.4 30.1 26.1 12.9 14.8 16.6 11.6 18.4 14.5 18.2 30.1 24.1 19.5 13.4 14.8 11.6 12.2 16.8 24.2 13.0 23.0 11.6 11.3 20.6 16.4 18.8 12.9 25.9 11.3 18.0 19.3 19.9 18.2 15.2 29.1 21.5 13.4 16.8 11.6 14.1 19.0 15.6 11.1 23.3 18.2 20.2 28.9 20.8 15.6 11.6 34.1 44.7 44.3 27.1 23.5 15.9 32.7 33.7 33.5 37.6 30.4 49.4 42.9 16.8 45.8 29.2 45.4 37.9 77.1 32.4 40.6 42.0 49.7 52.7 22.7 58.7 33.3 38.0 44.9 34.9 61.4 30.6 38.5 28.7 23.6 28.5 62.8 33.9 39.8 35.7 29.5 48.3 52.0 45.0 21.1 33.4 38.2 26.0 49.0 64.6 41.1 42.0 34.6 36.7 87.0 71.5 58.6 47.9 16.8 27.5 34.9 26.1 48.8 53.1 104.0 41.8 25.2 50.7 34.5 138.6 59.2 98.2 47.9 57.0 51.8 64.8 54.1 52.3 56.1 61.1 53.9 53.4 117.4 70.4 62.8 51.6 69.9 65.9 10.9 11.4 12.9 14.8 11.6 12.2 11.6 11.3 11.3 11.6 11.1 11.6 18.3 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 108.2 19.1 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 82.2 10.0 0.0 0.0 0.0 0.0 0.0 0.0 69.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 92.9 2.7 0.0 0.0 0.0 C15orf40 MGC29937 ENSG00000169609 "Chromosome 15 open reading frame 40" Q8WUR7 15 82988441-83011641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041947, HPA042980" Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 7: Kidney - Transmembrane transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Golgi apparatus" "HPA041947: , HPA042980: AB_10964298" "unprognostic (8.30e-3)" "unprognostic (2.56e-2)" "unprognostic (3.96e-2)" "unprognostic (1.31e-1)" "unprognostic (3.58e-1)" "unprognostic (2.02e-2)" "unprognostic (1.17e-2)" "unprognostic (3.04e-2)" "unprognostic (8.65e-2)" "unprognostic (2.20e-2)" "unprognostic (8.55e-3)" "unprognostic (7.71e-2)" "prognostic favorable (4.35e-4)" "unprognostic (2.83e-1)" "unprognostic (1.84e-1)" "unprognostic (1.33e-1)" "unprognostic (2.51e-2)" 13.4 13.5 8.3 10.1 8.1 13.9 13.2 12.4 10.8 11.0 6.1 12.4 13.7 9.2 19.8 12.1 9.0 6.5 8.1 8.1 6.7 19.1 13.0 8.2 13.5 8.1 6.3 10.5 12.4 9.7 9.3 7.6 7.6 9.4 8.2 10.2 12.4 5.8 12.4 14.7 12.9 6.1 4.2 11.9 11.2 13.9 7.0 10.7 10.3 6.7 11.2 10.1 10.7 15.3 16.8 19.7 12.8 17.4 15.9 14.4 11.6 10.1 16.0 9.7 10.9 13.7 26.6 16.6 13.4 7.6 23.8 29.5 28.5 20.2 10.9 32.1 19.0 15.7 26.4 15.9 15.3 26.6 15.6 12.1 28.8 16.1 18.1 12.8 16.8 43.6 22.1 26.6 9.3 15.7 22.6 14.3 21.4 23.8 12.5 30.5 17.3 22.7 16.7 23.5 29.7 18.2 26.0 20.4 40.8 16.2 23.3 15.4 10.4 20.0 29.1 15.5 17.7 25.4 42.0 31.8 26.0 26.4 22.4 58.0 20.9 31.2 28.1 22.0 31.4 46.7 29.7 29.5 21.2 38.8 34.7 29.9 20.6 42.2 21.4 29.6 41.1 20.5 8.3 8.1 12.4 10.8 8.1 6.7 8.1 6.3 7.6 4.2 7.0 15.3 27.3 28.9 32.5 16.6 41.1 12.0 27.8 45.2 51.2 28.9 33.6 41.0 11.6 38.6 46.2 25.8 12.5 46.6 22.3 42.3 93.9 47.3 36.7 30.0 21.1 27.2 28.8 32.4 11.6 56.1 30.0 29.9 32.1 19.0 27.8 33.7 26.0 37.7 30.0 30.3 14.3 26.4 34.6 28.4 12.0 30.8 33.2 28.0 26.6 8.4 42.7 32.1 63.8 11.6 19.9 62.7 29.6 36.1 41.2 26.7 77.6 127.3 51.2 30.1 19.7 28.6 25.9 107.3 66.8 46.5 15.3 35.6 39.3 39.9 29.9 26.3 BTBD1 ENSG00000064726 "BTB domain containing 1" Q9H0C5 15 83016423-83067252 "Predicted intracellular proteins" "Differentiation, Myogenesis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 325.0;tongue: 230.8" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 84.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024263, HPA067671" Enhanced Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 80: Striated muscle - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Cytoplasmic bodies" "Nucleoplasm, Cytosol" "HPA024263: , HPA067671: AB_2685882" "unprognostic (1.63e-1)" "unprognostic (4.61e-2)" "unprognostic (1.35e-1)" "unprognostic (5.54e-2)" "unprognostic (1.80e-1)" "unprognostic (3.17e-2)" "unprognostic (4.80e-2)" "unprognostic (1.65e-1)" "unprognostic (1.85e-1)" "unprognostic (1.44e-1)" "unprognostic (2.73e-1)" "unprognostic (1.07e-1)" "prognostic favorable (6.21e-7)" "unprognostic (8.94e-3)" "unprognostic (8.27e-2)" "unprognostic (7.71e-2)" "unprognostic (1.89e-2)" 36.8 26.7 39.8 24.9 41.0 36.3 28.8 40.4 48.1 24.8 26.2 33.4 32.5 24.2 25.7 30.4 31.5 28.7 107.2 41.3 43.8 37.8 34.3 23.9 36.7 40.7 41.4 23.6 17.2 46.4 22.1 24.1 38.5 30.1 35.5 28.4 21.0 24.0 325.0 16.5 29.9 26.5 44.4 25.9 23.9 58.4 46.8 35.5 37.1 230.8 34.2 36.2 18.2 46.0 45.8 43.1 37.3 37.0 57.5 98.2 19.5 64.9 88.0 54.8 60.6 27.4 46.4 91.0 78.4 73.2 45.6 56.4 82.7 52.0 64.4 73.4 67.1 77.7 62.6 39.6 67.6 74.2 82.9 80.6 45.8 37.2 55.4 71.0 82.0 35.2 70.2 49.9 117.2 24.1 55.8 38.5 52.2 39.9 47.0 57.1 94.4 45.5 55.0 106.7 64.9 46.6 75.1 61.6 111.2 50.7 46.5 61.6 82.9 61.9 46.1 86.0 91.2 50.6 84.0 88.4 66.7 123.6 43.8 1.3 2.9 5.7 3.1 3.2 2.7 2.7 2.9 4.0 5.2 3.4 3.2 3.2 1.6 2.4 4.2 2.2 3.0 1.3 39.8 41.0 40.4 48.1 41.3 43.8 40.7 41.4 38.5 44.4 46.8 46.0 24.2 16.0 5.8 30.7 22.0 15.2 13.7 9.6 13.6 9.4 11.4 6.9 84.9 8.6 18.1 11.0 6.2 8.4 23.6 20.8 17.6 14.2 35.8 19.9 16.6 16.8 23.3 18.7 36.0 10.5 13.5 15.8 18.8 14.5 17.7 11.0 17.2 11.0 18.0 11.8 38.4 10.8 14.2 23.6 24.6 24.5 8.7 21.2 12.4 37.5 22.8 11.1 9.2 32.2 28.6 15.1 19.8 11.3 22.6 11.8 15.8 15.7 24.7 8.6 6.6 21.0 15.3 46.2 14.9 16.0 12.1 8.1 18.8 22.0 18.4 18.7 TM6SF1 ENSG00000136404 "Transmembrane 6 superfamily member 1" Q9BZW5 15 83107572-83144854 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 47.3" "Cell type enhanced" "Detected in many" "Adipocytes: 30.5;granulocytes: 44.4;Hofbauer cells: 50.9;Kupffer cells: 37.8;Langerhans cells: 46.4;Macrophages: 45.9;Microglial cells: 46.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 76.6;eosinophil: 195.8;neutrophil: 118.1" "Lineage enriched" "Detected in many" 6 "granulocytes: 195.8" "Cell line enhanced" "Detected in some" "HEL: 23.2;HHSteC: 49.6;HUVEC TERT2: 27.7;JURKAT: 36.4;TIME: 68.3;U-698: 17.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016051, HPA056857" Uncertain NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 80: Striated muscle - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 10: Non-specific - Unknown function" "HPA016051: AB_2203924, HPA056857: AB_2683259" "unprognostic (8.09e-2)" "unprognostic (1.31e-1)" "unprognostic (2.87e-2)" "unprognostic (4.67e-1)" "unprognostic (1.96e-1)" "unprognostic (1.43e-1)" "unprognostic (6.46e-2)" "unprognostic (3.52e-3)" "unprognostic (1.73e-1)" "unprognostic (1.70e-2)" "unprognostic (2.80e-1)" "unprognostic (2.55e-1)" "prognostic favorable (6.79e-4)" "unprognostic (1.15e-2)" "unprognostic (4.65e-3)" "unprognostic (2.60e-2)" "unprognostic (1.70e-1)" 6.5 3.9 5.4 5.2 6.0 5.3 4.6 7.7 8.8 3.3 6.3 2.6 2.0 2.8 2.1 3.1 2.8 3.7 9.6 5.2 5.6 1.9 2.3 10.7 5.7 6.8 6.0 1.7 1.2 1.8 0.9 7.8 6.6 2.1 2.6 2.8 2.9 1.3 47.3 1.8 2.6 3.9 6.9 6.2 2.1 3.6 5.4 2.2 10.4 21.8 3.0 3.8 1.5 7.6 0.0 0.5 0.2 0.1 0.0 0.0 0.0 0.3 5.6 0.0 0.2 0.0 0.3 0.1 1.0 0.0 0.3 0.0 3.7 0.0 0.0 0.0 0.3 23.2 0.0 0.0 49.6 1.6 0.1 0.2 0.0 0.0 0.1 0.3 27.7 36.4 0.9 0.0 0.4 0.0 0.0 3.0 0.6 0.0 0.0 0.0 4.2 0.0 0.1 0.4 1.2 0.3 0.2 0.0 1.9 0.5 0.0 14.9 68.3 0.6 0.9 0.1 0.3 2.1 0.0 17.0 0.1 3.4 0.1 76.6 31.7 195.8 5.0 13.4 0.0 0.3 0.5 0.8 18.9 0.9 0.1 0.8 118.1 5.0 6.4 2.6 0.0 11.8 5.4 6.0 7.7 8.8 5.2 5.6 6.8 6.0 6.6 6.9 5.4 7.6 30.5 0.0 6.0 2.9 0.9 2.4 0.1 0.4 0.6 1.6 0.5 1.8 1.2 1.5 0.8 0.0 0.0 0.3 7.5 0.0 0.0 0.2 13.1 0.6 0.2 16.7 0.0 4.4 18.7 2.0 0.4 1.5 0.0 0.3 44.4 0.0 7.9 0.1 50.9 0.0 22.4 0.0 0.0 37.8 46.4 7.4 0.9 45.9 3.6 46.9 19.4 0.5 16.5 2.0 1.9 0.4 0.0 0.0 0.7 0.1 0.0 0.0 1.4 1.3 0.0 1.4 0.6 13.1 7.5 0.1 1.7 0.3 4.2 0.1 0.0 0.1 HDGFL3 "Hdgfrp3, HRP-3" ENSG00000166503 "HDGF like 3" Q9Y3E1 15 83112738-83207823 "Predicted intracellular proteins" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 96.9;Breast glandular cells: 34.3;Endometrial ciliated cells: 34.2;Endometrial stromal cells: 48.4;Granulosa cells: 41.4;Theca cells: 48.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "NK-cell: 1.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040719 Approved Supported Nucleoplasm NA NA "Cluster 11: Basophils - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA040719: AB_2677097" "unprognostic (1.28e-3)" "unprognostic (1.13e-1)" "unprognostic (3.52e-2)" "unprognostic (3.38e-2)" "unprognostic (1.53e-1)" "unprognostic (2.55e-2)" "unprognostic (1.91e-2)" "unprognostic (2.95e-2)" "unprognostic (2.99e-2)" "unprognostic (4.68e-2)" "unprognostic (1.93e-3)" "unprognostic (3.39e-2)" "unprognostic (1.73e-1)" "unprognostic (1.06e-2)" "unprognostic (3.55e-1)" "unprognostic (1.25e-1)" "unprognostic (1.85e-1)" 6.3 5.9 11.1 2.9 12.0 2.4 5.6 11.6 14.9 5.0 7.2 7.0 1.2 6.0 8.3 3.6 4.7 4.0 5.7 11.8 11.5 4.8 0.8 5.1 2.9 10.5 10.5 5.0 1.7 17.7 6.8 3.0 10.5 4.9 2.6 8.5 2.4 4.6 2.5 2.0 2.9 5.3 11.1 3.4 2.9 9.7 11.8 4.3 6.5 2.5 2.2 5.6 3.8 10.7 7.2 6.2 17.9 9.3 7.4 10.1 5.9 6.7 11.9 7.0 7.3 0.5 13.2 0.1 8.0 1.8 7.5 2.9 19.9 10.3 10.1 33.5 10.2 11.6 3.0 0.1 10.3 0.4 1.8 6.0 8.4 8.0 13.9 10.8 17.0 12.4 9.0 0.3 13.2 7.4 7.1 0.7 13.3 0.0 3.5 0.1 17.4 0.1 10.5 14.6 22.5 17.1 10.1 2.4 8.9 12.9 2.8 1.3 14.7 14.5 10.8 3.0 20.9 2.1 0.8 8.6 6.7 5.5 10.0 0.7 0.3 1.0 0.5 0.1 0.0 0.1 0.1 0.1 0.2 0.2 0.2 0.2 0.8 1.8 0.1 0.2 0.0 0.1 11.1 12.0 11.6 14.9 11.8 11.5 10.5 10.5 10.5 11.1 11.8 10.7 96.9 12.8 17.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 34.3 27.3 0.0 0.0 10.5 20.2 0.0 0.3 14.1 0.0 15.6 21.1 0.0 34.2 48.4 25.8 0.0 0.0 0.0 22.9 0.6 15.4 0.0 25.6 5.1 41.4 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 23.6 0.0 0.0 3.1 0.0 0.0 0.3 9.5 0.0 0.0 0.0 20.4 0.0 0.0 0.0 0.0 0.3 3.5 48.1 0.0 0.0 BNC1 "BNC, HsT19447" ENSG00000169594 "Basonuclin 1" Q01954 15 83255903-83284714 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" DNA-binding "Disease variant, Premature ovarian failure" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 15.0;esophagus: 12.5;testis: 30.8" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 88.6;Early spermatids: 45.5;Late spermatids: 103.4;Suprabasal keratinocytes: 58.4" "Cancer enhanced" "Detected in many" "head and neck cancer: 25.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 51.1;HBEC3-KT: 116.6;hTCEpi: 128.1;hTERT-HME1: 123.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA063183, HPA066947, HPA077428" Enhanced Nucleoplasm NA NA "Cluster 71: Testis - DNA repair" "Cluster 30: Epithelial cell lines - Translation" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm "HPA063183: AB_2684957, HPA066947: AB_2685752, HPA077428: AB_2732345" "unprognostic (1.86e-3)" "unprognostic (1.08e-1)" "unprognostic (7.89e-3)" "unprognostic (5.55e-2)" "unprognostic (4.06e-2)" "unprognostic (2.47e-2)" "unprognostic (2.45e-2)" "unprognostic (7.91e-2)" "unprognostic (8.89e-4)" "unprognostic (6.94e-2)" "unprognostic (4.13e-1)" "unprognostic (3.85e-3)" "unprognostic (8.46e-3)" "unprognostic (2.20e-1)" "unprognostic (2.95e-3)" "unprognostic (1.01e-2)" 15.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 3.1 0.0 0.1 0.0 0.0 8.1 12.5 0.9 0.1 1.4 0.2 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.7 0.0 1.0 0.0 1.8 0.0 0.2 0.0 0.1 2.0 0.2 0.0 9.3 0.0 0.0 0.0 0.0 0.1 30.8 0.3 4.2 0.1 0.3 2.1 0.3 6.5 0.4 25.9 0.1 0.0 0.0 4.2 6.4 0.0 2.0 0.3 21.9 30.3 0.0 0.5 0.0 1.0 13.8 0.0 51.1 2.7 116.6 39.3 0.0 0.2 0.0 0.0 0.0 32.6 0.0 0.0 5.6 128.1 19.6 123.8 4.5 21.7 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 4.6 0.0 0.0 0.0 11.6 0.0 0.0 14.2 0.0 0.0 40.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.1 0.0 0.0 0.0 0.0 88.6 14.8 15.5 14.8 0.0 0.0 0.1 0.4 1.5 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 45.5 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 6.9 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 5.5 103.4 0.6 0.1 8.8 1.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.7 0.0 1.2 0.0 0.1 1.7 0.0 0.0 2.7 0.6 22.2 6.5 21.7 58.4 0.0 0.0 0.0 0.0 4.8 SH3GL3 "CNSA3, EEN-B2, HsT19371, SH3D2C, SH3P13" ENSG00000140600 "SH3 domain containing GRB2 like 3, endophilin A3" Q99963 15 83447228-83618743 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 77.2;choroid plexus: 19.4;testis: 26.5" "Group enriched" "Detected in many" 4 "Early spermatids: 557.6;Late spermatids: 1307.0;Oligodendrocytes: 1142.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 35.8;HEK 293: 16.8;K-562: 29.9;RH-30: 11.1;SuSa: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039381, HPA077877" Enhanced Approved Mitochondria NA NA "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 1: K-562 - Erythropoiesis" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Mitochondria "HPA039381: AB_10794635, HPA077877: AB_2686863" "unprognostic (1.10e-3)" "unprognostic (6.62e-2)" "unprognostic (4.25e-2)" "unprognostic (1.86e-1)" "unprognostic (6.01e-2)" "unprognostic (2.37e-1)" "unprognostic (9.76e-2)" "unprognostic (2.26e-1)" "unprognostic (8.20e-3)" "unprognostic (2.72e-3)" "unprognostic (1.43e-6)" "unprognostic (4.42e-2)" "unprognostic (3.59e-2)" "unprognostic (2.93e-1)" "unprognostic (5.78e-4)" 0.1 0.1 43.6 0.0 53.8 0.2 0.1 35.9 72.3 0.5 19.4 0.1 0.0 0.5 0.6 1.7 2.2 0.0 0.2 43.8 46.1 0.9 0.0 2.5 0.1 42.3 47.6 0.0 0.0 0.0 0.8 0.5 46.0 0.5 0.0 4.9 0.8 0.5 0.0 0.3 0.0 0.0 40.5 0.0 0.0 26.5 43.2 9.1 0.0 0.0 0.7 0.5 0.5 77.2 0.1 0.0 3.0 2.8 0.0 0.0 2.6 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.4 0.0 0.6 0.0 35.8 2.0 0.0 0.0 16.8 6.2 0.0 0.0 0.0 0.0 0.6 0.1 0.6 0.0 0.0 0.0 0.0 8.1 29.9 0.0 0.1 0.8 2.4 0.0 4.4 0.0 1.1 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 15.2 0.0 0.0 0.4 0.0 2.9 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.6 53.8 35.9 72.3 43.8 46.1 42.3 47.6 46.0 40.5 43.2 77.2 0.1 9.6 1.7 5.9 0.0 0.9 1.4 0.5 18.2 5.4 0.1 0.4 0.6 0.0 0.3 3.7 0.0 0.9 0.0 0.0 0.0 0.6 557.6 0.1 0.1 0.9 0.0 0.0 192.6 0.0 1.7 2.6 0.0 0.1 0.0 0.2 0.4 0.0 0.4 77.4 225.2 0.0 0.0 0.0 0.0 1307.0 9.3 0.5 1.8 6.5 0.0 3.1 0.0 29.1 1142.7 0.3 0.0 4.1 0.0 0.9 0.0 0.1 3.8 1.1 0.0 0.0 0.8 29.0 8.5 9.0 0.1 0.7 0.0 17.6 0.0 0.7 ADAMTSL3 "KIAA1233, punctin-2" ENSG00000156218 "ADAMTS like 3" P82987 15 83654088-84039842 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 141.1;Alveolar cells type 2: 111.8;Astrocytes: 86.5;Club cells: 61.7;granulocytes: 63.1;Inhibitory neurons: 91.6;Oligodendrocytes: 75.2;Respiratory ciliated cells: 56.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "EFO-21: 12.1;hTERT-RPE1: 3.6;RPTEC TERT1: 14.0;TIME: 13.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034773, HPA034774" Uncertain Uncertain Vesicles "Secreted in other tissues" NA NA 270000 "Cluster 46: Fibroblasts - ECM organization" "Cluster 38: EFO-21 - Unknown function" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles "HPA034773: AB_10601965, HPA034774: AB_2674326" "unprognostic (2.20e-1)" "unprognostic (1.37e-1)" "unprognostic (2.98e-2)" "unprognostic (1.07e-2)" "unprognostic (1.56e-1)" "unprognostic (9.89e-2)" "unprognostic (4.07e-2)" "unprognostic (3.27e-1)" "unprognostic (9.18e-3)" "unprognostic (5.92e-2)" "unprognostic (9.97e-2)" "unprognostic (3.85e-1)" "unprognostic (8.59e-3)" "unprognostic (5.00e-3)" "unprognostic (4.62e-1)" "unprognostic (8.64e-2)" "unprognostic (3.95e-5)" 6.3 4.2 1.1 1.0 1.7 0.0 1.7 1.4 1.0 3.1 4.4 10.6 1.4 6.9 1.5 3.3 4.4 1.1 10.7 1.1 1.1 3.3 10.4 7.4 1.1 1.4 1.5 1.2 7.3 0.8 1.4 10.4 1.7 6.6 3.2 0.3 2.4 7.1 2.6 1.4 1.8 4.7 1.5 1.9 4.6 2.7 1.1 1.0 2.6 4.8 0.5 5.2 2.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.9 0.0 14.0 0.0 0.0 0.0 0.2 0.2 0.0 1.3 0.0 0.0 13.3 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.7 1.4 1.0 1.1 1.1 1.4 1.5 1.7 1.5 1.1 3.0 8.7 141.1 111.8 86.5 0.1 7.0 5.2 1.7 0.6 0.2 0.2 0.3 9.4 0.0 61.7 1.8 0.0 0.1 0.8 0.0 0.0 0.5 14.9 0.6 0.4 10.6 0.0 0.0 31.3 2.4 0.2 29.0 1.5 1.2 63.1 0.1 1.1 10.2 0.2 6.7 91.6 0.0 0.0 0.6 0.5 16.9 49.4 5.9 0.0 5.6 0.0 0.1 1.0 4.5 75.2 1.0 0.0 17.0 0.4 2.4 0.0 0.6 56.4 0.2 26.3 13.0 8.3 2.1 2.8 0.6 1.1 0.1 5.0 0.4 0.0 2.3 GOLGA6L4 ENSG00000184206 "Golgin A6 family like 4" A6NEF3 15 84235773-84245368 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 5 "Early spermatids: 118.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "basophil: 1.1;NK-cell: 2.3" "Group enriched" "Detected in many" 7 "granulocytes: 1.1;NK-cells: 2.3" "Cell line enhanced" "Detected in many" "HEK 293: 4.3;U-266/70: 5.7" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 29: U-266 - Adaptive immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" "unprognostic (7.35e-3)" "unprognostic (6.23e-2)" "unprognostic (3.66e-1)" "unprognostic (3.74e-1)" "unprognostic (3.53e-1)" "unprognostic (6.83e-2)" "unprognostic (4.49e-2)" "unprognostic (1.41e-1)" "unprognostic (2.10e-2)" "unprognostic (1.75e-1)" "unprognostic (7.23e-2)" "unprognostic (6.23e-2)" "unprognostic (1.72e-3)" "unprognostic (4.70e-2)" "unprognostic (1.48e-1)" "unprognostic (3.55e-2)" "unprognostic (1.44e-1)" 6.7 7.1 1.5 1.3 1.5 2.2 6.3 1.0 2.8 8.8 1.9 5.7 0.8 5.9 3.5 4.2 5.5 1.7 4.4 1.5 1.7 4.9 4.9 4.7 1.3 1.4 1.3 15.0 6.3 0.9 4.8 1.3 1.4 5.8 1.8 3.1 4.4 1.3 2.9 4.5 3.9 1.8 1.2 3.3 4.2 10.2 1.3 0.7 6.3 1.1 0.7 5.6 7.6 1.5 0.2 0.1 1.4 1.6 1.7 1.6 0.1 1.3 0.5 0.0 0.4 0.0 0.3 1.1 1.3 1.1 0.5 0.3 1.1 0.4 0.3 0.7 4.3 0.7 1.4 1.1 0.4 1.5 2.1 0.6 0.7 0.2 0.4 2.1 2.1 1.7 2.6 1.8 0.8 1.0 0.1 1.3 0.6 0.0 0.5 0.3 0.3 1.0 1.3 1.4 0.6 1.1 0.8 0.6 0.9 2.9 0.6 1.0 1.6 0.4 1.0 1.2 1.3 5.7 1.8 0.5 0.6 0.7 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.2 0.0 0.1 0.0 2.3 0.0 0.2 0.0 0.0 1.5 1.5 1.0 2.8 1.5 1.7 1.4 1.3 1.4 1.2 1.3 1.5 5.0 0.0 2.0 0.0 0.9 3.6 1.6 2.1 1.2 7.8 2.1 2.8 1.2 1.5 3.8 1.8 12.5 1.1 1.7 0.6 0.0 4.3 118.3 2.8 6.6 5.0 1.2 0.8 0.2 4.4 0.1 5.9 5.6 4.9 5.1 8.3 4.6 3.9 1.8 0.0 0.1 0.4 0.0 1.6 7.7 17.1 6.8 2.2 7.2 0.0 0.7 3.0 2.1 0.0 0.0 11.2 2.7 5.7 1.7 1.5 0.4 0.6 2.3 8.7 13.1 6.0 5.9 22.8 4.7 2.7 4.5 0.8 3.4 10.9 1.2 0.7 ZSCAN2 "FLJ20595, ZFP29, ZNF854" ENSG00000176371 "Zinc finger and SCAN domain containing 2" Q7Z7L9 15 84600986-84627796 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 18.0;Proximal tubular cells: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007296, HPA024331" Supported Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 22: Non-specific - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm Cytosol "HPA007296: , HPA024331: AB_1859497" "unprognostic (4.05e-1)" "unprognostic (2.08e-1)" "unprognostic (9.49e-2)" "unprognostic (6.76e-2)" "unprognostic (7.84e-2)" "unprognostic (2.47e-2)" "unprognostic (3.58e-2)" "unprognostic (1.73e-1)" "unprognostic (1.06e-1)" "unprognostic (1.95e-1)" "prognostic favorable (3.52e-4)" "unprognostic (4.24e-1)" "prognostic favorable (7.46e-4)" "unprognostic (2.42e-2)" "unprognostic (3.53e-3)" "unprognostic (2.98e-1)" "prognostic favorable (4.16e-5)" 7.6 5.8 3.0 4.2 3.9 8.7 7.2 4.8 3.6 6.7 2.3 4.5 3.1 6.4 2.3 2.3 4.0 3.5 6.0 3.2 4.1 7.5 8.8 3.0 4.1 3.2 3.3 6.0 16.6 4.1 4.1 2.1 3.8 5.2 2.9 6.2 6.8 3.0 8.2 2.6 4.4 3.3 2.8 5.9 8.1 11.8 3.7 10.1 4.1 3.1 3.1 4.6 3.5 4.8 2.2 13.4 9.0 14.6 5.7 3.5 8.5 2.5 6.2 5.3 6.4 10.4 5.2 4.9 6.9 3.5 9.8 5.6 6.9 5.0 4.6 10.4 13.0 6.2 8.4 22.0 4.9 3.9 4.4 5.6 4.9 7.0 6.6 7.0 15.5 24.0 8.4 3.9 5.6 6.7 16.8 9.6 16.9 4.5 7.9 16.8 5.6 9.2 5.3 16.7 13.5 23.1 7.6 4.1 11.7 14.5 9.1 9.8 10.8 6.3 12.4 3.2 3.3 6.3 9.5 16.8 4.3 8.7 3.7 6.4 5.8 5.0 5.7 6.4 2.8 3.9 5.2 4.3 6.6 3.5 3.8 4.3 3.1 5.6 8.4 5.9 7.8 3.9 3.0 3.9 4.8 3.6 3.2 4.1 3.2 3.3 3.8 2.8 3.7 4.8 9.1 0.0 2.0 1.6 3.9 0.9 1.2 2.6 2.2 3.1 3.5 3.2 2.5 4.3 1.7 7.3 2.1 1.6 2.5 1.3 5.9 6.9 18.0 5.7 3.3 3.0 3.0 3.0 1.6 8.6 5.1 2.3 4.6 6.9 1.3 8.0 1.1 7.5 3.6 0.0 1.6 3.2 4.1 2.8 2.3 12.3 0.9 2.9 1.8 1.0 5.5 2.3 2.1 4.0 2.5 9.9 4.2 1.5 11.1 2.6 1.9 22.6 1.8 3.1 6.6 2.3 3.9 7.1 8.2 0.9 0.4 1.4 3.7 3.6 2.6 1.5 WDR73 "FLJ14888, HSPC264" ENSG00000177082 "WD repeat domain 73" Q6P4I2 15 84639285-84654343 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 98.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039357 Uncertain NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 51: Non-specific - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 52: Non-specific - Transcription" "HPA039357: AB_10673242" "unprognostic (8.49e-2)" "unprognostic (2.16e-1)" "unprognostic (4.77e-2)" "unprognostic (6.86e-2)" "unprognostic (1.74e-1)" "unprognostic (1.48e-1)" "unprognostic (1.18e-2)" "unprognostic (6.59e-2)" "unprognostic (1.02e-1)" "unprognostic (2.32e-2)" "unprognostic (1.26e-2)" "unprognostic (7.19e-4)" "unprognostic (9.21e-4)" "unprognostic (4.12e-1)" "unprognostic (3.16e-2)" "unprognostic (8.58e-2)" "unprognostic (4.02e-2)" 2.2 3.6 1.8 2.2 2.1 2.8 3.3 3.0 2.3 3.2 3.1 3.2 2.3 3.4 4.2 2.7 3.3 1.5 2.2 2.3 2.1 3.2 2.3 2.4 2.3 2.0 2.2 3.3 3.1 3.7 3.2 1.6 2.3 3.5 2.7 3.4 2.9 2.4 2.2 3.0 3.1 2.9 1.8 3.3 2.9 1.8 2.1 3.0 3.9 1.8 2.8 2.9 2.8 2.8 2.8 4.6 5.5 2.7 2.7 3.1 2.8 1.4 2.7 2.4 1.8 4.3 4.7 3.2 1.5 4.7 2.5 6.6 6.4 4.3 2.6 1.7 3.4 2.3 5.5 2.5 3.7 3.4 3.2 5.6 4.0 3.9 5.5 4.5 2.2 3.9 3.9 1.8 1.4 4.7 4.0 5.1 4.7 2.9 1.9 4.2 4.1 2.4 3.7 7.0 3.5 5.8 3.6 5.1 5.8 3.0 8.4 6.5 2.4 2.9 3.3 3.1 4.2 3.4 6.0 2.6 5.1 5.7 4.2 0.4 0.3 0.4 0.4 0.4 0.4 0.3 0.2 0.4 0.1 0.6 0.3 0.3 0.8 0.4 0.2 0.3 0.1 0.4 1.8 2.1 3.0 2.3 2.3 2.1 2.0 2.2 2.3 1.8 2.1 2.8 17.0 25.6 32.8 21.9 17.5 5.4 18.9 18.6 12.5 48.4 16.9 20.1 1.1 27.1 25.9 29.5 73.0 33.6 14.4 13.9 23.5 27.6 4.8 32.2 26.3 14.9 18.0 14.3 13.6 14.0 16.1 18.2 16.3 21.8 17.1 38.0 18.9 9.5 13.2 40.4 15.2 13.8 22.4 10.7 5.1 2.3 22.7 9.8 5.4 15.0 17.4 36.8 21.6 13.6 12.2 17.3 11.5 16.1 8.4 17.7 10.1 20.7 70.1 98.5 6.6 27.2 17.7 44.9 18.0 8.7 5.3 25.7 17.1 44.5 15.0 13.9 NMB "MGC17211, MGC2277, MGC3936" ENSG00000197696 "Neuromedin B" P08949 15 84655129-84658563 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 68.3;brain: 58.9" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 319.5;Club cells: 164.2;Ductal cells: 123.9" "Cancer enhanced" "Detected in all" "glioma: 93.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 90.1" "Region enriched" "Detected in all" 16 "olfactory bulb: 168.0" "Group enriched" "Detected in all" 5 "olfactory bulb: 43.3;pons: 14.1" CAB019302 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" "Secreted to blood" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nucleoplasm, Vesicles" "Plasma membrane" "CAB019302: " "unprognostic (2.44e-2)" "unprognostic (1.10e-1)" "unprognostic (2.34e-3)" "unprognostic (3.79e-1)" "prognostic favorable (3.43e-4)" "unprognostic (3.81e-1)" "unprognostic (6.45e-2)" "unprognostic (1.45e-2)" "unprognostic (2.17e-1)" "unprognostic (4.36e-1)" "unprognostic (7.24e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (2.25e-4)" "unprognostic (7.92e-3)" "unprognostic (1.45e-1)" "unprognostic (1.71e-2)" "unprognostic (1.00e-1)" 68.3 24.0 19.9 4.1 17.9 6.0 30.7 18.2 23.5 8.3 16.3 5.3 3.1 7.5 4.9 6.9 8.6 4.8 5.4 21.4 58.9 10.7 3.1 6.2 5.7 29.3 22.7 7.1 8.4 4.5 9.8 1.9 26.2 5.0 2.9 3.0 7.4 2.5 2.5 4.9 4.1 4.7 22.4 4.8 5.5 11.9 21.4 4.5 17.7 3.1 3.0 8.5 6.5 44.7 90.1 35.3 6.1 1.3 17.1 7.7 0.8 4.7 10.5 12.5 16.6 12.9 23.5 3.4 12.9 14.7 0.1 15.0 34.0 7.0 7.4 30.3 36.7 12.4 13.2 59.7 4.4 8.2 13.6 7.6 2.8 18.2 7.2 7.6 17.9 23.3 0.2 1.4 6.9 55.2 8.8 30.0 22.9 18.0 8.9 25.7 0.1 38.7 11.5 7.3 3.1 34.6 8.2 5.1 40.5 6.0 5.9 33.8 4.0 2.4 10.3 10.3 7.9 0.7 9.9 8.2 26.3 52.9 14.1 0.0 1.0 7.8 7.9 0.7 2.9 5.9 5.9 7.7 4.5 11.3 5.8 4.1 1.6 1.8 0.5 13.4 7.6 3.4 19.9 17.9 18.2 23.5 21.4 58.9 29.3 22.7 26.2 22.4 21.4 44.7 39.0 3.2 2.7 5.5 13.6 15.6 29.5 319.5 21.6 1.9 30.7 37.6 3.5 20.0 164.2 31.3 0.0 2.4 25.3 5.3 13.7 123.9 33.7 21.3 7.3 19.6 18.6 7.4 0.6 58.2 14.1 19.7 11.2 15.6 5.7 12.0 7.5 3.7 32.3 5.0 1.2 6.5 18.3 8.8 86.4 29.0 4.4 26.0 33.8 1.9 18.5 6.5 25.7 2.0 1.0 45.2 5.1 3.8 32.5 39.3 0.8 32.0 57.8 4.1 13.1 22.5 28.6 24.0 21.6 29.5 12.8 3.1 19.7 8.2 9.1 60.6 SEC11A "SEC11L1, sid2895, SPC18, SPCS4A" ENSG00000140612 "SEC11 homolog A, signal peptidase complex subunit" P67812 15 84669538-84716460 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047533 Approved "Nuclear membrane,Golgi apparatus" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 10: Non-specific - Unknown function" "Nuclear membrane" "Golgi apparatus" "HPA047533: AB_2680078" "unprognostic (8.81e-3)" "unprognostic (1.97e-1)" "unprognostic (3.19e-2)" "prognostic favorable (1.94e-5)" "unprognostic (3.39e-2)" "prognostic unfavorable (5.99e-5)" "unprognostic (1.51e-1)" "unprognostic (1.95e-1)" "unprognostic (2.79e-1)" "unprognostic (1.42e-2)" "unprognostic (6.17e-2)" "unprognostic (6.24e-2)" "unprognostic (1.09e-2)" "unprognostic (1.04e-1)" "unprognostic (1.80e-1)" "prognostic favorable (2.95e-4)" "unprognostic (7.89e-2)" 142.9 138.1 66.2 83.4 69.4 172.2 136.2 69.0 80.4 147.1 76.6 110.8 82.9 111.0 202.5 81.6 103.6 97.5 98.4 63.7 72.6 137.2 152.3 107.9 112.6 74.1 67.2 168.6 139.4 114.6 84.5 115.1 73.9 82.0 124.9 37.0 95.9 87.5 154.3 70.5 86.4 96.3 72.4 86.2 95.3 61.5 69.4 93.2 177.5 147.4 98.2 137.3 94.0 75.3 201.7 320.7 286.7 425.4 368.5 462.8 225.4 310.1 356.5 241.9 291.2 347.1 443.0 99.0 198.8 370.3 277.2 408.3 409.1 243.4 255.5 267.1 239.4 279.4 358.8 324.9 311.7 213.4 281.2 315.8 305.0 169.1 285.1 366.0 337.9 116.7 295.8 244.3 315.1 363.1 89.2 345.8 282.1 266.2 135.4 101.6 368.4 302.9 472.6 424.4 131.2 300.8 257.3 239.5 598.5 407.0 248.5 416.6 254.3 240.0 181.0 209.8 361.9 224.4 509.6 150.0 226.4 331.7 180.6 83.5 161.1 89.7 95.1 173.7 95.0 101.0 114.8 104.7 165.8 90.0 95.1 98.0 111.6 134.3 184.8 160.9 168.8 200.8 66.2 69.4 69.0 80.4 63.7 72.6 74.1 67.2 73.9 72.4 69.4 75.3 261.1 89.8 99.1 25.8 131.8 107.1 179.4 356.6 90.5 30.0 163.7 202.6 68.2 228.8 188.0 128.8 22.9 309.1 171.9 111.1 238.7 258.8 46.3 118.5 268.0 217.2 157.4 101.7 21.2 247.3 655.3 206.0 120.8 184.1 218.4 191.0 197.7 165.5 363.3 20.2 22.8 218.7 168.9 386.7 337.2 100.6 299.5 337.3 158.3 24.4 396.7 110.5 204.9 26.7 38.3 183.4 136.3 166.3 197.9 185.7 142.7 350.9 99.3 38.2 170.9 173.5 225.5 233.5 169.6 135.2 119.9 305.8 153.4 237.6 210.7 242.2 ZNF592 "CAMOS, KIAA0211, SCAR5" ENSG00000166716 "Zinc finger protein 592" Q92610 15 84748592-84806445 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020332, HPA021600" Approved Approved Nucleoplasm NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 80: Striated muscle - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA020332: AB_1859365, HPA021600: AB_1859364" "unprognostic (2.83e-1)" "unprognostic (1.90e-1)" "unprognostic (2.48e-2)" "unprognostic (2.35e-2)" "unprognostic (1.15e-1)" "unprognostic (7.63e-2)" "unprognostic (4.15e-1)" "unprognostic (2.26e-1)" "unprognostic (1.13e-1)" "unprognostic (5.04e-1)" "unprognostic (7.98e-2)" "unprognostic (2.84e-1)" "unprognostic (4.80e-3)" "unprognostic (3.64e-1)" "unprognostic (6.62e-2)" "unprognostic (3.90e-1)" "unprognostic (2.62e-1)" 9.7 8.7 9.4 6.7 10.0 11.1 9.6 10.4 9.4 9.7 7.4 9.4 7.9 9.1 7.9 7.4 9.8 4.9 9.6 9.8 9.0 8.7 10.9 9.0 9.5 11.5 10.1 11.8 10.9 9.1 7.9 5.9 10.2 8.7 7.1 7.5 7.5 6.5 18.2 10.1 10.7 6.8 9.3 11.2 8.1 8.0 10.2 11.4 8.8 14.5 9.4 8.5 8.3 10.6 7.7 12.8 11.6 6.5 12.7 8.5 12.8 5.3 7.5 8.6 6.8 12.2 8.9 11.1 6.7 11.9 7.4 13.9 18.0 7.6 6.0 9.0 10.8 12.9 12.9 11.0 7.8 10.6 9.9 9.4 10.6 6.7 11.0 10.2 7.6 7.7 13.0 6.8 9.1 12.0 7.2 13.0 10.6 7.3 5.0 10.3 10.4 9.8 9.2 15.4 10.5 11.4 12.1 10.7 9.0 16.1 6.0 22.3 10.8 12.7 7.4 7.1 10.2 7.8 9.0 11.8 8.0 15.5 7.5 0.0 1.2 0.9 1.2 1.4 0.4 1.5 0.7 1.2 1.3 1.4 1.0 0.9 2.6 1.0 1.3 1.0 0.8 0.8 9.4 10.0 10.4 9.4 9.8 9.0 11.5 10.1 10.2 9.3 10.2 10.6 9.2 9.6 10.5 23.8 15.2 8.4 4.2 8.2 6.2 9.0 14.3 8.8 5.3 8.6 7.5 3.7 8.4 5.6 9.6 18.8 0.0 8.4 7.8 24.7 10.8 9.8 7.8 12.0 21.7 8.1 8.9 8.7 13.7 40.3 3.8 10.2 10.4 16.7 11.3 3.3 20.7 10.8 4.1 21.1 9.8 11.8 4.7 14.6 7.2 28.1 14.9 3.7 11.3 10.1 29.9 9.8 11.1 9.8 16.9 5.6 16.2 6.3 8.4 8.5 6.6 13.1 9.2 13.2 12.4 8.9 7.1 4.8 11.6 8.1 11.4 5.1 ALPK3 "KIAA1330, MAK, Midori" ENSG00000136383 "Alpha kinase 3" Q96L96 15 84817356-84873479 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 62.7;skeletal muscle: 195.8;tongue: 59.1" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 64.1;Exocrine glandular cells: 20.5;Skeletal myocytes: 51.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 14.3;HDLM-2: 10.7;HUVEC TERT2: 15.5;LHCN-M2: 21.2;NTERA-2: 12.9;RH-30: 37.7;THP-1: 9.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA026558 Uncertain Approved Nucleoplasm NA NA "Cluster 13: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 37: Myocytes - Muscle contraction" Nucleoplasm "HPA026558: AB_1844774" "unprognostic (2.69e-2)" "unprognostic (1.42e-1)" "unprognostic (2.71e-2)" "unprognostic (4.61e-2)" "unprognostic (2.08e-1)" "unprognostic (6.53e-2)" "unprognostic (1.44e-3)" "unprognostic (1.42e-1)" "unprognostic (1.68e-2)" "unprognostic (1.82e-1)" "unprognostic (1.74e-3)" "unprognostic (1.23e-1)" "prognostic favorable (3.95e-7)" "unprognostic (1.76e-2)" "unprognostic (1.77e-1)" "unprognostic (2.96e-2)" "unprognostic (4.87e-2)" 12.5 9.6 1.2 0.9 1.6 0.1 4.4 1.0 2.2 2.2 9.3 7.5 0.6 1.5 5.4 3.0 1.7 1.8 62.7 1.3 3.8 13.5 5.9 5.5 0.6 2.2 3.4 0.8 7.7 11.2 26.1 2.5 4.5 2.4 0.8 2.5 2.6 1.3 195.8 1.0 2.1 3.1 1.6 0.5 5.2 0.9 3.9 0.6 3.6 59.1 0.4 3.6 1.4 1.1 1.8 0.1 0.1 0.2 0.3 0.1 14.3 0.0 0.0 0.0 0.1 0.1 6.3 0.0 0.4 0.0 0.1 1.1 0.0 0.0 0.1 10.7 1.7 1.8 0.3 0.0 0.2 0.0 0.1 1.3 0.2 0.0 0.0 0.1 15.5 0.1 0.0 0.1 21.2 0.9 0.0 0.2 12.9 0.3 0.1 0.0 37.7 0.2 0.0 4.0 0.0 0.2 0.0 2.0 0.1 1.9 0.1 9.6 0.3 0.1 0.0 0.0 0.0 0.3 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.6 1.0 2.2 1.3 3.8 2.2 3.4 4.5 1.6 3.9 1.1 3.3 6.4 2.7 2.6 0.2 0.9 0.1 0.6 1.2 4.1 1.3 0.8 64.1 17.2 2.4 9.2 16.7 0.3 0.2 0.5 0.0 2.9 0.3 11.5 1.0 8.7 9.1 0.0 3.0 20.5 0.7 3.8 0.5 8.9 1.3 8.7 1.8 1.7 10.2 0.0 3.4 0.3 0.0 0.3 12.0 0.0 0.0 5.2 3.6 9.4 4.7 1.0 1.0 0.5 0.3 10.4 1.2 0.0 1.5 0.7 0.1 2.2 4.2 3.4 0.0 51.9 8.4 0.5 3.2 0.2 0.1 0.7 0.5 0.2 0.3 1.6 SLC28A1 CNT1 ENSG00000156222 "Solute carrier family 28 member 1" O00337 15 84884654-84945798 "Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "intestine: 49.1;kidney: 48.2;liver: 111.3" "Group enriched" "Detected in some" 5 "Hepatocytes: 38.6;Hofbauer cells: 54.3;Proximal enterocytes: 86.9;Proximal tubular cells: 93.4" "Group enriched" "Detected in some" 63 "liver cancer: 10.9;renal cancer: 33.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA019551, HPA056247" Enhanced Approved "Nuclear speckles,Plasma membrane,Cytosol" NA NA "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Plasma membrane" "Nuclear speckles, Cytosol" "HPA019551: AB_2670187, HPA056247: " "unprognostic (3.81e-2)" "unprognostic (1.60e-1)" "unprognostic (2.22e-1)" "unprognostic (7.49e-2)" "unprognostic (5.08e-2)" "unprognostic (7.08e-2)" "unprognostic (8.68e-3)" "unprognostic (1.82e-1)" "unprognostic (1.98e-1)" "unprognostic (2.18e-2)" "unprognostic (1.63e-1)" "unprognostic (8.37e-2)" "unprognostic (1.35e-1)" "unprognostic (7.42e-2)" "unprognostic (7.72e-3)" "unprognostic (6.65e-2)" "unprognostic (1.55e-1)" 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.2 0.1 0.3 0.0 0.0 37.9 0.0 0.5 0.1 0.7 0.2 1.0 0.1 0.3 48.2 111.3 0.0 0.2 0.9 0.3 0.0 0.0 0.2 0.2 1.2 0.7 0.0 0.0 0.0 0.1 0.0 1.5 0.0 49.1 0.0 0.4 0.0 0.1 0.1 0.2 0.0 0.0 3.3 0.0 0.0 0.0 0.6 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.1 0.3 0.9 0.3 0.7 0.4 0.2 0.6 0.2 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.3 2.2 4.3 0.6 7.3 0.0 0.5 0.0 0.0 11.7 3.0 0.0 0.4 0.1 0.1 0.0 0.0 0.5 0.0 0.5 0.4 0.0 0.6 0.0 0.0 0.4 38.6 54.3 0.0 0.5 2.8 0.0 0.6 0.0 0.0 0.0 0.9 0.0 0.0 0.6 0.0 0.0 0.5 1.1 0.3 2.5 0.0 0.0 0.0 86.9 93.4 1.4 0.0 0.0 2.6 0.2 0.0 0.0 0.0 0.0 0.8 0.4 0.3 1.5 0.1 PDE8A HsT19550 ENSG00000073417 "Phosphodiesterase 8A" O60658 15 84980440-85139145 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "Oligodendrocytes: 968.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "RT4: 89.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007722 Approved Approved "Golgi apparatus" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 45: Intestine - Brush border" "Cluster 15: RT4 - Unknown function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" "HPA007722: AB_1855130" "unprognostic (1.68e-1)" "unprognostic (2.83e-2)" "unprognostic (4.81e-2)" "unprognostic (4.97e-2)" "unprognostic (6.25e-2)" "unprognostic (3.47e-2)" "unprognostic (2.97e-2)" "unprognostic (3.94e-2)" "unprognostic (1.03e-1)" "unprognostic (2.45e-1)" "unprognostic (8.99e-3)" "unprognostic (2.75e-2)" "unprognostic (3.42e-1)" "unprognostic (3.72e-1)" "unprognostic (4.26e-1)" "unprognostic (1.31e-1)" "unprognostic (1.94e-2)" 16.7 16.6 20.9 8.5 32.3 3.3 10.5 21.9 22.4 11.6 15.2 24.0 15.3 9.1 7.3 6.4 9.0 15.8 8.0 17.3 20.1 24.3 30.0 10.8 5.6 23.8 28.5 12.7 14.5 16.9 6.7 11.4 23.6 6.9 21.9 14.5 6.4 9.6 5.8 6.3 13.6 10.6 19.5 6.3 11.0 11.0 26.9 4.6 12.3 6.5 5.1 17.7 7.0 45.2 29.0 48.4 7.9 5.4 32.7 17.2 9.6 19.4 21.1 16.6 18.9 10.9 16.9 5.8 14.6 25.9 19.7 20.2 33.8 14.9 22.0 10.8 20.2 7.7 30.3 15.6 23.5 4.5 11.3 17.4 9.1 19.6 18.6 14.3 21.6 6.4 15.6 18.3 15.2 24.5 2.6 4.5 3.8 9.5 8.6 3.6 6.5 8.1 13.2 89.0 18.3 14.1 18.9 20.3 55.5 8.7 6.7 8.7 17.1 38.4 13.6 13.9 31.6 8.9 16.7 6.2 26.1 18.1 11.0 0.0 0.9 0.6 0.3 0.7 0.6 0.2 0.5 0.6 0.5 0.3 0.7 0.3 0.0 0.2 1.6 0.0 1.1 0.2 20.9 32.3 21.9 22.4 17.3 20.1 23.8 28.5 23.6 19.5 26.9 45.2 30.7 6.4 26.5 83.9 14.8 11.3 11.1 13.9 18.2 13.0 6.6 5.2 6.8 41.5 15.4 7.3 12.5 8.0 5.5 58.7 7.9 11.3 6.4 12.5 21.6 24.3 14.5 0.8 60.8 9.6 7.1 16.2 26.5 20.6 22.1 17.9 14.3 23.3 10.8 10.1 126.2 19.0 4.1 12.3 18.9 5.6 10.8 19.2 10.6 85.3 9.0 2.6 10.3 119.1 968.6 11.5 31.8 11.3 7.2 25.4 22.1 21.1 10.5 31.2 39.5 17.8 24.5 25.6 17.3 7.5 10.4 4.5 10.8 25.3 28.5 26.4 AKAP13 "AKAP-Lbc, ARHGEF13, BRX, c-lbc, HA-3, Ht31, LBC, PROTO-LB" ENSG00000170776 "A-kinase anchoring protein 13" Q12802 15 85380571-85749358 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 161.8" "Low region specificity" "Detected in all" HPA019773 Approved Supported Cytosol NA NA 14000 "Cluster 2: Granulocytes - Unknown function" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 3: HMC-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "HPA019773: AB_1844686" "unprognostic (4.61e-2)" "unprognostic (1.16e-1)" "unprognostic (3.96e-2)" "unprognostic (2.78e-2)" "unprognostic (1.04e-1)" "unprognostic (1.58e-1)" "unprognostic (5.33e-2)" "unprognostic (7.72e-2)" "unprognostic (1.33e-1)" "unprognostic (1.11e-1)" "unprognostic (3.99e-2)" "unprognostic (3.92e-1)" "unprognostic (6.69e-2)" "unprognostic (4.88e-2)" "unprognostic (4.80e-2)" "unprognostic (1.46e-1)" "unprognostic (3.81e-3)" 37.7 18.9 10.0 38.7 9.2 56.1 32.1 1.7 9.3 28.5 66.1 25.9 16.7 83.0 20.7 25.6 22.7 44.6 66.6 11.0 17.7 14.4 22.2 54.1 47.6 16.7 17.6 26.7 54.5 11.8 18.5 26.0 13.9 20.3 21.3 8.3 23.9 23.5 83.9 24.7 32.5 40.3 9.7 38.3 34.4 20.0 15.0 46.3 32.7 60.3 46.5 32.9 26.7 16.3 13.2 29.0 20.8 7.8 31.3 34.6 11.2 10.6 23.5 9.4 9.0 11.3 11.0 62.0 14.6 19.2 23.8 26.5 23.9 9.9 9.0 45.2 11.0 83.8 20.0 8.6 17.3 17.2 161.8 25.6 25.5 11.6 39.8 10.6 25.2 22.4 5.5 29.6 14.7 6.3 24.7 12.8 13.5 22.8 11.5 16.7 20.6 23.5 15.3 27.0 13.1 23.4 27.9 8.3 14.5 22.7 6.0 14.3 30.2 11.4 7.8 6.7 10.7 46.1 30.1 48.9 6.8 55.2 9.0 282.9 66.0 181.4 122.2 54.9 68.3 74.9 81.6 93.3 38.8 68.8 68.2 75.5 104.3 108.2 77.5 100.6 73.2 48.0 10.0 9.2 1.7 9.3 11.0 17.7 16.7 17.6 13.9 9.7 15.0 16.3 110.5 125.0 431.2 88.2 186.8 75.7 105.2 29.1 57.5 18.6 50.2 39.9 215.2 91.5 71.6 40.5 41.7 36.7 336.8 143.3 5.9 83.4 258.9 155.6 327.0 121.5 63.5 37.0 51.2 69.6 27.6 119.6 170.2 323.6 279.5 65.6 75.7 53.7 79.2 13.5 13.0 57.8 36.7 147.1 276.3 166.3 77.6 257.9 99.6 290.4 197.3 45.8 252.4 123.6 13.2 101.2 118.7 63.6 205.8 77.0 68.6 10.5 60.1 17.9 85.5 139.6 117.4 23.3 37.2 77.6 79.0 23.4 269.7 30.5 61.7 179.6 KLHL25 "ENC-2, ENC2, FLJ12587" ENSG00000183655 "Kelch like family member 25" Q9H0H3 15 85759326-85794925 "Predicted intracellular proteins" "Translation regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Horizontal cells: 13.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 3.8" "Group enriched" "Detected in many" 4 "monocytes: 3.8;NK-cells: 2.5;T-cells: 1.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "cerebral cortex: 29.1;hippocampal formation: 16.3" HPA023450 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 15: Liver - Metabolism" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoplasm, Cytosol" "HPA023450: AB_1852583" "unprognostic (1.18e-1)" "unprognostic (1.06e-2)" "unprognostic (2.78e-2)" "unprognostic (1.99e-2)" "unprognostic (1.30e-1)" "unprognostic (1.42e-1)" "unprognostic (2.94e-2)" "unprognostic (8.98e-2)" "unprognostic (6.60e-2)" "unprognostic (9.29e-3)" "unprognostic (4.25e-2)" "unprognostic (5.18e-2)" "unprognostic (2.22e-2)" "unprognostic (3.57e-2)" "unprognostic (1.80e-1)" "unprognostic (2.08e-1)" "unprognostic (2.66e-2)" 6.5 2.4 5.6 2.6 7.6 0.5 5.4 5.8 7.5 4.3 4.3 3.8 4.7 6.6 3.1 5.7 4.0 2.2 3.9 6.0 7.6 3.7 15.1 4.3 1.9 5.4 8.2 3.3 1.6 2.2 3.6 1.1 6.9 4.6 1.1 0.8 3.6 3.1 6.5 9.3 3.4 2.8 4.7 1.6 5.0 10.5 7.6 2.0 2.4 3.0 1.3 3.7 5.0 6.7 2.7 8.1 11.6 5.7 2.3 1.2 6.0 3.4 1.6 4.6 3.5 10.9 4.4 1.7 1.7 2.8 2.9 6.6 12.5 6.4 1.0 1.7 5.8 0.5 3.5 8.4 2.7 0.5 2.0 2.4 2.1 4.5 1.5 2.0 2.5 5.8 0.7 1.5 2.0 5.0 4.3 2.6 10.5 4.6 4.2 8.7 6.9 2.8 1.7 5.6 16.1 11.1 4.9 5.6 2.2 4.7 10.2 0.6 2.1 4.9 8.9 3.2 6.2 1.6 3.7 1.7 2.2 3.0 2.8 0.0 0.1 0.2 1.0 1.2 0.5 0.0 1.0 0.7 0.2 0.2 1.7 1.1 0.0 2.5 3.8 0.6 0.9 0.5 5.6 7.6 5.8 7.5 6.0 7.6 5.4 8.2 6.9 4.7 7.6 6.7 0.8 0.0 1.9 3.6 1.2 2.7 4.0 2.1 0.0 3.3 4.0 2.8 4.3 1.5 1.5 0.0 0.0 1.0 3.6 6.3 1.9 2.3 13.0 3.0 3.6 1.8 10.7 0.0 7.7 2.7 1.5 2.4 8.6 3.2 0.0 2.0 2.2 12.4 0.8 13.5 4.1 7.6 4.1 1.3 2.7 4.6 0.9 1.4 7.2 1.0 0.6 2.7 2.1 6.0 0.9 5.3 3.1 1.5 1.3 2.7 2.7 2.1 2.1 1.1 6.6 2.9 2.9 3.3 4.1 4.4 4.7 1.8 4.0 1.4 5.2 4.3 AGBL1 "CCP4, FLJ32310" ENSG00000273540 "ATP/GTP binding protein like 1" Q96MI9 15 86079871-87049169 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Corneal dystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 10 "skeletal muscle: 7.8;tongue: 23.2" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 16.7;Astrocytes: 28.7;Excitatory neurons: 15.6;Inhibitory neurons: 25.6;Oligodendrocyte precursor cells: 47.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 13: Striated muscle - Muscle contraction" "Cluster 68: Oligodendrocytes - Mixed function" "unprognostic (3.70e-2)" "unprognostic (4.46e-2)" "unprognostic (1.06e-1)" 0.0 0.0 0.6 0.0 1.4 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.0 0.3 0.0 0.0 0.7 0.0 1.0 0.8 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.7 0.0 7.8 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.4 0.0 0.0 23.2 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.4 0.0 0.7 1.0 0.3 1.0 0.8 0.3 0.9 0.4 0.4 0.0 3.2 16.7 28.7 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.1 0.0 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.6 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 1.9 0.0 0.0 0.0 47.3 6.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 5.2 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 NTRK3 TRKC ENSG00000140538 "Neurotrophic receptor tyrosine kinase 3" Q16288 15 87859751-88256768 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.8" "Cell type enhanced" "Detected in many" "Astrocytes: 239.3;Early spermatids: 119.6;Excitatory neurons: 360.0;Inhibitory neurons: 277.8;Late spermatids: 148.9;Microglial cells: 177.1;Oligodendrocyte precursor cells: 499.6" "Group enriched" "Detected in some" 4 "glioma: 2.5;testis cancer: 1.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 8 "U-138 MG: 100.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009233, HPA027484, HPA048065" Approved Supported "Nuclear membrane,Nucleoli,Nucleoli rim" NA NA 19000000 "Cluster 10: Brain - Neuronal signaling" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nucleoli, Nucleoli rim" "Nuclear membrane" "CAB009233: AB_632555, HPA027484: AB_2672297, HPA048065: AB_2680245" "unprognostic (1.27e-3)" "unprognostic (1.24e-2)" "unprognostic (1.98e-2)" "unprognostic (2.04e-2)" "unprognostic (1.65e-1)" "unprognostic (3.34e-1)" "unprognostic (3.18e-2)" "unprognostic (2.23e-2)" "unprognostic (2.34e-1)" "unprognostic (3.91e-1)" "unprognostic (2.88e-1)" "unprognostic (1.09e-1)" "unprognostic (5.78e-3)" "unprognostic (6.45e-3)" "unprognostic (1.06e-2)" "unprognostic (1.26e-2)" "unprognostic (2.49e-3)" 12.8 3.7 31.3 0.8 33.2 0.1 7.8 30.7 34.3 12.8 0.0 3.4 0.5 10.4 3.2 1.3 15.0 1.6 5.8 38.8 25.8 5.1 1.0 5.3 1.2 21.5 19.6 7.2 1.0 0.1 12.2 1.0 22.1 9.0 2.0 5.2 6.8 4.3 1.8 4.8 2.2 3.7 10.9 2.5 3.2 9.8 33.4 1.2 3.0 1.9 2.0 8.7 7.4 21.5 0.0 13.1 2.7 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 2.5 0.0 0.0 0.0 2.6 0.1 0.1 0.1 0.7 0.1 0.0 0.0 0.0 0.9 0.1 0.1 0.0 100.6 1.8 0.0 1.3 0.0 0.0 0.0 3.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 31.3 33.2 30.7 34.3 38.8 25.8 21.5 19.6 22.1 10.9 33.4 21.5 0.5 0.0 0.0 239.3 0.0 0.5 6.4 0.0 0.0 53.8 3.7 6.0 5.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 119.6 0.4 25.0 1.2 0.0 0.0 360.0 0.0 0.0 5.7 0.0 0.5 0.0 0.0 2.2 0.0 1.0 1.7 277.8 0.0 0.0 0.0 0.6 148.9 3.4 0.6 0.0 177.1 0.0 8.6 0.0 499.6 7.4 0.0 0.0 27.4 0.0 1.3 0.0 0.1 0.0 3.7 52.6 20.3 40.9 11.0 3.7 0.0 0.1 0.1 0.2 0.0 0.0 0.7 MRPL46 "C15orf4, LIECG2, P2ECSL" ENSG00000259494 "Mitochondrial ribosomal protein L46" Q9H2W6 15 88459477-88467390 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 119.3;Proximal tubular cells: 133.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050166, HPA076046" Approved Supported "Nucleoplasm,Cell Junctions,Mitochondria" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 39: CACO-2 - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "Nucleoplasm, Cell Junctions" "HPA050166: AB_2681039, HPA076046: " "unprognostic (1.42e-1)" "unprognostic (6.94e-3)" "unprognostic (1.02e-1)" "unprognostic (1.21e-2)" "unprognostic (3.28e-2)" "unprognostic (5.16e-2)" "unprognostic (6.22e-2)" "unprognostic (1.84e-1)" "unprognostic (1.79e-1)" "unprognostic (4.64e-3)" "unprognostic (7.78e-2)" "unprognostic (5.65e-2)" "prognostic favorable (2.09e-6)" "unprognostic (7.73e-2)" "unprognostic (9.18e-2)" "unprognostic (6.96e-3)" "unprognostic (1.63e-1)" 25.1 51.5 20.3 12.9 21.7 11.3 22.7 23.7 25.4 14.6 22.0 24.2 20.0 17.1 18.2 26.4 17.1 13.0 76.1 20.8 23.6 34.7 70.9 12.7 20.9 23.1 22.1 17.2 16.2 24.6 16.2 19.6 23.6 14.9 23.6 16.8 17.1 15.2 73.3 17.9 19.7 18.4 21.7 19.1 24.8 28.1 22.7 18.9 17.2 84.6 20.3 20.7 16.2 22.6 27.8 87.2 27.2 29.8 38.0 28.6 51.5 38.6 35.5 56.9 50.4 108.6 59.3 64.9 38.6 34.9 51.0 65.9 107.4 47.4 44.8 26.3 86.4 53.6 61.5 114.3 24.6 54.2 40.4 32.7 56.6 42.8 28.7 29.0 50.2 63.2 60.7 26.6 42.7 59.6 44.2 68.4 43.5 50.5 52.9 51.9 37.9 49.2 44.5 88.2 42.1 26.5 36.6 57.7 81.8 44.6 64.8 65.7 31.3 44.0 41.9 23.3 56.4 24.2 55.7 53.0 48.5 58.1 34.2 27.1 45.5 33.7 60.0 60.5 69.6 78.8 63.3 58.7 58.7 69.5 69.5 61.6 7.9 62.9 45.0 50.5 68.0 61.5 20.3 21.7 23.7 25.4 20.8 23.6 23.1 22.1 23.6 21.7 22.7 22.6 18.9 0.0 10.3 5.2 21.0 13.8 22.4 59.8 9.6 21.2 17.3 21.3 70.4 37.1 32.3 36.8 27.1 94.3 10.7 20.4 119.3 35.0 67.1 20.0 16.6 18.4 28.3 17.7 4.2 38.0 42.1 19.2 19.9 19.5 22.2 25.8 17.2 105.0 35.6 15.2 5.9 20.6 44.7 13.4 5.5 16.3 14.3 10.8 7.2 3.7 42.1 25.1 20.6 4.5 6.1 31.7 18.4 18.8 17.3 21.9 32.1 133.6 26.2 28.4 26.3 19.5 25.5 55.3 27.4 27.1 23.3 80.7 18.5 66.9 36.1 29.4 AC013489.1 ENSG00000173867 "Novel transcript" 15 88459501-88546585 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in some" "Group enriched" "Detected in some" 5 "granulocytes: 1.3;Respiratory ciliated cells: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" HPA048873 Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes NA "Cluster 32: T-cells - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 49: Ciliated cells - Cilium organization" Microtubules "Nucleoplasm, Cytokinetic bridge" "HPA048873: AB_2680541" "unprognostic (3.32e-2)" "unprognostic (9.46e-3)" "unprognostic (1.47e-1)" "unprognostic (1.47e-1)" "unprognostic (2.84e-2)" "unprognostic (6.56e-3)" "unprognostic (4.03e-1)" "unprognostic (1.88e-2)" "unprognostic (1.01e-1)" "unprognostic (1.02e-2)" "unprognostic (2.29e-2)" "unprognostic (1.10e-2)" "unprognostic (2.62e-3)" "unprognostic (1.79e-1)" "unprognostic (4.47e-1)" "unprognostic (2.21e-1)" "unprognostic (1.66e-2)" 0.4 0.4 0.6 0.2 0.6 0.4 1.1 0.7 0.7 0.4 0.9 0.5 0.3 2.2 1.0 0.3 1.0 0.5 0.8 0.5 0.9 0.7 0.8 0.5 0.4 0.6 0.6 2.2 1.0 0.7 0.5 0.7 0.6 0.6 1.3 0.4 0.7 1.4 0.3 0.4 0.9 0.6 0.7 0.4 0.4 0.7 0.5 0.7 1.2 0.5 0.3 0.8 0.3 0.6 0.5 0.8 1.2 0.6 0.6 1.0 0.7 1.0 0.7 0.6 1.1 0.9 0.7 1.2 0.7 0.6 2.1 0.6 0.9 0.3 1.0 1.0 0.5 0.8 0.4 0.8 0.7 1.0 1.1 0.7 0.8 0.4 0.5 1.2 1.0 0.9 0.1 0.4 1.0 0.5 0.6 0.7 0.2 0.4 0.7 1.2 0.6 0.8 0.6 0.4 0.9 0.4 1.4 1.0 0.7 1.5 0.8 0.7 0.5 0.9 0.9 0.5 0.9 0.6 0.9 0.7 0.5 0.0 0.5 0.3 0.7 0.9 0.8 0.9 0.9 0.8 0.8 0.7 1.0 1.1 0.0 0.9 0.6 0.6 0.8 0.9 0.6 0.6 0.7 0.7 0.5 0.9 0.6 0.6 0.7 0.6 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MRPS11 "FLJ22512, FLJ23406, HCC-2" ENSG00000181991 "Mitochondrial ribosomal protein S11" P82912 15 88467453-88480776 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043752, HPA050345" Enhanced Supported Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA043752: AB_2678653, HPA050345: AB_2681100" "unprognostic (2.66e-1)" "prognostic favorable (3.60e-4)" "unprognostic (6.51e-2)" "unprognostic (1.35e-1)" "unprognostic (1.12e-1)" "unprognostic (3.21e-1)" "unprognostic (3.45e-1)" "unprognostic (1.44e-1)" "unprognostic (6.45e-2)" "prognostic favorable (4.75e-4)" "unprognostic (8.31e-2)" "unprognostic (3.37e-1)" "unprognostic (1.83e-1)" "unprognostic (9.44e-2)" "unprognostic (7.26e-2)" "unprognostic (7.85e-2)" "unprognostic (1.74e-1)" 9.4 16.9 12.0 4.0 12.1 2.8 8.6 12.8 18.3 5.3 11.4 9.3 7.9 5.3 3.8 10.9 4.8 4.5 26.1 12.5 12.1 14.0 20.5 5.2 5.6 12.7 12.3 3.5 10.5 3.8 7.6 2.3 12.9 7.4 3.5 2.5 6.0 3.4 24.7 7.2 7.4 4.3 11.7 8.0 9.6 9.0 12.7 5.1 9.6 15.0 4.4 8.4 5.6 12.1 10.5 41.1 6.1 10.4 13.8 6.6 16.1 8.3 14.6 10.7 11.5 28.9 16.0 9.7 17.0 7.1 11.3 14.8 17.9 11.5 5.5 12.8 43.8 13.2 23.1 32.0 16.5 4.5 8.3 13.4 11.1 9.2 9.2 5.8 14.3 12.3 9.6 4.3 18.1 45.1 9.3 19.0 16.3 13.4 43.8 19.0 11.6 23.0 15.5 28.4 19.3 9.6 8.6 21.6 33.6 5.3 19.8 24.7 6.8 15.2 16.8 9.9 12.5 8.5 16.5 11.7 18.3 11.2 16.3 31.1 25.1 19.3 15.1 27.6 17.6 27.5 17.2 17.8 29.5 18.2 18.1 17.6 9.5 30.1 17.8 31.9 35.1 26.0 12.0 12.1 12.8 18.3 12.5 12.1 12.7 12.3 12.9 11.7 12.7 12.1 42.1 6.4 20.4 10.4 30.4 22.8 27.5 69.2 31.9 36.9 38.1 47.2 6.3 35.8 39.6 46.0 47.9 91.0 34.6 85.5 135.0 63.9 30.2 27.1 37.8 34.2 24.7 40.6 14.0 66.8 89.7 32.7 25.0 32.5 33.6 40.4 44.6 92.6 90.5 26.9 15.0 60.3 50.8 33.1 24.5 34.2 33.2 31.0 32.0 8.4 65.0 44.4 72.1 16.6 16.8 67.0 70.7 42.5 36.5 32.2 90.8 145.3 29.7 45.1 19.7 29.7 51.8 90.3 42.0 49.1 28.3 89.6 32.3 96.0 64.6 34.5 DET1 FLJ10103 ENSG00000140543 "DET1 partner of COP1 E3 ubiquitin ligase" Q7L5Y6 15 88494440-88546681 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA048873 Uncertain Approved "Nucleoplasm,Microtubules,Cytokinetic bridge" Yes No "Cluster 7: Monocytes - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 52: Non-specific - Transcription" Microtubules "Nucleoplasm, Cytokinetic bridge" "HPA048873: AB_2680541" "unprognostic (9.21e-2)" "unprognostic (1.83e-1)" "unprognostic (2.34e-1)" "unprognostic (1.26e-1)" "unprognostic (3.17e-1)" "unprognostic (1.86e-1)" "unprognostic (1.20e-2)" "unprognostic (6.64e-2)" "unprognostic (1.84e-1)" "unprognostic (4.01e-2)" "unprognostic (1.52e-1)" "unprognostic (4.00e-2)" "unprognostic (2.82e-3)" "unprognostic (2.62e-2)" "unprognostic (1.20e-1)" "unprognostic (8.69e-2)" "unprognostic (4.67e-2)" 3.7 5.2 2.5 2.0 2.8 1.2 3.6 2.7 2.7 6.0 3.2 4.2 3.5 6.7 5.4 2.2 5.6 3.0 5.6 2.5 2.6 3.2 2.7 2.1 2.9 2.7 2.5 10.3 3.6 3.7 3.7 3.5 2.8 4.1 3.2 5.0 4.1 3.8 9.7 2.6 3.2 5.5 2.4 2.5 3.4 1.5 2.6 5.6 4.1 11.7 3.0 4.5 3.3 3.2 1.7 6.2 8.6 6.0 3.4 6.0 1.1 5.4 6.1 4.5 5.1 1.0 4.8 3.3 4.1 7.3 4.5 2.4 8.7 1.3 3.9 0.2 5.9 6.9 3.1 1.5 6.7 2.5 1.1 5.0 5.9 1.9 6.9 4.4 3.8 2.9 8.5 3.8 6.7 2.6 3.2 2.8 3.6 2.6 1.8 4.2 6.9 3.8 2.4 5.3 3.0 4.9 6.5 2.0 14.9 5.6 2.9 5.2 3.0 5.1 3.7 4.8 5.4 2.3 1.4 2.1 5.4 4.3 4.5 0.0 2.3 1.6 2.2 3.4 1.4 1.8 1.7 1.9 3.7 2.2 2.6 1.9 0.3 1.4 2.3 1.9 2.4 1.3 2.5 2.8 2.7 2.7 2.5 2.6 2.7 2.5 2.8 2.4 2.6 3.2 3.5 3.2 2.7 6.8 3.5 0.6 2.0 3.7 4.6 11.5 4.3 3.8 2.3 1.5 2.1 3.7 10.4 7.2 1.7 2.1 1.9 3.4 1.2 3.4 6.1 2.3 3.0 5.5 5.7 3.9 6.3 4.9 2.0 2.4 0.0 10.6 2.2 2.8 4.4 6.7 6.8 2.7 2.0 1.6 2.2 0.6 4.4 2.5 3.6 3.7 4.7 7.1 2.1 6.0 9.5 3.1 1.0 3.8 1.6 1.5 3.1 2.6 3.1 7.9 0.0 5.6 4.5 8.1 9.9 1.5 1.3 4.1 2.7 8.4 3.3 1.4 AEN "FLJ12484, FLJ12562, ISG20L1" ENSG00000181026 "Apoptosis enhancing nuclease" Q8WTP8 15 88621337-88632281 "Predicted intracellular proteins" "Apoptosis, DNA damage" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 62.7" "Cancer enhanced" "Detected in all" "testis cancer: 38.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048599 Supported "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 29: Non-specific - Vesicular transport" "Cluster 5: NTERA-2 - Transcription" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoplasm, Nucleoli" "Nuclear membrane" "HPA048599: AB_2756313" "unprognostic (8.64e-2)" "unprognostic (1.94e-1)" "unprognostic (2.16e-2)" "prognostic favorable (1.72e-4)" "unprognostic (1.52e-2)" "unprognostic (4.40e-2)" "unprognostic (4.08e-2)" "unprognostic (9.42e-2)" "unprognostic (4.28e-2)" "unprognostic (1.17e-2)" "unprognostic (9.00e-2)" "unprognostic (7.88e-2)" "unprognostic (8.58e-3)" "unprognostic (3.39e-2)" "unprognostic (2.73e-1)" "unprognostic (8.71e-2)" "unprognostic (6.10e-2)" 9.1 12.2 6.8 10.7 7.1 17.7 6.0 6.6 6.8 6.8 7.0 8.4 5.1 7.6 9.6 9.6 7.0 12.5 7.3 6.3 11.5 9.0 13.5 10.1 12.8 8.6 7.7 8.0 20.9 4.4 22.4 6.9 7.7 12.1 8.6 1.0 8.3 8.2 15.1 7.2 9.1 10.1 8.1 15.2 13.2 9.8 9.5 10.7 10.3 3.7 11.9 11.5 5.9 7.7 14.9 64.5 39.6 34.2 17.4 20.7 83.7 51.5 46.8 39.1 47.8 53.8 28.2 63.6 16.1 28.3 35.0 20.9 148.0 42.1 32.6 15.7 58.2 34.0 26.4 89.9 42.0 28.5 32.8 25.6 36.4 48.5 39.7 14.0 33.0 20.6 54.6 35.2 48.3 34.4 35.5 24.0 96.0 30.8 36.9 45.4 28.2 46.9 16.5 31.9 31.1 28.5 20.8 23.7 40.1 90.7 19.7 32.0 29.9 39.5 55.1 16.2 70.5 67.0 48.5 54.7 36.0 31.5 79.1 0.0 2.3 0.8 6.2 3.7 12.0 10.9 10.8 8.4 5.2 10.3 11.6 10.6 0.6 3.9 4.9 3.1 19.6 9.2 6.8 7.1 6.6 6.8 6.3 11.5 8.6 7.7 7.7 8.1 9.5 7.7 6.9 6.4 8.1 4.2 21.0 18.6 25.8 6.2 12.0 1.2 21.4 15.4 3.9 8.6 12.9 1.8 0.0 4.7 8.4 5.6 3.9 11.4 23.6 22.5 5.3 7.6 9.0 11.8 20.5 7.6 16.3 9.0 11.7 17.7 2.5 12.3 2.5 6.3 4.5 1.7 16.0 9.9 26.4 4.7 26.4 62.7 4.4 7.8 14.2 3.7 14.2 3.1 9.2 9.0 2.5 11.5 6.2 2.6 26.9 27.8 2.3 5.5 5.4 0.9 13.1 12.0 11.6 10.2 18.2 10.9 28.3 6.2 14.9 6.8 9.7 25.4 ISG20 "CD25, HEM45" ENSG00000172183 "Interferon stimulated exonuclease gene 20" Q96AZ6 15 88635670-88656483 "Enzymes, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity, rRNA processing" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 188.9" "Cell type enhanced" "Detected in many" "Langerhans cells: 500.2;Paneth cells: 476.1;Plasma cells: 663.4;Urothelial cells: 538.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 202.9;Karpas-707: 117.4;SK-MEL-30: 718.4;U-698: 123.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 16: Immune cells - Immune response" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 55: Plasma cells - Humoral immune response" "unprognostic (2.55e-3)" "unprognostic (1.19e-3)" "unprognostic (2.00e-2)" "unprognostic (1.32e-1)" "prognostic unfavorable (6.51e-5)" "unprognostic (1.55e-2)" "unprognostic (1.46e-1)" "unprognostic (4.54e-2)" "unprognostic (1.35e-3)" "prognostic favorable (1.85e-5)" "unprognostic (5.60e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (4.86e-8)" "unprognostic (1.04e-1)" "unprognostic (4.69e-2)" "unprognostic (3.39e-1)" "unprognostic (1.58e-2)" 22.4 8.1 7.0 78.3 9.0 41.3 21.7 8.0 11.3 12.9 6.0 28.5 77.2 7.4 9.5 30.1 15.2 38.7 14.5 6.7 8.2 15.1 28.2 62.8 188.9 10.7 8.0 19.1 10.5 2.6 28.6 12.5 8.5 18.7 9.5 0.2 25.1 11.2 5.0 11.2 65.6 3.3 8.2 148.5 69.1 6.7 9.2 87.2 31.0 3.1 64.0 27.4 13.4 9.3 9.1 15.0 0.6 0.2 0.2 0.6 2.4 0.4 7.0 41.4 56.7 4.5 20.8 202.9 10.5 0.6 20.2 3.1 1.1 4.2 1.7 65.1 0.6 0.7 6.3 9.6 26.8 0.3 0.2 3.7 9.3 13.3 10.3 1.2 6.5 15.1 0.8 117.4 0.0 16.4 0.7 1.7 2.1 34.2 30.1 8.8 1.0 39.7 3.3 2.3 0.7 1.0 2.4 84.9 718.4 0.4 3.8 4.7 8.6 1.6 5.0 0.3 3.0 81.2 22.4 123.2 1.8 4.0 8.7 141.9 37.4 75.9 303.2 63.5 402.9 1150.1 509.2 432.4 32.5 1184.0 365.5 390.7 1340.3 381.9 52.3 140.3 1244.0 369.5 7.0 9.0 8.0 11.3 6.7 8.2 10.7 8.0 8.5 8.2 9.2 9.3 70.4 48.1 46.7 0.0 424.2 178.7 152.3 98.5 3.4 0.2 84.3 58.8 1.9 51.5 97.0 3.7 0.0 2.3 378.8 213.5 1.9 66.1 23.7 318.8 29.4 86.6 37.6 108.2 0.6 148.9 71.5 63.5 130.0 254.1 7.6 2.9 21.8 13.3 8.2 0.0 1.9 144.1 168.9 34.4 500.2 5.2 2.1 72.2 225.9 5.6 195.4 0.0 224.6 1.5 3.1 307.1 476.1 1.9 663.4 318.7 131.8 8.6 118.4 0.2 26.3 14.6 26.9 1.1 2.9 9.9 287.0 52.0 318.4 4.9 19.7 538.6 ACAN "AGC1, CSPG1, CSPGCP, MSK16" ENSG00000157766 Aggrecan P16112 15 88803436-88875353 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.5;seminal vesicle: 3.1" "Group enriched" "Detected in some" 15 "Extravillous trophoblasts: 127.1;Granulosa cells: 132.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "WM-115: 24.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB016377, HPA038241, HPA038242" Enhanced "Secreted to extracellular matrix" NA NA 17000000 "Cluster 57: Non-specific - Angiogenesis" "Cluster 17: WM-115 - Nervous system development" "Cluster 40: Granulosa cells - Unknown function" "CAB016377: AB_626650, HPA038241: AB_2675909, HPA038242: AB_2675910" "unprognostic (2.69e-3)" "unprognostic (4.09e-2)" "unprognostic (2.52e-1)" "unprognostic (1.82e-1)" "unprognostic (4.43e-2)" "unprognostic (2.13e-2)" "unprognostic (1.40e-2)" "unprognostic (1.15e-1)" "unprognostic (7.12e-2)" "unprognostic (8.57e-2)" "unprognostic (2.34e-1)" "unprognostic (2.38e-2)" "prognostic unfavorable (1.47e-6)" "unprognostic (7.79e-2)" "unprognostic (1.53e-1)" "unprognostic (7.71e-2)" "unprognostic (7.27e-2)" 1.2 0.2 0.6 0.9 1.0 0.1 0.1 2.2 1.6 0.9 0.1 0.3 0.1 0.4 0.2 0.1 0.2 0.7 0.5 0.7 6.5 0.7 0.1 0.7 0.1 2.1 1.6 0.4 0.2 0.1 0.4 0.2 1.5 0.5 0.3 0.1 0.1 3.1 0.2 0.2 0.1 0.5 1.3 0.2 0.2 1.4 1.5 0.0 0.3 0.0 0.0 0.8 0.7 1.4 0.0 0.0 0.0 0.0 0.8 0.0 4.8 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 2.2 1.6 0.7 6.5 2.1 1.6 1.5 1.3 1.5 1.4 0.1 0.0 0.0 0.7 0.0 0.4 0.5 0.0 0.0 0.0 0.2 0.1 1.9 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.1 0.2 0.3 0.3 0.0 0.0 1.2 0.0 127.1 0.7 0.0 0.4 1.3 132.4 0.0 0.0 2.5 0.0 4.5 0.0 0.0 0.0 0.5 2.1 0.0 0.2 1.8 1.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 8.4 2.3 6.3 0.0 0.4 3.6 0.1 1.8 0.0 0.4 HAPLN3 "EXLD1, HsT19883" ENSG00000140511 "Hyaluronan and proteoglycan link protein 3" Q96S86 15 88877294-88895597 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in many" 9 "Extravillous trophoblasts: 966.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 50.9" "Lineage enriched" "Detected in all" 5 "T-cells: 50.9" "Cell line enhanced" "Detected in many" "HDLM-2: 34.7;U-2 OS: 31.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039237 Approved Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 64: Macrophages - Immune response" "Cluster 9: U-2 OS - Unknown function" "Cluster 38: Extravillous trophoblasts - Unknown function" "Plasma membrane, Cytosol" "HPA039237: AB_10805357" "unprognostic (1.67e-2)" "unprognostic (1.04e-3)" "unprognostic (2.57e-1)" "unprognostic (2.53e-2)" "unprognostic (3.27e-1)" "unprognostic (2.24e-2)" "unprognostic (4.21e-1)" "unprognostic (3.82e-1)" "unprognostic (3.37e-3)" "unprognostic (7.37e-3)" "unprognostic (1.13e-3)" "unprognostic (4.30e-1)" "prognostic unfavorable (4.18e-13)" "unprognostic (1.95e-1)" "unprognostic (3.01e-2)" "unprognostic (6.12e-2)" "unprognostic (1.12e-1)" 10.3 1.9 2.1 11.5 2.0 3.1 8.6 1.9 2.7 5.1 2.1 3.2 0.6 4.3 0.1 6.1 6.2 2.7 4.6 2.1 2.0 6.1 0.9 9.7 11.7 2.4 2.1 2.7 1.4 0.5 2.2 1.4 2.5 5.7 0.4 4.2 6.0 0.7 3.6 6.2 4.6 2.7 2.3 5.7 3.5 1.0 2.4 2.9 4.6 0.6 3.2 6.9 5.6 2.1 2.0 7.0 1.3 15.4 4.4 4.2 4.7 4.4 1.0 1.6 2.0 4.4 6.4 0.0 11.9 5.4 2.5 1.7 14.7 1.9 0.0 34.7 12.9 4.9 0.3 0.0 0.6 0.0 0.1 1.6 0.8 3.0 0.2 0.2 7.1 0.6 0.1 9.3 0.8 0.2 0.1 0.0 11.2 0.0 0.2 0.0 0.6 11.5 2.9 0.1 0.1 4.2 0.9 0.7 6.1 1.9 0.0 0.6 1.3 10.8 31.2 8.1 0.7 1.1 0.1 0.1 3.8 0.0 9.3 1.4 1.1 0.0 1.2 0.8 5.4 0.2 18.3 7.4 2.2 1.5 18.3 8.6 0.3 10.1 0.2 0.8 50.9 5.9 2.1 2.0 1.9 2.7 2.1 2.0 2.4 2.1 2.5 2.3 2.4 2.1 16.0 0.0 3.4 1.3 4.0 32.0 10.8 13.5 4.6 2.5 47.1 42.4 9.3 1.5 10.4 1.8 10.4 5.8 3.2 0.5 0.0 5.3 0.0 6.3 3.7 29.4 0.0 0.0 1.3 2.0 966.2 8.5 1.5 12.1 1.3 2.5 3.3 0.1 19.3 0.0 0.1 0.9 6.1 0.3 22.0 0.2 0.9 3.0 17.8 2.8 9.7 3.8 3.1 0.5 0.1 9.9 0.1 0.7 0.5 10.4 0.0 0.2 2.7 103.8 13.1 7.2 24.5 0.3 2.1 6.3 24.2 20.4 9.4 0.2 0.5 7.8 MFGE8 "BA46, EDIL1, hP47, HsT19888, MFG-E8, OAcGD3S, SED1, SPAG10" ENSG00000140545 "Milk fat globule EGF and factor V/VIII domain containing" Q08431 15 88898683-88913381 "Cancer-related genes, Predicted secreted proteins" "Angiogenesis, Cell adhesion, Fertilization" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 407.0;Cone photoreceptor cells: 385.7;Rod photoreceptor cells: 978.7;Sertoli cells: 1084.7;Smooth muscle cells: 476.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 14.9" "Group enriched" "Detected in many" 8 "granulocytes: 5.3;NK-cells: 7.7;T-cells: 14.9" "Cell line enhanced" "Detected in many" "ASC diff: 1784.6;ASC TERT1: 918.2;fHDF/TERT166: 660.4;HSkMC: 935.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002753, HPA002807" Enhanced Approved Cytosol "Secreted to blood" NA NA 2830000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 30: Mammary glandular cells - Lactation" Cytosol "CAB002753: , HPA002807: AB_1078072" "unprognostic (1.28e-1)" "unprognostic (1.23e-1)" "unprognostic (1.63e-2)" "unprognostic (7.68e-2)" "unprognostic (2.75e-1)" "unprognostic (1.12e-1)" "unprognostic (2.32e-1)" "unprognostic (1.42e-1)" "unprognostic (8.11e-3)" "unprognostic (6.27e-2)" "unprognostic (8.49e-2)" "unprognostic (3.99e-1)" "prognostic unfavorable (6.06e-9)" "prognostic unfavorable (3.08e-4)" "unprognostic (4.85e-2)" "unprognostic (7.36e-3)" "unprognostic (2.41e-3)" 237.2 95.2 44.2 45.2 49.6 3.7 226.7 56.4 61.8 272.8 52.4 113.7 21.2 444.7 77.0 67.6 361.8 120.2 485.8 41.6 47.2 69.0 15.6 137.2 47.4 55.9 47.4 228.5 36.5 18.9 49.3 79.6 55.6 129.3 29.3 68.7 97.1 195.8 264.3 118.9 106.9 162.7 47.0 40.7 124.9 38.3 46.5 18.8 90.6 124.1 36.9 163.6 223.4 55.6 19.7 85.4 78.7 98.7 1784.6 918.2 6.9 482.7 142.4 95.4 110.3 90.5 23.5 0.0 147.5 660.4 144.6 10.2 27.6 95.8 31.1 82.3 64.7 138.1 4.6 10.2 469.8 0.2 50.1 935.7 251.8 73.5 122.5 205.3 37.0 35.3 23.4 41.1 185.1 6.2 22.6 3.2 405.4 8.3 38.4 22.7 74.4 26.4 32.6 7.3 8.2 42.9 28.0 2.5 226.1 165.6 2.4 11.1 42.0 233.2 127.8 62.3 36.3 145.3 30.5 15.9 31.6 12.2 91.5 5.3 0.2 0.4 1.3 0.0 4.2 1.2 4.2 2.9 0.0 0.9 4.3 3.3 0.0 7.7 0.1 0.1 14.9 2.1 44.2 49.6 56.4 61.8 41.6 47.2 55.9 47.4 55.6 47.0 46.5 55.6 72.1 12.8 5.4 39.2 4.0 48.7 32.2 116.3 24.5 22.1 407.0 190.4 92.8 8.6 25.5 3.7 385.7 4.5 13.1 1.6 0.0 15.7 11.0 33.3 202.2 66.9 44.8 3.8 5.1 4.3 18.6 220.0 12.8 29.7 5.1 30.1 22.1 15.5 8.1 16.8 0.4 6.4 36.7 32.9 39.7 27.9 187.0 12.9 119.2 15.0 1.8 75.9 9.2 5.5 9.6 28.3 0.2 109.1 8.8 15.8 0.1 0.2 8.3 978.7 1084.7 51.8 476.0 3.3 9.0 21.7 35.9 5.3 12.5 25.8 2.0 10.2 ABHD2 LABH2 ENSG00000140526 "Abhydrolase domain containing 2, acylglycerol lipase" P08910 15 89087459-89202355 "Enzymes, Predicted membrane proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 331.8;Hepatocytes: 402.5;Late spermatids: 462.1;Oligodendrocyte precursor cells: 421.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 69.8;neutrophil: 52.2" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "HEL: 340.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005999 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 85: Liver - Metabolism" "Cluster 36: HEL - Hemostasis" "Cluster 2: Hepatocytes - Metabolism" Cytosol Nucleoplasm "HPA005999: AB_1078080" "unprognostic (6.60e-2)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (3.00e-2)" "unprognostic (2.16e-1)" "unprognostic (1.56e-1)" "unprognostic (2.26e-1)" "unprognostic (1.67e-1)" "unprognostic (3.34e-1)" "unprognostic (3.67e-3)" "unprognostic (3.41e-3)" "unprognostic (1.80e-1)" "prognostic favorable (2.18e-7)" "unprognostic (4.17e-1)" "unprognostic (3.07e-2)" "unprognostic (1.34e-2)" "unprognostic (1.60e-1)" 18.5 36.3 20.0 20.2 20.9 34.9 22.5 40.2 27.2 19.5 130.3 21.1 47.9 20.7 56.1 17.4 23.4 47.2 36.1 29.0 20.3 22.4 137.6 45.3 14.7 13.3 32.4 24.5 57.9 18.4 14.0 11.1 13.5 44.2 18.9 14.5 12.7 18.6 21.8 13.1 35.9 22.4 11.0 24.6 72.9 52.0 24.2 15.5 17.1 46.3 16.1 31.1 9.6 16.4 33.0 62.3 14.7 16.3 29.2 39.0 8.2 21.4 62.5 19.8 18.6 15.7 55.3 9.4 23.9 27.4 54.1 42.6 32.4 26.4 28.0 48.1 15.8 340.5 14.0 12.8 14.8 24.2 74.4 20.1 18.6 70.1 45.5 33.7 25.3 20.7 30.3 27.4 56.3 13.3 15.0 5.8 6.6 76.9 18.1 20.7 32.2 71.9 27.0 51.5 25.2 39.0 41.4 19.4 34.4 13.5 21.7 18.6 38.6 70.9 23.7 24.2 55.8 23.5 49.3 10.9 58.2 21.5 55.4 8.4 13.4 69.8 3.5 11.3 2.1 2.4 3.2 3.4 7.1 2.2 3.2 3.2 52.2 11.2 17.8 5.7 8.7 6.9 20.0 20.9 40.2 27.2 29.0 20.3 13.3 32.4 13.5 11.0 24.2 16.4 43.4 96.1 118.1 87.5 10.7 18.6 47.3 27.0 7.4 25.5 26.6 17.8 52.0 130.1 82.1 42.3 18.8 4.6 53.7 65.9 1.9 48.9 331.8 28.3 36.8 27.7 48.7 40.8 103.6 85.2 7.7 26.6 103.0 25.9 60.7 18.5 21.0 402.5 40.8 20.2 114.7 58.7 87.5 59.2 26.6 462.1 32.9 67.3 58.7 46.9 46.4 45.5 36.0 421.2 54.4 106.4 38.0 59.8 27.4 171.1 53.1 18.0 158.0 14.7 78.9 36.1 53.4 119.8 13.2 20.8 17.5 2.6 24.5 35.2 38.7 117.5 RLBP1 CRALBP ENSG00000140522 "Retinaldehyde binding protein 1" P12271 15 89209869-89221614 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Sensory transduction, Transport, Vision" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "retina: 265.6" "Cell type enriched" "Detected in some" 34 "Muller glia cells: 3148.2" "Group enriched" "Detected in some" 30 "glioma: 3.7;melanoma: 7.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 53 "SK-MEL-30: 22.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042051, HPA044083" Enhanced Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA "Cluster 46: Basophils - DNA binding" "Cluster 77: Retina - Visual perception" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 5: Muller glia cells - Visual perception" Cytosol "Nucleoplasm, Centrosome" "HPA042051: AB_2732495, HPA044083: AB_2678802" "unprognostic (3.19e-2)" "unprognostic (2.66e-1)" "unprognostic (1.86e-1)" "unprognostic (1.25e-1)" "unprognostic (8.68e-2)" "unprognostic (1.76e-1)" "unprognostic (8.24e-3)" "unprognostic (5.21e-2)" "unprognostic (3.17e-1)" "unprognostic (2.63e-2)" "unprognostic (1.76e-1)" "unprognostic (2.78e-1)" "unprognostic (1.13e-1)" "unprognostic (8.42e-2)" 0.0 0.2 14.9 0.1 16.9 0.1 0.0 15.0 20.8 0.0 16.7 1.6 0.2 0.0 0.2 0.0 0.0 0.0 0.0 15.7 14.5 0.0 0.0 0.0 0.0 14.5 14.2 0.0 0.0 0.0 2.6 0.0 14.3 0.0 0.1 265.6 0.0 0.0 0.1 0.0 0.4 0.1 14.0 0.0 0.2 0.9 14.9 0.0 0.0 0.1 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 14.9 16.9 15.0 20.8 15.7 14.5 14.5 14.2 14.3 14.0 14.9 14.9 0.0 0.0 0.0 19.6 0.0 0.0 0.0 0.0 0.0 21.4 0.0 0.0 0.3 0.0 0.0 0.0 39.6 4.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.5 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 5.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.9 2.0 3148.2 0.0 5.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 90.9 0.0 0.0 0.0 0.2 0.2 0.0 0.0 20.0 0.0 0.0 0.0 0.0 FANCI "FLJ10719, KIAA1794" ENSG00000140525 "FA complementation group I" Q9NVI1 15 89243945-89317261 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, DNA damage, DNA repair" DNA-binding "Disease variant, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 31.4;lymphoid tissue: 44.2;testis: 32.6" "Cell type enhanced" "Detected in many" "Erythroid cells: 48.6;Spermatocytes: 69.5;Spermatogonia: 60.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "basophil: 23.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA039972, HPA040379" Approved Enhanced Nucleoplasm NA NA "Cluster 38: Basophils - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA039972: AB_10673265, HPA040379: AB_2676951" "unprognostic (6.88e-2)" "unprognostic (1.37e-2)" "unprognostic (1.66e-1)" "unprognostic (2.50e-2)" "unprognostic (2.99e-1)" "unprognostic (2.64e-2)" "prognostic unfavorable (1.11e-4)" "unprognostic (6.82e-3)" "unprognostic (1.15e-2)" "unprognostic (4.59e-3)" "prognostic unfavorable (3.59e-4)" "unprognostic (1.04e-1)" "prognostic unfavorable (2.71e-13)" "unprognostic (2.40e-2)" "unprognostic (2.72e-1)" "unprognostic (1.27e-1)" "unprognostic (2.12e-1)" 3.2 2.1 1.6 13.0 1.3 31.4 6.0 3.8 2.5 3.3 0.0 10.5 6.0 4.7 1.1 8.1 3.4 3.0 1.7 1.7 0.7 1.7 2.9 3.4 23.9 1.2 0.9 3.8 3.0 3.0 0.6 11.3 1.7 3.6 12.4 5.4 2.8 2.0 0.8 8.0 7.3 6.9 0.6 6.0 6.7 32.6 1.3 44.2 2.0 0.8 26.6 5.4 3.7 1.7 108.2 122.4 127.8 86.1 10.8 16.0 78.5 101.4 58.3 123.6 150.5 96.8 95.4 198.8 53.4 33.8 79.3 143.9 196.8 69.0 116.2 127.8 123.5 197.2 176.7 45.8 1.7 146.0 96.3 8.6 6.8 87.1 44.4 17.6 51.7 120.2 139.2 142.3 83.5 61.5 150.9 49.6 101.1 70.3 44.5 130.6 187.1 84.6 28.5 196.8 93.9 80.8 105.2 73.3 46.7 85.7 81.2 64.8 35.4 103.2 103.8 94.9 155.8 93.3 209.5 151.9 38.5 125.7 104.7 23.4 2.3 3.0 4.7 3.0 2.8 3.5 4.7 6.5 2.2 3.6 3.3 5.6 3.1 5.1 4.3 4.1 11.8 3.1 1.6 1.3 3.8 2.5 1.7 0.7 1.2 0.9 1.7 0.6 1.3 1.7 2.6 3.2 1.5 3.6 3.8 4.2 2.6 4.0 0.6 2.4 2.9 2.7 3.9 0.0 3.3 1.8 0.0 17.0 3.9 4.2 0.0 2.0 7.9 5.0 3.7 3.0 1.2 48.6 7.0 2.9 18.3 3.9 5.6 4.5 2.5 14.9 6.8 0.8 8.1 1.7 5.8 5.9 0.0 3.0 3.8 7.9 3.4 4.8 1.8 1.9 3.3 11.6 1.0 9.0 6.9 2.5 1.2 1.5 13.9 2.0 1.3 1.0 6.3 1.9 6.6 3.6 4.0 69.5 60.2 9.2 2.4 12.4 8.1 2.5 9.1 2.8 POLG "POLG1, POLGA" ENSG00000140521 "DNA polymerase gamma, catalytic subunit" P54098 15 89305198-89334861 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA replication" "DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase" "Disease variant, Epilepsy, Leigh syndrome, Neurodegeneration, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056821, HPA078482" Approved Supported Mitochondria NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 65: Plasmacytoid DCs - Unknown function" Mitochondria "HPA056821: AB_2683247, HPA078482: " "unprognostic (1.87e-1)" "unprognostic (4.71e-2)" "unprognostic (2.61e-2)" "unprognostic (3.64e-1)" "unprognostic (1.62e-1)" "unprognostic (3.19e-1)" "unprognostic (2.22e-1)" "unprognostic (1.13e-1)" "unprognostic (8.41e-2)" "unprognostic (2.63e-1)" "unprognostic (1.41e-1)" "prognostic unfavorable (5.73e-4)" "unprognostic (2.65e-3)" "unprognostic (1.58e-2)" "unprognostic (4.29e-2)" "unprognostic (2.07e-1)" "unprognostic (3.45e-1)" 13.3 11.1 6.8 4.0 5.0 2.6 12.0 4.8 6.3 12.0 4.5 13.3 5.5 12.9 0.4 14.6 11.2 0.9 13.8 6.1 3.5 10.1 12.9 13.8 3.0 9.0 5.8 10.8 10.7 2.9 8.4 2.5 6.5 10.5 0.9 1.4 12.3 2.2 25.0 16.0 14.5 1.3 5.4 16.2 11.9 5.4 5.7 7.3 10.5 10.9 2.4 12.2 12.7 6.3 8.0 17.0 6.7 10.0 7.7 1.6 16.4 16.4 2.7 7.9 5.9 28.0 10.9 14.4 33.6 5.9 16.9 11.8 14.3 4.8 0.9 35.8 31.3 19.4 19.5 11.1 10.8 21.3 33.6 2.4 8.7 7.0 3.0 8.3 12.2 26.8 19.5 5.4 6.1 22.8 16.3 16.5 8.7 13.7 8.2 18.2 13.7 17.4 3.2 19.2 24.5 6.9 26.8 9.6 16.8 6.0 7.7 10.8 17.3 12.8 15.6 28.5 14.2 17.0 9.4 18.6 9.5 14.3 11.6 3.3 4.3 6.1 5.5 4.0 4.3 2.0 4.6 6.8 6.0 3.0 3.7 4.4 1.8 5.0 3.5 4.1 3.3 5.3 6.8 5.0 4.8 6.3 6.1 3.5 9.0 5.8 6.5 5.4 5.7 6.3 15.7 12.8 11.9 11.4 17.2 12.2 11.0 10.7 9.1 7.6 12.0 10.3 19.0 11.5 9.5 11.0 2.1 15.0 33.8 17.2 9.8 10.4 1.3 8.4 9.4 12.4 5.4 9.0 12.9 10.9 15.8 11.9 21.4 11.3 8.2 14.8 14.6 17.8 12.7 3.3 9.9 24.9 4.1 18.5 14.7 1.5 14.3 17.2 19.6 8.4 21.8 6.1 30.9 9.5 11.9 11.4 15.9 10.5 16.8 17.7 10.5 7.5 7.8 6.4 6.6 13.3 12.9 9.2 11.1 11.8 11.9 21.8 21.7 14.8 17.6 15.5 RHCG "C15orf6, PDRC2, RHGK, SLC42A3" ENSG00000140519 "Rh family C glycoprotein" Q9UBD6 15 89471398-89496589 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ammonia transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 4022.4;vagina: 1728.8" "Cell type enriched" "Detected in many" 21 "Squamous epithelial cells: 1544.7" "Cancer enhanced" "Detected in many" "cervical cancer: 152.9;head and neck cancer: 154.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 3.8;hTCEpi: 2.0;RT4: 1.2" "Region enriched" "Detected in many" 5 "olfactory bulb: 8.4" "Low region specificity" "Detected in some" "HPA041874, HPA043317" Enhanced NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 61: Squamous epithelial cells - Keratinization" "HPA041874: AB_2677719, HPA043317: AB_2678424" "unprognostic (1.60e-1)" "unprognostic (4.28e-2)" "unprognostic (1.52e-1)" "unprognostic (3.86e-3)" "unprognostic (1.98e-2)" "unprognostic (9.39e-3)" "unprognostic (2.07e-1)" "prognostic unfavorable (3.80e-4)" "unprognostic (1.07e-1)" "unprognostic (9.82e-2)" "unprognostic (1.39e-2)" "unprognostic (4.84e-2)" "unprognostic (2.55e-3)" "unprognostic (2.68e-1)" "unprognostic (2.80e-2)" "unprognostic (2.27e-1)" "unprognostic (9.45e-3)" 1.3 2.1 5.3 0.0 5.4 0.0 0.8 4.9 6.9 823.5 3.9 0.5 0.0 0.6 0.0 4022.4 0.7 0.7 1.4 5.1 4.9 117.4 3.4 0.3 0.0 4.8 4.9 0.8 3.2 0.0 4.3 0.0 4.8 3.4 0.0 2.5 593.6 0.8 1.0 14.6 0.9 0.3 5.1 0.6 3.5 1.3 5.0 0.8 0.5 0.0 461.7 3.7 1728.8 5.2 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.3 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 5.4 4.9 6.9 5.1 4.9 4.8 4.9 4.8 5.1 5.0 5.2 0.0 0.0 0.0 2.0 0.3 1.3 28.9 22.9 6.2 1.0 0.9 0.5 0.7 0.0 47.6 14.7 0.0 0.0 0.0 0.6 15.6 1.5 2.0 0.0 0.1 0.7 0.0 0.0 6.0 0.4 0.0 2.6 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 2.0 0.0 0.7 1.4 0.0 1.5 0.0 0.0 0.0 64.4 0.0 4.0 0.3 0.7 4.8 0.0 0.0 34.8 0.0 0.0 1.6 2.8 0.0 0.0 5.4 1.5 0.1 1544.7 17.8 0.0 0.3 0.0 0.2 70.5 TICRR "C15orf42, FLJ41618, MGC45866, SLD3, Treslin" ENSG00000140534 "TOPBP1 interacting checkpoint and replication regulator" Q7Z2Z1 15 89575469-89631056 "Metabolic proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 3.4;esophagus: 4.2;lymphoid tissue: 4.2" "Cell type enhanced" "Detected in some" "Erythroid cells: 6.5;Extravillous trophoblasts: 6.0;Granulosa cells: 5.1;Spermatocytes: 5.4;Spermatogonia: 5.3;Squamous epithelial cells: 8.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA046746, HPA049454" Supported Nucleoplasm NA Yes "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA046746: AB_2732533, HPA049454: AB_2680773" "unprognostic (3.52e-2)" "unprognostic (1.41e-1)" "unprognostic (3.77e-1)" "prognostic unfavorable (4.44e-4)" "unprognostic (3.41e-1)" "unprognostic (1.10e-1)" "unprognostic (6.22e-5)" "unprognostic (7.73e-3)" "prognostic unfavorable (2.87e-6)" "unprognostic (1.64e-1)" "unprognostic (1.31e-4)" "unprognostic (5.87e-2)" "unprognostic (0.00e+0)" "unprognostic (3.54e-2)" "unprognostic (7.38e-2)" "unprognostic (4.53e-2)" "unprognostic (3.59e-2)" 0.3 0.1 0.1 1.0 0.1 3.4 0.3 0.0 0.0 0.5 0.0 0.8 1.0 0.4 0.0 4.2 0.3 0.1 0.1 0.0 0.0 0.1 0.1 0.2 1.4 0.1 0.0 0.3 0.0 0.0 0.1 0.9 0.0 0.2 1.1 0.1 0.5 0.0 0.0 0.5 0.9 0.2 0.1 0.5 0.4 1.5 0.2 4.2 0.1 0.0 1.8 0.3 1.1 0.0 11.0 15.0 19.0 11.0 0.7 1.5 10.7 8.0 3.7 11.0 11.4 16.4 8.4 14.7 4.2 2.6 9.2 21.5 26.3 7.0 10.0 7.4 25.4 21.9 15.5 8.7 0.1 15.8 7.6 0.4 0.5 9.0 6.6 1.6 5.5 12.8 21.3 16.6 6.4 10.4 13.9 13.3 12.7 11.0 7.6 19.6 17.1 11.8 2.6 15.5 8.1 8.0 19.0 10.6 3.1 13.9 7.9 10.5 3.3 11.9 14.8 24.4 16.5 3.9 8.0 12.3 4.1 13.2 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.2 1.2 0.0 0.3 0.8 1.4 0.0 0.0 0.0 0.0 2.0 0.0 1.4 0.0 0.0 1.7 0.1 0.3 0.3 0.0 6.5 0.4 0.0 6.0 0.5 2.0 0.3 0.0 5.1 0.0 0.0 1.3 0.0 0.6 1.6 0.0 0.0 0.7 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.2 0.1 0.0 2.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.5 5.4 5.3 8.6 0.1 1.0 0.1 0.1 1.6 0.1 KIF7 JBTS12 ENSG00000166813 "Kinesin family member 7" Q2M1P5 15 89608789-89655467 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Motor protein, Repressor" "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Joubert syndrome, Mental retardation, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Astrocytes: 14.4;Oligodendrocyte precursor cells: 10.1;Sertoli cells: 6.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-2197: 33.9" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA043145 Approved NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 18: U-2197 - ECM organization" "Cluster 43: Cardiomyocytes - Nuclear processes" "HPA043145: AB_10969200" "unprognostic (9.52e-2)" "unprognostic (1.07e-1)" "unprognostic (2.74e-3)" "prognostic unfavorable (3.80e-5)" "unprognostic (1.81e-1)" "unprognostic (3.67e-3)" "unprognostic (5.17e-2)" "unprognostic (1.61e-1)" "unprognostic (2.81e-2)" "unprognostic (3.54e-1)" "unprognostic (4.01e-2)" "unprognostic (3.13e-1)" "unprognostic (1.39e-8)" "unprognostic (2.67e-1)" "unprognostic (2.92e-2)" "unprognostic (4.84e-2)" "unprognostic (1.66e-1)" 6.8 3.2 2.0 1.3 1.7 0.2 5.4 1.4 1.7 8.3 3.3 5.6 0.6 7.0 0.5 1.9 7.6 1.2 5.4 1.6 1.7 2.4 0.9 2.2 1.2 1.9 2.0 9.1 1.1 2.2 4.2 1.0 1.8 6.6 0.4 0.2 2.5 2.4 1.3 2.3 3.0 1.4 1.5 2.2 3.4 1.8 2.0 1.0 4.9 0.4 0.3 7.0 4.9 1.1 0.4 2.7 3.9 9.8 9.8 3.6 6.9 15.5 4.9 8.4 6.8 5.4 3.4 0.0 4.0 11.2 2.2 3.7 3.8 0.0 2.0 0.0 15.5 3.5 10.4 6.0 9.3 0.0 0.1 6.7 1.9 5.1 0.0 1.5 3.6 7.9 2.7 0.1 2.9 0.8 5.3 0.5 9.4 0.1 2.4 0.1 0.3 0.0 0.1 1.5 2.2 5.7 16.5 0.2 6.1 2.1 1.8 1.1 7.6 13.5 11.0 33.9 7.3 6.7 2.5 0.0 13.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.7 1.4 1.7 1.6 1.7 1.9 2.0 1.8 1.5 2.0 1.1 0.5 0.0 0.0 14.4 0.0 0.3 1.0 0.5 2.2 0.9 1.8 1.8 5.4 0.0 0.2 0.0 0.0 0.3 0.3 0.7 0.0 0.1 0.5 0.5 4.0 2.1 0.0 0.8 2.9 0.4 0.2 4.3 1.5 0.6 0.0 4.8 1.4 0.1 0.1 0.0 4.5 0.4 0.0 0.0 0.4 0.4 5.6 0.1 0.0 5.6 0.0 1.2 0.0 10.1 0.3 0.1 0.1 4.1 0.0 1.3 0.0 0.3 0.1 0.2 6.6 3.2 3.7 0.7 1.4 0.3 0.4 0.3 0.4 4.2 0.4 0.8 PLIN1 PLIN ENSG00000166819 "Perilipin 1" O60240 15 89664367-89679427 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 17 "adipose tissue: 956.3;breast: 463.0" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 59.0" "Group enriched" "Detected in many" 5 "breast cancer: 8.4;liver cancer: 2.3;pancreatic cancer: 2.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 171 "ASC diff: 208.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA024299, CAB033821, CAB037333" Enhanced Uncertain Peroxisomes NA NA 22000 "Cluster 82: Adipose tissue - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 2: Hepatocytes - Metabolism" Peroxisomes "CAB033821: AB_2252681, CAB037333: , HPA024299: AB_1855467" "unprognostic (4.62e-2)" "unprognostic (2.22e-1)" "unprognostic (2.13e-1)" "unprognostic (1.67e-1)" "unprognostic (1.90e-1)" "unprognostic (3.51e-3)" "unprognostic (9.89e-3)" "unprognostic (3.54e-1)" "unprognostic (7.01e-2)" "unprognostic (2.13e-2)" "unprognostic (8.00e-3)" "unprognostic (2.28e-3)" "unprognostic (2.62e-6)" "unprognostic (5.56e-2)" "unprognostic (1.22e-1)" "unprognostic (1.63e-1)" "unprognostic (4.85e-2)" 956.3 11.3 12.0 3.5 14.8 0.3 463.0 7.4 10.6 1.4 5.3 9.3 0.5 0.7 0.4 1.3 1.4 6.6 10.4 10.0 10.3 2.7 40.8 0.7 1.7 6.9 11.5 2.1 6.1 0.2 1.3 0.2 7.8 2.6 3.7 0.6 20.8 0.6 9.5 16.0 13.9 1.5 6.6 1.0 5.5 13.2 10.6 2.3 5.3 17.3 0.1 7.9 3.1 8.2 0.0 0.2 0.2 0.0 208.2 0.7 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.5 0.7 0.5 0.1 0.7 0.2 0.0 0.2 0.6 0.7 0.0 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.5 0.0 0.1 0.0 0.1 0.3 0.2 0.1 0.3 1.2 0.1 0.5 0.1 0.1 0.0 0.1 0.2 0.2 0.1 0.4 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 14.8 7.4 10.6 10.0 10.3 6.9 11.5 7.8 6.6 10.6 8.2 2.6 0.0 0.0 4.2 0.2 0.1 0.3 0.1 0.0 0.3 0.7 3.0 1.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.2 7.5 0.1 0.2 0.2 0.0 0.0 0.5 0.2 0.0 0.3 0.0 0.2 0.0 0.1 1.1 59.0 0.0 0.0 0.3 0.3 0.0 1.0 0.3 7.5 0.9 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.2 1.3 0.0 0.0 0.6 0.3 0.1 0.1 0.1 0.0 1.3 1.3 4.8 0.2 0.0 0.4 0.0 0.1 0.1 0.5 0.9 PEX11A "MGC119947, MGC138534, PEX11-ALPHA" ENSG00000166821 "Peroxisomal biogenesis factor 11 alpha" O75192 15 89677764-89690783 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Peroxisome biogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Hepatocytes: 38.7;Late spermatids: 39.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 54.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "unprognostic (3.67e-1)" "unprognostic (2.58e-1)" "unprognostic (1.18e-1)" "unprognostic (1.08e-1)" "unprognostic (3.73e-2)" "prognostic unfavorable (2.57e-4)" "unprognostic (1.40e-1)" "unprognostic (6.17e-2)" "unprognostic (6.80e-3)" "unprognostic (2.82e-2)" "unprognostic (2.38e-1)" "unprognostic (3.24e-1)" "unprognostic (2.74e-2)" "unprognostic (1.10e-2)" "unprognostic (5.44e-2)" "unprognostic (4.82e-2)" "unprognostic (1.32e-2)" 25.6 10.4 7.9 3.4 8.3 0.8 20.0 6.9 8.5 7.2 12.8 14.5 16.3 6.0 10.5 6.5 9.6 5.4 8.1 7.9 8.7 11.7 39.1 6.1 2.5 7.1 7.8 13.1 11.8 10.0 5.5 3.6 7.2 18.3 12.0 12.7 11.3 10.1 17.9 5.4 12.2 5.5 7.2 4.1 11.3 11.4 9.0 2.3 10.9 12.0 3.7 9.2 6.1 7.9 10.2 6.1 4.6 0.3 23.4 8.4 3.7 5.0 8.5 7.4 12.0 4.3 11.9 4.7 5.5 5.8 10.6 13.3 0.0 7.6 8.5 7.5 16.8 7.1 7.2 6.0 16.8 4.7 2.4 10.4 9.2 4.3 7.1 5.8 5.2 4.6 0.1 1.8 5.6 10.2 0.0 0.6 2.6 20.6 11.1 0.0 0.0 4.2 6.1 6.8 3.4 8.7 16.0 54.4 15.5 8.3 14.4 4.4 4.7 4.9 4.8 13.2 4.0 5.3 9.5 0.2 11.9 0.7 4.3 1.2 0.7 2.3 3.6 1.0 2.0 1.6 1.8 2.0 1.8 0.9 2.2 2.5 0.8 3.1 0.7 0.4 1.7 1.5 7.9 8.3 6.9 8.5 7.9 8.7 7.1 7.8 7.2 7.2 9.0 7.9 1.5 6.4 8.4 12.4 2.0 1.8 9.3 5.2 7.4 8.6 15.3 10.9 8.7 10.0 11.4 5.5 2.1 10.8 1.3 22.1 5.9 7.6 24.8 7.1 5.5 3.1 3.6 0.8 3.0 4.6 7.1 4.6 3.1 5.2 1.3 6.2 4.6 38.7 4.0 18.5 3.5 8.9 6.1 3.5 0.8 39.0 5.3 1.6 3.6 2.8 1.9 14.5 1.0 3.5 3.5 5.5 11.6 2.6 0.6 11.5 20.7 12.6 16.2 9.7 0.0 6.4 4.6 22.6 8.7 5.0 2.0 2.7 1.5 11.0 11.8 11.9 WDR93 "C1d-87, CFAP297, FAP297" ENSG00000140527 "WD repeat domain 93" Q6P2C0 15 89690811-89743638 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 8.9;testis: 11.6" "Cell type enhanced" "Detected in some" "Cone photoreceptor cells: 20.9;Early spermatids: 49.1;Endometrial ciliated cells: 28.1;Late spermatids: 42.4;Respiratory ciliated cells: 47.7;Spermatocytes: 30.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SK-MEL-30: 1.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA046196, HPA048112" Uncertain Uncertain "Actin filaments" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 49: Ciliated cells - Cilium organization" "Actin filaments" "HPA046196: AB_2679582, HPA048112: AB_2680267" "unprognostic (2.56e-3)" "unprognostic (3.21e-3)" "unprognostic (7.31e-2)" "unprognostic (1.54e-2)" "unprognostic (1.90e-2)" "unprognostic (3.01e-1)" "unprognostic (1.15e-2)" "unprognostic (2.08e-2)" "unprognostic (1.22e-2)" "unprognostic (7.40e-2)" "unprognostic (3.03e-1)" "unprognostic (1.66e-1)" "unprognostic (1.07e-1)" "unprognostic (2.40e-2)" "unprognostic (4.73e-2)" "unprognostic (9.84e-2)" "unprognostic (4.44e-2)" 0.4 0.2 0.6 0.0 0.6 0.4 0.7 1.6 0.6 0.6 3.5 0.1 0.0 0.4 4.9 0.0 8.9 0.2 1.2 0.8 1.0 1.0 0.1 1.0 0.2 2.4 2.9 0.4 0.6 0.5 0.8 0.1 1.1 0.6 0.1 2.8 0.3 0.5 0.3 0.2 0.1 0.0 1.6 0.1 0.1 11.6 0.9 0.1 1.8 0.0 0.1 0.0 0.0 1.0 0.3 0.2 0.0 0.1 0.3 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.7 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.3 0.1 0.1 0.3 0.0 0.3 0.3 0.0 0.4 0.5 0.0 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.7 0.0 0.5 0.2 0.7 0.2 1.0 0.1 0.1 0.4 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.6 0.6 1.6 0.6 0.8 1.0 2.4 2.9 1.1 1.6 0.9 1.0 0.1 3.2 0.5 2.9 0.0 0.3 0.7 1.8 0.0 2.7 0.8 0.6 0.5 0.0 4.2 9.2 20.9 0.4 0.1 0.1 3.9 0.8 49.1 28.1 0.6 0.7 0.0 0.0 2.7 0.2 0.3 0.4 0.0 0.8 0.0 0.4 0.4 0.0 0.2 3.3 2.1 0.1 0.0 0.3 0.8 42.4 1.5 0.3 1.8 0.0 0.6 0.6 0.0 0.5 1.0 0.3 1.1 0.7 0.1 0.7 0.0 2.1 47.7 14.8 0.0 0.9 0.6 30.4 5.7 0.0 0.1 0.3 0.6 2.9 0.2 0.4 MESP1 "bHLHc5, MGC10676" ENSG00000166823 "Mesoderm posterior bHLH transcription factor 1" Q9BRJ9 15 89748661-89751310 "Predicted intracellular proteins, Transcription factors" "Notch signaling pathway, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 4.5;prostate: 7.3;skeletal muscle: 4.5" "Cell type enhanced" "Detected in many" "Breast glandular cells: 52.2;Breast myoepithelial cells: 58.9;Distal enterocytes: 40.1;Exocrine glandular cells: 43.0;Spermatocytes: 41.5" "Cancer enriched" "Detected in many" 4 "prostate cancer: 26.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 3.5;HDLM-2: 3.1;HEK 293: 3.0;PC-3: 5.7;SCLC-21H: 2.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA069981 Supported Nucleoplasm,Nucleoli NA NA "Cluster 47: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm Nucleoli "HPA069981: AB_2686225" "unprognostic (4.17e-2)" "unprognostic (1.52e-2)" "unprognostic (1.49e-1)" "unprognostic (1.27e-1)" "unprognostic (4.83e-2)" "unprognostic (7.21e-2)" "unprognostic (2.68e-2)" "unprognostic (4.95e-3)" "unprognostic (2.26e-2)" "unprognostic (2.47e-1)" "unprognostic (8.38e-2)" "unprognostic (2.06e-1)" "unprognostic (2.24e-3)" "unprognostic (2.22e-2)" "unprognostic (1.36e-1)" "unprognostic (1.10e-1)" "unprognostic (7.03e-2)" 4.5 1.4 2.4 0.0 2.7 0.1 3.0 1.7 3.5 0.5 0.5 1.4 0.1 0.1 0.0 0.3 0.2 0.0 1.3 2.7 2.1 0.7 0.8 0.2 0.0 1.7 1.5 0.2 1.2 0.2 1.0 0.0 1.9 7.3 0.0 0.2 2.1 0.1 4.5 0.2 0.5 0.0 1.2 0.1 0.5 1.3 2.6 0.0 0.5 0.3 0.0 0.3 0.4 2.0 3.5 1.3 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.2 0.0 1.3 0.0 0.4 0.0 0.2 0.0 0.0 3.1 3.0 0.1 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.1 0.0 0.1 0.5 0.8 0.0 0.0 5.7 0.1 0.0 0.8 0.0 0.0 2.6 0.1 0.7 1.1 0.8 0.0 0.0 0.4 0.0 0.0 0.2 2.0 0.6 1.3 0.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 2.7 1.7 3.5 2.7 2.1 1.7 1.5 1.9 1.2 2.6 2.0 1.7 0.0 1.1 2.6 2.9 0.3 2.8 5.1 0.6 11.6 52.2 58.9 6.3 17.2 33.9 1.8 10.4 3.0 3.2 40.1 11.7 18.6 5.3 0.3 0.3 2.1 6.1 3.0 2.8 43.0 0.2 3.5 0.5 0.9 4.5 22.1 4.2 12.8 2.0 8.4 3.0 7.4 12.2 1.6 2.1 2.1 1.2 2.5 7.2 1.0 2.1 19.2 2.1 1.5 1.7 4.8 17.9 0.0 4.6 35.7 7.2 16.2 8.7 20.6 0.0 4.0 3.7 41.5 21.7 2.0 0.3 0.3 2.2 18.0 15.5 6.2 MESP2 "bHLHc6, SCDO2" ENSG00000188095 "Mesoderm posterior bHLH transcription factor 2" Q0VG99 15 89760591-89778754 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Notch signaling pathway, Transcription, Transcription regulation" "Developmental protein, DNA-binding" Dwarfism "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in single" "Cell type enhanced" "Detected in some" "Breast glandular cells: 3.7;Exocrine glandular cells: 3.8;Rod photoreceptor cells: 7.0;Spermatogonia: 2.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.1;U-2197: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "Cluster 57: Non-specific - Angiogenesis" "Cluster 18: U-2197 - ECM organization" "Cluster 46: Photoreceptor cells - Phototransduction" "unprognostic (1.13e-1)" "unprognostic (1.76e-2)" "unprognostic (3.75e-2)" "unprognostic (8.64e-2)" "unprognostic (2.39e-1)" "unprognostic (1.50e-3)" "unprognostic (6.59e-4)" "unprognostic (5.58e-2)" "unprognostic (4.00e-1)" "unprognostic (5.90e-2)" "unprognostic (3.14e-5)" "unprognostic (2.69e-1)" "unprognostic (1.01e-2)" "unprognostic (2.50e-1)" "unprognostic (3.81e-2)" "unprognostic (2.76e-1)" "unprognostic (1.11e-1)" 0.5 0.2 0.9 0.0 0.9 0.0 0.5 0.7 1.2 0.8 0.4 0.5 0.0 0.0 0.7 0.4 0.1 0.3 0.1 0.9 0.9 0.1 0.0 0.0 0.1 0.9 0.9 0.0 0.1 0.1 0.0 0.0 1.0 0.3 0.4 0.9 0.4 0.2 0.0 0.4 0.2 0.0 0.8 0.0 0.1 0.7 0.8 0.0 0.1 0.0 0.0 0.0 0.5 0.8 0.0 1.1 0.0 0.4 0.6 0.1 0.2 0.2 0.1 0.5 0.1 0.3 0.5 0.0 0.1 0.1 0.0 1.1 0.3 0.5 0.1 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.6 0.2 0.4 0.2 0.0 0.3 0.5 0.3 0.0 0.1 0.2 0.0 0.1 0.2 0.0 1.0 0.0 0.0 0.7 0.0 0.0 0.5 0.1 0.5 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 3.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.9 0.7 1.2 0.9 0.9 0.9 0.9 1.0 0.8 0.8 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.2 3.7 1.5 0.4 0.0 1.3 0.0 0.0 0.6 0.1 1.2 1.9 1.2 0.0 0.0 0.2 0.1 0.0 0.0 0.3 3.8 0.0 0.8 0.0 0.0 0.0 0.4 0.4 0.2 0.5 0.0 0.3 0.8 0.0 0.3 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.6 1.0 0.0 0.0 0.5 0.2 0.4 0.0 0.6 0.0 0.7 0.7 7.0 0.0 0.3 0.3 1.2 2.1 0.2 0.0 0.1 0.0 0.9 0.7 0.9 ANPEP "CD13, gp150, LAP1, p150, PEPN" ENSG00000166825 "Alanyl aminopeptidase, membrane" P15144 15 89784895-89815401 "CD markers, Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Angiogenesis, Differentiation, Host-virus interaction" "Aminopeptidase, Developmental protein, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "intestine: 2384.1;pancreas: 675.0" "Cell type enriched" "Detected in many" 14 "Proximal enterocytes: 6315.2" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 5 "cerebral cortex: 9.2;thalamus: 17.4" "Immune cell enriched" "Detected in many" 4 "neutrophil: 227.1" "Lineage enriched" "Detected in many" 4 "granulocytes: 227.1" "Cell line enhanced" "Detected in many" "ASC diff: 613.7;ASC TERT1: 764.2;BJ: 738.4;BJ hTERT+: 1135.6;fHDF/TERT166: 703.8;HMC-1: 660.3;HSkMC: 670.0;HUVEC TERT2: 874.8;TIME: 815.1;U-2197: 891.4" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 5 "spinal cord: 14.8" "CAB002417, HPA004625" Enhanced Supported "Plasma membrane" NA NA 1200000000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 56: Intestine - Transmembrane transport" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 45: Enterocytes - Digestion" "Plasma membrane" "CAB002417: AB_563491, HPA004625: AB_2667199" "unprognostic (6.31e-2)" "unprognostic (7.94e-3)" "unprognostic (6.91e-2)" "unprognostic (2.16e-1)" "unprognostic (2.50e-1)" "unprognostic (1.13e-1)" "unprognostic (2.23e-2)" "unprognostic (1.89e-1)" "unprognostic (2.50e-1)" "unprognostic (7.73e-2)" "unprognostic (5.28e-3)" "unprognostic (3.96e-1)" "unprognostic (4.04e-3)" "unprognostic (3.20e-2)" "unprognostic (2.01e-2)" "unprognostic (4.61e-3)" "unprognostic (1.99e-2)" 55.4 7.0 1.6 36.6 1.6 103.4 55.9 1.3 9.2 41.4 3.4 266.8 2384.1 3.6 1.7 4.8 8.0 120.3 6.9 1.3 1.5 249.7 271.8 34.3 12.8 1.5 2.1 1.9 675.0 0.8 1.9 33.1 2.5 94.0 59.9 0.0 42.1 5.5 2.5 32.5 1970.6 29.7 1.3 25.9 8.0 2.0 17.4 7.1 8.2 3.8 4.7 16.8 15.0 1.2 0.1 45.6 0.0 0.5 613.7 764.2 6.2 738.4 1135.6 95.3 81.6 5.8 0.4 0.2 8.4 703.8 0.0 0.6 5.6 0.2 38.6 0.1 0.1 137.3 4.6 122.8 352.0 11.4 660.3 670.0 1.4 302.3 0.3 4.4 874.8 0.0 3.8 0.8 37.8 0.1 0.6 355.4 1.9 0.0 49.9 0.3 0.1 9.5 449.2 0.0 1.2 7.2 0.1 1.3 0.1 1.8 0.5 72.1 815.1 385.3 0.6 891.4 0.1 0.4 0.1 0.1 0.9 0.9 20.5 22.2 56.3 41.1 0.1 27.4 0.0 0.2 0.0 0.0 26.2 0.2 0.0 0.0 227.1 0.0 49.7 0.7 0.0 25.7 1.6 1.6 1.3 9.2 1.3 1.5 1.5 2.1 2.5 1.3 17.4 1.2 2.4 0.0 3.0 0.0 5.2 9.9 2.8 1.4 0.6 0.0 35.7 12.8 1.2 391.7 19.7 20.2 0.0 13.0 0.7 429.8 43.0 15.4 0.2 0.5 10.1 8.4 3.0 6.6 0.3 386.2 16.3 31.0 0.0 0.4 24.1 0.3 79.2 192.4 37.5 0.0 0.3 199.6 2.0 54.1 63.2 0.2 2.8 71.9 3.6 0.0 38.3 0.0 0.0 0.0 0.1 75.5 316.9 1.5 2.1 20.9 6315.2 435.0 3.3 0.0 26.3 0.8 8.1 0.3 0.5 0.2 5.8 6.4 3.7 187.8 290.9 1.4 AP3S2 sigma3b ENSG00000157823 "Adaptor related protein complex 3 subunit sigma 2" P59780 15 89830599-89894638 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049270 Uncertain Approved Vesicles NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 8: Non-specific - Mitochondria" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Vesicles "HPA049270: AB_2680696" "unprognostic (1.46e-1)" "unprognostic (1.60e-2)" "unprognostic (1.18e-2)" "unprognostic (1.12e-1)" "unprognostic (2.28e-1)" "unprognostic (2.68e-1)" "unprognostic (3.78e-2)" "unprognostic (5.27e-2)" "unprognostic (3.03e-1)" "unprognostic (7.59e-2)" "unprognostic (1.22e-1)" "unprognostic (4.31e-2)" "prognostic favorable (5.55e-16)" "unprognostic (7.97e-2)" "unprognostic (1.13e-1)" "unprognostic (2.43e-1)" "unprognostic (8.67e-3)" 24.2 20.3 15.1 11.2 15.8 10.4 19.4 14.9 18.1 17.3 13.3 19.3 10.9 13.0 16.3 20.7 17.3 17.5 30.7 15.0 17.0 36.5 40.5 16.3 12.9 16.0 18.4 20.0 19.0 32.6 9.0 18.5 18.4 15.3 19.2 44.0 13.5 21.4 44.8 8.7 10.2 18.0 15.0 12.6 10.0 12.5 16.7 20.1 26.2 45.2 17.7 15.3 6.8 16.7 13.5 60.6 33.4 35.6 66.7 45.6 28.0 58.8 75.2 74.3 59.7 26.0 34.8 12.1 51.3 39.1 48.9 31.0 57.4 33.1 58.3 51.2 29.0 37.3 25.4 33.6 28.1 16.1 22.3 30.9 40.4 20.7 41.6 40.6 38.8 30.8 29.1 32.8 48.0 27.7 27.6 8.7 37.2 68.5 11.6 15.9 33.8 25.0 42.1 35.9 25.5 22.3 69.4 43.1 40.4 69.8 26.9 14.1 16.3 40.0 19.2 62.1 19.6 28.3 94.5 28.9 35.8 18.7 24.1 6.3 16.6 7.8 5.0 15.4 7.8 4.5 7.2 7.4 11.6 6.3 5.7 4.0 16.1 8.3 19.9 7.4 8.4 10.6 15.1 15.8 14.9 18.1 15.0 17.0 16.0 18.4 18.4 15.0 16.7 16.7 5.9 12.8 15.4 0.0 5.9 3.3 4.0 6.0 5.2 22.0 8.0 5.7 18.2 10.0 11.2 5.5 35.5 8.9 6.1 34.4 9.8 13.4 3.1 5.9 10.8 7.2 14.4 5.0 0.0 16.1 4.2 9.0 8.2 7.1 8.2 15.4 8.9 17.0 6.4 18.5 0.0 11.4 2.0 12.0 6.4 3.2 7.2 9.7 8.8 0.0 16.9 17.3 9.2 0.0 0.0 13.4 16.4 7.5 8.6 5.8 15.8 13.7 9.8 30.6 0.0 6.1 6.0 11.6 8.3 6.1 2.8 6.4 6.2 28.5 15.2 4.2 ARPIN-AP3S2 C15orf38-AP3S2 ENSG00000250021 "ARPIN-AP3S2 readthrough" 15 89834308-89912882 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA040513, HPA047173, HPA049270, HPA052278" Uncertain Approved Vesicles NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 39: CACO-2 - Unknown function" Vesicles "HPA040513: AB_2677015, HPA047173: AB_2679969, HPA049270: AB_2680696, HPA052278: AB_2681783" "unprognostic (1.27e-1)" "unprognostic (8.88e-2)" "unprognostic (4.94e-2)" "unprognostic (1.04e-1)" "unprognostic (3.25e-2)" "unprognostic (3.44e-1)" "unprognostic (2.56e-1)" "unprognostic (1.80e-1)" "unprognostic (1.84e-1)" "unprognostic (2.19e-1)" "unprognostic (1.82e-1)" "unprognostic (1.42e-1)" "unprognostic (1.44e-2)" "unprognostic (1.27e-1)" "unprognostic (8.35e-2)" "unprognostic (2.29e-1)" "unprognostic (4.49e-2)" 12.3 12.8 12.4 7.9 14.1 5.9 11.5 14.5 13.3 9.2 10.7 14.6 10.4 9.1 11.4 12.8 9.1 8.1 19.4 11.2 14.2 13.9 23.4 10.2 5.8 14.6 15.1 10.6 20.3 10.9 10.2 9.3 15.0 11.0 15.0 10.9 10.3 8.7 22.0 10.3 9.6 9.4 13.2 9.5 9.4 12.0 15.0 9.0 11.2 15.2 8.0 11.0 10.0 14.9 11.7 25.0 19.5 26.1 27.7 12.5 13.9 20.3 22.8 25.5 25.5 8.1 26.8 6.2 20.8 17.1 21.6 14.2 15.9 17.8 17.2 12.6 14.7 8.6 11.2 18.4 16.1 4.2 6.6 15.2 14.7 15.1 15.2 13.8 23.0 7.5 8.3 14.4 19.8 16.6 6.4 7.0 20.2 29.7 6.0 5.0 7.7 4.1 24.4 13.3 6.1 9.9 36.3 35.2 27.9 25.1 23.3 8.9 11.8 22.6 16.8 31.4 13.0 4.6 13.0 6.6 19.1 5.6 17.0 13.1 26.7 11.8 6.8 23.1 9.1 7.2 8.4 7.5 20.0 6.8 6.2 6.2 18.7 10.9 16.8 8.4 9.3 16.9 12.4 14.1 14.5 13.3 11.2 14.2 14.6 15.1 15.0 13.2 15.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ARPIN "C15orf38, MGC61550" ENSG00000242498 "Actin related protein 2/3 complex inhibitor" Q7Z6K5 15 89895006-89912952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 109.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 5.3;intermediate monocyte: 2.9;myeloid DC: 4.5" "Group enriched" "Detected in many" 6 "dendritic cells: 4.5;monocytes: 5.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040513, HPA047173, HPA052278" Uncertain NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 25: Pancreas - Digestion" "Cluster 20: HeLa - Mitochondria" "Cluster 31: Spermatids - Spermatogenesis" "HPA040513: AB_2677015, HPA047173: AB_2679969, HPA052278: AB_2681783" "unprognostic (2.63e-1)" "unprognostic (1.09e-1)" "unprognostic (4.35e-2)" "unprognostic (5.01e-2)" "unprognostic (2.08e-2)" "unprognostic (1.27e-1)" "unprognostic (1.18e-1)" "unprognostic (1.30e-1)" "unprognostic (7.46e-2)" "unprognostic (2.67e-3)" "unprognostic (1.75e-2)" "unprognostic (1.57e-1)" "prognostic favorable (4.19e-4)" "unprognostic (8.47e-2)" "unprognostic (1.36e-1)" "unprognostic (2.23e-1)" "unprognostic (6.62e-3)" 10.6 4.7 9.3 7.0 10.1 0.9 8.4 11.2 8.5 11.4 5.4 15.0 14.5 11.9 13.9 10.3 11.5 8.1 8.1 8.1 9.7 7.5 5.2 11.9 4.6 10.8 9.3 14.7 40.0 12.9 5.0 8.6 9.7 12.6 16.7 9.5 9.0 11.3 9.5 12.2 16.9 11.5 9.3 7.7 8.0 6.0 10.5 3.3 8.7 8.1 5.4 9.5 10.7 10.4 13.9 18.5 18.6 12.3 10.9 14.9 3.5 12.8 9.5 8.5 9.6 2.6 18.8 0.1 6.3 11.6 3.4 6.4 0.1 12.6 7.6 0.1 4.6 0.1 22.1 3.5 7.2 0.1 1.2 9.7 12.2 10.2 2.1 6.5 14.9 0.1 0.1 0.6 11.1 2.8 0.0 0.3 7.5 11.6 2.1 0.0 0.5 0.1 4.5 13.2 0.6 6.1 28.1 11.4 14.5 9.9 22.4 3.8 10.3 15.8 17.6 20.3 6.4 0.3 0.1 0.2 13.1 0.1 5.9 0.5 5.3 0.1 0.1 2.9 0.3 0.1 0.1 0.0 4.5 0.2 0.1 0.1 0.7 0.2 0.4 0.3 0.0 1.3 9.3 10.1 11.2 8.5 8.1 9.7 10.8 9.3 9.7 9.3 10.5 10.4 14.8 25.6 21.0 0.0 1.0 0.0 16.2 0.0 11.4 9.5 11.1 10.3 10.2 22.8 8.1 16.5 12.5 16.1 0.3 19.0 3.9 10.0 33.3 13.0 11.8 13.2 12.2 1.7 0.0 15.8 17.5 13.6 9.2 10.9 6.3 15.7 13.2 13.4 24.4 5.0 0.0 18.3 0.0 26.6 0.0 109.0 15.2 18.5 0.0 0.0 23.0 14.0 0.0 0.0 0.0 12.8 23.8 17.0 0.2 12.5 50.6 19.2 5.1 15.4 13.1 18.3 11.9 20.2 5.7 18.2 0.0 6.7 0.8 6.4 20.6 12.1 ZNF710 "DKFZp547K1113, FLJ00306, FLJ37393" ENSG00000140548 "Zinc finger protein 710" Q8N1W2 15 90001324-90082206 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 44.2" "Cell type enhanced" "Detected in many" "Astrocytes: 38.8;Microglial cells: 149.9;Oligodendrocytes: 36.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 5.7" "Group enriched" "Detected in many" 6 "dendritic cells: 1.4;granulocytes: 1.9;monocytes: 5.7" "Cell line enhanced" "Detected in all" "SK-BR-3: 44.8" "Low region specificity" "Detected in all" "HPA030226, HPA030227, HPA030228" Uncertain Approved Nucleoplasm,Mitochondria NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 10: Non-specific - Unknown function" Mitochondria Nucleoplasm "HPA030226: AB_2673384, HPA030227: AB_10599855, HPA030228: AB_10601899" "unprognostic (6.24e-2)" "unprognostic (7.07e-2)" "unprognostic (1.49e-2)" "unprognostic (2.40e-1)" "unprognostic (2.32e-1)" "unprognostic (1.36e-2)" "unprognostic (4.34e-2)" "unprognostic (8.45e-2)" "unprognostic (1.02e-1)" "unprognostic (1.49e-1)" "unprognostic (9.86e-2)" "unprognostic (1.57e-1)" "unprognostic (2.91e-3)" "unprognostic (1.03e-2)" "unprognostic (3.24e-2)" "unprognostic (1.65e-2)" "unprognostic (8.65e-2)" 3.6 4.3 12.0 14.7 13.0 8.7 5.4 6.4 11.2 6.3 3.1 8.3 9.1 5.3 5.0 17.1 5.2 7.0 10.0 6.9 8.8 5.7 5.3 9.8 10.0 12.2 13.6 4.8 44.2 3.3 4.5 5.7 12.9 7.5 6.9 1.2 9.6 4.3 33.4 12.6 8.0 3.4 10.4 14.2 10.2 1.7 12.4 5.6 6.2 1.5 6.5 7.7 9.2 11.5 9.2 10.7 20.1 7.6 2.7 4.0 10.5 9.4 8.8 6.8 8.6 7.7 8.3 9.3 4.3 9.1 6.4 6.2 5.1 13.5 3.8 6.0 9.4 17.1 4.6 13.1 5.5 5.0 25.6 6.6 7.2 14.6 7.9 3.2 11.8 10.0 5.8 6.2 2.6 23.7 11.1 13.9 15.8 11.3 6.9 13.5 4.5 10.2 2.7 11.4 18.3 12.3 12.5 44.8 6.4 5.2 9.6 17.2 17.1 13.9 6.8 4.2 7.4 5.0 2.7 9.0 10.6 14.6 7.4 0.0 1.6 1.2 0.2 3.5 0.2 0.1 0.1 0.2 1.2 0.1 0.4 0.4 1.9 0.2 5.7 1.4 0.5 0.7 12.0 13.0 6.4 11.2 6.9 8.8 12.2 13.6 12.9 10.4 12.4 11.5 1.7 3.2 8.2 38.8 2.7 5.4 4.7 2.8 1.8 1.4 7.1 3.6 12.1 4.3 6.3 11.0 2.1 2.3 6.8 7.7 0.0 3.6 0.8 4.0 4.1 4.3 4.8 2.5 10.2 6.1 3.0 3.1 7.1 6.2 1.3 2.1 5.7 1.6 11.6 3.3 12.0 8.1 0.0 15.8 33.5 5.5 2.5 15.7 1.8 149.9 13.3 1.4 2.1 22.1 36.4 10.1 11.5 3.0 3.8 8.5 2.3 0.8 3.6 0.9 6.6 1.6 3.0 0.3 2.5 4.3 7.5 2.3 2.5 2.0 6.5 13.7 IDH2 ENSG00000182054 "Isocitrate dehydrogenase (NADP(+)) 2" P48735 15 90083045-90102477 "Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Glyoxylate bypass, Tricarboxylic acid cycle" Oxidoreductase "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "heart muscle: 492.6;skeletal muscle: 1302.3;tongue: 1611.3" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 732.5;Distal tubular cells: 1168.0;Extravillous trophoblasts: 586.7;Syncytiotrophoblasts: 573.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MOLT-4: 425.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007831 Enhanced Supported Mitochondria NA NA 5200000 "Cluster 51: Monocytes - Innate immune response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 14: REH - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" Mitochondria "HPA007831: AB_1851397" "unprognostic (2.45e-2)" "prognostic favorable (5.15e-5)" "unprognostic (2.92e-1)" "unprognostic (1.53e-1)" "unprognostic (3.53e-1)" "unprognostic (8.46e-2)" "unprognostic (3.83e-2)" "unprognostic (2.55e-3)" "unprognostic (1.86e-2)" "unprognostic (1.89e-2)" "unprognostic (2.76e-1)" "unprognostic (4.90e-2)" "unprognostic (2.19e-3)" "unprognostic (3.92e-3)" "unprognostic (4.46e-1)" "unprognostic (1.30e-2)" "unprognostic (2.58e-2)" 32.8 10.5 56.5 60.2 67.8 161.1 51.1 57.1 59.8 36.6 76.6 95.9 97.2 29.0 12.5 140.6 32.7 31.7 492.6 47.2 55.0 208.3 274.7 32.0 77.1 61.0 61.3 13.6 128.7 104.0 15.5 87.3 54.4 76.2 84.1 5.4 163.1 90.4 1302.3 61.8 84.3 79.8 52.9 36.8 175.7 5.3 71.6 148.7 16.0 1611.3 66.0 53.3 49.4 57.6 61.3 33.5 169.9 169.8 23.3 28.3 144.5 74.5 110.8 68.0 72.6 16.1 51.1 72.7 21.0 61.2 65.1 20.8 25.1 22.4 32.0 143.8 16.9 122.9 12.7 119.7 28.1 85.1 118.2 59.7 12.7 16.3 13.0 82.1 141.0 246.4 18.9 59.3 53.0 175.3 425.0 131.2 51.8 81.9 14.3 352.0 122.4 213.7 105.6 71.3 244.5 125.3 92.1 359.8 29.9 94.2 290.9 256.9 34.0 120.4 17.0 16.1 34.9 101.5 20.5 9.0 38.4 175.0 71.2 45.0 112.8 75.6 105.9 199.1 53.2 70.1 77.0 120.1 136.9 47.7 42.9 71.8 22.9 99.9 252.1 79.4 72.4 163.4 56.5 67.8 57.1 59.8 47.2 55.0 61.0 61.3 54.4 52.9 71.6 57.6 16.9 6.4 21.0 40.1 64.2 39.9 98.8 91.6 12.5 6.2 90.5 48.1 445.9 114.4 95.8 75.4 10.4 732.5 84.0 70.0 1168.0 252.8 5.6 96.4 25.7 41.6 61.7 193.8 11.8 288.8 586.7 44.7 88.2 50.9 31.6 29.2 38.2 283.1 263.7 10.1 8.3 158.3 229.9 77.7 101.1 3.2 14.0 79.0 58.7 5.6 85.3 20.9 119.4 16.6 27.3 116.6 105.0 35.3 185.9 170.3 69.6 205.0 167.9 5.4 13.1 60.8 73.4 0.6 15.6 113.3 67.1 573.0 88.1 14.7 305.1 140.1 SEMA4B "KIAA1745, MGC131831, SEMAC, SemC" ENSG00000185033 "Semaphorin 4B" Q9NPR2 15 90160604-90229679 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 124.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 16.9;naive B-cell: 14.9;neutrophil: 5.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "CAPAN-2: 182.4;RPTEC TERT1: 111.1;RT4: 124.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013372 Approved Approved "Nucleoplasm,Vesicles,Cell Junctions" NA NA 61000000 "Cluster 19: B-cells - Humoral immune response" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" "Cell Junctions" "Nucleoplasm, Vesicles" "HPA013372: AB_1856670" "unprognostic (3.33e-2)" "unprognostic (5.96e-2)" "unprognostic (2.23e-2)" "unprognostic (2.50e-2)" "unprognostic (7.78e-2)" "unprognostic (4.48e-2)" "unprognostic (6.34e-3)" "prognostic unfavorable (1.25e-4)" "unprognostic (2.04e-1)" "unprognostic (9.31e-2)" "unprognostic (1.58e-3)" "unprognostic (4.67e-2)" "prognostic unfavorable (3.33e-8)" "unprognostic (1.66e-1)" "unprognostic (1.23e-2)" "unprognostic (3.57e-2)" "unprognostic (7.09e-2)" 11.9 37.6 20.3 18.0 21.9 9.8 22.5 18.8 21.6 35.1 12.8 50.2 30.2 17.1 8.2 124.4 22.6 17.1 24.9 17.3 21.0 47.7 43.2 20.5 12.0 23.5 24.0 21.6 38.5 18.1 18.6 18.3 21.4 31.4 12.1 27.1 41.2 17.6 7.8 50.9 34.7 13.3 21.0 30.3 32.2 10.7 22.9 13.2 34.2 7.9 13.0 42.2 59.8 26.8 21.2 56.3 4.2 13.2 3.8 2.6 30.4 6.4 13.9 7.8 8.3 7.0 182.4 14.9 69.2 4.7 45.0 97.8 3.7 91.2 6.4 85.4 11.7 19.7 13.5 9.4 15.1 2.6 8.7 10.8 39.1 8.5 17.5 32.5 8.8 4.4 9.6 23.0 4.3 15.6 5.4 8.4 18.7 46.8 51.1 6.4 3.1 33.1 111.1 124.0 13.3 13.5 22.3 35.4 8.5 9.3 24.7 6.0 20.0 6.3 11.4 13.1 14.5 33.0 43.2 7.5 58.8 16.1 6.3 0.0 2.4 0.3 0.9 1.4 0.6 16.9 0.5 0.5 1.2 14.9 0.5 0.6 5.1 0.4 2.8 0.2 0.2 1.5 20.3 21.9 18.8 21.6 17.3 21.0 23.5 24.0 21.4 21.0 22.9 26.8 1.8 16.0 22.5 67.3 29.2 65.0 40.0 51.4 23.9 5.7 29.1 18.9 7.8 8.6 44.6 16.5 25.0 13.9 2.4 47.8 3.9 27.3 0.9 15.6 19.6 4.4 4.2 4.0 23.5 35.5 74.5 6.4 34.1 28.3 0.0 8.6 4.6 16.8 13.3 16.8 28.2 17.5 18.3 6.9 7.5 1.2 13.1 5.5 5.4 2.8 5.3 25.1 1.0 8.0 8.3 44.7 26.1 12.0 8.0 46.9 19.6 4.5 22.6 48.3 19.7 5.7 15.3 0.7 3.2 65.3 57.1 12.4 4.3 5.2 20.2 52.0 CIB1 "CIB, KIP, SIP2-28" ENSG00000185043 "Calcium and integrin binding 1" Q99828 15 90229975-90234047 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Angiogenesis, Apoptosis, Cell adhesion, Cell cycle, Cell division, Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 1385.8;Respiratory ciliated cells: 1103.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012991, HPA042413, HPA048825" Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Plasma membrane" "CAB012991: AB_2533205, HPA042413: AB_2732498, HPA048825: AB_2680533" "unprognostic (1.20e-1)" "unprognostic (1.59e-1)" "unprognostic (1.73e-2)" "prognostic favorable (2.26e-5)" "unprognostic (7.56e-2)" "unprognostic (5.51e-2)" "unprognostic (1.21e-2)" "unprognostic (8.29e-3)" "unprognostic (1.77e-1)" "unprognostic (4.09e-2)" "unprognostic (5.25e-3)" "unprognostic (2.44e-1)" "unprognostic (1.29e-3)" "unprognostic (1.85e-1)" "unprognostic (6.31e-2)" "unprognostic (1.39e-1)" "unprognostic (2.68e-2)" 65.6 163.6 65.4 79.7 69.2 205.5 67.4 67.8 76.5 93.8 96.7 147.9 130.1 44.6 88.1 127.3 146.6 77.4 101.9 62.7 68.8 220.1 195.7 86.7 97.0 70.1 70.3 43.9 214.1 98.3 93.0 38.0 68.7 127.6 138.1 29.1 116.6 72.7 58.8 40.4 128.5 45.3 69.3 117.0 99.3 113.8 69.2 64.4 89.1 42.3 120.9 93.7 68.3 69.3 119.5 261.4 23.8 83.7 98.7 102.7 38.9 123.8 107.2 99.6 87.2 104.7 207.4 34.7 129.7 144.0 125.7 124.2 48.0 141.8 54.0 81.9 114.2 77.5 182.3 175.9 96.2 155.2 71.4 72.2 84.9 91.9 64.6 113.7 129.1 83.7 105.8 53.5 76.4 233.3 118.4 179.4 36.7 223.9 134.0 66.1 62.8 139.7 256.1 199.4 18.7 22.8 168.7 136.5 135.7 41.5 105.3 93.3 81.7 109.6 77.0 132.0 153.2 73.0 122.0 40.3 176.1 174.9 47.8 168.9 201.8 271.3 226.9 248.9 188.0 476.4 269.9 249.4 224.4 418.0 221.5 218.0 118.2 205.7 230.0 149.7 245.8 399.6 65.4 69.2 67.8 76.5 62.7 68.8 70.1 70.3 68.7 69.3 69.2 69.3 77.4 89.8 104.2 14.7 203.7 85.7 253.6 520.1 84.8 12.0 152.0 118.5 86.9 128.7 469.1 183.9 10.4 106.7 198.7 670.9 453.9 372.1 380.8 480.8 101.3 83.9 97.1 62.3 7.7 662.9 117.6 96.5 149.9 222.8 138.8 66.9 79.6 230.1 209.0 3.3 6.6 379.5 463.9 102.5 148.0 1385.8 105.3 180.5 128.1 4.7 187.5 138.4 184.4 5.0 12.2 620.2 794.2 92.6 88.8 699.6 661.4 668.6 1103.6 25.5 39.5 62.3 140.4 160.3 69.0 218.1 67.3 66.1 227.5 91.8 315.5 577.8 GDPGP1 C15orf58 ENSG00000183208 "GDP-D-glucose phosphorylase 1" Q6ZNW5 15 90233808-90245811 "Enzymes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor, Hydrolase, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA048189, HPA059841" Approved Approved Cytosol NA NA "Cluster 24: B-cells - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 6: T47d - Mammary gland" "Cluster 1: Pancreatic cells - Digestion" Cytosol "HPA048189: AB_2680307, HPA059841: AB_2684138" "prognostic favorable (6.32e-4)" "unprognostic (1.85e-1)" "unprognostic (2.17e-1)" "unprognostic (2.42e-2)" "unprognostic (2.14e-1)" "unprognostic (1.18e-1)" "unprognostic (1.18e-1)" "unprognostic (2.58e-1)" "unprognostic (3.68e-2)" "unprognostic (4.46e-3)" "unprognostic (1.53e-1)" "unprognostic (3.00e-1)" "unprognostic (1.82e-2)" "unprognostic (2.93e-3)" "unprognostic (8.43e-2)" "unprognostic (1.87e-1)" "unprognostic (1.02e-3)" 1.8 3.2 3.9 3.0 3.0 2.0 2.3 4.3 4.2 2.0 3.1 5.7 5.3 2.2 3.0 2.4 4.6 3.0 5.8 3.2 2.9 4.3 4.9 2.9 3.5 3.7 2.9 2.9 3.5 4.9 3.7 1.0 4.6 3.7 7.7 2.7 3.8 3.1 7.9 2.1 3.9 2.8 1.8 3.2 3.5 4.6 2.9 3.1 3.8 1.5 4.1 3.4 1.5 5.0 3.0 11.8 1.4 4.3 4.3 0.9 3.9 2.7 1.7 3.5 3.3 3.5 11.5 7.5 5.2 2.1 2.6 5.0 4.5 3.2 1.4 6.7 7.8 6.7 7.0 5.1 4.6 3.6 4.2 1.1 2.1 2.4 1.3 3.9 4.2 4.4 2.5 2.6 2.1 6.5 2.7 1.6 1.8 9.2 4.8 4.7 1.0 3.8 4.1 5.9 4.5 2.0 4.3 6.6 4.5 2.6 7.6 3.7 4.2 1.8 1.9 2.7 2.7 5.8 7.3 3.4 4.1 3.0 3.3 3.8 2.2 1.0 3.1 2.6 2.7 2.3 2.9 3.7 2.0 4.2 3.0 2.8 3.1 3.4 2.2 2.1 3.9 1.4 3.9 3.0 4.3 4.2 3.2 2.9 3.7 2.9 4.6 1.8 2.9 5.0 1.4 0.0 3.2 0.3 2.1 0.0 2.8 0.9 1.8 3.8 3.4 2.2 6.4 8.6 1.5 7.3 6.2 2.4 2.5 6.5 3.9 3.8 3.0 3.8 1.6 1.7 5.4 1.7 2.6 6.0 1.2 1.5 4.1 2.3 3.8 2.3 1.4 4.5 4.1 1.7 2.8 3.6 0.0 2.2 0.0 2.4 2.8 3.5 0.0 1.0 2.3 3.5 2.1 1.0 2.1 4.9 5.5 2.2 2.4 2.2 3.8 5.8 3.4 4.4 0.0 3.8 1.0 2.9 2.8 1.8 0.3 0.4 3.2 1.5 4.2 3.1 TTLL13P "FLJ46079, MGC33417, TTLL13" ENSG00000213471 "Tubulin tyrosine ligase like 13, pseudogene" A6NNM8 15 90249530-90265482 "Predicted intracellular proteins" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 41 "testis: 8.9" "Cell type enhanced" "Detected in single" "Inhibitory neurons: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041305 Enhanced NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 43: Cardiomyocytes - Nuclear processes" "HPA041305: AB_2732492" "unprognostic (6.23e-3)" "unprognostic (2.19e-2)" "unprognostic (6.49e-4)" "unprognostic (6.09e-4)" "unprognostic (2.46e-1)" "unprognostic (1.43e-1)" "unprognostic (8.58e-2)" "unprognostic (5.17e-3)" "unprognostic (3.61e-3)" "unprognostic (9.23e-3)" "unprognostic (2.89e-1)" "unprognostic (1.79e-2)" "unprognostic (1.63e-3)" "unprognostic (1.04e-2)" "unprognostic (3.12e-1)" "unprognostic (8.32e-2)" "unprognostic (1.88e-4)" 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.1 0.1 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NGRN DSC92 ENSG00000182768 "Neugrin, neurite outgrowth associated" Q9NPE2 15 90265659-90275778 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 385.3;skeletal muscle: 376.8" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 75.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041367, HPA076267" Approved Supported "Nucleoplasm,Cytokinetic bridge,Mitochondria" "Intracellular and membrane" Yes No "Cluster 35: T-regs - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 16: U-266 - Nucleosome" "Cluster 59: Non-specific - Transcription" Mitochondria "Nucleoplasm, Cytokinetic bridge" "HPA041367: AB_10796668, HPA076267: " "unprognostic (2.82e-1)" "unprognostic (1.04e-2)" "unprognostic (1.66e-3)" "unprognostic (2.34e-1)" "unprognostic (2.21e-1)" "unprognostic (3.19e-2)" "unprognostic (2.94e-2)" "unprognostic (5.00e-2)" "unprognostic (7.78e-2)" "unprognostic (1.93e-2)" "unprognostic (5.22e-2)" "unprognostic (7.22e-2)" "unprognostic (3.31e-2)" "unprognostic (2.10e-1)" "unprognostic (2.05e-1)" "unprognostic (1.68e-3)" "unprognostic (3.21e-1)" 61.0 91.8 322.8 32.9 334.0 31.7 61.4 312.4 385.3 68.8 312.1 47.0 39.7 63.4 98.3 51.7 65.3 47.1 133.0 332.8 329.8 71.7 59.1 50.3 31.8 316.3 322.1 67.8 46.4 87.6 3.0 46.4 318.1 80.1 51.1 157.0 46.3 88.9 376.8 32.6 35.6 74.6 324.8 37.0 41.5 54.2 334.5 39.6 74.0 291.8 37.4 69.2 2.7 320.9 62.1 127.8 151.7 99.7 138.4 63.9 70.4 100.7 88.4 110.5 94.0 133.2 90.5 38.4 113.8 108.9 110.2 118.2 120.3 64.7 121.5 42.6 104.6 61.0 88.4 110.6 117.7 44.5 36.1 83.4 183.3 60.8 132.9 83.7 79.5 45.7 105.0 64.7 112.8 106.5 35.9 53.5 152.7 198.8 55.0 65.6 72.8 63.1 109.8 168.3 145.8 117.0 107.1 90.1 239.1 149.1 141.9 82.6 64.6 138.3 92.3 85.7 161.7 96.9 268.2 66.4 76.8 90.1 106.4 66.4 62.1 99.0 87.2 65.2 109.9 107.7 106.1 101.9 59.2 105.7 122.6 106.8 23.4 86.7 76.0 62.8 133.5 108.0 322.8 334.0 312.4 385.3 332.8 329.8 316.3 322.1 318.1 324.8 334.5 320.9 10.8 19.2 27.4 21.5 26.2 7.1 10.6 3.7 75.1 10.4 9.1 5.8 10.1 1.5 21.6 5.5 10.4 5.9 5.0 12.1 5.9 33.6 1.9 16.2 14.6 15.8 26.5 12.0 58.3 23.4 4.5 23.0 30.1 9.4 20.3 5.5 7.5 3.8 4.2 16.8 54.0 14.4 4.1 3.8 3.6 4.0 9.0 8.4 8.8 16.9 11.6 15.1 0.0 12.5 22.2 29.9 20.0 8.6 25.0 9.2 12.6 7.8 59.8 11.2 13.1 10.5 19.6 5.2 4.3 55.2 5.1 6.7 19.9 5.7 15.4 8.7 AC091167.6 ENSG00000275674 "Novel protein" 15 90266317-90314499 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 1.2;pancreas: 1.1" "Cell type enriched" "Detected in single" 5 "Alveolar cells type 2: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.9;CACO-2: 1.0;U-266/84: 1.1" NA NA "Cluster 22: Non-specific - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 52: Non-specific - Transcription" "unprognostic (1.02e-1)" "unprognostic (6.86e-2)" "unprognostic (7.11e-2)" "unprognostic (9.39e-2)" "unprognostic (4.70e-2)" "unprognostic (2.50e-2)" "unprognostic (6.17e-2)" "unprognostic (1.27e-1)" "unprognostic (1.23e-1)" "unprognostic (9.18e-2)" "unprognostic (4.73e-2)" "unprognostic (1.52e-1)" "unprognostic (3.05e-2)" 0.0 0.0 0.8 0.0 0.5 0.0 0.1 0.2 0.7 0.1 0.0 0.2 1.2 0.1 0.1 0.0 0.2 0.0 0.0 0.5 0.8 0.1 0.1 0.1 0.0 0.1 0.1 0.1 1.1 0.3 0.2 0.0 0.1 0.1 0.0 0.3 0.5 0.2 0.1 0.0 0.7 0.2 0.1 0.0 0.4 0.2 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.3 0.3 0.3 0.2 0.0 0.0 1.9 0.1 0.0 0.1 0.1 1.0 0.3 0.0 0.4 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 0.1 0.5 0.1 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.4 0.3 0.2 0.1 0.1 0.4 1.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.8 0.5 0.2 0.7 0.5 0.8 0.1 0.1 0.1 0.1 0.4 0.5 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ZNF774 MGC75360 ENSG00000196391 "Zinc finger protein 774" Q6NX45 15 90352284-90369146 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 15.4;Granulosa cells: 45.3;Spermatocytes: 11.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HeLa: 9.0" "HPA030839, HPA030840" Uncertain Supported "Intermediate filaments,Cytosol" No No "Cluster 11: Basophils - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 20: HeLa - Mitochondria" "Cluster 40: Granulosa cells - Unknown function" "Intermediate filaments" Cytosol "HPA030839: AB_2673630, HPA030840: AB_10602691" "unprognostic (1.11e-1)" "unprognostic (2.14e-1)" "unprognostic (1.38e-1)" "unprognostic (5.82e-3)" "unprognostic (3.29e-2)" "unprognostic (1.35e-1)" "unprognostic (6.89e-2)" "unprognostic (9.22e-3)" "unprognostic (7.82e-2)" "unprognostic (1.94e-1)" "unprognostic (3.43e-1)" "unprognostic (2.89e-2)" "unprognostic (2.71e-1)" "unprognostic (5.62e-2)" "unprognostic (1.27e-1)" "unprognostic (4.48e-2)" "unprognostic (4.82e-2)" 0.7 2.7 2.3 1.2 4.2 1.0 3.4 4.3 3.6 2.6 0.0 4.6 2.2 2.8 4.1 1.4 3.0 2.9 2.8 1.9 2.6 1.4 1.1 1.1 0.7 0.7 1.0 1.1 3.9 3.1 3.0 0.7 0.8 2.4 7.1 4.0 3.9 5.7 6.2 3.1 2.0 1.8 0.0 0.6 2.6 2.2 2.7 1.5 2.7 7.2 0.9 1.9 1.6 3.3 1.7 0.7 2.1 2.4 0.9 0.5 5.0 1.0 1.7 1.3 1.6 2.7 2.0 0.6 2.0 1.3 3.7 2.5 2.2 3.7 1.3 1.2 4.2 1.8 9.0 1.3 1.6 1.0 1.3 0.5 4.4 1.9 1.8 3.6 2.3 3.4 2.0 0.8 2.1 1.6 1.4 0.9 0.6 4.5 2.5 1.3 1.8 0.5 2.6 4.6 4.8 2.0 2.0 3.1 0.8 2.4 2.1 0.2 1.1 1.4 1.3 1.1 2.2 5.2 3.8 0.4 2.3 2.8 0.7 1.4 0.3 0.7 0.2 0.1 0.1 0.2 0.2 0.3 0.6 0.4 0.2 0.2 1.2 0.7 0.2 0.3 0.1 0.1 2.3 4.2 4.3 3.6 1.9 2.6 0.7 1.0 0.8 0.0 2.7 3.3 0.6 6.4 3.2 0.3 0.7 0.8 2.5 1.0 2.2 6.4 2.4 2.4 4.9 0.0 1.1 0.0 0.0 1.7 0.2 6.8 1.9 2.8 15.4 1.7 2.3 1.0 2.4 0.0 2.5 2.0 1.1 0.9 4.1 3.2 0.0 45.3 0.0 1.5 0.8 8.4 2.3 3.3 0.0 0.3 0.7 11.0 0.3 0.8 0.0 0.0 0.2 2.0 0.0 1.5 1.1 1.7 5.5 2.2 0.7 1.4 1.9 1.1 0.7 5.3 0.0 1.7 1.9 11.8 4.5 1.3 0.3 1.4 0.5 0.3 5.5 2.0 IQGAP1 "HUMORFA01, KIAA0051, p195, SAR1" ENSG00000140575 "IQ motif containing GTPase activating protein 1" P46940 15 90388242-90502239 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013302, HPA014055" Enhanced Supported "Plasma membrane,Cell Junctions" NA NA 1500000 "Cluster 9: Neutrophils - Innate immune response" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 24: Non-specific - Transcription regulation" "Plasma membrane, Cell Junctions" "CAB013302: AB_2533146, HPA014055: AB_1851856" "unprognostic (2.83e-1)" "unprognostic (7.73e-2)" "unprognostic (1.85e-1)" "unprognostic (1.02e-2)" "unprognostic (5.95e-2)" "unprognostic (4.24e-2)" "unprognostic (7.07e-2)" "unprognostic (1.17e-1)" "unprognostic (3.82e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.67e-5)" "unprognostic (2.01e-1)" "unprognostic (1.26e-1)" "unprognostic (2.02e-1)" "unprognostic (1.03e-2)" "unprognostic (1.87e-1)" "unprognostic (1.25e-3)" 57.3 31.1 14.4 69.3 30.0 69.7 51.6 19.8 20.5 62.0 26.9 67.1 32.3 72.2 21.3 75.6 45.1 55.0 22.9 17.0 21.5 35.6 18.8 74.2 58.9 29.0 24.6 39.6 30.1 49.7 12.1 79.8 28.1 36.2 66.9 7.1 72.2 38.0 15.0 64.9 37.9 81.3 16.5 57.7 52.6 13.0 27.9 65.4 64.3 25.4 63.4 63.5 31.4 63.4 148.9 81.5 39.8 46.6 99.3 128.4 229.6 139.7 127.0 124.7 132.4 93.6 150.5 82.7 66.2 231.5 111.4 259.2 80.6 153.5 149.5 106.4 56.6 55.5 145.8 34.3 120.2 102.9 113.6 76.2 139.5 147.2 206.5 152.7 172.8 53.0 49.0 112.8 192.3 76.5 55.4 30.8 51.6 235.8 45.6 67.5 106.5 72.1 126.9 233.8 49.5 37.3 195.1 96.9 100.7 162.8 85.1 86.5 224.2 141.1 73.4 120.4 145.6 43.3 67.0 82.4 128.3 98.5 77.5 30.6 27.5 20.0 21.8 25.2 19.3 12.6 13.5 18.9 23.3 12.5 7.9 14.0 89.9 27.6 31.0 13.8 16.1 16.9 14.4 30.0 19.8 20.5 17.0 21.5 29.0 24.6 28.1 16.5 27.9 63.4 180.9 266.0 286.3 36.2 129.2 103.0 124.9 87.7 72.8 4.6 115.1 88.4 18.0 54.3 167.2 77.3 16.7 89.7 215.3 204.5 7.9 95.9 8.8 133.8 127.9 135.7 60.7 46.7 39.7 98.7 159.4 116.5 91.7 242.0 209.3 130.2 95.3 11.6 149.0 1.7 24.4 121.1 63.1 407.5 175.1 13.2 47.8 261.6 71.2 60.9 272.2 13.5 200.8 9.5 316.0 128.1 112.1 48.2 137.3 98.6 72.7 19.6 134.2 30.2 78.9 108.8 131.0 18.9 32.6 99.3 113.4 95.6 176.8 56.0 152.0 151.5 CRTC3 FLJ21868 ENSG00000140577 "CREB regulated transcription coactivator 3" Q6UUV7 15 90529923-90645345 "Cancer-related genes, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" Activator "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 160.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 21.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 83.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043735, HPA063691" Approved Enhanced Nucleoplasm,Cytosol NA NA "Cluster 38: Basophils - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 20: HeLa - Mitochondria" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm Cytosol "HPA043735: AB_10794286, HPA063691: AB_2685092" "unprognostic (7.60e-2)" "unprognostic (6.13e-2)" "unprognostic (1.35e-1)" "unprognostic (2.31e-2)" "unprognostic (5.12e-2)" "unprognostic (3.51e-1)" "unprognostic (1.75e-2)" "unprognostic (1.69e-1)" "unprognostic (6.48e-2)" "unprognostic (3.60e-1)" "unprognostic (1.47e-1)" "unprognostic (2.23e-1)" "unprognostic (5.22e-3)" "unprognostic (4.67e-2)" "unprognostic (9.32e-2)" "unprognostic (9.51e-2)" "unprognostic (2.30e-1)" 27.0 15.5 16.8 14.2 25.3 10.7 21.7 20.0 19.8 26.3 10.1 28.4 7.3 26.0 10.9 12.5 23.8 14.8 19.8 17.0 16.4 14.5 13.2 23.2 15.8 21.8 23.1 36.8 10.7 13.8 9.9 17.1 21.1 18.8 9.4 13.5 17.4 17.0 19.9 19.1 16.6 20.9 16.3 13.3 15.2 16.8 23.2 15.0 22.3 17.4 15.7 28.4 18.3 31.6 9.6 15.1 9.7 16.7 21.6 15.7 46.0 11.7 16.0 17.6 15.9 12.4 9.3 0.2 8.3 23.8 14.9 15.2 15.1 9.8 13.2 16.3 18.8 23.7 83.9 6.1 24.8 6.5 38.8 17.2 16.3 14.5 19.3 13.2 12.5 10.2 12.8 5.5 13.6 11.5 2.6 9.7 3.7 2.7 7.2 8.3 16.3 0.5 6.6 20.3 18.5 16.5 34.7 11.6 19.3 10.8 11.2 12.2 16.4 19.7 14.9 19.0 14.0 7.3 10.2 7.2 8.0 12.6 9.8 21.4 2.6 1.5 3.5 0.8 3.8 2.9 4.3 3.7 1.6 5.0 6.1 3.9 0.5 3.3 0.3 2.1 4.4 3.4 16.8 25.3 20.0 19.8 17.0 16.4 21.8 23.1 21.1 16.3 23.2 31.6 17.9 6.4 9.2 44.1 35.6 23.6 27.8 8.0 13.1 24.9 15.7 12.7 17.0 14.3 7.8 12.9 27.1 14.8 30.0 8.6 1.9 14.9 29.3 6.6 18.5 20.4 15.6 17.1 70.1 10.7 43.3 23.2 14.8 12.7 23.5 34.8 24.7 16.2 15.3 57.2 72.4 9.1 6.1 18.2 18.8 24.3 26.8 21.7 17.8 39.4 20.6 17.7 58.7 75.4 160.8 11.1 10.9 43.6 21.3 26.2 6.4 11.0 2.8 59.7 46.0 30.5 45.8 10.2 17.8 11.4 24.0 17.8 36.0 13.7 11.3 38.2 BLM "BS, RECQ2, RECQL3" ENSG00000197299 "BLM RecQ like helicase" P54132 15 90717346-90816166 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 5.7;lymphoid tissue: 7.9;salivary gland: 7.8" "Cell type enhanced" "Detected in many" "Erythroid cells: 18.3;Oligodendrocyte precursor cells: 58.3;Plasma cells: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005689 Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 46: Basophils - DNA binding" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Cytosol "HPA005689: AB_1845372" "unprognostic (2.77e-1)" "unprognostic (3.82e-3)" "unprognostic (4.03e-2)" "unprognostic (2.98e-2)" "unprognostic (4.75e-2)" "unprognostic (9.89e-2)" "unprognostic (6.12e-5)" "unprognostic (2.82e-2)" "unprognostic (4.55e-3)" "unprognostic (5.24e-3)" "unprognostic (1.80e-3)" "unprognostic (9.12e-2)" "unprognostic (1.55e-15)" "unprognostic (6.53e-3)" "unprognostic (6.55e-2)" "unprognostic (2.43e-1)" "unprognostic (1.83e-2)" 0.3 0.2 0.9 3.6 1.1 5.7 0.5 2.3 0.9 0.1 0.3 1.4 1.0 0.4 0.4 0.6 0.3 0.3 0.3 0.8 1.1 0.1 0.1 0.4 6.4 1.2 1.4 0.1 0.2 0.0 0.6 1.2 1.1 0.1 1.7 2.4 7.8 0.0 0.5 0.4 1.6 0.4 1.0 1.6 1.1 2.2 0.9 7.9 0.3 0.1 6.2 1.0 0.2 1.0 13.0 14.4 20.4 12.6 0.1 0.9 14.6 9.4 3.2 11.1 13.4 11.7 10.1 35.1 5.9 2.6 14.1 20.4 25.7 7.1 15.1 19.1 20.5 36.4 14.8 3.9 0.0 33.7 17.3 0.3 0.1 10.6 4.7 1.3 7.9 16.9 32.7 9.9 11.0 7.4 28.3 14.5 22.2 24.9 4.2 25.4 39.1 14.7 2.3 18.9 14.6 14.7 8.5 11.5 4.8 18.1 7.2 23.4 3.7 8.6 13.6 9.6 21.0 6.4 30.4 39.5 5.6 25.8 15.7 1.7 0.6 2.6 1.6 0.8 2.6 4.6 1.4 2.1 0.7 2.3 1.0 1.1 0.7 3.1 1.0 0.7 3.2 0.9 0.9 1.1 2.3 0.9 0.8 1.1 1.2 1.4 1.1 1.0 0.9 1.0 0.9 3.2 8.9 1.0 12.9 0.3 0.5 0.5 0.6 3.6 1.3 1.0 7.9 0.0 4.2 0.0 2.1 5.5 6.9 2.2 1.9 1.0 2.7 1.3 1.3 2.0 0.0 18.3 0.7 0.7 6.8 1.8 3.6 1.7 13.3 8.1 2.2 0.6 5.7 0.0 8.6 1.3 0.0 7.7 1.3 1.6 0.0 7.7 0.0 7.5 2.7 1.7 10.3 58.3 2.6 1.2 0.3 0.4 20.6 0.7 0.2 0.0 5.4 7.1 0.0 0.9 1.7 17.1 12.9 2.2 0.6 1.0 10.2 0.7 4.0 0.4 FURIN "FUR, PACE, PCSK3, SPC1" ENSG00000140564 "Furin, paired basic amino acid cleaving enzyme" P09958 15 90868588-90883564 "Enzymes, Plasma proteins, Predicted membrane proteins" "Host-virus interaction" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 305.6;salivary gland: 220.5" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 117.5;Hepatocytes: 131.8;Pancreatic endocrine cells: 108.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009499, HPA067869" Enhanced Supported "Nucleoplasm,Golgi apparatus" "Intracellular and membrane" NA NA 130000 "Cluster 10: Basophils - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 38: EFO-21 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" "Golgi apparatus" Nucleoplasm "CAB009499: AB_2105095, HPA067869: " "unprognostic (2.46e-1)" "unprognostic (2.73e-2)" "unprognostic (7.33e-2)" "unprognostic (2.30e-2)" "unprognostic (4.11e-3)" "unprognostic (4.37e-2)" "unprognostic (8.11e-2)" "prognostic unfavorable (1.58e-4)" "unprognostic (2.24e-1)" "unprognostic (9.92e-3)" "unprognostic (1.78e-1)" "unprognostic (1.96e-1)" "unprognostic (4.52e-3)" "unprognostic (4.57e-2)" "unprognostic (4.46e-2)" "unprognostic (4.27e-3)" "unprognostic (8.20e-2)" 54.5 24.4 12.8 36.4 10.5 73.8 42.4 10.6 14.5 26.4 11.7 32.8 27.6 32.3 9.8 33.7 30.4 19.4 58.5 14.9 9.0 56.8 305.6 63.2 13.0 12.5 10.8 22.4 108.6 27.3 45.9 40.6 11.3 60.1 12.1 12.9 220.5 17.7 61.3 62.7 35.5 14.3 10.4 51.4 34.0 8.6 15.6 11.8 56.1 25.3 11.2 30.2 33.3 9.3 50.8 31.2 6.8 29.8 49.4 32.1 77.5 64.4 48.1 26.3 18.1 45.4 54.3 1.9 148.8 47.5 46.1 91.5 14.0 32.5 5.4 148.0 35.2 90.9 52.8 57.7 26.2 13.0 141.2 35.6 35.3 29.5 13.2 62.4 84.7 14.6 70.5 8.5 17.8 32.3 5.0 29.2 21.5 44.2 9.3 7.9 26.6 10.9 35.2 39.1 13.1 9.2 54.5 28.5 42.5 31.9 10.7 31.4 125.9 29.4 60.1 43.7 95.5 15.2 93.4 3.4 55.8 40.1 60.7 2.0 0.9 1.5 0.7 0.1 0.2 0.4 0.2 0.3 0.6 0.1 0.0 0.1 0.7 0.4 0.0 0.3 0.0 1.1 12.8 10.5 10.6 14.5 14.9 9.0 12.5 10.8 11.3 10.4 15.6 9.3 44.1 3.2 27.4 4.2 7.3 19.4 10.0 10.4 2.8 12.8 12.0 9.0 16.3 21.5 8.5 22.0 25.0 20.9 26.9 49.5 0.0 47.1 0.5 15.2 9.7 29.4 37.8 26.5 7.9 117.5 16.5 11.4 21.9 32.3 15.8 7.0 23.9 131.8 24.8 8.4 7.5 31.7 10.2 35.3 42.1 1.4 11.1 33.6 16.0 5.6 14.0 13.6 24.7 2.0 4.4 108.3 26.4 10.9 7.2 24.3 28.7 7.8 2.0 28.0 26.3 10.5 18.6 2.8 3.6 8.5 23.0 84.3 19.6 4.7 17.9 16.4 FES FPS ENSG00000182511 "FES proto-oncogene, tyrosine kinase" P07332 15 90883695-90895776 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Proto-oncogene, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 83.4;lymphoid tissue: 110.9" "Cell type enhanced" "Detected in many" "Adipocytes: 46.8;Hofbauer cells: 48.7;Kupffer cells: 92.3;Macrophages: 51.9;monocytes: 57.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 315.8" "Group enriched" "Detected in many" 4 "dendritic cells: 162.6;granulocytes: 315.8;monocytes: 151.7" "Cell line enhanced" "Detected in many" "HEL: 63.5;HL-60: 56.9;HMC-1: 116.6;NB-4: 76.1;THP-1: 110.8;U-937: 48.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA001376 Approved Approved Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Cytosol" Vesicles "HPA001376: AB_1078847" "unprognostic (1.07e-2)" "unprognostic (2.54e-2)" "prognostic unfavorable (5.78e-4)" "unprognostic (2.31e-2)" "unprognostic (4.05e-3)" "unprognostic (7.33e-2)" "unprognostic (1.74e-1)" "unprognostic (2.22e-1)" "unprognostic (1.58e-3)" "unprognostic (1.35e-1)" "unprognostic (4.66e-2)" "unprognostic (5.15e-3)" "unprognostic (1.78e-3)" "unprognostic (2.53e-3)" "unprognostic (6.08e-2)" "unprognostic (1.18e-1)" "unprognostic (1.40e-1)" 30.8 8.0 9.4 20.2 8.8 83.4 21.3 9.6 10.8 18.1 9.6 12.5 5.8 15.7 2.4 5.9 19.0 14.0 19.6 8.3 8.7 18.9 25.2 30.9 13.8 11.1 9.2 13.5 7.8 2.3 5.6 16.3 10.1 17.9 4.6 1.5 58.3 8.0 6.1 8.0 12.5 10.7 10.4 110.9 9.6 4.5 10.9 4.2 16.0 7.0 5.7 15.1 13.5 9.8 0.4 0.8 0.8 10.3 3.1 8.8 17.9 2.9 0.1 5.1 2.9 2.6 0.1 6.8 0.5 6.0 0.2 1.5 1.7 0.3 1.6 3.3 1.1 63.5 0.0 11.9 6.8 56.9 116.6 8.8 0.1 7.6 0.0 0.0 31.2 9.4 1.8 0.2 0.0 21.3 1.8 76.1 3.2 2.5 0.0 8.6 0.1 0.1 0.0 0.2 0.4 0.1 0.0 2.8 2.3 2.9 0.1 110.8 24.9 0.2 10.4 0.2 0.2 0.1 8.0 2.5 0.3 48.0 2.4 64.4 151.7 315.8 0.5 88.6 0.4 5.2 0.3 0.4 162.6 4.1 0.2 0.3 100.5 51.4 39.8 65.0 0.2 81.5 9.4 8.8 9.6 10.8 8.3 8.7 11.1 9.2 10.1 10.4 10.9 9.8 46.8 3.2 5.8 3.6 5.0 3.8 5.4 0.5 0.6 0.2 4.1 3.8 3.4 8.6 0.5 1.8 0.0 5.3 25.6 0.6 3.9 7.3 1.7 2.0 4.2 29.1 3.0 8.0 2.8 4.3 4.2 9.0 2.0 4.2 29.2 10.7 20.0 15.0 48.7 0.0 0.2 2.0 2.0 92.3 27.9 8.4 9.0 51.9 7.2 5.6 57.8 2.5 26.8 2.0 0.3 2.1 2.0 10.1 4.0 3.1 0.7 1.5 0.2 1.9 13.1 4.6 12.9 4.4 15.9 1.0 2.8 4.5 6.7 3.3 3.7 5.2 MAN2A2 "HsT19662, MANA2X" ENSG00000196547 "Mannosidase alpha class 2A member 2" P49641 15 90902218-90922584 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 92.6;Rod photoreceptor cells: 74.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 8.8;neutrophil: 7.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEL: 100.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077930 Approved "Cytoplasmic bodies" NA NA 43000000 "Cluster 38: Basophils - Unknown function" "Cluster 54: Non-specific - Microtubule organization" "Cluster 36: HEL - Hemostasis" "Cluster 46: Photoreceptor cells - Phototransduction" "Cytoplasmic bodies" "HPA077930: AB_2732363" "unprognostic (5.17e-2)" "unprognostic (9.80e-2)" "unprognostic (2.43e-2)" "unprognostic (2.41e-1)" "unprognostic (2.58e-1)" "unprognostic (1.86e-2)" "unprognostic (1.82e-1)" "unprognostic (1.82e-1)" "unprognostic (3.41e-1)" "unprognostic (2.27e-1)" "unprognostic (5.06e-3)" "unprognostic (1.09e-2)" "prognostic unfavorable (8.95e-4)" "unprognostic (7.55e-3)" "unprognostic (1.13e-1)" "unprognostic (8.36e-2)" "unprognostic (2.33e-2)" 24.8 18.3 29.7 12.8 53.6 78.2 22.9 43.4 38.9 12.3 12.7 18.2 13.3 11.0 9.4 9.2 14.7 9.6 41.7 29.8 36.6 15.1 34.5 22.9 14.1 51.9 47.4 15.8 44.3 13.4 25.0 11.4 53.3 14.3 8.9 74.9 28.1 12.9 61.0 16.8 20.9 7.7 34.7 35.1 24.4 15.4 49.0 12.3 21.9 44.0 9.9 13.3 10.6 85.1 14.4 15.4 9.6 22.3 27.7 7.0 20.2 11.3 9.6 11.9 8.6 13.2 9.6 2.1 24.6 12.0 9.2 16.0 11.0 6.5 6.0 35.2 29.5 100.7 23.8 8.8 8.4 16.4 55.4 5.4 10.9 13.1 9.7 20.2 13.4 26.8 41.7 11.7 4.7 20.4 8.8 30.9 3.2 22.3 5.0 12.5 10.1 13.8 12.1 35.1 25.1 15.6 15.0 24.2 20.3 9.2 11.5 42.5 11.9 8.5 9.3 10.4 12.8 19.6 62.3 5.2 9.8 21.0 14.5 8.8 1.2 0.5 1.0 0.8 0.7 0.8 0.4 0.6 0.2 0.9 0.3 0.3 7.9 0.1 2.9 1.6 1.1 1.4 29.7 53.6 43.4 38.9 29.8 36.6 51.9 47.4 53.3 34.7 49.0 85.1 22.3 12.8 22.6 20.2 5.5 6.0 3.4 2.8 4.0 26.4 9.9 8.8 14.7 12.8 7.7 9.2 27.1 10.0 10.6 12.2 0.0 5.0 9.1 6.6 9.6 9.5 4.2 19.1 27.3 6.5 2.3 7.5 13.3 12.9 15.8 7.1 7.1 22.5 6.0 25.2 26.6 6.4 2.0 13.9 14.1 7.1 6.8 17.9 30.2 11.2 11.7 17.4 3.1 29.7 92.6 3.8 4.3 4.9 6.9 5.3 8.7 2.9 4.5 74.5 13.1 12.0 11.4 12.4 9.6 5.2 4.7 7.5 10.2 1.6 9.3 3.6 HDDC3 "MESH1, MGC45386" ENSG00000184508 "HD domain containing 3" Q8N4P3 15 90929968-90935196 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040895 Approved Approved Nucleoplasm,Cytosol No No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 22: Non-specific - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Cytosol" "HPA040895: AB_10795494" "unprognostic (1.03e-1)" "unprognostic (3.78e-2)" "unprognostic (1.32e-1)" "unprognostic (1.29e-2)" "unprognostic (1.10e-1)" "unprognostic (3.75e-2)" "unprognostic (2.53e-1)" "unprognostic (3.57e-1)" "unprognostic (1.28e-1)" "unprognostic (5.93e-3)" "unprognostic (1.08e-1)" "unprognostic (1.91e-2)" "unprognostic (3.43e-2)" "unprognostic (2.26e-1)" "unprognostic (4.86e-2)" "unprognostic (3.15e-1)" "unprognostic (4.65e-1)" 13.0 13.1 15.5 7.9 15.1 10.4 9.2 15.0 20.0 6.5 13.9 11.2 10.3 4.3 8.2 5.9 10.4 4.6 13.3 15.1 14.8 12.1 11.4 6.4 8.2 15.1 14.8 6.5 20.0 15.7 8.0 7.0 14.7 7.0 9.1 7.1 20.7 5.8 13.3 7.7 11.9 3.9 15.3 9.3 9.7 4.5 16.1 7.4 9.8 14.6 9.2 5.5 5.5 15.7 12.7 15.7 5.3 6.4 11.8 11.8 9.0 8.5 11.4 7.7 11.5 7.7 25.5 24.2 8.5 7.0 6.1 19.3 11.1 19.3 6.3 30.4 24.4 30.5 6.0 17.7 23.9 11.6 14.1 10.5 30.1 13.9 24.8 12.2 17.0 19.5 24.6 20.7 6.9 19.1 16.1 10.0 4.3 47.2 15.6 13.2 2.1 38.2 15.8 13.2 13.3 8.5 7.1 19.2 21.4 11.0 29.2 30.5 9.8 4.7 10.5 8.1 10.9 33.5 41.4 16.7 17.5 22.4 14.3 10.1 20.1 8.5 23.3 27.4 30.1 35.1 30.0 26.3 27.4 31.4 34.6 25.5 4.7 31.5 26.7 44.0 31.9 25.6 15.5 15.1 15.0 20.0 15.1 14.8 15.1 14.8 14.7 15.3 16.1 15.7 42.8 28.9 7.4 5.9 23.5 5.6 14.1 22.5 6.8 13.8 27.8 30.1 1.1 44.3 21.6 16.5 4.2 48.2 19.1 18.1 76.3 42.3 4.6 18.8 12.4 19.0 19.9 34.3 4.8 56.5 33.0 12.7 13.7 18.6 7.0 14.3 15.7 41.4 45.9 15.2 5.2 32.9 12.2 15.1 10.9 4.3 14.3 19.6 14.2 1.9 36.3 39.9 34.0 1.0 3.9 28.4 30.2 11.7 31.7 14.7 59.7 71.5 20.6 38.8 6.6 13.2 11.5 29.6 38.4 17.2 8.4 24.2 21.4 21.7 33.0 13.5 UNC45A "GC-UNC45, SMAP-1" ENSG00000140553 "Unc-45 myosin chaperone A" Q9H3U1 15 90930180-90954093 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Myogenesis" "Chaperone, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039228 Approved Supported "Nuclear speckles,Cytosol" NA NA 17000 "Cluster 27: Non-specific - Gene expression" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 55: Plasma cells - Humoral immune response" "Nuclear speckles" Cytosol "HPA039228: AB_2676402" "unprognostic (1.46e-1)" "unprognostic (3.83e-2)" "unprognostic (4.51e-2)" "unprognostic (1.97e-1)" "unprognostic (2.68e-2)" "unprognostic (1.70e-3)" "prognostic unfavorable (7.72e-4)" "unprognostic (2.27e-2)" "unprognostic (1.58e-1)" "unprognostic (1.16e-1)" "unprognostic (1.98e-1)" "unprognostic (9.85e-2)" "prognostic favorable (7.46e-7)" "unprognostic (9.30e-2)" "unprognostic (1.74e-1)" "unprognostic (1.95e-1)" "unprognostic (2.28e-2)" 25.0 25.3 7.7 16.7 8.2 17.3 23.2 8.6 9.1 32.0 10.0 41.2 16.4 38.1 11.0 31.4 28.4 17.3 15.9 7.8 7.7 18.9 13.0 20.2 18.9 8.9 11.6 26.1 22.3 33.2 17.5 19.6 9.5 25.2 13.4 5.6 25.8 34.1 9.6 37.7 23.5 28.0 8.3 19.7 28.5 13.1 9.6 18.0 19.5 10.6 17.3 39.3 29.4 8.0 38.2 76.3 30.9 27.2 83.0 38.0 27.3 42.4 36.2 56.5 45.1 61.3 49.4 44.7 55.5 53.8 32.5 82.1 52.9 54.4 26.6 49.8 75.9 86.2 77.0 44.4 46.8 21.5 56.2 47.3 65.8 55.7 40.5 54.2 77.5 35.1 38.6 35.8 43.3 62.2 28.1 18.6 41.8 69.5 38.0 54.8 46.9 48.1 38.4 89.2 43.1 39.4 57.1 55.9 54.3 36.8 50.8 44.3 77.0 48.0 34.1 40.4 45.0 33.6 50.5 21.1 46.6 49.7 49.8 11.5 8.3 5.0 11.8 7.3 11.3 7.9 9.6 9.1 10.4 6.3 7.8 7.4 1.6 9.8 11.6 9.1 9.3 9.8 7.7 8.2 8.6 9.1 7.8 7.7 8.9 11.6 9.5 8.3 9.6 8.0 21.7 22.4 22.4 9.4 23.2 16.3 24.8 26.1 30.1 27.2 17.2 19.6 12.7 35.8 23.8 18.4 18.8 53.6 17.5 26.9 13.7 33.6 26.7 12.8 20.3 25.3 37.0 25.2 19.1 18.2 22.7 23.7 26.5 22.1 29.2 30.9 18.9 13.4 28.2 18.5 18.4 15.9 26.4 12.2 14.0 29.0 29.5 20.7 19.6 9.4 28.8 21.5 27.8 7.1 11.0 23.3 26.0 51.6 20.6 16.8 22.0 19.6 11.7 35.1 32.9 15.2 33.9 24.8 6.4 33.9 18.8 46.2 21.4 26.0 22.7 20.3 RCCD1 MGC14386 ENSG00000166965 "RCC1 domain containing 1" A6NED2 15 90954870-90963125 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 56.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039683, HPA040776" Enhanced Enhanced "Plasma membrane,Cytosol" NA Yes "Cluster 35: T-regs - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 20: HeLa - Mitochondria" "Cluster 12: Non-specific - Cell cycle regulation" "Plasma membrane, Cytosol" "HPA039683: AB_10794752, HPA040776: AB_10795478" "unprognostic (1.01e-2)" "unprognostic (1.69e-2)" "unprognostic (7.22e-3)" "unprognostic (8.63e-2)" "unprognostic (6.18e-2)" "unprognostic (2.91e-2)" "unprognostic (8.75e-2)" "unprognostic (5.86e-2)" "unprognostic (4.83e-2)" "unprognostic (5.10e-2)" "unprognostic (5.69e-2)" "unprognostic (2.72e-2)" "unprognostic (1.49e-3)" "unprognostic (1.32e-2)" "unprognostic (2.41e-1)" "unprognostic (4.71e-2)" "unprognostic (3.94e-2)" 3.9 8.8 4.1 3.0 4.3 4.6 3.5 5.5 5.2 6.9 5.0 6.3 5.1 5.5 3.5 6.6 6.0 2.0 5.9 4.0 3.6 6.2 6.7 2.6 3.9 3.3 3.2 7.3 9.2 5.2 2.9 2.2 3.7 5.4 4.5 3.1 5.0 2.8 3.8 7.4 4.8 2.8 2.9 4.3 6.7 5.8 3.5 4.7 4.5 1.0 4.7 5.5 5.7 3.4 8.0 11.7 2.7 5.7 6.6 7.8 20.2 9.1 1.6 2.6 2.7 5.6 14.9 28.0 14.2 5.6 0.2 16.8 8.9 2.4 4.3 23.7 18.2 20.3 21.2 8.0 5.5 9.8 7.7 5.8 8.0 2.6 3.6 10.3 4.3 16.2 15.7 18.0 7.8 2.7 11.8 10.2 10.4 9.6 4.8 14.0 13.6 30.4 12.0 3.6 8.8 10.1 15.8 10.0 11.6 14.2 11.5 18.7 6.9 1.6 11.2 6.6 0.4 31.9 14.1 16.9 3.0 21.4 7.7 0.0 0.2 0.0 0.2 0.6 0.5 0.8 0.4 0.7 0.4 0.5 0.8 0.2 0.0 0.5 0.3 0.6 0.6 0.2 4.1 4.3 5.5 5.2 4.0 3.6 3.3 3.2 3.7 2.9 3.5 3.4 6.0 0.0 2.2 7.5 9.7 7.4 11.3 9.0 7.4 6.2 9.9 10.9 8.5 4.3 5.3 7.3 4.2 20.9 5.0 14.9 3.9 8.0 3.1 3.2 8.2 5.0 22.1 56.8 9.6 4.9 18.4 8.0 8.2 5.7 0.0 12.5 4.2 8.5 12.0 0.0 11.3 20.5 6.1 8.1 4.0 6.5 8.7 5.7 5.4 3.7 4.3 11.1 10.3 8.5 2.0 5.0 11.7 7.9 9.4 9.8 17.4 13.7 2.9 2.9 26.3 9.7 9.2 22.2 20.1 17.2 8.9 9.0 4.6 10.2 25.7 7.3 PRC1 ASE1 ENSG00000198901 "Protein regulator of cytokinesis 1" O43663 15 90966040-90995629 "Predicted intracellular proteins" "Cell cycle, Cell division" Oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 89.9;testis: 55.0" "Cell type enhanced" "Detected in many" "Erythroid cells: 142.9;Extravillous trophoblasts: 68.3;Spermatocytes: 136.4;Spermatogonia: 74.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "basophil: 34.4" "Lineage enriched" "Detected in many" 4 "granulocytes: 34.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034521, HPA048816" Enhanced Supported "Nucleoplasm,Plasma membrane,Microtubules,Cytokinetic bridge,Midbody" Yes Yes "Cluster 38: Basophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Plasma membrane, Microtubules, Cytokinetic bridge, Midbody" Nucleoplasm "HPA034521: AB_10670169, HPA048816: " "unprognostic (1.14e-1)" "unprognostic (3.98e-2)" "unprognostic (9.21e-2)" "unprognostic (1.75e-3)" "unprognostic (2.39e-1)" "unprognostic (3.43e-2)" "prognostic unfavorable (2.11e-4)" "unprognostic (1.24e-3)" "unprognostic (3.86e-3)" "unprognostic (1.65e-2)" "prognostic unfavorable (2.76e-5)" "unprognostic (2.49e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.09e-2)" "unprognostic (1.79e-1)" "unprognostic (7.90e-2)" "unprognostic (3.92e-2)" 7.4 6.2 6.4 10.0 6.1 89.9 6.4 10.3 8.4 8.1 5.0 16.3 10.6 5.7 2.3 37.6 6.0 3.0 6.9 5.6 4.9 5.6 4.8 9.0 16.9 4.8 5.2 8.1 8.9 2.6 3.6 15.3 5.2 4.9 16.5 4.9 9.5 1.5 4.1 20.1 13.0 9.4 4.9 12.5 11.7 55.0 4.2 43.0 4.3 2.3 24.9 4.8 13.7 5.6 167.9 199.9 164.8 113.6 16.8 28.7 87.5 237.8 139.3 257.2 195.3 134.6 158.5 65.5 91.4 151.9 156.9 220.9 188.8 101.2 240.6 118.7 206.4 135.6 263.5 123.5 4.1 71.4 109.0 7.7 12.8 145.8 146.9 56.6 146.4 100.5 114.0 132.4 241.1 144.4 66.9 98.5 66.6 216.4 84.9 69.7 205.1 86.3 115.3 123.6 151.2 118.9 225.4 121.9 82.7 112.3 149.1 127.1 91.2 168.2 146.0 140.5 345.1 43.5 127.7 80.0 74.5 162.0 265.3 34.4 0.6 2.9 0.6 0.1 0.4 1.1 1.3 1.3 2.4 0.5 1.2 0.4 0.4 3.0 0.3 2.6 8.0 1.0 6.4 6.1 10.3 8.4 5.6 4.9 4.8 5.2 5.2 4.9 4.2 5.6 2.5 0.0 3.1 1.3 6.8 16.6 6.6 8.0 2.2 6.4 3.4 4.3 3.2 0.0 7.6 3.7 0.0 45.5 2.8 16.5 0.0 3.2 41.5 4.5 4.0 4.7 5.4 142.9 5.0 2.9 68.3 7.2 16.3 6.8 8.9 13.2 9.3 2.1 21.5 3.3 5.2 17.0 10.2 8.7 15.0 15.4 3.7 5.2 3.6 1.9 5.5 3.8 4.1 2.0 1.7 2.3 3.2 1.9 17.5 5.9 2.0 0.1 3.2 4.6 6.6 7.4 10.9 136.4 74.2 38.0 14.2 14.6 6.8 0.4 24.1 6.7 VPS33B FLJ14848 ENSG00000184056 "VPS33B late endosome and lysosome associated" Q9H267 15 90998673-91022603 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA040415 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 27: Brain & Skin - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 47: Cytotrophoblasts - Unknown function" "HPA040415: AB_10795419" "unprognostic (7.49e-2)" "unprognostic (1.40e-1)" "unprognostic (1.15e-1)" "unprognostic (2.55e-2)" "unprognostic (3.06e-1)" "unprognostic (1.79e-2)" "unprognostic (2.97e-2)" "unprognostic (2.42e-2)" "unprognostic (1.30e-1)" "unprognostic (2.84e-3)" "unprognostic (2.78e-2)" "unprognostic (7.94e-2)" "unprognostic (3.70e-1)" "unprognostic (6.75e-2)" "unprognostic (6.04e-2)" "unprognostic (8.24e-2)" "unprognostic (1.00e-2)" 5.7 5.4 5.9 5.1 7.2 2.8 6.1 6.3 7.6 6.6 6.7 6.7 5.8 6.3 7.0 6.8 8.1 4.7 3.8 6.6 7.1 5.9 4.3 5.6 6.9 6.3 6.3 6.8 6.9 8.1 5.3 6.8 6.4 6.6 6.4 5.8 6.7 6.7 4.1 11.0 6.9 6.2 6.3 6.9 7.9 6.1 7.2 5.4 5.5 4.3 6.5 6.1 6.4 7.7 5.6 16.4 3.4 6.0 8.9 15.1 17.7 6.8 12.7 10.7 10.9 7.0 11.0 7.1 9.4 11.9 9.6 10.0 4.7 10.3 5.6 3.8 4.9 7.7 6.6 10.3 10.9 9.6 10.3 17.0 10.7 8.0 9.5 9.3 15.2 8.6 12.6 1.7 7.9 11.9 6.5 6.8 8.3 14.8 5.8 4.9 8.9 8.7 12.2 12.3 5.2 9.6 10.0 7.9 17.5 8.1 8.1 12.6 10.4 7.0 7.8 5.0 5.2 3.6 12.9 2.7 14.7 9.3 6.4 12.5 7.1 12.1 7.7 11.8 8.9 5.6 6.8 6.9 9.5 7.8 7.8 11.0 3.2 7.9 13.4 4.7 5.9 6.4 5.9 7.2 6.3 7.6 6.6 7.1 6.3 6.3 6.4 6.3 7.2 7.7 2.2 0.0 7.3 5.5 5.3 2.2 3.0 3.5 1.8 9.2 2.6 1.8 4.8 2.8 4.4 3.7 2.1 16.8 5.0 6.9 5.9 9.0 3.1 3.0 2.7 4.7 2.4 5.7 11.4 9.4 10.8 2.9 7.7 2.9 8.2 6.7 5.7 4.9 8.0 8.4 11.3 5.1 4.1 6.0 4.1 4.0 3.7 4.5 8.8 3.7 7.7 6.3 3.1 7.5 9.7 9.3 5.0 5.3 4.9 4.1 7.9 4.3 7.9 7.0 6.6 2.7 3.5 11.0 8.2 2.3 2.6 12.3 5.0 3.6 4.3 3.0 SV2B "HsT19680, KIAA0735" ENSG00000185518 "Synaptic vesicle glycoprotein 2B" Q7L1I2 15 91099950-91302565 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 24 "brain: 34.5;retina: 56.3" "Group enriched" "Detected in some" 5 "Bipolar cells: 137.1;Cone photoreceptor cells: 150.1;Excitatory neurons: 455.0;Rod photoreceptor cells: 139.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "RPMI-8226: 2.1;SCLC-21H: 3.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046247 Approved NA NA "Cluster 58: Brain - Synaptic function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA046247: AB_10963538" "unprognostic (2.92e-1)" "unprognostic (7.92e-2)" "unprognostic (1.32e-3)" "unprognostic (4.01e-5)" "unprognostic (2.66e-3)" "unprognostic (7.77e-2)" "unprognostic (3.36e-2)" "unprognostic (1.01e-1)" "unprognostic (3.57e-2)" "unprognostic (9.89e-2)" "unprognostic (1.20e-2)" "unprognostic (2.49e-1)" "unprognostic (1.39e-1)" "unprognostic (3.88e-2)" "unprognostic (1.66e-1)" "unprognostic (1.11e-2)" "unprognostic (3.10e-4)" 1.8 1.1 17.2 0.2 17.5 0.1 0.8 7.3 34.5 0.1 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.2 0.8 22.4 0.0 0.3 0.1 0.2 0.4 8.5 0.0 0.0 1.4 0.1 1.0 0.2 10.7 0.8 0.3 56.3 1.0 0.1 0.6 0.2 0.4 0.2 0.0 0.2 0.3 0.8 1.4 0.6 0.2 1.0 1.2 0.1 0.1 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 17.2 17.5 7.3 34.5 22.4 0.0 8.5 0.0 10.7 0.0 1.4 14.8 10.9 0.0 0.0 7.2 0.1 0.4 0.1 0.1 0.0 137.1 0.2 0.5 3.0 1.5 0.0 0.0 150.1 0.0 0.0 0.0 0.0 4.2 6.4 0.0 0.0 3.3 0.0 0.0 455.0 5.0 0.0 0.9 0.0 0.0 0.0 0.0 1.1 0.0 0.1 3.3 11.4 0.0 0.0 0.0 0.4 2.0 0.0 0.2 0.0 27.2 0.0 43.4 0.0 5.5 39.4 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 139.0 0.0 0.5 0.2 8.0 0.4 0.1 0.1 0.0 0.1 0.1 0.0 0.2 SLCO3A1 "OATP-D, OATP3A1, SLC21A11" ENSG00000176463 "Solute carrier organic anion transporter family member 3A1" Q9UIG8 15 91853708-92172435 "Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 39.5" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 625.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 63.1;HaCaT: 95.5;HMC-1: 55.3;RPMI-8226: 44.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066327 Approved NA NA "Cluster 10: Basophils - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "HPA066327: AB_2732743" "unprognostic (1.05e-3)" "prognostic favorable (8.61e-4)" "unprognostic (5.40e-2)" "prognostic unfavorable (6.57e-6)" "unprognostic (1.03e-1)" "unprognostic (7.39e-2)" "unprognostic (2.16e-1)" "unprognostic (1.57e-1)" "unprognostic (2.52e-1)" "unprognostic (1.84e-1)" "unprognostic (1.42e-2)" "unprognostic (1.49e-2)" "unprognostic (2.64e-2)" "unprognostic (3.06e-2)" "unprognostic (1.86e-1)" "unprognostic (7.17e-2)" "unprognostic (1.62e-2)" 11.7 6.2 19.3 6.8 29.5 9.6 8.6 33.7 23.0 8.4 24.1 4.0 1.8 5.3 3.3 10.6 6.9 6.3 26.4 20.3 20.2 10.6 2.9 13.8 6.3 30.2 29.6 4.2 3.0 15.7 6.7 1.0 27.8 4.3 3.4 1.5 4.7 6.2 5.8 15.7 4.2 5.0 22.5 11.1 4.6 17.9 26.1 2.6 10.6 9.6 6.2 8.6 10.8 39.5 10.1 12.3 13.9 0.2 20.9 12.6 0.2 4.0 3.4 1.6 0.4 0.0 63.1 12.1 5.3 1.3 9.1 95.5 2.7 6.3 0.2 8.8 0.4 27.8 20.9 0.0 0.9 0.6 55.3 5.7 6.7 2.9 7.3 5.4 0.0 3.6 0.0 0.1 0.0 1.8 0.0 5.1 3.7 0.2 1.7 0.0 1.1 44.0 13.4 10.0 2.0 3.3 10.5 0.9 0.1 2.0 0.1 8.5 0.0 3.3 4.7 0.0 10.3 25.5 16.0 11.7 4.2 16.9 6.0 4.3 2.4 6.9 1.4 2.0 1.1 0.2 1.5 1.7 1.6 0.0 0.5 0.6 7.5 0.3 1.7 0.0 2.7 0.6 19.3 29.5 33.7 23.0 20.3 20.2 30.2 29.6 27.8 22.5 26.1 39.5 53.5 48.1 32.0 17.0 4.3 39.0 29.3 14.2 22.8 28.1 3.1 13.0 44.0 24.3 16.4 51.5 4.2 0.0 33.1 6.2 1.9 26.6 105.6 15.8 29.0 26.2 37.8 6.1 89.5 8.7 0.1 22.9 0.5 36.2 22.8 94.9 34.6 0.8 4.6 0.0 149.4 7.2 8.2 24.7 95.2 38.5 5.0 34.0 10.6 56.2 43.6 5.2 25.7 20.6 625.8 8.4 11.1 3.0 17.3 41.5 0.0 0.4 22.1 3.1 39.5 17.4 62.0 69.5 11.9 22.6 60.1 0.0 23.3 0.8 7.9 38.2 ST8SIA2 "HsT19690, SIAT8B, ST8SIA-II, STX" ENSG00000140557 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2" Q92186 15 92393881-92468728 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.4;heart muscle: 3.9" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 2.9;Cardiomyocytes: 4.3;Inhibitory neurons: 3.5;Muller glia cells: 2.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 25.8;LHCN-M2: 7.7;RH-30: 11.7;RPMI-8226: 8.9;SH-SY5Y: 5.0;WM-115: 7.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA054518, HPA057819" Approved Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 12: NES - Nervous system development" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA054518: AB_2682514, HPA057819: " "unprognostic (4.70e-2)" "unprognostic (2.48e-2)" "unprognostic (1.26e-1)" "unprognostic (9.32e-3)" "unprognostic (1.03e-1)" "unprognostic (2.87e-2)" "unprognostic (2.32e-1)" "unprognostic (1.28e-5)" "unprognostic (3.91e-2)" "unprognostic (5.39e-3)" "unprognostic (1.59e-2)" "unprognostic (4.44e-3)" "unprognostic (4.78e-2)" "unprognostic (2.29e-1)" "unprognostic (3.16e-1)" "unprognostic (3.00e-1)" 0.0 0.3 0.6 0.0 0.6 0.0 0.4 0.6 2.2 0.8 0.0 0.1 0.0 0.4 0.8 0.0 0.0 0.2 3.9 1.5 1.2 0.1 0.0 0.0 0.0 8.4 1.9 0.0 0.0 0.0 0.2 0.0 8.2 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.4 1.8 0.0 0.5 0.3 0.0 0.0 0.1 0.0 0.2 25.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 2.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.2 0.0 4.1 0.0 0.0 0.0 11.7 8.9 0.0 0.0 0.6 5.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 4.2 0.3 0.0 0.2 0.9 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.6 2.2 1.5 1.2 8.4 1.9 8.2 0.1 0.4 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 2.9 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.6 0.1 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.4 0.1 0.3 0.0 0.0 1.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 FAM174B "LOC400451, MGC102891" ENSG00000185442 "Family with sequence similarity 174 member B" Q3ZCQ3 15 92617448-92809884 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 76.6" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 105.8;Intestinal goblet cells: 60.9;Late spermatids: 57.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "T-reg: 8.9" "Group enriched" "Detected in many" 7 "dendritic cells: 3.5;granulocytes: 2.9;T-cells: 8.9" "Cell line enhanced" "Detected in many" "CACO-2: 74.3;MCF7: 91.8;OE19: 76.3;RPMI-8226: 109.6;RT4: 221.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015306 Approved Approved "Intermediate filaments" No No "Cluster 4: T-regs - Cell cycle regulation" "Cluster 25: Pancreas - Digestion" "Cluster 15: RT4 - Unknown function" "Cluster 27: Mucus-secreting cells - Mucin production" "Intermediate filaments" "HPA015306: AB_2669182" "unprognostic (3.00e-3)" "unprognostic (1.80e-1)" "unprognostic (1.50e-1)" "prognostic favorable (9.03e-5)" "unprognostic (4.68e-2)" "unprognostic (1.63e-1)" "unprognostic (8.35e-2)" "unprognostic (8.23e-3)" "unprognostic (7.67e-3)" "unprognostic (5.05e-3)" "unprognostic (6.60e-2)" "unprognostic (1.33e-1)" "unprognostic (4.67e-2)" "unprognostic (2.01e-1)" "unprognostic (6.64e-2)" "unprognostic (1.61e-2)" "unprognostic (2.35e-2)" 5.6 5.6 13.8 5.9 13.2 1.1 27.2 9.7 14.6 16.9 9.1 10.7 6.3 8.2 7.2 8.4 24.0 6.1 10.5 13.9 14.5 5.3 6.9 21.0 8.5 14.0 16.0 16.2 76.6 2.9 26.5 6.7 14.6 32.2 15.2 6.4 52.5 16.2 16.2 8.4 8.5 4.9 7.8 4.0 35.0 17.9 14.9 8.0 37.2 15.9 7.4 26.3 6.6 19.5 0.3 12.2 8.0 2.4 0.0 0.2 1.0 4.6 21.8 0.2 0.0 74.3 8.6 1.2 20.6 0.6 5.8 0.4 13.9 0.5 0.0 0.5 6.5 0.7 1.4 1.0 1.3 1.1 3.2 1.0 0.3 0.2 0.2 0.5 10.5 6.8 1.2 54.7 12.2 91.8 2.7 0.1 39.2 76.3 0.0 8.9 22.5 109.6 5.4 221.3 4.9 3.9 6.4 42.7 14.3 22.7 33.8 7.9 0.0 0.0 1.6 0.3 10.3 1.7 17.2 2.6 0.2 0.8 5.3 0.9 0.6 0.8 0.1 0.7 0.2 0.3 1.8 0.0 0.5 0.3 2.0 2.6 2.9 0.7 0.0 3.5 8.9 0.6 13.8 13.2 9.7 14.6 13.9 14.5 14.0 16.0 14.6 7.8 14.9 19.5 8.5 105.8 22.2 13.7 1.7 2.3 14.7 1.7 5.7 7.0 26.3 11.3 5.2 5.7 12.6 7.3 8.4 1.4 2.3 3.7 7.9 5.5 22.6 17.8 4.2 10.3 42.1 0.8 24.0 14.6 21.2 4.9 19.4 23.4 18.4 1.3 22.1 7.0 5.4 11.8 24.4 60.9 24.4 3.8 4.8 57.8 5.9 4.9 12.4 22.5 0.4 3.9 0.0 17.1 44.8 19.1 1.6 1.9 6.6 24.2 3.0 1.5 14.5 3.7 0.0 7.7 3.7 1.0 5.0 3.9 3.0 0.7 3.4 1.8 5.5 24.3 AC013394.1 ENSG00000279765 "Novel protein" 15 92883413-92949230 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "bone marrow: 383.8" "Cell type enhanced" "Detected in many" "Breast glandular cells: 18.5;Breast myoepithelial cells: 17.1;dendritic cells: 13.0;Endometrial ciliated cells: 25.9;Endometrial stromal cells: 20.7;Glandular and luminal cells: 35.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 7: Non-specific - Mitochondria" "unprognostic (7.26e-3)" "unprognostic (1.34e-1)" "unprognostic (1.53e-3)" "unprognostic (1.42e-1)" "unprognostic (2.84e-2)" "unprognostic (8.97e-2)" "unprognostic (4.62e-2)" "unprognostic (9.34e-2)" "unprognostic (7.20e-2)" "unprognostic (3.69e-2)" "unprognostic (4.12e-2)" "unprognostic (2.33e-2)" "unprognostic (1.46e-6)" "unprognostic (2.74e-1)" "unprognostic (3.13e-1)" "unprognostic (2.94e-2)" "unprognostic (3.12e-2)" 34.6 43.5 56.0 36.4 63.4 383.8 82.9 62.5 79.9 49.6 56.2 47.9 35.7 50.9 47.6 40.9 45.2 47.5 37.1 53.0 57.0 56.5 44.8 68.4 65.3 62.7 58.6 60.3 40.4 41.1 0.5 55.4 61.1 56.4 53.0 68.1 50.9 44.9 27.7 47.9 38.9 39.2 60.2 58.4 40.5 36.2 57.0 68.3 93.9 36.4 58.0 42.3 0.2 75.2 31.1 23.9 88.6 57.1 27.0 35.0 64.8 30.1 53.6 47.0 35.1 24.5 70.6 32.8 29.3 39.0 35.6 47.2 37.7 30.8 46.9 0.2 37.0 57.7 48.6 23.6 56.0 30.9 36.8 37.5 44.6 17.4 88.5 68.2 45.0 43.0 60.4 92.5 52.5 33.2 36.3 47.6 77.4 68.2 20.1 50.8 44.5 71.0 66.5 59.3 46.9 53.4 64.4 46.0 115.0 82.6 106.4 69.5 31.5 35.0 27.0 27.4 66.7 67.1 86.0 70.9 27.2 58.5 41.2 10.0 0.9 2.9 2.2 0.7 2.4 4.7 2.5 2.6 0.9 2.8 3.2 2.6 5.7 2.7 1.4 3.0 3.1 0.6 56.0 63.4 62.5 79.9 53.0 57.0 62.7 58.6 61.1 60.2 57.0 75.2 6.9 6.4 11.2 0.0 3.9 0.0 0.0 0.0 0.0 0.0 18.5 17.1 0.0 0.0 3.7 1.8 0.0 2.1 13.0 0.0 3.9 1.2 0.0 25.9 20.7 3.5 0.0 0.0 0.0 1.4 2.3 3.8 0.0 35.4 3.8 12.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 2.0 3.6 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 3.0 8.0 8.4 0.0 0.0 CHD2 "DKFZp547I1315, DKFZp686E01200, DKFZp781D1727, FLJ38614" ENSG00000173575 "Chromodomain helicase DNA binding protein 2" O14647 15 92900189-93027996 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Myogenesis, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060744, HPA060960" Enhanced Enhanced Nucleoplasm NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 2: Karpas-707 - Immune response" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA060744: AB_2684353, HPA060960: AB_2684398" "unprognostic (1.65e-2)" "unprognostic (2.43e-1)" "unprognostic (2.14e-2)" "unprognostic (5.98e-2)" "unprognostic (2.12e-2)" "unprognostic (3.10e-2)" "unprognostic (2.67e-2)" "unprognostic (7.85e-2)" "unprognostic (7.51e-3)" "unprognostic (1.14e-1)" "unprognostic (2.84e-1)" "unprognostic (1.79e-2)" "unprognostic (4.64e-2)" "unprognostic (1.16e-1)" "unprognostic (1.58e-1)" "unprognostic (3.15e-1)" "unprognostic (1.70e-2)" 13.9 12.3 22.7 20.7 25.5 73.5 20.4 42.0 32.7 15.7 32.0 15.2 14.8 19.4 29.1 14.6 16.2 15.6 12.0 21.3 24.7 16.9 15.4 21.6 26.4 29.0 23.3 26.1 19.6 18.2 16.6 20.5 24.5 20.4 14.8 30.8 21.2 13.4 17.4 18.8 18.7 13.3 22.1 23.3 17.7 20.8 25.9 27.0 26.3 14.7 25.4 13.7 16.1 27.6 21.3 11.6 30.6 13.6 17.9 45.3 23.0 19.4 20.0 13.0 16.1 14.5 27.4 5.2 16.1 17.3 22.1 31.1 17.6 19.5 18.0 0.1 10.6 25.3 26.1 12.9 24.6 27.1 19.0 28.7 23.0 15.5 31.1 26.8 22.4 36.7 26.8 57.1 19.9 13.1 14.2 14.0 19.5 10.5 12.6 19.9 27.6 28.4 13.3 28.5 16.8 18.1 34.2 12.3 25.9 30.6 14.1 22.6 36.2 10.7 13.9 9.3 12.8 53.4 23.2 21.6 15.9 15.9 9.4 35.9 10.8 27.7 22.1 6.6 21.8 48.7 21.5 20.5 7.4 39.6 30.1 22.1 53.7 20.6 13.4 27.9 24.9 10.9 22.7 25.5 42.0 32.7 21.3 24.7 29.0 23.3 24.5 22.1 25.9 27.6 59.3 70.5 176.3 182.2 137.8 164.3 112.3 102.3 153.7 71.4 62.6 46.5 42.3 37.1 137.3 46.0 91.8 30.7 116.3 59.6 3.9 36.1 56.5 96.9 61.7 58.6 59.3 65.4 161.5 38.3 28.5 64.5 96.4 189.8 99.3 70.7 25.0 34.9 24.8 57.2 146.2 54.9 91.6 55.1 297.4 39.2 34.8 89.5 96.0 119.9 50.7 34.2 48.4 140.8 155.9 64.2 61.6 37.6 133.0 110.0 39.9 11.5 93.9 82.2 32.9 52.7 64.4 15.3 14.7 125.2 180.7 60.5 153.2 42.9 51.5 143.6 RGMA RGM ENSG00000182175 "Repulsive guidance molecule BMP co-receptor a" Q96B86 15 93035273-93089204 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 126.3;skeletal muscle: 199.1" "Cell type enhanced" "Detected in many" "Astrocytes: 143.3;Leydig cells: 119.0;Peritubular cells: 116.9;Prostatic glandular cells: 61.3;Skeletal myocytes: 69.3;Squamous epithelial cells: 58.3" "Cancer enriched" "Detected in many" 6 "glioma: 26.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 50.0;BEWO: 14.6;MOLT-4: 15.5;NTERA-2: 22.2;REH: 13.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012343, HPA039880, HPA044222" Approved Approved Nucleoplasm,Cytosol "Secreted - unknown location" NA NA 2000000 "Cluster 80: Striated muscle - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm Cytosol "CAB012343: AB_777667, HPA039880: AB_2676723, HPA044222: AB_2678861" "unprognostic (3.21e-2)" "unprognostic (1.59e-1)" "unprognostic (8.85e-2)" "unprognostic (3.96e-3)" "unprognostic (5.73e-2)" "unprognostic (4.72e-3)" "unprognostic (2.53e-2)" "prognostic favorable (2.78e-4)" "unprognostic (2.19e-2)" "unprognostic (1.12e-1)" "unprognostic (2.11e-1)" "unprognostic (6.25e-2)" "unprognostic (3.59e-4)" "unprognostic (8.11e-2)" "unprognostic (2.92e-2)" "unprognostic (1.73e-1)" "unprognostic (7.98e-5)" 30.2 3.2 62.1 22.5 73.8 0.4 30.3 72.5 59.1 55.9 7.7 79.4 9.9 50.9 2.9 57.4 39.9 7.7 29.4 60.4 68.0 3.6 0.6 4.6 2.4 126.3 113.9 38.5 11.4 0.8 6.9 1.3 70.4 12.8 6.2 1.0 24.2 6.4 199.1 17.1 42.9 60.6 91.5 1.3 73.6 33.5 120.6 2.6 10.0 45.0 3.4 10.0 29.2 62.8 2.1 0.3 50.0 0.8 10.3 5.7 14.6 0.3 0.0 0.0 0.0 0.6 0.6 0.1 0.2 0.4 0.0 3.4 8.4 0.2 0.0 0.0 9.2 0.1 0.3 0.0 0.0 0.1 0.2 6.1 0.2 0.0 0.0 0.3 0.0 0.9 0.0 0.1 0.0 1.0 15.5 0.2 22.2 0.1 0.0 13.1 11.4 0.1 0.0 0.5 5.1 3.0 0.5 0.2 0.0 2.6 4.0 2.7 0.0 0.1 10.4 0.3 0.1 0.1 0.0 0.2 0.2 0.2 1.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 62.1 73.8 72.5 59.1 60.4 68.0 126.3 113.9 70.4 91.5 120.6 62.8 4.2 0.0 1.5 143.3 0.5 5.5 20.4 10.2 40.5 1.9 7.5 4.4 4.4 0.0 3.9 0.0 2.1 4.4 0.5 0.3 0.0 6.5 1.2 0.6 10.9 2.7 0.0 0.4 16.8 0.7 1.2 40.5 1.5 2.3 0.0 0.6 1.8 0.3 2.1 0.0 2.8 0.0 12.2 2.5 2.3 6.4 119.0 1.6 3.6 9.4 0.6 4.5 0.0 11.1 1.6 0.4 0.0 116.9 0.1 61.3 0.0 0.1 1.3 1.2 13.1 69.3 20.3 0.9 43.8 58.3 2.8 2.5 1.4 0.1 0.1 29.2 MCTP2 "FLJ11175, FLJ33303" ENSG00000140563 "Multiple C2 and transmembrane domain containing 2" Q6DN12 15 94231538-94483952 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "dendritic cells: 72.8;NK-cells: 97.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 6.8" "Immune cell enhanced" "Detected in many" "neutrophil: 32.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 20.8;HMC-1: 16.4;U-698: 22.4;U-87 MG: 24.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA051176, HPA070541" Uncertain Enhanced Nucleoplasm,Cytosol NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoplasm, Cytosol" "HPA051176: AB_2681373, HPA070541: AB_2686277" "unprognostic (1.70e-2)" "unprognostic (4.32e-2)" "unprognostic (5.63e-2)" "unprognostic (7.15e-4)" "unprognostic (3.57e-2)" "unprognostic (2.66e-3)" "unprognostic (3.45e-2)" "unprognostic (3.68e-3)" "unprognostic (2.83e-1)" "unprognostic (1.45e-1)" "unprognostic (2.97e-1)" "unprognostic (1.80e-1)" "prognostic unfavorable (2.18e-5)" "unprognostic (5.87e-2)" "unprognostic (4.36e-1)" "unprognostic (1.76e-3)" "unprognostic (9.41e-2)" 4.1 3.8 1.0 6.6 1.8 18.0 2.9 0.0 6.8 5.4 0.8 10.6 6.9 1.8 8.6 3.9 4.1 4.5 0.6 1.1 2.8 2.3 1.5 8.7 6.1 0.0 0.3 1.6 5.7 3.5 7.3 19.3 1.0 5.4 12.2 2.6 5.9 4.1 0.1 3.6 6.4 1.6 0.0 21.1 4.7 1.0 1.3 3.0 5.5 0.4 6.2 6.6 3.7 0.6 3.6 0.0 0.1 0.0 0.0 0.0 2.5 1.9 1.1 0.3 0.1 2.4 4.4 10.3 0.5 0.1 0.1 8.0 0.1 6.6 0.0 2.1 0.8 20.8 2.9 1.2 1.4 4.4 16.4 1.1 7.8 0.1 8.2 0.0 0.0 3.6 0.8 5.9 0.0 0.0 2.0 11.4 0.8 3.6 3.7 4.7 0.1 4.0 0.5 10.7 1.9 0.4 0.2 3.4 1.3 0.8 0.0 0.3 0.2 0.1 1.7 0.0 0.0 12.0 0.3 22.4 24.1 11.1 1.2 6.6 0.8 12.1 6.1 0.2 3.0 3.5 1.7 2.8 0.0 3.6 0.7 2.7 32.1 10.9 0.9 0.3 0.1 1.9 1.0 1.8 0.0 6.8 1.1 2.8 0.0 0.3 1.0 0.0 1.3 0.6 1.1 3.2 18.6 1.0 38.9 4.2 12.9 8.6 22.8 15.6 3.8 4.3 1.1 7.2 13.2 3.7 0.0 17.0 72.8 39.4 0.0 3.4 4.0 6.5 3.4 1.8 15.6 35.7 15.6 4.7 7.3 7.8 5.6 6.6 36.2 0.3 1.4 1.4 9.6 0.0 10.3 43.8 8.2 8.7 2.1 4.8 0.3 11.1 1.8 25.3 4.7 0.1 97.9 0.0 0.7 4.2 24.6 0.0 45.8 14.2 18.1 1.9 8.7 0.6 0.0 2.5 1.6 3.4 2.5 15.0 2.3 24.5 26.6 0.5 21.5 19.6 NR2F2 "ARP1, COUP-TFII, COUPTF2, COUPTFB, NF-E3, SVP40, TFCOUP2" ENSG00000185551 "Nuclear receptor subfamily 2 group F member 2" P24468 15 96325938-96340263 "Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 292.4" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 542.2;Hepatic stellate cells: 395.5;Leydig cells: 510.4;Peritubular cells: 610.5;Sertoli cells: 486.4;Smooth muscle cells: 385.7;Theca cells: 572.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058974 Approved Nucleoplasm,Cytosol NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 48: Smooth muscle cells - ECM organization" Nucleoplasm Cytosol "HPA058974: AB_2732629" "unprognostic (9.28e-2)" "unprognostic (2.52e-2)" "unprognostic (2.34e-1)" "unprognostic (1.42e-2)" "unprognostic (8.96e-2)" "unprognostic (5.44e-2)" "unprognostic (3.38e-1)" "unprognostic (1.14e-1)" "unprognostic (2.61e-1)" "unprognostic (1.87e-1)" "unprognostic (1.89e-1)" "unprognostic (9.19e-2)" "unprognostic (5.14e-2)" "unprognostic (5.96e-2)" "unprognostic (1.72e-2)" "unprognostic (7.47e-2)" "unprognostic (1.28e-2)" 95.5 43.1 32.7 18.8 19.2 0.1 59.7 15.0 19.6 128.6 23.5 52.6 21.5 120.9 61.8 22.1 101.5 65.7 44.4 20.0 24.8 79.8 32.1 56.8 42.4 16.2 21.9 292.4 20.0 30.7 20.3 74.7 18.2 60.6 26.7 2.5 22.9 126.4 33.1 24.1 32.1 81.8 12.5 106.2 82.3 26.7 49.3 7.8 46.2 31.5 15.1 46.3 74.5 10.7 154.7 39.1 125.6 78.5 249.1 85.5 41.9 109.1 83.2 111.1 94.3 134.8 153.4 0.1 86.8 55.2 44.1 90.4 22.3 78.3 138.8 0.5 86.5 49.9 48.7 24.6 69.5 38.7 18.0 61.3 26.5 92.5 19.8 130.5 207.3 0.1 135.3 0.4 71.2 105.5 0.1 27.6 1.2 59.6 52.7 0.1 30.9 0.2 244.7 165.7 15.8 0.2 12.3 3.7 17.5 55.0 61.1 2.8 215.3 119.9 39.7 28.3 38.8 0.1 0.4 0.4 67.0 18.9 85.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.7 19.2 15.0 19.6 20.0 24.8 16.2 21.9 18.2 12.5 49.3 10.7 133.4 28.9 18.1 0.7 1.1 14.4 24.9 71.7 39.3 7.5 51.9 50.8 46.4 203.0 34.6 62.5 25.0 126.2 2.0 35.7 46.9 22.0 3.2 70.9 542.2 166.1 26.4 5.3 0.1 10.9 50.3 125.8 80.0 68.9 0.0 41.5 395.5 51.6 10.3 3.3 24.8 35.5 32.6 12.2 20.1 22.9 510.4 5.0 26.6 36.5 0.6 30.2 0.0 0.0 0.5 15.6 23.9 610.5 2.8 22.3 14.3 65.5 37.3 13.8 486.4 27.8 385.7 6.4 7.9 20.5 10.4 35.3 5.8 572.5 27.1 21.3 ARRDC4 FLJ36045 ENSG00000140450 "Arrestin domain containing 4" Q8NCT1 15 97960703-97973833 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 82.8" "Cell type enhanced" "Detected in many" "Distal enterocytes: 105.7;Paneth cells: 82.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 1.1;classical monocyte: 2.5;eosinophil: 1.5;intermediate monocyte: 1.7;myeloid DC: 1.1;neutrophil: 1.4" "Group enriched" "Detected in many" 8 "dendritic cells: 1.1;granulocytes: 1.5;monocytes: 2.5" "Cell line enhanced" "Detected in many" "BJ: 103.2;HSkMC: 55.8;hTCEpi: 86.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039934, HPA042109" Approved Supported "Vesicles,Plasma membrane" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 70: Brain - Nervous system development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane" Vesicles "HPA039934: , HPA042109: AB_10795606" "unprognostic (2.13e-1)" "unprognostic (1.10e-1)" "unprognostic (2.32e-1)" "unprognostic (5.60e-3)" "unprognostic (4.49e-3)" "unprognostic (8.23e-2)" "unprognostic (1.16e-2)" "unprognostic (2.78e-1)" "unprognostic (7.65e-2)" "unprognostic (1.10e-1)" "unprognostic (1.01e-2)" "unprognostic (1.42e-2)" "unprognostic (2.02e-3)" "unprognostic (2.90e-2)" "unprognostic (1.65e-1)" "unprognostic (3.04e-2)" "unprognostic (6.77e-2)" 12.5 12.2 21.6 16.5 24.6 11.5 19.8 24.1 22.4 16.2 16.9 43.9 15.8 14.6 15.6 10.0 14.5 17.2 12.1 30.5 39.1 25.1 30.2 19.8 7.5 76.6 24.1 7.3 34.7 6.3 8.9 18.3 73.9 10.9 23.0 4.5 8.1 16.4 14.8 35.5 22.6 18.1 45.9 8.0 26.9 14.7 20.5 5.7 17.3 9.6 5.1 14.9 10.8 82.8 5.8 0.2 0.8 15.0 6.6 47.7 0.0 103.2 45.8 13.5 6.0 6.2 3.6 0.0 14.2 4.8 1.2 6.0 3.7 36.0 21.6 0.0 9.6 10.1 1.9 4.1 2.6 7.0 15.2 55.8 86.9 15.4 17.9 18.8 0.7 2.9 14.4 0.0 4.9 19.2 1.2 5.8 3.0 17.4 2.1 0.1 0.9 0.2 26.3 12.7 5.0 8.8 15.7 5.7 29.5 3.1 2.1 10.6 0.1 4.0 2.9 21.2 5.0 0.0 0.0 0.2 8.7 1.2 10.6 1.1 2.5 1.5 0.0 1.7 0.0 0.2 0.0 0.0 1.1 0.1 0.0 0.0 1.4 0.0 0.2 0.2 0.0 0.4 21.6 24.6 24.1 22.4 30.5 39.1 76.6 24.1 73.9 45.9 20.5 82.8 5.7 3.2 10.4 19.9 4.0 25.4 3.1 11.0 23.9 1.6 14.4 8.3 12.9 8.6 9.4 22.0 6.2 0.3 1.4 105.7 7.9 2.7 4.5 21.5 17.6 5.9 38.3 4.4 8.1 8.2 0.2 12.3 15.8 18.0 23.5 1.4 6.4 17.1 21.5 0.0 6.0 29.5 10.2 23.9 10.5 10.9 5.0 19.7 24.9 3.7 13.4 0.7 3.1 38.7 3.4 12.0 82.4 8.2 0.2 12.2 30.2 3.1 15.6 3.5 0.0 7.8 12.5 2.0 12.6 11.8 31.1 0.7 1.3 17.5 31.3 12.2 IGF1R "CD221, IGFIR, IGFR, JTK13, MGC18216" ENSG00000140443 "Insulin like growth factor 1 receptor" P08069 15 98648539-98964530 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Host-virus interaction" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 239.4;Inhibitory neurons: 194.6;Microglial cells: 245.4;Oligodendrocyte precursor cells: 237.7;Oligodendrocytes: 261.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "neutrophil: 4.3" "Group enriched" "Detected in many" 6 "granulocytes: 4.3;T-cells: 1.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010268, HPA045563" Approved NA NA 46000 "Cluster 50: Neutrophils - Cellular senescence" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 20: HeLa - Mitochondria" "Cluster 40: Granulosa cells - Unknown function" "CAB010268: AB_671792, HPA045563: AB_2679368" "unprognostic (1.30e-3)" "unprognostic (5.81e-3)" "unprognostic (1.53e-1)" "unprognostic (3.34e-2)" "unprognostic (2.65e-1)" "unprognostic (2.05e-2)" "unprognostic (1.29e-2)" "unprognostic (6.87e-2)" "unprognostic (2.64e-2)" "unprognostic (2.87e-2)" "unprognostic (8.56e-2)" "unprognostic (1.62e-1)" "prognostic favorable (3.75e-7)" "unprognostic (1.57e-1)" "unprognostic (3.59e-1)" "unprognostic (1.41e-1)" "unprognostic (1.06e-1)" 7.3 11.3 10.1 3.6 11.2 11.0 12.2 12.0 12.0 10.1 35.5 12.5 2.5 11.0 11.1 7.5 13.0 4.5 9.6 9.5 8.2 11.6 0.9 9.5 2.7 12.4 13.4 15.8 15.4 2.1 8.8 12.1 11.2 14.7 4.5 16.0 10.0 9.6 7.0 11.1 6.5 6.1 10.3 5.8 9.6 8.4 13.2 6.1 12.9 11.6 3.4 9.9 10.0 11.1 6.1 34.0 22.6 0.2 11.9 8.3 16.3 8.0 14.5 2.5 2.2 15.6 17.5 1.6 22.1 13.8 14.7 31.6 10.9 25.0 1.9 0.1 11.1 27.5 32.3 31.2 10.4 11.1 2.5 12.1 14.9 4.5 18.6 9.3 8.4 2.8 1.4 5.4 9.9 48.1 5.4 9.8 23.0 11.8 1.3 7.7 19.3 6.7 7.4 37.8 8.1 35.9 56.0 3.3 30.1 50.2 16.7 3.8 24.5 1.5 26.5 6.5 12.0 1.9 9.8 5.9 4.6 10.0 5.9 1.9 0.3 0.9 0.4 0.2 0.2 0.1 0.3 0.1 0.1 0.4 1.4 0.4 4.3 0.5 0.3 0.1 0.0 0.3 10.1 11.2 12.0 12.0 9.5 8.2 12.4 13.4 11.2 10.3 13.2 11.1 30.8 28.9 13.4 157.7 3.5 32.8 28.8 31.1 35.3 51.5 58.3 33.4 30.8 5.7 30.2 22.0 91.8 33.7 8.0 10.7 1.9 16.6 27.6 79.7 39.6 26.1 35.0 7.8 239.4 11.2 20.3 25.2 11.2 91.3 0.0 106.5 52.5 1.5 6.5 75.7 194.6 21.1 20.3 6.6 8.3 53.4 18.0 8.3 21.4 245.4 8.5 45.6 14.4 237.7 261.0 29.1 12.9 13.5 4.3 70.9 5.3 21.8 55.4 36.1 0.0 20.4 27.6 4.0 17.2 17.9 32.0 27.5 6.4 20.9 24.5 51.5 PGPEP1L ENSG00000183571 "Pyroglutamyl-peptidase I like" A6NFU8 15 98968229-99007792 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "skeletal muscle: 30.9" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 2.1;Distal tubular cells: 1.9;Early spermatids: 3.8;Excitatory neurons: 3.8;Inhibitory neurons: 3.3;Late spermatids: 1.7;Skeletal myocytes: 2.1;Spermatocytes: 2.7;Spermatogonia: 2.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA041781 Uncertain NA NA "Cluster 46: Basophils - DNA binding" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 37: Myocytes - Muscle contraction" "HPA041781: AB_10795642" "unprognostic (2.48e-1)" "unprognostic (2.82e-2)" "unprognostic (8.26e-2)" "unprognostic (2.43e-3)" "unprognostic (7.18e-2)" "unprognostic (3.99e-2)" "unprognostic (1.69e-1)" "unprognostic (5.44e-2)" "unprognostic (9.78e-2)" "unprognostic (1.58e-1)" "unprognostic (4.53e-3)" "unprognostic (1.86e-1)" "unprognostic (2.62e-1)" "unprognostic (2.00e-2)" "unprognostic (1.65e-1)" 0.2 0.1 0.7 0.2 0.9 0.1 0.4 0.0 1.1 0.2 0.0 0.5 0.2 0.2 0.0 0.8 0.1 0.5 3.8 0.5 0.4 0.4 0.0 0.2 0.3 0.2 0.3 0.1 0.5 0.0 0.1 0.2 0.1 0.5 0.0 0.1 0.6 0.5 30.9 0.1 0.1 0.1 0.0 0.0 0.2 2.0 0.4 0.1 0.1 7.5 0.0 0.3 0.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 1.1 0.5 0.4 0.2 0.3 0.1 0.0 0.4 1.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.4 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 3.8 0.1 0.1 0.0 0.0 0.0 3.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.1 0.9 2.7 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 SYNM "DMN, KIAA0353, SYN" ENSG00000182253 Synemin O15061 15 99098217-99135593 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 594.1;skeletal muscle: 624.7;urinary bladder: 406.3" "Cell type enhanced" "Detected in many" "Breast myoepithelial cells: 103.5;Cardiomyocytes: 502.5;Muller glia cells: 127.8;Smooth muscle cells: 98.5" "Cancer enhanced" "Detected in all" "prostate cancer: 28.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 36.8;HeLa: 58.0;WM-115: 124.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017192, HPA040066, HPA044200, HPA077856" Enhanced Supported "Intermediate filaments" NA NA "Cluster 13: Striated muscle - Muscle contraction" "Cluster 17: WM-115 - Nervous system development" "Cluster 54: Cardiomyocytes - Muscle contraction" "Intermediate filaments" "CAB017192: , HPA040066: AB_2676830, HPA044200: AB_2678854, HPA077856: AB_2686861" "unprognostic (1.04e-2)" "unprognostic (1.37e-1)" "unprognostic (3.00e-2)" "unprognostic (6.10e-2)" "unprognostic (1.87e-1)" "unprognostic (1.15e-1)" "unprognostic (3.52e-2)" "unprognostic (1.10e-1)" "unprognostic (2.54e-1)" "unprognostic (1.00e-1)" "unprognostic (1.34e-2)" "unprognostic (6.75e-2)" "unprognostic (3.54e-3)" "unprognostic (2.80e-2)" "unprognostic (7.27e-2)" "unprognostic (5.92e-3)" "unprognostic (3.26e-3)" 37.2 20.3 51.4 26.5 66.0 0.4 56.7 70.1 58.2 11.8 52.5 594.1 27.1 50.8 12.7 169.6 36.5 19.2 144.2 44.4 75.4 6.9 4.8 23.1 4.2 81.7 66.6 14.1 6.3 8.2 23.2 14.0 81.6 150.6 52.0 40.3 25.6 291.3 624.7 17.0 105.7 160.9 71.6 2.9 158.4 5.2 69.3 3.7 11.2 277.1 4.0 406.3 41.0 79.8 6.6 36.8 8.1 21.9 15.9 0.9 0.5 3.7 5.3 2.1 1.3 5.4 4.9 0.0 5.3 5.3 17.7 4.2 5.5 0.1 1.6 0.5 9.0 0.1 58.0 5.4 9.0 0.0 1.0 0.9 0.3 3.7 0.8 6.0 4.3 0.0 0.2 7.4 5.5 3.7 0.7 0.8 7.2 0.7 11.4 0.0 7.5 5.5 2.1 3.6 3.6 4.2 21.9 3.4 13.5 12.7 0.2 3.6 4.8 4.1 0.4 2.9 8.9 0.1 1.0 0.0 0.4 0.0 124.5 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.3 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 51.4 66.0 70.1 58.2 44.4 75.4 81.7 66.6 81.6 71.6 69.3 79.8 14.8 0.0 1.7 15.3 0.9 2.3 0.7 0.9 2.8 12.6 32.7 103.5 502.5 0.0 1.2 0.0 16.7 1.5 6.6 2.1 0.0 0.5 9.5 1.3 1.0 24.2 3.0 0.0 15.6 1.3 0.7 20.3 5.1 4.2 0.0 1.1 3.6 1.3 0.3 42.1 9.8 0.9 0.0 0.0 5.1 4.5 1.2 2.0 5.4 12.2 0.6 127.8 1.0 2.5 14.0 0.2 2.3 4.1 5.4 2.0 0.6 0.3 3.1 10.2 32.9 19.6 98.5 7.9 11.5 2.1 3.7 0.4 5.9 0.2 0.7 0.9 TTC23 "FLJ12572, HCC-8" ENSG00000103852 "Tetratricopeptide repeat domain 23" Q5W5X9 15 99136323-99251223 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 27.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 1.8" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039806, HPA040369" Uncertain Approved Cytosol NA NA "Cluster 34: Basophils - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 38: EFO-21 - Unknown function" "Cluster 52: Non-specific - Transcription" Cytosol "HPA039806: AB_10793921, HPA040369: AB_10795381" "prognostic favorable (3.17e-4)" "unprognostic (5.41e-2)" "unprognostic (1.45e-1)" "prognostic favorable (1.07e-4)" "unprognostic (1.40e-2)" "unprognostic (6.53e-2)" "unprognostic (9.25e-3)" "unprognostic (2.56e-1)" "unprognostic (6.18e-2)" "unprognostic (1.76e-3)" "unprognostic (1.88e-1)" "unprognostic (3.24e-1)" "unprognostic (3.21e-2)" "unprognostic (1.11e-2)" "unprognostic (4.31e-1)" "unprognostic (7.99e-2)" "unprognostic (1.23e-1)" 8.3 10.1 5.3 4.3 6.6 1.1 8.0 5.1 6.3 11.6 6.6 17.1 3.5 11.2 6.9 9.8 10.0 8.8 10.6 4.5 6.2 8.9 8.1 6.6 3.1 6.7 5.8 14.9 8.0 8.9 5.3 9.4 6.5 10.7 7.8 7.2 6.7 9.2 8.1 8.4 6.8 10.0 5.7 5.2 9.1 13.0 6.0 3.7 12.7 7.6 3.3 13.2 10.1 8.1 9.9 9.8 15.3 17.8 18.0 20.2 6.4 12.0 14.8 12.6 14.2 8.8 17.0 2.4 23.7 13.7 11.4 19.0 5.0 12.0 13.7 3.3 16.3 10.7 17.1 7.0 10.4 2.4 0.7 14.5 10.5 9.9 9.5 13.7 21.6 4.8 8.3 1.4 11.8 6.0 8.6 2.7 8.4 2.7 7.0 2.7 19.9 3.8 10.0 13.2 6.7 3.0 15.8 6.4 14.7 15.4 10.7 10.9 14.3 16.0 9.4 10.7 15.5 8.1 12.4 3.3 14.3 0.8 9.6 1.8 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.1 0.7 0.1 0.0 0.0 0.5 0.5 0.1 0.5 0.1 0.0 5.3 6.6 5.1 6.3 4.5 6.2 6.7 5.8 6.5 5.7 6.0 8.1 5.9 3.2 7.0 27.1 0.6 2.4 4.6 4.4 4.6 1.7 4.6 4.3 9.5 4.3 5.2 5.5 0.0 4.6 0.1 4.3 5.9 6.0 12.5 3.3 10.6 7.0 0.0 0.8 3.3 6.2 4.6 7.4 10.2 4.5 1.3 13.5 9.3 5.3 4.0 8.4 3.5 5.7 6.1 3.8 1.7 8.5 9.0 2.5 1.8 15.9 0.6 11.5 0.0 6.6 13.2 3.9 2.6 10.1 0.1 3.1 3.8 5.5 4.0 5.4 6.6 6.5 5.5 18.0 9.2 7.9 4.0 1.9 0.4 10.9 6.7 2.6 LRRC28 "FLJ34269, FLJ45242, MGC24976" ENSG00000168904 "Leucine rich repeat containing 28" Q86X40 15 99251362-99390729 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 47.1" "Cell type enhanced" "Detected in many" "Early spermatids: 159.2;Excitatory neurons: 127.4;Late spermatids: 406.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039378, HPA040784, HPA066130" Approved Approved "Nucleoplasm,Golgi apparatus,Mitochondria" No No "Cluster 2: Granulocytes - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 21: OE19 - Mitochondria" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm "Golgi apparatus, Mitochondria" "HPA039378: AB_2676476, HPA040784: AB_2677135, HPA066130: AB_2685623" "unprognostic (4.84e-2)" "prognostic favorable (1.41e-4)" "unprognostic (2.82e-3)" "unprognostic (9.86e-2)" "unprognostic (2.20e-1)" "unprognostic (1.47e-1)" "unprognostic (8.02e-2)" "unprognostic (1.02e-1)" "unprognostic (1.22e-1)" "prognostic favorable (9.97e-5)" "unprognostic (2.62e-1)" "unprognostic (1.21e-1)" "unprognostic (5.89e-2)" "unprognostic (8.37e-2)" "unprognostic (3.95e-1)" "unprognostic (1.65e-3)" "unprognostic (1.41e-1)" 8.1 7.8 4.4 4.4 5.1 8.6 6.4 4.5 5.8 6.1 4.3 8.0 16.9 5.8 7.4 9.7 4.8 9.1 9.7 5.3 3.9 19.4 47.1 5.3 6.9 3.7 3.5 4.9 19.5 9.4 4.1 6.1 3.5 5.3 9.7 6.8 6.1 6.6 18.3 10.4 16.5 7.9 3.3 4.9 8.2 28.5 3.9 22.6 6.6 18.4 9.4 6.5 6.3 4.4 4.0 9.8 9.5 12.3 13.2 18.7 4.0 4.2 11.9 7.1 8.3 7.4 8.6 8.2 7.6 10.1 8.7 8.8 7.0 13.5 10.3 5.0 10.2 5.5 4.0 7.7 11.7 5.5 8.6 11.1 18.2 6.7 13.4 16.0 22.7 13.0 4.9 8.1 14.9 8.0 15.2 8.9 4.0 31.2 3.7 9.3 8.0 7.6 15.1 12.8 4.3 5.5 10.1 5.4 16.4 14.4 8.4 10.2 8.3 7.0 4.8 5.4 8.4 15.9 24.1 5.1 8.8 5.4 13.3 23.4 9.3 32.0 7.2 7.8 5.8 6.2 6.7 7.7 8.4 5.8 6.2 5.4 5.0 5.1 8.0 6.9 10.4 6.1 4.4 5.1 4.5 5.8 5.3 3.9 3.7 3.5 3.5 3.3 3.9 4.4 13.2 16.0 4.1 29.0 13.5 13.8 14.5 14.5 12.5 19.9 8.9 12.4 13.4 12.8 11.0 11.0 22.9 17.5 11.4 18.6 27.4 12.7 159.2 7.4 8.4 11.9 9.1 12.4 127.4 29.5 22.6 8.5 15.8 6.5 2.5 15.0 12.8 37.0 19.3 21.9 86.8 16.0 20.3 19.8 20.1 406.4 12.8 15.3 14.2 37.5 19.1 14.4 14.4 63.3 63.0 14.8 24.2 8.6 14.7 8.4 72.3 74.1 10.1 19.8 0.0 10.7 11.7 77.1 39.0 15.1 15.8 13.0 11.3 18.0 19.5 15.4 MEF2A "RSRFC4, RSRFC9" ENSG00000068305 "Myocyte enhancer factor 2A" Q02078 15 99565417-99716466 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 262.8;Microglial cells: 708.3;Oligodendrocytes: 264.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004499, HPA046597" Approved Supported Nucleoplasm NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 38: Heart - Muscle contraction" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "CAB004499: AB_627921, HPA046597: AB_2679714" "unprognostic (1.89e-1)" "unprognostic (8.82e-2)" "unprognostic (5.91e-2)" "unprognostic (8.04e-2)" "unprognostic (8.68e-2)" "unprognostic (2.05e-1)" "unprognostic (2.25e-1)" "unprognostic (6.26e-2)" "unprognostic (1.93e-2)" "unprognostic (1.91e-2)" "unprognostic (7.08e-3)" "unprognostic (1.46e-1)" "prognostic favorable (6.93e-4)" "prognostic unfavorable (7.96e-4)" "unprognostic (4.69e-2)" "unprognostic (1.32e-1)" "unprognostic (1.69e-3)" 32.8 22.9 18.7 20.3 25.4 18.3 22.1 16.4 27.6 27.7 12.9 23.5 12.8 34.5 23.8 21.7 21.8 22.6 89.7 21.9 12.1 24.8 24.5 30.4 25.0 17.4 20.7 30.1 12.8 37.6 9.8 26.4 15.4 23.0 15.0 24.2 19.5 23.7 61.5 54.8 17.6 35.7 18.4 27.2 17.8 15.0 28.4 23.3 19.7 81.9 22.9 22.5 16.6 25.7 17.9 10.1 16.7 8.5 20.7 26.3 8.2 17.8 40.8 14.4 19.5 10.4 24.4 22.3 24.5 38.6 22.1 19.3 17.1 14.1 18.6 15.3 24.8 45.2 22.3 9.4 35.4 18.1 21.3 17.6 23.2 19.3 39.7 59.6 26.5 18.3 16.3 41.6 27.0 7.4 29.7 26.3 8.9 11.9 14.6 43.3 36.1 18.5 29.5 24.9 10.7 14.8 27.2 11.6 51.0 17.6 11.0 16.4 43.7 39.8 21.9 19.9 21.7 22.6 27.8 48.5 27.8 19.6 38.7 7.7 12.1 14.3 3.9 15.6 3.3 15.8 3.6 3.6 13.3 12.1 5.0 3.9 10.8 6.5 19.3 7.8 2.6 5.6 18.7 25.4 16.4 27.6 21.9 12.1 17.4 20.7 15.4 18.4 28.4 25.7 152.7 80.1 43.9 113.9 87.2 88.6 31.7 26.9 62.0 52.0 31.6 37.0 175.8 20.0 40.7 29.5 50.1 7.7 32.9 26.5 25.4 18.0 10.4 80.3 60.6 100.6 12.7 24.8 262.8 18.8 3.4 61.5 34.7 130.7 31.0 30.5 50.3 41.0 39.5 30.3 174.9 17.2 12.2 107.5 63.1 7.8 55.9 104.1 35.6 708.3 65.8 25.2 23.7 157.3 264.4 26.8 22.6 64.7 55.6 27.0 18.9 19.7 51.7 44.9 72.3 62.4 69.4 29.9 29.6 29.4 50.4 9.2 27.8 28.8 17.9 26.8 LYSMD4 FLJ33008 ENSG00000183060 "LysM domain containing 4" Q5XG99 15 99715697-99733561 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029152, HPA059824" Approved Approved "Actin filaments,Cytosol" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 31: Skin - Epidermis development" "Cluster 21: OE19 - Mitochondria" "Cluster 62: Horizontal cells - Visual perception" Cytosol "Actin filaments" "HPA029152: AB_10602033, HPA059824: AB_2684135" "unprognostic (2.43e-3)" "unprognostic (1.30e-2)" "unprognostic (1.53e-1)" "unprognostic (2.81e-1)" "unprognostic (4.07e-3)" "unprognostic (3.80e-2)" "unprognostic (1.53e-3)" "unprognostic (3.75e-1)" "unprognostic (1.37e-1)" "unprognostic (1.88e-1)" "unprognostic (6.35e-3)" "unprognostic (9.77e-2)" "unprognostic (1.02e-2)" "unprognostic (2.06e-1)" "unprognostic (9.23e-2)" "unprognostic (3.29e-2)" "unprognostic (3.30e-1)" 7.1 5.5 6.3 1.7 6.8 3.1 6.7 6.3 7.1 8.4 6.2 9.7 4.8 9.4 3.4 11.1 8.1 1.5 20.2 6.4 6.0 11.8 11.8 7.6 2.3 5.9 6.4 8.9 8.0 5.7 7.1 2.8 6.2 9.5 3.2 5.2 9.5 4.2 10.3 16.7 7.9 3.8 5.9 8.0 7.8 7.7 7.0 3.9 5.0 5.9 3.8 7.9 9.4 6.8 3.5 3.3 6.5 3.8 7.1 6.4 3.9 3.9 2.7 3.3 4.8 8.2 3.0 3.8 2.3 3.6 5.8 10.1 5.1 6.3 3.8 0.8 9.2 2.5 7.2 5.7 4.1 1.8 4.6 3.7 9.2 3.0 3.6 2.0 4.5 10.9 6.2 4.8 2.2 4.1 4.8 5.1 4.3 9.7 3.7 3.4 4.6 1.9 5.9 9.0 3.7 3.3 7.2 2.2 3.9 8.3 1.5 3.5 5.8 2.7 7.3 3.7 1.7 6.3 9.1 3.1 3.5 4.5 2.9 0.0 1.3 5.3 2.1 1.9 1.7 1.0 3.0 2.6 0.6 1.7 3.5 1.6 0.4 0.7 2.7 3.0 3.2 2.4 6.3 6.8 6.3 7.1 6.4 6.0 5.9 6.4 6.2 5.9 7.0 6.8 7.0 6.4 3.3 4.6 2.5 8.7 8.1 4.6 8.0 8.0 3.5 6.3 12.8 7.2 3.9 3.7 10.4 2.6 4.9 4.4 1.9 4.1 7.3 1.3 3.0 4.8 3.0 6.1 9.8 9.7 2.0 6.8 3.6 1.7 0.0 2.9 3.9 3.4 4.3 10.1 11.4 6.2 6.1 2.2 3.7 8.1 5.3 3.9 1.8 8.4 8.1 11.6 3.1 6.0 7.4 7.2 3.0 6.8 3.9 2.1 3.9 5.3 2.5 10.0 13.1 3.9 5.7 12.7 11.3 8.1 9.1 1.4 2.9 2.2 2.6 3.5 ADAMTS17 "FLJ16363, FLJ32769" ENSG00000140470 "ADAM metallopeptidase with thrombospondin type 1 motif 17" Q8TE56 15 99971437-100342005 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Deafness, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 10.7" "Group enriched" "Detected in many" 8 "Astrocytes: 116.9;Early spermatids: 108.4;Inhibitory neurons: 275.7;Late spermatids: 91.0;Oligodendrocyte precursor cells: 337.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEK 293: 6.4;JURKAT: 19.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA062487 Approved Nucleoplasm "Secreted to extracellular matrix" NA NA "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "HPA062487: AB_2684780" "unprognostic (7.73e-2)" "unprognostic (2.38e-2)" "unprognostic (1.79e-2)" "unprognostic (9.03e-3)" "unprognostic (2.56e-1)" "unprognostic (9.90e-3)" "unprognostic (5.78e-2)" "unprognostic (1.18e-3)" "unprognostic (5.03e-3)" "unprognostic (4.70e-2)" "unprognostic (2.93e-1)" "unprognostic (1.27e-1)" "unprognostic (3.35e-2)" "unprognostic (8.48e-2)" "unprognostic (1.21e-1)" "unprognostic (7.43e-3)" "unprognostic (6.43e-2)" 0.8 1.2 1.6 0.5 1.1 0.6 0.6 0.3 2.7 1.4 6.0 0.9 0.6 1.2 0.6 2.1 1.8 0.3 1.3 1.3 0.6 1.1 7.5 1.5 0.5 1.2 0.7 1.7 5.0 0.2 1.2 0.5 0.8 1.0 0.4 0.7 2.6 0.5 5.6 2.2 1.2 0.5 0.7 0.9 1.0 2.7 1.0 10.7 0.7 0.1 0.5 1.6 1.4 1.1 0.0 0.0 0.0 0.3 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 1.2 0.3 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.7 2.0 0.5 0.2 0.9 1.0 0.0 0.3 2.3 0.0 0.2 1.7 0.2 0.2 2.2 2.7 0.4 0.0 0.2 0.3 0.0 0.6 0.6 0.0 0.2 0.0 0.0 0.0 0.4 2.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 1.1 0.3 2.7 1.3 0.6 1.2 0.7 0.8 0.7 1.0 1.1 0.7 0.0 0.0 116.9 0.3 1.0 0.9 0.1 3.4 0.8 1.5 1.3 4.3 1.5 0.9 0.0 0.0 0.1 2.6 0.4 1.9 0.1 108.4 1.2 2.8 0.9 0.0 0.0 8.2 0.9 0.0 1.6 5.1 1.8 0.0 0.1 0.4 4.4 8.2 21.9 275.7 0.7 0.0 0.6 0.3 91.0 2.1 0.4 0.0 22.5 0.0 1.3 1.0 337.3 9.5 0.3 0.2 0.0 0.8 1.6 0.5 0.1 0.0 0.7 0.0 3.2 0.9 1.7 1.9 2.1 0.6 0.1 3.7 2.5 0.4 0.9 CERS3 "LASS3, MGC27091" ENSG00000154227 "Ceramide synthase 3" Q8IU89 15 100400395-100544995 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase Ichthyosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 55.1;skin 1: 64.0;vagina: 30.3" "Group enriched" "Detected in some" 5 "Basal keratinocytes: 18.9;Basal squamous epithelial cells: 39.3;Early spermatids: 23.5;Late spermatids: 17.5;Spermatocytes: 28.2;Squamous epithelial cells: 48.3;Suprabasal keratinocytes: 50.2" "Cancer enhanced" "Detected in some" "head and neck cancer: 14.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "hTCEpi: 65.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA006092, HPA024356" Approved Supported Nucleoplasm NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 61: Squamous epithelial cells - Keratinization" Nucleoplasm "HPA006092: AB_1079236, HPA024356: AB_1852721" "unprognostic (5.01e-3)" "unprognostic (3.43e-2)" "unprognostic (6.47e-4)" "unprognostic (2.35e-2)" "unprognostic (5.58e-2)" "unprognostic (1.68e-1)" "unprognostic (6.84e-3)" "unprognostic (3.23e-1)" "unprognostic (1.43e-1)" "unprognostic (2.09e-1)" "unprognostic (1.31e-5)" "unprognostic (2.65e-1)" "unprognostic (4.74e-4)" "unprognostic (1.83e-1)" "unprognostic (4.33e-2)" "unprognostic (1.78e-1)" "unprognostic (4.05e-3)" 0.1 0.0 0.1 0.0 0.2 0.2 3.3 0.3 0.2 15.1 0.0 0.0 0.0 0.0 0.5 55.1 0.7 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.4 0.0 0.1 0.6 0.0 0.1 8.4 0.1 0.6 64.0 0.1 0.0 0.0 0.1 0.1 18.3 0.2 0.4 0.1 0.0 16.0 0.3 30.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 65.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.3 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.0 1.3 0.0 18.9 5.0 3.9 39.3 0.4 0.1 0.3 0.5 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 23.5 0.2 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 2.1 17.5 0.6 0.1 0.0 0.0 0.0 0.2 0.0 2.0 1.4 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 28.2 0.7 48.3 50.2 0.0 0.1 0.0 0.0 6.0 LINS1 "LINS, MRT27, WINS1" ENSG00000140471 "Lines homolog 1" Q8NG48 15 100559369-100603230 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038578, HPA038579" Approved Approved Nucleoplasm NA NA "Cluster 32: T-cells - Unknown function" "Cluster 16: Immune cells - Immune response" "Cluster 21: OE19 - Mitochondria" "Cluster 58: T-cells - T-cell receptor" Nucleoplasm "HPA038578: AB_2676095, HPA038579: AB_10697393" "unprognostic (9.87e-2)" "unprognostic (3.32e-3)" "unprognostic (2.93e-1)" "unprognostic (2.00e-1)" "unprognostic (7.37e-2)" "unprognostic (6.16e-2)" "unprognostic (7.14e-2)" "unprognostic (1.06e-1)" "unprognostic (2.48e-2)" "unprognostic (3.36e-2)" "unprognostic (1.65e-1)" "unprognostic (1.71e-3)" "unprognostic (1.14e-2)" "unprognostic (2.93e-1)" "unprognostic (2.08e-1)" "unprognostic (1.47e-1)" "unprognostic (1.28e-2)" 4.2 4.1 2.5 8.3 2.2 5.7 7.7 3.1 3.3 7.2 2.8 5.8 4.1 6.6 9.4 7.0 5.4 4.4 3.1 2.4 1.7 6.0 5.5 6.2 11.5 1.6 1.4 6.4 5.4 6.1 3.5 6.4 1.8 6.1 7.0 6.6 5.1 4.6 4.3 6.9 4.5 6.2 1.1 8.4 6.3 7.6 2.3 9.1 8.4 5.1 10.0 5.8 4.9 2.8 4.4 6.6 8.2 8.2 5.9 8.0 7.5 6.8 7.6 7.6 8.1 6.2 8.4 11.6 3.9 6.2 5.7 18.5 7.8 8.6 7.9 4.0 11.1 10.4 10.7 4.9 4.9 8.9 6.3 7.7 7.4 5.9 9.4 7.6 9.0 6.4 17.3 9.1 4.7 5.7 5.3 7.6 9.6 16.7 8.1 7.8 13.1 10.8 6.6 11.8 4.2 5.5 6.3 6.1 10.2 10.4 10.3 6.7 6.5 9.5 8.5 6.8 8.9 9.7 13.4 10.5 6.1 11.4 7.7 12.4 7.9 11.7 16.3 7.5 23.9 12.7 25.7 18.1 8.4 11.9 35.0 25.1 10.4 15.0 6.7 6.8 17.6 10.5 2.5 2.2 3.1 3.3 2.4 1.7 1.6 1.4 1.8 1.1 2.3 2.8 7.7 19.2 5.9 0.0 16.6 0.0 9.7 0.0 11.4 16.1 11.3 8.3 0.0 5.7 2.5 12.9 18.8 8.8 20.4 4.9 5.9 5.9 10.8 6.6 11.4 5.7 4.9 11.6 0.0 5.1 5.5 7.2 15.3 6.3 1.3 10.3 7.1 7.6 15.3 16.8 0.0 5.8 0.0 6.0 0.0 1.7 12.2 6.9 0.0 0.0 7.9 9.3 26.8 0.0 0.0 5.4 3.2 7.2 12.5 9.0 10.5 4.7 7.3 16.0 13.1 8.5 5.8 20.7 12.9 9.9 0.0 12.4 29.8 18.9 4.8 7.5 ASB7 ENSG00000183475 "Ankyrin repeat and SOCS box containing 7" Q9H672 15 100602589-100651701 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003300 Approved Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 34: Non-specific - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 59: Non-specific - Transcription" "Golgi apparatus, Vesicles" Nucleoplasm "HPA003300: AB_1845071" "unprognostic (1.38e-1)" "unprognostic (3.48e-2)" "unprognostic (3.91e-2)" "unprognostic (4.65e-2)" "unprognostic (1.37e-1)" "unprognostic (1.82e-1)" "unprognostic (1.20e-1)" "unprognostic (5.55e-2)" "unprognostic (1.34e-1)" "unprognostic (1.55e-2)" "unprognostic (1.51e-2)" "unprognostic (3.14e-2)" "unprognostic (2.18e-2)" "unprognostic (3.09e-2)" "unprognostic (1.10e-1)" "unprognostic (2.17e-1)" "unprognostic (1.46e-2)" 4.6 3.6 4.2 4.5 4.7 12.8 5.1 4.9 4.6 5.2 5.6 6.8 4.6 5.3 6.5 4.6 5.7 3.8 3.9 4.2 4.1 6.7 6.8 4.9 6.3 4.5 4.3 5.7 3.5 6.7 3.1 4.3 4.2 4.7 6.3 4.9 4.5 4.3 3.1 4.4 4.4 6.0 4.2 5.9 4.3 6.8 4.9 7.0 6.2 4.7 6.3 5.1 3.5 5.0 6.7 14.5 6.6 7.9 8.6 9.2 7.5 7.2 13.0 11.8 12.3 8.8 13.2 10.9 6.4 9.2 11.6 14.5 9.2 9.4 12.2 7.6 9.8 14.4 9.0 8.8 13.0 8.6 12.3 8.9 10.3 9.6 15.8 11.4 11.0 11.7 8.6 8.9 6.8 7.2 6.7 8.7 6.3 14.9 6.9 9.0 14.1 9.2 11.8 14.8 6.5 9.2 11.1 10.8 15.0 12.5 7.6 10.7 8.4 10.3 9.5 7.3 10.2 10.6 23.5 10.4 8.0 7.8 8.3 1.2 5.8 10.2 5.2 4.7 4.2 4.3 4.5 6.4 5.1 4.2 6.2 4.4 5.2 4.3 3.1 3.3 5.7 4.8 4.2 4.7 4.9 4.6 4.2 4.1 4.5 4.3 4.2 4.2 4.9 5.0 4.6 0.0 5.4 14.7 6.6 6.5 2.3 3.5 13.1 4.9 6.2 4.1 3.4 12.8 6.4 3.7 6.2 3.8 9.9 12.9 1.9 5.7 4.0 8.1 8.3 6.7 8.4 3.0 20.6 4.9 3.0 4.0 7.1 8.1 10.8 7.3 4.2 8.0 6.0 13.5 15.0 6.2 4.1 7.8 4.3 2.1 5.0 5.2 3.6 20.6 7.8 3.1 6.2 16.6 17.4 6.5 9.7 5.3 4.9 5.5 5.4 7.1 10.3 5.0 0.0 4.3 4.3 9.9 8.2 10.8 4.5 5.9 8.2 6.7 5.8 5.6 ALDH1A3 "ALDH6, RALDH3" ENSG00000184254 "Aldehyde dehydrogenase 1 family member A3" P47895 15 100877714-100916626 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 134.5;urinary bladder: 125.1" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 175.4;Endometrial stromal cells: 247.9;Leydig cells: 194.5;Prostatic glandular cells: 580.3;Urothelial cells: 468.7" "Cancer enriched" "Detected in many" 5 "prostate cancer: 80.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 363.3;HaCaT: 441.7;HBEC3-KT: 1096.9;hTERT-RPE1: 347.7;U-2197: 619.0;U-87 MG: 484.7;WM-115: 516.1" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "olfactory bulb: 4.5;spinal cord: 15.8" "HPA046271, HPA064749" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm Cytosol "HPA046271: AB_10965992, HPA064749: AB_2685344" "unprognostic (6.87e-2)" "unprognostic (2.23e-1)" "unprognostic (6.20e-3)" "unprognostic (1.21e-3)" "unprognostic (1.76e-2)" "unprognostic (1.14e-1)" "unprognostic (6.28e-2)" "unprognostic (5.46e-2)" "unprognostic (9.62e-2)" "unprognostic (4.53e-2)" "unprognostic (3.64e-2)" "unprognostic (2.56e-1)" "unprognostic (1.25e-2)" "unprognostic (2.61e-2)" "unprognostic (2.12e-1)" "unprognostic (7.34e-2)" "unprognostic (6.07e-3)" 83.7 11.4 3.0 41.5 2.7 0.6 30.5 4.7 5.2 37.1 16.2 16.6 15.0 8.2 30.3 28.7 24.9 17.0 12.4 3.1 1.9 8.2 5.3 9.8 3.0 4.8 3.4 6.1 15.0 9.0 7.5 8.4 2.6 134.5 8.9 0.3 93.7 49.3 5.9 3.9 25.2 40.8 2.8 3.1 12.8 16.6 3.3 1.6 2.5 6.9 15.7 125.1 22.3 3.9 363.3 43.5 0.6 0.7 75.0 32.8 1.4 3.2 3.2 1.9 0.8 1.0 285.8 2.6 4.7 97.1 55.7 441.7 8.8 1096.9 6.7 0.1 2.0 1.7 20.1 0.3 25.5 1.4 1.9 23.5 29.8 24.4 4.5 347.7 4.0 0.0 0.7 2.4 1.8 3.8 0.2 1.2 9.0 9.6 316.3 0.7 4.2 2.3 0.2 283.6 0.3 25.4 113.9 94.9 33.3 3.6 9.3 3.2 58.3 0.3 1.0 619.0 14.2 0.7 3.4 1.5 484.7 0.2 516.1 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.0 2.7 4.7 5.2 3.1 1.9 4.8 3.4 2.6 2.8 3.3 3.9 10.0 16.0 6.3 0.3 0.5 0.6 175.4 70.5 4.6 0.0 64.6 18.9 2.0 1.5 141.6 103.0 0.0 9.6 0.9 1.0 3.9 70.5 1.2 20.6 247.9 11.6 3.5 0.0 2.9 1.4 0.5 48.9 1.1 11.7 5.7 0.0 1.8 0.1 1.2 0.0 2.3 2.1 30.5 0.0 1.3 8.5 194.5 3.3 0.0 1.0 0.6 0.0 0.0 36.7 4.6 29.4 0.0 135.4 0.0 580.3 0.1 0.7 78.7 0.0 13.1 20.4 11.5 0.5 0.9 2.9 1.6 4.9 2.0 1.5 0.8 468.7 LRRK1 "FLJ23119, KIAA1790, RIPK6, Roco1" ENSG00000154237 "Leucine rich repeat kinase 1" Q38SD2 15 100919327-101078257 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 64.6;Microglial cells: 107.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebral cortex: 3.6" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-698: 27.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA010537 Uncertain Supported Mitochondria,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 64: Macrophages - Immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Cytosol Mitochondria "HPA010537: AB_1079283" "unprognostic (3.74e-2)" "unprognostic (1.41e-1)" "unprognostic (2.82e-1)" "unprognostic (3.72e-1)" "unprognostic (6.68e-2)" "unprognostic (6.35e-2)" "unprognostic (1.94e-1)" "unprognostic (4.75e-2)" "unprognostic (3.43e-2)" "unprognostic (3.34e-2)" "unprognostic (2.95e-2)" "unprognostic (8.50e-2)" "prognostic unfavorable (5.71e-5)" "unprognostic (2.92e-2)" "unprognostic (1.82e-2)" "unprognostic (3.13e-1)" "unprognostic (5.25e-2)" 2.9 1.0 1.3 5.8 0.5 6.4 2.3 0.0 3.6 3.8 0.0 5.3 3.8 3.8 1.7 4.5 4.9 3.2 1.4 0.8 0.0 0.9 0.8 3.3 7.2 0.0 0.0 3.8 5.9 2.0 0.9 4.1 0.1 4.0 5.1 0.2 3.9 3.5 1.0 4.7 5.0 3.0 0.0 6.2 3.7 5.2 0.0 2.2 1.6 1.3 7.9 2.9 3.0 1.3 4.5 15.3 0.3 0.0 4.9 3.9 1.8 3.7 7.1 2.3 2.0 3.1 7.2 20.2 4.2 6.3 0.0 17.3 5.2 2.8 2.8 3.1 2.8 17.4 12.8 0.0 2.0 5.2 9.0 3.3 4.7 3.0 6.3 2.3 2.4 0.4 3.6 18.4 1.1 0.4 0.0 4.2 1.4 5.1 5.2 2.9 2.0 15.3 0.0 0.6 0.4 3.3 8.8 2.5 6.2 0.4 1.5 4.4 6.3 0.0 3.1 5.2 0.1 15.9 18.2 27.4 1.1 2.1 6.7 0.0 0.4 1.2 0.0 0.1 0.0 1.0 0.0 0.0 0.4 0.4 0.0 0.0 0.3 0.0 0.4 1.3 0.0 0.0 1.3 0.5 0.0 3.6 0.8 0.0 0.0 0.0 0.1 0.0 0.0 1.3 8.3 16.0 13.6 2.9 17.3 3.2 8.0 3.5 7.4 0.9 5.7 5.1 2.9 2.8 6.0 0.0 6.2 9.6 13.6 19.8 0.0 4.5 3.7 12.6 19.4 8.8 13.8 3.4 64.6 3.3 4.2 11.5 3.6 6.6 1.3 1.4 9.7 0.4 10.7 0.0 10.0 11.7 0.0 24.8 10.1 4.6 32.3 19.9 3.6 107.7 28.3 0.6 1.0 12.5 1.2 7.5 11.4 21.4 14.2 10.7 11.6 0.3 6.3 0.7 6.6 11.2 3.9 6.5 1.5 6.6 3.4 3.6 1.3 2.8 12.5 9.9 CHSY1 "CSS1, KIAA0990" ENSG00000131873 "Chondroitin sulfate synthase 1" Q86X52 15 101175727-101252048 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted secreted proteins" Transferase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Karpas-707: 216.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 2: Karpas-707 - Immune response" "Cluster 41: Macrophages - Immune response" "unprognostic (7.28e-2)" "unprognostic (6.39e-2)" "unprognostic (9.24e-2)" "unprognostic (1.55e-1)" "unprognostic (7.60e-2)" "unprognostic (9.51e-3)" "unprognostic (1.46e-1)" "unprognostic (3.02e-3)" "unprognostic (1.77e-1)" "unprognostic (1.32e-2)" "unprognostic (5.97e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (6.33e-5)" "unprognostic (3.44e-2)" "unprognostic (1.02e-1)" "unprognostic (8.91e-3)" "unprognostic (5.58e-3)" 27.5 18.6 10.3 18.5 9.8 23.0 21.7 9.0 11.8 19.5 14.4 7.7 6.0 17.3 9.5 10.8 14.9 22.7 20.1 9.2 10.3 13.7 10.0 23.6 11.6 14.2 13.8 19.7 7.3 7.4 8.5 46.7 11.9 14.4 8.2 7.0 10.1 11.4 6.5 15.0 7.7 20.0 11.5 13.9 10.4 8.7 12.5 10.5 10.0 7.4 10.3 34.8 14.0 9.8 9.1 11.2 36.8 18.7 18.9 25.0 24.5 21.8 19.2 25.8 26.2 9.7 7.1 22.0 12.7 36.3 16.8 24.7 24.5 27.7 28.2 24.6 12.4 43.4 12.2 11.4 23.3 66.9 42.9 23.2 22.8 22.3 20.1 29.3 30.8 9.7 16.2 216.3 19.7 7.9 9.2 46.3 42.5 17.7 7.9 20.6 36.9 32.8 18.1 17.7 6.4 34.6 23.0 11.1 40.8 29.8 12.6 81.6 26.2 41.9 24.1 20.0 46.5 38.2 94.5 12.7 32.5 62.2 32.0 0.0 1.3 2.9 1.5 0.8 1.7 0.9 0.9 1.6 0.8 1.0 0.5 1.0 4.9 0.7 0.9 0.5 1.8 0.6 10.3 9.8 9.0 11.8 9.2 10.3 14.2 13.8 11.9 11.5 12.5 9.8 55.0 0.0 15.7 27.7 11.4 57.9 20.7 10.1 20.5 10.7 41.9 29.8 9.3 5.7 9.4 16.5 6.2 6.1 14.6 1.6 1.9 5.3 1.2 10.0 33.4 45.8 3.0 12.0 34.2 2.2 28.8 40.0 5.1 13.8 25.9 51.9 60.0 5.4 16.6 38.7 36.1 3.6 10.2 17.8 37.1 2.5 55.0 41.2 26.6 59.0 10.2 9.2 10.3 21.1 24.2 5.5 2.5 47.0 9.3 19.3 1.2 2.4 8.1 7.5 46.0 47.9 53.5 3.9 7.5 10.5 62.5 13.8 15.2 23.0 3.9 10.2 SELENOS "AD-015, MGC2553, SBBI8, SELS, SEPS1, VIMP" ENSG00000131871 "Selenoprotein S" Q9BQE4 15 101270817-101277500 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 229.2;Glandular and luminal cells: 211.7;Pancreatic endocrine cells: 226.1;Syncytiotrophoblasts: 303.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "plasmacytoid DC: 606.9" "Lineage enriched" "Detected in all" 5 "dendritic cells: 606.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010025 Approved Enhanced "Endoplasmic reticulum" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 7: Non-specific - Mitochondria" "Endoplasmic reticulum" "HPA010025: AB_1079900" "unprognostic (1.90e-1)" "unprognostic (4.03e-2)" "unprognostic (1.06e-1)" "prognostic favorable (1.33e-4)" "unprognostic (2.42e-2)" "unprognostic (3.74e-3)" "unprognostic (3.18e-2)" "unprognostic (1.98e-1)" "unprognostic (9.83e-2)" "prognostic favorable (5.19e-4)" "unprognostic (2.42e-3)" "unprognostic (4.42e-1)" "unprognostic (1.11e-1)" "unprognostic (1.52e-1)" "unprognostic (1.67e-1)" "unprognostic (1.44e-1)" "unprognostic (2.66e-2)" 65.6 75.4 30.6 48.4 32.8 50.6 55.0 33.8 39.8 50.1 39.7 82.4 80.0 41.9 75.5 55.6 44.6 45.5 66.3 29.8 32.7 48.7 84.7 59.6 49.2 35.2 33.2 41.6 103.7 51.1 44.5 57.6 35.3 53.6 87.2 28.7 73.8 49.1 71.0 48.4 82.2 42.9 33.7 58.7 67.2 92.7 32.4 24.1 55.8 48.7 53.1 60.7 45.3 36.3 45.3 68.8 61.2 54.5 129.8 91.1 52.4 136.4 100.2 89.8 90.2 82.3 105.0 33.6 49.6 117.5 150.8 125.1 66.6 59.7 58.6 63.5 91.8 57.2 62.5 86.8 206.5 43.5 63.9 80.2 166.3 60.3 177.7 70.7 68.1 44.3 58.3 369.0 97.4 71.7 31.7 67.6 46.8 169.9 45.7 41.6 50.1 74.7 90.7 104.2 34.5 88.5 93.0 85.7 193.8 79.9 64.0 96.2 73.6 84.0 57.1 116.4 103.3 272.5 246.3 49.9 92.2 50.8 104.2 134.4 66.4 81.2 94.1 84.0 91.1 62.2 71.4 101.1 58.6 51.4 53.7 79.6 23.1 95.6 100.1 606.9 71.4 63.7 30.6 32.8 33.8 39.8 29.8 32.7 35.2 33.2 35.3 33.7 32.4 36.3 164.0 118.6 108.6 0.0 47.8 0.0 0.0 0.0 0.0 0.0 172.5 129.4 0.0 0.0 64.4 154.5 0.0 125.9 87.7 0.0 31.3 183.9 0.0 127.0 165.2 53.3 0.0 0.0 0.0 189.3 229.2 91.6 0.0 211.7 30.3 53.5 0.0 0.0 120.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.4 0.0 0.0 92.0 0.0 0.0 0.0 0.0 226.1 0.0 0.0 101.0 0.0 0.0 73.0 56.9 0.0 0.0 0.0 78.5 0.0 0.0 0.0 0.0 303.7 40.4 100.9 0.0 0.0 SNRPA1 "Lea1, U2A'" ENSG00000131876 "Small nuclear ribonucleoprotein polypeptide A'" P09661 15 101281510-101295282 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045622, HPA048499" Supported Supported "Nucleoplasm,Nuclear speckles,Nuclear bodies" NA NA 48000 "Cluster 39: Non-specific - mRNA processing" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "Nuclear speckles, Nuclear bodies" "HPA045622: AB_2679394, HPA048499: AB_2680421" "unprognostic (2.73e-1)" "unprognostic (1.48e-1)" "unprognostic (8.09e-2)" "unprognostic (2.20e-1)" "unprognostic (8.08e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (8.56e-5)" "unprognostic (5.80e-2)" "unprognostic (1.66e-3)" "prognostic favorable (8.83e-5)" "unprognostic (4.74e-2)" "unprognostic (6.77e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.06e-2)" "unprognostic (2.84e-1)" "unprognostic (2.43e-1)" "unprognostic (1.37e-2)" 19.0 18.2 11.0 35.5 11.4 68.1 20.8 13.2 15.4 14.7 14.7 30.6 24.3 15.5 33.0 33.8 18.6 12.7 25.8 12.0 11.6 25.2 25.5 19.5 43.3 11.5 11.3 13.6 22.2 18.3 13.9 30.4 11.7 16.3 30.8 15.5 23.1 12.6 19.7 18.5 30.1 19.3 10.9 25.2 23.2 37.8 12.4 37.4 18.3 12.4 51.9 26.3 18.2 12.6 175.5 119.5 112.7 57.4 31.3 25.6 111.3 158.2 72.8 139.2 105.1 255.8 150.7 192.9 89.2 107.8 109.0 101.7 170.2 113.1 148.1 98.0 262.5 151.4 196.7 137.3 24.0 175.1 103.7 21.0 83.0 89.0 111.3 30.9 90.9 147.1 216.1 175.8 86.5 194.6 177.6 185.7 144.5 232.0 100.1 174.5 121.7 194.8 103.3 450.2 88.6 92.7 97.2 109.0 125.1 117.1 105.2 136.4 66.2 74.1 141.0 86.8 160.3 143.5 464.8 378.9 59.9 162.9 89.3 3.8 36.6 21.5 55.7 47.2 55.3 53.0 57.7 56.1 58.0 47.4 46.6 59.0 6.8 48.5 44.0 54.7 68.9 39.0 11.0 11.4 13.2 15.4 12.0 11.6 11.5 11.3 11.7 10.9 12.4 12.6 41.5 19.2 54.6 16.3 71.6 65.6 73.4 141.6 70.6 37.8 41.8 52.6 30.5 18.6 80.3 36.8 12.5 124.3 69.6 37.4 68.4 94.6 96.2 52.7 42.5 47.2 27.0 61.4 30.9 109.0 154.1 51.5 27.0 55.6 65.8 37.7 21.4 35.5 67.0 37.0 29.2 44.2 126.1 24.1 39.2 22.4 34.8 36.4 42.7 13.1 76.4 39.6 47.4 16.6 28.6 95.3 41.8 28.6 76.1 142.3 78.7 87.1 89.2 34.9 13.1 37.9 67.1 192.9 65.9 68.3 50.6 112.3 68.1 42.3 52.4 101.6 PCSK6 "PACE4, SPC4" ENSG00000140479 "Proprotein convertase subtilisin/kexin type 6" P29122 15 101289784-101525202 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 153.6;liver: 160.0;lymphoid tissue: 81.4" "Cell type enhanced" "Detected in many" "Hepatocytes: 231.6;Horizontal cells: 196.9;Oligodendrocytes: 561.9;Theca cells: 106.5" "Cancer enhanced" "Detected in many" "liver cancer: 8.1" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "NK-cell: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 47.2;CACO-2: 35.7;HEK 293: 60.3;Hep G2: 53.8;OE19: 65.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004774 Uncertain "Secreted to extracellular matrix" NA NA 480000 "Cluster 15: NK-cells - Transcription" "Cluster 15: Liver - Metabolism" "Cluster 21: OE19 - Mitochondria" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "HPA004774: AB_1079583" "prognostic favorable (9.99e-4)" "unprognostic (1.09e-1)" "unprognostic (4.37e-2)" "unprognostic (2.46e-2)" "unprognostic (9.83e-2)" "unprognostic (8.14e-2)" "unprognostic (2.20e-3)" "unprognostic (8.56e-2)" "unprognostic (2.16e-1)" "unprognostic (2.39e-2)" "unprognostic (3.85e-3)" "unprognostic (2.01e-1)" "prognostic unfavorable (7.06e-7)" "unprognostic (2.02e-1)" "unprognostic (1.87e-1)" "unprognostic (1.15e-1)" "unprognostic (1.03e-2)" 5.3 2.2 17.5 3.0 67.3 1.1 11.2 57.8 37.0 2.2 4.2 16.5 6.8 2.0 3.3 9.0 2.8 3.1 20.0 19.3 34.1 3.2 160.0 3.6 2.5 113.0 64.5 6.1 2.6 0.6 5.1 32.0 95.6 3.1 14.8 7.6 2.8 0.6 11.4 10.1 10.1 3.6 42.9 81.4 9.8 13.0 54.0 20.9 2.2 16.3 1.8 3.7 2.6 153.6 19.7 14.6 2.6 0.9 0.2 0.4 47.2 0.7 2.5 0.0 0.1 35.7 8.3 0.4 2.4 0.6 1.1 11.4 12.5 1.5 0.0 2.8 60.3 33.5 8.4 53.8 1.6 4.5 0.4 0.3 7.5 0.2 0.2 0.2 0.1 4.3 24.5 0.2 0.0 8.8 0.1 4.7 9.3 65.9 6.5 0.2 0.4 4.4 4.4 25.4 7.3 8.6 26.2 1.5 9.1 6.6 2.2 21.9 0.2 0.3 1.2 0.3 0.2 0.5 0.6 0.7 0.2 0.6 7.3 0.8 0.2 0.9 0.2 0.4 0.3 0.5 0.4 0.2 0.1 1.0 0.6 0.5 0.4 3.3 1.3 0.4 0.1 1.2 17.5 67.3 57.8 37.0 19.3 34.1 113.0 64.5 95.6 42.9 54.0 153.6 1.7 3.2 0.6 2.9 1.3 0.4 0.3 0.9 0.6 1.7 15.4 6.6 2.0 8.6 1.4 1.8 20.9 6.7 0.6 22.6 0.0 0.6 1.6 4.7 21.6 4.9 0.0 3.2 19.4 0.8 24.3 15.5 1.5 6.9 0.0 4.2 12.5 231.6 1.4 196.9 30.8 3.7 0.0 5.2 1.1 2.4 10.5 1.7 0.0 5.6 1.0 1.7 3.1 25.6 561.9 7.3 8.2 0.0 0.0 1.7 2.3 0.1 1.2 1.6 0.0 2.0 1.0 4.7 2.4 0.9 0.1 3.3 1.0 106.5 8.5 0.2 TM2D3 "BLP2, FLJ22604" ENSG00000184277 "TM2 domain containing 3" Q9BRN9 15 101621444-101652391 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054064 Uncertain Approved Nucleoplasm,Cytosol Yes No "Cluster 5: Granulocytes - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm Cytosol "HPA054064: AB_2682366" "unprognostic (1.41e-1)" "unprognostic (8.76e-2)" "unprognostic (2.06e-2)" "unprognostic (2.55e-3)" "unprognostic (1.15e-1)" "unprognostic (8.37e-2)" "unprognostic (2.29e-1)" "unprognostic (8.62e-2)" "unprognostic (2.51e-2)" "unprognostic (5.40e-2)" "unprognostic (4.09e-2)" "unprognostic (1.06e-1)" "unprognostic (3.14e-2)" "unprognostic (2.92e-2)" "unprognostic (2.63e-1)" "unprognostic (3.78e-2)" "unprognostic (2.78e-2)" 32.2 38.3 58.9 23.5 62.8 28.2 33.9 57.0 74.7 36.7 51.4 31.1 24.6 40.8 43.5 23.9 34.2 29.6 47.8 62.0 70.1 32.2 58.1 28.1 30.5 54.9 58.7 55.7 30.3 40.6 35.7 31.7 58.5 32.7 24.2 32.3 34.4 35.3 44.5 27.0 26.2 32.1 55.9 29.2 29.1 28.0 61.1 29.5 45.2 55.7 31.7 32.8 28.5 58.0 20.1 48.9 25.6 46.6 71.9 53.1 31.3 25.9 42.6 30.0 33.4 26.4 55.5 32.5 34.9 35.5 50.7 45.9 40.3 33.3 23.7 31.2 88.4 48.7 39.9 45.4 47.2 38.4 55.8 44.2 66.3 18.1 37.4 42.1 42.1 41.5 40.6 47.8 47.9 40.8 28.3 40.2 39.5 90.4 16.2 33.9 32.3 51.0 61.5 52.0 34.3 31.3 35.8 37.4 54.3 43.7 35.5 49.8 33.7 31.6 32.5 21.2 28.9 45.0 71.2 35.3 26.9 47.5 26.7 36.4 40.6 81.9 41.2 41.9 46.4 30.6 33.6 31.6 29.1 44.8 44.1 41.4 69.6 52.4 32.4 24.6 38.4 41.3 58.9 62.8 57.0 74.7 62.0 70.1 54.9 58.7 58.5 55.9 61.1 58.0 52.4 25.6 28.7 22.2 55.8 66.3 58.5 142.3 32.5 47.1 42.6 45.8 35.7 35.8 67.9 42.3 33.3 73.7 51.9 23.0 19.6 61.0 8.0 28.1 38.2 48.8 27.0 30.3 41.5 42.3 64.7 53.7 23.0 44.8 25.3 37.6 60.3 56.6 32.3 69.0 55.3 23.2 91.6 42.1 36.4 10.8 73.7 39.2 26.6 37.5 44.4 60.6 56.7 29.1 45.8 27.8 20.7 62.8 41.3 66.6 32.6 39.5 47.2 46.8 72.3 40.1 67.0 89.3 84.2 25.0 55.4 91.0 55.1 21.5 27.8 40.0 TARS3 "FLJ25005, TARSL2, ThrRS-L" ENSG00000185418 "Threonyl-tRNA synthetase 3" A2RTX5 15 101653596-101724473 "Enzymes, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 33.8;skeletal muscle: 38.5;tongue: 36.7" "Cell type enhanced" "Detected in some" "Adipocytes: 7.7;B-cells: 9.5;Cardiomyocytes: 41.0;dendritic cells: 27.6;Plasma cells: 19.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066697 Enhanced Approved Cytosol NA NA "Cluster 37: B-cells - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 24: Non-specific - Transcription regulation" Cytosol "HPA066697: AB_2685705" "unprognostic (9.33e-3)" "unprognostic (2.13e-2)" "unprognostic (1.88e-1)" "unprognostic (2.54e-1)" "unprognostic (8.44e-2)" "unprognostic (1.92e-1)" "unprognostic (8.45e-2)" "unprognostic (3.40e-2)" "unprognostic (3.24e-2)" "unprognostic (7.77e-2)" "unprognostic (2.26e-3)" "unprognostic (9.76e-3)" "unprognostic (4.00e-2)" "unprognostic (2.23e-1)" "unprognostic (7.52e-2)" "unprognostic (6.48e-3)" "unprognostic (2.79e-2)" 4.9 4.2 16.1 4.1 24.8 3.1 4.6 20.1 21.1 6.4 9.0 7.9 3.8 4.3 3.5 3.8 5.2 3.4 15.2 14.7 18.4 5.2 3.6 3.7 4.7 20.0 19.8 6.9 6.4 7.5 6.3 1.9 20.2 5.7 3.7 6.2 4.9 5.9 38.5 3.3 6.2 4.2 17.5 4.4 5.7 3.5 19.1 4.2 6.2 36.7 4.7 6.9 4.6 33.8 2.5 4.6 7.9 4.3 8.4 6.4 3.9 8.6 5.8 6.5 4.0 6.8 2.2 3.3 3.3 10.3 5.3 7.6 13.8 4.9 6.0 3.8 22.0 8.1 2.9 5.5 3.9 3.8 1.7 4.5 4.6 3.2 3.7 7.7 4.7 7.0 8.0 6.9 6.6 4.3 2.0 7.4 9.5 12.5 3.3 4.1 12.0 8.6 5.7 2.7 12.5 8.2 11.5 4.5 5.1 14.5 2.9 8.0 6.4 3.2 7.4 6.4 2.8 9.6 11.5 4.1 8.2 6.6 5.9 0.8 1.0 1.5 2.7 1.5 2.7 4.9 5.0 4.3 0.7 7.5 4.9 2.6 0.2 7.9 0.7 1.7 0.9 1.1 16.1 24.8 20.1 21.1 14.7 18.4 20.0 19.8 20.2 17.5 19.1 33.8 7.7 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.0 0.0 0.0 0.0 0.0 3.3 27.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 5.8 5.4 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 4.2 7.3 0.0 0.0 0.0 OR4F6 OR4F12 ENSG00000184140 "Olfactory receptor family 4 subfamily F member 6" Q8NGB9 15 101803509-101806887 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4F15 ENSG00000182854 "Olfactory receptor family 4 subfamily F member 15" Q8NGB8 15 101812202-101820197 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.2 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR4F4 OR4F18 ENSG00000177693 "Olfactory receptor family 4 subfamily F member 4" Q96R69 15 101922042-101923113 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Evidence at transcript level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0